FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ridwan-Pramana, A
   Wolff, J
   Raziei, A
   Ashton-James, CE
   Forouzanfar, T
AF Ridwan-Pramana, Angela
   Wolff, Jan
   Raziei, Ashkan
   Ashton-James, Claire E.
   Forouzanfar, Tymour
TI Porous polyethylene implants in facial reconstruction: Outcome and
   complications
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Porous polyethylene; Medpor (R); Craniofacial reconstruction;
   Complication
ID ORBITAL FLOOR RECONSTRUCTION; CRANIOFACIAL RECONSTRUCTION; FRACTURES;
   BONE; POLYETHERETHERKETONE; DEFECTS; AUGMENTATION; CRANIOPLASTY;
   DEFORMITIES; INFECTION
AB The aim of the present study was to assess the indications, results and complications of patients treated with porous polyethylene (Medpor (R)) implants in the Department of Oral and Maxillofacial Surgery of VU Medical Centre, Amsterdam over 17 years. A total of 69 high-density porous polyethylene implants (Medpore (R) Biomaterial; Porex Surgical, Newman, GA) were used in forty patients (22 males, 18 females). All patients were analysed for gender, age, diagnosis, indications for surgery, follow-up period and postoperative complications. A mean age of 34.1 years was observed. The main reason for implant surgery was post-traumatic functional impairment (27.5%). Most implants were placed at the mandibular angel and the orbital floor. Unsatisfactory appearance scored the highest in postoperative complications (10.1%) followed by infection rate (7.2%). Comparing the number of implants placed over the years and the incidence of complications, makes the overall complications rate of porous polyethylene very low. A consensus about antibiotic prophylaxis is needed. The objective measurements in patient satisfaction and proper implant design would be of great use. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Ridwan-Pramana, Angela; Wolff, Jan; Raziei, Ashkan; Ashton-James, Claire E.; Forouzanfar, Tymour] Vrije Univ Amsterdam, Dept Oral & Maxillofacial Surg Oral Pathol, Med Ctr, NL-1081 HV Amsterdam, Netherlands.
   [Ridwan-Pramana, Angela] Ctr Special Care Dent, Dept Maxillofacial Prosthodont, Amsterdam, Netherlands.
   [Ridwan-Pramana, Angela; Wolff, Jan; Forouzanfar, Tymour] Vrije Univ Amsterdam, Med Ctr, Innovat Lab 3D, NL-1081 HV Amsterdam, Netherlands.
   [Raziei, Ashkan; Ashton-James, Claire E.] Acad Ctr Dent Amsterdam ACTA, NL-1066 EA Amsterdam, Netherlands.
RP Ridwan-Pramana, A (reprint author), Vrije Univ Amsterdam, Dept Oral & Maxillofacial Surg Oral Pathol, Med Ctr, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.
EM a.ridwan@vumc.nl
CR Aldekhayel S, 2014, J CRANIOFAC SURG, V25, P258, DOI 10.1097/SCS.0000000000000441
   Baumann A, 2002, INT J ORAL MAX SURG, V31, P367, DOI 10.1054/ijom.2001.0219
   Carboni A, 2002, EUR J PLAST SURG, V25, P310, DOI DOI 10.1007/S00238-002-0407-3
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Draenert GF, 2008, ACTA BIOMATER, V5, P1158
   Eski M, 2007, J CRANIOFAC SURG, V18, P520, DOI 10.1097/scs.0b013e318053432c
   Frodel JL, 1998, ARCH OTOLARYNGOL, V124, P1219, DOI 10.1001/archotol.124.11.1219
   Gosau M, 2008, J BIOMED MATER RES B, V87B, P83, DOI 10.1002/jbm.b.31072
   Gosau M, 2011, CLIN ORAL INVEST, V15, P305, DOI 10.1007/s00784-010-0385-y
   Guevara-Rojas G, 2014, J ORAL MAXIL SURG, V72, P1801, DOI 10.1016/j.joms.2014.02.013
   Hollier LH, 2001, J CRANIOFAC SURG, V12, P242, DOI 10.1097/00001665-200105000-00009
   Kim HS, 2014, YONSEI MED J, V55, P1617, DOI 10.3349/ymj.2014.55.6.1617
   Kim MM, 2009, ARCH FACIAL PLAST S, V11, P53, DOI 10.1001/archfaci.11.1.53
   Lethaus B, 2014, J CRANIOFAC SURG, V25, P206, DOI 10.1097/SCS.0000000000000396
   Lethaus B, 2011, J CRANIO MAXILL SURG, V39, P435, DOI 10.1016/j.jcms.2010.10.003
   Lin IC, 2007, J FORMOS MED ASSOC, V106, P51, DOI 10.1016/S0929-6646(09)60216-3
   MAAS CS, 1990, ARCH OTOLARYNGOL, V116, P551
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   Niechajev I, 2012, AESTHET PLAST SURG, V36, P917, DOI 10.1007/s00266-012-9911-4
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   O'Connell JE, 2015, J CRANIO MAXILL SURG, V43, P192, DOI 10.1016/j.jcms.2014.11.001
   Ozturk S, 2005, J CRANIOFAC SURG, V16, P973, DOI 10.1097/01.scs.0000179744.91165.3a
   Ram H, 2010, J MAXILLOFAC ORAL SU, V9, P134, DOI 10.1007/s12663-010-0047-2
   RUBIN PAD, 1994, OPHTHALMOLOGY, V101, P1697
   Rudman K, 2011, FACIAL PLAST SURG, V27, P358, DOI 10.1055/s-0031-1283054
   Sclafani AP, 1997, ARCH OTOLARYNGOL, V123, P328
   Scolozzi P, 2007, J CRANIOFAC SURG, V18, P224, DOI 10.1097/01.scs.0000249359.56417.7e
   Tsouknidas A, 2011, BIO-MED MATER ENG, V21, P139, DOI 10.3233/BME-2011-0663
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P877, DOI 10.1097/00006534-200203000-00007
   Yang Ng Zhi, 2014, J CRANIOFAC SURG, V25, P55
NR 31
TC 14
Z9 14
U1 3
U2 11
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD OCT
PY 2015
VL 43
IS 8
BP 1330
EP 1334
DI 10.1016/j.jcms.2015.06.022
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA CT2AI
UT WOS:000362604000003
PM 26276064
DA 2018-10-20
ER

PT J
AU Erisken, C
   Kalyon, DM
   Zhou, J
   Kim, SG
   Mao, JJ
AF Erisken, Cevat
   Kalyon, Dilhan M.
   Zhou, Jian
   Kim, Sahng G.
   Mao, Jeremy J.
TI Viscoelastic Properties of Dental Pulp Tissue and Ramifications on
   Biomaterial Development for Pulp Regeneration
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Biomaterial; compression; pulp; regeneration; tooth; viscoelastic
ID ARTICULAR-CARTILAGE; ALGINATE HYDROGELS; ENGINEERING APPLICATIONS;
   EXTRACELLULAR MATRICES; MECHANICAL-PROPERTIES; STROMAL CELLS;
   STEM-CELLS; IN-VITRO; COLLAGEN; SCAFFOLD
AB Introduction: A critical step in biomaterial selection effort is the determination of material as well as the biological properties of the target tissue. Previously, the selection of biomaterials and carriers for dental pulp regeneration has been solely based on empirical experience. Methods: In this study, first, the linear, viscoelastic material functions and compressive properties of miniature pig dental pulp were characterized using small-amplitude oscillatory shear and uniaxial compression at a constant rate. They were then compared with the properties of hydrogels (ie, agarose, alginate, and collagen) that are widely used in tissue regeneration. Results: The comparisons of the linear viscoelastic material functions of the native pulp tissue with those of the 3 hydrogels revealed the gel-like behavior of the pulp tissue over a relatively large range of time scales (ie, over the frequency range of 0.1-100 rps). At the constant gelation agent concentration of 2%, the dynamic properties (ie, storage and loss moduli and the tan delta) of the collagen-based gel approached those of the native tissue. Under uniaxial compression, the peak normal stresses and compressive moduli of the agarose gel were similar to those of the native tissue, whereas alginate and collagen exhibited significantly lower compressive properties. Conclusions: The linear viscoelastic and uniaxial compressive properties of the dental pulp tissue reported here should enable the more appropriate selection of biogels for dental pulp regeneration via the better tailoring of gelation agents and their concentrations to better mimic the dynamic and compressive properties of native pulp tissue.
C1 [Erisken, Cevat] TOBB Univ Econ & Technol, Dept Biomed Engn, TR-06560 Ankara, Turkey.
   [Erisken, Cevat; Zhou, Jian; Kim, Sahng G.; Mao, Jeremy J.] Columbia Univ, Med Ctr, Ctr Craniofacial Regenerat, New York, NY USA.
   [Kalyon, Dilhan M.] Stevens Inst Technol, Highly Filled Mat Inst, Hoboken, NJ 07030 USA.
RP Erisken, C (reprint author), TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
EM cerisken@etu.edu.tr
RI Erisken, Cevat/P-7850-2014
OI Erisken, Cevat/0000-0002-6337-8022; Kalyon, Dilhan/0000-0003-2066-0359
CR Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Cameron AR, 2014, BIOMATERIALS, V35, P1857, DOI 10.1016/j.biomaterials.2013.11.023
   Cao Y, 2014, ACS APPL MATER INTER, V6, P410, DOI 10.1021/am4044823
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Dobie K, 2002, CONNECT TISSUE RES, V43, P387, DOI 10.1080/03008200290000574
   Ergun A, 2012, TISSUE ENG PT A, V18, P2426, DOI [10.1089/ten.tea.2011.0625, 10.1089/ten.TEA.2011.0625]
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]
   Erisken C, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001884
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103
   Hargreaves KM, 2008, J ENDODONT, V34, pS51, DOI 10.1016/j.joen.2008.02.032
   HAYES WC, 1978, J BIOMECH, V11, P407, DOI 10.1016/0021-9290(78)90075-1
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518
   Ji J, 2014, CELL TISSUE RES, V358, P123, DOI 10.1007/s00441-014-1907-8
   Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kuo TF, 2008, J BIOMED MATER RES A, V86A, P1062, DOI 10.1002/jbm.a.31.746
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LINDE A, 1970, ARCH ORAL BIOL, V15, P1035, DOI 10.1016/0003-9969(70)90116-0
   Mintz BR, 2014, J BIOMED MATER RES A, V102, P2918, DOI 10.1002/jbm.a.34957
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x
   SPIRT AA, 1989, J ORTHOP RES, V7, P43, DOI 10.1002/jor.1100070107
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Xu B, 2013, BIOMATTER, V3, pe4651
   Yuan ZL, 2011, TISSUE ENG PART B-RE, V17, P373, DOI [10.1089/ten.TEB.2011.0041, 10.1089/ten.teb.2011.0041]
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 35
TC 4
Z9 4
U1 1
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
EI 1878-3554
J9 J ENDODONT
JI J. Endod.
PD OCT
PY 2015
VL 41
IS 10
BP 1711
EP 1717
DI 10.1016/j.joen.2015.07.005
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CS9CG
UT WOS:000362386100022
PM 26321063
DA 2018-10-20
ER

PT J
AU de Santana, JF
   Pilla, V
   Silva, ACA
   Dantas, NO
   Messias, DN
   Andrade, AA
AF de Santana, Juliana F.
   Pilla, Viviane
   Silva, Anielle C. A.
   Dantas, Noelio O.
   Messias, Djalmir N.
   Andrade, Acacio A.
TI Optical characterization of core-shell quantum dots embedded in
   synthetic saliva: Temporal dynamics
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Quantum dots; Saliva; Fluorescence; Radiative quantum efficiency;
   Thermal lens
ID THERMAL LENS SPECTROMETRY; CDSE; NANOCRYSTALS; LUMINESCENCE;
   DIAGNOSTICS; DEPENDENCE; EFFICIENCY; EMISSION; CARBOXYL; CELLS
AB The present work reports the spectroscopic and thermo-optical properties of CdSe/ZnS and CdSe/CdS core-shell quantum dots (QDs) embedded in synthetic saliva. Spectroscopy studies were performed applying nonfunctionalized CdSe/ZnS QDs (3.4, 3.9 and 5.1 nm cores) and hydroxyl group-functionalized ultrasmall CdSe/CdS core-shell quantum dots (1.6 nm core) suspended in artificial saliva at different potential of hydrogen (pH) values. Saliva was chosen because it is important in a variety of functions such as protecting teeth through the buffering capacity of the formed biofilm, hydration, and dental remineralization. Thermo-optical characterizations using the thermal lens (TL) technique were performed in QD-biofluids for different QD sizes and pH values (3.9-8.3) of the synthetic oral fluids. Transient TL measurements were applied to determine the fluorescence quantum efficiency (eta) in QD-biomaterial systems. High eta value was obtained for ultrasmall CdSe/CdS QDs. Fluorescence spectral measurements of the biomaterials support the TL results. In addition, for nonfunctionalized (3.4 and 5.1 nm) and hydroxyl group-functionalized QDs, the temporal behavior of the fluorescence spectra was accomplished about approximately 1200 h at two different biofluid pH values (3.9 and 8.3). The temporal fluorescence intensity result is dependent on the pH of the saliva in which the QDs were embedded, QD functionalization and QD sizes. The time for an approximately 50% decrease in the peak intensity fluorescence of CdSe/ZnS QDs (3.4 nm core) and ultrasmall CdSe/CdS QDs is respectively 25 h and 312 h at pH 3.9 and 48 h and 360 h at pH 8.3. (C) 2015 Elsevier B.V. All rights reserved.
C1 [de Santana, Juliana F.; Pilla, Viviane; Messias, Djalmir N.; Andrade, Acacio A.] Univ Fed Uberlandia, Inst Fis, GPOTM, BR-38400902 Uberlandia, MG, Brazil.
   [Silva, Anielle C. A.; Dantas, Noelio O.] Univ Fed Uberlandia, Inst Fis, LNMIS, BR-38400902 Uberlandia, MG, Brazil.
RP Pilla, V (reprint author), Univ Fed Uberlandia, Inst Fis, GPOTM, Ave Joao Naves de Avila 2121, BR-38400902 Uberlandia, MG, Brazil.
EM vivianepilla@infis.ufu.br
RI Almeida Silva, Anielle Christine/D-8300-2015; Andrade,
   Acacio/N-3905-2017; MESSIAS, DJALMIR/G-1699-2014
OI Andrade, Acacio/0000-0001-6815-2842; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq
   [479084/2013-0, 305425/2012-9, 473951/2010-0]; Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais FAPEMIG [APQ-00360-14, APQ-00576-11];
   Rede NANOBIOTEC BRAZIL
FX This research was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico CNPq (Proc. 479084/2013-0, 305425/2012-9,
   473951/2010-0), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   FAPEMIG (Proc. APQ-00360-14, APQ-00576-11) and Rede NANOBIOTEC BRAZIL.
   We are also grateful for the use of the Cary Eclipse spectrophotometer
   (Varian) provided by NANOBIOTEC BRAZIL.
CR Silva ACA, 2014, SENSOR ACTUAT B-CHEM, V191, P108, DOI 10.1016/j.snb.2013.09.063
   Amerongen AV, 2007, ANN NY ACAD SCI, V1098, P1, DOI 10.1196/annals.1384.033
   Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598
   Brochard P, 1997, J OPT SOC AM B, V14, P405, DOI 10.1364/JOSAB.14.000405
   Castagnola M, 2011, ACTA OTORHINOLARYNGO, V31, P347
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72
   Georges J, 1999, ANAL CHIM ACTA, V386, P287, DOI 10.1016/S0003-2670(99)00046-X
   Gerdova I, 2005, OPT COMMUN, V246, P205, DOI 10.1016/j.optcom.2004.10.068
   GORDON JP, 1965, J APPL PHYS, V36, P3, DOI 10.1063/1.1713919
   Huang CP, 2008, J NANOSCI NANOTECHNO, V8, P3434, DOI 10.1166/jnn.2008.111
   Huang CP, 2007, BIOSENS BIOELECTRON, V22, P1835, DOI 10.1016/j.bios.2006.09.003
   Jasieniak J, 2007, ADV FUNCT MATER, V17, P1654, DOI 10.1002/adfm.200600955
   JUN S, 1992, CHEM PHYS, V165, P385, DOI 10.1016/0301-0104(92)87053-C
   Kang M.S., 2013, CHONNAM MED J, V49, P75
   Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209
   Kim S, 2003, J AM CHEM SOC, V125, P11466, DOI 10.1021/ja0361749
   Klimov VI, 2003, LOS ALAMOS SCI, V28, P214
   KORTAN AR, 1990, J AM CHEM SOC, V112, P1327, DOI 10.1021/ja00160a005
   Lima SM, 2000, J NON-CRYST SOLIDS, V273, P215, DOI 10.1016/S0022-3093(00)00169-1
   Mittal S, 2011, J CLIN EXP DENT, V3, pe314, DOI DOI 10.4317/JCED.3.E314
   Molnar M, 2011, SENSOR ACTUAT B-CHEM, V155, P823, DOI 10.1016/j.snb.2011.01.055
   NIRMAL M, 1994, PHYS REV B, V50, P2293, DOI 10.1103/PhysRevB.50.2293
   Norris DJ, 1996, PHYS REV B, V53, P16338, DOI 10.1103/PhysRevB.53.16338
   OMullane D. W., 1990, ROLE SALIVA DEMINERA, P19
   Parak WJ, 2005, NANOTECHNOLOGY, V16, pR9, DOI 10.1088/0957-4484/16/2/R01
   Pilla V., 2012, QUANTUM DOTS VARIETY, P3, DOI [10.5772/2645, DOI 10.5772/2645]
   Pilla V, 2013, APPL SPECTROSC, V67, P997, DOI 10.1366/12-06836
   Pilla V, 2013, CHEM PHYS LETT, V580, P130, DOI 10.1016/j.cplett.2013.07.007
   Pilla V, 2012, J APPL PHYS, V112, DOI 10.1063/1.4767470
   Pilla V, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1147-3
   Pilla V, 2008, OPT COMMUN, V281, P5925, DOI 10.1016/j.optcom.2008.09.004
   Pilla V, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/10/105201
   Qian J, 2007, J PHYS CHEM B, V111, P6969, DOI 10.1021/jp070620n
   Qian J, 2010, J NANOSCI NANOTECHNO, V10, P1668, DOI 10.1166/jnn.2010.2043
   Ruedas-Rama MJ, 2011, CHEM COMMUN, V47, P2898, DOI 10.1039/c0cc05252c
   Salata O.V., 2004, J NANOBIOTECHNOL, V2, P3, DOI DOI 10.1186/1477-3155-2-3
   Schartl W, 2009, J LUMIN, V129, P1428, DOI 10.1016/j.jlumin.2009.03.028
   Sewall SL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235328
   Silva ACA, 2014, ACS NANO, V8, P1913, DOI 10.1021/nn406478f
   SNOOK RD, 1995, ANALYST, V120, P2051, DOI 10.1039/an9952002051
   Sounderyal N., 2008, RECENT PAT BIOMED EN, V1, P34
   SPANHEL L, 1987, J AM CHEM SOC, V109, P5649, DOI 10.1021/ja00253a015
   Szabadvary F., 1964, J CHEM EDUC, V41, P105
   Valerini D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235409
   Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180
   Wu ZY, 2009, J LUMIN, V129, P1125, DOI 10.1016/j.jlumin.2009.05.014
   Yu WW, 2006, BIOCHEM BIOPH RES CO, V348, P781, DOI 10.1016/j.bbrc.2006.07.160
   Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k
   Zhang AH, 2012, J PROTEOMICS, V75, P1079, DOI 10.1016/j.jprot.2011.10.027
   Zou W, 2011, POLYMER, V52, P1938, DOI 10.1016/j.polymer.2011.02.043
NR 51
TC 1
Z9 1
U1 2
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD OCT
PY 2015
VL 151
BP 208
EP 212
DI 10.1016/j.jphotobiol.2015.08.016
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CT2BT
UT WOS:000362607700028
PM 26313857
DA 2018-10-20
ER

PT J
AU Lee, S
   Maeda, H
   Obata, A
   Ueda, K
   Narushima, T
   Kasuga, T
AF Lee, Sungho
   Maeda, Hirotaka
   Obata, Akiko
   Ueda, Kyosuke
   Narushima, Takayuki
   Kasuga, Toshihiro
TI Structure and dissolution behavior of MgO-P2O5-TiO2/Nb2O5 (Mg/P >= 1)
   invert glasses
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Biomaterial; Phosphate glass; Invert glass; Magnesium; Niobium;
   Titanium; Structure
ID MAGNESIUM PHOSPHATE-GLASSES; X-RAY-DIFFRACTION; ULTRAPHOSPHATE GLASSES;
   OPTICAL-PROPERTIES; SYSTEM; ZINC; RANGE; IONS; MGO; DEGRADATION
AB Magnesium phosphate glasses exhibit unusual properties and were classified as 'anomalous phosphate glasses', because magnesium is attributed to a variation of the oxygen coordination number from 6 to 4. Magnesium in phosphate glasses acts as an intermediate oxide and its role was determined, relating to the phosphate chain length. In the present work, MgO-P2O5-TiO2/Nb2O5 glasses with Mg/P ratio between 1.00 and 1.36 were successfully prepared by a melt-quenching method. Magnesium in the glasses worked as a network former to form P-O-Mg bonds, which are cross-linked short phosphate chains that improved the glass-forming ability. Intermediate oxides (i.e., TiO2 and Nb2O5) in the glasses also cross-linked short phosphate chains to form P-O-Ti/Nb bonds. The chemical durability of the glasses decreased with an increase in the Mg/P ratio, because magnesium, which entered the phosphate network, weakened the glass network to induce hydrolysis. The dissolution rate of Ti4+ and Nb5+ ions showed a decreasing tendency with an increase in the Mg/P ratio. The surfaces of the glasses were considered to be covered with gel-like oxide layers containing titanium or niobium and phosphate.
C1 [Lee, Sungho; Maeda, Hirotaka; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.
   [Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Met Mat Sci & Mat Proc, Aoba Ku, Sendai, Miyagi 9808579, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
RI Lee, Sungho/T-1734-2017
OI Lee, Sungho/0000-0002-4367-9573
FU JSPS KAKENHI [25249094, 26289238, 267992]
FX This work was supported in part by JSPS KAKENHI Grant Numbers 25249094,
   26289238, and 267992.
CR Ahmed I, 2010, J BIOMATER APPL, V24, P555, DOI 10.1177/0885328209102761
   Brauer DS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0647
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Brow RK, 1997, PHYS CHEM GLASSES, V38, P300
   Chu CM, 2011, J NON-CRYST SOLIDS, V357, P939, DOI 10.1016/j.jnoncrysol.2010.12.009
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   ELJAZOULI A, 1988, J SOLID STATE CHEM, V73, P433, DOI 10.1016/0022-4596(88)90129-6
   Fayon F, 2001, J NON-CRYST SOLIDS, V283, P88, DOI 10.1016/S0022-3093(01)00357-X
   Flambard A, 2008, J NON-CRYST SOLIDS, V354, P3540, DOI 10.1016/j.jnoncrysol.2008.03.017
   Franks K, 2002, J MATER SCI-MATER M, V13, P549, DOI 10.1023/A:1015122709576
   HOPPE U, 1992, PHYS CHEM GLASSES, V33, P216
   HOPPE U, 1995, J NON-CRYST SOLIDS, V193, P28, DOI 10.1016/0022-3093(95)00325-8
   Hsu SM, 2012, J NON-CRYST SOLIDS, V358, P14, DOI 10.1016/j.jnoncrysol.2011.08.006
   KANAZAWA T, 1982, J NON-CRYST SOLIDS, V52, P187, DOI 10.1016/0022-3093(82)90293-9
   Karakassides MA, 2004, J NON-CRYST SOLIDS, V347, P69, DOI 10.1016/j.jnoncrysol.2004.08.111
   Kasuga Toshihiro, 2012, Phosphorus Research Bulletin, V26, P8
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   Khor SF, 2013, OPT MATER, V35, P629, DOI 10.1016/j.optmat.2012.10.013
   Khor SF, 2011, J MATER SCI, V46, P7895, DOI 10.1007/s10853-011-5777-0
   KORDES E, 1953, Z ELEKTROCHEM, V57, P282
   Lee IH, 2013, J NON-CRYST SOLIDS, V363, P57, DOI 10.1016/j.jnoncrysol.2012.11.036
   Lee S., 2010, BIOCERAM DEV APPL, V1, P1, DOI DOI 10.4303/BDA/D110148
   Lee S, 2009, J CERAM SOC JPN, V117, P935, DOI 10.2109/jcersj2.117.935
   Li YB, 2008, PHYS CHEM GLASSES-B, V49, P41
   Maeda H, 2014, J CERAM SOC JPN, V122, P122, DOI 10.2109/jcersj2.122.122
   MATSUBARA E, 1988, J NON-CRYST SOLIDS, V103, P117, DOI 10.1016/0022-3093(88)90423-1
   Mazali IO, 2004, J MATER SCI, V39, P1987, DOI 10.1023/B:JMSC.0000017760.85512.60
   Meyer K, 2001, PHYS CHEM GLASSES, V42, P79
   Morikawa H, 2013, J NON-CRYST SOLIDS, V380, P53, DOI 10.1016/j.jnoncrysol.2013.08.029
   Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   OKURA T, 1988, PHYS CHEM GLASSES, V29, P13
   Omrani RO, 2015, J ALLOY COMPD, V632, P766, DOI 10.1016/j.jallcom.2015.01.297
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004
   SAKKA S, 1989, J NON-CRYST SOLIDS, V112, P64, DOI 10.1016/0022-3093(89)90494-8
   Segawa H, 2010, J CERAM SOC JPN, V118, P278, DOI 10.2109/jcersj2.118.278
   Sene FF, 2004, J NON-CRYST SOLIDS, V348, P30, DOI 10.1016/j.jnoncrysol.2004.08.122
   Smith CE, 2014, J NON-CRYST SOLIDS, V390, P51, DOI 10.1016/j.jnoncrysol.2014.02.010
   Suzuya K, 1999, J PHYS CHEM SOLIDS, V60, P1457, DOI 10.1016/S0022-3697(99)00140-7
   TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6
   Kyosuke U, 2007, MATER TRANS, V48, P307, DOI 10.2320/matertrans.48.307
   WALTER G, 1994, PHYS CHEM GLASSES, V35, P245
   Walter G, 2003, J NON-CRYST SOLIDS, V320, P210, DOI 10.1016/S0022-3093(03)00016-4
   Walter G, 2001, J NON-CRYST SOLIDS, V296, P212, DOI 10.1016/S0022-3093(01)00912-7
   WALTER G, 1990, PHYS CHEM GLASSES, V31, P188
   Watts SJ, 2010, J NON-CRYST SOLIDS, V356, P517, DOI 10.1016/j.jnoncrysol.2009.04.074
   Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
NR 51
TC 5
Z9 5
U1 0
U2 7
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD OCT
PY 2015
VL 123
IS 1442
BP 942
EP 948
DI 10.2109/jcersj2.123.942
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CT0SH
UT WOS:000362506300003
OA Bronze
DA 2018-10-20
ER

PT J
AU Rosalbino, F
   Maccio, D
   Scavino, G
   Saccone, A
AF Rosalbino, F.
   Maccio, D.
   Scavino, G.
   Saccone, A.
TI Corrosion behavior of new ternary zirconium alloys as alternative
   materials for biomedical applications
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID ANODIC-OXIDE-FILMS; IN-VITRO CORROSION; TITANIUM-ALLOYS;
   ELECTROCHEMICAL-BEHAVIOR; METALLIC BIOMATERIALS; MECHANICAL-PROPERTIES;
   TI-13NB-13ZR ALLOYS; VALVE METALS; MO ALLOYS; TI
AB The in vitro corrosion behavior of four Zr-based alloys (Zr97.5Nb1.5VM1.0; VM = valve metal: Ti, Mo, W, Ta; at%) to be used as implant materials has been assessed and compared with that of Grade 2 Ti, which is known to be a highly compatible metal standard. Corrosion resistance was investigated by open circuit potential and electrochemical impedance spectroscopy (EIS) measurements, as a function of exposure time to an artificial physiological environment (Ringer's solution). Open circuit potential values indicated that Zr-based alloys and Grade 2 Ti undergo spontaneous passivation due to spontaneously formed oxide film passivating the metallic surface, in the simulated aggressive environment. It also indicated that the tendency for the formation of a spontaneous oxide is greater for the Zr97.5Nb1.5Ta1.0 alloy and that this oxide has better corrosion protection characteristics than the ones formed on Grade 2 Ti or on Zr97.5Nb1.5Ti1.0, Zr97.5Nb1.5Mo1.0, and Zr97.5Nb1.5W1.0 alloys. EIS study showed high impedance values for all samples, increasing with exposure time, indicating an improvement in corrosion resistance of the spontaneous oxide film. The fit obtained suggests a single passive film present on the metals surface, improving their resistance with exposure time, presenting the highest values to the Zr97.5Nb1.5Ta1.0 alloy. All these electrochemical results suggest that Zr97.5Nb1.5VM1.0 alloys are promising materials for osteo-synthesis prosthetic devices, since corrosion stability is directly associated with biocompatibility and is a necessary condition for applying a material as biomaterial.
C1 [Rosalbino, F.; Scavino, G.] Politecn Torino, Dipartimento Sci Appl & Tecnol DISAT, I-10129 Turin, Italy.
   [Maccio, D.; Saccone, A.] Univ Genoa, Dipartimento Chim & Chim Ind, I-16146 Genoa, Italy.
RP Rosalbino, F (reprint author), Politecn Torino, Dipartimento Sci Appl & Tecnol DISAT, Corso Duca degli Abruzzi 24, I-10129 Turin, Italy.
EM francesco.rosalbino@polito.it
OI SACCONE, ADRIANA/0000-0002-0949-8859; scavino,
   giorgio/0000-0002-7832-1117
CR Abriata JP, 1982, B ALLOY PHASE DIAGR, V3, P34
   BADAWY WA, 1989, ELECTROCHIM ACTA, V34, P1711, DOI 10.1016/0013-4686(89)85053-4
   Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII
   Biaggio SR, 1997, ELECTROCHIM ACTA, V42, P1751, DOI 10.1016/S0013-4686(96)00375-1
   Biehl V, 2001, MATERIALWISS WERKST, V32, P137, DOI 10.1002/1521-4052(200102)32:2<137::AID-MAWE137>3.3.CO;2-Z
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Changqing X., 2006, J ALLOY COMPD, V419, P57
   Changqing Xia, 2006, Journal of Alloys and Compounds, V415, P126, DOI 10.1016/j.jallcom.2005.08.004
   Chelariu R, 2013, MATER CORROS, V64, P585, DOI 10.1002/maco.201206717
   Cordaro L, 2013, QUINTESSENCE INT, V44, P37, DOI 10.3290/j.qi.a28745
   Cox B., 1976, ADV CORROS SCI TECHN, V5, P12
   Gao X., 2010, J ARTHROPLASTY, V26, P665
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guglielmotti M B, 1997, Acta Odontol Latinoam, V10, P11
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   HAMMAD AM, 1992, J NUCL MATER, V186, P166, DOI 10.1016/0022-3115(92)90331-E
   Hanawa T., 2011, ACTA BIOMATER, V7, P4259
   ITO A, 1995, J BIOMED MATER RES, V29, P893, DOI 10.1002/jbm.820290715
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   LOHRENGEL MM, 1994, ELECTROCHIM ACTA, V39, P1265, DOI 10.1016/0013-4686(94)E0046-3
   Macdonald J. R., 1987, IMPEDANCE SPECTROSCO
   MALIK F, 1991, THIN SOLID FILMS, V206, P345, DOI 10.1016/0040-6090(91)90448-7
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Martins DQ, 2008, ELECTROCHIM ACTA, V53, P2809, DOI 10.1016/j.electacta.2007.10.060
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Nomura SN, 2010, ACTA BIOMATER, V6, P1033, DOI 10.1016/j.actbio.2009.09.013
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Oliveira NTC, 2002, J BRAZIL CHEM SOC, V13, P463, DOI 10.1590/S0103-50532002000400009
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Ries MD, 2002, J BONE JOINT SURG AM, V84A, P129, DOI 10.2106/00004623-200200002-00018
   Rokkum M, 2002, ACTA ORTHOP SCAND, V73, P298, DOI 10.1080/000164702320155293
   Rosalbino F, 2011, J MATER SCI-MATER M, V22, P1293, DOI 10.1007/s10856-011-4301-z
   Rosalbino F, 2010, J SOLID STATE ELECTR, V14, P1451, DOI 10.1007/s10008-009-0971-6
   Salot R, 1996, J ELECTROCHEM SOC, V143, P3902, DOI 10.1149/1.1837314
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Temiselvi S., 2006, ELECTROCHIM ACTA, V52, P839
   Thakur R. R., 2013, ORTHOPEDICS, P36
   Tolentino L., 2013, CLIN ORAL IMPLANTS R
   Wagner C, 1938, Z ELKTROCHEM ANGEW P, V44, P391
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
NR 47
TC 6
Z9 6
U1 0
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-5117
EI 1521-4176
J9 MATER CORROS
JI Mater. Corros.
PD OCT
PY 2015
VL 66
IS 10
BP 1125
EP 1132
DI 10.1002/maco.201407894
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CS8RC
UT WOS:000362355000013
DA 2018-10-20
ER

PT J
AU Wormwood, KL
   Aslebagh, R
   Channaveerappa, D
   Dupree, EJ
   Borland, MM
   Ryan, JP
   Darie, CC
   Woods, AG
AF Wormwood, Kelly L.
   Aslebagh, Roshanak
   Channaveerappa, Devika
   Dupree, Emmalyn J.
   Borland, Megan M.
   Ryan, Jeanne P.
   Darie, Costel C.
   Woods, Alisa G.
TI Salivary proteomics and biomarkers in neurology and psychiatry
SO PROTEOMICS CLINICAL APPLICATIONS
LA English
DT Review
DE Biomarkers; Proteomics
ID TUMOR DIFFERENTIATION FACTOR; AUTISM SPECTRUM DISORDERS; PROTEIN-PROTEIN
   INTERACTIONS; CORTISOL CIRCADIAN-RHYTHMS; HUMAN CEREBROSPINAL-FLUID;
   MAJOR DEPRESSION PATIENTS; MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; FACTOR
   TDF; POTENTIAL BIOMARKERS
AB Biomarkers are greatly needed in the fields of neurology and psychiatry, to provide objective and earlier diagnoses of CNS conditions. Proteomics and other omics MS-based technologies are tools currently being utilized in much recent CNS research. Saliva is an interesting alternative biomaterial for the proteomic study of CNS disorders, with several advantages. Collection is noninvasive and saliva has many proteins. It is easier to collect than blood and can be collected by professionals without formal medical training. For psychiatric and neurological patients, supplying a saliva sample is less anxiety-provoking than providing a blood sample, and is less embarrassing than producing a urine specimen. The use of saliva as a biomaterial has been researched for the diagnosis of and greater understanding of several CNS conditions, including neurodegenerative diseases, autism, and depression. Salivary biomarkers could be used to rule out nonpsychiatric conditions that are often mistaken for psychiatric/neurological conditions, such as fibromyalgia, and potentially to assess cognitive ability in individuals with compromised brain function. As MS and omics technology advances, the sensitivity and utility of assessing CNS conditions using distal human biomaterials such as saliva is becoming increasingly possible.
C1 [Wormwood, Kelly L.; Aslebagh, Roshanak; Channaveerappa, Devika; Dupree, Emmalyn J.; Borland, Megan M.; Darie, Costel C.; Woods, Alisa G.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.
   [Ryan, Jeanne P.] SUNY Coll Plattsburgh, Dept Psychol, Plattsburgh, NY 12901 USA.
   [Woods, Alisa G.] SUNY Coll Plattsburgh, Ctr Neurobehav Hlth, Plattsburgh, NY 12901 USA.
RP Woods, AG (reprint author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, 8 Clarkson Ave, Potsdam, NY 13699 USA.
EM awoods@clarkson.edu
FU David A. Walsh fellowship; US Army research office (DURIP)
   [W911NF-11-1-0304]; T. Urling and Mabel Walker Research Fellowship
   Program; ASPIRE program; McNair Program at Clarkson University; Shire
   Development, LLC; generosity of SciFund Challenge 3 Donors
FX Many thanks for the support of Shire Development, LLC, David A. Walsh
   fellowship, the US Army research office (DURIP grant W911NF-11-1-0304),
   the generosity of SciFund Challenge 3 Donors, the T. Urling and Mabel
   Walker Research Fellowship Program and the ASPIRE program and McNair
   Program at Clarkson University. We would like to give special thanks to
   the families and individuals who have been participants in our research
   studies.
CR Barr T. L., 2014, BIOL RES NURS
   Bazzichi L, 2009, PROTEOM CLIN APPL, V3, P1296, DOI 10.1002/prca.200900076
   Bermejo-Pareja F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-108
   Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1
   Blumberg SJ, 2013, CHANGES PREVALENCE P
   Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088
   Cockburn Andrew F, 2012, Investig Genet, V3, P19, DOI 10.1186/2041-2223-3-19
   Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876
   Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943
   Corbett BA, 2006, PSYCHONEUROENDOCRINO, V31, P59, DOI 10.1016/j.psyneuen.2005.05.011
   Corbett BA, 2008, J PSYCHIATR NEUROSCI, V33, P227
   Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346
   Cuenca AG, 2013, AM J PERINAT, V30, P105, DOI 10.1055/s-0032-1333412
   D'Acquisto F, 2009, CURR OPIN PHARMACOL, V9, P521, DOI 10.1016/j.coph.2009.04.007
   Dallner C, 2002, GLIA, V37, P374
   Darie CC, 2005, J BIOL CHEM, V280, P37585, DOI 10.1074/jbc.M506709200
   Darie CC, 2011, PROTEOMICS, V11, P4514, DOI 10.1002/pmic.201000819
   Deng YH, 2008, J SEP SCI, V31, P3088, DOI 10.1002/jssc.200800339
   Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015
   Diamond B, 2011, BIOESSAYS, V33, P588, DOI 10.1002/bies.201100042
   Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532
   Dominy SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089366
   Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3
   Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4
   Duits F. H., 2014, ALZHEIMERS DEMENT
   Egami M, 2013, HUM PSYCHOPHARM CLIN, V28, P7, DOI 10.1002/hup.2273
   Feldman R, 2014, BRIT J PSYCHIAT, V205, P107, DOI 10.1192/bjp.bp.113.137513
   Filiou MD, 2011, PROTEOM CLIN APPL, V5, P38, DOI 10.1002/prca.201000060
   Gesundheit B, 2013, J AUTOIMMUN, V44, P1, DOI 10.1016/j.jaut.2013.05.005
   Guest PC, 2012, PROTEOMICS, V12, P3580, DOI 10.1002/pmic.201200376
   Hamilos DL, 2013, J ALLERGY CLIN IMMUN, V131, P1263, DOI 10.1016/j.jaci.2013.02.020
   Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008
   Hu S, 2007, EXPERT REV PROTEOMIC, V4, P531, DOI 10.1586/14789450.4.4-531
   Kekesi KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050532
   la Marca G, 2014, J PHARMACEUT BIOMED, V101, P174, DOI 10.1016/j.jpba.2014.03.047
   Li SY, 2010, BIOCOMPUT-PAC SYM, P337
   Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050
   Majewska MD, 2014, EUR CHILD ADOLES PSY, V23, P485, DOI 10.1007/s00787-013-0472-0
   Martins-de-Souza D, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.13
   Martins-De-Souza D, 2014, DIALOGUES CLIN NEURO, V16, P63
   Masi A, 2015, MOL PSYCHIATR, V20, P440, DOI 10.1038/mp.2014.59
   Momeni N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.19
   Momeni N., 2012, AUTISM RES TREAT, V2012
   Nam JW, 2007, ORAL DIS, V13, P187, DOI 10.1111/j.1601-0825.2006.01265.x
   Ninan PT, 2014, PROG NEURO-PSYCHOPH, V48, P86, DOI 10.1016/j.pnpbp.2013.09.016
   Oh YS, 2006, AM J PHYSIOL-CELL PH, V291, pC76, DOI 10.1152/ajpcell.00508.2005
   Perry M, 2009, ANAL CHIM ACTA, V653, P1, DOI 10.1016/j.aca.2009.08.038
   Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767
   Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384
   Roy U, 2013, PROTEIN J, V32, P512, DOI 10.1007/s10930-013-9510-5
   Roy U, 2012, BIOTECHNOL APPL BIOC, V59, P445, DOI 10.1002/bab.1046
   Samsam M, 2014, WORLD J GASTROENTERO, V20, P9942, DOI 10.3748/wjg.v20.i29.9942
   Saxena V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048835
   Scarano E, 2010, ACTA OTORHINOLARYNGO, V30, P125
   Schulz BL, 2013, CRIT REV BIOTECHNOL, V33, P246, DOI 10.3109/07388551.2012.687361
   Shetty V, 2010, ORAL MAXIL SURG CLIN, V22, P269, DOI 10.1016/j.coms.2010.01.004
   Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731
   Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009
   Sokolowska I, 2013, CELL MOL LIFE SCI, V70, P2835, DOI 10.1007/s00018-012-1185-0
   Sokolowska I, 2011, ACS SYM SER, V1083, P369
   Sokolowska I, 2012, FEBS J, V279, P2579, DOI 10.1111/j.1742-4658.2012.08641.x
   Sokolowska I, 2012, J BIOL CHEM, V287, P1719, DOI 10.1074/jbc.M111.284091
   St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929
   Stelzhammer V, 2014, INT J NEUROPSYCHOPH, V17, P1599, DOI 10.1017/S1461145714000819
   Taurines R, 2011, J PSYCHOPHARMACOL, V25, P151, DOI 10.1177/0269881109106931
   Tecles F, 2014, J VET MED EDUC, V41, P37, DOI 10.3138/jvme.0513-073R1
   To Stephen E, 2005, J Neurosci Nurs, V37, P102
   Wetie AGN, 2015, AUTISM RES, V8, P338, DOI 10.1002/aur.1450
   Wetie AGN, 2014, ELECTROPHORESIS, V35, P2046, DOI 10.1002/elps.201300370
   Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1
   Wetie AGN, 2013, PROTEOMICS, V13, P538, DOI 10.1002/pmic.201200328
   Wilcken B, 2012, PATHOLOGY, V44, P73, DOI 10.1097/PAT.0b013e32834e843f
   Wingate M, 2014, MMWR SURVEILL SUMM, V63
   Woods AG, 1998, NEUROSCIENCE, V83, P663
   Woods AG, 2014, ADV EXP MED BIOL, V806, P509, DOI 10.1007/978-3-319-06068-2_25
   Woods AG, 2014, ADV EXP MED BIOL, V806, P545, DOI 10.1007/978-3-319-06068-2_27
   Woods AG, 2014, ADV EXP MED BIOL, V806, P1, DOI 10.1007/978-3-319-06068-2_1
   Woods Alisa G, 2013, J Mol Psychiatry, V1, P6, DOI 10.1186/2049-9256-1-6
   Woods AG, 2012, J CELL MOL MED, V16, P1184, DOI 10.1111/j.1582-4934.2012.01543.x
   Woodside A.G., 2014, PSYCHIATIC TIMES, P1, DOI 10.1108/S1871-3173_2014_0000008001
   Wormwood K., 2013, J PROTEOMICS BIOIN S, VS5, P1
   Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140
   Zerbo O, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-113
NR 83
TC 12
Z9 13
U1 0
U2 23
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1862-8346
EI 1862-8354
J9 PROTEOM CLIN APPL
JI Proteom. Clin. Appl.
PD OCT
PY 2015
VL 9
IS 9-10
SI SI
BP 899
EP 906
DI 10.1002/prca.201400153
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CT0QK
UT WOS:000362501200012
PM 25631118
DA 2018-10-20
ER

PT J
AU Watarai, A
   Schirmer, L
   Thones, S
   Freudenberg, U
   Werner, C
   Simon, JC
   Anderegg, U
AF Watarai, Akira
   Schirmer, Lucas
   Thoenes, Stephan
   Freudenberg, Uwe
   Werner, Carsten
   Simon, Jan C.
   Anderegg, Ulf
TI TGF beta functionalized starPEG-heparin hydrogels modulate human dermal
   fibroblast growth and differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE starPEG; Heparin; Hydrogels; Wound healing; Myofibroblast; Alpha-smooth
   muscle actin (alpha SMA); Extracellular matrix (ECM); Metalloprotease
   (MMP)
ID MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; TRANSFORMING
   GROWTH-FACTOR-BETA-1; MECHANICAL-PROPERTIES; FACTOR DELIVERY;
   CELL-ADHESION; COLLAGEN I; PROTEIN; REGENERATION; TGF-BETA-1
AB Hydrogels are promising biomaterials that can adapt easily to complex tissue entities. Furthermore, chemical modifications enable these hydrogels to become an instructive biomaterial to a variety of cell types. Human dermal fibroblasts play a pivotal role during wound healing, especially for the synthesis of novel dermal tissue replacing the primary fibrin clot. Thus, the control of growth and differentiation of dermal fibroblasts is important to modulate wound healing. In here, we utilized a versatile starPEG-heparin hydrogel platform that can be independently adjusted with respect to mechanical and biochemical properties for cultivating human dermal fibroblasts. Cell-based remodeling of the artificial matrix was ensured by using matrix metalloprotease (MMP) cleavable crosslinker peptides. Attachment and proliferation of fibroblasts on starPEG-heparin hydrogels of differing stiffness, density of pro-adhesive RGD peptides and MMP cleavable peptide linkers were tested. Binding and release of human TGF beta(1) as well as biological effect of the pre-adsorbed growth factor on fibroblast gene expression and myofibroblast differentiation were investigated. Hydrogels containing RGD peptides supported fibroblast attachment, spreading, proliferation matrix deposition and remodeling compared to hydrogels without any modifications. Reversibly conjugated TGF beta(1) was demonstrated to be constantly released from starPEG-heparin hydrogels for several days and capable of inducing myofibroblast differentiation of fibroblasts as determined by induction of collagen type I, ED-A-Fibronectin expression and incorporation of alpha smooth muscle actin and palladin into F-actin stress fibers. Taken together, customized starPEG-heparin hydrogels could be of value to promote dermal wound healing by stimulating growth and differentiation of human dermal fibroblasts.
   Statement of Significance
   The increasing number of people of advanced age within the population results in an increasing demand for the treatment of non-healing wounds. Hydrogels are promising biomaterials for the temporary closure of large tissue defects: They can adapt to complex tissue geometry and can be engineered for specific tissue needs. We used a starPEG-heparin hydrogel platform that can be independently adjusted to mechanical and biochemical characteristics. We investigated how these hydrogels can support attachment, proliferation and differentiation of dermal fibroblasts. After introducing adhesive peptides these hydrogels support cell attachment and proliferation. Moreover, TGF beta - an essential growth and differentiation factor for fibroblasts - can be immobilized reversibly and functionally on these hydrogels. Thus, starPEG-heparin hydrogels could be developed to bioactive temporary wound dressings. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Watarai, Akira; Thoenes, Stephan; Simon, Jan C.; Anderegg, Ulf] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany.
   [Schirmer, Lucas; Freudenberg, Uwe; Werner, Carsten] Tech Univ Dresden, Leibniz Inst Polymer Res, Dresden, Germany.
   [Watarai, Akira] Kitasato Univ, Sch Med, Dept Dermatol, Tokyo, Japan.
RP Anderegg, U (reprint author), Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany.
EM ulf.anderegg@medizin.uni-leipzig.de
RI Schirmer, Lucas/P-9635-2015; Werner, Carsten/F-8127-2010; Umlauf,
   Ursula/D-3356-2014
OI Schirmer, Lucas/0000-0003-1132-808X; Werner,
   Carsten/0000-0003-0189-3448; 
FU Deutsche Forschungsgemeinschaft [TRR 67];  [TRR67]
FX Authors gratefully acknowledge the financial support of the Deutsche
   Forschungsgemeinschaft (TRR 67 collaborative research group (Projects B4
   to UA, A10 to UF and CW, B3 to JS). AW received a TRR67 scholarship
   award. And, we like to thank Sibylle Vorberg and Armen Majok for
   excellent assistance, as well as Mikhail Tsurkan, Marcus Binner and
   Nelly Rein for their major support and providing the materials this
   study was based on.
CR AGACHE PG, 1980, ARCH DERMATOL RES, V269, P221, DOI 10.1007/BF00406415
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Boresi A. P., 2003, ADV MECH MAT, V6
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19
   Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414
   Chwalek K, 2011, BIOMATERIALS, V32, P9649, DOI 10.1016/j.biomaterials.2011.08.078
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fields G. B., 1996, PEPT SCI, V40, P399, DOI DOI 10.1002/(SICI)1097-0282(1996)40:4&LT;399::AI
   Freudenberg U, 2012, ADV FUNCT MATER, V22, P1391, DOI 10.1002/adfm.201101868
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000
   MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226
   MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441
   Miyazaki K, 2012, EXP CELL RES, V318, P1716, DOI 10.1016/j.yexcr.2012.05.006
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tsurkan MV, 2013, J CONTROL RELEASE, V167, P248, DOI 10.1016/j.jconrel.2013.01.030
   Tsurkan MV, 2010, MACROMOL RAPID COMM, V31, P1529, DOI 10.1002/marc.201000155
   van der Smissen A, 2013, ACTA BIOMATER, V9, P7775, DOI 10.1016/j.actbio.2013.04.023
   van der Smissen A, 2011, BIOMATERIALS, V32, P8938, DOI 10.1016/j.biomaterials.2011.08.025
   VINCENT S, 1993, NUCLEIC ACIDS RES, V21, P1498, DOI 10.1093/nar/21.6.1498
   Webster R, 2009, MILESTONES DRUG THER, P127, DOI 10.1007/978-3-7643-8679-5_8
   Weitz DS, 2010, J THROMB THROMBOLYS, V29, P199, DOI 10.1007/s11239-009-0411-6
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Zahouani H, 2009, SKIN RES TECHNOL, V15, P68, DOI 10.1111/j.1600-0846.2008.00329.x
   Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042
   Zieris A, 2010, J MATER SCI-MATER M, V21, P915, DOI 10.1007/s10856-009-3913-z
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 42
TC 23
Z9 23
U1 8
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT 1
PY 2015
VL 25
BP 65
EP 75
DI 10.1016/j.actbio.2015.07.036
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS2WX
UT WOS:000361933800007
PM 26219861
DA 2018-10-20
ER

PT J
AU Palumbo, FS
   Puleio, R
   Fiorica, C
   Pitarresi, G
   Loria, GR
   Cassata, G
   Giammona, G
AF Palumbo, Fabio Salvatore
   Puleio, Roberto
   Fiorica, Calogero
   Pitarresi, Giovanna
   Loria, Guido Ruggero
   Cassata, Giovanni
   Giammona, Gaetano
TI Matrices of a hydrophobically functionalized hyaluronic acid derivative
   for the locoregional tumour treatment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronic acid; Biomaterials; Locoregional tumour treatment; Paclitaxel
ID CONTROLLED-RELEASE; LYMPH-NODES; DELIVERY; PACLITAXEL;
   IMMUNOHISTOCHEMISTRY; COPOLYMERS; SCAFFOLDS; HYDROGELS; EFFICACY;
   BEHAVIOR
AB A hyaluronic acid (HA) derivative bearing octadecylamine and acylhydrazine functionalities has been here employed for the production of a paclitaxel delivering matrix for locoregional chemotherapy. Through a strategy consisting in a powder compression and a plasticization with a mixture water/ethanol, a physically assembled biomaterial, stable in solutions with physiologic ionic strengths, has been produced. Two different drug loading strategies have been adopted, by using paclitaxel as chemotherapic agent, and obtained samples have been assayed in terms of release in enhanced solubility conditions and in vitro and in vivo tumoural cytotoxicity. In particular sample with the best releasing characteristics was chosen for an in vivo evaluation against a HCT-116 xenograft on mice. Local tumour establishment and metastatic diffusion was assayed locally at the site of xenograft implantation and at the tributary lymph nodes. Obtained results demonstrated how loading procedure influenced paclitaxel crystallinity into the matrix and consequently drug diffusion and its cytoreductive potential. Chosen paclitaxel loaded matrix was able to drastically inhibit HCT-116 establishment and metastatic diffusion. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Palumbo, Fabio Salvatore; Fiorica, Calogero; Pitarresi, Giovanna; Giammona, Gaetano] Univ Palermo, Sez Chim & Tecnol Farmaceut, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, I-90123 Palermo, Italy.
   [Puleio, Roberto; Loria, Guido Ruggero; Cassata, Giovanni] Ist Zooprofilatt Sperimentale Sicilia A Mirri, Histopathol & Immunohistochem Lab, Palermo, Italy.
   [Pitarresi, Giovanna; Giammona, Gaetano] IBIM CNR, I-90146 Palermo, Italy.
   [Pitarresi, Giovanna; Giammona, Gaetano] Italian Natl Res Council, Inst Biophys Palermo, I-90146 Palermo, Italy.
RP Palumbo, FS (reprint author), Univ Palermo, Sez Chim & Tecnol Farmaceut, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Via Archirafi 32, I-90123 Palermo, Italy.
EM fabiosalvatore.palumbo@unipa.it
RI Cassata, Giovanni/P-7161-2015; Puleio, Roberto/B-2146-2013
OI Cassata, Giovanni/0000-0003-1742-1082; Puleio,
   Roberto/0000-0002-3461-3353; Loria, Guido Ruggero/0000-0002-4368-6773
FU MIUR
FX Authors thanks MIUR for financial support
CR Amini-Fazl MS, 2014, DRUG DEV IND PHARM, V40, P519, DOI 10.3109/03639045.2013.771646
   Arifin DY, 2009, J CONTROL RELEASE, V137, P203, DOI 10.1016/j.jconrel.2009.04.013
   Bajaj G, 2012, J CONTROL RELEASE, V158, P386, DOI 10.1016/j.jconrel.2011.12.001
   Balazs EA, 2009, STRUCT CHEM, V20, P341, DOI 10.1007/s11224-009-9435-y
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488
   Cserni G, 2006, J CLIN PATHOL, V59, P518, DOI 10.1136/jcp.2005.02991
   Eenschooten C, 2012, CARBOHYD POLYM, V87, P444, DOI 10.1016/j.carbpol.2011.08.004
   Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Finelli I, 2014, MACROMOL CHEM PHYS, V215, P140, DOI 10.1002/macp.201300503
   Harper E, 1999, CLIN CANCER RES, V5, P4242
   Hart MG, 1996, COCHRANE DATABASE SY
   Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456
   Kipp JE, 2004, INT J PHARMACEUT, V284, P109, DOI 10.1016/j.ijpharm.2004.07.019
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Linden MD, 2001, APPL IMMUNOHISTO M M, V9, P297, DOI 10.1097/00022744-200112000-00002
   Liu JP, 2011, INT J NANOMED, V6, P2143, DOI 10.2147/IJN.S24038
   Palumbo FS, 2010, ACTA BIOMATER, V6, P195, DOI 10.1016/j.actbio.2009.06.014
   Palumbo FS, 2006, CARBOHYD POLYM, V66, P379, DOI 10.1016/j.carbpol.2006.03.023
   Palumbo FS, 2014, J MATER CHEM B, V2, P3243, DOI 10.1039/c4tb00311j
   Palumbo FS, 2012, SOFT MATTER, V8, P4918, DOI 10.1039/c2sm07310b
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Pelletier S, 2000, CARBOHYD POLYM, V43, P343, DOI 10.1016/S0144-8617(00)00188-0
   Pravata L, 2008, BIOMACROMOLECULES, V9, P340, DOI 10.1021/bm700843m
   Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391
   Tomasina J, 2013, BIOMATERIALS, V34, P1073, DOI 10.1016/j.biomaterials.2012.10.055
   TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234
   Vrekoussis T, 2009, ANTICANCER RES, V29, P4995
   Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/S1522851702000236
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Wolinsky JB, 2010, J CONTROL RELEASE, V144, P280, DOI 10.1016/j.jconrel.2010.02.022
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
NR 33
TC 4
Z9 4
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT 1
PY 2015
VL 25
BP 205
EP 215
DI 10.1016/j.actbio.2015.07.022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS2WX
UT WOS:000361933800020
PM 26190798
DA 2018-10-20
ER

PT J
AU Huang, YJ
   Wang, YJ
   Wang, YZ
   Yi, SJ
   Fan, Z
   Sun, LM
   Lin, D
   Anreddy, N
   Zhu, H
   Schmidt, M
   Chen, ZS
   Zhang, MJ
AF Huang, Yujian
   Wang, Yi-Jun
   Wang, Yongzhong
   Yi, Sijia
   Fan, Zhen
   Sun, Leming
   Lin, Derrick
   Anreddy, Nagaraju
   Zhu, Hua
   Schmidt, Michael
   Chen, Zhe-Sheng
   Zhang, Mingjun
TI Exploring naturally occurring ivy nanoparticles as an alternative
   biomaterial
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Ivy nanoparticle; Drug delivery; Tissue engineering; Bio-inspiration;
   Biocompatibility
ID EPIDERMAL-GROWTH-FACTOR; SEQUENTIAL BMP-2/BMP-7 DELIVERY; DRUG-DELIVERY;
   ENDOTHELIAL-CELLS; ENGLISH IVY; IN-VITRO; LIPOPROTEIN NANOPARTICLES;
   VIRAL NANOPARTICLES; CONTRAST AGENTS; HEDERA-HELIX
AB Arabinoglactan protein (AGP)-rich nanoparticles obtained from the sticky exudates of Hedera helix (English ivy), have shown promising potential to be used in nanomedicine owing to their excellent aqueous solubility, low intrinsic viscosity, biocompatibility, and biodegradability. In this study, the feasibilities of utilizing ivy nanoparticles (INPs) as nano-carriers for delivering chemotherapeutic drugs in cancer therapy and as nano-fillers to develop novel scaffolds for tissue engineering in regenerative medicine are evaluated. Via electrostatic and hydrophobic interactions, pH-responsive nanoconjugates are formed between the INPs and the doxorubicin (DOX) with an entrapment ratio of 77.9 +/- 3.9%. While the INPs show minimal cytotoxicity, the formed INP-DOX conjugates exhibit substantially stronger cytotoxic activity than free DOX against multiple cancer cell lines, suggesting a synergistic effect is established upon conjugation. The anti-cancer effects of the INP-DOX conjugates are further evaluated via in vivo xenograft assays by subcutaneously implanting DOX resistant cell line, SW620/Ad-300, into nude mice. The tumor volumes in mice treated with the INP-DOX conjugates are significantly less than those of the mice treated with free DOX. In addition, the INPs are further exploited as nano-fillers to develop fibrous scaffolds with collagen, via mimicking the porous matrix where the INPs are embedded under natural condition. Enhanced adhesion of smooth muscle cells (SMCs) and accelerated proliferation of mouse aortic SMCs are observed in this newly constructed scaffold. Overall, the results obtained from the present study suggest great potential of the INPs to be used as biocompatible nanomaterials in nanomedicine. The AGP-rich INP renders a glycoprotein architecture that is amenable for modification according to the functional designs, capable of being developed as versatile nanomaterials for extensive biomedical applications.
   Statement of Significance
   Naturally occurring organic nanomaterials have drawn increasing interest for their potential biomedical applications in recent years. In this study, a new type of naturally occurring nanoparticles obtained from the sticky exudates on the adventitious roots of English ivy (H. helix), was explored for its potential biomedical application. In particular, the feasibilities of utilizing ivy nanoparticles (INPs) as nano-carriers for delivering chemotherapeutic drugs in cancer therapy and as nano-fillers to develop novel scaffolds for tissue engineering in regenerative medicine were evaluated both in vitro and in vivo. Overall, the results obtained from the present study suggest the great potential of the INPs to be used as biocompatible nanomaterials in nanomedicine. This study may open a totally new frontier for exploring the biomedical application of naturally occurring nanomaterials. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Huang, Yujian; Wang, Yongzhong; Fan, Zhen; Sun, Leming; Lin, Derrick; Schmidt, Michael; Zhang, Mingjun] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA.
   [Huang, Yujian; Wang, Yongzhong; Fan, Zhen; Sun, Leming; Zhu, Hua; Zhang, Mingjun] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.
   [Huang, Yujian; Wang, Yongzhong; Fan, Zhen; Sun, Leming; Zhang, Mingjun] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA.
   [Wang, Yi-Jun; Anreddy, Nagaraju; Chen, Zhe-Sheng] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY 11439 USA.
   [Yi, Sijia] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.
RP Zhang, MJ (reprint author), Ohio State Univ, 340C-D Biomed Res Tower,460W 12th Ave, Columbus, OH 43210 USA.
EM zhang.4882@osu.edu
RI Wang, Yi-Jun/K-3218-2016; Huang, Yujian/B-2085-2016
OI Huang, Yujian/0000-0001-8543-0269; Anreddy,
   Nagaraju/0000-0001-8914-8404; Sun, Leming/0000-0002-3188-9557
FU National Science Foundation [CMMI: 1300167]; Department of
   Pharmaceutical Science, St. John's University
FX This research was sponsored by the National Science Foundation (CMMI:
   1300167) and partially by Department of Pharmaceutical Science, St.
   John's University. The authors are grateful for the support. We thank
   Drs. Susan E. Bates and Robert W. Robey (NCI, NIH, Bethesda, MD) for the
   SW620 and SW620/Ad300 cell lines.
CR Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P
   Anderson EA, 2006, NANO LETT, V6, P1160, DOI 10.1021/nl060378g
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Bowron DT, 2013, FARADAY DISCUSS, V160, P239, DOI 10.1039/c2fd20071f
   Burris JN, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-41
   Chen DQ, 2013, J PHYS CHEM B, V117, P1261, DOI 10.1021/jp310677p
   Chen J, 2007, J AM CHEM SOC, V129, P5798, DOI 10.1021/ja069336k
   Chen N, 2012, BIOMATERIALS, V33, P1238, DOI 10.1016/j.biomaterials.2011.10.070
   Chen NC, 2012, BIOMATERIALS, V33, P1353, DOI 10.1016/j.biomaterials.2011.10.062
   Cormode DP, 2010, ADV DRUG DELIVER REV, V62, P329, DOI 10.1016/j.addr.2009.11.005
   Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499
   Deng XJ, 2014, BIOMATERIALS, V35, P5006, DOI 10.1016/j.biomaterials.2014.03.005
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Emre Y, 2014, SEMIN IMMUNOPATHOL, V36, P253, DOI 10.1007/s00281-014-0420-1
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Flenniken ML, 2003, NANO LETT, V3, P1573, DOI 10.1021/nl034786l
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Golub JS, 2010, AM J PHYSIOL-HEART C, V298, pH1959, DOI 10.1152/ajpheart.00199.2009
   Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85
   Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33
   Grainger DJ, 1997, J LIPID RES, V38, P2344
   Gyawali D, 2010, BIOMATERIALS, V31, P9092, DOI 10.1016/j.biomaterials.2010.08.022
   HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382
   Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123
   He XX, 2009, BIOMATERIALS, V30, P5601, DOI 10.1016/j.biomaterials.2009.06.030
   Huang Y., 2013, J NANOBIOTECHNOL, V11
   Huang YJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0226
   Huang YJ, 2013, COLLOID SURFACE B, V101, P361, DOI 10.1016/j.colsurfb.2012.06.034
   Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003
   Kim JO, 2009, J CONTROL RELEASE, V138, P197, DOI 10.1016/j.jconrel.2009.04.019
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Leming S., 2014, BIOINSPIR BIOMIM, V9
   Lenaghan SC, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046009
   Lenaghan SC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0392
   Lenaghan SC, 2012, PLANT SCI, V183, P206, DOI 10.1016/j.plantsci.2011.08.013
   Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368
   Li WM, 2015, ACTA BIOMATER, V15, P191, DOI 10.1016/j.actbio.2014.12.013
   Liu YW, 2015, ACTA BIOMATER, V11, P114, DOI 10.1016/j.actbio.2014.10.004
   Ma Z, 2015, BIOMATERIALS, V52, P517, DOI 10.1016/j.biomaterials.2015.02.063
   MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M
   McConathy WJ, 2008, ANTI-CANCER DRUG, V19, P183, DOI 10.1097/CAD.0b013e3282f1da86
   MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689
   Mehdizadeh M, 2012, BIOMATERIALS, V33, P7972, DOI 10.1016/j.biomaterials.2012.07.055
   Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639
   Pan LM, 2012, J AM CHEM SOC, V134, P5722, DOI 10.1021/ja211035w
   Qin YP, 2015, ACTA BIOMATER, V17, P201, DOI 10.1016/j.actbio.2015.01.026
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Singh P, 2007, J CONTROL RELEASE, V120, P41, DOI 10.1016/j.jconrel.2007.04.003
   Tan Q, 2011, INT J NANOMED, V6, P929, DOI 10.2147/IJN.S18753
   Tiwari AK, 2013, CANCER LETT, V328, P307, DOI 10.1016/j.canlet.2012.10.001
   Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823
   VISTICA DT, 1991, CANCER RES, V51, P2515
   Wang KY, 2015, ACTA BIOMATER, V16, P196, DOI 10.1016/j.actbio.2015.01.002
   Wang YZ, 2014, ACTA BIOMATER, V10, P4269, DOI 10.1016/j.actbio.2014.06.020
   Wang YZ, 2013, ADV FUNCT MATER, V23, P2175, DOI 10.1002/adfm.201202619
   Wang YZ, 2012, INT J PHARMACEUT, V422, P409, DOI 10.1016/j.ijpharm.2011.10.029
   WIEGANT FAC, 1986, J CELL BIOL, V103, P87, DOI 10.1083/jcb.103.1.87
   Xia Lijin, 2010, Journal of Nanobiotechnology, V8, P12, DOI 10.1186/1477-3155-8-12
   Xu PS, 2007, ANGEW CHEM INT EDIT, V46, P4999, DOI 10.1002/anie.200605254
   Yang Z, 2007, CHEM COMMUN, P3453, DOI 10.1039/b705326f
   Yi SJ, 2014, J BIOMED NANOTECHNOL, V10, P1016, DOI 10.1166/jbn.2014.1782
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Yin LC, 2013, BIOMATERIALS, V34, P2340, DOI 10.1016/j.biomaterials.2012.11.064
   Yoo HS, 2000, J CONTROL RELEASE, V68, P419, DOI 10.1016/S0168-3659(00)00280-7
   Zhang M, 2011, COLLOID SURFACE B, V85, P32, DOI 10.1016/j.colsurfb.2010.10.042
   Zhang MJ, 2008, NANO LETT, V8, P1277, DOI 10.1021/nl0725704
   Zhang Y, 2013, BIOMATERIALS, V34, P4048, DOI 10.1016/j.biomaterials.2013.02.040
   Zheng G, 2005, P NATL ACAD SCI USA, V102, P17757, DOI 10.1073/pnas.0508677102
   Zhu X, 2015, ACTA BIOMATER, V18, P155, DOI 10.1016/j.actbio.2015.02.023
   Zhu X, 2014, ACTA BIOMATER, V10, P244, DOI 10.1016/j.actbio.2013.08.043
NR 71
TC 9
Z9 9
U1 3
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT 1
PY 2015
VL 25
BP 268
EP 283
DI 10.1016/j.actbio.2015.07.035
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS2WX
UT WOS:000361933800025
PM 26219859
DA 2018-10-20
ER

PT J
AU Feyerabend, F
   Wendel, HP
   Mihailova, B
   Heidrich, S
   Agha, NA
   Bismayer, U
   Willumeit-Romer, R
AF Feyerabend, Frank
   Wendel, Hans-Peter
   Mihailova, Boriana
   Heidrich, Stefanie
   Agha, Nezha Ahmad
   Bismayer, Ulrich
   Willumeit-Roemer, Regine
TI Blood compatibility of magnesium and its alloys
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium alloys; Chandler-Loop system; Inflammation; Cell-material
   interactions; Carbonic anhydrase
ID CORONARY-ARTERIES; CARBON-DIOXIDE; PMN ELASTASE; BIOMATERIALS;
   DEGRADATION; CORROSION; INVITRO; SC5B-9; STENTS; CELLS
AB Rationale: Blood compatibility analysis in the field of biomaterials is a highly controversial topic. Especially for degradable materials like magnesium and its alloys no established test methods are available.
   Objective: The purpose of this study was to apply advanced test methodology for the analysis of degrading materials to get a mechanistic insight into the corrosion process in contact with human blood and plasma.
   Methods and results: Pure magnesium and two magnesium alloys were analysed in a modified Chandler-Loop setup. Standard clinical parameters were determined, and a thorough analysis of the resulting implant surface chemistry was performed. The contact of the materials to blood evoked an accelerated inflammatory and cell-induced osteoconductive reaction. Corrosion products formed indicate a more realistic, in vivo like situation.
   Conclusions: The active regulation of corrosion mechanisms of magnesium alloys by different cell types should be more in the focus of research to bridge the gap between in vitro and in vivo observations and to understand the mechanism of action. This in turn could lead to a better acceptance of these materials for implant applications.
   Statement of Significance
   The presented study deals with the first mechanistic insights during whole human blood contact and its influence on a degrading magnesium-based biomaterial. The combination of clinical parameters and corrosion layer analysis has been performed for the first time. It could be of interest due to the intended use of magnesium-based stents and for orthopaedic applications for clinical applications. An interest for the readers of Acta Biomaterialia may be given, as one of the first clinically approved magnesium-based devices is a wound-closure device, which is in direct contact with blood. Moreover, for orthopaedic applications also blood contact is of high interest. Although this is not the focus of the manuscript, it could help to rise awareness for potential future applications. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Feyerabend, Frank; Agha, Nezha Ahmad; Willumeit-Roemer, Regine] Helmholtz Zentrum Geesthacht, Inst Mat Res, Dept Mat Design & Characterisat, D-21502 Geesthacht, Germany.
   [Wendel, Hans-Peter] Univ Tubingen Hosp, Clin Res Lab, Dept Cardiovasc Surg, D-72076 Tubingen, Germany.
   [Mihailova, Boriana; Heidrich, Stefanie; Bismayer, Ulrich] Univ Hamburg, Dept Earth Sci, D-20146 Hamburg, Germany.
RP Feyerabend, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Dept Mat Design & Characterisat, Max Planck Str 1, D-21502 Geesthacht, Germany.
EM frank.feyerabend@hzg.de
RI Willumeit, Regine/I-8029-2013; Feyerabend, Frank/A-1124-2010
OI Willumeit, Regine/0000-0002-6004-6946; Feyerabend,
   Frank/0000-0001-9532-0207
FU Helmholtz Virtuelles Institute [VHVI-523]
FX The authors would like to thank Prof. Jochen Schluter (Mineralogical
   Museum, University of Hamburg) for providing reference samples for IR
   microspectroscopy. This work was supported by Helmholtz Virtuelles
   Institute, VHVI-523: In vivo studies of biodegradable magnesium based
   implant materials "MetBioMat".
CR Akyol N, 1997, ACTA OPHTHALMOL SCAN, V75, P287
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Avci-Adali M, 2013, J BIOMED MATER RES B, V101B, P1061, DOI 10.1002/jbm.b.32916
   Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021
   Bosiers M., 2005, VASC DIS MANAG, V2
   BOSSCHE HV, 1966, CLIN CHIM ACTA, V14, P112, DOI 10.1016/0009-8981(66)90072-6
   Carrim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113679
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   Chiu YY, 1998, J INVEST ALLERG CLIN, V8, P239
   Corallini F, 2009, RHEUMATOLOGY, V48, P293, DOI 10.1093/rheumatology/ken495
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Fischer J, 2011, MATER SCI ENG B-ADV, V176, P830, DOI 10.1016/j.mseb.2011.04.008
   Gamble JL, 1941, CHEM ANATOMY PHYSL P
   Geers C, 2000, PHYSIOL REV, V80, P681
   Geis-Gerstorfer J, 2011, MATER SCI ENG B-ADV, V176, P1761, DOI 10.1016/j.mseb.2011.06.006
   Han B, 2014, CHEM ENG TECHNOL, V37, P1363, DOI 10.1002/ceat.201300855
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   JACOBS M. H., 1942, JOUR GEN PHYSIOL, V25, P539, DOI 10.1085/jgp.25.4.539
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   KEITEL HG, 1955, BLOOD, V10, P370
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Liu XL, 2013, MAT SCI ENG C-MATER, V33, P4144, DOI 10.1016/j.msec.2013.06.004
   MA AQ, 1995, CHINESE MED J-PEKING, V108, P86
   MAGID E, 1968, BIOCHIM BIOPHYS ACTA, V165, P515, DOI 10.1016/0304-4165(68)90232-8
   PETERS KM, 1994, INT ORTHOP, V18, P352
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   ROSSIBER.L, 1967, J PHYSIOL-LONDON, V189, P1
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sinn S, 2011, J MATER SCI-MATER M, V22, P1521, DOI 10.1007/s10856-011-4335-2
   Slottow TLP, 2008, CARDIOVASC REVASCULA, V9, P248, DOI 10.1016/j.carrev.2008.04.001
   VERSMOLD H, 1973, RESP PHYSIOL, V18, P14, DOI 10.1016/0034-5687(73)90018-2
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wang DW, 2011, J BIOMED MATER RES A, V99A, P166, DOI 10.1002/jbm.a.33134
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Weckler B, 1996, SPECTROCHIM ACTA A, V52, P1507, DOI 10.1016/0584-8539(96)01693-5
   Willumeit R, 2013, ACTA BIOMATER, V9, P8722, DOI 10.1016/j.actbio.2013.02.042
   Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yang L, 2012, CORROS ENG SCI TECHN, V47, P335, DOI 10.1179/1743278212Y.0000000024
   Yokota M, 2003, J AUTOM METHOD MANAG, V25, P17, DOI [10.1155/S1463924603000038, 10.1080/1463924031000066212]
NR 43
TC 17
Z9 18
U1 2
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT 1
PY 2015
VL 25
BP 384
EP 394
DI 10.1016/j.actbio.2015.07.029
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS2WX
UT WOS:000361933800035
PM 26210283
DA 2018-10-20
ER

PT J
AU Mertins, O
   Mathews, PD
   Gomide, AB
   Baptista, MS
   Itri, R
AF Mertins, Omar
   Mathews, Patrick D.
   Gomide, Andreza B.
   Baptista, Mauricio S.
   Itri, Rosangela
TI Effective protection of biological membranes against photo-oxidative
   damage: Polymeric antioxidant forming a protecting shield over the
   membrane
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Giant vesicles; Polymer shield; Photo-protection; Biomembrane;
   Biopolymer; Biomaterial
ID GIANT VESICLES; GALLIC ACID; SINGLET OXYGEN; CHITOSAN; OXIDATION;
   ELECTROFORMATION; PHOSPHOLIPIDS; MOLECULES; DYNAMICS; INSIGHTS
AB We have prepared a chitosan polymer modified with gallic acid in order to develop an efficient protection strategy biological membranes against photodamage. Lipid bilayers were challenged with photoinduced damage by photosensitization with methylene blue, which usually causes formation of hydroperoxides, increasing area per lipid, and afterwards allowing leakage of internal materials. The damage was delayed by a solution of gallic acid in a concentration dependent manner, but further suppressed by the polymer at very low concentrations. The membrane of giant unilamellar vesicles was covered with this modified macromolecule leading to a powerful shield against singlet oxygen and thus effectively protecting the lipid membrane from oxidative stress. The results have proven the discovery of a promising strategy for photo protection of biological membranes. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mertins, Omar; Mathews, Patrick D.] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, BR-04023062 Sao Paulo, Brazil.
   [Mertins, Omar; Gomide, Andreza B.; Itri, Rosangela] Univ Sao Paulo, Inst Phys, Dept Appl Phys, BR-05508900 Sao Paulo, Brazil.
   [Baptista, Mauricio S.] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, Brazil.
RP Mertins, O (reprint author), Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Rua Botucatu 862, BR-04023062 Sao Paulo, Brazil.
EM mertins@unifesp.br; itri@if.usp.br
RI Baptista, Mauricio/A-5140-2008; Institute of Physics, USP/H-5191-2017;
   Mathews, Patrick/R-9159-2017; Mertins, Omar/S-5248-2017
OI Baptista, Mauricio/0000-0001-7079-7666; Mathews,
   Patrick/0000-0003-1138-6642; Mertins, Omar/0000-0002-5028-9215
FU Sao Paulo Research Foundation (FAPESP) [2012/50680-5]; FAPESP
   [2012/50680-5, 2010/18163-5]; CNPq
FX This work was supported by Grant No. 2012/50680-5, Sao Paulo Research
   Foundation (FAPESP). O.M. also thanks FAPESP for postdoctoral fellowship
   (process: 2010/18163-5, 2012/50680-5), H.C. Junqueira for the support on
   NIR experiments and R. Dimova for the critical reading of the text.
   M.S.B. and R.I. acknowledge CNPq for research fellowship.
CR ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303
   Awah FM, 2012, FOOD CHEM, V131, P1279, DOI 10.1016/j.foodchem.2011.09.118
   BRAULT D, 1986, BIOCHIM BIOPHYS ACTA, V857, P238, DOI 10.1016/0005-2736(86)90352-4
   Caetano W, 2007, LANGMUIR, V23, P1307, DOI 10.1021/la061510v
   Chiarelli-Neto O, 2011, FREE RADICAL BIO MED, V51, P1195, DOI 10.1016/j.freeradbiomed.2011.06.013
   Cho YS, 2011, CARBOHYD POLYM, V83, P1617, DOI 10.1016/j.carbpol.2010.10.019
   Cho YS, 2011, BIOORG MED CHEM LETT, V21, P3070, DOI 10.1016/j.bmcl.2011.03.033
   Curcio M, 2009, J AGR FOOD CHEM, V57, P5933, DOI 10.1021/jf900778u
   Diguet A, 2012, J AM CHEM SOC, V134, P4898, DOI 10.1021/ja211664f
   Dimova R, 2014, ADV COLLOID INTERFAC, V208, P225, DOI 10.1016/j.cis.2014.03.003
   Domingues MRM, 2008, CHEM PHYS LIPIDS, V156, P1, DOI 10.1016/j.chemphyslip.2008.07.003
   Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s
   Haluska CK, 2012, BBA-BIOMEMBRANES, V1818, P666, DOI 10.1016/j.bbamem.2011.11.025
   Itri Rosangela, 2014, Biophys Rev, V6, P47, DOI 10.1007/s12551-013-0128-9
   Mertins, 2014, BIOPHYS J, V106, P162
   Mertins O, 2005, CHEM PHYS LIPIDS, V138, P29, DOI 10.1016/j.chemphyslip.2005.07.004
   Mertins O, 2013, EUR BIOPHYS J BIOPHY, V42, pS127
   Mertins O, 2011, INORG CHIM ACTA, V374, P59, DOI 10.1016/j.ica.2011.04.030
   Mertins O, 2013, LANGMUIR, V29, P14545, DOI 10.1021/la403218c
   Mertins O, 2013, LANGMUIR, V29, P14552, DOI 10.1021/la4032199
   Mertins O, 2011, LANGMUIR, V27, P5506, DOI 10.1021/la200553t
   Mertins O, 2009, MAT SCI ENG C-BIO S, V29, P463, DOI 10.1016/j.msec.2008.08.038
   Mertins O, 2009, BIOPHYS J, V96, P2719, DOI 10.1016/j.bpj.2008.12.3928
   Pajares A, 2010, J PHOTOCH PHOTOBIO A, V209, P89, DOI 10.1016/j.jphotochem.2009.10.011
   Qaqish RB, 1999, CARBOHYD POLYM, V38, P99, DOI 10.1016/S0144-8617(98)00109-X
   Redmond RW, 1999, PHOTOCHEM PHOTOBIOL, V70, P391, DOI 10.1111/j.1751-1097.1999.tb08240.x
   Riske KA, 2005, BIOPHYS J, V88, P1143, DOI 10.1529/biophysj.104.050310
   Riske KA, 2009, BIOPHYS J, V97, P1362, DOI 10.1016/j.bpj.2009.06.023
   Rodrigues E, 2012, MAR DRUGS, V10, P1784, DOI 10.3390/md10081784
   Runas KA, 2015, SOFT MATTER, V11, P499, DOI 10.1039/c4sm01478b
   Sankhagowit S, 2014, BBA-BIOMEMBRANES, V1838, P2615, DOI 10.1016/j.bbamem.2014.06.020
   Weber G, 2014, SOFT MATTER, V10, P4241, DOI 10.1039/c3sm52740a
   Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565
   Xie MH, 2014, J AGR FOOD CHEM, V62, P9128, DOI 10.1021/jf503207s
NR 34
TC 7
Z9 7
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD OCT
PY 2015
VL 1848
IS 10
BP 2180
EP 2187
DI 10.1016/j.bbamem.2015.06.005
PN A
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS5YE
UT WOS:000362153400026
PM 26055894
OA Bronze
DA 2018-10-20
ER

PT J
AU Deep, A
   Sharma, AL
   Kumar, P
AF Deep, Akash
   Sharma, Arnit L.
   Kumar, Parveen
TI Lipase immobilized carbon nanotubes for conversion of Jatropha oil to
   fatty acid methyl esters
SO BIOMASS & BIOENERGY
LA English
DT Article
DE Bioimmobilized CNTs; Biocatalysis; Fatty acid methyl esters; Jatropha
   curcus; Enzymatic activity
ID PACKED-BED REACTOR; BIODIESEL PRODUCTION; ENZYMATIC TRANSESTERIFICATION;
   SUNFLOWER OIL; PALM OIL; FUEL; OPTIMIZATION; COMPOSITE
AB Lipase has been immobilized on multi-walled carbon nanotubes (MWCNTs) through the reaction of the carboxylated nanotubes with the enzyme in the presence of N-hydroxysulfosuccinimide (NHS) and 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride. Successful immobilization has been verified by infrared spectroscopy and scanning electron microscopy. The synthesized biomaterial has been used for catalyzing the conversion of Jatropha oil to the fatty acid methyl esters (FAME). Progress of the conversion reaction has been monitored with NIR spectroscopy. Gas chromatographic studies have indicated that the use of lipase-MWCNT bioconjuagate leads to almost quantitative conversion of Jatropha oil to the FAME. Around 1 h of the reaction, in the presence of around 15% of catalyst (mass fraction of catalyst on the total mixture), has yielded the desired results. The above used catalyst support has been regenerated 10 times without any adverse effect on the enzyme activity. (c). 2015 Elsevier Ltd. All rights reserved.
C1 [Deep, Akash; Kumar, Parveen] CSIR, CSIO, Nanotechnol Lab, Div H1, Chandigarh 160030, India.
   [Sharma, Arnit L.] CSIR, CSIO, Opt Devices & Syst Div, Chandigarh 160030, India.
RP Deep, A (reprint author), CSIR, CSIO, Nanotechnol Lab, Div H1, Sect 30, Chandigarh 160030, India.
EM dr.akashdeep@gmail.com
CR Abdulla R., 2010, CRIT REV BIOTECHNOL, V31, P53
   Akoh CC, 2007, J AGR FOOD CHEM, V55, P8995, DOI 10.1021/jf071724y
   Azocar L, 2010, APPL MICROBIOL BIOT, V88, P621, DOI 10.1007/s00253-010-2804-z
   Da Ros PCM, 2010, BIORESOURCE TECHNOL, V101, P5508, DOI 10.1016/j.biortech.2010.02.061
   Dossat V, 1999, ENZYME MICROB TECH, V25, P194, DOI 10.1016/S0141-0229(99)00026-5
   Du W, 2008, APPL MICROBIOL BIOT, V79, P331, DOI 10.1007/s00253-008-1448-8
   Fjerbaek L, 2009, BIOTECHNOL BIOENG, V102, P1298, DOI 10.1002/bit.22256
   Fukuda H, 2001, J BIOSCI BIOENG, V92, P405, DOI 10.1263/jbb.92.405
   Gressel J, 2008, PLANT SCI, V174, P246, DOI 10.1016/j.plantsci.2007.11.009
   Halim SFA, 2009, BIORESOURCE TECHNOL, V100, P710, DOI 10.1016/j.biortech.2008.07.031
   Heering HA, 2006, CHEMPHYSCHEM, V7, P1705, DOI 10.1002/cphc.200600108
   Iso M, 2001, J MOL CATAL B-ENZYM, V16, P53, DOI 10.1016/S1381-1177(01)00045-5
   Khan MM, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-504
   Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef`700639e
   Kumari A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-1
   Kumari V, 2007, ENERG FUEL, V21, P368, DOI 10.1021/ef0602168
   Moreira ABR, 2007, ENERG FUEL, V21, P3689, DOI 10.1021/ef700399b
   Nazir N, 2009, EUR J LIPID SCI TECH, V111, P1185, DOI 10.1002/ejlt.200800259
   Nie KL, 2006, J MOL CATAL B-ENZYM, V43, P142, DOI 10.1016/j.molcatb.2006.07.016
   Ranganathan SV, 2008, BIORESOURCE TECHNOL, V99, P3975, DOI 10.1016/j.biortech.2007.04.060
   Reich S, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155411
   Sahoo NG, 2011, CHEM COMMUN, V47, P5235, DOI 10.1039/c1cc00075f
   Sails A., 2008, J MOL CATAL B-ENZYM, V54, P19
   Sails A., 2009, J MOL CATAL B-ENZYM, V57, P262
   Severac E, 2011, ENZYME MICROB TECH, V48, P61, DOI 10.1016/j.enzmictec.2010.09.008
   Shah S, 2007, PROCESS BIOCHEM, V42, P409, DOI 10.1016/j.procbio.2006.09.024
   Sharma AL, 2012, POLYM-PLAST TECHNOL, V51, P1382, DOI 10.1080/03602559.2012.704113
   Soumanou MM, 2003, ENZYME MICROB TECH, V33, P97, DOI 10.1016/S0141-0229(03)00090-5
   Szczesna-Antczak M, 2009, RENEW ENERG, V34, P1185, DOI 10.1016/j.renene.2008.11.013
   Tamalampudi S, 2008, BIOCHEM ENG J, V39, P185, DOI 10.1016/j.bej.2007.09.002
   Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012
NR 31
TC 6
Z9 6
U1 2
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0961-9534
EI 1873-2909
J9 BIOMASS BIOENERG
JI Biomass Bioenerg.
PD OCT
PY 2015
VL 81
BP 83
EP 87
DI 10.1016/j.biombioe.2015.06.008
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA CS5QZ
UT WOS:000362134400012
DA 2018-10-20
ER

PT J
AU Ba, OM
   Hindie, M
   Marmey, P
   Gallet, O
   Anselme, K
   Ponche, A
   Duncan, AC
AF Ba, O. M.
   Hindie, M.
   Marmey, P.
   Gallet, O.
   Anselme, K.
   Ponche, A.
   Duncan, A. C.
TI Protein covalent immobilization via its scarce thiol versus abundant
   amine groups: Effect on orientation, cell binding domain exposure and
   conformational lability
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polystyrene; Cold plasma treatment; Protein grafting; Adsorption;
   Fibronectin; Cell adhesive protein; Surface characterization; Protein
   immobilization
ID POLY(VINYL ALCOHOL) HYDROGELS; FIBRONECTIN FIBRILLOGENESIS; SURFACE
   MODIFICATION; PLASMA FIBRONECTIN; ADSORPTION; POLYSTYRENE; CONJUGATION;
   BIOACTIVITY; ATTACHMENT; BACTERIA
AB Quantity, orientation, conformation and covalent linkage of naturally cell adhesive proteins adsorbed or covalently linked to a surface, are known to influence the preservation of their subsequent long term cell adhesion properties and bioactivity. In the present work, we explore two different strategies for the covalent linking of plasma fibronectin (pFN) - used as a cell adhesive model protein, onto a polystyrene (PS) surface. One is aimed at tethering the protein to the surface in a semi-oriented fashion (via one of the 4 free thiol reactive groups on the protein) with a heterofunctional coupling agent (SSMPB method). The other aims to immobilize the protein in a more random fashion by reaction between the abundant pendant primary amine bearing amino acids of the pFN and activated carboxylic surface functions obtained after glutaric anhydride surface treatment (GA method). The overall goal will be to verify the hypothesis of a correlation between covalent immobilization of a model cell adhesive protein to a PS surface in a semi-oriented configuration (versus randomly oriented) with promotion of enhanced exposure of the protein's cell binding domain. This in turn would lead to enhanced cell adhesion. Ideally the goal is to elaborate substrates exhibiting a long term stable protein monolayer with preserved cell adhesive properties and bioactivity for biomaterial and/or cell adhesion commercial plate applications. However, the initial restrictive objective of this paper is to first quantitatively and qualitatively investigate the reversibly (merely adsorbed) versus covalently irreversibly bound protein to the surface after the immobilization procedure.
   Although immobilized surface amounts were similar (close to the monolayer range) for all immobilization approaches, covalent grafting showed improved retention and stronger "tethering" of the pFN protein to the surface (roughly 40%) after SDS rinsing compared to that for mere adsorption (0%) suggesting an added value to the covalent grafting immobilization methods. However no differences in exposure of the cell binding domains were observed (ELISA results) before SDS rinsing, suggesting that pFN protein grafting to the surface is initially kinetically driven be a stochastic random adsorption phenomenon. Covalent grafting acts in the final stage as a process that simply tethers and stabilizes (or freezes) the initial conformation/orientation of the adsorbed protein on the surface. In addition covalent linkage via the SSMPB approach is likely favored by surface-induce exposure of one of the normally hidden free thiol group pair, thus optimizing covalent linkage to the surface.
   However after SDS rinsing, this "tethering"/"freezing" effect was significantly more prominent for the GA grafting approach (due to greater number of potential covalent links between the protein and the surface) compared to that for the SSMPB approach. This hypothesis was buttressed by the improved resistance to denaturation (smaller conformational lability) for the GA compared to the SMPB approach and improved exposure of the cell binding domain for the former (>50%) even after SDS rinsing.
   These results are promising in that they suggest covalent tethering of fibronectin to PS substrate in a monolayer range, with significantly improved irreversible protein surface bonding via both approaches (compared to that for mere adsorption). The latter are likely applicable to a wide range of proteins. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ba, O. M.; Duncan, A. C.] Univ Rouen, Fac Sci & Technol, CNRS, PBS Lab,UMR 6270, F-76821 Mont St Aignan, France.
   [Ba, O. M.; Anselme, K.; Ponche, A.] CNRS, LRC, IS2M, F-68057 Mulhouse, France.
   [Hindie, M.; Gallet, O.] Equipe Rech Relat Matrice Extracellulaire Cellule, EA 1391, F-95302 Cergy Pontoise, France.
   [Marmey, P.] Ctr Transfert Technol Mans, Pole Ingn Biol & Med, F-72000 Le Mans, France.
RP Duncan, AC (reprint author), Univ Rouen, Fac Sci & Technol, CNRS, PBS Lab,UMR 6270, Batiment Pierre Louis DULONG, F-76821 Mont St Aignan, France.
EM anthony.duncan@univ-rouen.fr
OI Anselme, Karine/0000-0002-6669-205X; Ponche, Arnaud/0000-0002-8993-2896
FU French ANR (National Agency for Research) [ANR-10-BLAN-1530]
FX The authors acknowledge the French ANR (National Agency for Research)
   for the funding of the ANR-10-BLAN-1530 Green FIB project to which this
   work relates. We are also thankful to Dr. Virginie Gadenne for her
   diligent work and assistance with the atomic force microscopy.
CR Afara N, 2012, THIN SOLID FILMS, V522, P381, DOI 10.1016/j.tsf.2012.08.025
   AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   Anamelechi CC, 2005, BIOMATERIALS, V26, P6887, DOI 10.1016/.biomaterials.2005.04.027
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Anselme K., 2011, COMPREHENSIVE BIOMAT, V3, P235
   Ba O. M., LANGMUIR UNPUB
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   Boireau W, 2005, METH MOL B, V300, P349
   Borghol N, 2010, BIOTECHNOL BIOPROC E, V15, P220, DOI 10.1007/s12257-009-0146-4
   CANTINI M, 2012, PROTEINS INTERFACES, V1120, P471
   Chen S, 2014, COLLOID SURFACE B, V113, P125, DOI 10.1016/j.colsurfb.2013.08.041
   Chollet C., 2007, ITBM RBM, V28, P2
   Duncan AC, 2004, APPL SURF SCI, V221, P93, DOI 10.1016/S0169-4332(03)00819-5
   Duncan AC, 2001, EUR POLYM J, V37, P1821, DOI 10.1016/S0014-3057(01)00015-5
   Duncan AC, 1996, J BIOMAT SCI-POLYM E, V7, P647, DOI 10.1163/156856296X00426
   Duncan AC, 1997, BIOMATERIALS, V18, P1585, DOI 10.1016/S0142-9612(97)00100-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gonzalez-Garcia C, 2013, COLLOID SURFACE B, V111, P618, DOI 10.1016/j.colsurfb.2013.07.016
   Guruvenket S, 2004, APPL SURF SCI, V236, P278, DOI 10.1016/j.apsusc.2004.04.033
   Khang D., 2007, BIOMATERIALS, V28, P4756
   KOTELIANSKY VE, 1981, EUR J BIOCHEM, V119, P619, DOI 10.1111/j.1432-1033.1981.tb05652.x
   LAI CS, 1989, BIOPHYS J, V56, P395, DOI 10.1016/S0006-3495(89)82685-2
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Lopez-Santos C, 2011, SURF COAT TECH, V205, P3356, DOI 10.1016/j.surfcoat.2010.11.038
   Mayingi J, 2008, IRBM, V29, P1, DOI 10.1016/j.rbmret.2007.10.001
   Pellenc D, 2006, J COLLOID INTERF SCI, V298, P132, DOI 10.1016/j.jcis.2005.11.059
   Pernodet N, 2003, J BIOMED MATER RES A, V64A, P684, DOI 10.1002/jbm.a.10394
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   Sima F, 2011, ACTA BIOMATER, V7, P3780, DOI 10.1016/j.actbio.2011.06.016
   Souiri M, 2009, COLLOID SURFACE B, V68, P125, DOI 10.1016/j.colsurfb.2008.07.006
   Souri M., 2012, J ENV SCI ENG A, P924
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Tang ZL, 2010, BIOMATERIALS, V31, P7435, DOI 10.1016/j.biomaterials.2010.06.040
   Vakonakis I, 2007, CURR OPIN CELL BIOL, V19, P578
   Vallieres K, 2007, MACROMOL BIOSCI, V7, P738, DOI 10.1002/mabi.200600267
   Zanina N, 2013, BIOTECHNOL BIOPROC E, V18, P144, DOI 10.1007/s12257-012-0207-y
   Zhang Y, 2007, MAT SCI ENG C-BIO S, V27, P213, DOI 10.1016/j.msec.2006.03.013
NR 43
TC 5
Z9 5
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2015
VL 134
BP 73
EP 80
DI 10.1016/j.colsurfb.2015.06.009
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CS5TU
UT WOS:000362142000010
PM 26149946
DA 2018-10-20
ER

PT J
AU Chen, M
   Zhang, Y
   Zhou, Y
   Zhang, Y
   Lang, MD
   Ye, ZY
   Tan, WS
AF Chen, Min
   Zhang, Yi
   Zhou, Yan
   Zhang, Yan
   Lang, Meidong
   Ye, Zhaoyang
   Tan, Wen-Song
TI Pendant small functional groups on poly(E-caprolactone) substrate
   modulate adhesion, proliferation and differentiation of human
   mesenchymal stem cells
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Poly(epsilon-caprolactone); Small functional groups; Mesenchymal stem
   cells; Cell fate; Tissue engineering
ID SELF-ASSEMBLED MONOLAYERS; SURFACE MODIFICATION; INTEGRIN BINDING;
   CARBOXYL GROUPS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; POLYMER SURFACES;
   CHEMISTRY; BEHAVIOR; MEMBRANES
AB Probing stem cell-biomaterial interactions is of great significance in both gaining profound understanding of stem cell biology and advancing tissue regeneration. In the present work, we developed a series of poly(E-caprolactone) (PCL) films bearing distinct pendant small functional groups to study the effects of biomaterial substrate chemistry on stem cell behaviors. PCL films, bearing hydroxyl (-OH), methyl (-CH3), carboxyl (-COOH) and amino (-NH2), demonstrated varied surface properties, such as wettability, serum protein adsorption and surface topographical feature. In comparison with pristine PCL film, the adhesion of hMSCs on PCL-COOH, PCL-OH and PCL-C=O films was significantly promoted and cells slightly outgrew on PCL-NH2 and PCL-COOH films. Most importantly, the tri-lineage differentiation of hMSCs varied on this series of PCL films, with the best osteogenesis achieved on PCL-NH2 film, PCL and PCL-CH3 films supporting the superior adipogenic differentiation and PCL-CH3 film being the most favorable one for chondrogenesis. This study highlights the critical roles of surface chemistry in modulating the fates of MSCs and potentially provides a practical guidance in developing instructive tissue engineering scaffolds. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Chen, Min; Zhou, Yan; Ye, Zhaoyang; Tan, Wen-Song] E China Univ Sci & Technol, Sch Bioengn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
   [Zhang, Yi; Zhang, Yan; Lang, Meidong] E China Univ Sci & Technol, Sch Mat Sci & Engn, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
RP Ye, ZY (reprint author), E China Univ Sci & Technol, Sch Bioengn, State Key Lab Bioreactor Engn, 130 Mei Long Rd,POB 309, Shanghai 200237, Peoples R China.
EM zhaoyangye@ecust.edu.cn; wstan@ecust.edu.cn
OI Lang, Meidong/0000-0003-2053-9284
FU National Natural Science Foundation of China [31000424, 31170951];
   Shanghai Pujiang Program [10PJ1402200]; Specialized Research Fund for
   the Doctoral Program of Higher Education [20100074120009]
FX This work was financially supported by National Natural Science
   Foundation of China (31000424, 31170951), Shanghai Pujiang Program
   (10PJ1402200), and Specialized Research Fund for the Doctoral Program of
   Higher Education (20100074120009).
CR aoka R., 2010, J BIOMED MATER RES A, V94, P524
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054
   Chieh HF, 2013, J BIOMAT SCI-POLYM E, V24, P94, DOI 10.1163/156856212X626208
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dai WF, 2009, EUR POLYM J, V45, P1659, DOI 10.1016/j.eurpolymj.2009.03.010
   Drevelle O, 2010, BIOMATERIALS, V31, P6468, DOI 10.1016/j.biomaterials.2010.05.010
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Ho M, 2006, BIOMATERIALS, V27, P4333, DOI 10.1016/j.biomaterials.2006.03.037
   Huang XJ, 2005, LANGMUIR, V21, P2941, DOI 10.1021/la047419d
   Ishihara K, 2015, ACS BIOMATER SCI ENG, V1, P103, DOI 10.1021/ab500048w
   Jones JA, 2008, J BIOMED MATER RES A, V86A, P261, DOI 10.1002/jbm.a.31660
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Kuddannaya S, 2013, ACS APPL MATER INTER, V5, P9777, DOI 10.1021/am402903e
   Liu XJ, 2014, ACS APPL MATER INTER, V6, P9733, DOI 10.1021/am502170s
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Sun Y, 2009, ACTA CHIM SINICA, V67, P1259
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474
   Wang C, 2011, J POLYM SCI POL CHEM, V49, P5293, DOI 10.1002/pola.25007
   Wang PY, 2015, ACTA BIOMATER, V11, P58, DOI 10.1016/j.actbio.2014.09.027
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yan JL, 2010, REACT FUNCT POLYM, V70, P400, DOI 10.1016/j.reactfunctpolym.2010.03.008
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Zhang Y, 2014, J POLYM SCI POL CHEM, V52, P188, DOI 10.1002/pola.26987
   Zhang Y, 2012, J COLLOID INTERF SCI, V368, P64, DOI 10.1016/j.jcis.2011.11.010
NR 45
TC 13
Z9 13
U1 3
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2015
VL 134
BP 322
EP 331
DI 10.1016/j.colsurfb.2015.07.018
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CS5TU
UT WOS:000362142000040
PM 26209965
DA 2018-10-20
ER

PT J
AU Jin, YS
   Kundu, B
   Cai, YR
   Kundu, SC
   Yao, JM
AF Jin, Yashi
   Kundu, Banani
   Cai, Yurong
   Kundu, Subhas C.
   Yao, Juming
TI Bio-inspired mineralization of hydroxyapatite in 3D silk fibroin
   hydrogel for bone tissue engineering
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Silk fibroin; Hydrogel; Crystal growth; Hydroxyapatite; Biomaterials;
   Bone tissue engineering
ID CALCIUM-CARBONATE CRYSTALS; POROUS SCAFFOLDS; STEM-CELLS; NUCLEATION;
   GROWTH; FILM; FABRICATION; SYSTEM; MODEL; GRAFT
AB To fabricate hard tissue implants with bone-like structure using a biomimetic mineralization method is drawing much more attentions in bone tissue engineering. The present work focuses in designing 3D silk fibroin hydrogel to modulate the nucleation and growth of hydroxyapatite crystals via a simple ion diffusion method. The study indicates that Ca2+ incorporation within the hydrogel provides the nucleation sites for hydroxyapatite crystals and subsequently regulates their oriented growth. The mineralization process is regulated in a Ca2+ concentration-and minerlization time-dependent way. Further, the compressive strength of the mineralized hydrogels is directly proportional with the mineral content in hydrogel. The orchestrated organic/inorganic composite supports well the viability and proliferation of human osteoblast cells; improved cyto-compatibility with increased mineral content. Together, the present investigation reports a simple and biomimetic process to fabricate 3D bone-like biomaterial with desired efficacy to repair bone defects. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Jin, Yashi; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
   [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kundu, Banani] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Ctr Regenerat Med, Cheonan 330714, South Korea.
   [Kundu, Banani] Dankook Univ, Dept Nanobiomed Sci Plus NBM Global Res BK21, Ctr Regenerat Med, Cheonan 330714, South Korea.
RP Yao, JM (reprint author), 5 Second Ave, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Kundu, Banani/O-9320-2016; Yao, Juming/N-7886-2014
OI Kundu, Banani/0000-0003-1251-700X; Kundu, Subhas C./0000-0002-7170-2291
FU Program for National Natural Science Foundation of China [51172207,
   51202219, 51372226]
FX This work is supported by the Program for National Natural Science
   Foundation of China under Grant [51172207, 51202219 and 51372226]. SCK
   is grateful to Zhejiang Sci-Tech University, Hangzhou for providing
   excellent work facilities during his short stay at Biomacromolecular
   Science Laboratory.
CR Ak F, 2013, BIOMACROMOLECULES, V14, P719, DOI 10.1021/bm3018033
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2014, J MATER CHEM B, V2, P7375, DOI 10.1039/c4tb01301h
   Asenath-Smith E, 2012, ADV FUNCT MATER, V22, P2891, DOI 10.1002/adfm.201200300
   Cai YR, 2010, MATER LETT, V64, P2676, DOI 10.1016/j.matlet.2010.08.071
   Du XJ, 2014, COLLOID SURFACE B, V122, P79, DOI 10.1016/j.colsurfb.2014.06.049
   Ekholm J., 2003, J MATER SCI-MATER M, V14, P913
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Kino R, 2006, J APPL POLYM SCI, V99, P2822, DOI 10.1002/app.22910
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Koh LD, 2015, PROG POLYM SCI, V46, P86, DOI 10.1016/j.progpolymsci.2015.02.001
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu B, 2013, BIOMATERIALS, V34, P9462, DOI 10.1016/j.biomaterials.2013.08.047
   Lee JH, 2013, LANGMUIR, V29, P10940, DOI 10.1021/la402434v
   Li TT, 2013, PROG BIOMATER, V2, DOI 10.1186/2194-0517-2-13
   Li ZY, 2014, CRYSTENGCOMM, V16, P4202, DOI 10.1039/c3ce42517g
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Ma YF, 2013, MAT SCI ENG C-MATER, V33, P2413, DOI 10.1016/j.msec.2013.02.006
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Mottaghitalab F, 2015, J CONTROL RELEASE, V206, P161, DOI 10.1016/j.jconrel.2015.03.020
   Panda N, 2014, J BIOMAT SCI-POLYM E, V25, P1440, DOI 10.1080/09205063.2014.943548
   Pecheva E, 2007, LANGMUIR, V23, P3912, DOI 10.1021/la061593f
   Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   Shi PJ, 2013, BIOMATERIALS, V34, P5947, DOI 10.1016/j.biomaterials.2013.04.046
   Tao JH, 2009, CRYST GROWTH DES, V9, P3154, DOI 10.1021/cg801130w
   Teh T., 2014, 15 INT C BIOM ENG
   Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Yang MY, 2015, J MATER CHEM B, V3, P2455, DOI 10.1039/c4tb01944j
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Yang MY, 2014, BIO-MED MATER ENG, V24, P731, DOI 10.3233/BME-130861
   Yang MY, 2013, J POLYM SCI POL PHYS, V51, P742, DOI 10.1002/polb.23249
   Yao HB, 2014, ADV MATER, V26, P163, DOI 10.1002/adma.201303470
   Zhang FY, 2006, MATER DESIGN, V27, P422, DOI 10.1016/j.matdes.2004.11.007
   Zhang JL, 2014, MATER DESIGN, V53, P1077, DOI 10.1016/j.matdes.2013.08.016
NR 40
TC 15
Z9 16
U1 3
U2 115
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2015
VL 134
BP 339
EP 345
DI 10.1016/j.colsurfb.2015.07.015
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CS5TU
UT WOS:000362142000042
PM 26209967
DA 2018-10-20
ER

PT J
AU Brauner, E
   Guarino, G
   Jamshir, S
   Papi, P
   Valentini, V
   Pompa, V
   Pompa, G
AF Brauner, Edoardo
   Guarino, Giorgio
   Jamshir, Sara
   Papi, Piero
   Valentini, Valentino
   Pompa, Valentina
   Pompa, Giorgio
TI Evaluation of Highly Porous Dental Implants in Postablative Oral and
   Maxillofacial Cancer Patients: A Prospective Pilot Clinical Case Series
   Report
SO IMPLANT DENTISTRY
LA English
DT Article
DE oral cancer; PTTM dental implants; prosthodontic rehabilitation
ID HYPERBARIC-OXYGEN TREATMENT; BONE-GRAFTS; IRRADIATED BONE; FREE FLAPS;
   TANTALUM; REHABILITATION; RECONSTRUCTION; TITANIUM; RESECTION;
   BIOMATERIAL
AB Purpose:The aim of this study was to evaluate the clinical efficacy of new porous tantalum trabecular metal (PTTM)-enhanced titanium dental implants used for the prosthodontic rehabilitation of postablative cancer patients. First-year interim results of a prospective clinical case series are presented.Materials and Methods:A total of 25 PTTM-enhanced titanium implants were placed in both maxillas and mandibles of 6 patients, who met specific inclusion criteria. Resonance frequency analysis was conducted, and implant stability was recorded in Implant Stability Quotient (ISQ) values at implant placement and after 2, 4, 6, and 12 months of functional loading. Bone levels were calculated by digitally measuring the distance from the implant shoulder to the first bone-to-implant on periapical radiographs taken at surgery and after 2, 4, 6, and 12 months of functioning.Results:Cumulative implant survival was 100% (n = 25/25). At implant placement and the 2-, 4-, 6- and 12-month monitoring appointments, mean ISQ values were 72.14 5.61 (range = 50-81), 64.39 +/- 8.12 (range = 44-74), 74.26 +/- 7.14 (range = 44-74), 76.84 +/- 7.65 (range = 60-83), and 78.13 +/- 4.14 (range = 64-84), respectively, and mean crestal marginal bone loss was 0.19 +/- 0.25, 0.22 +/- 0.4, 0.3 +/- 0.46, and 0.57 +/- 0.62 mm, respectively.Conclusions:PTTM-enhanced dental implants were clinically effective in the prosthetic rehabilitation of postoncological patients. Larger long-term follow-up studies will help to evaluate clinical efficacy of PTTM dental implants.
C1 [Brauner, Edoardo; Guarino, Giorgio; Jamshir, Sara; Papi, Piero] Univ Roma La Sapienza, Dept Oral & Maxillofacial Sci, I-00161 Rome, Italy.
   [Valentini, Valentino] Univ Roma La Sapienza, Dept Oral & Maxillofacial Sci, Maxillofacial Specializat Sch, I-00161 Rome, Italy.
   [Pompa, Giorgio] Univ Roma La Sapienza, Implant Prosthet Unit, I-00161 Rome, Italy.
RP Jamshir, S (reprint author), Univ Roma La Sapienza, Dept Oral & Maxillofacial Sci, I-00161 Rome, Italy.
EM sara.jamshir@hotmail.it
OI JAMSHIR, SARA/0000-0001-7537-9850
CR Bencharit S, 2014, CLIN IMPLANT DENT R, V16, P817, DOI 10.1111/cid.12059
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Brauner E, 2012, EUR REV MED PHARMACO, V16, P1882
   Chan MFWY, 1997, INT J ORAL MAX IMPL, V12, P820
   Chang YM, 1998, PLAST RECONSTR SURG, V102, P680, DOI 10.1097/00006534-199809030-00010
   Chiapasco M, 2000, CLIN ORAL IMPLAN RES, V11, P66, DOI 10.1034/j.1600-0501.2000.011001066.x
   Chiapasco M, 1999, IMPLANT DENT, P557
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   De Santis C, 1996, J MATER SCI, V7, P21
   Dholam KP, 2013, IMPLANT DENT, V22, P604, DOI 10.1097/ID.0b013e3182a4d7bc
   Donoff RB, 2006, J ORAL MAXIL SURG, V64, P819, DOI 10.1016/j.joms.2006.01.011
   Esposito M, 2013, COCHRANE DB SYST REV, V9
   Garrett N, 2006, J PROSTHET DENT, V96, P13, DOI 10.1016/j.prosdent.2006.05.010
   Goga D., 1998, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V99, P231
   Goiato MC, 2009, J CRANIOFAC SURG, V20, P2163, DOI 10.1097/SCS.0b013e3181bf014a
   Granstrom G, 2006, J ORAL MAXIL SURG, V64, P812, DOI 10.1016/j.joms.2006.01.012
   Granstrom G, 2005, J ORAL MAXIL SURG, V63, P579, DOI 10.1016/j.joms.2005.01.008
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Harrison AK, 2010, CLIN ORTHOP RELAT R, V468, P2739, DOI 10.1007/s11999-009-1222-y
   Hotz G, 1996, J PROSTHET DENT, V76, P350, DOI 10.1016/S0022-3913(96)90537-5
   Johnsson AA, 1999, INT J ORAL MAX IMPL, V14, P699
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim DG, 2013, IMPLANT DENT, V22, P399, DOI 10.1097/ID.0b013e31829b17b5
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   Kovacs AF, 2000, OTOLARYNG HEAD NECK, V123, P598, DOI 10.1067/mhn.2000.107317
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Linkow L I, 1988, Int J Oral Maxillofac Implants, V3, P109
   Lopez B. C., 2011, J CLIN EXP DENT, V3, pe31
   de la Plata MM, 2012, J ORAL MAXIL SURG, V70, P1052, DOI 10.1016/j.joms.2011.03.032
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Mizbah K, 2012, INT J ORAL MAXILLOF, V42, P651
   Myers R A, 1990, NCI Monogr, P151
   Pompa G, 2012, EUR J INFLAMM, V10, P11, DOI 10.1177/1721727X1201000102
   Pompa V, 2012, EUR REV MED PHARMACO, V16, P407
   Rees TD, 1997, J PERIODONTOL, V68, P791
   Schlee M, 2015, CLIN IMPLANT DENT R, V17, pE308, DOI 10.1111/cid.12127
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Trisi P, 2003, INT J PERIODONT REST, V23, P427
   Verdonck HWD, 2007, INT J ORAL MAX IMPL, V22, P774
   World Health Organization, 2005, GLOB DAT INC OR CANC
   Yang YZ, 2000, J BIOMED MATER RES, V52, P333, DOI 10.1002/1097-4636(200011)52:2<333::AID-JBM12>3.3.CO;2-K
NR 41
TC 10
Z9 10
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD OCT
PY 2015
VL 24
IS 5
BP 631
EP 637
DI 10.1097/ID.0000000000000295
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CS5LN
UT WOS:000362119700020
PM 26115199
DA 2018-10-20
ER

PT J
AU Lesho, E
   Carling, P
   Hosford, E
   Ong, A
   Snesrud, E
   Sparks, M
   Onmus-Leone, F
   Dzialowy, N
   Fraser, S
   Kwak, Y
   Miller, S
   Chukwuma, U
   Julius, M
   McGann, P
   Clifford, R
AF Lesho, Emil
   Carling, Philip
   Hosford, Eve
   Ong, Ana
   Snesrud, Erik
   Sparks, Michael
   Onmus-Leone, Fatma
   Dzialowy, Nicole
   Fraser, Susan
   Kwak, Yoon
   Miller, Sonia
   Chukwuma, Uzo
   Julius, Michael
   McGann, Patrick
   Clifford, Robert
TI Relationships Among Cleaning, Environmental DNA, and
   Healthcare-Associated Infections in a New Evidence-Based Design Hospital
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article
ID ACINETOBACTER-BAUMANNII; STAPHYLOCOCCUS-AUREUS; SURFACES; OPPORTUNITIES;
   TRANSMISSION; ROOM; ACQUISITION; PREVENTION; PATHOGENS; OUTBREAK
AB OBJECTIVE. Hospital environments influence healthcare-associated infection (HAI) patterns, but the role of evidenced-based design (EBD) and residual bacterial DNA (previously thought to be clinically inert) remain incompletely understood.
   METHODS. In a newly built EBD hospital, we used culture-based and culture-free (molecular) assays, pulsed-field gel electrophoresis (PFGE), and whole-genome sequencing (WGS) to determine: (1) patterns of environmental contamination with target organisms (TOs) and multidrug-resistant (MDR) target organisms (MDR-TOs); (2) genetic relatedness between environmentally isolated MDR-TO and those from HAIs; and (3) correlation between surface contamination and HAIs.
   RESULTS. A total of 1,273 high-touch surfaces were swabbed before and after terminal cleaning during 77 room visits. Of the 2,546 paired swabs, 47% had cultivable biomaterial and 42% had PCR-amplifiable DNA. The ratios of TOs detected to surfaces assayed were 85 per 1,273 for the culture-based method and 106 per 1,273 for the PCR-based method. Sinks, toilet rails, and bedside tables most frequently harbored biomaterial. Although cleaned surfaces were less likely to have cultivable TOs than precleaned surfaces, they were not less likely to harbor bacterial DNA. The rate of MDR-TOs to surfaces swabbed was 0.1% (3/2546). Although environmental MDR-TOs and MDR-TOs from HAIs were genetically related by PFGE, WGS revealed that they were unrelated. Environmental levels of cultivable Enterococcus spp. and E. coli DNA were positively correlated with infection incidences (P<.04 and P<.005, respectively).
   CONCLUSION. MDR-TOs were rarely detected during surveillance and were not implicated in HAIs. The roles of environmental DNA and EBD, particularly with respect to water-associated fixtures or the potential suppression of cultivable environmental MDR-TOs, warrant multicenter investigations.
C1 [Lesho, Emil; Hosford, Eve; Ong, Ana; Snesrud, Erik; Sparks, Michael; Onmus-Leone, Fatma; Kwak, Yoon; Julius, Michael; McGann, Patrick; Clifford, Robert] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA.
   [Carling, Philip] Boston Univ, Dept Med, Sch Med, Boston, MA 02215 USA.
   [Dzialowy, Nicole; Chukwuma, Uzo] Navy & Marine Corps Public Hlth Ctr, Epidata Ctr Dept, Portsmouth, VA USA.
   [Fraser, Susan; Miller, Sonia] Ft Belvoir Community Hosp, Ft Belvoir, VA USA.
RP Lesho, E (reprint author), 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
EM carolinelesho@yahoo.com
OI Mc Gann, Patrick/0000-0003-1548-9438
FU Military Infectious Disease Research Program; Congressional War
   Supplement Fund; Global Emerging Infections Surveillance System; US Army
   Medical Research and Materiel Command
FX Financial support: This work was supported by the Military Infectious
   Disease Research Program; the Congressional War Supplement Fund; the
   Global Emerging Infections Surveillance System; and the US Army Medical
   Research and Materiel Command.
CR Bogusz A., 2013, Healthcare Infection, V18, P3, DOI 10.1071/HI12063
   Carling PC, 2008, INFECT CONT HOSP EP, V29, P1, DOI 10.1086/524329
   Carling PC, 2008, INFECT CONT HOSP EP, V29, P1035, DOI 10.1086/591940
   Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558
   Denham ME, 2013, HERD-HEALTH ENV RES, V7, P99, DOI 10.1177/193758671300701S08
   Department of Health and Human Services, 2013, NAT ACT PLAN PREV HE
   Guet-Revillet H, 2012, AM J INFECT CONTROL, V40, P845, DOI 10.1016/j.ajic.2011.10.007
   Hall KK, 2013, HERD-HEALTH ENV RES, V7, P13, DOI 10.1177/193758671300701S03
   Hignett S, 2010, APPL ERGON, V41, P666, DOI 10.1016/j.apergo.2009.12.010
   Hota S, 2009, INFECT CONT HOSP EP, V30, P25, DOI 10.1086/592700
   Huslage K, 2013, INFECT CONT HOSP EP, V34, P211, DOI 10.1086/669092
   Jefferson Julie, 2011, AORN J, V93, P358, DOI 10.1016/j.aorn.2010.08.022
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   Landelle C, 2013, INFECT CONT HOSP EP, V34, P119, DOI 10.1086/669093
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   Manian FA, 2011, INFECT CONT HOSP EP, V32, P667, DOI 10.1086/660357
   McGann P, 2014, MBIO, V5, DOI 10.1128/mBio.00915-14
   Mulvey D, 2011, J HOSP INFECT, V77, P25, DOI 10.1016/j.jhin.2010.08.006
   Overballe-Petersen S, 2013, P NATL ACAD SCI USA, V110, P19860, DOI 10.1073/pnas.1315278110
   Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Rupp ME, 2013, INFECT CONT HOSP EP, V34, P100, DOI 10.1086/668779
   Sattar SA, 2010, AM J INFECT CONTROL, V38, pS34, DOI 10.1016/j.ajic.2010.04.207
   Septimus E, 2014, INFECT CONT HOSP EP, V35, P797, DOI [10.1086/676535, 10.1017/S0899823X00193808]
   Sharpe PA, 2011, HERD-HEALTH ENV RES, V5, P94, DOI 10.1177/193758671100500109
   Stewart M, 2014, INFECT CONT HOSP EP, V35, P1505, DOI 10.1086/678595
   Thom KA, 2012, J CLIN MICROBIOL, V50, P2140, DOI 10.1128/JCM.00448-12
   Weber DJ, 2013, INFECT CONT HOSP EP, V34, P449, DOI 10.1086/670223
   Zimring C, 2013, INFECT CONT HOSP EP, V34, P514, DOI 10.1086/670220
NR 29
TC 2
Z9 4
U1 2
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0899-823X
EI 1559-6834
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD OCT
PY 2015
VL 36
IS 10
BP 1130
EP 1138
DI 10.1017/ice.2015.151
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CS2RV
UT WOS:000361919700002
PM 26152338
DA 2018-10-20
ER

PT J
AU Gouveia, RM
   Hamley, IW
   Connon, CJ
AF Gouveia, Ricardo M.
   Hamley, Ian W.
   Connon, Che J.
TI Bio-fabrication and physiological self-release of tissue equivalents
   using smart peptide amphiphile templates
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; REGENERATIVE MEDICINE;
   ARTICULAR-CARTILAGE; COLLAGEN FIBRILS; CELL; ORGANIZATION; CORNEA;
   SUBSTRATE; ADHESION
AB In this study we applied a smart biomaterial formed from a self-assembling, multi-functional synthetic peptide amphiphile (PA) to coat substrates with various surface chemistries. The combination of PA coating and alignment-inducing functionalised substrates provided a template to instruct human corneal stromal fibroblasts to adhere, become aligned and then bio-fabricate a highly-ordered, multi-layered, three-dimensional tissue by depositing an aligned, native-like extracellular matrix. The newly-formed corneal tissue equivalent was subsequently able to eliminate the adhesive properties of the template and govern its own complete release via the action of endogenous proteases. Tissues recovered through this method were structurally stable, easily handled, and carrier-free. Furthermore, topographical and mechanical analysis by atomic force microscopy showed that tissue equivalents formed on the alignment-inducing PA template had highly-ordered, compact collagen deposition, with a two-fold higher elastic modulus compared to the less compact tissues produced on the non-alignment template, the PA-coated glass. We suggest that this technology represents a new paradigm in tissue engineering and regenerative medicine, whereby all processes for the bio-fabrication and subsequent self-release of natural, bio-prosthetic human tissues depend solely on simple template-tissue feedback interactions.
C1 [Gouveia, Ricardo M.; Connon, Che J.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Hamley, Ian W.] Univ Reading, Dept Chem, Reading RG6 6AD, Berks, England.
RP Connon, CJ (reprint author), Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM che.connon@newcastle.ac.uk
RI Hamley, Ian/D-1643-2009; Connon, Che/B-3128-2012
OI Hamley, Ian/0000-0002-4549-0926; Connon, Che/0000-0001-8264-6531;
   Gouveia, Ricardo/0000-0002-2968-1298
FU Biotechnology and Biological Sciences Research Council (BBSRC Grant)
   [BB/I008187/1]; Biotechnology and Biological Sciences Research Council
   [BB/I008187/1, BB/I008187/2]
FX We thank Dr C. A. Bipes from Nanosurf AG, Switzerland for his expert
   technical support in atomic force microscopy. This work was funded by
   the Biotechnology and Biological Sciences Research Council (BBSRC Grant
   Reference BB/I008187/1).
CR Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90
   Aranaz I, 2014, J MATER CHEM B, V2, P3839, DOI 10.1039/c4tb00371c
   Boekhoven J, 2014, ADV MATER, V26, P1642, DOI 10.1002/adma.201304606
   Chen B, 2012, SOFT MATTER, V8, P8379, DOI 10.1039/c2sm26175h
   Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012
   Dehsorkhi A, 2015, SOFT MATTER, V11, P3115, DOI 10.1039/c5sm00459d
   Dworak A, 2014, J MATER SCI-MATER M, V25, P1149, DOI 10.1007/s10856-013-5135-7
   Foster JW, 2014, EXP EYE RES, V127, P37, DOI 10.1016/j.exer.2014.06.020
   Gouveia RM, 2015, TISSUE ENG PT A, V21, P1772, DOI [10.1089/ten.tea.2014.0671, 10.1089/ten.TEA.2014.0671]
   Gouveia RM, 2013, J MATER CHEM B, V1, P6157, DOI 10.1039/c3tb21031f
   Gouveia RM, 2013, INVEST OPHTH VIS SCI, V54, P7483, DOI 10.1167/iovs.13-13092
   Hama T, 2017, J TISSUE ENG REGEN M, V11, P1089, DOI 10.1002/term.2012
   Hamley IW, 2015, CHEM COMMUN, V51, P8574, DOI 10.1039/c5cc01535a
   Hamley IW, 2010, J PHYS CHEM B, V114, P8244, DOI 10.1021/jp101374e
   Hayashida Y, 2006, INVEST OPHTH VIS SCI, V47, P552, DOI 10.1167/iovs.05-0995
   Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598
   Hruschka V, 2015, TISSUE ENG PT A, V21, P310, DOI [10.1089/ten.TEA.2013.0710, 10.1089/ten.tea.2013.0710]
   Jones RR, 2014, INSTRUCTIVE BIOMATER, P73
   KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244
   Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013
   Lin DC, 2008, SOFT MATTER, V4, P669, DOI 10.1039/b714637j
   Liu JS, 2012, TRENDS CELL BIOL, V22, P683, DOI 10.1016/j.tcb.2012.09.004
   Lombardo M, 2012, INVEST OPHTH VIS SCI, V53, P1050, DOI 10.1167/iovs.11-8720
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Matsuura K, 2014, J CONTROL RELEASE, V190, P228, DOI 10.1016/j.jconrel.2014.05.024
   Miotto M, 2015, J FUNCT BIOMATER, V6, P687, DOI 10.3390/jfb6030687
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Sakaguchi K, 2015, J CONTROL RELEASE, V205, P83, DOI 10.1016/j.jconrel.2014.12.016
   Samchenko Y, 2011, ADV COLLOID INTERFAC, V168, P247, DOI 10.1016/j.cis.2011.06.005
   Sekiya S, 2013, REGEN MED, V8, P371, DOI [10.2217/RME.13.16, 10.2217/rme.13.16]
   Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007
   WITTMANN JC, 1991, NATURE, V352, P414, DOI 10.1038/352414a0
NR 34
TC 4
Z9 4
U1 1
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2015
VL 26
IS 10
AR 242
DI 10.1007/s10856-015-5581-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS9OA
UT WOS:000362419200003
PM 26411438
DA 2018-10-20
ER

PT J
AU Perez-Tanoira, R
   Kinnari, TJ
   Hyyrynen, T
   Soininen, A
   Pietola, L
   Tiainen, VM
   Konttinen, YT
   Aarnisalo, AA
AF Perez-Tanoira, R.
   Kinnari, T. J.
   Hyyrynen, T.
   Soininen, A.
   Pietola, L.
   Tiainen, V. -M.
   Konttinen, Y. T.
   Aarnisalo, A. A.
TI Effects of S53P4 bioactive glass on osteoblastic cell and biomaterial
   surface interaction
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MIDDLE-EAR; IN-VITRO; CHRONIC OSTEOMYELITIS; GAS-COMPOSITION; BONE;
   ADHESION; MICROORGANISMS; OBLITERATION; INFECTION; BACTERIA
AB To study the effect of bioactive glass bone substitute granules (S53P4) and hypoxic atmospheric conditions on human osteoblastic cell adhesion on different biomaterials. Cellular adhesion and cytoskeletal organization were studied on titanium, polytetrafluoroethylene, polydimethylsiloxane and S53P4 plates in the presence or absence of S53P4 granules. Cells used were human osteoblast-like SaOS-2 cells. The experiments were done either in normal atmospheric conditions or in hypoxia which simulates conditions prevailing in chronically infected bone or bone cavities. Vinculin-containing focal adhesions, organization of actin cytoskeleton and nuclear staining of cells on biomaterial surfaces were studied at 4.5 h, 2 and 4 days. In normoxic conditions S53P4 granules alkalinized the cell culture medium but cellular adhesion and cytoskeletal organization were usually not affected by their presence. Hypoxic conditions associated with lower pH and impaired cellular adhesion, vinculin-containing focal adhesion formation and rearrangement of the actin filaments to actin cytoskeleton. On most materials studied in hypoxic conditions, however, S53P4 granules prevented this impairment of cellular adhesion and cytoskeletal reorganization. The S53P4 granules promote the adhesion of SaOS-2 cells to various biomaterial surfaces especially in hypoxic conditions, in which S53P4 granules increase pH. The presence of S53P4 granules may protect biomaterial surface from bacterial colonization and promote osteointegration of implants used together with S53P4 granules for fixation and weight bearing.
C1 [Perez-Tanoira, R.; Kinnari, T. J.; Hyyrynen, T.; Pietola, L.; Aarnisalo, A. A.] Univ Helsinki, Otorhinolaryngol Head & Neck Surg, Hus Helsinki 00029, Finland.
   [Perez-Tanoira, R.; Kinnari, T. J.; Hyyrynen, T.; Pietola, L.; Konttinen, Y. T.; Aarnisalo, A. A.] Helsinki Univ Hosp, Helsinki 00029, Finland.
   [Perez-Tanoira, R.] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Madrid, Spain.
   [Soininen, A.; Tiainen, V. -M.; Konttinen, Y. T.] ORTON Res Inst, Helsinki, Finland.
   [Soininen, A.; Tiainen, V. -M.; Konttinen, Y. T.] ORTON Orthoped Hosp, Helsinki, Finland.
   [Konttinen, Y. T.] Univ Helsinki, Dept Med, Helsinki, Finland.
   [Konttinen, Y. T.] COXA Hosp Joint Replacement, Tampere, Finland.
RP Perez-Tanoira, R (reprint author), Univ Helsinki, Otorhinolaryngol Head & Neck Surg, Haartmaninkatu 4 E, Hus Helsinki 00029, Finland.
EM ramontanoira@hotmail.com
RI Perez Tanoira, Ramon/K-4898-2014
OI Perez Tanoira, Ramon/0000-0002-9816-3208
FU FinskaLakaresallskapet; Sigrid Juselius Foundation; Helsinki University
   Hospital
FX This project was financially supported by the FinskaLakaresallskapet,
   Sigrid Juselius Foundation, and the special subsidiary funding of the
   Helsinki University Hospital.
CR Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Baxter L. C., 2002, European Cells & Materials, V4, P1
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Cui X, 2014, J MATER SCI-MATER M, V25, P733, DOI 10.1007/s10856-013-5122-z
   DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104
   Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584
   FELDING JU, 1987, SCAND J CLIN LAB INV, V47, P31
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HERGILS L, 1990, ACTA OTO-LARYNGOL, V110, P92, DOI 10.3109/00016489009122520
   Issing PR, 1996, LARYNGO RHINO OTOL, V75, P727, DOI 10.1055/s-2007-997666
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   LEHTO VP, 1985, CELL DIFFER DEV, V16, P153, DOI 10.1016/0045-6039(85)90512-3
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   LUNTZ M, 1995, LARYNGOSCOPE, V105, P510, DOI 10.1288/00005537-199505000-00012
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   OSTFELD EJ, 1991, ARCH OTOLARYNGOL, V117, P1390
   Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Soininen A, 2014, J BIOMED MATER RES B, V102, P1462, DOI 10.1002/jbm.b.33125
   Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034
   Stoor P, 1999, J BIOMED MATER RES, V48, P869, DOI 10.1002/(SICI)1097-4636(1999)48:6<869::AID-JBM16>3.3.CO;2-Y
   Stoor P, 2001, J BIOMED MATER RES, V58, P113, DOI 10.1002/1097-4636(2001)58:1<113::AID-JBM170>3.0.CO;2-V
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Stoor P, 2010, ANN OTO RHINOL LARYN, V119, P377, DOI 10.1177/000348941011900603
   Suominen E, 1996, SCAND J PLAST RECONS, V30, P281, DOI 10.3109/02844319609056406
   Wilson J, 1993, J Oral Implantol, V19, P295
   Yung M, 2011, J LARYNGOL OTOL, V125, P221, DOI 10.1017/S0022215110002343
   Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183
NR 32
TC 4
Z9 4
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2015
VL 26
IS 10
AR 246
DI 10.1007/s10856-015-5568-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS9OA
UT WOS:000362419200007
PM 26411442
DA 2018-10-20
ER

PT J
AU Romano, CL
   Scarponi, S
   Gallazzi, E
   Romano, D
   Drago, L
AF Romano, Carlo Luca
   Scarponi, Sara
   Gallazzi, Enrico
   Romano, Delia
   Drago, Lorenzo
TI Antibacterial coating of implants in orthopaedics and trauma: a
   classification proposal in an evolving panorama
SO JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH
LA English
DT Review
DE Orthopaedics; Trauma; Implant; Joint; Prosthesis; Biofilm; Infection;
   Coating; Antibacterial; Classification
ID PERIPROSTHETIC JOINT INFECTION; SURGICAL SITE INFECTION; LOADED
   BONE-CEMENT; BACTERIAL ADHESION; BIOFILM FORMATION; IN-VITRO; SURFACE;
   TITANIUM; RISK; BIOMATERIALS
AB Implanted biomaterials play a key role in current success of orthopedic and trauma surgery. However, implant-related infections remain among the leading reasons for failure with high economical and social associated costs. According to the current knowledge, probably the most critical pathogenic event in the development of implant-related infection is biofilm formation, which starts immediately after bacterial adhesion on an implant and effectively protects the microorganisms from the immune system and systemic antibiotics. A rationale, modern prevention of biomaterial-associated infections should then specifically focus on inhibition of both bacterial adhesion and biofilm formation. Nonetheless, currently available prophylactic measures, although partially effective in reducing surgical site infections, are not based on the pathogenesis of biofilm-related infections and unacceptable high rates of septic complications, especially in high-risk patients and procedures, are still reported.
   In the last decade, several studies have investigated the ability of implant surface modifications to minimize bacterial adhesion, inhibit biofilm formation, and provide effective bacterial killing to protect implanted biomaterials, even if there still is a great discrepancy between proposed and clinically implemented strategies and a lack of a common language to evaluate them.
   To move a step forward towards a more systematic approach in this promising but complicated field, here we provide a detailed overview and an original classification of the various technologies under study or already in the market. We may distinguish the following: 1. Passive surface finishing/modification (PSM): passive coatings that do not release bactericidal agents to the surrounding tissues, but are aimed at preventing or reducing bacterial adhesion through surface chemistry and/or structure modifications; 2. Active surface finishing/modification (ASM): active coatings that feature pharmacologically active pre-incorporated bactericidal agents; and 3. Local carriers or coatings (LCC): local antibacterial carriers or coatings, biodegradable or not, applied at the time of the surgical procedure, immediately prior or at the same time of the implant and around it. Classifying different technologies may be useful in order to better compare different solutions, to improve the design of validation tests and, hopefully, to improve and speed up the regulatory process in this rapidly evolving field.
C1 [Romano, Carlo Luca; Scarponi, Sara; Gallazzi, Enrico; Romano, Delia] IRCCS, Galeazzi Orthopaed Inst, Dept Reconstruct Surg, Osteoarticular Infect CRIO Unit, I-20161 Milan, Italy.
   [Drago, Lorenzo] IRCCS, Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, I-20161 Milan, Italy.
RP Romano, CL (reprint author), IRCCS, Galeazzi Orthopaed Inst, Dept Reconstruct Surg, Osteoarticular Infect CRIO Unit, Via R Galeazzi 4, I-20161 Milan, Italy.
EM carlo.romano@grupposandonato.it
OI Gallazzi, Enrico/0000-0001-9287-9937; ROMANO, CARLO
   LUCA/0000-0001-6726-0593
FU DePuySynthes Inc.; Zimmer-Biomet Inc.; Link Italia Srl; Heraeus GmbH;
   Tecres SpA; AdlerOrtho Srl
FX CLR is a co-inventor of the DAC hydrogel technology and has received
   reimbursements, fees, and funding from the following companies, involved
   in the development of some of the technologies cited in the text:
   DePuySynthes Inc., Zimmer-Biomet Inc., Link Italia Srl, Heraeus GmbH,
   Tecres SpA, AdlerOrtho Srl. LD has received reimbursements, fees, and
   funding from the following companies, involved in the development of
   some of the technologies cited in the text: Zimmer-Biomet Inc., Heraeus
   GmbH. DR, EG, and SS have no competing interests.
CR Aggarwal VK, 2014, J KNEE SURG, V27, P399, DOI 10.1055/s-0033-1364102
   Aggarwal VK, 2013, J ARTHROPLASTY, V28, P193, DOI [10.1016/j.arth.2013.09.028, 10.1016/j.arth.2012.06.023]
   Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1997, J BONE JOINT SURG BR, V79B, P816, DOI 10.1302/0301-620X.79B5.7228
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Arenas MA, 2013, COLLOID SURFACE B, V105, P106, DOI 10.1016/j.colsurfb.2012.12.051
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Berbari EF, 2012, INFECT CONT HOSP EP, V33, P774, DOI 10.1086/666641
   Boot W, 2015, EUROPEAN CELLS MA S2, V30, P19
   Braem A, 2014, J BIOMED MATER RES A, V102, P215, DOI 10.1002/jbm.a.34688
   Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095
   Buchholz HW, 1970, CHIRURG, V41, p511e5
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Buttaro MA, 2005, J BONE JT SURG BR, V87, p314e9
   Campbell AA, 2000, J BIOMED MAT RES, V53, p400e7
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Cats-Baril W, 2013, CLIN ORTHOP RELAT R, V471, P4065, DOI 10.1007/s11999-013-3329-4
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Costa F, 2014, ACTA BIOMATER, DOI [10.1016/j.actbio.2014.02.028, DOI 10.1016/J.ACTBI0.2014.02.028]
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   Dale H, 2009, ACTA ORTHOP, V80, P639, DOI 10.3109/17453670903506658
   De Grood MP, 1951, ARCH CHIR NEERL, V3
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521
   Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1
   DUNBAR MJ, 2009, ORTHOPEDICS, P32, DOI DOI 10.3928/01477447-20090728-20
   Engelsman AF, 2010, BIOFOULING, V26, P761, DOI 10.1080/08927014.2010.515027
   Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135
   Fei J, 2011, J MATER SCI-MATER M, V22, P989, DOI 10.1007/s10856-011-4277-8
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Fuchs T, 2011, ARCH ORTHOP TRAUM SU, V131, P1419, DOI 10.1007/s00402-011-1321-6
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Gautier H, 2000, BIOMATERIALS, V21, P243, DOI 10.1016/S0142-9612(99)00139-8
   Giavaresi G, 2014, INT ORTHOP, V38, P1505, DOI 10.1007/s00264-013-2237-2
   Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003
   Gutowski CJ, 2014, BONE JOINT J, V96B, P65, DOI 10.1302/0301-620X.96B1.31428
   Haney EF, 2013, BIOPOLYMERS, V100, P572, DOI 10.1002/bip.22250
   Hardes J, 2010, J SURG ONCOL, V101, P389, DOI 10.1002/jso.21498
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hensler D, 2013, J BONE JOINT SURG AM, V95A, P2029, DOI 10.2106/JBJS.L.01315
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   HEYDEMANN JS, 1986, CLIN ORTHOP RELAT R, P184
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406
   Hold V., 2006, SCRIPTA MED, V79, P169
   Holinka J, 2013, BONE JOINT J, V95B, P678, DOI 10.1302/0301-620X.95B5.31216
   Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Humphreys H, 2012, J HOSP INFECT, V81, P71, DOI 10.1016/j.jhin.2012.03.007
   Jamsen E, 2010, ACTA ORTHOP, V81, p660e6
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jennison T, 2014, ACTA BIOMATER, V10, P595, DOI 10.1016/j.actbio.2013.09.019
   Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847
   Kozlovsky A, 2006, J PERIODONTOL, V77, P1194, DOI 10.1902/jop.2006.050401
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI [10.2217/FMB.13.7, 10.2217/fmb.13.7]
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Logoluso N, 2015, EUROPEAN CELLS MA S2, V30, P35
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Martynkova GS, 2014, J NANOSCI NANOTECHNO, V14, P673, DOI 10.1166/jnn.2014.8903
   Mijnendonckx K, 2013, BIOMETALS, V26, P609, DOI 10.1007/s10534-013-9645-z
   Moriarty TF, 2010, J MATER SCI-MATER M, V21
   Moseke C, 2011, J MATER SCI-MATER M, V22, P2711, DOI 10.1007/s10856-011-4457-6
   Muszanska AK, 2014, BIOMACROMOLECULES, V15, P2019, DOI 10.1021/bm500168s
   Namba RS, 2012, J BONE JOINT SURG BR, V94B, P1330, DOI 10.1302/0301-620X.94B10.29184
   Neut D, 2005, ACTA ORTHOP, V76, P109, DOI 10.1080/00016470510030427
   Neut D, 2012, J BIOMED MATER RES A, V100A, P3220, DOI 10.1002/jbm.a.34258
   Noda I, 2009, J BIOMED MATER RES B, V89B, P456, DOI 10.1002/jbm.b.31235
   Oh S, 2013, J NANOMATER, V2013, P1
   Overstreet D, 2015, CLIN ORTHOP RELAT R, V473, P337, DOI 10.1007/s11999-014-3935-9
   Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065
   Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pitarresi G, 2013, INT J PHARMACEUT, V449, P84, DOI 10.1016/j.ijpharm.2013.03.059
   Pruzansky JS, 2014, J ARTHROPLASTY, V29, P272, DOI 10.1016/j.arth.2013.06.019
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Rivardo F, 2009, APPL MICROBIOL BIOT, V83, P541, DOI 10.1007/s00253-009-1987-7
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   Romano CL, 2014, PERI OPERATIVE MED M, P269, DOI [10.1007/978-3-319-07203-6, DOI 10.1007/978-3-319-07203-6]
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Shchukin D, 2013, SCIENCE, V341, P1458, DOI 10.1126/science.1242895
   Shi XW, 2013, J BIOMED MATER RES A, V101, P1373, DOI 10.1002/jbm.a.34432
   Shtansky DV, 2006, BIOMATERIALS, V27, P3519, DOI 10.1016/j.biomaterials.2006.02.012
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Stoodley P., 2013, BIOMATERIALS SCI INT, P565
   Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf
   Tang YW, 2012, J BIOMED MATER RES A, V100A, P2071, DOI 10.1002/jbm.a.34116
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tran PA, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S21729
   Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   van de Belt H, 2001, BIOMATERIALS, V22, P1607, DOI 10.1016/S0142-9612(00)00313-6
   Wafa H, 2015, BONE JOINT J, V97B, P252, DOI 10.1302/0301-620X.97B2.34554
   Wagner C, 2011, INT J ARTIF ORGANS, V34, P811, DOI 10.5301/ijao.5000061
   Wang Y, 2012, BIOFOULING, V28, P1011, DOI 10.1080/08927014.2012.725471
   Yamamura K, 1992, J BIOMED MATER RES, V26
   Yang CC, 2013, MAT SCI ENG C-MATER, V33, P2203, DOI 10.1016/j.msec.2013.01.038
   Yeo IS, 2012, INT J ARTIF ORGANS, V35, P762, DOI 10.5301/ijao.5000154
   Yount NY, 2012, ANNU REV PHARMACOL, V52, P337, DOI 10.1146/annurev-pharmtox-010611-134535
   Yu JC, 2003, ENVIRON SCI TECHNOL, V37, P2296, DOI 10.1021/es0259483
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Zhang F, 2008, BIOMATERIALS, V29, P4751, DOI 10.1016/j.biomaterials.2008.08.043
   Zhu H, 2014, CHEM COMMUN, V50, P3900, DOI 10.1039/c3cc47818a
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
   Zmistowski B, 2013, J BONE JOINT SURG AM, V95A, P2177, DOI 10.2106/JBJS.L.00789
NR 118
TC 37
Z9 38
U1 0
U2 52
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-799X
J9 J ORTHOP SURG RES
JI J. Orthop. Surg. Res.
PD OCT 1
PY 2015
VL 10
AR 157
DI 10.1186/s13018-015-0294-5
PG 11
WC Orthopedics
SC Orthopedics
GA CS4TJ
UT WOS:000362068500003
PM 26429342
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yukseloglu, SM
   Sokmen, N
   Canoglu, S
AF Yukseloglu, S. Muge
   Sokmen, Nihal
   Canoglu, Suat
TI Biomaterial applications of silk fibroin electrospun nanofibres
SO MICROELECTRONIC ENGINEERING
LA English
DT Article
DE Biomaterial; Silk; Fibroin; Electrospinning; Nanofibre
ID BOMBYX-MORI SILK; IN-VITRO; EXTRACELLULAR-MATRIX; VASCULAR GRAFTS;
   DRUG-DELIVERY; CELL-GROWTH; SCAFFOLDS; FIBERS; MEMBRANES; CHITOSAN
AB Electrospinning has been very interesting for the recent years and is used since 1994. Today, continuous ultra-fine fibres can be formed with the help of electrical forces to produce various polymer fibres at nanometre scale diameters. Here, it is aimed to discuss this process, for silk fibroin nanofibres and their applications. Silk can be varied in composition, structure and properties. Bombyx mori is one of the most studied silk which is widely used as a suture in biomaterial applications. This study focuses on a review of silk fibroin nanofibres and their biomaterial applications. Also, both electrospinning method, the selection of a solvent for the process and SF (silk fibroin) electrospun nanofibre fabrication methods are discussed. Additionally, some studies using SF as biomaterial methods are discussed for tissue engineering applications in this manuscript. It is noteworthy that SF fibres in biomaterials have increased over the last decade due to its excellent mechanical properties, water and thermal resistance, biodegradability and biocompatibility with a variety of end-use in the biomaterials. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Yukseloglu, S. Muge; Sokmen, Nihal; Canoglu, Suat] Marmara Univ, Fac Technol, Dept Text Engn, TR-34722 Istanbul, Turkey.
RP Yukseloglu, SM (reprint author), Marmara Univ, Fac Technol, Dept Text Engn, TR-34722 Istanbul, Turkey.
EM myuksseloglu@marmara.edu.tr
FU Marmara University [FEN-D-090414-0114]
FX Authors are grateful for the funding by Scientific Research Project
   Unite (FEN-D-090414-0114) of Marmara University.
CR Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anitha A., 2014, PROG POLYM SCI
   Ashammakhi N, 2007, J NANOSCI NANOTECHNO, V7, P862, DOI 10.1166/jnn.2007.485
   Aytemiz D, 2014, BIOL INSPIR SYST, V5, P69, DOI 10.1007/978-94-007-7119-2_4
   Ayutsede J. E., 2005, THESIS DREXEL U, P7
   Bunsell A. R., 2009, HDB TENSILE PROPERTI, V91, P9
   CAPPELLO J, 1994, ACS SYM SER, V544, P311
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen F, 2008, J BIOMAT SCI-POLYM E, V19, P677, DOI 10.1163/156856208784089661
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Chutipakdeevong J., 2013, J APPL POLYM SCI, P3634
   Duan B, 2007, J BIOMAT SCI-POLYM E, V18, P95, DOI 10.1163/156856207779146105
   Elakkiya T, 2014, POLYM INT, V63, P100, DOI 10.1002/pi.4499
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Gulrajani M., 1992, REV PROG COLOR RELAT, V22, P79, DOI DOI 10.1111/J.14784408.1992.TB00091.X
   Han F, 2014, ACTA BIOMATER, V10, P921, DOI 10.1016/j.actbio.2013.09.026
   He JH, 2007, CHAOS SOLITON FRACT, V33, P26, DOI 10.1016/j.chaos.2006.09.023
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Jeong L, 2006, INT J BIOL MACROMOL, V38, P140, DOI 10.1016/j.ijbiomac.2006.02.009
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kaplan DL, 2002, ADV DRUG DELIV REV, V54, P1131, DOI DOI 10.1016/S0169-409X(02)00061-3
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Karaca E., 2014, WORKSHOP NANOFIBRE P
   Khanam N, 2007, ACTA BIOMATER, V3, P1050, DOI 10.1016/j.actbio.2007.06.005
   Ki CS, 2007, J MEMBRANE SCI, V302, P20, DOI 10.1016/j.memsci.2007.06.003
   Ki CS, 2007, J APPL POLYM SCI, V105, P1605, DOI 10.1002/app.26176
   Kim KW, 2004, FIBER POLYM, V5, P122, DOI 10.1007/BF02902925
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Li D, 2006, J AM CERAM SOC, V89, P1861, DOI 10.1111/j.1551-2916.2006.00989.x
   Li Y., 2006, BIOMECHANICAL ENG TE, P164
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Mhuka V, 2013, INT J BIOL MACROMOL, V52, P305, DOI 10.1016/j.ijbiomac.2012.09.010
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mohammadi Y, 2007, INT J ARTIF ORGANS, V30, P204
   Nogueira GM, 2010, BIORESOURCE TECHNOL, V101, P8446, DOI 10.1016/j.biortech.2010.06.064
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P2665, DOI 10.1021/bm7006983
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Sheikh F. A., 2013, J BIOMED MATER RES A, V00A, P1
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Sukigara S, 2004, POLYMER, V45, P3701, DOI 10.1016/j.polymer.2004.03.059
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   Teo WE, 2005, NANOTECHNOLOGY, V16, P918, DOI 10.1088/0957-4484/16/6/049
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2006, MACROMOLECULES, V39, P1102, DOI 10.1021/ma0517749
   YIN G, 2009, J APPL POLYM SCI, V111, P1471
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhou WT, 2011, IRAN POLYM J, V20, P389
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
NR 66
TC 7
Z9 9
U1 1
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
EI 1873-5568
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD OCT 1
PY 2015
VL 146
BP 43
EP 47
DI 10.1016/j.mee.2015.04.008
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA CS5QP
UT WOS:000362133300009
DA 2018-10-20
ER

PT J
AU Majumder, S
   Kaulaskar, MD
   Neogi, S
AF Majumder, Soumyadip
   Kaulaskar, Mahadev D.
   Neogi, Sudarsan
TI "Biosteel": an exciting product from nature that is superior to many
   manmade alternatives
SO REVIEWS IN CHEMICAL ENGINEERING
LA English
DT Review
DE biodegradable; biosteel; recombinant spider silk; spider dragline silk;
   transgenic goat
ID SPIDER DRAGLINE SILK; CONSERVED C-TERMINI; X-RAY-DIFFRACTION;
   MECHANICAL-PROPERTIES; BIOMATERIAL COATINGS; FLAGELLIFORM SILK;
   ESCHERICHIA-COLI; DRUG-DELIVERY; BOMBYX-MORI; PROTEIN
AB Biotechnology continues to offer routes for many exciting and unique products. Researchers genetically altered goats with a spider gene. These goats produce milk that contains a protein that can be extracted to produce biosteel fibers for use in bulletproof vests. It is referred to as "biosteel" to highlight its strength comparable to steel. This review paper describes the important aspects of produced dragline spider silk proteins via cell culture techniques using silk genes derived from two species of weaving spiders. These fibers were tested for a number of mechanical properties and compared to natural spider silk. In effect, fibers of biosteel were able to absorb similar amounts of energy as natural spider silk by stretching further. As opposed to most other synthetic fibers, biosteel is ecofriendly both in terms of its composition and production process.
C1 [Majumder, Soumyadip; Kaulaskar, Mahadev D.; Neogi, Sudarsan] Indian Inst Technol, Dept Chem Engn, Kharagpur 721302, W Bengal, India.
RP Neogi, S (reprint author), Indian Inst Technol, Dept Chem Engn, Kharagpur 721302, W Bengal, India.
EM sneogi@che.iitkgp.ernet.in
CR Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Cassinelli C, 2006, INT J ARTIF ORGANS, V29, P881
   Chung H, 2012, CURR OPIN BIOTECH, V23, P957, DOI 10.1016/j.copbio.2012.03.013
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   GORDON JE, 1978, STRUCTURES WHY THING, P395
   Gordon JE, 1988, SCI STRUCTURES MAT, P217
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gould P., 2002, MATER TODAY, V5, P42
   Grubb DT, 1999, INT J BIOL MACROMOL, V24, P203, DOI 10.1016/S0141-8130(98)00086-5
   Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hawthorn AC, 2003, J EXP BIOL, V206, P3905, DOI 10.1242/jeb.00618
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 2001, BIOESSAYS, V23, P750, DOI 10.1002/bies.1105
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0
   Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Li A, 2001, EUR J BIOCHEM, V268, P6600
   Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020
   Mayes EL, 1998, ADV MATER, V10, P801, DOI 10.1002/(SICI)1521-4095(199807)10:10<801::AID-ADMA801>3.0.CO;2-I
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Mukhopadhyay S, 2005, J IND TEXT, V35, P91
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Romer L, 2008, PRION, V2, P154
   Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tai P-L, 2004, INT J BIOL MACROMOL, V34, P237
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Termonia Y, 2000, MOL MODELING STRESS, P335
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   van Beek JD, 1999, INT J BIOL MACROMOL, V24, P173, DOI 10.1016/S0141-8130(98)00083-X
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Vincent J, 1982, STRUCTURAL BIOMATERI, P204
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P387, DOI 10.1098/rspb.1996.0059
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Wainwright SA, 1982, MECH DESIGN ORGANISM, P423
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   WORK RW, 1982, TEXT RES J, V52, P349, DOI 10.1177/004051758205200508
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
   Xiao XX, 2010, P NATL ACAD SCI USA, V107, P14059
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yasutomo N., 2002, J APPL POLYM SCI, V86, P3425
NR 82
TC 0
Z9 0
U1 9
U2 83
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0167-8299
EI 2191-0235
J9 REV CHEM ENG
JI Rev. Chem. Eng.
PD OCT
PY 2015
VL 31
IS 5
BP 509
EP 519
DI 10.1515/revce-2014-0055
PG 11
WC Engineering, Chemical
SC Engineering
GA CS2MG
UT WOS:000361904400005
DA 2018-10-20
ER

PT J
AU Ahearne, M
   Lynch, AP
AF Ahearne, Mark
   Lynch, Amy P.
TI Early Observation of Extracellular Matrix-Derived Hydrogels for Corneal
   Stroma Regeneration
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; LINKED COLLAGEN HYDROGELS; COMPRESSED
   COLLAGEN; GROWTH-FACTOR; PLASTIC COMPRESSION; EPITHELIAL-CELLS;
   ELASTIC-MODULUS; RETINOIC ACID; ASCORBIC-ACID; SILK FIBROIN
AB A lack of healthy transplantable tissue to treat corneal blindness has led researchers to investigate the development and application of different scaffold materials for corneal tissue engineering and regeneration. In this study, hydrogels fabricated from decellularized corneal extracellular matrix were developed as a new approach to corneal stromal tissue regeneration. Porcine corneas were decellularized using a technique that combined freeze-thaw cycles with a nuclease treatment. The corneas were then freeze-dried, milled, and digested in an acidic pepsin solution that was used to form a hydrogel after adjusting the pH and gelation temperature. The resultant corneal matrix hydrogels (CMHs) were seeded with human corneal stromal cells and cultured for several days. When compared to collagens hydrogels, CMHs had superior optical transparency, similar mechanical properties, and were better able to retain the stromal cells native keratocyte phenotype. The CMHs also supported cell viability and proliferation and contained sulfated glycosaminoglycan, a vital constituent, for maintaining corneal transparency. These results suggest that the CMHs could provide an exceptional biomaterial for corneal stroma regeneration.
C1 [Ahearne, Mark; Lynch, Amy P.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Ahearne, Mark; Lynch, Amy P.] Univ Dublin Trinity Coll, Sch Engn, Dept Mech & Mfg Engn, Dublin 2, Ireland.
RP Ahearne, M (reprint author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
EM ahearnm@tcd.ie
RI ahearne, mark/C-2745-2014
OI Ahearne, Mark/0000-0002-4540-4434
FU Science Foundation Ireland; Marie Curie Action COFUND [11/SIRG/B2104]
FX This publication has emanated from research conducted with the financial
   support of Science Foundation Ireland & the Marie Curie Action COFUND
   under Grant Number 11/SIRG/B2104.
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Ahearne M, 2008, BRIT J OPHTHALMOL, V92, P268, DOI 10.1136/bjo.2007.130104
   Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   Ahearne M, 2010, TISSUE ENG PART C-ME, V16, P319, DOI [10.1089/ten.tec.2008.0650, 10.1089/ten.TEC.2008.0650]
   Ahearne M, 2010, EXP EYE RES, V91, P584, DOI 10.1016/j.exer.2010.07.013
   Ahn JI, 2013, ACTA BIOMATER, V9, P7796, DOI 10.1016/j.actbio.2013.04.014
   Borderie VM, 1999, GRAEF ARCH CLIN EXP, V237, P861, DOI 10.1007/s004170050324
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Fagerholm P, 2014, BIOMATERIALS, V35, P2420, DOI 10.1016/j.biomaterials.2013.11.079
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Gouveia RM, 2013, INVEST OPHTH VIS SCI, V54, P7483, DOI 10.1167/iovs.13-13092
   Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216
   Haber M, 2003, VET OPHTHALMOL, V6, P211, DOI 10.1046/j.1463-5224.2003.00296.x
   Hadjipanayi E, 2011, J TISSUE ENG REGEN M, V5, P505, DOI 10.1002/term.343
   HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373
   Inayama S, 1978, Keio J Med, V27, P43
   Isnard N, 2003, CELL BIOL INT, V27, P779, DOI 10.1016/S1065-6995(03)00167-7
   Karamichos D, 2013, INVEST OPHTH VIS SCI, V54, P6612, DOI 10.1167/iovs.13-12861
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   KENNEY MC, 1986, BIOCHIM BIOPHYS ACTA, V889, P156, DOI 10.1016/0167-4889(86)90099-6
   Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200
   Kimoto M, 2014, INVEST OPHTH VIS SCI, V55, P2337, DOI 10.1167/iovs.13-13167
   Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993
   Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Mi SL, 2011, J BIOMED MATER RES A, V99A, P1, DOI 10.1002/jbm.a.33152
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Mimura T, 2008, MOL VIS, V14, P1819
   Musselmann K, 2003, EXP EYE RES, V77, P273, DOI 10.1016/S0014-4835(03)00160-X
   Musselmann K, 2008, EXP EYE RES, V86, P506, DOI 10.1016/j.exer.2007.12.004
   Ozcelik B, 2014, ADV HEALTHC MATER, V3, P1496, DOI 10.1002/adhm.201400045
   Ozcelik B, 2013, ACTA BIOMATER, V9, P6594, DOI 10.1016/j.actbio.2013.01.020
   Patel SV, 2001, INVEST OPHTH VIS SCI, V42, P333
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Proulx S, 2009, TISSUE ENG PT A, V15, P1709, DOI 10.1089/ten.tea.2008.0208
   Proulx S, 2009, INVEST OPHTH VIS SCI, V50, P2686, DOI 10.1167/iovs.08-2793
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   SAIKA S, 1991, GRAEF ARCH CLIN EXP, V229, P79, DOI 10.1007/BF00172267
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Thomasy SM, 2014, ACTA BIOMATER, V10, P785, DOI 10.1016/j.actbio.2013.09.025
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Vasiliev AV, 2005, BIOL BULL+, V32, P1, DOI 10.1007/s10525-005-0001-x
   Wilson SL, 2012, ADV FUNCT MATER, V22, P3641, DOI 10.1002/adfm.201200655
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.tea.2012.0545, 10.1089/ten.TEA.2012.0545]
   Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055
   Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
NR 57
TC 5
Z9 5
U1 1
U2 27
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD OCT 1
PY 2015
VL 21
IS 10
BP 1059
EP 1069
DI 10.1089/ten.tec.2015.0008
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CS5AI
UT WOS:000362087300007
PM 25951055
DA 2018-10-20
ER

PT J
AU Lv, XP
   Yang, Y
   Han, SL
   Li, DX
   Tu, HX
   Li, W
   Zhou, XD
   Zhang, LL
AF Lv, Xueping
   Yang, Yang
   Han, Sili
   Li, Danxue
   Tu, Huanxin
   Li, Wei
   Zhou, Xuedong
   Zhang, Linglin
TI Potential of an amelogenin based peptide in promoting reminerlization of
   initial enamel caries
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Enamel caries; Peptide; Amelogenin; Remineralization; Biomaterial
ID DEVELOPING DENTAL ENAMEL; BETA-SHEET TAPES; IN-VITRO; MINIMAL
   INTERVENTION; CRYSTAL-GROWTH; REMINERALIZATION; MATRIX; PROTEINS;
   FLUORIDE; MINERALIZATION
AB Objective: In this study we give a preliminary study of a rationally designed small peptide, which is based on the enamel matrix protein amelogenin, to investigate its effect on remineralization of initial enamel caries lesions.
   Design: A novel peptide was designed and synthesized to investigate its effects on the remineralization of initial enamel carious lesions during pH cycling that simulates intra-oral conditions. Initial lesions were created in bovine enamel blocks, which were then pH-cycled for 12 days in the presence of 25 mu M peptide, 1 g/L NaF (positive control), 50 mM HEPES buffer(negative control). Before and after pH cycling, enamel blocks were analyzed by surface microhardness testing, polarized light microscopy and transverse microradiography.
   Results: Percentage of surface microhardness recovery (SMHR%) after pH cycling was significantly higher in peptide group than HEPES group. Lower lesion depth and less mineral mineral loss were found in peptide or NaF treatment groups after the cycling, and were significantly different to HEPES group. No significant differences were observed between the blocks treated with peptide and those treated with NaF.
   Conclussion: This study provides in vitro evidence that this amelogenin based peptide promotes enamel caries remineralization, offering a promising remineralizing biomaterial in initial enamel carious treatment. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Lv, Xueping; Yang, Yang; Han, Sili; Li, Danxue; Tu, Huanxin; Li, Wei; Zhou, Xuedong; Zhang, Linglin] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China.
RP Zhang, LL (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, 14,3rd Sect,Renmin South Rd, Chengdu 610041, Sichuan, Peoples R China.
EM zhanglinglin_sc@163.com
FU National Natural Science Foundation of China [81271128]; New Century
   Excellent Talents University Support Program; Key Technology Program of
   Sichuan Province [2014SZ0024]
FX This work was funded by the National Natural Science Foundation of China
   (81271128), the New Century Excellent Talents University Support Program
   and the Key Technology Program of Sichuan Province (2014SZ0024).
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   BROOKES SJ, 1995, ARCH ORAL BIOL, V40, P1, DOI 10.1016/0003-9969(94)00135-X
   CHEN Y, 1992, J BIOL CHEM, V267, P24871
   Chew HP, 2014, CARIES RES, V48, P254, DOI 10.1159/000354411
   Cochrane NJ, 2010, J DENT RES, V89, P1187, DOI 10.1177/0022034510376046
   Cury JA, 2005, CARIES RES, V39, P255, DOI 10.1159/000084807
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Featherstone J D, 2012, Adv Dent Res, V24, P28, DOI 10.1177/0022034512452885
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729
   Guerrieri A, 2012, BRIT DENT J, V213, P551, DOI 10.1038/sj.bdj.2012.1087
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   Hosseini S, 2013, J BIOL CHEM, V288, P7885, DOI 10.1074/jbc.M112.422048
   Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j
   Jefferies Steven R, 2014, Compend Contin Educ Dent, V35, P237
   Jingawar MM, 2014, J CLIN DIAGN RES, V8, pZE4, DOI 10.7860/JCDR/2014/9128.4583
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   Le Norcy E, 2011, J DENT RES, V90, P1091, DOI 10.1177/0022034511411301
   Li QL, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-32
   Meyer-Lueckel H, 2015, CARIES RES, V49, P56, DOI 10.1159/000363073
   Moradian-Oldak J, 2002, MATRIX BIOL, V21, P197, DOI 10.1016/S0945-053X(01)00190-1
   Mount GJ, 2000, QUINTESSENCE INT, V31, P527
   Nyrkova IA, 2000, EUR PHYS J B, V17, P499, DOI 10.1007/s100510070128
   Paine ML, 2003, J BONE MINER RES, V18, P466, DOI 10.1359/jbmr.2003.18.3.466
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x
   Ruan QC, 2013, ACTA BIOMATER, V9, P7289, DOI 10.1016/j.actbio.2013.04.004
   Shafiei F., 2015, SCANNING, V9999, P1
   Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101
   ten Cate JM, 2013, BRIT DENT J, V214, P161, DOI 10.1038/sj.bdj.2013.162
   ten Cate JM, 2012, J DENT RES, V91, P813, DOI 10.1177/0022034512455032
   TENCATE JM, 1983, CARIES RES, V17, P193, DOI 10.1159/000260667
   VANDIJK JWE, 1980, ARCH ORAL BIOL, V25, P591, DOI 10.1016/0003-9969(80)90072-2
   Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440
   WHITE DJ, 1987, CARIES RES, V21, P126, DOI 10.1159/000261013
   Williams DM, 2014, MED PRIN PRACT, V23, P52, DOI 10.1159/000356934
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yang Y, 2014, J DENT RES, V93, P520, DOI 10.1177/0022034514522815
   Zeichner-David M, 2001, MATRIX BIOL, V20, P307, DOI 10.1016/S0945-053X(01)00155-X
NR 41
TC 5
Z9 5
U1 3
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD OCT
PY 2015
VL 60
IS 10
BP 1482
EP 1487
DI 10.1016/j.archoralbio.2015.07.010
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CS0UX
UT WOS:000361778800004
PM 26263536
DA 2018-10-20
ER

PT J
AU Irani, YD
   Tian, Y
   Wang, MJ
   Klebe, S
   McInnes, SJ
   Voelcker, NH
   Coffer, JL
   Williams, KA
AF Irani, Yazad D.
   Tian, Yuan
   Wang, Mengjia
   Klebe, Sonja
   McInnes, Steven J.
   Voelcker, Nicolas H.
   Coffer, Jeffery L.
   Williams, Keryn A.
TI A novel pressed porous silicon-polycaprolactone composite as a
   dual-purpose implant for the delivery of cells and drugs to the eye
SO EXPERIMENTAL EYE RESEARCH
LA English
DT Article
DE Polycaprolactone; Nanostructured porous silicon; Composite biomaterial;
   Drug release; Cell proliferation; Inflammation
ID AMNIOTIC MEMBRANE TRANSPLANTATION; SURFACE RECONSTRUCTION; SCAFFOLDS;
   DEPOSITION; RELEASE
AB Dysfunction of corneal epithelial stem cells can result in painful and blinding disease of the ocular surface. In such cases, treatment may involve transfer of growth factor and normal adult stem cells to the ocular surface. Our purpose was to develop an implantable scaffold for the delivery of drugs and cells to the ocular surface. We examined the potential of novel composite biomaterials fabricated from electrospun polycaprolactone (PCL) fibres into which nanostructured porous silicon (pSi) microparticles of varying sizes (150-250 mu m or <40 mu m) had been pressed. The PCL fabric provided a flexible support for mammalian cells, whereas the embedded pSi provided a substantial surface area for efficient delivery of adsorbed drugs and growth factors. Measurements of tensile strength of these composites revealed that the pSi did not strongly influence the mechanical properties of the polymer microfiber component for the Si loadings evaluated. Human lens epithelial cells (SRA01/04) attached to the composite materials, and exhibited enhanced attachment and growth when the materials were coated with foetal bovine serum. To examine the ability of the materials to deliver a small-drug payload, pSi microparticles were loaded with fluorescein diacetate prior to cell attachment. After 6 hours (h), cells exhibited intracellular fluorescence, indicative of transfer of the fluorescein diacetate into viable cells and its subsequent enzymatic conversion to fluorescein. To investigate loading of large-molecule biologics, murine BALB/c 3T3 cells, responsive to epidermal growth factor, insulin and transferrin, were seeded on composite materials. The cells showed significantly more proliferation at 48 h when seeded on composites loaded with these biologics, than on unloaded composites. No cell proliferation was observed on PCL alone, indicating the biologics had loaded into the pSi microparticles. Drug release, measured by ELISA for insulin, indicated a burst followed by a slower, continuous release over six days. When implanted under the rat conjunctiva, the most promising composite material did not cause significant neovascularization but did elicit a macrophage and mild foreign body response. These novel pressed pSi PCL materials have potential for delivery of both small and large drugs that can be released in active form, and can support the growth of mammalian cells. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Irani, Yazad D.; Williams, Keryn A.] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.
   [Tian, Yuan; Wang, Mengjia; Coffer, Jeffery L.] Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA.
   [Klebe, Sonja] Flinders Univ S Australia, Dept Anat Pathol, Bedford Pk, SA 5042, Australia.
   [McInnes, Steven J.; Voelcker, Nicolas H.] Univ S Australia, Mawson Inst, Mawson Lakes 5095, Australia.
RP Williams, KA (reprint author), Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.
EM keryn.williams@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012
OI Voelcker, Nicolas/0000-0002-1536-7804; Irani, Yazad/0000-0002-2861-5774;
   McInnes, Steven/0000-0003-4415-619X; Coffer, Jeffery/0000-0003-0267-9646
FU Australian National Health & Medical Research Council (NHMRC) [595901];
   Faculty of Medicine, Nursing and Health Sciences of Flinders University;
   National Eye Institute of the US National Institutes of Health
   [R21EY021583]; Robert A. Welch Foundation [P-1212]
FX Financial support from the Australian National Health & Medical Research
   Council (NHMRC, grant number 595901), the Faculty of Medicine, Nursing
   and Health Sciences of Flinders University, the National Eye Institute
   of the US National Institutes of Health (under award number
   R21EY021583), and the Robert A. Welch Foundation (Grant P-1212) is
   gratefully acknowledged. The funding sources did not influence the
   outcomes of the research presented in this manuscript in any way. YDI,
   YT, MY, SJM all performed experimentation and provided intellectual
   input. SK reviewed all the pathology sections. SK, NHV, JLC and KAW were
   instrumental in acquiring competitive grant funding for the work, had a
   substantial supervisory role, and provided intellectual input. YDI and
   KAW wrote the manuscript, which was then further improved by SK, NHV and
   JLC. All authors approved the final version of this manuscript.
CR Anderson MC, 2010, J BIOMED MATER RES A, V92A, P1598, DOI 10.1002/jbm.a.32498
   Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512
   Baranov P., 2014, J TISSUE ENG, V5
   Bottenstein J, 1979, Methods Enzymol, V58, P94
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   Fan DM, 2011, NANOSCALE, V3, P354, DOI 10.1039/c0nr00550a
   Feng YQ, 2014, CURR EYE RES, V39, P541, DOI 10.3109/02713683.2013.853803
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Joe AW, 2014, STEM CELL TRANSL MED, V3, P318, DOI 10.5966/sctm.2013-0137
   Kashanian S, 2010, ACTA BIOMATER, V6, P3566, DOI 10.1016/j.actbio.2010.03.031
   Li X, 1998, J AM CHEM SOC, V120, P11706, DOI 10.1021/ja9823666
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Mann AP, 2011, ADV MATER, V23, P278
   McInnes SJP, 2015, J MATER CHEM B, V3, P4123, DOI 10.1039/c5tb00397k
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Mogal VT, 2014, ACS APPL MATER INTER, V6, P5749, DOI 10.1021/am500454b
   Notara M, 2010, EXP EYE RES, V90, P188, DOI 10.1016/j.exer.2009.09.023
   Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794
   Park JS, 2011, SMALL, V7, P2061, DOI 10.1002/smll.201100438
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134
   RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415
   Sant S, 2011, J TISSUE ENG REGEN M, V5, P283, DOI 10.1002/term.313
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400
NR 30
TC 11
Z9 12
U1 1
U2 30
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0014-4835
EI 1096-0007
J9 EXP EYE RES
JI Exp. Eye Res.
PD OCT
PY 2015
VL 139
BP 123
EP 131
DI 10.1016/j.exer.2015.08.007
PG 9
WC Ophthalmology
SC Ophthalmology
GA CS0VW
UT WOS:000361781300013
PM 26277579
OA Green Published
DA 2018-10-20
ER

PT J
AU Gierth, M
   Denzinger, S
   Liebig-Horl, G
   Burger, M
   Furst, A
AF Gierth, M.
   Denzinger, S.
   Liebig-Hoerl, G.
   Burger, M.
   Fuerst, A.
TI Management of rectourinary fistula after urological interventions using
   biodesigned mesh: first experiences of an innovative technique
SO INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
LA English
DT Article
DE Rectourinary fistula; Biomaterial; Mesh; Radical prostatectomy;
   Transanal surgery
ID LAPAROSCOPIC RADICAL PROSTATECTOMY; ACQUIRED RECTOURETHRAL FISTULA;
   RETROPUBIC PROSTATECTOMY; SURGICAL-MANAGEMENT; RECTAL INJURY; REPAIR;
   CLOSURE
AB Rectourinary fistula (RUF) is an uncommon but devastating condition that usually occurs as a complication of surgical treatment or radiotherapy of prostate cancer. Although operative fistula repair remains the most successful treatment, there still is no consensus concerning the management of RUF. We present first experiences and transanal surgical technique using biological mesh for fistula repair after urological intervention.
   From January 2009 to December 2013, four cases of RUF were reported at our university hospital. Fistula occurred after extraperitoneal laparoscopic radical prostatectomy, open radical prostatectomy, and high-intensity focused ultrasound, respectively. All patients were initially treated with transanal Cook Biodesign (TM) mesh, whereas two patients received reoperation with rectal mucosa advancement flap and gracilis muscle flap interposition, respectively. Mean follow-up was 36 months (range 9-62).
   Fistula diameters ranged from 0.6 to 3.0 cm and were located 5 to 6 cm of anocutaneous line. The time from diagnosis to fistula repair was 3 to 7 weeks. The median operative time for Cook Biodesing (TM) mesh procedure was 79 min (IQR 60, 98). The initial success rate for biological mesh was 50 % (2/4 patients). Larger fistulae were minimalized successfully and finally closed with reoperation mentioned above. No deterioration of continence was documented.
   Management of rectourinary fistula is still challenging. Using biomaterials for fistula closure seems to be a promising and minimally invasive transanal technique in future. Further analysis including more patients is needed to clarify its exact role in comparison to traditional surgical techniques.
C1 [Gierth, M.; Denzinger, S.; Burger, M.] Univ Regensburg, St Josef Med Ctr, Dept Urol, D-93053 Regensburg, Germany.
   [Liebig-Hoerl, G.; Fuerst, A.] St Josef Med Ctr Regensburg, Dept Surg, Regensburg, Germany.
RP Gierth, M (reprint author), Univ Regensburg, St Josef Med Ctr, Dept Urol, Landshuter Str 65, D-93053 Regensburg, Germany.
EM Michael.Gierth@klinik.uni-regensburg.de
CR BORLAND RN, 1992, J UROLOGY, V147, P905, DOI 10.1016/S0022-5347(17)37418-9
   Boushey RP, 1998, CAN J SURG, V41, P241
   BUKOWSKI TP, 1995, J UROLOGY, V153, P730, DOI 10.1016/S0022-5347(01)67701-2
   Castillo OA, 2006, UROLOGY, V68, P198, DOI 10.1016/j.urology.2006.04.002
   Ellis CN, 2008, DIS COLON RECTUM, V51, P1084, DOI 10.1007/s10350-008-9339-8
   Falavolti C, 2013, WORLD J SURG, V37, P2950, DOI 10.1007/s00268-013-2199-y
   Katz R, 2003, UROLOGY, V62, P310, DOI 10.1016/S0090-4295(03)00326-1
   Kitamura H, 2011, PROSTATE CANC, V2011
   Onaitis M, 2006, J SURG ONCOL, V94, P194, DOI 10.1002/jso.20591
   Polom W, 2014, CENT EUR J UROL, V67, P93, DOI 10.5173/ceju.2014.01.art21
   Pye PK, 2004, DIS COLON RECTUM, V47, P1554, DOI 10.1007/s10350-004-0613-0
   Schwandner O, 2009, SURG INNOV, V16, P162, DOI 10.1177/1553350609338041
   Shin PR, 2000, J AM COLL SURGEONS, V191, P547, DOI 10.1016/S1072-7515(00)00734-1
   SMITH AM, 1972, J UROLOGY, V108, P778, DOI 10.1016/S0022-5347(17)60866-8
   Wilbert DM, 1996, J UROLOGY, V155, P256, DOI 10.1016/S0022-5347(01)66612-6
   Youssef AH, 1999, J UROLOGY, V161, P1498, DOI 10.1016/S0022-5347(05)68937-9
NR 16
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-1958
EI 1432-1262
J9 INT J COLORECTAL DIS
JI Int. J. Colorectal Dis.
PD OCT
PY 2015
VL 30
IS 10
BP 1417
EP 1422
DI 10.1007/s00384-015-2262-2
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA CR8XD
UT WOS:000361636700016
PM 26018389
DA 2018-10-20
ER

PT J
AU Jeevithan, E
   Bao, B
   Zhang, JY
   Hong, ST
   Wu, WH
AF Jeevithan, Elango
   Bao, Bin
   Zhang, Jingyi
   Hong, Shaotong
   Wu, Wenhui
TI Purification, characterization and antioxidant properties of low
   molecular weight collagenous polypeptide (37 kDa) prepared from whale
   shark cartilage (Rhincodon typus)
SO JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE
LA English
DT Article
DE Collagenous polypeptide; Thermolysin; Glycoprotein content; Amino acid
   composition; Antioxidant activity
ID ACID-SOLUBLE COLLAGEN; T-CELL TOLERANCE; II COLLAGEN;
   FUNCTIONAL-PROPERTIES; INDUCED ARTHRITIS; PHYSICOCHEMICAL PROPERTIES;
   PROTEIN HYDROLYSATE; GADUS-MORHUA; SKIN; PEPTIDE
AB A low molecular weight type-II collagenous polypeptide (CIIp) from whale shark (WS) cartilage was prepared by thermolysin digestion; and examined for their physico-functional and antioxidant properties. The purified collagen was composed of an identical (alpha(1))(3) chains and was characterized as type-II. After hydrolysis with thermolysin, the alpha-chain of the WS collagen was degraded into smaller peptides with molecular weight ranging from 70 to 20KDa. CIIp was successfully separated from the hydrolysates with molecular weight of approximately 37 kDa. Amino acid analysis of CII, and CIIp indicated imino acid contents of 155 and 121 amino acid residues per 1000 residues, respectively. Differing Fourier transform infrared (FTIR) spectra of CII and CIIp were observed, which suggested that the hydrolysis process by thermolysin affected the secondary structure and molecular order of collagen, particularly the triple-helical structure. The denaturation temperature of CII (34 A degrees C) was higher than that of CIIp. Low content of glycoprotein was observed in CII than CIIp due to removal of some polypeptides by thermolysin digestion. The antioxidant activity against 1,1-diphenyl-2-picrylhydrazyl radicals and the reducing power of CIIp was greater than that of CII. The results proposed that the purified CIIp from WS cartilage with excellent antioxidant activities could be the suitable biomaterial for therapeutic applications.
C1 [Jeevithan, Elango; Bao, Bin; Zhang, Jingyi; Hong, Shaotong; Wu, Wenhui] Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Pharmacol, Shanghai 201306, Peoples R China.
   [Wu, Wenhui] Shanghai Ocean Univ, Inst Marine Sci, Shanghai 201306, Peoples R China.
RP Jeevithan, E (reprint author), Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Pharmacol, Shanghai 201306, Peoples R China.
EM srijeevithan@gmail.com; whwu@shou.edu.cn
OI Wu, Wen Hui/0000-0002-1710-8582; Elango, Jeevithan/0000-0003-4115-9918
FU National High Technology Research and Development Program of China
   [2011AA09070109]; National Natural Science Foundation of China
   [81341082]
FX This work received financial support from National High Technology
   Research and Development Program of China (No. 2011AA09070109) and
   National Natural Science Foundation of China (No. 81341082).
CR ADLERNISSEN J, 1979, J AGR FOOD CHEM, V27, P1256, DOI 10.1021/jf60226a042
   Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Cao H, 2013, EUR REV MED PHARMACO, V17, P1427
   Chen LJ, 2012, PHARMACEUTICALS, V5, P339, DOI 10.3390/ph5040339
   Chi CF, 2014, MOLECULES, V19, P11211, DOI 10.3390/molecules190811211
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   Ehrlich H, 2015, BIOL MAT MAR ORIG, P69
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   GIBSON GJ, 1983, BIOCHEM J, V211, P417, DOI 10.1042/bj2110417
   Gimenez B, 2009, FOOD HYDROCOLLOID, V23, P1322, DOI 10.1016/j.foodhyd.2008.09.010
   He LR, 2012, J INORG BIOCHEM, V117, P124, DOI 10.1016/j.jinorgbio.2012.08.017
   He R, 2013, J FUNCT FOODS, V5, P219, DOI 10.1016/j.jff.2012.10.008
   Hernandez-Ledesma B, 2006, J CHROMATOGR A, V1116, P31, DOI 10.1016/j.chroma.2006.03.006
   Jeevithan E, 2015, PROCESS BIOCHEM, DOI [10.1016/j.procbio.2014.11.015, DOI 10.1016/J.PR0CBIO.2014.11.015]
   Jeevithan E, 2014, PROCESS BIOCHEM, V49, P1767, DOI 10.1016/j.procbio.2014.06.011
   Jeevithan E, 2014, MAR DRUGS, V12, P3852, DOI 10.3390/md12073852
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Kittiphattanabawon P, 2010, LWT-FOOD SCI TECHNOL, V43, P792, DOI 10.1016/j.lwt.2010.01.006
   Klompong V, 2007, FOOD CHEM, V102, P1317, DOI 10.1016/j.foodchem.2006.07.016
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067
   Lima OC, 1999, BRAZ J MED BIOL RES, V32, P651, DOI 10.1590/S0100-879X1999000500020
   LUNDIN K, 1989, CELL TISSUE RES, V257, P641, DOI 10.1007/BF00221475
   Mendis E, 2005, LIFE SCI, V77, P2166, DOI 10.1016/j.lfs.2005.03.016
   Merly L, 2013, INT IMMUNOPHARMACOL, V15, P309, DOI [10.1016/j.intimp2012.12.001, 10.1016/j.intimp.2012.12.001]
   Montero P, 2000, J FOOD SCI, V65, P434, DOI 10.1111/j.1365-2621.2000.tb16022.x
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Myers LK, 2004, AM J MED SCI, V327, P212, DOI 10.1097/00000441-200404000-00007
   Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087
   Rochdi A, 2000, FOOD CHEM, V69, P295, DOI 10.1016/S0308-8146(99)00267-8
   Ronnestad I, 2010, J NUTR, V140, P893, DOI 10.3945/jn.109.118240
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   SCHMID TM, 1982, J BIOL CHEM, V257, P2444
   SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005
   Tang CH, 2009, FOOD CHEM, V114, P1484, DOI 10.1016/j.foodchem.2008.11.049
   Veeruraj A, 2013, PROCESS BIOCHEM, V48, P1592, DOI 10.1016/j.procbio.2013.07.011
   Wang L, 2014, FOOD HYDROCOLLOID, V38, P104, DOI 10.1016/j.foodhyd.2013.12.002
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Wong DWS, 1989, MECH THEORY FOOD CHE, P428
   Xi CX, 2009, MOL IMMUNOL, V46, P729, DOI 10.1016/j.molimm.2008.10.016
   Xie J., 2014, International Food Research Journal, V21, P1171
   Zhou DY, 2012, FOOD CHEM, V132, P815, DOI 10.1016/j.foodchem.2011.11.041
   Zhu BW, 2012, FOOD HYDROCOLLOID, V28, P182, DOI 10.1016/j.foodhyd.2011.12.010
NR 46
TC 6
Z9 6
U1 6
U2 32
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0022-1155
EI 0975-8402
J9 J FOOD SCI TECH MYS
JI J. Food Sci. Technol.-Mysore
PD OCT
PY 2015
VL 52
IS 10
BP 6312
EP 6322
DI 10.1007/s13197-015-1715-5
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA CR7TT
UT WOS:000361554900019
PM 26396376
OA Green Published
DA 2018-10-20
ER

PT J
AU Skwarek, E
AF Skwarek, Ewa
TI Thermal analysis of hydroxyapatite with adsorbed oxalic acid
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Hydroxyapatite; Oxalic acid; Adsorption; Thermal analysis
ID WEIGHT ORGANIC-ACIDS; ELECTRICAL DOUBLE-LAYER; NANOSIZED HYDROXYAPATITE;
   ZERO CHARGE; BEHAVIOR; IONS; ADSORPTION; SURFACE; CRYSTALLINITY;
   NANOPARTICLES
AB The specific adsorption of oxalic acid ions at the hydroxyapatite interface was investigated by means of the radioisotope method (C-14) as a function of oxalic acid ions concentration, NaCl concentration and pH. Application of hydroxyapatite has become extensive in the biomaterial field due to its biocompatibility with human hard tissue. Hydroxyapatite was synthesized using wet methods. Physical properties of the resulting powder were characterized by DTA/TG, XRD, AFM and SEM microscopy. Physicochemical properties characterizing the electrical double layer of the hydroxyapatite/NaCl solution interface were determined. The zeta potential and the adsorption of oxalic acid molecules were studied as a function of pH. The point of zero charge and the isoelectric point of samples were determined: its values are as follows: pH(PZC) = 7 and pH(IEP) = 4. Temperature has insignificant influence on pure substance and with oxalic acid adsorbed, as thermal analysis has shown, and characterization of hydroxyapatite structure can be carried out by this thermal analysis. Two phenomena are responsible for oxalic acid adsorption: phosphate group replacement at the hydroxyapatite surface by oxalic ions simultaneous to intraspherical complexes formation.
C1 Marie Curie Sklodowska Univ, Fac Chem, PL-20031 Lublin, Poland.
RP Skwarek, E (reprint author), Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
EM ewunias@hektor.umcs.lublin.pl
CR Adamczyk Z., 2008, PRACE INSTYTUTU ODLE, VXLVIII
   BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Bianco A, 2007, J THERM ANAL CALORIM, V88, P237, DOI 10.1007/s10973-006-8011-6
   DAVIS JA, 1978, J COLLOID INTERF SCI, V63, P480, DOI 10.1016/S0021-9797(78)80009-5
   Dean-Mo L, 1996, BIOMATERIALS, V17, P1955
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   HAYES KF, 1991, J COLLOID INTERF SCI, V142, P448, DOI 10.1016/0021-9797(91)90075-J
   Janusz W, 2008, POL J CHEM, V82, P57
   Janusz W., 1991, J CHEM, V65, P799
   Kohutova A, 2012, J THERM ANAL CALORIM, V108, P163, DOI 10.1007/s10973-011-1942-6
   Krajewski A, 2005, J MOL STRUCT, V744, P221, DOI 10.1016/j.molstruc.2004.10.044
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Mezahi FZ, 2009, J THERM ANAL CALORIM, V95, P21, DOI 10.1007/s10973-008-9065-4
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Skwarek E, 2014, J RADIOANAL NUCL CH, V299, P2027, DOI 10.1007/s10967-013-2825-z
   Smiciklas ID, 2000, SEP PURIF TECHNOL, V18, P185, DOI 10.1016/S1383-5866(99)00066-0
   Tonsuaadu K, 2012, J THERM ANAL CALORIM, V110, P647, DOI 10.1007/s10973-011-1877-y
   Wang Y, 2011, DESALINATION, V276, P161, DOI 10.1016/j.desal.2011.03.033
   Wang YJ, 2009, J HAZARD MATER, V162, P1135, DOI 10.1016/j.jhazmat.2008.06.001
   Wei W, 2011, COLLOID SURFACE A, V392, P67, DOI 10.1016/j.colsurfa.2011.09.034
   Wei W, 2009, J LIQ CHROMATOGR R T, V32, P106, DOI 10.1080/10826070802548705
   Xu RK, 2004, J COLLOID INTERF SCI, V277, P243, DOI 10.1016/j.jcis.2004.04.020
NR 22
TC 6
Z9 6
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1572-8943
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD OCT
PY 2015
VL 122
IS 1
BP 33
EP 45
DI 10.1007/s10973-015-4692-z
PG 13
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA CR6CP
UT WOS:000361431200004
OA Other Gold
DA 2018-10-20
ER

PT J
AU Li, XL
   Shi, W
   Yu, XG
   Yu, JS
AF Li, Xiaolong
   Shi, Wei
   Yu, Xinge
   Yu, Junsheng
TI Performance improvement of organic field-effect transistor based
   nitrogen dioxide gas sensor using biocompatible PMMA/silk fibroin
   bilayer dielectric
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID THIN-FILM TRANSISTORS; SILK FIBROIN; POLYMER; LAYER; ENHANCEMENT;
   ELECTRONICS; MONOLAYERS; STABILITY; BUFFER
AB High performance organic field-effect transistors (OFETs) based nitrogen dioxide (NO2) gas sensors were fabricated by using biocompatible bilayer dielectric of poly(methyl methacrylate) (PMMA) and silk fibroin (SF). Compared to those sensor devices with single PMMA dielectrics, NO2 sensing properties of the devices with PMMA/SF bilayer dielectric were significantly improved. By analyzing the electrical characteristics of the OFETs under various concentrations of NO2 systematically, it was found that the enhancement of the sensing properties of PMMA/SF based OFET-sensors was ascribed to different surface properties between PMMA and SF. The superior sensing performance is owing to the interaction between the hydroxyl and the amidogen of the SF biomaterial and NO2 molecules at the interface of dielectric/organic layer.
C1 [Li, Xiaolong; Shi, Wei; Yu, Xinge; Yu, Junsheng] Univ Elect Sci & Technol China, Sch Optoelect Informat, State Key Lab Elect Thin Films & Integrated Devic, Chengdu 610054, Peoples R China.
RP Yu, JS (reprint author), Univ Elect Sci & Technol China, Sch Optoelect Informat, State Key Lab Elect Thin Films & Integrated Devic, Chengdu 610054, Peoples R China.
EM jsyu@uestc.edu.cn
OI Yu, Xinge/0000-0003-0522-1171
FU Foundation of Innovation Groups of NSFC [61421002]; National Science
   Foundation of China [61177032]; Fundamental Research Funds for Central
   Universities [ZYGX2010Z004]
FX This work is supported by the Foundation of Innovation Groups of NSFC
   (Grant No. 61421002), the National Science Foundation of China (Grant
   No. 61177032), and the Fundamental Research Funds for the Central
   Universities (Grant No. ZYGX2010Z004).
CR Alexandru O., 2007, SENSOR ACTUAT B-CHEM, V127, P161
   Andringa A.M., 2013, CHEM MATER, V26, P773
   Andringa AM, 2012, SENSOR ACTUAT B-CHEM, V171, P1172, DOI 10.1016/j.snb.2012.06.062
   DiBenedetto SA, 2009, ADV MATER, V21, P1407, DOI 10.1002/adma.200803267
   Georgakopoulos S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525933
   Gu G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841918
   Huang W, 2013, ORG ELECTRON, V14, P3453, DOI 10.1016/j.orgel.2013.09.018
   Huang W, 2012, THIN SOLID FILMS, V520, P6677, DOI 10.1016/j.tsf.2012.06.084
   Huang WG, 2012, J AM CHEM SOC, V134, P14650, DOI 10.1021/ja305287p
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2013, GREEN CHEM, V15, P1473, DOI 10.1039/c3gc40388b
   Kano M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3115826
   Kim C, 2007, SCIENCE, V318, P76, DOI 10.1126/science.1146458
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Klauk H, 2010, CHEM SOC REV, V39, P2643, DOI 10.1039/b909902f
   Ko G, 2010, CURR APPL PHYS, V10, P1002, DOI 10.1016/j.cap.2009.12.024
   Kumar B., 2013, J MATER SCI-MATER EL, V25, P1
   Li HQ, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/3/038505
   Li LQ, 2013, ADV MATER, V25, P3419, DOI 10.1002/adma.201301138
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Mao LK, 2013, ORG ELECTRON, V14, P1170, DOI 10.1016/j.orgel.2013.02.010
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Nalage S. R., 2012, J MATER SCI-MATER EL, V24, P368
   Pernstich KP, 2004, J APPL PHYS, V96, P6431, DOI 10.1063/1.1810205
   Qiu Y, 2003, APPL PHYS LETT, V83, P1644, DOI 10.1063/1.1604193
   Rapson TD, 2014, BIOSENS BIOELECTRON, V62, P214, DOI 10.1016/j.bios.2014.06.045
   Sasaki DY, 2001, SENSOR ACTUAT B-CHEM, V72, P51, DOI 10.1016/S0925-4005(00)00632-8
   Sekitani T, 2010, NAT MATER, V9, P1015, DOI [10.1038/nmat2896, 10.1038/NMAT2896]
   Shi LL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862198
   Shi W, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907325
   Shi W, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/20/205402
   Shu LF, 2014, J MATER SCI-MATER EL, V25, P5540, DOI 10.1007/s10854-014-2341-0
   Tsai CL, 2012, ORG ELECTRON, V13, P3315, DOI 10.1016/j.orgel.2012.10.007
   Vijayalakshmi K., 2012, J MATER SCI-MATER EL, V24, P1895
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wang Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3153946
   Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727
   Yu XG, 2015, ADV MATER, V27, P2390, DOI 10.1002/adma.201405400
   Yu X, 2015, P NATL ACAD SCI USA, V112, P3217, DOI 10.1073/pnas.1501548112
   Yu XG, 2013, J MATER CHEM C, V1, P6532, DOI 10.1039/c3tc31412j
   Yu XG, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3624586
   Zhang J, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187510
NR 42
TC 2
Z9 2
U1 3
U2 76
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD OCT
PY 2015
VL 26
IS 10
BP 7948
EP 7954
DI 10.1007/s10854-015-3448-7
PG 7
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA CR6VV
UT WOS:000361487100086
DA 2018-10-20
ER

PT J
AU Laverty, G
   McCloskey, AP
   Gorman, SP
   Gilmore, BF
AF Laverty, Garry
   McCloskey, Alice P.
   Gorman, Sean P.
   Gilmore, Brendan F.
TI Anti-biofilm activity of ultrashort cinnamic acid peptide derivatives
   against medical device-related pathogens
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE antimicrobial; biofilm; MBEC; biomaterials; peptide; kill kinetics
ID ANTIBACTERIAL PEPTIDES; ANTIMICROBIAL PEPTIDES; MEMBRANE; ALGINATE;
   BACTERIA
AB The threat of antimicrobial resistance has placed increasing emphasis on the development of innovative approaches to eradicate multidrug-resistant pathogens. Biofilm-forming microorganisms, for example, Staphylococcus epidermidis and Staphylococcus aureus, are responsible for increased incidence of biomaterial infection, extended hospital stays and patient morbidity and mortality. This paper highlights the potential of ultrashort tetra-peptide conjugated to hydrophobic cinnamic acid derivatives. These peptidomimetic molecules demonstrate selective and highly potent activity against resistant biofilm forms of Gram-positive medical device-related pathogens. 3-(4-Hydroxyphenyl)propionic)-Orn-Orn-Trp-Trp-NH2 displays particular promise with minimum biofilm eradication concentration (MBEC) values of 125 mu g/ml against methicillin sensitive (ATCC 29213) and resistant (ATCC 43300) S. aureus and activity shown against biofilm forms of Escherichia coli (MBEC: 1000 mu g/ml). Kill kinetics confirms complete eradication of established 24-h biofilms at MBEC with 6-h exposure. Reduced cell cytotoxicity, relative to Gram-positive pathogens, was proven via tissue culture (HaCaT) and haemolysis assays (equine erythrocytes). Existing in nature as part of the immune response, antimicrobial peptides display great promise for exploitation by the pharmaceutical industry in order to increase the library of available therapeutic molecules. Ultrashort variants are particularly promising for translation as clinical therapeutics as they are more cost-effective, easier to synthesise and can be tailored to specific functional requirements based on the primary sequence allowing factors such as spectrum of activity to be varied. Copyright (C) 2015 European Peptide Society and John Wiley & Sons, Ltd.
C1 [Laverty, Garry; McCloskey, Alice P.; Gorman, Sean P.; Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, Biomat Biofilm & Infect Control Res Grp, Belfast BT9 7BL, Antrim, North Ireland.
RP Laverty, G (reprint author), Queens Univ Belfast, Sch Pharm, Biomat Biofilm & Infect Control Res Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM garry.laverty@qub.ac.uk
OI McCloskey, Alice/0000-0003-3014-1624; Laverty, Garry/0000-0002-1435-2942
CR Avila HP, 2008, BIOORGAN MED CHEM, V16, P9790, DOI 10.1016/j.bmc.2008.09.064
   Bisht GS, 2007, BIOORG MED CHEM LETT, V17, P4343, DOI 10.1016/j.bmcl.2007.05.015
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200
   Cudic M, 2002, CURR DRUG TARGETS, V3, P101, DOI 10.2174/1389450024605445
   Figueroa-Espinoza MC, 2005, J AGR FOOD CHEM, V53, P2779, DOI 10.1021/jf0484273
   Folkesson A, 2008, PLOS ONE, V3, P1
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   Gurkok G, 2009, CHEMOTHERAPY, V55, P15, DOI 10.1159/000166999
   Ioannou CJ, 2007, ANTIMICROB AGENTS CH, V51, P296, DOI 10.1128/AAC.00375-06
   Kamimori H, 2005, BIOL PHARM BULL, V28, P148, DOI 10.1248/bpb.28.148
   Laverty G, 2015, CHEM BIOL DRUG DES, V85, P645, DOI 10.1111/cbdd.12441
   Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566
   Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x
   Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004
   Lopez-Garcia B, 2004, BBA-BIOMEMBRANES, V1660, P131, DOI 10.1016/j.bbamem.2003.11.006
   Mann CM, 2000, LETT APPL MICROBIOL, V30, P294, DOI 10.1046/j.1472-765x.2000.00712.x
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006
   Mohammadzadeh S, 2007, FOOD CHEM, V103, P1097, DOI 10.1016/j.foodchem.2006.10.006
   MULCAHY H., 2008, PLOS PATHOG, V4, P1
   Naz S, 2006, MICROBIOL RES, V161, P43, DOI 10.1016/j.micres.2005.05.001
   Peters C, 2002, NATURWISSENSCHAFTEN, V89, P381, DOI 10.1007/s00114-002-0354-7
   Rastogi N, 2008, INDIAN J EXP BIOL, V46, P783
   Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039
   Tesaki S, 1998, BIOSCI BIOTECH BIOCH, V62, P998, DOI 10.1271/bbb.62.998
   Truchado P, 2009, FOOD CHEM, V115, P1337, DOI 10.1016/j.foodchem.2009.01.065
   VIITALA J, 1985, TRENDS BIOCHEM SCI, V10, P392, DOI 10.1016/0968-0004(85)90067-2
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100
   Yoya GK, 2009, BIOORG MED CHEM LETT, V19, P341, DOI 10.1016/j.bmcl.2008.11.082
NR 30
TC 6
Z9 6
U1 2
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD OCT
PY 2015
VL 21
IS 10
BP 770
EP 778
DI 10.1002/psc.2805
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA CR6SM
UT WOS:000361477700004
PM 26310860
OA Green Published
DA 2018-10-20
ER

PT J
AU Hossain, A
   Bhattacharyya, SR
   Aditya, G
AF Hossain, Asif
   Bhattacharyya, Satya Ranjan
   Aditya, Gautam
TI Biosorption of cadmium from aqueous solution by shell dust of the
   freshwater snail Lymnaea luteola
SO ENVIRONMENTAL TECHNOLOGY & INNOVATION
LA English
DT Article
DE Biosorption; Cadmium; Shell dust; ANN; Isotherm; Kinetic
AB An assessment of the metal biosorption potential of shell dust of the freshwater snail (Lymnaea luteola) was made using cadmium as model metal. Artificial Neural Network (ANN) model was constructed for portraying the biosorption process under varied conditions. Under optimal conditions, the shell dust of L. luteola (LSD) exhibited a biosorption capacity of 20.00 mg g(-1) at pH 6. The adsorption data at equilibrium fitted significantly more to Langmuir (R-2 = 0.997) than Freundlich equation (R-2 = 0.790). The kinetics for the biosorption process followed the pseudo-second order model (R-2 = 0.998) better than the Lagergren model (R-2 = 0.835). Confirmation of cadmium adsorption by LSD was further revealed through EDX studies, and the experimental results fitted well with the predicted pattern of biosorption based on ANN model (R-2 = 0.924). It appears that shell dust of the snail L. luteola (LSD), a waste biomaterial, can be used as a low cost and environment friendly biosorbent for cadmium removal from aqueous solution. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Hossain, Asif; Aditya, Gautam] Univ Burdwan, Dept Zool, Burdwan 713104, W Bengal, India.
   [Bhattacharyya, Satya Ranjan] Saha Inst Nucl Phys, Ctr Nanomat & Surface Phys, Kolkata 700064, India.
   [Aditya, Gautam] Univ Calcutta, Dept Zool, Kolkata 700019, India.
RP Aditya, G (reprint author), Univ Burdwan, Dept Zool, Burdwan 713104, W Bengal, India.
EM asifhossain.bu@gmail.com; satyar.bhattacharyya@saha.ac.in;
   gautamaditya2001@gmail.com
OI ADITYA, GAUTAM/0000-0001-9445-879X
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India
   [20-12/2009(ii)EU-IV]
FX The authors acknowledge the comments of two anonymous reviewers that
   enhanced the manuscript in its present form. The authors are thankful to
   the respective Heads, Department of Zoology, Department of Chemistry and
   Department of Environmental Science, The University of Burdwan, Burdwan,
   India and the Head, Department of Zoology, University of Calcutta, for
   the facilities provided including DST-FIST. The authors acknowledge The
   Director, SINP, Kolkata for providing the facilities to carry out a part
   of this work. AH thankfully acknowledges the financial assistance
   provided Council of Scientific and Industrial Research (CSIR), New
   Delhi, India (Sanction no. 20-12/2009(ii)EU-IV dated 31-5-2010).
CR Ahmad MF, 2014, BIOCHEM ENG J, V84, P83, DOI 10.1016/j.bej.2014.01.004
   Amini M, 2009, COLLOID SURFACE A, V337, P67, DOI 10.1016/j.colsurfa.2008.11.053
   Aziz MA, 1996, MEM I OSWALDO CRUZ, V91, P119, DOI 10.1590/S0074-02761996000100022
   Azouaou N., 2008, J APPL SCI, V8, P4638
   Blazquez G, 2011, CHEM ENG J, V168, P170, DOI 10.1016/j.cej.2010.12.059
   Boro J, 2012, RENEW SUST ENERG REV, V16, P904, DOI 10.1016/j.rser.2011.09.011
   Bulut Y, 2007, J ENVIRON SCI-CHINA, V19, P160, DOI 10.1016/S1001-0742(07)60026-6
   Cavas L, 2011, CHEM ENG J, V171, P557, DOI 10.1016/j.cej.2011.04.030
   Celekli A, 2013, BIORESOURCE TECHNOL, V129, P396, DOI 10.1016/j.biortech.2012.11.085
   Celekli A, 2011, BIORESOURCE TECHNOL, V102, P5634, DOI 10.1016/j.biortech.2011.02.052
   Chakravarty P, 2010, CHEM ENG J, V162, P949, DOI 10.1016/j.cej.2010.06.048
   Cui LZ, 2010, CAN J CHEM ENG, V88, P109, DOI 10.1002/cjce.20241
   Dahiya S, 2008, BIORESOURCE TECHNOL, V99, P179, DOI 10.1016/j.biortech.2006.11.011
   Ding Y, 2012, BIORESOURCE TECHNOL, V114, P20, DOI 10.1016/j.biortech.2012.01.110
   Du Y, 2011, ENVIRON POLLUT, V159, P1763, DOI 10.1016/j.envpol.2011.04.017
   Farhan AM, 2013, INT J IND CHEM, V4, DOI 10.1186/2228-5547-4-24
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gifford S, 2007, TRENDS BIOTECHNOL, V25, P60, DOI 10.1016/j.tibtech.2006.12.002
   Hetzer A, 2006, APPL ENVIRON MICROB, V72, P4020, DOI 10.1128/AEM.00295-06
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2006, BIOCHEM ENG J, V30, P117, DOI 10.1016/j.bej.2006.02.012
   Jahan M. S., 1998, Bangladesh Journal of Zoology, V26, P67
   Jana BB, 1997, ECOL ENG, V8, P179, DOI 10.1016/S0925-8574(97)00259-0
   Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X
   Khataee AR, 2011, CHEM ENG RES DES, V89, P172, DOI 10.1016/j.cherd.2010.05.009
   Khataee AR, 2010, J MOL CATAL A-CHEM, V331, P86, DOI 10.1016/j.molcata.2010.07.016
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Leyva-Ramos R, 2005, SEP PURIF TECHNOL, V45, P41, DOI 10.1016/j.seppur.2005.02.005
   Liu Y, 2009, J HAZARD MATER, V168, P156, DOI 10.1016/j.jhazmat.2009.02.009
   Maghsoudi M, 2015, SPECTROCHIM ACTA A, V134, P1, DOI 10.1016/j.saa.2014.06.106
   Nouri L, 2007, J HAZARD MATER, V149, P115, DOI 10.1016/j.jhazmat.2007.03.055
   Ozdemir U, 2011, CHEM ENG J, V178, P183, DOI 10.1016/j.cej.2011.10.046
   Pena-Rodriguez S, 2010, J HAZARD MATER, V180, P622, DOI 10.1016/j.jhazmat.2010.04.079
   Prieto M, 2003, GEOCHIM COSMOCHIM AC, V67, P3859, DOI 10.1016/S0016-7037(00)00309-0
   Reddy DHK, 2010, J HAZARD MATER, V174, P831, DOI 10.1016/j.jhazmat.2009.09.128
   ROY JK, 1994, MEM I OSWALDO CRUZ, V89, P11, DOI 10.1590/S0074-02761994000100003
   Sen TK, 2010, CLEAN-SOIL AIR WATER, V38, P850, DOI 10.1002/clen.200900246
   Shanmugaprakash M, 2013, BIORESOURCE TECHNOL, V148, P550, DOI 10.1016/j.biortech.2013.08.149
   Sharma M., 2011, ECOL ENG, V37, P1589
   Sinha RK, 2007, ENV BIOREMEDIATION T
   Subba Rao NV, 1989, HDB FRESHWATER MOLLU
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
   Vimala R, 2009, J HAZARD MATER, V168, P376, DOI 10.1016/j.jhazmat.2009.02.062
   Wang FY, 2010, J HAZARD MATER, V177, P300, DOI 10.1016/j.jhazmat.2009.12.032
   Witek-Krowiak A, 2014, BIORESOURCE TECHNOL, V160, P150, DOI 10.1016/j.biortech.2014.01.021
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
   Yang YY, 2011, BIORESOURCE TECHNOL, V102, P828, DOI 10.1016/j.biortech.2010.08.125
   Yetilmezsoy K, 2008, J HAZARD MATER, V153, P1288, DOI 10.1016/j.jhazmat.2007.09.092
   Zheng LC, 2010, J HAZARD MATER, V176, P650, DOI 10.1016/j.jhazmat.2009.11.081
NR 50
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-1864
J9 ENVIRON TECHNOL INNO
JI Environ. Technol. Innov.
PD OCT
PY 2015
VL 4
BP 82
EP 91
DI 10.1016/j.eti.2015.05.001
PG 10
WC Biotechnology & Applied Microbiology; Engineering, Environmental;
   Environmental Sciences
SC Biotechnology & Applied Microbiology; Engineering; Environmental
   Sciences & Ecology
GA VG0JN
UT WOS:000444436400009
DA 2018-10-20
ER

PT J
AU Pigossi, SC
   de Oliveira, GJPL
   Finoti, LS
   Nepomuceno, R
   Spolidorio, LC
   Rossa, C
   Ribeiro, SJL
   Saska, S
   Scarel-Caminaga, RM
AF Pigossi, Suzane C.
   de Oliveira, Guilherme J. P. L.
   Finoti, Livia S.
   Nepomuceno, Rafael
   Spolidorio, Luis Carlos
   Rossa, C., Jr.
   Ribeiro, Sidney J. L.
   Saska, Sybele
   Scarel-Caminaga, Raquel M.
TI Bacterial cellulose-hydroxyapatite composites with osteogenic growth
   peptide (OGP) or pentapeptide OGP on bone regeneration in critical-size
   calvarial defect model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; bacterial cellulose; bone regeneration; osteogenic peptide;
   gene expression
ID C-TERMINAL PENTAPEPTIDE; MESENCHYMAL STEM-CELLS; OGP(10-14);
   OSTEOBLASTS; DIFFERENTIATION; OSTEOPROTEGERIN; NANOCOMPOSITE; MEMBRANES;
   ACTIVATOR; SCAFFOLD
AB This study aimed to evaluate the potential of bacterial cellulose-hydroxyapatite (BC-HA) composites associated with osteogenic growth peptide (OGP) or pentapeptide OGP(10-14) in bone regeneration in critical-size calvarial defects in mice. In this study, the BC-HA, BC-HA-OGP, and BC-HA-OGP(10-14) membranes were analyzed at 3, 7, 15, 30, 60, and 90 days. In each period, the specimens were evaluated by micro-computed tomography (mu CT), descriptive histology, gene expression of bone biomarkers by qPCR and VEGFR-2 (vascular endothelial growth factor) quantification by ELISA. Three days post-operative, Runx2, Tnfrsf11b and Bglap bone biomarkers were upregulated mainly by BC-HA OGP and BC-HA OGP(10-14) membranes, suggesting an acceleration of the osteoblast differentiation/activity with the use of these biomaterials. At 60 and 90 days, a high percentage of bone formation was observed by mu CT for BC-HA and BC-HA OGP(10-14) membranes. High expression of some bone biomarkers, such as Alpl, Spp1, and Tnfrsf11b, was also observed for the same membranes on days 60 and 90. In conclusion, the BC-HA membrane promoted a better bone formation in critical-size mice calvarial defects. Nevertheless, incorporation of the peptides at the concentration of 10(-9) molL(-1) did not improve bone regeneration potential in the long-term. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3397-3406, 2015.
C1 [Pigossi, Suzane C.; de Oliveira, Guilherme J. P. L.; Finoti, Livia S.; Nepomuceno, Rafael; Rossa, C., Jr.; Scarel-Caminaga, Raquel M.] Univ Estadual Paulista, UNESP, Sch Dent, Dept Oral Diag & Surg, BR-14801903 Araraquara, SP, Brazil.
   [Pigossi, Suzane C.; Finoti, Livia S.; Nepomuceno, Rafael; Scarel-Caminaga, Raquel M.] Univ Estadual Paulista, UNESP, Sch Dent, Dept Morphol, BR-14801903 Araraquara, SP, Brazil.
   [Spolidorio, Luis Carlos] Univ Estadual Paulista, UNESP, Sch Dent, Dept Physiol & Pathol, BR-14801903 Araraquara, SP, Brazil.
   [Ribeiro, Sidney J. L.; Saska, Sybele] Univ Estadual Paulista, UNESP, Inst Chem, Dept Gen & Inorgan Chem, BR-14800900 Araraquara, SP, Brazil.
RP Scarel-Caminaga, RM (reprint author), Univ Estadual Paulista, UNESP, Sch Dent, Dept Oral Diag & Surg, Humaita St 1680, BR-14801903 Araraquara, SP, Brazil.
EM raquel@foar.unesp.br
RI Spolidorio, Luis Carlos/G-1857-2012; Pigossi, Suzane/I-8058-2012;
   Nepomuceno, Rafael/F-5781-2014; Rossa Jr, Carlos/D-8328-2012; Saska,
   Sybele/B-6745-2011
OI Spolidorio, Luis Carlos/0000-0002-0592-542X; Pigossi,
   Suzane/0000-0001-7067-6119; Nepomuceno, Rafael/0000-0002-3120-0617;
   Rossa Jr, Carlos/0000-0003-1705-5481; Saska, Sybele/0000-0002-0229-946X;
   Ribeiro, Sidney/0000-0002-8162-6747; Scarel-Caminaga,
   Raquel/0000-0001-5068-0268; Oliveira, Guilherme Jose Pimentel
   Lopes/0000-0001-8778-0115; Finoti, Livia/0000-0002-3389-4026
CR Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083
   American Society for testing and materials, 2010, F98104 ASTM
   BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x
   Bernhardt A, 2013, J MATER SCI-MATER M, V24, P1755, DOI 10.1007/s10856-013-4933-2
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Brager MA, 2000, J ORTHOPAED RES, V18, P133, DOI 10.1002/jor.1100180119
   Chen YC, 2002, J MED CHEM, V45, P1624, DOI 10.1021/jm010479l
   Chen YC, 2000, J PEPT RES, V56, P147, DOI 10.1034/j.1399-3011.2000.00763.x
   Chen ZX, 2007, REGUL PEPTIDES, V142, P16, DOI 10.1016/j.regpep.2007.01.003
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   dos Anjos B, 1998, J PERIODONTOL, V69, P454, DOI 10.1902/jop.1998.69.4.454
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Fei QM, 2010, ACTA BIOCH BIOPH SIN, V42, P801, DOI 10.1093/abbs/gmq086
   Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049
   Gabarin N, 2001, J CELL BIOCHEM, V81, P594, DOI 10.1002/jcb.1083
   Galli C, 2006, J PERIODONTOL, V77, P1223, DOI 10.1902/jop.2006.050304
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   GREENBERG Z, 1993, BIOCHIM BIOPHYS ACTA, V1178, P273, DOI 10.1016/0167-4889(93)90204-3
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Jaiswal AK, 2013, J BIOMED NANOTECHNOL, V9, P2073, DOI 10.1166/jbn.2013.1736
   Kim SS, 2008, DENT MATER J, V27, P368, DOI 10.4012/dmj.27.368
   Ma SQ, 2008, J PLAST RECONSTR AES, V61, P1558, DOI 10.1016/j.bjps.2008.03.040
   Moore NM, 2010, BIOMATERIALS, V31, P1604, DOI [10.1016/j.biomatetials.2009.11.011, 10.1016/j.biomaterials.2009.11.011]
   Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278
   Novaes A B Jr, 1993, Clin Oral Implants Res, V4, P106, DOI 10.1034/j.1600-0501.1993.040207.x
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Rajzer I, 2014, J MATER SCI-MATER M, V25, P1239, DOI 10.1007/s10856-014-5149-9
   Sagar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077578
   Saska S, 2011, INT J BIOMATER, DOI 10.1155/2011/175362
   Saska S, 2012, J MATER CHEM, V22, P22102, DOI 10.1039/c2jm33762b
   Saska S, 2012, J MATER SCI-MATER M, V23, P2253, DOI 10.1007/s10856-012-4676-5
   Shi Q, 2012, BIOMATERIALS, V33, P6644, DOI 10.1016/j.biomaterials.2012.05.071
   Sun YQ, 1998, CELL BIOL INT, V22, P313, DOI 10.1006/cbir.1998.0253
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Zhao ZY, 2011, J INT MED RES, V39, P456, DOI 10.1177/147323001103900213
NR 37
TC 12
Z9 13
U1 2
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2015
VL 103
IS 10
BP 3397
EP 3406
DI 10.1002/jbm.a.35472
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CQ3KP
UT WOS:000360501300028
PM 25850694
DA 2018-10-20
ER

PT J
AU Barbeck, M
   Udeabor, S
   Lorenz, J
   Schlee, M
   Holthaus, MG
   Raetscho, N
   Choukroun, J
   Sader, R
   Kirkpatrick, CJ
   Ghanaati, S
AF Barbeck, Mike
   Udeabor, Samuel
   Lorenz, Jonas
   Schlee, Markus
   Holthaus, Marzellus Grosse
   Raetscho, Nina
   Choukroun, Joseph
   Sader, Robert
   Kirkpatrick, C. James
   Ghanaati, Shahram
TI High-Temperature Sintering of Xenogeneic Bone Substitutes Leads to
   Increased Multinucleated Giant Cell Formation: In Vivo and Preliminary
   Clinical Results
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE xenograft; bone substitutes; angiogenesis; animal study; biomaterials
AB The present preclinical and clinical study assessed the inflammatory response to a high-temperature-treated xenogeneic material (Bego-Oss) and the effects of this material on the occurrence of multinucleated giant cells, implantation bed vascularization, and regenerative potential. After evaluation of the material characteristics via scanning electron microscopy, subcutaneous implantation in CD-1 mice was used to assess the inflammatory response to the material for up to 60 days. The clinical aspects of this study involved the use of human bone specimens 6 months after sinus augmentation. Established histologic and histomorphometric analysis methods were applied. After implantation, the material was well integrated into both species without any adverse reactions. Material-induced multinucleated giant cells were observed in both species and were associated with enhanced vascularization. These results revealed the high heat treatment led to an increase in the inflammatory tissue response to the biomaterial, and a combined increase in multinucleated giant cell formation. Further clarification of the differentiation of the multinucleated giant cells toward so-called osteoclast-like cells or foreign-body giant cells is needed to relate these cells to the physicochemical composition of the material.
C1 [Barbeck, Mike; Lorenz, Jonas; Sader, Robert; Ghanaati, Shahram] Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, FORM Lab, Frankfurt, Germany.
   [Barbeck, Mike; Kirkpatrick, C. James; Ghanaati, Shahram] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, REPAIR Lab, Mainz, Germany.
   [Udeabor, Samuel] Univ Port Harcourt, Dept Oral & Maxillofacial Surg, Port Harcourt, Nigeria.
   [Holthaus, Marzellus Grosse; Raetscho, Nina] BEGO Implant Syst, Bremen, Germany.
   [Choukroun, Joseph] Pain Clin, Nice, France.
RP Ghanaati, S (reprint author), Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, FORM Lab, Frankfurt, Germany.
EM shahram.ghanaati@kgu.de
OI Barbeck, Mike/0000-0002-3001-1347
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Athanasiou VT, 2010, MED SCI MONITOR, V16, pBR24
   Barbeck M, 2014, Ann Maxillofac Surg, V4, P150, DOI 10.4103/2231-0746.147106
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   de Lange GL, 2014, OR SURG OR MED OR PA, V117, P8, DOI 10.1016/j.oooo.2013.08.008
   Deschamps JY, 2005, XENOTRANSPLANTATION, V12, P91, DOI 10.1111/j.1399-3089.2004.00199.x
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Froum SJ, 2013, INT J PERIODONT REST, V33, P269, DOI 10.11607/prd.1614
   Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003
   Ghanaati Shahram, 2013, Ann Maxillofac Surg, V3, P126, DOI 10.4103/2231-0746.119221
   Ghanaati S, 2013, CLIN IMPLANT DENT R, V15, P883, DOI 10.1111/j.1708-8208.2011.00433.x
   Ghanaati S, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-1
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Goff T, 2013, INJURY, V44, pS86, DOI 10.1016/S0020-1383(13)70019-6
   Goller G, 2006, J SOL-GEL SCI TECHN, V37, P111, DOI 10.1007/s10971-006-6428-9
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Jensen SS, CLIN ORAL IMPLANTS R
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Lee YM, 2006, INT J PERIODONT REST, V26, P471
   Lorenzetti M, 1998, INT J ORAL MAX IMPL, V13, P69
   McNally AK, 2011, EXP MOL PATHOL, V91, P673, DOI 10.1016/j.yexmp.2011.06.012
   Meijndert L, 2005, INT J ORAL MAX SURG, V34, P877, DOI 10.1016/j.ijom.2005.04.017
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Miyamoto I, 2012, CLIN IMPLANT DENT R, V14, P304, DOI 10.1111/j.1708-8208.2009.00257.x
   Moghadam HG, 2009, IMPLANT DENT, V18, P230, DOI 10.1097/ID.0b013e31819b663f
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   Rothamel D, 2011, ZZI, V27, pS60
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Seidel P, 2004, MAT WISS WERKSTOFFTE, V35
   Simion M, 2004, Minerva Stomatol, V53, P191
   Sukumar Sujith, 2008, Acta Medica (Hradec Kralove), V51, P203
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Trice ME, 2009, AAOS NOW         JUN
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Wang W, 1997, J BONE JOINT SURG BR, V79B, P849, DOI 10.1302/0301-620X.79B5.7780
   Willershausen I, 2014, J APPL ORAL SCI, V22, P29, DOI 10.1590/1678-775720130316
NR 51
TC 11
Z9 11
U1 0
U2 2
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD OCT
PY 2015
VL 41
IS 5
BP E212
EP E222
DI 10.1563/aaid-joi-D-14-00168
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA V62ZE
UT WOS:000211002900008
PM 25105868
DA 2018-10-20
ER

PT J
AU Yang, EY
   Kronenfeld, JP
   Gartas-Asfura, KM
   Bayer, AL
   Stabler, CL
AF Yang, E. Y.
   Kronenfeld, J. P.
   Gartas-Asfura, K. M.
   Bayer, A. L.
   Stabler, C. L.
TI Engineering an "infectious" T-reg biomimetic through chemoselective
   tethering of TGF-beta 1 to PEG brush surfaces
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Immunomodulation; Staudinger ligation; Regulatory T cells
ID GROWTH-FACTOR-BETA; VERSUS-HOST-DISEASE; LATENT TGF-BETA; DENDRITIC
   CELLS; IN-VIVO; TRANSPLANTATION TOLERANCE; REGULATORY CELLS; CUTTING
   EDGE; NOD MICE; ANTIGEN
AB Modulation of immunological responses to allografts following transplantation is of pivotal importance to improving graft outcome and duration. Of the many approaches, harnessing the dominant tolerance induced by regulatory T cells (T-reg) holds tremendous promise. Recent studies have highlighted the unique potency of cell surface-bound TGF-beta 1 on T-reg for promoting infectious tolerance, i.e. to confer suppressive capacity from one cell to another. To mimic this characteristic, TGF-beta 1 was chemoselectively tethered to inert and viable polymer grafting platforms using Staudinger ligation. We report the synthesis and functional characterization of these engineered TGF-beta 1 surfaces. Inert beads tethered with TGF-beta 1 were capable of efficiently converting naive CD4(+) CD62L(hi) T cells to functional T-reg. Concordantly, translation of conjugation scheme from inert surfaces to viable cells also led to efficient generation of functional T-reg. Further, the capacity of these platforms to generate antigen-specific T-reg was demonstrated. These findings illustrate the unique faculty of tethered TGF-beta 1 biomaterial platforms to function as an "infectious" T-reg and provide a compelling approach for generating tolerogenic microenvironments for allograft transplantation. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yang, E. Y.; Kronenfeld, J. P.; Gartas-Asfura, K. M.; Bayer, A. L.; Stabler, C. L.] Univ Miami, Diabet Res Inst, Miami, FL USA.
   [Yang, E. Y.; Stabler, C. L.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA.
   [Kronenfeld, J. P.] Univ Miami, Dept Med, Miami, FL USA.
   [Bayer, A. L.] Univ Miami, Dept Microbiol & Immunol, Miami, FL USA.
   [Stabler, C. L.] Univ Miami, Dept Biomed Engn, Miami, FL USA.
   [Stabler, C. L.] Univ Miami, Dept Surg, Miami, FL USA.
RP Stabler, CL (reprint author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.
EM cstabler@bme.ufl.edu
RI Stabler, Cherie/E-8227-2011
OI Bayer, Allison/0000-0003-4778-0238
FU National Institutes of Health [1DP2 DK08309601, R01DK100654]; Diabetes
   Research Institute Foundation
FX This work was supported by the National Institutes of Health (1DP2
   DK08309601 and R01DK100654) and the Diabetes Research Institute
   Foundation. We thank the DRI Analytical Imaging Core for use of their
   facilities and Dr. Marcia Boulina for her invaluable assistance. We
   thank Cecilia Cabello-Kindelan for her assistance in animal breeding and
   phenotyping. We would especially like to thank the Director of the
   Diabetes Research Institute, Dr. Camillo Ricordi, for his consult and
   guidance.
CR Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014
   Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308
   Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816
   Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x
   Bayer AL, 2014, AM J TRANSPLANT, V14, P2432, DOI 10.1111/ajt.12854
   Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179
   Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062
   Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021
   Bluestone JA, 2011, IMMUNOL REV, V241, P5, DOI 10.1111/j.1600-065X.2011.01019.x
   Border W, 1994, NEW ENGL J MED, V11, P1286, DOI DOI 10.1056/NEJM199411103311907
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Cabello-Kindelan C, 2014, AM J TRANSPLANT, V14, P1032, DOI 10.1111/ajt.12650
   Chen AM, 2001, BIODRUGS, V15, P833, DOI 10.2165/00063030-200115120-00005
   Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152
   Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0
   Cozzo C, 2003, J IMMUNOL, V171, P5678, DOI 10.4049/jimmunol.171.11.5678
   Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199
   EPSTEIN FH, 1994, NEW ENGL J MED, V331, P1286
   Fan HM, 2011, SEMIN IMMUNOL, V23, P453, DOI 10.1016/j.smim.2011.08.012
   Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x
   Gattas-Asfura KM, 2013, ACS APPL MATER INTER, V5, P9964, DOI 10.1021/am401981g
   Gattas-Asfura KM, 2009, BIOMACROMOLECULES, V10, P3122, DOI 10.1021/bm900789a
   Giraldo Jaime A, 2010, J Diabetes Sci Technol, V4, P1238
   Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460
   Graham JG, 2013, TISSUE ENG PT A, V19, P1465, DOI [10.1089/ten.tea.2012.0643, 10.1089/ten.TEA.2012.0643]
   Grewal IS, 2002, J AUTOIMMUN, V19, P9, DOI 10.1006/jaut.2002.0599
   Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111
   Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010
   Hori S, 2014, IMMUNOL REV, V259, P159, DOI 10.1111/imr.12175
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037
   Kubo M, 2001, ARTHRITIS RHEUM, V44, P731, DOI 10.1002/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U
   Le Y, 2010, ACTA BIOMATER, V6, P2631, DOI 10.1016/j.actbio.2010.01.031
   LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224
   Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014
   Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   McHugh MD, 2015, BIOMATERIALS, V59, P172, DOI 10.1016/j.biomaterials.2015.04.003
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8
   Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178
   Nagahama Kanji, 2007, Methods Mol Biol, V380, P431
   Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629
   Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834
   Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010
   Pannu J, 2006, ARTHRITIS RHEUM, V54, P3011, DOI 10.1002/art.22063
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pothoven KL, 2010, AM J TRANSPLANT, V10, P1774, DOI 10.1111/j.1600-6143.2010.03199.x
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076
   Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418
   Schreiber TH, 2012, ONCOIMMUNOLOGY, V1, P642, DOI 10.4161/onci.20298
   Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684
   Tanchot C, 2004, J IMMUNOL, V172, P4285, DOI 10.4049/jimmunol.172.7.4285
   Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139
   Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289
   Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180
   Tonkin DR, 2008, J IMMUNOL, V181, P4516, DOI 10.4049/jimmunol.181.7.4516
   Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106
   Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702
   Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102
   Wang DC, 2011, BIOMATERIALS, V32, P9494, DOI 10.1016/j.biomaterials.2011.08.061
   Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730
   Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062
   Wolf D, 2012, TRANSPLANTATION, V94, P569, DOI 10.1097/TP.0b013e318264d3ef
   Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1081/jem.20030422
   Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923
   Yu P, 2005, J IMMUNOL, V174, P6772, DOI 10.4049/jimmunol.174.11.6772
   Zakrzewski JL, 2014, NAT BIOTECHNOL, V32, P786, DOI 10.1038/nbt.2960
   Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531
NR 77
TC 4
Z9 4
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 67
BP 20
EP 31
DI 10.1016/j.biomaterials.2015.07.009
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CR1IO
UT WOS:000361078600003
PM 26197412
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mahadik, BP
   Haba, SP
   Skertich, LJ
   Harley, BAC
AF Mahadik, Bhushan P.
   Haba, Sara Pedron
   Skertich, Luke J.
   Harley, Brendan A. C.
TI The use of covalently immobilized stem cell factor to selectively affect
   hematopoietic stem cell activity within a gelatin hydrogel
SO BIOMATERIALS
LA English
DT Article
DE Bone marrow; Stem cell; Cell activation; Hydrogel; Growth factor
ID EX-VIVO EXPANSION; COLLAGEN-GAG SCAFFOLDS; FOCAL ADHESION KINASE;
   BONE-MARROW NICHE; PROGENITOR CELLS; IN-VITRO; MICROENVIRONMENTS;
   INTERNALIZATION; VIABILITY; PROTEINS
AB Hematopoietic stem cells (HSCs) are a rare stem cell population found primarily in the bone marrow and responsible for the production of the body's full complement of blood and immune cells. Used clinically to treat a range of hematopoietic disorders, there is a significant need to identify approaches to selectively expand their numbers ex vivo. Here we describe a methacrylamide-functionalized gelatin (GelMA) hydrogel for in vitro culture of primary murine HSCs. Stem cell factor (SCF) is a critical biomolecular component of native HSC niches in vivo and is used in large dosages in cell culture media for HSC expansion in vitro. We report a photochemistry based approach to covalently immobilize SCF within GelMA hydrogels via acrylate-functionalized polyethylene glycol (PEG) tethers. PEG-functionalized SCF retains the native bioactivity of SCF but can be stably incorporated and retained within the GelMA hydrogel over 7 days. Freshly-isolated murine HSCs cultured in GelMA hydrogels containing covalently-immobilized SCF showed reduced proliferation and improved selectivity for maintaining primitive HSCs. Comparatively, soluble SCF within the GelMA hydrogel network induced increased proliferation of differentiating hematopoietic cells. We used a microfluidic templating approach to create GelMA hydrogels containing gradients of immobilized SCF that locally direct HSC response. Together, we report a biomaterial platform to examine the effect of the local presentation of soluble vs. matrix-immobilized biomolecular signals on HSC expansion and lineage specification. This approach may be a critical component of a biomaterial-based artificial bone marrow to provide the correct sequence of niche signals to grow HSCs in the laboratory. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Mahadik, Bhushan P.; Skertich, Luke J.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Haba, Sara Pedron; Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Roger Adams Lab 110, Inst Genom Biol, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Pedron, Sara/E-6404-2015
OI Mahadik, Bhushan/0000-0001-5989-9880; Harley,
   Brendan/0000-0001-5458-154X
FU National Science Foundation [1254738]; NIH [R01 DK099528]; Illini 4000;
   American Cancer Society, Illinois Division, Inc. [189782]
FX The authors would like to acknowledge Barbara Pilas, Angela Kouris and
   Bill Hanafin for assistance with flow cytometry; Dr. Mayandi Sivaguru,
   Dr. Peter Yau, and Dr. Brian Ismai for assistance with fluorescence
   imaging; and Dr. Paul Kenis, Dr. Amit Desai, Joseph Whittenberg, Matthew
   Au and Asha Kirchoff for their help with microfluidic device
   fabrication. This material is based upon work supported by the National
   Science Foundation under Grant No. 1254738. Research reported in this
   publication was also supported by NIH R01 DK099528. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH. The authors are grateful for
   additional funding provided by the Illini 4000 as well as Grant #189782
   from the American Cancer Society, Illinois Division, Inc. The authors
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   this work that could have influenced its outcome.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Anderson SM, 2011, INTEGR BIOL-UK, V3, P887, DOI 10.1039/c1ib00037c
   Brinkman WT, 2003, BIOMACROMOLECULES, V4, P890, DOI 10.1021/bm0257412
   Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688
   Cosson S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04462
   Cuchiara ML, 2013, ACTA BIOMATER, V9, P9258, DOI 10.1016/j.actbio.2013.08.012
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Doran MR, 2009, BIOMATERIALS, V30, P4047, DOI 10.1016/j.biomaterials.2009.04.043
   Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015
   Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Fosser KA, 2003, ANAL CHEM, V75, P5775, DOI 10.1021/ac034634a
   Gabrielson NP, 2013, SMALL, V9, P3076, DOI 10.1002/smll.201203030
   Gammaitoni L, 2003, EXP HEMATOL, V31, P261, DOI 10.1016/S0301-472X(02)01077-9
   Gandavarapu NR, 2014, ADV MATER, V26, P2521, DOI 10.1002/adma.201304847
   Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769
   Gorgieva S, 2012, J BIOMED MATER RES A, V100A, P1655, DOI 10.1002/jbm.a.34106
   Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056
   Hines M, 2008, J CHEM TECHNOL BIOT, V83, P421, DOI 10.1002/jctb.1856
   Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538
   Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Isern Joan, 2011, Curr Osteoporos Rep, V9, P210, DOI 10.1007/s11914-011-0075-y
   Jansen LE, 2015, J MECH BEHAV BIOMED, V50, P299, DOI 10.1016/j.jmbbm.2015.06.023
   Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kishimoto S, 2009, J BIOCHEM, V145, P275, DOI 10.1093/jb/mvn169
   Kishimoto S, 2009, J CONTROL RELEASE, V133, P185, DOI 10.1016/j.jconrel.2008.10.005
   Kobel S, 2010, BIOTECHNIQUES, V48, pIX, DOI 10.2144/000113401
   Kobel S, 2009, LANGMUIR, V25, P8774, DOI 10.1021/la9002115
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kucia M, 2005, BIOL CELL, V97, P133, DOI 10.1042/BC20040069
   Kurth I, 2009, INTEGR BIOL, V1, P427, DOI 10.1039/b903711j
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282
   Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436
   Liaw TYE, 2008, MOL CANCER THER, V7, P3150, DOI 10.1158/1535-7163.MCT-08-0442
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Mahadik BP, 2014, ADV HEALTHC MATER, V3, P449, DOI 10.1002/adhm.201300263
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Nichols JE, 2010, REGEN MED, V5, P289, DOI 10.2217/RME.10.7
   Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513
   Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311
   Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730
   Oh IH, 2012, STEM CELLS, V30, P82, DOI 10.1002/stem.776
   Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017
   Panuganti S, 2013, TISSUE ENG PT A, V19, P998, DOI [10.1089/ten.tea.2011.0111, 10.1089/ten.TEA.2011.0111]
   Park SY, 2013, J IMMUNOL, V190, P1094, DOI 10.4049/jimmunol.1202639
   Pedron S., 2013, J BIOMED MATER RES A, V101, P3405
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Pineault N, 2011, CYTOTHERAPY, V13, P467, DOI 10.3109/14653249.2010.530651
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Shimizu YJ, 1996, J IMMUNOL, V156, P3443
   Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009
   Shin JW, 2013, DIFFERENTIATION, V86, P77, DOI 10.1016/j.diff.2013.05.001
   Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370
   Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115
   Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166
   Tavernier-Tardy E, 2009, LEUKEMIA RES, V33, P764, DOI 10.1016/j.leukres.2008.10.014
   Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329
   THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102
   Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001
   Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Wolff SN, 2002, BONE MARROW TRANSPL, V29, P545, DOI 10.1038/sj/bmt/1703389
   Zandstra PW, 1999, BIOTECHNOL BIOENG, V63, P493, DOI 10.1002/(SICI)1097-0290(19990520)63:4<493::AID-BIT13>3.3.CO;2-S
   Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342
   Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood2004-11-4418
   Zhou K, 2010, ANN HEMATOL, V89, P749, DOI 10.1007/s00277-010-0923-3
NR 82
TC 27
Z9 27
U1 5
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 67
BP 297
EP 307
DI 10.1016/j.biomaterials.2015.07.042
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CR1IO
UT WOS:000361078600030
PM 26232879
OA Other Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Salbach-Hirsch, J
   Samsonov, SA
   Hintze, V
   Hofbauer, C
   Picke, AK
   Rauner, M
   Gehrcke, JP
   Moeller, S
   Schnabelrauch, M
   Scharnweber, D
   Pisabarro, MT
   Hofbauer, LC
AF Salbach-Hirsch, Juliane
   Samsonov, Sergey A.
   Hintze, Vera
   Hofbauer, Christine
   Picke, Ann-Kristin
   Rauner, Martina
   Gehrcke, Jan-Philip
   Moeller, Stephanie
   Schnabelrauch, Matthias
   Scharnweber, Dieter
   Pisabarro, M. Teresa
   Hofbauer, Lorenz C.
TI Structural and functional insights into sclerostin-glycosaminoglycan
   interactions in bone
SO BIOMATERIALS
LA English
DT Article
DE Sclerostin; Low-density lipoprotein receptor-related protein 5/6
   (LRP5/6); Hyaluronic acid/hyaluronan (HA) sulfate; Chondroitin sulfate
   (CS); Surface plasmon resonance (SPR); Molecular docking
ID CHONDROITIN SULFATE; RECEPTOR ACTIVATOR; COMPLEX-FORMATION; BMP
   ANTAGONIST; HYALURONAN; DERIVATIVES; OSTEOPROTEGERIN; REGULATOR;
   PATHWAYS; DOCKING
AB In order to improve bone defect regeneration, the development of new adaptive biomaterials and their functional and biological validation is warranted. Glycosaminoglycans (GAGs) are important extracellular matrix (ECM) components in bone and may display osteogenic properties that are potentially useful for biomaterial coatings. Using hyaluronan (HA), chondroitin sulfate (CS) and chemically modified highly sulfated HA and CS derivatives (sHA3 and sCS3; degree of sulfation similar to 3), we evaluated how GAG sulfation modulates Wnt signaling, a major regulator of osteoblast, osteoclast and osteocyte biology. GAGs were tested for their capability to bind to sclerostin, an inhibitor of Wnt signaling, using surface plasmon resonance and molecular modeling to characterize their interactions. GAGs bound sclerostin in a concentration- and sulfate-dependent manner at a common binding region. These findings were confirmed in an LRP5/sclerostin interaction study and an in vitro model of Wnt activation. Here, pre-incubation of sclerostin with different GAGs led to a sulfate- and dose-dependent loss of its bioactivity. Using GAG-biotin derivatives in a competitive ELISA approach sclerostin was shown to be the preferred binding partner over Wnt3a. In conclusion, highly sulfated GAGs might control bone homeostasis via interference with sclerostin/LRP5/6 complex formation. Whether these properties can be utilized to improve bone regeneration needs to be validated in vivo. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Salbach-Hirsch, Juliane; Picke, Ann-Kristin; Rauner, Martina; Hofbauer, Lorenz C.] Tech Univ Dresden, Med Ctr, Dept Med 3, Div Endocrinol Diabet & Bone Dis, D-01307 Dresden, Germany.
   [Samsonov, Sergey A.; Gehrcke, Jan-Philip; Pisabarro, M. Teresa] Tech Univ Dresden, BIOTEC, Struct Bioinformat, D-01307 Dresden, Germany.
   [Hintze, Vera; Scharnweber, Dieter] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01069 Dresden, Germany.
   [Hofbauer, Christine] Tech Univ Dresden, Med Ctr, Dept Orthoped Surg, D-01307 Dresden, Germany.
   [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
   [Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany.
RP Hofbauer, LC (reprint author), Tech Univ Dresden, Med Ctr, Dept Med 3, Div Endocrinol Diabet & Bone Dis, D-01307 Dresden, Germany.
EM lorenz.hofbauer@uniklinikum-dresden.de
RI Hofbauer, Lorenz/G-2490-2010; Samsonov, Sergey/P-6280-2015; Pisabarro,
   M. Teresa/D-4270-2012
OI Hofbauer, Lorenz/0000-0002-8691-8423; 
FU German Research Council [SFB-TRR67]; Studienstiftung des deutschen
   Volkes
FX This work was supported by the German Research Council [SFB-TRR67: A2,
   A3, A7, B2, Z3].; J.-P.G. was supported by a fellowship of the
   Studienstiftung des deutschen Volkes.
CR Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108
   Case DA, 2010, AMBER
   Ester M, 1996, KDD, V96, P226, DOI DOI 10.1023/A:1009745219419
   Galli C, 2012, EUR CELLS MATER, V24, P46, DOI 10.22203/eCM.v024a04
   Hamann C, 2013, J BONE MINER RES, V28, P627, DOI 10.1002/jbmr.1803
   Hassler N, 2014, J BONE MINER RES, V29, P2144, DOI 10.1002/jbmr.2259
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2014, BIOMACROMOLECULES, V15, P3083, DOI 10.1021/bm5006855
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Husoy T, 2005, INT J CANCER, V116, P351, DOI 10.1002/ijc.21025
   Kunze R, 2010, GLYCOCONJUGATE J, V27, P151, DOI 10.1007/s10719-009-9270-9
   Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200
   Ling L., 2010, J BIOL CHEM, V285, P26233
   McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120
   Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028
   Salbach-Hirsch J, 2014, J CELL BIOCHEM, V115, P1101, DOI 10.1002/jcb.24750
   Salbach-Hirsch J, 2013, BIOMATERIALS, V34, P7653, DOI 10.1016/j.biomaterials.2013.06.053
   Samsonov SA, 2014, J CHEM INF MODEL, V54, P582, DOI 10.1021/ci4006047
   Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200
   Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120
   Tsourdi E, 2014, J BIOACT COMPAT POL, V29, P474, DOI 10.1177/0883911514546983
   van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454
   van der Smissen A, 2013, ACTA BIOMATER, V9, P7775, DOI 10.1016/j.actbio.2013.04.023
   Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200
   Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599
NR 27
TC 12
Z9 13
U1 5
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 67
BP 335
EP 345
DI 10.1016/j.biomaterials.2015.07.021
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CR1IO
UT WOS:000361078600033
PM 26232882
DA 2018-10-20
ER

PT J
AU Pence, JC
   Clancy, KBH
   Harley, BAC
AF Pence, Jacquelyn C.
   Clancy, Kathryn B. H.
   Harley, Brendan A. C.
TI The induction of pro-angiogenic processes within a collagen scaffold via
   exogenous estradiol and endometrial epithelial cells
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE angiogenesis; endometrium; collagen; scaffold
ID ENDOTHELIAL GROWTH-FACTOR; GAG SCAFFOLDS; MENSTRUAL-CYCLE; IN-VITRO;
   FACTOR SUPPLEMENTATION; ENGINEERED TISSUES; ESTROGEN-RECEPTOR; VESSEL
   MATURATION; FACTOR EXPRESSION; VASCULARIZATION
AB Nutrient transport remains a major limitation in the design of biomaterials. One approach to overcome this constraint is to incorporate features to induce angiogenesis-mediated microvasculature formation. Angiogenesis requires a temporal presentation of both pro- and anti-angiogenic factors to achieve stable vasculature, leading to increasingly complex biomaterial design scheme. The endometrium, the lining of the uterus and site of embryo implantation, exemplifies a non-pathological model of rapid growth, shedding, and re-growth of dense vascular networks regulated by the dynamic actions of estradiol and progesterone. In this study, we examined the individual and combined response of endometrial epithelial cells and human umbilical vein endothelial cells to exogenous estradiol within a three-dimensional collagen scaffold. While endothelial cells did not respond to exogenous estradiol, estradiol directly stimulated endometrial epithelial cell transduction pathways and resulted in dose-dependent increases in endogenous VEGF production. Co-culture experiments using conditioned media demonstrated estradiol stimulation of endometrial epithelial cells can induce functional changes in endothelial cells within the collagen biomaterial. We also report the effect of direct endometrial epithelial and endothelial co-culture as well as covalent immobilization of estradiol within the collagen biomaterial. These efforts establish the suitability of an endometrial-inspired model for promoting pro-angiogenic events within regenerative medicine applications. These results also suggest the potential for developing biomaterial-based models of the endometrium. Biotechnol. Bioeng. 2015;112: 2185-2194. (c) 2015 Wiley Periodicals, Inc.
C1 [Pence, Jacquelyn C.; Harley, Brendan A. C.] Univ Illinois, Dept Chem Biomol Engn, Urbana, IL 61820 USA.
   [Clancy, Kathryn B. H.] Univ Illinois, Dept Anthropol, Urbana, IL USA.
   [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem Biomol Engn, Urbana, IL 61820 USA.
EM bharley@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1105300]; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [R03 AR062811]
FX Contract grant sponsor: National Science Foundation; Contract grant
   number: 1105300; Contract grant sponsor: National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health; Contract grant number: R03 AR062811
CR Albrecht ED, 2003, HUM REPROD, V18, P2039, DOI 10.1093/humrep/deg415
   Alsop AT, 2014, ACTA BIOMATER
   Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Caliari SR, 2014, TISSUE ENG PT A, V20, P2463, DOI [10.1089/ten.tea.2013.0400, 10.1089/ten.TEA.2013.0400]
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291
   CHARNOCKJONES DS, 1993, BIOL REPROD, V48, P1120, DOI 10.1095/biolreprod48.5.1120
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Clancy KBH, 2009, YEARB PHYS ANTHROPOL, V52, P137, DOI 10.1002/ajpa.21188
   Davies NH, 2012, TISSUE ENG PT A, V18, P26, DOI 10.1089/ten.tea.2011.0192
   Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004
   Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Evron A, 2011, HUM REPROD, V26, P176, DOI 10.1093/humrep/deq296
   Gambino LS, 2002, HUM REPROD, V17, P1199, DOI 10.1093/humrep/17.5.1199
   Girling Jane E., 2005, Angiogenesis, V8, P89, DOI 10.1007/s10456-005-9006-9
   Girling JE, 2009, REPRODUCTION, V138, P883, DOI 10.1530/REP-09-0147
   Greb RR, 1997, HUM REPROD, V12, P1280
   Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186
   Hornung D, 1998, FERTIL STERIL, V69, P909, DOI 10.1016/S0015-0282(98)00044-2
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Iruela-Arispe ML, 1999, MICROCIRCULATION, V6, P127, DOI 10.1038/sj.mn.7300061
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kayisli UA, 2004, J CLIN ENDOCR METAB, V89, P5794, DOI 10.1210/jc.2003-030820
   Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117
   Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009
   Koos RD, 2011, ENDOCRINOLOGY, V152, P4481, DOI 10.1210/en.2011-1449
   Lash GE, 2012, HUM REPROD, V27, P183, DOI 10.1093/humrep/der376
   Ling SH, 2006, STEROIDS, V71, P799, DOI 10.1016/j.steroids.2006.05.010
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755
   Nayak NR, 2002, J CLIN ENDOCR METAB, V87, P1845, DOI 10.1210/jc.87.4.1845
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   Pence JC, 2014, BIOMATER SCI-UK, V2, P1296, DOI 10.1039/c4bm00193a
   Peterson AW, 2014, BIOMATER SCI-UK, V2, P1497, DOI 10.1039/c4bm00141a
   Rogers PAW, 2009, REPROD SCI, V16, P147, DOI 10.1177/1933719108325509
   Schutte SC, 2012, FERTIL STERIL, V97, P997, DOI 10.1016/j.fertnstert.2012.01.098
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shifren JL, 1996, J CLIN ENDOCR METAB, V81, P3112, DOI 10.1210/jc.81.8.3112
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tian L, 2011, J CARDIOVASC TRANSL, V4, P685, DOI 10.1007/s12265-011-9301-3
   Torry DS, 1996, FERTIL STERIL, V66, P72, DOI 10.1016/S0015-0282(16)58390-3
   von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje
   Wang H, 2013, TISSUE ENG PART C-ME, V19, P676, DOI [10.1089/ten.tec.2012.0616, 10.1089/ten.TEC.2012.0616]
   Weimar CHE, 2013, REPROD BIOMED ONLINE, V27, P461, DOI 10.1016/j.rbmo.2013.08.002
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 54
TC 4
Z9 4
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD OCT
PY 2015
VL 112
IS 10
BP 2185
EP 2194
DI 10.1002/bit.25622
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CQ0UR
UT WOS:000360313500022
PM 25944769
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rahim, TNAT
   Abdullah, AM
   Akil, HM
   Mohamad, D
   Rajion, ZA
AF Rahim, Tuan Noraihan Azila Tuan
   Abdullah, Abdul Manaf
   Akil, Hazizan Md
   Mohamad, Dasmawati
   Rajion, Zainul Ahmad
TI Preparation and characterization of a newly developed polyamide
   composite utilising an affordable 3D printer
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article
DE Three-dimensional printer; RepRap; filament extruder; polyamide
ID TISSUE ENGINEERING APPLICATIONS; SCAFFOLD; CRYSTALLIZATION;
   HYDROXYAPATITE; BIOCOMPOSITES; BEHAVIOR; FILLER
AB In this work, the potential of polyamide composite prepared by a 3D printer was evaluated. Polyamide 12 was compounded with 5wt% hydroxyapatite and 15wt% zirconium oxide fillers via a twin screw extruder. The compound was then pelletized prior to the preparation of the filament by a desktop filament extruder. The filament was finally applied to a 3D printer to prepare the printed tensile samples. Pure polyamide 12 and commercial polyamide filament, Taulman 618, were also printed and tested for control. Melt flow and thermal analysis were carried out to estimate the processing conditions. Tensile test was also conducted to evaluate the strength and modulus. The new polyamide composite was successfully prepared and tested. The strength of polyamide composite was comparable to Taulman 618. The modulus of the composite was improved due to the incorporation of fillers. The morphology of the printed composite was porous, which could provide pros and cons to biological and mechanical properties, respectively. Polyamide composite presented a promising polymer material for a 3D printer and may be applied for biomaterial application.
C1 [Rahim, Tuan Noraihan Azila Tuan; Akil, Hazizan Md] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Pulau Pinang, Malaysia.
   [Abdullah, Abdul Manaf; Mohamad, Dasmawati; Rajion, Zainul Ahmad] Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian, Kelantan, Malaysia.
RP Akil, HM (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia.
EM hazizan@usm.my
RI abdullah, abdul manaf/I-3212-2017; Md Akil, Hazizan/C-3685-2008
OI Md Akil, Hazizan/0000-0002-7422-4627; Abdullah, Abdul
   Manaf/0000-0001-6080-7605
FU RUT grant [1001/PPSG/852004]; MyBrain15 Program under the Malaysian
   Ministry of Education
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the RUT grant [1001/PPSG/852004]. First and second
   authors are supported by MyBrain15 Program under the Malaysian Ministry
   of Education.
CR 3D printer and 3D printing news, 3D PRINT 3D PRINT NE
   Afzal A, 2014, MATER EXPRESS, V4, P1, DOI 10.1166/mex.2014.1148
   Athreya SR, 2011, COMPOS SCI TECHNOL, V71, P506, DOI 10.1016/j.compscitech.2010.12.028
   Boots Industries, IMP HIGH QUAL FIL 3D
   Castelan-Velazco LI, 2009, POLYM BULL, V62, P99, DOI 10.1007/s00289-008-1014-7
   Cowie JMG, 2008, POLYM CHEM PHYS MODE, V3rd, P279
   Elmore T., INSTRUCTION ASSESMBL
   Fornes TD, 2003, POLYMER, V44, P3945, DOI 10.1016/S0032-3861(03)00344-6
   Hofmann D, 2014, MACROMOL MATER ENG, V299, P1329, DOI 10.1002/mame.201400066
   Hoque ME, 2014, MATER LETT, V131, P255, DOI 10.1016/j.matlet.2014.05.111
   Instructables, FAQ PRINT NYL NEW MA
   Mehrabanian M, 2011, INT J NANOMED, V6, P1651, DOI 10.2147/IJN.S21203
   Nakahira A, 2002, J MATER SCI, V37, P4425, DOI 10.1023/A:1020681309572
   Puska M, 2005, J BIOMATER APPL, V19, P287, DOI 10.1177/0885328205048044
   Sarwar MI, 2009, POLYM COMPOSITE, V30, P95, DOI 10.1002/pc.20538
   Saudi Basic Industries Corp, 2015, MAT DAT SHEET CYC RE
   The Freedonia Group Inc, 2013, WORLD 3D PRINT ADD M
   Wei J, 2007, COMPOS PART B-ENG, V38, P301, DOI 10.1016/j.compositesb.2006.05.006
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang X, 2006, POLYM DEGRAD STABIL, V91, P1202, DOI 10.1016/j.polymdegradstab.2005.02.006
   Zhou S, 2014, POLYM ENG SCI, V54, P1003, DOI 10.1002/pen.23636
NR 21
TC 7
Z9 7
U1 6
U2 99
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
EI 1530-7964
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD OCT
PY 2015
VL 34
IS 19
BP 1628
EP 1638
DI 10.1177/0731684415594692
PG 11
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA CR2JN
UT WOS:000361155500006
DA 2018-10-20
ER

PT J
AU Sarhane, KA
   Tuffaha, SH
   Krick, K
   Cashman, CR
   Martin, RA
   Abraham, J
   Ibrahim, Z
   Lee, WPA
   Mao, HQ
   Brandacher, G
AF Sarhane, Karim A.
   Tuffaha, Sami H.
   Krick, Kellin
   Cashman, Christopher R.
   Martin, Russell A.
   Abraham, James
   Ibrahim, Zuhaib
   Lee, W. P. Andrew
   Mao, Hai-Quan
   Brandacher, Gerald
TI Critical Analysis of Peripheral Nerve Regeneration in a Chronic
   Denervation Rat Model Using a Sustained Biomaterial-Based Delivery of
   Glial Cell-Derived Neurotrophic Factor (GDNF), Chondroitinase, and GDNF
   Plus Chondroitinase Growth Factors
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Meeting Abstract
CT 70th Annual Sessions of the Scientific Forum and Annual Clinical
   Congress of the American-College-of-Surgeons
CY OCT 04-08, 2015
CL Chicago, IL
SP Amer Coll Surg
C1 [Sarhane, Karim A.; Tuffaha, Sami H.; Krick, Kellin; Cashman, Christopher R.; Martin, Russell A.; Abraham, James; Ibrahim, Zuhaib; Lee, W. P. Andrew; Mao, Hai-Quan; Brandacher, Gerald] Johns Hopkins Univ, Baltimore, MD USA.
RI Brandacher, Gerald/L-7540-2016
NR 0
TC 0
Z9 0
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1072-7515
EI 1879-1190
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD OCT
PY 2015
VL 221
IS 4
SU 1
BP S111
EP S111
DI 10.1016/j.jamcollsurg.2015.07.257
PG 1
WC Surgery
SC Surgery
GA CR1XX
UT WOS:000361119700220
DA 2018-10-20
ER

PT J
AU de Val, JEMS
   Guirado, JLC
   Ruiz, RAD
   Moreno, GG
   Fernandez, MPR
   Romanos, GE
AF Mate Sanchez de Val, Jose E.
   Luis Calvo Guirado, Jose
   Delgado Ruiz, Rafael A.
   Gomez Moreno, Gerardo
   Ramirez Fernandez, Maria P.
   Romanos, Georgios E.
TI Bone neo-formation and mineral degradation of 4Bone.((R)) Part I:
   material characterization and SEM study in critical size defects in
   rabbits
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal experiments; biomaterials; bone; guided tissue regeneration;
   regeneration
ID CALCIUM-PHOSPHATE CERAMICS; BETA-TRICALCIUM PHOSPHATE; ANORGANIC BOVINE
   BONE; HYDROXYAPATITE; BIOMATERIALS; SUBSTITUTES; RESORPTION; GRAFTS;
   VITRO
AB ObjectiveThis study reports the characterization process and in vivo application of a new high-porosity biphasic calcium phosphate (4Bone((R)) - HA 60%/-TCP 40%) inserted into the critical size defect of a rabbit tibiae.
   Material and methodsTwo critical size defects of 6mm diameter were created in each tibia of 15 New Zealand rabbits, and a total of 60 defects were divided into a test group filled with 4Bone((R)) (n=30) and a control group (n=30). The material and the implants were characterized by scanning electron microscope (SEM) fitted with energy-dispersive X-ray spectroscopy (EDX).
   ResultsThe biomaterial's grain size decreased progressively with the graft integration process over the 60-day study period. Element analysis revealed increased percentages of Ca/P (2.860.32 vs. 1.97 +/- 0.59) in new bone and at the interface (P<0.05). Element mapping showed that Ca and P were concentrated in the medullary and cortical zones in the test group but were concentrated only in cortical zones in the control group.
   ConclusionsCritical size defects in a rabbit tibia model can be sealed using this highly porous biphasic calcium phosphate; it supports new bone formation, creates a bridge between defect borders, and facilitates bone in growth
C1 [Mate Sanchez de Val, Jose E.; Luis Calvo Guirado, Jose; Ramirez Fernandez, Maria P.] Univ Murcia, Fac Med & Dent, Murcia, Spain.
   [Delgado Ruiz, Rafael A.; Romanos, Georgios E.] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA.
   [Gomez Moreno, Gerardo] Univ Granada, Fac Dent, Granada, Spain.
RP de Val, JEMS (reprint author), Univ Murcia, Fac Med & Dent, Murcia, Spain.
EM jmsodont@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X
CR Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Calvo-Guirado JL, 2012, CLIN ORAL IMPLAN RES, V23, P667, DOI 10.1111/j.1600-0501.2011.02193.x
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1228, DOI 10.1111/clr.12258
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Eder C., 2013, EUROPEAN SPINE J, V1, P1
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Mangano C, 2015, CLIN IMPLANT DENT R, V17, P610, DOI 10.1111/cid.12145
   Mangano C, 2013, INT J ORAL MAX IMPL, V28, P51, DOI 10.11607/jomi.2667
   de Val JEMS, 2014, J BIOMED MATER RES A, V102, P1037, DOI 10.1002/jbm.a.34785
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   RAWLINGS CE, 1993, NEUROSURGERY, V33, P935
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.3.CO;2-Y
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Yamauchi K, 2010, INT J ORAL MAX SURG, V39, P1000, DOI 10.1016/j.ijom.2010.05.008
   Yang C, 2014, J BIOMED MATER RES B, V102, P80, DOI 10.1002/jbm.b.32984
   Yuasa T, 2005, DENT MATER J, V24, P207, DOI 10.4012/dmj.24.207
NR 26
TC 1
Z9 1
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2015
VL 26
IS 10
BP 1165
EP 1169
DI 10.1111/clr.12420
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CQ7FU
UT WOS:000360769200008
PM 24861692
DA 2018-10-20
ER

PT J
AU Cassetta, M
   Perrotti, V
   Calasso, S
   Piattelli, A
   Sinjari, B
   Iezzi, G
AF Cassetta, Michele
   Perrotti, Vittoria
   Calasso, Sabrina
   Piattelli, Adriano
   Sinjari, Bruna
   Iezzi, Giovanna
TI Bone formation in sinus augmentation procedures using autologous bone,
   porcine bone, and a 50:50 mixture: a human clinical and histological
   evaluation at 2months
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE autologous bone; bone regeneration; histology; porcine bone; sinus
   augmentation
ID DENTAL IMPLANTS; HISTOMORPHOMETRIC ANALYSIS; AUTOGENOUS BONE; ELEVATION;
   OSTEOINTEGRATION; HYDROXYAPATITE; BIOMATERIAL; DEFECTS
AB ObjectivesThe aim of this study was to perform a 2months clinical and histological comparison of autologous bone, porcine bone, and a 50:50 mixture in maxillary sinus augmentation procedures.
   Materials and methodsA total of 10 consecutive patients, undergoing two-stage sinus augmentation procedures using 100% autologous bone (Group A), 100% porcine bone (Group B), and a 50:50 mixture of autologous and porcine bone (Group C) were included in this study. After a 2-month healing period, at the time of implant insertion, clinical evaluation was performed and bone core biopsies were harvested and processed for histological analysis.
   ResultsThe postoperative healing was uneventful regardless of the materials used for the sinus augmentation procedures. The histomorphometrical analysis revealed comparable percentages of newly formed bone, marrow spaces, and residual grafted material in the three groups.
   ConclusionThe clinical and histological results of this study indicated that porcine bone alone or in combination with autologous bone are biocompatible and osteoconductive materials and can be successfully used in sinus augmentation procedures.
C1 [Cassetta, Michele; Calasso, Sabrina] Univ Roma La Sapienza, Sch Dent, I-00185 Rome, Italy.
   [Perrotti, Vittoria; Piattelli, Adriano; Sinjari, Bruna; Iezzi, Giovanna] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
RP Perrotti, V (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM v.perrotti@unich.it
FU PRIN - Ministry of Education, University and Research (M.I.U.R.), Rome,
   Italy [PRIN 20102ZLNJ5]
FX This work was supported by PRIN 2010-2011 (PRIN 20102ZLNJ5) financed by
   the Ministry of Education, University and Research (M.I.U.R.), Rome,
   Italy. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Arcuri C, 2005, Minerva Stomatol, V54, P351
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Borie DC, 1998, INFECT CONT HOSP EP, V19, P355
   Calvo Guirado J. L., 2011, MED ORAL PATOL ORAL, V16, P260
   Guirado JLC, 2013, CLIN IMPLANT DENT R, V15, P143, DOI 10.1111/j.1708-8208.2011.00337.x
   Cassetta M, 2012, INT J PERIODONT REST, V32, P581
   CAWOOD JI, 1991, INT J ORAL MAX SURG, V20, P75, DOI 10.1016/S0901-5027(05)80711-8
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Calvo-Guirado JL, 2010, J PINEAL RES, V48, P194, DOI 10.1111/j.1600-079X.2009.00743.x
   Calvo-Guirado JL, 2009, J PINEAL RES, V47, P164, DOI 10.1111/j.1600-079X.2009.00696.x
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Ramirez-Fernandez MP, 2011, CLIN ORAL IMPLAN RES, V22, P767, DOI 10.1111/j.1600-0501.2010.02058.x
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Scarano A, 2010, J ORAL MAXIL SURG, V68, P1869, DOI 10.1016/j.joms.2009.09.015
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
NR 28
TC 3
Z9 3
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2015
VL 26
IS 10
BP 1180
EP 1184
DI 10.1111/clr.12423
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CQ7FU
UT WOS:000360769200010
PM 24861978
DA 2018-10-20
ER

PT J
AU Dewi, AH
   Ana, ID
   Wolke, J
   Jansen, J
AF Dewi, Anne Handrini
   Ana, Ika Dewi
   Wolke, Joop
   Jansen, John
TI Behavior of POP-calcium carbonate hydrogel as bone substitute with
   controlled release capability: A study in rat
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium sulfate; calcium carbonate hydrogel; bone substitute;
   degradation; bone formation
ID GRAFT SUBSTITUTES; HYDROXYAPATITE; COMPOSITE; SCAFFOLDS; DEFECT; CEMENT;
   RABBIT
AB Gypsum or calcium sulfate (CS) or plaster of Paris (POP) is considered as a fast degradable material that usually resorbs before the bone defect area is completely filled by new bone. In this study, the incorporation of CaCO3 hydrogel into POP in different compositions was proposed to enhance the bone biological activity of POP and to decrease its degradability. The mechanical and degradation properties of the various materials were characterized by in vitro analysis. Subsequently, the materials were inserted into cylindrically sized bone defects as created into the femoral condyle of rats and left in situ for 1, 4, and 8 weeks. Histological analysis of the retrieved specimens indicated that the addition of CaCO3 hydrogel into POP increased bone formation, angiogenesis and collagen density and resulted into faster bone formation and maturation. It was also confirmed that the degradation rate of the POP decreased by the addition of CaCO3 hydrogel. The in vivo findings did corroborate with the in vitro analysis. In conclusion, the incorporation of CaCO3 hydrogel provides a promising technology to improve the properties of POP, the oldest biomaterial used for bone grafting. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3273-3283, 2015.
C1 [Dewi, Anne Handrini; Ana, Ika Dewi] GadjahMada Univ, Dept Dent Biomed Sci, Fac Dent, Yogyakarta 55281, Indonesia.
   [Wolke, Joop; Jansen, John] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, J (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
EM john.jansen@radboudumc.nl
RI Wolke, J.G.C./L-4768-2015
FU Ministry of Research, Technology and Higher Education of The Republic of
   Indonesia PhD Scholarship Program (Radboud University Nijmegen Medical
   Center, The Netherlands); Ministry of Research, Technology and Higher
   Education of The Republic of Indonesia PhD Scholarship Program
   (Universitas Gadjah Mada, Yogyakarta, Indonesia)
FX Contract grant sponsor: The Ministry of Research, Technology and Higher
   Education of The Republic of Indonesia PhD Scholarship Program (Radboud
   University Nijmegen Medical Center, The Netherlands and in Universitas
   Gadjah Mada, Yogyakarta, Indonesia).
CR BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, P53
   Bundela H, 2008, EXPRESS POLYM LETT, V2, P201, DOI 10.3144/expresspolymlett.2008.25
   Cirotteau Y., 2001, EUR J ORTHOP SURG TR, V11, P149
   Combes C, 2006, J BIOMED MATER RES A, V79A, P318, DOI 10.1002/jbm.a.30795
   Dewi AH, 2013, J BIOMED MATER RES A, V101, P2143, DOI 10.1002/jbm.a.34513
   Frayssinet P., 1998, EUR J ORTHOP SURG TR, V8, P17
   Glazer P A, 2001, Spine J, V1, P395, DOI 10.1016/S1529-9430(01)00108-5
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hu GF, 2010, J MATER SCI-MATER M, V21, P627, DOI 10.1007/s10856-009-3885-z
   Kentley RA, 1993, PHARM RES, V10, P1393
   Kim HW, 2005, J BIOMED MATER RES B, V74B, P686, DOI 10.1002/jbm.b.30236
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee Y, 2007, J MATER SCI, V42, P7843, DOI 10.1007/s10853-007-1629-3
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lewry JL, 1994, J MATER SCI, V29, P6085
   Maeda H, 2007, J MATER SCI-MATER M, V18, P2269, DOI 10.1007/s10856-007-3108-4
   Mazor Z, 2011, J ORAL IMPLANTOL, V37, P287, DOI 10.1563/AAID-JOI-D-10-00006.1
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Patel ZS, 2008, BONE, V43, P735
   Ratanavaraporn J, 2006, J METALS MAT MINERAL, V16, P31
   Ricci JL, 2000, BONE ENG, P332
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   Thomas MV, 2008, J BIOMED MATER RES B, V88B, P597
   Vaccaro AR, 2002, ORTHOPEDICS, V25, P571
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   Wang C, 2013, BIOMATERIALS, V34, P64, DOI 10.1016/j.biomaterials.2012.09.021
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
NR 33
TC 4
Z9 4
U1 2
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2015
VL 103
IS 10
BP 3273
EP 3283
DI 10.1002/jbm.a.35460
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CQ3KP
UT WOS:000360501300015
PM 25809017
DA 2018-10-20
ER

PT J
AU Khanlou, HM
   Ang, BC
   Barzani, MM
   Silakhori, M
   Talebian, S
AF Khanlou, Hossein Mohammad
   Ang, Bee Chin
   Barzani, Mohsen Marani
   Silakhori, Mahyar
   Talebian, Sepehr
TI Prediction and characterization of surface roughness using sandblasting
   and acid etching process on new non-toxic titanium biomaterial:
   adaptive-network-based fuzzy inference System
SO NEURAL COMPUTING & APPLICATIONS
LA English
DT Article
DE ANFIS; Acid etching and sandblasting (SLA); Biocompatibility; Titanium
   alloys; Surface roughness; Prediction and modeling; Surface
   characterization
ID ETCHED TITANIUM; WETTABILITY; TEMPERATURE; TOPOGRAPHY; PORCELAIN;
   CORROSION; STRENGTH; IMPLANTS; BEHAVIOR; ALLOYS
AB An adaptive neuro-fuzzy system (ANFIS) model was employed to predict the surface roughness. Surface roughening of titanium biomaterials has a crucial effect on increasing the biocompatibility. For this purpose, sandblasted, large-grit, acid-etched (SLA) has been introduced as an effective method to change the surface texturing and roughness. Subsequent processes-polishing, sandblasting and acid etching or SLA-were employed to modify the surface. Alumina particles for surface blasting and Kroll's etchant (3 ml HF + 6 ml HNO3 + 100 ml H2O) for acid etching were utilized in this experiment. This was performed for three different periods of time (10, 20 and 30 s) and temperatures (25, 45 and 60 centigrade). Correspondingly, the Ti-13Zr-13Nb surfaces were evaluated using a field emission scanning electron microscope for texturing, contact mode profile meter for the average surface roughness (Ra) (nm) and atomic force microscopy for surface texturing at the nano-scale. In addition, the surface roughness was reduced in each condition, particularly in extremely high conditions. Significantly, the ANFIS model predicted the Ra amount of textured surface with an error band of 10 %. This research presents an idea to use the ANFIS model to obtain proper biological signs on the roughened surface in terms of surface roughness.
C1 [Khanlou, Hossein Mohammad; Ang, Bee Chin; Talebian, Sepehr] Univ Malaya, Dept Mech Engn, Ctr Adv Mat, Fac Engn, Kuala Lumpur 50603, Malaysia.
   [Barzani, Mohsen Marani; Silakhori, Mahyar] Univ Malaya, Dept Mech Engn, Ctr Adv Mfg & Mat Proc, Fac Engn, Kuala Lumpur 50603, Malaysia.
RP Khanlou, HM (reprint author), Univ Malaya, Dept Mech Engn, Ctr Adv Mat, Fac Engn, Kuala Lumpur 50603, Malaysia.
EM khanlou2@gmail.com
RI Engineering, Faculty/I-7935-2015; Ang, Bee Chin/B-8227-2010
OI Engineering, Faculty/0000-0002-4848-7052; Mohammad Khanlou,
   Hossein/0000-0003-0896-1714; Silakhori, Mahyar/0000-0001-6713-1425
FU University of Malaya [UM.C/HIR/H-16001-00-D000027, RP011D-13AET]
FX The authors would like to thank University of Malaya
   (UM.C/HIR/H-16001-00-D000027 and RP011D-13AET) for providing the
   research grant support.
CR Al Jabbari YS, 2012, DENT MATER J, V31, P249, DOI 10.4012/dmj.2011-210
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Aydin M, 2013, INT J ADV MANUF TECH, V67, P957, DOI 10.1007/s00170-012-4540-2
   Azwadi CSN, 2013, NUMER HEAT TR A-APPL, V63, P906, DOI 10.1080/10407782.2013.757154
   Barranco V, 2010, SURF COAT TECH, V204, P3783, DOI 10.1016/j.surfcoat.2010.04.051
   Barzani MM, 2015, MEASUREMENT, V61, P150, DOI 10.1016/j.measurement.2014.10.003
   Carvalho Daniel Rey de, 2010, Braz. Dent. J., V21, P3, DOI 10.1590/S0103-64402010000100001
   Chang Q, 2011, J MATER SCI, V46, P6118, DOI 10.1007/s10853-011-5576-7
   Deng FL, 2010, MAT SCI ENG C-MATER, V30, P141, DOI 10.1016/j.msec.2009.09.010
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Goodarzi M, 2010, EUR J MED CHEM, V45, P1352, DOI 10.1016/j.ejmech.2009.12.028
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   Guney K, 2007, IEEE T ANTENN PROPAG, V55, P659, DOI 10.1109/TAP.2007.891566
   Iwaya Y, 2008, DENT MATER J, V27, P415, DOI 10.4012/dmj.27.415
   Jang J-S R, 1997, PRENTICE HALL INT, p[42, 1482], DOI DOI 10.1109/TAC.1997.633847
   JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541
   Juodzbalys G, 2003, STOMATOLOGIJA BALTIC, V5, P101
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P307
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P125
   Khanlou HM, 2015, TEXT RES J, V85, P356, DOI 10.1177/0040517514547208
   Khanlou HM, 2014, NEURAL COMPUT APPL, V25, P767, DOI 10.1007/s00521-014-1554-8
   Kim BS, 2013, MAT SCI ENG C-MATER, V33, P1554, DOI 10.1016/j.msec.2012.12.061
   Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu X, 2007, MAT SCI ENG C-BIO S, V27, P700, DOI 10.1016/j.msec.2006.06.030
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Nishimoto SK, 2008, INT J ORAL MAX IMPL, V23, P675
   Oates CJ, 2011, MATERIALS, V4, P893, DOI 10.3390/ma4050893
   Orsini G, 2000, INT J ORAL MAX IMPL, V15, P779
   Pereira K, 2010, BRAZ DENT J, V21, P371
   Pypen CMJM, 1997, J MATER SCI-MATER M, V8, P781, DOI 10.1023/A:1018568830442
   Roshan SB, 2013, INT J ADV MANUF TECH, V69, P1803, DOI 10.1007/s00170-013-5131-6
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Son MK, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.378
   Suganthi XH, 2013, INT J ADV MANUF TECH, V68, P339, DOI 10.1007/s00170-013-4731-5
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Talebian S, 2014, MATER RES INNOV, V18, P331, DOI 10.1179/1432891714Z.000000000979
   Talebian S, 2014, MATER RES INNOV, V18, P510, DOI 10.1179/1432891714Z.0000000001034
   Talebian S, 2014, RSC ADV, V4, P49144, DOI 10.1039/c4ra06761d
   Vafaeenezhad H, 2013, INT J ADV MANUF TECH, V68, P1471, DOI 10.1007/s00170-013-4935-8
   Wang CS, 2010, DENT MATER J, V29, P381, DOI 10.4012/dmj.2009-119
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
NR 45
TC 5
Z9 5
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-0643
EI 1433-3058
J9 NEURAL COMPUT APPL
JI Neural Comput. Appl.
PD OCT
PY 2015
VL 26
IS 7
BP 1751
EP 1761
DI 10.1007/s00521-015-1833-z
PG 11
WC Computer Science, Artificial Intelligence
SC Computer Science
GA CP6OC
UT WOS:000360005900019
DA 2018-10-20
ER

PT J
AU Magenau, AJD
   Saurabh, S
   Andreko, SK
   Telmer, CA
   Schmidt, BF
   Waggoner, AS
   Bruchez, MP
AF Magenau, Andrew J. D.
   Saurabh, Saumya
   Andreko, Susan K.
   Telmer, Cheryl A.
   Schmidt, Brigitte F.
   Waggoner, Alan S.
   Bruchez, Marcel P.
TI Genetically targeted fluorogenic macromolecules for subcellular imaging
   and cellular perturbation
SO BIOMATERIALS
LA English
DT Article
DE Polymer modified cells; Targeting polymers to subcellular organelles;
   Genetically targetable macromolecules; Subcellular imaging; Protein
   polymer hybrids; Biomaterial structure-property relationships; Atom
   transfer radical polymerization (ATRP); Fluorogen-activating proteins
   (FAPs)
ID TRANSFER RADICAL POLYMERIZATION; SURFACE-PROTEINS; DRUG-DELIVERY;
   NANOPARTICLES; BINDING; DESIGN; CELLS; CONJUGATE; POLYMERS; TRACKING
AB The alteration of cellular functions by anchoring macromolecules to specified organelles may reveal a new area of therapeutic potential and clinical treatment. In this work, a unique phenotype was evoked by influencing cellular behavior through the modification of subcellular structures with genetically targetable macromolecules. These fluorogen-functionalized polymers, prepared via controlled radical polymerization, were capable of exclusively decorating actin, cytoplasmic, or nuclear compartments of living cells expressing localized fluorgen-activating proteins. The macromolecular fluorogens were optimized by establishing critical polymer architecture-biophysical property relationships which impacted binding rates, binding affinities, and the level of internalization. Specific labeling of subcellular structures was realized at nanomolar concentrations of polymer, in the absence of membrane per-meabilization or transduction domains, and fluorogen-modified polymers were found to bind to protein intact after delivery to the cytosol. Cellular motility was found to be dependent on binding of macromolecular fluorogens to actin structures causing rapid cellular ruffling without migration. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Magenau, Andrew J. D.; Andreko, Susan K.; Telmer, Cheryl A.; Schmidt, Brigitte F.; Waggoner, Alan S.; Bruchez, Marcel P.] Carnegie Mellon Univ, Mol Biosensors & Imaging Ctr, Pittsburgh, PA 15213 USA.
   [Magenau, Andrew J. D.; Saurabh, Saumya; Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA.
   [Telmer, Cheryl A.; Waggoner, Alan S.; Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.
RP Magenau, AJD (reprint author), Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
EM amagenau@coe.drexel.edu; bruchez@cmu.edu
RI Bruchez, Marcel/C-2271-2009
OI Bruchez, Marcel/0000-0002-7370-4848
FU NIH, through the Technology Centers for Networks and Pathways program
   [U54GM103529]; McWilliams Graduate Fellowship
FX This work was supported by the NIH, through the Technology Centers for
   Networks and Pathways program (U54GM103529). SS was supported in part by
   the McWilliams Graduate Fellowship. AJDM thanks Robert T. Mathers for
   assistance with GPC-MALLS.
CR Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251
   Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340
   Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104
   Chang CW, 2009, CHEM COMMUN, P3580, DOI 10.1039/b904456f
   Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951
   Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107
   Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e
   Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935
   Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104
   Cummings C, 2013, BIOMATERIALS, V34, P7437, DOI 10.1016/j.biomaterials.2013.06.027
   Dong HC, 2010, MACROMOLECULES, V43, P4623, DOI 10.1021/ma100570s
   DUDA JL, 1982, AICHE J, V28, P279, DOI 10.1002/aic.690280217
   GEORGES MK, 1993, MACROMOLECULES, V26, P2987, DOI 10.1021/ma00063a054
   Grover A, 2012, ANGEW CHEM INT EDIT, V51, P4838, DOI 10.1002/anie.201108107
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   KORPPITOMMOLA J, 1981, CAN J CHEM, V59, P191, DOI 10.1139/v81-030
   Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227
   Lim CS, 2007, ADV DRUG DELIVER REV, V59, P697, DOI 10.1016/j.addr.2007.06.001
   Lutz JF, 2007, MACROMOLECULES, V40, P8540, DOI 10.1021/ma7021474
   Lutz JF, 2011, ADV MATER, V23, P2237, DOI 10.1002/adma.201100597
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Mcrae RL, 2008, J AM CHEM SOC, V130, P7851, DOI 10.1021/ja8007402
   Mecinovic J, 2011, J AM CHEM SOC, V133, P14017, DOI 10.1021/ja2045293
   Moon JH, 2007, ANGEW CHEM INT EDIT, V46, P8223, DOI 10.1002/anie.200701991
   Nobs L, 2006, BIOCONJUGATE CHEM, V17, P139, DOI 10.1021/bc050137k
   Orlova A, 2007, CANCER RES, V67, P2178, DOI 10.1158/0008-5472.CAN-06-2887
   Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Recamier V, 2014, NUCLEUS-PHILA, V5, P75, DOI 10.4161/nucl.28227
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Rossi NAA, 2010, J AM CHEM SOC, V132, P3423, DOI 10.1021/ja909174x
   Scott MD, 1997, P NATL ACAD SCI USA, V94, P7566, DOI 10.1073/pnas.94.14.7566
   Senutovitch N, 2012, BIOCHEMISTRY-US, V51, P2471, DOI 10.1021/bi201422g
   Shank NI, 2013, J AM CHEM SOC, V135, P242, DOI 10.1021/ja308629w
   Shimada K., 2005, J CHEM PHYS, V122
   Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110
   Szent-Gyorgyi C, 2013, J MOL BIOL, V425, P4595, DOI 10.1016/j.jmb.2013.08.014
   Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368
   Szent-Gyorgyi C, 2010, J AM CHEM SOC, V132, P11103, DOI 10.1021/ja9099328
   van V.L.E., 2007, PHARM RES, V24, P1405
   Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263
   Yushchenko DA, 2012, CHEMBIOCHEM, V13, P1564, DOI 10.1002/cbic.201200334
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 45
TC 4
Z9 4
U1 3
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 66
BP 1
EP 8
DI 10.1016/j.biomaterials.2015.07.002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CO7GS
UT WOS:000359328200001
PM 26183934
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pawar, K
   Cummings, BJ
   Thomas, A
   Shea, LD
   Levine, A
   Pfaff, S
   Anderson, AJ
AF Pawar, Kiran
   Cummings, Brian J.
   Thomas, Aline
   Shea, Lonnie D.
   Levine, Ariel
   Pfaff, Sam
   Anderson, Aileen J.
TI Biomaterial bridges enable regeneration and re-entry of corticospinal
   tract axons into the caudal spinal cord after SCI: Association with
   recovery of forelimb function
SO BIOMATERIALS
LA English
DT Article
DE Spinal cord injury; Bridge; Poly(lactide-co-glycolide) (PLG); Nerve
   guide; Regeneration; Macrophage; Growth associated protein 43 (GAP-43);
   Ladder beam; Cylinder reaching
ID CENTRAL-NERVOUS-SYSTEM; MULTIPLE-CHANNEL BRIDGES; NEURAL STEM-CELLS;
   CHONDROITINASE ABC; GLIAL SCAR; ADULT-RATS; INJURY; MICE; SCAFFOLDS;
   HYDROGELS
AB Severed axon tracts fail to exhibit robust or spontaneous regeneration after spinal cord injury (SCI). Regeneration failure reflects a combination of factors, including the growth state of neuronal cell bodies and the regeneration-inhibitory environment of the central nervous system. However, while spared circuitry can be retrained, target reinnervation depends on longitudinally directed regeneration of transected axons. This study describes a biodegradable implant using poly(lactide-co-glycolide) (PLG) bridges as a carrier scaffold to support regeneration after injury. In order to detect regeneration of descending neuronal tracts into the bridge, and beyond into intact caudal parenchyma, we developed a mouse cervical implantation model and employed Crym:GFP transgenic mice. Characterization of Crym:GFP mice revealed that descending tracts, including the corticospinal tract, were labeled by green fluorescent protein (GFP), while ascending sensory neurons and fibers were not. Robust co-localization between GFP and neurofilament-200 (NF-200) as well as GFP and GAP-43 was observed at both the rostral and caudal bridge/tissue interface. No evidence of similar regeneration was observed in mice that received gelfoam at the lesion site as controls. Minimal co-localization between GFP reporter labeling and macrophage markers was observed. Taken together, these data suggest that axons originating from descending fiber tracts regenerated, entered into the PLG bridge at the rostral margin, continued through the bridge site, and exited to re-enter host tissue at the caudal edge of the intact bridge. Finally, regeneration through implanted bridges was associated with a reduction in ipsilateral forelimb errors on a horizontal ladder task. Published by Elsevier Ltd.
C1 [Pawar, Kiran; Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, IMIND, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.
   [Thomas, Aline; Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL USA.
   [Levine, Ariel; Pfaff, Sam] Salk Inst, San Diego, CA 92186 USA.
RP Anderson, AJ (reprint author), Univ Calif Irvine 2030, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA.
EM aja@uci.edu
RI Cummings, Brian/C-9180-2012
OI Cummings, Brian/0000-0003-3628-5290; Anderson,
   Aileen/0000-0002-8203-8891
FU NIH [2R01EB005678-05]; Christopher and Dana Reeve Foundation (CDRF)
FX We thank Rebecca Nishi and Hong-Li Liu for assistance with animal
   surgeries, and Jovanny Lucero for assistance with behavioral
   assessments. Funding for this work was provided by NIH 2R01EB005678-05
   (LDS, AJA and BJC) and the Christopher and Dana Reeve Foundation (CDRF)
   (AJA).
CR Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006
   Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199
   Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371
   Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Aoki N, 2000, J INVEST DERMATOL, V115, P402, DOI 10.1046/j.1523-1747.2000.00070.x
   Baba H, 1996, J NEUROL, V243, P109, DOI 10.1007/BF02443999
   Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2
   Blair JA, 2012, SPINE J, V12, P762, DOI 10.1016/j.spinee.2011.10.009
   Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652
   Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X
   Bunge Mary Bartlett, 2012, Handb Clin Neurol, V109, P523, DOI 10.1016/B978-0-444-52137-8.00032-2
   Center NSCIS, 2012, SPIN CORD INJ FACTS
   Cigognini D., 2011, PLOS ONE, V6
   Collyer E, 2014, EXP NEUROL, V261, P451, DOI 10.1016/j.expneurol.2014.07.014
   Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042
   Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007
   Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0
   Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8
   Foundation CaDR, 2009, ON DEGR SEP PAR SPIN
   Freund P., 2012, PLOS ONE, V7
   Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033
   Gorski JA, 2002, J NEUROSCI, V22, P6309
   Hurd C, 2013, EXP NEUROL, V247, P605, DOI 10.1016/j.expneurol.2013.02.013
   JOOSTEN EAJ, 1987, DEV BRAIN RES, V36, P121, DOI 10.1016/0165-3806(87)90070-8
   Joosten EAJ, 2012, CELL TISSUE RES, V349, P375, DOI 10.1007/s00441-012-1352-5
   Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670
   Kang KN, 2012, BIOMATERIALS, V33, P4828, DOI 10.1016/j.biomaterials.2012.03.043
   Khaing ZZ, 2012, J NEUROTRAUM, V29, P488, DOI 10.1089/neu.2011.2106
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   lancu R., 2005, BEHAV BRAIN RES, V162, P1
   Lang C., 2012, PLOS ONE, V7
   Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603
   Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Manso Y, 2010, J NEUROSCI RES, V88, P1708, DOI 10.1002/jnr.22342
   McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3
   McKerracher L, 2013, CURR PHARM DESIGN, V19, P4400, DOI 10.2174/1381612811319240007
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Mueller R, 2009, CHEM ENG METHOD TECH, P397
   Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2
   Nielson JL, 2011, J COMP NEUROL, V519, P2852, DOI 10.1002/cne.22661
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189
   Pawar K, 2011, ACTA BIOMATER, V7, P2826, DOI 10.1016/j.actbio.2011.04.006
   Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Rhee P, 2006, J TRAUMA, V61, P1166, DOI 10.1097/01.ta.0000188163.52226.97
   Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691
   Schmidt EF, 2013, COLD SPRING HARB PRO, V2013
   Schnell L, 2011, EUR J NEUROSCI, V34, P1256, DOI 10.1111/j.1460-9568.2011.07862.x
   Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96
   Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017
   Steward O, 2004, J COMP NEUROL, V472, P463, DOI 10.1002/cne.20090
   Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Tuinstra HM, 2014, TISSUE ENG PT A, V20, P1027, DOI [10.1089/ten.tea.2013.0111, 10.1089/ten.TEA.2013.0111]
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Wang X., 1991, CORTICAL PKC INHIBIT, P2013
   WILLEN JAG, 1989, SPINE, V14, P1316, DOI 10.1097/00007632-198912000-00008
   Yabe JT, 2001, CELL MOTIL CYTOSKEL, V50, P1, DOI 10.1002/cm.1037
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
   Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2
NR 77
TC 16
Z9 18
U1 2
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 65
BP 1
EP 12
DI 10.1016/j.biomaterials.2015.05.032
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN9YH
UT WOS:000358806600001
PM 26134079
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Ha, SW
   Jang, HL
   Nam, KT
   Beck, GR
AF Ha, Shin-Woo
   Jang, Hae Lin
   Nam, Ki Tae
   Beck, George R., Jr.
TI Nano-hydroxyapatite modulates osteoblast lineage commitment by
   stimulation of DNA methylation and regulation of gene expression
SO BIOMATERIALS
LA English
DT Article
DE Hydroxyapatite; Nanoparticle; Gene expression; Alkaline phosphatase;
   Osteoblast; Osteogenesis
ID MUSCLE-CELL CALCIFICATION; CHRONIC KIDNEY-DISEASE; ALKALINE-PHOSPHATASE;
   INORGANIC-PHOSPHATE; VASCULAR CALCIFICATION; SURFACE MODIFICATION;
   MATRIX VESICLES; CALCIUM HYDROXYAPATITE; BONE TISSUE; STEM-CELLS
AB Hydroxyapatite (HA) is the primary structural component of the skeleton and dentition. Under biological conditions, HA does not occur spontaneously and therefore must be actively synthesized by mineralizing cells such as osteoblasts. The mechanism(s) by which HA is actively synthesized by cells and deposited to create a mineralized matrix are not fully understood and the consequences of mineralization on cell function are even less well understood. HA can be chemically synthesized (HAp) and is therefore currently being investigated as a promising therapeutic biomaterial for use as a functional scaffold and implant coating for skeletal repair and dental applications. Here we investigated the biological effects of nano-HAp (10 x 100 nm) on the lineage commitment and differentiation of bone forming osteoblasts. Exposure of early stage differentiating osteoblasts resulted in dramatic and sustained changes in gene expression, both increased and decreased, whereas later stage osteoblasts were much less responsive. Analysis of the promoter region one of the most responsive genes, alkaline phosphatase, identified the stimulation of DNA methylation following cell exposure to nano-HAp. Collectively, the results reveal the novel epigenetic regulation of cell function by nano-HAp which has significant implication on lineage determination as well as identifying a novel potential therapeutic use of nanomaterials. Published by Elsevier Ltd.
C1 [Beck, George R., Jr.] Atlanta Dept Vet Affairs Med Ctr, Decatur, GA 30033 USA.
   [Ha, Shin-Woo; Beck, George R., Jr.] Emory Univ, Div Endocrinol Metab & Lipids, Dept Med, Atlanta, GA 30322 USA.
   [Jang, Hae Lin; Nam, Ki Tae] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
   [Beck, George R., Jr.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.
RP Beck, GR (reprint author), 101 Woodruff Circle,1026 WMRB, Atlanta, GA 30322 USA.
EM george.beck@emory.edu
OI Nam, Ki Tae/0000-0001-6353-8877
FU VA Office of Research and Development (Biomedical Laboratory Research &
   Development Service Award) [I01BX002363]; NCI [CA136716]; International
   Research & Development Program of the National Research Foundation of
   Korea (NRF) [2013K1A3A1A32035536]
FX This study was supported in part by grants to G.R Beck Jr. from the VA
   Office of Research and Development (Biomedical Laboratory Research &
   Development Service Award Number I01BX002363) and a grant from the NCI
   (CA136716). H. L. Jang and K. T. Nam appreciate support from the
   International Research & Development Program of the National Research
   Foundation of Korea (NRF, No. 2013K1A3A1A32035536). The content is
   solely the responsibility of the authors and does not represent the
   official views of the Department of Veterans Affairs, National
   Institutes of Health, or the United States Government.
CR Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576
   Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064
   AUBIN JE, 2002, MESENCHYMAL STEM CEL
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A
   Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1
   Belem LC, 2014, RESP MED, V108, P668, DOI 10.1016/j.rmed.2014.01.012
   Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]
   Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176
   Bohner M., 2013, BIOMATTER, V3
   Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5
   Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004
   Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312
   Camalier CE, 2010, CANCER PREV RES, V3, P359, DOI 10.1158/1940-6207.CAPR-09-0068
   Cheng XD, 2011, HANDBOOK OF EPIGENETICS: THE NEW MOLECULAR AND MEDICAL GENETICS, P9, DOI 10.1016/B978-0-12-375709-8.00002-2
   Cho YD, 2014, J BIOL CHEM, V289, P20120, DOI 10.1074/jbc.M114.558064
   Choi HW, 2006, J COLLOID INTERF SCI, V304, P277, DOI 10.1016/j.jcis.2006.05.069
   Chow LC, 2009, DENT MATER J, V28, P1
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006
   Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200
   Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482
   DALINKA MK, 1980, B NEW YORK ACAD MED, V56, P539
   Delgado-Calle J, 2013, MOL CELL ENDOCRINOL, V369, P27, DOI 10.1016/j.mce.2013.02.002
   Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006
   EscalanteAlcalde D, 1996, MECH DEVELOP, V57, P21, DOI 10.1016/0925-4773(96)00524-2
   Farbod K, 2014, TISSUE ENG PART B-RE, V20, P173, DOI [10.1089/ten.teb.2013.0221, 10.1089/ten.TEB.2013.0221]
   Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015
   Furuzono Tsutomu, 2004, J Artif Organs, V7, P137, DOI 10.1007/s10047-004-0264-x
   Garcia Glenn M, 2003, Semin Musculoskelet Radiol, V7, P187
   Ha S. W., 2013, TOXICOL IN VITRO, V28, P354
   Ha SW, 2014, ACS NANO, V8, P5898, DOI 10.1021/nn5009879
   Ha SW, 2009, CHEM COMMUN, P2881, DOI 10.1039/b902195g
   Hashimoto K, 2007, EPIGENETICS, V2, P86, DOI 10.4161/epi.2.2.4203
   Hunter GK, 2013, CALCIFIED TISSUE INT, V93, P348, DOI 10.1007/s00223-013-9698-6
   Hunter LW, 2014, INT J NANOMED, V9, P2689, DOI 10.2147/IJN.S63189
   Ito Y, 2004, J BIOMED MATER RES A, V69A, P454, DOI 10.1002/jbm.a.30014
   Itoh S, 2004, CELL TRANSPLANT, V13, P451, DOI 10.3727/000000004783983774
   Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002
   Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]
   Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10
   Ketteler M, 2006, HYPERTENSION, V47, P1027, DOI 10.1161/01.HYP.0000219635.51844.da
   Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Lee SY, 2012, KIDNEY BLOOD PRESS R, V35, P349, DOI 10.1159/000335952
   Li L, 2008, J MATER CHEM, V18, P4079, DOI 10.1039/b806090h
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Noor Z., 2013, J OSTEOPOROS, P1
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Park JW, 2008, J BIOMED MATER RES A, V86A, P117, DOI 10.1002/jbm.a.31618
   Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240
   RATHBUN JC, 1948, AM J DIS CHILD, V75, P822, DOI 10.1001/archpedi.1948.02030020840003
   Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28
   Rosser J, 2012, METHODS MOL BIOL, V816, P67, DOI 10.1007/978-1-61779-415-5_6
   Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914
   Stein GS, 2009, BIOCHEM CELL BIOL, V87, P1, DOI 10.1139/O08-094
   Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Stoccoro A, 2013, TOXICOLOGY, V313, P3, DOI 10.1016/j.tox.2012.12.002
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Sun DW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06912
   Tanabe Hirotaka, 2004, Journal of Medical and Dental Sciences, V51, P129
   Tanaka H, 2004, J COLLOID INTERF SCI, V269, P358, DOI 10.1016/j.jcis.2003.07.039
   Vaes BLT, 2010, BONE, V46, P514, DOI 10.1016/j.bone.2009.09.033
   Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010
   WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439
   Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404
   Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826
   Zhang JZ, 2012, J BIONIC ENG, V9, P243, DOI 10.1016/S1672-6529(11)60117-0
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 78
TC 22
Z9 22
U1 2
U2 98
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 65
BP 32
EP 42
DI 10.1016/j.biomaterials.2015.06.039
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN9YH
UT WOS:000358806600004
PM 26141836
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ostdiek, AM
   Ivey, JR
   Grant, DA
   Gopaldas, J
   Grant, SA
AF Ostdiek, A. M.
   Ivey, J. R.
   Grant, D. A.
   Gopaldas, J.
   Grant, S. A.
TI An in vivo study of a gold nanocomposite biomaterial for vascular repair
SO BIOMATERIALS
LA English
DT Article
DE Vascular patch; Gold nanoparticles; Decellularized tissue; Biomaterials
ID SMOOTH-MUSCLE-CELLS; BIONANOCOMPOSITE SCAFFOLDS; IMPROVED
   BIOCOMPATIBILITY; CAROTID-ENDARTERECTOMY; MECHANICAL-PROPERTIES;
   MOLECULAR-MECHANISMS; INTIMAL HYPERPLASIA; ENDOTHELIAL-CELLS; PATCH
   ANGIOPLASTY; AU NANOPARTICLES
AB Currently vascular repairs are treated using synthetic or biologic patches, however these patches have an array of complications, including calcification, rupture, re-stenosis, and intimal hyperplasia. An active patch material composed of decellularized tissue conjugated to gold nanoparticles (AuNPs) was developed and the long term biocompatibility and cellular integration was investigated. Porcine abdominal aortic tissue was decellularized and conjugated with 100 nm gold nanoparticles (AuNP). These patches were placed over a longitudinal arteriotomy of the thoracic aorta in six pigs. The animals were monitored for six months. Gross, histological, and immunohistochemical analyses of the patches were performed after euthanasia. Grossly there was minimal scar tissue with the patches still visible on the outer surface of the vessel. The inner lumen was smooth with a seamless transition from patch to native tissue. Histology demonstrated infiltration of host cells into the patch material. The immunohistochemical results demonstrated an endothelial cell layer forming over the patch within the vessel. Smooth muscle cells were repopulating the biomaterial in all animals. These results demonstrated that the AuNP biomaterial patch integrated well with the host tissue and did not failed over the six month implantation time. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ostdiek, A. M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Ivey, J. R.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA.
   [Grant, D. A.; Grant, S. A.] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
   [Gopaldas, J.] Prairie Cardiovasc, Springfield, IL 62701 USA.
RP Grant, SA (reprint author), Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
EM amostdiek@gmail.com; iveyj@missouri.edu; grantdav@missouri.edu;
   rgopaldas@icloud.com; grantsa@missouri.edu
FU University of Missouri by NIH [T32RR007004]; University of Missouri
   Department Bioengineering; University of Missouri Department Surgery
FX This research was sponsored in part by the University of Missouri by NIH
   Grant T32RR007004, and the University of Missouri Departments
   Bioengineering and Surgery. The authors would like to thank Drs. Scott
   Korte, Erin O'Connor, Marcia Hart, Sarah Hansen, Mike Fink, and Beth
   Ahner for their anesthetic and surgical assistance. Dr. Cindy
   Besch-Williford, Jan Adair, and Jill Hansen at IDEXX Bioresearch ensured
   the success of all histological and immunohistochemical slide staining.
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Bader A, 2000, TRANSPLANTATION, V70, P7
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Bordenave L, 2008, EXPERT REV MED DEVIC, V5, P337, DOI 10.1586/17434440-5.3-337
   CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   CHAMLEYCAMPBELL JH, 1981, ATHEROSCLEROSIS, V40, P347, DOI 10.1016/0021-9150(81)90145-3
   Cho SW, 2005, BIOMATERIALS, V26, P1915, DOI 10.1016/j.biomaterials.2004.06.018
   Collins MJ, 2012, EXPERT REV CARDIOVAS, V10, P635, DOI [10.1586/ERC.12.33, 10.1586/erc.12.33]
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   de Valence S, 2013, EUR J PHARM BIOPHARM, V85, P78, DOI 10.1016/j.ejpb.2013.06.012
   Deeken CR, 2011, J BIOMED MATER RES B, V96B, P351, DOI 10.1002/jbm.b.31778
   Deeken CR, 2012, J MATER SCI-MATER M, V23, P537, DOI 10.1007/s10856-011-4486-1
   Deeken CR, 2011, J BIOMED MATER RES B, V97B, P334, DOI 10.1002/jbm.b.31819
   Everts M, 2006, NANO LETT, V6, P587, DOI 10.1021/nl0500555
   Fink H, 2010, ACTA BIOMATER, V6, P1125, DOI 10.1016/j.actbio.2009.09.019
   Freese C, 2012, BIOMACROMOLECULES, V13, P1533, DOI 10.1021/bm300248u
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Ghista DN, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-129
   GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018
   Grant DN, 2011, J MATER SCI-MATER M, V22, P2803, DOI 10.1007/s10856-011-4449-6
   Grant SA, 2014, J BIOMED MATER RES A, V102, P332, DOI 10.1002/jbm.a.34698
   Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Hsu SH, 2008, BIOMACROMOLECULES, V9, P241, DOI 10.1021/bm700471k
   Hsu SH, 2006, J BIOMED MATER RES A, V79A, P759, DOI 10.1002/bm.a.30879
   Kamenskiy AV, 2013, ANN BIOMED ENG, V41, P263, DOI 10.1007/s10439-012-0640-2
   Kumar VA, 2013, ACTA BIOMATER, V9, P8067, DOI 10.1016/j.actbio.2013.05.024
   Lehr EJ, 2011, J THORAC CARDIOV SUR, V141, P1056, DOI 10.1016/j.jtcvs.2010.02.060
   Leroux-Berger M, 2011, J BONE MINER RES, V26, P1543, DOI 10.1002/jbmr.382
   Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038844
   Li X, 2011, ANN VASC SURG, V25, P561, DOI 10.1016/j.avsg.2010.11.007
   Liang MS, 2013, BIOMATERIALS, V34, P7281, DOI 10.1016/j.biomaterials.2013.05.073
   Lim ZZJ, 2011, ACTA PHARMACOL SIN, V32, P983, DOI 10.1038/aps.2011.82
   Matsagas MI, 2006, ANN VASC SURG, V20, P614, DOI 10.1007/s10016-006-9102-3
   Mehta RI, 2011, CARDIOVASC PATHOL, V20, P213, DOI 10.1016/j.carpath.2010.06.005
   Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062
   Neethling W.M.L, 2013, INTERACT CARDIOV TH, V2013, P1
   Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I
   Ostdiek A.M., 2015, INT J BIOMA IN PRESS
   Punnakitikashem P, 2014, ACTA BIOMATER, V10, P4618, DOI 10.1016/j.actbio.2014.07.031
   Qu YH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025007
   Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   RODBARD S, 1970, PERSPECT BIOL MED, V13, P507
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Simmers P, 2015, TISSUE ENG PT A, V21, P1455, DOI [10.1089/ten.tea.2014.0363, 10.1089/ten.TEA.2014.0363]
   Stickler P, 2010, ACTA BIOMATER, V6, P2448, DOI 10.1016/j.actbio.2010.01.041
   Sylvester A, 2013, ACTA BIOMATER, V9, P9292, DOI 10.1016/j.actbio.2013.07.032
   Thitiwuthikiat P, 2015, TISSUE ENG PT A, V21, P1309, DOI [10.1089/ten.tea.2014.0237, 10.1089/ten.TEA.2014.0237]
   Thyberg J, 1997, J HISTOCHEM CYTOCHEM, V45, P837, DOI 10.1177/002215549704500608
   Varcoe RL, 2006, J THROMB HAEMOST, V4, P1125, DOI 10.1111/j.1538-7836.2006.01924.x
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z
   Wang ZH, 2014, BIOMATERIALS, V35, P5700, DOI 10.1016/j.biomaterials.2014.03.078
   Wang ZY, 2014, J MATER CHEM B, V2, P5898, DOI 10.1039/c4tb00522h
   Weber K.T., 1995, WOUND HEALING CARDIO, P137
   Whelove OE, 2011, J BIOMED MATER RES B, V99B, P142, DOI 10.1002/jbm.b.31881
   Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028
   Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.TEA.2011.0172, 10.1089/ten.tea.2011.0172]
   Zwirner K, 2010, METAB BRAIN DIS, V25, P407, DOI 10.1007/s11011-010-9222-x
NR 64
TC 6
Z9 6
U1 2
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2015
VL 65
BP 175
EP 183
DI 10.1016/j.biomaterials.2015.06.045
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN9YH
UT WOS:000358806600019
PM 26164402
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Skolucka-Szary, K
   Ramiega, A
   Piaskowska, W
   Janicki, B
   Grala, M
   Rieske, P
   Stoczynska-Fidelus, E
   Piaskowski, S
AF Skolucka-Szary, Karolina
   Ramiega, Aleksandra
   Piaskowska, Wanda
   Janicki, Bartosz
   Grala, Magdalena
   Rieske, Piotr
   Stoczynska-Fidelus, Ewelina
   Piaskowski, Sylwester
TI Chitin dipentanoate as the new technologically usable biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Chitin; Esterification; Biomaterial; Scaffolds
ID DIBUTYRYL CHITIN; CHITOSAN; WATER; PART
AB In this article, the synthesis of novel biopolymer, chitin dipentanoate (Di-O-Valeryl Chitin, DVCH) has been described. DVCH is a chitin derivative esterified with two valeryl groups at positions 3 and 6 of the N-acetylglucosamine units and it is soluble in common organic solvents like ethanol, methanol, acetone, dichloromethane, 1,2-dichloroethane, N,N-dimethylmethanamide, N,N-dimethylacetamide and ethyl acetate. Highly efficient synthesis (degree of esterification close to 2) of DVCH was achieved by employing a huge excess of valeric anhydride used as both the acylation agent and the reaction medium in the presence of perchloric acid as catalyst. Studies on the DVCH synthesis were aimed at finding optimal conditions (temperature, reaction time) to obtain DVCH with high reaction yield and desirable physicochemical properties. Biological data demonstrate that DVCH is non-cytotoxic in vitro and doesn't exert irritating or allergic effects to animal skin. Thanks to its filmogenic properties, it can be used to manufacture threads, foils, foams and non-woven materials. Moreover, DVCH can be easily processed by salt-leaching method to prepare highly porous structures exhibiting open-cell architecture, that can be further employed in wound dressing therapies and scaffolds for tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Skolucka-Szary, Karolina; Ramiega, Aleksandra; Piaskowska, Wanda; Rieske, Piotr; Stoczynska-Fidelus, Ewelina; Piaskowski, Sylwester] Celther Polska Sp Zoo, Dept Res & Dev, PL-05170 Zakroczym, Poland.
   [Janicki, Bartosz] Silesian Tech Univ, Fac Chem, Dept Phys Chem & Technol Polymers, PL-44100 Gliwice, Poland.
   [Grala, Magdalena] Polish Acad Sci, Ctr Mol & Macromol Studies, PL-90363 Lodz, Poland.
RP Skolucka-Szary, K (reprint author), Celther Polska Sp Zoo, Ostrzykowizna 14A, PL-05170 Zakroczym, Poland.
EM karolina.skolucka@celther.com
RI Stoczynska-Fidelus, Ewelina/S-9948-2016; Rieske, Piotr/M-4821-2015
OI Rieske, Piotr/0000-0002-2970-0970; Stoczynska-Fidelus,
   Ewelina/0000-0002-7779-3075
FU Polish Agency for Enterprise Development [POIG.01.04.00-10-020/10]
FX This study was sponsored by the Polish Agency for Enterprise
   Development, Grant No. POIG.01.04.00-10-020/10. A special gratitude to
   professor Zbigniew Bartczak for all advices relating to this work.
CR Almond A, 2003, GLYCOBIOLOGY, V13, P255, DOI 10.1093/glycob/cwg031
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   [Anonymous], 2002, 10993102011 PNEN ISO
   [Anonymous], 2009, 109935 PNEN ISO
   AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561
   Bhatt LR, 2011, CARBOHYD RES, V346, P691, DOI 10.1016/j.carres.2011.01.033
   Blasinska A., 2004, FIBRES TEXT EAST EUR, V4, P51
   Blasinska A, 2008, BIOMACROMOLECULES, V9, P776, DOI 10.1021/bm7006373
   Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028
   Capozza R. C., 1976, US Patent, Patent No. 3988411
   Capozza RC, 1976, US Patent, Patent No. [3989535, 3,989,535]
   Castagnino E, 2008, CARBOHYD POLYM, V74, P640, DOI 10.1016/j.carbpol.2008.04.016
   Chen BQ, 2004, CARBOHYD POLYM, V58, P65, DOI 10.1016/j.carbpol.2004.06.030
   EDWARD JT, 1955, CHEM IND-LONDON, P1102
   Ehrlich H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03497
   Ehrlich H., 2013, BIOMIMETIC BIOMATERI, P47
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Hu XW, 2007, CARBOHYD POLYM, V70, P451, DOI 10.1016/j.carbpol.2007.05.002
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jin J., 2013, ADV MAT, V25
   Juarez-de La Rosa BA, 2012, J MATER SCI, V47, P990, DOI 10.1007/s10853-011-5878-9
   KAIFU K, 1981, POLYM J, V13, P241, DOI 10.1295/polymj.13.241
   Kaya M., 2014, FOOD BIOPHYS, V10, P162
   Kaya M., 2014, INT J BIOL MACROMOL, V65, P553
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Krucinska I., 2007, FIBRES TEXT EAST EUR, V15, P64
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   Moeller H., 1999, Patent No. [DE 19826953 C1, 19826953]
   Muzzarelli RAA, 2005, BIOMATERIALS, V26, P5844, DOI 10.1016/j.biomaterials.2005.03.006
   MUZZARELLI RAA, 1977, CHITIN
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Pielka S., 2003, FIBRES TEXT EAST EUR, V2, P79
   Pillai C. K. S., 2009, PROG POLYM SCI, V34, P641
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   ROELOFSEN P. A., 1951, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V17, P297, DOI 10.1007/BF02062277
   Rutherford III F. A., 1978, P 1 INT C CHIT CHIT, P182
   SCHLEDE E, 1995, CONTACT DERMATITIS, V32, P1, DOI 10.1111/j.1600-0536.1995.tb00830.x
   Schoukens G, 2009, INT J CLOTH SCI TECH, V21, P93, DOI 10.1108/09556220910933817
   Sobecki P., 2010, PROGR CHEM APPL CHIT, VXV
   Szosland L, 1996, J BIOACT COMPAT POL, V11, P61, DOI 10.1177/088391159601100105
   Szosland L, 2001, FIBRES TEXT EAST EUR, V9, P54
   Szosland L., 2003, FIBRES TEXT EAST EUR, V9, P49
   Szumielewicz J., 2003, PROGR CHEM APPL CHIT, VIX, P41
   Tamura H., 2004, ADV CHITIN SCI, P94
   TERBOJEVICH M, 1988, CARBOHYD RES, V180, P73, DOI 10.1016/0008-6215(88)80065-X
   TOKURA S, 1994, CHITIN CHITOSAN, P67
   Vikhoreva GA, 1999, FIBRE CHEM+, V31, P274, DOI 10.1007/BF02358332
   Vincendon M., 1985, CHITIN NATURE TECHNO, P343
   Wilmer P, 1990, INVERTEBRATE RELATIO
   Wszyszczytiski A., 1995, POLYM B, V34, P493
   Wysokowski M, 2015, POLYMERS-BASEL, V7, P235, DOI 10.3390/polym7020235
   Yang BY, 2009, CARBOHYD RES, V344, P336, DOI 10.1016/j.carres.2008.11.006
NR 55
TC 3
Z9 3
U1 2
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 50
EP 60
DI 10.1016/j.msec.2015.05.051
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500007
PM 26117738
DA 2018-10-20
ER

PT J
AU Teong, B
   Manousakas, I
   Chang, SJ
   Huang, HH
   Ju, KC
   Kuo, SM
AF Teong, Benjamin
   Manousakas, Ioannis
   Chang, Shwu Jen
   Huang, Han Hsiang
   Ju, Kuen-Cheng
   Kuo, Shyh Ming
TI Alternative approach of cell encapsulation by Volvox spheres
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Volvox sphere; Alginate; Collagen; Mesenchymal stem cell; Cell
   encapsulation
ID HEPATOCYTE-LIKE CELLS; MESENCHYMAL STEM-CELLS; ALGINATE ENCAPSULATION;
   CRYOPRESERVATION; DIFFERENTIATION; MICROCAPSULES; REGENERATION;
   EXPRESSION; SYSTEM; MODEL
AB Volvox sphere is a bio-mimicking concept of a biomaterial structure design able to encapsulate chemicals, drugs and/or cells. The aim of this study was to prepare Volvox spheres encapsulating AML12 liver cells and mesenchymal stem cells (MSCs) via a high voltage electrostatic field system. The results demonstrated that AML12 liver cells and MSCs could be successfully encapsulated into the inner spheres and the outer sphere of the Volvox spheres. The improved cell viability of MSCs was achieved by the addition of collagen and polyethylene glycol into the preparation components of the Volvox spheres. Collagen material potentially provides extracellular matrix-like structure for cell adhesion while polyethylene glycol provides a void/loose space for permeability of metabolites. The encapsulated MSCs were able to differentiate into hepatocytes or hepatocyte-like cells and express liver cell markers including albumin, alpha feto-protein and cytokeratin 18. The encapsulated cells secreted albumin to about 140 ng on day 14. Based on these observations, we conclude that Volvox spheres can be used as an alternative approach to encapsulate multiple types of cells, here AML12 hepatocyte cell line and MSCs. Nevertheless, efforts are still needed to hi-Trove the viability of the encapsulated cells and increase the differentiation of MSCs into functional liver cells. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Teong, Benjamin; Manousakas, Ioannis; Chang, Shwu Jen; Ju, Kuen-Cheng; Kuo, Shyh Ming] I Shou Univ, Dept Biomed Engn, Kaohsiung 82445, Taiwan.
   [Huang, Han Hsiang] Natl Chiayi Univ, Dept Vet Med, Chiayi 60080, Taiwan.
RP Kuo, SM (reprint author), I Shou Univ, Dept Biomed Engn, 8 Yida Rd, Kaohsiung 82445, Taiwan.
EM smkuo@isu.edu.tw
CR Ahmad HF, 2013, ACTA BIOMATER, V9, P6814, DOI 10.1016/j.actbio.2013.03.002
   [Anonymous], 2001, METHODS ACHIEV EXP P, V25, P402
   Dabeva MD, 1998, CANCER RES, V58, P5825
   Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031
   Goren A, 2010, FASEB J, V24, P22, DOI 10.1096/fj.09-131888
   Gryshkov O, 2014, MAT SCI ENG C-MATER, V36, P77, DOI 10.1016/j.msec.2013.11.048
   Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045
   Hunt NC, 2009, BIOMATERIALS, V30, P6435, DOI 10.1016/j.biomaterials.2009.08.014
   Hwang JH, 2012, BIOMED ENG-APP BAS C, V24, P185, DOI 10.4015/S1016237212500019
   Kaji H, 2010, BIOCHIM BIOPHYS ACTA, V1810, P239
   Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Liu Y, 2008, ACTA METEOROL SIN, V22, P22
   Nishiofuku M, 2011, J BIOSCI BIOENG, V111, P71, DOI 10.1016/j.jbiosc.2010.08.005
   Orive G, 2003, INT J PHARMACEUT, V259, P57, DOI 10.1016/S0378-5173(03)00201-1
   Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143
   Panouille M, 2009, FOOD HYDROCOLLOID, V23, P1074, DOI 10.1016/j.foodhyd.2008.06.011
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pravdyuk AI, 2013, CRYOBIOLOGY, V66, P215, DOI 10.1016/j.cryobiol.2013.02.002
   Read TA, 1999, INT J DEV NEUROSCI, V17, P653, DOI 10.1016/S0736-5748(99)00052-0
   Ringel M, 2005, TOXICOLOGY, V206, P153, DOI 10.1016/j.tox.2004.07.017
   Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014
   Seifert DB, 1997, BIOTECHNOL PROGR, V13, P569, DOI 10.1021/bp970071a
   Simpson NE, 2006, BIOMATERIALS, V27, P2577, DOI 10.1016/j.biomaterials.2005.11.042
   Teong B, 2013, MAT SCI ENG C-MATER, V33, P4859, DOI 10.1016/j.msec.2013.08.005
   Tsai SW, 2006, BIOMED ENG-APP BAS C, V18, DOI 10.4015/S1016237206000129
   Vaithilingam V, 2011, BIOMATERIALS, V32, P8416, DOI 10.1016/j.biomaterials.2011.06.044
   Yi Y., 2008, J MED COLL PLA, V23, P63
NR 28
TC 3
Z9 3
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 79
EP 87
DI 10.1016/j.msec.2015.05.063
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500010
PM 26117741
DA 2018-10-20
ER

PT J
AU Park, M
   Shin, HK
   Kim, BS
   Kim, MJ
   Kim, IS
   Park, BY
   Kim, HY
AF Park, Mira
   Shin, Hye Kyoung
   Kim, Byoung-Suhk
   Kim, Myung Jin
   Kim, In-Shik
   Park, Byung-Yong
   Kim, Hak-Yong
TI Effect of discarded keratin-based biocomposite hydrogels on the wound
   healing process in vivo
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogel; Keratin; Wound healing; Electron beam; Fibroblast and collagen
   fiber
ID BIOMEDICAL APPLICATIONS; ELECTRON-BEAM; BIOLOGY; REGENERATION;
   BIOMATERIAL; RADIATION; MEDICINE; MATRIX; CELLS
AB Biocompatible keratin-based hydrogels prepared by electron beam irradiation (EBI) were examined in wound healing. As the EBI dose increased to 60 kGy, the tensile strength of the hydrogels increased, while the percentage of elongation of the hydrogels decreased. After 7 days, the dehydrated wool-based hydrogels show the highest mechanical properties (the % elongation of 1341 and the tensile strength of 6030 g/cm(2) at an EBI dose of 30 kGy). Excision wound models were used to evaluate the effects of human hair-based hydrogels and wool-based hydrogels on various phases of healing. On post-wounding days 7 and 14, wounds treated with either human hair-based or wool-based hydrogels were greatly reduced in size compared to wounds that received other treatments, although the hydrocolloid wound dressing-treated wound also showed a pronounced reduction in size compared to an open wound as measured by a histological assay. On the 14th postoperative day, the cellular appearances were similar in the hydrocolloid wound dressing and wool-based hydrogel-treated wounds, and collagen fibers were substituted with fibroblasts and mixed with fibroblasts in the dermis. Furthermore, the wound treated with a human hair-based hydrogel showed almost complete epithelial regeneration, with the maturation of immature connective tissue and hair follicles and formation of a sebaceous gland. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Park, Mira] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Shin, Hye Kyoung] Inha Univ, Dept Chem, Inchon 402751, South Korea.
   [Kim, Byoung-Suhk; Kim, Hak-Yong] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea.
   [Kim, Myung Jin; Kim, In-Shik; Park, Byung-Yong] Chonbuk Natl Univ, Dept Vet Anat, Coll Vet Med, Jeonju 561756, South Korea.
   [Kim, Myung Jin; Kim, In-Shik; Park, Byung-Yong] Chonbuk Natl Univ, Biosafety Res Inst, Jeonju 561756, South Korea.
RP Park, BY (reprint author), Chonbuk Natl Univ, Dept Vet Anat, Coll Vet Med, Jeonju 561756, South Korea.
EM parkb@jbnu.ac.kr; khy@jbnu.ac.kr
RI Kim, Byoung-Suhk/K-1573-2015; Park, Mira/F-8443-2015; Kim, Hak
   Yong/G-3826-2013
OI Kim, Byoung-Suhk/0000-0001-8070-3424; Park, Mira/0000-0002-1896-0558;
   Kim, Hak Yong/0000-0002-4133-124X
FU National Research Foundation of Korea (NRF) - Ministry of Education
   [NRF-2014R1A1A2008489]; Ministry of Education, Science Technology
   (MEST); National Research Foundation of Korea (NRF) through the Human
   Resource Training Project for Regional Innovation [201210A0404613010100]
FX This research was supported Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education (No. NRF-2014R1A1A2008489). This research was also financially
   supported by the Ministry of Education, Science Technology (MEST) and
   National Research Foundation of Korea (NRF) through the Human Resource
   Training Project for Regional Innovation (No. 201210A0404613010100).
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Abreu-Velez AM, 2012, N AM J MED SCI, V4, P1, DOI 10.4103/1947-2714.92892
   Ajji Z, 2005, NUCL INSTRUM METH B, V229, P375, DOI 10.1016/j.nimb.2004.12.135
   Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021
   Bhalerao VS, 1998, POLYMER, V39, P2255, DOI 10.1016/S0032-3861(97)00502-8
   Buenger D, 2012, PROG POLYM SCI, V37, P1678, DOI 10.1016/j.progpolymsci.2012.09.001
   Burnett L.R., 2013, BIOMATERIALS, V34, P2632
   Burnett LR, 2013, BIOMATERIALS, V34, P2632, DOI 10.1016/j.biomaterials.2012.12.022
   Choi SG, 2013, INT J PHARMACEUT, V447, P102, DOI 10.1016/j.ijpharm.2013.02.053
   Cilurzo F, 2013, POLYM ADVAN TECHNOL, V24, P1025, DOI 10.1002/pat.3168
   Coulombe PA, 1993, CURR OPIN CELL BIOL, V5, P17, DOI 10.1016/S0955-0674(05)80004-3
   Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lugao AB, 2002, RADIAT PHYS CHEM, V63, P543, DOI 10.1016/S0969-806X(01)00551-5
   Maclaren J.A., 1981, WOOL SCI CHEM REACTI, P35
   Mark H.F., 1985, ENCY POLYM SCI ENG, V8, P566
   Michael M., 2013, SECRETOME PERIPHERAL
   Murti K., 2011, PHARMACOLOGIA, V2, P369
   Park M, 2013, MAT SCI ENG C-MATER, V33, P5051, DOI 10.1016/j.msec.2013.08.032
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Sahiner N, 2013, PROG POLYM SCI, V38, P1329, DOI 10.1016/j.progpolymsci.2013.06.004
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shukla A, 1999, PHYTOTHER RES, V13, P50, DOI 10.1002/(SICI)1099-1573(199902)13:1<50::AID-PTR368>3.3.CO;2-M
   Sung JH, 2010, INT J PHARMACEUT, V392, P232, DOI 10.1016/j.ijpharm.2010.03.024
   Togel F, 2007, DEV DYNAM, V236, P3321, DOI 10.1002/dvdy.21258
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x
   Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007
NR 35
TC 21
Z9 21
U1 3
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 88
EP 94
DI 10.1016/j.msec.2015.03.033
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500011
PM 26117742
DA 2018-10-20
ER

PT J
AU Mahapatro, A
AF Mahapatro, Anil
TI Bio-functional nano-coatings on metallic biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Nanocoatings; Metallic biomaterials; Surface modification;
   Self-assembled monolayers (SAMs)
ID SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   NITROGEN-ION-IMPLANTATION; CALCIUM AND/OR PHOSPHORUS; DIP-PEN
   NANOLITHOGRAPHY; OT-4-0 TITANIUM-ALLOY; 316L STAINLESS-STEEL; IN-VITRO
   STABILITY; PROTEIN-LIGAND INTERACTIONS; CHEMICAL-VAPOR-DEPOSITION
AB Metals and their alloys have been widely used in all aspects of science, engineering and medicine. Metals in biomedical devices are used due to their inertness and structural functions. They are generally preferred over polymers or ceramics and are especially desirable in applications where the implants are subjected to static, dynamic or cyclic loads that require a combination of strength and ductility. In biomedicine, the choice of a specific biomaterial is governed by many factors that include biocompatibility, corrosion resistance, controlled degradability, modulus of elasticity, fatigue strength and many other application specific criterions. Nanotechnology is driving newer demands and requirements for better performance of existing materials and presents an opportunity for surface modification of metals in response to demands on the surface of metals for their biomedical applications. Self-assembled monolayers (SAMs) are nanosized coatings that present a flexible method of carrying out surface modification of biomaterials to tailor its surface properties for specific end applications. These nanocoatings can serve primary functions such as surface coverage, etch protection and anti-corrosion along with a host of other secondary chemical functions such as drug delivery and biocompatibility. We present a brief introduction to surface modification of biomaterials and their alloys followed by a detailed description of organic nanocoatings based on self-assembled monolayers and their biomedical applications including patterning techniques and biological applications of patterned SAMs. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mahapatro, Anil] Wichita State Univ, Bioengn Program, Wichita, KS 67260 USA.
   [Mahapatro, Anil] Wichita State Univ, Dept Ind & Mfg Engn, Wichita, KS 67260 USA.
RP Mahapatro, A (reprint author), Wichita State Univ, Bioengn Program, 1845 Fairmount St, Wichita, KS 67260 USA.
EM anil.mahapatro@wichita.edu
CR Abdel-Fattah TM, 2011, J BIOMED NANOTECHNOL, V7, P794, DOI 10.1166/jbn.2011.1346
   ALLARA DL, 1995, LANGMUIR, V11, P2357, DOI 10.1021/la00007a007
   ANGST DL, 1991, LANGMUIR, V7, P2236, DOI 10.1021/la00058a043
   Ankur S. Kulshrestha, 2012, BIOMATERIALS
   Arnold S, 1997, J ELECTROANAL CHEM, V438, P91, DOI 10.1016/S0022-0728(96)05065-6
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   Arya SK, 2007, ANAL BIOCHEM, V363, P210, DOI 10.1016/j.ab.2007.01.029
   Ayadim M, 1996, TETRAHEDRON LETT, V37, P7039, DOI 10.1016/0040-4039(96)01543-2
   Badea I., 2013, REV NANOSCI NANOTECH, V2, P275
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   Balgar T, 2004, LANGMUIR, V20, P3525, DOI 10.1021/la040006s
   Balgar T, 2003, SURF SCI, V532, P963, DOI 10.1016/S0039-6028(03)00101-8
   Baneyx F, 2014, CURR OPIN BIOTECH, V28, P39, DOI 10.1016/j.copbio.2013.11.001
   Baptiste A, 2002, LANGMUIR, V18, P3916, DOI 10.1021/la015572r
   Barnes-Seeman D, 2003, ANGEW CHEM INT EDIT, V42, P2376, DOI 10.1002/anie.200351043
   Basabe-Desmonts L, 2004, J AM CHEM SOC, V126, P7293, DOI 10.1021/ja049901o
   BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898
   Baumann H, 2002, NUCL INSTRUM METH B, V196, P286, DOI 10.1016/S0168-583X(02)01298-3
   Baur B, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2150280
   Behm JM, 1996, LANGMUIR, V12, P2121, DOI 10.1021/la950811u
   Belosludtsev Y, 2001, ANAL BIOCHEM, V292, P250, DOI 10.1006/abio.2001.5088
   Ben Ali M, 2008, MAT SCI ENG C-BIO S, V28, P628, DOI 10.1016/j.msec.2007.10.048
   Benor A, 2008, ORG ELECTRON, V9, P209, DOI 10.1016/j.orgel.2007.10.012
   Benters R, 2001, CHEMBIOCHEM, V2, P686, DOI 10.1002/1439-7633(20010903)2:9<686::AID-CBIC686>3.0.CO;2-S
   Berberich F, 2001, APPL SURF SCI, V179, P13, DOI 10.1016/S0169-4332(01)00256-2
   Bhat S, 2007, BIOMATERIALS
   Bhure R, 2013, ECS TRANSACTIONS, V53, P9, DOI 10.1149/05329.0009ecst
   Bhure R, 2013, MAT SCI ENG C-MATER, V33, P2050, DOI 10.1016/j.msec.2013.01.022
   Bhure R, 2011, ECS TRANSACTIONS, V33, P91, DOI 10.1149/1.3583518
   Bhure R, 2010, ACS SYM SER, V1054, P65
   Bhure R, 2011, APPL SURF SCI, V257, P5605, DOI 10.1016/j.apsusc.2011.01.055
   Bhure R, 2010, SILICON-NETH, V2, P117, DOI 10.1007/s12633-010-9055-6
   Bhure R, 2010, J BIOMED NANOTECHNOL, V6, P117, DOI 10.1166/jbn.2010.1106
   BIERBAUM K, 1995, LANGMUIR, V11, P2143, DOI 10.1021/la00006a049
   BIGELOW WC, 1947, J COLL SCI IMP U TOK, V2, P563, DOI 10.1016/0095-8522(47)90058-5
   BIGELOW WC, 1946, J COLL SCI IMP U TOK, V1, P513, DOI 10.1016/0095-8522(46)90059-1
   BLAHA P, 1985, PHYS REV B, V31, P2316, DOI 10.1103/PhysRevB.31.2316
   Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011
   Boncheva M, 2005, MRS BULL, V30, P736, DOI 10.1557/mrs2005.208
   Boukherroub R, 1999, LANGMUIR, V15, P3831, DOI 10.1021/la9901478
   Bouos M.I., 1993, PLASMA SPRAYING THEO, P3
   BRADSHAW DI, 1980, J CHEM SOC FARAD T 1, V76, P979, DOI 10.1039/f19807600979
   BRANDRISS S, 1993, LANGMUIR, V9, P1232, DOI 10.1021/la00029a014
   Brasola E, 2003, CHEM COMMUN, P3026, DOI 10.1039/b310582b
   Breen TL, 2002, LANGMUIR, V18, P194, DOI 10.1021/la015543g
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   BRZOSKA JB, 1992, NATURE, V360, P719, DOI 10.1038/360719a0
   BRZOSKA JB, 1994, LANGMUIR, V10, P4367, DOI 10.1021/la00023a072
   Bunker BC, 2003, NANO LETT, V3, P1723, DOI 10.1021/nl034759v
   Buseman-Williams J, 2004, LANGMUIR, V20, P2026, DOI 10.1021/la030246s
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Busse S, 2001, SENSOR ACTUAT B-CHEM, V80, P116, DOI 10.1016/S0925-4005(01)00889-9
   Calhoun MF, 2008, NAT MATER, V7, P84, DOI 10.1038/nmat2059
   CalistriYeh M, 1996, LANGMUIR, V12, P2747, DOI 10.1021/la950518u
   Cano-Serrano E, 2003, CHEM COMMUN, P246, DOI 10.1039/b210766j
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Carraro C, 1998, J PHYS CHEM B, V102, P4441, DOI 10.1021/jp981019f
   CARSON G, 1989, J APPL POLYM SCI, V37, P2767, DOI 10.1002/app.1989.070370925
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9
   Chance R. R., 1978, ADV CHEM PHYS, V37, P1, DOI DOI 10.1002/9780470142561.CH1
   Chandekar A, 2010, APPL SURF SCI, V256, P2742, DOI 10.1016/j.apsusc.2009.11.020
   CHAUDHURY MK, 1992, SCIENCE, V255, P1230, DOI 10.1126/science.255.5049.1230
   Chen H, 2007, THIN SOLID FILMS, V515, P7181, DOI 10.1016/j.tsf.2007.02.083
   CHEN KM, 1993, J AM CHEM SOC, V115, P1193, DOI 10.1021/ja00056a080
   Chen R, 2014, CURR OPIN BIOTECH, V28, P59, DOI 10.1016/j.copbio.2013.11.007
   Choi I, 2006, LANGMUIR, V22, P4885, DOI 10.1021/la0519406
   Choi J, 2004, APPL SURF SCI, V228, P191, DOI [10.1016/j.apsusc.2004.01.022, 10.1016/j.apsuse.2004.01.022]
   Chowdhury D, 2007, NANO LETT, V7, P1770, DOI 10.1021/nl070842x
   CHUPA JA, 1993, J AM CHEM SOC, V115, P4383, DOI 10.1021/ja00063a075
   COHEN SR, 1986, J PHYS CHEM-US, V90, P3054, DOI 10.1021/j100405a004
   Collins RJ, 1996, LANGMUIR, V12, P5509, DOI 10.1021/la9601566
   Crego-Calama M, 2001, ADV MATER, V13, P1171, DOI 10.1002/1521-4095(200108)13:15<1171::AID-ADMA1171>3.0.CO;2-7
   Creigton T. E., 1983, PROTEINS STRUCTURES
   Daillant J, 2009, CURR OPIN COLLOID IN, V14, P396, DOI 10.1016/j.cocis.2009.04.003
   Dannenberger O, 1999, J PHYS CHEM B, V103, P2202, DOI 10.1021/jp983433l
   Davidovits JV, 1996, SURF SCI, V352, P369, DOI 10.1016/0039-6028(95)01162-5
   Davies PR, 2001, APPL SURF SCI, V181, P296, DOI 10.1016/S0169-4332(01)00404-4
   Dayss E, 1999, SURF COAT TECH, V116, P986, DOI 10.1016/S0257-8972(99)00184-X
   Palma R, 2007, LANGMUIR, V23, P443, DOI 10.1021/la061951e
   Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914
   Demirci S, 2010, SURF SCI, V604, P649, DOI 10.1016/j.susc.2010.01.009
   Devaprakasam D, 2004, LANGMUIR, V20, P1329, DOI 10.1021/la0359676
   Dingal PCDP, 2014, CURR OPIN BIOTECH, V28, P46, DOI 10.1016/j.copbio.2013.11.003
   Donachie M, 1998, ADV MATER PROCESS, V154, P63
   DOUGLAS K, 1990, APPL PHYS LETT, V56, P692, DOI 10.1063/1.102685
   Driskell T. D., 1994, EARLY HIST CALCIUM P
   Duan XX, 2008, LANGMUIR, V24, P3621, DOI 10.1021/la702975q
   DUBOIS LH, 1990, J AM CHEM SOC, V112, P570, DOI 10.1021/ja00158a013
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Dulkeith E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.203002
   Duran-Lobato M, 2014, J BIOMED NANOTECHNOL, V10, P1068, DOI 10.1166/jbn.2014.1806
   Einati H, 2009, ELECTROCHIM ACTA, V54, P6063, DOI 10.1016/j.electacta.2009.02.090
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Elbs M, 2003, ANAL CHEM, V75, P4793, DOI 10.1021/ac034381l
   Fadeev AY, 2000, LANGMUIR, V16, P7268, DOI 10.1021/la000471z
   Fadeev AY, 2002, LANGMUIR, V18, P7521, DOI 10.1021/la020178u
   Fadeev AY, 1999, LANGMUIR, V15, P7238, DOI 10.1021/la9903806
   Fadeev AY, 1999, J AM CHEM SOC, V121, P12184, DOI 10.1021/ja9931269
   Fan FQ, 2003, LANGMUIR, V19, P3254, DOI 10.1021/la026453u
   Fang JY, 2001, LANGMUIR, V17, P1549, DOI 10.1021/la001156f
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   FINKLEA HO, 1986, LANGMUIR, V2, P239, DOI 10.1021/la00068a022
   Flink S, 2001, J PHYS ORG CHEM, V14, P407, DOI 10.1002/poc.372
   Fraker A. C., 1983, ASTM STP, V786, P206
   Franklin B., 1774, PHILOS T R SOC LONDO, V64, P445
   Friebel S, 2000, APPL PHYS LETT, V77, P2406, DOI 10.1063/1.1316066
   Fu Y, 2014, CURR OPIN BIOTECH, V28, P33, DOI 10.1016/j.copbio.2013.10.014
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   GAINES GL, 1966, INSOLUBLE MONOLAYERS
   Gao EF, 2014, J NANOSCI NANOTECHNO, V14, P4626, DOI 10.1166/jnn.2014.8203
   Gao LN, 2004, J PHYS CHEM B, V108, P1207, DOI 10.1021/jp0372385
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Garcia AJ, 2006, ADV POLYM SCI, P171, DOI 10.1007/12_071
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Gehrig LMB, 2011, AM J SURG, V202, P364, DOI 10.1016/j.amjsurg.2011.06.007
   Glaser A, 2004, ANAL BIOANAL CHEM, V379, P653, DOI 10.1007/s00216-004-2620-3
   Glaser A, 2004, LANGMUIR, V20, P5599, DOI 10.1021/la049910a
   Goetting LB, 1999, LANGMUIR, V15, P1182, DOI 10.1021/la981094h
   Goldmann M, 1998, THIN SOLID FILMS, V327, P166, DOI 10.1016/S0040-6090(98)00621-X
   Gomes A., 2013, J NANOPHARM DRUG DEL, V1, P206
   Grook K, 1987, J BIOMED MATER RES, V21, P1375
   Guinan JL, 2005, AM J INFECT CONTROL, V33, P310, DOI 10.1016/j.ajic.2005.03.005
   GUN J, 1986, J COLLOID INTERF SCI, V112, P457, DOI 10.1016/0021-9797(86)90114-1
   GUN J, 1984, J COLLOID INTERF SCI, V101, P201, DOI 10.1016/0021-9797(84)90020-1
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   HANAWA T, 1993, J ELECTRON SPECTROSC, V63, P347, DOI 10.1016/0368-2048(93)80032-H
   Hanawa T., 1994, P S COMP BIOM IMPL S
   Hartmann N, 2006, SURF SCI, V600, P4034, DOI 10.1016/j.susc.2006.01.118
   Hatton RA, 2001, THIN SOLID FILMS, V394, P292
   Hazra S, 2014, J NANOSCI NANOTECHNO, V14, P1983, DOI 10.1166/jnn.2014.8745
   Heiman R. B., 1996, PLASMA SPRAY COATING
   Heiney PA, 2000, LANGMUIR, V16, P2651, DOI 10.1021/1a990557w
   Heinz B, 1997, SURF SCI, V372, P100, DOI 10.1016/S0039-6028(96)01131-4
   Helmy R, 2002, LANGMUIR, V18, P8924, DOI 10.1021/la0262506
   Hergenrother PJ, 2000, J AM CHEM SOC, V122, P7849, DOI 10.1021/ja0014032
   Hidber PC, 1996, LANGMUIR, V12, P1375, DOI 10.1021/la9507500
   Hillebrenner H, 2006, J AM CHEM SOC, V128, P4236, DOI 10.1021/ja058455h
   Hobara D, 2002, NANO LETT, V2, P1021, DOI 10.1021/nl0256863
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Hoffmann C, 2006, J COLLOID INTERF SCI, V295, P427, DOI 10.1016/j.jcis.2005.10.005
   HONG HG, 1994, LANGMUIR, V10, P153, DOI 10.1021/la00013a023
   Hsu EW, 2014, J BIOMED NANOTECHNOL, V10, P1130, DOI 10.1166/jbn.2014.1823
   Hu MH, 2001, APPL SURF SCI, V181, P307, DOI 10.1016/S0169-4332(01)00399-3
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Ide Y, 2014, J NANOSCI NANOTECHNO, V14, P2135, DOI 10.1166/jnn.2014.8525
   Iimura K, 2000, THIN SOLID FILMS, V379, P230, DOI 10.1016/S0040-6090(00)01544-3
   Iizuka T, 2006, J ORAL MAXIL SURG, V64, P989, DOI 10.1016/j.joms.2005.11.050
   Isaacs L., 1999, PERSPECTIVES SUPRAMO
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Ito T, 2008, LANGMUIR, V24, P6630, DOI 10.1021/la800716r
   Itoh Y, 1999, SURF COAT TECH, V111, P172, DOI 10.1016/S0257-8972(98)00728-2
   Iwasaki Y, 2003, COLLOID SURFACE B, V32, P77, DOI 10.1016/S0927-7765(03)00147-4
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Jang JW, 2007, SMALL, V3, P600, DOI 10.1002/smll.200600679
   Jang LS, 2009, BIOMED MICRODEVICES, V11, P331, DOI 10.1007/s10544-008-9239-7
   Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372
   JEON NL, 1995, LANGMUIR, V11, P3024, DOI 10.1021/la00008a029
   Jiang XY, 2003, J AM CHEM SOC, V125, P2366, DOI 10.1021/ja029485c
   Jing WX, 2014, J NANOSCI NANOTECHNO, V14, P4251, DOI 10.1166/jnn.2014.8225
   Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000
   Jun Y, 2003, J ADHES SCI TECHNOL, V17, P593, DOI 10.1163/15685610360554438
   Jung DH, 2002, LANGMUIR, V18, P6133, DOI 10.1021/la025558u
   KAKKAR AK, 1993, LANGMUIR, V9, P388, DOI 10.1021/la00026a006
   Kakuta T, 2014, J NANOSCI NANOTECHNO, V14, P4090, DOI 10.1166/jnn.2014.8227
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kang H, 2009, ULTRAMICROSCOPY, V109, P1011, DOI 10.1016/j.ultramic.2009.03.036
   Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164
   Kanta A, 2006, COLLOID SURFACE A, V291, P51, DOI 10.1016/j.colsurfa.2005.12.057
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kato S, 1998, LANGMUIR, V14, P2372, DOI 10.1021/la971215y
   Kaufmann CR, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025008
   KERN M, 1994, J DENT, V22, P300, DOI 10.1016/0300-5712(94)90067-1
   KESSEL CR, 1991, LANGMUIR, V7, P532, DOI 10.1021/la00051a020
   Kim BJ, 2008, MACROMOLECULES, V41, P436, DOI 10.1021/ma701931z
   Kim DH, 2014, J NANOSCI NANOTECHNO, V14, P4557, DOI 10.1166/jnn.2014.8285
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim S, 2002, LANGMUIR, V18, P2125, DOI 10.1021/la011020x
   Kim S, 2008, THIN SOLID FILMS, V516, P940, DOI 10.1016/j.tsf.2007.05.092
   Kira A, 2009, APPL SURF SCI, V255, P7647, DOI 10.1016/j.apsusc.2009.04.044
   Kluth GJ, 1997, LANGMUIR, V13, P3775, DOI 10.1021/la970135r
   KNOTEK O, 1992, SURF COAT TECH, V55, P536
   Koide Y, 2003, LANGMUIR, V19, P86, DOI 10.1021/la020604b
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kong G, 2009, J RARE EARTH, V27, P164, DOI 10.1016/S1002-0721(08)60213-6
   Koul S, 2009, JACC-CARDIOVASC INTE, V2, P337, DOI 10.1016/j.jcin.2009.02.003
   Koutsoulas C, 2014, J NANOSCI NANOTECHNO, V14, P4529, DOI 10.1166/jnn.2014.9026
   Krasnoslobodtsev AV, 2002, LANGMUIR, V18, P3181, DOI 10.1021/la015628h
   Kristensen EME, 2006, LANGMUIR, V22, P9651, DOI 10.1021/la060586o
   Krumpfer JW, 2006, LANGMUIR, V22, P8271, DOI 10.1021/la060969m
   Krupa D, 2002, BIOMATERIALS, V23, P3329, DOI 10.1016/S0142-9612(02)00020-0
   Krupa D, 1999, SURF COAT TECH, V111, P86, DOI 10.1016/S0257-8972(98)00714-2
   Krupa D, 2001, VACUUM, V63, P715, DOI 10.1016/S0042-207X(01)00263-9
   Krupa D, 1999, SURF COAT TECH, V114, P250, DOI 10.1016/S0257-8972(99)00052-3
   Krupa D, 1996, SURF COAT TECH, V79, P240, DOI 10.1016/0257-8972(95)02457-3
   Krysinski P, 2003, LANGMUIR, V19, P3875, DOI 10.1021/la026946z
   Kulkarni SA, 2006, THIN SOLID FILMS, V496, P420, DOI 10.1016/j.tsf.2005.08.321
   Kulkarni SA, 2006, J PHYS CONF SER, V34, P322, DOI 10.1088/1742-6596/34/1/053
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   Kumar N, 2001, LANGMUIR, V17, P7789, DOI 10.1021/la010257q
   Kumar S, 2014, J NANOSCI NANOTECHNO, V14, P1838, DOI 10.1166/jnn.2014.9050
   KURTH DG, 1993, LANGMUIR, V9, P2965, DOI 10.1021/la00035a039
   Laffineur F, 2003, APPL SURF SCI, V212, P452, DOI 10.1016/S0169-4332(03)00141-7
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   Lamb BM, 2008, CHEMBIOCHEM, V9, P2628, DOI 10.1002/cbic.200800473
   Landel R.F., 1994, MECH PROPERTIES POLY
   LASIC DD, 1994, ANGEW CHEM INT EDIT, V33, P1685, DOI 10.1002/anie.199416851
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lausmaa J., 2001, TITANIUM MED, P231
   LeClair P, 2000, THIN SOLID FILMS, V376, P9, DOI 10.1016/S0040-6090(00)01192-5
   Lee C, 2014, J NANOSCI NANOTECHNO, V14, P4325, DOI 10.1166/jnn.2014.8060
   Lee DK, 2003, SURF COAT TECH, V169, P433, DOI 10.1016/S0257-8972(03)00184-1
   Lee J, 2015, APPL SURF SCI, V330, P445, DOI 10.1016/j.apsusc.2015.01.043
   Lee JP, 2003, ADV FUNCT MATER, V13, P873, DOI 10.1002/adfm.200304445
   Lee K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2899965
   Lee MT, 2001, LANGMUIR, V17, P762, DOI 10.1021/la000865q
   Lee NS, 2014, J NANOSCI NANOTECHNO, V14, P1463, DOI 10.1166/jnn.2014.9087
   LEE YW, 1993, LANGMUIR, V9, P3009, DOI 10.1021/la00035a045
   LEGRANGE JD, 1993, LANGMUIR, V9, P1749, DOI 10.1021/la00031a023
   Leipert D, 1998, ANGEW CHEM INT EDIT, V37, P3308, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3308::AID-ANIE3308>3.0.CO;2-#
   Leitner T, 2000, MIKROCHIM ACTA, V133, P331, DOI 10.1007/s006040070115
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   LI DQ, 1990, J AM CHEM SOC, V112, P7389, DOI 10.1021/ja00176a045
   LI DQ, 1993, LANGMUIR, V9, P3341, DOI 10.1021/la00036a004
   Li JR, 2008, NANO LETT, V8, P1916, DOI 10.1021/nl0806062
   Li JS, 2014, J NANOSCI NANOTECHNO, V14, P1181, DOI 10.1166/jnn.2014.8744
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Li ZF, 2013, APPL SURF SCI, V282, P487, DOI 10.1016/j.apsusc.2013.05.158
   Li ZY, 2003, LANGMUIR, V19, P6744, DOI 10.1021/la034245b
   LINFORD MR, 1995, J AM CHEM SOC, V117, P3145, DOI 10.1021/ja00116a019
   Liu GY, 2000, ACCOUNTS CHEM RES, V33, P457, DOI 10.1021/ar980081s
   Liu HB, 2008, CHEMPHYSCHEM, V9, P1979, DOI 10.1002/cphc.200800381
   Liu HB, 2014, J NANOSCI NANOTECHNO, V14, P1533, DOI 10.1166/jnn.2014.9133
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu Y, 2001, LANGMUIR, V17, P4329, DOI 10.1021/la010123c
   Liu ZC, 2003, MATER CHEM PHYS, V82, P301, DOI 10.1016/S0254-0584(03)00135-4
   Long YT, 2002, PHYS CHEM CHEM PHYS, V4, P522, DOI 10.1039/b107091f
   Love JC, 2003, J AM CHEM SOC, V125, P2597, DOI 10.1021/ja028692+
   Love JC, 2001, LANGMUIR, V17, P6005, DOI 10.1021/la010655t
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Luscombe CK, 2003, LANGMUIR, V19, P5273, DOI 10.1021/la0342114
   Luth H., 1993, SURFACES INTERFACES
   Luzinov I, 2000, LANGMUIR, V16, P504, DOI 10.1021/la990500+
   Maboudian R, 2002, TRIBOL LETT, V12, P95, DOI 10.1023/A:1014044207344
   MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q
   Magnussen OM, 1996, NATURE, V384, P250, DOI 10.1038/384250a0
   Mahapatro A, 2006, NANOMED-NANOTECHNOL, V2, P182, DOI 10.1016/j.nano.2006.07.006
   Mahapatro A, 2012, ECS TRANSACTIONS, V30, P61, DOI 10.1149/1.3697746
   Mahapatro A, 2013, J BIOMATER TISS ENG, V3, P196, DOI 10.1166/jbt.2013.1084
   Mahapatro A, 2012, J BIOMATER TISS ENG, V2, P259, DOI 10.1166/jbt.2012.1059
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Maitz MF, 2002, BIOMOL ENG, V19, P269, DOI 10.1016/S1389-0344(02)00039-4
   Mani G, 2008, LANGMUIR, V24, P6774, DOI 10.1021/la8003646
   Mani G, 2009, APPL SURF SCI, V255, P5961, DOI 10.1016/j.apsusc.2009.01.046
   MAOZ R, 1984, J COLLOID INTERF SCI, V100, P465, DOI 10.1016/0021-9797(84)90452-1
   MAOZ R, 1985, THIN SOLID FILMS, V132, P135, DOI 10.1016/0040-6090(85)90465-1
   Maoz R, 1996, NATURE, V384, P150, DOI 10.1038/384150a0
   Maoz R., 1995, SUPRAMOL SCI, V2, P9
   MARGEL S, 1991, LANGMUIR, V7, P2317, DOI 10.1021/la00058a057
   Matejka V, 2014, J NANOSCI NANOTECHNO, V14, P1597, DOI 10.1166/jnn.2014.9081
   MATHAUER K, 1993, LANGMUIR, V9, P3002, DOI 10.1021/la00035a044
   MATHAUER K, 1993, LANGMUIR, V9, P3446, DOI 10.1021/la00036a019
   Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07
   Mattox D. M., 1994, HDB DEPOSITION TECHN
   Mattox DM, 2010, HANDBOOK OF PHYSICAL VAPOR DEPOSITION (PVD) PROCESSING, 2ND EDITION, P301
   Matyjaszewski K, 1999, MACROMOLECULES, V32, P8716, DOI 10.1021/ma991146p
   McCallien DWJ, 1997, J CHEM SOC PERK T 1, P2581, DOI 10.1039/a701968h
   Meiners F, 2014, COLLOID SURFACE A, V449, P31, DOI 10.1016/j.colsurfa.2014.02.015
   Mekhalif Z, 2003, LANGMUIR, V19, P637, DOI 10.1021/la020332c
   Mendes PM, 2004, CURR OPIN COLLOID IN, V9, P236, DOI 10.1016/j.cocis.2004.06.005
   Meng XW, 2014, J NANOSCI NANOTECHNO, V14, P1617, DOI 10.1166/jnn.2014.9136
   MEZGER PR, 1992, J DENT, V20, P342, DOI 10.1016/0300-5712(92)90021-4
   Mhlanga N, 2014, J NANOSCI NANOTECHNO, V14, P4269, DOI 10.1166/jnn.2014.8271
   Michel B, 2001, IBM J RES DEV, V45, P697, DOI 10.1147/rd.455.0697
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1068, DOI 10.1016/j.msec.2011.08.022
   Mitamura Y, 1986, ASAIO Trans, V32, P444, DOI 10.1097/00002480-198609000-00012
   Mittal K. L., 1979, SURFACE CONTAMINATIO, V1, P3
   Mundra RV, 2014, CURR OPIN BIOTECH, V28, P25, DOI 10.1016/j.copbio.2013.10.012
   Muruganandham M, 2014, J NANOSCI NANOTECHNO, V14, P1898, DOI 10.1166/jnn.2014.8718
   Naha P. C., 2013, J NANOPHARM DRUG DEL, V1, P74
   Nakamura A, 2014, J NANOSCI NANOTECHNO, V14, P2198, DOI 10.1166/jnn.2014.8522
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nanjwade B. K., 2013, J NANOPHARMA DRUG DE, V1, P165
   Napier ME, 2007, POLYM REV, V47, P321, DOI 10.1080/15583720701454999
   Nederberg F, 2005, BIOMACROMOLECULES, V6, P3088, DOI 10.1021/bm0504173
   Nederberg F, 2004, J AM CHEM SOC, V126, P15350, DOI 10.1021/ja0457314
   NETZER L, 1983, J AM CHEM SOC, V105, P674, DOI 10.1021/ja00341a087
   Neves BRA, 2001, LANGMUIR, V17, P8193, DOI 10.1021/la010909a
   Nihonyanagi S, 2008, LANGMUIR, V24, P5161, DOI 10.1021/la702024x
   Noble-Luginbuhl AR, 2001, LANGMUIR, V17, P3937, DOI 10.1021/la010142m
   Noeske M, 2004, INT J ADHES ADHES, V24, P171, DOI 10.1016/j.ijadhadh.2003.09.006
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   ODonnell MJ, 1997, ANAL CHEM, V69, P2438, DOI 10.1021/ac961007v
   OFFORD DA, 1993, LANGMUIR, V9, P3015, DOI 10.1021/la00035a046
   Ohring M., 2002, MAT SCI THIN FILM DE
   OHTAKE T, 1992, LANGMUIR, V8, P2081, DOI 10.1021/la00045a001
   Oliveira EM, 2007, BIOELECTROCHEMISTRY, V71, P186, DOI 10.1016/j.bioelechem.2007.04.005
   Onclin S, 2005, ANGEW CHEM INT EDIT, V44, P6282, DOI 10.1002/anie.200500633
   Oskarsson H, 2006, J COLLOID INTERF SCI, V301, P360, DOI 10.1016/j.jcis.2006.05.045
   Owens TM, 2002, J AM CHEM SOC, V124, P6800, DOI 10.1021/ja025755f
   Padma N, 2014, J NANOSCI NANOTECHNO, V14, P4418, DOI 10.1166/jnn.2014.8200
   Pandey R, 2005, INT J PHARM, V301, P268, DOI 10.1016/j.ijpharm.2005.05.027
   Panigrahi A., 2013, REV NANOSCI NANOTECH, V2, P247, DOI DOI 10.1166/RNN.2013.1034
   PARIKH AN, 1994, J PHYS CHEM-US, V98, P7577, DOI 10.1021/j100082a031
   Pawlowski L, 2008, SURF COAT TECH, V202, P4318, DOI 10.1016/j.surfcoat.2008.04.004
   Pawsey S, 2002, LANGMUIR, V18, P5205, DOI 10.1021/la015749h
   Pellerite MJ, 2003, J PHYS CHEM B, V107, P11726, DOI 10.1021/jp0354200
   Pelton AR, 2008, J MECH BEHAV BIOMED, V1, P153, DOI 10.1016/j.jmbbm.2007.08.001
   Pham MT, 2000, THIN SOLID FILMS, V379, P50, DOI 10.1016/S0040-6090(00)01553-4
   Pileni MP, 1997, LANGMUIR, V13, P3266, DOI 10.1021/la960319q
   Pilloud DL, 1998, J PHYS CHEM B, V102, P1926, DOI 10.1021/jp973348y
   Pilloud DL, 1998, LANGMUIR, V14, P4809, DOI 10.1021/la980596s
   Pirrung MC, 2002, ANGEW CHEM INT EDIT, V41, P1277
   Pirrung MC, 2000, LANGMUIR, V16, P2185, DOI 10.1021/la991298d
   PLUEDDEMANN EP, 1970, J ADHESION, V2, P184, DOI 10.1080/0021846708544592
   POMERANTZ M, 1985, THIN SOLID FILMS, V132, P153, DOI 10.1016/0040-6090(85)90466-3
   Poulose S, 2014, J NANOSCI NANOTECHNO, V14, P2038, DOI 10.1166/jnn.2014.9019
   Prucker O, 1998, MACROMOLECULES, V31, P592, DOI 10.1021/ma970660x
   Quinones R, 2008, THIN SOLID FILMS, V516, P8774, DOI 10.1016/j.tsf.2008.06.055
   Quinones R, 2007, LANGMUIR, V23, P10123, DOI 10.1021/la701110p
   Raman A, 2006, LANGMUIR, V22, P6469, DOI 10.1021/la060636p
   Ratner B.D., 2013, BIOMATERIALS SCI INT
   Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970
   Rawcliffe R, 2008, CHEM COMMUN, P871, DOI 10.1039/b715536k
   Reese S, 1998, J PHYS CHEM B, V102, P9820, DOI 10.1021/jp9821174
   Reiniger M, 2002, SURF INTERFACE ANAL, V33, P85, DOI 10.1002/sia.1167
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Risse T, 1996, LANGMUIR, V12, P5512, DOI 10.1021/la9606759
   Rogers JA, 2005, MATER TODAY, V8, P50, DOI 10.1016/S1369-7021(05)00702-9
   Rogers YH, 1999, ANAL BIOCHEM, V266, P23, DOI 10.1006/abio.1998.2857
   Rosa LG, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/48/483001
   Rosario R, 2002, LANGMUIR, V18, P8062, DOI 10.1021/la025963l
   Roscoe SB, 1996, LANGMUIR, V12, P4218, DOI 10.1021/la950142k
   Rozlosnik N, 2003, LANGMUIR, V19, P1182, DOI 10.1021/la025906s
   Ruan CM, 2002, THIN SOLID FILMS, V419, P95, DOI 10.1016/S0040-6090(02)00730-7
   Rudzinski CM, 2002, J AM CHEM SOC, V124, P1723, DOI 10.1021/ja010176g
   Rye RR, 1997, LANGMUIR, V13, P2965, DOI 10.1021/la960919p
   SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Sanger W., 1986, PRINCIPLES NUCL ACID
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schmid H, 2000, MACROMOLECULES, V33, P3042, DOI 10.1021/ma982034l
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Scholz MS, 2011, COMPOS SCI TECHNOL, V71, P1791, DOI 10.1016/j.compscitech.2011.08.017
   Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1
   Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900
   Schvartzman M, 2003, J VAC SCI TECHNOL B, V21, P148, DOI 10.1116/1.1532026
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Scoles G., 1992, ATOMIC MOL BEAN METH, V1-2
   Sekar MMA, 1999, J AM CHEM SOC, V121, P5135, DOI 10.1021/ja983912y
   Shadnam MR, 2004, LANGMUIR, V20, P2667, DOI 10.1021/la0354584
   SHAFRIN EG, 1949, J COLL SCI IMP U TOK, V4, P571, DOI 10.1016/0095-8522(49)90054-9
   Shin MJ, 2014, J IND ENG CHEM, V20, P91, DOI 10.1016/j.jiec.2013.04.022
   Shin MJ, 2011, BIOCHEM ENG J, V54, P57, DOI 10.1016/j.bej.2011.01.008
   Shirahata N, 2014, J NANOSCI NANOTECHNO, V14, P2640, DOI 10.1166/jnn.2014.8640
   SILBERZAN P, 1991, LANGMUIR, V7, P1647, DOI 10.1021/la00056a017
   Sinapi F, 2003, APPL SURF SCI, V212, P464, DOI 10.1016/S0169-4332(03)00142-9
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   Smith RK, 2004, PROG SURF SCI, V75, P1, DOI 10.1016/j.progsurf.2003.12.001
   Sobiecki JR, 2001, VACUUM, V64, P41, DOI 10.1016/S0042-207X(01)00373-6
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Spriano S, 2010, MATER SCI TECHNOL, P269
   Spriano S, 2012, SURFACE TAILORING OF INORGANIC MATERIALS FOR BIOMEDICAL APPLICATIONS, P279
   Sproul WD, 1996, SURF COAT TECH, V81, P1, DOI 10.1016/0257-8972(95)02616-9
   Srinivasan U, 1998, J MICROELECTROMECH S, V7, P252, DOI 10.1109/84.679393
   Stanley S, 2014, CURR OPIN BIOTECH, V28, P69, DOI 10.1016/j.copbio.2013.11.014
   STAYTON PS, 1992, J AM CHEM SOC, V114, P9298, DOI 10.1021/ja00050a008
   Stohr J., 1992, NEXAFS SPECTROSCOPY
   Subramanian B, 2013, J NANOSCI NANOTECHNO, V13, P4565, DOI 10.1166/jnn.2013.7170
   Sumita M., 1997, SEIKEI GEKA, V48, P927
   Sunday D, 2010, MACROMOLECULES, V43, P4871, DOI 10.1021/ma1004259
   Sung MM, 2000, J PHYS CHEM B, V104, P1556, DOI 10.1021/jp993288r
   Sung MM, 1999, J VAC SCI TECHNOL A, V17, P540, DOI 10.1116/1.581616
   Sutar DS, 2007, SENSOR ACTUAT B-CHEM, V128, P286, DOI 10.1016/j.snb.2007.06.015
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   Suzuki I., 2004, J NANOBIOTECHNOL, V2, P7, DOI DOI 10.1186/1477-3155-2-7
   Tamai K, 2009, J ORTHOP SCI, V14, P204, DOI 10.1007/s00776-008-1306-7
   Tan A, 2013, J BIOTECHNOL, V164, P151, DOI 10.1016/j.jbiotec.2013.01.020
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Tasker S, 1996, LANGMUIR, V12, P6436, DOI 10.1021/la951087i
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   TIDSWELL IM, 1990, PHYS REV B, V41, P1111, DOI 10.1103/PhysRevB.41.1111
   TILLMAN N, 1989, LANGMUIR, V5, P101, DOI 10.1021/la00085a019
   TILLMAN N, 1988, J AM CHEM SOC, V110, P6136, DOI 10.1021/ja00226a031
   Tinazli A, 2007, NAT NANOTECHNOL, V2, P220, DOI 10.1038/nnano.2007.63
   Tolan M., 1999, SPRINGER TRACTS MOD, V148
   TORREGROSA F, 1995, THIN SOLID FILMS, V266, P245, DOI 10.1016/0040-6090(96)80028-9
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   TREDGOLD RH, 1985, NATURE, V313, P348, DOI 10.1038/313348a0
   TRIPP CP, 1992, LANGMUIR, V8, P1120, DOI 10.1021/la00040a018
   TRIPP CP, 1995, LANGMUIR, V11, P1215, DOI 10.1021/la00004a029
   Tseng JY, 2001, COLLOID SURFACE A, V182, P239, DOI 10.1016/S0927-7757(00)00832-3
   Tsukagoshi T, 2007, COLLOID SURFACE B, V54, P101, DOI 10.1016/j.colsurfb.2006.10.004
   TSUKRUK VV, 1994, LANGMUIR, V10, P996, DOI 10.1021/la00016a006
   Tsyganov I, 2002, SURF COAT TECH, V158, P318, DOI 10.1016/S0257-8972(02)00190-1
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Ulman A., 1998, THIN FILMS, V24
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Vaidya R, 1998, BIOTECHNOL PROGR, V14, P371, DOI 10.1021/bp980039w
   Vallant T, 1998, J PHYS CHEM B, V102, P7190, DOI 10.1021/jp981282g
   Vallant T, 1999, LANGMUIR, V15, P5339, DOI 10.1021/la9900977
   Van Alsten JG, 1999, LANGMUIR, V15, P7605, DOI 10.1021/la981694g
   van der Boom ME, 2002, LANGMUIR, V18, P3704, DOI 10.1021/la011561m
   van der Veen NJ, 2000, J AM CHEM SOC, V122, P6112, DOI 10.1021/ja000713h
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Viviente JL, 1999, VACUUM, V52, P141, DOI 10.1016/S0042-207X(98)00213-9
   Waite D E, 1989, Oral Surg Oral Med Oral Pathol, V68, P495, DOI 10.1016/0030-4220(89)90228-4
   Wang AF, 2005, J COLLOID INTERF SCI, V291, P438, DOI 10.1016/j.jcis.2005.05.008
   Wang DH, 2005, THIN SOLID FILMS, V471, P177, DOI 10.1016/j.tsf.2004.06.158
   Wang RW, 2000, LANGMUIR, V16, P5008, DOI 10.1021/la991635i
   Wang YL, 2000, CHEM COMMUN, P587, DOI 10.1039/b000419g
   Wang YL, 2003, LANGMUIR, V19, P1159, DOI 10.1021/la020697x
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WASSERMAN SR, 1989, J AM CHEM SOC, V111, P5852, DOI 10.1021/ja00197a054
   Weber M, 1998, HELV CHIM ACTA, V81, P1359, DOI 10.1002/hlca.19980810546
   WEGNER G, 1992, THIN SOLID FILMS, V216, P105, DOI 10.1016/0040-6090(92)90878-F
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Wen F, 2002, SURF COAT TECH, V156, P208, DOI 10.1016/S0257-8972(02)00088-9
   Wen K, 2008, ACS NANO, V2, P579, DOI 10.1021/nn800011t
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Whitesides GM, 2005, SMALL, V1, P172, DOI 10.1002/smll.200400130
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Widmer A, 2008, INT J INFECT DIS, V12, pE15, DOI 10.1016/j.ijid.2008.05.082
   WIEGAND BC, 1993, J PHYS CHEM-US, V97, P11553, DOI 10.1021/j100146a033
   Wieser E, 1999, SURF COAT TECH, V111, P103, DOI 10.1016/S0257-8972(98)00717-8
   WILBUR JL, 1994, ADV MATER, V6, P600, DOI 10.1002/adma.19940060719
   Williams D. F., BIOCOMPATIBILITY CLI, P9
   Wilson DS, 2003, ANGEW CHEM INT EDIT, V42, P494, DOI 10.1002/anie.200390150
   WISBEY A, 1987, BIOMATERIALS, V8, P477, DOI 10.1016/0142-9612(87)90085-8
   Wong SWY, 2013, REV NANOSCI NANOTECH, V2, P79
   Wu CD, 2012, POLYMER, V53, P857, DOI 10.1016/j.polymer.2011.12.037
   Wydro P, 2013, J COLLOID INTERF SCI, V397, P122, DOI 10.1016/j.jcis.2013.01.060
   XIA Y, 1998, CHEM INT ED, V37, P550, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<LESSTHAN>550::AID-ANIE550<GREATERTHAN>3.0.CO;2-G
   Xia YN, 1996, MICROELECTRON ENG, V32, P255, DOI 10.1016/0167-9317(95)00174-3
   Xia YN, 1996, LANGMUIR, V12, P4033, DOI 10.1021/la960387c
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xie XN, 2006, MAT SCI ENG R, V54, P1, DOI 10.1016/j.mser.2006.10.001
   Xu S, 1999, LANGMUIR, V15, P7244, DOI 10.1021/la9906727
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Yadav PK, 2011, APPL SURF SCI, V258, P361, DOI 10.1016/j.apsusc.2011.08.068
   Yadav S. K., 2013, REV NANOSCI NANOTECH, V2, P127
   Yam CM, 1999, LANGMUIR, V15, P3807, DOI 10.1021/la9816961
   Yan L, 1998, J AM CHEM SOC, V120, P6179, DOI 10.1021/ja980770z
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang JX, 2010, SURF COAT TECH, V205, pS182, DOI 10.1016/j.surfcoat.2010.07.045
   Yang P, 2002, SURF COAT TECH, V156, P284, DOI 10.1016/S0257-8972(02)00087-7
   Yang Q, 2014, J BIOMED NANOTECHNOL, V10, P580, DOI 10.1166/jbn.2014.1746
   Yatsuzuka M, 2000, VACUUM, V59, P330, DOI 10.1016/S0042-207X(00)00286-4
   Ye S, 2003, SURF SCI, V529, P163, DOI 10.1016/S0039-6028(03)00239-5
   YEGANEH MS, 1995, PHYS REV LETT, V74, P1811, DOI 10.1103/PhysRevLett.74.1811
   Yim CT, 2002, J PHYS CHEM B, V106, P1728, DOI 10.1021/jp013649e
   Yoo B, 2014, J BIOMED NANOTECHNOL, V10, P1114, DOI 10.1166/jbn.2014.1795
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   Yu WQ, 2014, J NANOSCI NANOTECHNO, V14, P4387, DOI 10.1166/jnn.2014.7929
   Yue M, 2008, NANO LETT, V8, P520, DOI 10.1021/nl072740c
   Zammatteo N, 2000, ANAL BIOCHEM, V280, P143, DOI 10.1006/abio.2000.4515
   Zhai L, 2006, NANO LETT, V6, P1213, DOI 10.1021/nl060644q
   Zhang L, 2014, J BIOMED NANOTECHNOL, V10, P278, DOI 10.1166/jbn.2014.1790
   Zhang ZJ, 2000, LANGMUIR, V16, P1158, DOI 10.1021/la991106e
   Zhao XY, 2014, J NANOSCI NANOTECHNO, V14, P2658, DOI 10.1166/jnn.2014.8484
   Zheng XX, 2014, J BIOMED NANOTECHNOL, V10, P900, DOI 10.1166/jbn.2014.1856
   Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191
   Zhu XL, 2002, J BIOMED MATER RES, V60, P333, DOI 10.1002/jbm.10105
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   ZHURAVLEV LT, 1987, LANGMUIR, V3, P316, DOI 10.1021/la00075a004
   Zong C, 2014, J BIOMED NANOTECHNOL, V10, P1091, DOI 10.1166/jbn.2014.1696
   Zorn G, 2005, CHEM MATER, V17, P4218, DOI 10.1021/cm050477f
   Zu YB, 2014, J BIOMED NANOTECHNOL, V10, P982, DOI 10.1166/jbn.2014.1797
NR 484
TC 40
Z9 40
U1 10
U2 262
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 227
EP 251
DI 10.1016/j.msec.2015.05.018
PG 25
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500028
PM 26117759
DA 2018-10-20
ER

PT J
AU Shadjou, N
   Hasanzadeh, M
AF Shadjou, Nasrin
   Hasanzadeh, Mohammad
TI Bone tissue engineering using silica-based mesoporous
   nanobiomaterials:Recent progress
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Biomaterial; Bone tissue engineering; Nanotechnology; Silica mesoporous
   material; Scaffold
ID BIOACTIVE GLASS SCAFFOLDS; CERAMIC FOAM SCAFFOLDS; DRUG-DELIVERY;
   ELECTROPHORETIC DEPOSITION; ORTHOPEDIC APPLICATIONS;
   MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE;
   CARBON NANOTUBES; IN-VIVO
AB Bone disorders are of significant concern due to increase in the median age of our population. It is in this context that tissue engineering has been emerging as a valid approach to the current therapies for bone regeneration/substitution. Tissue-engineered bone constructs have the potential to alleviate the demand arising from the shortage of suitable autograft and allograft materials for augmenting bone healing. Silica based mesostructured nanomaterials possessing pore sizes in the range 2-50 nm and surface reactive functionalities have elicited immense interest due to their exciting prospects in bone tissue engineering. In this review we describe application of silica-based mesoporous nanomaterials for bone tissue engineering. We summarize the preparation methods, the effect of mesopore templates and composition on the mesopore-structure characteristics, and different forms of these materials, including particles, fibers, spheres, scaffolds and composites. Also, the effect of structural and textural properties of mesoporous materials on development of new biomaterials for production of bone implants and bone cements was discussed. Also, application of different mesoporous materials on construction of manufacture 3-dimensional scaffolds for bone tissue engineering was discussed. It begins by giving the reader a brief background on tissue engineering, followed by a comprehensive description of all the relevant components of silica-based mesoporous biomaterials on bone tissue engineering, going from materials to scaffolds and from cells to tissue engineering strategies that will lead to "engineered" bone. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shadjou, Nasrin; Hasanzadeh, Mohammad] Urmia Univ, Nano Technol Res Ctr, Dept Nanochem, Orumiyeh, Iran.
   [Shadjou, Nasrin; Hasanzadeh, Mohammad] Urmia Univ, Fac Chem, Orumiyeh, Iran.
   [Hasanzadeh, Mohammad] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz 51664, Iran.
RP Shadjou, N (reprint author), Urmia Univ, Nano Technol Res Ctr, Dept Nanochem, Orumiyeh, Iran.
EM nasrin.shadjou@gmail.com; mhmmd_hasanzadeh@yahoo.com
OI Hasanzadeh, Mohammad/0000-0003-4918-1239; Shadjou,
   Nasrin/0000-0001-5961-3686
FU Drug Applied Research Center, Tabriz University of Medical Sciences;
   Nano Technology Center, Urmia University
FX We gratefully acknowledge the support of this work by Drug Applied
   Research Center, Tabriz University of Medical Sciences. Also, we are
   thanking Nano Technology Center, Urmia University for partial support.
CR Baino F, 2014, MATER LETT, V118, P27, DOI 10.1016/j.matlet.2013.12.037
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Boccaccini AR, 2006, J MATER SCI, V41, P8152, DOI 10.1007/s10853-006-0556-z
   Boccaccini AR, 2010, J R SOC INTERFACE, V7, pS581, DOI 10.1098/rsif.2010.0156.focus
   Campbell TA, 2013, NANO TODAY, V8, P119, DOI 10.1016/j.nantod.2012.12.002
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chen Q, 2013, MAT SCI ENG C-MATER, V33, P1530, DOI 10.1016/j.msec.2012.12.058
   Chen ZD, 2012, COLLOID SURFACE B, V95, P274, DOI 10.1016/j.colsurfb.2012.03.012
   Chien KB, 2013, TISSUE ENG PART C-ME, V19, P417, DOI [10.1089/ten.tec.2012.0383, 10.1089/ten.TEC.2012.0383]
   Coti KK, 2009, NANOSCALE, V1, P16, DOI 10.1039/b9nr00162j
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Diba M, 2012, INT J APPL GLASS SCI, V3, P221, DOI 10.1111/j.2041-1294.2012.00095.x
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Eftekhari A, 2008, NANOSTRUCTURED MAT E
   Fielding GA, 2012, DENT MATER, V28, P113, DOI 10.1016/j.dental.2011.09.010
   Fiorilli S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5346-6
   Garcia A, 2011, ACTA BIOMATER, V7, P1265, DOI 10.1016/j.actbio.2010.10.006
   Gun Z., 2013, COLLOID SURFACE B, V101, P228
   Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400
   He XX, 2008, ANAL CHEM, V80, P9597, DOI 10.1021/ac801882g
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hornez JC, 2007, KEY ENG MATER, V330-332, P927, DOI 10.4028/www.scientific.net/KEM.330-332.927
   Jayasuriya RL, 2013, J BONE JOINT SURG AM, V95A, P19, DOI 10.2106/JBJS.K.00657
   Kaiser C, 1997, SPEC PUBL R SOC CHEM, V213, P406
   Khaled SMZ, 2011, J BIOMATER APPL, V25, P515, DOI 10.1177/0885328209356944
   Kneser U, 2002, MINIM INVASIV THER, V11, P107, DOI 10.1080/136457002320174177
   Krause D, 2006, SURF COAT TECH, V200, P4835, DOI 10.1016/j.surfcoat.2005.04.029
   Kumar B., 2006, FRACTURE NANO ENG MA, P1023
   Kuo YC, 2011, COLLOID SURFACE B, V84, P63, DOI 10.1016/j.colsurfb.2010.12.021
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lath R., 2006, MACROMOL MATER ENG, V291, P263
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee JH, 2015, TISSUE ENG REGEN MED, V12, P90, DOI 10.1007/s13770-015-0102-7
   Lee JE, 2011, ACCOUNTS CHEM RES, V44, P893, DOI 10.1021/ar2000259
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Lennon AB, 2008, ORTHOPAEDIC BONE CEMENTS, P265, DOI 10.1533/9781845695170.3.265
   Leroux F, 2006, J MATER CHEM, V16, P2074, DOI 10.1039/b600513f
   Li HW, 2015, MAT SCI ENG C-MATER, V49, P210, DOI 10.1016/j.msec.2014.12.082
   Li J, 2008, IMPLANT DENT, V17, P389, DOI 10.1097/ID.0b013e31818c4992
   Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g
   Lim MH, 1999, CHEM MATER, V11, P3285, DOI 10.1021/cm990369r
   Lin YS, 2009, CHEM MATER, V21, P3979, DOI 10.1021/cm901259n
   Lu J, 2010, SMALL, V6, P1794, DOI 10.1002/smll.201000538
   Masuda Y, 2013, COLLOID SURFACE B, V101, P26, DOI 10.1016/j.colsurfb.2012.05.037
   Meng DC, 2011, J BIOMED MATER RES A, V99A, P435, DOI 10.1002/jbm.a.33185
   Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]
   Ormsby R, 2012, ACTA BIOMATER, V8, P1201, DOI 10.1016/j.actbio.2011.10.010
   Patel KD, 2012, J MATER CHEM, V22, P24945, DOI 10.1039/c2jm33830k
   Pegel S, 2008, POLYMER, V49, P974, DOI 10.1016/j.polymer.2007.12.024
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Ravichandran R, 2014, MICROPOR MESOPOR MAT, V187, P53, DOI 10.1016/j.micromeso.2013.12.018
   Ravichandran R, 2013, J BIOMAT SCI-POLYM E, V24, P1988, DOI 10.1080/09205063.2013.816930
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Sayari A, 2001, CHEM MATER, V13, P3151, DOI 10.1021/cm0110391
   Sethuraman S, 2011, J BIOMAT SCI-POLYM E, V22, P733, DOI 10.1163/092050610X491670
   Sethuraman S, 2010, ACTA BIOMATER, V6, P1931, DOI 10.1016/j.actbio.2009.12.012
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   Shruti S, 2013, ACTA BIOMATER, V9, P4836, DOI 10.1016/j.actbio.2012.09.024
   Slane J, 2014, J MECH BEHAV BIOMED, V37, P141, DOI 10.1016/j.jmbbm.2014.05.015
   Slane J, 2014, J MECH BEHAV BIOMED, V29, P451, DOI 10.1016/j.jmbbm.2013.10.008
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suwanprateeb J, 2009, J MATER SCI-MATER M, V20, P1281, DOI 10.1007/s10856-009-3697-1
   Tabasi O., 2012, COLLOID SURFACE B, V98, P18
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Trewyn BG, 2007, CHEM COMMUN, P3236, DOI 10.1039/b701744h
   Vallet-Regi M, 2012, PHILOS T R SOC A, V370, P1400, DOI 10.1098/rsta.2011.0258
   Vitale-Brovarone C, 2012, J MATER SCI-MATER M, V23, P2369, DOI 10.1007/s10856-012-4643-1
   Walcarius A, 2013, CHEM SOC REV, V42, P4098, DOI 10.1039/c2cs35322a
   Wang XL, 2011, COLLOID SURFACE B, V82, P233, DOI 10.1016/j.colsurfb.2010.08.047
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu ZY, 2014, COLLOID SURFACE B, V120, P38, DOI 10.1016/j.colsurfb.2014.04.010
   Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w
   Yang L, 2005, J MOL CATAL A-CHEM, V229, P199, DOI 10.1016/j.molcata.2004.11.024
   Yun HS, 2007, CHEM MATER, V19, P6363, DOI 10.1021/cm7023923
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Zhang JH, 2014, ACTA BIOMATER, V10, P2269, DOI 10.1016/j.actbio.2014.01.001
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhao XS, 2006, J MATER CHEM, V16, P623, DOI 10.1039/B600327N
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zongxi L., 2012, CHEM SOC REV, V41, P2590
NR 92
TC 44
Z9 47
U1 6
U2 193
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 401
EP 409
DI 10.1016/j.msec.2015.05.027
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500040
PM 26117771
DA 2018-10-20
ER

PT J
AU Xue, ZH
   Hu, BB
   Dai, SX
   Du, ZL
AF Xue, Zhonghui
   Hu, Binbin
   Dai, Shuxi
   Du, Zuliang
TI Transformation of amorphous calcium carbonate to rod-like single crystal
   calcite via "copying" collagen template
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanostructures; Interfaces; Crystal growth; Crystal structure
ID BIOMIMETIC MINERALIZATION; MAGNESIUM-IONS; SILK FIBROIN;
   CRYSTALLIZATION; BIOMINERALIZATION; NUCLEATION; HYDROXYAPATITE;
   MONOLAYERS; PHOSPHATE; NANOPARTICLES
AB Collagen Langmuir films were prepared by spreading the solution of collagen over deionized water, CaCl2 solution and Ca(HCO3)(2) solution. Resultant collagen Langmuir monolayers were then compressed to a lateral pressure of 10 mN/m and held there for different duration, allowing the crystallization of CaCO3. The effect of crystallization time on the phase composition and microstructure of CaCO3 was investigated. It was found that amorphous calcium carbonate (ACC) was obtained at a crystallization time of 6 h. The amorphous CaCO3 was transformed to rod-like single crystal calcite crystals at an extended crystallization time of 12 h and 24 h, via "copying" the symmetry and dimensionalities of collagen fibers. Resultant calcite crystallites were well oriented along the longitudinal axis of collagen fibers. The ordered surface structure of collagen fibers and electrostatic interactions played key roles in tuning the oriented nucleation and growth of the calcite crystallites. The mineralized collagen possessing both desired mechanical properties of collagen fiber and good biocompatibility of calcium carbonate may be assembled into an ideal biomaterial for bone implants. (C) 2015 Published by Elsevier B.V.
C1 [Xue, Zhonghui; Hu, Binbin; Dai, Shuxi; Du, Zuliang] Henan Univ, Minist Educ, Key Lab Special Funct Mat, Kaifeng 475004, Peoples R China.
   [Xue, Zhonghui] Henan Polytech Univ, Sch Phys & Chem, Jiaozuo 454000, Peoples R China.
RP Du, ZL (reprint author), Henan Univ, Minist Educ, Key Lab Special Funct Mat, Kaifeng 475004, Peoples R China.
EM zld@henu.edu.cn
FU National Natural Science Foundation of China [20371015, 10874040,
   20903034, 21203055]; Cultivation Fund of Key Scientific and Technical
   Innovation Project, Ministry of Education of China [708062]; Annual
   Scientific and Technical Guidance Programs of the China National Coal
   Association [MTKJ-2011-404]; Program for Changjiang Scholars and
   Innovative Research Team in University [PCS IRT1126]
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 20371015, 10874040, 20903034 and 21203055), the Cultivation
   Fund of Key Scientific and Technical Innovation Project, Ministry of
   Education of China (No. 708062), 2011 Annual Scientific and Technical
   Guidance Programs of the China National Coal Association (No.:
   MTKJ-2011-404), and the Program for Changjiang Scholars and Innovative
   Research Team in University, No. PCS IRT1126. Binbin Hu and Zhonghui Xue
   contributed equally to this paper.
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   An XQ, 2008, J PHYS CHEM C, V112, P15844, DOI 10.1021/jp8048q
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Cao B, 2007, LANGMUIR, V23, P10701, DOI 10.1021/1a7014435
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   CUI Fu-Zhai, 2007, BIOMINERALIZATION
   Dai LJ, 2008, CHEM MATER, V20, P6917, DOI 10.1021/cm800760p
   Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f
   Dove P. M., 2004, BIOMINERALISATION, V54, P57
   Fadeev AS, 2008, BIOCHEM MOSC SUPPL S, V2, P62, DOI 10.1134/S1990747808010108
   Fadeev AS, 1999, COLLOID J+, V61, P520
   Fuller G. G., 2007, 81 ACS COLL SURF SCI
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   Georgalis Y, 2000, J PHYS CHEM B, V104, P3405, DOI 10.1021/jp000132e
   Gotliv B., 2004, CHEM BIOCH, V6, P304
   Hall SR, 2009, P R SOC A, V465, P335, DOI 10.1098/rspa.2008.0384
   Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z
   Jiao YF, 2006, MAT SCI ENG C-BIO S, V26, P648, DOI 10.1016/j.msec.2005.08.038
   Kato T., 2000, CHEM LETT, V29, P186
   KITANO Y, 1962, B CHEM SOC JPN, V35, P1973, DOI 10.1246/bcsj.35.1973
   Landis WJ, 2006, J MATER CHEM, V16, P1495, DOI 10.1039/b505706j
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Lowenstam H. A., 1989, BIOMINERALZATION
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mann S., 2001, BIOMINERALIZATION
   Mayes EL, 1998, ADV MATER, V10, P801, DOI 10.1002/(SICI)1521-4095(199807)10:10<801::AID-ADMA801>3.0.CO;2-I
   Metzler RA, 2008, LANGMUIR, V24, P2680, DOI 10.1021/la7031237
   Ouyang J. M., 2006, MATRIX MODULATION BI
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Pichon BP, 2008, J AM CHEM SOC, V130, P4034, DOI 10.1021/ja710416h
   Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434
   Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Schuth F, 2001, CHEM MATER, V13, P3184, DOI 10.1021/cm011030j
   Shen FH, 2002, J CRYST GROWTH, V242, P239, DOI 10.1016/S0022-0248(02)01376-3
   Sommerdijk NAJM, 2007, CRYSTENGCOMM, V9, P1209, DOI 10.1039/b710277a
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Wang CG, 2009, CRYST GROWTH DES, V9, P2620, DOI 10.1021/cg801069t
   Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+
   Wang LJ, 2007, J PHYS CHEM C, V111, P6398, DOI 10.1021/jp0675429
   Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920
   Wiesmann HP, 2005, INT REV CYTOL, V242, P121
   Xu Z, 2010, MAT SCI ENG C-MATER, V30, P822, DOI 10.1016/j.msec.2010.03.014
   YANG B, 2007, CURR APPL PHYS, pE2
   Zeiger DN, 2011, LANGMUIR, V27, P8263, DOI 10.1021/la201361e
NR 46
TC 1
Z9 2
U1 3
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 506
EP 511
DI 10.1016/j.msec.2015.05.079
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500052
PM 26117783
DA 2018-10-20
ER

PT J
AU Zheng, YY
   Xiong, CD
   Zhang, SL
   Li, XY
   Zhang, LF
AF Zheng, Yanyan
   Xiong, Chengdong
   Zhang, Shenglan
   Li, Xiaoyu
   Zhang, Lifang
TI Bone-like apatite coating on functionalized poly(etheretherketone)
   surface via tailored silanization layers technique
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(etheretherketone); Surface modification; Silanization layers;
   Bone-like apatite; Simulated body fluid (SBF); Biomineralization
ID SIMULATED BODY-FLUID; SELF-ASSEMBLED MONOLAYERS; IN-VITRO;
   TITANIUM-ALLOYS; POLYETHERETHERKETONE; HYDROXYAPATITE; BIOACTIVITY;
   PEEK; WETTABILITY; CYTOCOMPATIBILITY
AB Poly(etheretherketone) (PEEK) is a rigid semi-crystalline polymer with outstanding mechanical properties, bone-like stiffness and suitable biocompatibility that has attracted much interest as a biomaterial for orthopedic and dental implants. However, the bio-inert surface of PEEK limits its biomedical applications when direct osteointegration between the implants and the host tissue is desired. In this work, -PO4H2, -COOH and -OH groups were introduced on the PEEK surface by further chemical treatments of the vinyl-terminated silanization layers formed on the hydroxylation-pretreated PEEK surface. Both the surface-functionalized and pristine specimens were characterized by X-ray photoelectron spectroscopy (XPS), attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy and water contact angle measurements. When placed in 1.5 strength simulated body fluid (SBF) solution, apatite was observed to form uniformly on the functionalized PEEK surface and firmly attach to the substrate. The characterized results demonstrated that the coating was constituted by poorly crystallized bone-like apatite and the effect of surface functional groups on coating formation was also discussed in detail. In addition, in vitro biocompatibility of PEEK, in terms of pre-osteoblast cell (MC3T3-E1) attachment, spreading and proliferation, was remarkably enhanced by the bone-like apatite coating. Thus, this study provides a method to enhance the bioactivity of PEEK and expand its applications in orthopedic and dental implants. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zheng, Yanyan; Xiong, Chengdong; Zhang, Shenglan; Zhang, Lifang] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Zheng, Yanyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Li, Xiaoyu] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
RP Zhang, LF (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM zhanglfcioc@163.com
OI zheng, yanyan/0000-0003-0441-3008
FU key project of "Western Light" Foundation of Chinese Academy of Sciences
FX The authors thank Prof. Chuan Xin (Analysis and Testing Center Chengdu
   Branch, Chinese Academy of Sciences) for the XPS measurements and
   related data analysis. This work was supported financially by the key
   project of "Western Light" Foundation of Chinese Academy of Sciences.
CR Arpagaus C, 2005, APPL SURF SCI, V252, P1581, DOI 10.1016/j.apsusc.2005.02.099
   Balas F, 2006, BIOMATERIALS, V27, P1704, DOI 10.1016/j.biomaterials.2005.10.004
   Balcar M.S.A., 2003, BIOMATERIALS, V24, P2245
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Godara A, 2007, ACTA BIOMATER, V3, P209, DOI 10.1016/j.actbio.2006.11.005
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Hahn BD, 2013, APPL SURF SCI, V283, P6, DOI 10.1016/j.apsusc.2013.05.073
   Han CT, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0203-8
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kim HM, 2000, J MATER SCI-MATER M, V11, P421, DOI 10.1023/A:1008935924847
   Lee JH, 2013, ACTA BIOMATER, V9, P6177, DOI 10.1016/j.actbio.2012.11.030
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li XH, 2014, J BIOMATER APPL, V29, P321, DOI 10.1177/0885328214526765
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Liu ZX, 2012, CRYSTENGCOMM, V14, P6695, DOI 10.1039/c2ce25546d
   Long TM, 2006, LANGMUIR, V22, P4104, DOI 10.1021/la052977t
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   Noiset O, 1997, MACROMOLECULES, V30, P540, DOI 10.1021/ma960368+
   Park K, 2010, J BIOACT COMPAT POL, V25, P27, DOI 10.1177/0883911509353677
   Pino M, 2008, ACTA BIOMATER, V4, P1827, DOI 10.1016/j.actbio.2008.05.004
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Robotti P, 2012, PDL HANDB SER, P119, DOI 10.1016/B978-1-4377-4463-7.10009-0
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Takadama H, 2001, SCI TECHNOL ADV MAT, V2, P389
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
   Zhang FM, 2012, MAT SCI ENG C-MATER, V32, P1057, DOI 10.1016/j.msec.2010.07.007
   Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071
   Zheng YY, 2015, J BIOACT COMPAT POL, V30, P302, DOI 10.1177/0883911515572494
   Zheng YY, 2014, APPL SURF SCI, V320, P93, DOI 10.1016/j.apsusc.2014.09.091
   Zheng YY, 2014, MATER LETT, V126, P147, DOI 10.1016/j.matlet.2014.04.021
NR 42
TC 14
Z9 15
U1 7
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 512
EP 523
DI 10.1016/j.msec.2015.05.070
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500053
PM 26117784
DA 2018-10-20
ER

PT J
AU Ferreri, I
   Calderon, VS
   Galindo, RE
   Palacio, C
   Henriques, M
   Piedade, AP
   Carvalho, S
AF Ferreri, I.
   Calderon, S., V
   Escobar Galindo, R.
   Palacio, C.
   Henriques, M.
   Piedade, A. P.
   Carvalho, S.
TI Silver activation on thin films of Ag-ZrCN coatings for antimicrobial
   activity
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Sputtering; Biomaterial; Bacterial adhesion; Silver activation
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOMEDICAL APPLICATIONS; BIOFILM FORMATION;
   NANOPARTICLES; INFECTIONS; STRATEGIES; BEHAVIOR; RELEASE; COMPOSITES;
   OXIDATION
AB Nowadays, with the increase of elderly population and related health problems, knee and hip joint prosthesis are being widely used worldwide. However, failure of these invasive devices occurs in a high percentage thus demanding the revision of the chirurgical procedure. Within the reasons of failure, microbial infections, either hospital or subsequently-acquired, contribute in high number to the statistics. Staphylococcus epidermidis (S. epidermidis) has emerged as one of the major nosocomial pathogens associated with these infections. Silver has a historic performance in medicine due to its potent antimicrobial activity, with a broad-spectrum on the activity of different types of microorganisms. Consequently, the main goal of this work was to produce Ag-ZrCN coatings with antimicrobial activity, for the surface modification of hip prostheses.
   Thin films of ZrCN with several silver concentrations were deposited onto stainless steel 316 L, by DC reactive magnetron sputtering, using two targets, Zr and Zr with silver pellets (Zr + Ag target), in an atmosphere containing Ar, C2H2 and N-2. The antimicrobial activity of the modified surfaces was tested against S. epidermidis and the influence of an activation step of silver was assessed by testing samples after immersion in a 5% (w/v) NaClO solution for 5 min.
   The activation procedure revealed to be essential for the antimicrobial activity, as observed by the presence of an inhibition halo on the surface with 11 at.% of Ag. The morphology analysis of the surface before and after the activation procedure revealed differences in silver distribution indicating segregation/diffusion of the metallic element to the film's surface.
   Thus, the results indicate that the silver activation step is responsible for an antimicrobial effect of the coatings, due to silver oxidation and silver ion release. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ferreri, I.; Calderon, S., V; Carvalho, S.] Univ Minho, GRF CFUM, P-4800058 Guimaraes, Portugal.
   [Ferreri, I.; Henriques, M.] Univ Minho, CEB, Ctr Biol Engn, LIBRO Lab Invest Biofilmes Rosario Oliveira, P-4700057 Braga, Portugal.
   [Calderon, S., V; Piedade, A. P.; Carvalho, S.] Univ Coimbra, CEMUC, Dept Mech Engn, P-3030788 Coimbra, Portugal.
   [Escobar Galindo, R.] Inst Ciencia Mat Madrid ICVIM CSIC, Madrid 28049, Spain.
   [Palacio, C.] Univ Autonoma Madrid, Dept Fis Aplicada, Madrid 28049, Spain.
RP Ferreri, I (reprint author), Univ Minho, GRF CFUM, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM isabelferreri@gmail.com
RI Escobar Galindo, Ramon/B-1886-2010; Carvalho, Sandra/F-3530-2013;
   Piedade, Ana/K-8637-2012; Henriques, Mariana/A-2117-2013
OI Escobar Galindo, Ramon/0000-0001-9952-9489; Carvalho,
   Sandra/0000-0002-3643-4973; Henriques, Mariana/0000-0003-0317-4877;
   Piedade, Ana/0000-0002-1588-0640; Calderon,
   Sebastian/0000-0002-3604-6356
FU FCT-Fundacao para a Ciencia e a Tecnologia [SFRH/BD/71139/2010]; FEDER
   funds through the program COMPETE-Programa Operacional Factores de
   Competitividade; Portuguese national funds through FCT-Fundacao para a
   Ciencia e a Tecnologia [ANTIMICROBCOAT-PTDC/CTM/102853/2008,
   PEST-C/FIS/UI607/2011, PEST-C/EME/UI0285/2011]; FCT Strategic Project
   [PEST-OE/EQB/LA0023/2013]; Project "BioHealth-Biotechnology and
   Bioengineering approaches to improve health quality"
   [NORTE-07-0124-FEDER-000027]; Programa Operacional Regional do Norte
   (ON.2 - O Novo Norte); QREN; FEDER; project "Consolidating Research
   Expertise and Resources on Cellular and Molecular Biotechnology at
   CEB/IBB" [FCOMP-01-0124-FEDER-027462]
FX IF acknowledges the financial support of FCT-Fundacao para a Ciencia e a
   Tecnologia through grant SFRH/BD/71139/2010.; This research is partially
   sponsored by FEDER funds through the program COMPETE-Programa
   Operacional Factores de Competitividade and by Portuguese national funds
   through FCT-Fundacao para a Ciencia e a Tecnologia, under the projects
   ANTIMICROBCOAT-PTDC/CTM/102853/2008 and in the framework of the
   Strategic Projects PEST-C/FIS/UI607/2011, and PEST-C/EME/UI0285/2011.;
   The authors thank the FCT Strategic Project PEST-OE/EQB/LA0023/2013 and
   the Project "BioHealth-Biotechnology and Bioengineering approaches to
   improve health quality", Ref. NORTE-07-0124-FEDER-000027, co-funded by
   the Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN,
   FEDER. The authors also acknowledge the project "Consolidating Research
   Expertise and Resources on Cellular and Molecular Biotechnology at
   CEB/IBB", Ref. FCOMP-01-0124-FEDER-027462.
CR Alexander JW, 2009, SURG INFECT, V10, P289, DOI 10.1089/sur.2008.9941
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Azocar I, 2012, MATER CHEM PHYS, V137, P396, DOI 10.1016/j.matchemphys.2012.09.042
   Balaceanu M, 2005, SURF COAT TECH, V200, P1084, DOI 10.1016/j.surfcoat.2005.01.077
   Balaceanu M, 2010, SURF COAT TECH, V204, P2046, DOI 10.1016/j.surfcoat.2009.11.022
   Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033
   Bootharaju MS, 2013, J MATER CHEM A, V1, P611, DOI 10.1039/c2ta00254j
   Calderon S, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/32/325303
   Calderon S, 2013, SURF COAT TECH, V222, P104, DOI 10.1016/j.surfcoat.2013.02.011
   Velasco SC, 2014, CORROS SCI, V80, P229, DOI 10.1016/j.corsci.2013.11.036
   Carvalho I., 2013, ADV MATER, V14
   Carvalho S, 2009, VACUUM, V83, P1206, DOI 10.1016/j.vacuum.2009.03.009
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chen LM, 2010, SURF COAT TECH, V204, P3871, DOI 10.1016/j.surfcoat.2010.05.003
   Chiang WC, 2010, MATER CHEM PHYS, V119, P123, DOI 10.1016/j.matchemphys.2009.08.035
   Chung CJ, 2007, SURF COAT TECH, V202, P1302, DOI 10.1016/j.surfcoat.2007.07.077
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Endrino J L, 2010, Journal of Physics: Conference Series, V252, DOI 10.1088/1742-6596/252/1/012012
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ferreri I, 2014, MAT SCI ENG C-MATER, V42, P782, DOI 10.1016/j.msec.2014.06.007
   Grigore E, 2010, SURF COAT TECH, V204, P1889, DOI 10.1016/j.surfcoat.2009.11.012
   Hardes J, 2007, BIOMATERIALS, V28, P2869, DOI 10.1016/j.biomaterials.2007.02.033
   Hecht D, 1997, J ELECTROANAL CHEM, V440, P211, DOI 10.1016/S0022-0728(97)80058-7
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hollstein F, 2001, SURF COAT TECH, V142, P1063, DOI 10.1016/S0257-8972(01)01222-1
   Huang C., 2004, J AM CERAM SOC, V84, P1637
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012
   Klasen H.J., 2000, I EARLY USES, V26
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Kotz JC, 2011, CHEM CHEM REACTIVITY
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Kurek A, 2011, POL J MICROBIOL, V60, P3
   Lai CH, 2011, THIN SOLID FILMS, V520, P1525, DOI 10.1016/j.tsf.2011.06.043
   Lalueza P, 2011, MATER RES BULL, V46, P2070, DOI 10.1016/j.materresbull.2011.06.041
   Li B, 2008, APPL SURF SCI, V255, P452, DOI 10.1016/j.apsusc.2008.06.143
   Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Mulligan CP, 2005, SURF COAT TECH, V200, P1495, DOI 10.1016/j.surfcoat.2005.08.063
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Oliveira C, 2008, SURF COAT TECH, V203, P490, DOI 10.1016/j.surfcoat.2008.06.121
   Palacio C, 1997, VACUUM, V48, P709, DOI 10.1016/S0042-207X(97)00036-5
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Quin G.F., 2002, J FOOD ENG, V54, P111
   Rajcic-Vujasinovic M, 2013, CORROS SCI, V70, P221, DOI 10.1016/j.corsci.2013.01.033
   Roy M, 2012, ACS APPL MATER INTER, V4, P1341, DOI 10.1021/am201610q
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Sanchez-Lopez JC, 2012, SURF COAT TECH, V206, P2192, DOI 10.1016/j.surfcoat.2011.09.059
   Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010
   Silva E, 2010, SURF COAT TECH, V205, P2134, DOI 10.1016/j.surfcoat.2010.08.126
   Siozios A, 2014, SURF COAT TECH, V255, P28, DOI 10.1016/j.surfcoat.2013.11.025
   Taglietti A., 2013, BIOMATERIALS, P1
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Yao SH, 2005, MATER LETT, V59, P3230, DOI 10.1016/j.matlet.2005.04.064
   Zhao GQ, 2011, CELL BIOCHEM BIOPHYS, V61, P371, DOI 10.1007/s12013-011-9220-6
   Zhao J, 2006, NUCL INSTRUM METH B, V243, P299, DOI 10.1016/j.nimb.2005.08.189
NR 57
TC 9
Z9 11
U1 7
U2 48
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2015
VL 55
BP 547
EP 555
DI 10.1016/j.msec.2015.05.071
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CN9ZK
UT WOS:000358809500057
PM 26117788
OA Bronze
DA 2018-10-20
ER

PT J
AU Wong, DY
   Ranganath, T
   Kasko, AM
AF Wong, Darice Y.
   Ranganath, Thanmayi
   Kasko, Andrea M.
TI Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human
   Mesenchymal Stem Cells
SO PLOS ONE
LA English
DT Article
ID FORKHEAD TRANSCRIPTION FACTORS; CULTURED HUMAN KERATINOCYTES; SINGLET
   OXYGEN; PHOTODEGRADABLE HYDROGELS; FAMILY-MEMBERS; DRUG-DELIVERY;
   KAPPA-B; ACTIVATION; P53; PHOTOPOLYMERIZATION
AB Light is a non-invasive tool that is widely used in a range of biomedical applications. Techniques such as photopolymerization, photodegradation, and photouncaging can be used to alter the chemical and physical properties of biomaterials in the presence of live cells. Long-wave UV light (315 nm-400 nm) is an easily accessible and commonly used energy source for triggering biomaterial changes. Although exposure to low doses of long-wave UV light is generally accepted as biocompatible, most studies employing this wavelength only establish cell viability, ignoring other possible (non-toxic) effects. Since light exposure of wavelengths longer than 315 nm may potentially induce changes in cell behavior, we examined changes in gene expression of human mesenchymal stem cells exposed to light under both 2D and 3D culture conditions, including two different hydrogel fabrication techniques, decoupling UV exposure and radical generation. While exposure to long-wave UV light did not induce significant changes in gene expression regardless of culture conditions, significant changes were observed due to scaffold fabrication chemistry and between cells plated in 2D versus encapsulated in 3D scaffolds. In order to facilitate others in searching for more specific changes between the many conditions, the full data set is available on Gene Expression Omnibus for querying.
C1 [Wong, Darice Y.; Ranganath, Thanmayi; Kasko, Andrea M.] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA 90042 USA.
RP Kasko, AM (reprint author), Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA 90042 USA.
EM akasko@ucla.edu
FU National Institutes of Health through the NIH Director's New Innovator
   Award Program [1-DP2-OD008533]
FX This work was funded by the National Institutes of Health through the
   NIH Director's New Innovator Award Program, 1-DP2-OD008533 awarded to
   AK. The website for this funding program is
   http://commonfund.nih.gov/newinnovator/index. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BASUMODAK S, 1993, CANCER RES, V53, P4505
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780
   Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173
   Chang TY, ANN REV CELL DEV BIO, V222006, P129
   Chaudhuri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7365
   Chaudhuri O, 2012, NAT MATER, V11, P568, DOI 10.1038/nmat3366
   Djavaheri-Mergny M, 2001, EXP DERMATOL, V10, P204, DOI 10.1034/j.1600-0625.2001.010003204.x
   Djavaheri-Mergny M, 1999, BIOCHEM J, V338, P607, DOI 10.1042/0264-6021:3380607
   DjavaheriMergny M, 1996, FEBS LETT, V384, P92, DOI 10.1016/0014-5793(96)00294-3
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586
   Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s
   Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w
   Griffin DR, 2010, BIOTECHNOL BIOENG, V107, P1012, DOI 10.1002/bit.22882
   Groves JT, 2007, ANNU REV PHYS CHEM, V58, P697, DOI 10.1146/annurev.physchem.56.092503.141216
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790
   HARRIS MG, 1993, OPTOMETRY VISION SCI, V70, P839, DOI 10.1097/00006324-199310000-00011
   Hensman C, 1998, SURG ENDOSC-ULTRAS, V12, P335, DOI 10.1007/s004649900665
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Iwaguchi S, 2000, COLLOID SURFACE B, V18, P113, DOI 10.1016/S0927-7765(99)00144-7
   Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8
   Kawabata K, 2013, J TOXICOL SCI, V38, P215, DOI 10.2131/jts.38.215
   Kersters I, 1998, INDIAN J ENG MATER S, V5, P211
   Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844
   Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lajoie P, INT REV CELL MOL BIO, V282, P135
   Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524
   Lippincott-Schwartz J, ANN REV BIOPHYSICS, V39, P559
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Maziere C, 2000, FREE RADICAL BIO MED, V28, P1430, DOI 10.1016/S0891-5849(00)00264-1
   Menicanin D, 2009, STEM CELL REV REP, V5, P36, DOI 10.1007/s12015-009-9056-2
   Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034
   Occhetta P, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035002
   Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787
   Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576
   Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031
   Shamay Y, 2011, BIOMATERIALS, V32, P1377, DOI 10.1016/j.biomaterials.2010.10.029
   Silvers AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P302, DOI 10.1562/0031-8655(2002)075<0302:UIIAOA>2.0.CO;2
   Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000
   Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   VILE GF, 1995, PHOTOCHEM PHOTOBIOL, V62, P463, DOI 10.1111/j.1751-1097.1995.tb02369.x
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   WLASCHEK M, 1995, J INVEST DERMATOL, V104, P194, DOI 10.1111/1523-1747.ep12612751
   Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200
NR 65
TC 14
Z9 14
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 29
PY 2015
VL 10
IS 9
AR e0139307
DI 10.1371/journal.pone.0139307
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS6EV
UT WOS:000362171400073
PM 26418040
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chiappone, A
   Gerbaldi, C
   Roppolo, I
   Garino, N
   Bongiovanni, R
AF Chiappone, A.
   Gerbaldi, C.
   Roppolo, I.
   Garino, N.
   Bongiovanni, R.
TI Degradable photopolymerized thiol-based solid polymer electrolytes
   towards greener Li-ion batteries
SO POLYMER
LA English
DT Article
DE Degradable polymer electrolyte; Thiol; UV curing
ID MICROFIBRILLATED CELLULOSE; ACRYLATE PHOTOPOLYMERS; BIODEGRADABLE
   POLYMER; ENE CHEMISTRY; LITHIUM; BEHAVIOR; CONDUCTIVITY; BIOMATERIAL;
   HYDROLYSIS; NETWORKS
AB Thermoset initiator-free membranes are prepared by the UV-induced photopolymerization of thiol and (meth) acrylic monomers having polyethylene oxide chains, being known that the use of such monomers can lead to the formation of readily degradable membranes. The photopolymerization of different formulations is studied and the influence of the addition of a monofunctional methacrylate is investigated. By incorporation of lithium bis(oxalate) borate salt, solid polymer electrolytes are prepared and used as electrolyte membranes in Li-ion batteries. The ionic conductivity of the samples is measured and correlated to their thermal characteristics. The best performing sample shows encouraging cycling behaviour when tested in a truly-solid state lab-scale lithium test cell, thus enlightening the promising prospects of the newly designed polymer electrolytes. Furthermore, a preliminary degradation study is performed demonstrating the possibility to hydrolytically degrade the proposed UV cured networks making them extremely appealing for the development of sustainable and easily recyclable, thus greener, energy power sources. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Chiappone, A.; Gerbaldi, C.; Roppolo, I.; Garino, N.] Ist Italiano Tecnol, Ctr Space Human Robot Polito, I-10129 Turin, Italy.
   [Gerbaldi, C.; Bongiovanni, R.] Politecn Torino, Dept Appl Sci & Technol, I-10129 Turin, Italy.
RP Chiappone, A (reprint author), Ist Italiano Tecnol, Ctr Space Human Robot Polito, Corso Trento 21, I-10129 Turin, Italy.
EM annalisa.chiappone@iit.it
OI Gerbaldi, Claudio/0000-0002-8084-0143
CR Agrawal RC, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/22/223001
   Anastas P. T., 2000, GREEN CHEM THEORY PR
   Bauman R.P., 1962, ABSORPTION SPECTROSO
   Chiappone A, 2011, J POWER SOURCES, V196, P10280, DOI 10.1016/j.jpowsour.2011.07.015
   Chiappone A, 2013, J POLYM SCI POL PHYS, V51, P1571, DOI 10.1002/polb.23371
   Chiappone A, 2013, CELLULOSE, V20, P2439, DOI 10.1007/s10570-013-0002-8
   Cramer NB, 2002, MACROMOLECULES, V35, P5361, DOI 10.1021/ma0200672
   Cramer NB, 2001, J POLYM SCI POL CHEM, V39, P3311, DOI 10.1002/pola.1314
   Di Lupo F, 2015, ELECTROCHIM ACTA, V156, P188, DOI 10.1016/j.electacta.2015.01.048
   Di Noto V, 2010, ELECTROCHIM ACTA, V55, P1431, DOI 10.1016/j.electacta.2009.06.011
   Dinoto V, 2010, WOODHEAD PUBL MATER, P219, DOI 10.1533/9781845699772.1.219
   Fergus JW, 2010, J POWER SOURCES, V195, P4554, DOI 10.1016/j.jpowsour.2010.01.076
   Fonseca CP, 2006, J POWER SOURCES, V155, P381, DOI 10.1016/j.jpowsour.2005.05.004
   Fonseca P.C., 2006, J POWER SOURCES, V159, P712
   Fouassier J.-P., 1995, PHOTOINITIATION PHOT
   Kade MJ, 2010, J POLYM SCI POL CHEM, V48, P743, DOI 10.1002/pola.23824
   Lee SI, 2011, CHEM MATER, V23, P2685, DOI 10.1021/cm103696g
   Li Q, 2009, POLYMER, V50, P2237, DOI 10.1016/j.polymer.2009.03.026
   Markus W., 2012, POLYM ENERGY STORAGE, P55
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Nair DP, 2013, CHEM MATER, V26, P724, DOI DOI 10.1021/CM402180T
   Nair JR, 2012, MEMBRANES, V2, P687, DOI 10.3390/membranes2040687
   Nair JR, 2013, J APPL ELECTROCHEM, V43, P137, DOI 10.1007/s10800-012-0492-3
   Patil A., 1913, MAT RES B, V43, P1913
   Pieczonka NPW, 2013, J PHYS CHEM C, V117, P22603, DOI 10.1021/jp408717x
   Plichta EJ, 2001, J POWER SOURCES, V94, P160, DOI 10.1016/S0378-7753(00)00578-4
   Qiu B, 2003, BIOMATERIALS, V24, P11, DOI 10.1016/S0142-9612(02)00227-2
   Quartarone E, 2011, CHEM SOC REV, V40, P2525, DOI 10.1039/c0cs00081g
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2007, ACTA BIOMATER, V3, P449, DOI 10.1016/j.actbio.2006.12.001
   Rydholm AE, 2006, BIOMACROMOLECULES, V7, P2827, DOI 10.1021/bm0603793
   Ryou MH, 2012, ELECTROCHIM ACTA, V60, P23, DOI 10.1016/j.electacta.2011.10.072
   Sangermano M, 2015, RSC SMART MATER, P121
   Schoenmakers RG, 2004, J CONTROL RELEASE, V95, P291, DOI 10.1016/j.jconrel.2003.12.009
   Sownthari K, 2013, EXPRESS POLYM LETT, V7, P495, DOI 10.3144/expresspolymlett.2013.46
   Walker CN, 2012, ACS MACRO LETT, V1, P737, DOI 10.1021/mz300090m
   Willgert M, 2013, SOLID STATE IONICS, V236, P22, DOI 10.1016/j.ssi.2013.01.019
   Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k
   Woo HJ, 2011, SOLID STATE IONICS, V199, P14, DOI 10.1016/j.ssi.2011.07.007
   Wright P. V., 1975, British Polymer Journal, V7, P319, DOI 10.1002/pi.4980070505
   Wu XL, 2011, SOLID STATE IONICS, V186, P1, DOI 10.1016/j.ssi.2011.01.010
   Xu K, 2005, J POWER SOURCES, V146, P79, DOI 10.1016/j.jpowsour.2005.03.153
   Zhang J., 2014, SCI REP, V4
NR 43
TC 6
Z9 7
U1 7
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD SEP 28
PY 2015
VL 75
BP 64
EP 72
DI 10.1016/j.polymer.2015.08.019
PG 9
WC Polymer Science
SC Polymer Science
GA CS2DZ
UT WOS:000361879300009
DA 2018-10-20
ER

PT J
AU Yu, XM
   Tan, LL
   Yang, HZ
   Yang, K
AF Yu, Xiaoming
   Tan, Lili
   Yang, Huazhe
   Yang, Ke
TI Surface characterization and preparation of Ta coating on Ti6Al4V alloy
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Ti6Al4V; Ta; CVD; Coating; Corrosion
ID POROUS TANTALUM BIOMATERIAL; BIOACTIVE TITANIUM METAL;
   HYDROGEN-PEROXIDE; CELL-ADHESION; OXIDE-FILMS; IMPLANTS; FABRICATION;
   DEPOSITION; ROUGHNESS; BIOCOMPATIBILITY
AB In this study, high quality Ta coating was made on both plate and porous Ti6Al4V alloy substrates by atmospheric pressure chemical vapor deposition (APCVD) in order to further improve the corrosion resistance and biocompatibility of Ti alloys for medical application. XRD analyses showed that the coatings were mainly composed of Ta with the substrate temperature (T-s) of 1000 degrees C, 950 degrees C and 900 degrees C. The morphology, microstructure and elements composition were characterized by optical microscope, scanning electron microscopy (SEM), atomic force microscopy (AFM) and energy-dispersive spectroscopy (EDS). It was found that the coating surface became much more smooth and uniform at low H-2 gas flow rate of 120 mL/min, and the root-mean-square (RMS) roughness was decreased with the increase of T-s,. The wettability of Ta coating was investigated by measuring contact angel of water and alpha-bromonaphthalene (alpha-BrNp). The Ta coating with Ts of 950 degrees C showed the lowest of gamma(s), gamma(d)(s) and gamma(d)(s)/gamma(p)(s)), indicating a better hemocompatibility of the Ta coating than that of substrate. The corrosion behavior of the coating was studied by electrochemical test in 0.9% NaCl solution at 37 degrees C. The Ta coating exhibited higher corrosion potential (E-corr) and lower corrosion current density indicating an improved corrosion resistance compared with the Ti6Al4V substrate. Ta coating was fabricated not only on the plate substrate, but also on a porous Ti6Al4V substrate. The above results made it possible to develop a novel class of Ta-coated Ti alloy implants with wide clinical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Yu, Xiaoming; Tan, Lili; Yang, Huazhe; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Yu, XM (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM xmyu@imr.ac.cn
FU National Basic Research Program of China (973 Program) [2012CB619101];
   Foundation of the Education Department of Liaoning Province [L2013285]
FX The authors would like to thank the financial support of the National
   Basic Research Program of China (973 Program, No. 2012CB619101) and the
   Foundation of the Education Department of Liaoning Province (No.
   L2013285).
CR Abizaid A, 2007, CATHETER CARDIO INTE, V70, P914, DOI 10.1002/ccd.21279
   Anselme K, 2014, SCANNING, V36, P11, DOI 10.1002/sca.21067
   Balagna C, 2012, MAT SCI ENG C-MATER, V32, P887, DOI 10.1016/j.msec.2012.02.007
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   CAMPBELL IE, 1949, J ELECTROCHEM SOC, V96, P318, DOI 10.1149/1.2776795
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Khan FA, 2012, CLIN ORTHOP RELAT R, V470, P594, DOI 10.1007/s11999-011-2117-2
   Krygier J., 1999, P SIROT SYD AUSTR
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Levesque A, 2004, CHEM VAPOR DEPOS, V10, P23, DOI 10.1002/cvde.200306204
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Macionczyk F, 2001, SURF COAT TECH, V142, P1084, DOI 10.1016/S0257-8972(01)01096-9
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   POWELL CF, 1948, J ELECTROCHEM SOC, V93, P258, DOI 10.1149/1.2773813
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Roy M, 2010, ADV ENG MATER, V12, pB637, DOI 10.1002/adem.201080017
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Silva RA, 2002, J MATER SCI-MATER M, V13, P495, DOI 10.1023/A:1014779008598
   Stackpool G., 1995, COMBINED ORS, V1995, P45
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Wu JM, 2002, SCRIPTA MATER, V46, P101, DOI 10.1016/S1359-6462(01)01207-6
   Xiao F, 2003, THIN SOLID FILMS, V441, P271, DOI 10.1016/S0040-6090(03)00913-1
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang WM, 2007, SURF COAT TECH, V201, P8062, DOI 10.1016/j.surfcoat.2006.02.058
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang Y, 2012, ELIFE, V1, DOI [10.1007/s13225-011-0117-x, 10.7554/eLife.00065]
NR 34
TC 5
Z9 5
U1 3
U2 79
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD SEP 25
PY 2015
VL 644
BP 698
EP 703
DI 10.1016/j.jallcom.2015.04.207
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA CL7HU
UT WOS:000357143900101
DA 2018-10-20
ER

PT J
AU Zeng, HX
   Johnson, ME
   Oldenhuis, NJ
   Tiambeng, TN
   Guan, ZB
AF Zeng, Hanxiang
   Johnson, Mark E.
   Oldenhuis, Nathan J.
   Tiambeng, Timothy N.
   Guan, Zhibin
TI Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA
   Delivery
SO ACS CENTRAL SCIENCE
LA English
DT Article
ID NONVIRAL GENE DELIVERY; SMALL INTERFERING RNA; IN-VIVO; CATIONIC LIPIDS;
   INTRACELLULAR TRAFFICKING; MOLECULAR-DYNAMICS; ENDOSOMAL ESCAPE;
   NANOPARTICLES; TOXICITY; CELLS
AB Development of safe and effective delivery vectors is a critical challenge for the application of RNA interference (RNAi)-based biotechnologies. In this study we show the rational design of a series of novel dendritic peptide bolaamphiphile vectors that demonstrate high efficiency for the delivery of small interfering RNA (siRNA) while exhibiting low cytotoxicity and hemolytic activity. Systematic investigation into structure-property relationships revealed an important correlation between molecular design, self-assembled nanostructure, and biological activity. The unique bolaamphiphile architecture proved a key factor for improved complex stability and transfection efficiency. The optimal vector contains a fluorocarbon core and exhibited enhanced delivery efficiency to a variety of cell lines and improved serum resistance when compared to hydrocarbon analogues and lipofectamine RNAiMAX. In addition to introducing a promising new vector system for siRNA delivery, the structure-property relationships and "fluorocarbon effect" revealed herein offer critical insight for further development of novel materials for nucleic acid delivery and other biomaterial applications.
C1 [Zeng, Hanxiang; Johnson, Mark E.; Oldenhuis, Nathan J.; Tiambeng, Timothy N.; Guan, Zhibin] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.
RP Guan, ZB (reprint author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.
EM zguan@uci.edu
FU NIDDK NIH HHS [R01 DK098446]
CR Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758
   Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940
   Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215
   Dafik L, 2009, J AM CHEM SOC, V131, P12091, DOI 10.1021/ja902777d
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310
   Deshayes S, 2012, SMALL, V8, P2184, DOI 10.1002/smll.201102413
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351
   Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111
   Eguchi A, 2009, TRENDS PHARMACOL SCI, V30, P341, DOI 10.1016/j.tips.2009.04.009
   Giljohann DA, 2009, J AM CHEM SOC, V131, P2072, DOI 10.1021/ja808719p
   Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612
   Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008
   Ivanov A., 2008, EXOCYTOSIS ENDOCYTOS, V440, P15
   Jain N, 2012, INT J PHARMACEUT, V423, P392, DOI 10.1016/j.ijpharm.2011.12.026
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Khan M, 2012, BIOMATERIALS, V33, P4673, DOI 10.1016/j.biomaterials.2012.02.067
   Kim ST, 2012, SMALL, V8, P3253, DOI 10.1002/smll.201201141
   Kim T, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.5
   Klein E, 2010, BIOMATERIALS, V31, P4781, DOI 10.1016/j.biomaterials.2010.02.047
   Knudsen KB, 2015, NANOMED-NANOTECHNOL, V11, P467, DOI 10.1016/j.nano.2014.08.004
   Kulkarni A, 2012, J AM CHEM SOC, V134, P7596, DOI 10.1021/ja300690j
   Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901
   Landesman-Milo D, 2014, DRUG DELIV TRANSL RE, V4, P96, DOI 10.1007/s13346-013-0158-7
   Liu XF, 2012, LANGMUIR, V28, P3474, DOI 10.1021/la204653b
   Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077
   Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363
   Nuraje N, 2013, PROG POLYM SCI, V38, P302, DOI 10.1016/j.progpolymsci.2012.09.003
   Popov M, 2013, EUR J PHARM BIOPHARM, V85, P381, DOI 10.1016/j.ejpb.2013.06.005
   Rehman ZU, 2013, J CONTROL RELEASE, V166, P46, DOI 10.1016/j.jconrel.2012.12.014
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104
   Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104
   Saito H, 2008, J PHYS CHEM B, V112, P11305, DOI 10.1021/jp801057k
   Saito H, 2009, CHEM PHYS LETT, V468, P260, DOI 10.1016/j.cplett.2008.12.001
   Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602
   Shete HK, 2014, J NANOSCI NANOTECHNO, V14, P460, DOI 10.1166/jnn.2014.9082
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Son S, 2012, ACCOUNTS CHEM RES, V45, P1100, DOI 10.1021/ar200248u
   Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429
   Tschiche A, 2014, NANOMEDICINE-UK, V9, P667, DOI [10.2217/NNM.14.32, 10.2217/nnm.14.32]
   Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619
   Wang M., 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4053, DOI 10.1038/NCOMS4053]
   Wang MM, 2014, BIOMATERIALS, V35, P6603, DOI 10.1016/j.biomaterials.2014.04.065
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Won YW, 2014, NAT MATER, V13, P1157, DOI [10.1038/NMAT4092, 10.1038/nmat4092]
   Wong SC, 2012, NUCLEIC ACID THER, V22, P380, DOI 10.1089/nat.2012.0389
   Wu JY, 2013, SCI WORLD J, DOI 10.1155/2013/630654
   Yu TZ, 2012, ANGEW CHEM INT EDIT, V51, P8478, DOI 10.1002/anie.201203920
   Zeng HX, 2013, J AM CHEM SOC, V135, P4962, DOI 10.1021/ja400986u
NR 56
TC 18
Z9 18
U1 1
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2374-7943
EI 2374-7951
J9 ACS CENTRAL SCI
JI ACS Central Sci.
PD SEP 23
PY 2015
VL 1
IS 6
BP 303
EP 312
DI 10.1021/acscentsci.5b00233
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CX8QR
UT WOS:000365969200007
PM 26436138
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, NY
   Lock, J
   Sallee, A
   Liu, HN
AF Zhang, Naiyin
   Lock, Jaclyn
   Sallee, Amy
   Liu, Huinan
TI Magnetic Nanocomposite Hydrogel for Potential Cartilage Tissue
   Engineering: Synthesis, Characterization, and Cytocompatibility with
   Bone Marrow Derived Mesenchymal Stem Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE magnetic nanocomposite hydrogel (MagGel); magnetic nanoparticles; hybrid
   gel; bone marrow derived mesenchymal stem cells; cytocompatibility;
   cartilage tissue engineering
ID IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; GLYCOL) HYDROGELS; SCAFFOLDS;
   COLLAGEN; BIOMATERIAL; DISEASE; EDC/NHS; FIELDS; REPAIR
AB Hydrogels possess high water content and closely mimic the microenvironment of extracellular matrix. In this study, we created a hybrid hydrogel containing type II collagen, hyaluronic acid (HA), and polyethylene glycol (PEG) and incorporated magnetic nanoparticles into the hybrid hydrogels of type II collagen-HA-PEG to produce a magnetic nanocomposite hydrogel (MagGel) for cartilage tissue engineering. The results showed that both the MagGel and hybrid gel (Gel) were successfully cross-linked and the MagGel responded to an external magnet while maintaining structural integrity. That is, the MagGel could travel to the tissue defect sites in physiological fluids under remote magnetic guidance. The adhesion density of bone marrow derived mesenchymal stem cells (BMSCs) on the MagGel group in vitro was similar to the control group and greater than the Gel group. The morphology of BMSCs was normal and consistent in all groups. We also found that BMSCs engulfed magnetic nanoparticles in culture and the presence of magnetic nanoparticles did not affect BMSC adhesion and morphology. We hypothesized that the ingested nanopartides may be eventually broken down by lysosome and excreted through exocytosis; further studies are necessary to confirm this. This study reports a promising magnetic responsive nanocomposite hydrogel for potential cartilage tissue engineering applications, which should be further studied for its effects on cell functions when combined with electromagnetic stimulation.
C1 [Zhang, Naiyin; Lock, Jaclyn; Sallee, Amy; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU Hellman Faculty Fellowship; University of California Regents Faculty
   Fellowship; U.S. National Science Foundation Graduate Research
   Fellowship Program [GRF-P 2012125281]; California Institute for
   Regenerative Medicine (CIRM) Bridges to Stem Cell Research; NIH
   [HD031226]
FX The authors thank Hellman Faculty Fellowship (H.L.) and the University
   of California Regents Faculty Fellowship (H.L.) for financial support.
   The authors thank U.S. National Science Foundation Graduate Research
   Fellowship Program for supporting the graduate student researcher (GRF-P
   2012125281 for J.L.) and California Institute for Regenerative Medicine
   (CIRM) Bridges to Stem Cell Research for supporting the undergraduate
   student researcher (A.S.). The authors thank Central Facility for
   Advanced Microscopy and Microanalysis (CFAMM) at the University of
   California, Riverside, for the use of SEM and EDS and Dr. Krassimir
   Bozhilov for SEM/EDS training. The authors thank Dr. Lawrence D. Longo
   (NIH Grant HD031226) at Loma Linda University for providing sheep stifle
   joints for Type II collagen extraction. The authors thank Dr. Gary
   Botimer at Loma Linda University for the kind gift of Arithrex
   Osteochondral Autograft Transfer System (OATS) for harvesting the
   subchondral bone plugs.y
CR Abedini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090055
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Bakandritsos A, 2010, NANOSCALE, V2, P564, DOI 10.1039/b9nr00253g
   Balasundaram G, 2014, INT J NANOMED, V9, P1845, DOI 10.2147/IJN.S55865
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Beeran AE, 2015, RSC ADV, V5, P36742, DOI 10.1039/c4ra16185h
   Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Chen CH, 2013, J APPL PHYSIOL, V114, P647, DOI 10.1152/japplphysiol.01216.2012
   CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734
   Cipriano AF, 2014, J BIOMED NANOTECHNOL, V10, P660, DOI 10.1166/jbn.2014.1760
   Corr SA, 2008, J AM CHEM SOC, V130, P4214, DOI 10.1021/ja710172z
   Costantini F, 2014, RSC ADV, V4, P2073, DOI 10.1039/c3ra46058d
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   Elahi MF, 2014, MATERIALS, V7, P2956, DOI 10.3390/ma7042956
   Gloria A., 2013, J R SOC INTERFACE, V10, P1
   Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032
   Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   Kilian KA, 2008, ANGEW CHEM INT EDIT, V47, P2697, DOI 10.1002/anie.200704784
   Kobayashi T, 2009, ARTHROSCOPY, V25, P1435, DOI 10.1016/j.arthro.2009.06.009
   Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]
   Levett PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113216
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Lu CH, 2014, J PHARM SCI-US, V103, P216, DOI 10.1002/jps.23777
   Luengo Y, 2013, NANOSCALE, V5, P11428, DOI 10.1039/c3nr02148c
   Corchero J, 2009, TRENDS BIOTECHNOL, V27, P468, DOI 10.1016/j.tibtech.2009.04.003
   Mayer-Wagner S, 2011, BIOELECTROMAGNETICS, V32, P283, DOI 10.1002/bem.20633
   Meenach SA, 2009, J BIOMED MATER RES A, V91A, P903, DOI 10.1002/jbm.a.32322
   Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nordin M., 2001, BASIC BIOMECHANICS M
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Park S, 2012, INT J PHARMACEUT, V424, P107, DOI 10.1016/j.ijpharm.2011.12.044
   Pfister PM, 2007, BIOMATERIALS, V28, P567, DOI 10.1016/j.biomaterials.2006.09.016
   Sam S, 2010, LANGMUIR, V26, P809, DOI 10.1021/la902220a
   Shen JF, 2007, NEUROSCI LETT, V415, P164, DOI 10.1016/j.neulet.2007.01.015
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   THIHIEP N, 2013, J BIOMEDICAL SCI ENG, V6, P854
   Unterman SA, 2012, TISSUE ENG PT A, V18, P2497, DOI [10.1089/ten.TEA.2011.0711, 10.1089/ten.tea.2011.0711]
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   Wilhelm C, 2002, LANGMUIR, V18, P8148, DOI 10.1021/la0257337
   Xing Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04706
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Zhang JH, 2014, J MATER CHEM B, V2, P7583, DOI 10.1039/c4tb01063a
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
   Zhou L, 2012, ACS APPL MATER INTER, V4, P192, DOI 10.1021/am201649b
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 52
TC 23
Z9 24
U1 14
U2 105
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 23
PY 2015
VL 7
IS 37
BP 20987
EP 20998
DI 10.1021/acsami.5b06939
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CS2WB
UT WOS:000361931600058
PM 26360342
DA 2018-10-20
ER

PT J
AU Bartunek, J
   Vanderheyden, M
   Behfar, A
AF Bartunek, Jozef
   Vanderheyden, Marc
   Behfar, Atta
TI Integrate and boost: bioscaffolds nurture the cardiac regenerative
   paradigm
SO STEM CELL RESEARCH & THERAPY
LA English
DT Editorial Material
ID MESENCHYMAL STEM-CELLS; MYOCARDIAL-INFARCTION; HEART-FAILURE; TRIAL;
   MEDICINE; THERAPY
AB The traditional cardiac regenerative paradigm using non-modified adult stem cells with various routes of delivery into the myocardial target has thus far yielded unconvincing clinical outcomes. Besides factors related to heterogeneity in trial methodology, inter-patient variability and the rare incidence of adult stem cells with intrinsic repair potency underscore the importance of further optimization and standardization of regenerative platforms. Cardiac tissue engineering seizing upon the advances of cellular, molecular, and biomaterial development is shaping the next generation of the regenerative paradigm and thereby fostering disruptive curative treatments in heart failure.
C1 [Bartunek, Jozef; Vanderheyden, Marc] Onze Lieve Vrouw Hosp, Cardiovasc Ctr, B-9300 Aalst, Belgium.
   [Behfar, Atta] Mayo Clin, Div Cardiovasc Dis, Ctr Regenerat Med, Rochester, MN 55902 USA.
RP Bartunek, J (reprint author), Onze Lieve Vrouw Hosp, Cardiovasc Ctr, Moorselbaan 164, B-9300 Aalst, Belgium.
EM jozef.bartunek@olvz-aalst.be
CR Assmus B, 2013, JAMA-J AM MED ASSOC, V309, P1622, DOI 10.1001/jama.2013.3527
   Bartunek J, 2009, CLIN PHARMACOL THER, V85, P548, DOI 10.1038/clpt.2008.295
   Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9
   Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066
   Christman KL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004565
   Galvez-Monton C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0101-6
   Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
NR 10
TC 0
Z9 0
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD SEP 23
PY 2015
VL 6
AR 183
DI 10.1186/s13287-015-0184-0
PG 3
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA CS3BS
UT WOS:000361946700001
PM 26395766
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yan, D
   Wang, B
   Sun, SQ
   Feng, X
   Jin, Y
   Yao, XP
   Cao, SZ
   Guo, HC
AF Yan, Dan
   Wang, Bin
   Sun, Shiqi
   Feng, Xia
   Jin, Ye
   Yao, Xueping
   Cao, Suizhong
   Guo, Huichen
TI Quantum Dots Encapsulated with Canine Parvovirus-Like Particles
   Improving the Cellular Targeted Labeling
SO PLOS ONE
LA English
DT Article
ID VIRUS-LIKE PARTICLES; DRUG-DELIVERY; NANOPARTICLES; SINGLE; CELLS;
   INDUCTION; STABILITY; VESICLES; TRACKING; LIGANDS
AB Quantum dots (QDs) have a promising prospect in live-cell imaging and sensing because of unique fluorescence features. QDs aroused significant interest in the bio-imaging field through integrating the fluorescence properties of QDs and the delivery function of biomaterial. The natural tropism of Canine Parvovirus (CPV) to the transferrin receptor can target specific cells to increase the targeting ability of QDs in cell imaging. CPV virus-like particles (VLPs) from the expression of the CPV-VP2 capsid protein in a prokaryotic expression system were examined to encapsulate the QDs and deliver to cells with an expressed transferrin receptor. CPV-VLPs were used to encapsulate QDs that were modified using 3-mercaptopropionic acid. Gel electrophoresis, fluorescence spectrum, particle size, and transmission electron microscopy verified the conformation of a complex, in which QDs were encapsulated in CPV-VLPs (CPV-VLPs-QDs). When incubated with different cell lines, CPV-VLPs-QDs significantly reduced the cytotoxicity of QDs and selectively labeled the cells with high-level transferrin receptors. Cell-targeted labeling was achieved by utilizing the specific binding between the CPV capsid protein VP2 of VLPs and cellular receptors. CPV-VLPs-QDs, which can mimic the native CPV infection, can recognize and attach to the transferrin receptors on cellular membrane. Therefore, CPV-VLPs can be used as carriers to facilitate the targeted delivery of encapsulated nanomaterials into cells via receptor-mediated pathways. This study confirmed that CPV-VLPs can significantly promote the biocompatibility of nanomaterials and could expand the application of CPV-VLPs in biological medicine.
C1 [Yan, Dan; Wang, Bin; Sun, Shiqi; Feng, Xia; Jin, Ye; Guo, Huichen] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China.
   [Yan, Dan; Wang, Bin; Sun, Shiqi; Feng, Xia; Jin, Ye; Guo, Huichen] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, Lanzhou 730046, Gansu, Peoples R China.
   [Wang, Bin; Yao, Xueping; Cao, Suizhong] Sichuan Agr Univ, Coll Vet Med, Chengdu 611130, Sichuan, Peoples R China.
RP Sun, SQ (reprint author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Xujiaping 1, Lanzhou 730046, Gansu, Peoples R China.
EM sunshiqi@caas.cn; ghch-2004@hotmail.com
FU International Science & Technology Cooperation Program of China
   [2014DFA31890]; National Science and Technology Support Program
   [2013BAD12B00]; "Twelfth Five-Year" National Science and technology
   program [2011AA10A211]
FX International Science & Technology Cooperation Program of China
   (No.2014DFA31890), the National Science and Technology Support Program
   (2013BAD12B00), and the "Twelfth Five-Year" National Science and
   technology program in rural areas (2011AA10A211).
CR Adamczak M, 2012, COLLOID SURFACE B, V90, P211, DOI 10.1016/j.colsurfb.2011.10.028
   Anderson RE, 2008, ACS NANO, V2, P1341, DOI 10.1021/nn700450g
   Bottrill M, 2011, CHEM COMMUN, V47, P7039, DOI 10.1039/c1cc10692a
   Brasch M, 2011, J AM CHEM SOC, V133, P6878, DOI 10.1021/ja110752u
   Byers RJ, 2011, PROG HISTOCHEM CYTO, V45, P201, DOI 10.1016/j.proghi.2010.11.001
   Charoenphol P, 2014, ACTA BIOMATER, V10, P1683, DOI 10.1016/j.actbio.2013.07.021
   Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006
   Delehanty JB, 2006, BIOCONJUGATE CHEM, V17, P920, DOI 10.1021/bc060044i
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Gao JH, 2010, CURR TOP MED CHEM, V10, P1147, DOI 10.2174/156802610791384162
   Geszke-Moritz M, 2013, MAT SCI ENG C-MATER, V33, P1008, DOI 10.1016/j.msec.2013.01.003
   He L, 2013, ACS NANO, V7, P8447, DOI 10.1021/nn4017839
   Ho YP, 2010, NANOSCALE, V2, P60, DOI 10.1039/b9nr00178f
   Howarth M, 2008, NAT METHODS, V5, P397, DOI [10.1038/nmeth.1206, 10.1038/NMETH.1206]
   Joo KI, 2008, ACS NANO, V2, P1553, DOI 10.1021/nn8002136
   Kairdolf BA, 2013, ANNU REV ANAL CHEM, V6, P143, DOI 10.1146/annurev-anchem-060908-155136
   Kaji N, 2007, ANAL SCI, V23, P21, DOI 10.2116/analsci.23.21
   Lee YK, 2012, J NUCL MED, V53, P1462, DOI 10.2967/jnumed.111.092759
   Li F, 2009, SMALL, V5, P718, DOI 10.1002/smll.200801303
   Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008
   Lipin DI, 2008, ARCH VIROL, V153, P2027, DOI 10.1007/s00705-008-0220-9
   Liu JH, 2012, CURR DRUG METAB, V13, P1046, DOI 10.2174/138920012802850083
   Lockney DM, 2011, BIOCONJUGATE CHEM, V22, P67, DOI 10.1021/bc100361z
   Lucon J, 2012, NAT CHEM, V4, P781, DOI [10.1038/NCHEM.1442, 10.1038/nchem.1442]
   Mukthavaram R, 2011, BIOCONJUGATE CHEM, V22, P1638, DOI 10.1021/bc200201e
   Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]
   Pokorski JK, 2011, CHEMBIOCHEM, V12, P2441, DOI 10.1002/cbic.201100469
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Ren SC, 2013, PROSTATE, V73, P1591, DOI 10.1002/pros.22709
   Rzigalinski BA, 2009, TOXICOL APPL PHARM, V238, P280, DOI 10.1016/j.taap.2009.04.010
   Sanchez-Rodriguez SP, 2012, BIOCHIMIE, V94, P870, DOI 10.1016/j.biochi.2011.12.006
   Santra S, 2012, NANOMEDICINE-UK, V7, P623, DOI [10.2217/NNM.12.45, 10.2217/nnm.12.45]
   Shao LJ, 2011, SENSORS-BASEL, V11, P11736, DOI 10.3390/s111211736
   Shi YF, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-115
   Singh P, 2009, CURR TOP MICROBIOL, V327, P123
   Singh Pratik, 2006, J Nanobiotechnology, V4, P2, DOI 10.1186/1477-3155-4-2
   Tan WB, 2005, J BIOMED MATER RES A, V75A, P56, DOI 10.1002/jbm.a.30410
   Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848
   Valizadeh A, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-480
   Veeranarayanan S, 2012, INT J NANOMED, V7, P3769, DOI 10.2147/IJN.S31310
   Wang TJ, 2011, NANOSCALE, V3, P4275, DOI 10.1039/c1nr10568j
   Wen L, 2014, BIOMATERIALS, V35, P2295, DOI 10.1016/j.biomaterials.2013.11.069
   Xu JM, 2012, J PHYS CHEM B, V116, P11370, DOI 10.1021/jp306453y
   Xu J, 2014, APPL MICROBIOL BIOT, V98, P3529, DOI 10.1007/s00253-013-5485-6
   Ye F, 2014, BIOMATERIALS, V35, P3885, DOI 10.1016/j.biomaterials.2014.01.041
   Yin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063500
   Zhang Y, 2012, ACS NANO, V6, P3695, DOI 10.1021/nn301218z
   Zhao QH, 2011, BIOCONJUGATE CHEM, V22, P346, DOI 10.1021/bc1002532
   Zhou WB, 2011, ACS NANO, V5, P8013, DOI 10.1021/nn2024896
   Zhu YQ, 2014, ACS NANO, V8, P6644, DOI 10.1021/nn502386j
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
NR 51
TC 8
Z9 8
U1 1
U2 41
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2015
VL 10
IS 9
AR e0138883
DI 10.1371/journal.pone.0138883
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS1BM
UT WOS:000361797500123
PM 26398132
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Liang, KN
   Gao, Y
   Li, JS
   Liao, Y
   Xiao, SM
   Zhou, XD
   Li, JY
AF Liang, Kunneng
   Gao, Yuan
   Li, Jianshu
   Liao, Ying
   Xiao, Shimeng
   Zhou, Xuedong
   Li, Jiyao
TI Biomimetic mineralization of collagen fibrils induced by
   amine-terminated PAMAM dendrimers - PAMAM dendrimers for
   remineralization
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE collagen fibrils; biomimetic mineralization; biomaterial;
   amine-terminated PAMAM dendrimer; intrafibrillar mineralization
ID IN-VITRO; CALCIUM-CARBONATE; GALLA-CHINENSIS; ENAMEL LESIONS; DENTIN;
   HYDROXYAPATITE; NUCLEATION; BIOMINERALIZATION; PERSPECTIVE; INHIBITION
AB Objective: Achieving biomimetic mineralization of collagen fibrils by mimicking the role of non-collagenous proteins (NCPs) with biomimetic analogs is of great interest in the fields of material science and stomatology. Amine-terminated PAMAM dendrimer (PAMAM-NH2), which possesses a highly ordered architecture and many calcium coordination sites, may be a desirable template for simulating NCPs to induce mineralization of collagen fibrils. In this study, we focused on the ability of PAMAM-NH2 to mineralize collagen fibrils. Design: Type-I collagen fibrils were reconstituted over 400-mesh formvar-and-carbon-coated gold grids and treated with a third-generation PAMAM-NH2 (G3-PAMAM-NH2) solution. The treated collagen fibrils were immersed in artificial saliva for different lengths of time. The morphologies of the mineralized reconstituted type-I collagen fibrils were characterized by transmission electron microscopy. Results: No obvious mineralized collagen fibrils were detected in the control group. On the contrary, collagen fibrils were heavily mineralized in the experimental group. Most importantly, intrafibrillar mineralization was achieved within the reconstituted type-I collagen fibrils. Conclusions: In this study, we successfully induced biomimetic mineralization within type-I collagen fibrils using G3-PAMAM-NH2. This strategy may serve as a potential therapeutic technique for restoring completely demineralized collagenous mineralized tissues.
C1 [Liang, Kunneng; Gao, Yuan; Liao, Ying; Xiao, Shimeng; Zhou, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Liang, Kunneng; Gao, Yuan; Liao, Ying; Zhou, Xuedong; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu 610041, Sichuan, Peoples R China.
   [Li, Jianshu] Sichuan Univ, Coll Polymer Sci & Engn, Dept Biomed Polymers & Artificial Organs, Chengdu 610065, Peoples R China.
RP Li, JY (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
EM kqnkjys@163.com
FU National Natural Science Foundation of China [81170958, 81400508,
   51073102]; Specialized Research Fund for the Doctoral Program of Higher
   Education of China [20100181110056, 20130181120125]; Sichuan Province
   Science and Technology support program [2011SZ0130]
FX This work was financially supported by the National Natural Science
   Foundation of China [grant number 81170958], [grant number 81400508],
   [grant number 51073102]; Specialized Research Fund for the Doctoral
   Program of Higher Education of China [grant number 20100181110056],
   [grant number 20130181120125]; Sichuan Province Science and Technology
   support program [grant number 2011SZ0130] is gratefully acknowledged.
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593
   Bertassoni LE, 2011, J BIOMECH, V44, P176, DOI 10.1016/j.jbiomech.2010.09.005
   Chen L, 2013, ARCH ORAL BIOL, V58, P975, DOI 10.1016/j.archoralbio.2013.03.008
   Cheng L, 2010, INT J ORAL SCI, V2, P15, DOI 10.4248/IJOS10019
   Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911
   Deng M, 2013, INT J ORAL SCI, V5, P103, DOI 10.1038/ijos.2013.31
   Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200
   Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6
   Gu LS, 2011, ACTA BIOMATER, V7, P268, DOI 10.1016/j.actbio.2010.07.036
   Guo B, 2012, INT J ORAL SCI, V4, P152, DOI 10.1038/ijos.2012.45
   Jee SS, 2010, ACTA BIOMATER, V6, P3676, DOI 10.1016/j.actbio.2010.03.036
   Landis WJ, 2006, J MATER CHEM, V16, P1495, DOI 10.1039/b505706j
   Li JH, 2013, BIOMATERIALS, V34, P6738, DOI 10.1016/j.biomaterials.2013.05.046
   Li YP, 2012, BIOMACROMOLECULES, V13, P49, DOI 10.1021/bm201070g
   Liang KN, 2015, MACROMOL MATER ENG, V300, P107, DOI 10.1002/mame.201400207
   Liang KN, 2014, RSC ADV, V4, P43496, DOI 10.1039/c4ra07100j
   Liu Y, 2011, BIOMATERIALS, V32, P1291, DOI 10.1016/j.biomaterials.2010.10.018
   Liu Y, 2011, ADV MATER, V23, P975, DOI 10.1002/adma.201003882
   Lungu A, 2009, DIG J NANOMATER BIOS, V4, P97
   LUSSI A, 1988, ARCH ORAL BIOL, V33, P685, DOI 10.1016/0003-9969(88)90124-0
   Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014
   Niu LN, 2014, DENT MATER, V30, P77, DOI 10.1016/j.dental.2013.07.013
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X
   Sauro S, 2013, J BIOMAT SCI-POLYM E, V24, P940, DOI 10.1080/09205063.2012.727377
   Sear RP, 2012, INT MATER REV, V57, P328, DOI 10.1179/1743280411Y.0000000015
   Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839
   Sun Y, 2011, CELLS TISSUES ORGANS, V194, P199, DOI 10.1159/000324672
   Svenson S., 2012, ADV DRUG DELIVERY RE, V64, P102, DOI DOI 10.1016/J.ADDR.2012.09.030
   TENCATE JM, 1982, CARIES RES, V16, P201, DOI 10.1159/000260599
   Thula TT, 2011, ACTA BIOMATER, V7, P3158, DOI 10.1016/j.actbio.2011.04.014
   Thula TT, 2011, POLYMERS-BASEL, V3, P10, DOI 10.3390/polym3010010
   Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200
   Tsiourvas D, 2011, J AM CERAM SOC, V94, P2023, DOI 10.1111/j.1551-2916.2010.04342.x
   Wang ZJ, 2011, J DENT, V39, P746, DOI 10.1016/j.jdent.2011.08.006
   Weiner JMLAS, 2011, CELLS TISSUES ORGANS, V194, P92
   Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001
   Wu D, 2013, BIOMATERIALS, V34, P5036, DOI 10.1016/j.biomaterials.2013.03.053
   Xu HHK, 2011, DENT MATER, V27, P762, DOI 10.1016/j.dental.2011.03.016
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
   Zhou ZH, 2007, MATER RES BULL, V42, P1611, DOI 10.1016/j.materresbull.2006.11.041
NR 44
TC 11
Z9 12
U1 3
U2 57
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD SEP 22
PY 2015
VL 26
IS 14
BP 963
EP 974
DI 10.1080/09205063.2015.1068606
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA CP0ZP
UT WOS:000359605900005
PM 26140519
DA 2018-10-20
ER

PT J
AU Hasan, A
   Pandey, LM
AF Hasan, Abshar
   Pandey, Lalit M.
TI Review: Polymers, Surface-Modified Polymers, and Self Assembled
   Monolayers as Surface-Modifying Agents for Biomaterials
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Review
DE Biocompatibility; Cell adhesion; Polymers; Protein adsorption; Self
   assembled monolayers; Wettability
ID TRANSFER RADICAL POLYMERIZATION; ENHANCED BLOOD COMPATIBILITY; PLASMA
   GLOW-DISCHARGE; POLY(ETHYLENE OXIDE)-GRAFTED POLYURETHANE; DENDRITIC
   POLYGLYCEROL DERIVATIVES; WEIGHT HYPERBRANCHED POLYGLYCEROLS;
   NONSPECIFIC PROTEIN ADSORPTION; LOW-DENSITY POLYETHYLENE; BOVINE
   SERUM-ALBUMIN; LOW-PRESSURE PLASMA
AB Biocompatibility and nontoxicity of biomaterials are of utmost importance when foreign bodies come in contact with a biological system. Irrespective of the nature of material, nonspecific protein adsorption is the first process observed at surface-biological system interfaces followed by cellular processes. Nonspecific protein adsorption leads to deleterious cellular processes such as biofouling and finally immunological host response. Hence, surface modification becomes mandatory for preventing undesirable implant failure and inflammatory responses. Various polymers, surface-modified polymers and surfaces withself assembled monolayers, have been tested to tune surface properties for a given application. Surface functional groups and surface structures of polymers and copolymers regulate surface hydrophobicity, nonspecific protein adsorption, biomaterial stability, and antifouling property, etc. Self assembled monolayers are formed by covalent linkage with more controlled surface structure and smoothness. Mixed and hybrid self assembled monolayers containing both hydrophilic and hydrophobic groups result in moderate wettability. Further, we have discussed different methods of surface modification using polymers, modified polymers, and self assembled monolayers for improved surface biocompatibility and nonfouling properties.
C1 [Hasan, Abshar; Pandey, Lalit M.] Indian Inst Technol, Dept Biotechnol, Gauhati 781039, India.
RP Pandey, LM (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Gauhati 781039, India.
EM abshar@iitg.ernet.in; lalitpandey@iitg.ernet.in
OI Pandey, Lalit/0000-0002-1664-5730
CR Abate AR, 2008, LAB CHIP, V8, P516, DOI 10.1039/b800001h
   Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Alexander A, 2013, J CONTROL RELEASE, V172, P715, DOI 10.1016/j.jconrel.2013.10.006
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Archambault JG, 2004, COLLOID SURFACE B, V39, P9, DOI 10.1016/j.colsurfb.2004.08.009
   Arefi-Khonsari F, 2001, SURF COAT TECH, V142, P437, DOI 10.1016/S0257-8972(01)01240-3
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Bain C. D., 1989, ANGEW CHEM, V101, P522
   BAIN CD, 1988, J AM CHEM SOC, V110, P5897, DOI 10.1021/ja00225a050
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195
   Bolbasov EN, 2014, MATER LETT, V132, P281, DOI 10.1016/j.matlet.2014.06.115
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Calderon M, 2010, BIOCHIMIE, V92, P1242, DOI 10.1016/j.biochi.2010.02.017
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Cao ZQ, 2012, NANO TODAY, V7, P404, DOI 10.1016/j.nantod.2012.08.001
   Carneiro LB, 2011, APPL SURF SCI, V257, P10514, DOI 10.1016/j.apsusc.2011.07.031
   Casiano-Maldonado M, 2013, INT J MASS SPECTROM, V354, P391, DOI 10.1016/j.ijms.2013.08.007
   Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   CHAUDHURY MK, 1991, LANGMUIR, V7, P1013, DOI 10.1021/la00053a033
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen NP, 2002, POLYMER, V43, P1429, DOI 10.1016/S0032-3861(01)00671-1
   Chen YS, 2013, APPL SURF SCI, V265, P452, DOI 10.1016/j.apsusc.2012.11.027
   CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
   Chien HW, 2013, COLLOID SURFACE B, V107, P152, DOI 10.1016/j.colsurfb.2013.01.071
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Christenson EM, 2005, J BIOMED MATER RES A, V73A, P108, DOI 10.1002/jbm.a.30271
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   CHUPA JA, 1993, J AM CHEM SOC, V115, P4383, DOI 10.1021/ja00063a075
   Chuysinuan P, 2012, ACS APPL MATER INTER, V4, P3031, DOI 10.1021/am300404v
   Ciampi S, 2007, LANGMUIR, V23, P9320, DOI 10.1021/la701035g
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CLAESSON PM, 1987, J COLLOID INTERF SCI, V117, P366, DOI 10.1016/0021-9797(87)90395-X
   Coad BR, 2012, ACTA BIOMATER, V8, P608, DOI 10.1016/j.actbio.2011.10.006
   COSTELLO BAD, 1993, J COLLOID INTERF SCI, V156, P72
   Cuggino JC, 2011, SOFT MATTER, V7, P11259, DOI 10.1039/c1sm06357j
   Damodaran VB, 2010, APPL SURF SCI, V256, P4894, DOI 10.1016/j.apsusc.2010.02.088
   DAVIES WL, 1972, J PHARM SCI, V61, P618, DOI 10.1002/jps.2600610428
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Dernedde J, 2010, P NATL ACAD SCI USA, V107, P19679, DOI 10.1073/pnas.1003103107
   DEVANATHAN T, 1981, BIOMATER ARTIF CELL, V9, P225, DOI 10.3109/10731198109119002
   Dey P, 2014, ACS APPL MATER INTER, V6, P8937, DOI 10.1021/am502018x
   Dicke C, 2002, J AM CHEM SOC, V124, P12619, DOI 10.1021/ja027447n
   Ding X, 2012, BIOMATERIALS, V33, P6593, DOI 10.1016/j.biomaterials.2012.06.001
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Eddington DT, 2006, SENSOR ACTUAT B-CHEM, V114, P170, DOI 10.1016/j.snb.2005.04.037
   Ekinci D, 2012, J MATER CHEM, V22, P21100, DOI [10.1039/c2jm34271, 10.1039/c2jm34271e]
   Farhat S, 2014, SURF COAT TECH, V241, P123, DOI 10.1016/j.surfcoat.2013.10.077
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Florence AT, 2006, PHYSICOCHEMICAL PRIN
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   Fryxell GE, 1996, LANGMUIR, V12, P5064, DOI 10.1021/la9506842
   Glodek J, 2002, SENSOR ACTUAT B-CHEM, V83, P82, DOI 10.1016/S0925-4005(01)01048-6
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   GORDIENOK NI, 1986, ZH PRIKL KHIM, V59, P1549
   Guillemette MD, 2011, ACTA BIOMATER, V7, P2492, DOI 10.1016/j.actbio.2011.02.019
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   Guo Z, 2009, APPL SURF SCI, V255, P6771, DOI 10.1016/j.apsusc.2009.02.034
   Gupta T, 2008, ANGEW CHEM INT EDIT, V47, P2260, DOI 10.1002/anie.200705841
   Guruvenket S, 2004, APPL SURF SCI, V236, P278, DOI 10.1016/j.apsusc.2004.04.033
   Haag R, 2000, MACROMOLECULES, V33, P8158, DOI 10.1021/ma000831p
   Haensch C, 2008, LANGMUIR, V24, P12981, DOI 10.1021/la8026682
   Haensch C, 2010, CHEM SOC REV, V39, P2323, DOI 10.1039/b920491a
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Han S, 1997, POLYMER, V38, P317, DOI 10.1016/S0032-3861(97)88175-X
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hayama M, 2004, J MEMBRANE SCI, V234, P41, DOI 10.1016/j.memsci.2004.01.020
   Heise A, 1998, THIN SOLID FILMS, V327, P199, DOI 10.1016/S0040-6090(98)00628-2
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Hillborg H, 1999, IEEE T DIELECT EL IN, V6, P703, DOI 10.1109/94.798127
   Himmelhaus M, 2003, EUROPHYS LETT, V64, P378, DOI 10.1209/epl/i2003-00205-7
   Hu XF, 2014, ACTA BIOMATER, V10, P3497, DOI 10.1016/j.actbio.2014.04.032
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Inoue Y, 2013, LANGMUIR, V29, P10752, DOI 10.1021/la4021492
   Inoue Y, 2010, COLLOID SURFACE B, V81, P350, DOI 10.1016/j.colsurfb.2010.07.030
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   JOHNSTON DS, 1980, BIOCHIM BIOPHYS ACTA, V602, P57, DOI 10.1016/0005-2736(80)90289-8
   Junkar I, 2009, VACUUM, V84, P83, DOI 10.1016/j.vacuum.2009.04.011
   Kainthan RK, 2007, BIOMATERIALS, V28, P4779, DOI 10.1016/j.biomaterials.2007.07.046
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   Kang IK, 1997, BIOMATERIALS, V18, P1099, DOI 10.1016/S0142-9612(97)00035-5
   Kang IK, 2001, J BIOMAT SCI-POLYM E, V12, P1091, DOI 10.1163/15685620152691878
   KATO M, 1995, MACROMOLECULES, V28, P1721, DOI 10.1021/ma00109a056
   Khandare J, 2010, BIOMATERIALS, V31, P4268, DOI 10.1016/j.biomaterials.2010.02.001
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Kim MC, 2009, REACT FUNCT POLYM, V69, P287, DOI 10.1016/j.reactfunctpolym.2009.01.013
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   KISS E, 1990, COLLOID SURFACE, V49, P335, DOI 10.1016/0166-6622(90)80114-J
   Klajnert B, 2003, BBA-PROTEINS PROTEOM, V1648, P115, DOI 10.1016/S1570-9639(03)00117-1
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kondyurina I, 2014, APPL SURF SCI, V314, P670, DOI 10.1016/j.apsusc.2014.07.057
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   KUHL TL, 1994, BIOPHYS J, V66, P1479, DOI 10.1016/S0006-3495(94)80938-5
   Kull KR, 2005, J MEMBRANE SCI, V246, P203, DOI 10.1016/j.memsci.2004.08.019
   Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee HJ, 2000, COLLOID SURFACE B, V18, P355, DOI 10.1016/S0927-7765(99)00161-7
   Lee HU, 2008, APPL SURF SCI, V254, P5700, DOI 10.1016/j.apsusc.2008.03.049
   Lee HU, 2011, POLYM DEGRAD STABIL, V96, P1204, DOI 10.1016/j.polymdegradstab.2011.04.012
   Lee J, 2005, MACROMOL BIOSCI, V5, P1085, DOI 10.1002/mabi.200500146
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Lee SW, 1998, BIOMATERIALS, V19, P1669, DOI 10.1016/S0142-9612(98)00044-1
   Lee WH, 2014, COLLOID SURFACE B, V122, P823, DOI 10.1016/j.colsurfb.2014.07.029
   Li L, 2009, J APPL POLYM SCI, V111, P1942, DOI 10.1002/app.29204
   Li LL, 2010, J MEMBRANE SCI, V349, P56, DOI 10.1016/j.memsci.2009.11.018
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Li R, 2014, APPL SURF SCI, V301, P300, DOI 10.1016/j.apsusc.2014.02.068
   Li SS, 2013, J COLLOID INTERF SCI, V402, P284, DOI 10.1016/j.jcis.2013.04.003
   Li ZF, 2004, J COLLOID INTERF SCI, V269, P62, DOI 10.1016/S0021-9797(03)00606-4
   Lin JH, 2014, LANGMUIR, V30, P10328, DOI 10.1021/la5020362
   Liu PS, 2010, J MEMBRANE SCI, V350, P387, DOI 10.1016/j.memsci.2010.01.015
   Liu PS, 2009, BIOMACROMOLECULES, V10, P2809, DOI 10.1021/bm9006503
   Liu PS, 2013, MAT SCI ENG C-MATER, V33, P3865, DOI 10.1016/j.msec.2013.05.025
   Liu XL, 2013, MACROMOL BIOSCI, V13, P147, DOI 10.1002/mabi.201200269
   Liu XL, 2012, LANGMUIR, V28, P9451, DOI 10.1021/la300728j
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu ZF, 2002, J CONTROL RELEASE, V81, P91, DOI 10.1016/S0168-3659(02)00048-2
   Liu ZM, 2004, EUR POLYM J, V40, P2077, DOI 10.1016/j.eurpolymj.2004.05.020
   Long LX, 2014, MATER CHEM PHYS, V143, P929, DOI 10.1016/j.matchemphys.2013.09.041
   Lu F, 2011, INT J PHARMACEUT, V419, P77, DOI 10.1016/j.ijpharm.2011.07.020
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Malek C. K., 2007, SENSOR ACTUAT B-CHEM, V120, P719
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Menzies DJ, 2012, SURF SCI, V606, P1798, DOI 10.1016/j.susc.2012.07.017
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   Nagata H, 2006, J AM CERAM SOC, V89, P2816, DOI [10.1111/j.1551-2916-2006.01137.x, 10.1111/j.1551-2916.2006.01137.x]
   Neghlani PK, 2011, J HAZARD MATER, V186, P182, DOI 10.1016/j.jhazmat.2010.10.121
   Nisol B, 2014, SURF COAT TECH, V252, P126, DOI 10.1016/j.surfcoat.2014.04.056
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   Ostaci RV, 2008, LANGMUIR, V24, P2732, DOI 10.1021/la703086x
   Pandey LM, 2013, J CHEM ENG DATA, V58, P3440, DOI 10.1021/je400712k
   Pandey LM, 2013, J PHYS CHEM C, V117, P6151, DOI 10.1021/jp309483p
   Pandey LM, 2013, APPL SURF SCI, V264, P832, DOI 10.1016/j.apsusc.2012.10.150
   Pandey LM, 2012, COLLOID SURFACE B, V100, P69, DOI 10.1016/j.colsurfb.2012.05.022
   Pandey LM, 2011, APPL SURF SCI, V257, P4731, DOI 10.1016/j.apsusc.2010.12.148
   Pandiyaraj KN, 2014, MAT SCI ENG C-MATER, V36, P309, DOI 10.1016/j.msec.2013.12.018
   Peng Q, 2007, MACROMOL BIOSCI, V7, P1149, DOI 10.1002/mabi.200700068
   Perrino C, 2008, LANGMUIR, V24, P8850, DOI 10.1021/la800947z
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Popelka A, 2014, VACUUM, V100, P53, DOI 10.1016/j.vacuum.2013.07.016
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Qin JJ, 2004, SEP PURIF TECHNOL, V36, P149, DOI 10.1016/S1383-5866(03)00210-7
   Ran F, 2011, ACTA BIOMATER, V7, P3370, DOI 10.1016/j.actbio.2011.05.026
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Recek N, 2014, INT J POLYM MATER PO, V63, P685, DOI 10.1080/00914037.2013.854243
   Reimer K, 2000, DERMATOLOGY, V201, P235, DOI 10.1159/000018494
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016
   Sanchis MR, 2006, EUR POLYM J, V42, P1558, DOI 10.1016/j.eurpolymj.2006.02.001
   Sarapirom S, 2014, APPL SURF SCI, V310, P42, DOI 10.1016/j.apsusc.2014.03.141
   Sawoo S, 2008, CHEM COMMUN, P5957, DOI 10.1039/b813296h
   Shabat S. B., 2006, MACROMOL BIOSCI, V6, P1019
   SHENG Q, 1995, J PHYS CHEM-US, V99, P11018, DOI 10.1021/j100027a050
   Shukla AD, 2005, ANGEW CHEM INT EDIT, V44, P3237, DOI 10.1002/anie.200461958
   Sibarani J, 2007, COLLOID SURFACE B, V54, P88, DOI 10.1016/j.colsurfb.2006.09.024
   Siegers C, 2004, CHEM-EUR J, V10, P2831, DOI 10.1002/chem.200306073
   Sisson AL, 2010, SOFT MATTER, V6, P4968, DOI 10.1039/c0sm00149j
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Slepicka P, 2012, POLYM DEGRAD STABIL, V97, P1075, DOI 10.1016/j.polymdegradstab.2012.04.013
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Srinivasan S, 2012, APPL SURF SCI, V258, P8094, DOI 10.1016/j.apsusc.2012.04.178
   Srinivasan V, 2004, ANAL CHIM ACTA, V507, P145, DOI 10.1016/j.aca.2003.12.030
   Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z
   Sui Y, 2012, J MEMBRANE SCI, V394, P107, DOI 10.1016/j.memsci.2011.12.038
   Sun C, 2013, ELECTROCHIM ACTA, V89, P549, DOI 10.1016/j.electacta.2012.11.005
   Sun MC, 2014, COLLOID SURFACE B, V122, P134, DOI 10.1016/j.colsurfb.2014.06.041
   Sun Q, 2006, J MEMBRANE SCI, V285, P299, DOI 10.1016/j.memsci.2006.08.035
   Sun XF, 2008, ELECTROPHORESIS, V29, P2760, DOI 10.1002/elps.200800005
   Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w
   Sunder A, 2000, MACROMOLECULES, V33, P309, DOI 10.1021/ma991191x
   Szmigiel D, 2006, APPL SURF SCI, V253, P1506, DOI 10.1016/j.apsusc.2006.02.027
   Taha AA, 2012, J ENVIRON SCI-CHINA, V24, P610, DOI 10.1016/S1001-0742(11)60806-1
   Takahashi N., 2003, NO SHINKEI GEKA, V10, P1081
   Talarico T, 1998, BIOCHEM BIOPH RES CO, V250, P354, DOI 10.1006/bbrc.1998.9312
   Taylor JD, 2009, ANAL CHEM, V81, P1146, DOI 10.1021/ac8023137
   Telford AM, 2010, ACS APPL MATER INTER, V2, P2399, DOI 10.1021/am100406j
   Tijink MSL, 2012, ACTA BIOMATER, V8, P2279, DOI 10.1016/j.actbio.2012.03.008
   Tria MCR, 2010, BIOMACROMOLECULES, V11, P3422, DOI 10.1021/bm1009365
   Tsukagoshi T, 2007, COLLOID SURFACE B, V55, P19, DOI 10.1016/j.colsurfb.2006.10.038
   Tsukagoshi T, 2007, COLLOID SURFACE B, V54, P94, DOI 10.1016/j.colsurfb.2006.10.005
   Tu Q, 2013, COLLOID SURFACE B, V102, P361, DOI 10.1016/j.colsurfb.2012.08.033
   Ukiwe C, 2005, J COLLOID INTERF SCI, V285, P760, DOI 10.1016/j.jcis.2004.12.027
   ul-Haq MI, 2012, BIOMATERIALS, V33, P9135, DOI 10.1016/j.biomaterials.2012.09.007
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   Vestberg R, 2007, J POLYM SCI POL CHEM, V45, P2835, DOI 10.1002/pola.22178
   Wan LS, 2005, POLYMER, V46, P7715, DOI 10.1016/j.polymer.2005.05.147
   Wang AJ, 2006, TALANTA, V69, P210, DOI 10.1016/j.talanta.2005.09.029
   Wang HT, 2009, FIBER POLYM, V10, P1, DOI 10.1007/s12221-009-0001-4
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   Wang PP, 2012, LANGMUIR, V28, P4776, DOI 10.1021/la203494z
   Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   Wentrup-Byrne E, 2005, POLYM INT, V54, P1581, DOI 10.1002/pi.1902
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilms D, 2010, ACCOUNTS CHEM RES, V43, P129, DOI 10.1021/ar900158p
   Wu DP, 2005, ELECTROPHORESIS, V26, P211, DOI 10.1002/elps.200406157
   Wu ZQ, 2009, LANGMUIR, V25, P2900, DOI 10.1021/la8037523
   Wyszogrodzka M, 2009, LANGMUIR, V25, P5703, DOI 10.1021/la803017b
   Wyszogrodzka M, 2009, BIOMACROMOLECULES, V10, P1043, DOI 10.1021/bm801093t
   Xiang T, 2014, J COLLOID INTERF SCI, V432, P47, DOI 10.1016/j.jcis.2014.06.044
   Xiang T, 2013, COLLOID SURFACE B, V110, P15, DOI 10.1016/j.colsurfb.2013.04.034
   Xu XH, 2007, J BIOACT COMPAT POL, V22, P195, DOI 10.1177/0883911507076454
   YAM CM, 1995, J CHEM SOC CHEM COMM, P907, DOI 10.1039/c39950000907
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang Q, 2007, LANGMUIR, V23, P6684, DOI 10.1021/la700275t
   Yang Y, 2014, MAT SCI ENG C-MATER, V45, P539, DOI 10.1016/j.msec.2014.10.010
   Yoshida S, 2013, SURF COAT TECH, V233, P99, DOI 10.1016/j.surfcoat.2013.02.042
   Yuan JA, 2004, COLLOID SURFACE B, V36, P27, DOI [10.1016/j.colsurfc.2004.03.017, 10.1016/j.colsurfb.2004.03.017]
   Yuan J, 2008, COLLOID SURFACE B, V66, P90, DOI 10.1016/j.colsurfb.2008.05.020
   Yue WW, 2013, J MEMBRANE SCI, V446, P79, DOI 10.1016/j.memsci.2013.06.029
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang F, 2002, BIOMATERIALS, V23, P787, DOI 10.1016/S0142-9612(01)00184-3
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   Zhang ZY, 2011, COLLOID SURFACE B, V88, P85, DOI 10.1016/j.colsurfb.2011.06.019
   Zhao GW, 2011, PLASMA SCI TECHNOL, V13, P230, DOI 10.1088/1009-0630/13/2/20
   Zhao J, 2011, J MEMBRANE SCI, V369, P5, DOI 10.1016/j.memsci.2010.10.046
   Zheng B, 2003, J AM CHEM SOC, V125, P11170, DOI 10.1021/ja037166v
   Zhou Y, 2007, J COLLOID INTERF SCI, V305, P62, DOI 10.1016/j.jcis.2006.09.058
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 260
TC 12
Z9 12
U1 8
U2 181
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD SEP 17
PY 2015
VL 54
IS 13
BP 1358
EP 1378
DI 10.1080/03602559.2015.1021488
PG 21
WC Polymer Science
SC Polymer Science
GA CV0QP
UT WOS:000363956500005
DA 2018-10-20
ER

PT J
AU Hizal, F
   Zhuk, I
   Sukhishvili, S
   Busscher, HJ
   van der Mei, HC
   Choi, CH
AF Hizal, Ferdi
   Zhuk, Iryna
   Sukhishvili, Svetlana
   Busscher, Henk J.
   van der Mei, Henny C.
   Choi, Chang-Hwan
TI Impact of 3D Hierarchical Nanostructures on the Antibacterial Efficacy
   of a Bacteria-Triggered Self-Defensive Antibiotic Coating
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterial; titanium; nanostructure; antibacterial coating; bacterial
   adhesion
ID STAPHYLOCOCCUS-AUREUS ADHESION; BY-LAYER FILMS; POLYELECTROLYTE
   MULTILAYERS; CONTROLLED-RELEASE; BIOFILM FORMATION; TIO2 NANOTUBES;
   TITANIUM; SURFACE; FABRICATION; GENTAMICIN
AB Titanium is often applied in implant surgery, but frequently implicated in infections associated with bacterial adhesion and growth on the implant surface. Here, we show that hierarchical nanostructuring of titanium and the subsequent coating of resulting topographical features with a self-defensive, antibacterial layer-by-layer (LbL) film enables a synergistic action of hierarchical nanotopography and localized, bacteria-triggered antibiotic release to dramatically enhance the antibacterial efficiency of surfaces. Although sole nanostructuring of titanium substrates did not significantly affect adhesion and growth of Staphylococcus aureus, the coating of 3D-nanopillared substrates with an ultrathin tannic acid/gentamicin (TA/G) LbL film resulted in a 10-fold reduction of the number of surface-attached bacteria. This effect is attributed to the enlarged surface area of the nanostructured coating available for localized bacteria-triggered release of antibiotics, as well as to the lower bacterial adhesion forces resulting in subsided activation of bacterial antibiotic-defense mechanisms when bacteria land on nanopillar tips. The result shows that a combination of 3D nanostructuring with a bacteria-triggered antibiotic-releasing coating presents a unique way to dramatically enhance antibacterial efficacy of biomaterial implants.
C1 [Hizal, Ferdi; Choi, Chang-Hwan] Stevens Inst Technol, Dept Mech Engn, Castle Point Hudson, Inst Technol, Hoboken, NJ 07030 USA.
   [Zhuk, Iryna; Sukhishvili, Svetlana] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Castle Point Hudson, Inst Technol, Hoboken, NJ 07030 USA.
   [Hizal, Ferdi; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn FB40, NL-9713 AV Groningen, Netherlands.
   [Hizal, Ferdi; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.
RP Choi, CH (reprint author), Stevens Inst Technol, Dept Mech Engn, Castle Point Hudson, Inst Technol, Hoboken, NJ 07030 USA.
EM cchoi@stevens.edu
FU Stevens Institute of Technology, Hoboken, NJ; University Medical Center
   Groningen, Groningen, The Netherlands
FX This research was funded by Stevens Institute of Technology, Hoboken,
   NJ, and the University Medical Center Groningen, Groningen, The
   Netherlands.
CR Aimi MF, 2004, NAT MATER, V3, P103, DOI 10.1038/nmat1058
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Balamuralidhara V., 2011, AM J DRUG DISCOV DEV, V1, P24, DOI DOI 10.3923/AJDD.2011.24.48
   Bos R, 2000, FEMS MICROBIOL LETT, V189, P311, DOI 10.1016/S0378-1097(00)00298-6
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Camesano TA, 2000, LANGMUIR, V16, P4563, DOI 10.1021/la990805o
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chuang HF, 2008, BIOMACROMOLECULES, V9, P1660, DOI 10.1021/bm800185h
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Hizal F., 2014, P 9 IEEE INT C NAN M, P17
   Ismail AF, 2012, INT J PHARM PHARM SC, V4, P685
   Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838
   Jeong CY, 2012, ACS APPL MATER INTER, V4, P842, DOI 10.1021/am201514n
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lim JH, 2007, SMALL, V3, P1504, DOI 10.1002/smll.200700114
   Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535
   Lv HB, 2014, J DENT, V42, P1464, DOI 10.1016/j.jdent.2014.06.003
   McEligoi D. M., 1970, INT J HEAT MASS TRAN, V13, P1641
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Muszanska AK, 2012, ANTIMICROB AGENTS CH, V56, P4961, DOI 10.1128/AAC.00431-12
   Neut D, 2003, ACTA ORTHOP SCAND, V74, P670, DOI 10.1080/00016470310018180
   Nguyen PM, 2007, CHEM MATER, V19, P5524, DOI 10.1021/cm070981f
   Pavlukhina S., 2002, ENCY POLYM SCI TECHN
   Perez-Jorge C, 2012, J BIOMED MATER RES A, V100A, P1696, DOI 10.1002/jbm.a.34118
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Shin HG, 2011, J NANOSCI NANOTECHNO, V11, P427, DOI 10.1166/jnn.2011.3286
   Tang PF, 2011, J NANOMATER, DOI 10.1155/2011/178921
   THITIYANAPORN C, 2013, SONGKLA J SCI TECHNO, V35, P293
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Yang LX, 2010, CHINESE SCI BULL, V55, P331, DOI 10.1007/s11434-009-0712-3
   Zhuk I, 2014, ACS NANO, V8, P7733, DOI 10.1021/nn500674g
NR 39
TC 31
Z9 32
U1 5
U2 121
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 16
PY 2015
VL 7
IS 36
BP 20304
EP 20313
DI 10.1021/acsami.5b05947
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CR7BA
UT WOS:000361501700052
PM 26305913
DA 2018-10-20
ER

PT J
AU Chen, MJ
   Lu, YQ
   Simpson, NE
   Beveridge, MJ
   Elshikha, AS
   Akbar, MA
   Tsai, HY
   Hinske, S
   Qin, JL
   Grunwitz, CR
   Chen, TN
   Brantly, ML
   Song, SH
AF Chen, Mong-Jen
   Lu, Yuanqing
   Simpson, Nicholas E.
   Beveridge, Mark J.
   Elshikha, Ahmed S.
   Akbar, Mohammad Ahsanul
   Tsai, Hsin-Yin
   Hinske, Stephanie
   Qin, Junling
   Grunwitz, Christian R.
   Chen, Tina
   Brantly, Mark L.
   Song, Sihong
TI In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues
   Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model
SO PLOS ONE
LA English
DT Article
ID HEPATOCYTE-LIKE CELLS; LIVER FIBROSIS; VIVO; DIFFERENTIATION; DISEASE;
   VITRO; MICROSPHERES; REPOPULATION; ENGRAFTMENT; GENERATION
AB Objective
   Adipose tissue derived stem cells (ADSCs) transplantation has recently gained widespread enthusiasm, particularly in the perspective to use them as potential alternative cell sources for hepatocytes in cell based therapy, mainly because of their capability of hepatogenic differentiation in vitro and in vivo. But some challenges remain to be addressed, including whether ADSCs can be provided effectively to the target organ and whether subsequent proliferation of transplanted cells can be achieved. To date, intrasplenic injection is the conventional method to deliver ADSCs into the liver; however, a number of donor cells retained in the spleen has been reported. In this study, our objective is to evaluate a novel route to transplant ADSCs specifically to the liver. We aimed to test the feasibility of in situ transplantation of ADSCs by injecting bioencapsulated ADSCs into the liver in mouse model.
   Methods
   The ADSCs isolated from human alpha 1 antitrypsin (M-hAAT) transgenic mice were used to allow delivered ADSCs be readily identified in the liver of recipient mice, and alginate was selected as a cell carrier. We first evaluated whether alginate microspheres are implantable into the liver tissue by injection and whether ADSCs could migrate from alginate microspheres (study one). Once proven, we then examined the in vivo fate of ADSCs loaded microspheres in the liver. Specifically, we evaluated whether transplanted, undifferentiated ASDCs could be induced by the local microenvironment toward hepatogenic differentiation and the distribution of surviving ADSCs in major tissue organs (study two).
   Results
   Our results indicated ADSCs loaded alginate microspheres were implantable into the liver. Both degraded and residual alginate microspheres were observed in the liver up to three weeks. The viable ADSCs were detectable surrounding degraded and residual alginate microspheres in the liver and other major organs such as bone marrow and the lungs. Importantly, transplanted ADSCs underwent hepatogenic differentiation to become cells expressing albumin in the liver. These findings improve our understanding of the interplay between ADSCs (donor cells), alginate (biomaterial), and local microenvironment in a hepatectomized mouse model, and might improve the strategy of in situ transplantation of ADSCs in treating liver diseases.
C1 [Chen, Mong-Jen; Lu, Yuanqing; Elshikha, Ahmed S.; Akbar, Mohammad Ahsanul; Tsai, Hsin-Yin; Hinske, Stephanie; Qin, Junling; Grunwitz, Christian R.; Chen, Tina; Song, Sihong] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA.
   [Simpson, Nicholas E.; Beveridge, Mark J.; Brantly, Mark L.] Univ Florida, Dept Med, Gainesville, FL USA.
RP Song, SH (reprint author), Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA.
EM shsong@ufl.edu
CR Allen KJ, 2004, J GASTROEN HEPATOL, V19, P1283, DOI 10.1111/j.1400-1746.2004.03451.x
   Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880
   Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704
   Chen MJ, 2014, HUM GENE THER METHOD, V25, P72, DOI 10.1089/hgtb.2013.011
   De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054
   Grompe M, 1999, Hum Cell, V12, P171
   Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959
   Jain E, 2014, HEPATOL INT, V8, P185, DOI 10.1007/s12072-013-9503-7
   Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058
   Joseph B, 2006, HEPATOLOGY, V44, P1411, DOI 10.1002/hep.21416
   KAHN D, 1984, J SURG RES, V37, P290, DOI 10.1016/0022-4804(84)90191-4
   Kim SJ, 2011, J KOREAN SURG SOC, V81, P176, DOI 10.4174/jkss.2011.81.3.176
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Li H, 2011, J HEPATOL, V54, P930, DOI 10.1016/j.jhep.2010.07.051
   Li KG, 2004, BIOTECHNOL LETT, V26, P879, DOI 10.1023/B:bile.0000025896.61490.6d
   Li YS, 2013, CELL TRANSPLANT, V22, P685, DOI 10.3727/096368912X655163
   Lin N, 2010, CELL PROLIFERAT, V43, P427, DOI 10.1111/j.1365-2184.2010.00692.x
   Meier RPH, 2015, J HEPATOL, V62, P634, DOI 10.1016/j.jhep.2014.10.030
   Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048
   Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9
   Moyer HR, 2010, ANN PLAS SURG, V65, P497, DOI 10.1097/SAP.0b013e3181d37713
   PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217
   Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046
   Sohni A, 2013, STEM CELLS INT, V2013, P8, DOI DOI 10.1155/2013/130763
   Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010
   Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7
   Sugii S, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.199
   Waelzlein JH, 2009, CURR OPIN NEPHROL HY, V18, P481, DOI 10.1097/MNH.0b013e3283318e1c
   Yao R, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025007
   Yin LB, 2015, MOL MED REP, V11, P1722, DOI 10.3892/mmr.2014.2935
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zhao YS, 2010, TISSUE ENG PART C-ME, V16, P653, DOI [10.1089/ten.tec.2009.0053, 10.1089/ten.TEC.2009.0053]
   Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270
NR 37
TC 6
Z9 6
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 15
PY 2015
VL 10
IS 9
AR e0138184
DI 10.1371/journal.pone.0138184
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR8LR
UT WOS:000361604400054
PM 26372641
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Beam, JC
   LeBlanc, G
   Gizzie, EA
   Ivanov, BL
   Needell, DR
   Shearer, MJ
   Jennings, GK
   Lukehart, CM
   Cliffel, DE
AF Beam, Jeremiah C.
   LeBlanc, Gabriel
   Gizzie, Evan A.
   Ivanov, Borislav L.
   Needell, David R.
   Shearer, Melinda J.
   Jennings, G. Kane
   Lukehart, Charles M.
   Cliffel, David E.
TI Construction of a Semiconductor Biological Interface for Solar Energy
   Conversion: p-Doped Silicon/Photosystem I/Zinc Oxide
SO LANGMUIR
LA English
DT Article
ID PHOTOSYSTEM-I; GOLD ELECTRODE; PHOTOCURRENT; COMPLEXES; PROTEIN; GROWTH;
   CELLS; ZNO
AB The interface between photoactive biological materials with two distinct semiconducting electrodes is challenging both to develop and analyze. Building off of our previous work using films of photosystem I (PSI) on p-doped silicon, we have deposited a crystalline zinc oxide (ZnO) anode using confined-plume chemical deposition (CPCD). We demonstrate the ability of CPCD to deposit crystalline ZnO without damage to the PSI biomaterial. Using electrochemical techniques, we were able to probe this complex semiconductor biological interface. Finally, as a proof of concept, a solid-state photovoltaic device consisting of p-doped silicon, PSI, ZnO, and ITO was constructed and evaluated.
C1 [Beam, Jeremiah C.; LeBlanc, Gabriel; Gizzie, Evan A.; Needell, David R.; Shearer, Melinda J.; Lukehart, Charles M.; Cliffel, David E.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.
   [Ivanov, Borislav L.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
   [Jennings, G. Kane] Vanderbilt Univ, Dept Biomol & Chem Engn, Nashville, TN 37235 USA.
RP Lukehart, CM (reprint author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.
EM charles.m.lukehart@vanderbilt.edu; d.cliffel@vanderbilt.edu
RI Ivanov, Borislav/G-2309-2011
OI Ivanov, Borislav/0000-0003-1837-6113; Shearer,
   Melinda/0000-0001-6121-3614; Needell, David/0000-0001-8343-5883
FU National Science Foundation [DMR0907619, DMR 1263182]; NSF EPSCoR [EPS
   1004083]; United States Department of Agriculture [2013-67021-21029
   USDA]; U.S. Environmental Protection Agency [SU8360221]; Vanderbilt
   University; Research Corporation for Science Advancement
FX We gratefully acknowledge the financial support of the National Science
   Foundation (DMR0907619, DMR 1263182 (D.R.N)), the NSF EPSCoR (EPS
   1004083), the United States Department of Agriculture (2013-67021-21029
   USDA), the U.S. Environmental Protection Agency (SU8360221), Vanderbilt
   University for partial support through an IDEAS grant award, and the
   Scialog Program from the Research Corporation for Science Advancement.
   We also gratefully acknowledge J. Scott Niezgoda, Andrew G. Harris, and
   Maxwell Robinson for their assistance in data collection.
CR Baba K, 1996, PHOTOSYNTH RES, V47, P121, DOI 10.1007/BF00016175
   Ciesielski PN, 2010, ADV FUNCT MATER, V20, P4048, DOI 10.1002/adfm.201001193
   Ciesielski PN, 2010, BIORESOURCE TECHNOL, V101, P3047, DOI 10.1016/j.biortech.2009.12.045
   Ciobanu M, 2005, LANGMUIR, V21, P692, DOI 10.1021/la048075
   Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f
   den Hollander MJ, 2011, LANGMUIR, V27, P10282, DOI 10.1021/la2013528
   Frolov L, 2008, J PHYS CHEM C, V112, P13426, DOI 10.1021/jp800586w
   Golbeck J., 2006, PHOTOSYSTEM 1 LIGHT, V24, P764
   Gordiichuk PI, 2014, ADV MATER, V26, P4863, DOI 10.1002/adma.201401135
   Hogewoning S. W., 2012, PLANT CELL, V24, P1921
   Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H
   Ivanov BL, 2009, J AM CHEM SOC, V131, P11744, DOI 10.1021/ja901570s
   Nguyen K, 2014, BBA-BIOENERGETICS, V1837, P1553, DOI 10.1016/j.bbabio.2013.12.013
   Kievit O, 2001, J ELECTROANAL CHEM, V497, P139, DOI 10.1016/S0022-0728(00)00467-8
   Kondo M, 2012, BIOMACROMOLECULES, V13, P432, DOI 10.1021/bm201457s
   LeBlanc G, 2014, LANGMUIR, V30, P10990, DOI 10.1021/la500129q
   LeBlanc G, 2012, ADV MATER, V24, P5959, DOI 10.1002/adma.201202794
   Mershin A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00234
   Mukherjee D, 2010, LANGMUIR, V26, P16048, DOI 10.1021/la102832x
   Nagy L, 2014, CURR PROTEIN PEPT SC, V15, P363, DOI 10.2174/1389203715666140327102757
   Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740
   Reeves SG, 1980, METHOD ENZYMOL, V69, P85
   Terasaki N, 2009, ANGEW CHEM INT EDIT, V48, P1585, DOI 10.1002/anie.200805748
   Wahab R, 2008, J ALLOY COMPD, V461, P66, DOI 10.1016/j.jallcom.2007.07.029
   Weintraub B, 2007, J PHYS CHEM C, V111, P10162, DOI 10.1021/jp073806v
NR 25
TC 6
Z9 7
U1 2
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 15
PY 2015
VL 31
IS 36
BP 10002
EP 10007
DI 10.1021/acs.langmuir.5b02334
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA CR5WU
UT WOS:000361415900030
PM 26318861
DA 2018-10-20
ER

PT J
AU Battiston, KG
   Ouyang, B
   Honarparvar, E
   Qian, J
   Labow, RS
   Simmons, CA
   Santerre, JP
AF Battiston, K. G.
   Ouyang, B.
   Honarparvar, E.
   Qian, J.
   Labow, R. S.
   Simmons, C. A.
   Santerre, J. P.
TI Interaction of a block-co-polymeric biomaterial with immunoglobulin G
   modulates human monocytes towards a non-inflammatory phenotype
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Monocyte; Protein adsorption; Polyurethane; Immunoglobulin; Biomaterials
ID ENGINEERED VASCULAR GRAFTS; MACROPHAGE POLARIZATION; INFLAMMATORY
   RESPONSE; SURFACE-CHEMISTRY; CYTOKINE RELEASE; PROTEIN-BINDING; HOST
   RESPONSE; IN-VITRO; ACTIVATION; ADHESION
AB Monocyte interactions with implanted biomaterials can contribute significantly to the ability of a biomaterial to support tissue integration and wound healing, as opposed to a chronic pro-inflammatory foreign body reaction, provided the materials are designed to do so. However, there are few biomaterials available designed to regulate immune cell response with the intention of reducing the pro-inflammatory activation state. Material chemistry is a powerful tool for regulating protein and cell interactions that can be incorporated into surfaces while maintaining desired mechanical properties. The aspects of material chemistry that can support monocyte activation away from a pro-inflammatory state are still poorly understood. Protein adsorption is a key initial event that transforms the surface of a biomedical device into a biological substrate that will govern subsequent cellular interactions. In this study, the chemistry of degradable block polyurethanes, termed degradable polar hydrophobic ionic (D-PHI) polyurethanes, were studied for their unique interactions with bound immunoglobulin G (IgG), a pro-inflammatory protein that supports monocyte-biomaterial interactions. The specific immunological active sites of the polyurethane-adsorbed protein were compared with IgG's adsorbed state on a homopolymeric material with surface chemistry conducive to cell interactions, e.g. tissue culture polystyrene (TCPS). IgG-coated TCPS supported sustained monocyte adhesion and enhanced monocyte spreading, effects not observed with IgG-coated PU. The degradable PU was subsequently shown to reduce the number of exposed IgG-Fab sites following pre-adsorption vs. IgG adsorbed to TCPS, with antibody inhibition experiments demonstrating that Fab-site exposure appears to dominate monocyte-biomaterial interactions. Minor changes in chemical segments within the PU molecular chains were subsequently investigated for their influence on directing IgG interactions towards reducing pro-inflammatory activity. A reduction in chemical heterogeneity within the PU, without significant differences in other material properties known to regulate monocyte response, was shown to increase Fab exposure and subsequently led to monocyte interactions similar to those observed for IgG-coated TCPS. These results infer that reduced IgG-Fab site exposure can be directed by material chemistry to attenuate pro-inflammatory monocyte interactions with biomaterial surfaces, and identify the chemical features of polymeric biomaterial design responsible for this process.
   Statement of Significance
   There is currently limited understanding of material design features that can regulate protein-material interactions in order to prevent adverse inflammatory responses to implanted biomaterials. In this paper, monocyte interactions with biomaterials (specifically a block co-polymeric degradable polyurethane [D-PHI] and tissue culture polystyrene ITCPS]) were investigated as a function of their interactions with adsorbed immunoglobulin G (IgG). D-PHI was shown to attenuate IgG-induced monocyte retention and spreading by reducing IgG-Fab site exposure upon adsorption relative to TCPS. Aspects of D-PHI chemistry important in regulating Fab site exposure were determined. This study thus identifies features of biomaterials, using D-PHI as a case study, which can contribute to the development of new immunomodulatory biomaterial design. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Battiston, K. G.; Ouyang, B.; Qian, J.; Simmons, C. A.; Santerre, J. P.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Honarparvar, E.; Simmons, C. A.; Santerre, J. P.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [Labow, R. S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, 124 Edward St,Room 464D, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772
FU CIHR [230762, STP-53877]; Ontario Graduate Scholarship (OGS)
FX This study was funded by CIHR operating grant #230762 (J.P. Santerre,
   R.S. Labow, C.A. Simmons). K.G. Battiston was funded by a CIHR Strategic
   Training Fellowship (STP-53877) and by an Ontario Graduate Scholarship
   (OGS).
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Battiston KG, 2014, ACTA BIOMATER, V10, P1146, DOI 10.1016/j.actbio.2013.12.022
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Battiston KG, 2012, ACTA BIOMATER, V8, P89, DOI 10.1016/j.actbio.2011.09.015
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Boccafoschi F, 2013, J BIOMED MATER RES A, V101, P3131, DOI 10.1002/jbm.a.34630
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Fitzpatrick LE, 2011, BIOMATERIALS, V32, P8957, DOI 10.1016/j.biomaterials.2011.08.021
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x
   Gretzer C, 2002, BIOMATERIALS, V23, P1639, DOI 10.1016/S0142-9612(01)00290-3
   Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Maciel J, 2014, TISSUE ENG PT A, V20, P250, DOI [10.1089/ten.tea.2012.0439, 10.1089/ten.TEA.2012.0439]
   Marom B, 2007, J LEUKOCYTE BIOL, V81, P1466, DOI 10.1189/jlb.0506328
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102
   Mosser DM, 2010, NAT REV IMMUNOL, V10, P460, DOI 10.1038/nri2788
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   Patel RJ, 2012, J BIOMED MATER RES A, V100A, P2054, DOI 10.1002/jbm.a.34101
   POLAT GL, 1993, IMMUNOLOGY, V80, P287
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Schmidt D, 2011, ACTA BIOMATER, V7, P515, DOI 10.1016/j.actbio.2010.08.022
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Sivaraman B, 2012, LANGMUIR, V28, P2745, DOI 10.1021/la204777x
   Thyparambil AA, 2014, ACTA BIOMATER, V10, P2404, DOI 10.1016/j.actbio.2014.01.027
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q
NR 40
TC 4
Z9 4
U1 3
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP 15
PY 2015
VL 24
BP 35
EP 43
DI 10.1016/j.actbio.2015.06.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CQ8OL
UT WOS:000360867700004
PM 26074158
DA 2018-10-20
ER

PT J
AU Battiston, KG
   Labow, RS
   Simmons, CA
   Santerre, JP
AF Battiston, K. G.
   Labow, R. S.
   Simmons, C. A.
   Santerre, J. P.
TI Immunomodulatory polymeric scaffold enhances extracellular matrix
   production in cell co-cultures under dynamic mechanical stimulation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Macrophage; Tissue regeneration; Polyurethane; Immuno-modulation;
   Biomechanics
ID SMOOTH-MUSCLE-CELLS; ENGINEERED VASCULAR GRAFTS; IN-VITRO; MACROPHAGE
   PHENOTYPE; POLYURETHANE SCAFFOLD; NEOVESSEL FORMATION;
   CONNECTIVE-TISSUE; CYCLIC DISTENSION; BLOOD-VESSELS; SHEAR-STRESS
AB Despite the importance of immune cells in regulating the wound healing process following injury, there are few examples of synthetic biomaterials that have the capacity to push the body's immune cells toward pro-regeneration phenotypes, and fewer still that are designed with the intention of achieving this immunomodulatory character. While monocytes and their derived macrophages have been recognized as important contributors to tissue remodeling in vivo, this is primarily believed to be due to their ability to regulate other cell types. The ability of monocytes and macrophages to generate tissue products themselves, however, is currently not well appreciated within the field of tissue regeneration. Furthermore, while monocytes/macrophages are found in remodeling tissue that is subjected to mechanical loading, the effect this biomechanical strain on monocytes/macrophages and their ability to regulate tissue-specific cellular activity has not been understood due to the complexity of the many factors involved in the in vivo setting, hence necessitating the use of controlled in vitro culture platforms to investigate this phenomenon. In this study, human monocytes were co-cultured with human coronary artery smooth muscle cells (VSMCs) on a tubular (3 mm ID) degradable polyurethane scaffold, with a unique combination of non-ionic polar, hydrophobic and ionic chemistry (D-PHI). The goal was to determine if such a synthetic matrix could be used in a co-culture system along with dynamic biomechanical stimulus (10% circumferential strain, 1 Hz) conditions in order to direct monocytes to enhance tissue generation, and to better comprehend the different ways in which monocytes/macrophages may contribute to new tissue production. Mechanical strain and monocyte co-culture had a complementary and non-mitigating effect on VSMC growth. Co-culture samples demonstrated increased deposition of sulphated glycosaminoglycans (GAGs) and elastin, as well as increases in the release of FGF-2, a growth factor that can stimulate VSMC growth, while dynamic culture supported increases in collagen I and III as well as increased mechanical properties (elastic modulus, tensile strength) vs. static controls. Macrophage polarization toward an M1 state was not promoted by the biomaterial or culture conditions tested. Monocytes/macrophages cultured on D-PHI were also shown to produce vascular extracellular matrix components, including collagen I, collagen III, elastin, and GAGs. This study highlights the use of synthetic biomaterials having immunomodulatory character in order to promote cell and tissue growth when used in tissue engineering strategies, and identifies ECM deposition by monocytes/macrophages as an unexpected source of this new tissue.
   Statement of Significance
   The ability of biomaterials to regulate macrophage activation towards a wound healing phenotype has recently been shown to support positive tissue regeneration. However, the ability of immunomodulatory biomaterials to harness monocyte/macrophage activity to support tissue engineering strategies in vitro holds enormous potential that has yet to be investigated. This study used a monocyte co-culture on a degradable polyurethane (D-PHI) to regulate the response of VSMCs in combination with biomechanical strain in a vascular tissue engineering context. Results demonstrate that immunomodulatory biomaterials, such as D-PHI, that support a desirable macrophage activation state can be combined with biomechanical strain to augment vascular tissue production in vitro, in part due to the novel and unexpected contribution of monocytes/macrophages themselves producing vascular ECM proteins. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Battiston, K. G.; Simmons, C. A.; Santerre, J. P.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Labow, R. S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [Simmons, C. A.; Santerre, J. P.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [Simmons, C. A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, 124 Edward St,Room 4640, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772
FU Canadian Institutes of Health Research (CIHR) [230762]; CIHR
   [STP-53877]; Ontario Graduate Scholarship (OGS)
FX This study was funded by Canadian Institutes of Health Research (CIHR)
   Operating Grant #230762 (J.P. Santerre, R.S. Labow, C.A. Simmons). K.G.
   Battiston was funded by a CIHR Strategic Training Fellowship (STP-53877)
   and by an Ontario Graduate Scholarship (OGS). Special thanks to the
   staff at the MC-78 machine shop (Mechanical and Industrial Engineering,
   University of Toronto); Maxfield Bradshaw, Sina Makaremi, and Bradley
   Menezes for assistance with bioreactor design; Dr. Jian Wang for help
   with mechanical testing; and Feryal Sarraf for preparation of histology
   samples and staining.
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Dahl SLM, 2007, ANN BIOMED ENG, V35, P1749, DOI 10.1007/s10439-007-9340-8
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Govindraj P, 2006, MATRIX BIOL, V25, P232, DOI 10.1016/j.matbio.2006.01.003
   Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585
   Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246
   Huang AH, 2014, CELL MOL LIFE SCI, V71, P2103, DOI 10.1007/s00018-013-1546-3
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Johann AM, 2007, FASEB J, V21, P2704, DOI 10.1096/fj.06-7815com
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5
   Larsson M, 2011, IEEE T ULTRASON FERR, V58, P2244, DOI 10.1109/TUFFC.2011.2074
   Matsumoto T, 2012, J BIOMECH, V45, P745, DOI 10.1016/j.jbiomech.2011.11.014
   Mazighi M, 2004, AM J PHYSIOL-HEART C, V287, pH866, DOI 10.1152/ajpheart.00918.2003
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   Mecham RP, 2008, METHODS, V45, P32, DOI 10.1016/j.ymeth.2008.01.007
   Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102
   Mosser DM, 2010, NAT REV IMMUNOL, V10, P460, DOI 10.1038/nri2788
   Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405
   Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   NUGENT MA, 1993, CIRC RES, V73, P1051, DOI 10.1161/01.RES.73.6.1051
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Sakamoto N, 2006, ANN BIOMED ENG, V34, P408, DOI 10.1007/s10439-005-9043-y
   Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051
   Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2
   Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707
   Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Sharifpoor S, 2011, BIOMATERIALS, V32, P4816, DOI 10.1016/j.biomaterials.2011.03.034
   Sharifpoor S, 2010, ACTA BIOMATER, V6, P4218, DOI 10.1016/j.actbio.2010.06.018
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Syedain ZH, 2011, J BIOMECH, V44, P848, DOI 10.1016/j.jbiomech.2010.12.007
   Teixeira R, 2013, EUR HEART J-CARD IMG, V14, P631, DOI 10.1093/ehjci/jes221
   Venkataraman L, 2014, TISSUE ENG PT A, V20, P1403, DOI [10.1089/ten.tea.2013.0294, 10.1089/ten.TEA.2013.0294]
   Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI 10.1089/ten.TEB.2009.0527
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Wang HQ, 2006, ENDOTHELIUM-J ENDOTH, V13, P171, DOI 10.1080/10623320600760282
   Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096
   Weitkamp B, 1999, FASEB J, V13, P1445
   WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
   Yuda S, 2011, ECHOCARDIOGR-J CARD, V28, P899, DOI 10.1111/j.1540-8175.2011.01443.x
NR 65
TC 9
Z9 9
U1 2
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP 15
PY 2015
VL 24
BP 74
EP 86
DI 10.1016/j.actbio.2015.05.038
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CQ8OL
UT WOS:000360867700008
PM 26093069
DA 2018-10-20
ER

PT J
AU Mellier, C
   Fayon, F
   Boukhechba, F
   Verron, E
   LeFerrec, M
   Montavon, G
   Lesoeur, J
   Schnitzler, V
   Massiot, D
   Janvier, P
   Gauthier, O
   Bouler, JM
   Bujoli, B
AF Mellier, Charlotte
   Fayon, Franck
   Boukhechba, Florian
   Verron, Elise
   LeFerrec, Myriam
   Montavon, Gilles
   Lesoeur, Julie
   Schnitzler, Verena
   Massiot, Dominique
   Janvier, Pascal
   Gauthier, Olivier
   Bouler, Jean-Michel
   Bujoli, Bruno
TI Design and properties of novel gallium-doped injectable apatitic cements
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Calcium phosphate cements; Gallium; Design; Handling properties;
   Biocompatibility
ID CALCIUM-PHOSPHATE CEMENT; CANCER-RELATED HYPERCALCEMIA; DRUG-RELEASE
   RATE; ADVANCED PAGETS-DISEASE; BONE-GRAFT SUBSTITUTES; 300 DEGREES-C;
   DELIVERY SYSTEM; PHYSICOCHEMICAL PROPERTIES; IN-VITRO; DEFICIENT APATITE
AB Different possible options were investigated to combine an apatitic calcium phosphate cement with gallium ions, known as bone resorption inhibitors. Gallium can be either chemisorbed onto calcium-deficient apatite or inserted in the structure of B-tricalcium phosphate, and addition of these gallium-doped components into the cement formulation did not significantly affect the main properties of the biomaterial, in terms of injectability and setting time. Under in vitro conditions, the amount of gallium released from the resulting cement pellets was found to be low, but increased in the presence of osteoclastic cells. When implanted in rabbit bone critical defects, a remodeling process of the gallium-doped implant started and an excellent bone interface was observed.
   Statement of Significance
   The integration of drugs and materials is a growing force in the medical industry. The incorporation of pharmaceutical products not only promises to expand the therapeutic scope of biomaterials technology but to design a new generation of true combination products whose therapeutic value stem equally from both the structural attributes of the material and the intrinsic therapy of the drug. In this context, for the first time an injectable calcium phosphate cement containing gallium was designed with properties suitable for practical application as a local delivery system, implantable by minimally invasive surgery. This important and original paper reports the design and in-depth chemical and physical characterization of this groundbreaking technology. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mellier, Charlotte; Boukhechba, Florian; LeFerrec, Myriam; Schnitzler, Verena] Graftys SA, F-13854 Aix En Provence 3, France.
   [Fayon, Franck; Massiot, Dominique] CNRS, CEMHTI, UPR3079, F-45071 Orleans, France.
   [Verron, Elise; Lesoeur, Julie; Gauthier, Olivier] Univ Nantes, INSERM, Fac Chirurg Dentaire, LIOAD,UMR 791, F-44042 Nantes 1, France.
   [Janvier, Pascal; Bouler, Jean-Michel; Bujoli, Bruno] Univ Nantes, CNRS, UFR Sci & Tech, CEISAM,UMR 6230, F-44322 Nantes 3, France.
   [Montavon, Gilles] Univ Nantes, Ecole Mines Nantes, CNRS, IN2P3,SUBATECH,UMR 6457, F-44307 Nantes 3, France.
RP Bouler, JM (reprint author), Univ Nantes, CNRS, UFR Sci & Tech, CEISAM,UMR 6230, F-44322 Nantes 3, France.
EM jean-michel.bouler@univ-nantes.fr
RI Fayon, Franck/C-1835-2008; Montavon, Gilles/O-1225-2017
OI Montavon, Gilles/0000-0002-3049-0106; BOULER,
   Jean-Michel/0000-0001-9784-5584
FU ANR [ANR-08-BIOT-008-02]; Graftys company; TGIR RMN THC [FR3050]
FX E. Veron and M. Allix are acknowledged for EDS and TEM analysis. The
   ICMN laboratory (Orleans, France) is thanked for providing TEM access.
   This work was partially supported by ANR (BiotecS 2008 program - grant
   ANR-08-BIOT-008-02), and the Graftys company. Financial support from the
   TGIR RMN THC FR3050 for conducting the research is gratefully
   acknowledged.
CR Ambrosio L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024113
   Benezeth P, 1997, GEOCHIM COSMOCHIM AC, V61, P1345, DOI 10.1016/S0016-7037(97)00012-4
   Bernstein LR, 1998, PHARMACOL REV, V50, P665
   Beswick A, 2011, INJURY, V42, pS40, DOI 10.1016/j.injury.2011.06.009
   Bockman R, 2003, SEMIN ONCOL, V30, P5, DOI 10.1016/S0093-7754(03)00170-2
   BOCKMAN RS, 1994, SEMIN ARTHRITIS RHEU, V23, P268
   BOCKMAN RS, 1995, J CLIN ENDOCR METAB, V80, P595, DOI 10.1210/jc.80.2.595
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5400-z
   Canal C, 2014, PLASMA PROCESS POLYM, V11, P694, DOI 10.1002/ppap.201400018
   Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0
   Chitambar CR, 2004, EXPERT OPIN INV DRUG, V13, P531, DOI 10.1517/13543784.13.5.531
   DeLeon K, 2009, ANTIMICROB AGENTS CH, V53, P1331, DOI 10.1128/AAC.01330-08
   Diakonov II, 1997, GEOCHIM COSMOCHIM AC, V61, P1333, DOI 10.1016/S0016-7037(97)00011-2
   Doebelin N., 2010, CHIMIA, V64, P723
   Dorozhkin S.V., 2013, INT J CHEM MAT SCI, V1, P105
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Eby G, 2005, MED HYPOTHESES, V65, P1136, DOI 10.1016/j.mehy.2005.06.021
   Einhorn L, 2003, SEMIN ONCOL, V30, P34, DOI 10.1016/S0093-7754(03)00174-X
   FIAT D, 1966, J AM CHEM SOC, V88, P4754, DOI 10.1021/ja00972a059
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Ginebra M. P., 2012, ADV DRUG DELIV REV
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   HALL TJ, 1990, BONE MINER, V8, P211, DOI 10.1016/0169-6009(90)90106-P
   Jabbour E, 2007, CANCER, V109, P2481, DOI 10.1002/cncr.22714
   Jager C, 2006, MAGN RESON CHEM, V44, P573, DOI 10.1002/mrc.1774
   Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783
   KING SC, 1994, J CLIN ONCOL, V12, P306, DOI 10.1200/JCO.1994.12.2.306
   Leyland-Jones B, 2003, SEMIN ONCOL, V30, P13, DOI 10.1016/S0093-7754(03000171-4
   Lindqvist-Reis P, 1998, INORG CHEM, V37, P6675, DOI 10.1021/ic980750y
   Lopez-Heredia MA, 2012, ACTA BIOMATER, V8, P3500, DOI 10.1016/j.actbio.2012.05.033
   Lopez-Heredia MA, 2011, BIOMATERIALS, V32, P5411, DOI 10.1016/j.biomaterials.2011.04.010
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   Mellier C, 2011, INORG CHEM, V50, P8252, DOI 10.1021/ic2007777
   Obadia L, 2007, J BIOMED MATER RES B, V80B, P32, DOI 10.1002/jbm.b.30565
   OTSUKA M, 1994, J PHARM SCI, V83, P611, DOI 10.1002/jps.2600830502
   OTSUKA M, 1994, J PHARM SCI, V83, P255, DOI 10.1002/jps.2600830229
   OTSUKA M, 1994, J PHARM SCI, V83, P1565, DOI 10.1002/jps.2600831109
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   Panchbhavi VK, 2010, FOOT ANKLE CLIN, V15, P559, DOI 10.1016/j.fcl.2010.07.004
   Parratte S, 2010, OSTEOPOROSIS INT, V21, P346
   Pastorino D, 2015, ACTA BIOMATER, V12, P250, DOI 10.1016/j.actbio.2014.10.031
   Pei Y, 2011, BIOL TRACE ELEM RES, V141, P207, DOI 10.1007/s12011-010-8708-z
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   Salloum E, 1997, J CLIN ONCOL, V15, P518, DOI 10.1200/JCO.1997.15.2.518
   Schnitzler V, 2011, ACTA BIOMATER, V7, P759, DOI 10.1016/j.actbio.2010.09.017
   Stiller M, 2014, BIOMATERIALS, V35, P3154, DOI 10.1016/j.biomaterials.2013.12.068
   Valappil SP, 2009, ACTA BIOMATER, V5, P1198, DOI 10.1016/j.actbio.2008.09.019
   Valappil SP, 2008, ADV FUNCT MATER, V18, P732, DOI 10.1002/adfm.200700931
   Valappil SP, 2012, ACTA BIOMATER, V8, P1957, DOI 10.1016/j.actbio.2012.01.017
   vanAmsterdam JAG, 1996, ANN HEMATOL, V72, P202, DOI 10.1007/s002770050161
   Verron E, 2012, DRUG DISCOV TODAY, V17, P1127, DOI 10.1016/j.drudis.2012.06.007
   Verron E, 2012, ACTA BIOMATER, V8, P3541, DOI 10.1016/j.actbio.2012.06.022
   Verron E, 2012, BIOCHEM PHARMACOL, V83, P671, DOI 10.1016/j.bcp.2011.12.015
   Verron E, 2014, DRUG DISCOV TODAY, V19, P1419, DOI 10.1016/j.drudis.2014.04.004
   Verron E, 2014, ACTA BIOMATER, V10, P4887, DOI 10.1016/j.actbio.2014.07.012
   Verron E, 2010, BIOMATERIALS, V31, P7776, DOI 10.1016/j.biomaterials.2010.06.047
   Verron E, 2010, DRUG DISCOV TODAY, V15, P547, DOI 10.1016/j.drudis.2010.05.003
   Verron E, 2010, BRIT J PHARMACOL, V159, P1681, DOI 10.1111/j.1476-5381.2010.00665.x
   Vyalikh A, 2011, J PHYS CHEM C, V115, P1513, DOI 10.1021/jp1082399
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Wang Y, 2013, NAT MATER, V12, P1144, DOI [10.1038/NMAT3787, 10.1038/nmat3787]
   WARRELL RP, 1985, CANCER TREAT REP, V69, P653
   WARRELL RP, 1984, J CLIN INVEST, V73, P1487, DOI 10.1172/JCI111353
   WARRELL RP, 1991, J CLIN ONCOL, V9, P1467, DOI 10.1200/JCO.1991.9.8.1467
NR 68
TC 13
Z9 13
U1 3
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP 15
PY 2015
VL 24
BP 322
EP 332
DI 10.1016/j.actbio.2015.05.027
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CQ8OL
UT WOS:000360867700030
PM 26074157
DA 2018-10-20
ER

PT J
AU Martel-Estrada, SA
   Rodriguez-Espinoza, B
   Santos-Rodriguez, E
   Jimenez-Vega, F
   Garcia-Casillas, PE
   Martinez-Perez, CA
   Armendariz, IO
AF Adriana Martel-Estrada, Santos
   Rodriguez-Espinoza, Brenda
   Santos-Rodriguez, Eli
   Jimenez-Vega, Florinda
   Garcia-Casillas, Perla E.
   Martinez-Perez, Carlos A.
   Olivas Armendariz, Imelda
TI Biocompatibility of chitosan/Mimosa tenuiflora scaffolds for tissue
   engineering
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Composite; Biocompatibility; Mimosa tenuiflora; Chitosan
ID IN-VITRO; BONE; PROTEOGLYCANS; COMPOSITES
AB In search of a plant that exhibits osteogenic activity, Mimosa tenuiflora (M. tenuiflora) cortex represents the opportunity to create a biomaterial that, together with the chitosan, is osteoconductive and promote better and rapid regeneration of bone tissue. Thus, the composite of chitosan/M. tenuiflora cortex fabricated will have properties of biocompatibility and allow the osteoblast proliferation. Composites were developed with different concentrations of chitosan/M. tenuiflora cortex (w/w) using thermally induced phase separation technique (TIPS). To analyze the effects of composite on osteoblasts, primary cultures, each sample was collected on days I, 3 and 7 after seeding. The evaluation of composites consisted of viability and proliferation tests in which we observed the metabolic activity of the cells using MTT reagent and determined the DNA concentration by means of fluorescence. The expression of the marker alkaline phosphatase (ALP) using p-nitrophenyl phosphate was examined, allowing the observation to the activity of proliferation and differentiation of osteoblastic cells. Moreover, an analysis of biomineralization was performed using scanning electron microscopy (SEM), energy dispersive spectroscopy, infrared spectroscopy and X-ray diffraction. The results showed that 80/20 chitosan/M. tenuiflora cortex biocomposite has the best performance with osteoblasts compared to biomaterials 100/0 and 70/30 chitosan/M. tenuiflora composites. Finally, it was determined that the composite of chitosan/M. tenuiflora cortex presents no cytotoxicity and increases the capacity of the osteoblasts to proliferate and differentiate. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Adriana Martel-Estrada, Santos] Univ Autanoma Ciudad Juarez, Inst Arquitectura Diseno & Arte, Ciudad Juarez 32320, Chihuahua, Mexico.
   [Rodriguez-Espinoza, Brenda; Jimenez-Vega, Florinda] Univ Autanoma Ciudad Juarez, Inst Ciencias Biomed, Ciudad Juarez 32320, Chihuahua, Mexico.
   [Santos-Rodriguez, Eli] Univ Autonoma Chiapas, ICTP Meso Amer Ctr Theoret Phys ICTP MCTP, Tuxtla Gutierrez, Chiapas, Mexico.
   [Garcia-Casillas, Perla E.; Martinez-Perez, Carlos A.; Olivas Armendariz, Imelda] Univ Autanoma Ciudad Juarez, Inst Ingn & Tecnol, Ciudad Juarez 32320, Chihuahua, Mexico.
RP Armendariz, IO (reprint author), Univ Autanoma Ciudad Juarez, Inst Ingn & Tecnol, Ave Charro 610 Norte, Ciudad Juarez 32320, Chihuahua, Mexico.
EM iolivas@uacj.mx
OI Rodriguez-Espinoza, Brenda/0000-0002-6878-154X; Martel-Estrada,
   Santos-Adriana/0000-0002-8803-9406
FU Mexican Council for Science and Technology; Mexican Public Education
   Secretary (SEP-CONACyT) [2012-180909]
FX The authors gratefully acknowledge the financial support of the Mexican
   Council for Science and Technology and the Mexican Public Education
   Secretary (SEP-CONACyT 2012-180909) and the support of Susana Garcia
   during language edition of this document.
CR BOSKEY AL, 1989, BONE MINER, V6, P111, DOI 10.1016/0169-6009(89)90044-5
   Budiraharjo R, 2012, J COLLOID INTERF SCI, V366, P224, DOI 10.1016/j.jcis.2011.09.072
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Martel-Estrada SA, 2014, MATER LETT, V119, P146, DOI 10.1016/j.matlet.2014.01.004
   Ngueguim FT, 2012, J ETHNOPHARMACOL, V141, P331, DOI 10.1016/j.jep.2012.02.041
   de Souza RSO, 2008, BRAZ ARCH BIOL TECHN, V51, P937, DOI 10.1590/S1516-89132008000500010
   Olivas-Armendariz I, 2010, J ALLOY COMPD, V495, P592, DOI 10.1016/j.jallcom.2009.10.205
   Rivera-Arce E, 2007, J ETHNOPHARMACOL, V113, P400, DOI 10.1016/j.jep.2007.06.023
   Shoufeng Y., 2001, TISSUE ENG, V7, P679
   Soumya S, 2012, CARBOHYD POLYM, V87, P1787, DOI 10.1016/j.carbpol.2011.09.094
   Veis A., 1993, J BONE MINER RES S2, V8, P493
   WADDINGTON RJ, 1991, ARCH ORAL BIOL, V36, P859, DOI 10.1016/0003-9969(91)90115-B
   Waddington RJ, 1998, MATRIX BIOL, V17, P255, DOI 10.1016/S0945-053X(98)90079-8
   Welsch U., 2008, HISTOLOGIA, Vsecond
   Yang-Jo S., 2004, BIOTECHNOL LETT, V26, P1037
   Zippel J, 2009, J ETHNOPHARMACOL, V124, P391, DOI 10.1016/j.jep.2009.05.034
NR 17
TC 6
Z9 6
U1 0
U2 30
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD SEP 15
PY 2015
VL 643
SU 1
BP S119
EP S123
DI 10.1016/j.jallcom.2015.01.034
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA CM7VA
UT WOS:000357903400023
DA 2018-10-20
ER

PT J
AU Balaz, M
   Bujnakova, Z
   Balaz, P
   Zorkovska, A
   Dankova, Z
   Briancin, J
AF Balaz, M.
   Bujnakova, Z.
   Balaz, P.
   Zorkovska, A.
   Dankova, Z.
   Briancin, J.
TI Adsorption of cadmium(II) on waste biomaterial
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Eggshell; Milling; Cadmium; Adsorption
ID HEAVY-METAL ADSORPTION; AQUEOUS-SOLUTIONS; EGGSHELL MEMBRANE; WATER
   SOLUTION; REMOVAL; SORPTION; IONS; WASTEWATERS; CALCITE; SOLIDS
AB Significant increase of the adsorption ability of the eggshell biomaterial toward cadmium was observed upon milling, as is evidenced by the value of maximum monolayer adsorption capacity of 329 mg g(-1), which is markedly higher than in the case of most "green" sorbents. The main driving force of the adsorption was proven to be the presence of aragonite phase as a consequence of phase transformation from calcite occurring during milling. Cadmium is adsorbed in a non-reversible way, as documented by different techniques (desorption tests, XRD and EDX measurements). The optimum pH for cadmium adsorption was 7. The adsorption process was accompanied by the increase of the value of specific surface area. The course of adsorption has been described by Langmuir, Freundlich and Dubinin-Radushkevich isotherms. The adsorption kinetics was evaluated using three models, among which the best correlation coefficients and the best normalized standard deviation values were achieved for the pseudo-second order model and the intraparticle diffusion model, respectively. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Balaz, M.; Bujnakova, Z.; Balaz, P.; Zorkovska, A.; Dankova, Z.; Briancin, J.] Slovak Acad Sci, Inst Geotech, Kosice 04001, Slovakia.
RP Balaz, M (reprint author), Slovak Acad Sci, Inst Geotech, Watsonova 45, Kosice 04001, Slovakia.
FU Slovak Grant Agency [VEGA 2/0027/14, 2/0114/13]; Slovak Agency for
   Science and Development [APVV-14-0103]; European Regional Development
   Fund (Project nanoCEXmat II) [ITMS 26220120035]; Centre of Excellence of
   Slovak Academy of Sciences (CFNT-MVEP)
FX This work was supported by the Slovak Grant Agency (Projects VEGA
   2/0027/14 and 2/0114/13), Slovak Agency for Science and Development
   (project APVV-14-0103) and European Regional Development Fund (Project
   nanoCEXmat II, ITMS 26220120035). The support of Centre of Excellence of
   Slovak Academy of Sciences (CFNT-MVEP) is also gratefully acknowledged.
CR Ahmad M, 2012, J IND ENG CHEM, V18, P198, DOI 10.1016/j.jiec.2011.11.013
   [Anonymous], 2006, APPL SCI
   Argun M. E., 2008, Journal of International Environmental Application & Science, V3, P37
   Bala'z P., 2000, EXTRACTIVE METALLURG
   Balaz M, 2014, ACTA BIOMATER, V10, P3827, DOI 10.1016/j.actbio.2014.03.020
   Balaz M, 2013, MAT SCI SEMICON PROC, V16, P1899, DOI 10.1016/j.mssp.2013.06.024
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Balaz P., 2008, MECHANOCHEMISTRY NAN
   Balaz P, 2013, CHEM SOC REV, V42, P7571, DOI 10.1039/c3cs35468g
   Barakat MA, 2011, ARAB J CHEM, V4, P361, DOI 10.1016/j.arabjc.2010.07.019
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Bernhoft RA, 2013, SCI WORLD J, DOI 10.1155/2013/394652
   Bhattacharyya KG, 2008, ADV COLLOID INTERFAC, V140, P114, DOI 10.1016/j.cis.2007.12.008
   Bujnakova Z, 2013, J HAZARD MATER, V262, P1204, DOI 10.1016/j.jhazmat.2013.03.007
   Chada VGR, 2005, J COLLOID INTERF SCI, V288, P350, DOI 10.1016/j.jcis.2005.03.018
   Chen J.P., 2010, DECONTAMINATION HEAV
   Demirbas A, 2008, J HAZARD MATER, V157, P220, DOI 10.1016/j.jhazmat.2008.01.024
   Du Y, 2011, ENVIRON POLLUT, V159, P1763, DOI 10.1016/j.envpol.2011.04.017
   DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006
   Erdem B, 2009, J HAZARD MATER, V163, P418, DOI 10.1016/j.jhazmat.2008.06.112
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   GILES CH, 1960, J CHEM SOC, P3973, DOI 10.1039/jr9600003973
   Godt J, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-22
   Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1
   Guru PS, 2014, ADV COLLOID INTERFAC, V209, P49, DOI 10.1016/j.cis.2013.12.013
   HEDVALL JA, 1938, REAKTIONSFAHIGKEIT F
   Ho Y. S., 1995, ADSORPTION HEAVY MET
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a
   Kohler SJ, 2007, ENVIRON SCI TECHNOL, V41, P112, DOI 10.1021/es060756j
   KOZAR S, 1992, MAR CHEM, V40, P215, DOI 10.1016/0304-4203(92)90024-5
   Kuh SE, 2000, ENVIRON TECHNOL, V21, P883, DOI 10.1080/09593330.2000.9618973
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Leyva-Ramos R, 2012, CHEM ENG J, V180, P113, DOI 10.1016/j.cej.2011.11.021
   LIN IJ, 1979, MATER SCI ENG, V39, P193, DOI 10.1016/0025-5416(79)90059-4
   Lin JX, 2009, FRONT ENVIRON SCI EN, V3, P320, DOI 10.1007/s11783-009-0030-7
   Low KS, 2000, PROCESS BIOCHEM, V36, P59, DOI 10.1016/S0032-9592(00)00177-1
   Mahramanlioglu M, 2002, J FLUORINE CHEM, V115, P41, DOI 10.1016/S0022-1139(02)00003-9
   MARTINEZ G, 1981, J COLLOID INTERF SCI, V81, P500, DOI 10.1016/0021-9797(81)90431-8
   Orolinova Z, 2010, DESALIN WATER TREAT, V24, P284, DOI 10.5004/dwt.2010.1644
   Padilla-Ortega E, 2014, APPL CLAY SCI, V88-89, P10, DOI 10.1016/j.clay.2013.12.012
   Pagnanelli F, 2003, CHEM ENG SCI, V58, P4709, DOI 10.1016/j.ces.2003.08.001
   Park HJ, 2007, J ENVIRON SCI-CHINA, V19, P1436, DOI 10.1016/S1001-0742(07)60234-4
   Rao K.S., 2010, INT J ENG SCI TECHNO, V2, P81
   Shaheen SM, 2013, J ENVIRON MANAGE, V128, P514, DOI 10.1016/j.jenvman.2013.05.061
   Stadelman WJ, 2000, ENCY FOOD SCI TECHNO, P593
   Suresh C, 2014, SCI WORLD J, DOI 10.1155/2014/154809
   Tashauoei HR, 2010, INT J ENVIRON SCI TE, V7, P497, DOI 10.1007/BF03326159
   Tsai WT, 2008, MICROPOR MESOPOR MAT, V111, P379, DOI 10.1016/j.micromeso.2007.08.010
   Flores-Cano JV, 2013, APPL SURF SCI, V276, P682, DOI 10.1016/j.apsusc.2013.03.153
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Wu FC, 2001, WATER RES, V35, P613, DOI 10.1016/S0043-1354(00)00307-9
   Wu FC, 2009, CHEM ENG J, V153, P1, DOI 10.1016/j.cej.2009.04.042
NR 58
TC 31
Z9 33
U1 4
U2 70
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD SEP 15
PY 2015
VL 454
BP 121
EP 133
DI 10.1016/j.jcis.2015.03.046
PG 13
WC Chemistry, Physical
SC Chemistry
GA CL5JR
UT WOS:000356996700016
PM 26005798
DA 2018-10-20
ER

PT J
AU Allaf, RM
   Rivero, IV
   Ivanov, IN
AF Allaf, Rula M.
   Rivero, Iris V.
   Ivanov, Ilia N.
TI Fabrication of co-continuous poly(epsilon-caprolactone)/polyglycolide
   blend scaffolds for tissue engineering
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; blends; porous materials; properties and
   characterization; synthesis and processing
ID ARTICULAR CHONDROCYTE ADHESION; BIODEGRADABLE POLYMERS; CARTILAGE
   TISSUE; IN-VITRO; POLYCAPROLACTONE SCAFFOLD; MECHANICAL-PROPERTIES;
   POROUS SCAFFOLDS; POLY(L-LACTIDE); DEGRADATION; MORPHOLOGY
AB The apparent inability of a single biomaterial to meet all the requirements for tissue engineering scaffolds has led to continual research in novel engineered biomaterials. One method to provide new materials and fine-tune their properties is via mixing materials. In this study, a biodegradable powder blend of poly(epsilon-caprolactone) (PCL), polyglycolide (PGA), and poly(ethylene oxide) (PEO) was prepared and three-dimensional interconnected porous PCL/PGA scaffolds were fabricated by combining cryomilling and compression molding/polymer leaching techniques. The resultant porous scaffolds exhibited co-continuous morphologies with similar to 50% porosity. Mean pore sizes of 24 and 56 mu m were achieved by varying milling time. The scaffolds displayed high mechanical properties and water uptake, in addition to a remarkably fast degradation rate. The results demonstrate the potential of this fabrication approach to obtain PCL/PGA blend scaffolds with interconnected porosity. In general, these results provide significant insight into an approach that will lead to the development of new composites and blends in scaffold manufacturing. (C) 2015 Wiley Periodicals, Inc.
C1 [Allaf, Rula M.] German Jordanian Univ, Dept Ind Engn, Amman 11180, Jordan.
   [Rivero, Iris V.] Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
   [Ivanov, Ilia N.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.
RP Rivero, IV (reprint author), Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
EM rivero@iastate.edu
OI ivanov, ilia/0000-0002-6726-2502; Allaf, Rula/0000-0003-2094-7165
FU Center for Nanophase Materials Sciences a DOE Office of Science User
   Facility [CNMS2009-052]
FX The authors gratefully acknowledge the Texas Tech University Imaging
   Center, Department of Biological Sciences, for use of the Hitachi
   S-4300SE/N (NSF MRI 04-511). Thermal analysis was performed under
   project CNMS2009-052 at the Center for Nanophase Materials Sciences,
   which is a DOE Office of Science User Facility.
CR Aghdam RM, 2012, J APPL POLYM SCI, V124, P123, DOI 10.1002/app.35071
   Allaf RM, 2013, J BIOMED MATER RES B, V101B, P1050, DOI 10.1002/jbm.b.32915
   Allaf RM, 2011, J MATER SCI-MATER M, V22, P1843, DOI 10.1007/s10856-011-4367-7
   Andrady A. L., 2007, PHYS PROPERTIES POLY, P951
   [Anonymous], 2008, D69508 ASTM
   [Anonymous], 2008, F231308 ASTM
   Bramfeldt H, 2008, POLYM DEGRAD STABIL, V93, P877, DOI 10.1016/j.polymdegradstab.2008.01.023
   Brown M, 2008, PLAST RUBBER COMPOS, V37, P46, DOI 10.1179/174328908X283339
   Bureau MN, 2005, THERMOPLASTIC FOAM P, P235
   Chen B. Y., 2014, J APPL POLYM SCI, DOI [10.1002/A41181, DOI 10.1002/A41181]
   Chiono V, 2009, MAT SCI ENG C-MATER, V29, P2174, DOI 10.1016/j.msec.2009.04.020
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   Doppalapudi S, 2014, POLYM ADVAN TECHNOL, V25, P427, DOI 10.1002/pat.3305
   Eastmond GC, 1999, ADV POLYM SCI, V149, P59
   Gabay O, 2010, JOINT BONE SPINE, V77, P283, DOI 10.1016/j.jbspin.2010.02.029
   Ghosh S, 2007, J MATER SCI-MATER M, V18, P185, DOI 10.1007/s10856-006-0680-y
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jonnalagadda JB, 2015, J BIOMAT SCI-POLYM E, V26, P401, DOI 10.1080/09205063.2015.1015864
   Jonnalagadda JB, 2014, J MECH BEHAV BIOMED, V40, P33, DOI 10.1016/j.jmbbm.2014.08.009
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Lebourg M, 2008, EUR POLYM J, V44, P2207, DOI 10.1016/j.eurpolymj.2008.04.033
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   Lee CT, 2006, BIOMACROMOLECULES, V7, P2200, DOI 10.1021/bm060451x
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Maglio G, 2004, MACROMOL CHEM PHYSIC, V205, P946, DOI 10.1002/macp.200300150
   Menczel JD, 2009, THERMAL ANAL POLYM F, P7, DOI DOI 10.1002/9780470423837.CH2
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mills NJ, 2007, POLYMER FOAMS HANDBOOK: ENGINEERING AND BIOMECHANICS APPLICATIONS AND DESIGN GUIDE, P1
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Okamoto M, 2013, PROG POLYM SCI, V38, P1487, DOI 10.1016/j.progpolymsci.2013.06.001
   Potschke P., 2003, POLYM REV, V43, P87
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Sarazin P, 2006, J APPL POLYM SCI, V100, P1039, DOI 10.1002/app.23185
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Sarazin P, 2003, BIOMACROMOLECULES, V4, P1669, DOI 10.1021/bm030034+
   Schindler C, 2013, POLYMER, V54, P6824, DOI 10.1016/j.polymer.2013.10.025
   Stranz M, 2005, J METASTAB NANOCRYST, V24-25, P609, DOI 10.4028/www.scientific.net/JMNM.24-25.609
   Tan LL, 2013, J MATER SCI TECHNOL, V29, P503, DOI 10.1016/j.jmst.2013.03.002
   Thadavirul N, 2014, J BIOMED MATER RES A, V102, P3379, DOI 10.1002/jbm.a.35010
   Varga F, 2007, PHYSIOL RES, V56, pS61
   Vertuccio L, 2009, CARBOHYD POLYM, V75, P172, DOI 10.1016/j.carbpol.2008.07.020
   Vial X., 2009, CURR RHEUMATOL REV, V5, P51, DOI DOI 10.2174/157339709787315366
   Wan YQ, 2003, BIOMATERIALS, V24, P2195, DOI 10.1016/S0142-9612(03)00107-8
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Zhao J, 2004, J APPL POLYM SCI, V91, P1676, DOI 10.1002/app.13323
   Zhu YG, 2006, J POLYM SCI POL PHYS, V44, P1161, DOI 10.1002/polb.20780
   Zhu YG, 2006, J APPL POLYM SCI, V99, P501, DOI 10.1002/app.22296
NR 54
TC 6
Z9 6
U1 5
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 12
PY 2015
VL 132
IS 35
AR 42471
DI 10.1002/app.42471
PG 12
WC Polymer Science
SC Polymer Science
GA CL2XY
UT WOS:000356812400001
DA 2018-10-20
ER

PT J
AU Wilems, TS
   Sakiyama-Elbert, SE
AF Wilems, Thomas S.
   Sakiyama-Elbert, Shelly E.
TI Sustained dual drug delivery of anti-inhibitory molecules for treatment
   of spinal cord injury
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE PLGA microspheres; Lipid microtubes; Chondroitinase ABC; NEP1-40;
   Controlled release
ID CHONDROITIN SULFATE PROTEOGLYCAN; MYELIN-ASSOCIATED GLYCOPROTEIN;
   PROMOTES AXONAL REGENERATION; NOGO-66 RECEPTOR; PLGA MICROSPHERES;
   CONTUSION INJURY; FUNCTIONAL RECOVERY; CONTROLLED-RELEASE; NEURITE
   OUTGROWTH; MEDIATED INHIBITION
AB Myelin-associated inhibitors (MAIs) and chondroitin sulfate proteoglycans (CSPGs) are major contributors to axon growth inhibition following spinal cord injury and limit functional recovery. The NEP1-40 peptide competitively binds the Nogo receptor and partially blocks inhibition from MAIs, while chondroitinase ABC (ChABC) enzymatically digests CSPGs, which are upregulated at the site of injury. In vitro studies showed that the combination of ChABC and NEP1-40 increased neurite extension compared to either treatment alone when dissociated embryonic dorsal root ganglia were seeded onto inhibitory substrates containing both MAIs and CSPGs. Furthermore, the ability to provide sustained delivery of biologically active ChABC and NEP1-40 from biomaterial scaffolds was achieved by loading ChABC into lipid microtubes and NEP1-40 into poly (lactic-co-glycolic acid) (PLGA) microspheres, obviating the need for invasive intrathecal pumps or catheters. Fibrin scaffolds embedded with the drug delivery systems (PLGA microspheres and lipid microtubes) were capable of releasing active ChABC for up to one week and active NEP1-40 for over two weeks in vitro. In addition, the loaded drug delivery systems in fibrin scaffolds decreased CSPG deposition and development of a glial scar, while also increasing axon growth after spinal cord injury in vivo. Therefore, the sustained, local delivery of ChABC and NEP1-40 within the injured spinal cord may block both myelin and CSPG-associated inhibition and allow for improved axon growth. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Wilems, Thomas S.; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, 1097 Brookings Dr, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NINDS NIH HHS [R01 NS051454]
CR Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   [Anonymous], 2012, J SPINAL CORD MED, V35, P480
   Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Beck L. R., 1980, BIODEGRADABLES DELIV, V1
   Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226
   Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550
   Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje
   CROWE JH, 1988, BIOCHIM BIOPHYS ACTA, V947, P367, DOI 10.1016/0304-4157(88)90015-9
   Dergham P, 2002, J NEUROSCI, V22, P6570
   Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070
   Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5
   Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011
   Forgione N., 2013, WORLD NEUROSURG, V82, pE535
   Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092
   Fournier AE, 2003, J NEUROSCI, V23, P1416
   Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/NEUROSCI.4353-06.2007
   Gopalakrishnan SM, 2008, J NEUROSCI RES, V86, P2214, DOI 10.1002/jnr.21671
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Gutierro I, 2002, VACCINE, V20, P2181, DOI 10.1016/S0264-410X(02)00146-9
   Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323
   Huang YC, 2011, CARBOHYD POLYM, V84, P788, DOI 10.1016/j.carbpol.2010.03.034
   Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108
   Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026
   Iaci JF, 2007, J NEUROTRAUM, V24, P1743, DOI 10.1089/neu.2007.0366
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Johnson MR, 2009, ACTA BIOMATER, V5, P23, DOI 10.1016/j.actbio.2008.09.001
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144
   Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6
   Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016
   KAMEI S, 1992, BIOMATERIALS, V13, P953, DOI 10.1016/0142-9612(92)90120-D
   Kang F, 2001, AAPS PharmSciTech, V2, P30
   Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014
   Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI [10.1021/bp070352a, 10.1021/bp.070352a]
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Lam XM, 2000, J CONTROL RELEASE, V67, P281, DOI 10.1016/S0168-3659(00)00224-8
   Lee H., 2009, P NATL ACAD SCI USA, V107, P3340
   Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013
   Li SX, 2003, J NEUROSCI, V23, P4219
   Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627
   Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Ma T. C., 2014, J BIOL CHEM, V289
   Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085
   McCreedy DA, 2014, BIOMATER SCI-UK, V2, P1672, DOI 10.1039/c4bm00106k
   McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6
   Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0
   Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001
   Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022
   Mondello SE, 2015, EXP NEUROL, V267, P64, DOI 10.1016/j.expneurol.2015.02.028
   Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124
   Nakamae T, 2010, NEUROSCI LETT, V476, P14, DOI 10.1016/j.neulet.2010.03.049
   NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x
   OH TH, 1995, GLIA, V13, P319, DOI 10.1002/glia.440130408
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Pakulska MM, 2013, J CONTROL RELEASE, V171, P11, DOI 10.1016/j.jconrel.2013.06.029
   Pean JM, 1998, J CONTROL RELEASE, V56, P175, DOI 10.1016/S0168-3659(98)00086-8
   RHODES DG, 1988, CHEM PHYS LIPIDS, V49, P39, DOI 10.1016/0009-3084(88)90062-X
   Rossi Filippo, 2012, J Funct Biomater, V3, P199, DOI 10.3390/jfb3010199
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009
   Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310
   SPARGO BJ, 1995, J MICROENCAPSUL, V12, P247, DOI 10.3109/02652049509010293
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Takai C, 2011, CHEM LETT, V40, P638, DOI 10.1246/cl.2011.638
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416
   Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   YAGER P, 1984, MOL CRYST LIQ CRYST, V106, P371, DOI 10.1080/00268948408071454
   Yang YY, 2000, J CONTROL RELEASE, V69, P81, DOI 10.1016/S0168-3659(00)00291-1
   Zhao RR, 2013, EUR J NEUROSCI, V38, P2946, DOI 10.1111/ejn.12276
   Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016
NR 79
TC 21
Z9 22
U1 0
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 10
PY 2015
VL 213
BP 103
EP 111
DI 10.1016/j.jconrel.2015.06.031
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CP6KQ
UT WOS:000359996500261
PM 26122130
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, JH
   Xu, C
   Jing, YB
   Lv, SH
   Liu, SJ
   Fang, DQ
   Zhuang, JP
   Zhang, ML
   Wu, RZ
AF Zhang, Jinghuai
   Xu, Chi
   Jing, Yongbin
   Lv, Shuhui
   Liu, Shujuan
   Fang, Daqing
   Zhuang, Jinpeng
   Zhang, Milin
   Wu, Ruizhi
TI New horizon for high performance Mg-based biomaterial with uniform
   degradation behavior: Formation of stacking faults
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IN-VIVO CORROSION; MAGNESIUM ALLOYS; MECHANICAL-PROPERTIES; ORDERED
   STRUCTURE; ORTHOPEDIC BIOMATERIALS; BIODEGRADABLE IMPLANTS; VITRO
   CORROSION; CA ALLOYS; GD ALLOYS; ZR ALLOYS
AB Designing the new microstructure is an effective way to accelerate the biomedical application of magnesium (Mg) alloys. In this study, a novel Mg-8Er-1Zn alloy with profuse nano-spaced basal plane stacking faults (SFs) was prepared by combined processes of direct-chill semi-continuous casting, heat-treatment and hot-extrusion. The formation of SFs made the alloy possess outstanding comprehensive performance as the biodegradable implant material. The ultimate tensile strength (UTS: 318 MPa), tensile yield strength (TYS: 207 MPa) and elongation (21%) of the alloy with SFs were superior to those of most reported degradable Mg-based alloys. This new alloy showed acceptable biotoxicity and degradation rate (0.34 mm/year), and the latter could be further slowed down through optimizing the microstructure. Most amazing of all, the uniquely uniform in vitro/vivo corrosion behavior was obtained due to the formation of SFs. Accordingly we proposed an original corrosion mechanism for the novel Mg alloy with SFs. The present study opens a new horizon for developing new Mg-based biomaterials with highly desirable performances.
C1 [Zhang, Jinghuai; Xu, Chi; Zhang, Milin; Wu, Ruizhi] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Minist Educ, Key Lab Superlight Mat & Surface Technol, Harbin 150001, Peoples R China.
   [Jing, Yongbin; Zhuang, Jinpeng] Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin 150001, Peoples R China.
   [Lv, Shuhui] Changchun Univ Sci & Technol, Sch Mat Sci & Engn, Changchun 130022, Peoples R China.
   [Liu, Shujuan] Harbin Inst Technol, Dept Mat Phys & Chem, Harbin 150001, Peoples R China.
   [Fang, Daqing] Taiyuan Univ Sci & Technol, Sch Mat Sci & Engn, Taiyuan 030024, Peoples R China.
   [Jing, Yongbin] Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China.
RP Zhang, JH (reprint author), Harbin Engn Univ, Coll Mat Sci & Chem Engn, Minist Educ, Key Lab Superlight Mat & Surface Technol, Harbin 150001, Peoples R China.
EM jinghuaizhang@gmail.com
RI Lv, Shuhui/O-1231-2013
OI Xu, Chi/0000-0002-1299-7667
FU National Natural Science Foundation of China [51301048]
FX This work was supported by National Natural Science Foundation of China
   (51301048).
CR Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Boccaccini A. R., 2011, BIOMATERIALS, V32, P2757
   Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367
   Ding WJ, 2009, J MATER RES, V24, P1842, DOI 10.1557/JMR.2009.0215
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Egusa D, 2012, ACTA MATER, V60, P166, DOI 10.1016/j.actamat.2011.09.030
   Erinc M, 2009, MAGNESIUM TECHNOLOGY, P209
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hadorn JP, 2014, SCRIPTA MATER, V93, P28, DOI 10.1016/j.scriptamat.2014.08.022
   Hagihara K, 2010, ACTA MATER, V58, P6282, DOI 10.1016/j.actamat.2010.07.050
   Hamu G B, 2009, J ALLOY COMPD, V468, P222, DOI DOI 10.1016/J.JALLCOM.2008.01.084
   He SM, 2007, J ALLOY COMPD, V427, P316, DOI 10.1016/j.jallcom.2006.03.015
   HOFMANN G O, 1992, Clinical Materials, V10, P75, DOI 10.1016/0267-6605(92)90088-B
   Homma T, 2009, SCRIPTA MATER, V61, P644, DOI 10.1016/j.scriptamat.2009.06.003
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Izumi S, 2009, CORROS SCI, V51, P395, DOI 10.1016/j.corsci.2008.11.003
   Jian WW, 2013, MATER RES LETT, V1, P61, DOI 10.1080/21663831.2013.765927
   Kawamura Y, 2007, MATER TRANS, V48, P2986, DOI 10.2320/matertrans.MER2007142
   Li H, 2014, MATER DESIGN, V58, P43, DOI 10.1016/j.matdes.2014.01.031
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610
   Lu Y, 2014, J ALLOY COMPD, V614, P345, DOI 10.1016/j.jallcom.2014.06.078
   Mao L, 2012, MATER LETT, V88, P1, DOI 10.1016/j.matlet.2012.08.012
   Nie JF, 2012, METALL MATER TRANS A, V43A, P3891, DOI 10.1007/s11661-012-1217-2
   Peng QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03620
   Precival M., 1999, APPL SCI NUTR, V5, P1
   Qin H, 2015, BIOMATERIALS, V53, P211, DOI 10.1016/j.biomaterials.2015.02.096
   Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012
   Shao XH, 2010, ACTA MATER, V58, P4760, DOI 10.1016/j.actamat.2010.05.012
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2012, CORROS SCI, V60, P238, DOI 10.1016/j.corsci.2012.03.030
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun M, 2009, MAT SCI ENG A-STRUCT, V523, P145, DOI 10.1016/j.msea.2009.06.002
   Walker J, 2012, J BIOMED MATER RES B, V100B, P1134, DOI 10.1002/jbm.b.32680
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Woo S. L. Y., 1983, J BIOMED MATER RES, V3, P427
   Wu Z. N., 2001, FOUNDRY, V50, P583
   Yamasaki M, 2007, ACTA MATER, V55, P6798, DOI 10.1016/j.actamat.2007.08.033
   Yang L, 2013, ACTA BIOMATER, V9, P8499, DOI 10.1016/j.actbio.2013.03.017
   Yang L, 2013, ACTA BIOMATER, V9, P8475, DOI 10.1016/j.actbio.2012.10.001
   Yao HB, 2001, APPL SURF SCI, V173, P54, DOI 10.1016/S0169-4332(00)00878-3
   Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zeng RC, 2015, CORROS SCI, V96, P23, DOI 10.1016/j.corsci.2015.03.018
   Zhang C., 2010, ACTA METALL SIN, V46, P1192
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang XB, 2014, CORROS SCI, V88, P1, DOI 10.1016/j.corsci.2014.07.004
   Zhou WR, 2013, ACTA BIOMATER, V9, P8488, DOI 10.1016/j.actbio.2013.01.032
NR 54
TC 16
Z9 16
U1 2
U2 53
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 9
PY 2015
VL 5
AR 13933
DI 10.1038/srep13933
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ9DA
UT WOS:000360909900001
PM 26349676
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Grulova, I
   Slovinska, L
   Blasko, J
   Devaux, S
   Wisztorski, M
   Salzet, M
   Fournier, I
   Kryukov, O
   Cohen, S
   Cizkova, D
AF Grulova, I.
   Slovinska, L.
   Blasko, J.
   Devaux, S.
   Wisztorski, M.
   Salzet, M.
   Fournier, I.
   Kryukov, O.
   Cohen, S.
   Cizkova, D.
TI Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal
   Cord Injury Repair
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IMPROVES FUNCTIONAL RECOVERY; NERVE-FIBER GROWTH; ADULT-RAT;
   HORSERADISH-PEROXIDASE; SULFATE PROTEOGLYCANS; CORTICOSPINAL TRACT;
   DESCENDING PATHWAYS; PROSTAGLANDIN E-2; PROGENITOR CELLS; STROMAL CELLS
AB Spinal cord injury (SCI) has been implicated in neural cell loss and consequently functional motor and sensory impairment. In this study, we propose an alginate - based neurobridge enriched with/without trophic growth factors (GFs) that can be utilized as a therapeutic approach for spinal cord repair. The bioavailability of key GFs, such as Epidermal Growth factor (EGF) and basic Fibroblast Growth Factor (bFGF) released from injected alginate biomaterial to the central lesion site significantly enhanced the sparing of spinal cord tissue and increased the number of surviving neurons (choline acetyltransferase positive motoneurons) and sensory fibres. In addition, we document enhanced outgrowth of corticospinal tract axons and presence of blood vessels at the central lesion. Tissue proteomics was performed at 3, 7 and 10 days after SCI in rats indicated the presence of anti-inflammatory factors in segments above the central lesion site, whereas in segments below, neurite outgrowth factors, inflammatory cytokines and chondroitin sulfate proteoglycan of the lectican protein family were overexpressed. Collectively, based on our data, we confirm that functional recovery was significantly improved in SCI groups receiving alginate scaffold with affinity-bound growth factors (ALG + GFs), compared to SCI animals without biomaterial treatment.
C1 [Grulova, I.; Slovinska, L.; Blasko, J.; Devaux, S.; Cizkova, D.] Slovak Acad Sci, Inst Neurobiol, Ctr Excellence Brain Res, Dept Regenerat Med & Stem Cell Therapy, Kosice 04001, Slovakia.
   [Devaux, S.; Wisztorski, M.; Salzet, M.; Fournier, I.; Cizkova, D.] Univ Lille 1, Lab PRISM Prote Reponse Inflammatoire Spectrometr, INSERM U1192, F-59655 Villeneuve Dascq, France.
   [Kryukov, O.; Cohen, S.] Ben Gurion Univ Negev, Ctr Regenerat Med & Stem Cell Res, IL-84105 Beer Sheva, Israel.
   [Kryukov, O.; Cohen, S.] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
RP Cizkova, D (reprint author), Slovak Acad Sci, Inst Neurobiol, Ctr Excellence Brain Res, Dept Regenerat Med & Stem Cell Therapy, Soltesovej 4-6, Kosice 04001, Slovakia.
EM cizkova.dasa@gmail.com
RI Wisztorski, Maxence/F-4380-2010; FOURNIER, Isabelle/H-9195-2015; Michel,
   Salzet/A-7675-2011
OI Wisztorski, Maxence/0000-0003-1320-075X; FOURNIER,
   Isabelle/0000-0003-1096-5044; Michel, Salzet/0000-0003-4318-0817;
   cizkova, dasa/0000-0002-2504-3993
FU PRISM (INSERM U1192); Thermofisher (Bremen); Ministere de L'Education
   Nationale, L'Enseignement Superieur et de la Recherche; Agence Stefanick
   PHC Region Nord-Pas de Calais; SIRIC ONCOLille; Grant INCa-DGOS-Inserm
   6041aa; Universite de Lille 1;  [APVV 0472-11];  [VEGA 2/0125/15]
FX This research was supported by APVV 0472-11 (DC), VEGA 2/0125/15, PRISM
   (INSERM U1192) (MS) and Thermofisher (Bremen) and grants from Ministere
   de L'Education Nationale, L'Enseignement Superieur et de la Recherche,
   Agence Stefanick PHC (MS, DC) Region Nord-Pas de Calais (to SD), SIRIC
   ONCOLille (IF), Grant INCa-DGOS-Inserm 6041aa and Universite de Lille 1
   (SD, DC). Professor Cohen holds the Clair and Harold Oshry Professor
   Chair in Biotechnology. The authors gratefully thank Maria Spontakova
   (Institute of Neurobiology) for technical assistance with
   immunocytochemical analyses.
CR Bareyre FM, 2008, J NEUROL SCI, V265, P63, DOI 10.1016/j.jns.2007.05.004
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Bird GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-31
   Cafferty WBJ, 2008, J NEUROSCI, V28, P11998, DOI 10.1523/JNEUROSCI.3877-08.2008
   CARBONETTO S, 1983, J NEUROSCI, V3, P2324
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065
   Cizkova D, 2009, J NEUROSCI METH, V184, P88, DOI 10.1016/j.jneumeth.2009.07.030
   Cizkova D, 2015, J TISSUE ENG REGEN M, V9, P918, DOI 10.1002/term.1797
   Cizkova D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07514
   Cizkova D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00105
   Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413
   Cizkova D, 2009, CELL MOL NEUROBIOL, V29, P999, DOI 10.1007/s10571-009-9387-1
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Ferrari D, 1997, J IMMUNOL, V159, P1451
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010
   Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hua XY, 1999, NEUROSCIENCE, V89, P525, DOI 10.1016/S0306-4522(98)00488-6
   JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017
   Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Kakulas B A, 1999, J Spinal Cord Med, V22, P119
   Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   KEAST JR, 1992, J COMP NEUROL, V319, P615, DOI 10.1002/cne.903190411
   Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007
   Lam HJ, 2010, TISSUE ENG PT A, V16, P2641, DOI [10.1089/ten.tea.2009.0414, 10.1089/ten.TEA.2009.0414]
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008
   Minami T, 1999, EUR J NEUROSCI, V11, P1849, DOI 10.1046/j.1460-9568.1999.00602.x
   NADELHAFT I, 1984, J COMP NEUROL, V226, P238, DOI 10.1002/cne.902260207
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Novotna I, 2011, CELL MOL NEUROBIOL, V31, P1129, DOI 10.1007/s10571-011-9714-1
   NUDO RJ, 1988, J COMP NEUROL, V277, P53, DOI 10.1002/cne.902770105
   NUDO RJ, 1990, J COMP NEUROL, V296, P584, DOI 10.1002/cne.902960406
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Andrade MSR, 2010, BRAIN RES, V1346, P266, DOI 10.1016/j.brainres.2010.05.070
   Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2
   Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Shanbhag MS, 2010, BIOMACROMOLECULES, V11, P2936, DOI 10.1021/bm100699q
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6
   SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5
   Suzuki K, 1999, NEUROREPORT, V10, P2891, DOI 10.1097/00001756-199909290-00003
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   Svensson CI, 2005, NEUROPEPTIDES, V39, P485, DOI 10.1016/j.npep.2005.08.002
   Tan LP, 2009, J BIOMAT SCI-POLYM E, V20, P1381, DOI 10.1163/092050609X12457418874260
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Urdzikova L. M., INT J MOL SCI, V15, P11275
   Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687
   Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839
   Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Zhong YH, 2001, J REHABIL RES DEV, V38, P627
NR 76
TC 15
Z9 16
U1 1
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 8
PY 2015
VL 5
AR 13702
DI 10.1038/srep13702
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ7PI
UT WOS:000360795700001
PM 26348665
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Federico, S
   Pierce, BF
   Piluso, S
   Wischke, C
   Lendlein, A
   Neffe, AT
AF Federico, Stefania
   Pierce, Benjamin F.
   Piluso, Susanna
   Wischke, Christian
   Lendlein, Andreas
   Neffe, Axel T.
TI Design of Decorin-Based Peptides That Bind to CollagenI and their
   Potential as Adhesion Moieties in Biomaterials
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE biomaterials; collagen; gels; peptides; protein-protein interactions
ID PROTEIN-PROTEIN INTERACTIONS; I COLLAGEN; CORE; FIBRIL; FIBRILLOGENESIS;
   INHIBITION; DELIVERY; SEQUENCE
AB Mimicking the binding epitopes of protein-protein interactions by using small peptides is important for generating modular biomimetic systems. A strategy is described for the design of such bioactive peptides without accessible structural data for the targeted interaction, and the effect of incorporating such adhesion peptides in complex biomaterial systems is demonstrated. The highly repetitive structure of decorin was analyzed to identify peptides that are representative of the inner and outer surface, and it was shown that only peptides based on the inner surface of decorin bind to collagen. The peptide with the highest binding affinity for collagenI, LHERHLNNN, served to slow down the diffusion of a conjugated dye in a collagen gel, while its dimer could physically crosslink collagen, thereby enhancing the elastic modulus of the gel by one order of magnitude. These results show the potential of the identified peptides for the design of biomaterials for applications in regenerative medicine.
C1 [Federico, Stefania; Pierce, Benjamin F.; Piluso, Susanna; Wischke, Christian; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Federico, Stefania; Pierce, Benjamin F.; Piluso, Susanna; Wischke, Christian; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
   [Federico, Stefania; Pierce, Benjamin F.; Lendlein, Andreas; Neffe, Axel T.] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
RP Neffe, AT (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM axel.neffe@hzg.de
RI Neffe, Axel/H-6997-2013; Wischke, Christian/K-9651-2013; Lendlein,
   Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Wischke, Christian/0000-0001-5531-9033;
   Lendlein, Andreas/0000-0003-4126-4670; Piluso,
   Susanna/0000-0003-0508-711X
CR Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/NCHEM.1568, 10.1038/nchem.1568]
   Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0
   Carrino DA, 2003, J BIOL CHEM, V278, P17566, DOI 10.1074/jbc.M300124200
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Hindle KL, 2009, PROTEINS, V77, P342, DOI 10.1002/prot.22440
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Islam M, 2013, J BIOL CHEM, V288, P35526, DOI 10.1074/jbc.M113.504530
   Jackrel ME, 2010, ACS CHEM BIOL, V5, P553, DOI 10.1021/cb900272j
   Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200
   Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200
   Lesser G. J., 1987, PROTEIN ENG, P175
   Little LE, 2011, BIOMATERIALS, V32, P1484, DOI 10.1016/j.biomaterials.2010.10.032
   Liu Q, 2014, BIOMATERIALS, V35, P6206, DOI 10.1016/j.biomaterials.2014.04.068
   Maslovskis A, 2011, SOFT MATTER, V7, P6025, DOI 10.1039/c1sm05288h
   Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x
   Neffe AT, 2004, ANGEW CHEM INT EDIT, V43, P2937, DOI 10.1002/anie.200353271
   NEFFE AT, 2004, ANGEW CHEM, V116, P2997
   Neffe AT, 2007, J MED CHEM, V50, P3482, DOI 10.1021/jm070206b
   Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028
   Paderi JE, 2008, BIOMACROMOLECULES, V9, P2562, DOI 10.1021/bm8006852
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Pierrot C, 2012, CURR PHARM DESIGN, V18, P3522
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Raspanti M, 2007, BIOMACROMOLECULES, V8, P2087, DOI 10.1021/bm070091t
   SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877
   Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t
   Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101
   Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200
   Takahashi H, 2007, BIOMACROMOLECULES, V8, P3281, DOI 10.1021/bm700540p
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x
   Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767
NR 35
TC 6
Z9 6
U1 3
U2 38
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD SEP 7
PY 2015
VL 54
IS 37
BP 10980
EP 10984
DI 10.1002/anie.201505227
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA CQ5FK
UT WOS:000360628500053
PM 26216251
DA 2018-10-20
ER

PT J
AU Teixeira, RSS
   da Silva, AS
   Jang, JH
   Kim, HW
   Ishikawa, K
   Endo, T
   Lee, SH
   Bon, EPS
AF Sobral Teixeira, Ricardo Sposina
   da Silva, Ayla Sant'Ana
   Jang, Jae-Hyuk
   Kim, Han-Woo
   Ishikawa, Kazuhiko
   Endo, Takashi
   Lee, Seung-Hwan
   Bon, Elba P. S.
TI Combining biomass wet disk milling and endoglucanase/beta-glucosidase
   hydrolysis for the production of cellulose nanocrystals
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Cellulose nanocrystals; Cellulose microfibers; Wet disk milling;
   Enzymatic hydrolysis; Endoglucanases
ID PYROCOCCUS-HORIKOSHII; MICROCRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS;
   BEHAVIOR
AB Cellulose nanocrystals (CNCs), a biomaterial with high added value, were obtained from pure cellulose, Eucalyptus holocellulose, unbleached Kraft pulp, and sugarcane bagasse, by fibrillating these biomass substrates using wet disk milling (WDM) followed by enzymatic hydrolysis using endoglucanase/(beta-glucosidase. The hydrolysis experiments were conducted using the commercial enzyme Optimash (TM) BG or a blend of Pyrococcus horikoshii endoglucanase and Pyrococcus furiosus beta-glucosidase. The fibrillated materials and CNCs were analyzed by X-ray diffraction, atomic force microscopy, scanning electron microscopy, and the specific surface area (SSA) was measured. WDM resulted in the formation of long and twisted microfibers of 1000-5000nm in length and 4-35 nm in diameter, which were hydrolyzed into shorter and straighter CNCs of 500-1500 nm in length and 4-12 nm in diameter, with high cellulose crystallinity. Therefore, the CNC's aspect ratio was successfully adjusted by endoglucanases under mild reaction conditions, relative to the reported acidic hydrolysis method. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Sobral Teixeira, Ricardo Sposina; da Silva, Ayla Sant'Ana; Bon, Elba P. S.] Univ Fed Rio de Janeiro, Inst Chem, CT, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [da Silva, Ayla Sant'Ana] Natl Inst Technol, Minist Sci Technol & Innovat, BR-20081312 Rio De Janeiro, RJ, Brazil.
   [Jang, Jae-Hyuk; Lee, Seung-Hwan] Kangwon Natl Univ, Coll Forest & Environm Sci, Div Forest Mat Sci & Engn, Chunchen 200701, South Korea.
   [Ishikawa, Kazuhiko; Endo, Takashi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7390046, Japan.
   [Kim, Han-Woo] Korea Polar Res Inst, Div Life Sci, Inchon 406840, South Korea.
RP Lee, SH (reprint author), Kangwon Natl Univ, Coll Forest & Environm Sci, Div Forest Mat Sci & Engn, Chunchen 200701, South Korea.
EM sposina55@gmail.com; aylasantana@gmail.com; jhtojh@kangwon.ac.kr;
   hwkim@kopri.re.kr; kazu-ishikawa@aist.go.jp; t-endo@aist.go.jp;
   lshyhk@kangwon.ac.kr; elba1996@iq.ufrj.br
RI ishikawa, kazuhiko/L-8764-2018; Teixeira, Ricardo/A-2128-2013; Endo,
   Takashi/C-7461-2018; Bon, Elba/C-5331-2013; da Silva, Ayla/A-5922-2012
OI ishikawa, kazuhiko/0000-0001-9845-0461; Teixeira,
   Ricardo/0000-0002-9839-0013; Endo, Takashi/0000-0002-4580-1704; da
   Silva, Ayla/0000-0001-8466-9390
FU FINEP from the Brazilian Ministry of Science, Technology, and Innovation
   [01.09.0566.001421/08]; Japan International Cooperation Agency (JICA);
   Japan Science and Technology Agency (JST); BIOMM S/A (Montes Claros,
   Brazil)
FX This work was financed by FINEP from the Brazilian Ministry of Science,
   Technology, and Innovation (grant number 01.09.0566.001421/08), by the
   Japan International Cooperation Agency (JICA), and by the Japan Science
   and Technology Agency (JST). R. S. S. Teixeira is grateful to BIOMM S/A
   (Montes Claros, Brazil) for a postdoctoral fellowship.
CR Ando S, 2002, APPL ENVIRON MICROB, V68, P430, DOI 10.1128/AEM.68.1.430-433.2002
   Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186
   Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Chose T., 1987, PURE APPL CHEM, V59, P257
   Duran N, 2011, J CHIL CHEM SOC, V56, P672, DOI 10.4067/S0717-97072011000200011
   Filson PB, 2009, GREEN CHEM, V11, P1808, DOI 10.1039/b915746h
   Filson PB, 2009, BIORESOURCE TECHNOL, V100, P2259, DOI 10.1016/j.biortech.2008.09.062
   Neto WPF, 2013, IND CROP PROD, V42, P480, DOI 10.1016/j.indcrop.2012.06.041
   George J, 2011, INT J BIOL MACROMOL, V48, P50, DOI 10.1016/j.ijbiomac.2010.09.013
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hancock BC, 2000, INT J PHARM, V209, P27, DOI 10.1016/S0378-5173(00)00541-X
   Henriksson G, 1999, EUR J BIOCHEM, V259, P88, DOI 10.1046/j.1432-1327.1999.00011.x
   Henriksson M, 2007, EUR POLYM J, V43, P3434, DOI 10.1016/j.eurpolymj.2007.05.038
   Hideno A, 2009, BIORESOURCE TECHNOL, V100, P2706, DOI 10.1016/j.biortech.2008.12.057
   Josefsson P, 2008, BIOMACROMOLECULES, V9, P249, DOI 10.1021/bm700980b
   Kado Y, 2011, ACTA CRYSTALLOGR F, V67, P1473, DOI 10.1107/S1744309111035238
   Kilburn D.G., 1993, FDN BIOTECHNOL IND F, P281
   Kim HW, 2010, PROTEINS, V78, P496, DOI 10.1002/prot.22602
   Kim HW, 2008, ACTA CRYSTALLOGR F, V64, P1169, DOI 10.1107/S1744309108036919
   Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Rabinovich ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P850, DOI 10.1023/A:1019958419032
   Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Silva A. S., 2013, GREEN CHEM, V15, P1991
   Silva A. S. da, 2010, Bioresource Technology, V101, P7402
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Sluiter A., 2011, NRELTP51042618, P1
   Teixeira RSS, 2013, BIORESOURCE TECHNOL, V149, P551, DOI 10.1016/j.biortech.2013.09.019
   Wickholm K, 1998, CARBOHYD RES, V312, P123, DOI 10.1016/S0008-6215(98)00236-5
   Wise L. E., 1946, Paper Trade Journal, V122, P35
   Xu XZ, 2013, ACS APPL MATER INTER, V5, P2999, DOI 10.1021/am302624t
   Zhu JY, 2011, GREEN CHEM, V13, P1339, DOI 10.1039/c1gc15103g
NR 34
TC 9
Z9 9
U1 1
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD SEP 5
PY 2015
VL 128
BP 75
EP 81
DI 10.1016/j.carbpol.2015.03.087
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CK4RC
UT WOS:000356209900008
PM 26005141
OA Other Gold
DA 2018-10-20
ER

PT J
AU Narita, K
   Niinomi, M
   Nakai, M
   Suyalatu
AF Narita, Kengo
   Niinomi, Mitsuo
   Nakai, Masaaki
   Suyalatu
TI Effect of heterogeneous precipitation caused by segregation of
   substitutional and interstitial elements on mechanical properties of a
   beta-type Ti alloy
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Beta-type Ti alloy; Heterogeneous structure; Fatigue strength; Elemental
   segregation; Metallic biomaterial
ID RIGIDITY TITANIUM-ALLOY; ALPHA TITANIUM; BIOMEDICAL APPLICATIONS; PHASE
   PRECIPITATION; HIGH-TEMPERATURE; TI-29NB-13TA-4.6ZR; FIXATION;
   TRANSFORMATIONS; PERFORMANCE; MICROSCOPY
AB This study investigates the effect of heterogeneous precipitation induced by the segregation of substitutional and interstitial elements in Ti-29Nb-13Ta-4.6Zr alloy (TNTZ) on its mechanical properties. For this, samples both with and without segregation of substitutional elements were prepared, with only the latter being subjected to long-term homogenization. It was found that micro-scale segregation of substitutional elements such as Nb, Ta, and Zr does not significantly affect mechanical properties such as fatigue strength, not even if heterogeneous precipitation occurs as a result of this segregation. On the other hand, segregation of interstitial elements was achieved by controlling the aging time. The segregation of interstitial elements creates precipitate-free zones (PFZs), grain boundary (GB) plates, and Widmanstatten alpha phases with migrating O atoms that all significantly affect the mechanical properties. Specifically, the PFZs have the potential to improve fatigue life, while the Widmanstatten alpha phase increases the tensile strength and reduces the fatigue ratio, the GB-plates reduce elongation, These results indicate that the formation of a Widmanstatten alpha phase by the migration of interstitial elements has a varying influence on the tensile and fatigue properties. 0 2015 Elsevier B.V. All rights reserved.
C1 [Narita, Kengo; Niinomi, Mitsuo; Nakai, Masaaki; Suyalatu] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Narita, Kengo] Maruemu Works Co LTD, Dept Med, Daito 5740015, Japan.
   [Suyalatu] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan.
RP Narita, K (reprint author), Maruemu Works Co LTD, Dept Med, 4-7-12 Nozaki, Daito 5740015, Japan.
EM narita@imr.tohoku.ac.jp
FU Ministry of Education, Sports, Culture, Science and Technology, Japan;
   "Translational Research Network Program" from Ministry of Education,
   Sports, Culture, Science and Technology, Japan
FX The authors thank Mr. Ueta, Dido Steel Co., Ltd., for melting the alloy.
   The work was supported by Grant-In-Aid for Science Research in a
   Priority Area on "Research and Development Project on Advanced Materials
   Development and Integration of Novel Structured Metallic and Inorganic
   Materials" from the Ministry of Education, Sports, Culture, Science and
   Technology, Japan; and the "Translational Research Network Program" from
   the Ministry of Education, Sports, Culture, Science and Technology,
   Japan.
CR Ahmed T, 1998, MAT SCI ENG A-STRUCT, V243, P206, DOI 10.1016/S0921-5093(97)00802-2
   Akahori T, 2006, J JPN I MET, V70, P295, DOI 10.2320/jinstmet.70.295
   Banerjee R, 2004, ACTA MATER, V52, P377, DOI 10.1016/j.actamat.2003.09.038
   Brandes MC, 2012, MAT SCI ENG A-STRUCT, V551, P13, DOI 10.1016/j.msea.2012.04.058
   Cui WF, 2009, MAT SCI ENG A-STRUCT, V527, P258, DOI 10.1016/j.msea.2009.08.057
   Devaraj A, 2012, ACTA MATER, V60, P596, DOI 10.1016/j.actamat.2011.10.008
   FUJII H, 1991, J JPN I MET, V55, P1063, DOI 10.2320/jinstmet1952.55.10_1063
   Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064
   Hanada S, 2014, J MECH BEHAV BIOMED, V30, P140, DOI 10.1016/j.jmbbm.2013.11.002
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   INABA T, 1991, ISIJ INT, V31, P792, DOI 10.2355/isijinternational.31.792
   Kang Q, 2000, MAT SCI ENG A-STRUCT, V280, P182, DOI 10.1016/S0921-5093(99)00663-2
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Luitjering G., 2007, MAT SCI ENG A-STRUCT, V468-470, P201
   Min XH, 2012, MAT SCI ENG A-STRUCT, V554, P53, DOI 10.1016/j.msea.2012.06.009
   Min XH, 2011, MAT SCI ENG A-STRUCT, V528, P4569, DOI 10.1016/j.msea.2011.02.071
   Nag S, 2009, ACTA MATER, V57, P2136, DOI 10.1016/j.actamat.2009.01.007
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Narita K, 2014, J MECH BEHAV BIOMED, V29, P393, DOI 10.1016/j.jmbbm.2013.09.017
   Narita K, 2012, MATER LETT, V86, P178, DOI 10.1016/j.matlet.2012.07.027
   Narita K, 2012, J MECH BEHAV BIOMED, V9, P207, DOI 10.1016/j.jmbbm.2012.01.011
   Narita K, 2011, J JPN I MET, V75, P198, DOI 10.2320/jinstmet.75.198
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Ogura T., 2006, Journal of Japan Institute of Light Metals, V56, P644, DOI 10.2464/jilm.56.644
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   RAMACHANDRA C, 1993, METALL TRANS A, V24, P1273, DOI 10.1007/BF02668196
   Salib M, 2013, ACTA MATER, V61, P3758, DOI 10.1016/j.actamat.2013.03.007
   Shi XH, 2015, J ALLOY COMPD, V631, P340, DOI 10.1016/j.jallcom.2015.01.077
   Sukedai E, 2004, ULTRAMICROSCOPY, V98, P209, DOI 10.1016/j.ultramic.2003.08.014
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   WILLIAMS JC, 1972, METALL TRANS, V3, P2979, DOI 10.1007/BF02652870
   WOOD FW, 1972, MATER SCI ENG, V10, P182, DOI 10.1016/0025-5416(72)90085-7
   WOODFIELD AP, 1988, ACTA METALL MATER, V36, P507, DOI 10.1016/0001-6160(88)90082-X
NR 34
TC 3
Z9 3
U1 4
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 3
PY 2015
VL 643
BP 109
EP 118
DI 10.1016/j.msea.2015.07.002
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA CP9XX
UT WOS:000360250300014
DA 2018-10-20
ER

PT J
AU Oh, JK
   Lu, XX
   Min, YJ
   Cisneros-Zevallos, L
   Akbulut, M
AF Oh, Jun Kyun
   Lu, Xiaoxu
   Min, Younjin
   Cisneros-Zevallos, Luis
   Akbulut, Mustafa
TI Bacterially Antiadhesive, Optically Transparent Surfaces Inspired from
   Rice Leaves
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE bioinspiration; bacterial fouling optical transparency; biosensors;
   endoscopes
ID SUPERHYDROPHOBIC SURFACES; ADHESION; FORCE; SHEAR; BIOMATERIAL;
   PERFORMANCE; INTERFACES; KINETICS; COATINGS; TISSUE
AB Because of the growing prevalence of antimicrobial resistance strains, there is an increasing need to develop material surfaces that prevent bacterial attachment and contamination in the absence of antibiotic agents. Herein, we present bacterial antiadhesive materials inspired from rice leaves. "Rice leaf-like surfaces" (RLLS) were fabricated by a templateless, self-masking reactive-ion etching approach. Bacterial attachment on RLLS was characterized under both static and dynamic conditions using Gram-negative Escherichia coli O157:H7 and Gram-positive Staphylococcus aureus. RLLS surfaces showed exceptional bacterial antiadhesion properties with a >99.9% adhesion inhibition efficiency. Furthermore, the optical properties of RLLS were investigated using UV-vis-NIR spectrophotometry. In contrast to most other bacterial antiadhesive surfaces, RLLS demonstrated optical-grade transparency (i.e., >= 92% transmission). We anticipate that the combination of bacterial antiadhesion efficiency, optical grade transparency, and the convenient single-step method of preparation makes RLLS a very attractive candidate for the surfaces of biosensors; endoscopes; and microfluidic, bio-optical, lab-on-a-chip, and touchscreen devices.
C1 [Oh, Jun Kyun; Akbulut, Mustafa] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.
   [Lu, Xiaoxu; Min, Younjin] Univ Akron, Dept Polymer Engn, Akron, OH 44325 USA.
   [Cisneros-Zevallos, Luis] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA.
   [Akbulut, Mustafa] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.
RP Akbulut, M (reprint author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.
EM makbulut@tamu.edu
FU Agriculture and Food Research Initiative Competitive Grant from the USDA
   National Institute of Food and Agriculture [2011-67017-30028]; National
   Science Foundation (NSF) [1434421]; NSF [1511626]
FX This project was partially supported by Agriculture and Food Research
   Initiative Competitive Grant no. 2011-67017-30028 from the USDA National
   Institute of Food and Agriculture to MA and L.C.-Z., by National Science
   Foundation (NSF) Grant no. 1434421 to MA and J.K.O., and by NSF Grant
   no. 1511626 to X.L. and Y.M. Acknowledgment is made to the Donors of the
   American Chemical Society Petroleum Research Fund for partial support of
   this research.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   BUSSCHER HJ, 1986, APPL ENVIRON MICROB, V51, P910
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162
   Chen L, 2012, SMALL, V8, P962, DOI 10.1002/smll.201102345
   Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109
   Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h
   FUKSHANSKY L, 1991, APPL OPTICS, V30, P3145, DOI 10.1364/AO.30.003145
   Gao LC, 2006, LANGMUIR, V22, P6234, DOI 10.1021/la060254j
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hedlund C., 1993, Journal of Micromechanics and Microengineering, V3, P65, DOI 10.1088/0960-1317/3/2/006
   Hensel R, 2014, ADV MATER, V26, P2029, DOI 10.1002/adma.201305408
   Hsu CH, 2004, NANO LETT, V4, P471, DOI 10.1021/nl049925t
   Jansen H, 1996, J MICROMECH MICROENG, V6, P14, DOI 10.1088/0960-1317/6/1/002
   Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a
   Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6
   Laser DJ, 2004, J MICROMECH MICROENG, V14, pR35, DOI 10.1088/0960-1317/14/6/R01
   Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078
   Lohmuller T, 2008, NANO LETT, V8, P1429, DOI 10.1021/nl080330y
   Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028
   Ludecke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084837
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   MANDOLI DF, 1982, P NATL ACAD SCI-BIOL, V79, P2902, DOI 10.1073/pnas.79.9.2902
   Mannoor MS, 2010, P NATL ACAD SCI USA, V107, P19207, DOI 10.1073/pnas.1008768107
   Massad-Ivanir N, 2010, ADV FUNCT MATER, V20, P2269, DOI 10.1002/adfm.201000406
   McConney ME, 2009, ADV FUNCT MATER, V19, P2527, DOI 10.1002/adfm.200900606
   Min WL, 2008, ADV MATER, V20, P3914, DOI 10.1002/adma.200800791
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   Nakajima A, 1999, ADV MATER, V11, P1365, DOI 10.1002/(SICI)1521-4095(199911)11:16<1365::AID-ADMA1365>3.0.CO;2-F
   Pokroy B, 2009, ADV MATER, V21, P463, DOI 10.1002/adma.200801432
   Pranzetti A, 2012, ADV FUNCT MATER, V22, P3672, DOI 10.1002/adfm.201103067
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Rahmawan Y, 2013, J MATER CHEM A, V1, P2955, DOI 10.1039/c2ta00288d
   Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013
   RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255
   Shivapooja P, 2013, ADV MATER, V25, P1430, DOI 10.1002/adma.201203374
   SMYTH CJ, 1978, INFECT IMMUN, V22, P462
   Stoffels WW, 1998, J VAC SCI TECHNOL A, V16, P87, DOI 10.1116/1.581016
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Vogelmann TC, 1996, PHYSIOL PLANTARUM, V98, P43
   VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447
   Wu D, 2011, ADV FUNCT MATER, V21, P2927, DOI 10.1002/adfm.201002733
   Xu LB, 2012, ACS APPL MATER INTER, V4, P1118, DOI 10.1021/am201750h
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b
NR 54
TC 13
Z9 13
U1 7
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 2
PY 2015
VL 7
IS 34
BP 19274
EP 19281
DI 10.1021/acsami.5b05198
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CQ8OU
UT WOS:000360868700048
PM 26237234
DA 2018-10-20
ER

PT J
AU Cheng, C
   Tang, MC
   Wu, CS
   Simon, T
   Ko, FH
AF Cheng, Chieh
   Tang, Meng-Che
   Wu, Chung-Shu
   Simon, Turibius
   Ko, Fu-Hsiang
TI New Synthesis Route of Hydrogel through A Bioinspired Supramolecular
   Approach: Gelation, Binding Interaction, and in Vitro Dressing
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE gold nanoparticles; supramolecular; hydrogel; calcium ions; in vitro
   dressing
ID CROSS-LINKING APPROACH; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   DRUG-DELIVERY; PEPTIDE; NANOFIBERS; STABILITY; GELS; NANOMATERIALS;
   DIPEPTIDE
AB Peptide-based supramolecular hydrogels have been comprehensively investigated in biomaterial applications because of their unique bioactivity, biofunctionality, and biocompatible features. However, the presence of organic building blocks in peptide-based hydrogels often results in low mechanical stability. To expand their practical use and range of applications, it is necessary to develop the tool kit available to prepare bioinspired, peptide-based supramolecular hydrogels with improved mechanical stability. In this paper, we present an innovative electrostatic and cross-linking approach in which naphthyl-Phe-Phe-Cys (NapFFC) oligopeptides are combined with gold nanoparticles (AuNPs) and calcium ions (Ca2+) to produce peptide-based supramolecular hydrogels. We further investigate the interactions among NapFFC, AuNPs and Ca" by microscopy. The morphology of the nanofibrous network constructions and the binding forces exhibited from the hydrogel demonstrated that the combination of two mechanisms successfully enhanced the mechanical stability through the formation of a densely entangled fibrous network of peptide multimers that is attributed to the AuNP linkage and Ca2+-induced agglomeration. UV vis spectrophotometry and fluorescence analysis were also used to demonstrate the enhanced stability of the hydrogel under various conditions such as thermal, solvent erosion, pH value and sonication. All results indicate that the presence of AuNPs and Ca2+ can strengthen the prepared hydrogel by more than doubling the diameter of NapFFC nanofibers, enabling the formation of stronger frameworks and slowing the release of components. Further experiments confirmed that HeLa cells can grow on the bioinspired NapFFC-AuNP hydrogel and exhibit high cell viability and that these cells were killed on contact with a hydrogel containing a drug. Our peptide-based supramolecular hydrogels prepared from the observed electrostatic and cross-linking mechanisn exhibited a significantly improved mechanical stability, making them well suited to use as a drug carrier in hydrogel dressings and as extracellular materials (ECMs) for tissue engineering.
C1 [Cheng, Chieh; Tang, Meng-Che; Wu, Chung-Shu; Simon, Turibius; Ko, Fu-Hsiang] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
RP Ko, FH (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Univ Rd, Hsinchu 300, Taiwan.
EM fhko@mail.nctu.edu.tw
FU Ministry of Science and Technology [MOST 104-2113-M-009-008-MY3]
FX This investigation was supported by fund provided by the Ministry of
   Science and Technology (MOST 104-2113-M-009-008-MY3).
CR Adhikari B, 2011, SOFT MATTER, V7, P9259, DOI 10.1039/c1sm06330h
   Amdursky N, 2009, NANO LETT, V9, P3111, DOI 10.1021/nl9008265
   Apostolov AA, 2000, J APPL POLYM SCI, V76, P2041, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2041::AID-APP6>3.3.CO;2-Y
   Brandon V, 2009, ADV MATER, V21, P3307
   Buerkle LE, 2012, CHEM SOC REV, V41, P6089, DOI 10.1039/c2cs35106d
   Bush MF, 2008, J AM CHEM SOC, V130, P6463, DOI 10.1021/ja711343q
   de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c
   de Loos M, 2001, ANGEW CHEM INT EDIT, V40, P613, DOI 10.1002/1521-3773(20010202)40:3<613::AID-ANIE613>3.0.CO;2-K
   Ding Y, 2013, LANGMUIR, V29, P13299, DOI 10.1021/la4029639
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gao J, 2009, J AM CHEM SOC, V131, P11286, DOI 10.1021/ja9042142
   Garmo OA, 2008, ANAL CHEM, V80, P9220, DOI 10.1021/ac801437j
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Jayawarna V, 2007, BIOCHEM SOC T, V35, P535, DOI 10.1042/BST0350535
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Li Y, 2013, CHEM COMMUN, V49, P8653, DOI 10.1039/c3cc45127e
   Lin DC, 2008, SOFT MATTER, V4, P669, DOI 10.1039/b714637j
   Locke AK, 2014, ANAL CHEM, V86, P9091, DOI 10.1021/ac501791u
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Ma ML, 2010, J AM CHEM SOC, V132, P2719, DOI 10.1021/ja9088764
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Mantion A., 2011, MACROMOL BIOSCI, V7, P208
   Mantion A, 2008, J AM CHEM SOC, V130, P2517, DOI 10.1021/ja0762588
   McKay CA, 2014, ACS APPL MATER INTER, V6, P1424, DOI 10.1021/am4027423
   Nanda J, 2012, J PHYS CHEM B, V116, P12235, DOI 10.1021/jp306262t
   Pan Y, 2011, J MATER CHEM, V21, P6804, DOI 10.1039/c1jm10822k
   Panda JJ, 2010, ACS APPL MATER INTER, V2, P2839, DOI 10.1021/am1005173
   Rabotyagova OS, 2011, BIOMACROMOLECULES, V12, P269, DOI 10.1021/bm100928x
   Raeburn J, 2013, CHEM SOC REV, V42, P5143, DOI 10.1039/c3cs60030k
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shi JF, 2015, CHEM COMMUN, V51, P4899, DOI 10.1039/c4cc10374b
   TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055
   Vandermeulen GWM, 2004, MACROMOL BIOSCI, V4, P383, DOI 10.1002/mabi.200300079
   Volkringer C, 2008, CRYST GROWTH DES, V8, P685, DOI 10.1021/cg700685g
   WADE LG, 2006, ORGANIC CHEM
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xu XD, 2010, ACS APPL MATER INTER, V2, P2663, DOI 10.1021/am100484c
   Yamguchi S., 2005, J AM CHEM SOC, V127, P11835
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang YG, 2005, CHEM COMMUN, P2032, DOI 10.1039/b418267g
   Yang ZM, 2007, J MATER CHEM, V17, P850, DOI 10.1039/b611255b
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zheng JK, 2012, ACS MACRO LETT, V1, P1071, DOI 10.1021/mz3003775
   Zheng XN, 2014, ACS APPL MATER INTER, V6, P19840, DOI 10.1021/am505177c
NR 50
TC 12
Z9 12
U1 6
U2 100
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 2
PY 2015
VL 7
IS 34
BP 19306
EP 19315
DI 10.1021/acsami.5b05360
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CQ8OU
UT WOS:000360868700051
PM 26271338
DA 2018-10-20
ER

PT J
AU Jose, RR
   Brown, JE
   Polido, KE
   Omenetto, FG
   Kaplan, DL
AF Jose, Rod R.
   Brown, Joseph E.
   Polido, Katherine E.
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI Polyol-Silk Bioink Formulations as Two-Part Room-Temperature Curable
   Materials for 3D Printing
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE rapid prototyping; 3D printing; biomaterial inks; silk; self-curing
ID FIBROIN; BIOMATERIAL; SCAFFOLDS; FABRICATION; FEATURES; DROPLET; DESIGN;
   FILMS
AB Silk-based bioinks were developed for 2D and 3D printing. By incorporating nontoxic polyols into silk solutions, two-part formulations with self curing features at room temperature were generated. By varying the formulations the crystallinity of the silk polymer matrix could be controlled to support printing in 2D and 3D formats interfaced with CAD geometry and with good feature resolution. The self-curing phenomenon was tuned and exploited in order to demonstrate the formation of both structural and support materials. Biocompatible aqueous protein inks for printing that avoid the need for chemical or photo initiators and that form aqueous-stable structures with good resolution at ambient temperatures provide useful options for biofunctionalization and a broad range of applications.
C1 [Jose, Rod R.; Brown, Joseph E.; Polido, Katherine E.; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ Sci & Technol, Dept Biomed Engn, Ctr 4 Colby St, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ Sci & Technol, Dept Biomed Engn, Ctr 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [P41 EB002520, 3 P41 EB002520-09S1]; AFOSR
FX This work was supported by NIH awards P41 EB002520 and 3 P41
   EB002520-09S1 and the AFOSR.
CR Boreyko JB, 2013, J AM CHEM SOC, V135, P5545, DOI 10.1021/ja4019435
   Franca DCC, 2011, J CRANIOFAC SURG, V22, P837, DOI 10.1097/SCS.0b013e31820f367b
   Chen ZG, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269930
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Farahmandghavi F, 2012, J BIOMED MATER RES B, V100B, P1636, DOI 10.1002/jbm.b.32732
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jose R. R., 2014, J BIOMED MATER RES B, P1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mironov V, 2006, TISSUE ENG, V12, P631, DOI 10.1089/ten.2006.12.631
   Pei YZ, 2015, ACTA BIOMATER, V13, P168, DOI 10.1016/j.actbio.2014.11.016
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Senses E, 2013, LANGMUIR, V29, P2588, DOI 10.1021/la400032u
   Tao H, 2015, ADV MATER, V27, P4273, DOI 10.1002/adma.201501425
   Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005
   Vaghef Davari Farzad, 2015, Arch Iran Med, V18, P24, DOI 0151801/AIM.007
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
NR 29
TC 25
Z9 25
U1 3
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD SEP
PY 2015
VL 1
IS 9
BP 780
EP 788
DI 10.1021/acsbiomaterials.5b00160
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RS
UT WOS:000369347900007
DA 2018-10-20
ER

PT J
AU Gao, YH
   Childers, EP
   Becker, ML
AF Gao, Yaohua
   Childers, Erin P.
   Becker, Matthew L.
TI L-Leucine-Based Poly(ester urea)s for Vascular Tissue Engineering
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE resorbable; biomaterial; poly(ester urea)s; protein absorption; vascular
   tissue engineering
ID BIODEGRADABLE SYNTHETIC-POLYMERS; IN-VITRO; MECHANICAL-PROPERTIES;
   CELL-GROWTH; L-LACTIDE; DEGRADATION; GRAFTS; SCAFFOLDS; ACID; VIVO
AB Poly(ester urea)s (PEUs) derived from a-amino acids are promising for vascular tissue engineering applications. The objective of this work was to synthesize and characterize L-leucine-based PEUs and evaluate their suitability for vascular tissue engineering. Four different PEUs were prepared from di-p-toluenesulfonic acid salts of bis-L-leucine esters and triphosgene using interfacial condensation polymerizations. Mechanical testing indicated that the elastic moduli of the respective polymers were strongly dependent on the chain length of diols in the monomers. Three of the resulting PEUs showed elastic moduli that fall within the range of native blood vessels (0.16 to 12 MPa). The in vitro degradation assays over 6 months indicated that the polymers are surface eroding and no significant pH drop was observed during the degradation process. Human umbilical vein endothelial cells (HUVECs) and A-10 smooth muscle cells (A-10 SMCs) were cultured on PEU thin films. Protein studies showed the PEUs did not led to significant platelet adsorption in platelet adsorption in platelet rich plasma (PRP) after pretreatment with fibrinogen. Taken together, our data suggest that the L-leucine-based PEUs are viable candidate materials for use in vascular tissue engineering applications.
C1 [Gao, Yaohua; Childers, Erin P.; Becker, Matthew L.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Becker, Matthew L.] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
RP Becker, ML (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
EM becker@uakron.edu
FU Akron Functional Materials Center
FX The authors are thankful for financial support from the Akron Functional
   Materials Center. Drs. Fei Lin, Jinjun Zhou, and Mary Beth Wade are
   acknowledged for useful discussions and comments on the manuscript.
   Additional thanks to Prof. Fayez F. Safadi and Douglas C. Crowder from
   the Northeast Ohio Medical University (NEOMED) for the donation of PRP,
   and Prof. Hossein Tavana in Biomedical Engineering at the University of
   Akron for use of the HUVEC cells.
CR Allen RA, 2014, BIOMATERIALS, V35, P165, DOI 10.1016/j.biomaterials.2013.09.081
   Ambrose CG, 2004, ANN BIOMED ENG, V32, P171, DOI 10.1023/B:ABME.0000007802.59936.fc
   Amsden B, 2004, BIOMACROMOLECULES, V5, P1399, DOI 10.1021/bm034538j
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Dargaville BL, 2011, BIOMACROMOLECULES, V12, P3856, DOI 10.1021/bm201291e
   de Valence S, 2012, ACTA BIOMATER, V8, P3914, DOI 10.1016/j.actbio.2012.06.035
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hoglund A, 2007, BIOMACROMOLECULES, V8, P2025, DOI 10.1021/bm070292x
   Ji Q, 2013, BIOMACROMOLECULES, V14, P4099, DOI 10.1021/bm401239a
   Karimi P, 2010, MATERIALS, V3, P2346, DOI 10.3390/ma3042346
   Katsarava R, 1999, J POLYM SCI POL CHEM, V37, P391, DOI 10.1002/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Li S, 2015, BIOMACROMOLECULES, V16, P615, DOI 10.1021/bm501669u
   Li S, 2014, WIRES SYST BIOL MED, V6, P61, DOI 10.1002/wsbm.1246
   Lin F, 2013, MACROMOLECULES, V46, P9515, DOI 10.1021/ma401964e
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Melchiorri AJ, 2015, BIOMACROMOLECULES, V16, P437, DOI 10.1021/bm501853s
   Montanez MI, 2011, BIOMACROMOLECULES, V12, P2114, DOI 10.1021/bm200201y
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Neffe AT, 2010, MACROMOL CHEM PHYS, V211, P182, DOI 10.1002/macp.200900441
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Orelma H, 2012, BIOMACROMOLECULES, V13, P1051, DOI 10.1021/bm201771m
   Pang X, 2010, BIOMATERIALS, V31, P3745, DOI 10.1016/j.biomaterials.2010.01.027
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   Policastro GM, 2015, BIOMACROMOLECULES, V16, P1358, DOI 10.1021/acs.biomac.5b00153
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041
   Sauerbrey G., 1959, PHYSIK, V155, P206, DOI DOI 10.1021/AM505510M
   Sell SA, 2006, BIOMED MATER, V1, P72, DOI 10.1088/1748-6041/1/2/004
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Srinath D, 2014, J TISSUE ENG REGEN M, V8, P578, DOI 10.1002/term.1562
   Stakleff KS, 2013, ACTA BIOMATER, V9, P5132, DOI 10.1016/j.actbio.2012.08.035
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Teng ZZ, 2009, J BIOMECH, V42, P2535, DOI 10.1016/j.jbiomech.2009.07.009
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Wang ZH, 2014, BIOMATERIALS, V35, P5700, DOI 10.1016/j.biomaterials.2014.03.078
   Weir NA, 2004, P I MECH ENG H, V218, P307, DOI 10.1243/0954411041932782
   Weir NA, 2004, P I MECH ENG H, V218, P321, DOI 10.1243/0954411041932809
   Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Yu JY, 2014, MACROMOLECULES, V47, P121, DOI 10.1021/ma401752b
   Zhang Y, 2006, ANAL CHEM, V78, P2001, DOI 10.1021/ac051919+
   Zhou JJ, 2015, BIOMACROMOLECULES, V16, P266, DOI 10.1021/bm501456g
NR 56
TC 10
Z9 10
U1 5
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD SEP
PY 2015
VL 1
IS 9
BP 795
EP 804
DI 10.1021/acsbiomaterials.5b00168
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RS
UT WOS:000369347900009
DA 2018-10-20
ER

PT J
AU Nishiguchi, A
   Matsusaki, M
   Akashi, M
AF Nishiguchi, Akihiro
   Matsusaki, Michiya
   Akashi, Mitsuru
TI Structural and Viscoelastic Properties of Layer-by-Layer Extracellular
   Matrix (ECM) Nanofilms and Their Interactions with Living Cells
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE surface science; layer-by-layer assembly; extracellular matrix;
   nanofilm; QCM-D
ID SURFACE-PLASMON RESONANCE; ASSEMBLY PROCESS; DENDRITIC CELLS; IN-SITU;
   QCM-D; FILMS; ADSORPTION; IMMOBILIZATION; IMMUNOTHERAPY; CONSTRUCTION
AB Modulation of living cell surfaces by chemical and biological engineering and the control of cellular functions has enormous potential for immunotherapy, transplantation, and drug delivery. However, traditional detection techniques have limitations in the identification of physical properties of viscoelastic films and interaction with living cells in real time. Here, we present the structural analysis of extracellular matrix (ECM) based nanofilms and their interaction with living cells using a quartz crystal microbalance (QCM) with dissipation (QCM-D), multiple parameter surface plasmon resonance (SPR), and flow cytometry measurements. QCM-D measurements according to the Voigt-based viscoelastic model allowed for the evaluation of the kinetic adsorption of extracellular matrix (ECM) proteins and physical parameters of viscoelastic ECM-nanofilms in a swelled state. These results reflected the characteristics of viscoelastic films as compared to Sauerbrey's equation. Moreover, we found that gelatin molecules played a crucial role as a binder to build up layered films and control their properties. Using the multiple parameter SPR approach, we confirmed the interaction between FN-G nanofilms and living cells from signal response in real time which was different from the gold substrate-protein signal. Moreover, flow cytometry analysis supported the importance of the domain interaction between the RGD sequence in FN and integrin as a driving force to form the films on cell surfaces. The use of three different analyses supported clarification of the contribution of the protein protein interaction and viscoelastic properties of ECM films and investigation of the interaction between films and living cells. The knowledge regarding protein protein and protein cell interaction in real time would make a contribution to biomaterial design by using protein interactions for modulating the living cell surfaces in biomedical applications.
C1 [Nishiguchi, Akihiro; Matsusaki, Michiya; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
RP Akashi, M (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.
EM akashi@fbs.osaka-u.ac.jp
RI NISHIGUCHI, Akihiro/D-1084-2017
OI NISHIGUCHI, Akihiro/0000-0002-3160-6385
FU NEXT Program [LR026]; SENTAN-JST Program [13A1204];  [A232250040]; 
   [24.622]
FX This work was supported by the NEXT Program (LR026), a Grant-in-Aid for
   Scientific Research (S) (A232250040), the SENTAN-JST Program (13A1204),
   and Grand-in-Aid for JSPS Fellows (24.622).
CR Albers W.M., 2010, NANOBIOSENSING
   Banchereau J, 2001, CELL, V106, P271, DOI 10.1016/S0092-8674(01)00448-2
   Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457
   Belegrinou S, 2008, LANGMUIR, V24, P7251, DOI 10.1021/la8003454
   Buttner B, 2002, J NEUROSCI, V22, P8869
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   De Bank PA, 2003, BIOTECHNOL BIOENG, V81, P800, DOI 10.1002/bit.10525
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106
   Gong PY, 2013, ADV FUNCT MATER, V23, P42, DOI 10.1002/adfm.201201275
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52
   Jeong JH, 2013, J AM CHEM SOC, V135, P8770, DOI 10.1021/ja400636d
   Kadowaki K, 2010, LANGMUIR, V26, P5670, DOI 10.1021/la903738n
   KAYSER H, 1992, J BIOL CHEM, V267, P16934
   Kellam B, 2003, CHEM SOC REV, V32, P327, DOI 10.1039/b211643j
   Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n
   Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108
   Matsusaki M, 2012, ADV MATER, V24, P454, DOI 10.1002/adma.201103698
   Matsuzawa A, 2013, LANGMUIR, V29, P7362, DOI 10.1021/la303459v
   McHugh RS, 1999, CANCER RES, V59, P2433
   Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787
   Notley SM, 2005, J COLLOID INTERF SCI, V292, P29, DOI 10.1016/j.jcis.2005.05.057
   Reimhult E, 2003, LANGMUIR, V19, P1681, DOI 10.1021/la0263920
   Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sauerbrey G., 1959, PHYSIK, V155, P206, DOI DOI 10.1021/AM505510M
   Schasfoort R, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, pX, DOI 10.1039/9781847558220-FP010
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Viitala T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072192
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Watarai E, 2012, SENSOR ACTUAT B-CHEM, V171, P1297, DOI 10.1016/j.snb.2012.05.010
   Wilson JT, 2009, J AM CHEM SOC, V131, P18228, DOI 10.1021/ja908887v
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
NR 42
TC 4
Z9 4
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD SEP
PY 2015
VL 1
IS 9
BP 816
EP 824
DI 10.1021/acsbiomaterials.5b00188
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RS
UT WOS:000369347900011
DA 2018-10-20
ER

PT J
AU Egydio, FM
   Freitas, LG
   Sayeg, K
   Laks, M
   Oliveira, AS
   Almeida, FG
AF Egydio, Fernanda M.
   Freitas Filho, Luiz G.
   Sayeg, Kleber
   Laks, Marcus
   Oliveira, Andreia S.
   Almeida, Fernando G.
TI Acellular human glans extracellular matrix as a scaffold for tissue
   engineering: in vitro cell support and biocompatibility
SO INTERNATIONAL BRAZ J UROL
LA English
DT Article
DE Extracellular Matrix; Materials Testing; Neoplasms
ID BLADDER; COLLAGEN; RECONSTRUCTION; BIOMATERIAL; GRAFT; RAT
AB Objectives: Diseases of the genitourinary tract can lead to significant damage. Current reconstructive techniques are limited by tissue availability and compatibility. This study aims to assess if the decellularized human glans can be used as a biomaterial for penile reconstruction.
   Materials and Methods: Samples of the glans matrices were descellularized. We evaluate the presence of collagen type I and III, and elastic fibers. Biocompatibility assays were performed to assess the cytotoxic and non-cytotoxic interactions between the acellular matrix and 3T3 cells. The matrices were seeded with mesenchymal stem cells and were assessed for viability and integration of these cells. Biomechanical tests in native tissue, descellularized matrix and seeded matrix were performed to characterize their biomechanical properties.
   Results: The tissue architecture of the decellularized matrix of human glans was preserved as well as the maintenance of the biomechanical and biological properties. The analyzes of glans seeded with mesenchymal stem cells revealed the integration of these cells to the matrices, and its viability during two weeks "in vitro".
   Conclusion: The decellularization process did not alter the biological and biomechanical characteristics of the human glans. When these matrices were seeded they were able to maintain the cells integrity and vitality.
C1 [Egydio, Fernanda M.; Freitas Filho, Luiz G.; Sayeg, Kleber; Laks, Marcus] Univ Fed Sao Paulo, Dept Cirurgia, Sao Paulo, SP, Brazil.
   [Oliveira, Andreia S.] Univ Fed Sao Paulo, Dept Nefrol, Sao Paulo, SP, Brazil.
   [Almeida, Fernando G.] Univ Fed Sao Paulo, Dept Urol Feminina, Sao Paulo, SP, Brazil.
RP Freitas, LG (reprint author), Disciplina Cirurgia Pediat Sao Paulo, Rua Coronel Lisboa 667, BR-04020041 Sao Paulo, SP, Brazil.
EM luizfreitasepm@gmail.com
RI Almeida, Fernando/D-3604-2012
OI Almeida, Fernando/0000-0002-0273-4943
CR Atala A, 2009, UROL CLIN N AM, V36, P199, DOI 10.1016/j.ucl.2009.02.009
   Barbanti SH, 2011, J MATER SCI-MATER M, V22, P2377, DOI 10.1007/s10856-011-4398-0
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Dahms SE, 1998, BRIT J UROL, V82, P411
   De Castro R, 2007, J UROLOGY, V177, P1112, DOI 10.1016/j.juro.2006.10.095
   Goldberg M, 2003, CONNECT TISSUE RES, V44, P184, DOI 10.1080/03008200390152304
   Kwon TG, 2002, J UROLOGY, V168, P1754, DOI 10.1097/01.ju.0000030103.53181.7d
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Olson Jennifer L, 2011, Chonnam Med J, V47, P1, DOI 10.4068/cmj.2011.47.1.1
   Patel MN, 2011, THESCIENTIFICWORLDJO, V11, P2567, DOI 10.1100/2011/323989
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P47, DOI 10.1016/S1063-4584(05)80037-8
   Selvaggi G, 2008, CURR OPIN UROL, V18, P589, DOI 10.1097/MOU.0b013e328313679c
   Selvaggi G, 2011, NAT REV UROL, V8, P273, DOI 10.1038/nrurol.2011.46
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P67
   Silver RI, 1997, J UROLOGY, V157, P999, DOI 10.1016/S0022-5347(01)65131-0
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Van Minnen B, 2005, J MATER SCI-MATER M, V16, P221, DOI 10.1007/s10856-005-6683-2
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yoo JJ, 2000, WORLD J UROL, V18, P62, DOI 10.1007/s003450050011
NR 24
TC 4
Z9 4
U1 0
U2 2
PU BRAZILIAN SOC UROL
PI RIO DE JANEIRO
PA RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL
SN 1677-5538
EI 1677-6119
J9 INT BRAZ J UROL
JI Int. Braz J Urol
PD SEP-OCT
PY 2015
VL 41
IS 5
BP 990
EP 1001
DI 10.1590/S1677-5538.IBJU.2014.0422
PG 12
WC Urology & Nephrology
SC Urology & Nephrology
GA DB1KH
UT WOS:000368266600022
PM 26689526
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Prunty, MC
   Aung, MH
   Hanif, AM
   Allen, RS
   Chrenek, MA
   Boatright, JH
   Thule, PM
   Kundu, K
   Murthy, N
   Pardue, MT
AF Prunty, Megan C.
   Aung, Moe H.
   Hanif, Adam M.
   Allen, Rachael S.
   Chrenek, Micah A.
   Boatright, Jeffrey H.
   Thule, Peter M.
   Kundu, Kousik
   Murthy, Niren
   Pardue, Machelle T.
TI In Vivo Imaging of Retinal Oxidative Stress Using a Reactive Oxygen
   Species-Activated Fluorescent Probe
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE oxidative stress; fluorescent probes; retinal degeneration
ID BIOMATERIAL-ASSOCIATED INFLAMMATION; DIABETIC-RETINOPATHY; OCULAR
   BIOMARKERS; CORNEAL LESIONS; DAMAGE; RATS; LIGHT; SUPEROXIDE; DISEASE;
   MODEL
AB PURPOSE. In vivo methods for detecting oxidative stress in the eye would improve screening and monitoring of the leading causes of blindness: diabetic retinopathy, glaucoma, and age-related macular degeneration.
   METHODS. To develop an in vivo biomarker for oxidative stress in the eye, we tested the efficacy of a reactive oxygen species (ROS)-activated, near-infrared hydrocyanine-800CW (H-800CW) fluorescent probe in light-induced retinal degeneration (LIRD) mouse models. After intravitreal delivery in LIRD rats, fluorescent microscopy was used to confirm that the oxidized H-800CW appeared in the same retinal layers as an established ROS marker (dichlorofluorescein).
   RESULTS. Dose-response curves of increasing concentrations of intravenously injected H-800CW demonstrated linear increases in both intensity and total area of fundus hyperfluorescence in LIRD mice, as detected by scanning laser ophthalmoscopy. Fundus hyperfluorescence also correlated with the duration of light damage and functional deficits in vision after LIRD. In LIRD rats with intravitreal injections of H-800CW, fluorescent labeling was localized to photoreceptor inner segments, similar to dichlorofluorescein.
   CONCLUSIONS. Hydrocyanine-800CW detects retinal ROS in vivo and shows potential as a novel biomarker for ROS levels in ophthalmic diseases.
C1 [Prunty, Megan C.; Aung, Moe H.; Chrenek, Micah A.; Boatright, Jeffrey H.; Pardue, Machelle T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Hanif, Adam M.; Allen, Rachael S.; Boatright, Jeffrey H.; Pardue, Machelle T.] Atlanta VA Ctr Visual & Neurocognit Rehabil, Atlanta, GA USA.
   [Thule, Peter M.] Atlanta VA Med Ctr, Biomed Res, Atlanta, GA USA.
   [Thule, Peter M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA.
   [Kundu, Kousik] LI COR, Lincoln, NE USA.
   [Murthy, Niren] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
RP Pardue, MT (reprint author), Atlanta VA Med Ctr, Res Serv Oph 151, Clairmont Rd, Decatur, GA 30033 USA.
EM mpardue@emory.edu
FU Department of Veterans Affairs Rehab RD Merit Award [E0951-R];
   Department of Veterans Affairs Research Career Scientist Award [C6774S];
   National Institutes of Health (NIH) [EY016435]; NIH [R01 EY014026, P30
   EY006360]; Research to Prevent Blindness; Abraham J. and Phyllis Katz
   Foundation
FX Supported by Department of Veterans Affairs Rehab R&D Merit Award
   E0951-R (MTP) and Research Career Scientist Award C6774S (MTP), National
   Institutes of Health (NIH) EY016435 (MTP), NIH R01 EY014026 (JHB), NIH
   P30 EY006360, departmental grant from Research to Prevent Blindness, and
   a grant from the Abraham J. and Phyllis Katz Foundation (JHB).
CR Allen RS, 2014, EXP NEUROL, V254, P206, DOI 10.1016/j.expneurol.2014.02.005
   Arden GB, 2012, DOC OPHTHALMOL, V124, P15, DOI 10.1007/s10633-011-9305-y
   Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014
   Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927
   Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007
   Blasiak J, 2014, BIOMED RES INT, DOI 10.1155/2014/768026
   Boatright JH, 2006, MOL VIS, V12, P1706
   Demontis GC, 2002, INVEST OPHTH VIS SCI, V43, P2421
   Dinjaski N, 2014, BIOMATERIALS, V35, P14, DOI 10.1016/j.biomaterials.2013.09.059
   Pinazo-Duran MD, 2014, CLIN INTERV AGING, V9, P637, DOI 10.2147/CIA.S52662
   Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110
   Elahy M, 2014, J ENDOCRINOL, V222, pR129, DOI 10.1530/JOE-14-0065
   Frost S, 2010, J ALZHEIMERS DIS, V22, P1, DOI 10.3233/JAD-2010-100819
   Frost SM, 2014, MED J AUSTRALIA, V201, P128, DOI 10.5694/mja14.00924
   Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240
   Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011
   GUILLET R, 1988, INVEST OPHTH VIS SCI, V29, P949
   Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009
   Kiang AS, 2014, ADV EXP MED BIOL, V801, P783, DOI 10.1007/978-1-4614-3209-8_98
   Kim JY, 2011, J CONTROL RELEASE, V156, P398, DOI 10.1016/j.jconrel.2011.07.017
   Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/icp.21152
   Kundu K, 2010, ANGEW CHEM INT EDIT, V49, P6134, DOI 10.1002/anie.201002228
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   KUTTY RK, 1995, P NATL ACAD SCI USA, V92, P1177, DOI 10.1073/pnas.92.4.1177
   Lawson EC, 2014, J NEUROSCI, V34, P2406, DOI 10.1523/JNEUROSCI.2062-13.2014
   Lee D, 2014, APOPTOSIS, V19, P603, DOI 10.1007/s10495-013-0956-x
   Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033
   Liu Q, 2007, INVEST OPHTH VIS SCI, V48, P4580, DOI 10.1167/iovs.07-0170
   Magalotti S, 2013, MOL IMAGING BIOL, V15, P423, DOI 10.1007/s11307-013-0614-2
   Maleki S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016004
   Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x
   Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI [10.1167/10-6750, 10.1167/iovs.10-6750]
   Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC
   Noell W K, 1966, Invest Ophthalmol, V5, P450
   Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004
   Osborne NN, 2013, CURR OPIN PHARMACOL, V13, P16, DOI 10.1016/j.coph.2012.09.002
   Park SW, 2012, INVEST OPHTH VIS SCI, V53, P7718, DOI 10.1167/iovs.11-8790
   Payne AJ, 2014, INT J MOL SCI, V15, P1865, DOI 10.3390/ijms15021865
   Pinazo-Duran MD, 2013, CURR OPIN PHARMACOL, V13, P98, DOI 10.1016/j.coph.2012.10.007
   Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525
   PRITSOS CA, 1985, ANAL BIOCHEM, V150, P294, DOI 10.1016/0003-2697(85)90513-5
   Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X
   Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541
   Rayner CL, 2014, EXP EYE RES, V129, P48, DOI 10.1016/j.exer.2014.10.013
   Schoknecht K, 2014, J CEREBR BLOOD F MET, V34, P1791, DOI 10.1038/jcbfm.2014.147
   Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Suri S, 2015, J BIOMED MATER RES A, V103, P76, DOI 10.1002/jbm.a.35162
   Tas A, 2015, ACTA OPHTHALMOL, V93, pE507, DOI 10.1111/aos.12614
   Turner PV, 2005, COMPARATIVE MED, V55, P175
   Willett NJ, 2011, ANTIOXID REDOX SIGN, V15, P1369, DOI 10.1089/ars.2010.3550
   Williams M, 2013, CURR DIABETES REP, V13, P481, DOI 10.1007/s11892-013-0384-x
   Xie LQ, 2012, ARTHRITIS RHEUM-US, V64, P1899, DOI 10.1002/art.34370
   Zarebski M, 2014, PHOTOCHEM PHOTOBIOL, V90, P709, DOI 10.1111/php.12216
   Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473
NR 55
TC 16
Z9 16
U1 0
U2 18
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2015
VL 56
IS 10
BP 5862
EP 5870
DI 10.1167/iovs.15-16810
PG 9
WC Ophthalmology
SC Ophthalmology
GA DB3QL
UT WOS:000368426300020
PM 26348635
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Maridati, P
   Dellavia, C
   Pellegrini, G
   Canciani, E
   Maragno, A
   Maiorana, C
AF Maridati, Paolo
   Dellavia, Claudia
   Pellegrini, Gaia
   Canciani, Elena
   Maragno, Andrea
   Maiorana, Carlo
TI Histologic and Radiographic Comparison of Bone Scraper and Trephine Bur
   for Autologous Bone Harvesting in Maxillary Sinus Augmentation
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE autograft; bone regeneration; cone beam computed tomography; sinus
   augmentation; tissue harvesting; xenograft
ID AUTOGENOUS BONE; FLOOR AUGMENTATION; CLINICAL-OUTCOMES; CELL VIABILITY;
   PARTICLE-SIZE; IN-VITRO; BIO-OSS; GRAFTS; DIFFERENTIATION; MIXTURE
AB Purpose: The aims of this study were to investigate the best two of five common methods of collecting autologous bone (preliminary study [PS]) and to test clinically the effects of autografts harvested using a trephine bur or bone scraper for sinus augmentation surgery (main study [MS]). Materials and Methods: In the PS, five autograft samples from five patients (n = 25) were harvested with a bone scraper, round bur, piezoelectric device, implant bur, and trephine bur and were processed for histomorphometric analysis. In the MS, sinus augmentation was performed on 20 patients using bovine-derived bone substitute and autograft collected with a trephine bur (group A, n = 10) or collected with a bone scraper (group B, n = 10). Narrow implants were also placed. At 6 months, changes in graft volume were evaluated with cone beam computed tomography. The amounts of regenerated bone, residual graft, and osseointegration of the implants were assessed histologically. Results: In the PS, the trephine bur and bone scraper harvested bone chips that were medium to large and more vital than those obtained with the other tools. In the MS, no significant differences were seen between groups in terms of the amount of residual biomaterial, regenerated bone, change in graft volume, and osseointegration. Conclusion: Biologic differences between these two bone particulates may not influence regeneration and implant osseointegration in sinus augmentation when mixed with xenograft bone.
C1 [Maridati, Paolo; Dellavia, Claudia; Pellegrini, Gaia; Canciani, Elena; Maragno, Andrea; Maiorana, Carlo] Univ Milan, Dept Biomed Surg & Dent Sci, I-20122 Milan, Italy.
   [Maridati, Paolo; Maiorana, Carlo] Policlin Hosp, Dent Clin, Ca Granda Fdn, Milan, Italy.
RP Pellegrini, G (reprint author), Via Mangiagalli 31, I-20133 Milan, Italy.
EM gaiapellegrini.perio@gmail.com
RI Maiorana, Carlo/K-2244-2015
OI Maiorana, Carlo/0000-0001-8748-9483
CR Berengo M, 2006, Minerva Stomatol, V55, P189
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Chiriac G, 2005, J CLIN PERIODONTOL, V32, P994, DOI 10.1111/j.1600-051X.2005.00809.x
   CUSHING M, 1969, J PERIODONTOL, V40, P492, DOI 10.1902/jop.1969.40.8.492
   Dellavia C, 2014, CLIN IMPLANT DENT R, V16, P684, DOI 10.1111/cid.12058
   Erpenstein H, 2001, INT J PERIODONT REST, V21, P609
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Galindo-Moreno P, 2011, CLIN ORAL IMPLAN RES, V22, P857, DOI 10.1111/j.1600-0501.2010.02073.x
   Gruber R, 2006, CLIN ORAL IMPLAN RES, V17, P188, DOI 10.1111/j.1600-0501.2005.01216.x
   Gruber R, 2008, INT J ORAL MAX IMPL, V23, P417
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Jensen T, 2013, CLIN ORAL IMPLAN RES, V24, P635, DOI 10.1111/j.1600-0501.2012.02438.x
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P493, DOI [10.1089/ten.teb.2010.0035, 10.1089/ten.TEB.2010.0035]
   Klijn RJ, 2011, CLIN ORAL IMPLAN RES, V23, P409
   Marchetti C, 2007, INT J ORAL MAX IMPL, V22, P399
   Miron RJ, 2013, CLIN IMPLANT DENT R, V15, P481, DOI 10.1111/j.1708-8208.2012.00440.x
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Pejrone G, 2002, INT J ORAL MAX SURG, V31, P383, DOI 10.1054/ijom.2002.0286
   Pikdoken L, 2011, J ORAL MAXIL SURG, V69, P160, DOI 10.1016/j.joms.2010.07.036
   SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P198
   Springer ING, 2004, CLIN ORAL IMPLAN RES, V15, P205, DOI 10.1111/j.1600-0501.2004.00976.x
   Srouji S, 2010, INT J ORAL MAX SURG, V39, P793, DOI 10.1016/j.ijom.2010.03.009
   Testori T, 2013, INT J PERIODONT REST, V33, P467, DOI 10.11607/prd.1423
   Thorwarth M, 2006, ORAL SURG ORAL MED O, V101, P309, DOI 10.1016/j.tripleo.2005.04.024
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   Ullmark G, 2000, ARCH ORTHOP TRAUM SU, V120, P445, DOI 10.1007/s004029900122
   World Medical Association, 1964, DECL HELS ETH MED RE
   Yamashita M, 2010, INT J PERIODONT REST, V30, P457
NR 31
TC 2
Z9 3
U1 0
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2015
VL 30
IS 5
BP 1128
EP 1136
DI 10.11607/jomi.3810
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ7AC
UT WOS:000367251300018
PM 26394350
OA Bronze
DA 2018-10-20
ER

PT J
AU Di Stefano, DA
   Gastaldi, G
   Vinci, R
   Cinci, L
   Pieri, L
   Gherlone, E
AF Di Stefano, Danilo Alessio
   Gastaldi, Giorgio
   Vinci, Raffaele
   Cinci, Lorenzo
   Pieri, Laura
   Gherlone, Enrico
TI Histomorphometric Comparison of Enzyme-Deantigenic Equine Bone and
   Anorganic Bovine Bone in Sinus Augmentation: A Randomized Clinical Trial
   with 3-Year Follow-Up
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone remodeling; biomaterial; sinus augmentation; xenograft
ID VERTICAL RIDGE AUGMENTATION; HUMAN OSTEOCLAST FORMATION; BIO-OSS; FLOOR
   AUGMENTATION; AUTOGENOUS BONE; MORPHOGENETIC PROTEIN; IMPLANT PLACEMENT;
   MAXILLARY; COLLAGEN; SUBSTITUTE
AB Purpose: To conduct a histomorphometric investigation comparing the use of enzyme-deantigenic equine bone (EDEB) and anorganic bovine bone (ABB) for maxillary sinus augmentation. Materials and Methods: Forty patients with Cawood Class V atrophic ridges who required maxillary sinus augmentation randomly received EDEB (n = 20) or ABB (n = 20) granules. Six months later, biopsy specimens were obtained, and implants were placed. Bone specimens were subjected to histomorphometric analysis, and newly formed bone (NFB) and residual biomaterial (RB) percentages were calculated. Patients were followed up for 3 years after definitive prosthetic rehabilitation, and implant success and survival rates were determined according to the criteria of Albrektsson and Zarb. Results: All patients healed uneventfully. Histomorphometric results for the EDEB were as follows: NFB = 46.86% +/- 12.81% and RB = 11.05% +/- 9.27%. For ABB, they were: NFB = 25.12% +/- 7.25% and RB = 28.65% +/- 9.70%. The difference was significant at a .05 level of confidence both for NFB and RB. At the 3-year follow-up, the implant survival rate was identical in the two groups (100%). Conclusion: Grafting with EDEB resulted in a greater quantity of NFB at implant insertion. No significant clinical differences were observed between the two patient groups at the 3-year follow-up. EDEB was as effective as ABB for sinus augmentation.
C1 [Di Stefano, Danilo Alessio; Vinci, Raffaele; Gherlone, Enrico] Univ Vita Salute San Raffaele, Sch Dent, Milan, Italy.
   [Di Stefano, Danilo Alessio; Vinci, Raffaele; Gherlone, Enrico] IRCCS San Raffaele, Milan, Italy.
   [Gastaldi, Giorgio] Univ Brescia, Sch Dent, Brescia, Italy.
   [Cinci, Lorenzo] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth Neuro, Pharmacol & Toxicol Sect, Florence, Italy.
   [Pieri, Laura] Univ Florence, Dept Hlth Sci, Interdept Forens Med Sect, Florence, Italy.
RP Di Stefano, DA (reprint author), Via Matteo Civitali 40, I-20148 Milan, Italy.
EM distefano@centrocivitali.it
RI Gherlone, Enrico/M-7376-2016
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Albrektsson T, 1998, INT J PROSTHODONT, V11, P517
   Artese L, 2011, IMPLANT DENT, V20, P383, DOI 10.1097/ID.0b013e3182310b3d
   Baldini N, 2011, DENT MATER, V27, P61, DOI 10.1016/j.dental.2010.10.017
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   Benlidayi ME, 2009, INT J ORAL MAX IMPL, V24, P704
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bou-Gharios G, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P285, DOI 10.1016/B978-0-12-373884-4.00034-3
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Buser D, 1994, Quintessence Int, V25, P679
   Buser D, 1999, PERIODONTOL 2000, V19, P151, DOI 10.1111/j.1600-0757.1999.tb00153.x
   CAWOOD JI, 1991, INT J ORAL MAX SURG, V20, P75, DOI 10.1016/S0901-5027(05)80711-8
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   De Angelis N, 2011, INT J PERIODONT REST, V31, P383
   Di Stefano D A, 2012, Minerva Stomatol, V61, P477
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Esposito M, 2014, COCHRANE DB SYST REV, V5
   Esposito M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003607.PUB4
   Felice P, 2013, INT J PERIODONT REST, V33, P159, DOI 10.11607/prd.1098
   Froum SJ, 2008, INT J PERIODONT REST, V28, P273
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090
   Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Liu Gang, 2004, Chin J Traumatol, V7, P358
   Ludovichetti M, 2011, INT J PERIODONT REST, V31, P401
   MARINO AA, 1970, NATURE, V226, P652, DOI 10.1038/226652a0
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Misch CM, 2011, ORAL MAXIL SURG CLIN, V23, P229, DOI 10.1016/j.coms.2011.01.003
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   Perrotti V, 2009, CLIN ORAL IMPLAN RES, V20, P17, DOI 10.1111/j.1600-0501.2008.01608.x
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Piattelli Adriano, 2002, Implant Dent, V11, P370
   Pistilli R, 2013, IMPLANT DENT, V22, P8, DOI 10.1097/ID.0b013e3182777239
   Regazzoni C, 2001, BIOCHEM BIOPH RES CO, V283, P316, DOI 10.1006/bbrc.2001.4813
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   Santini S, 2011, MINERVA CHIR, V66, P63
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Stievano D, 2008, Minerva Chir, V63, P79
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tete S, 2013, EUR J HISTOCHEM, V57, P60, DOI 10.4081/ejh.2013.e10
   Tete S, 2014, J CRANIOFAC SURG, V25, P835, DOI 10.1097/SCS.0000000000000679
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zinser MJ, 2013, OR SURG OR MED OR PA, V115, P571, DOI 10.1016/j.oooo.2012.06.015
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
   Zitzmann NU, 2001, INT J PERIODONT REST, V21, P289
NR 60
TC 8
Z9 8
U1 0
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2015
VL 30
IS 5
BP 1161
EP 1167
DI 10.11607/jomi.4057
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ7AC
UT WOS:000367251300023
PM 26394355
OA Bronze
DA 2018-10-20
ER

PT J
AU Takeda, Y
   Katsutoshi, K
   Matsuzaka, K
   Inoue, T
AF Takeda, Yukihiro
   Katsutoshi, Kokubun
   Matsuzaka, Kenichi
   Inoue, Takashi
TI The Effect of Concentrated Growth Factor on Rat Bone Marrow Cells In
   Vitro and on Calvarial Bone Healing In Vivo
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone healing; bone marrow; calvarial bone defect; concentrated growth
   factor; platelet-poor plasma gel
ID PLATELET-RICH PLASMA; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION;
   OSTEOBLAST DIFFERENTIATION; STEM-CELLS; FIBRIN; REGENERATION; TGF-BETA-1
AB Purpose: Concentrated growth factor (CGF) is an autologous leukocyte- and platelet-rich fibrin biomaterial that has recently been used for bone healing therapy. Previous studies used fibrin membrane or CGF extract without fibrin without soluble factors in vitro. This study investigated the effects of CGF that contained soluble factors on cultured rat bone marrow (RBM) cells in vitro. Furthermore, the effects of CGF implanted in rat calvarial bone defects in vivo were also investigated. Materials and Methods: CGF and platelet-poor plasma (PPP) gel, which both have fibrin networks, were prepared from rat blood. For the in vitro study, CGF and PPP gel were frozen, and thin sections approximately 30 mu m thick were cut and coated onto the surfaces of cell disks. RBM cells were then harvested and cultured on the coated disks in serum-free medium. For the in vivo study, rat calvarial bone defects (3.8 mm in diameter) were created and implanted with CGF, PPP gel, or left unfilled. Results: In vitro, the actin stress fibers of RBM cells cultured on disks coated with CGF or PPP gel tended to extend more than cells cultured on uncoated disks. However, no significant difference was observed in terms of cell morphology between RBM cells cultured on CGF- and PPP gel-coated disks. Cell proliferation and osteoblastic differentiation were significantly higher in cells cultured on the CGF-coated disks than on the PPP gel-coated disks. In vivo, more new bone had formed in defects treated with CGF than in defects treated with PPP gel. Conclusion: In this preliminary study, fibrin and soluble factors in CGF promoted initial cell stretching, proliferation, and osteoblastic differentiation of RBM cells in vitro and bone regeneration in rat calvarial bone defects in vivo.
C1 [Takeda, Yukihiro; Katsutoshi, Kokubun; Matsuzaka, Kenichi; Inoue, Takashi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo 1010061, Japan.
   [Takeda, Yukihiro; Katsutoshi, Kokubun; Matsuzaka, Kenichi; Inoue, Takashi] Tokyo Dent Coll, Dept Clin Pathophysiol, Tokyo 1010061, Japan.
RP Takeda, Y (reprint author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiyoda Ku, 2-9-18 Misakichou, Tokyo 1010061, Japan.
EM takedayukihiro@tdc.ac.jp
CR Abiraman S, 2002, BIOMATERIALS, V23, P3023, DOI 10.1016/S0142-9612(02)00064-9
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Conover CA, 2000, GROWTH HORM IGF RES, V10, pS107
   Ehrenfest DMD, 2012, CURR PHARM BIOTECHNO, V13, P1145
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Eyrich D, 2006, ADV EXP MED BIOL, V585, P379
   Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x
   Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]
   Honda H, 2013, J ARTIF ORGANS, V16, P305, DOI 10.1007/s10047-013-0711-7
   Kim JM, 2014, IMPLANT DENT, V23, P168, DOI 10.1097/ID.0000000000000053
   Kobayashi M, 2012, BIOLOGICALS, V40, P323, DOI 10.1016/j.biologicals.2012.07.004
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091
   Ochiai H, 2010, J HARD TISSUE BIOL, V19, P187, DOI 10.2485/jhtb.19.187
   Oh JH, 2012, BIOMATERIALS, V33, P4089, DOI 10.1016/j.biomaterials.2012.02.028
   Plachokova AS, 2008, CLIN ORAL IMPLAN RES, V19, P539, DOI 10.1111/j.1600-0501.2008.01525.x
   Rodella LF, 2011, MICROSC RES TECHNIQ, V74, P772, DOI 10.1002/jemt.20968
   Sohn DS, 2011, IMPLANT DENT, V20, P389, DOI 10.1097/ID.0b013e31822f7a70
   Takemoto K, 2011, ORAL MED PATHOL, V15, P45
   Tanabe K, 2012, DENT MATER J, V31, P489, DOI 10.4012/dmj.2012-008
   Torigoe I, 2009, TISSUE ENG PT A, V15, P1489, DOI 10.1089/ten.tea.2008.0317
   Walsh S, 2003, BONE, V33, P80, DOI 10.1016/S8756-3282(03)00165-0
   Yokota J, 2014, INT J MOL MED, V33, P534, DOI 10.3892/ijmm.2013.1606
   Yu BH, 2014, MOL MED REP, V9, P235, DOI 10.3892/mmr.2013.1756
   Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]
NR 29
TC 6
Z9 8
U1 1
U2 23
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2015
VL 30
IS 5
BP 1187
EP 1196
DI 10.11607/jomi.3995
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ7AC
UT WOS:000367251300026
PM 26394358
OA Bronze
DA 2018-10-20
ER

PT J
AU Gooch, NW
   Hlady, V
AF Gooch, Nathan W.
   Hlady, Vladimir
TI Two surface gradients of polyethylene glycol for a reduction in protein
   adsorption
SO SURFACE INNOVATIONS
LA English
DT Article
DE adsorption; protein; surface
ID INTERNAL-REFLECTION FLUORESCENCE; GRAFTED POLY(ETHYLENE GLYCOL); BLOOD
   COMPATIBILITY; PLATELET-ADHESION; FIBRINOGEN ADSORPTION;
   PLASMA-PROTEINS; BIOMATERIALS; POLYMERS; COATINGS; DENSITY
AB Polyethylene glycol (PEG) coatings have been commonly used in reducing protein adsorption with the intent of improving a biomaterial's biocompatibility. To elucidate the role of PEG surface density in reducing protein adsorption, two types of grafted PEG surface density gradients were evaluated for the adsorption and desorption of albumin and fibrinogen, two blood proteins. PEG density gradients were characterized using contact angle measurements and X-ray photoelectron spectroscopy. Total internal reflection fluorescence was used to measure protein adsorption kinetics and adsorption profiles on the two types of PEG gradients. The PEG gradient generated by the flow method decreased adsorption of both proteins in proportion to the PEG surface density; however, their desorption by buffer solution from the grafted PEG layer was not complete. In contrast, desorption of two proteins from the grafted PEG layer generated by a UV oxidation method resulted in near-zero adsorbed amount. The difference between the two types of gradients might have originated from counter-diffusion of PEG and water molecules occurring during the flow method procedure.
C1 [Gooch, Nathan W.; Hlady, Vladimir] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Hlady, V (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM vladimir.hlady@utah.edu
FU NIH [R01 HL084586]
FX The authors acknowledge support from an NIH grant (R01 HL084586).
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907
   Corum LE, 2010, BIOMATERIALS, V31, P3148, DOI 10.1016/j.biomaterials.2010.01.025
   Ding YX, 2011, CROAT CHEM ACTA, V84, P193, DOI 10.5562/cca1821
   Fang F, 2002, LANGMUIR, V18, P5497, DOI 10.1021/la020027r
   Fang F, 2006, P NATL ACAD SCI USA, V103, P5769, DOI 10.1073/pnas.0509688103
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hlady V, 2000, SURF SCI SERIES, V88, P405
   HLADY V, 1986, J COLLOID INTERF SCI, V111, P555, DOI 10.1016/0021-9797(86)90059-7
   HLADY V, 1991, APPL SPECTROSC, V45, P246, DOI 10.1366/0003702914337533
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Ho C.-H., 1995, PROTEIN INTERFACES 9, P372
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lin Y S, 1994, Colloids Surf B Biointerfaces, V3, P49, DOI 10.1016/0927-7765(93)01114-7
   Liu J, 1996, COLLOID SURFACE B, V8, P25, DOI 10.1016/S0927-7765(96)01298-2
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Siow KS, 2015, PLASMA PROCESS POLYM, V12, P8, DOI 10.1002/ppap.201400116
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   von Recum A.F., 1998, HDB BIOMATERIALS EVA
   Vroman L, 1967, BLOOD
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 40
TC 2
Z9 2
U1 3
U2 16
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD SEP
PY 2015
VL 3
IS 3
BP 172
EP 180
DI 10.1680/jsuin.15.00005
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3BU
UT WOS:000366979900005
PM 28316787
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mazoteras, P
   Casaroli-Marano, RP
AF Mazoteras, Paloma
   Pedro Casaroli-Marano, Ricardo
TI In vitro biofilm distribution on the intraocular lens surface of
   different biomaterials
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; CATARACT-SURGERY; BACTERIAL ADHESION;
   POSTOPERATIVE ENDOPHTHALMITIS; RISK-FACTORS; ADHERENCE; PREVENTION;
   PROPHYLAXIS; EXTRACTION
AB PURPOSE: To study the disposition of bacterial adhesion to intraocular lens (IOL) biomaterials depending on the material and region of the optic IOL surface: center or peripheral edge.
   SETTING: School of Medicine, University of Barcelona, Barcelona, Spain.
   DESIGN: Experimental study.
   METHODS: For the in vivo study, IOLs were explanted from donor ocular globes without clinical symptoms of endophthalmitis. Biofilm formation was qualitatively studied by scanning electron microscopy (SEM). For the in vitro study, 5 IOL biomaterials (hydrophilic acrylic, hydrophobic acrylic, poly[methyl methacrylate] [PMMA], heparinized PMMA, and silicone) were contaminated with a biofilm-producing strain of Staphylococcus epidermidis. Bacterial densities were quantitatively (colony-forming units per area) compared by SEM and direct counting of viable adherent bacteria, according to the biomaterial, region of the IOL optic surface, and time of incubation. For SEM, bacterial adhesion was also qualitatively classified according to the characteristics of biofilm observed: structure, cocci per cluster, homogeneity of cluster distribution, and extracellular matrix production.
   RESULTS: At 3 hours of incubation, bacterial counts for hydrophilic acrylic and PMMA IOLs were significantly lower, but at 72 hours there were no statistically significant differences among biomaterials. A higher density of bacteria was observed at the periphery of the IOL's optic of assayed biomaterials for in vitro and in vivo studies. Biofilm formation and the presence of extracellular matrix were predominantly restricted to the edges of IOL optic surface.
   CONCLUSION: Bacterial adhesion and biofilm development on the IOL optic surface depended on the region and biomaterial of the IOL.
C1 [Mazoteras, Paloma; Pedro Casaroli-Marano, Ricardo] Univ Barcelona, Sch Med, Dept Surg, Barcelona, Spain.
   [Mazoteras, Paloma; Pedro Casaroli-Marano, Ricardo] Univ Barcelona, CellTec UB, Barcelona, Spain.
   [Pedro Casaroli-Marano, Ricardo] Hosp Clin Barcelona, E-08028 Barcelona, Spain.
RP Casaroli-Marano, RP (reprint author), Hosp Clin Barcelona, Inst Clin Oftalmol, Calle Sabino Arana 1,Second Floor, E-08028 Barcelona, Spain.
EM rcasaroli@ub.edu
FU Fondos de lnvestigaciones Sanitarias [FIS PI09/0992]; Instituto de Salud
   Carlos III, Madrid, Spain; Fundacio Marato TV3 [120630/2012]
FX Supported in part by Fondos de lnvestigaciones Sanitarias (FIS
   PI09/0992), Instituto de Salud Carlos III, Madrid, Spain and Fundacio
   Marato TV3 (Project: 120630/2012).
CR Baillif S, 2009, J FR OPHTALMOL, V32, P515, DOI 10.1016/j.jfo.2009.04.026
   Baillif S, 2008, J CATARACT REFR SURG, V34, P153, DOI 10.1016/j.jcrs.2007.07.058
   Baillif S, 2006, INVEST OPHTH VIS SCI, V47, P3410, DOI 10.1167/iovs.05-1070
   Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032
   Burillon C, 2002, DRUG DEV IND PHARM, V28, P95, DOI 10.1081/DDC-120001490
   Casaroli-Marano RP, 2008, ENFERM INFEC MICR CL, V26, P581, DOI 10.1157/13128276
   Ciulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5
   Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1
   Kodjikian L, 2006, J FR OPHTALMOL, V29, P74, DOI 10.1016/S0181-5512(06)73753-6
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Kodjikian L, 2004, BIO-MED MATER ENG, V14, P395
   Le Katherine Y, 2014, Front Cell Infect Microbiol, V4, P167, DOI 10.3389/fcimb.2014.00167
   Lundstrom M, 2012, J CATARACT REFR SURG, V38, P1086, DOI 10.1016/j.jcrs.2012.03.006
   Mazoteras P, 2015, CURR EYE RES, V40, P697, DOI 10.3109/02713683.2014.957327
   Montan P, 2002, ACTA OPHTHALMOL SCAN, V80, P258, DOI 10.1034/j.1600-0420.2002.800305.x
   Olson RJ, 2004, SURV OPHTHALMOL, V49, pS55, DOI 10.1016/j.survophthal.2004.01.002
   Pinna A, 2000, OPHTHALMOLOGY, V107, P1042, DOI 10.1016/S0161-6420(00)00080-4
   Schauersberger J, 2003, J CATARACT REFR SURG, V29, P361, DOI 10.1016/S0886-3350(02)01741-8
   Shimizu K, 2006, CURR EYE RES, V31, P989, DOI 10.1080/02713680601038816
   Werner L, 2007, J CATARACT REFR SURG, V33, P713, DOI 10.1016/j.jcrs.2007.01.015
   Wong TY, 2004, BRIT J OPHTHALMOL, V88, P29, DOI 10.1136/bjo.88.1.29
   Yu CQ, 2012, CURR OPIN OPHTHALMOL, V23, P19, DOI 10.1097/ICU.0b013e32834cd5a9
NR 22
TC 2
Z9 2
U1 1
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
EI 1873-4502
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD SEP
PY 2015
VL 41
IS 9
BP 1980
EP 1988
DI 10.1016/j.jcrs.2015.05.029
PG 9
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA CY2KN
UT WOS:000366237600026
PM 26603407
DA 2018-10-20
ER

PT J
AU Rodriguez-Diaz, RA
   Ramirez-Ledesma, AL
   Aguilar-Mendez, MA
   Chavarin, JU
   Gallegos, MAH
   Juarez-Islas, JA
AF Rodriguez-Diaz, R. A.
   Ramirez-Ledesma, A. L.
   Aguilar-Mendez, M. A.
   Uruchurtu Chavarin, J.
   Hernandez Gallegos, M. A.
   Juarez-Islas, J. A.
TI Electrochemical Corrosion Behavior of a Co20Cr Alloy in Artificial
   Saliva.
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Corrosion; Co-Cr alloy; dental materials; electrochemical techniques;
   artificial saliva
ID SIMULATED PHYSIOLOGICAL SOLUTION; CR-MO ALLOY; ATMOSPHERIC CORROSION;
   DENTAL ALLOYS; IRON-OXIDES; CO; CHROMIUM; STEEL; NI; OXYHYDROXIDES
AB The corrosion behavior of Co20Cr (at. %) together with 316L stainless steel (SS) in artificial saliva solution during nine immersion days at room temperature have been studied and assessed by means of electrochemical techniques. Techniques included potentiodynamic polarization curves, electrochemical impedance spectroscopy (EIS) and linear polarization resistance (LPR) measurements. Results have shown that the corrosion rate of Co20Cr alloy resulted higher as compared with that of stainless steel 316L biomaterial, using polarization curves. Besides, corrosion potential of Co-20Cr alloy resulted more active. 316 L stainless steel exhibited a more defined passivation zone, while the Co20Cr alloy exhibited a pseudo-passivation zone. Although the pitting potential of binary alloy is higher. The measured values of Rp at the end of the exposure time are related to a higher stability of the film composed by the corrosion products formed on Co20Cr alloy as compared with those of the 316 L SS, which is related to a minor corrosion rate of the CoCr alloy after the third day of immersion. Corrosion behavior is explained in terms of the stability of the corrosion products formed film.
C1 [Uruchurtu Chavarin, J.] UAEM, Ctr Invest Ingn & Ciencias Aplicadas, Col Chamilpa, Cuernavaca Mor, Mexico.
   [Rodriguez-Diaz, R. A.; Ramirez-Ledesma, A. L.; Juarez-Islas, J. A.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
   [Aguilar-Mendez, M. A.; Hernandez Gallegos, M. A.] Univ Nacl Autonoma Mexico, Fac Ingn, Mexico City 04510, DF, Mexico.
   [Rodriguez-Diaz, R. A.] Univ Politecn Estado Morelos, Jiutepec, Morelos, Mexico.
RP Rodriguez-Diaz, RA (reprint author), Univ Nacl Autonoma Mexico, Inst Invest Mat, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.
EM rdiaz.unam@gmail.com
FU CONACyT
FX The authors express their gratitude to CONACyT for the financial support
   granted for the development of this research.
CR Ameer MA, 2004, CORROS SCI, V46, P2825, DOI 10.1016/j.corsci.2004.03.011
   Anusavice KJ, 1996, PHILLIPS SCI DENT MA
   Codaro EN, 2000, RUSS J ELECTROCHEM+, V36, P1117, DOI 10.1007/BF02757531
   Cook DC, 2005, CORROS SCI, V47, P2550, DOI 10.1016/j.corsci.2004.10.018
   deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B
   Dubois F., 2008, CORROSION SCI, V50, P12
   Dunn DS, 2000, CORROSION, V56, P470, DOI 10.5006/1.3280551
   FERRACANE JA, 2001, MAT DENT PRINCIPLES
   Fraunhofer J. A. V., 1994, CORROSION, V1
   Giacomelli FC, 2004, J BRAZIL CHEM SOC, V15, P541, DOI 10.1590/S0103-50532004000400016
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Ishida K., 1990, J PHASE EQUILIB, V11, P357, DOI DOI 10.1007/BF02843315
   Jallad KN, 2001, MATER SCI TECH SER, V17, P1479, DOI 10.1179/026708301101509502
   Kamimura T, 2001, CORROS SCI, V43, P429, DOI 10.1016/S0010-938X(00)00098-6
   Kocijan A, 2004, J MATER SCI-MATER M, V15, P643, DOI 10.1023/B:JMSM.0000030204.08616.3d
   Kocijan A, 2011, CORROS SCI, V53, P776, DOI 10.1016/j.corsci.2010.11.010
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   Mansfeld F., 1985, J ORAL REHABIL, V12, P469
   Mareci D, 2005, Eur Cell Mater, V10, P1
   Mareci D, 2010, B MATER SCI, V33, P491, DOI 10.1007/s12034-010-0075-z
   Matkovic T, 2004, J ALLOY COMPD, V366, P293, DOI 10.1016/j.jallcom.2003.07.004
   Metikos-Hukovic M., 2007, ECS T, V2, P43
   Milosev I, 2003, ELECTROCHIM ACTA, V48, P2767, DOI 10.1016/S0013-4686(03)00396-7
   Nie FL, 2011, DENT MATER, V27, P677, DOI 10.1016/j.dental.2011.03.009
   O'Brien W.J, 1997, DENT MAT THEIR SELEC
   Ozcelik F, 1999, PRAKT METALLOGR-PR M, V36, P385
   Qiu J, 2011, J MATER SCI, V46, P1359, DOI 10.1007/s10853-010-4927-0
   Ramya S, 2010, CORROS SCI, V52, P2114, DOI 10.1016/j.corsci.2010.02.028
   SILVA RA, 1994, J MATER SCI-MATER M, V5, P353, DOI 10.1007/BF00058962
   Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003
   Venkatraman M., 1986, B ALLOY PHASE DIAGRA, V7, P457
   Wataha JC, 2002, J PROSTHET DENT, V87, P351, DOI 10.1067/mpr.2002.123817
   Yamanaka K, 2014, MAT SCI ENG A-STRUCT, V592, P173, DOI 10.1016/j.msea.2013.11.002
   YAMASHITA M, 1994, CORROS SCI, V36, P283, DOI 10.1016/0010-938X(94)90158-9
   YUKAWA N, 1972, METALL TRANS, V3, P887, DOI 10.1007/BF02647663
NR 36
TC 0
Z9 0
U1 2
U2 19
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD SEP
PY 2015
VL 10
IS 9
BP 7212
EP 7226
PG 15
WC Electrochemistry
SC Electrochemistry
GA CW6IS
UT WOS:000365101700029
DA 2018-10-20
ER

PT J
AU Grzesiak, J
   Kolankowski, J
   Marycz, K
AF Grzesiak, Jakub
   Kolankowski, Jakub
   Marycz, Krzysztof
TI Osteogenic Differentiation of Canine Adipose Stem Cells Cultured in
   Alginate-Fibrin-Based Hydrogel
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Mesenchymal Stem Cells; Three-Dimensional Cell Culture; Biomaterial;
   Osteogenesis; Dog
ID MARROW STROMAL CELLS; MESENCHYMAL STEM; BONE-MARROW; IN-VITRO;
   VETERINARY-MEDICINE; CALCIUM-PHOSPHATE; TISSUE; STRENGTH; FRACTURE;
   PLASMA
AB The aim of this research was to evaluate the usefulness of a novel hydrogel composed of calcium alginate and fibrin for highly efficient in vitro osteogenic differentiation of adipose stem cells isolated from canine subcutaneous adipose tissue, resulting in the deposition of natural calcium phosphate within the material. Cells were seeded in hydrogel scaffolds and analyzed morphologically. Materials colonized by CaASC (canine adipose stem cells) were introduced into osteogenic cultures for 21 days. After that time, osteogenic differentiation was evaluated using Alizarin Red staining, SEM-EDS and mapping analyses. Additionally, osteocalcin and osteopontin concentrations as well as the activity of alkaline phosphatase in culture supernatants were determined by enzyme-linked immunosorbent assays (ELISA). The results showed that CaASC successfully differentiated towards the osteoblast lineage in the tested hydrogel. Moreover, the application of hydrogel provided space, wherein the naturally formed calcium phosphate could be deposited. Therefore, the biomaterial colonized with osteogenically differentiated ASC, containing additionally bone ECM components, may be a promising tool for in vivo treatment of bone wounds in dogs. Moreover, the analyzed hydrogel may also be applied as a three-dimensional environment for in vitro culture and analysis of mesenchymal stem cells.
C1 [Grzesiak, Jakub; Kolankowski, Jakub; Marycz, Krzysztof] Univ Environm & Life Sci Wroclaw, Electron Microscopy Lab, PL-51631 Wroclaw, Poland.
RP Grzesiak, J (reprint author), Univ Environm & Life Sci Wroclaw, Electron Microscopy Lab, Kozuchowska 5b, PL-51631 Wroclaw, Poland.
RI Marycz, Krzysztof/A-2249-2017
CR Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704
   Black LL, 2007, VET THER, V8, P272
   Carrade DD, 2013, COMPARATIVE MED, V63, P207
   Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   Djouad F., 2012, J BIOMATER TISS ENG, V2, P13
   Fortier LA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt50
   Giannini G, 2004, TRANSFUS APHER SCI, V30, P139, DOI 10.1016/j.transci.2003.11.009
   Gonzalez-Garza M. T., 2014, STEM CELL DISCOVERY, V4, P1
   Grzesiak J, 2011, INT J MORPHOL, V29, P1012, DOI 10.4067/S0717-95022011000300059
   Harasen G, 2003, CAN VET J, V44, P503
   Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12
   Jarvand M, 2015, J BIOMATER TISS ENG, V5, P45, DOI 10.1166/jbt.2015.1242
   Jin XB, 2007, ACTA PHARMACOL SIN, V28, P663, DOI 10.1111/j.1745-7254.2007.00553.x
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kiraly M, 2011, NEUROCHEM INT, V59, P371, DOI 10.1016/j.neuint.2011.01.006
   Lohse N, 2012, EUR CELLS MATER, V23, P413
   Majumdar S., 2014, J ADV MED DENT SCI R, V2, P53
   Marycz K, 2012, VET MED-CZECH, V57, P610, DOI 10.17221/6469-VETMED
   Marycz K., 2013, BIOMED MAT ENG, V24, P1625
   Marycz K, 2012, J ANIM VET ADV, V11, P4324
   Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217
   Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   MOE S, 1994, J APPL POLYM SCI, V51, P1771, DOI 10.1002/app.1994.070511010
   Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334
   Ng MH, 2014, J BIOMATER TISS ENG, V4, P573, DOI 10.1166/jbt.2014.1204
   Nicpon J, 2013, POL J VET SCI, V16, P753, DOI 10.2478/pjvs-2013-0107
   Ozturk A, 2006, INT ORTHOP, V30, P147, DOI 10.1007/s00264-006-0079-x
   Richardson LE, 2007, TRENDS BIOTECHNOL, V25, P409, DOI 10.1016/j.tibtech.2007.07.009
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, P300
   VANSTRAALEN JP, 1991, CLIN CHIM ACTA, V201, P27, DOI 10.1016/0009-8981(91)90021-4
   Via Alessio Giai, 2012, Muscles Ligaments Tendons J, V2, P154
NR 33
TC 6
Z9 6
U1 1
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD SEP
PY 2015
VL 5
IS 9
BP 703
EP 710
DI 10.1166/jbt.2015.1366
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA CX2VM
UT WOS:000365554900005
DA 2018-10-20
ER

PT J
AU Periayah, MH
   Halim, AS
   Saad, AZM
   Yaacob, NS
   Hussein, AR
   Karim, FA
   Rashid, AHA
   Ujang, Z
AF Periayah, Mercy Halleluyah
   Halim, Ahmad Sukari
   Saad, Arman Zaharil Mat
   Yaacob, Nik Soriani
   Hussein, Abdul Rahim
   Karim, Faraizah Abdul
   Rashid, Ahmad Hazri Abdul
   Ujang, Zanariah
TI Effect of the Novel Biodegradable N, O-Carboxymethylchitosan and
   Oligo-Chitosan on the Platelet Thrombogenicity Cascade in von Willebrand
   Disease
SO THROMBOSIS RESEARCH
LA English
DT Article
DE Von Willebrand disease (vWD); N,O-Carboxymethylchitosan (NO-CMC);
   Oligo-Chitosan (O-C); Platelet mechanisms; Hemostasis
ID TUALANG HONEY; INFLAMMATION; AGGREGATION; ADHESION
AB Introduction: Von Willebrand disease (vWD) is the second least common hemostatic disorder in Malaysia, and it has a low prevalence. This study examined the underlying platelet thrombogenicity cascades in the presence of different formulations of chitosan-derivatives in vWD patients. This paper aimed to determine the significant influence of chitosan biomaterial in stimulating the platelet thrombogenicity cascades that involve the von Willebrand factor, Factor 8, Thromboxane A(2), P2Y(12) and Glycoprotein IIb/IIIa in vWD.
   Materials and methods: Variable chitosan formulations of N, O-Carboxymethylchitosan (NO-CMC) and Oligo-Chitosan (O-C) were tested. Fourteen vWD subjects voluntarily participated in this study after signing informed consent forms. The patient's demographic profiles, family history, type of vWD, clinical symptoms and laboratory profiles were recorded and analyzed. Enzyme-linked immunosorbent assay, flow cytometry and Western blot tests were used to determine the level of the chitosan-adhered-platelet-mechanisms.
   Results: The study revealed that most patients were predominantly affected by vWD type I. The O-C group of chitosan's scaffold pores is sufficient to allow for nutrients and cells. The O-C-stimulated-mediators are capable of initiating the platelet actions and were detected to expedite the blood coagulation processes. The oligo-group of chitosans was capable of amplifying and triggering more platelet activator's pathways via the studied mediators. The present findings suggest that the ability of each type of chitosan to coagulate blood varies depending on its chemical composition.
   Conclusion: The oligo group of chitosans is potentially capable of triggering platelet thrombogenicity cascades by activating platelets in vWD patients to form a platelet plug for hemostasis process. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Periayah, Mercy Halleluyah; Halim, Ahmad Sukari; Saad, Arman Zaharil Mat] Univ Sains Malaysia, Reconstruct Sci Unit, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia.
   [Yaacob, Nik Soriani] Univ Sains Malaysia, Dept Chem Pathol, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia.
   [Hussein, Abdul Rahim] Univ Sains Malaysia, Regenerat Med Cluster, Adv Med & Dent Inst, Kepala Batas 13200, Pulau Pinang, Malaysia.
   [Karim, Faraizah Abdul] Natl Blood Ctr, Hemophilia Clin, Kuala Lumpur 50400, Malaysia.
   [Rashid, Ahmad Hazri Abdul; Ujang, Zanariah] SIRIM Berhad, Ind Biotechnol Res Ctr, Shah Alam 40700, Selangor, Malaysia.
RP Halim, AS (reprint author), Univ Sains Malaysia, Reconstruct Sci Unit, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia.
EM jr.mercy@yahoo.com; ashalim@usm.my; armanzaharil@gmail.com;
   soriani@usm.my; rahim@amdi.usm.edu.my; faraizah@gmail.com;
   ahazri@sirim.my; zanariah@sirim.my
OI Halim, Ahmad Sukari/0000-0001-8999-6403; Mat Saad, Arman
   Zaharil/0000-0002-4003-6783
FU USM [1001/PPSP/813068]
FX This project was funded by USM Research Grant, numbered
   1001/PPSP/813068. We would like to thank Miss. Faridah MD Afandi and
   Madam. Jamaliah Daud from PDN for helping us recruit vWD patients for
   this study. In addition, we thank all of the vWD patients who donated
   their blood. We would also like to express our gratitude to Director
   General of Health Malaysia, YBhg. Datuk Dr Noor Hisham bin Abdullah for
   approving this paper to be published.
CR Ahmad I, 2012, PHOTOCHEM PHOTOBIOL, V88, P1198, DOI 10.1111/j.1751-1097.2012.01100.x
   Badawy Mohamed E. I., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/460381
   Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6
   d'Ayala GG, 2008, MOLECULES, V13, P2069, DOI 10.3390/molecules13092069
   Garbaraviciene J, 2010, EXP DERMATOL, V19, P736, DOI 10.1111/j.1600-0625.2010.01095.x
   JENNINGS LK, 1982, J BIOL CHEM, V257, P458
   Mannucci PM, 2001, BLOOD, V97, P1915, DOI 10.1182/blood.V97.7.1915
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Periayah M. H., 2014, INT J BASIC APPL SCI, V3, P532
   Periayah M. H., 2012, REGEN RES, V1, P38
   Periayah M. H., 2014, ONLINE INT INTERDISC, V4, P5
   Periayah MH, 2014, INT J PHARM SCI RES, V5, P4689, DOI 10.13040/IJPSR.0975-8232.5(11).4689-98
   Periayah MH, 2014, BIOMED RES INT, DOI 10.1155/2014/653149
   Periayah MH, 2013, INT J BIOL MACROMOL, V52, P244, DOI 10.1016/j.ijbiomac.2012.10.001
   Periayah MH, PREVALENCE VON UNPUB
   Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x
   Venes D., 2009, TABERS CYCLOPEDIC ME
   Wagner WR, 1996, J SURG RES, V66, P100, DOI 10.1006/jsre.1996.0379
   Yaacob NS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-106
NR 19
TC 0
Z9 0
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD SEP
PY 2015
VL 136
IS 3
BP 625
EP 633
DI 10.1016/j.thromres.2015.07.027
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CX6GT
UT WOS:000365799900022
PM 26254703
DA 2018-10-20
ER

PT J
AU Mu, JS
   Niu, HX
   Zhang, JQ
   Hu, P
   Bo, P
   Wang, Y
AF Mu, Junsheng
   Niu, Hongxing
   Zhang, Jianqun
   Hu, Ping
   Bo, Ping
   Wang, Yan
TI Examination of bone marrow mesenchymal stem cells seeded onto poly
   (3-hydroxybutyrate-co-4-hydroxybutyrate) biological materials for
   myocardial patch
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE Bone marrow mesenchymal stem cell; Myocardial infarction myocardial
   regeneration; Poly(3-hydroxybutyrate-co-4-hydroxybutyrate)
ID IN-VITRO; THERAPY; PEPTIDE; TRANSPLANTATION; REPAIR; HEART;
   DIFFERENTIATION; REGENERATION; NANOFIBERS; INFARCTION
AB The implantation of bone marrow mesenchymal stem cells (BMSCs) into the heart has been reported to be effective for myocardial infarction; however, it is unknown what methods are most suitable for supporting stem cell growth in a myocardial patch. This study used a new polymer material composed of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] co-cultured with BMSCs to create a myocardial patch. Bone marrow mesenchymal stem cells were obtained from healthy male BSL-C57 mice. The cells were treated with 5-azacytidine to investigate their differentiation into cardiomyocytes. The cells were seeded for 24-hours onto P(3HB-co-4HB) biological material films (n=8). Cell-biomaterial constructs were fixed and analyzed using different methods. Bone marrow mesenchymal stem cells were CD34, CD45(-), CD90(+) (low), and CD73(+) . The cells were stained with anti-cardiac troponin T (anti-cTnT) and anti-connexin 43 (anti-CX43) antibodies after 5-azacytidine treatment. Scanning electron microscopy showed that BMSC morphology was normal, and cell numbers were more abundant on the P(3HB-co-4HB) material surfaces. The growth curve of BMSCs on the biomaterial patches showed that the P(3HB-co-4HB) material permitted good stem cell growth. Owing to its excellent biocompatibility and biodegradability properties, in particular its porosity, P(3HB-co-4HB) is highlighted as an optimal material to support myocardial cell growth and myocardial patch formation in patients with myocardial infarction.
C1 [Mu, Junsheng; Niu, Hongxing; Zhang, Jianqun; Bo, Ping] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiac Surg, Beijing 100029, Peoples R China.
   [Hu, Ping; Wang, Yan] Tsinghua Univ, Polymer Res Inst, Dept Chem Engn, Beijing 100084, Peoples R China.
RP Mu, JS (reprint author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiac Surg, Beijing 100029, Peoples R China.
EM wesleymu@hotmail.com
FU Beijing High Technique Professor Funding [2011-3-065]; Beijing Chaoyang
   District Research Project Fund [SF1218]
FX This study was supported by grants from Beijing High Technique Professor
   Funding (No. 2011-3-065) and Beijing Chaoyang District Research Project
   Fund (No. SF1218).
CR Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066
   Antonitsis P, 2008, THORAC CARDIOV SURG, V56, P77, DOI 10.1055/s-2007-989328
   Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dimmeler S, 2008, ARTERIOSCL THROM VAS, V28, P208, DOI 10.1161/ATVBAHA.107.155317
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Hamada K, 2008, J BIOMED MATER RES A, V84A, P128, DOI 10.1002/jbm.a.31439
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Park BW, 2012, DIFFERENTIATION, V83, P249, DOI 10.1016/j.diff.2012.02.008
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172
   Saeed H, 2012, STEM CELL REV REP, V8, P318, DOI 10.1007/s12015-011-9315-x
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Thornhoff JR, 2008, BRAIN RES, V1187, P42
   Valarmathi MT, 2010, BIOMATERIALS, V31, P3185, DOI 10.1016/j.biomaterials.2010.01.041
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SH, 2006, J CELL BIOCHEM, V99, P1132, DOI 10.1002/jcb.20949
   Zhou Q, 2010, J THORAC CARDIOV SUR, V140, P1388, DOI 10.1016/j.jtcvs.2010.02.036
NR 30
TC 0
Z9 0
U1 1
U2 16
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0147-8885
EI 2046-0236
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD SEP
PY 2015
VL 38
IS 3
BP 83
EP 90
DI 10.1179/2046023615Y.0000000006
PG 8
WC Cell Biology
SC Cell Biology
GA CX0KO
UT WOS:000365385500004
DA 2018-10-20
ER

PT J
AU Novajra, G
   Perdika, P
   Pisano, R
   Miola, M
   Bari, A
   Jones, JR
   Detsch, R
   Boccaccini, AR
   Vitale-Brovarone, C
AF Novajra, G.
   Perdika, P.
   Pisano, R.
   Miola, M.
   Bari, A.
   Jones, J. R.
   Detsch, R.
   Boccaccini, A. R.
   Vitale-Brovarone, C.
TI Structure optimisation and biological evaluation of bone scaffolds
   prepared by co-sintering of silicate and phosphate glasses
SO Advances in Applied Ceramics
LA English
DT Article
DE Bone scaffold; Silicate glass; Phosphate glass; Co-sintering; Gel cast
   foaming; Microcomputed tomography; Cell test
ID CERAMIC SCAFFOLDS; BIOACTIVE GLASS; BIOMATERIAL; FABRICATION; STRENGTH;
   POROSITY; 45S5
AB A degradable phosphate glass (ICEL) and a bioactive silicate glass (CEL2) were mixed in different ratios (wt-%: 100% ICEL, 70% ICEL-30% CEL2, 30% ICEL-70% CEL2, 100% CEL2; codes 100-0, 70-30, 30-70, 0-100) and then co-sintered to obtain three-dimensional porous scaffolds by gel casting foaming. Thermal analyses were carried out on the glass mixtures and were used as a starting point for the optimisation of the scaffold sintering treatment. The microcomputed tomography and field emission scanning electron microscope analyses allowed the selection of the optimal sintering temperature to obtain an adequate structure in terms of total and open porosity. The scaffolds showed an increasing solubility with increasing ICEL glass content, and for 30-70 and 0-100, the precipitation of hydroxyapatite in simulated body fluid was observed. In vitro tests indicated that all the scaffolds showed no cytotoxic effect. The co-sintering of silicate and phosphate glasses showed to be a promising strategy to tailor the scaffold osteoconductivity, degradation and bioactivity.
C1 [Novajra, G.; Perdika, P.; Pisano, R.; Miola, M.; Bari, A.; Vitale-Brovarone, C.] Politecn Torino, Inst Mat Phys & Engn, Dept Appl Sci & Technol, I-10129 Turin, Italy.
   [Jones, J. R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Detsch, R.; Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Vitale-Brovarone, C (reprint author), Politecn Torino, Inst Mat Phys & Engn, Dept Appl Sci & Technol, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM chiara.vitale@polito.it
RI Jones, Julian/B-1007-2012; Boccaccini, Aldo/C-7905-2013; Vitale
   Brovarone, Chiara/G-9630-2012
OI Jones, Julian/0000-0002-2647-8024; Vitale Brovarone,
   Chiara/0000-0003-2413-5594
FU European Union's Seventh Framework Programme [GlaCERCo GA 264526]
FX The research leading to these results has received funding from the
   European Union's Seventh Framework Programme managed by REA-Research
   Executive Agency http://ec.europa.eu/research/rea and it participates in
   a Marie Curie Action (GlaCERCo GA 264526).
CR Abou Neel E. A., 2011, BIOMATER, V1, P285
   Baino F., 2011, J BIOMATER APPL, V27, P872
   Bretcanu O, 2014, J BIOMATER APPL, V28, P1287, DOI 10.1177/0885328213506759
   Brovarone CV, 2006, J MATER SCI-MATER M, V17, P1069, DOI 10.1007/s10856-006-0533-8
   Chen J, 2013, ADV APPL CERAM, V112, P436, DOI 10.1179/1743676113Y.0000000099
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Chen ZC, 2015, ADV APPL CERAM, V114, P183, DOI 10.1179/1743676114Y.0000000213
   Detsch R., 2012, ADV ENG MATER, V14, P38
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Gong WL, 2001, J BIOMED MATER RES, V54, P320, DOI 10.1002/1097-4636(20010305)54:3<320::AID-JBM20>3.0.CO;2-E
   Hench LL, 2009, J EUR CERAM SOC, V29, P1257, DOI 10.1016/j.jeurceramsoc.2008.08.002
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Jalota S, 2007, J BIOMED MATER RES B, V80B, P304, DOI 10.1002/jbm.b.30598
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Leonardi E, 2010, ACTA BIOMATER, V6, P598, DOI 10.1016/j.actbio.2009.07.017
   Liu X, 2011, ACTA BIOMATER, V7, P406, DOI 10.1016/j.actbio.2010.08.025
   Mondal B, 2014, ADV APPL CERAM, V113, P129, DOI 10.1179/1743676113Y.0000000126
   Sepulveda P, 2001, CHEM MATER, V13, P3882, DOI 10.1021/cm0102180
   Shilo AE, 2003, SCI SINTER, V35, P117, DOI 10.2298/SOS0303117S
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Vitale-Brovarone C, 2011, J BIOMATER APPL, V26, P465, DOI 10.1177/0885328210372149
   Vitale-Brovarone C, 2009, J MATER SCI-MATER M, V20, P2197, DOI 10.1007/s10856-009-3788-z
   Vitale-Brovarone C, 2009, J MATER SCI-MATER M, V20, P643, DOI 10.1007/s10856-008-3605-0
   Wu ZY, 2011, ACTA BIOMATER, V7, P1807, DOI 10.1016/j.actbio.2010.11.041
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 25
TC 4
Z9 4
U1 0
U2 9
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1743-6753
EI 1743-6761
J9 ADV APPL CERAM
JI Adv. Appl. Ceram.
PD SEP
PY 2015
VL 114
SU 1
BP S48
EP S55
DI 10.1179/1743676115Y.0000000035
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA CV7DV
UT WOS:000364433500008
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhu, YL
   Zhu, RQ
   Ma, J
   Weng, ZQ
   Wang, Y
   Shi, XL
   Li, YC
   Yan, XD
   Dong, Z
   Xu, JK
   Tang, CZ
   Jin, L
AF Zhu, Yinglan
   Zhu, Ruiqiao
   Ma, Juan
   Weng, Zhiqiang
   Wang, Yang
   Shi, Xiaolei
   Li, Yicai
   Yan, Xiaodong
   Dong, Zhen
   Xu, Jinke
   Tang, Chengzhong
   Jin, Lei
TI In vitro cell proliferation evaluation of porous nano-zirconia scaffolds
   with different porosity for bone tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE zirconia; scaffold; porosity; pore size; cell culture; compressive
   strength
ID MARROW STROMAL CELLS; SEEDING DENSITY; ADHESION; BIOMATERIAL; CERAMICS;
   STRENGTH; SURFACES; BEHAVIOR; GROWTH; DISKS
AB The selection of scaffold materials and the optimization of scaffold morphological and mechanical properties are critical for successful bone tissue engineering. We fabricated porous scaffolds of nano-sized zirconia using a replication technique. The study aimed to explore the relationship between porosity, pore size, mechanical strength, cell adhesion, and cell proliferation in the zirconia scaffolds. Macro-and micro-structures and compressive strength were comparatively tested. Beagle bone marrow stromal cells were seeded onto the scaffolds to evaluate cell seeding efficiency and cell proliferation profile over 14 d of incubation. The zirconia scaffolds presented a complex porous structure with good interconnectivity of pores. By increasing the sinter cycles, the porosity and pore size of the scaffolds decreased, with mean values ranging from 92.7-68.0% and 830-577 mu m, respectively, accompanied by increased compressive strengths of 0.6-4.4 MPa. Cell seeding efficiency and cell proliferation over the first 7 d of incubation increased when the porosity decreased, with cell viability highest in the scaffold with a porosity of 75.2%. After 7 d of incubation, the cell proliferation increased when the porosity increased, highest in the scaffolds with a porosity of 92.7%. These results showed that the zirconia scaffold with a porosity of 75.2% possesses favorable mechanical and biological properties for future applications in bone tissue engineering.
C1 [Zhu, Yinglan; Zhu, Ruiqiao; Ma, Juan] Southern Med Univ, Jinling Hosp, Dept Stomatol, Guangzhou 510282, Guangdong, Peoples R China.
   [Weng, Zhiqiang] Nanjing Med Univ, Sch Clin, Jinling Med Sch, Jinling Hosp,Dept Outpatient, Nanjing 210002, Jiangsu, Peoples R China.
   [Wang, Yang] Nanjing Univ, Natl Lab Solid State Microstruct, Inst Mat Engn, Nanjing 210093, Jiangsu, Peoples R China.
   [Wang, Yang] Nanjing Univ, Coll Engn & Appl Sci, Nanjing 210093, Jiangsu, Peoples R China.
   [Wang, Yang] Nanjing Univ, Jinling Med Sch, Jinling Hosp, Dept Stomatol, Nanjing 210002, Jiangsu, Peoples R China.
   [Shi, Xiaolei; Li, Yicai; Dong, Zhen; Tang, Chengzhong] Nanjing Med Univ, Sch Clin, Jinling Med Sch, Jinling Hosp,Dept Stomatol, Nanjing 210002, Jiangsu, Peoples R China.
   [Yan, Xiaodong] Nanjing Med Univ, Sch Clin, Jinling Hosp, Dept Stomatol, Nanjing 210002, Jiangsu, Peoples R China.
   [Xu, Jinke] Nanjing Med Univ, Sch Clin, Jinling Med Sch, Jinling Hosp,Dept Stomatol, Nanjing 210002, Jiangsu, Peoples R China.
   [Jin, Lei] Second Mil Med Univ, Sch Med, Nanjing Med Univ, Clin Sch,Southern Med Univ,Jinling Hosp,Dept Stom, Nanjing 210002, Jiangsu, Peoples R China.
   [Jin, Lei] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710023, Shaanxi, Peoples R China.
RP Zhu, YL (reprint author), Southern Med Univ, Jinling Hosp, Dept Stomatol, Guangzhou 510282, Guangdong, Peoples R China.
EM Ljin@nju.edu.cn
FU National Nature Science Foundation of China Grant [81071261, 81571817];
   Jiangsu Provincial Fund for Distinguished Young Scholars [BK20140031];
   Jiangsu Provincial Talent Project [BRA2011234]
FX This work was supported by National Nature Science Foundation of China
   Grant (No. 81071261 and 81571817), Jiangsu Provincial Fund for
   Distinguished Young Scholars (No. BK20140031), and Jiangsu Provincial
   Talent Project (No. BRA2011234).
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chiara G, 2012, INT J MOL SCI, V13, P737, DOI 10.3390/ijms13010737
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Fostad G, 2009, J EUR CERAM SOC, V29, P2773, DOI 10.1016/j.jeurceramsoc.2009.03.017
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   HEISE U, 1990, INT ORTHOP, V14, P329
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim K, 2009, BIOMACROMOLECULES, V10, P1810, DOI 10.1021/bm900240k
   Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pittayachawan P, 2009, J BIOMED MATER RES B, V88B, P366, DOI 10.1002/jbm.b.31064
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tiainen H, 2010, J MATER SCI-MATER M, V21, P2783, DOI 10.1007/s10856-010-4142-1
   Toh YC, 2005, BIOMATERIALS, V26, P4149, DOI 10.1016/j.biomaterials.2004.10.033
   Wang Y, 2012, J MED POSTGRADUATES, V25, P635
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Xu L, 2012, J MATER SCI-MATER M, V23, P1073, DOI 10.1007/s10856-012-4558-x
NR 30
TC 9
Z9 9
U1 6
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2015
VL 10
IS 5
AR 055009
DI 10.1088/1748-6041/10/5/055009
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CV1XN
UT WOS:000364051500010
PM 26391576
DA 2018-10-20
ER

PT J
AU Madurantakam, P
   Yoganarasimha, S
   Hasan, FK
AF Madurantakam, Parthasarathy
   Yoganarasimha, Suyog
   Hasan, Fadi K.
TI Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 103; Wound Healing; Platelet Concentrates;
   Leukocyte-Platelet Rich Fibrin; Suture Retention Strength; Uniaxial
   Tensile Testing; Genipin Crosslinking
ID PLASMA GEL; PRP-GEL; ELASTICITY; RELEASE; GENIPIN
AB Autologous platelet concentrates represent promising innovative tools in the field of regenerative medicine and have been extensively used in oral surgery. Unlike platelet rich plasma (PRP) that is a gel or a suspension, Leukocyte-Platelet Rich Fibrin (L-PRF) is a solid 3D fibrin membrane generated chair-side from whole blood containing no anti-coagulant. The membrane has a dense three dimensional fibrin matrix with enriched platelets and abundant growth factors. L-PRF is a popular adjunct in surgeries because of its superior handling characteristics as well as its suturability to the wound bed. The goal of the study is to demonstrate generation as well as provide detailed characterization of relevant properties of L-PRF that underlie its clinical success.
C1 [Madurantakam, Parthasarathy] Virginia Commonwealth Univ, Sch Dent, Dept Gen Practice, Richmond, VA 23284 USA.
   [Yoganarasimha, Suyog] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.
   [Hasan, Fadi K.] Virginia Commonwealth Univ, Sch Dent, Dept Periodont, Richmond, VA 23284 USA.
RP Madurantakam, P (reprint author), Virginia Commonwealth Univ, Sch Dent, Dept Gen Practice, Richmond, VA 23284 USA.
EM madurantakap@vcu.edu
FU CTSA from National Center for Advancing Translational Sciences)
   [UL1TR000058]; CCTR Endowment Fund of Virginia Commonwealth University
FX The project was supported by CTSA (UL1TR000058) from the National Center
   for Advancing Translational Sciences) and the CCTR Endowment Fund of
   Virginia Commonwealth University. The contents are solely the
   responsibility of the authors and do not necessarily represent official
   views of the National Center for Advancing Translational Sciences or the
   National Institutes of Health.
CR American National Standard, 2001, 719819982001 ANSIAAM, P33
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102
   Del Corso M, 2012, CURR PHARM BIOTECHNO, V13, P1207, DOI 10.2174/138920112800624391
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan DM, 2006, ORAL SURG ORAL MED O, V101, P45, DOI DOI 10.1016/J.TRIPLE0.2005.07.009
   Dohan Ehrenfest DM, 2009, TRENDS BIOTECHNOL, V27, P158, DOI DOI 10.1016/J.TIBTECH.2008.11.009
   Ehrenfest DMD, 2012, CURR PHARM BIOTECHNO, V13, P1145
   Ehrenfest DMD, 2010, ORAL SURG ORAL MED O, V110, P413, DOI 10.1016/j.tripleo.2010.05.057
   Fernandez-Barbero JE, 2006, CLIN ORAL IMPLAN RES, V17, P687, DOI 10.1111/j.1600-0501.2006.01179.x
   Gorczyca G, 2014, CARBOHYD POLYM, V102, P901, DOI 10.1016/j.carbpol.2013.10.060
   Guilak F, 2014, J BIOMECH, V47, P1933, DOI 10.1016/j.jbiomech.2014.04.019
   Guilak F, 2014, J BIOMECH, V47, P1931, DOI 10.1016/j.jbiomech.2014.04.003
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x
   Mine Y, 2010, ACTA MED OKAYAMA, V64, P121
   Rodriguez I.A., 2014, BIOMED RES IN, V2014
   Rozman P, 2011, ADVANCES IN REGENERATIVE MEDICINE, P319
   Sell S. A., 2008, BIOMED MAT, V3
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
   Zhu J, 2013, J TISSUE ENG REGEN M, V7, P819, DOI 10.1002/term.1475
NR 24
TC 0
Z9 0
U1 0
U2 3
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD SEP
PY 2015
IS 103
AR e53221
DI 10.3791/53221
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CV4FL
UT WOS:000364222300050
PM 26485642
OA Green Published
DA 2018-10-20
ER

PT J
AU Hansen, AW
   Beltrami, LVR
   Antonini, LM
   Villarinho, DJ
   das Neves, JCK
   Marino, CEB
   Malfatti, CD
AF Hansen, Alana Witt
   Rossa Beltrami, Lilian Vanessa
   Antonini, Leonardo Marasca
   Villarinho, Denis Jardim
   Klein das Neves, Julio Cesar
   Bruno Marino, Claudia Eliana
   Malfatti, Celia de Fraga
TI Oxide Formation on NiTi Surface: Influence of the Heat Treatment Time to
   Achieve the Shape Memory
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE biomaterial; NiTi; shape-memory; heat treatment; oxide
ID MODERATE TEMPERATURES; BEHAVIOR; ROUGHNESS; OXIDATION; TITANIUM; ALLOY;
   WETTABILITY; WIRE
AB Several studies regarding superficial treatments of Nitinol (NiTi) shape-memory have been developed aiming to the improve corrosion resistance and to block the Ni release to adjacent tissues. The necessary heat treatment to achieve the shape memory effect normally occurs at temperatures between 500 and 600 degrees C. However, titanium oxide (TiO2) is formed on the NiTi surface during the shape memory process heat treatment. In this work the effects of the heat treatment time on the surface characteristics of the formed NiTi oxide, at temperatures that promote the shape-memory (530 and 570 degrees C), were evaluated. The TiO2 layers which were obtained were evaluated by X-ray diffraction (XRD), energy dispersive X-ray (EDX), scanning electron microscope (SEM), thermogravimetric analysis (TGA), wettability and roughness. The results show that by increasing the exposure time at the temperature of 570 degrees C the formation of a thicker oxide is promoted, with less superficial roughness and of a hydrophobic nature. According to the literature, these characteristics indicate that the obtained oxide layer has properties that accelerat the osseointegration process.
C1 [Hansen, Alana Witt; Rossa Beltrami, Lilian Vanessa; Antonini, Leonardo Marasca; Malfatti, Celia de Fraga] Univ Fed Rio Grande do Sul UFRGS, Lab Pesquisa Corrosao LAPEC, BR-91501970 Porto Alegre, RS, Brazil.
   [Villarinho, Denis Jardim] Univ Feevale, ICET, BR-93510250 Novo Hamburgo, RS, Brazil.
   [Klein das Neves, Julio Cesar] Univ Tecnol Fed Parana UTFPR, Dept Acad Mecan, BR-80230901 Curitiba, PR, Brazil.
   [Bruno Marino, Claudia Eliana] Univ Fed Parana UFPR, Dept Engn Mecan, BR-81531981 Curitiba, PR, Brazil.
RP Hansen, AW (reprint author), Univ Fed Rio Grande do Sul UFRGS, Lab Pesquisa Corrosao LAPEC, Av Bento Goncalves 9500,Bloco 4,Predio 75,2 Andar, BR-91501970 Porto Alegre, RS, Brazil.
EM lvrossa@yahoo.com.br
RI MALFATTI, CELIA/O-4102-2018; MARINO, CLAUDIA/H-8169-2017
OI MALFATTI, CELIA/0000-0002-0819-479X; MARINO, CLAUDIA/0000-0003-2660-4577
FU CAPES; CNPq; FAPERGS
FX The presented work was performed with support of CAPES, a Brazilian
   government agency focused on support and evaluation of graduate
   education. Authors would also like to express their gratitude to the
   financial support of the Brazilian agencies CNPq and FAPERGS.
CR [Anonymous], 1990, IARC MON EV CARC RIS, V49
   [Anonymous], 1996, 42881996 ISO
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Belaud V, 2015, TRIBOL INT, V82, P343, DOI 10.1016/j.triboint.2014.07.002
   Cai W, 2005, MAT SCI ENG A-STRUCT, V394, P78, DOI 10.1016/j.msea.2004.11.030
   Chen ZW, 2005, MAT SCI ENG A-STRUCT, V397, P356, DOI 10.1016/j.msea.2005.02.057
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dulub O, 2007, SCIENCE, V317, P1052, DOI 10.1126/science.1144787
   Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2
   Freiberg KE, 2014, ACTA BIOMATER, V10, P2290, DOI 10.1016/j.actbio.2014.01.003
   Galio AF, 2004, THESIS UFRGS PORTO A
   Gemelli E, 2007, REV MAT, V12
   Gentil V., 2003, CORROSAO
   Jones DA., 1996, PRINCIPLES PREVENTIO
   Krone L, 2005, ADV ENG MATER, V7, P613, DOI 10.1002/adem.200500029
   Lautenschlager E P, 1993, Int Dent J, V43, P245
   Mazare A, 2012, BIOELECTROCHEMISTRY, V87, P124, DOI 10.1016/j.bioelechem.2012.01.002
   Ramanathan L. V., 1988, CORROSAO SEU CONTROL
   Ribbe AP, 1971, CORROSAO TRATAMENTOS
   Svetina M, 2001, ACTA MATER, V49, P2169, DOI 10.1016/S1359-6454(01)00136-7
   Undisz A, 2012, J BIOMED MATER RES A, V100A, P1743, DOI 10.1002/jbm.a.34133
   Vargas ALM., 2007, THESIS PUCRS PORTO A
   Vojtech D, 2008, APPL SURF SCI, V254, P5664, DOI 10.1016/j.apsusc.2008.03.014
   Vojtech D, 2008, INTERMETALLICS, V16, P424, DOI 10.1016/j.intermet.2007.12.006
   Vojtech D, 2010, SURF COAT TECH, V204, P3895, DOI 10.1016/j.surfcoat.2010.05.010
   Vojtech D, 2010, METAL, V5, P18
   Wennerberg A, 1998, INT J MACH TOOL MANU, V38, P657, DOI 10.1016/S0890-6955(97)00114-4
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Xu CH, 2004, MAT SCI ENG A-STRUCT, V371, P45, DOI 10.1016/S0921-5093(103)00287-9
   Yahia H., 2000, SHAPE MEMORY IMPLANT
   Yu X, 2006, LANGMUIR, V22, P4483, DOI 10.1021/la053133c
NR 32
TC 2
Z9 2
U1 3
U2 13
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD SEP-OCT
PY 2015
VL 18
IS 5
BP 1053
EP 1061
DI 10.1590/1516-1439.022415
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA CV4TJ
UT WOS:000364259100024
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wu, YN
   Wen, F
   Gouk, SS
   Lee, EH
   Kuleshova, LL
AF Wu, Yingnan
   Wen, Feng
   Gouk, Sok Siam
   Lee, Eng Hin
   Kuleshova, Lilia L.
TI CRYOPRESERVATION STRATEGY FOR TISSUE ENGINEERING CONSTRUCTS CONSISTING
   OF HUMAN MESENHYMAL STEM CELLS AND HYDROGEL BIOMATERIALS
SO CRYOLETTERS
LA English
DT Article
DE vitrification; hydrogel; microcarrier; mesenchymal stem cell;
   chondrogenic differentiation
ID MESENCHYMAL STROMAL CELLS; HUMAN ARTICULAR-CARTILAGE; CHONDROGENIC
   DIFFERENTIATION; VITREOUS CRYOPRESERVATION; ENCAPSULATED HEPATOCYTES;
   PROGENITOR CELLS; VITRIFICATION; CULTURE; REPAIR; TRANSPLANTATION
AB BACKGROUND: The development of vitrification strategy for cell-biomaterial constructs, particularly biologically inspired nanoscale materials and hydrogels mimicking the in vivo environment is an active area. A cryopreservation strategy mimicking the in vivo environment for cell-hydrogel constructs may enhance cell proliferation and biological function. OBJECTIVE: To demonstrate the efficacy of vitrification as a platform technology involving tissue engineering and human mesenchymal stem cells (hMSCs). MATERIALS AND METHODS: Microcarriers made from alginate coated with chitosan and collagen are used. Conventional freezing and vitrification were compared. The vitrification strategy includes 10 min step-wise exposure to a vitrification solution (40% v/v EG, 0.6M sucrose) and immersion into liquid nitrogen. RESULTS: Confocal imaging of live/dead staining of hMSCs cultured on the surface of microcarriers demonstrated that vitrified cells had excellent appearance and prolonged spindle shape morphology. The proliferation ability of post-vitrified cells arbitrated to protein Ki-67 gene expression was not significantly different in comparison to untreated control, while that of post-freezing cells was almost lost. The ability of hMSCs cultured on the surface of microcarriers to proliferate has been not affected by vitrification and it was significantly better after vitrification than after conventional freezing during continuous culture. Collagen II related mRNA expression by 4 weeks post-vitrification and post-freezing showed that ability to differentiate into cartilage was sustained during vitrification and reduced during conventional freezing. No significant difference was found between control and vitrification groups only. CONCLUSION: Vitrification strategy coupled with advances in hMSC-expansion platform that completely preserves the ability of stem cells to proliferate and subsequently differentiate allows not only to reach a critical cell number, but also demonstrate prospects for effective utilization and transportation of cells with their support system, creating demand for novel biodegradable materials.
C1 [Wu, Yingnan; Lee, Eng Hin] Natl Univ Singapore, Tissue Engn Program, Singapore 117548, Singapore.
   [Wu, Yingnan; Lee, Eng Hin] Natl Univ Singapore, YLL Sch Med, Dept Orthopaed Surg, Singapore 117548, Singapore.
   [Wen, Feng; Gouk, Sok Siam; Kuleshova, Lilia L.] Natl Univ Singapore, YLL Sch Med, Natl Univ Med Inst, Low Temp Preservat Unit, Singapore 117548, Singapore.
RP Kuleshova, LL (reprint author), Natl Univ Singapore, YLL Sch Med, Natl Univ Med Inst, Low Temp Preservat Unit, Singapore 117548, Singapore.
EM kuleshova@imp.uni-hannover.de
FU NUHS Bridging Funds, Singapore [02/FY13]
FX The work was supported by NUHS Bridging Funds 02/FY13, Singapore.
CR Abazari A, 2013, CRYOBIOLOGY, V66, P201, DOI 10.1016/j.cryobiol.2013.03.001
   Araki S, 2015, ACTA ORTHOP, V86, P119, DOI 10.3109/17453674.2014.958807
   Baust JM, 2002, CELL PRESERV TECHNOL, V1, P17, DOI DOI 10.1089/15383440260073266
   Beier AF, 2013, CRYOBIOLOGY, V66, P8, DOI 10.1016/j.cryobiol.2012.10.001
   Bhakta G, 2009, BIOMATERIALS, V30, P336, DOI 10.1016/j.biomaterials.2008.09.030
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buchanan SS, 2004, STEM CELLS DEV, V13, P295, DOI 10.1089/154732804323099226
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Dahl SLM, 2006, TISSUE ENG, V12, P291, DOI 10.1089/ten.2006.12.291
   Fahy GM, 2015, METHODS MOL BIOL, V1257, P21, DOI 10.1007/978-1-4939-2193-5_2
   Farooque Tanya M, 2009, Bioprocessing (Williamsbg Va), V8, P29
   Fuller BJ, 2004, LIFE FROZEN STATE
   Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0
   Gong Z., 2014, BIOMED MATER, V5, DOI [10.1088/1748-604055005, DOI 10.1088/1748-604055005]
   Gouk SS, 2011, FERTIL STERIL, V95, P2399, DOI 10.1016/j.fertnstert.2011.03.035
   Heng B.C., BIOTECHNOL APPL BI 2, V41, P97
   Heng BC, 2004, J MICROENCAPSUL, V21, P455, DOI 10.1080/02652040410001729250
   Jomha NM, 2012, BIOMATERIALS, V33, P6061, DOI 10.1016/j.biomaterials.2012.05.007
   Jomha NM, 2010, CRYOBIOLOGY, V61, P297, DOI 10.1016/j.cryobiol.2010.10.002
   Katkov II, 2006, INT J REFRIG, V29, P346, DOI 10.1016/j.ijrefrig.2005.11.004
   Katsen-Globa A, 2014, J MATER SCI-MATER M, V25, P857, DOI 10.1007/s10856-013-5108-x
   Kelvin G.M., 2010, CRYOBIOLOGY, V60, P217
   Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Kuleshova L, 1999, HUM REPROD, V14, P3077, DOI 10.1093/humrep/14.12.3077
   Kuleshova LL, 2007, BIOMATERIALS, V28, P1585, DOI 10.1016/j.biomaterials.2006.11.047
   Kuleshova LL, 2009, CELL TRANSPLANT, V18, P135, DOI 10.3727/096368909788341298
   Kuleshova L. L., 2009, PRESERVATION HUMAN O, P36
   Kuleshova L, 2008, ACAD PR SER BIOM ENG, P363, DOI 10.1016/B978-0-12-370869-4.00013-6
   Kuleshova LL, 2002, FERTIL STERIL, V78, P449, DOI 10.1016/S0015-0282(02)03305-8
   Kuleshova LL, 2004, CRYOLETTERS, V25, P241
   Lippens E, 2010, CELLS TISSUES ORGANS, V192, P177, DOI 10.1159/000313419
   Ma AL, 2013, INT IMMUNOPHARMACOL, V16, P399, DOI 10.1016/j.intimp.2013.02.005
   Magalhaes R, 2008, CELL TRANSPLANT, V17, P813, DOI 10.3727/096368908786516765
   Magalhaes R, 2012, BIOMATERIALS, V33, P829, DOI 10.1016/j.biomaterials.2011.10.015
   Magalhaes R, 2009, BIOMATERIALS, V30, P4136, DOI 10.1016/j.biomaterials.2009.04.037
   Matsumura K, 2010, LOW TEMPERATURE MED, V36, P65
   Matsumura K, 2011, CRYOBIOLOGY, V63, P76, DOI 10.1016/j.cryobiol.2011.05.003
   Naaldijk Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-49
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   NOGAMI H, 1970, Experimental Cell Research, V63, P404, DOI 10.1016/0014-4827(70)90229-6
   Pal R, 2008, J TISSUE ENG REGEN M, V2, P436, DOI 10.1002/term.109
   Pegg DE, 2006, CRYOBIOLOGY, V52, P360, DOI 10.1016/j.cryobiol.2006.01.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planka L, 2009, ACTA VET BRNO, V78, P293, DOI 10.2754/avb200978020293
   Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Song YC, 2005, TRANSPL P, V37, P253, DOI 10.1016/j.transproceed.2004.11.027
   Tan FCK, 2007, CRYOLETTERS, V28, P445
   URIST MR, 1970, NATURE, V225, P1051, DOI 10.1038/2251051a0
   Wang L, 2006, TRANSPLANT P, V38, P2267, DOI 10.1016/j.transproceed.2006.06.048
   Wang XW, 2012, CRYOBIOLOGY, V65, P289, DOI 10.1016/j.cryobiol.2012.07.080
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Wen F, 2009, TISSUE ENG PART C-ME, V15, P105, DOI 10.1089/ten.tec.2008.0237
   Wibowo S, 2005, BIORESOURCE TECHNOL, V96, P665, DOI 10.1016/j.biortech.2004.06.024
   Wu YN, 2007, BIOMATERIALS, V28, P4056, DOI 10.1016/j.biomaterials.2007.05.039
   Wu YN, 2007, TISSUE ENG, V13, P649, DOI 10.1089/ten.2006.0075
   Xu X, 2014, J TISSUE ENG REGEN M, V8, P664, DOI 10.1002/term.1570
   Yuan T, 2014, J BIOMED MATER RES B, V102, P337, DOI 10.1002/jbm.b.33011
NR 60
TC 5
Z9 5
U1 1
U2 12
PU CRYO LETTERS
PI LONDON
PA C/O ROYAL VETERINARY COLLEGE, ROYAL COLLEGE ST, LONDON NW1 0TU, ENGLAND
SN 0143-2044
EI 1742-0644
J9 CRYOLETTERS
JI CryoLetters
PD SEP-OCT
PY 2015
VL 36
IS 5
BP 325
EP 335
PG 11
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA CU8YP
UT WOS:000363830300006
PM 26574680
DA 2018-10-20
ER

PT J
AU Hu, JW
   Qian, SY
   Sun, JN
   Lu, YB
   Hu, P
AF Hu Ji-Wen
   Qian Sheng-You
   Sun Jia-Na
   Lu Yun-Bin
   Hu Ping
TI Microflow-induced shear stress on biomaterial wall by ultrasound-induced
   encapsulated microbubble oscillation
SO CHINESE PHYSICS B
LA English
DT Article
DE encapsulated microbubble; shear stress; sonoporation
ID CAVITATION BUBBLES; CONTRAST AGENTS; SONOPORATION; DYNAMICS; BOUNDARY;
   CELLS
AB A model of an ultrasound-driven encapsulated microbubble (EMB) oscillation near biomaterial wall is presented and used for describing the microflow-induced shear stress on the wall by means of a numerical method. The characteristic of the model lies in the explicit treatment of different types of wall for the EMB responses. The simulation results show that the radius-time change trends obtained by our model are consistent with the existing models and experimental results. In addition, the effect of the elastic wall on the acoustic EMB response is stronger than that of the rigid wall, and the shear stress on the elastic wall is larger than that of the rigid wall. The closer the EMB to the wall, the greater the shear stress on the wall. The substantial shear stress on the wall surface occurs inside a circular zone with a radius about two-thirds of the bubble radius. This paper may be of interest in the study of potential damage mechanisms to the microvessel for drug and gene delivery due to sonoporation.
C1 [Hu Ji-Wen; Sun Jia-Na; Lu Yun-Bin; Hu Ping] Univ South China, Sch Math & Phys, Hengyang 421001, Peoples R China.
   [Hu Ji-Wen; Qian Sheng-You] Hunan Normal Univ, Sch Phys & Informat Sci, Changsha 410081, Hunan, Peoples R China.
RP Qian, SY (reprint author), Hunan Normal Univ, Sch Phys & Informat Sci, Changsha 410081, Hunan, Peoples R China.
EM syqian@foxmail.com
FU National Natural Science Foundation of China [11174077, 11474090];
   Natural Science Foundation of Hunan Province, China [13JJ3076]; Science
   Research Program of Education Department of Hunan Province, China
   [14A127]; University of South China [2011XQD46]
FX Projects supported by the National Natural Science Foundation of China
   (Grant Nos. 11174077 and 11474090), the Natural Science Foundation of
   Hunan Province, China (Grant No. 13JJ3076), the Science Research Program
   of Education Department of Hunan Province, China (Grant No. 14A127), and
   the Doctoral Fund of University of South China (Grant No. 2011XQD46).
CR Brenner MP, 2002, REV MOD PHYS, V74, P425, DOI 10.1103/RevModPhys.74.425
   Brujan EA, 2001, J FLUID MECH, V433, P251, DOI 10.1017/S0022112000003347
   Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301
   Doinikov AA, 2011, PHYS MED BIOL, V56, P6951, DOI 10.1088/0031-9155/56/21/012
   Doinikov AA, 2010, J ACOUST SOC AM, V128, P11, DOI 10.1121/1.3419775
   Garbin V, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713164
   Glaser R, 2001, BIOPHYSICS-USSR, P87
   Gregorcic P, 2007, J APPL PHYS, V102, DOI 10.1063/1.2805645
   Hallow DM, 2006, ULTRASOUND MED BIOL, V32, P1111, DOI 10.1016/j.ultrasmedbio.2006.03.008
   Kaddur K, 2010, IEEE T ULTRASON FERR, V57, P1558, DOI 10.1109/TUFFC.2010.1586
   Karshafian R, 2010, ULTRASONICS, V50, P691, DOI 10.1016/j.ultras.2010.01.009
   Krasovitski B, 2004, IEEE T ULTRASON FERR, V51, P973, DOI 10.1109/TUFFC.2004.1324401
   Lamb H., 1945, HYDRODYNAMICS
   LEWIN PA, 1982, J ACOUST SOC AM, V71, P728, DOI 10.1121/1.387549
   Mettin R, 1997, PHYS REV E, V56, P2924, DOI 10.1103/PhysRevE.56.2924
   Mo RY, 2011, ACTA PHYS SIN-CH ED, V60
   Mukundakrishnan K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3153310
   Ni BY, 2012, ACTA MECH SINICA-PRC, V28, P1248, DOI 10.1007/s10409-012-0147-y
   NYBORG WL, 1958, J ACOUST SOC AM, V30, P329, DOI 10.1121/1.1909587
   Ohl CD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2337506
   Qin SP, 2010, J ACOUST SOC AM, V128, P1511, DOI 10.1121/1.3409476
   Samtaney R, 2014, FLUIDS ENG, V137
   Shao WH, 2014, ACTA PHYS SIN-CH ED, V63, DOI 10.7498/aps.63.204702
   Shen YY, 2013, CHINESE SCI BULL, V58, P291, DOI 10.1007/s11434-012-5546-8
   Sun L, 2013, BIOMATERIALS, V34, P2107, DOI 10.1016/j.biomaterials.2012.11.041
   Sundaram J, 2003, BIOPHYS J, V84, P3087, DOI 10.1016/S0006-3495(03)70034-4
   van Wamel A, 2006, J CONTROL RELEASE, V112, P149, DOI 10.1016/j.jconrel.2006.02.007
   Wang CH, 2014, ACTA PHYS SIN-CH ED, V63, DOI 10.7498/aps.63.134301
   Wang L, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/12/124302
   Ward M, 2000, ULTRASOUND MED BIOL, V26, P1169, DOI 10.1016/S0301-5629(00)00260-X
   Ward M, 1999, J ACOUST SOC AM, V105, P2951, DOI 10.1121/1.426908
   Wiedemair W, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4883482
   Wu JR, 2002, J ACOUST SOC AM, V111, P1460, DOI 10.1121/1.1420389
   Wu JR, 2007, PROG BIOPHYS MOL BIO, V93, P363, DOI 10.1016/j.pbiomolbio.2006.07.016
   Yang F, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/10/104301
   Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7
NR 36
TC 1
Z9 2
U1 0
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1674-1056
EI 1741-4199
J9 CHINESE PHYS B
JI Chin. Phys. B
PD SEP
PY 2015
VL 24
IS 9
AR 094301
DI 10.1088/1674-1056/24/9/094301
PG 6
WC Physics, Multidisciplinary
SC Physics
GA CU2BC
UT WOS:000363325200049
DA 2018-10-20
ER

PT J
AU Yuan, J
   Geng, J
   Xing, ZC
   Shim, KJ
   Han, I
   Kim, JC
   Kang, IK
   Shen, J
AF Yuan, Jiang
   Geng, Jia
   Xing, Zhicai
   Shim, Kyoung-Jin
   Han, Insook
   Kim, Jung-Chul
   Kang, Inn-Kyu
   Shen, Jian
TI Novel wound dressing based on nanofibrous PHBV-keratin mats
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE wound dressing; keratin; PHBV; electrospinning; nanofibre
ID CARBOXYMETHYLATED FEATHER KERATINS; HUMAN HAIR; BIOMEDICAL APPLICATIONS;
   WOOL KERATINS; CROSS-LINKING; SILK FIBROIN; BIOMATERIAL; FABRICATION;
   SCAFFOLDS; FILMS
AB Keratin is an important protein used for wound healing and tissue recovery. In this study, keratin was first extracted from raw materials and chemically modified to obtain stable keratin (m-keratin). The raw and m-keratin were examined by Raman spectroscopy. The molecular weight of the m-keratin was analysed by SDS-PAGE. The m-keratin was then blended with poly(hydroxybutylate-co-hydroxyvalerate) (PHBV) and electrospun to afford nanofibrous mats. These mats were characterized by field emission scanning electron microscopy (FE-SEM), electron spectroscopy for chemical analysis (ESCA) and atomic forcemicroscopy (AFM). Fromthe 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) data, it was found that introduction of keratin enhanced cell proliferation. From wound-healing test and histological examination results, it was shown that the composite mats accelerated wound recovery remarkably as compared to the PHBV control. It was concluded that PHBV-keratin may be a good candidate as a wound dressing. Copyright (C) 2012 John Wiley & Sons, Ltd.
C1 [Yuan, Jiang; Geng, Jia; Xing, Zhicai; Kang, Inn-Kyu] Kyungpook Natl Univ, Dept Polymer Sci, Taegu 702701, South Korea.
   [Yuan, Jiang; Shen, Jian] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing, Jiangsu, Peoples R China.
   [Shim, Kyoung-Jin; Han, Insook; Kim, Jung-Chul] Kyungpook Natl Univ, Sch Med, Dept Immunol, Taegu 702701, South Korea.
RP Kang, IK (reprint author), Kyungpook Natl Univ, Dept Polymer Sci, Taegu 702701, South Korea.
EM ikkang@knu.ac.kr; jshen@njnu.edu.cn
RI Geng, Jia/G-4332-2010
OI Geng, Jia/0000-0003-4753-1039
FU Ministry of Education, Science and Technology of Korea [2010-0011125];
   Nanjing Normal University [2011103XGQ0055]; Natural Science Foundation
   of the Jiangsu Higher Education Institutions of China [11KJD430003];
   National Natural Science Foundation of China [21274063]
FX This research was supported by the Ministry of Education, Science and
   Technology of Korea (Grant No. 2010-0011125), Nanjing Normal University
   (Grant No. 2011103XGQ0055), the Natural Science Foundation of the
   Jiangsu Higher Education Institutions of China (Grant No. 11KJD430003)
   and the National Natural Science Foundation of China (21274063).
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Cabodi M, 2007, J BIOMED MATER RES B, V82B, P210, DOI 10.1002/jbm.b.30723
   CECIL R, 1959, ADV PROTEIN CHEM, V14, P255, DOI 10.1016/S0065-3233(08)60613-0
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Cheon YW, 2010, ARTIF ORGANS, V34, P384, DOI 10.1111/j.1525-1594.2009.00871.x
   Dawlee S, 2005, BIOMACROMOLECULES, V6, P2040, DOI 10.1021/bm050013a
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   Ferreira LM, 2010, J PLAST RECONSTR AES, V63, P865, DOI 10.1016/j.bjps.2009.01.086
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Han I, 2007, ARTIF ORGANS, V31, P801, DOI 10.1111/j.1525-1594.2007.00466.x
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jones I, 2003, WOUND REPAIR REGEN, V11, P132, DOI 10.1046/j.1524-475X.2003.11209.x
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Kuzuhara A, 2003, J APPL POLYM SCI, V90, P3806, DOI 10.1002/app.12986
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Li JS, 2009, POLYM DEGRAD STABIL, V94, P1800, DOI 10.1016/j.polymdegradstab.2009.06.004
   Lionelli GT, 2003, SURG CLIN N AM, V83, P617, DOI 10.1016/S0039-6109(02)00192-5
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Meng W, 2008, J MATER SCI-MATER M, V19, P2799, DOI 10.1007/s10856-007-3356-3
   Meng W, 2007, J BIOMAT SCI-POLYM E, V18, P81, DOI 10.1163/156856207779146114
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   Schrooyen PMM, 2001, J AGR FOOD CHEM, V49, P221, DOI 10.1021/jf0004154
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Timmons S.F., 2000, US Patent, Patent No. [611,0487., 6110487]
   Tonin C, 2007, J THERM ANAL CALORIM, V89, P60
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Van Dyke M.E., 2002, POLYM MAT SCI ENG, V87, P453
   Van Dyke ME, 2000, US Patent, Patent No. 528893
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Yamauchi K, 1997, COLLOID SURFACE B, V9, P117, DOI 10.1016/S0927-7765(96)01322-7
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yuan J, 2008, POLYM INT, V57, P1188, DOI 10.1002/pi.2463
   Yuan J, 2009, MACROMOL RES, V17, P850, DOI 10.1007/BF03218625
   Zoccola M, 2007, E-POLYMERS, V105, P1
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
NR 52
TC 15
Z9 15
U1 6
U2 52
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2015
VL 9
IS 9
BP 1027
EP 1035
DI 10.1002/term.1653
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CU1GH
UT WOS:000363267900005
PM 23208930
DA 2018-10-20
ER

PT J
AU Wang, CY
   Zhao, YQ
   Zheng, SN
   Xue, J
   Zhou, JL
   Tang, Y
   Jiang, L
   Li, W
AF Wang, Chuanyong
   Zhao, Yongqi
   Zheng, Sainan
   Xue, Jing
   Zhou, Jinglin
   Tang, Yi
   Jiang, Li
   Li, Wei
TI Effect of enamel morphology on nanoscale adhesion forces of
   streptococcal bacteria : An AFM study
SO SCANNING
LA English
DT Article
DE bacterial adhesion; dental enamel; topography; roughness; etching;
   atomic force microscope
ID SURFACE-ROUGHNESS; BIOMATERIAL SURFACES; DENTAL-CARIES; PLAQUE; CELL;
   MICROSCOPY; BIOFILM; QUANTIFICATION; COLONIZATION; TOPOGRAPHY
AB We explore the influence of enamel surface morphology on nanoscale bacterial adhesion forces. Three dimensional morphology characteristics of enamel slices, which were treated with phosphoric acid (for 0s, 5s, 10s, 20s, and 30s), were acquired. Adhesion forces of three initial colonizers (Streptococcus oralis, Streptococcus sanguinis, and Streptococcus mitis) and two cariogenic bacterial strains (Streptococcus mutans and Streptococcus sobrinus) with etched enamel surfaces were determined. Comparison of the forces was made by using bacterial probe method under atomic force microscope (AFM) in adhesion buffer. The results showed that enamel morphology was significantly altered by etching treatment. The roughness, peak-to-valley height, and valley-to-valley width of the depth profile, surface area, and volume increased linearly with acid exposure time, and reached the maximum at 30s, respectively. The adhesion forces of different strains increased accordingly with etching time. Adhesion forces of S. oralis, S. mitis, S. mutans, and S. sobrinus reached the maximum values of 0.81nN, 0.84nN, 0.73nN, and 0.64nN with enamel treated for 20s, respectively, whereas that of S. sanguinis at 10s (1.28nN), and dropped on coarser enamel surfaces. In conclusion, enamel micro-scale morphology may significantly alter the direct adhesion forces of bacteria. And there may be a threshold roughness for bacterial adhesion on enamel surface. SCANNING 37:313-321, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Wang, Chuanyong; Zheng, Sainan; Xue, Jing; Zhou, Jinglin; Tang, Yi; Jiang, Li; Li, Wei] Sichuan Univ, W China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.
   [Zhao, Yongqi] Zhejiang Univ, Dept Stomatol, Coll Med, Hangzhou, Zhejiang, Peoples R China.
   [Wang, Chuanyong; Zheng, Sainan; Xue, Jing; Zhou, Jinglin; Tang, Yi; Jiang, Li; Li, Wei] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China.
   [Zhao, Yongqi] Zhejiang Univ, Coll Med, Dept Stomatol, Hangzhou, Zhejiang, Peoples R China.
RP Li, W (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China.
EM echojiang999@gmail.com; leewei@scu.edu.cn
FU National Natural Science Foundation of China [31200720]
FX Contract grant sponsor: National Natural Science Foundation of China;
   Contract grant number: 31200720.
CR Ahn SJ, 2009, DENT MATER, V25, P206, DOI 10.1016/j.dental.2008.06.002
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   Anami LC, 2012, J DENT, V40, P742, DOI 10.1016/j.jdent.2012.05.005
   Athanasiou KA, 1999, BIOMATERIALS, V20, P2405, DOI 10.1016/S0142-9612(99)00168-4
   Bagramian RA, 2009, AM J DENT, V22, P3
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   BUONOCORE M G, 1955, J Dent Res, V34, P849
   CHRISTERSSON CE, 1988, SCAND J DENT RES, V96, P91
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Eichenlaub S, 2004, J COLLOID INTERF SCI, V280, P289, DOI 10.1016/j.jcis.2004.08.017
   Eliades T, 2004, EUR J ORTHODONT, V26, P333, DOI 10.1093/ejo/26.3.333
   Fang HHP, 2000, BIOTECHNOL LETT, V22, P801, DOI 10.1023/A:1005620606868
   Flint SH, 1997, BIOFOULING, V11, P81, DOI 10.1080/08927019709378321
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   GWINNETT AJ, 1971, ARCH ORAL BIOL, V16, P731, DOI 10.1016/0003-9969(71)90118-X
   Hannig C, 2013, CARIES RES, V47, P150, DOI 10.1159/000345083
   Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x
   LIE T, 1979, ACTA ODONTOL SCAND, V37, P73, DOI 10.3109/00016357909027575
   LIE T, 1977, J PERIODONTAL RES, V12, P73, DOI 10.1111/j.1600-0765.1977.tb00111.x
   MANJI F, 1991, COMMUNITY DENT ORAL, V19, P324, DOI 10.1111/j.1600-0528.1991.tb00180.x
   Mei L, 2009, J DENT RES, V88, P841, DOI 10.1177/0022034509342523
   Mei L, 2011, DENT MATER, V27, P770, DOI 10.1016/j.dental.2011.03.017
   Mei L, 2009, EUR J ORAL SCI, V117, P419, DOI 10.1111/j.1600-0722.2009.00648.x
   NEWMAN HN, 1974, BRIT DENT J, V136, P491, DOI 10.1038/sj.bdj.4803220
   Loyola-Rodriguez JP, 2010, J ELECTRON MICROSC, V59, P119, DOI 10.1093/jmicro/dfp042
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   Rabinovich YI, 2000, J COLLOID INTERF SCI, V232, P10, DOI 10.1006/jcis.2000.7167
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Rumpf H., 1990, PARTICLE TECHNOLOGY
   RYAN V, 1980, BIOPHYS J, V31, P313, DOI 10.1016/S0006-3495(80)85061-2
   de Melo MAS, 2013, PHOTOMED LASER SURG, V31, P105, DOI 10.1089/pho.2012.3377
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   van Hoogmoed CG, 2006, J DENT RES, V85, P54, DOI 10.1177/154405910608500109
   Verran J, 2001, BIOFOULING, V17, P59, DOI 10.1080/08927010109378465
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
NR 39
TC 10
Z9 12
U1 3
U2 39
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0161-0457
EI 1932-8745
J9 SCANNING
JI Scanning
PD SEP-OCT
PY 2015
VL 37
IS 5
BP 313
EP 321
DI 10.1002/sca.21218
PG 9
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA CU4MI
UT WOS:000363503500002
PM 26482011
DA 2018-10-20
ER

PT J
AU Zhuo, Y
   Cunningham, BT
AF Zhuo, Yue
   Cunningham, Brian T.
TI Label-Free Biosensor Imaging on Photonic Crystal Surfaces
SO SENSORS
LA English
DT Review
DE photonic crystal; photonic crystal surface; photonic crystal biosensor;
   photonic crystal enhanced microscopy (PCEM); photonic crystal enhanced
   fluorescence (PCEF); label-free bioimaging; nanophotonics; biomaterial
   detection; live cell imaging; nanoparticle detection; protein-protein
   binding detection
ID CAVITY LASER BIOSENSOR; PLANAR WAVE-GUIDES; ENHANCED-FLUORESCENCE;
   SPONTANEOUS EMISSION; OPTICAL BIOSENSORS; BIOMOLECULAR INTERACTIONS;
   DIELECTRIC GRATINGS; CANCER BIOMARKERS; CELL ATTACHMENT; BAND-STRUCTURE
AB We review the development and application of nanostructured photonic crystal surfaces and a hyperspectral reflectance imaging detection instrument which, when used together, represent a new form of optical microscopy that enables label-free, quantitative, and kinetic monitoring of biomaterial interaction with substrate surfaces. Photonic Crystal Enhanced Microscopy (PCEM) has been used to detect broad classes of materials which include dielectric nanoparticles, metal plasmonic nanoparticles, biomolecular layers, and live cells. Because PCEM does not require cytotoxic stains or photobleachable fluorescent dyes, it is especially useful for monitoring the long-term interactions of cells with extracellular matrix surfaces. PCEM is only sensitive to the attachment of cell components within similar to 200 nm of the photonic crystal surface, which may correspond to the region of most interest for adhesion processes that involve stem cell differentiation, chemotaxis, and metastasis. PCEM has also demonstrated sufficient sensitivity for sensing nanoparticle contrast agents that are roughly the same size as protein molecules, which may enable applications in digital diagnostics with single molecule sensing resolution. We will review PCEM's development history, operating principles, nanostructure design, and imaging modalities that enable tracking of optical scatterers, emitters, absorbers, and centers of dielectric permittivity.
C1 [Zhuo, Yue; Cunningham, Brian T.] Univ Illinois, Dept Bioengn, Champaign, IL 61822 USA.
   [Cunningham, Brian T.] Univ Illinois, Dept Elect & Comp Engn, Champaign, IL 61822 USA.
RP Cunningham, BT (reprint author), Univ Illinois, Dept Bioengn, Champaign, IL 61822 USA.
EM yuezhuo2@illinois.edu; bcunning@illinois.edu
RI Zhuo, Yue/I-5526-2017
OI Zhuo, Yue/0000-0002-5739-1896
FU National Science Foundation (NSF) [CBET 0427657, CBET 0754122, CBET
   1132301]; National Institutes of Health (NIH) [R01 CA118562, R01
   GM086382]; Nano Sensors Group (NSG)
FX This work is supported by the National Science Foundation (NSF Grant
   CBET 0427657, CBET 0754122, CBET 1132301) and National Institutes of
   Health (NIH R01 CA118562, R01 GM086382). The authors would like to thank
   the Nano Sensors Group (NSG) and staff in Micro and Nanotechnology
   Laboratory (MNTL), the Center for innovative instrumentation Technology
   (CiiT) at University of Illinois at Urbana-Champaign for their support.
CR Astratov VN, 1999, J LIGHTWAVE TECHNOL, V17, P2050, DOI 10.1109/50.802994
   Baba T, 1999, ELECTRON LETT, V35, P654, DOI 10.1049/el:19990438
   Benisty H, 2000, APPL PHYS LETT, V76, P532, DOI 10.1063/1.125809
   Block ID, 2008, IEEE SENS J, V8, P274, DOI 10.1109/JSEN.2008.917127
   Block ID, 2009, APPL OPTICS, V48, P6567, DOI 10.1364/AO.48.006567
   Block ID, 2009, OPT EXPRESS, V17, P13222, DOI 10.1364/OE.17.013222
   Boroditsky M, 1999, J LIGHTWAVE TECHNOL, V17, P2096, DOI 10.1109/50.803000
   Carbonell J., 2012, NATURE SCI REPORTS, V2, P558
   Chan LL, 2008, SENSOR ACTUAT B-CHEM, V132, P418, DOI 10.1016/j.snb.2007.10.027
   Chan LL, 2007, APOPTOSIS, V12, P1061, DOI 10.1007/s10495-006-0031-y
   Chan LL, 2006, IEEE SENS J, V6, P1551, DOI 10.1109/JSEN.2006.884547
   Chan LL, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1155/2011/860605
   Chan LL, 2009, JALA-J ASSOC LAB AUT, V14, P348, DOI 10.1016/j.jala.2009.06.008
   Chaudhery V, 2012, IEEE SENS J, V12, P1272, DOI 10.1109/JSEN.2011.2169401
   Chen WL, 2014, ANALYST, V139, P5954, DOI 10.1039/c4an01508h
   Chen WL, 2013, ANALYST, V138, P5886, DOI 10.1039/c3an01541f
   Choi CJ, 2006, LAB CHIP, V6, P1373, DOI 10.1039/b603514k
   Choi CJ, 2010, ANAL BIOCHEM, V405, P1, DOI 10.1016/j.ab.2010.06.009
   Chutinan A, 2000, PHYS REV B, V62, P4488, DOI 10.1103/PhysRevB.62.4488
   Cowan AR, 2001, J OPT SOC AM A, V18, P1160, DOI 10.1364/JOSAA.18.001160
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V87, P365, DOI 10.1016/S0925-4005(02)00273-3
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V85, P219, DOI 10.1016/S0925-4005(02)00111-9
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V81, P316, DOI 10.1016/S0925-4005(01)00976-5
   Cunningham BT, 2006, EXPERT REV PROTEOMIC, V3, P271, DOI 10.1586/14789450.3.3.271
   Cunningham BT, 2010, JALA-J LAB AUTOM, V15, P120, DOI 10.1016/j.jala.2009.10.009
   Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604
   Descrovi E, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824387
   El Beheiry M, 2010, OPT EXPRESS, V18, P22702, DOI 10.1364/OE.18.022702
   Fan SH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235112
   Fan SH, 1997, PHYS REV LETT, V78, P3294, DOI 10.1103/PhysRevLett.78.3294
   Fang Y, 2008, COMB CHEM HIGH T SCR, V11, P357, DOI 10.2174/138620708784534789
   Fang Y, 2006, BIOPHYS J, V91, P1925, DOI 10.1529/biophysj.105.007818
   Ganesh N, 2007, NAT NANOTECHNOL, V2, P515, DOI 10.1038/nnano.2007.216
   Ganesh N, 2008, OPT EXPRESS, V16, P21626, DOI 10.1364/OE.16.021626
   Ganesh N, 2008, J APPL PHYS, V103, DOI 10.1063/1.2906175
   Ge C, 2013, LAB CHIP, V13, P1247, DOI 10.1039/c3lc41330f
   Ge C, 2010, OPT EXPRESS, V18, P12980, DOI 10.1364/OE.18.012980
   George S, 2010, ANAL CHEM, V82, P8551, DOI 10.1021/ac101551c
   George S, 2013, LAB CHIP, V13, P4053, DOI 10.1039/c3lc50579k
   George S, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-52
   Grepstad JO, 2012, OPT EXPRESS, V20, P7954, DOI 10.1364/OE.20.007954
   Guo YB, 2008, OPT EXPRESS, V16, P11741, DOI 10.1364/OE.16.011741
   HESSEL A, 1965, APPL OPTICS, V4, P1275, DOI 10.1364/AO.4.001275
   Hu H, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4831767
   Jamois C., 2011, BIOSENSORS EMERGING
   Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0
   Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1
   JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486
   Johnson SG, 1999, PHYS REV B, V60, P5751, DOI 10.1103/PhysRevB.60.5751
   Kanskar M, 1997, APPL PHYS LETT, V70, P1438, DOI 10.1063/1.118570
   Kikuta H, 2001, P SOC PHOTO-OPT INS, V4416, P219, DOI 10.1117/12.427053
   King W. P., 2013, ANN REV HEAT TRANSFE, V16, P287, DOI DOI 10.1615/ANNUALREVHEATTRANSFER.V16.100
   Konopsky VN, 2007, ANAL CHEM, V79, P4729, DOI 10.1021/ac070275y
   Konopsky Valery N., 2009, V503, P49, DOI 10.1007/978-1-60327-567-5_4
   Krebs FC, 2009, SOL ENERG MAT SOL C, V93, P465, DOI 10.1016/j.solmat.2008.12.012
   Kuchinsky S, 2000, OPT COMMUN, V175, P147, DOI 10.1016/S0030-4018(99)00768-3
   Li PY, 2004, SENSOR ACTUAT B-CHEM, V99, P6, DOI 10.1016/S0925-4005(03)00604-X
   Li YH, 2014, OPT EXPRESS, V22, P21403, DOI 10.1364/OE.22.021403
   Lidstone EA, 2011, ANALYST, V136, P3608, DOI 10.1039/c1an15171a
   Lin B, 2006, SENSOR ACTUAT B-CHEM, V114, P559, DOI 10.1016/j.snb.2005.04.022
   Lin B, 2002, BIOSENS BIOELECTRON, V17, P827, DOI 10.1016/S0956-5663(02)00077-5
   Lin SY, 2000, OPT LETT, V25, P1297, DOI 10.1364/OL.25.001297
   MAGNUSSON R, 1992, APPL PHYS LETT, V61, P1022, DOI 10.1063/1.107703
   Magnusson R, 2011, SENSORS-BASEL, V11, P1476, DOI 10.3390/s110201476
   MASHEV L, 1984, OPT COMMUN, V51, P131, DOI 10.1016/0030-4018(84)90220-7
   Mathias PC, 2007, APPL OPTICS, V46, P2351, DOI 10.1364/AO.46.002351
   Mathias PC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3184573
   Mathias PC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2917184
   MEADE RD, 1991, PHYS REV B, V44, P10961, DOI 10.1103/PhysRevB.44.10961
   Nazirizadeh Y, 2012, OPT EXPRESS, V20, P14451, DOI 10.1364/OE.20.014451
   Nazirizadeh Y, 2010, OPT EXPRESS, V18, P19120, DOI 10.1364/OE.18.019120
   Nazirizadeh Y, 2008, 2008 IEEE/LEOS INTERNATIONAL CONFERENCE ON OPTICAL MEMS AND NANOPHOTONICS, P112, DOI 10.1109/OMEMS.2008.4607854
   Pacradouni V, 2000, PHYS REV B, V62, P4204, DOI 10.1103/PhysRevB.62.4204
   Paddon P, 2000, PHYS REV B, V61, P2090, DOI 10.1103/PhysRevB.61.2090
   Painter O, 1999, J OPT SOC AM B, V16, P275, DOI 10.1364/JOSAB.16.000275
   Pal S, 2012, ANAL CHEM, V84, P8900, DOI 10.1021/ac3012945
   Pokhriyal A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3485672
   Pokhriyal A, 2014, J BIOPHOTONICS, V7, P332, DOI 10.1002/jbio.201200173
   Pokhriyal A, 2010, OPT EXPRESS, V18, P24793, DOI 10.1364/OE.18.024793
   POPOV E, 1986, OPT ACTA, V33, P607, DOI 10.1080/713821994
   Robertson WM, 1999, APPL PHYS LETT, V74, P1800, DOI 10.1063/1.123090
   Schulz S.C., 2008, VAC COAT, V68
   Sfez T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2970961
   Shafiee H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04116
   Shamah SM, 2011, ANALYST, V136, P1090, DOI 10.1039/c0an00899k
   Shinn A, 2005, SENSOR ACTUAT B-CHEM, V105, P360, DOI 10.1016/j.snb.2004.06.024
   Sinibaldi A, 2012, SENSOR ACTUAT B-CHEM, V174, P292, DOI [10.1016/j.snb.2012.07.015, 10.1016/j.Snb.2012.07.015]
   Skivesen N, 2007, OPT EXPRESS, V15, P3169, DOI 10.1364/OE.15.003169
   Threm D, 2012, J BIOPHOTONICS, V5, P601, DOI 10.1002/jbio.201200039
   Tian LM, 2012, LANGMUIR, V28, P17435, DOI 10.1021/la3034534
   Tian LM, 2012, ANAL CHEM, V84, P9928, DOI 10.1021/ac302332g
   Troia B., 2013, ADV PHOTONIC CRYSTAL
   Vahala K., 2004, ADV SERIES APPL PHYS
   Villa F, 2002, OPT LETT, V27, P646, DOI 10.1364/OL.27.000646
   Villeneuve PR, 1998, IEE P-OPTOELECTRON, V145, P384, DOI 10.1049/ip-opt:19982467
   Wu HY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125203
   YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059
   YEH P, 1978, APPL PHYS LETT, V32, P104, DOI 10.1063/1.89953
   Zhang M, 2014, J AM CHEM SOC, V136, P5840, DOI 10.1021/ja500636p
   Zhuo Y, 2014, ANALYST, V139, P1007, DOI 10.1039/c3an02295a
NR 100
TC 14
Z9 14
U1 1
U2 96
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD SEP
PY 2015
VL 15
IS 9
BP 21613
EP 21635
DI 10.3390/s150921613
PG 23
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA CT0UH
UT WOS:000362512200034
PM 26343684
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gandhi, JK
   Zivkovic, L
   Fisher, JP
   Yoder, MC
   Brey, EM
AF Gandhi, Jarel K.
   Zivkovic, Lada
   Fisher, John P.
   Yoder, Mervin C.
   Brey, Eric M.
TI Enhanced Viability of Endothelial Colony Forming Cells in Fibrin
   Microbeads for Sensor Vascularization
SO SENSORS
LA English
DT Article
DE tissue engineering; vascularization; bioreactor; long-term sensors;
   implantable sensors; fibrin
ID TUBULAR PERFUSION SYSTEM; MESENCHYMAL STEM-CELLS; PROGENITOR CELLS;
   DYNAMIC CULTURE; IN-VITRO; BONE REGENERATION; BLOOD-VESSELS; DNA-DAMAGE;
   CORD BLOOD; SCAFFOLDS
AB Enhanced vascularization at sensor interfaces can improve long-term function. Fibrin, a natural polymer, has shown promise as a biomaterial for sensor coating due to its ability to sustain endothelial cell growth and promote local vascularization. However, the culture of cells, particularly endothelial cells (EC), within 3D scaffolds for more than a few days is challenging due to rapid loss of EC viability. In this manuscript, a robust method for developing fibrin microbead scaffolds for long-term culture of encapsulated ECs is described. Fibrin microbeads are formed using sodium alginate as a structural template. The size, swelling and structural properties of the microbeads were varied with needle gauge and composition and concentration of the pre-gel solution. Endothelial colony-forming cells (ECFCs) were suspended in the fibrin beads and cultured within a perfusion bioreactor system. The perfusion bioreactor enhanced ECFCs viability and genome stability in fibrin beads relative to static culture. Perfusion bioreactors enable 3D culture of ECs within fibrin beads for potential application as a sensor coating.
C1 [Gandhi, Jarel K.; Zivkovic, Lada; Brey, Eric M.] Dept Biomed Engn, Chicago, IL 60616 USA.
   [Zivkovic, Lada] Univ Belgrade, Dept Physiol, Fac Pharm, Belgrade 11000, Serbia.
   [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Yoder, Mervin C.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46201 USA.
   [Brey, Eric M.] Edward Hines Vet Adm Med Ctr, Res Serv, Hines, IL 60141 USA.
RP Brey, EM (reprint author), Dept Biomed Engn, Wishnick Hall 223,3255 South Dearborn St, Chicago, IL 60616 USA.
EM jgandhi2@hawk.iit.edu; lada@pharmacy.bg.ac.rs; jpfisher@umd.edu;
   myoder@iupui.edu; brey@iit.edu
FU Department of Veterans Affairs; National Science Foundation [IIS
   1125412]; National Institutes of Health [R01AR061460]; Fulbright
   Program; Ministry of Education, Science and Technological development of
   the Republic of Serbia [OI 173034]
FX The authors on this work are supported, in part, by funding from the
   Department of Veterans Affairs (EMB), National Science Foundation (Grant
   No: IIS 1125412) and National Institutes of Health (Grant No:
   R01AR061460). We also gratefully acknowledge research funding received
   from Fulbright Program (LZ), and the Ministry of Education, Science and
   Technological development of the Republic of Serbia (Grant No: OI
   173034).
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Allen P, 2015, J TISSUE ENG REGEN M, V9, P632, DOI 10.1002/term.1803
   ANDERSON D, 1994, MUTAT RES, V307, P261, DOI 10.1016/0027-5107(94)90300-X
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Bhakta G, 2009, BIOMATERIALS, V30, P336, DOI 10.1016/j.biomaterials.2008.09.030
   Butt OI, 2007, TISSUE ENG, V13, P2053, DOI 10.1089/ten.2006.0225
   Chandrasekhar KS, 2011, CALCIFIED TISSUE INT, V89, P347, DOI 10.1007/s00223-011-9524-y
   Chen B, 2013, TRANSPL P, V45, P2034, DOI 10.1016/j.transproceed.2013.01.096
   Chung Y, 2011, CLIN INVEST MED, V34, pE304
   Corstorphine L, 2011, J TISSUE ENG REGEN M, V5, P119, DOI 10.1002/term.296
   Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x
   Critser PJ, 2010, MICROVASC RES, V80, P23, DOI 10.1016/j.mvr.2010.03.001
   Gautier A, 2011, EUR CELLS MATER, V21, P94, DOI 10.22203/eCM.v021a08
   Gorodetsky R, 2008, EXPERT OPIN BIOL TH, V8, P1831, DOI [10.1517/14712590802494576, 10.1517/14712590802494576 ]
   Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Kang KT, 2011, BLOOD, V118, P6718, DOI 10.1182/blood-2011-08-375188
   Kaunas R, 2011, CELL MOL BIOENG, V4, P547, DOI 10.1007/s12195-011-0208-5
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Liu YC, 2013, TISSUE ENG PT A, V19, P893, DOI [10.1089/ten.tea.2012.0187, 10.1089/ten.TEA.2012.0187]
   Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6
   Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y
   Mughal A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051305
   Nakatsu M. N., 2007, JOVE-J VIS EXP, DOI [10.3791/18618978935, DOI 10.3791/18618978935]
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Naruse K, 2005, DIABETES, V54, P1823, DOI 10.2337/diabetes.54.6.1823
   Nor JE, 2001, LAB INVEST, V81, P453
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Pisanti P, 2012, J BIOMED MATER RES A, V100A, P2563, DOI 10.1002/jbm.a.34191
   PRASAIN N, 2012, JOVE J VIS EXP APR, P26095, DOI DOI 10.3791/3872
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Squires TM, 2008, NAT BIOTECHNOL, V26, P417, DOI 10.1038/nbt1388
   Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763
   Wei P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-2
   Whittington CF, 2013, MACROMOL BIOSCI, V13, P1135, DOI 10.1002/mabi.201300128
   Yeatts AB, 2014, TISSUE ENG PT A, V20, P139, DOI [10.1089/ten.tea.2013.0168, 10.1089/ten.TEA.2013.0168]
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI 10.1089/ten.TEC.2010.0172
   Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007
   Yeatts AB, 2012, BIOTECHNOL BIOENG, V109, P2381, DOI 10.1002/bit.24497
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P1171, DOI 10.1089/ten.tec.2011.0263
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
   Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zigdon-Giladi H., 2013, CLIN IMPLANT DENT R, V17, P353, DOI [10.1111/cid.1210423848193, DOI 10.1111/CID.1210423848193]
NR 46
TC 2
Z9 2
U1 2
U2 15
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD SEP
PY 2015
VL 15
IS 9
BP 23886
EP 23902
DI 10.3390/s150923886
PG 17
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA CT0UH
UT WOS:000362512200146
PM 26393602
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Trembecka-Wojciga, K
   Major, R
   Lackner, JM
   Bruckert, F
   Jasek, E
   Major, B
AF Trembecka-Wojciga, K.
   Major, R.
   Lackner, J. M.
   Bruckert, F.
   Jasek, E.
   Major, B.
TI Biomechanical properties of the thin PVD coatings defined by red blood
   cells
SO BULLETIN OF THE POLISH ACADEMY OF SCIENCES-TECHNICAL SCIENCES
LA English
DT Article
DE biomechanical properties; thin PVD coatings; red blood cells
ID AORTIC-VALVE-REPLACEMENT; 10-YEAR EXPERIENCE; HANCOCK-II; IN-VITRO;
   BIOPROSTHESIS; PROSTHESIS; HEMOCOMPATIBILITY; BIOMATERIALS; PERFORMANCE;
   ADHESION
AB The measurement of the strength of bonds between biomaterials and cells is a major challenge in biotribology since it allows for the identification of different species in adhesion phenomena. Biomaterials, such as diamond-like carbon (DLC), titanium, and titanium nitride, seem to be good candidates for future blood-contact applications. These materials were deposited as thin films by the hybrid pulsed laser deposition (PLD) technique to examine the influence of such surfaces on cell behavior. The biomaterial examinations were performed in static conditions with red blood cells and then subjected to a dynamical test to observe the cell detachment kinetics. The tests revealed differences in behavior with respect to the applied coating material. The strongest cell-biomaterial interaction was observed for the carbon-based materials compared to the titanium and titanium nitride. Among many tests, a radial flow interaction analysis gives the opportunity to analyze cell adhesion to the applied material with the high accuracy. Analysis of concentrates helped to select materials for further dynamic tests on blood using an aortic flow simulator. In this case, the platelet adhesion to the surface and their degree of activation was analyzed. The quality of the selected coating was tested using a scratch test. The analyses of the microstructure were done using high resolution transmission electron microscopy. The phase composition and the residual stress were analyzed using X-ray diffraction methods.
C1 [Trembecka-Wojciga, K.; Major, R.; Major, B.] Polish Acad Sci, Inst Met & Mat Sci, PL-30059 Krakow, Poland.
   [Lackner, J. M.] Joanneum Res Forsch mbH, Inst Surface Technol & Photon, Funct Surfaces, A-8712 Niklasdorf, Austria.
   [Bruckert, F.] Grenoble Inst Technol Minatec, Mat & Genie Phys Lab, F-38016 Grenoble 1, France.
   [Jasek, E.] Jagiellonian Univ, Coll Med, Dept Histol, PL-31034 Krakow, Poland.
RP Major, R (reprint author), Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta St, PL-30059 Krakow, Poland.
EM r.major@imim.pl
OI Jasek-Gajda, Ewa/0000-0002-2030-0356
FU Polish National Center of Science [2011/03/D/ST8/04103]
FX This research was financially supported by the project
   2011/03/D/ST8/04103 "Self-assembling, bio-mimetic porous scaffolds in
   terms of inhibiting the activation of the coagulation system" of the
   Polish National Center of Science.
CR Aagaard J, 2005, J HEART VALVE DIS, V14, P82
   Bach DS, 2005, ANN THORAC SURG, V80, P480, DOI 10.1016/j.athoracsur.2005.03.027
   Borger MA, 2006, J HEART VALVE DIS, V15, P49
   Borger MA, 2007, ANN THORAC SURG, V84, P737, DOI 10.1016/j.athoracsur.2007.04.061
   Bottio T, 2004, J THORAC CARDIOV SUR, V128, P457, DOI 10.1016/j.jtcvs.2004.03.021
   Cohen G, 2002, ANN THORAC SURG, V73, P767, DOI 10.1016/S0003-4975(01)03338-0
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   Demilly M, 2006, COLLOID SURFACE B, V51, P71, DOI 10.1016/j.colsurfb.2006.05.007
   Emery RW, 2005, ANN THORAC SURG, V79, P776, DOI 10.1016/j.athoracsur.2004.08.047
   HAEFER R, 1987, OBERFLACHEN DUNNSC 1
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Jones D.A., 1996, WEIRS HDB EXPT IMMUN
   Kustosz R., 2011, NANOSTRUCTURAL MAT I
   Lackner JM, 2010, BIOMED TECH, V55, P57, DOI 10.1515/BMT.2010.001
   Lopez S, 2008, J CARDIAC SURG, V23, P331, DOI 10.1111/j.1540-8191.2008.00631.x
   Major R., 2011, NANOSTRUCTURAL MAT I
   Mueller M., 2012, BIOMED TECH S1, V57
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   Qiao A., 2008, J BEIJING U TECHNOLO, V02
   Riess FC, 2007, ANN THORAC SURG, V83, P1310, DOI 10.1016/j.athoracsur.2006.07.034
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Stefanidis C, 2005, ANN THORAC SURG, V79, P1934, DOI 10.1016/j.athoracsur.2005.01.002
   Takaseya T, 2007, ANN THORAC SURG, V83, P2050, DOI 10.1016/j.athoracsur.2007.01.044
   Tobolski L., 2000, ASM HDB, V8
   Tominaga R, 2005, ANN THORAC SURG, V79, P784, DOI 10.1016/j.athoracsur.2004.08.067
   Totaro P, 2005, J THORAC CARDIOV SUR, V130, P1668, DOI 10.1016/j.jtcvs.2005.07.011
   Valfre C, 2006, J THORAC CARDIOV SUR, V132, P595, DOI 10.1016/j.jtcvs.2006.03.062
   VARON D, 1998, AM HEART J, V135, P187
   Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144
NR 29
TC 0
Z9 0
U1 0
U2 7
PU POLSKA AKAD NAUK, POLISH ACAD SCI, DIV IV TECHNICAL SCIENCES PAS
PI WARSZAWA
PA PL DEFILAD 1, WARSZAWA, 00-901, POLAND
SN 0239-7528
EI 2300-1917
J9 B POL ACAD SCI-TECH
JI Bull. Pol. Acad. Sci.-Tech. Sci.
PD SEP
PY 2015
VL 63
IS 3
BP 697
EP 705
DI 10.1515/bpasts-2015-0081
PG 9
WC Engineering, Multidisciplinary
SC Engineering
GA CT6XM
UT WOS:000362956500016
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Miller, PR
   Boehm, RD
   Skoog, SA
   Edwards, TL
   Rodriguez, M
   Brozik, S
   Brener, I
   Byrd, T
   Baca, JT
   Ashley, C
   Narayan, RJ
   Polsky, R
AF Miller, Philip R.
   Boehm, Ryan D.
   Skoog, Shelby A.
   Edwards, Thayne L.
   Rodriguez, Mark
   Brozik, Susan
   Brener, Igal
   Byrd, Thomas
   Baca, Justin T.
   Ashley, Carlee
   Narayan, Roger J.
   Polsky, Ronen
TI Electrodeposited Iron as a Biocompatible Material for Microneedle
   Fabrication
SO ELECTROANALYSIS
LA English
DT Article
DE Microneedle; Electroplating; Coating; Iron
ID HOLLOW MICRONEEDLES; ELECTROFORMED IRON; INSERTION; ARRAY; SKIN;
   BIOMATERIAL; DEPOSITION; GROWTH; DRUG
AB Electroplated iron was investigated as a novel material for microneedle fabrication due to its recent success as a biocompatible metal in other medical device applications. Hollow polymer microneedles were made using a laser direct write process that involved two-photon polymerization of a commercially available Class 2a biocompatible polymer and subsequent electroplating of this structure with iron. Electroplating bath and deposition conditions were shown to affect the mechanical properties of both iron plated microneedles and iron plated on planar polymer substrates. Conditions for depositing the iron coatings were investigated in terms of grain size, residual strain, and elemental composition for planar iron samples. Fracture strength and puncture mechanics into ex vivo porcine skin for iron coated hollow microneedles were examined. Biocompatibility testing was performed using the MTT assay against human epidermal keratinocytes with several concentrations of iron extract to investigate iron as a material used for transdermal applications. Iron coatings proved to significantly improve the strength of the hollow polymer microneedles and sustained structural integrity up to 7 insertions into porcine skin without bending. A commercially available device (Medtronic MiniMed Quick-Serter O) was used for controlled application of microneedles into porcine skin and estimations of insertion forces for the device were made. Plating conditions were optimized such that an adherent, uniform, and high purity iron coating was deposited onto polymer substrates and polymer microneedles without delamination or fracturing of the microneedles upon ex vivo insertion into porcine skin.
C1 [Miller, Philip R.; Edwards, Thayne L.; Rodriguez, Mark; Brozik, Susan; Brener, Igal; Ashley, Carlee; Polsky, Ronen] Sandia Natl Labs, Albuquerque, NM 87185 USA.
   [Miller, Philip R.; Boehm, Ryan D.; Skoog, Shelby A.; Narayan, Roger J.] Univ N Carolina, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.
   [Miller, Philip R.; Boehm, Ryan D.; Skoog, Shelby A.; Narayan, Roger J.] N Carolina State Univ, Raleigh, NC USA.
   [Skoog, Shelby A.] US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.
   [Brener, Igal] Sandia Natl Labs, Ctr Integrated Nanotechnol, Albuquerque, NM 87185 USA.
   [Byrd, Thomas; Baca, Justin T.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.
   [Baca, Justin T.] Univ New Mexico, Hlth Sci Ctr, Dept Emergency Med, Albuquerque, NM 87131 USA.
RP Narayan, RJ (reprint author), Univ N Carolina, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.
EM roger_narayan@unc.edu; rpolsky@sandia.gov
OI Boehm, Ryan/0000-0002-2355-1329; brener, igal/0000-0002-2139-5182
FU United States Department of Energy's National Nuclear Security
   Administration [DE-AC04449-4AL85000]
FX We would like to thank Amy Allen for her help with the scanning electron
   micrographs, Graham Yelton for his insight with electroplating, as well
   as Steve Jett and Tamara Howard for access to the cyrosectioning system.
   Sandia is a multiprogram laboratory operated by Sandia Corporation, a
   Lockheed Martin Company, for the United States Department of Energy's
   National Nuclear Security Administration under Contract
   DE-AC04449-4AL85000. The authors acknowledge the Sandia National
   Laboratories' Laboratory Directed Research & Development (LDRD) program.
CR Brongersma SH, 2002, J MATER RES, V17, P582, DOI 10.1557/JMR.2002.0082
   CALNAN CD, 1956, BRIT J DERMATOL, V68, P229, DOI 10.1111/j.1365-2133.1956.tb12808.x
   Ceyssens F, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/7/075023
   Chua B, 2013, SENSOR ACTUAT A-PHYS, V203, P373, DOI 10.1016/j.sna.2013.09.026
   Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010
   Doraiswamy A, 2006, ACTA BIOMATER, V2, P267, DOI 10.1016/j.actbio.2006.01.004
   Gardeniers HJGE, 2003, J MICROELECTROMECH S, V12, P855, DOI [10.1109/JMEMS.2003.820293, 10.1109/JMEMS.2003.080293]
   Invernale MA, 2014, ADV HEALTHC MATER, V3, P338, DOI 10.1002/adhm.201300142
   Izaki M., 2011, MODERN ELECTROPLATIN, V4, P461
   Jin JH, 2014, ADV HEALTHC MATER, V3, P349, DOI 10.1002/adhm.201300185
   Jina Arvind, 2014, J Diabetes Sci Technol, V8, P483, DOI 10.1177/1932296814526191
   Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005
   Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017
   Miller PR, 2014, ADV HEALTHC MATER, V3, P876, DOI 10.1002/adhm.201300541
   Miller PR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3569945
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, MATER SCI ENG B-ADV, V176, P1812, DOI 10.1016/j.mseb.2011.02.031
   Mukerjee E, 2004, SENSOR ACTUAT A-PHYS, V114, P267, DOI 10.1016/j.sna.2003.11.008
   Myung NV, 2004, ELECTROCHIM ACTA, V49, P4397, DOI 10.1016/j.electacta.2004.04.031
   Norman JJ, 2013, BIOMED MICRODEVICES, V15, P203, DOI 10.1007/s10544-012-9717-9
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Philippe L, 2008, CHEM MATER, V20, P3377, DOI 10.1021/cm703591n
   Schlesinger M., 2011, MODERN ELECTROPLATIN, V55
   Shikida M, 2006, J MICROMECH MICROENG, V16, P2230, DOI 10.1088/0960-1317/16/10/041
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Uda T, 2006, SCI TECHNOL ADV MAT, V7, P490, DOI 10.1016/j.stam.2006.02.016
   Vazquez P, 2014, SENSOR ACTUAT B-CHEM, V201, P572, DOI 10.1016/j.snb.2014.04.080
   Verbaan FJ, 2008, J CONTROL RELEASE, V128, P80, DOI 10.1016/j.jconrel.2008.02.009
   Wang PC, 2009, IEEE ENG MED BIO, P7026, DOI 10.1109/IEMBS.2009.5333317
   Windmiller JR, 2011, ANALYST, V136, P1846, DOI 10.1039/c1an00012h
   Yang SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2715
   YOSHIMURA S, 1994, ELECTROCHIM ACTA, V39, P589, DOI 10.1016/0013-4686(94)80105-3
NR 33
TC 1
Z9 1
U1 3
U2 48
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1040-0397
EI 1521-4109
J9 ELECTROANAL
JI Electroanalysis
PD SEP
PY 2015
VL 27
IS 9
SI SI
BP 2239
EP 2249
DI 10.1002/elan.201500199
PG 11
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA CT6DL
UT WOS:000362901800023
DA 2018-10-20
ER

PT J
AU Sheikh, Z
   Brooks, PJ
   Barzilay, O
   Fine, N
   Glogauer, M
AF Sheikh, Zeeshan
   Brooks, Patricia J.
   Barzilay, Oriyah
   Fine, Noah
   Glogauer, Michael
TI Macrophages, Foreign Body Giant Cells and Their Response to Implantable
   Biomaterials
SO MATERIALS
LA English
DT Review
DE biomaterials; foreign body reaction; macrophages; implantable materials;
   cellular and tissue response; cell-material interaction
ID POLYCARBONATE-BASED POLYURETHANES; MONOCYTE-DERIVED MACROPHAGES; BONE
   MORPHOGENETIC PROTEIN-2; TITANIUM SURFACE-TOPOGRAPHY; TOLL-LIKE
   RECEPTORS; IN-VIVO; TISSUE-RESPONSE; CORROSION PRODUCTS; SOFT-TISSUE;
   T-CELLS
AB All biomaterials, when implanted in vivo, elicit cellular and tissue responses. These responses include the inflammatory and wound healing responses, foreign body reactions, and fibrous encapsulation of the implanted materials. Macrophages are myeloid immune cells that are tactically situated throughout the tissues, where they ingest and degrade dead cells and foreign materials in addition to orchestrating inflammatory processes. Macrophages and their fused morphologic variants, the multinucleated giant cells, which include the foreign body giant cells (FBGCs) are the dominant early responders to biomaterial implantation and remain at biomaterial-tissue interfaces for the lifetime of the device. An essential aspect of macrophage function in the body is to mediate degradation of bio-resorbable materials including bone through extracellular degradation and phagocytosis. Biomaterial surface properties play a crucial role in modulating the foreign body reaction in the first couple of weeks following implantation. The foreign body reaction may impact biocompatibility of implantation devices and may considerably impact short- and long-term success in tissue engineering and regenerative medicine, necessitating a clear understanding of the foreign body reaction to different implantation materials. The focus of this review article is on the interactions of macrophages and foreign body giant cells with biomaterial surfaces, and the physical, chemical and morphological characteristics of biomaterial surfaces that play a role in regulating the foreign body response. Events in the foreign body response include protein adsorption, adhesion of monocytes/macrophages, fusion to form FBGCs, and the consequent modification of the biomaterial surface. The effect of physico-chemical cues on macrophages is not well known and there is a complex interplay between biomaterial properties and those that result from interactions with the local environment. By having a better understanding of the role of macrophages in the tissue healing processes, especially in events that follow biomaterial implantation, we can design novel biomaterials-based tissue-engineered constructs that elicit a favorable immune response upon implantation and perform for their intended applications.
C1 [Sheikh, Zeeshan; Brooks, Patricia J.; Barzilay, Oriyah; Fine, Noah; Glogauer, Michael] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada.
RP Sheikh, Z (reprint author), Univ Toronto, Fac Dent, Matrix Dynam Grp, 150 Coll St, Toronto, ON M5S 3E2, Canada.
EM zeeshan.sheikh@utoronto.ca; patricia.brooks@utoronto.ca;
   oriyah.barzilay@mail.utoronto.ca; noah.fine@utoronto.ca;
   Michael.Glogauer@utoronto.ca
CR Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142
   Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723
   Babu RS Arvind, 2015, Dent Clin North Am, V59, P305, DOI 10.1016/j.cden.2014.10.010
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461
   Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   Boehlert C.J., 2015, TITANIUM ALLOYS BIOM, P179
   Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brunette D., 1996, BIOSYST INTEGR MAT S, P335
   BURKE BLC, 2002, MACROPHAGE
   Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486
   Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506
   Ciuti G, 2015, SENSORS-BASEL, V15, P6441, DOI 10.3390/s150306441
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660
   Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P18, DOI 10.1109/TNB.2002.806933
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Das A., 2015, AM J PATHOL, DOI [10.1016/j.ajpath.2015.06.00126118749, DOI 10.1016/J.AJPATH.2015.06.00126118749]
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DiEgidio P, 2014, ANN PLAS SURG, V73, P451, DOI 10.1097/SAP.0000000000000287
   Dittmar T, 2011, CELL FUSION HLTH DIS
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   Dugast C, 1997, J LEUKOCYTE BIOL, V61, P517
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Flatebo RS, 2006, J PERIODONTOL, V77, P1201, DOI 10.1902/jop.2006.050406
   Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729
   Futami T, 2000, J PERIODONTOL, V71, P287, DOI 10.1902/jop.2000.71.2.287
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Glogauer M., 2015, EC DENT SCI, V2, P216
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOODMAN S, 1995, J APPL BIOMATER, V6, P161, DOI 10.1002/jab.770060303
   Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Gross U M, 1988, J Dent Educ, V52, P798
   Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124
   Gwinnett AJ, 1998, AM J DENT, V11, pS35
   Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hallab N.J., 2014, CHRONIC INFLAMMATION, P109
   Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Heymann D, 1999, HISTOL HISTOPATHOL, V14, P871, DOI 10.14670/HH-14.871
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hotaling N. A., 2015, ANNU REV BIOMED ENG, P1
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Hunt JA, 2001, CURR OPIN SOLID ST M, V5, P161, DOI 10.1016/S1359-0286(01)00012-2
   Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790
   Jena BP, 2003, BIOPHYS J, V84, P1337, DOI 10.1016/S0006-3495(03)74949-2
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jeremic A, 2004, CELL BIOL INT, V28, P19, DOI 10.1016/j.cellbi.2003.11.004
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002
   KSANDER GA, 1985, ANN PLAS SURG, V14, P351, DOI 10.1097/00000637-198504000-00009
   Kwee BJ, 2015, ANN BIOMED ENG, V43, P628, DOI 10.1007/s10439-014-1145-y
   Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2005, J BIOMAT SCI-POLYM E, V16, P1167, DOI 10.1163/1568562054798563
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Lamba N, 1997, POLYURETHANES BIOMED
   Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257
   Latour R.A., 2005, ENCY BIOMATERIALS BI, P1
   Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926
   London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Lyu SP, 2009, INT J MOL SCI, V10, P4033, DOI 10.3390/ijms10094033
   Mackaness G B, 1977, Adv Exp Med Biol, V93, P65
   Major MR, 2015, PLAST RECONSTR SURG, V135, P1489, DOI 10.1097/PRS.0000000000001193
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Milleret V, 2015, ACTA BIOMATER, V24, P343, DOI 10.1016/j.actbio.2015.06.020
   Mills CD, 2015, J INNATE IMMUN, V7, P443, DOI 10.1159/000380910
   Mitchelson AJ, 2015, BIOMED RES INT, DOI 10.1155/2015/137287
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Mukai A, 2009, EXP CELL RES, V315, P3052, DOI 10.1016/j.yexcr.2009.07.010
   Murthy T., 2010, INT J PHARMTECH RES, V2, P2152
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901
   O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002
   Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025
   Palis J, 1999, DEVELOPMENT, V126, P5073
   Parker JATC, 2002, J BIOMED MATER RES, V61, P91, DOI 10.1002/jbm.10170
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   PEARSON BS, 1988, J DENT RES, V67, P515, DOI 10.1177/00220345880670021701
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   Rajesh P., 2015, HOST RESPONSE IMPLAN, P106
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   RICH A, 1981, J CELL SCI, V50, P1
   Rodgers KE, 2000, FERTIL STERIL, V73, P831, DOI 10.1016/S0015-0282(99)00642-1
   Ross J., 2002, BIOL MACROPHAGE MACR, V2, P16
   Roy N, 2015, CHEM SOC REV, V44, P3786, DOI 10.1039/c5cs00194c
   Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119
   SENNERBY L, 1993, J MATER SCI-MATER M, V4, P240, DOI 10.1007/BF00122275
   Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Sharma J, 2015, POLYMERS-BASEL, V7, P186, DOI 10.3390/polym7020186
   Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113
   Sheikh Z. A., 2013, BONE REPLACEMENT GRA
   Sheikh Z, 2015, MATERIALS, V8, P2953, DOI 10.3390/ma8062953
   Sheikh Z, 2015, CERAM INT, V41, P10010, DOI 10.1016/j.ceramint.2015.04.083
   Sheikh Z, 2015, MATERIALS, V8, P1778, DOI 10.3390/ma8041778
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837
   Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810
   Stokes K, 1987, J Biomater Appl, V1, P411
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tamimi F, 2012, ACTA BIOMATER, V8, P3161, DOI 10.1016/j.actbio.2012.04.025
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tarique A.A., 2015, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2015-0012OC25870903, DOI 10.1165/RCMB.2015-0012OC25870903]
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thomas P, 2003, ORTHOPADE, V32, P60, DOI 10.1007/s00132-002-0413-y
   Thomas P, 2015, BIOMED RES INT, DOI 10.1155/2015/910156
   Thompson B.C., 2015, BIOMATERIALS BIONICS, DOI [10.1002/adma.20150041125914294, DOI 10.1002/ADMA.20150041125914294]
   Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1
   Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0
   Trindade R., 2014, CLIN IMPLANT DENT R, DOI [10.1111/cid.1227425257971, DOI 10.1111/CID.1227425257971]
   Trindade R, 2015, ORAL MAXIL SURG CLIN, V27, P175, DOI 10.1016/j.coms.2015.01.004
   URBAN RM, 1994, J BONE JOINT SURG AM, V76A, P1345, DOI 10.2106/00004623-199409000-00009
   Van der Mei H.C., 2014, THESIS RIJKSUNIVERSI
   VARDAXIS NJ, 1994, J BIOMED MATER RES, V28, P1013, DOI 10.1002/jbm.820280906
   Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025
   Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001
   Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
   Ward PA, 1997, J LAB CLIN MED, V129, P400, DOI 10.1016/S0022-2143(97)90072-X
   Ward WK, 2002, BIOMATERIALS, V23, P4185, DOI 10.1016/S0142-9612(02)00160-6
   Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wujcik EK, 2013, WIRES NANOMED NANOBI, V5, P233, DOI 10.1002/wnan.1213
   Xia ZD, 2004, J BIOMED MATER RES A, V71A, P538, DOI 10.1002/jbm.a.30185
   XIA ZD, 1994, CHINESE MED J-PEKING, V107, P845
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   YANG J, 1994, J BIOMED MATER RES, V28, P1249, DOI 10.1002/jbm.820281102
   Yang J, 1996, J BIOMED MATER RES, V31, P71, DOI 10.1002/(SICI)1097-4636(199605)31:1<71::AID-JBM9>3.0.CO;2-N
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023
NR 223
TC 40
Z9 42
U1 10
U2 98
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD SEP
PY 2015
VL 8
IS 9
BP 5671
EP 5701
DI 10.3390/ma8095269
PG 31
WC Materials Science, Multidisciplinary
SC Materials Science
GA CT2NM
UT WOS:000362639200007
PM 28793529
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cojocaru, I
   Moldovan, M
   Sarosi, C
   Leordean, D
   Alb, C
AF Cojocaru, Ileana
   Moldovan, Marioara
   Sarosi, Codruta
   Leordean, Dan
   Alb, Camelia
TI Morphological Biodegradation and the Citotoxicity Effect of Some
   Experimental Biomaterials
SO MATERIALE PLASTICE
LA English
DT Article
DE chitosan; biodegradable polymers; hydroxyapatite; SEM; AFM; citotoxicity
ID CHITOSAN; BONE; COMPOSITES; CELLS
AB The purpose of this work was the detailed study of morphological biodegradation and the citotoxicity effect of some experimental biomaterials. The study has four experimental biomaterials based on polylactic acid, polyethylene glycol, tricalcium phosphate, chitosan and hydroxyapatite in different percent cured in air followed by heat treatment at 120 degrees C. The experimental biomaterials were characterized by AFM (Multimode V-SPM, Veeco) and SEM (Q130 -FEI Company) microscopy. For the citotoxicity were used cell cultures of normal human fibroblasts and the viability testing was made with trypan blue. According to the experimental results, the biomaterial with highest percent in polylactic acid presents a high degradation, compared with the rest of the biomaterials which have HA in composition, who decrease this process. Fibroblasts cell culture showed good adhesion to the surface of the biomaterials. The viability of the biomaterials increases at 48h compared with 24h, which suggest the absence of the materials cytotoxicity. Our results sustain idea that biomaterials based on chitosan with additions can be successfully used for further studies in reparative medicine.
C1 [Cojocaru, Ileana] Univ Craiova, Craiova 200585, Romania.
   [Moldovan, Marioara; Sarosi, Codruta] Babes Bolyai Univ, Raluca Ripan Chem Res Inst, Cluj Napoca 400294, Romania.
   [Leordean, Dan] Tehn Univ Cluj Napoca, Dept Chem & Phys, Cluj Napoca 400641, Romania.
   [Alb, Camelia] Univ Med & Pharm Iuliu Hatieganu, Fac Med Dent, Cluj Napoca 400006, Romania.
RP Cojocaru, I (reprint author), Univ Craiova, 13 Al I Cuza, Craiova 200585, Romania.
EM i_cojocaru2005@yahoo.com
RI Leordean, Dan/O-8425-2016; Sarosi, Codruta/A-5036-2017; Moldovan,
   Marioara/N-6387-2017
OI Leordean, Dan/0000-0002-3162-0283; Sarosi, Codruta/0000-0003-2960-9832; 
FU European Social Fund through POSDRU Program [DMI 1.5, ID 137516 PARTING]
FX This paper was supported by the European Social Fund through POSDRU
   Program, DMI 1.5, ID 137516 PARTING.
CR CHARLES L.F., 2009, J MATER SCI-MATER M, V21, P1845
   CLARKSON B.H., United States Patent Application, Patent No. 20080220148
   Durkut S, 2006, ARTIF CELL BLOOD SUB, V34, P263, DOI 10.1080/10731190600581866
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo BL, 2014, SCI CHINA CHEM, V57, P490, DOI 10.1007/s11426-014-5086-y
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   MALAFAYA PATRICIA B., 2009, ACTA BIOMATER, V5, P644
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   REIS J.L., 1995, J MATER SCI-MATER M, V6, P786
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   TAMARIZ E., 2013, INTECH, P4
   TANVEER A.K., 2003, J PHARM PHARM SCI, V6, P20
   Trif M, 2007, J OPTOELECTRON ADV M, V9, P3312
   Ural E, 2000, BIOMATERIALS, V21, P2147, DOI 10.1016/S0142-9612(00)00098-3
   Wan Y, 2007, J BIOMED MATER RES A, V80A, P776, DOI 10.1002/jbm.a.31025
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Zhang J, 2006, J BIOACT COMPAT POL, V21, P415, DOI 10.1177/0883911506068553
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 22
TC 0
Z9 0
U1 0
U2 9
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD SEP
PY 2015
VL 52
IS 3
BP 321
EP 324
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA CS9AU
UT WOS:000362382300010
DA 2018-10-20
ER

PT J
AU Zilm, M
   Thomson, SD
   Wei, M
AF Zilm, Michael
   Thomson, Seamus D.
   Wei, Mei
TI A Comparative Study of the Sintering Behavior of Pure and
   Manganese-Substituted Hydroxyapatite
SO MATERIALS
LA English
DT Article
DE hydroxyapatite; ion substitution; sintering behavior
ID BETA-TRICALCIUM PHOSPHATE; CONTAINING SYNTHETIC HYDROXYAPATITES;
   MECHANICAL-PROPERTIES; IRON; TEMPERATURE; SCAFFOLDS; CERAMICS;
   DEFICIENCY; EXPRESSION; MORPHOLOGY
AB Hydroxyapatite (HA) is a widely studied biomaterial for its similar chemical composition to bone and its osteoconductive properties. The crystal structure of HA is flexible, allowing for a wide range of substitutions which can alter bioactivity, biodegradation, and mechanical properties of the substituted apatite. The thermal stability of a substituted apatite is an indication of its biodegradation in vivo. In this study, we investigated the thermal stability and mechanical properties of manganese-substituted hydroxyapatite (MnHA) as it is reported that manganese can enhance cell attachment compared to pure HA. Pure HA and MnHA pellets were sintered over the following temperature ranges: 900 to 1300 degrees C and 700 to 1300 degrees C respectively. The sintered pellets were characterized via density measurements, mechanical testing, X-ray diffraction, and field emission electron microscopy. It was found that MnHA was less stable than HA decomposing around 800 degrees C compared to 1200 degrees C for HA. The flexural strength of MnHA was weaker than HA due to the decomposition of MnHA at a significantly lower temperature of 800 degrees C compared to 1100 degrees C for HA. The low thermal stability of MnHA suggests that a faster in vivo dissolution rate compared to pure HA is expected.
C1 [Zilm, Michael; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Thomson, Seamus D.] Univ Sydney, Dept Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, 97 North Eagleville Rd,Unit 3136, Storrs, CT 06269 USA.
EM michael.zilm@uconn.edu; stho6915@uni.sydney.edu.au;
   meiwei@engr.uconn.edu
FU NSF [CBET-1133883, CBET-1347130]; NSF GK-12 program [0947869]
FX The authors would like to thank NSF grants (CBET-1133883 and
   CBET-1347130) and NSF GK-12 program (0947869) for their support. We
   extend our gratitude to Changmin Hu for her aid with TEM imaging.
CR Afshari FT, 2010, BRAIN, V133, P448, DOI 10.1093/brain/awp319
   AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   Aminzare M, 2013, CERAM INT, V39, P2197, DOI 10.1016/j.ceramint.2012.09.023
   An Y. H., 2000, MECH TESTING BONE BO
   [Anonymous], 1996, F394 ASTM INT
   Armulik A, 2000, EXP CELL RES, V254, P55, DOI 10.1006/excr.1999.4722
   BALY DL, 1986, BIOL TRACE ELEM RES, V11, P201, DOI 10.1007/BF02795535
   Barinov SM, 2006, J MATER SCI-MATER M, V17, P597, DOI 10.1007/s10856-006-9221-y
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bigi A, 2007, INORG CHIM ACTA, V360, P1009, DOI 10.1016/j.ica.2006.07.074
   Boilet L, 2013, CERAM INT, V39, P283, DOI 10.1016/j.ceramint.2012.06.023
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Erikson KM, 2005, ENVIRON TOXICOL PHAR, V19, P415, DOI 10.1016/j.etap.2004.12.053
   Fujitani W., 2010, NANO BIOMED, V2, P37
   Gillot B, 2001, MATER CHEM PHYS, V70, P54, DOI 10.1016/S0254-0584(00)00473-9
   Golden DC, 1999, SOIL SCI SOC AM J, V63, P657, DOI 10.2136/sssaj1999.03615995006300030032x
   Guo LH, 2003, J MATER SCI-MATER M, V14, P817, DOI 10.1023/A:1025048724330
   He LH, 2008, ACTA BIOMATER, V4, P577, DOI 10.1016/j.actbio.2007.11.002
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Kramer E., 2013, BIOCERAM DEV APPL, V3, DOI [10.4172/2090-5025.1000067, DOI 10.4172/2090-5025.1000067]
   Leventouri T, 2006, BIOMATERIALS, V27, P3339, DOI 10.1016/j.biomaterials.2006.02.021
   Li Y, 2009, J PHYS CONF SER, V187, DOI 10.1088/1742-6596/187/1/012024
   Li YQ, 2012, J MATER SCI, V47, P730, DOI 10.1007/s10853-011-5846-4
   Liang K., 2015, HYDROXYAPATITE SYNTH
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   Mayer I, 2008, J INORG BIOCHEM, V102, P311, DOI 10.1016/j.jinorgbio.2007.09.004
   Mayer I, 2006, EUR J INORG CHEM, P1460, DOI 10.1002/ejic.200501009
   Mayer I, 2003, EUR J INORG CHEM, P1445
   Medvecky L, 2006, COLLOID SURFACE A, V281, P221, DOI 10.1016/j.colsurfa.2006.02.042
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Paluszkiewicz C, 2010, J MOL STRUCT, V976, P301, DOI 10.1016/j.molstruc.2010.04.001
   Pattanayak D.K., 2005, TRENDS BIOMATER ARTI, V18, P87
   Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   RABINOVITCH M, 1973, J CELL BIOL, V59, P165, DOI 10.1083/jcb.59.1.165
   Ramesh S, 2007, SCI TECHNOL ADV MAT, V8, P257, DOI 10.1016/j.stam.2007.02.006
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Seol YJ, 2014, TISSUE ENG PT A, V20, P2840, DOI [10.1089/ten.tea.2012.0726, 10.1089/ten.TEA.2012.0726]
   Silverthorn DU, 2010, HUMAN PHYSL INTEGRAT
   Sureshbabu S, 2012, J AM CERAM SOC, V95, P915, DOI 10.1111/j.1551-2916.2011.04987.x
   Sutter B, 2005, SOIL SCI SOC AM J, V69, P362, DOI 10.2136/sssaj2005.0362
   Sutter B, 2003, SOIL SCI SOC AM J, V67, P1935, DOI 10.2136/sssaj2003.1935
   Sutter B, 2002, SOIL SCI SOC AM J, V66, P1359, DOI 10.2136/sssaj2002.1359
   Sutter B, 2002, SOIL SCI SOC AM J, V66, P455, DOI 10.2136/sssaj2002.4550
   Tanimoto Y, 2008, J BIOMED MATER RES A, V85A, P427, DOI 10.1002/jbm.a.31569
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Vladescu A, 2014, J MECH BEHAV BIOMED, V40, P362, DOI 10.1016/j.jmbbm.2014.08.025
   Wang JW, 2007, ADV MATER, V19, P2364, DOI 10.1002/adma.200602333
   Wang Jiwen, 2009, Biomaterials, V30, P6565, DOI 10.1016/j.biomaterials.2009.08.048
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yoshida K, 2005, J AM CERAM SOC, V88, P2315, DOI 10.1111/j.1551-2916.2005.00399.x
   Zhang ZX, 2013, EXP THER MED, V6, P707, DOI 10.3892/etm.2013.1204
   Zilm ME, 2014, J MATER CHEM B, V2, P7176, DOI 10.1039/c4tb00925h
NR 61
TC 4
Z9 4
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD SEP
PY 2015
VL 8
IS 9
BP 6419
EP 6436
DI 10.3390/ma8095308
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA CT2NW
UT WOS:000362640300009
PM 28793572
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sudhakar, YN
   Selvakumar, M
   Bhat, DK
AF Sudhakar, Y. N.
   Selvakumar, M.
   Bhat, D. Krishna
TI Effect of acid dopants in biodegradable gel polymer electrolyte and the
   performance in an electrochemical double layer capacitor
SO PHYSICA SCRIPTA
LA English
DT Article; Proceedings Paper
CT 12th Russia/CIS/Baltic/Japan Symposium on Ferroelectricity (RCBJSF) and
   9th International Conference on Functional Materials and
   Nanotechnologies (FM&NT)
CY SEP 29-OCT 02, 2014
CL Riga, LATVIA
SP Univ Latvia, Inst Solid State Phys
DE polymer; sol-gel growth; electrochemical properties; biomaterial
ID ACTIVATED CARBON; CONDUCTIVITY; N,N-DIMETHYLFORMAMIDE; SUPERCAPACITORS;
   MEMBRANES; NMR
AB Proton-conducting biodegradable gellan gum gel polymer electrolytes (GPEs) have been prepared using three different dopants, namely ortho-phosphoric (o-H3PO4), sulfuric (H2SO4) and hydrochloric acids (HCl). The GPEs were cross-linked using borax. The polymeric gels were characterized by spectroscopic, thermal, ionic conductivities and dielectric measurements. Proton conductivity was in the range of 5.1. x. 10(-3) to 3.7. x. 10(-4) s cm(-1) and activation energies were between 0.14 meV and 0.19 meV, at different temperatures. Among the doped acids, the H3PO4 doped GPE exhibited thermal stability at varying temperature. Electrochemical double layer capacitors (EDLCs) were fabricated using activated carbon as electrode material and GPEs. The EDLCs were tested using cyclic voltammetry, ac impedance spectroscopic and galvanostatic charge-discharge techniques. The maximum specific capacitance value was 146 F g(-1) at a scan rate of 2 mV s(-1). Quite stable values were obtained at a constant current density up to 1000 cycles.
C1 [Sudhakar, Y. N.] Sri Dharmasthala Manjunatheshwara Coll Autonomous, Dept PG Chem, Ujire, Karnataka, India.
   [Selvakumar, M.] Manipal Inst Technol, Dept Chem, Manipal, Karnataka, India.
   [Bhat, D. Krishna] Natl Inst Technol Karnataka, Dept Chem, Mangalore, India.
RP Sudhakar, YN (reprint author), Sri Dharmasthala Manjunatheshwara Coll Autonomous, Dept PG Chem, Ujire, Karnataka, India.
EM chemselva@rediffmail.com
OI Bhat, Denthaje Krishna/0000-0003-0383-6017
FU Defence and Research Development Organization (DRDO), Govt. of India,
   New Delhi
FX The authors acknowledge the financial support received from the Defence
   and Research Development Organization (DRDO), Govt. of India, New Delhi.
CR Arof A K, 2008, MOL CRYST LIQ CRYST, V484, P107
   Asmara SN, 2011, ELECTROCHIM ACTA, V57, P91, DOI 10.1016/j.electacta.2011.06.045
   Beguin F., 2014, ADV MATER, V26, P1
   Garcia MC, 2011, BIOCHEM ENG J, V55, P73, DOI 10.1016/j.bej.2011.02.017
   Choudhury NA, 2008, J ELECTROCHEM SOC, V155, pA74, DOI 10.1149/1.2803501
   Coviello T, 2003, BIOMATERIALS, V24, P2789, DOI 10.1016/S0142-9612(03)00087-5
   Deka M, 2013, IONICS, V19, P1367, DOI 10.1007/s11581-013-0874-5
   Fialho AM, 2008, APPL MICROBIOL BIOT, V79, P889, DOI 10.1007/s00253-008-1496-0
   Picone CSF, 2011, CARBOHYD POLYM, V84, P662, DOI 10.1016/j.carbpol.2010.12.045
   Ganesh B, 2008, IONICS, V14, P339, DOI 10.1007/s11581-008-0230-3
   GOVINDARAJ G, 1995, SOLID STATE IONICS, V76, P47, DOI 10.1016/0167-2738(94)00204-6
   Halim NFA, 2012, MOL CRYST LIQ CRYST, V554, P232, DOI 10.1080/15421406.2012.634344
   Hamdine M, 2006, RHEOL ACTA, V45, P659, DOI 10.1007/s00397-005-0024-8
   Handa N, 2008, J POWER SOURCES, V185, P1585, DOI 10.1016/j.jpowsour.2008.08.086
   Hassoun J, 2013, J POWER SOURCES, V229, P117, DOI 10.1016/j.jpowsour.2012.11.130
   Hastak RS, 2012, ELECTROCHIM ACTA, V59, P296, DOI 10.1016/j.electacta.2011.10.102
   Judeinstein P, 2005, ACTA CHIM SLOV, V52, P349
   Khandale AP, 2013, IONICS, V19, P1619, DOI 10.1007/s11581-013-0899-9
   Kumar GG, 2009, J POLYM RES, V16, P55, DOI 10.1007/s10965-008-9202-6
   Largeot C, 2008, J AM CHEM SOC, V130, P2730, DOI 10.1021/ja7106178
   Lin HL, 2003, J POLYM RES-TAIWAN, V10, P171, DOI 10.1023/A:1026060630998
   Matricardi P, 2009, MOLECULES, V14, P3376, DOI 10.3390/molecules14093376
   Noor ISM, 2012, SOLID STATE IONICS, V225, P649, DOI 10.1016/j.ssi.2012.03.019
   Pandey GP, 2010, J ELECTROCHEM SOC, V157, pA105, DOI 10.1149/1.3258317
   Qiao JL, 2003, SOLID STATE IONICS, V156, P415, DOI 10.1016/S0167-2738(02)00691-4
   Rathod D, 2009, J APPL ELECTROCHEM, V39, P1097, DOI 10.1007/s10800-008-9764-3
   Rikukawa M, 2000, PROG POLYM SCI, V25, P1463, DOI 10.1016/S0079-6700(00)00032-0
   Sampath S, 2009, J CHEM SCI, V121, P727, DOI 10.1007/s12039-009-0087-7
   Sekhon SS, 2004, SOLID STATE IONICS, V175, P545, DOI 10.1016/j.ssi.2004.03.040
   Senel M, 2007, IONICS, V13, P263, DOI 10.1007/s11581-007-0100-4
   Shmukler LE, 2012, J POLYM RES, V19, DOI 10.1007/s10965-011-9770-8
   Shmukler LE, 2011, POLYM SCI SER A+, V53, P44, DOI 10.1134/S0965545X11010056
   Shmukler LE, 2013, IONICS, V19, P701, DOI 10.1007/s11581-012-0800-2
   Shukur MF, 2013, OPT MATER, V35, P1834, DOI 10.1016/j.optmat.2013.03.004
   Stevens JR, 1997, SOLID STATE IONICS, V97, P347, DOI 10.1016/S0167-2738(97)00036-2
   Sudhakar YN, 2014, MATER SCI ENG B-ADV, V180, P12, DOI 10.1016/j.mseb.2013.10.013
   Sudhakar YN, 2013, IONICS, V19, P277, DOI 10.1007/s11581-012-0745-5
   Sudhakar YN, 2013, J APPL ELECTROCHEM, V43, P21, DOI 10.1007/s10800-012-0493-2
   Sudhakar YN, 2012, ELECTROCHIM ACTA, V78, P398, DOI 10.1016/j.electacta.2012.06.032
   Tambelli CE, 2007, ELECTROCHIM ACTA, V53, P1535, DOI 10.1016/j.electacta.2007.05.008
   Yamagata M, 2013, RSC ADV, V3, P1037, DOI 10.1039/c2ra22188h
   Yu HJ, 2012, J POWER SOURCES, V198, P402, DOI 10.1016/j.jpowsour.2011.09.110
NR 42
TC 2
Z9 2
U1 0
U2 14
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD SEP
PY 2015
VL 90
IS 9
AR 095702
DI 10.1088/0031-8949/90/9/095702
PG 11
WC Physics, Multidisciplinary
SC Physics
GA CT0NI
UT WOS:000362492500037
DA 2018-10-20
ER

PT J
AU Al Qaysi, M
   Walters, NJ
   Foroutan, F
   Owens, GJ
   Kim, HW
   Shah, R
   Knowles, JC
AF Al Qaysi, Mustafa
   Walters, Nick J.
   Foroutan, Farzad
   Owens, Gareth J.
   Kim, Hae-Won
   Shah, Rishma
   Knowles, Jonathan C.
TI Strontium- and calcium-containing, titanium-stabilised phosphate-based
   glasses with prolonged degradation for orthopaedic tissue engineering
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Phosphate-based glass; strontium; calcium; biomaterial; tissue
   engineering
ID RANELATE TREATMENT; BIOACTIVE GLASS; OSTEOPOROSIS; RESORPTION;
   FRACTURES; DELIVERY; AGENT; CELLS; RISK
AB Strontium- and calcium-releasing, titanium-stabilised phosphate-based glasses with a controlled degradation rate are currently under development for orthopaedic tissue engineering applications. Ca and/or Sr were incorporated at varying concentrations in quaternary phosphate-based glasses, in order to promote osteoinduction. Ti was incorporated at a fixed concentration in order to prolong degradation. Glasses of the general formula (P2O5)-(Na2O)-(TiO2)-(CaO)-(SrO) were prepared via the melt-quench technique. The materials were characterised by energy-dispersive X-ray spectroscopy, X-ray diffraction, P-31 magic angle spinning nuclear magnetic resonance, Fourier transform infrared spectroscopy, differential thermal analysis and density determination. The dissolution rate in distilled water was determined by measuring mass loss, ion release and pH change over a two-week period. In addition, the cytocompatibility and alkaline phosphatase activity of an osteoblast-like cell line cultured on the surface of glass discs was assessed. The glasses were shown to be amorphous and contained Q(1), Q(2) and Q(3) species. Fourier transform infrared spectroscopy revealed small changes in the glass structure as Ca was substituted with Sr and differential thermal analysis confirmed a decrease in crystallisation temperature with increasing Sr content. Degradation and ion release studies also showed that mass loss was positively correlated with Sr content. These results were attributed to the lower electronegativity of Sr in comparison to Ca favouring the formation of phosphate-based mineral phases. All compositions supported cell proliferation and survival and induced at least 2.3-fold alkaline phosphatase activity relative to the control. Glass containing 17.5 mol% Sr had 3.6-fold greater alkaline phosphatase activity than the control. The gradual release of Ca and Sr supported osteoinduction, indicating their potential suitability in orthopaedic tissue engineering applications.
C1 [Al Qaysi, Mustafa; Walters, Nick J.; Foroutan, Farzad; Owens, Gareth J.; Knowles, Jonathan C.] UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Walters, Nick J.] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.
   [Walters, Nick J.] Univ Tampere, Inst Biomed Technol, Adult Stem Cell Grp, FIN-33101 Tampere, Finland.
   [Walters, Nick J.] BioMediTech, Inst Biosci & Med Technol, Tampere, Finland.
   [Foroutan, Farzad] UCL, Fac Math & Phys Sci, Dept Chem, London, England.
   [Kim, Hae-Won; Knowles, Jonathan C.] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Kim, Hae-Won; Knowles, Jonathan C.] Dankook Univ, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea.
   [Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan, South Korea.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Cheonan, South Korea.
   [Shah, Rishma] UCL Eastman Dent Inst, Dept Craniofacial Growth & Dev, Unit Orthodont, London WC1X 8LD, England.
RP Knowles, JC (reprint author), UCL Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
EM j.knowles@ucl.ac.uk
OI Walters, Nick/0000-0002-4138-9695
FU UCL Industrial Doctorate Centre in Molecular Modelling & Material
   Science
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   project was supported by the UCL Industrial Doctorate Centre in
   Molecular Modelling & Material Science.
CR Abou Neel EA, 2008, J MATER SCI-MATER M, V19, P377, DOI 10.1007/s10856-007-3079-5
   Abou Neel EA, 2009, J R SOC INTERFACE, V6, P435, DOI 10.1098/rsif.2008.0348
   [Anonymous], 2009, 109932009E ISO
   Baia L, 2007, VIB SPECTROSC, V43, P313, DOI 10.1016/j.vibspec.2006.03.006
   Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Cianferotti L, 2013, THER ADV MUSCULOSKEL, V5, P127, DOI 10.1177/1759720X13483187
   Foroutan F, 2015, ACS NANO, V9, P1868, DOI 10.1021/nn506789y
   Foroutan F, 2015, J SOL-GEL SCI TECHN, V73, P434, DOI 10.1007/s10971-014-3555-6
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1
   KIRKPATRICK RJ, 1995, SOLID STATE NUCL MAG, V5, P9, DOI 10.1016/0926-2040(95)00042-O
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Lakhkar NJ, 2009, J MATER SCI-MATER M, V20, P1339, DOI 10.1007/s10856-008-3688-7
   Lakhkar N, 2011, J BIOMATER APPL, V25, P877, DOI 10.1177/0885328210362125
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Lee H-I, 2013, MAT SCI ENG C, V33, P2104
   Liu LL, 2014, J BIOMED MATER RES B, V102, P423, DOI 10.1002/jbm.b.33019
   Lopa S, 2013, J BIOMED MATER RES A, V101, P3396, DOI 10.1002/jbm.a.34649
   MARIE PJ, 1993, J BONE MINER RES, V8, P607
   Martell A. E., 1988, DETERMINATION USE ST
   Mentaverri Romuald, 2012, Curr Mol Pharmacol, V5, P189
   Meunier PJ, 2009, OSTEOPOROSIS INT, V20, P1663, DOI 10.1007/s00198-008-0825-6
   Moustafa YM, 1998, J NON-CRYST SOLIDS, V240, P144, DOI 10.1016/S0022-3093(98)00711-X
   Newman SD, 2014, TISSUE ENG PT A, V20, P1850, DOI [10.1089/ten.tea.2013.0304, 10.1089/ten.TEA.2013.0304]
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461
   Reginster JY, 2014, EXPERT OPIN DRUG SAF, V13, P1209, DOI 10.1517/14740338.2014.939169
   Stahli C, 2015, J CONTROL RELEASE, V200, P222, DOI 10.1016/j.jconrel.2015.01.002
   Tan S, 2014, BIOMED RES INT, DOI 10.1155/2014/814057
   Valappil SP, 2008, APPL ENVIRON MICROB, V74, P5228, DOI 10.1128/AEM.00086-08
NR 34
TC 8
Z9 8
U1 1
U2 23
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD SEP
PY 2015
VL 30
IS 3
BP 300
EP 310
DI 10.1177/0885328215588898
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CS0QN
UT WOS:000361767300005
PM 26023179
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kai, D
   Low, ZW
   Liow, SS
   Karim, AA
   Ye, HY
   Jin, GR
   Li, K
   Loh, XJ
AF Kai, Dan
   Low, Zhi Wei
   Liow, Sing Shy
   Karim, Anis Abdul
   Ye, Hongye
   Jin, Guorui
   Li, Kai
   Loh, Xian Jun
TI Development of Lignin Supramolecular Hydrogels with Mechanically
   Responsive and Self-Healing Properties
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Biomass; Cyclodextrin; PEGMA; Self-assembly; Rheology
ID TRANSFER RADICAL POLYMERIZATION; ALPHA-CYCLODEXTRIN; BIOMEDICAL
   APPLICATIONS; NANOCOMPOSITE HYDROGELS; GRAFT-COPOLYMERIZATION; INCLUSION
   COMPLEXES; DELIVERY; COMPOSITES; POLYMERS; POLY(DMAEMA-CO-PPGMA)
AB The development of functional polymers from renewable lignin is attractive due to the depletion of fossil fuel and increasing environmental usage. A series of poly(ethylene glycol) methyl ether methacrylate (PEGMA)-grafted lignin hyperbranched copolymers were prepared by atom transfer radical polymerization (ATRP). The chemical structures, molecular characteristic and thermal properties of these copolymers were evaluated and such copolymers were prepared in a range of molecular weights from 38.7 to 65.0 kDa by adjusting the PEGMA-to-lignin weight ratio. As a result from their hyperbranch architecture, their aqueous solutions were found to form supramolecular hydrogels with a very low critical gelation concentration of 1 wt % copolymers, in the presence of alpha-cyclodextrin (alpha-CD). The rheological properties of the supramolecular assemblies were investigated and these hydrogel systems showed tunable mechanical response and excellent self-healing capability. Combined with good biocompatibility, these new types of green supramolecular hydrogels based on lignin-PEGMA/cyclodextrin inclusion are potentially useful as a smart biomaterial for biomedical application.
C1 [Kai, Dan; Liow, Sing Shy; Karim, Anis Abdul; Ye, Hongye; Jin, Guorui; Li, Kai; Loh, Xian Jun] ASTAR, IMRE, Singapore 117602, Singapore.
   [Low, Zhi Wei; Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, Singapore 168751, Singapore.
RP Kai, D (reprint author), ASTAR, IMRE, 3 Res Link, Singapore 117602, Singapore.
EM kaid@imre.a-star.edu.sg; lohxj@imre.a-star.edu.sg
RI Li, Kai/H-4271-2018
OI Li, Kai/0000-0003-1664-5439; Loh, Xian Jun/0000-0001-8118-6502
CR Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Chen G, 2011, CHEM SOC REV, V40, P2254, DOI 10.1039/c0cs00153h
   Chen Y, 2010, CHEM SOC REV, V39, P495, DOI 10.1039/b816354p
   Chirila TV, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39932
   Cui CZ, 2013, BIORESOURCES, V8, P864
   Gao GZ, 2012, BIOMACROMOLECULES, V13, P3602, DOI 10.1021/bm301039f
   Guan Y, 2013, CHEM SOC REV, V42, P8106, DOI 10.1039/c3cs60152h
   Guo CG, 2013, J APPL POLYM SCI, V129, P901, DOI 10.1002/app.38902
   Harada A, 2009, CHEM SOC REV, V38, P875, DOI 10.1039/b705458k
   Harada A, 2014, ACCOUNTS CHEM RES, V47, P2128, DOI 10.1021/ar500109h
   Harada A, 2011, NAT CHEM, V3, P34, DOI [10.1038/nchem.893, 10.1038/NCHEM.893]
   Haraguchi K, 2007, CURR OPIN SOLID ST M, V11, P47, DOI 10.1016/j.cossms.2008.05.001
   Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248
   He WW, 2013, POLYM CHEM-UK, V4, P2919, DOI 10.1039/c3py00122a
   Hilburg SL, 2014, POLYMER, V55, P995, DOI 10.1016/j.polymer.2013.12.070
   HUANG YF, 1992, J APPL POLYM SCI, V45, P71, DOI 10.1002/app.1992.070450108
   Huh KM, 2004, MACROMOL BIOSCI, V4, P92, DOI 10.1002/mabi.200300037
   Jiang H, 2013, CHEM SOC REV, V42, P3394, DOI 10.1039/c2cs35453e
   Kai D, 2015, J MATER CHEM B, V3, P6194, DOI 10.1039/c5tb00765h
   Kakuta T, 2013, ADV MATER, V25, P2849, DOI 10.1002/adma.201205321
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Laurichesse S, 2014, PROG POLYM SCI, V39, P1266, DOI 10.1016/j.progpolymsci.2013.11.004
   LI J, 1994, POLYM J, V26, P1019, DOI 10.1295/polymj.26.1019
   Li J, 2010, NPG ASIA MATER, V2, P112, DOI 10.1038/asiamat.2010.84
   Liu KL, 2011, SOFT MATTER, V7, P11290, DOI 10.1039/c1sm06340e
   Loh XJ, 2015, CHEM COMMUN, V51, P10815, DOI 10.1039/c5cc03686k
   Loh XJ, 2014, MATER HORIZ, V1, P185, DOI 10.1039/c3mh00057e
   Loh XJ, 2013, MAT SCI ENG C-MATER, V33, P4545, DOI 10.1016/j.msec.2013.07.011
   Loh XJ, 2013, J APPL POLYM SCI, V127, P992, DOI 10.1002/app.37530
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Low ZW, 2015, RSC ADV, V5, P57678, DOI 10.1039/c5ra09926a
   Ma D, 2011, J COLLOID INTERF SCI, V359, P399, DOI 10.1016/j.jcis.2011.04.032
   Mai C, 1999, APPL MICROBIOL BIOT, V51, P527, DOI 10.1007/s002530051428
   Mai C, 2000, ENZYME MICROB TECH, V27, P167, DOI 10.1016/S0141-0229(00)00214-3
   MEISTER JJ, 1992, MACROMOLECULES, V25, P611, DOI 10.1021/ma00028a020
   Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521
   Panesar SS, 2013, IND CROP PROD, V46, P191, DOI [10.1016/j.indcrop.2012.12.031, 10.1016/j.indcrop.2013.01.031]
   Phadke A, 2012, P NATL ACAD SCI USA, V109, P4383, DOI 10.1073/pnas.1201122109
   Pradal C, 2013, BIOMACROMOLECULES, V14, P3780, DOI 10.1021/bm401168h
   Ren LX, 2009, MACROMOL BIOSCI, V9, P902, DOI 10.1002/mabi.200900021
   Saito T, 2012, GREEN CHEM, V14, P3295, DOI 10.1039/c2gc35933b
   Seiffert S, 2015, ADV POLYM SCI, V268, P1, DOI 10.1007/978-3-319-15404-6
   Simoes SMN, 2012, EUR J PHARM BIOPHARM, V80, P103, DOI 10.1016/j.ejpb.2011.09.017
   Taira T, 2010, CHEM-EUR J, V16, P6518, DOI 10.1002/chem.200903315
   Taira T, 2009, CHEM COMMUN, P7027, DOI 10.1039/b911667b
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Wang JF, 2011, J POLYM SCI POL CHEM, V49, P3728, DOI 10.1002/pola.24809
   Wei HL, 2005, J POLYM SCI POL CHEM, V43, P2941, DOI 10.1002/pola.20773
   Wei HL, 2005, EUR POLYM J, V41, P948, DOI 10.1016/j.eurpolymj.2004.11.041
   Ye EY, 2014, MATER TODAY, V17, P194, DOI 10.1016/j.mattod.2014.04.004
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
   Yuan RX, 2008, J POLYM SCI POL PHYS, V46, P782, DOI 10.1002/polb.21412
   Zheng JY, 2015, RSC ADV, V5, P62314, DOI 10.1039/c5ra12816a
   Zhu XY, 2004, LANGMUIR, V20, P484, DOI 10.1021/la035740a
NR 55
TC 57
Z9 57
U1 18
U2 193
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD SEP
PY 2015
VL 3
IS 9
BP 2160
EP 2169
DI 10.1021/acssuschemeng.5b00405
PG 10
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA CR1MY
UT WOS:000361090200031
DA 2018-10-20
ER

PT J
AU Perikamana, SKM
   Lee, J
   Lee, YB
   Shin, YM
   Lee, EJ
   Mikos, AG
   Shin, H
AF Perikamana, Sajeesh Kumar Madhurakkat
   Lee, Jinkyu
   Lee, Yu Bin
   Shin, Young Min
   Lee, Esther J.
   Mikos, Antonios G.
   Shin, Heungsoo
TI Materials from Mussel-Inspired Chemistry for Cell and Tissue Engineering
   Applications
SO BIOMACROMOLECULES
LA English
DT Review
ID POTENTIAL BIOMEDICAL APPLICATIONS; MEDIATED SURFACE MODIFICATION;
   SELF-ASSEMBLED MONOLAYERS; ENDOTHELIAL GROWTH-FACTOR; GUIDED BONE
   REGENERATION; MESENCHYMAL STEM-CELLS; GLY-ASP PEPTIDES; IN-VITRO;
   ELECTROSPUN FIBERS; OSTEOGENIC DIFFERENTIATION
AB Current advances in biomaterial fabrication techniques have broadened their application in different realms of biomedical engineering, spanning from drug delivery to tissue engineering. The success of biomaterials depends highly on the ability to modulate cell and tissue responses, including cell adhesion, as well as induction of repair and immune processes. Thus, most recent approaches in the field have concentrated on functionalizing biomaterials with different biomolecules intended to evoke cell- and tissue-specific reactions. Marine mussels produce mussel adhesive proteins (MAPs), which help them strongly attach to different surfaces, even under wet conditions in the ocean. Inspired by mussel adhesiveness, scientists discovered that dopamine undergoes self-polymerization at alkaline conditions. This reaction provides a universal coating for metals, polymers, and ceramics, regardless of their chemical and physical properties. Furthermore, this polymerized layer is enriched with catechol groups that enable immobilization of primary amine or thiol-based biomolecules via a simple dipping process. Herein, this review explores the versatile surface modification techniques that have recently been exploited in tissue engineering and summarizes polydopamine polymerization mechanisms, coating process parameters, and effects on substrate properties. A brief discussion of polydopamine-based reactions in the context of engineering various tissue types, including bone, blood vessels, cartilage, nerves, and muscle, is also provided.
C1 [Perikamana, Sajeesh Kumar Madhurakkat; Lee, Jinkyu; Lee, Yu Bin; Shin, Young Min; Shin, Heungsoo] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Dept Bioengn, Seoul 133791, South Korea.
   [Perikamana, Sajeesh Kumar Madhurakkat; Lee, Jinkyu; Lee, Yu Bin; Shin, Young Min; Shin, Heungsoo] Hanyang Univ, Plus Future Biopharmaceut Human Resources Trainin, Seoul 133791, South Korea.
   [Lee, Esther J.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77030 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77030 USA.
EM mikos@rice.edu; hshin@hanyang.ac.kr
FU LG Yonam Foundation; National Institutes of Health [R01 AR048756, R01
   CA180279, R21 AR067527]; National Science Foundation
FX H.S. acknowledges support from a Yonam Professor Fellowship through the
   LG Yonam Foundation. A.G.M. acknowledges support from the National
   Institutes of Health for research towards the development of
   biomaterials for tissue engineering applications (R01 AR048756, R01
   CA180279, and R21 AR067527). E.J.L. acknowledges support from a National
   Science Foundation Graduate Research Fellowship.
CR Adamczak M., 2010, ACTA BIOENGINEERING, V13, P63
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137
   Bae IH, 2012, J MATER SCI-MATER M, V23, P1259, DOI 10.1007/s10856-012-4587-5
   Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030
   Ball V, 2011, J COLLOID INTERF SCI, V364, P359, DOI 10.1016/j.jcis.2011.08.038
   Beckwith KM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045009
   Benhabbour SR, 2008, BIOMATERIALS, V29, P4177, DOI 10.1016/j.biomaterials.2008.07.016
   Bernsmann F, 2011, LANGMUIR, V27, P2819, DOI 10.1021/la104981s
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Bhang SH, 2013, BIOCHEM BIOPH RES CO, V430, P1294, DOI 10.1016/j.bbrc.2012.11.123
   Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   Boccafoschi F, 2012, J BIOMED MATER RES A, V100A, P2373, DOI 10.1002/jbm.a.34180
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Bourmaud A, 2009, POLYM TEST, V28, P668, DOI 10.1016/j.polymertesting.2009.04.006
   Bramfeldt H, 2009, J BIOMED MATER RES A, V88A, P520, DOI 10.1002/jbm.a.31889
   Cai YL, 2014, COLLOID SURFACE B, V116, P681, DOI 10.1016/j.colsurfb.2013.11.004
   Cai YL, 2013, J MATER CHEM B, V1, P5971, DOI 10.1039/c3tb20680g
   Chassepot A, 2014, J COLLOID INTERF SCI, V414, P97, DOI 10.1016/j.jcis.2013.10.002
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chen Q, 2014, J ADHES DENT, V16, P177, DOI 10.3290/j.jad.a31810
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chien HW, 2012, LANGMUIR, V28, P5775, DOI 10.1021/la300147p
   Cho HJ, 2014, ACS APPL MATER INTER, V6, P11225, DOI 10.1021/am501391z
   Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55
   Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024
   Chu CY, 2006, BRIT J DERMATOL, V154, P1071, DOI 10.1111/j.1365-2133.2006.07293.x
   Chua D, 2013, NEW ENGL J MED, V368, P1557, DOI 10.1056/NEJMc1301999
   Ciofani G, 2013, ACTA BIOMATER, V9, P5111, DOI 10.1016/j.actbio.2012.10.016
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Dreyer DR, 2013, CHEM SCI, V4, P3796, DOI 10.1039/c3sc51501j
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Elsner Jonathan J, 2012, Biomatter, V2, P239, DOI 10.4161/biom.22838
   Faure E, 2013, PROG POLYM SCI, V38, P236, DOI 10.1016/j.progpolymsci.2012.06.004
   Feng JJ, 2011, J CHROMATOGR A, V1218, P3601, DOI 10.1016/j.chroma.2011.04.018
   Fishero BA, 2015, CRANIOMAX TRAUM REC, V8, P23, DOI 10.1055/s-0034-1393724
   Fishman JM, 2013, TISSUE ENG PART B-RE, V19, P503, DOI [10.1089/ten.teb.2013.0120, 10.1089/ten.TEB.2013.0120]
   Gao AL, 2014, J MEMBRANE SCI, V452, P390, DOI 10.1016/j.memsci.2013.10.016
   Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   He CL, 2011, J BIOMED MATER RES A, V99A, P655, DOI 10.1002/jbm.a.33235
   Ho CC, 2013, J MATER SCI-MATER M, V24, P2381, DOI 10.1007/s10856-013-4994-2
   Hong L, 2007, J PHYS CHEM B, V111, P7938, DOI 10.1021/jp071439h
   Hong S, 2013, ANGEW CHEM INT EDIT, V52, P9187, DOI 10.1002/anie.201301646
   Hong S, 2013, ADV FUNCT MATER, V23, P1774, DOI 10.1002/adfm.201202365
   Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156
   Hong S, 2011, NANOMEDICINE-UK, V6, P793, DOI [10.2217/nnm.11.76, 10.2217/NNM.11.76]
   Hopper AP, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045009
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Jo S, 2013, MACROMOL BIOSCI, V13, P1389, DOI 10.1002/mabi.201300203
   Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b
   Juhas M, 2013, CURR OPIN BIOTECH, V24, P880, DOI 10.1016/j.copbio.2013.04.013
   Jun DR, 2014, COLLOID SURFACE B, V121, P395, DOI 10.1016/j.colsurfb.2014.06.027
   Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kang SM, 2010, ANGEW CHEM INT EDIT, V49, P9401, DOI 10.1002/anie.201004693
   Karig J., 2013, BIOMED RES INT, V2013, P1
   Kasemset S, 2013, J MEMBRANE SCI, V425, P208, DOI 10.1016/j.memsci.2012.08.049
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim M, 2013, COLLOID SURFACE B, V112, P134, DOI 10.1016/j.colsurfb.2013.07.021
   Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054
   Kim S, 2010, BIOMATERIALS, V31, P6628, DOI 10.1016/j.biomaterials.2010.05.004
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Ku SH, 2013, ADV HEALTHC MATER, V2, P1445, DOI 10.1002/adhm.201300067
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lautenschlager F, 2013, CURR OPIN CELL BIOL, V25, P116, DOI 10.1016/j.ceb.2012.10.017
   LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314
   Lee AY, 2014, TRANSL RES, V163, P321, DOI 10.1016/j.trsl.2014.01.014
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee C, 2013, BIOMACROMOLECULES, V14, P2004, DOI 10.1021/bm400352d
   Lee H, 2008, ADV MATER, V20, P1619, DOI 10.1002/adma.200702378
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee JH, 2014, TISSUE ENG PT A, V20, P2031, DOI 10.1089/ten.tea.2013.0282
   Lee JS, 2014, MACROMOL BIOSCI, V14, P1181, DOI 10.1002/mabi.201400052
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011
   Levato R, 2015, ACTA BIOMATER, V18, P59, DOI 10.1016/j.actbio.2015.02.008
   Li SC, 2009, J AM CHEM SOC, V131, P980, DOI 10.1021/ja803595u
   Liang RP, 2011, ELECTROPHORESIS, V32, P3331, DOI 10.1002/elps.201100403
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   Lin SC, 2014, SOFT MATTER, V10, P457, DOI 10.1039/c3sm51810h
   Liu T, 2014, ACS APPL MATER INTER, V6, P8729, DOI 10.1021/am5015309
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Liu ZG, 2014, MAT SCI ENG C-MATER, V44, P44, DOI 10.1016/j.msec.2014.07.063
   Low WC, 2013, BIOMATERIALS, V34, P3581, DOI 10.1016/j.biomaterials.2013.01.093
   Luo RF, 2013, COLLOID SURFACE B, V106, P66, DOI 10.1016/j.colsurfb.2013.01.033
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   McCloskey BD, 2010, POLYMER, V51, P3472, DOI 10.1016/j.polymer.2010.05.008
   Musumeci G, 2014, WORLD J ORTHOP, V5, P80, DOI 10.5312/wjo.v5.i2.80
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Nijhuis AWG, 2013, TISSUE ENG PART C-ME, V19, P610, DOI [10.1089/ten.tec.2012.0313, 10.1089/ten.TEC.2012.0313]
   Nijhuis AG, 2014, J BIOMED MATER RES A, V102, P1102, DOI 10.1002/jbm.a.34776
   Oh YJ, 2012, CHEM COMMUN, V48, P11895, DOI 10.1039/c2cc36843a
   Rodrigues MCO, 2012, NEUROSCI BIOBEHAV R, V36, P177, DOI 10.1016/j.neubiorev.2011.05.010
   Ou JF, 2009, J PHYS CHEM C, V113, P20429, DOI 10.1021/jp9073416
   Ou JF, 2009, APPL SURF SCI, V256, P894, DOI 10.1016/j.apsusc.2009.08.081
   Pan HT, 2014, J BIOMED MATER RES A, V102, P4526, DOI 10.1002/jbm.a.35129
   Park H, 2007, MACROMOL RES, V15, P238, DOI 10.1007/BF03218782
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Ponzio F, 2014, J COLLOID INTERF SCI, V431, P176, DOI 10.1016/j.jcis.2014.06.025
   Rim NG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014102
   Rim NG, 2012, COLLOID SURFACE B, V91, P189, DOI 10.1016/j.colsurfb.2011.10.057
   Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x
   Ryu J, 2011, SOFT MATTER, V7, P7201, DOI 10.1039/c1sm05307h
   Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347
   Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722
   Shi XT, 2014, ACS APPL MATER INTER, V6, P11915, DOI 10.1021/am5029236
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin YM, 2013, MACROMOL MATER ENG, V298, P555, DOI 10.1002/mame.201200217
   Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b
   Shin YM, 2011, MACROMOL RES, V19, P835, DOI 10.1007/s13233-011-0815-y
   Shin YM, 2011, COLLOID SURFACE B, V87, P79, DOI 10.1016/j.colsurfb.2011.05.004
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sun K, 2012, LANGMUIR, V28, P2131, DOI 10.1021/la2041967
   Sun K, 2011, LANGMUIR, V27, P5709, DOI 10.1021/la2012099
   Sun YH, 2013, COLLOID SURFACE B, V111, P107, DOI 10.1016/j.colsurfb.2013.05.037
   Tan XW, 2012, J BIOMED MATER RES B, V100B, P2090, DOI 10.1002/jbm.b.32774
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Toh WS, 2014, MAT SCI ENG C-MATER, V45, P690, DOI 10.1016/j.msec.2014.04.026
   Tsai WB, 2014, J BIOMATER APPL, V28, P837, DOI 10.1177/0885328213483842
   Tsai WB, 2011, ACTA BIOMATER, V7, P4187, DOI 10.1016/j.actbio.2011.07.024
   Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109
   Van der Westen R, 2012, BIOINTERPHASES, V7, P1
   Vanderleyden E, 2014, MAT SCI ENG C-MATER, V42, P396, DOI 10.1016/j.msec.2014.05.048
   Vasanthan Asvin, 2008, J Prosthodont, V17, P357, DOI 10.1111/j.1532-849X.2008.00307.x
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Wang JL, 2013, MACROMOL BIOSCI, V13, P483, DOI 10.1002/mabi.201200390
   Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a
   Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011
   Wood JB, 2013, LANGMUIR, V29, P10868, DOI 10.1021/la402425n
   Wu CT, 2014, ACTA BIOMATER, V10, P428, DOI 10.1016/j.actbio.2013.10.013
   Xie JW, 2013, ACTA BIOMATER, V9, P5698, DOI 10.1016/j.actbio.2012.10.042
   Xie JW, 2012, J BIOMED MATER RES A, V100A, P929, DOI 10.1002/jbm.a.34030
   Yan PH, 2011, APPL SURF SCI, V257, P4849, DOI 10.1016/j.apsusc.2010.12.111
   Yang HW, 2012, J MATER CHEM, V22, P16994, DOI 10.1039/c2jm33251e
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Yang ZL, 2014, J MATER CHEM B, V2, P6767, DOI 10.1039/c4tb01118j
   Yao Y, 2014, ACTA BIOMATER, V10, P2739, DOI 10.1016/j.actbio.2014.02.042
   Ye WC, 2010, ELECTROCHIM ACTA, V55, P2004, DOI 10.1016/j.electacta.2009.11.022
   You I, 2011, BIOCONJUGATE CHEM, V22, P1264, DOI 10.1021/bc2000534
   Yu XH, 2014, RSC ADV, V4, P7185, DOI 10.1039/c3ra44137g
   Zhang Y, 2013, LANGMUIR, V29, P10213, DOI 10.1021/la402118u
   Zhang Y, 2012, LANGMUIR, V28, P17585, DOI 10.1021/la304080c
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
   Zhou P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113087
   Zhou WH, 2010, J MATER CHEM, V20, P880, DOI 10.1039/b916619j
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 161
TC 72
Z9 72
U1 24
U2 322
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2015
VL 16
IS 9
BP 2541
EP 2555
DI 10.1021/acs.biomac.5b00852
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR4WV
UT WOS:000361341700001
PM 26280621
DA 2018-10-20
ER

PT J
AU Dubinov, AE
   Kozhayeva, JP
   Lyubimtseva, VA
AF Dubinov, Alexander E.
   Kozhayeva, Julia P.
   Lyubimtseva, Valeria A.
TI Simple Device to Study Influence of Nanosecond Surface Microdischarge
   Plasma on Biomaterials
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article
DE Biomaterial; microscope; surface nanosecond microdischarge;
   visualization
ID ATMOSPHERIC-PRESSURE; SLIDING DISCHARGE; ARRAY DEVICE; GENERATION; AIR
AB This paper presents the development and description of research aimed at investigation of nanosecond surface microdischarge plasma effect on biomaterials. The technique is based on application of a simple discharge device. The device is assembled on a standard microscope slide from inexpensive materials. An optical microscope equipped with a digital camera is used for visualization of the studied samples and microdischarges. Many images of the microdischarges on the biological objects are presented in this paper. Spatial resolution of the images allows studying the discharges along the cellular structure of the tissue.
C1 [Dubinov, Alexander E.] Russian Fed Nucl Ctr All Russia Sci, Sarov 607188, Russia.
   Res Inst Expt Phys, Sarov 607188, Russia.
   Natl Res Nucl Univ MEPhI, Sarov State Inst Phys & Technol, Sarov 607186, Russia.
RP Dubinov, AE (reprint author), Russian Fed Nucl Ctr All Russia Sci, Sarov 607188, Russia.
EM dubinov-ae@yandex.ru; julia_1992_kogaeva28@mail.ru; valerik128@mail.ru
CR Bhushan B, 2010, BIOL MED PHYS BIOMED, P1
   Dubinov AE, 2000, PLASMA SOURCES SCI T, V9, P597, DOI 10.1088/0963-0252/9/4/316
   Dubinov AE, 2000, SHOCK WAVES, V10, P73, DOI 10.1007/s001930050180
   Dubinov AE, 2014, IEEE T PLASMA SCI, V42, P2049, DOI 10.1109/TPS.2014.2331802
   Gianchandani YB, 2009, ANAL BIOANAL CHEM, V395, P559, DOI 10.1007/s00216-009-3011-6
   Hsu CC, 2012, J MICROELECTROMECH S, V21, P1013, DOI 10.1109/JMEMS.2012.2196495
   Iza F, 2008, PLASMA PROCESS POLYM, V5, P322, DOI 10.1002/ppap.200700162
   Jin Y, 2006, PLASMA SCI TECHNOL, V8, P720, DOI 10.1088/1009-0630/8/6/21
   Kozhayeva JP, 2015, PLASMA PROCESS POLYM, V12, P293, DOI 10.1002/ppap.201400132
   Lee DS, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.106002
   Louste C, 2005, J ELECTROSTAT, V63, P615, DOI 10.1016/j.elstat.2005.03.026
   Lu M, 2007, J MICROELECTROMECH S, V16, P1397, DOI 10.1109/JMEMS.2006.886034
   Mastanaiah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070840
   Mitra B, 2008, IEEE T PLASMA SCI, V36, P1913, DOI 10.1109/TPS.2008.927135
   Nijdam S, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103038
   Samukawa S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/25/253001
   Wright SA, 2007, J VAC SCI TECHNOL B, V25, P1711, DOI 10.1116/1.2782510
   Yang YJ, 2014, IEEE T PLASMA SCI, V42, P3756, DOI 10.1109/TPS.2014.2342212
   Yang YJ, 2013, J MICROELECTROMECH S, V22, P256, DOI 10.1109/JMEMS.2012.2234725
NR 19
TC 3
Z9 3
U1 2
U2 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0093-3813
EI 1939-9375
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD SEP
PY 2015
VL 43
IS 9
BP 3224
EP 3227
DI 10.1109/TPS.2015.2458900
PN 2
PG 4
WC Physics, Fluids & Plasmas
SC Physics
GA CR7KX
UT WOS:000361529600014
DA 2018-10-20
ER

PT J
AU Atta, S
   Khaliq, S
   Islam, A
   Javeria, I
   Jamil, T
   Athar, MM
   Shafiq, MI
   Ghaffar, A
AF Atta, Sadia
   Khaliq, Shaista
   Islam, Atif
   Javeria, Irtaza
   Jamil, Tahir
   Athar, Muhammad Makshoof
   Shafiq, Muhammad Imtiaz
   Ghaffar, Abdul
TI Injectable biopolymer based hydrogels for drug delivery applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Injectable; Biopolymer; Hydrogels; Drug delivery
ID POLY(ETHYLENE GLYCOL) MACROMER; PEG-GRAFTED CHITOSAN; VISCOELASTIC
   PROPERTIES; ALCOHOL BLEND; IN-VITRO; RELEASE; NANOPARTICLES; COPOLYMERS;
   FILMS; MICROCAPSULES
AB Biopolymer based pH-sensitive hydrogels were prepared using chitosan (CS) with polyethylene glycol (PEG) of different molecular weights in the presence of silane crosslinker. The incorporated components remain undissolved in different swelling media as they are connected by siloxane linkage which was confirmed by Fourier transform infrared spectroscopy. The swelling in water was enhanced by the addition of higher molecular weight PEG. The swelling behaviour of the hydrogels against pH showed high swelling in acidic and basic pH, whereas, low swelling was examined at pH 6 and 7. This characteristic pH responsive behaviour at neutral pH made them suitable for injectable controlled drug delivery. The controlled release analysis of Cefixime (CFX) (model drug) loaded CS/PEG hydrogel exhibited that the entire drug was released in 30 min in simulated gastric fluid (SGF) while in simulated intestinal fluid (SIF), 85% of drug was released in controlled manner within 80 min. This inferred that the developed hydrogels can be an attractive biomaterial for injectable drug delivery with physiological pH and other biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Atta, Sadia; Khaliq, Shaista; Athar, Muhammad Makshoof] Univ Punjab, Inst Chem, Lahore, Pakistan.
   [Khaliq, Shaista; Islam, Atif; Javeria, Irtaza; Jamil, Tahir] Univ Punjab, Dept Polymer Engn & Technol, Lahore, Pakistan.
   [Shafiq, Muhammad Imtiaz] Univ Punjab, Inst Biochem & Biotechnol, Lahore, Pakistan.
   [Javeria, Irtaza; Ghaffar, Abdul] Univ Engn & Technol, Dept Chem, Lahore, Pakistan.
RP Islam, A (reprint author), Univ Punjab, Dept Polymer Engn & Technol, Quaid E Azam Campus, Lahore, Pakistan.
EM dratifislam@gmail.com
OI Islam, Atif/0000-0003-3375-9817
CR Altinisik A, 2011, J APPL POLYM SCI, V122, P1556, DOI 10.1002/app.34278
   Alvarez-Lorenzo C, 2002, J CONTROL RELEASE, V80, P247, DOI 10.1016/S0168-3659(02)00032-9
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Chandy T, 1999, ARTIF ORGANS, V23, P894, DOI 10.1046/j.1525-1594.1999.06244.x
   Chandy T, 1998, J APPL POLYM SCI, V70, P2143, DOI 10.1002/(SICI)1097-4628(19981212)70:11<2143::AID-APP7>3.0.CO;2-L
   Chen SH, 2013, MAT SCI ENG C-MATER, V33, P2584, DOI 10.1016/j.msec.2013.02.031
   Das N., 2013, INT J PHARM PHARM SC, V5, P112
   Driscoll AJ, 2012, CLIN INFECT DIS, V54, P159
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Gorochovceva N, 2004, EUR POLYM J, V40, P685, DOI 10.1016/j.eurpolymj.2003.12.005
   Gorochovceva N, 2005, EUR POLYM J, V41, P2653, DOI 10.1016/j.eurpolymj.2005.05.021
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hu YQ, 2005, CARBOHYD POLYM, V61, P472, DOI 10.1016/j.carbpol.2005.06.022
   Islam A, 2013, INT J BIOL MACROMOL, V59, P119, DOI 10.1016/j.ijbiomac.2013.04.044
   Islam A, 2012, CARBOHYD POLYM, V88, P1055, DOI 10.1016/j.carbpol.2012.01.070
   Islam A, 2012, J APPL POLYM SCI, V124, P4184, DOI 10.1002/app.35392
   Ito T, 2013, MAT SCI ENG C-MATER, V33, P3697, DOI 10.1016/j.msec.2013.04.056
   Kaewpirom S, 2006, EUR POLYM J, V42, P1609, DOI 10.1016/j.eurpolymj.2006.01.010
   Kammoun M, 2013, INT J BIOL MACROMOL, V62, P433, DOI 10.1016/j.ijbiomac.2013.09.025
   Kim SJ, 2003, J MACROMOL SCI PURE, VA40, P501, DOI 10.1081/MA-120019888
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P53, DOI 10.1016/S1381-5148(02)00214-6
   Kulbokaite R, 2009, REACT FUNCT POLYM, V69, P771, DOI 10.1016/j.reactfunctpolym.2009.06.010
   Kurisawa M., 2005, CHEMICAL COMMUNICATI, V34, P4312
   Lee SY, 2007, J CONTROL RELEASE, V119, P313, DOI 10.1016/j.jconrel.2007.03.007
   Lee SJ, 2000, CARBOHYD POLYM, V41, P197, DOI 10.1016/S0144-8617(99)00088-0
   Levy R J, 1996, Drug Deliv, V3, P137, DOI 10.3109/10717549609029442
   Lowman A., 2000, INT J CHEM ENG APPL, V88, P933
   Lu SX, 2000, MACROMOLECULES, V33, P2509, DOI 10.1021/ma9915024
   Ma GP, 2010, POLYM ADVAN TECHNOL, V21, P189, DOI 10.1002/pat.1415
   Mahatmanti FW, 2014, INDONES J CHEM, V14, P131
   Mohamed NA, 2012, INT J MOL SCI, V13, P11194, DOI 10.3390/ijms130911194
   Pasut G, 2007, REACT FUNCT POLYM, V67, P529, DOI 10.1016/j.reactfunctpolm.2007.03.005
   Pawar H., 2012, COLLOID SURFACE B, P102
   Richard C, 2012, ADV INTEL SOFT COMPU, V120, P37
   Roy N, 2010, SOFT MATER, V8, P130, DOI 10.1080/15394451003756282
   Roy N, 2010, J APPL POLYM SCI, V117, P1703, DOI 10.1002/app.32056
   Sachdev A, 2013, RSC ADV, V3, P16958, DOI 10.1039/c3ra42415d
   Saha N., 2011, J BIOMATER NANOBIOTE, V2, P85, DOI DOI 10.4236/JBNB.2011.21011
   Sathik S. J., 2014, INT J PHARM CHEM BIO, V4, P378
   Sen M, 2005, J BIOMED MATER RES A, V74A, P187, DOI 10.1002/jbm.a.30308
   Seo DH, 2009, COLLOID SURFACE B, V69, P157, DOI 10.1016/j.colsurfb.2008.10.020
   Singh A, 2006, B MATER SCI, V29, P233, DOI 10.1007/BF02706490
   Tang YF, 2007, CARBOHYD POLYM, V67, P491, DOI 10.1016/j.carbpol.2006.06.015
   Teng DY, 2010, POLYMER, V51, P639, DOI 10.1016/j.polymer.2009.12.003
   Won CY, 1998, POLYMER, V39, P6677, DOI 10.1016/S0032-3861(98)00032-9
   Won CY, 1998, J POLYM SCI POL CHEM, V36, P2949, DOI 10.1002/(SICI)1099-0518(19981130)36:16<2949::AID-POLA13>3.0.CO;2-A
   Yang XD, 2008, COLLOID SURFACE B, V61, P125, DOI 10.1016/j.colsurfb.2007.07.012
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 49
TC 21
Z9 21
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2015
VL 80
BP 240
EP 245
DI 10.1016/j.ijbiomac.2015.06.044
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000027
PM 26118484
DA 2018-10-20
ER

PT J
AU Sillerova, H
   Komarek, M
   Liu, C
   Poch, J
   Villaescusa, I
AF Sillerova, Hana
   Komarek, Michael
   Liu, Chang
   Poch, Jordi
   Villaescusa, Isabel
TI Biosorbent encapsulation in calcium alginate: Effects of process
   variables on Cr(VI) removal from solutions
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Encapsulation; Alginate beads; Chromium sorption
ID IRON-REDUCING BACTERIA; AQUEOUS-SOLUTIONS; HEAVY-METALS; BEADS;
   CHROMIUM; WASTES; ADSORPTION; SORPTION; FRACTIONATION; BIOSORPTION
AB Selected biosorbents, brewers draff and grape waste, have been encapsulated in calcium alginate beads and used for the removal of Cr(VI) from aqueous solutions. The effects of encapsulation variables, including the type of waste, the percentage of waste in the beads and the curing time of the beads in CaCl2, on the diameters of the beads and Cr(VI) sorption kinetics have been evaluated. In total, 21 different types of beads were produced. The diameters of the beads increased with increasing amounts of encapsulated biomaterial. Beads that contained grape waste were larger than those containing brewers draft. The most efficient beads for Cr(VI) removal were beads that contained 4% (w/w) of grape waste. No significant differences in the kinetics of Cr(VI) sorption were found with respect to the curing time variable in the case of grape waste calcium alginate beads. Statistical analysis confirmed that the type and percentage of waste are the critical parameters influencing the diameters of the beads and Cr(VI) removal. It was proven that the sorption efficiencies of the beads containing draff and grape waste encapsulated under the optimum conditions were much higher than the efficiencies obtained when using both wastes in their native states. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Sillerova, Hana; Komarek, Michael] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Environm Geosci, Prague 16521 6, Suchdol, Czech Republic.
   [Liu, Chang; Villaescusa, Isabel] Univ Girona, Dept Chem Engn, Girona 17071, Spain.
   [Poch, Jordi] Univ Girona, Dept Appl Math, Girona 17071, Spain.
RP Sillerova, H (reprint author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Environm Geosci, Kamycka 129, Prague 16521 6, Suchdol, Czech Republic.
EM sillerovah@fzp.czu.cz
RI Villaescusa, Isabel/N-9644-2015; Poch, Jordi/G-6731-2011; Komarek,
   Michael/B-8307-2008
OI Villaescusa, Isabel/0000-0003-2103-7550; Poch,
   Jordi/0000-0002-8205-842X; Komarek, Michael/0000-0003-3644-9961
FU Technology Agency of the Czech Republic [TA01021055]; Czech University
   of Life Sciences Prague [IGA 42400/1312/3161]; ERASMUS Programme
FX This work was funded by the Technology Agency of the Czech Republic
   (Project TA01021055). Hana Sillerova is thankful for the financial
   support from the Czech University of Life Sciences Prague (Project IGA
   42400/1312/3161) and from the ERASMUS Programme.
CR Ahmaruzzaman M, 2011, ADV COLLOID INTERFAC, V166, P36, DOI 10.1016/j.cis.2011.04.005
   Albadarin AB, 2011, CHEM ENG J, V169, P20, DOI 10.1016/j.cej.2011.02.044
   An B, 2013, CHEM ENG J, V232, P51, DOI 10.1016/j.cej.2013.07.079
   Araujo MM, 1997, INT BIODETER BIODEGR, V40, P63, DOI 10.1016/S0964-8305(97)00064-4
   Bai RS, 2003, BIORESOURCE TECHNOL, V87, P17
   Bajpai SK, 2004, REACT FUNCT POLYM, V59, P129, DOI 10.1016/j.reactfunctpolym.2004.01.002
   Bezbaruah AN, 2009, J HAZARD MATER, V166, P1339, DOI 10.1016/j.jhazmat.2008.12.054
   Bhatnagar A, 2010, CHEM ENG J, V157, P277, DOI 10.1016/j.cej.2010.01.007
   Chardin B, 2002, APPL MICROBIOL BIOT, V60, P352, DOI 10.1007/s00253-002-1091-8
   Chen DZ, 2013, BIORESOURCE TECHNOL, V139, P87, DOI 10.1016/j.biortech.2013.04.037
   Clasceri L. S., 1998, STANDARD METHODS EXA
   Dogan NM, 2011, ENVIRON SCI TECHNOL, V45, P2278, DOI 10.1021/es102095t
   Escudero C., 2013, ARAB J CHEM IN PRESS
   Escudero C, 2009, J HAZARD MATER, V164, P533, DOI 10.1016/j.jhazmat.2008.08.042
   Fiol N, 2006, REACT FUNCT POLYM, V66, P795, DOI 10.1016/j.reactfunetpolym.2005.11.006
   Fiol N, 2005, SEPAR SCI TECHNOL, V40, P1013, DOI 10.1081/SS-200048041
   Fiol N, 2004, CHEM SPEC BIOAVAILAB, V16, P25, DOI 10.3184/095422904782775153
   Fredrickson JK, 1996, CURR OPIN BIOTECH, V7, P287, DOI 10.1016/S0958-1669(96)80032-2
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Han X, 2008, J HAZARD MATER, V158, P615, DOI 10.1016/j.jhazmat.2008.02.024
   Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P401, DOI 10.1016/S0016-7037(02)01081-5
   Jung W, 2015, J IND ENG CHEM, V26, P364, DOI 10.1016/j.jiec.2014.12.010
   Klokk TI, 2002, J MICROENCAPSUL, V19, P415, DOI 10.1080/02652040210144234
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Lazaridis NK, 2005, WATER RES, V39, P4385, DOI 10.1016/j.watres.2005.09.013
   Lee H, 2015, J HAZARD MATER, V292, P146, DOI 10.1016/j.jhazmat.2015.03.026
   Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002
   Nurchi VM, 2014, ARAB J CHEM, V7, P133, DOI 10.1016/j.arabjc.2013.07.006
   Pandey AK, 2003, J HAZARD MATER, V98, P177, DOI 10.1016/S0304-3894(02)00316-3
   Pereira CD, 2012, J ENVIRON MONITOR, V14, P1559, DOI 10.1039/c2em10949b
   Rehm B. H. A, 2009, ALGINATES BIOL APPL
   Samuel J, 2013, BIORESOURCE TECHNOL, V128, P423, DOI 10.1016/j.biortech.2012.10.116
   Sillerova H, 2014, CHEMOSPHERE, V95, P402, DOI 10.1016/j.chemosphere.2013.09.054
   Sillerova H, 2013, J COLLOID INTERF SCI, V396, P227, DOI 10.1016/j.jcis.2013.01.029
   Soltani RDC, 2014, J TAIWAN INST CHEM E, V45, P973, DOI 10.1016/j.jtice.2013.09.014
   U.S. Environmental Agency (EPA), 1996, EPA REG 3 RISK BAS C
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t
NR 38
TC 7
Z9 7
U1 2
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2015
VL 80
BP 260
EP 270
DI 10.1016/j.ijbiomac.2015.06.032
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000030
PM 26102330
DA 2018-10-20
ER

PT J
AU Shakir, M
   Jolly, R
   Khan, MS
   Iram, NE
   Khan, HM
AF Shakir, Mohammad
   Jolly, Reshma
   Khan, Mohd Shoeb
   Iram, Noor E.
   Khan, Hans M.
TI Nano-hydroxyapatite/chitosan-starch nanocomposite as a novel bone
   construct: Synthesis and in vitro studies
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Starch; Chitosan; Hydroxyapatite; In vitro bioactivity; Biomaterial
ID CELL-ENVELOPE BIOMOLECULES; DIOXIDE NANOCOMPOSITE;
   MECHANICAL-PROPERTIES; SILVER NANOPARTICLES; THERMOPLASTIC STARCH;
   PHYSICAL-PROPERTIES; BIODEGRADABLE FILM; ESCHERICHIA-COLI; CHITOSAN;
   COMPOSITE
AB A novel ternary nanocomposite system incorporating hydroxyapatite, chitosan and starch (n-HA/CS-ST) has been synthesized by co-precipitation method at room temperature, addressing the issues of biocompatibility, mechanical strength and cytotoxicity required for bone tissue engineering. The interactions, crystallite size, surface morphology and thermal stability against n-HA/CS nanocomposite have been obtained by comparing the results of FTIR, SEM, TEM, DLS, XRD and TGA/DTA. A comparative study of bioactivity and thermal stability of n-HA/CS and n-HA/CS-ST nanocomposites revealed that the incorporation of starch as templating agent enhanced these properties in n-HA/CS-ST nanocomposite. A lower swelling rate of n-HA/CS-ST relative to n-HA/CS indicates a higher mechanical strength supportive of bone tissue ingrowths. The MU assay on murine fibroblast L929 and human osteoblasts-like MG-63 cells and in vitro bioactivity of n-HA/CS-ST matrix referred superior non-toxic nature of n-HA/CS-ST nanocomposite and greater possibility of osteointegration in vivo respectively. Furthermore n-HA/CS-ST exhibited improved antibacterial property against both Gram-positive and Gram-negative bacteria relative to n-HA/CS. (C) 2015 Published by Elsevier B.V.
C1 [Shakir, Mohammad; Jolly, Reshma; Khan, Mohd Shoeb; Iram, Noor E.] Aligarh Muslim Univ, Dept Chem, Aligarh 202002, Uttar Pradesh, India.
   [Khan, Hans M.] Aligarh Muslim Univ, Dept Microbiol, JN Med Coll, Aligarh 202002, Uttar Pradesh, India.
RP Shakir, M (reprint author), Aligarh Muslim Univ, Dept Chem, Aligarh 202002, Uttar Pradesh, India.
EM shakir078@yahoo.co.in
RI JOLLY, RESHMA/O-6648-2017
OI JOLLY, RESHMA/0000-0002-9120-7853
FU DRS-II; FIST; PURSE; University Grants Commission (UGC/UGC-MANF)
FX Prof. M. Shakir acknowledges the grant supports from DRS-II, FIST and
   PURSE to the Department of Chemistry, A.M.U., Aligarh. The authors
   acknowledge and thank to JNMC, AMU, Aligarh, for providing human bone
   material employed for XRD analysis. The authors, Mohd Shoeb Khan and
   Reshma Jolly are thankful to University Grants Commission (UGC/UGC-MANF)
   for financial assistance.
CR Ali SS, 2011, J AGR FOOD CHEM, V59, P12384, DOI 10.1021/jf201119v
   Ansari MA, 2014, J APPL MICROBIOL, V116, P772, DOI 10.1111/jam.12423
   Ansari MA, 2014, J BASIC MICROB, V54, P905, DOI 10.1002/jobm.201300457
   Ansari MA, 2014, J BASIC MICROB, V54, P688, DOI 10.1002/jobm.201300748
   Boomi P, 2013, COLLOID SURFACE A, V429, P51, DOI 10.1016/j.colsurfa.2013.03.053
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Bourtoom T, 2008, LWT-FOOD SCI TECHNOL, V41, P1633, DOI 10.1016/j.lwt.2007.10.014
   Cathell MD, 2008, BIOMACROMOLECULES, V9, P289, DOI 10.1021/bm700845z
   Chen L, 2013, J MATER SCI-MATER M, V24, P1843, DOI 10.1007/s10856-013-4954-x
   Chillo S, 2008, J FOOD ENG, V88, P159, DOI 10.1016/j.jfoodeng.2008.02.002
   Ehrlich H, 2006, J MEMBRANE SCI, V273, P124, DOI 10.1016/j.memsci.2005.11.050
   Gandhi MR, 2011, INT J BIOL MACROMOL, V48, P119, DOI 10.1016/j.ijbiomac.2010.10.009
   Gupta TK, 2014, NANOSCALE, V6, P842, DOI 10.1039/c3nr04565j
   Huan ZG, 2009, ACTA BIOMATER, V5, P1253, DOI 10.1016/j.actbio.2008.10.006
   Huang MF, 2004, POLYMER, V45, P7017, DOI 10.1016/j.polymer.2004.07.068
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jack KS, 2009, ACTA BIOMATER, V5, P2657, DOI 10.1016/j.actbio.2009.03.017
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Lima H.S., 2010, SOFT MATTER, V6, P5184
   Liu FJ, 2009, CARBOHYD POLYM, V78, P146, DOI 10.1016/j.carbpol.2009.03.021
   Matzinos P, 2002, EUR POLYM J, V38, P1713, DOI 10.1016/S0014-3057(02)00061-7
   Mollazadeh S, 2007, CERAM INT, V33, P1579, DOI 10.1016/j.ceramint.2006.06.006
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Nikpour MR, 2012, COMPOS PART B-ENG, V43, P1881, DOI 10.1016/j.compositesb.2012.01.056
   Raafat A.I., 2013, J APPL POLYM SCI, P1697
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   Rodrigues AP, 2008, J APPL POLYM SCI, V109, P2703, DOI 10.1002/app.28203
   Sadjadi MS, 2010, MATER CHEM PHYS, V124, P217, DOI 10.1016/j.matchemphys.2010.06.022
   Shakir M, 2015, POLYM ADVAN TECHNOL, V26, P41, DOI 10.1002/pat.3417
   Shakir M, 2015, INT J BIOL MACROMOL, V72, P1196, DOI 10.1016/j.ijbiomac.2014.10.045
   Shakir M, 2014, RSC ADV, V4, P39174, DOI 10.1039/c4ra05173d
   Shakir M, 2014, IND ENG CHEM RES, V53, P8035, DOI 10.1021/ie404314q
   Shi R, 2006, POLYM DEGRAD STABIL, V91, P3289, DOI 10.1016/j.polymdegradstab.2006.06.007
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Tuhin MO, 2012, RADIAT PHYS CHEM, V81, P1659, DOI 10.1016/j.radphyschem.2012.04.015
   Vasconez MB, 2009, FOOD RES INT, V42, P762, DOI 10.1016/j.foodres.2009.02.026
   Weeraphat P., 2008, MATER CHEM PHYS, V112, P453
   Wilhelm HM, 2003, CARBOHYD POLYM, V52, P101, DOI 10.1016/S0144-8617(02)00239-4
   Xiea F., 2013, PROG POLYM SCI, V38, P1590
   Xiong HG, 2008, CARBOHYD POLYM, V71, P263, DOI 10.1016/j.carbpol.2007.05.035
   Xu HT, 2007, POLYM ADVAN TECHNOL, V18, P869, DOI 10.1002/pat.906
   Yang L, 2013, MATER LETT, V113, P142, DOI 10.1016/j.matlet.2013.09.059
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
NR 48
TC 23
Z9 25
U1 3
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2015
VL 80
BP 282
EP 292
DI 10.1016/j.ijbiomac.2015.05.009
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000032
PM 26116779
DA 2018-10-20
ER

PT J
AU Shavandi, A
   Bekhit, AEDA
   Ali, MA
   Sun, Z
AF Shavandi, Amin
   Bekhit, Alaa El-Din A.
   Ali, M. Azam
   Sun, Zhifa
TI Bio-mimetic composite scaffold from mussel shells, squid pen and crab
   chitosan for bone tissue engineering
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Squid pen; Chitosan; Hydroxyapatite
ID BETA-CHITIN; POLYMER SCAFFOLDS; HYDROXYAPATITE; REGENERATION; IMPLANTS;
   BEHAVIOR; CULTURE; FIBERS; CELLS; WASTE
AB In the present study, chitosan/hydroxyapatite (HA)/beta-tircalcium phosphate (beta-TCP) composites were produced using squid pen derived chitosan (CHS) and commercial crab derived chitosan (CHC). CHS was prepared from squid pens by alkaline N-deacetylation. HA and beta-TCP were extracted from mussel shells using a microwave irradiation method. Two different composites were prepared by incorporating 50% (w/w) HA/(beta-TCP) in CHS or CHC followed by lyophilization and cross-linking of composites by tripolyphosphate (TPP). The effect of different freezing temperatures of -20, -80 and -196 degrees C on the physicochemical characteristics of composites was investigated. A simulated body fluid (SBF) solution was used for preliminary in vitro study for 1, 7, 14 and 28 days and the composites were characterized by XRD, FTIR, TGA, SEM, mu-CT and ICP-MS. Porosity, pore size, water uptake; water retention abilities and in vitro degradations of the prepared composites were evaluated. The CHS composites were found to have higher porosity (62%) compared to the CHC composites (porosity 42%) and better mechanical properties. The results of this study indicated that composites produced at -20 degrees C had higher mechanical properties and lower degradation rate compared with -80 degrees C. Chitosan from the squid pen is an excellent biomaterial candidate for bone tissue engineering applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shavandi, Amin; Bekhit, Alaa El-Din A.] Univ Otago, Dept Food Sci, Dunedin, New Zealand.
   [Ali, M. Azam] Univ Otago, Dept Appl Sci, Dunedin, New Zealand.
   [Sun, Zhifa] Univ Otago, Dept Phys, Dunedin, New Zealand.
RP Shavandi, A (reprint author), Univ Otago, Dept Food Sci, Dunedin, New Zealand.
EM amin.shavandi@postgrad.otago.ac.nz
OI Ali, Dr Azam/0000-0002-0136-6800; shavandi, amin/0000-0002-0188-3090
CR Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Barabas R, 2013, CHEM PAP, V67, P1414, DOI 10.2478/s11696-013-0409-6
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chaussard G, 2004, BIOMACROMOLECULES, V5, P559, DOI 10.1021/bm.034401t
   Czechowska J, 2014, CERAM INT, V40, P5523, DOI 10.1016/j.ceramint.2013.10.142
   Dorozhkin Sergey V, 2011, Biomatter, V1, P3, DOI 10.4161/biom.1.1.16782
   DWELTZ NE, 1961, BIOCHIM BIOPHYS ACTA, V51, P283, DOI 10.1016/0006-3002(61)90169-X
   Gisela M. L., 2012, BIOMED MATER, V7
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Katti KS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034122
   Khor Eugene, 2014, CHITIN, P51
   Kuboki Y., 2001, J BONE JOINT SURG AM, V83, P105
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   KURITA K, 1993, J POLYM SCI POL CHEM, V31, P485, DOI 10.1002/pola.1993.080310220
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Martins AM, 2009, ACTA BIOMATER, V5, P3328, DOI 10.1016/j.actbio.2009.05.027
   Meneghini C, 2003, BIOPHYS J, V84, P2021, DOI 10.1016/S0006-3495(03)75010-3
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Ouyang A, 2015, ADV ENG MATER, V17, P460, DOI 10.1002/adem.201400250
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Pu XM, 2012, INT J BIOL MACROMOL, V51, P868, DOI 10.1016/j.ijbiomac.2012.07.008
   Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x
   Reys L.L, 2013, BIOMED MATER, V8, P1
   RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x
   Sagheer FAA, 2009, CARBOHYD POLYM, V77, P410, DOI DOI 10.1016/J.CARBP0L.2009.01.032
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shavandi A, 2015, POWDER TECHNOL, V273, P33, DOI 10.1016/j.powtec.2014.12.029
   Shavandi A, 2015, MATER CHEM PHYS, V149, P607, DOI 10.1016/j.matchemphys.2014.11.016
   Shimojoh M, 1998, CARBOHYD POLYM, V35, P223, DOI 10.1016/S0144-8617(97)00244-0
   Silva TH, 2012, INT MATER REV, V57, P276, DOI 10.1179/1743280412Y.0000000002
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Sunny MC, 2002, J MATER SCI-MATER M, V13, P623, DOI 10.1023/A:1015709705074
   Tas AC, 2014, J NON-CRYST SOLIDS, V400, P27, DOI 10.1016/j.jnoncrysol.2014.04.031
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang XJ, 2009, J BIOMAT SCI-POLYM E, V20, P1995, DOI 10.1163/156856208X396083
   Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b
   Yoshida A, 2004, MATER TRANS, V45, P994, DOI 10.2320/matertrans.45.994
   Youn DK, 2013, INT J FOOD SCI TECH, V48, P571, DOI 10.1111/ijfs.12001
   Yu SH, 2013, MOLECULES, V18, P27, DOI 10.3390/molecules18010027
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zugravu MV, 2013, J BIOMATER APPL, V28, P566, DOI 10.1177/0885328212465662
NR 57
TC 7
Z9 7
U1 3
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2015
VL 80
BP 445
EP 454
DI 10.1016/j.ijbiomac.2015.07.012
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000052
PM 26187191
DA 2018-10-20
ER

PT J
AU Pour, ZS
   Makvandi, P
   Ghaemy, M
AF Pour, Zahra Sekhavat
   Makvandi, Pooyan
   Ghaemy, Mousa
TI Performance properties and antibacterial activity of crosslinked films
   of quaternary ammonium modified starch and poly(vinyl alcohol)
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Poly(vinyl alcohol); Antibacterial activity; Biomaterial; Quaternary
   ammonium starch; Chemical crosslinking
ID CITRIC-ACID; BLEND FILMS; ANTIMICROBIAL ACTIVITY; BIODEGRADABLE FILMS;
   PHYSICAL-PROPERTIES; CHITOSAN; EPICHLOROHYDRIN; DEGRADATION;
   TEMPERATURE; OXIDATION
AB There has been a growing interest in developing antibacterial polymeric materials. In the present work, novel antibacterial cross-linked blend films were prepared based on polyvinyl alcohol (PVA) and quaternary ammonium starch (ST-GTMAC) using citric acid (CA) as plasticizer and glutaraldehyde (GA) as cross-linker. The ST-GTMAC was successfully synthesized from reaction between water-soluble oxidized starch and glycidyltrimethylammonium chloride (GTMAC). The effect of ST-GTMAC, CA and GA contents on the swelling, solubility, mechanical and thermal properties of the films was investigated. It was found that incorporation of ST-GTMAC reduced UV-transmittance and provided antibacterial properties, increasing GA content increased tensile strength and decreased solubility and swelling degree of the films, while CA acted as plasticizer when its concentration was above 10 wt%. The results showed that ST-GTMAC/PVA/CA/GA film has fair antibacterial activity against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Escherichia coli and Pseudomonas aeruginosa) bacteria. These results suggest that the prepared film might be used as potential antibacterial material in medical and packaging applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Pour, Zahra Sekhavat; Makvandi, Pooyan; Ghaemy, Mousa] Univ Mazandaran, Dept Chem, Polymer Res Lab, Babol Sar, Iran.
RP Ghaemy, M (reprint author), Univ Mazandaran, Dept Chem, Polymer Res Lab, Babol Sar, Iran.
EM ghaemy@umz.ac.ir
RI makvandi, pooyan/G-9237-2016
OI makvandi, pooyan/0000-0003-2456-0961
CR Abdelrazek EM, 2010, PHYSICA B, V405, P2021, DOI 10.1016/j.physb.2010.01.095
   Bonilla J, 2014, FOOD HYDROCOLLOID, V35, P463, DOI 10.1016/j.foodhyd.2013.07.002
   Chen XY, 2013, SURF COAT TECH, V216, P158, DOI 10.1016/j.surfcoat.2012.11.049
   Ghaemy M, 2013, REACT FUNCT POLYM, V73, P555, DOI 10.1016/j.reactfunctpolym.2012.12.005
   Ghanbarzadeh B, 2011, IND CROP PROD, V33, P229, DOI 10.1016/j.indcrop.2010.10.016
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   In YW, 2013, J FOOD SAFETY, V33, P79, DOI 10.1111/jfs.12025
   Kanatt SR, 2012, FOOD HYDROCOLLOID, V29, P290, DOI 10.1016/j.foodhyd.2012.03.005
   Kenawy E, 2014, ARAB J CHEM, V7, P372, DOI 10.1016/j.arabjc.2013.05.026
   Kim DH, 2002, EUR POLYM J, V38, P1199, DOI 10.1016/S0014-3057(01)00301-9
   Kim JY, 2003, INT J BIOL MACROMOL, V32, P23, DOI 10.1016/S0141-8130(03)00021-7
   Kim TS, 1996, J AM OIL CHEM SOC, V73, P67, DOI 10.1007/BF02523450
   Kisku SK, 2014, POLYM-PLAST TECHNOL, V53, P1664, DOI 10.1080/03602559.2014.919650
   Kochkar H, 2001, APPL CATAL A-GEN, V210, P325, DOI 10.1016/S0926-860X(00)00815-2
   Komulainen S, 2013, CARBOHYD POLYM, V93, P73, DOI 10.1016/j.carbpol.2012.06.001
   Lee WJ, 2007, J POLYM ENVIRON, V15, P35, DOI 10.1007/s10924-006-0040-5
   Limpan N, 2012, FOOD HYDROCOLLOID, V29, P226, DOI 10.1016/j.foodhyd.2012.03.007
   Ma XF, 2008, BIOMACROMOLECULES, V9, P3314, DOI 10.1021/bm800987c
   Pavlovic S, 2003, MINER ENG, V16, P1117, DOI 10.1016/j.mineng.2003.06.011
   Rahman WAWA, 2010, CARBOHYD POLYM, V81, P805, DOI 10.1016/j.carbpol.2010.03.052
   Ramaraj B, 2007, J APPL POLYM SCI, V103, P909, DOI 10.1002/app.25237
   Ramis X, 2004, POLYM DEGRAD STABIL, V86, P483, DOI 10.1016/j.polymdegradstab.2004.05.021
   Sajomsang W, 2009, INT J BIOL MACROMOL, V44, P419, DOI 10.1016/j.ijbiomac.2009.03.003
   Sedlarik V, 2010, POLYM DEGRAD STABIL, V95, P399, DOI 10.1016/j.polymdegradstab.2009.11.017
   Serrero A, 2010, BIOMACROMOLECULES, V11, P1534, DOI 10.1021/bm1001813
   Shi R, 2008, CARBOHYD POLYM, V74, P763, DOI 10.1016/j.carbpol.2008.04.045
   SHIBASAKI I, 1978, J AM OIL CHEM SOC, V55, pA235
   Tang XZ, 2012, J AGR FOOD CHEM, V60, P1954, DOI 10.1021/jf2024962
   Tang XZ, 2011, CARBOHYD POLYM, V85, P7, DOI 10.1016/j.carbpol.2011.01.030
   Woggum T, 2014, INT J BIOL MACROMOL, V67, P490, DOI 10.1016/j.ijbiomac.2014.03.029
   Yang XM, 2008, CARBOHYD POLYM, V73, P401, DOI 10.1016/j.carbpol.2007.12.008
   Yu QA, 2011, CARBOHYD POLYM, V84, P465, DOI 10.1016/j.carbpol.2010.12.006
   Yun YH, 2010, POLYM BULL, V64, P553, DOI 10.1007/s00289-009-0158-4
   Yun YH, 2008, J POLYM ENVIRON, V16, P12, DOI 10.1007/s10924-008-0084-9
NR 34
TC 12
Z9 12
U1 6
U2 87
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2015
VL 80
BP 596
EP 604
DI 10.1016/j.ijbiomac.2015.07.008
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000071
PM 26188297
DA 2018-10-20
ER

PT J
AU Summa, N
   Eshar, D
   Reynolds, D
   Caines, D
   Singh, A
AF Summa, Noemie
   Eshar, David
   Reynolds, Debbie
   Caines, Deanne
   Singh, Ameet
TI SUCCESSFUL DIAGNOSIS AND TREATMENT OF BILATERAL PERINEAL HERNIAS IN A
   SKUNK (MEPHITIS MEPHITIS)
SO JOURNAL OF ZOO AND WILDLIFE MEDICINE
LA English
DT Article
DE Descenting; Mephitis mephitis; perineal hernia; skunk; surgical repair
ID INTERNAL OBTURATOR MUSCLE; HERNIORRHAPHY; LAPAROTOMY; REPAIR; DOGS
AB This brief communication describes the diagnosis and surgical treatment of bilateral perineal hernias in a 1-yr-old, intact female, striped skunk (Mephitis mephitis) that was evaluated for chronic intermittent constipation, following early age, bilateral anal sacculectomy for descenting. Complete blood count and biochemistry results were within the reference ranges. Diagnosis was based on history, physical exam, clinical signs, and diagnostic imaging. A two-stage surgical approach for treatment was performed. First, colopexy and cystopexy were performed via celiotomy, which was followed by unilateral perineal herniorrhaphy by using an internal obturator muscle flap augmented with porcine small intestinal submucosa biomaterial. Long-term resolution of clinical signs was achieved without evidence of recurrence. This is the first description of bilateral perineal hernia in a skunk following routine anal sacculectomy for descenting.
C1 [Summa, Noemie; Eshar, David; Reynolds, Debbie; Caines, Deanne; Singh, Ameet] Univ Guelph, Ontario Vet Coll, Hlth Sci Ctr, Guelph, ON N1G 2W1, Canada.
RP Eshar, D (reprint author), Kansas State Univ, Coll Vet Med, Dept Clin Sci, 1800 Denison Ave, Manhattan, KS 66506 USA.
EM deshar@vet.k-state.edu
CR Bellenger CR, 2003, TXB SMALL ANIMAL SUR, V1, P487
   Brissot HN, 2004, VET SURG, V33, P412, DOI 10.1111/j.1532-950X.2004.04060.x
   Capello Vittorio, 2006, Exotic DVM, V8, P15
   Dorner J, 2008, WIEN TIERARZTL MONAT, V95, P269
   ENDERS RK, 1946, J AM VET MED ASSOC, V108, P84
   Eshar D, 2010, LAB ANIMAL, V39, P339, DOI 10.1038/laban1110-339
   Fossum T.W., 2007, SMALL ANIMAL SURG, P339
   International Species Information System, 2002, PHYS DAT REF VAL
   RAFFAN PJ, 1993, J SMALL ANIM PRACT, V34, P13, DOI 10.1111/j.1748-5827.1993.tb02568.x
   Skipworth R J E, 2007, Hernia, V11, P541, DOI 10.1007/s10029-007-0234-3
   Vnuk Drazen, 2008, Veterinarski Arhiv, V78, P197
   WELCHES CD, 1992, J AM ANIM HOSP ASSOC, V28, P431
NR 12
TC 1
Z9 1
U1 0
U2 3
PU AMER ASSOC ZOO VETERINARIANS
PI YULEE
PA 581705 WHITE OAK ROAD, YULEE, FL 32097 USA
SN 1042-7260
EI 1937-2825
J9 J ZOO WILDLIFE MED
JI J. Zoo Wildl. Med.
PD SEP
PY 2015
VL 46
IS 3
BP 575
EP 579
DI 10.1638/2013-0043.1
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA CR0YN
UT WOS:000361049800017
PM 26352963
DA 2018-10-20
ER

PT J
AU Mareci, D
   Dragoi, EN
   Bolat, G
   Chelariu, R
   Gordin, D
   Curteanu, S
AF Mareci, D.
   Dragoi, E. -N.
   Bolat, G.
   Chelariu, R.
   Gordin, D.
   Curteanu, S.
TI Modelling the influence of pH, fluoride, and caffeine on the corrosion
   resistance of TiMo alloys by artificial neural networks developed with
   differential evolution algorithm
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; BIOMEDICAL APPLICATIONS;
   TINBTAZR ALLOYS; CARBON-STEEL; SLURRY FLOW; BEHAVIOR; TITANIUM;
   ADSORPTION; REGRESSION; PIPELINE
AB Titanium (Ti) and its alloys are widely used in dental applications due to the excellent corrosion resistance and mechanical properties. However, it has been reported that Ti is sensitive to fluor ions (F-) and lactic acid. Corrosion behaviour of the TiMo alloys, together with the currently used metallic biomaterial commercial pure titanium (Cp-Ti), was investigated considering the use of alloys for dental applications. All the samples were examined using electrochemical impedance spectroscopy (EIS) in acidic artificial saliva with NaF and/or caffeine, at 37 degrees C. Equivalent circuits were used for modeling EIS data, in order to characterize samples surface and better understanding the effect of Mo addition on Cp-Ti. The TiMo alloys appear to possess superior corrosion resistance than Cp-Ti in all electrochemical media. In addition, a modelling technique based on differential evolution and artificial neural network was applied. The scope of this procedure was to determine an efficient model of the process and to eliminate the need for new experiments based on the predictions provided by the developed models.
C1 [Mareci, D.; Dragoi, E. -N.; Bolat, G.; Curteanu, S.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Chelariu, R.] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Iasi 700050, Romania.
   [Gordin, D.] INSA Rennes, F-35708 Rennes, France.
RP Curteanu, S (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, 73 Prof Dr Doc D Mangeron St, Iasi 700050, Romania.
EM silvia_curteanu@yahoo.com
RI Curteanu, Silvia/D-7347-2011; Dragoi, Elena-Niculina/D-6256-2011
OI Curteanu, Silvia/0000-0002-5281-1265; Dragoi,
   Elena-Niculina/0000-0001-5006-000X; Gordin, Doina
   Margareta/0000-0003-2200-9930; Mareci, Daniel/0000-0002-5859-1996
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-ID-PCE-2011-3-0218]
FX The authors are grateful to Prof. Thierry Gloriant (INSA Rennes, France)
   for kindly providing the TiMo alloys used in this work. This work was
   supported by the Romanian National Authority for Scientific Research,
   CNCS-UEFISCDI (project number PN-II-ID-PCE-2011-3-0218).
CR Rezende MCRA, 2007, J MATER SCI-MATER M, V18, P149, DOI 10.1007/s10856-006-0674-9
   Austin RS, 2010, J DENT, V38, P782, DOI 10.1016/j.jdent.2010.06.009
   Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Barbinta AC, 2014, MATER CORROS, V65, P1017, DOI 10.1002/maco.201307294
   Benali O, 2007, APPL SURF SCI, V253, P6130, DOI 10.1016/j.apsusc.2007.01.075
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Curteanu S, 2011, J CHEMOMETR, V25, P527, DOI 10.1002/cem.1401
   da Trindade LG, 2009, CORROS SCI, V51, P1578, DOI 10.1016/j.corsci.2009.03.038
   Dilea M, 2013, MATER CORROS, V64, P493, DOI 10.1002/maco.201206526
   Dragoi EN, 2013, DRY TECHNOL, V31, P72, DOI 10.1080/07373937.2012.718308
   Dragoi EN, 2013, APPL SOFT COMPUT, V13, P222, DOI 10.1016/j.asoc.2012.08.004
   Dragoi EN, 2012, ENG OPTIMIZ, V44, P1261, DOI 10.1080/0305215X.2011.644546
   Dragoi EN, 2012, CHEM ENG SCI, V72, P195, DOI 10.1016/j.ces.2012.01.021
   Dragoi EN, 2011, ENG APPL ARTIF INTEL, V24, P1214, DOI 10.1016/j.engappai.2011.06.004
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Gabrielli C., 1983, 00483 SOL INSTR
   Gordin DM, 2008, ADV ENG MATER, V10, P714, DOI 10.1002/adem.200800041
   Khan WQ, 2012, MATER CORROS, V63, P992, DOI 10.1002/maco.201206523
   Lahiri SK, 2009, CHEM IND CHEM ENG Q, V15, P103, DOI 10.2298/CICEQ0902103L
   Lahiri SK, 2009, KOREAN J CHEM ENG, V26, P1175, DOI 10.2478/s11814-009-0195-6
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   Mareci D, 2015, MATER CORROS, V66, P375, DOI 10.1002/maco.201307502
   Mareci D, 2011, MATER CORROS, V62, P1117, DOI 10.1002/maco.201106185
   Mareci D, 2010, MATER CORROS, V61, P829, DOI 10.1002/maco.201005761
   Mareci D, 2013, EUR J SCI THEOL, V9, P189
   Mareci D, 2013, CORROS SCI, V73, P106, DOI 10.1016/j.corsci.2013.03.030
   Mareci D, 2010, J MATER SCI-MATER M, V21, P2907, DOI 10.1007/s10856-010-4147-9
   Mirza J. C., 2012, MATER CORROS, V63, P527
   Moreno JMC, 2014, MATER CORROS, V65, P703, DOI 10.1002/maco.201307053
   Nagarajan S, 2007, MATER CORROS, V58, P33, DOI 10.1002/maco.200503973
   Noor RAM, 2010, CAN J CHEM ENG, V88, P1065, DOI 10.1002/cjce.20364
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   RAJAGOPALAN KV, 1988, ANNU REV NUTR, V8, P401, DOI 10.1146/annurev.nu.08.070188.002153
   Saba P, 2006, MATER CHEM PHYS, V100, P285, DOI 10.1016/j.matchemphys.2005.12.045
   Sabino R, 2010, J SOLID STATE ELECTR, V14, P1255, DOI 10.1007/s10008-009-0928-9
   Subudhi B, 2011, APPL SOFT COMPUT, V11, P861, DOI 10.1016/j.asoc.2010.01.006
   Venasakulchai A, 2010, J DENT, V38, pS21, DOI 10.1016/S0300-5712(11)70005-7
   Yang S, 2013, MATER CORROS, V64, P402, DOI 10.1002/maco.201106478
NR 39
TC 3
Z9 3
U1 1
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-5117
EI 1521-4176
J9 MATER CORROS
JI Mater. Corros.
PD SEP
PY 2015
VL 66
IS 9
BP 982
EP 994
DI 10.1002/maco.201408077
PG 13
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CQ9WH
UT WOS:000360965400017
DA 2018-10-20
ER

PT J
AU Tagaya, M
AF Tagaya, Motohiro
TI In situ QCM-D study of nano-bio interfaces with enhanced
   biocompatibility
SO POLYMER JOURNAL
LA English
DT Review
ID QUARTZ-CRYSTAL MICROBALANCE; COMPETITIVE PROTEIN ADSORPTION; INDUCED
   CONFORMATIONAL-CHANGES; GLOMERULAR BASEMENT MEMBRANE; SURFACE-PLASMON
   RESONANCE; TEQUILANA WEBER BAGASSE; SHEAR-WAVE RESONATORS;
   CELL-ADHESION; HYDROXYAPATITE PARTICLES; VISCOELASTIC PROPERTIES
AB When biomaterials are implanted into an animal body, the body fluid proteins initially adsorb and then cells recognize these surfaces. Adherent cell functions respond differently to diverse biomaterial surfaces with different properties. Thus, an understanding of cellular responses to biomaterials is crucial for effective control of biomaterial - cell interactions. I have researched how to clarify interfacial phenomena via protein adsorption and subsequent cell adhesion to hydroxyapatite nanocrystals using a quartz crystal microbalance with a dissipation technique. In this review, I focused on the current understanding of enhanced biocompatibility by exploring the roles of protein mediation at the interface. The most promising nano-bio interfaces are explained, and different protein adsorption and cell adhesion processes are highlighted depending on their interfacial states. This approach will clarify several ambiguities of interfacial phenomena between biomaterials and cells and will help in the design of novel biomaterials that can be implanted.
C1 [Tagaya, Motohiro] Nagaoka Univ Technol, Runner Incubat Ctr Acad Ind Fus, Nagaoka, Niigata 9402188, Japan.
   [Tagaya, Motohiro] Nagaoka Univ Technol, Dept Mat Sci & Technol, Grad Sch Engn, Nagaoka, Niigata 9402188, Japan.
RP Tagaya, M (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.
EM tagaya@mst.nagaokaut.ac.jp
FU MEXT/JSPS KAKENHI [26709052]; Izumi Science and Technology Foundation
   [H26-J-028]
FX This work was partially supported by a Grant-in-Aid for Young Scientists
   (A) (grant no. 26709052) from MEXT/JSPS KAKENHI and was also partially
   supported by Izumi Science and Technology Foundation (grant no.
   H26-J-028).
CR Addiel VSJ, 2014, ULTRASON SONOCHEM, V21, P295, DOI 10.1016/j.ultsonch.2013.06.011
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AOKI H, 1987, MED PROG TECHNOL, V12, P213
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   BEISSINGER RL, 1981, T AM SOC ART INT ORG, V27, P225
   BERTHETCOLOMINAS C, 1979, J MOL BIOL, V134, P431, DOI 10.1016/0022-2836(79)90362-0
   Brash J.L., 1995, PROTEINS INTERFACE 2, V602, P1
   Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   Choi KH, 2002, APPL PHYS LETT, V81, P1335, DOI 10.1063/1.1500777
   Chot NJ, 2007, ANAL CHEM, V79, P7027, DOI 10.1021/ac0709504
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Fernandez P, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/419
   Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337
   Furuzono T, 2009, J BIOMED MATER RES B, V89B, P77, DOI 10.1002/jbm.b.31189
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021
   Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Hemmersam AG, 2008, J COLLOID INTERF SCI, V320, P110, DOI 10.1016/j.jcis.2007.11.047
   Holmberg M, 2008, J MATER SCI-MATER M, V19, P2179, DOI 10.1007/s10856-007-3318-9
   Holmberg M, 2009, LANGMUIR, V25, P2081, DOI 10.1021/la8031978
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Ikoma T, 2007, J NANOSCI NANOTECHNO, V7, P822, DOI 10.1166/jnn.2007.523
   Ikoma T, 2009, J AM CERAM SOC, V92, P1125, DOI 10.1111/j.1551-2916.2009.02957.x
   Janshoff A, 1996, EUR BIOPHYS J BIOPHY, V25, P93, DOI 10.1007/s002490050021
   Kandori K, 2004, J COLLOID INTERF SCI, V273, P406, DOI 10.1016/j.jcis.2004.01.069
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KEFALIDES NA, 1966, BIOCHEMISTRY-US, V5, P702, DOI 10.1021/bi00866a043
   KEFALIDES NA, 1969, BIOCHEMISTRY-US, V8, P4613, DOI 10.1021/bi00839a057
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, J BIOMED MATER RES B, V74B, P686, DOI 10.1002/jbm.b.30236
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Le Guillou-Buffello D, 2008, TISSUE ENG PT A, V14, P1445, DOI 10.1089/ten.tea.2007.0292
   Letic-Gavrilovic A, 2003, J MATER SCI-MATER M, V14, P95, DOI 10.1023/A:1022099208535
   Li F, 2008, SENSOR ACTUAT B-CHEM, V128, P399, DOI 10.1016/j.snb.2007.06.032
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Lubarsky GV, 2007, BIOSENS BIOELECTRON, V22, P1275, DOI 10.1016/j.bios.2006.05.024
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   LUTANIE E, 1992, P NATL ACAD SCI USA, V89, P9890, DOI 10.1073/pnas.89.20.9890
   Marx KA, 2005, ANAL BIOCHEM, V343, P23, DOI 10.1016/j.ab.2005.05.013
   Marx KA, 2003, BIOTECHNOL PROGR, V19, P987, DOI 10.1021/bp0201096
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Marxer CM, 2003, ANAL BIOANAL CHEM, V377, P578, DOI 10.1007/s00216-003-2080-1
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Monkawa A, 2006, BIOMATERIALS, V27, P5748, DOI 10.1016/j.biomaterials.2006.07.029
   Moseke C, 2009, MATERIALWISS WERKST, V40, P36, DOI 10.1002/mawe.200800414
   MURAMATSU H, 1988, ANAL CHEM, V60, P2142, DOI 10.1021/ac00170a032
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Okuda M, 2011, MICROSC MICROANAL, V17, P788, DOI 10.1017/S1431927611011949
   Okuda M, 2009, MICRON, V40, P665, DOI 10.1016/j.micron.2009.04.001
   Ozeki T, 2007, ANAL CHEM, V79, P79, DOI 10.1021/ac060873x
   Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1996, SENSOR ACTUAT A-PHYS, V54, P448, DOI 10.1016/S0924-4247(97)80002-7
   Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   SPIRO RG, 1967, J BIOL CHEM, V242, P1915
   STEELE JG, 1992, J BIOMED MATER RES, V26, P681
   Tagaya M., 2011, IOP C SER MAT SCI EN, V18
   Tagaya M., 2011, BIOCERAM DEV APPL, V1
   Tagaya M., 2011, BIOCERAM DEV APPL, V1
   Tagaya M, 2013, HANDBOOK OF ADVANCED CERAMICS: MATERIALS, APPLICATIONS, PROCESSING, AND PROPERTIES, 2ND EDITION, P557, DOI 10.1016/B978-0-12-385469-8.00030-7
   Tagaya M, 2014, INORG CHEM, V53, P6817, DOI 10.1021/ic500609g
   Tagaya M, 2013, KOBUNSHI RONBUNSHU, V70, P398, DOI 10.1295/koron.70.398
   Tagaya M, 2012, MATER EXPRESS, V2, P1, DOI 10.1166/mex.2012.1053
   Tagaya M, 2012, ACS APPL MATER INTER, V4, P6169, DOI 10.1021/am301789v
   Tagaya M, 2012, J MATER CHEM, V22, P18741, DOI 10.1039/c2jm34155g
   Tagaya M, 2012, IND ENG CHEM RES, V51, P11294, DOI 10.1021/ie301755z
   Tagaya M, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/3/034411
   Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p
   Tagaya M, 2011, LANGMUIR, V27, P7635, DOI 10.1021/la200008z
   Tagaya M, 2013, MICRON, V46, P22, DOI 10.1016/j.micron.2012.11.009
   Tovar-Carrillo K. L., 2013, J MAT SCI CHEM ENG, V1, P1, DOI DOI 10.4236/MSCE.2013.17002
   Tovar-Carrillo KL, 2013, IND ENG CHEM RES, V52, P11607, DOI 10.1021/ie401793w
   Tovar-Carrillo KL, 2014, MAT SCI ENG C-MATER, V42, P808, DOI 10.1016/j.msec.2014.06.023
   Tovar-Carrillo KL, 2014, IND ENG CHEM RES, V53, P4650, DOI 10.1021/ie403257a
   Venegas-Sanchez JA, 2013, POLYM J, V45, P1224, DOI 10.1038/pj.2013.47
   Venegas-Sanchez JA, 2013, ULTRASON SONOCHEM, V20, P1081, DOI 10.1016/j.ultsonch.2013.01.002
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wei T, 2009, J PHYS CHEM C, V113, P2053, DOI 10.1021/jp806586n
   Yamada R, 2014, J BIOSCI BIOENG, V118, P315, DOI 10.1016/j.jbiosc.2014.02.009
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
   Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
NR 121
TC 7
Z9 7
U1 3
U2 81
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0032-3896
EI 1349-0540
J9 POLYM J
JI Polym. J.
PD SEP
PY 2015
VL 47
IS 9
BP 599
EP 608
DI 10.1038/pj.2015.43
PG 10
WC Polymer Science
SC Polymer Science
GA CQ9ZM
UT WOS:000360976700002
DA 2018-10-20
ER

PT J
AU Bouten, CV
   Smits, AI
   Talacua, H
   Muylaert, DE
   Janssen, HM
   Bosman, A
   Verhaar, MC
   Dankers, PY
   Driessen, A
   Kluin, J
   Baaijens, FP
AF Bouten, C. V.
   Smits, A. I.
   Talacua, H.
   Muylaert, D. E.
   Janssen, H. M.
   Bosman, A.
   Verhaar, M. C.
   Dankers, P. Y.
   Driessen, A.
   Kluin, J.
   Baaijens, F. P.
TI Biomaterial-based In Situ Tissue Engineering of Heart Valves
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Bouten, C. V.; Smits, A. I.; Dankers, P. Y.; Driessen, A.; Baaijens, F. P.] Eindhoven Univ Technol, Biomed Engn, NL-5600 MB Eindhoven, Netherlands.
   [Talacua, H.; Kluin, J.] Univ Amsterdam, Acad Med Ctr, Cardiothorac Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Muylaert, D. E.; Verhaar, M. C.] Univ Med Ctr, Nephrol & Hypertens, Utrecht, Netherlands.
   [Janssen, H. M.] SyMO Chem BV, Eindhoven, Netherlands.
   [Bosman, A.] SupraPolix BV, Eindhoven, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S6
EP S6
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205200015
DA 2018-10-20
ER

PT J
AU Butbika, H
   Cohen, S
   Goldenberg-Shachar, M
AF Butbika, H.
   Cohen, S.
   Goldenberg-Shachar, M.
TI In Vitro Maturation of Primordial Follicles-Study of the Biomaterial for
   the Task
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Butbika, H.; Cohen, S.] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Cohen, S.] Regenerat Med & Stem Cell RMSC Res Ctr, Beer Sheva, Israel.
   [Cohen, S.] Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel.
   [Goldenberg-Shachar, M.] Sami Shamoon Coll Engn, Dept Chem Engn, Beer Sheva, Israel.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S30
EP S30
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205200111
DA 2018-10-20
ER

PT J
AU Dai, X
   Hopfner, U
   Zheng, H
   Liu, J
   Sudhop, S
   Prein, C
   Shen, Y
   Machens, HG
   Schilling, A
AF Dai, X.
   Hopfner, U.
   Zheng, H.
   Liu, J.
   Sudhop, S.
   Prein, C.
   Shen, Y.
   Machens, H. G.
   Schilling, A.
TI Electrospun Curcumin-gelatin Blended Nanofibrous Membrane: A Novel
   Medicated Biomaterial for Drug Delivery and Accelerated Wound Healing
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Dai, X.; Hopfner, U.; Zheng, H.; Liu, J.; Machens, H. G.; Schilling, A.] Tech Univ Munich, Klinikum Rechts Isar, Fac Med, Dept Plast Surg & Hand Surg, D-80290 Munich, Germany.
   [Sudhop, S.; Prein, C.] Munich Univ Appl Sci, Ctr Appl Tissue Engn & Regenerat Med CANTER, Munich, Germany.
   [Shen, Y.] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China.
NR 0
TC 0
Z9 0
U1 3
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S351
EP S351
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205202466
DA 2018-10-20
ER

PT J
AU Graney, PL
   Roohani-Esfahani, S
   Zreiqat, H
   Spiller, KL
AF Graney, P. L.
   Roohani-Esfahani, S.
   Zreiqat, H.
   Spiller, K. L.
TI Biomaterial-Mediated Control over Macrophage Behavior in Bone
   Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Graney, P. L.; Spiller, K. L.] Drexel Univ, Dept Biomed Engn, Philadelphia, PA 19104 USA.
   [Roohani-Esfahani, S.; Zreiqat, H.] Univ Sydney, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S106
EP S106
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205201017
DA 2018-10-20
ER

PT J
AU Mahadik, B
   Harley, B
AF Mahadik, B.
   Harley, B.
TI Instructive Biomaterial Platform to Engineer Hematopoietic Stem Cell
   Activity
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Mahadik, B.; Harley, B.] Univ Illinois, Chem & Biomol Engn, Urbana, IL USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S170
EP S170
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205201266
DA 2018-10-20
ER

PT J
AU Majumdar, S
   Sommerfeld, SD
   Wang, X
   Guo, Q
   Singh, A
   Elisseeff, JH
AF Majumdar, S.
   Sommerfeld, S. D.
   Wang, X.
   Guo, Q.
   Singh, A.
   Elisseeff, J. H.
TI Novel Cornea-mimetic, Collagen Based, Tissue Engineered Biomaterial
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Majumdar, S.; Sommerfeld, S. D.; Wang, X.; Guo, Q.; Singh, A.; Elisseeff, J. H.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S191
EP S191
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205201346
DA 2018-10-20
ER

PT J
AU Monaghan, MG
   Brauchle, E
   Berrio, DC
   Pandit, A
   Nsair, A
   Schenke-Layland, K
AF Monaghan, M. G.
   Brauchle, E.
   Berrio, D. Carvajal
   Pandit, A.
   Nsair, A.
   Schenke-Layland, K.
TI Biomaterial Delivery of Exogenous Mir-29b to the Infarcted Myocardium
   Yields Improved Myocardial Recovery
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Monaghan, M. G.; Brauchle, E.; Schenke-Layland, K.] Fraunhofer Inst Interfacial Engn & Biotechnol, Dept Cell & Tissue Engn, Stuttgart, Germany.
   [Brauchle, E.; Berrio, D. Carvajal; Schenke-Layland, K.] Univ Tubingen, Res Inst Womens Hlth, Dept Womens Hlth, Tubingen, Germany.
   [Pandit, A.] Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Nsair, A.; Schenke-Layland, K.] Univ Calif Los Angeles, Cardiovasc Res Labs, Dept Med Cardiol, Los Angeles, CA USA.
RI Monaghan, Michael/N-8866-2013; Pandit, Abhay/B-6187-2008
OI Monaghan, Michael/0000-0002-5530-4998; Pandit, Abhay/0000-0002-6292-4933
CR van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105
NR 1
TC 0
Z9 0
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S52
EP S53
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205200202
DA 2018-10-20
ER

PT J
AU Mozdzen, L
   Grier, W
   Hortensius, R
   Moy, A
   Harley, B
AF Mozdzen, L.
   Grier, W.
   Hortensius, R.
   Moy, A.
   Harley, B.
TI Multi-Scale Composite Collagen Biomaterial for Tendon Repair
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Mozdzen, L.; Grier, W.; Harley, B.] Univ Illinois, Chem & Biomol Engn, Urbana, IL USA.
   [Hortensius, R.; Moy, A.] Univ Illinois, Bioengn, Urbana, IL USA.
NR 0
TC 0
Z9 0
U1 1
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S73
EP S73
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205200286
DA 2018-10-20
ER

PT J
AU Pilmane, M
   Salma, I
   Salms, G
   Loca, D
   Locs, J
AF Pilmane, M.
   Salma, I.
   Salms, G.
   Loca, D.
   Locs, J.
TI Effects of Mesenchymal Stem Cells on the Healing Process of Osteoporotic
   Bone after Biomaterial Implantation
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th TERMIS World Congress
CY SEP 08-11, 2015
CL Boston, MA
SP TERMIS
C1 [Pilmane, M.] Riga Stradins Univ, Inst Anat & Anthropol, Riga, Latvia.
   [Salma, I.; Salms, G.] Riga Stradins Univ, Inst Stomatol, Riga, Latvia.
   [Loca, D.; Locs, J.] Riga Tech Univ, Riga Biomat Innovat & Dev Ctr, Riga, Latvia.
NR 0
TC 0
Z9 0
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
SU 1
BP S411
EP S411
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP9HR
UT WOS:000360205202708
DA 2018-10-20
ER

PT J
AU Meyer, RA
   Sunshine, JC
   Green, JJ
AF Meyer, Randall A.
   Sunshine, Joel C.
   Green, Jordan J.
TI Biomimetic particles as therapeutics
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
DE biomimetic; micro/nanoparticle; biomaterial; drug delivery
ID ANTIGEN-PRESENTING CELLS; POLYMER-SUPPORTED MEMBRANES; MESENCHYMAL
   STEM-CELLS; HUMAN DENDRITIC CELLS; VIRUS-LIKE PARTICLES;
   RED-BLOOD-CELLS; DRUG-DELIVERY; LIPID-BILAYERS; IMMUNOLOGICAL SYNAPSE;
   PLASMA-MEMBRANE
AB In recent years, there have been major advances in the development of novel nanoparticle- and microparticle-based therapeutics. An emerging paradigm is the incorporation of biomimetic features into these synthetic therapeutic constructs to enable them to better interface with biological systems. Through the control of size, shape, and material consistency, particle cores have been generated that better mimic natural cells and viruses. In addition, there have been significant advances in biomimetic surface functionalization of particles through the integration of bio-inspired artificial cell membranes and naturally derived cell membranes. Biomimetic technologies enable therapeutic particles to have increased potency to benefit human health.
C1 [Meyer, Randall A.; Sunshine, Joel C.; Green, Jordan J.] Johns Hopkins Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Meyer, Randall A.; Sunshine, Joel C.; Green, Jordan J.] Johns Hopkins Sch Med, Inst Nanobiotechnol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Sch Med, Dept Mat Sci & Engn, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), Johns Hopkins Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, 400 N Broadway,Smith 5017, Baltimore, MD 21231 USA.
EM green@jhu.edu
OI Sunshine, Joel/0000-0001-9987-6712
FU NIH Cancer Nanotechnology Training Center at the JHU Institute for
   Nanobiotechnology [R25CA153952]; NIH MSTP program; NIH [R01-EB016721]
FX R.A.M. thanks the NIH Cancer Nanotechnology Training Center
   (R25CA153952) at the JHU Institute for Nanobiotechnology for fellowship
   support. J.C.S. thanks the NIH MSTP program for support. The authors
   also thank the NIH (R01-EB016721) for support.
CR Agarwal R, 2013, P NATL ACAD SCI USA, V110, P17247, DOI 10.1073/pnas.1305000110
   Alarcon B, 2011, IMMUNOLOGY, V133, P420, DOI 10.1111/j.1365-2567.2011.03458.x
   Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Barua S, 2013, P NATL ACAD SCI USA, V110, P3270, DOI 10.1073/pnas.1216893110
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245
   Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r
   Chu KS, 2014, NANO LETT, V14, P1472, DOI 10.1021/nl4046558
   Chu KS, 2013, BIOMATERIALS, V34, P8424, DOI 10.1016/j.biomaterials.2013.07.038
   Chu KS, 2013, NANOMED-NANOTECHNOL, V9, P686, DOI 10.1016/j.nano.2012.11.008
   COHEN CM, 1977, J CELL BIOL, V75, P119, DOI 10.1083/jcb.75.1.119
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Dyson S., 2014, J NANOMATER MOL NANO
   Fadel TR, 2008, NANO LETT, V8, P2070, DOI 10.1021/nl080332i
   Fadel TR, 2014, NAT NANOTECHNOL, V9, P639, DOI [10.1038/NNANO.2014.154, 10.1038/nnano.2014.154]
   Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u
   Fenner Frank J., 2013, BIOL ANIMAL VIRUSES
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Florez L, 2012, SMALL, V8, P2222, DOI 10.1002/smll.201102002
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Furman NET, 2013, NANO LETT, V13, P3248, DOI 10.1021/nl401376w
   Galneder R, 2001, BIOPHYS J, V80, P2298, DOI 10.1016/S0006-3495(01)76201-7
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Giannoni F, 2005, J IMMUNOL, V174, P3204, DOI 10.4049/jimmunol.174.6.3204
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Groves JT, 2003, J IMMUNOL METHODS, V278, P19, DOI 10.1016/S0022-1759(03)00193-5
   Haghgooie R, 2010, MACROMOL RAPID COMM, V31, P128, DOI 10.1002/marc.200900302
   Hasan W, 2012, NANO LETT, V12, P287, DOI 10.1021/nl2035354
   HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Hu CMJ, 2013, NANOSCALE, V5, P2664, DOI 10.1039/c3nr00015j
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009
   JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278
   Jiang X, 2013, ADV MATER, V25, P227, DOI 10.1002/adma.201202932
   Jiang X, 2011, PHARM RES-DORDR, V28, P1317, DOI 10.1007/s11095-011-0436-3
   Karagoz B, 2014, POLYM CHEM-UK, V5, P350, DOI 10.1039/c3py01306e
   Kaufmann S, 2003, CHEMPHYSCHEM, V4, P699, DOI 10.1002/cphc.200200537
   Kolhar P, 2013, P NATL ACAD SCI USA, V110, P10753, DOI 10.1073/pnas.1308345110
   Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010
   Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Liu JW, 2009, CHEM COMMUN, P5100, DOI 10.1039/b911472f
   Liu JW, 2009, J AM CHEM SOC, V131, P7567, DOI 10.1021/ja902039y
   Liu JW, 2009, J AM CHEM SOC, V131, P1354, DOI 10.1021/ja808018y
   LoidlStahlhofen A, 1996, NAT BIOTECHNOL, V14, P999, DOI 10.1038/nbt0896-999
   Luo GS, 2011, PARTICUOLOGY, V9, P545, DOI 10.1016/j.partic.2011.06.004
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   MENTER DG, 1987, CANCER RES, V47, P6751
   Merkel TJ, 2012, J CONTROL RELEASE, V162, P37, DOI 10.1016/j.jconrel.2012.06.009
   Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108
   MESCHER MF, 1992, J IMMUNOL, V149, P2402
   Meyer R. A., 2015, WILEY INTERDISCIP RE
   Meyer R. A., 2014, SMALL, V11, P1519
   Meyer RA, 2015, J BIOMED MATER RES A, V103, P2747, DOI 10.1002/jbm.a.35399
   Morton SW, 2013, ADV MATER, V25, P4707, DOI 10.1002/adma.201302025
   Mout R, 2012, CHEM SOC REV, V41, P2539, DOI 10.1039/c2cs15294k
   Muzykantov VR, 2010, EXPERT OPIN DRUG DEL, V7, P403, DOI 10.1517/17425241003610633
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Oelke M, 2005, TRENDS MOL MED, V11, P412, DOI 10.1016/j.molmed.2005.07.005
   Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]
   Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212
   Patel PD, 2008, CURR PHARM DESIGN, V14, P63
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pena JR, 2015, BIOMATERIALS, V46, P26, DOI 10.1016/j.biomaterials.2014.12.050
   Perica K, 2015, BBA-MOL CELL RES, V1853, P781, DOI 10.1016/j.bbamcr.2014.09.001
   Perica K, 2014, ACS NANO, V8, P2252, DOI 10.1021/nn405520d
   Perica K, 2014, NANOMED-NANOTECHNOL, V10, P119, DOI 10.1016/j.nano.2013.06.015
   Popova TG, 2015, NANOMATERIALS-BASEL, V5, P298, DOI 10.3390/nano5010298
   Prakken B, 2000, NAT MED, V6, P1406
   Roder F, 2014, ACS CHEM BIOL, V9, P2479, DOI 10.1021/cb5005806
   Roder F, 2013, J AM CHEM SOC, V135, P1189, DOI 10.1021/ja310186g
   Roder F, 2011, ANAL CHEM, V83, P6792, DOI 10.1021/ac201294v
   Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI 10.1586/ERV.10.115
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Rosenthal JA, 2014, CURR OPIN BIOTECH, V28, P51, DOI 10.1016/j.copbio.2013.11.005
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794
   Shalaby WSW, 2004, J BIOMED MATER RES B, V69B, P173, DOI 10.1002/jbm.b.20040
   Sharma G, 2010, J CONTROL RELEASE, V147, P408, DOI 10.1016/j.jconrel.2010.07.116
   Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11
   Steenblock ER, 2011, J BIOL CHEM, V286, P34883, DOI 10.1074/jbc.M111.276329
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2013, NANOMEDICINE-UK, V8, P1173, DOI [10.2217/NNM.13.98, 10.2217/nnm.13.98]
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191
   Valitutti S, 2010, FEBS LETT, V584, P4851, DOI 10.1016/j.febslet.2010.10.010
   Vallhov H, 2007, NANO LETT, V7, P3576, DOI [10.1021/nl0714785, 10.1021/nI0714785]
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Waichman S, 2013, SMALL, V9, P570, DOI 10.1002/smll.201201530
   Wang YP, 2011, LANGMUIR, V27, P524, DOI 10.1021/la1045095
   Xu J, 2013, MOL PHARMACEUT, V10, P3366, DOI 10.1021/mp400190z
   Yan F, 2008, CHEM COMMUN, P4579, DOI 10.1039/b810949d
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Zarrin A, 2014, EXPERT OPIN DRUG DEL, V11, P433, DOI 10.1517/17425247.2014.880422
   Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
NR 103
TC 32
Z9 34
U1 7
U2 81
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD SEP
PY 2015
VL 33
IS 9
BP 514
EP 524
DI 10.1016/j.tibtech.2015.07.001
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CQ9RH
UT WOS:000360952200005
PM 26277289
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hlavaty, KA
   Luo, XR
   Shea, LD
   Miller, SD
AF Hlavaty, Kelan A.
   Luo, Xunrong
   Shea, Lonnie D.
   Miller, Stephen D.
TI Cellular and molecular targeting for nanotherapeutics in transplantation
   tolerance
SO CLINICAL IMMUNOLOGY
LA English
DT Review
DE Transplantation; Tolerance; Nanocarrier; Targeting
ID SINUSOIDAL ENDOTHELIAL-CELLS; REGULATORY T-CELLS; EXPERIMENTAL
   AUTOIMMUNE ENCEPHALOMYELITIS; DONOR SPLENOCYTE INFUSIONS; ANTIGEN
   CROSS-PRESENTATION; DENDRITIC CELLS; IN-VIVO; IMMUNOLOGICAL-TOLERANCE;
   ALLOGRAFT-REJECTION; IMMUNE-RESPONSES
AB The induction of donor-specific tolerance to transplanted cells and organs, while preserving immune function as a whole, remains a highly sought after and elusive strategy for overcoming transplant rejection. Tolerance necessitates modulating a diverse array of cell types that recognize and respond to alloantigens, including antigen presenting cells and T lymphocytes. Nanotherapeutic strategies that employ cellular and biomaterial engineering represent an emerging technology geared towards the goal of inducing transplant tolerance. Nanocarriers offer a platform for delivering antigens of interest to specific cell types in order to achieve tolerogenic antigen presentation. Furthermore, the technologies also provide an opportunity for local immunomodulation at the graft site. Nanocarriers delivering a combination of antigens and immunomodulating agents, such as rapamycin, provide a unique technology platform with the potential to enhance outcomes for the induction of transplant tolerance. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hlavaty, Kelan A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Hlavaty, Kelan A.] Northwestern Univ, Simpson Querrey Inst BioNanoTechnol SQI, Chicago, IL 60611 USA.
   [Luo, Xunrong] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [Luo, Xunrong] Northwestern Univ, Comprehens Transplant Ctr, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Miller, Stephen D.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA.
   [Miller, Stephen D.] Northwestern Univ, Interdept Immunobiol Ctr, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Univ Michigan, Dept Biomed Engn, 2200 Bonisteel Blvd, Ann Arbor, MI 48109 USA.
EM k-hlavaty@u.northwestern.edu; xunrongluo@northwestern.edu;
   ldshea@umich.edu; s-d-miller@northwestern.edu
FU National Institutes of Health [EB013198, NS026543]; Juvenile Diabetes
   Research Foundation [2-SRA-2014-279-Q-R]
FX This work was supported by grants from the National Institutes of Health
   (EB013198 and NS026543) and the Juvenile Diabetes Research Foundation
   (2-SRA-2014-279-Q-R).
CR AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193
   Akhter A, 2014, INT J PHARMACEUT, V475, P227, DOI 10.1016/j.ijpharm.2014.08.048
   Angaswamy N, 2013, HUM IMMUNOL, V74, P1478, DOI 10.1016/j.humimm.2013.07.002
   Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731
   Azad A. K., 2014, J CYTOL MOL BIOL, V1, P1
   Barker RN, 1999, PATHOBIOLOGY, V67, P302, DOI 10.1159/000028085
   Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932
   Berg M, 2006, EUR J IMMUNOL, V36, P2960, DOI 10.1002/eji.200636033
   BERTAGNOLLI MM, 1994, TRANSPLANTATION, V58, P1091, DOI 10.1097/00007890-199411270-00006
   Bisht S, 2008, MOL CANCER THER, V7, P3878, DOI 10.1158/1535-7163.MCT-08-0476
   Blagosklonny MV, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26961
   Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598
   Brazelton TR, 1996, CURR OPIN IMMUNOL, V8, P710, DOI 10.1016/S0952-7915(96)80090-2
   Bryant J, 2014, BIOMATERIALS, V35, P8887, DOI 10.1016/j.biomaterials.2014.06.044
   Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276
   Chappell CP, 2014, J IMMUNOL, V192, P5789, DOI 10.4049/jimmunol.1303259
   Chen H, 1998, TRANSPLANT P, V30, P1039, DOI 10.1016/S0041-1345(98)00141-9
   Chen YC, 2013, BIOMATERIALS, V34, P1115, DOI 10.1016/j.biomaterials.2012.10.034
   Cruz LJ, 2014, J CONTROL RELEASE, V192, P209, DOI 10.1016/j.jconrel.2014.07.040
   D'Addio SM, 2013, J CONTROL RELEASE, V168, P41, DOI 10.1016/j.jconrel.2013.02.004
   Dai WB, 2014, BIOMATERIALS, V35, P5347, DOI 10.1016/j.biomaterials.2014.03.036
   Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009
   Das S, 2008, J BIOMED MATER RES A, V85A, P983, DOI 10.1002/jbm.a.31557
   den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685
   Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203
   Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080
   Ebrahimkhani MR, 2011, HEPATOLOGY, V54, P1379, DOI 10.1002/hep.24508
   Fehres CM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00149
   Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200
   Fitzhugh CD, 2013, BONE MARROW TRANSPL, V48, P1335, DOI 10.1038/bmt.2013.60
   Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618
   Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2
   Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569
   Getts DR, 2013, J IMMUNOL, V191, P5341, DOI 10.4049/jimmunol.1302070
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175
   Gu YJ, 2014, J IMMUNOL METHODS, V402, P82, DOI 10.1016/j.jim.2013.11.009
   Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10
   Hachem RR, 2009, CURR OPIN ORGAN TRAN, V14, P477, DOI 10.1097/MOT.0b013e32832fb981
   Haddadi A, 2008, J BIOMED MATER RES A, V84A, P885, DOI 10.1002/jbm.a.31373
   Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769
   Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492
   Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018
   Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419
   Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140
   KAMEI T, 1990, J SURG RES, V48, P393, DOI 10.1016/0022-4804(90)90001-I
   Kawakami S, 2000, GENE THER, V7, P292, DOI 10.1038/sj.gt.3301089
   Kel J, 2007, AM J PATHOL, V170, P272, DOI 10.2353/ajpath.2007.060335
   Kheradmand T, 2012, J IMMUNOL, V189, P804, DOI 10.4049/jimmunol.1103705
   Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009
   Klintmalm GB, 2014, J TRANSPLANT, V2014
   Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1
   Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399
   LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508
   Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105
   Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673
   Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111
   Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040
   Masri MA, 2003, MOL IMMUNOL, V39, P1073, DOI 10.1016/S0161-5890(03)00075-0
   McCarthy DP, 2014, WIRES NANOMED NANOBI, V6, P298, DOI 10.1002/wnan.1263
   McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028
   Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990
   Nanji SA, 2004, BIODRUGS, V18, P315, DOI 10.2165/00063030-200418050-00004
   Napoli KL, 1997, CLIN BIOCHEM, V30, P135, DOI 10.1016/S0009-9120(96)00157-9
   Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139
   Page EK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00198
   Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467
   Pilat N, 2011, SEMIN IMMUNOL, V23, P293, DOI 10.1016/j.smim.2011.04.002
   Platt N, 2000, J IMMUNOL, V164, P4861, DOI 10.4049/jimmunol.164.9.4861
   Prasad S, 2012, J AUTOIMMUN, V39, P347, DOI 10.1016/j.jaut.2012.04.005
   Ravishankar B, 2013, CELL MOL LIFE SCI, V70, P3571, DOI 10.1007/s00018-013-1261-0
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Reynoso ED, 2009, J LEUKOCYTE BIOL, V86, P795, DOI 10.1189/jlb.0509362
   Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004
   Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10
   Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750
   Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x
   Scheffert JL, 2014, J THORAC DIS, V6, P1039, DOI 10.3978/j.issn.2072-1439.2014.04.23
   Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944
   Schurich A, 2010, J IMMUNOL, V184, P4107, DOI 10.4049/jimmunol.0902580
   Schurich A, 2009, HEPATOLOGY, V50, P909, DOI 10.1002/hep.23075
   Shan J, 2014, IMMUNOL LETT, V162, P74, DOI 10.1016/j.imlet.2014.07.006
   Shilling RA, 2009, AM J TRANSPLANT, V9, P1714, DOI 10.1111/j.1600-6143.2009.02690.x
   Shin SB, 2010, EUR J PHARM BIOPHARM, V74, P164, DOI 10.1016/j.ejpb.2009.08.006
   Simpson E, 2001, EUR J IMMUNOGENET, V28, P505, DOI 10.1046/j.0960-7420.2001.00252.x
   Smarr CB, 2011, J IMMUNOL, V187, P5090, DOI 10.4049/jimmunol.1100608
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   STEPKOWSKI SM, 1991, TRANSPLANT P, V23, P3262
   Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973
   Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876
   Tel J, 2013, J IMMUNOL, V191, P5005, DOI 10.4049/jimmunol.1300787
   Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008
   Tokita D, 2005, TRANSPLANT INT, V18, P237, DOI 10.1111/j.1432-2277.2004.00045.x
   Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012
   von Oppen N, 2009, HEPATOLOGY, V49, P1664, DOI 10.1002/hep.22795
   Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600
   White KL, 2006, J PHARM PHARMACOL, V58, P729, DOI 10.1211/jpp.58.6.0003
   WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110
   Wong SHY, 2001, CLIN CHIM ACTA, V313, P241, DOI 10.1016/S0009-8981(01)00678-7
   Woo HN, 2012, INT J NANOMED, V7, P2197, DOI 10.2147/IJN.S29480
   Xu W, 2014, INT J PHARMACEUT, V460, P173, DOI 10.1016/j.ijpharm.2013.10.035
   Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033
   Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983
   You Q, 2008, HEPATOLOGY, V48, P978, DOI 10.1002/hep.22395
   Zou WW, 2009, DRUG DELIV, V16, P15, DOI 10.1080/10717540802481307
NR 108
TC 10
Z9 11
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1521-6616
EI 1521-7035
J9 CLIN IMMUNOL
JI Clin. Immunol.
PD SEP
PY 2015
VL 160
IS 1
BP 14
EP 23
DI 10.1016/j.clim.2015.03.013
PG 10
WC Immunology
SC Immunology
GA CQ7JU
UT WOS:000360780600003
PM 25805659
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lewis, JS
   Dolgova, NV
   Zhang, Y
   Xia, CQ
   Wasserfall, CH
   Atkinson, MA
   Clare-Salzler, MJ
   Keselowsky, BG
AF Lewis, Jamal S.
   Dolgova, Natalia V.
   Zhang, Ying
   Xia, Chang Qing
   Wasserfall, Clive H.
   Atkinson, Mark A.
   Clare-Salzler, Michael J.
   Keselowsky, Benjamin G.
TI A combination dual-sized microparticle system modulates dendritic cells
   and prevents type 1 diabetes in prediabetic NOD mice
SO CLINICAL IMMUNOLOGY
LA English
DT Article
DE Microparticle; Dendritic cells; Tolerance; NOD; Diabetes; Prevention
ID REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; TOLL-LIKE RECEPTORS;
   IN-VIVO; POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES; EXPRESS IL-4;
   AUTOIMMUNITY; BETA; VACCINES; TRANSPLANTATION
AB We developed a novel poly(lactic-co-glycolic acid)-based, microparticle (MP) system providing concurrent delivery of multiple encapsulated immuno-suppressive factors and antigen, for in vivo conditioning of dendritic cells (DCs) toward a tolerance promoting pathway. Subcutaneous administration prevents onset of type 1 diabetes (T1D) in NOD mice. Two MP sizes were made: phagocytosable MPs were fabricated encapsulating vitamin D3 or insulin B(9-23) peptide, while unphagocytosable MPs were fabricated encapsulating TGF-beta 1 or GM-CSF. The combination of Vit D3/TGF-beta 1 MPs confers an immature and LPS activation-resistant phenotype to DCs, and MP-delivered antigen is efficiently and functionally presented. Notably, two subcutaneous injections into 4 week old NOD mice using the combination of MPs encapsulating Vit D3, Ins B, TGF-beta 1 and GM-CSF protected 40% of mice from T1D development, significant in comparison to the control. This work represents one of the first applications of a biomaterial-based, MP vaccine system to successfully prevent autoimmune diabetes. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Lewis, Jamal S.; Dolgova, Natalia V.; Zhang, Ying; Keselowsky, Benjamin G.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   [Xia, Chang Qing; Wasserfall, Clive H.; Atkinson, Mark A.; Clare-Salzler, Michael J.; Keselowsky, Benjamin G.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.
RP Keselowsky, BG (reprint author), J Crayton Pruitt Family Dept Biomed Engn, POB 116131, Gainesville, FL 32611 USA.
EM bgk@ufl.edu
FU NIH NIDDK [R01DK098589, R01 DK091658]; NIAID [AI42288, R21A1094360];
   Blanche J. Salisbury Diabetes Research Fund
FX The efforts herein were supported by the NIH NIDDK (R01DK098589, R01
   DK091658 - to B.G.K.) and NIAID (AI42288 - to M.A.A.; R21A1094360 - to
   B.G.K.), and a gift to the University of Florida Foundation from the
   Blanche J. Salisbury Diabetes Research Fund (in support of the research
   of M.A.A.).
CR Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Anderson M.S., 2005, NOD MOUSE MODEL IMMU
   Baeke F, 2007, NUTR RES REV, V20, P106, DOI 10.1017/S0954422407742713
   Banchereau J., 2000, IMMUNOBIOLOGY DENDRI
   Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006
   Bertera S, 1999, ENDOCRIN METAB CLIN, V28, P841, DOI 10.1016/S0889-8529(05)70105-5
   Boudaly S, 2002, EUR CYTOKINE NETW, V13, P29
   Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407
   Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001
   Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409
   CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946
   Cobbold SP, 2003, IMMUNOL REV, V196, P109, DOI 10.1046/j.1600-065X.2003.00078.x
   FLOHR K, 1983, CLIN EXP IMMUNOL, V53, P605
   Gaudreau S, 2008, DIABETOLOGIA, V51, pS228
   Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472
   Haller MJ, 2005, PEDIATR CLIN N AM, V52, P1553, DOI 10.1016/j.pcl.2005.07.006
   Jain S, 2011, EXPERT REV VACCINES, V10, P1731, DOI [10.1586/ERV.11.126, 10.1586/erv.11.126]
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Karounos DG, 1997, J CLIN INVEST, V100, P1344, DOI 10.1172/JCI119654
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Keselowsky BG, 2011, HUM VACCINES, V7, P37, DOI 10.4161/hv.7.1.12916
   Kim SH, 2001, J IMMUNOL, V166, P3499, DOI 10.4049/jimmunol.166.5.3499
   KOLB H, 1980, DIABETOLOGIA, V19, P216, DOI 10.1007/BF00275272
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Lo J, 2006, AUTOIMMUN REV, V5, P419, DOI 10.1016/j.autrev.2005.12.001
   Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104
   Mantel P.Y., 2011, TRANSFORMING GROWTH
   MCCULLOCH DK, 1989, CLIN RES, V37, pA132
   Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490
   O'Hagan DT, 1998, ADV DRUG DELIVER REV, V32, P225, DOI 10.1016/S0169-409X(98)00012-X
   Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394
   Orban T, 2010, J AUTOIMMUN, V34, P408, DOI 10.1016/j.jaut.2009.10.005
   Pallotta MT, 2014, J CELL MOL MED, V18, P2082, DOI 10.1111/jcmm.12360
   Pedersen AE, 2004, IMMUNOL LETT, V91, P63, DOI 10.1016/j.imlet.2003.11.004
   Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044
   Penna G, 2005, MICROBES INFECT, V7, P1033, DOI 10.1016/j.micinf.2005.03.025
   Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405
   Phillips B, 2008, DIABETES, V57, P1544, DOI 10.2337/db07-0507
   Santamaria P, 2010, IMMUNITY, V32, P437, DOI 10.1016/j.immuni.2010.04.003
   Steptoe RJ, 2005, DIABETES, V54, P434, DOI 10.2337/diabetes.54.2.434
   Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173
   Tarbell KV, 2006, SEMIN IMMUNOL, V18, P93, DOI 10.1016/j.smim.2006.01.009
   Trepiakas R, 2010, CYTOTHERAPY, V12, P721, DOI 10.3109/14653241003774045
   Turnquist HR, 2008, CURR OPIN ORGAN TRAN, V13, P350, DOI 10.1097/MOT.0b013e328306116c
   VERGE CF, 1995, DIABETES, V44, P1176, DOI 10.2337/diabetes.44.10.1176
   Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008
   WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788
   Yang H, 2012, TRANSPLANTATION, V93, P580, DOI 10.1097/TP.0b013e318244dd67
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
NR 51
TC 22
Z9 23
U1 0
U2 30
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1521-6616
EI 1521-7035
J9 CLIN IMMUNOL
JI Clin. Immunol.
PD SEP
PY 2015
VL 160
IS 1
BP 90
EP 102
DI 10.1016/j.clim.2015.03.023
PG 13
WC Immunology
SC Immunology
GA CQ7JU
UT WOS:000360780600010
PM 25842187
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kotoka, R
   Yarmolenko, S
   Pai, D
   Sankar, J
AF Kotoka, Ruben
   Yarmolenko, Sergey
   Pai, Devdas
   Sankar, Jag
TI Corrosion Behavior of Reactive Sputtered Al2O3 and ZrO2 Thin Films on Mg
   Disk Immersed in Saline Solution
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Magnetron sputtering; Magnesium; Aluminum oxide; Zirconium oxide;
   Porosity
ID PLASMA ELECTROLYTIC OXIDATION; MAGNESIUM ALLOY; COATINGS; BIOMATERIALS;
   BIOACTIVITY; RESISTANCE; POROSITY; SURFACE; RF
AB Magnesium has attracted a lot of attention over the last few decades due to its light weight and potential use as biomaterial. However, the poor corrosion resistance of magnesium restricts its practical use for application where exposure to aggressive aqueous media is unavoidable. This paper describes the growth, characterization and corrosion analyses of Al2O3 and ZrO2 thin film coatings aimed at slowing down the fast degradation of Mg in saline solution. In this study, different thicknesses of Al2O3 and ZrO2 were deposited on pure magnesium (99.95%) disk using pulsed-DC reactive sputtering process. The microstructure and phase analyses were performed using scanning electron microscopy (SEM) and X-ray diffraction (XRD), respectively. The corrosion protection behavior of the Al2O3 and ZrO2 coated magnesium samples immersed in 0.9 wt% NaCl solution were evaluated using electrochemical measurement techniques, such as open-circuit potential (OCP), potentiodynamic polarization (PD) and electrochemical impedance spectroscopy (EIS). The microstructural analyses showed that the Al2O3 thin film coatings have circular grains between 5 and 25 nm, while the ZrO2 coatings have bigger ellipsoidal grains. The results from the electrochemical corrosion analyses showed that the Al2O3 coated Mg disk had corrosion resistance of approximately 3 times that of ZrO2 coated Mg disk. It was also observed that increasing the thickness of the Al2O3 coating improved the corrosion resistance of the Mg disk. These results suggest that Al2O3 and ZrO2 coating can be used to effectively control the fast degradation of magnesium for medical implant applications. Copyright (C) 2015, The editorial office of Journal of Materials Science & Technology. Published by Elsevier Limited. All rights reserved.
C1 [Kotoka, Ruben; Yarmolenko, Sergey; Pai, Devdas; Sankar, Jag] N Carolina Agr & Tech State Univ, Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
RP Kotoka, R (reprint author), N Carolina Agr & Tech State Univ, Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
EM rkotoka@ncat.edu
RI Yarmolenko, Sergey/E-6819-2017
FU Engineering Research Center for Revolutionizing Metallic Biomaterials
   [NSF EEC 0812348]
FX The authors acknowledge the financial support of the Engineering
   Research Center for Revolutionizing Metallic Biomaterials (NSF EEC
   0812348) for their financial support and the Center for Advanced
   Materials and Smart Structures at North Carolina A&T State University
   for access to the necessary laboratory facilities and equipment.
CR Aal AA, 2008, J MATER SCI, V43, P2947, DOI 10.1007/s10853-007-1796-2
   Ahn SH, 2004, APPL SURF SCI, V233, P105, DOI 10.1016/j.apsusc.2004.03.213
   Aita CR, 2004, SURF COAT TECH, V188, P179, DOI 10.1016/j.surfcoat.2004.08.019
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ben Amor S, 1998, MAT SCI ENG B-SOLID, V57, P28, DOI 10.1016/S0921-5107(98)00205-0
   Cano E, 2010, J SOLID STATE ELECTR, V14, P381, DOI 10.1007/s10008-009-0902-6
   Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005
   Cremer R, 1999, SURF COAT TECH, V120, P213, DOI 10.1016/S0257-8972(99)00458-2
   Creus J, 2000, SURF COAT TECH, V130, P224, DOI 10.1016/S0257-8972(99)00659-3
   Eddy G., 2012, AM J BIOMED ENG, V2, P218, DOI DOI 10.5923/J.AJBE.20120206.02
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Koski K, 1999, THIN SOLID FILMS, V339, P240, DOI 10.1016/S0040-6090(98)01232-2
   Li Q, 2000, J VAC SCI TECHNOL A, V18, P2333, DOI 10.1116/1.1286715
   Liang J, 2009, CORROS SCI, V51, P2483, DOI 10.1016/j.corsci.2009.06.034
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Sandhyarani M, 2013, J ALLOY COMPD, V553, P324, DOI 10.1016/j.jallcom.2012.11.147
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   SUHAIL MH, 1991, J VAC SCI TECHNOL A, V9, P2675, DOI 10.1116/1.577223
   Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin YC, 2008, J ELECTROCHEM SOC, V155, pC178, DOI 10.1149/1.2844433
   Zhang J, 2008, T NONFERR METAL SOC, V18, pS312, DOI 10.1016/S1003-6326(10)60223-3
NR 24
TC 9
Z9 9
U1 6
U2 59
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD SEP
PY 2015
VL 31
IS 9
BP 873
EP 880
DI 10.1016/j.jmst.2015.07.020
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CQ5NW
UT WOS:000360653000001
DA 2018-10-20
ER

PT J
AU Franceschini, G
   Visconti, G
   Sanchez, AM
   Di Leone, A
   Salgarello, M
   Masetti, R
AF Franceschini, Gianluca
   Visconti, Giuseppe
   Sanchez, Alejandro Martin
   Di Leone, Alba
   Salgarello, Marzia
   Masetti, Riccardo
TI Oxidized regenerated cellulose in breast surgery: experimental model
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE Breast cancer; Oncoplastic surgery; Cosmetic results; Oxidized
   regenerated cellulose; QUORC technique
ID 20-YEAR FOLLOW-UP; CONSERVATIVE SURGERY; CONSERVING SURGERY; TURKISH
   DELIGHT; WOUND REPAIR; CANCER; MASTECTOMY; MATRIX; REINFORCEMENT;
   ANGIOGENESIS
AB Background: Breast-conserving surgery (BCS) combined with postoperative radiotherapy has become the gold standard of locoregional treatment in patients with early-stage breast cancer. When large tumor resections are needed in small medium size breasts, oncoplastic procedures (OPP) have been introduced to improve the cosmetic result; but in several cases, OPP may be not sufficient to accomplish this purpose. Oxidized regenerated cellulose (ORC, Tabotamp fibrillar; Johnson & Johnson; Ethicon) has been reported to be useful in OPP to optimize the cosmetic results after OPP. However, no ultrastructural study is available on the use of ORC as a filler in BCS.
   Materials and methods: A BCS cavity was simulated in both groin regions in 24 consecutive Wistar rats. The right groin underwent soft tissue displacement and ORC implantation, whereas the left groin was treated only by soft tissue displacement (control side). Rats were sacrificed at 10, 20, and 30 wk to evaluate volume retainment and microscopic features (vascularization, fibrosis, cell population, inflammation, liponecrosis, andcapsule formation).
   Results: The use of ORC was characterized by diffuse fibrosis and homogeneous neovascularization within the construct, with no capsule formation and no inflammation. Volume retainment was similar in the 20- and 30-wk specimens (mean 80.4%, standard deviation, 6.65 and mean 79.9%, standard deviation, 6.51).
   Conclusions: Implanted ORC was well integrated within the soft tissue with diffuse fibrosis, angiogenesis, and absence of capsule formation. Preliminary results confirmed that this biomaterial could further contribute to optimize cosmetic results in the oncoplastic surgical spectrum of breast-conservation therapy. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Franceschini, Gianluca; Visconti, Giuseppe; Sanchez, Alejandro Martin; Di Leone, Alba; Salgarello, Marzia; Masetti, Riccardo] Univ Cattolica Sacro Cuore, Multidisciplinary Breast Ctr, I-00168 Rome, Italy.
RP Franceschini, G (reprint author), Univ Cattolica Sacro Cuore, Multidisciplinary Breast Ctr, Policin Agostino Gemelli, Largo Agostino Gemelli 8, I-00168 Rome, Italy.
EM franceschinigianluca@gmail.com
RI Sanchez, Alejandro/M-6703-2016
OI Sanchez, Alejandro/0000-0002-4840-507X; Franceschini,
   Gianluca/0000-0002-2950-3395; MASETTI, Riccardo/0000-0002-7520-9111
CR Alfieri S, 2011, MINERVA CHIR, V66, P55
   Anderson BO, 2005, LANCET ONCOL, V6, P145, DOI 10.1016/S1470-2045(05)01765-1
   Bassetto F, 2008, AESTHET PLAST SURG, V32, P807, DOI 10.1007/s00266-008-9203-1
   Bauer Stephen M, 2005, Vasc Endovascular Surg, V39, P293, DOI 10.1177/153857440503900401
   Bazylev VV, 2009, USE OXIDIZED REGENER, V10
   Clough KB, 2010, ANN SURG ONCOL, V17, P1375, DOI 10.1245/s10434-009-0792-y
   Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7
   Cullen B, 2002, INT J BIOCHEM CELL B, V34, P1544, DOI 10.1016/S1357-2725(02)00054-7
   DELAROCHEFORDIERE A, 1992, INT J RADIAT ONCOL, V23, P925, DOI 10.1016/0360-3016(92)90896-P
   Erol OO, 2000, PLAST RECONSTR SURG, V105, P2229, DOI 10.1097/00006534-200005000-00051
   Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Franceschini G, 2012, EUR REV MED PHARMACO, V16, P966
   Franceschini G, 2014, BREAST J, V20, P447, DOI 10.1111/tbj.12297
   Franceschini G, 2013, ANN ITAL CHIR, V84, P483
   Gago LA, 2003, AM J OBSTET GYNECOL, V189, P1620, DOI 10.1016/j.ajog.2003.08.018
   Gottrup F, 2013, WOUND REPAIR REGEN, V21, P216, DOI 10.1111/wrr.12020
   Habal Petr, 2011, Acta Medica (Hradec Kralove), V54, P153
   Hart J, 2002, INT J BIOCHEM CELL B, V34, P1557, DOI 10.1016/S1357-2725(02)00062-6
   IruelaArispe ML, 1997, THROMB HAEMOSTASIS, V78, P672
   Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P324, DOI 10.1111/j.1067-1927.2005.130316.x
   Krizova P, 2007, J BIOMED MATER RES A, V82A, P274, DOI 10.1002/jbm.a.31060
   Liu SA, 2012, J CHIN MED ASSOC, V75, P176, DOI 10.1016/j.jcma.2012.03.007
   Madbouly KM, 2010, DIS COLON RECTUM, V53, P889, DOI 10.1007/DCR.0b013e3181d3206e
   Masova L, 2003, Sb Lek, V104, P231
   Mills JM, 1997, INT J RADIAT ONCOL, V39, P637, DOI 10.1016/S0360-3016(97)00381-7
   Mittal S, 2006, INT UROGYNECOL J, V17, P426, DOI 10.1007/s00192-005-0017-2
   Nahabedian MY, 2009, ONCOPLASTIC SURG BRE
   OLIVOTTO IA, 1989, INT J RADIAT ONCOL, V17, P747, DOI 10.1016/0360-3016(89)90061-8
   Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x
   Rassu PC, 2013, ANN ITAL CHIR, V84
   Rassu PC, 2013, GLAND SURG, V2, P170, DOI 10.3978/j.issn.2227-684X.2013.07.03
   Richardson S, 2011, INT J ORAL MAX SURG, V40, P979, DOI 10.1016/j.ijom.2011.03.013
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Salgarello M, 2012, PLAST RECONSTR SURG, V129, P317, DOI 10.1097/PRS.0b013e31822b6619
   Sharma J. B., 2007, Archives of Gynecology and Obstetrics, V275, P231, DOI 10.1007/s00404-006-0256-6
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Spangler Daniel, 2003, Surg Infect (Larchmt), V4, P255, DOI 10.1089/109629603322419599
   Tanaka S, 2014, BREAST J, V20, P154, DOI 10.1111/tbj.12229
   TAYLOR ME, 1995, INT J RADIAT ONCOL, V31, P753, DOI 10.1016/0360-3016(94)00480-3
   VERONESI U, 1990, EUR J CANCER, V26, P671, DOI 10.1016/0277-5379(90)90114-9
   Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989
NR 42
TC 4
Z9 4
U1 3
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD SEP
PY 2015
VL 198
IS 1
BP 237
EP 244
DI 10.1016/j.jss.2015.05.012
PG 8
WC Surgery
SC Surgery
GA CQ6IG
UT WOS:000360707300034
PM 26055212
DA 2018-10-20
ER

PT J
AU Sato, K
   Kobayashi, S
   Kusakari, M
   Watahiki, S
   Oikawa, M
   Hoshiba, T
   Tanaka, M
AF Sato, Kazuhiro
   Kobayashi, Shingo
   Kusakari, Miho
   Watahiki, Shogo
   Oikawa, Masahiko
   Hoshiba, Takashi
   Tanaka, Masaru
TI The Relationship Between Water Structure and Blood Compatibility in
   Poly(2-methoxyethyl Acrylate) (PMEA) Analogues
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial; blood compatibility; intermediate water; protein
   adsorption; water structure
ID DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN ADSORPTION; POLY(ETHYLENE
   GLYCOL); PLATELET-ADHESION; PLASMA-PROTEINS; DRUG-DELIVERY; POLYMERS;
   SURFACE; MECHANISM; SYSTEMS
AB Six types of poly(2-methoxyethyl acrylate) (PMEA) analogues were synthesized and the water structure in the hydrated polymers was characterized using differential scanning calorimetry (DSC). The hydrated PMEA analogues exhibited the different amounts of intermediate water. Non-thrombogenicity evaluation was performed on PMEA analogues for platelet adhesion and protein adsorption. Platelet adhesion was suppressed on PMEA analogues. In addition, the protein adsorption and deformation were suppressed by increasing the amount of intermediate water. This study demonstrates that the amount of intermediate water might play a key role in expressing the blood compatibility of polymeric materials.
C1 [Sato, Kazuhiro; Kobayashi, Shingo; Kusakari, Miho; Watahiki, Shogo; Oikawa, Masahiko; Hoshiba, Takashi; Tanaka, Masaru] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan.
   [Hoshiba, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan.
   [Kobayashi, Shingo; Tanaka, Masaru] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 8190395, Japan.
RP Tanaka, M (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.
EM tanaka@yz.yamagata-u.ac.jp
RI U-ID, Kyushu/C-5291-2016
OI Tanaka, Masaru/0000-0002-1115-2080; Kobayashi,
   Shingo/0000-0002-8357-8654
FU Ministry of Education, Culture, Sports, Science and Technology, Japan;
   Funding Program for Next Generation World-Leading Researchers (NEXT
   Program, Japan)
FX This work is supported by Grants-in-Aid and Special Coordination Funds
   for Promoting Science and Technology of Ministry of Education, Culture,
   Sports, Science and Technology, Japan. We gratefully acknowledge the
   financial support from the Funding Program for Next Generation
   World-Leading Researchers (NEXT Program, Japan).
CR Ayako O., 2005, ADV MATER, V17, P2329
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   Cavadas M, 2011, NANOMED-NANOTECHNOL, V7, P730, DOI 10.1016/j.nano.2011.04.006
   Chen CY, 2013, BIOMATERIALS, V34, P4501, DOI 10.1016/j.biomaterials.2013.02.049
   Djikaev YS, 2010, ADV COLLOID INTERFAC, V154, P77, DOI 10.1016/j.cis.2010.01.009
   Gemmei-Ide M, 2012, J PHYS CHEM B, V116, P1850, DOI 10.1021/jp211473p
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0
   Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018
   Hatakeyma T, 2007, THERMOCHIM ACTA, V465, P59, DOI 10.1016/j.tca.2007.09.005
   Hayashi T, 2012, PHYS CHEM CHEM PHYS, V14, P10196, DOI 10.1039/c2cp41236e
   Huang L, 2001, J POLYM SCI POL PHYS, V39, P496, DOI 10.1002/1099-0488(20010301)39:5<496::AID-POLB1023>3.0.CO;2-H
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239
   Kawai K, 2006, BIOPHYS J, V90, P3732, DOI 10.1529/biophysj.105.075986
   Kishi A, 2008, J APPL POLYM SCI, V111, P476
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Lutz JF, 2007, MACROMOLECULES, V40, P8540, DOI 10.1021/ma7021474
   Medel S, 2011, J POLYM SCI POL CHEM, V49, P690, DOI 10.1002/pola.24480
   Miwa Y, 2010, J BIOMAT SCI-POLYM E, V21, P1911, DOI 10.1163/092050610X489682
   Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998
   Morita S, 2014, LANGMUIR, V30, P10698, DOI 10.1021/la502550d
   Nagasaki Y, 2011, POLYM J, V43, P949, DOI 10.1038/pj.2011.93
   Nishinari K, 1997, COLLOID POLYM SCI, V275, P1078, DOI 10.1007/s003960050186
   Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r
   Sefcik LS, 2013, CELL MOL BIOENG, V6, P287, DOI 10.1007/s12195-013-0286-7
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   Tanaka M, 2010, J BIOMAT SCI-POLYM E, V21, P1849, DOI 10.1163/092050610X517220
   Tsuruta T, 2010, J BIOMAT SCI-POLYM E, V21, P1831, DOI 10.1163/092050610X488269
   Vogler A. E., 2009, BIOMATERIALS, V30, P1857
   Wei-Bor T., 1999, J BIOMED MATER RES, V44, P130
   Wei-Hsuan K., 2011, BIOMACROMOLECULES, V12, P4348
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xuan J, 2012, LANGMUIR, V28, P16463, DOI 10.1021/la303946b
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   ZHANG ZL, 1983, PHYSIOL CHEM PHYS, V15, P407
NR 40
TC 15
Z9 15
U1 4
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP
PY 2015
VL 15
IS 9
BP 1296
EP 1303
DI 10.1002/mabi.201500078
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CQ6NN
UT WOS:000360721300013
PM 26017931
DA 2018-10-20
ER

PT J
AU Lin, YQ
   Wang, LR
   Wang, JT
   Pan, LL
   Zhu, GQ
   Liu, WY
   Braddock, M
   Zheng, MH
AF Lin, Yi-Qian
   Wang, Li-Ren
   Wang, Jiang-Tao
   Pan, Liang-Liang
   Zhu, Gui-Qi
   Liu, Wen-Yue
   Braddock, Martin
   Zheng, Ming-Hua
TI New advances in liver decellularization and recellularization:
   innovative and critical technologies
SO EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Review
DE liver decellularization; tissue engineering; liver recellularization;
   regenerative medicine; biomaterials
ID MESENCHYMAL STEM-CELLS; REGENERATIVE MEDICINE APPROACH;
   EXTRACELLULAR-MATRIX; IN-VITRO; HEPATOCYTE FUNCTION; HEPATIC TISSUE;
   CHEMICAL DECELLULARIZATION; BIOLOGIC SCAFFOLDS; GAMMA-IRRADIATION;
   ACELLULAR MATRIX
AB Techniques for producing decellularized scaffolds for use in liver tissue engineering are emerging as promising methods for tissue reconstruction. In this article, the authors present an overview of liver decellularization methods developed and applied in recent years. These include the widespread use of various perfusion methods for the generation of a 3D scaffold, which may function as a template for either cell recellularization or direct biological application. The authors evaluate methods for scaffold production and explore some factors that may affect the decellularization process. In addition to tissue engineering, this overview includes a description of other potential applications for a decellularized liver scaffold. The authors also introduce the concept of fabrication of fragile biomaterial architecture and finally review the cell types applied to liver scaffold engineering.
C1 [Lin, Yi-Qian; Wang, Li-Ren; Wang, Jiang-Tao; Zhu, Gui-Qi; Zheng, Ming-Hua] Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou 325000, Peoples R China.
   [Lin, Yi-Qian] Wenzhou Med Univ, Renji Sch, Wenzhou 325000, Peoples R China.
   [Wang, Li-Ren; Wang, Jiang-Tao; Zhu, Gui-Qi] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325000, Peoples R China.
   [Pan, Liang-Liang] Wenzhou Med Univ, Sch Lab & Life Sci, Wenzhou 325000, Peoples R China.
   [Liu, Wen-Yue] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol, Wenzhou 325000, Peoples R China.
   [Braddock, Martin] AstraZeneca R&D, Global Med Dev, Alderley Pk, Cheshire, England.
   [Zheng, Ming-Hua] Wenzhou Med Univ, Inst Hepatol, Wenzhou 325000, Peoples R China.
RP Zheng, MH (reprint author), Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou 325000, Peoples R China.
EM zhengmh@wmu.edu.cn
OI Zhu, Gui-Qi/0000-0001-5089-6923; Zheng, Ming-Hua/0000-0003-4984-2631;
   Liu, Wen-yue/0000-0003-1454-7077
FU Scientific Research Foundation of Wenzhou, Zhejiang Province, China
   [H20090014, Y20090269]; Health Bureau of Zhejiang Province [2010KYB070];
   Research Foundation of Education Bureau of Zhejiang Province
   [Y201009942]; Fresh Talent Program for Science and Technology Wenzhou
   Medical University [wyx201401011, wyx201401087, wyx201401009,
   wyx201401085]; Research Funds for Tian Qing Liver Disease
   [TQGB20120057]; Project of New Century 551 Talent Nurturing in Wenzhou
FX The authors were supported by grants from the Scientific Research
   Foundation of Wenzhou, Zhejiang Province, China (grant numbers:
   H20090014, Y20090269), the Health Bureau of Zhejiang Province (grant
   number: 2010KYB070), the Research Foundation of Education Bureau of
   Zhejiang Province (grant number: Y201009942), the Fresh Talent Program
   for Science and Technology Wenzhou Medical University (grant numbers:
   wyx201401011, wyx201401087, wyx201401009 and wyx201401085), the Research
   Funds for Tian Qing Liver Diseases (grant number: TQGB20120057) and the
   Project of New Century 551 Talent Nurturing in Wenzhou. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Alhamdani MSS, 2010, J PROTEOME RES, V9, P963, DOI 10.1021/pr900844q
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Banas A, 2007, DEV DYNAM, V236, P3228, DOI 10.1002/dvdy.21330
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Booth C, 2012, WORLD J GASTROENTERO, V18, P6926, DOI 10.3748/wjg.v18.i47.6926
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Calandrelli L, 2008, BIOMACROMOLECULES, V9, P1527, DOI 10.1021/bm7013087
   Chivu M, 2009, TRANSL RES, V154, P122, DOI 10.1016/j.trsl.2009.05.007
   Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225
   Chung S, 2011, BIOTECHNOL APPL BIOC, V58, P423, DOI 10.1002/bab.60
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   COLLER BS, 1989, BLOOD, V74, P182
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dan YY, 2009, J GASTROEN HEPATOL, V24, P171
   De Kock J, 2011, ARCH TOXICOL, V85, P607, DOI 10.1007/s00204-011-0706-1
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   DUNN JCY, 1989, FASEB J, V3, P174
   Esaki K, 2009, BIOMACROMOLECULES, V10, P1265, DOI 10.1021/bm900089j
   Farnebo S, 2014, PLAST RECONSTR SURG, V133, P79, DOI 10.1097/01.prs.0000436823.64827.a0
   Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   FOY BD, 1993, BIOTECHNOL BIOENG, V42, P579, DOI 10.1002/bit.260420505
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Gao ST, 2014, J MATER SCI-MATER M, V25, P1283, DOI 10.1007/s10856-014-5150-3
   Gessner RC, 2013, BIOMATERIALS, V34, P9341, DOI 10.1016/j.biomaterials.2013.08.033
   Gouk SS, 2008, J BIOMED MATER RES B, V84B, P205, DOI 10.1002/jbm.b.30862
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170
   Hashemi SM, 2009, CELLS TISSUES ORGANS, V190, P135, DOI 10.1159/000187716
   Hirschfield GM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1670
   Hrebikova H, 2015, BIOMED PAP, V159, P12, DOI 10.5507/bp.2013.076
   Hussein KH, 2013, TRANSPL P, V45, P3092, DOI 10.1016/j.transproceed.2013.08.016
   Hussein KH, 2013, INT J ARTIF ORGANS, V36, P781, DOI 10.5301/ijao.5000246
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058
   Jiang WC, 2014, BIOMATERIALS, V35, P3607, DOI 10.1016/j.biomaterials.2014.01.024
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kadota Y, 2014, ORGANOGENESIS, V10, P268, DOI 10.4161/org.27879
   Kajbafzadeh AM, 2013, TISSUE ENG PART C-ME, V19, P642, DOI [10.1089/ten.tec.2012.0334, 10.1089/ten.TEC.2012.0334]
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469
   Lees JG, 2007, REGEN MED, V2, P289, DOI 10.2217/17460751.2.3.289
   Lehr EJ, 2011, J THORAC CARDIOV SUR, V141, P1056, DOI 10.1016/j.jtcvs.2010.02.060
   Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Manfredi AA, 2009, CRIT REV IMMUNOL, V29, P69, DOI 10.1615/CritRevImmunol.v29.i1.30
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Mattei G, 2014, ACTA BIOMATER, V10, P875, DOI 10.1016/j.actbio.2013.10.023
   Mirmalek-Sani SH, 2013, AM J PATHOL, V183, P558, DOI 10.1016/j.ajpath.2013.05.002
   Misra S, 2008, HERNIA, V12, P247, DOI 10.1007/s10029-007-0319-z
   Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Ozasa Y, 2013, J HAND SURG-AM, V38A, P1698, DOI 10.1016/j.jhsa.2013.05.023
   Patel N, 2008, PROTEOMICS, V8, P1055, DOI 10.1002/pmic.200700856
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Pulver Shevtsov A, 2014, CRYOLETT, V35, P400
   Qiu QQ, 2009, J BIOMED MATER RES B, V91B, P572, DOI 10.1002/jbm.b.31431
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Remlinger NT, 2010, BIOMATERIALS, V31, P3520, DOI 10.1016/j.biomaterials.2010.01.067
   ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546
   Soicher MA, 2014, J BIOMED MATER RES A, V102, P4480, DOI 10.1002/jbm.a.35118
   Soto-Gutierrez A, 2012, J CLIN INVEST, V122, P3817, DOI 10.1172/JCI61974
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Struecker B, 2015, TISSUE ENG PART C-ME, V21, P303, DOI [10.1089/ten.tec.2014.0321, 10.1089/ten.TEC.2014.0321]
   Sun WQ, 2008, ACTA BIOMATER, V4, P817, DOI 10.1016/j.actbio.2008.02.006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tsuchiya T, 2014, TISSUE ENG PART C-ME, V20, P1028, DOI [10.1089/ten.tec.2013.0492, 10.1089/ten.TEC.2013.0492]
   Uygun BE, 2012, NAT REV GASTRO HEPAT, V9, P738, DOI 10.1038/nrgastro.2012.140
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Uygun BE, 2011, JOVE-J VIS EXP, P48
   Vogel G, 2007, SCIENCE, V318, P1224, DOI 10.1126/science.318.5854.1224
   Wagner DE, 2014, BIOMATERIALS, V35, P3281, DOI 10.1016/j.biomaterials.2013.12.103
   Wagner DE, 2014, BIOMATERIALS, V35, P2664, DOI 10.1016/j.biomaterials.2013.11.078
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764
   Xu D, 2010, CELL MOL BIOL LETT, V15, P451, DOI 10.2478/s11658-010-0018-0
   Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939
   Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 91
TC 1
Z9 1
U1 3
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1747-4124
EI 1747-4132
J9 EXPERT REV GASTROENT
JI Expert Rev. Gastroenterol. Hepatol.
PD SEP
PY 2015
VL 9
IS 9
BP 1183
EP 1191
DI 10.1586/17474124.2015.1058155
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CQ0GN
UT WOS:000360273500006
PM 26220044
DA 2018-10-20
ER

PT J
AU Falcigno, L
   D'Auria, G
   Calvanese, L
   Marasco, D
   Iacobelli, R
   Scognamiglio, PL
   Brun, P
   Danesin, R
   Pasqualin, M
   Castagliuolo, I
   Dettin, M
AF Falcigno, Lucia
   D'Auria, Gabriella
   Calvanese, Luisa
   Marasco, Daniela
   Iacobelli, Roberta
   Scognamiglio, Pasqualina L.
   Brun, Paola
   Danesin, Roberta
   Pasqualin, Matteo
   Castagliuolo, Ignazio
   Dettin, Monica
TI Osteogenic properties of a short BMP-2 chimera peptide
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE peptides; binding; docking; ActRIIB receptor
ID BONE MORPHOGENETIC PROTEINS; MARROW STROMAL CELLS; MOLECULAR-DYNAMICS;
   REGENERATION; RECEPTOR; REPAIR; TRIFLUOROETHANOL; DIFFERENTIATION;
   ACTIVIN; PROGRAM
AB Bone morphogenetic proteins (BMPs) play a key role in bone and cartilage formation. For these properties, BMPs are employed in the field of tissue engineering to induce bone regeneration in damaged tissues. To overcome drawbacks due to the use of entire proteins, synthetic peptides derived from their parent BMPs have come out as promising molecules for biomaterial design. On the structural ground of the experimental BMP-2 receptor complexes reported in the literature, we designed three peptides, reproducing the BMP-2 region responsible for the binding to the type II receptor, ActRIIB. These peptides were characterized by NMR, and the structural features of the peptide-receptor binding interface were highlighted by docking experiments. Peptide-receptor binding affinities were analyzed by means of ELISA and surface plasmon resonance techniques. Furthermore, cellular assays were performed to assess their osteoinductive properties. A chimera peptide, obtained by combining the sequence portions 73-92 and 30-34 of BMP-2, shows the best affinity for ActRIIB in the series and represents a good starting point for the design of new compounds able to reproduce osteogenic properties of the parent BMP-2. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.
C1 [Falcigno, Lucia; D'Auria, Gabriella; Marasco, Daniela; Iacobelli, Roberta] Univ Naples Federico II, Dipartimento Farm, I-80134 Naples, Italy.
   [Falcigno, Lucia; D'Auria, Gabriella; Marasco, Daniela; Scognamiglio, Pasqualina L.] CNR, IBB, I-80134 Naples, Italy.
   [Calvanese, Luisa] Univ Naples Federico II, CIRPeB, I-80134 Naples, Italy.
   [Brun, Paola; Pasqualin, Matteo; Castagliuolo, Ignazio] Univ Padua, Dept Mol Med, I-35127 Padua, Italy.
   [Danesin, Roberta; Dettin, Monica] Univ Padua, Dept Ind Engn, I-35131 Padua, Italy.
RP Calvanese, L (reprint author), Univ Naples Federico II, Dipartimento Farm, Via Mezzocannone 16, I-80134 Naples, Italy.
EM falcigno@unina.it
RI D'Auria, Gabriella/E-2076-2011; castagliuolo, ignazio/K-9963-2016;
   Falcigno, Lucia/A-6720-2012; Calvanese, Luisa/S-8141-2018
OI D'Auria, Gabriella/0000-0002-1340-8545; castagliuolo,
   ignazio/0000-0001-9888-7030; Pasqualin, Matteo/0000-0002-9514-0115;
   daniela, Marasco/0000-0002-6618-2949
CR Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103
   Bagno A, 2007, BONE, V41, P704, DOI 10.1016/j.bone.2007.06.008
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X
   Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371
   DELMAS PD, 1993, J BONE MINER RES, V8, pS549
   desVries S. J., 2010, NAT PROTOC, V5, P883
   Fioroni M, 2002, J AM CHEM SOC, V124, P7737, DOI 10.1021/ja0259335
   Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Guntert Peter, 2004, Methods Mol Biol, V278, P353
   Ionescu RM, 1999, NAT STRUCT BIOL, V6, P304
   Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee YM, 2003, J PERIODONTOL, V74, P865, DOI 10.1902/jop.2003.74.6.865
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Senta H, 2011, CAN J CHEM ENG, V89, P227, DOI 10.1002/cjce.20453
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yamada Y, 2012, J PHYS CHEM A, V116, P2845, DOI 10.1021/jp300721r
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 37
TC 7
Z9 7
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD SEP
PY 2015
VL 21
IS 9
BP 700
EP 709
DI 10.1002/psc.2793
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA CP9KZ
UT WOS:000360214300003
PM 26292841
DA 2018-10-20
ER

PT J
AU Hirahara, AM
   Mueller, KW
AF Hirahara, Alan M.
   Mueller, Kenneth W.
TI BioCartilage: A New Biomaterial to Treat Chondral Lesions
SO SPORTS MEDICINE AND ARTHROSCOPY REVIEW
LA English
DT Review
DE BioCartilage; cartilage; chondral lesion; microfracture; PRP; arthritis;
   allograft
ID ARTICULAR-CARTILAGE REPAIR; MICROFRACTURE TECHNIQUE; KNEE; DEFECTS;
   TRANSPLANTATION; JOINT; IMPLANTATION; CHONDROCYTES; OUTCOMES; MATRIX
AB Articular cartilage damage affects almost everyone at some point. Our ability to heal these defects has been very limited. Microfracture, which is one of the most common attempted surgeries for chondral lesions, has resulted in poor long-term outcomes. Other solutions like allograft osteochondral autograft transfer system, DeNovo, or autologous chondrocyte implantation are more extensive, difficult, expensive surgeries, and are better served for larger lesions. Smaller lesions have shown good short-term outcomes with microfracture but result in creation of fibrocartilage, which is weaker and softer and does not hold up long term. A simple, inexpensive, longer-term solution is needed. BioCartilage is dehydrated, micronized allogeneic cartilage that can be implanted with platelet-rich plasma into these smaller cartilage defects. BioCartilage acts as scaffold, allowing for the creation of hyaline-like cartilage.
C1 [Mueller, Kenneth W.] Calif State Univ Sacramento, Dept Athlet, Sacramento, CA 95819 USA.
RP Hirahara, AM (reprint author), 2801 K St,330, Sacramento, CA 95816 USA.
FU Arthrex Inc.
FX A.M.H. receives support from Arthrex Inc. as a consultant and royalties.
   K.W.M. declares no conflict of interest.
CR Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   Apprich S, 2012, OSTEOARTHR CARTILAGE, V20, P703, DOI 10.1016/j.joca.2012.03.008
   Basevicius A, 2012, AM J SPORTS MED, V40, P2499
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Clanton TO, 2014, TECH FOOT ANKLE SURG, V13, P212, DOI 10.1097/BTF.0000000000000054
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Desai S, 2014, TECH FOOT ANKLE SURG, V13, P167, DOI 10.1097/BTF.0000000000000056
   Desnoyers J, 2013, J BONE JOINT SURG AM, V95, P1640
   Falah M, 2010, INT ORTHOP, V34, P621, DOI 10.1007/s00264-010-0959-y
   Farr J, 2014, AM J SPORT MED, V42, P1417, DOI 10.1177/0363546514528671
   Frappier Julie, 2014, J Med Econ, V17, P266, DOI 10.3111/13696998.2014.897626
   Frenkel S, 1999, FRONT BIOSCI, V4, P671, DOI DOI 10.2741/FRENKEL
   FRIEDMAN MJ, 1984, CLIN ORTHOP RELAT R, P200
   Gross CE, 2012, ARTHROSCOPY, V28, P1889, DOI 10.1016/j.arthro.2012.03.026
   Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018
   Hatic Safet O 2nd, 2010, Foot Ankle Spec, V3, P361, DOI 10.1177/1938640010388602
   Hayden M, 2010, INT ORTHOP, V34, P621
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Krych AJ, 2012, AM J SPORT MED, V40, P1053, DOI 10.1177/0363546511435780
   Malinin T, 2013, MUSCULOSKELETAL TISS
   McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001
   Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013
   Mithoefer K, 2006, AM J SPORT MED, V34, P1413, DOI 10.1177/0363546506288240
   Namdari S, 2009, AM J SPORT MED, V37, P943, DOI 10.1177/0363546508330150
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Riyami M, 2009, J ORTHOP SURG RES, V4, P1
   Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054
   Sohn DH, 2002, CLIN ORTHOP RELAT R, P254
   Steadman J Richard, 2003, J Knee Surg, V16, P83
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Takahashi T, 2006, SKELETAL RADIOL, V35, P16, DOI 10.1007/s00256-005-0002-3
   Xing LZ, 2013, KNEE SURG SPORT TR A, V21, P1770, DOI 10.1007/s00167-012-2031-5
NR 32
TC 9
Z9 10
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1062-8592
EI 1538-1951
J9 SPORTS MED ARTHROSC
JI Sports Med. Arthrosc. Rev.
PD SEP
PY 2015
VL 23
IS 3
BP 143
EP 148
DI 10.1097/JSA.0000000000000071
PG 6
WC Sport Sciences
SC Sport Sciences
GA CQ0OO
UT WOS:000360296200007
PM 26225574
DA 2018-10-20
ER

PT J
AU Keeler, GD
   Durdik, JM
   Stenken, JA
AF Keeler, Geoffrey D.
   Durdik, Jeannine M.
   Stenken, Julie A.
TI Effects of delayed delivery of dexamethasone-21-phosphate via
   subcutaneous microdialysis implants on macrophage activation in rats
SO ACTA BIOMATERIALIA
LA English
DT Article
DE CD68; CD163; Dexamethasone; Macrophage activation; Microdialysis
ID FOREIGN-BODY RESPONSE; NF-KAPPA-B; GLUCOCORTICOID-RECEPTOR; LOCALIZED
   DELIVERY; SIGNALING PATHWAYS; GENE-EXPRESSION; MESSENGER-RNA;
   POLARIZATION; MECHANISMS; INDUCTION
AB Macrophage activation is of interest in the biomaterials field since macrophages with an M(Dex) characteristic phenotype, i.e., CD68(+)CD163(+), are believed to result in improved integration of the biomaterial as well as improved tissue remodeling and increased biomaterial longevity. To facilitate delivery of a macrophage modulator, dexamethasone-21-phosphate (Dex), microdialysis probes were subcutaneously implanted in male Sprague-Dawley rats. Dex localized delivery was delayed to the third day post implantation as a means to alter macrophage activation state at an implant site. To better elucidate the molecular mechanisms associated with M(Dex) macrophage activation, CCL2 was quantified in dialysates, gene expression ratios were determined from excised tissue surrounding the implant, histological analyses, and immunohistochemical analyses (CD68, CD163) were performed. Delayed Dex infusion resulted in the up-regulation of IL-6 at the transcript level in the tissue in contact with the microdialysis probe and decreased CCL2 concentrations collected in dialysates. Histological analyses showed increased cellular density as compared to controls in response to delayed Dex infusion. Dex delayed infusion resulted in an increased percentage of CD68(+)CD163(+), M(Dex), macrophages in the tissue surrounding the microdialysis probe as compared to probes that served as controls. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Keeler, Geoffrey D.; Durdik, Jeannine M.; Stenken, Julie A.] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA.
   [Keeler, Geoffrey D.; Stenken, Julie A.] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
   [Durdik, Jeannine M.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.
RP Stenken, JA (reprint author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
EM jstenken@uark.edu
FU NIH [EB 014404]
FX Support for this work was provided by NIH EB 014404.
CR Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ARZT E, 1994, ENDOCRINOLOGY, V134, P672, DOI 10.1210/en.134.2.672
   Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200
   AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286
   AYANLARBATUMAN O, 1991, J CLIN INVEST, V88, P1574, DOI 10.1172/JCI115469
   Ayroldi E, 2012, FASEB J, V26, P4805, DOI 10.1096/fj.12-216382
   BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L
   Biswas S. K., 2014, MACROPHAGES BIOL ROL
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   DERENDORF H, 1986, J PHARMACEUT BIOMED, V4, P197, DOI 10.1016/0731-7085(86)80042-5
   Dhawan L, 2007, J BIOL CHEM, V282, P10146, DOI 10.1074/jbc.M605925200
   DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054
   DiPietro L.A., 1995, SHOCK, V4
   Earp JC, 2008, J PHARMACOL EXP THER, V326, P546, DOI 10.1124/jpet.108.137414
   FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638
   Graversen JH, 2012, MOL THER, V20, P1550, DOI 10.1038/mt.2012.103
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Hakim M., 2005, CLIN ORTHOP RELAT RE, V439
   Hoeppner MA, 1995, GENE EXPRESSION, V5, P133
   Hori Y, 1996, BRIT J PHARMACOL, V118, P1584, DOI 10.1111/j.1476-5381.1996.tb15578.x
   Joyce DA, 1996, J INTERF CYTOK RES, V16, P511, DOI 10.1089/jir.1996.16.511
   Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014
   Keeler GD, 2015, ACTA BIOMATER, V12, P11, DOI 10.1016/j.actbio.2014.10.022
   Keeler GD, 2014, EUR J PHARM SCI, V57, P60, DOI 10.1016/j.ejps.2013.11.005
   Klueh Ulrike, 2007, J Diabetes Sci Technol, V1, P496
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Mizuno H, 1997, BRAIN RES, V746, P256, DOI 10.1016/S0006-8993(96)01259-0
   Moore LB, 2015, ACTA BIOMATER, V11, P37, DOI 10.1016/j.actbio.2014.09.022
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mou X, 2010, BIOMATERIALS, V31, P4530, DOI 10.1016/j.biomaterials.2010.02.016
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   Palmer JA, 2014, CELLS TISSUES ORGANS, V199, P169, DOI 10.1159/000363693
   RE F, 1994, J EXP MED, V179, P739, DOI 10.1084/jem.179.2.739
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rubert M, 2014, RSC ADV, V4, P51537, DOI 10.1039/c4ra08358j
   Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101
   SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Sides CR, 2014, EUR J PHARM SCI, V57, P74, DOI 10.1016/j.ejps.2013.11.002
   Slivka PF, 2014, BIOMATER SCI-UK, V2, P1521, DOI 10.1039/c4bm00189c
   Spiller KL, 2015, ANN BIOMED ENG, V43, P616, DOI 10.1007/s10439-014-1156-8
   Trickler W, 2003, J PHARM SCI, V92, P1419, DOI 10.1002/jps.10410
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   Vallejo-Heligon SG, 2014, ACTA BIOMATER, V10, P4629, DOI 10.1016/j.actbio.2014.07.019
   Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Westerink B. H. C, 2007, HDB MICRODIALYSIS SA
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wood S., 2014, PLOS ONE, V8
   Yubero S, 2009, BBA-MOL BASIS DIS, V1792, P1205, DOI 10.1016/j.bbadis.2009.10.001
   Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662
NR 71
TC 2
Z9 2
U1 9
U2 445
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP 1
PY 2015
VL 23
BP 27
EP 37
DI 10.1016/j.actbio.2015.05.011
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP5ZL
UT WOS:000359964000004
PM 25985913
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jung, O
   Smeets, R
   Porchetta, D
   Kopp, A
   Ptock, C
   Muller, U
   Heiland, M
   Schwade, M
   Behr, B
   Kroger, N
   Kluwe, L
   Hanken, H
   Hartjen, P
AF Jung, Ole
   Smeets, Ralf
   Porchetta, Dario
   Kopp, Alexander
   Ptock, Christoph
   Mueller, Ute
   Heiland, Max
   Schwade, Max
   Behr, Bjoern
   Kroeger, Nadja
   Kluwe, Lan
   Hanken, Henning
   Hartjen, Philip
TI Optimized in vitro procedure for assessing the cytocompatibility of
   magnesium-based biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium; Cytocompatibility; In vitro cytotoxicity; In vitro
   biocompatibility; Plasma electrolytic oxidation (PEO)
ID ANTIBACTERIAL PROPERTIES; ORTHOPEDIC BIOMATERIALS; BONE SUBSTITUTE; VIVO
   CORROSION; ALLOYS; DEGRADATION; MG; PERFORMANCE; IMPLANTS; ASSAYS
AB Magnesium (Mg) is a promising biomaterial for degradable implant applications that has been extensively studied in vitro and in vivo in recent years. In this study, we developed a procedure that allows an optimized and uniform in vitro assessment of the cytocompatibility of Mg-based materials while respecting the standard protocol DIN EN ISO 10993-5:2009. The mouse fibroblast line L-929 was chosen as the preferred assay cell line and MEM supplemented with 10% FCS, penicillin/streptomycin and 4 mM L.-glutamine as the favored assay medium. The procedure consists of (1) an indirect assessment of effects of soluble Mg corrosion products in material extracts and (2) a direct assessment of the surface compatibility in terms of cell attachment and cytotoxicity originating from active corrosion processes. The indirect assessment allows the quantification of cell-proliferation (BrdU-assay), viability (XTT-assay) as well as cytotoxicity (LDH-assay) of the mouse fibroblasts incubated with material extracts. Direct assessment visualizes cells attached to the test materials by means of live-dead staining. The colorimetric assays and the visual evaluation complement each other and the combination of both provides an optimized and simple procedure for assessing the cytocompatibility of Mg-based biomaterials in vitro. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jung, Ole; Smeets, Ralf; Heiland, Max; Kroeger, Nadja; Kluwe, Lan; Hanken, Henning; Hartjen, Philip] Univ Med Ctr Hamburg Eppendorf, Dept Ora & Maxillofacial Surg, Hamburg, Germany.
   [Porchetta, Dario; Kopp, Alexander; Ptock, Christoph] Meotec GmbH & Co KG, Aachen, Germany.
   [Porchetta, Dario] Aachen Univ Appl Sci, Biomat Lab, Aachen, Germany.
   [Mueller, Ute] BMP, Lab Med Mat Testing, Aachen, Germany.
   [Schwade, Max] Rhein Westfal TH Aachen, Lab Machine Tools & Prod Engn WZL, Aachen, Germany.
   [Behr, Bjoern] Ruhr Univ Bochum, Dept Plast & Hand Surg, Burn Ctr, BG Univ Hosp Bergmannsheil, Bochum, Germany.
RP Jung, O (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Ora & Maxillofacial Surg, Hamburg, Germany.
EM ol.jung@uke.de
OI Heiland, Max/0000-0002-4987-2913
FU Bundesministerium fur Bildung und Forschung, BMBF [FKZ 0316206A-C]
FX This study was funded by the Bundesministerium fur Bildung und
   Forschung, BMBF (FKZ 0316206A-C, BIOMAGIK). This work is the result of
   the collaboration within the BIOMAGIK consortium. We would like to thank
   Franziska Flugge for excellent technical assistance.
CR Ascencio M, 2014, CORROS SCI, V87, P489, DOI 10.1016/j.corsci.2014.07.015
   Chen YG, 2014, J MATER SCI-MATER M, V25, P471, DOI 10.1007/s10856-013-5090-3
   Cipriano AF, 2015, ACTA BIOMATER, V12, P298, DOI 10.1016/j.actbio.2014.10.018
   Farraro KE, 2014, J BIOMECH, V47, P1979, DOI 10.1016/j.jbiomech.2013.12.003
   Fielding G.A., 2013, J BIOMED MAT RES A
   Fischer J, 2011, J CRANIO MAXILL SURG, V39, P54, DOI 10.1016/j.jcms.2010.03.016
   Fischer J, 2011, MATER SCI ENG B-ADV, V176, P1773, DOI 10.1016/j.mseb.2011.06.002
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Fischerauer SF, 2013, ACTA BIOMATER, V9, P5411, DOI 10.1016/j.actbio.2012.09.017
   Guo K.W., 2010, RECENT PAT CORROS SC, V2, P13, DOI DOI 10.2174/1877610801002010013
   Hong D, 2013, ACTA BIOMATER, V9, P8534, DOI 10.1016/j.actbio.2013.07.001
   Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Lock JY, 2014, J BIOMED MATER RES A, V102, P781, DOI 10.1002/jbm.a.34741
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Ng WF, 2010, MAT SCI ENG C-MATER, V30, P898, DOI 10.1016/j.msec.2010.04.003
   Park JW, 2012, J BIOMED MATER RES A, V100A, P834, DOI 10.1002/jbm.a.34017
   Payne KFB, 2014, BRIT J ORAL MAX SURG, V52, P7, DOI 10.1016/j.bjoms.2013.03.005
   Persaud-Sharma Dharam, 2012, J Biomim Biomater Tissue Eng, V12, P25, DOI 10.4028/www.scientific.net/JBBTE.12.25
   Robinson DA, 2010, ACTA BIOMATER, V6, P1869, DOI 10.1016/j.actbio.2009.10.007
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tie D, 2013, EUR CELLS MATER, V25, P284, DOI 10.22203/eCM.v025a20
   Walker J, 2012, J BIOMED MATER RES B, V100B, P1134, DOI 10.1002/jbm.b.32680
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Wang YB, 2011, ACTA BIOMATER, V7, P3196, DOI 10.1016/j.actbio.2011.04.027
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xin YC, 2011, CORROS SCI, V53, P1522, DOI 10.1016/j.corsci.2011.01.015
NR 30
TC 18
Z9 18
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP 1
PY 2015
VL 23
BP 354
EP 363
DI 10.1016/j.actbio.2015.06.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP5ZL
UT WOS:000359964000033
PM 26073090
DA 2018-10-20
ER

PT J
AU Herrick, WG
   Rattan, S
   Nguyen, TV
   Grunwald, MS
   Barney, CW
   Crosby, AJ
   Peyton, SR
AF Herrick, William G.
   Rattan, Shruti
   Nguyen, Thuy V.
   Grunwald, Michael S.
   Barney, Christopher W.
   Crosby, Alfred J.
   Peyton, Shelly R.
TI Smooth Muscle Stiffness Sensitivity is Driven by Soluble and Insoluble
   ECM Chemistry
SO CELLULAR AND MOLECULAR BIOENGINEERING
LA English
DT Article
DE Extracellular matrix; Mechanobiology; Poly(ethylene glycol); Hydrogel;
   Atherosclerosis
ID EXTRACELLULAR-MATRIX PROTEINS; ACTIN ISOFORM EXPRESSION;
   FIBROBLAST-GROWTH-FACTOR; CELL-PROLIFERATION; ALPHA-ACTIN; FACTOR-BB;
   MIGRATION; INTEGRIN; HYDROGELS; HEPARIN
AB Smooth muscle cell (SMC) invasion into plaques and subsequent proliferation is a major factor in the progression of atherosclerosis. During disease progression, SMCs experience major changes in their microenvironment, such as what integrin-binding sites are exposed, the portfolio of soluble factors available, and the elasticity and modulus of the surrounding vessel wall. We have developed a hydrogel biomaterial platform to examine the combined effect of these changes on SMC phenotype. We were particularly interested in how the chemical microenvironment affected the ability of SMCs to sense and respond to modulus. To our surprise, we observed that integrin binding and soluble factors are major drivers of several critical SMC behaviors, such as motility, proliferation, invasion, and differentiation marker expression, and these factors modulated the effect of stiffness on proliferation and migration. Overall, modulus only modestly affected behaviors other than proliferation, relative to integrin binding and soluble factors. Surprisingly, pathological behaviors (proliferation, motility) are not inversely related to SMC marker expression, in direct conflict with previous studies on substrates coupled with single extracellular matrix (ECM) proteins. A high-throughput bead-based ELISA approach and inhibitor studies revealed that differentiation marker expression is mediated chiefly via focal adhesion kinase (FAK) signaling, and we propose that integrin binding and FAK drive the transition from a migratory to a proliferative phenotype. We emphasize the importance of increasing the complexity of in vitro testing platforms to capture these subtleties in cell phenotypes and signaling, in order to better recapitulate important features of in vivo disease and elucidate potential context-dependent therapeutic targets.
C1 [Herrick, William G.; Nguyen, Thuy V.; Grunwald, Michael S.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
   [Rattan, Shruti; Crosby, Alfred J.] Univ Massachusetts, Polymer Sci & Engn Dept, Conte Polymer Res Ctr, Amherst, MA 01003 USA.
   [Barney, Christopher W.] Purdue Univ, Dept Mat Engn, W Lafayette, IN 47907 USA.
RP Peyton, SR (reprint author), Univ Massachusetts, Dept Chem Engn, 686 N Pleasant St,159 Goessmann Lab, Amherst, MA 01003 USA.
EM speyton@ecs.umass.edu
OI Peyton, Shelly/0000-0002-7364-8727
FU American Heart Association [13GRNT16190013]; National Science
   Foundation; National Cancer Institute [DMR-1234852, DMR-1304724];
   University of Massachusetts Amherst; UMass MRSEC [DMR-0820506];
   Institute of Cellular Engineering IGERT at UMass [DGE-0654128]; Pew
   Charitable Trusts
FX This work was supported by a Grant in Aid from the American Heart
   Association (13GRNT16190013), a Barry and Afsaneh Siadat Career
   Development Award, grants from the National Science Foundation and the
   National Cancer Institute (DMR-1234852 and DMR-1304724), start-up funds
   from the University of Massachusetts Amherst, and the UMass MRSEC on
   Polymers (DMR-0820506). WGH was supported by a fellowship from the
   Institute of Cellular Engineering IGERT at UMass (DGE-0654128). SRP is a
   Pew Biomedical Scholar supported by the Pew Charitable Trusts. We are
   also grateful to Dr. Nele Van Dessel for helpful discussions.
CR Abou Zeid Nancy, 2006, Cell Commun Signal, V4, P8, DOI 10.1186/1478-811X-4-8
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100
   Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375
   BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892
   BLANK RS, 1990, J CELL PHYSIOL, V142, P635, DOI 10.1002/jcp.1041420325
   Bornfeldt KE, 1996, TRENDS CARDIOVAS MED, V6, P143, DOI 10.1016/1050-1738(96)00038-2
   CASTELLOT JJ, 1989, J CELL BIOL, V109, P3147, DOI 10.1083/jcb.109.6.3147
   CORJAY MH, 1989, J BIOL CHEM, V264, P10501
   De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200
   De Donatis A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-20
   DESMOULIERE A, 1991, ARTERIOSCLER THROMB, V11, P244, DOI 10.1161/01.ATV.11.2.244
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Hautmann MB, 1997, J BIOL CHEM, V272, P10948
   Hazeltine Laurie B, 2012, Int J Cell Biol, V2012, P508294, DOI 10.1155/2012/508294
   Herrick WG, 2013, BIOMACROMOLECULES, V14, P2294, DOI 10.1021/bm400418g
   Hollenbeck ST, 2004, BIOCHEM BIOPH RES CO, V325, P328, DOI 10.1016/j.bbrc.2004.10.031
   HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525
   Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614
   JANAT MF, 1992, J CELL PHYSIOL, V151, P588, DOI 10.1002/jcp.1041510319
   Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482
   Li SH, 1999, CIRC RES, V85, P338, DOI 10.1161/01.RES.85.4.338
   LINDNER V, 1992, J CLIN INVEST, V90, P2044, DOI 10.1172/JCI116085
   Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441
   Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011
   Nelson PR, 1996, J VASC SURG, V24, P25, DOI 10.1016/S0741-5214(96)70141-6
   Nguyen TV, 2014, BIOMATERIALS, V35, P5749, DOI 10.1016/j.biomaterials.2014.03.058
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062
   Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963
   Sazonova OV, 2015, MATRIX BIOL, V41, P36, DOI 10.1016/j.matbio.2014.11.001
   Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196
   Shull KR, 1998, MACROMOL CHEM PHYSIC, V199, P489, DOI 10.1002/macp.1998.021990402
   SkaletzRorowski A, 1996, ARTERIOSCL THROM VAS, V16, P1063, DOI 10.1161/01.ATV.16.8.1063
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Stephan S, 2006, J ANAT, V209, P495, DOI 10.1111/j.1469-7580.2006.00633.x
   Ucuzian AA, 2010, J BIOMED MATER RES A, V94A, P988, DOI 10.1002/jbm.a.32786
   van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001
   WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027
   Zheng B, 1998, J BIOL CHEM, V273, P8994, DOI 10.1074/jbc.273.15.8994
NR 49
TC 4
Z9 4
U1 1
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1865-5025
EI 1865-5033
J9 CELL MOL BIOENG
JI Cell. Mol. Bioeng.
PD SEP
PY 2015
VL 8
IS 3
BP 333
EP 348
DI 10.1007/s12195-015-0397-4
PG 16
WC Cell & Tissue Engineering; Biophysics; Cell Biology
SC Cell Biology; Biophysics
GA CP5UU
UT WOS:000359951300004
PM 26495043
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kucukyildirim, BO
AF Kucukyildirim, Bedri Onur
TI The Effect of Aging Under Loading on the Phase Transformation Behavior
   of Near-Equiatomic NiTi Shape Memory Alloy
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE aging; axiomatic design; differential scanning calorimetry (DSC); phase
   transformations; shape memory alloys
ID MARTENSITIC-TRANSFORMATION; COMBUSTION SYNTHESIS; TEMPERATURE; CU;
   PARAMETERS; EVOLUTION; WIRES
AB The phase transformation temperature of nickel titanium (NiTi) shape memory alloy (SMA), which is commonly used in biomaterial fields, is strongly influenced by aging heat treatments. In this study, we apply a new aging heat treatment under loading conditions to near-equiatomic NiTi SMA wires to investigate its effect on phase transformation temperatures. We determine changes in the phase transformation temperatures via differential scanning calorimetry measurements. We analyze transformation temperatures, hysteresis properties, and enthalpy changes and discuss significant results with the help of micrographs. Moreover, we evaluate our results using two-way analysis of variance, axiomatic design methods, and customary analysis in order to make reliable inferences. We observe a significant difference between first and second heating-cooling cycle results for NiTi SMA samples on the basis of austenitic transformation temperatures. Consequently, we are able to theorize correlations between design parameters and functional requirements.
C1 Yildiz Tekn Univ, Dept Mech Engn, TR-34349 Istanbul, Turkey.
RP Kucukyildirim, BO (reprint author), Yildiz Tekn Univ, Dept Mech Engn, TR-34349 Istanbul, Turkey.
EM kucukyil@yildiz.edu.tr
CR Aghamiri SMS, 2011, J MECH BEHAV BIOMED, V4, P298, DOI 10.1016/j.jmbbm.2010.10.008
   Berzins DW, 2010, DENT MATER, V26, P666, DOI 10.1016/j.dental.2010.03.010
   Chastaing K, 2006, MAT SCI ENG A-STRUCT, V438, P661, DOI 10.1016/j.msea.2006.02.114
   Chu CL, 2005, MAT SCI ENG A-STRUCT, V392, P106, DOI 10.1016/j.msea.2004.09.005
   Chu CL, 2005, MATER LETT, V59, P404, DOI 10.1016/j.matlet.2004.08.036
   Bubani FD, 2013, MAT SCI ENG A-STRUCT, V583, P129, DOI 10.1016/j.msea.2013.06.071
   Eker AA, 2013, MATER TEST, V55, P92, DOI 10.3139/120.110411
   Font J, 2003, MAT SCI ENG A-STRUCT, V354, P207, DOI 10.1016/S0921-5093(03)00003-0
   Frenzel J, 2010, ACTA MATER, V58, P3444, DOI 10.1016/j.actamat.2010.02.019
   Jackson BK, 2010, J ELECTROCHEM SOC, V157, pE36, DOI 10.1149/1.3289996
   Jani JM, 2014, MATER DESIGN, V56, P1078, DOI 10.1016/j.matdes.2013.11.084
   Kaya M, 2009, J ALLOY COMPD, V475, P378, DOI 10.1016/j.jallcom.2008.07.023
   Kurita T, 2004, J ALLOY COMPD, V381, P158, DOI 10.1016/j.jallcom.2004.03.108
   Liu YN, 1997, J MATER SCI, V32, P5979, DOI 10.1023/A:1018615127911
   Matsumoto H, 2004, J ALLOY COMPD, V366, P182, DOI 10.1016/S0925-8388(03)00730-8
   Nurveren K, 2008, J MATER PROCESS TECH, V196, P129, DOI 10.1016/j.jmatprotec.2007.05.015
   Pattabi M, 2007, MAT SCI ENG A-STRUCT, V448, P33, DOI 10.1016/j.msea.2006.09.052
   Schmahl WW, 2004, MAT SCI ENG A-STRUCT, V378, P81, DOI 10.1016/j.msea.2003.11.081
   Suh N.P., 2001, AXIOMATIC DESIGN ADV
   Uchil J, 1998, PHYSICA B, V253, P83, DOI 10.1016/S0921-4526(98)00378-0
   Yeung KWK, 2004, MAT SCI ENG A-STRUCT, V383, P213, DOI 10.1061/j.msea.2004.05.063
NR 21
TC 1
Z9 1
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD SEP
PY 2015
VL 24
IS 9
BP 3228
EP 3240
DI 10.1007/s11665-015-1631-x
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP6QW
UT WOS:000360014000003
DA 2018-10-20
ER

PT J
AU Zhang, XP
   Ouyang, JH
   Wang, YJ
   Liu, ZG
   Wang, YM
AF Zhang, Xiu-Ping
   Ouyang, Jia-Hu
   Wang, Yu-Jin
   Liu, Zhan-Guo
   Wang, Ya-Ming
TI Microstructure and High-Temperature Mechanical Properties of
   ZrO2-Al2O3-SiC Ceramics
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE high-temperature flexural strength; microstructure; phase
   transformation; ZrO2-Al2O3-SiC ceramics
ID Y-TZP CERAMICS; MATRIX COMPOSITES; ZIRCONIA CERAMICS; BEHAVIOR;
   NANOCOMPOSITES; TOUGHNESS; STRENGTH; BIOMATERIAL; DEGRADATION;
   RESISTANCE
AB In the present work, ZrO2-Al2O3 ceramics incorporated with and without beta-SiC were prepared by hot pressing. ZrO2-Al2O3 ceramic powder used in this study is a mixture of 71 vol.% YSZ (3 mol.% Y2O3 partially stabilized zirconia) and 29 vol.% alpha-Al2O3. beta-SiC powders with different volume fractions are added into the ZrO2-Al2O3 powder to form the composite powder. The microstructure and high-temperature mechanical properties of ZrO2-Al2O3-SiC ceramics were investigated by tailoring the compositions and sintering parameters to optimize the strengthening mechanisms. For a comparative study, the TZ3Y20A powder was also hot-pressed under identical sintering condition to form dense bulk ceramic. ZrO2-Al2O3-SiC ceramics consist mainly of t-ZrO2, alpha-Al2O3, and beta-SiC phases. SiC particles in the ZrO2-Al2O3 ceramic restrain the grain growth of the oxide matrix. The incorporation of SiC into ZrO2-Al2O3 ceramic enhances high-temperature flexural strength at 1273 K. ZrO2-Al2O3 ceramic incorporated with 15 vol.% SiC has a flexural strength of 518 MPa at 1273 K, much higher than that (201 MPa) of unmodified ZrO2-Al2O3 ceramic.
C1 [Zhang, Xiu-Ping; Ouyang, Jia-Hu; Wang, Yu-Jin; Liu, Zhan-Guo; Wang, Ya-Ming] Harbin Inst Technol, Inst Adv Ceram, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Ouyang, JH (reprint author), Harbin Inst Technol, Inst Adv Ceram, Sch Mat Sci & Engn, 92 West Da Zhi St, Harbin 150001, Peoples R China.
EM ouyangjh@hit.edu.cn
RI Wang, Yaming/D-3200-2013; Ouyang, Jia-Hu/E-4876-2011
OI Wang, Yaming/0000-0002-8208-8696; Ouyang, Jia-Hu/0000-0003-1764-5676;
   Liu, Zhan-Guo/0000-0002-1437-5757
FU National Natural Science Foundation of China (NSFC) [51321061, 51021002,
   A2320132008]; Fundamental Research Funds for Central Universities
   [HIT.BRET 1.2010006]
FX This work was financially supported by the National Natural Science
   Foundation of China (NSFC, Grant Nos. 51321061, 51021002 and
   A2320132008), and the Fundamental Research Funds for the Central
   Universities ( Grant No. HIT.BRET 1.2010006). In addition, we would like
   to thank Prof. Richard M. Laine, The University of Michigan, for his
   careful language corrections.
CR Ando K, 2002, J EUR CERAM SOC, V22, P1313, DOI 10.1016/S0955-2219(01)00431-9
   Bamba N, 1998, J EUR CERAM SOC, V18, P693, DOI 10.1016/S0955-2219(97)00192-1
   Basu B, 2005, INT MATER REV, V50, P239, DOI 10.1179/174328005X41113
   Basu B, 2002, KEY ENG MAT, V206-2, P1185, DOI 10.4028/www.scientific.net/KEM.206-213.1185
   BECHER PF, 1988, J AM CERAM SOC, V71, P1050, DOI 10.1111/j.1151-2916.1988.tb05791.x
   Bhargava S, 2012, BIO-MED MATER ENG, V22, P383, DOI 10.3233/BME-2012-0727
   Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Fukushima KA, 2014, DENT MATER, V30, P105, DOI 10.1016/j.dental.2013.10.005
   Jansen SR, 1998, J EUR CERAM SOC, V18, P557, DOI 10.1016/S0955-2219(97)00153-2
   Jin XH, 2002, J MATER RES, V17, P1024, DOI 10.1557/JMR.2002.0151
   Kaya C, 1998, MAT SCI ENG A-STRUCT, V247, P75, DOI 10.1016/S0921-5093(97)00842-3
   Kern F, 2014, J EUR CERAM SOC, V34, P413, DOI 10.1016/j.jeurceramsoc.2013.08.037
   Kondo H, 2003, J AM CERAM SOC, V86, P523, DOI 10.1111/j.1151-2916.2003.tb03334.x
   Kovalcikova A, 2009, J EUR CERAM SOC, V29, P2387, DOI 10.1016/j.jeurceramsoc.2009.01.021
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEE HL, 1994, J MATER SCI LETT, V13, P974, DOI 10.1007/BF00701442
   Liu HF, 2014, CORROS SCI, V85, P87, DOI 10.1016/j.corsci.2014.04.001
   Magnani G, 2009, J EUR CERAM SOC, V29, P2411, DOI 10.1016/j.jeurceramsoc.2008.12.020
   Monaco C, 2013, J DENT, V41, P121, DOI 10.1016/j.jdent.2012.06.009
   Nam KW, 2010, MAT SCI ENG A-STRUCT, V527, P5400, DOI 10.1016/j.msea.2010.05.055
   NIIHARA K, 1983, J MATER SCI LETT, V2, P221, DOI 10.1007/BF00725625
   Nozawa T, 2014, FUSION ENG DES, V89, P1723, DOI 10.1016/j.fusengdes.2013.12.032
   Ohji T, 1998, J AM CERAM SOC, V81, P1453
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SELCUK A, 1995, J EUR CERAM SOC, V15, P33, DOI 10.1016/0955-2219(95)91297-2
   Stella J, 2013, WEAR, V300, P163, DOI 10.1016/j.wear.2013.01.104
   Taheri M, 2014, CERAM INT, V40, P3347, DOI 10.1016/j.ceramint.2013.09.098
   Wu ZK, 2013, CERAM INT, V39, P7199, DOI 10.1016/j.ceramint.2013.02.065
   Yang WS, 2013, MAT SCI ENG A-STRUCT, V588, P103, DOI 10.1016/j.msea.2013.09.014
NR 30
TC 4
Z9 5
U1 1
U2 37
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD SEP
PY 2015
VL 24
IS 9
BP 3615
EP 3621
DI 10.1007/s11665-015-1650-7
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP6QW
UT WOS:000360014000043
DA 2018-10-20
ER

PT J
AU Bai, Y
   Wang, PQ
   Bai, W
   Zhang, LF
   Li, Q
   Xiong, CD
AF Bai, Yang
   Wang, Pingquan
   Bai, Wei
   Zhang, Lifang
   Li, Qing
   Xiong, Chengdong
TI Miscibility, Thermal and Mechanical Properties of
   Poly(para-dioxanone)/Poly(lactic-co-glycolic acid) Blends
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE Biomaterials; Miscibility; Blends; Thermal properties
ID VITRO HYDROLYTIC DEGRADATION; MOLECULAR-WEIGHT;
   POLY(PARA-DIOXANONE)/POLY(D,L-LACTIDE) BLENDS; CRYSTALLIZATION;
   MORPHOLOGY; COPOLYMERS; POLY(LACTIDE-CO-GLYCOLIDE); POLY(P-DIOXANONE);
   BIOMATERIAL; TEMPERATURE
AB A series of biodegradable polymers was prepared by solution co-precipitation of poly(para-dioxanone) (PPDO) and poly(lactic-co-glycolic acid) (PLGA) in various blend ratios. Samples were compression-molded into bars using a platen vulcanizing press. The miscibility, thermal and mechanical properties of the materials were investigated using differential scanning calorimetry (DSC), polarized optical microscopy, and scanning electron microscopy (SEM). Dynamic contact angle was used to characterize the water wettability of PLGA/PPDO blends. The mechanical properties of blends and pure polymers were measured by tensile tests. The position of the glass transition temperatures (T (g) ) was dependent upon composition. When 10 % PLGA was added into PPDO, the DSC curve revealed only one T (g) (-7.35 A degrees C) which was located between the T (g) values of PPDO and PLGA. When 20 % PLGA was added into the blend, two independent T (g) values for PPDO/PLGA blends were observed, and such characteristics improved further upon addition of 30 % PLGA. SEM images of fractured surfaces displayed evidence of the morphology of PPDO/PLGA blends that were consistent with the DSC results. Hence, a relationship was found between homogeneity and the contents of PLGA in the blend. The compatibility of the blends increased with addition of small amounts of PLGA, followed by a leveling-off at higher content.
C1 [Bai, Yang; Wang, Pingquan; Bai, Wei] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu 610500, Peoples R China.
   [Bai, Wei; Zhang, Lifang; Li, Qing; Xiong, Chengdong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
RP Bai, W (reprint author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu 610500, Peoples R China.
EM baiwei@cioc.ac.cn
FU National Natural Science Foundation of China [51103156]; West Light
   Foundation of The Chinese Academy of Sciences
FX This work was supported by the National Natural Science Foundation of
   China (51103156), and the West Light Foundation of The Chinese Academy
   of Sciences.
CR Alexis F, 2005, POLYM INT, V54, P36, DOI 10.1002/pi.1697
   Aouak T, 2012, J APPL POLYM SCI, V125, P2262, DOI 10.1002/app.36470
   Bai W, 2010, MATER CHEM PHYS, V122, P79, DOI 10.1016/j.matchemphys.2010.02.064
   Bai W, 2009, PROG CHEM, V21, P2696
   Bai W, 2009, J POLYM RES, V16, P471, DOI 10.1007/s10965-008-9250-y
   Bai W, 2009, POLYM INT, V58, P183, DOI 10.1002/pi.2512
   Bai W, 2009, J BIOMED MATER RES B, V90B, P945, DOI 10.1002/jbm.b.31367
   Bai Y, 2013, J POLYM ENVIRON, V21, P1013
   Bai Y, 2012, POLYM COMPOSITE, V33, P1700, DOI 10.1002/pc.22303
   Bernal A, 2013, J APPL POLYM SCI, V127, P3560, DOI 10.1002/app.37723
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Chen SC, 2007, J BIOMED MATER RES A, V80A, P453, DOI 10.1002/jbm.a.30938
   Diban N, 2013, ACTA BIOMATER, V9, P6450, DOI 10.1016/j.actbio.2013.01.005
   Eisenbrey JR, 2008, POLYM ENG SCI, V48, P1785, DOI 10.1002/pen.21146
   Giller CB, 2013, MACROMOLECULES, V46, P2818, DOI 10.1021/ma302523c
   Han YR, 2012, POLYM ENG SCI, V52, P741, DOI 10.1002/pen.22137
   Ishikiriyama K, 1998, J MACROMOL SCI PHY B, VB3, P727
   Li G., 2010, E-POLYMERS, V51, P1
   Li QH, 2013, COLLOID POLYM SCI, V291, P2007, DOI 10.1007/s00396-013-2929-6
   Luckachan GE, 2011, J POLYM ENVIRON, V19, P637, DOI 10.1007/s10924-011-0317-1
   Meng ZX, 2011, MATER CHEM PHYS, V125, P606, DOI 10.1016/j.matchemphys.2010.10.010
   Muller AJ, 2005, ADV POLYM SCI, V190, P1, DOI 10.1007/12_001
   Pan PJ, 2013, MACROMOL MATER ENG, V298, P201, DOI 10.1002/mame.201200006
   Papageorgiou GZ, 2013, IND ENG CHEM RES, V52, P11948, DOI 10.1021/ie4011657
   Pezzin APT, 2003, J APPL POLYM SCI, V88, P2744, DOI 10.1002/app.11984
   Qiu JS, 2013, MACROMOLECULES, V46, P5806, DOI 10.1021/ma401084y
   Sabino MA, 2007, POLYM DEGRAD STABIL, V92, P986, DOI 10.1016/j.polymdegradstab.2007.03.010
   Samuel C, 2013, POLYMER, V54, P3931, DOI 10.1016/j.polymer.2013.05.021
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Terao K, 2012, MAT SCI ENG C-MATER, V32, P988, DOI 10.1016/j.msec.2012.02.026
   Tsuji H, 1996, POLYMER, V37, P595, DOI 10.1016/0032-3861(96)83146-6
   Tsuji H, 2011, POLYM J, V43, P317, DOI 10.1038/pj.2010.133
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Wang WJ, 2010, CARBOHYD POLYM, V79, P437, DOI 10.1016/j.carbpol.2009.08.031
   Yang KK, 2002, J MACROMOL SCI-POL R, VC42, P373, DOI 10.1081/MC-120006453
   Zhang LL, 1996, POLYMER, V37, P235, DOI 10.1016/0032-3861(96)81093-7
   Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017
   Zhao L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.3969/J.ISSN.1674-1749.2013.01.001
   Zhou SB, 2004, J APPL POLYM SCI, V91, P1848, DOI 10.1002/app.13385
NR 39
TC 1
Z9 2
U1 6
U2 40
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
EI 1572-8900
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD SEP
PY 2015
VL 23
IS 3
BP 367
EP 373
DI 10.1007/s10924-014-0686-3
PG 7
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA CP6MU
UT WOS:000360002300010
DA 2018-10-20
ER

PT J
AU Nam, IH
   Chon, CM
   Jung, KY
   Choi, SG
   Choi, H
   Park, SS
AF Nam, In-Hyun
   Chon, Chul-Min
   Jung, Ka-Young
   Choi, Sun-Gyu
   Choi, Hyeoksun
   Park, Sung-Sik
TI Calcite precipitation by ureolytic plant (Canavalia ensiformis) extracts
   as effective biomaterials
SO KSCE JOURNAL OF CIVIL ENGINEERING
LA English
DT Article
DE biomaterial; calcite precipitation; canavalia ensiformis extracts;
   urease
ID MICROBIAL CARBONATE PRECIPITATION; CAJANUS-CAJAN L.; UREASE ACTIVITY;
   BACILLUS-PASTEURII; SOILS; BIOREMEDIATION; MICROORGANISMS; SEEDS; SAND
AB An extract of the indigenous plant jack bean (Canavalia ensiformis) was used to produce calcite, an effective biomaterial. The formation of calcite using this extract was compared, under stable conditions, to that using commercially available purified urease. Xray diffraction and scanning electron microscopy were employed to elucidate the mechanism of calcite formation from the crude plant extracts. The results revealed that urease in the jack bean crude extracts catalyzed the hydrolysis of urea in liquid-state cultures. The procedure described herein is a simple and useful method of calcite mineral precipitation that does not require cultivation of microorganisms or further purification of crude extracts. This study suggests that crude extracts of Canavalia ensiformis have the potential to be used in place of purified forms of urease during remediation of cracks and to increase the strength of materials.
C1 [Nam, In-Hyun; Chon, Chul-Min; Jung, Ka-Young] Korea Inst Geosci & Mineral Resources KIGAM, Geol Environm Div, Taejon 305350, South Korea.
   [Choi, Sun-Gyu; Park, Sung-Sik] Kyungpook Natl Univ, Dept Civil Engn, Taegu 702701, South Korea.
   [Choi, Hyeoksun] Wonkwang Univ, Dept Civil & Environm Engn, Iksan 570749, South Korea.
RP Park, SS (reprint author), Kyungpook Natl Univ, Dept Civil Engn, Taegu 702701, South Korea.
EM nih@kigam.re.kr; femini@kigam.re.kr; ddingga1004@empas.com;
   skone1578@hanmail.net; choihs@wonkwang.ac.kr; sungpark@knu.ac.kr
FU Construction Technology Innovation Program - Ministry of Land,
   Infrastructure and Transport of the Korean government; Korea Institute
   of Geoscience and Mineral Resources (KIGAM) research fund [3212]
FX This work was supported, in part, by a grant (11 Technology Innovation
   F01) from the Construction Technology Innovation Program funded by the
   Ministry of Land, Infrastructure and Transport of the Korean government.
   This research was also partially supported by the Korea Institute of
   Geoscience and Mineral Resources (KIGAM) research fund (No. 3212).
CR Bachmeier KL, 2002, J BIOTECHNOL, V93, P171, DOI 10.1016/S0168-1656(01)00393-5
   Bang SS, 2001, ENZYME MICROB TECH, V28, P404, DOI 10.1016/S0141-0229(00)00348-3
   Burbank MB, 2012, GEOMICROBIOL J, V29, P389, DOI 10.1080/01490451.2011.575913
   Burbank MB, 2011, GEOMICROBIOL J, V28, P301, DOI 10.1080/01490451.2010.499929
   Castanier S, 1999, SEDIMENT GEOL, V126, P9, DOI 10.1016/S0037-0738(99)00028-7
   Das N, 1998, BIOTECHNOL APPL BIOC, V27, P25, DOI 10.1111/j.1470-8744.1998.tb01371.x
   Das N, 2002, PHYTOCHEMISTRY, V61, P513, DOI 10.1016/S0031-9422(02)00270-4
   De Muynck W, 2010, ECOL ENG, V36, P118, DOI 10.1016/j.ecoleng.2009.02.006
   Deepak S., 2009, J IND MICROBIOL BIOT, V36, P1111
   DeJong JT, 2006, J GEOTECH GEOENVIRON, V132, P1381, DOI 10.1061/(ASCE)1090-0241(2006)132:11(1381)
   Hamdan N., 2013, P 18 INT C SOIL MECH, V3, P2489
   Harkes MP, 2010, ECOL ENG, V36, P112, DOI 10.1016/j.ecoleng.2009.01.004
   Kayastha A. M., 2010, J PROTEINS PROTEOMIC, V1, P3
   Labana S, 2005, APPL MICROBIOL BIOT, V68, P417, DOI 10.1007/s00253-005-1926-1
   Lee BD, 2006, BIORESOURCE TECHNOL, V97, P2427, DOI 10.1016/j.biortech.2005.09.028
   Li L, 2010, J SOIL SEDIMENT, V10, P248, DOI 10.1007/s11368-009-0089-6
   LLOYD AB, 1973, PLANT SOIL, V39, P71, DOI 10.1007/BF00018046
   McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0
   MOBLEY HLT, 1995, MICROBIOL REV, V59, P451
   MOBLEY HLT, 1989, MICROBIOL REV, V53, P85
   Nam IH, 2006, APPL ENVIRON MICROB, V72, P112, DOI 10.1128/AEM.72.1.112-116.2006
   Nam IH, 2008, J HAZARD MATER, V157, P114, DOI 10.1016/j.jhazmat.2007.12.086
   Nemati M, 2003, ENZYME MICROB TECH, V33, P635, DOI 10.1016/S0141-0229(03)00191-1
   Prakash O, 2003, PLANT SCI, V164, P189, DOI 10.1016/S0168-9452(02)00382-5
   Ramachandran SK, 2001, ACI MATER J, V98, P3
   Ramanan R, 2010, BIORESOURCE TECHNOL, V101, P2616, DOI 10.1016/j.biortech.2009.10.061
   RIDDLES PW, 1991, GENE, V108, P265, DOI 10.1016/0378-1119(91)90443-F
   Rusznyak A, 2012, APPL ENVIRON MICROB, V78, P1157, DOI 10.1128/AEM.06568-11
   Sondi I, 2005, LANGMUIR, V21, P8876, DOI 10.1021/la051129v
   Spanos N, 1998, J CRYST GROWTH, V191, P783, DOI 10.1016/S0022-0248(98)00385-6
   Whiffin VS, 2007, GEOMICROBIOL J, V24, P417, DOI 10.1080/01490450701436505
NR 31
TC 2
Z9 2
U1 0
U2 11
PU KOREAN SOCIETY OF CIVIL ENGINEERS-KSCE
PI SEOUL
PA 50-7 OGUM-DONG, SONGPA-KU, SEOUL, 138-857, SOUTH KOREA
SN 1226-7988
EI 1976-3808
J9 KSCE J CIV ENG
JI KSCE J. Civ. Eng.
PD SEP
PY 2015
VL 19
IS 6
BP 1620
EP 1625
DI 10.1007/s12205-014-0558-3
PG 6
WC Engineering, Civil
SC Engineering
GA CP4PI
UT WOS:000359864200010
DA 2018-10-20
ER

PT J
AU Sorkio, A
   Porter, PJ
   Juuti-Uusitalo, K
   Meenan, BJ
   Skottman, H
   Burke, GA
AF Sorkio, Anni
   Porter, Patrick J.
   Juuti-Uusitalo, Kati
   Meenan, Brian J.
   Skottman, Heli
   Burke, George A.
TI Surface Modified Biodegradable Electrospun Membranes as a Carrier for
   Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; SUBRETINAL IMPLANTATION;
   NANOFIBER MESHES; PLASMA TREATMENT; SCAFFOLDS; RPE; TRANSPLANTATION;
   MONOLAYER; OPTIMIZATION
AB Human embryonic stem cell-derived retinal pigment epithelial (hESC-RPE) cells are currently undergoing clinical trials to treat retinal degenerative diseases. Transplantation of hESC-RPE cells in conjuction with a supportive biomaterial carrier holds great potential as a future treatment for retinal degeneration. However, there has been no such biodegradable material that could support the growth and maturation of hESC-RPE cells so far. The primary aim of this work was to create a thin porous poly (L-lactide-co-caprolactone) (PLCL) membrane that could promote attachment, proliferation, and maturation of the hESC-RPE cells in serum-free culture conditions. The PLCL membranes were modified by atmospheric pressure plasma processing and coated with collagen IV to enhance cell growth and maturation. Permeability of the membranes was analyzed with an Ussing chamber system. Analysis with scanning electron microscopy, contact angle measurement, atomic force microscopy, and X-ray photoelectron spectroscopy demonstrated that plasma surface treatment augments the surface properties of the membrane, which enhances the binding and conformation of the protein. Cell proliferation assays, reverse transcription-polymerase chain reaction, indirect immunofluoresence staining, trans-epithelial electrical resistance measurements, and in vitro phagocytosis assay clearly demonstrated that the plasma treated PLCL membranes supported the adherence, proliferation, maturation and functionality of hESC-RPE cells in serum-free culture conditions. Here, we report for the first time, how PLCL membranes can be modified with atmospheric pressure plasma processing to enable the formation of a functional hESC-RPE monolayer on a porous biodegradable substrate, which have a potential as a tissue-engineered construct for regenerative retinal repair applications.
C1 [Sorkio, Anni; Juuti-Uusitalo, Kati; Skottman, Heli] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.
   [Porter, Patrick J.; Meenan, Brian J.; Burke, George A.] Univ Ulster, Sch Engn, Nanotechnol & Integrated Bioengn Ctr NIBEC, Jordanstown Campus,Shore Rd, Newtownabbey BT37 0QB, Co Antrim, North Ireland.
RP Burke, GA (reprint author), Univ Ulster, Sch Engn, Nanotechnol & Integrated Bioengn Ctr NIBEC, Jordanstown Campus,Shore Rd, Newtownabbey BT37 0QB, Co Antrim, North Ireland.
EM g.burke@ulster.ac.uk
OI Juuti-Uusitalo, Kati/0000-0003-2275-5562
FU Academy of Finland [218050, 137801]; TEKES (the Finnish Funding Agency
   for Technology and Innovation); Finnish Cultural Foundation; Pirkanmaa
   Regional fund [50121465]; Invest Northern Ireland [RD0212954]; Northern
   Ireland Department for Employment and Learning (DEL)
FX The authors wish to thank the Academy of Finland (grant numbers 218050
   and 137801), TEKES (the Finnish Funding Agency for Technology and
   Innovation), the Finnish Cultural Foundation, Pirkanmaa Regional fund
   (grant number 50121465), Invest Northern Ireland (grant number
   RD0212954), and the Northern Ireland Department for Employment and
   Learning (DEL) for their support. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the article. OutiMelin, Hanna Pekkanen, and Outi Heikkila
   are thanked for technical assistance. Authors one and two equally
   contributed to this work.
CR Ai J, 2011, J NANOMATER, DOI 10.1155/2011/123724
   Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018
   AUMAILLEY M, 1986, J CELL BIOL, V103, P1569, DOI 10.1083/jcb.103.4.1569
   Baio JE, 2012, LANGMUIR, V28, P2107, DOI 10.1021/la203907t
   Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002
   Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003
   Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002
   Carr AJF, 2013, TRENDS NEUROSCI, V36, P385, DOI 10.1016/j.tins.2013.03.006
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   D'Sa RA, 2012, J COLLOID INTERF SCI, V375, P193, DOI 10.1016/j.jcis.2012.02.052
   D'Sa RA, 2010, ACTA BIOMATER, V6, P2609, DOI 10.1016/j.actbio.2010.01.015
   D'Sa RA, 2010, J MATER SCI-MATER M, V21, P1703, DOI 10.1007/s10856-010-4030-8
   Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239
   Dong YX, 2010, TISSUE ENG PT A, V16, P283, DOI 10.1089/ten.tea.2008.0537
   Fernandez-Robredo P, 2014, J OPHTHALMOL, DOI 10.1155/2014/510285
   Hu YT, 2012, OPHTHALMIC RES, V48, P186, DOI 10.1159/000338749
   Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Juuti-Uusitalo K, 2013, INVEST OPHTH VIS SCI, V54, P3510, DOI 10.1167/iovs.13-11800
   Kalluri R, 2000, J BIOL CHEM, V275, P12719, DOI 10.1074/jbc.275.17.12719
   Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007
   Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336
   Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217
   Krishna Y, 2011, BRIT J OPHTHALMOL, V95, P569, DOI 10.1136/bjo.2009.169953
   Lee J, 2008, BIOMATERIALS, V29, P1872, DOI 10.1016/j.biomaterials.2007.12.029
   Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7
   Liu CZ, 2006, SURF COAT TECH, V201, P2341, DOI 10.1016/j.surfcoat.2006.04.001
   Liu ZP, 2014, BIOMATERIALS, V35, P2837, DOI 10.1016/j.biomaterials.2013.12.069
   Lu B, 2012, BIOMED MICRODEVICES, V14, P659, DOI 10.1007/s10544-012-9645-8
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   McHugh KJ, 2014, INVEST OPHTH VIS SCI, V55, P1754, DOI 10.1167/iovs.13-12833
   Nandakumar A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015006
   Rowland TJ, 2013, J TISSUE ENG REGEN M, V7, P642, DOI 10.1002/term.1458
   Sakai Y, 2001, CELL TRANSPLANT, V10, P479
   Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Shadforth AMA, 2012, BIOMATERIALS, V33, P4110, DOI 10.1016/j.biomaterials.2012.02.040
   Singh S, 2001, BIOMATERIALS, V22, P3337, DOI 10.1016/S0142-9612(01)00171-5
   Skottman H, 2010, IN VITRO CELL DEV-AN, V46, P206, DOI 10.1007/s11626-010-9286-2
   Sorkio A, 2014, TISSUE ENG PT A, V20, P622, DOI 10.1089/ten.TEA.2013.0049
   Stanzel BV, 2014, STEM CELL REP, V2, P64, DOI 10.1016/j.stemcr.2013.11.005
   Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260
   Subrizi A, 2012, BIOMATERIALS, V33, P8047, DOI 10.1016/j.biomaterials.2012.07.033
   Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   Tezel TH, 1999, INVEST OPHTH VIS SCI, V40, P467
   Thieltges F, 2011, OPHTHALMIC RES, V46, P133, DOI 10.1159/000324045
   Thomson HAJ, 2011, BRIT J OPHTHALMOL, V95, P563, DOI 10.1136/bjo.2009.166728
   Treharne AJ, 2012, J BIOMED MATER RES A, V100A, P2358, DOI 10.1002/jbm.a.34178
   Ugarte M, 2006, BRIT J OPHTHALMOL, V90, P621, DOI 10.1136/bjo.2005.086579
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vaajasaari H, 2011, MOL VIS, V17, P558
   Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002
   Warnke PH, 2013, ACTA BIOMATER, V9, P9414, DOI 10.1016/j.actbio.2013.07.029
   Xiang P, 2014, BIOMATERIALS, V35, P9777, DOI 10.1016/j.biomaterials.2014.08.040
   Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398
   Zarbin MA, 2014, DEV OPHTHALMOL, V53, P1, DOI 10.1159/000358536
   Zhang YZ, 2007, INT J NANOMED, V2, P623
NR 58
TC 14
Z9 15
U1 1
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP 1
PY 2015
VL 21
IS 17-18
BP 2301
EP 2314
DI 10.1089/ten.tea.2014.0640
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP8KC
UT WOS:000360141500002
PM 25946229
DA 2018-10-20
ER

PT J
AU Krishnani, KK
   Boddu, VM
   Moon, DH
   Ghadge, SV
   Sarkar, B
   Brahmane, MP
   Choudhary, K
   Kathiravan, V
   Meng, XG
AF Krishnani, Kishore K.
   Boddu, Veera M.
   Moon, Deok Hyun
   Ghadge, S. V.
   Sarkar, Biplab
   Brahmane, M. P.
   Choudhary, K.
   Kathiravan, V.
   Meng, Xiaoguang
TI Metals Bioaccumulation Mechanism in Neem Bark
SO BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY
LA English
DT Article
DE Biomaterial; Characterization; Toxicants; Removal; Whewellite; Ion
   exchange
ID AQUEOUS-SOLUTIONS; HEAVY-METALS; WHEAT BRAN; REMOVAL; IONS; ADSORPTION;
   BIOSORPTION; SORPTION; BINDING; WASTE
AB The aim of this work was to define the bioaccumulation mechanism of metals onto the non-living biomaterial prepared from an extensively available plant bark biomass of neem (Azadirachta indica). Based on maximum ultimate fixation capacities (mmol/g) of the product, metals ions could be arranged as Hg2+ < Cd2+ < Pb2+ a parts per thousand... Cu2+. Surface properties of the biomaterial were characterized by X-ray photoelectron spectroscopy and X-ray diffraction techniques for their sorption mechanism. Whewellite (C2CaO4 center dot H2O) was identified in the biomaterial, which indicated that calcium ions are electrovalently bonded with carboxylate ions facilitating the ion exchange mechanism with metal ions. Bioaccumulation of metal ions was also studied by Fourier transform infrared spectroscopy, which indicated the presence of functional groups implicated in adsorbing metal ions. Biomaterial did not adsorb anionic As(III), As(V) and Cr(VI), because of their electrostatic repulsion with carboxylic functional groups. Neem bark can be used as bioindicators, bioaccumulators and biomonitors while determining environmental pressures. Metal bioaccumulative properties and structural investigation of plant bark has potential in providing quantitative information on the metal contamination in the surrounding environment.
C1 [Krishnani, Kishore K.; Ghadge, S. V.; Sarkar, Biplab; Brahmane, M. P.] Natl Inst Abiot Stress Management, Pune 413115, Maharashtra, India.
   [Boddu, Veera M.] US Army, Construct Engn Res Labs, Champaign, IL USA.
   [Moon, Deok Hyun] Chosun Univ, Dept Environm Engn, Kwangju 501759, South Korea.
   [Choudhary, K.] Directorate Weed Sci Res, Jabalpur, India.
   [Kathiravan, V.] Madura Coll, Madurai, TN, India.
   [Meng, Xiaoguang] Stevens Inst Technol, CEE, Hoboken, NJ 07030 USA.
RP Krishnani, KK (reprint author), Natl Inst Abiot Stress Management, Pune 413115, Maharashtra, India.
EM krishnanik@hotmail.com
CR Arshad M, 2008, J HAZARD MATER, V157, P534, DOI 10.1016/j.jhazmat.2008.01.017
   Athar M, 2007, B ENVIRON CONTAM TOX, V79, P288, DOI 10.1007/s00128-007-9217-4
   Bulut Y, 2006, J ENVIRON MANAGE, V78, P107, DOI 10.1016/j.jenvman.2005.03.010
   Dupont L, 2003, J COLLOID INTERF SCI, V263, P35, DOI 10.1016/S0021-9797(03)00241-8
   Dupont MF, 2006, J ENV SCI HLTH A, V41, P149
   Gerente C, 2004, ENVIRON TECHNOL, V25, P219, DOI 10.1080/09593330409355455
   Gerente C, 2000, REACT FUNCT POLYM, V46, P135, DOI 10.1016/S1381-5148(00)00047-X
   Gloaguen V, 1997, J ENVIRON SCI HEAL A, V32, P901, DOI 10.1080/10934529709376585
   Hanzlik J, 2004, WATER RES, V38, P2178, DOI 10.1016/j.watres.2004.01.037
   Horsfall M, 2006, BIORESOURCE TECHNOL, V97, P283, DOI 10.1016/j.biortech.2005.02.016
   ICDD, 2002, POWD DIFFR FIL REL 2
   Jang A, 2005, ENVIRON POLLUT, V133, P117, DOI 10.1016/j.envpol.2004.05.020
   Krishnani KK, 2008, WATER ENVIRON RES, V80, P2165, DOI 10.2175/106143008X304785
   Krishnani KK, 2008, J HAZARD MATER, V153, P1222, DOI 10.1016/j.jhazmat.2007.09.113
   Krishnani KK, 2009, J ENV SCI HLTH A, V44, P1
   Krishnani KK, 2006, REV ENVIRON CONTAM T, V88, P64
   Maharia RS, 2010, J ENVIRON SCI HEAL B, V45, P174, DOI 10.1080/03601230903472249
   MASRI MS, 1974, J APPL POLYM SCI, V18, P675, DOI 10.1002/app.1974.070180305
   MDI, 2005, JAD VERS 7 1
   Munagapati VS, 2010, CHEM ENG J, V157, P357, DOI 10.1016/j.cej.2009.11.015
   Samecka-Cymerman A, 2006, ECOTOX ENVIRON SAFE, V65, P108, DOI 10.1016/j.ecoenv.2005.05.009
   Sekhar CK, 2004, J HAZARDOUS MAT B, V108, P111
   Xin-Min Z, 2001, J CHEM ENG JPN, V34, P1204
   Xin-Min Z, 2003, WATER RES, V37, P3905
NR 24
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4861
EI 1432-0800
J9 B ENVIRON CONTAM TOX
JI Bull. Environ. Contam. Toxicol.
PD SEP
PY 2015
VL 95
IS 3
BP 414
EP 419
DI 10.1007/s00128-015-1609-2
PG 6
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA CP2XO
UT WOS:000359741300022
PM 26193837
DA 2018-10-20
ER

PT J
AU Sanluis-Verdes, A
   Vilar, MTYP
   Garcia-Barreiro, J
   Garcia-Camba, M
   Ibanez, JS
   Domenech, N
   Rendal-Vazquez, ME
AF Sanluis-Verdes, Anahi
   Teresa Yebra-Pimentel Vilar, Ma
   Javier Garcia-Barreiro, Juan
   Garcia-Camba, Marta
   Sanchez Ibanez, Jacinto
   Domenech, Nieves
   Esther Rendal-Vazquez, Ma
TI Production of an acellular matrix from amniotic membrane for the
   synthesis of a human skin equivalent
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Skin equivalent; Human amniotic membrane; Keratinocytes; Biomaterial;
   Trypsin
ID STEM-CELLS; IN-VITRO; SCAFFOLD; RECONSTRUCTION; DERMIS; REPAIR; FIBRIN
AB Human amniotic membrane (HAM) has useful properties as a dermal matrix substitute. The objective of our work was to obtain, using different enzymatic or chemical treatments to eliminate cells, a scaffold of acellular HAM for later use as a support for the development of a skin equivalent. The HAM was separated from the chorion, incubated and cryopreserved. The membrane underwent different enzymatic and chemical treatments to eliminate the cells. Fibroblasts and keratinocytes were separately obtained from skin biopsies of patients following a sequential double digestion with first collagenase and then trypsin-EDTA (T/E). A skin equivalent was then constructed by seeding keratinocytes on the epithelial side and fibroblasts on the chorionic side of the decellularizated HAM. Histological, immunohistochemical, inmunofluorescent and molecular biology studies were performed. Treatment with 1 % T/E at 37 A degrees C for 30 min totally removed epithelial and mesenchymal cells. The HAM thus treated proved to be a good matrix to support adherence of cells and allowed the achievement of an integral and intact scaffold for development of a skin equivalent, which could be useful as a skin substitute for clinical use.
C1 [Sanluis-Verdes, Anahi; Sanchez Ibanez, Jacinto; Esther Rendal-Vazquez, Ma] Complexo Hosp Univ A Coruna, Unidad Criobiol Banco Tejidos, Inst Invest Biomed A Coruna INIBIC, La Coruna 15006, Spain.
   [Teresa Yebra-Pimentel Vilar, Ma] Complexo Hosp Univ A Coruna, Serv Anat Patol, Inst Invest Biomed A Coruna INIBIC, La Coruna 15006, Spain.
   [Javier Garcia-Barreiro, Juan] Complexo Hosp Univ A Coruna, Unidad Quemados, Inst Invest Biomed A Coruna INIBIC, La Coruna 15006, Spain.
   [Garcia-Camba, Marta; Domenech, Nieves] Complexo Hosp Univ A Coruna, Biobanco A Coruna, Inst Invest Biomed A Coruna INIBIC, La Coruna 15006, Spain.
RP Rendal-Vazquez, ME (reprint author), Complexo Hosp Univ A Coruna, Unidad Criobiol Banco Tejidos, Inst Invest Biomed A Coruna INIBIC, Xubias S-N, La Coruna 15006, Spain.
EM Anahi.San.Luis.Verdes@sergas.es;
   Maria.Teresa.Yebra-Pimentel.Vilar@sergas.es;
   Juan.Javier.Garcia.Barreiro@sergas.es; Marta.Garcia.Camba@sergas.es;
   jacinto.sanchez.ibanez@sergas.es; Nieves.Domenech.Garcia@sergas.es;
   Esther.Rendal.Vazquez@sergas.es
RI DOMENECH, NIEVES/E-5812-2012; Rendal-Vazquez, Esther/T-3696-2017
OI DOMENECH, NIEVES/0000-0002-2056-9400; Rendal-Vazquez,
   Esther/0000-0001-5127-4771
FU Conselleria de Innovacion e Industria Direccion Xeral de I+D+I
   [08CSA065916PR]; Centro de Investigacion Biomedica en Red en
   Bioingenieria, Biomateriales y Nanomedicina [CIBER-BBN-CB06/01/0040]
FX This work was supported by a grant from "Conselleria de Innovacion e
   Industria Direccion Xeral de I+D+I (No. 08CSA065916PR)". A.
   Verdes-Sanluis was supported by a grant from "Centro de Investigacion
   Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina"
   (CIBER-BBN-CB06/01/0040).
CR Buinewicz B, 2004, ANN PLAS SURG, V52, P188, DOI 10.1097/01.sap.0000100895.41198.27
   Cervelli V, 2010, J WOUND CARE, V19, P186, DOI 10.12968/jowc.2010.19.5.48045
   Coolen NA, 2007, CELL TRANSPLANT, V16, P649, DOI 10.3727/000000007783465046
   DAVIS GE, 1987, DEV BRAIN RES, V33, P1, DOI 10.1016/0165-3806(87)90170-2
   Melo Gustavo Barreto de, 2007, Arq. Bras. Oftalmol., V70, P407, DOI 10.1590/S0004-27492007000300005
   Diaz-Prado S, 2011, TISSUE ENG PART C-ME, V17, P49, DOI [10.1089/ten.tec.2010.0136, 10.1089/ten.TEC.2010.0136]
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Kesting MR, 2008, J BURN CARE RES, V29, P907, DOI 10.1097/BCR.0b013e31818b9e40
   Kim DS, 2004, CELL MOL LIFE SCI, V61, P2774, DOI 10.1007/s00018-004-4288-4
   Kim SS, 2009, CELL TISSUE RES, V336, P59, DOI 10.1007/s00441-009-0766-1
   Liang HS, 2009, ACTA NEUROCHIR, V151, P1113, DOI 10.1007/s00701-009-0322-5
   Lim LS, 2009, MOL VIS, V15, P1962
   Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85
   Macri L, 2009, SKIN PHARMACOL PHYS, V22, P83, DOI 10.1159/000178867
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Pena I, 2010, J PERIODONTAL RES, V45, P375, DOI 10.1111/j.1600-0765.2009.01248.x
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215
   Theoret C, 2009, VET SURG, V38, P905, DOI 10.1111/j.1532-950X.2009.00585.x
   Velásquez Puerta Diego A, 2008, Rev. ing. biomed., V2, P77
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Yang L, 2006, CELL TISSUE RES, V326, P69, DOI 10.1007/s00441-006-0208-2
   Yang LJ, 2009, J DERMATOL SCI, V56, P188, DOI 10.1016/j.jdermsci.2009.09.009
   Yu Yu-rong, 2006, Zhonghua Shao Shang Za Zhi, V22, P296
NR 30
TC 6
Z9 6
U1 2
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD SEP
PY 2015
VL 16
IS 3
BP 411
EP 423
DI 10.1007/s10561-014-9485-2
PG 13
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA CO7YW
UT WOS:000359381100012
PM 25634343
DA 2018-10-20
ER

PT J
AU Paul, AJ
   Momier, D
   Boukhechba, F
   Michiels, JF
   Lagadec, P
   Rochet, N
AF Paul, Adrien J.
   Momier, David
   Boukhechba, Florian
   Michiels, Jean-Francois
   Lagadec, Patricia
   Rochet, Nathalie
TI Effect of G-CSF on the osteoinductive property of a BCP/blood clot
   composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE blood; biphasic calcium phosphate; G-CSF; granulocytes; osteoinduction
ID COLONY-STIMULATING FACTOR; STEM-CELL MOBILIZATION; CALCIUM-PHOSPHATE
   MICROPARTICLES; BONE-MARROW-TRANSPLANTATION; ACUTE
   MYOCARDIAL-INFARCTION; OSTEOGENIC PRECURSOR CELLS; PROGENITOR CELLS;
   REGENERATION; MICE; SUBSTITUTE
AB We previously reported that blood clot combined with biphasic calcium phosphate microparticles constitute a biomaterial (BRB) that can repair a bone critical defect in rat and induces subcutaneous bone formation in mice. The granulocyte colony-stimulating factor (G-CSF) is the agent most commonly used in human to enrich blood with hematopoietic stem and progenitor cells (HSPCs) as well as granulocytes (GCs). Moreover, recent data also suggest that it can mobilize mesenchymal stem cells (MSCs). Here, we asked whether the osteoinductive properties of the BRB could be further enhanced by G-CSF, either by replacing normal blood by G-CSF-mobilized blood (BRBe) or by treating the recipient animals with G-CSF. The experiments performed in C57BL/6 mice showed that G-CSF induces a marked increase of circulating HPCs and GCs, but not of MSCs. BRBe prepared with G-CSF-enriched blood induced a slight but significant decrease of subcutaneous bone formation compared to BRB prepared with normal blood. Additional injection of G-CSF to the recipient mice had no significant effect on the bone formation induced by BRB or BRBe. Altogether these results indicate that, in this model of ectopic implantation, cell mobilization induced by G-CSF has a negative effect on the osteoinductive property of this blood/BCP composite. (C) 2015 Wiley Periodicals, Inc.
C1 [Paul, Adrien J.; Momier, David; Boukhechba, Florian; Lagadec, Patricia; Rochet, Nathalie] Univ Nice Sophia Antipolis, iBV, UMR7277, F-06100 Nice, France.
   [Paul, Adrien J.; Momier, David; Boukhechba, Florian; Lagadec, Patricia; Rochet, Nathalie] CNRS, iBV, UMR7277, F-06100 Nice, France.
   [Paul, Adrien J.; Momier, David; Boukhechba, Florian; Lagadec, Patricia; Rochet, Nathalie] INSERM, iBV, U1091, F-06100 Nice, France.
   [Paul, Adrien J.] Univ Nice Sophia Antipolis, UFR Odontol, F-06000 Nice, France.
   [Paul, Adrien J.] Ctr Hosp Univ, Pole Odontol, F-06000 Nice, France.
   [Boukhechba, Florian] Graftys, F-13854 Aix En Provence, France.
   [Michiels, Jean-Francois] Ctr Hosp Univ, Serv Anatomopathol, F-06000 Nice, France.
RP Rochet, N (reprint author), Univ Nice Sophia Antipolis, iBV, UMR7277, F-06100 Nice, France.
EM rochet@unice.fr
RI ROCHET, Nathalie/N-1819-2018
OI ROCHET, Nathalie/0000-0002-9995-6699; LAGADEC,
   Patricia/0000-0002-5105-782X
FU ANR [ANR-2010-EMMA-032-01]; CNRS; ARS (Agence regionale de Sante)
FX Contract grant sponsor: ANR; contract grant number:
   ANR-2010-EMMA-032-01; Contract grant sponsors: CNRS; ARS (Agence
   regionale de Sante)
CR Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011
   Boukhechba F, 2011, TISSUE ENG PT A, V17, P2267, DOI [10.1089/ten.tea.2010.0461, 10.1089/ten.TEA.2010.0461]
   Bouvet-Gerbettaz S, 2014, TISSUE ENG PT A, V20, P2950, DOI [10.1089/ten.tea.2013.0633, 10.1089/ten.TEA.2013.0633]
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   Delgaudine M, 2011, CYTOTHERAPY, V13, P237, DOI 10.3109/14653249.2010.491820
   Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2
   Egan KP, 2011, ARTERIOSCL THROM VAS, V31, P2965, DOI 10.1161/ATVBAHA.111.234724
   Fukui T, 2012, CELL TRANSPLANT, V21, P707, DOI 10.3727/096368911X582769
   Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x
   Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380
   Hoggatt J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt54
   Hou XW, 2009, TOXICOL LETT, V187, P40, DOI 10.1016/j.toxlet.2009.01.025
   Ishida K, 2010, TISSUE ENG PT A, V16, P3271, DOI 10.1089/ten.tea.2009.0268
   Jager M, 2010, ORTHOP REV, V2, P79, DOI 10.4081/or.2010.e20
   Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114
   Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417
   Kumagai K, 2008, J ORTHOP RES, V26, P165, DOI 10.1002/jor.20477
   Kuroda R, 2014, TISSUE ENG PART B-RE, V20, P190, DOI [10.1089/ten.TEB.2013.0511, 10.1089/ten.teb.2013.0511]
   Lapid K, 2008, STEM CELL RES COMMUN
   Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076
   Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994
   Lim YH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-92
   Link DC, 2000, SEMIN HEMATOL, V37, P25, DOI 10.1016/S0037-1963(00)90086-6
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Marmotti A, 2013, KNEE SURG SPORT TR A, V21, P237, DOI 10.1007/s00167-012-2150-z
   Marmotti A, 2014, INT ORTHOP, V38, P1787, DOI 10.1007/s00264-014-2445-4
   Mifune Y, 2008, STEM CELLS, V26, P1395, DOI 10.1634/stemcells.2007-0820
   Motabi HI, 2012, BLOOD REV, V26, P267
   Mouline CC, 2010, EUR CELLS MATER, V20, P379
   Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813
   Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754
   Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649
   SHERIDAN WP, 1989, LANCET, V2, P891
   Song YS, 2013, ANN HEPATOL, V12, P115
   Suda RK, 2009, STEM CELLS, V27, P2209, DOI 10.1002/stem.150
   Tatsumi K, 2008, CIRC J, V72, P1351, DOI 10.1253/circj.72.1351
   Undale A, 2010, BONE, V47, P83, DOI 10.1016/j.bone.2010.03.018
   Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272
   Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003
NR 40
TC 3
Z9 3
U1 2
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2015
VL 103
IS 9
BP 2830
EP 2838
DI 10.1002/jbm.a.35424
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CO6HO
UT WOS:000359258000003
PM 25720300
DA 2018-10-20
ER

PT J
AU Nickels, JD
   Perticaroli, S
   Ehlers, G
   Feygenson, M
   Sokolov, AP
AF Nickels, Jonathan D.
   Perticaroli, Stefania
   Ehlers, Georg
   Feygenson, Mikhail
   Sokolov, Alexei P.
TI Rigidity of poly-L-glutamic acid scaffolds: Influence of secondary and
   supramolecular structure
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE neutron and light scattering; tissue engineering; boson peak; elastic
   modulus; mechanobiology nanomechanical
ID TITIN IMMUNOGLOBULIN DOMAINS; PLURIPOTENT STEM-CELLS; POLY(L-GLUTAMIC
   ACID); NEUTRON-SCATTERING; BOSON PEAK; BETA-SHEET; SOUND-VELOCITY;
   PROTEIN; DYNAMICS; SPECTROSCOPY
AB Poly-L-glutamic acid (PGA) is a widely used biomaterial, with applications ranging from drug delivery and biological glues to food products and as a tissue engineering scaffold. A biodegradable material with flexible conjugation functional groups, tunable secondary structure, and mechanical properties, PGA has potential as a tunable matrix material in mechanobiology. Recent studies in proteins connecting dynamics, nanometer length scale rigidity, and secondary structure suggest a new point of view from which to analyze and develop this promising material. We have characterized the structure, topology, and rigidity properties of PGA prepared with different molecular weights and secondary structures through various techniques including scanning electron microscopy, FTIR, light, and neutron scattering spectroscopy. On the length scale of a few nanometers, rigidity is determined by hydrogen bonding interactions in the presence of neutral species and by electrostatic interactions when the polypeptide is negatively charged. When probed over hundreds of nanometers, the rigidity of these materials is modified by long range intermolecular interactions that are introduced by the supramolecular structure. (C) 2015 Wiley Periodicals, Inc.
C1 [Nickels, Jonathan D.; Perticaroli, Stefania; Sokolov, Alexei P.] Oak Ridge Natl Lab, Joint Inst Neutron Sci, Oak Ridge, TN 37831 USA.
   [Nickels, Jonathan D.; Perticaroli, Stefania; Sokolov, Alexei P.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA.
   [Perticaroli, Stefania; Sokolov, Alexei P.] Oak Ridge Natl Lab, Div Chem & Mat Sci, Oak Ridge, TN 37831 USA.
   [Ehlers, Georg] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA.
   [Feygenson, Mikhail] Oak Ridge Natl Lab, Chem & Engn Mat Div, Oak Ridge, TN 37831 USA.
RP Perticaroli, S (reprint author), Oak Ridge Natl Lab, Joint Inst Neutron Sci, Oak Ridge, TN 37831 USA.
EM nickelsjd@ornl.gov; spertica@utk.edu
RI Ehlers, Georg/B-5412-2008; Instrument, CNCS/B-4599-2012; Feygenson,
   Mikhail/H-9972-2014; Nickels, Jonathan/I-1913-2012
OI Ehlers, Georg/0000-0003-3513-508X; Feygenson,
   Mikhail/0000-0002-0316-3265; Nickels, Jonathan/0000-0001-8351-7846
FU EPSCoR program (DOE) [DE-FG02-08ER46528]; Scientific User Facilities
   Division, Office of Basic Energy Sciences, U.S. Department of Energy
   (ORNL's Spallation Neutron Source); U.S. Department of Energy
   [DEAC05-00OR22725]
FX Contract grant sponsor: EPSCoR program (DOE); contract grant number:
   DE-FG02-08ER46528; Contract grant sponsors: Scientific User Facilities
   Division, Office of Basic Energy Sciences, U.S. Department of Energy
   (ORNL's Spallation Neutron Source). Oak Ridge National Laboratory
   facilities managed by UT-Battelle, LLC for the U.S. Department of
   Energy; contract grant number: DEAC05-00OR22725
CR Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104
   Auld B. A., 1973, ACOUSTIC FIELDS WAVE
   BANDEKAR J, 1988, BIOPOLYMERS, V27, P909, DOI 10.1002/bip.360270603
   Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002
   Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458
   Chi H, 2013, BIOMACROMOLECULES, V14, P3880, DOI 10.1021/bm401015f
   Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8
   DAMASCHUN G, 1986, INT J BIOL MACROMOL, V8, P226, DOI 10.1016/0141-8130(86)90031-0
   Diehl M, 1997, BIOPHYS J, V73, P2726, DOI 10.1016/S0006-3495(97)78301-2
   Dzubiella J, 2010, J PHYS CHEM B, V114, P7098, DOI 10.1021/jp1010814
   Ehlers G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626935
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FASMAN GD, 1978, BIOPOLYMERS, V17, P1729, DOI 10.1002/bip.1978.360170709
   Fulara A, 2011, J PHYS CHEM B, V115, P11010, DOI 10.1021/jp206271e
   Fulara A, 2010, J PHYS CHEM B, V114, P8278, DOI 10.1021/jp102440n
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Holtzer A, 1996, J AM CHEM SOC, V118, P4220, DOI 10.1021/ja954008y
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   ITOH K, 1976, BIOPOLYMERS, V15, P419, DOI 10.1002/bip.1976.360150302
   Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7
   KEITH HD, 1969, J MOL BIOL, V43, P423, DOI 10.1016/0022-2836(69)90350-7
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Khodadadi S, 2010, BBA-PROTEINS PROTEOM, V1804, P15, DOI 10.1016/j.bbapap.2009.05.006
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Krasnov I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048104
   Kurkal-Siebert V, 2006, J AM CHEM SOC, V128, P2356, DOI 10.1021/ja055962q
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Li C, 2000, CLIN CANCER RES, V6, P2829
   Li C, 1999, US Patent, Patent No. [5977163, 5,977,163]
   Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3
   Multani AS, 1997, ANTICANCER RES, V17, P4269
   Neuefeind J, 2012, NUCL INSTRUM METH B, V287, P68, DOI 10.1016/j.nimb.2012.05.037
   Nickels JD, 2013, BIOPHYS J, V105, P2182, DOI 10.1016/j.bpj.2013.09.029
   Nickels JD, 2013, J BIOMED MATER RES A, V101, P1464, DOI 10.1002/jbm.a.34435
   Nickels JD, 2012, BIOPHYS J, V103, P1566, DOI 10.1016/j.bpj.2012.08.046
   Nielsen OF, 1993, ANNU REP PROG CHEM C, V90, P3, DOI DOI 10.1039/PC9939000003
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Palombo F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0739
   Perticaroli S, 2014, J PHYS CHEM B, V118, P7317, DOI 10.1021/jp503788r
   Perticaroli S, 2014, BIOPHYS J, V106, P2667, DOI 10.1016/j.bpj.2014.05.009
   Perticaroli S, 2013, SOFT MATTER, V9, P9548, DOI 10.1039/c3sm50807b
   Pu YJ, 2013, BIOMATERIALS, V34, P3658, DOI 10.1016/j.biomaterials.2013.01.082
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Roh JH, 2011, J AM CHEM SOC, V133, P16406, DOI 10.1021/ja207667u
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   SGOURAS DNF, 1994, STP PHARMA SCI, V4, P87
   Singh A, 2013, NAT METHODS, V10, P438, DOI [10.1038/NMETH.2437, 10.1038/nmeth.2437]
   Solar M, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/10/105703
   Speziale S, 2003, BIOPHYS J, V85, P3202, DOI 10.1016/S0006-3495(03)74738-9
   Tachibana M, 2000, CHEM PHYS LETT, V332, P259, DOI 10.1016/S0009-2614(00)01267-7
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tarek M, 2001, J CHEM PHYS, V115, P1607, DOI 10.1063/1.1380708
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Yamamoto N, 2012, SOFT MATTER, V8, P1997, DOI 10.1039/c1sm06433a
   Yamaoki Y, 2012, J PHYS CHEM B, V116, P5172, DOI 10.1021/jp2125685
   ZIMMERMAN SS, 1975, BIOPOLYMERS, V14, P567, DOI 10.1002/bip.1975.360140311
NR 61
TC 7
Z9 7
U1 2
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2015
VL 103
IS 9
BP 2909
EP 2918
DI 10.1002/jbm.a.35427
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CO6HO
UT WOS:000359258000011
PM 25690698
DA 2018-10-20
ER

PT J
AU Nguyen, TY
   Cipriano, AF
   Guan, RG
   Zhao, ZY
   Liu, HN
AF Nguyen, T. Y.
   Cipriano, A. F.
   Guan, Ren-Guo
   Zhao, Zhan-Yong
   Liu, Huinan
TI In vitro interactions of blood, platelet, and fibroblast with
   biodegradable magnesium-zinc-strontium alloys
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE magnesium-zinc-strontium alloys; biodegradable Mg-Zn-Sr alloys; blood;
   platelet; fibroblast; in vitro culture; cardiovascular applications
ID CORONARY-ARTERIES; DEGRADATION; CELLS; CYTOCOMPATIBILITY;
   BIOCOMPATIBILITY; CORROSION; NITINOL; PLASMA; STENTS
AB Magnesium (Mg) alloy is an attractive class of metallic biomaterial for cardiovascular applications due to its biodegradability and mechanical properties. In this study, we investigated the degradation in blood, thrombogenicity, and cytocompatibility of Magnesium-Zinc-Strontium (Mg-Zn-Sr) alloys, specifically four Mg-4 wt % Zn-xSr (x=0.15, 0.5, 1, and 1.5 wt %) alloys, together with pure Mg control and relevant reference materials for cardiovascular applications. Human whole blood and platelet rich plasma (PRP) were used as the incubation media to investigate the degradation behavior of the Mg-Zn-Sr alloys. The results showed that the PRP had a greater pH increase and greater concentration of Mg2+ ions when compared with whole blood after 2 h of incubation with the same respective Mg alloys, suggesting that the Mg alloys degraded faster in PRP than in whole blood. The Mg alloy with 4 wt % Zn and 0.15 wt % Sr (named as ZSr41A) was identified as the most promising alloy for cardiovascular stent applications, because it showed slower degradation and less thrombogenicity, as indicated by the lower concentrations of Mg2+ ions released and less deposition of platelets. Additionally, ZSr41 alloys were cytocompatible with fibroblasts in direct exposure culture in which the cells adhered and proliferated around the samples, with no statistical difference in cell adhesion density compared with the blank reference. Future studies on the ZSr41 alloys are necessary to investigate their direct interactions with other important cells in cardiovascular system, such as vascular endothelial cells and smooth muscle cells. (C) 2015 Wiley Periodicals, Inc.
C1 [Nguyen, T. Y.; Cipriano, A. F.; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
   [Cipriano, A. F.; Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
   [Guan, Ren-Guo; Zhao, Zhan-Yong] Northeastern Univ, Sch Met & Mat, Shenyang 110004, Peoples R China.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU American Heart Association [12SDG12220014]; Hellman Faculty Fellowship;
   University of California Regents Faculty Fellowship; National Science
   Foundation Graduate Research Fellowship Program [2013142496]; National
   Natural Science Foundation for Outstanding Young Scholars of China
   [51222405]
FX Contract grant sponsor: American Heart Association; contract grant
   number: 12SDG12220014; Contract grant sponsor: Hellman Faculty
   Fellowship; Contract grant sponsor: University of California Regents
   Faculty Fellowship; Contract grant sponsor: National Science Foundation
   Graduate Research Fellowship Program; contract grant number: 2013142496;
   Contract grant sponsor: National Natural Science Foundation for
   Outstanding Young Scholars of China; contract grant number: 51222405
CR Bouchard BA, 2007, PLATELETS, 2ND EDITION, P377, DOI 10.1016/B978-012369367-9/50781-3
   Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13
   Cipriano AF, 2015, ACTA BIOMATER, V12, P298, DOI 10.1016/j.actbio.2014.10.018
   Cipriano AF, 2013, J MATER SCI-MATER M, V24, P989, DOI 10.1007/s10856-013-4853-1
   Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guan RG, 2013, MAT SCI ENG C-MATER, V33, P3661, DOI 10.1016/j.msec.2013.04.054
   Guidoin R, 2004, J ENDOVASC THER, V11, P385, DOI 10.1583/03-1143.1
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Huskens J, 1997, BBA-GEN SUBJECTS, V1336, P434, DOI 10.1016/S0304-4165(97)00054-8
   Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530
   Jaganathan SK, 2014, BIOMED RES INT, DOI 10.1155/2014/459465
   Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163
   Johnson I, 2011, J BIOMED MATER RES A, V29, P33290
   Johnson I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065603
   Kealey CP, 2010, BIOMATERIALS, V31, P8864, DOI 10.1016/j.biomaterials.2010.08.014
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Ma L, 2010, BRAIN INJURY, V24, P730, DOI 10.3109/02699051003610516
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200
   SALENIUS P, 1957, SCAND J CLIN LAB INV, V9, P160, DOI 10.3109/00365515709101216
   Sheth S, 1996, CIRCULATION, V94, P1733, DOI 10.1161/01.CIR.94.7.1733
   Swietach P, 2010, J PHYSIOL-LONDON, V588, P4995, DOI 10.1113/jphysiol.2010.197392
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
NR 28
TC 10
Z9 10
U1 4
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2015
VL 103
IS 9
BP 2974
EP 2986
DI 10.1002/jbm.a.35429
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CO6HO
UT WOS:000359258000018
PM 25690931
DA 2018-10-20
ER

PT J
AU Kosinski, AM
   Sivasankar, MP
   Panitch, A
AF Kosinski, Aaron M.
   Sivasankar, M. Preeti
   Panitch, Alyssa
TI Varying RGD concentration and cell phenotype alters the expression of
   extracellular matrix genes in vocal fold fibroblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE RGD; phenotype; fibroblast; extracellular matrix; real-time PCR
ID MARROW STROMAL CELLS; LAMINA PROPRIA; TRANSFORMING GROWTH-FACTOR-BETA-1;
   SUBSTRATE STIFFNESS; LIVER FIBROSIS; GROWTH-FACTOR; ADHESION;
   ACTIVATION; PEPTIDE; MYOFIBROBLAST
AB The impact of RGD integrin binding-peptide concentration and cell phenotype on directing extracellular matrix (ECM) gene expression in vocal fold fibroblasts is little understood. Less is known about cell response to RGD concentration on a biomaterial when fibroblasts are in a scar-like environment compared to a healthy environment. We investigated the effects of varying RGD integrin-binding peptide surface concentration on ECM gene expression of elastin, collagen type 3 alpha 1, decorin, fibronectin, hyaluronan synthase 2, and collagen type 1 alpha 2 in scarred and unscarred immortalized human vocal fold fibroblasts (I-HVFFs). Phenotype and RGD concentration affected ECM gene expression. Phenotype change from healthy to myofibroblast-like resulted in ECM gene up-regulation for all genes tested, except for decorin. Systematically altering RGD concentration affected the expression of elastin and collagen type 3 alpha 1 in a myofibroblast phenotype. Specifically greater up-regulation in gene expression was observed with higher RGD concentrations. This research demonstrates that controlling RGD concentration may influence ECM gene expression levels in fibroblasts. Such knowledge is critical in developing the next generation of bioactive materials that, when implanted into sites of tissue damage and scarring, will direct cells to regenerate healthy tissues with normal ECM ratios and morphologies. (C) 2015 Wiley Periodicals, Inc.
C1 [Kosinski, Aaron M.; Panitch, Alyssa] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Sivasankar, M. Preeti] Purdue Univ, Speech Language & Hearing Sci, W Lafayette, IN 47907 USA.
RP Panitch, A (reprint author), Purdue Univ, Weldon Sch Biomed Engn, 206 S Martin Jischke Dr, W Lafayette, IN 47907 USA.
EM apanitch@purdue.edu
FU NIDCD/NIH [R01DC005788, R21DC008428]
FX Contract grant sponsor: NIDCD/NIH; contract grant numbers: R01DC005788
   and R21DC008428
CR Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310
   Cao X, 2012, J MATER SCI-MATER M, V23, P527, DOI 10.1007/s10856-011-4479-0
   Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390
   Chia HN, 2012, ACTA BIOMATER, V8, P2602, DOI 10.1016/j.actbio.2012.03.027
   Edalat F, 2012, ANN BIOMED ENG, V40, P1301, DOI 10.1007/s10439-011-0452-9
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jette ME, 2013, LARYNGOSCOPE, V123, P738, DOI 10.1002/lary.23681
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Peppas N. A., 2007, NANOTECHNOLOGY THERA
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Vyas B, 2010, ANN OTO RHINOL LARYN, V119, P350, DOI 10.1177/000348941011900513
   Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969
   Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f
   Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 30
TC 2
Z9 2
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2015
VL 103
IS 9
BP 3094
EP 3100
DI 10.1002/jbm.a.35456
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CO6HO
UT WOS:000359258000029
PM 25778824
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Verdiyeva, G
   Koshy, K
   Glibbery, N
   Mann, H
   Seifalian, AM
AF Verdiyeva, Gunay
   Koshy, Kiron
   Glibbery, Natalia
   Mann, Haroon
   Seifalian, Alexander M.
TI Tendon Reconstruction with Tissue Engineering Approach-A Review
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Tissue Engineering; Tendon; Regenerative Medicine; Scaffold; Biomaterial
ID MESENCHYMAL STEM-CELLS; ROTATOR CUFF REPAIR; PLATELET-RICH PLASMA;
   SMALL-INTESTINE SUBMUCOSA; MARROW STROMAL CELLS; HEALING IN-VITRO;
   GROWTH-FACTOR-I; ACELLULAR DERMAL MATRIX; RABBIT ACHILLES-TENDON;
   COLLAGEN-GAG SCAFFOLDS
AB Tendon injuries are a common and rising occurrence, associated with significant impairment to quality of life and financial burden to the healthcare system. Clinically, they represent an unresolved problem, due to poor natural tendon healing and the inability of current treatment strategies to restore the tendon to its native state. Tissue engineering offers a promising alternative, with the incorporation of scaffolds, cells and growth factors to support the complete regeneration of the tendon. The materials used in tendon engineering to date have provided significant advances in structural integrity and biological compatibility and in many cases the results obtained are superior to those observed in natural healing. However, grafts fail to reproduce the qualities of the pre-injured tendon and each has weaknesses subject to its constituent parts. Furthermore, many materials and cell types are being investigated concurrently, with seemingly little association or comparison between research results. In this review the properties of the most-investigated and effective components have been appraised in light of the surrounding literature, with research from early in-vitro experiments to clinical trials being discussed. Extensive comparisons have been made between scaffolds, cell types and growth factors used, listing strengths and weaknesses to provide a stable platform for future research. Promising future endeavours are also described in the field of nanocomposite material science, stem cell sources and growth factors, which may bypass weaknesses found in individual elements. The future of tendon engineering looks bright, with growing understanding in material technology, cell and growth factor application and encouraging recent advances bringing us ever closer to regenerating the native tendon.
C1 [Verdiyeva, Gunay; Koshy, Kiron; Glibbery, Natalia; Seifalian, Alexander M.] UCL, UCL Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London NW3 2PF, England.
   [Mann, Haroon; Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, Dept Orthopaed & Trauma Surg, London NW3 2QG, England.
RP Seifalian, AM (reprint author), UCL, UCL Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London NW3 2PF, England.
EM a.seifalian@gmail.com
CR Abrahamsson SO, 1997, J ORTHOPAED RES, V15, P256, DOI 10.1002/jor.1100150215
   Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   An J, 2012, BIOMED MICRODEVICES, V14, P863, DOI 10.1007/s10544-012-9666-3
   Andia I, 2013, SPORTS MED ARTHROSC, V21, P191, DOI 10.1097/JSA.0b013e318299972b
   [Anonymous], 2013, TISSUEMEND SOFT TISS
   Arnhold SJ, 2007, AM J VET RES, V68, P1095, DOI 10.2460/ajvr.68.10.1095
   Aslan H, 2008, J CLIN INVEST, V118, P439, DOI [10.1172/JC133944, 10.1172/JCI33944]
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Baksh N, 2013, ARTHROSCOPY, V29, P596, DOI 10.1016/j.arthro.2012.10.025
   Barber JG, 2013, TISSUE ENG PT A, V19, P1265, DOI 10.1089/ten.tea.2010.0538
   Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161
   Barboni B, 2012, CELL TRANSPLANT, V21, P2377, DOI 10.3727/096368912X638892
   Barkhausen T, 2003, EXP TOXICOL PATHOL, V55, P153, DOI 10.1078/0940-2993-00302
   Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bleakney Robert R, 2005, Foot Ankle Clin, V10, P239, DOI 10.1016/j.fcl.2005.01.006
   Bond JL, 2008, ARTHROSCOPY, V24, P403, DOI 10.1016/j.arthro.2007.07.033
   Branch JP, 2011, J FOOT ANKLE SURG, V50, P257, DOI 10.1053/j.jfas.2010.12.015
   BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015
   Burkhead WZ, 2007, SEMIN ARTHROPLASTY, V18, P11, DOI DOI 10.1053/J.SART.2006.11.017
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Campbell BH, 2004, BIOMECH MODEL MECHAN, V2, P239, DOI [10.1007/s10237-004-0041-z, 10.1007/S10237-004-0041-Z]
   Canseco JA, 2012, TISSUE ENG PT A, V18, P2549, DOI [10.1089/ten.tea.2012.0030, 10.1089/ten.TEA.2012.0030]
   Cao DJ, 2006, TISSUE ENG, V12, P1369, DOI 10.1089/ten.2006.12.1369
   Cao YL, 2002, PLAST RECONSTR SURG, V110, P1280, DOI 10.1097/01.PRS.0000025290.49889.4D
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chang J, 2000, PLAST RECONSTR SURG, V105, P148, DOI 10.1097/00006534-200001000-00025
   Chen B, 2012, BIOMATERIALS, V33, P6086, DOI 10.1016/j.biomaterials.2012.05.022
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61
   Cheng XG, 2014, ACTA BIOMATER, V10, P1360, DOI 10.1016/j.actbio.2013.11.017
   Chokalingam K, 2009, TISSUE ENG PT A, V15, P2561, DOI 10.1089/ten.TEA.2008.0451
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Chung EJ, 2013, ACTA BIOMATER, V9, P5153, DOI 10.1016/j.actbio.2012.09.021
   Clarke AW, 2011, AM J SPORT MED, V39, P614, DOI 10.1177/0363546510387095
   Cohen S, 2010, TISSUE ENG PT A, V16, P3119, DOI [10.1089/ten.tea.2009.0716, 10.1089/ten.TEA.2009.0716]
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   Dahlgren LA, 2002, J ORTHOPAED RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Derwin KA, 2009, J BONE JOINT SURG AM, V91A, P1159, DOI 10.2106/JBJS.H.00775
   Dines JS, 2007, J SHOULDER ELB SURG, V16, p204S, DOI 10.1016/j.jse.2007.03.004
   Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233
   Dragoo JL, 2014, AM J SPORT MED, V42, P610, DOI 10.1177/0363546513518416
   DUNN GA, 1982, CELL BEHAVIOUR, P247
   Evans RB, 2012, J HAND THER, V25, P173, DOI 10.1016/j.jht.2011.10.004
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619
   Gigante A, 2009, J ORTHOP RES, V27, P826, DOI 10.1002/jor.20812
   Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942
   Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582
   Hamada Y, 2006, J HAND SURG-AM, V31A, P530, DOI 10.1016/j.jhsa.2005.12.003
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003
   Hou Y, 2009, BIOCHEM BIOPH RES CO, V383, P235, DOI 10.1016/j.bbrc.2009.03.159
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524
   Jamnig A, 2012, CAN J PHYSIOL PHARM, V90, P295, DOI [10.1139/y11-109, 10.1139/Y11-109]
   Jankovic B, 2013, INT J PHARMACEUT, V455, P338, DOI 10.1016/j.ijpharm.2013.06.083
   Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848
   Jiang K, 2014, J BIOMED MATER RES A, V102, P801, DOI 10.1002/jbm.a.34742
   Jo CH, 2012, AM J SPORT MED, V40, P1035, DOI 10.1177/0363546512437525
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P681, DOI 10.1089/ten.2006.12.681
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Karamuk E, 2004, COMPOS SCI TECHNOL, V64, P885, DOI 10.1016/j.compscitech.2003.09.004
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kim KC, 2012, KNEE SURG SPORT TR A, V20, P1022, DOI 10.1007/s00167-011-1664-0
   Kirk James F, 2013, Biomatter, V3, DOI 10.4161/biom.25633
   Kjaer M, 2005, J MUSCULOSKEL NEURON, V5, P41
   Klein MB, 2002, J HAND SURG-AM, V27A, P615, DOI 10.1053/jhsu.2002.34004
   Koerner J, 2006, STEM CELLS, V24, P1613, DOI 10.1634/stemcells.2005-0264
   Koh JL, 2002, AM J SPORT MED, V30, P410, DOI 10.1177/03635465020300031701
   Koivunen-Niemela T, 1995, SURG RADIOL ANAT, V17, P263, DOI 10.1007/BF01795061
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   Kurtz CA, 1999, AM J SPORT MED, V27, P363, DOI 10.1177/03635465990270031701
   Ladd MR, 2011, BIOMATERIALS, V32, P1549, DOI 10.1016/j.biomaterials.2010.10.038
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Lee DK, 2008, J FOOT ANKLE SURG, V47, P8, DOI 10.1053/j.jfas.2007.08.015
   Lee J, 2010, J BIOMAT SCI-POLYM E, V21, P1173, DOI 10.1163/092050609X12471222313524
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420
   Liao JF, 2014, J BIOMED NANOTECHNOL, V10, P3085, DOI 10.1166/jbn.2014.1934
   Liden BA, 2009, J AM PODIAT MED ASSN, V99, P104, DOI 10.7547/0980104
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Liu WY, 2014, ACS APPL MATER INTER, V6, P2842, DOI 10.1021/am405418g
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   MacGillivray JD, 2006, J SHOULDER ELB SURG, V15, P639, DOI 10.1016/j.jse.2005.11.009
   Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Malcarney HL, 2005, AM J SPORT MED, V33, P907, DOI 10.1177/0363546504271500
   Maletius W, 1997, AM J SPORT MED, V25, P288, DOI 10.1177/036354659702500303
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   Manning CN, 2011, J ORTHOP RES, V29, P1099, DOI 10.1002/jor.21301
   McCarron JA, 2010, J SHOULDER ELB SURG, V19, P688, DOI 10.1016/j.jse.2009.12.008
   Meimandi-Parizi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073016
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Mishra A, 2012, HAND CLIN, V28, P481, DOI 10.1016/j.hcl.2012.08.008
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Moro J., 2007, GRAFTJACKET REGENERA
   Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5
   Nakamura N, 1998, GENE THER, V5, P1165, DOI 10.1038/sj.gt.3300712
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Nezakati T., 2014, J COLLOID INTERF SCI, V1, P45
   Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   Nixon AJ, 2007, ANN NY ACAD SCI, V1117, P310, DOI 10.1196/annals.1402.065
   Obokata H, 2014, NATURE, V505, P641, DOI 10.1038/nature12968
   Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648
   Oryan A, 2013, J MUSCULOSKEL NEURON, V13, P353
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Paik DH, 2013, COLLOID SURFACE A, V429, P134, DOI 10.1016/j.colsurfa.2013.03.063
   Pang BSF, 2006, J ULTRAS MED, V25, P1291, DOI 10.7863/jum.2006.25.10.1291
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330
   Qiu Y., 2013, J TISSUE ENG REGEN M
   Ramalingam M, 2013, J BIOMATER APPL, V27, P695, DOI 10.1177/0885328211423783
   Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641
   Robbins RD, 2010, CURR OPIN ORGAN TRAN, V15, P61, DOI 10.1097/MOT.0b013e3283337196
   Ruzzini L, 2013, KNEE SURG SPORT TR A, V21, P1834, DOI 10.1007/s00167-012-2249-2
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Sakabe T, 2011, BRIT MED BULL, V99, P211, DOI 10.1093/bmb/ldr025
   Sakiyama-Elbert SE, 2008, J HAND SURG-AM, V33A, P1548, DOI 10.1016/j.jhsa.2008.05.030
   Sasaki JI, 2010, SOFT MATTER, V6, P1662, DOI 10.1039/b922418a
   Sawaguchi N, 2010, J ORTHOP SCI, V15, P569, DOI 10.1007/s00776-010-1488-7
   Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887
   Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400
   SCHWEITZER ME, 1993, SKELETAL RADIOL, V22, P411, DOI 10.1007/BF00538442
   Sclamberg SG, 2004, J SHOULDER ELB SURG, V13, P538, DOI 10.1016/j.jse.2004.03.005
   Sereysky JB, 2013, INT J EXP PATHOL, V94, P293, DOI 10.1111/iep.12031
   SHAH M, 1995, J CELL SCI, V108, P985
   Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181
   Sharma P, 2005, SURG-J R COLL SURG E, V3, P309, DOI 10.1016/S1479-666X(05)80109-X
   Shearn JT, 2007, J BIOMECH ENG-T ASME, V129, P848, DOI 10.1115/1.2800769
   Shen WL, 2012, CELL TRANSPLANT, V21, P943, DOI 10.3727/096368911X627453
   Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
   Singh D, 2014, J BIOMED NANOTECHNOL, V10, P3141, DOI 10.1166/jbn.2014.1941
   Snyder SJ, 2009, ARTHROSCOPY, V25, P329, DOI 10.1016/j.arthro.2008.05.023
   Soila K, 1999, AM J ROENTGENOL, V173, P323, DOI 10.2214/ajr.173.2.10430128
   Song N, 2014, TISSUE ENG PT A, V20, P239, DOI [10.1089/ten.TEA.2013.0197, 10.1089/ten.tea.2013.0197]
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Sun CH, 2012, MACROMOL BIOSCI, V12, P761, DOI 10.1002/mabi.201200004
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   Tang GW, 2014, AUST J CHEM, V67, P159, DOI 10.1071/CH13378
   Teh TKH, 2013, TISSUE ENG PT A, V19, P1360, DOI [10.1089/ten.tea.2012.0279, 10.1089/ten.TEA.2012.0279]
   Thaker H, 2012, STEM CELLS INT, V2012
   Thomopoulos S, 2005, J HAND SURG-AM, V30A, P441, DOI 10.1016/j.jhsa.2004.12.006
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Uquillas JA, 2012, J MECH BEHAV BIOMED, V15, P176, DOI 10.1016/j.jmbbm.2012.06.012
   Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011
   Van Kampen Craig, 2013, Muscles Ligaments Tendons J, V3, P229
   Vaquette C, 2010, J BIOMAT SCI-POLYM E, V21, P1737, DOI 10.1163/092050609X12560455246676
   Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893
   Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3105, DOI 10.1166/jbn.2014.1969
   Vidal MA, 2006, VET SURG, V35, P601, DOI 10.1111/j.1532-950X.2006.00197.x
   Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122
   Wagenhauser M. U., 2014, KNEE SURG SPORTS TRA
   Walton J. R., 2007, J BONE JOINT SURG AM, V89, P786
   Wang X, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035010
   Wang XT, 2005, J HAND SURG-AM, V30A, P1255, DOI 10.1016/j.jhsa.2005.06.001
   Wang XT, 2004, J HAND SURG-AM, V29A, P884, DOI 10.1016/j.jhsa.2004.05.016
   Webb WR, 2013, BIOMATERIALS, V34, P6683, DOI 10.1016/j.biomaterials.2013.05.041
   Xerogeanes JW, 2013, AM J SPORT MED, V41, P2392, DOI 10.1177/0363546513496626
   Xie JW, 2012, MACROMOL BIOSCI, V12, P1336, DOI 10.1002/mabi.201200115
   Xu W, 2013, TISSUE ENG PT A, V19, P2439, DOI [10.1089/ten.tea.2012.0453, 10.1089/ten.TEA.2012.0453]
   Xu Y, 2014, BIOMATERIALS, V35, P2760, DOI 10.1016/j.biomaterials.2013.12.042
   Xu Y, 2013, TISSUE ENG PART C-ME, V19, P925, DOI [10.1089/ten.tec.2012.0328, 10.1089/ten.TEC.2012.0328]
   Yao J., 2005, ZIMMER COLLAGEN REPA
   Yin Z, 2013, ACTA BIOMATER, V9, P9317, DOI 10.1016/j.actbio.2013.07.022
   Yin Z, 2010, EXPERT OPIN BIOL TH, V10, P689, DOI 10.1517/14712591003769824
   Yokoya S, 2012, AM J SPORT MED, V40, P1259, DOI 10.1177/0363546512442343
   Yun YR, 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/218142
   Zalavras CG, 2006, J SHOULDER ELB SURG, V15, P224, DOI 10.1016/j.jse.2005.06.007
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang BY, 2014, EXP CELL RES, V322, P208, DOI 10.1016/j.yexcr.2014.01.005
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
   Zhong SP, 2012, TISSUE ENG PART B-RE, V18, P77, DOI 10.1089/ten.teb.2011.0390
   Zooker Chad, 2013, Am J Orthop (Belle Mead NJ), V42, P317
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 204
TC 8
Z9 9
U1 2
U2 65
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD SEP
PY 2015
VL 11
IS 9
BP 1495
EP 1523
DI 10.1166/jbn.2015.2121
PG 29
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA CO8CD
UT WOS:000359391700001
PM 26485923
DA 2018-10-20
ER

PT J
AU Fu, L
   Cai, W
   Wang, AW
   Zheng, YH
   He, L
   Fu, ZX
AF Fu, L.
   Cai, W.
   Wang, A. W.
   Zheng, Y. H.
   He, L.
   Fu, Z. X.
TI Synthesis and photocatalytic properties of TiO2 - WO3 hybrid film
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Hybrid film; TiO2; WO3; Photocatalyst; 4-chlorophenol
ID FERRITE COMPOSITE NANOPARTICLES; VISIBLE-LIGHT; BIOMATERIAL SYSTEM;
   MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; THIN-FILMS; TITANIA; ANATASE;
   PHOTODEGRADATION; DEGRADATION
AB In this paper, TiO2-WO3 hybrid film was fabricated by a simple dip coating method. The synthesised hybrid thin film was characterised by SEM, XRD, UV-vis diffuse reflectance spectrophotometer, Raman spectroscopy, photocurrent measurement and N-2 adsorption/desorption. The TiO2-WO3 hybrid film exhibited a significant enhancement of photocatalytic activity towards degradation of 4-chlorophenol under visible light. The enhanced photocatalytic performance could ascribe to the formation of heterojunction, benefiting for effective utilisation of solar energy and suppressing the recombination of photogenerated electron-hole pairs.
C1 [Fu, L.; Zheng, Y. H.] Inst Bot, Nanjing 210014, Jiangsu, Peoples R China.
   [Fu, L.; Zheng, Y. H.] Chinese Acad Sci, Nanjing Bot Garden, Mem Sun Yat Sen, Nanjing 210014, Jiangsu, Peoples R China.
   [Fu, L.; Fu, Z. X.] Golden Yuanta Construct Engn Co Ltd, Hangzhou 311200, Zhejiang, Peoples R China.
   [Cai, W.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   [Cai, W.] City Univ Hong Kong, Ctr Funct Photon, Kowloon, Hong Kong, Peoples R China.
   [Wang, A. W.] City Univ Hong Kong, COSDAF, Hong Kong, Hong Kong, Peoples R China.
   [Wang, A. W.] City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
   [He, L.] Beijing Petrochem Engn Corp Ltd, Beijing, Peoples R China.
RP Zheng, YH (reprint author), Inst Bot, Nanjing 210014, Jiangsu, Peoples R China.
EM yuhongzhengcas@gmail.com
CR Akurati KK, 2008, APPL CATAL B-ENVIRON, V79, P53, DOI 10.1016/j.apcatb.2007.09.036
   Almquist CB, 2002, J CATAL, V212, P145, DOI 10.1006/jcat.2002.3783
   Andersson M, 2002, J PHYS CHEM B, V106, P10674, DOI 10.1021/jp025715y
   Andronic L, 2007, THIN SOLID FILMS, V515, P6294, DOI 10.1016/j.tsf.2006.11.150
   Asilturk M, 2009, J PHOTOCH PHOTOBIO A, V203, P64, DOI 10.1016/j.jphotochem.2008.12.021
   Cheng C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04181
   Depan D, 2014, MAT SCI ENG C-MATER, V34, P221, DOI 10.1016/j.msec.2013.09.025
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   Fu L, 2015, CERAM INT, V41, P2492, DOI 10.1016/j.ceramint.2014.10.069
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001
   Georgieva J, 2011, J APPL ELECTROCHEM, V41, P173, DOI 10.1007/s10800-010-0221-8
   Giraldi TR, 2012, MATER CHEM PHYS, V136, P505, DOI 10.1016/j.matchemphys.2012.07.018
   HEJZLAR J, 1990, ANALYST, V115, P1463, DOI 10.1039/an9901501463
   Iliev V, 2010, J MOL CATAL A-CHEM, V327, P51, DOI 10.1016/j.molcata.2010.05.012
   Ismail M, 2011, J PHOTOCH PHOTOBIO A, V222, P314, DOI 10.1016/j.jphotochem.2011.07.001
   Karunakaran C, 2009, J HAZARD MATER, V167, P664, DOI 10.1016/j.jhazmat.2009.01.034
   Ke DN, 2008, MATER LETT, V62, P447, DOI [10.1016/j.matlet.2007.05.060, 10.1016/j.matlet.2607.05.060]
   Kim YC, 2001, ANAL CHIM ACTA, V432, P59, DOI 10.1016/S0003-2670(00)01145-4
   Kwon YT, 2000, J CATAL, V191, P192
   Mahlambi M. M., 2012, J NANOMATER, V2012, P1
   Niu P, 2012, J CHEM SOC PAKISTAN, V34, P615
   Partha Mahata T. A., 2007, J PHYS CHEM C, V111, P1665
   Patrocinio AOT, 2014, ACS APPL MATER INTER, V6, P16859, DOI 10.1021/am504269a
   Pausova S, 2014, J CHEM TECHNOL BIOT, V89, P1129, DOI [10.1002/jctb.4436, 10.1002/jc]
   Pyrgiotakis G., 2005, MATER RES SOC S P, V876, P83
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Shengyuan Y, 2015, J NANOSCI NANOTECHNO, V15, P721, DOI 10.1166/jnn.2015.9169
   Soares ET, 2007, BRAZ J CHEM ENG, V24, P29, DOI 10.1590/S0104-66322007000100003
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Vernardou D, 2011, J MATER CHEM, V21, P513, DOI 10.1039/c0jm02413a
   Wang C, 2014, MATER TECHNOL, V29, P372, DOI 10.1179/1753555714Y.0000000169
   Wang WD, 2005, J MOL CATAL A-CHEM, V235, P194, DOI 10.1016/j.molcata.2005.02.027
   Wilcoxon JP, 2000, J PHYS CHEM B, V104, P7334, DOI 10.1021/jp0012653
   Woan K, 2009, ADV MATER, V21, P2233, DOI 10.1002/adma.200802738
   Wu TX, 1999, J PHYS CHEM B, V103, P4862, DOI 10.1021/jp9846678
   Xing H, 2015, MATER TECHNOL, V30, P122, DOI 10.1179/1753555714Y.0000000216
   Xu JJ, 2010, THIN SOLID FILMS, V518, P4170, DOI 10.1016/j.tsf.2009.12.005
   Zakrzewska K, 2007, THIN SOLID FILMS, V515, P8332, DOI 10.1016/j.tsf.2007.03.019
   Zhao L, 2015, MATER TECHNOL, V30, P60, DOI 10.1179/1753555714Y.0000000208
   Zhou BH, 2014, CRYSTENGCOMM, V16, P10863, DOI 10.1039/c4ce01774a
   Zhou W, 2011, ADV FUNCT MATER, V21, P1922, DOI 10.1002/adfm.201002535
NR 47
TC 5
Z9 5
U1 3
U2 42
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2015
VL 30
IS 5
BP 264
EP 268
DI 10.1179/1753555714Y.0000000256
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP2NT
UT WOS:000359714600002
DA 2018-10-20
ER

PT J
AU Qi, CX
   Yan, XJ
   Huang, CY
   Melerzanov, A
   Du, YA
AF Qi, Chunxiao
   Yan, Xiaojun
   Huang, Chenyu
   Melerzanov, Alexander
   Du, Yanan
TI Biomaterials as carrier, barrier and reactor for cell-based regenerative
   medicine
SO PROTEIN & CELL
LA English
DT Review
DE carrier; barrier; reactor; biomaterial-assisted therapy; regenerative
   medicine
ID TISSUE ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR
   DELIVERY; NICOTINE-PROMOTED ANGIOGENESIS; BONE MORPHOGENETIC PROTEIN-2;
   FLUIDIZED-BED BIOREACTOR; MARROW STROMAL CELLS; COLLAGEN-GAG MATRIX;
   FORMATION IN-VIVO; PANCREATIC-ISLETS
AB Cell therapy has achieved tremendous success in regenerative medicine in the past several decades. However, challenges such as cell loss, death and immune-rejection after transplantation still persist. Biomaterials have been designed as carriers to deliver cells to desirable region for local tissue regeneration; as barriers to protect transplanted cells from host immune attack; or as reactors to stimulate host cell recruitment, homing and differentiation. With the assistance of biomaterials, improvement in treatment efficiency has been demonstrated in numerous animal models of degenerative diseases compared with routine free cell-based therapy. Emerging clinical applications of biomaterial assisted cell therapies further highlight their great promise in regenerative therapy and even cure for complex diseases, which have been failed to realize by conventional therapeutic approaches.
C1 [Qi, Chunxiao; Yan, Xiaojun; Du, Yanan] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.
   [Du, Yanan] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
   [Huang, Chenyu] Tsinghua Univ, Med Ctr, Beijing Tsinghua Changgung Hosp, Dept Plast & Reconstruct Surg, Beijing 102218, Peoples R China.
   [Melerzanov, Alexander] MIPT, Cellular & Mol Technol Lab, Dolgoprudnyi 141701, Russia.
RP Du, YA (reprint author), Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.
EM duyanan@tsinghua.edu.cn
RI Huang, Chenyu/I-4410-2018
OI Huang, Chenyu/0000-0001-9521-5650
FU National Natural Science Foundation of China [81171474, 51273106,
   51461165302]; Beijing Municipal Natural Science Foundation [157142090]
FX Authors would like to thank all members of Du-lab for great support.
   This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 81171474, 51273106, and 51461165302), and the Beijing
   Municipal Natural Science Foundation (157142090).
CR Agata H, 2010, TISSUE ENG PT A, V16, P663, DOI [10.1089/ten.tea.2009.0500, 10.1089/ten.TEA.2009.0500]
   Antosiak-Iwanska M, 2009, POL ARCH MED WEWN, V119, P311, DOI 10.20452/pamw.681
   Astradsson A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6340
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Ayvazyan A, 2011, J SURG RES, V171, pE247, DOI 10.1016/j.jss.2011.06.059
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Balasundaram G, 2007, MACROMOL BIOSCI, V7, P635, DOI 10.1002/mabi.200600270
   Barczyk M, 2015, STEM CELL REV, V21, P1550
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Blumenthal B, 2010, ARTIF ORGANS, V34, pE46, DOI 10.1111/j.1525-1594.2009.00937.x
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Butler CE, 1999, BRIT J PLAST SURG, V52, P127, DOI 10.1054/bjps.1997.3047
   Calafiore R, 1999, ANN NY ACAD SCI, V875, P219, DOI 10.1111/j.1749-6632.1999.tb08506.x
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Cirone P, 2002, HUM GENE THER, V13, P1157, DOI 10.1089/104303402320138943
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   COOPER ML, 1991, BIOMATERIALS, V12, P243, DOI 10.1016/0142-9612(91)90207-Q
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Daly AB, 2012, TISSUE ENG PT A, V18, P1, DOI [10.1089/ten.tea.2011.0301, 10.1089/ten.TEA.2011.0301]
   David B, 2004, BIOTECHNOL PROGR, V20, P1204, DOI 10.1021/bp034031z
   David B, 2004, INT J ARTIF ORGANS, V27, P284
   de Graaff W, 2003, P NATL ACAD SCI USA, V100, P13362, DOI 10.1073/pnas.2237046100
   de Vos P, 2002, TRENDS MOL MED, V8, P363, DOI 10.1016/S1471-4914(02)02381-X
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   Desai TA, 1999, BIOMED MICRODEVICES, V1, P131, DOI 10.1023/A:1009948524686
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   DEVOS P, 1993, INT J ARTIF ORGANS, V16, P205
   Dionne KE, 1996, BIOMATERIALS, V17, P257, DOI 10.1016/0142-9612(96)85563-3
   Dufrane D, 2012, WORLD J GASTROENTERO, V18, P6885, DOI 10.3748/wjg.v18.i47.6885
   Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Grandoso L, 2007, INT J PHARMACEUT, V343, P69, DOI 10.1016/j.ijpharm.2007.05.027
   Greenhalgh DG, 2013, J SURG RES, V185, P543, DOI 10.1016/j.jss.2012.10.026
   Hao SG, 2005, EXP ONCOL, V27, P56
   He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.teb.2012.0340, 10.1089/ten.TEB.2012.0340]
   Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Hortelano G, 2000, ARTIF CELL BLOOD SUB, V28, P1, DOI 10.3109/10731190009119782
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Iwata H, 1995, TRANSPLANT P, V27, P3224
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058
   Kagami H, 2011, INT J BIOCHEM CELL B, V43, P286, DOI 10.1016/j.biocel.2010.12.006
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207
   Kizilel Seda, 2005, Diabetes Technol Ther, V7, P968, DOI 10.1089/dia.2005.7.968
   Klees RF, 2008, EXP CELL RES, V314, P763, DOI 10.1016/j.yexcr.2007.12.007
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Kofron MD, 2006, ADV DRUG DELIVER REV, V58, P555, DOI 10.1016/j.addr.2006.03.008
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Krishnamurthy N. V., 2011, Critical Reviews in Biomedical Engineering, V39, P473, DOI 10.1615/CritRevBiomedEng.v39.i6.10
   Krol S, 2006, NANO LETT, V6, P1933, DOI 10.1021/nl061049r
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Kumar A, 1999, IMMUNOL LETT, V65, P153, DOI 10.1016/S0165-2478(98)00085-6
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865
   Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Liu W, 2014, ACTA BIOMATER, V10, P1864, DOI 10.1016/j.actbio.2013.12.008
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   LYNCH SE, 1987, P NATL ACAD SCI USA, V84, P7696, DOI 10.1073/pnas.84.21.7696
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Martino MM, 2010, SCI TRANSL MED, V3, p100ra89
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McLaughlin CR, 2009, FRONT BIOSCI-LANDMRK, V14, P3326, DOI 10.2741/3455
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   O'Sullivan ES, 2011, ENDOCR REV, V32, P827, DOI 10.1210/er.2010-0026
   Okamoto T, 2003, ASAIO J, V49, P63, DOI 10.1097/01.MAT.0000044735.66921.DB
   Omer A, 2005, TRANSPLANTATION, V79, P52, DOI 10.1097/01.TP.0000149340.37865.46
   Orive G, 2005, MOL THER, V12, P283, DOI 10.1016/j.ymthe.2005.04.002
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Paul A, 2009, REGEN MED, V4, P733, DOI 10.2217/RME.09.43
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120
   Liem PH, 2013, J SURG RES, V182, P353, DOI 10.1016/j.jss.2012.10.018
   Pouch SM, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0482-9
   Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883
   Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]
   Rang A, 2014, BIOMATERIALS, V35, P2651, DOI 10.1016/j.biomaterials.2013.12.073
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com
   Schneider S, 2001, BIOMATERIALS, V22, P1961, DOI 10.1016/S0142-9612(00)00380-X
   SELLITTO P, 1995, PHYS REV B, V51, P16778, DOI 10.1103/PhysRevB.51.16778
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Street CN, 2003, CURR TOP DEV BIOL, V58, P111, DOI 10.1016/S0070-2153(03)58004-8
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Sugiyama O, 2005, MOL THER, V11, P390, DOI 10.1016/j.ymthe.2004.10.019
   Ti D, 2014, TISSUE ENG PART A, V20, P3085
   Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097
   Tomatsu S, 2015, DRUG DES DEV THER, V9, P1937, DOI 10.2147/DDDT.S68562
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Uchimura E, 2003, J BIOMED MATER RES A, V67A, P834, DOI 10.1002/jbm.a.10097
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   Webber MJ, 2015, ANN BIOMED ENG, V43, P641, DOI 10.1007/s10439-014-1104-7
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   WONG H, 1991, BIOMAT ARTIF CELL IM, V19, P687, DOI 10.3109/10731199109117847
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Wyman JL, 2007, SMALL, V3, P683, DOI 10.1002/smll.200600231
   Yamada Y, 2004, CELL TRANSPLANT, V13, P343, DOI 10.3727/000000004783983909
   Yang HK, 2015, J DIABETES COMPLICAT, V4, pe13
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang XL, 2008, BIOMATERIALS, V29, P4253, DOI 10.1016/j.biomaterials.2008.07.032
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
NR 166
TC 13
Z9 13
U1 2
U2 36
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD SEP
PY 2015
VL 6
IS 9
BP 638
EP 653
DI 10.1007/s13238-015-0179-8
PG 16
WC Cell Biology
SC Cell Biology
GA CP2XL
UT WOS:000359741000003
PM 26088192
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Guarnieri, R
   DeVilliers, P
   Belleggia, F
AF Guarnieri, Renzo
   DeVilliers, Patricia
   Belleggia, Fabrizio
TI GBR using cross-linked collagen membrane and a new highly purified
   bovine xenograft (Laddec) in horizontal ridge augmentation: Case report
   of clinical and histomorphometric analysis
SO QUINTESSENCE INTERNATIONAL
LA English
DT Article
DE bovine bone-derived biomaterial; cross-linked collagen membrane;
   horizontal bone augmentation
ID PARTICULATED AUTOGENOUS BONE; GUIDED TISSUE REGENERATION; PROSPECTIVE
   CASE SERIES; BARRIER MEMBRANES; GRAFT SUBSTITUTE; IMPLANTS; INTEGRIN;
   MATRIX; CELLS; HYDROXYAPATITE
AB This case report presents the clinical and histologic evaluation of the application of a cross-linked collagen membrane and a new highly purified bovine xenograft with type 1 collagen fiber preservation (Laddec) in mandibular horizontal ridge augmentation on a 50-year-old woman. Significant bone volume was achieved to restore severe bone defect in order to place two implants. Histomorphometric analysis of a bone core at the augmented site, at 6 months, showed new bone formation with bone substitute particles integrated to new viable bone.
C1 [Guarnieri, Renzo] SCS Sci Consulting Serv, Rome, Italy.
   [DeVilliers, Patricia] Pathol Associates Alabama, Oral & Maxillofacial Pathol, Birmingham, AL USA.
RP Guarnieri, R (reprint author), Via Deserto Gobi 85 A 2, I-00144 Rome, Italy.
EM renzoguarnieri@gmail.com
FU Classimplant, Rome, Italy; BioHorizons, Birmingham, AL, USA
FX This work was partially supported by Classimplant, Rome, Italy, and by
   BioHorizons, Birmingham, AL, USA.
CR Barbanti BG, 2012, EUR SPINE J, V21, pS3
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   Basle MF, 1998, ORTHOPADE, V27, P136
   Beitlitum I, 2010, CLIN ORAL IMPLAN RES, V21, P1242, DOI 10.1111/j.1600-0501.2010.01936.x
   BLOCK JE, 1995, MED HYPOTHESES, V45, P27, DOI 10.1016/0306-9877(95)90195-7
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   Chappard D, 1993, Bull Assoc Anat (Nancy), V77, P59
   CLOVER J, 1992, J CELL SCI, V103, P267
   Dahlin C, 1989, Int J Oral Maxillofac Implants, V4, P19
   Donos N, 2008, J CLIN PERIODONTOL, V35, P173, DOI 10.1111/j.1600-051X.2008.01269.x
   Gohel AR, 1995, J HISTOCHEM CYTOCHEM, V43, P1089
   Hammerle CHF, 2008, CLIN ORAL IMPLAN RES, V19, P19, DOI 10.1111/j.1600-0501.2007.01407.x
   Hammer C, 1998, INT ARCH ALLERGY IMM, V116, P5, DOI 10.1159/000023919
   Hemler ME, 1993, EXTRACELLULAR MATRIX, P143
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Kozlovsky A, 2009, CLIN ORAL IMPLAN RES, V20, P1116, DOI 10.1111/j.1600-0501.2009.01740.x
   Kuchler U, 2014, INT J ORAL MAX IMPL, V29, P14, DOI 10.11607/jomi.2014suppl.g1.1
   Langer B, 2010, INT J PERIODONT REST, V30, P227
   LeGeros R.Z., 1993, J BONE MINER RES, V8, P583
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Merli M, 2007, INT J ORAL MAX IMPL, V22, P373
   Moses O, 2005, CLIN ORAL IMPLAN RES, V16, P210, DOI 10.1111/j.1600-0501.2004.01100.x
   NYMAN S, 1987, J PERIODONTAL RES, V22, P252, DOI 10.1111/j.1600-0765.1987.tb01581.x
   Pappalardo S, 2013, J BIOMATER TISS ENG, V3, P1
   PINHOLT EM, 1991, SCAND J DENT RES, V99, P154
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   Simion M, 1997, INT J ORAL MAX IMPL, V12, P159
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P166
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Smiler Dennis, 2006, Implant Dent, V15, P122, DOI 10.1097/01.id.0000217780.69637.cc
   Stavropoulos A, 2003, J CLIN PERIODONTOL, V30, P636, DOI 10.1034/j.1600-051X.2003.00093.x
   Stavropoulos A, 2001, Clin Implant Dent Relat Res, V3, P156, DOI 10.1111/j.1708-8208.2001.tb00136.x
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Tinti C, 1998, Int J Periodontics Restorative Dent, V18, P434
   Urban IA, 2013, INT J PERIODONT REST, V33, P299, DOI 10.11607/prd.1407
   Urban IA, 2011, INT J ORAL MAX IMPL, V26, P404
   von Arx T, 2005, INT J ORAL MAX IMPL, V20, P843
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8
NR 44
TC 0
Z9 0
U1 0
U2 10
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0033-6572
EI 1936-7163
J9 QUINTESSENCE INT
JI Quintessence Int.
PD SEP
PY 2015
VL 46
IS 8
BP 717
EP 724
DI 10.3290/j.qi.a34178
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP2KB
UT WOS:000359704800008
PM 25988192
DA 2018-10-20
ER

PT J
AU Pal, S
   Jain, S
   Meena, PL
AF Pal, Sunita
   Jain, Swati
   Meena, P. L.
TI Preparation of Bio-Based Green Gels from Natural Biomaterial
SO ADVANCED SCIENCE LETTERS
LA English
DT Proceedings Paper
CT International Workshop / Conference on Computational Condensed Matter
   Physics and Materials Science (IWCCMP)
CY NOV 25-30, 2014
CL Atal Bihari Vajpayee Indian Inst Informat Technol & Management, Gwalior,
   INDIA
HO Atal Bihari Vajpayee Indian Inst Informat Technol & Management
DE Redox Initiator; HMA; Hydrogels; Grafting; Cross-Linking
ID GRAFT-COPOLYMERS; METHACRYLATE; MEMBRANES; POLYMER; XYLOGLUCAN;
   HYDROGELS
AB The present paper deals with the design of bio based green gels prepared by using redox initiator. In this process grafting of 2-hydroxymethacrylate (HMA) onto psyllium is done by using a ceric ammonium nitrate (CAN) as an initiator in presence of inert atmosphere created by passing of nitrogen in aqueous solution. Confirmation of grafting is checked by characterizing and comparing it through the Fourier Transform Infrared (FTIR) spectroscopy and Scanning Electron Microscopy (SEM) techniques. The best parameter for synthesis were obtained at psyllium = 1.0 g, CAN = 1.5 x 10(-3) mol/It, HMA = 3.12 x 10(-2) mol/It, reaction temperature = 30 degrees C, reaction time = 2 hrs. For cross-linking N,N-methylenebisacrylamide = 5.64 x 10(-2) mol/It. After analyzing results it shows that these hydrogels shows a high water absorption capacity therefore can be used for drug delivery system and wastewater treatment.
C1 [Pal, Sunita] Univ Mumbai, Dept Sci & Humanities, Saraswati Coll Engn, Navi Mumbai 410210, Maharastra, India.
   [Meena, P. L.] GB Pant Coll Engn, Dept Chem, New Delhi 110020, India.
   [Jain, Swati] Univ Delhi, Deen Dayal Upadhyaya Coll, Dept Phys, New Delhi 110015, India.
RP Meena, PL (reprint author), GB Pant Coll Engn, Dept Chem, New Delhi 110020, India.
CR Andrade J. D., 1975, J COLLOID INTERF SCI, V3, P1
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   Chen Y, 2006, CARBOHYD RES, V341, P887, DOI 10.1016/j.carres.2006.01.027
   DAVIES ML, 1992, BIOMATERIALS, V13, P971, DOI 10.1016/0142-9612(92)90147-G
   DESHMUKH SR, 1986, J APPL POLYM SCI, V32, P6163, DOI 10.1002/app.1986.070320803
   Hanson S. R, 1980, BIOMATERIALS, V11, P519
   Mishra A, 2008, POLYM ADVAN TECHNOL, V19, P99, DOI 10.1002/pat.973
   Mishra A, 2007, CARBOHYD POLYM, V68, P95, DOI 10.1016/j.carbpol.2006.07.014
   Mishra A, 2012, CARBOHYD POLYM, V87, P1899, DOI 10.1016/j.carbpol.2011.09.068
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   NISHIOKA N, 1989, POLYMER, V30, P182, DOI 10.1016/0032-3861(89)90401-1
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   RAO JK, 1994, BIOMATERIALS, V15, P383, DOI 10.1016/0142-9612(94)90251-8
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1
   Wichterle O., 1971, ENCYCLOPEDIA POLYMER, P273
   YAO KJ, 1992, J APPL POLYM SCI, V45, P349, DOI 10.1002/app.1992.070450217
NR 17
TC 0
Z9 0
U1 0
U2 2
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
EI 1936-7317
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD SEP
PY 2015
VL 21
IS 9
BP 2898
EP 2901
DI 10.1166/asl.2015.6335
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD2SG
UT WOS:000369771900053
DA 2018-10-20
ER

PT J
AU Van de Walle, AB
   Uzarski, JS
   McFetridge, PS
AF Van de Walle, Aurore B.
   Uzarski, Joseph S.
   McFetridge, Peter S.
TI The Consequence of Biologic Graft Processing on Blood Interface
   Biocompatibility and Mechanics
SO CARDIOVASCULAR ENGINEERING AND TECHNOLOGY
LA English
DT Article
DE Biocompatibility; Biomaterial; Decellularization; Flow chamber; Human
   umbilical vein; Vascular tissue engineering; Thrombosis
ID HUMAN UMBILICAL VEIN; VASCULAR GRAFTS; TISSUE; BYPASS; BIOMATERIALS;
   NEUTROPHIL; ACTIVATION; FLOW; REVASCULARIZATION; DECELLULARIZATION
AB Processing ex vivo derived tissues to reduce immunogenicity is an effective approach to create biologically complex materials for vascular reconstruction. Due to the sensitivity of small diameter vascular grafts to occlusive events, the effect of graft processing on critical parameters for graft patency, such as peripheral cell adhesion and wall mechanics, requires detailed analysis. Isolated human umbilical vein sections were used as model allogenic vascular scaffolds that were processed with either: 1. sodium dodecyl sulfate (SDS), 2. ethanol/acetone (EtAc), or 3. glutaraldehyde (Glu). Changes in material mechanics were assessed via uniaxial tensile testing. Peripheral cell adhesion to the opaque grafting material was evaluated using an innovative flow chamber that allows direct observation of the blood-graft interface under physiological shear conditions. All treatments modified the grafts tensile strain and stiffness properties, with physiological modulus values decreasing from Glu 240 +/- 12 kPa to SDS 210 +/- 6 kPa and EtAc 140 +/- 3 kPa, p<.001. Relative to glutaraldehyde treatments, neutrophil adhesion to the decellularized grafts increased, with no statistical difference observed between SDS or EtAc treatments. Early platelet adhesion (% surface coverage) showed no statistical difference between the three treatments; however, quantification of platelet aggregates was significantly higher on SDS scaffolds compared to EtAc or Glu. Tissue processing strategies applied to the umbilical vein scaffold were shown to modify structural mechanics and cell adhesion properties, with the EtAc treatment reducing thrombotic events relative to SDS treated samples. This approach allows time and cost effective prescreening of clinically relevant grafting materials to assess initial cell reactivity.
C1 [Van de Walle, Aurore B.; Uzarski, Joseph S.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, 1275 Ctr Dr,POB 116131, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, 1275 Ctr Dr,POB 116131, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
OI Van de Walle, Aurore/0000-0003-1579-9145
FU National Institutes of Health [R01-HL088207, R01-HL088207-03S1]
FX The authors would like to thank Dr. Christopher Cogle and the UF
   Clinical and Translational Science Institute for their assistance with
   blood draws. We also thank Dr. Cogle for contributing the GFP + HL-60
   cells for this study and Jorge Sefair for his comments on the
   statistical analyses. This work was supported by the National Institutes
   of Health (R01-HL088207 and R01-HL088207-03S1).
CR Balasubramanian V, 2002, BLOOD, V100, P2787, DOI 10.1182/blood-2002-03-0902
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bastian F, 2008, BIOMATERIALS, V29, P1824, DOI 10.1016/j.biomaterials.2008.01.005
   Bhuyan AK, 2010, BIOPOLYMERS, V93, P186, DOI 10.1002/bip.21318
   Brown MA, 2010, ARTERIOSCL THROM VAS, V30, P2150, DOI 10.1161/ATVBAHA.110.207076
   Buonocore S, 2004, IMMUNOL LETT, V94, P163, DOI 10.1016/j.imlet.2004.04.017
   Cardozo LAM, 2004, TRANSPLANTATION, V78, P1721, DOI 10.1097/01.TP.0000147341.40485.B4
   Coughlin MF, 2008, BIOPHYS J, V94, P1046, DOI 10.1529/biophysj.107.107102
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dardik A, 2011, REGENERATIVE MEDICINE USING PREGNANCY-SPECIFIC BIOLOGICAL SUBSTANCES, P189, DOI 10.1007/978-1-84882-718-9_19
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   EYBL E, 1992, J THORAC CARDIOV SUR, V104, P763
   GARRETT HE, 1973, JAMA-J AM MED ASSOC, V223, P792, DOI 10.1001/jama.223.7.792
   Gibson KD, 2001, J VASC SURG, V34, P694, DOI 10.1067/mva.2001.117890
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348
   Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585
   Hirayama S, 2006, MOL MED, V12, P208, DOI 10.2119/2006-00036.Hirayama
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4
   LIN PJ, 1994, ANN THORAC SURG, V58, P782, DOI 10.1016/0003-4975(94)90749-8
   Mayranpaa M, 2004, EUR J CARDIO-THORAC, V25, P560, DOI 10.1016/j.ejcts.2004.01.006
   Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01
   Mollinedo F, 2008, GENE, V419, P16, DOI 10.1016/j.gene.2008.04.015
   Montoya CV, 2009, TISSUE ENG PART C-ME, V15, P191, DOI 10.1089/ten.tec.2008.0372
   Moore M, 2012, J BIOMED MATER RES A, V100A, P2194, DOI 10.1002/jbm.a.34092
   Nemcova S, 2001, J INVEST SURG, V14, P321, DOI 10.1080/089419301753435693
   Neufang A, 2007, J VASC SURG, V46, P280, DOI 10.1016/j.jvs.2007.03.054
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995
   Rieder E, 2006, BIOMATERIALS, V27, P5634, DOI 10.1016/j.biomaterials.2006.06.020
   Sasaki Y, 2000, HEART, V83, P69, DOI 10.1136/heart.83.1.69
   SIMIONESCU A, 1991, J BIOMED MATER RES, V25, P1495, DOI 10.1002/jbm.820251207
   Tosun Z, 2013, BIOTECHNOL BIOENG, V110, P2035, DOI 10.1002/bit.24934
   Uzarski JS, 2014, TISSUE ENG PART C-ME, V20, P116, DOI [10.1089/ten.tec.2012.0771, 10.1089/ten.TEC.2012.0771]
   Uzarski JS, 2013, J BIOMED MATER RES A, V101, P123, DOI 10.1002/jbm.a.34308
   Van de Walle AB, 2012, ACTA BIOMATER, V8, P4080, DOI 10.1016/j.actbio.2012.07.013
   Zhang JN, 2002, THROMB HAEMOSTASIS, V88, P817
NR 44
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1869-408X
EI 1869-4098
J9 CARDIOVASC ENG TECHN
JI Cardiovasc. Eng. Technol.
PD SEP
PY 2015
VL 6
IS 3
BP 303
EP 313
DI 10.1007/s13239-015-0221-2
PG 11
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical
SC Cardiovascular System & Cardiology; Engineering
GA DS1LJ
UT WOS:000380356800009
PM 26322140
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kanazawa, T
   Shizawa, Y
   Takeuchi, M
   Tamano, K
   Ibaraki, H
   Seta, Y
   Takashima, Y
   Okada, H
AF Kanazawa, Takanori
   Shizawa, Yuki
   Takeuchi, Mayu
   Tamano, Kuniko
   Ibaraki, Hisako
   Seta, Yasuo
   Takashima, Yuuki
   Okada, Hiroaki
TI Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with
   Functional Peptides Containing Sericin-Based Hydrogel for Atopic
   Dermatitis
SO PHARMACEUTICS
LA English
DT Article
DE atopic dermatitis; skin topical application; siRNAs; NF-kappa B;
   sericin; hydrogel
AB The small interfering RNA (siRNA) is suggested to offer a novel means of treating atopic dermatitis (AD) because it allows the specific silencing of genes related to AD pathogenesis. In our previous study, we found that siRNA targeted against RelA, an important nuclear factor-kappa B (NF-kappa B) subdomain, with functional peptides, showed therapeutic effects in a mouse model of AD. In the present study, to develop a topical skin application against AD, we prepared a hydrogel containing anti-RelA siRNA and functional peptides and determined the intradermal permeation and the anti-AD effects in an AD mouse model. We selected the silk protein, sericin (SC), which is a versatile biocompatible biomaterial to prepare hydrogel as an aqueous gel base. We found that the siRNA was more widely delivered to the site of application in AD-induced ear skin of mice after topical application via the hydrogel containing functional peptides than via the preparation without functional peptides. In addition, the ear thickness and clinical skin severity of the AD-induced mice treated with hydrogel containing anti-RelA siRNA with functional peptides improved more than that of mice treated with the preparation formulated with negative siRNA.
C1 [Kanazawa, Takanori; Shizawa, Yuki; Takeuchi, Mayu; Tamano, Kuniko; Ibaraki, Hisako; Seta, Yasuo; Takashima, Yuuki; Okada, Hiroaki] Tokyo Univ Pharm & Life Sci, Dept Pharmaceut Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
RP Kanazawa, T (reprint author), Tokyo Univ Pharm & Life Sci, Dept Pharmaceut Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM kanazawa@toyaku.ac.jp; ykshizawa@gmail.com; mayu.2.takeuchi@gmail.com;
   tamano.kuniko.f8@gmail.com; ibaraki@toyaku.ac.jp; setayas@toyaku.ac.jp;
   takasima@toyaku.ac.jp; okada@toyaku.ac.jp
FU Japan Society for the Promotion of Science [22790049]; Promotion and
   Mutual Aid Corporation for Private Schools of Japan
FX We thank Ayumu Nishida and Masaki Yamada (Kissei Pharmaceutical Co.,
   Ltd., Nagano, Japan) for their kind assistance with the SC hydrogel
   preparation. This study was partly supported by a Grant-in-Aid for Young
   Scientists (B) (22790049) from the Japan Society for the Promotion of
   Science, and partly by a grant for private Universities provided by the
   Promotion and Mutual Aid Corporation for Private Schools of Japan.
CR Cheer S M, 2001, Am J Clin Dermatol, V2, P389, DOI 10.2165/00128071-200102060-00005
   Chen M, 2014, J CONTROL RELEASE, V179, P33, DOI 10.1016/j.jconrel.2014.01.006
   Dajee M, 2006, J INVEST DERMATOL, V126, P1792, DOI 10.1038/sj.jid.5700307
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Desai PR, 2013, J CONTROL RELEASE, V170, P51, DOI 10.1016/j.jconrel.2013.04.021
   Haigh O, 2014, J CONTROL RELEASE, V194, P148, DOI 10.1016/j.jconrel.2014.08.021
   Hou YW, 2007, EXP DERMATOL, V16, P999, DOI 10.1111/j.1600-0625.2007.00622.x
   Hsu T, 2011, P NATL ACAD SCI USA, V108, P15816, DOI 10.1073/pnas.1016152108
   Kanazawa T, 2015, INT J PHARMACEUT, V489, P261, DOI 10.1016/j.ijpharm.2015.05.003
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Kigasawa K, 2010, INT J PHARMACEUT, V383, P157, DOI 10.1016/j.ijpharm.2009.08.036
   Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484
   Lopes LB, 2005, PHARM RES, V22, P750, DOI 10.1007/s11095-005-2591-x
   Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894
   Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724
   Nasrollahi SA, 2012, CHEM BIOL DRUG DES, V80, P639, DOI 10.1111/cbdd.12008
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Nishida A, 2010, CHEM PHARM BULL, V58, P1480, DOI 10.1248/cpb.58.1480
   Partidos CD, 2003, VACCINE, V21, P776, DOI 10.1016/S0264-410X(02)00597-2
   Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x
   Robbins PB, 2002, BIOTECHNIQUES, V33, P190, DOI 10.2144/02331dd02
   Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359
   Siu KS, 2014, BIOMATERIALS, V35, P3435, DOI 10.1016/j.biomaterials.2013.12.079
   Uchida T, 2011, J PHARMACOL EXP THER, V338, P443, DOI 10.1124/jpet.111.180042
   Uchida T, 2011, CHEM PHARM BULL, V59, P196, DOI 10.1248/cpb.59.196
   Wei ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07618
   Wei ZW, 2014, LAB CHIP, V14, P4093, DOI 10.1039/c4lc00800f
   Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 29
TC 8
Z9 8
U1 1
U2 2
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD SEP
PY 2015
VL 7
IS 3
BP 294
EP 304
DI 10.3390/pharmaceutics7030294
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA VB8JQ
UT WOS:000418789700015
PM 26371030
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU El-Refaie, WM
   Elnaggar, YSR
   El-Massik, MA
   Abdallah, OY
AF El-Refaie, Wessam M.
   Elnaggar, Yosra S. R.
   El-Massik, Magda A.
   Abdallah, Ossama Y.
TI Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management
   of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE elastic nanovesicles; gel-core; hyaluronic acid; osteoarthritis;
   transdermal
ID HYALURONIC-ACID; SKIN DELIVERY; ULTRADEFORMABLE LIPOSOMES; TOPICAL
   DELIVERY; VACCINE DELIVERY; TRANSFERSOMES; VESICLES; CARRIER;
   NANOEMULSION; PENETRATION
AB Hyaluronic acid (HA) is an imperative biomaterial with desirable rheological properties to alleviate symptoms of osteoarthritis. Nevertheless, scantly percutaeous permeation of this macromolecule handicaps its effective use for orthopedics and triggers intra-articular injection as the only surrogate. This study presents novel self-assembeld HA-based gel core elastic nanovesicles, (hyaluosomes; GC-HS), for non-invasive transdermal delivery of HA.
   GC-HS were prepared with 1% HA using simple film hydration technique. Their size, zeta potential, percentage entrapment efficiency (% EE), elasticity, and ex-vivo transdermal permeation were evaluated compared to conventional liposomes CL. Structure elucidation of the formed novel system was performed using light, polarizing and transmission electron microscopy. In-vivo permeation of GC-HS through knee joints of female Sprague Dawley rats was compared to CL and HA alone.
   GC-HS showed nanosize (232.8 +/- 7.2), high negative zeta potential (-45.1 +/- 8.3) and higher elasticity (size alteration 5.43%) compared to CL. This novel system has self-penetration enhancing properties compared to CL and plain gel. GC-HS showed self-assembled properties and high physically stable for at least 6 months at 4A degrees C. Ex-vivo permeation of HS was significantly higher than CL and plain HA gel alone. In-vivo study exhibited significant six folds increase in transdermal permeation of HA to knee joints from GC-HS compared to plain HA gel.
   Novel GC-HS are promising nanogels for topical management of osteoarthritis surrogating the need for intra-articular injection.
C1 [El-Refaie, Wessam M.; El-Massik, Magda A.] Pharos Univ Alexandria, Fac Pharm & Drug Mfg, Dept Pharmaceut, Alexandria, Egypt.
   [Elnaggar, Yosra S. R.; Abdallah, Ossama Y.] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt.
RP Elnaggar, YSR (reprint author), Univ Alexandria, Fac Pharm, Dept Pharmaceut, 1 Khartoum Sq,Messalla PO,POB 21521, Alexandria, Egypt.
EM yosra_pharm@yahoo.com
OI Elnaggar, Yosra/0000-0002-6939-7777
CR An E, 2012, LANGMUIR, V28, P4095, DOI 10.1021/la2046349
   Bahia APCO, 2010, EUR J PHARM SCI, V39, P90, DOI 10.1016/j.ejps.2009.10.016
   BALAZS EA, 1993, J RHEUMATOL, V20, P3
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Birkenfeld B, 2011, POL J VET SCI, V14, P621, DOI 10.2478/v10181-011-0092-x
   Bragagni M, 2012, DRUG DELIV, V19, P354, DOI 10.3109/10717544.2012.724472
   Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x
   Brown TJ, 1999, J INVEST DERMATOL, V113, P740, DOI 10.1046/j.1523-1747.1999.00745.x
   CEVC G, 1992, BIOCHIM BIOPHYS ACTA, V1104, P226, DOI 10.1016/0005-2736(92)90154-E
   Chen M, 2014, J CONTROL RELEASE, V173, P67, DOI 10.1016/j.jconrel.2013.10.007
   Duangjit S, 2014, BIOL PHARM BULL, V37, P239, DOI 10.1248/bpb.b13-00576
   El Maghraby GMM, 2000, INT J PHARMACEUT, V196, P63, DOI 10.1016/S0378-5173(99)00441-X
   El Maghraby GMM, 1999, J PHARM PHARMACOL, V51, P1123, DOI 10.1211/0022357991776813
   Elnaggar YSR, 2014, J CONTROL RELEASE, V180, P10, DOI 10.1016/j.jconrel.2014.02.004
   Elnaggar YSR, 2011, INT J NANOMED, V6, P3195, DOI 10.2147/IJN.S25825
   Elnaggar YSR, 2011, INT J NANOTECHNOL, V8, P749, DOI 10.1504/IJNT.2011.041443
   Elsayed MMA, 2006, INT J PHARM, V322, P60, DOI 10.1016/j.ijpharm.2006.05.027
   Fagnola M, 2009, CONTACT LENS ANTERIO, V32, P108, DOI 10.1016/j.clae.2009.02.006
   Fang YP, 2008, INT J PHARM, V356, P144, DOI 10.1016/j.ijpharm.2008.01.020
   Freag M.S., 2013, INT J PHARMACEUT, V454, P642
   Gaafar PM, 2014, J LIPOSOME RES, V24, P1
   Gupta Ankit, 2012, Sci Pharm, V80, P1061, DOI 10.3797/scipharm.1208-02
   Gupta PN, 2005, INT J PHARM, V293, P73, DOI 10.1016/j.ijpharm.2004.12.022
   Helwa Y, 2013, SOFT MATTER, V9, P6151, DOI 10.1039/c3sm50837d
   Hiruta Y, 2006, J CONTROL RELEASE, V113, P146, DOI 10.1016/j.jconrel.2006.04.016
   Kage M, 2013, ARCH DERMATOL RES, V305, P69, DOI 10.1007/s00403-012-1252-2
   KIRBY C, 1984, BIO-TECHNOL, V2, P979, DOI 10.1038/nbt1184-979
   Kong M, 2011, CARBOHYD POLYM, V86, P837, DOI 10.1016/j.carbpol.2011.05.027
   Kong M, 2011, CARBOHYD POLYM, V83, P1303, DOI 10.1016/j.carbpol.2010.09.041
   KUTSCH H, 1989, FRESEN Z ANAL CHEM, V333, P810, DOI 10.1007/BF00472770
   Lei W, 2013, ASIAN J PHARM SCI, V8, P336, DOI 10.1016/j.ajps.2013.09.005
   Malakar J, 2012, SAUDI PHARM J, V20, P355, DOI 10.1016/j.jsps.2012.02.001
   Manosroi A, 2003, COLLOID SURFACE B, V30, P129, DOI 10.1016/S0927-7765(03)00080-8
   Muller-Goymann CC, 2004, EUR J PHARM BIOPHARM, V58, P343, DOI 10.1016/j.ejpb.2004.03.028
   Nikalje AP, 2012, INT J RES PHARM SCI, V2, P1
   Oka T, 2008, J OLEO SCI, V57, P567, DOI 10.5650/jos.57.567
   Rachakonda VK, 2008, PHARM RES-DORDR, V25, P2697, DOI 10.1007/s11095-008-9696-y
   Robert L, 2010, PATHOL BIOL, V58, P187, DOI 10.1016/j.patbio.2009.09.010
   Salk RS, 2006, J BONE JOINT SURG AM, V88A, P295, DOI 10.2106/JBJS.E.00193
   Saranraj P, 2011, INT J PHARM BIOL ARC, V2, P954
   Tiwari S, 2009, J CONTROL RELEASE, V140, P157, DOI 10.1016/j.jconrel.2009.08.004
   Tiwari S, 2009, J MICROENCAPSUL, V26, P75, DOI 10.1080/02652040802170897
   Touitou E, 2005, PERCUTANEOUS PENETRA
   Vyas L.K., 2013, INT J PHARM PHARM SC, V5, P512
   Witteveen Angelique G H, 2010, Foot Ankle Surg, V16, P159, DOI 10.1016/j.fas.2009.10.003
   Yang T, 2007, INT J PHARM, V338, P317, DOI 10.1016/j.ijpharm.2007.02.011
NR 46
TC 14
Z9 15
U1 0
U2 26
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD SEP
PY 2015
VL 32
IS 9
BP 2901
EP 2911
DI 10.1007/s11095-015-1672-8
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CO4OR
UT WOS:000359140800009
PM 25777613
DA 2018-10-20
ER

PT J
AU Canzonieri, V
   Steffan, A
   Cervo, S
   Perin, T
   De Paoli, P
AF Canzonieri, V.
   Steffan, A.
   Cervo, S.
   Perin, T.
   De Paoli, P.
TI Systematic cancer tissue collection with associated hematological
   biomaterial: The CRO-Biobank experience in a clinical setting
SO VIRCHOWS ARCHIV
LA English
DT Meeting Abstract
C1 [Canzonieri, V.] CRO Aviano IRCCS, Dept Pathol, Aviano, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD SEP
PY 2015
VL 467
SU 1
MA PS-18-007
BP S236
EP S236
PG 1
WC Pathology
SC Pathology
GA CO3KP
UT WOS:000359056402201
DA 2018-10-20
ER

PT J
AU Hong, MH
   Choi, HJ
   Ko, YM
   Lee, YK
AF Hong, Min-Ho
   Choi, Heon-Jin
   Ko, Yeong-Mu
   Lee, Yong-Keun
TI Engineered microstructure granules for tailored drug release rate
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE bone tissue engineering; microstructure; controlled drug release; EDC;
   NHS chemistry; hydroxyapatite; dexamethasone
ID CELLS-IN-VITRO; BONE-MARROW; OSTEOBLAST DIFFERENTIATION;
   DELIVERY-SYSTEM; SCAFFOLDS; HYDROXYAPATITE; DEXAMETHASONE; MICROSPHERES;
   EXPRESSION; PHOSPHATE
AB Biomaterials developed for controlled drug delivery have demonstrated excellent results in the present study. A biomaterial prepared using hydroxyapatite (HAp) was shown to have a hollow structure with the presence of interconnected pores to house drug carriers. The poly(lactic-co-glycolic acid) particles were used as drug carriers loaded with dexamethasone, a corticosteroid that is known to promote osteoinduction. The surface of the drug carriers was modified using polyethyleneimine, and then conjugated to the surface of HAp granules. The hollow HAp granules had drug carriers on both their inner and outer surfaces and showed a controlled drug release rate that was comparable to that of granules containing drug carriers on their outer surface alone. The pores were designed for insertion of drug carriers and preosteoblasts. Consequently, the biomaterials influenced cellular behavior by first promoting cell proliferation and then inducing early stage osteogenic differentiation. The effects of controlled release rate were evidenced for up to two weeks after cell seeding, resulting in an increase of osteogenic differentiation. In summary, drug carriers loaded onto hollow HAp granules were shown to be suitable for patients who require replacement of missing bone for repair of bone fractures that are extremely complex, pose a significant health risk to the patient, or fail to heal properly. Biotechnol. Bioeng. 2015;112: 1936-1947. (c) 2015 Wiley Periodicals, Inc.
C1 [Hong, Min-Ho; Choi, Heon-Jin] Yonsei Univ, Dept Mat Sci & Engn, Seoul 120749, South Korea.
   [Ko, Yeong-Mu; Lee, Yong-Keun] Chosun Univ, Sch Dent, Res Ctr Oral Dis Regulat Aged, Gwangju 501759, South Korea.
RP Lee, YK (reprint author), Chosun Univ, Sch Dent, Res Ctr Oral Dis Regulat Aged, 309 Pilmun Daero, Gwangju 501759, South Korea.
EM leeyk0129@naver.com
OI Hong, Min-Ho/0000-0001-9268-9906
FU Korea government MSIP [2008-0062283, 2014M3A7B4051594]; Yonsei-SNU
   Collaborative Research Fund
FX Contract grant sponsor: Korea government MSIP; Grant numbers:
   2008-0062283; 2014M3A7B4051594; Contract grant sponsor: Yonsei-SNU
   Collaborative Research Fund
CR Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   ANDERSON RE, 1984, IN VITRO CELL DEV B, V20, P847
   Barnett CP, 2011, EUR J HUM GENET, V19, P624, DOI 10.1038/ejhg.2010.259
   Boonsongrit Y, 2008, MATER SCI ENG B-ADV, V148, P162, DOI 10.1016/j.mseb.2007.09.006
   CHEN TL, 1983, ENDOCRINOLOGY, V112, P1739, DOI 10.1210/endo-112-5-1739
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a
   Dinopoulos H, 2012, SURG-J R COLL SURG E, V10, P230, DOI 10.1016/j.surge.2012.04.001
   Ducheyne P, 1984, METAL CERAMIC BIOMAT
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Franceschi RT, 2009, CELLS TISSUES ORGANS, V189, P144, DOI 10.1159/000151747
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GREEN S, 1986, NATURE, V324, P615, DOI 10.1038/324615a0
   Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Hong D, 2008, J STEROID BIOCHEM, V111, P164, DOI 10.1016/j.jsbmb.2008.06.015
   Hong MH, 2014, J MATER SCI-MATER M, V25, P1991, DOI 10.1007/s10856-014-5225-1
   Hong MH, 2014, ANN BIOMED ENG, V42, P1424, DOI 10.1007/s10439-013-0926-z
   Hong MH, 2013, CERAM INT, V39, P4991, DOI 10.1016/j.ceramint.2012.11.096
   Hong MH, 2012, MICRO NANO LETT, V7, P634, DOI 10.1049/mnl.2012.0321
   Hong MH, 2011, J MATER SCI-MATER M, V22, P349, DOI 10.1007/s10856-010-4197-z
   International Organization for Standardization SAIGILI, 2009, 10993122007 ISO
   Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasturi SP, 2005, BIOMATERIALS, V26, P6375, DOI 10.1016/j.biomaterials.2005.03.043
   KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim SM, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-78
   Kwun IS, 2010, BONE, V46, P732, DOI 10.1016/j.bone.2009.11.003
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Murshid SA, 2007, J BONE MINER METAB, V25, P151, DOI 10.1007/s00774-006-0745-5
   Polard E, 1996, INT J PHARM, V134, P37, DOI 10.1016/0378-5173(95)04402-7
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Sendzik J, 2010, INT J ANTIMICROB AG, V35, P366, DOI 10.1016/j.ijantimicag.2009.10.009
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Siepmann J, 2012, ADV DEL SCI TECHNOL, P1, DOI 10.1007/978-1-4614-0881-9
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Son JS, 2011, J CONTROL RELEASE, V153, P133, DOI 10.1016/j.jconrel.2011.03.010
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Taherian M, 2014, ELECTRON MATER LETT, V10, P393, DOI 10.1007/s13391-013-3211-2
   Xu LL, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065010
   Yang RS, 2005, BONE, V36, P276, DOI 10.1016/j.bone.2004.10.009
NR 51
TC 3
Z9 3
U1 1
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD SEP
PY 2015
VL 112
IS 9
BP 1936
EP 1947
DI 10.1002/bit.25595
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CN7UX
UT WOS:000358640600021
PM 25851987
DA 2018-10-20
ER

PT J
AU Di Nisio, C
   De Colli, M
   di Giacomo, V
   Rapino, M
   Di Valerio, V
   Marconi, GD
   Gallorini, M
   Di Giulio, M
   Cataldi, A
   Zara, S
AF Di Nisio, C.
   De Colli, M.
   di Giacomo, V.
   Rapino, M.
   Di Valerio, V.
   Marconi, G. D.
   Gallorini, M.
   Di Giulio, M.
   Cataldi, A.
   Zara, S.
TI A dual role for beta 1 integrin in an in vitro Streptococcus mitis/human
   gingival fibroblasts co-culture model in response to TEGDMA
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE co-culture; HGFs; inflammation; matrix metalloproteinases; tissue
   remodelling; beta 1 integrin
ID DENTAL RESTORATIVE MATERIALS; NF-KAPPA-B; 2-HYDROXYETHYL METHACRYLATE;
   MATRIX METALLOPROTEINASES; RESIN MONOMERS; PORPHYROMONAS-GINGIVALIS;
   ALPHA-5-BETA-1 INTEGRINS; ENDOTHELIAL-CELLS; GENE-EXPRESSION;
   PROTEIN-I/II
AB Aim To evaluate the effect of TEGDMA on human gingival fibroblasts (HGFs) in vitro co-cultured with Streptococcus mitis, focusing on the signalling pathways underlying cell tissue remodelling and inflammatory response processes.
   Methodology beta 1 integrin expression was evaluated by means of imaging flow cytometry. The Western blot technique was used to investigate the expression of protein kinase C (PKC), extracellular signal-regulated kinase (ERK), matrix metalloproteinase 9 (MMP9) and 3 (MMP3). RT-PCR was performed to quantify nuclear factor-kb subunits (Nf-kb1, ReLa), IkB kinase (IkBkB), cyclooxygenase II (COX-2) and tumour necrosis factor-alpha (TNF-alpha) mRNA levels. Statistical analysis was performed using the analysis of variance (ANOVA).
   Results When HGFs are co-cultured with S.mitis, beta 1 integrin intensity, phosphorylated PKC (p-PKC), activated ERK (p-ERK), IkBkB mRNA level and MMP9 expression increased (for all molecules P < 0.05 HGFs versus HGFs co-cultured with S.mitis). A higher level of MMP3 in HGFs treated with TEGDMA was recorded (P < 0.05 HGFs versus HGFs exposed to TEGDMA). COX-2 inflammatory factor mRNA level appeared higher in HGFs exposed to 1mmolL(-1) TEGDMA (P < 0.01 HGFs versus HGFs exposed to TEGDMA), whereas TNF-alpha gene expression was higher in HGFs co-cultured with S.mitis (P < 0.05 HGFs versus HGFs co-cultured with S.mitis).
   Conclusions beta 1 integrin triggered the signalling pathway, transduced by p-PKC alpha and involving ERK 1 and 2 and MMPs. This pathway resulted in an unbalanced equilibrium in tissue remodelling process, along with inflammatory response when HGFs are exposed to bacteria or biomaterial alone. On the contrary, the TEGDMA/S.mitis combination restored the balance between extracellular matrix deposition and degradation and prevented an inflammatory response.
C1 [Di Nisio, C.; De Colli, M.; di Giacomo, V.; Marconi, G. D.; Gallorini, M.; Di Giulio, M.; Cataldi, A.; Zara, S.] Univ G dAnnunzio, Dept Pharm, Sect Human Anat, I-66100 Chieti, Italy.
   [Rapino, M.] CNR, Inst Mol Genet, Unit Chieti, Chieti, Italy.
   [Di Valerio, V.] Univ G dAnnunzio, Dept Med & Aging Sci, I-66100 Chieti, Italy.
RP Zara, S (reprint author), Univ G dAnnunzio, Dept Pharm, Sect Human Anat, Via Vestini 31, I-66100 Chieti, Italy.
EM s.zara@unich.it
OI Gallorini, Marialucia/0000-0002-2283-4159
FU MIUR FIRB-Accordi di Programma 2010 Project
FX Authors would like to thank MIUR FIRB-Accordi di Programma 2010 Project
   'Processi degenerativi dei tessuti mineralizzati del cavo orale, impiego
   di bio-materiali e controllo delle interazioni con i microrganismi
   dell'ambiente' for the fellowships attributed to Dr. M. De Colli. No
   benefit of any kind will be received either directly or indirectly by
   the authors.
CR Al-Okla S, 1999, CELL MICROBIOL, V1, P157, DOI 10.1046/j.1462-5822.1999.00016.x
   Bakopoulou A, 2009, INT J MOL SCI, V10, P3861, DOI 10.3390/ijms10093861
   Becher R, 2006, DENT MATER, V22, P630, DOI 10.1016/j.dental.2005.05.013
   Bouillaguet S, 1996, J ENDODONT, V22, P244, DOI 10.1016/S0099-2399(06)80141-X
   Bulmanski Z, 2012, J PERIODONTOL, V83, P787, DOI 10.1902/jop.2011.110395
   Cataldi A, 2013, J BIOMED MATER RES A, V101, P378, DOI 10.1002/jbm.a.34337
   Chang HH, 2012, INT ENDOD J, V45, P848, DOI 10.1111/j.1365-2591.2012.02042.x
   Costa CAD, 1999, DENT MATER, V15, P434
   D'Ercole S, 2011, LETT APPL MICROBIOL, V52, P193, DOI 10.1111/j.1472-765X.2010.02985.x
   Di Giulio M, 2012, APMIS, V120, P139, DOI 10.1111/j.1600-0463.2011.02828.x
   disGiacomo V, 2013, INT ENDOD J, V46, P1164
   DisNisio C, 2013, INT ENDOD J, V46, P466
   Durner J, 2010, DENT MATER, V26, P91, DOI 10.1016/j.dental.2009.08.014
   Eckhardt A, 2009, BIOMATERIALS, V30, P2006, DOI 10.1016/j.biomaterials.2008.12.045
   Engels-Deutsch M, 2011, ARCH ORAL BIOL, V56, P22, DOI 10.1016/j.archoralbio.2010.08.010
   Galler KM, 2011, J DENT RES, V90, P257, DOI 10.1177/0022034510384618
   Gallorini M, 2013, J BIOMEDICAL MAT R A, V102, P3931
   Gutierrez-Venegas G, 2005, LIFE SCI, V77, P60, DOI 10.1016/j.lfs.2004.12.015
   HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Janke V, 2003, J DENT RES, V82, P814, DOI 10.1177/154405910308201010
   Kent LW, 1999, J PERIODONTOL, V70, P274, DOI 10.1902/jop.1999.70.3.274
   Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019
   Li XH, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/146142
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu CY, 2013, ACTA TROP, V127, P14, DOI 10.1016/j.actatropica.2013.03.004
   Miletic VJ, 2008, J BIOMED MATER RES B, V87B, P468, DOI 10.1002/jbm.b.31128
   Neff L, 2001, CELL MICROBIOL, V3, P703, DOI 10.1046/j.1462-5822.2001.00148.x
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Samuelsen JT, 2008, DENT MATER, V24, P134, DOI 10.1016/j.dental.2007.08.006
   Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001
   Schwengberg S, 2005, J DENT, V33, P49, DOI 10.1016/j.jdent.2004.08.001
   Sideridou ID, 2008, DENT MATER, V24, P737, DOI 10.1016/j.denta1.2007.08.004
   Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103
   Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022
   Spagnuolo G, 2004, J DENT RES, V83, P837, DOI 10.1177/154405910408301103
   Stewart PG, 2002, J PROSTHET DENT, V88, P277
   Surazynski A, 2005, PHARMACOL RES, V51, P217, DOI 10.1016/j.phrs.2004.08.004
   Tamai R, 2011, MICROB PATHOGENESIS, V51, P250, DOI 10.1016/j.micpath.2011.06.009
   Uzunova Y, 2008, J BIOCHEM BIOPH METH, V70, P883, DOI 10.1016/j.jbbm.2007.09.002
   Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044
   Vernier-Georgenthum A, 1998, CELL IMMUNOL, V187, P145, DOI 10.1006/cimm.1998.1327
   Volk J, 2006, DENT MATER, V22, P499, DOI 10.1016/j.dental.2005.06.002
   Wisniewska-Jarosinska M, 2011, MOL BIOL REP, V38, P4603, DOI 10.1007/s11033-010-0593-1
   Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948
   Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709
   Zara S, 2011, INT ENDOD J, V44, P1145, DOI 10.1111/j.1365-2591.2011.01935.x
NR 47
TC 2
Z9 2
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2885
EI 1365-2591
J9 INT ENDOD J
JI Int. Endod. J.
PD SEP
PY 2015
VL 48
IS 9
BP 839
EP 849
DI 10.1111/iej.12379
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN8II
UT WOS:000358683300003
PM 25231818
DA 2018-10-20
ER

PT J
AU Ngadiman, NHA
   Idris, A
   Irfan, M
   Kurniawan, D
   Yusof, NM
   Nasiri, R
AF Ngadiman, Nor Hasrul Akhmal
   Idris, Ani
   Irfan, Muhammad
   Kurniawan, Denni
   Yusof, Noordin Mohd
   Nasiri, Rozita
TI gamma-Fe2O3 nanoparticles filled polyvinyl alcohol as potential
   biomaterial for tissue engineering scaffold
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Electrospinning; Tissue engineering; Biomaterials; Nanofiber; Magnetic
   nanoparticle
ID IRON-OXIDE NANOPARTICLES; IN-VITRO; HEMODIALYSIS MEMBRANE; COMPOSITE
   SCAFFOLDS; NANOFIBER SCAFFOLDS; BONE REGENERATION; STEM-CELLS;
   ELECTROSPUN; FABRICATION; FIBERS
AB Maghemite (gamma-Fe2O3) nanoparticle with its unique magnetic properties is recently known to enhance the cell growth rate. In this study, gamma-Fe2O3 is mixed into polyvinyl alcohol (PVA) matrix and then electrospun to form nanofibers. Design of experiments was used to determine the optimum parameter settings for the electrospinning process so as to produce elctrospun mats with the preferred characteristics such as good morphology, Young's modulus and porosity. The input factors of the electrospinnning process were nanoparticles content (1-5%), voltage (25-35 kV), and flow rate (1-3 ml/h) while the responses considered were Young's modulus and porosity. Empirical models for both responses as a function of the input factors were developed and the optimum input factors setting were determined, and found to be at 5% nanoparticle content, 35 kV voltage, and 1 ml/h volume flow rate. The characteristics and performance of the optimum PVA/gamma-Fe2O3 nanofiber mats were compared with those of neat PVA nanofiber mats in terms of morphology, thermal properties, and hydrophilicity. The PVA/gamma-Fe2O3 nanofiber mats exhibited higher fiber diameter and surface roughness yet similar thermal properties and hydrophilicity compared to neat PVA PVA/gamma-Fe2O3 nanofiber mats. Biocompatibility test by exposing the nanofiber mats with human blood cells was performed. In terms of clotting time, the PVA/gamma-Fe2O3 nanofibers exhibited similar behavior with neat PVA. The PVA/gamma-Fe2O3 nanofibers also showed higher cells proliferation rate when MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was done using human skin fibroblast cells. Thus, the PVA/gamma-Fe2O3 electrospun nanofibers can be a promising biomaterial for tissue engineering scaffolds. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ngadiman, Nor Hasrul Akhmal; Kurniawan, Denni; Yusof, Noordin Mohd] Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
   [Idris, Ani; Irfan, Muhammad; Nasiri, Rozita] Univ Teknol Malaysia, Fac Chem Engn, Skudai, Malaysia.
RP Idris, A (reprint author), Univ Teknol Malaysia, Fac Chem Engn, Skudai, Malaysia.
EM ani@cheme.utm.my
RI Kurniawan, Denni/C-2703-2008
OI Kurniawan, Denni/0000-0002-4179-0454
FU Ministry of Higher Education (MOHE); Universiti Teknologi Malaysia
   (UTM); Research Management Center; Geran Universiti Penyelidikan (GUP)
   [Q.J130000.2524.06H09]
FX The authors wish to thank the Ministry of Higher Education (MOHE),
   Universiti Teknologi Malaysia (UTM) and Research Management Center, UTM
   for the financial support to this work through the Geran Universiti
   Penyelidikan (GUP) funding number Q.J130000.2524.06H09.
CR Abdal-hay A, 2013, CHEM ENG J, V215, P57, DOI 10.1016/j.cej.2012.10.046
   Akiyama H, 2010, BIOMATERIALS, V31, P1251, DOI 10.1016/j.biomaterials.2009.11.017
   Amarjargal A, 2013, EUR POLYM J, V49, P3796, DOI 10.1016/j.eurpolymj.2013.08.026
   Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215
   Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Attaluri A, 2011, INT J HYPERTHER, V27, P491, DOI 10.3109/02656736.2011.584856
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Brun P, 2011, ACTA BIOMATER, V7, P2526, DOI 10.1016/j.actbio.2011.02.025
   Fallahiarezoudar E, 2015, J DISPER SCI TECHNOL, V36, P28, DOI 10.1080/01932691.2014.888005
   Gao CX, 2012, J BIOMED MATER RES A, V100A, P1324, DOI 10.1002/jbm.a.34072
   Gloria A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0833
   Ha YM, 2013, COLLOID SURFACE B, V102, P795, DOI 10.1016/j.colsurfb.2012.09.018
   Haslauer C.M., 2013, J BIOMATER SCI   JAN, V1695-1712
   Idris A, 2012, J HAZARD MATER, V227, P309, DOI 10.1016/j.jhazmat.2012.05.065
   Idris A, 2010, WATER RES, V44, P1683, DOI 10.1016/j.watres.2009.11.026
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Lai KL, 2012, RSC ADV, V2, P13007, DOI 10.1039/c2ra22376g
   Lanza R., 2011, PRINCIPLES TISSUE EN
   Li LL, 2012, J MATER SCI-MATER M, V23, P547, DOI 10.1007/s10856-011-4495-0
   Li L, 2014, MAT SCI ENG C-MATER, V34, P252, DOI 10.1016/j.msec.2013.09.021
   Li LL, 2012, J MEMBRANE SCI, V405, P261, DOI 10.1016/j.memsci.2012.03.015
   Liao S, 2008, J MECH BEHAV BIOMED, V1, P252, DOI 10.1016/j.jmbbm.2008.01.007
   Linh NTB, 2010, J BIOMED MATER RES B, V95B, P184, DOI 10.1002/jbm.b.31701
   Long-Wee L., 2013, MALAYS J FUNDAM APPL, V10
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   Meng J, 2010, NANOSCALE, V2, P2565, DOI 10.1039/c0nr00178c
   Mikos A G, 2000, ELECTRON J BIOTECHN, V3, P23
   Montgomery DC, 2004, DESIGN ANAL EXPT, V7
   Morti S, 2003, J MEMBRANE SCI, V224, P39, DOI 10.1016/j.memsci.2003.06.001
   Nelson MT, 2012, PROC I MECH ENG PART, V226, P111, DOI 10.1177/1740349912450828
   Ngadiman N.H.A., 2014, P NAMRI SME, P42
   Nor Fethma M, 2012, P I MECH ENG H, V226, P693
   Qi YY, 2013, J APPL POLYM SCI, V127, P1885, DOI 10.1002/app.37924
   Qin XH, 2006, J APPL POLYM SCI, V102, P1285, DOI 10.1002/app.24361
   Rainer A, 2011, ANN BIOMED ENG, V39, P1882, DOI 10.1007/s10439-011-0289-2
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   Salifu AA, 2011, ANN BIOMED ENG, V39, P2510, DOI 10.1007/s10439-011-0350-1
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Shao DL, 2013, OPT MATER, V35, P563, DOI 10.1016/j.optmat.2012.10.026
   Shimizu K, 2007, J BIOSCI BIOENG, V103, P472, DOI 10.1263/jbb.103.472
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Singh Rajendra K., 2014, PLOS ONE, V9
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Su BH, 2008, J MATER SCI-MATER M, V19, P745, DOI 10.1007/s10856-007-3006-9
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Thien D. H., 2012, J MATER SCI, V48, P1640
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Vaquette C, 2013, ACTA BIOMATER, V9, P4599, DOI 10.1016/j.actbio.2012.08.015
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang C, 2012, J MATER SCI-MATER M, V23, P2381, DOI 10.1007/s10856-012-4669-4
   WATAHA JC, 1992, DENT MATER, V8, P65, DOI 10.1016/0109-5641(92)90056-I
   Wei Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055008
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Wu Y, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/1/015001
   Zhang HT, 2009, MATER LETT, V63, P1199, DOI 10.1016/j.matlet.2009.02.035
   Zhang HL, 2011, J BIOACT COMPAT POL, V26, P590, DOI 10.1177/0883911511424015
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
   Zheng QZ, 2006, J MEMBRANE SCI, V286, P7, DOI 10.1016/j.memsci.2006.09.033
NR 63
TC 16
Z9 16
U1 3
U2 82
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD SEP
PY 2015
VL 49
BP 90
EP 104
DI 10.1016/j.jmbbm.2015.04.029
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN2RQ
UT WOS:000358270000009
PM 26002419
DA 2018-10-20
ER

PT J
AU Li, P
   Jiang, S
   Yu, Y
   Yang, J
   Yang, ZY
AF Li, Pan
   Jiang, Shan
   Yu, Yan
   Yang, Jun
   Yang, Zhiyong
TI Biomaterial characteristics and application of silicone rubber and PVA
   hydrogels mimicked in organ groups for prostate brachytherapy
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Prostate brachytherapy; Organ group mockup; Polyvinyl alcohol hydrogel;
   Silicone rubber; Micro-structure; Mechanical properties
ID SOFT-TISSUE; BIOMEDICAL APPLICATIONS; NEEDLE INSERTION; SIMULATION
AB It is definite that transparent material with similar structural characteristics and mechanical properties to human tissue is favorable for experimental study of prostate brachytherapy. In this paper, a kind of transparent polyvinyl alcohol (PVA) hydrogel and silicone rubber are developed as suitable substitutions for human soft tissue. Segmentation and 3D reconstruction of medical image are performed to manufacture the mould of organ groups through rapid prototyping technology. Micro-structure observation, force test and CCD deformation test have been conducted to investigate the structure and mechanical properties of PVA hydrogel used in organ group mockup. Scanning electron microscope (SEM) image comparison results show that PVA hydrogel consisting of 3 g PVA, 17 g deionized water, 80 g dimethyl-sulfoxide (DMSO), 4 g NaCl, 1.5 g NaOH, 3 g epichlorohydrin (ECH) and 7 freeze/thaw cycles reveals similar micro-structure to human prostate tissue. Through the insertion force comparison between organ group mockup and clinical prostate brachytherapy, PVA hydrogel and silicone rubber are found to have the same mechanical properties as prostate tissue and muscle. CCD deformation test results show that insertion force suffers a sharp decrease and a relaxation of tissue deformation appears when needle punctures the capsule of prostate model. The results exhibit that organ group mockup consisting of PVA hydrogel, silicone rubber, membrane and agarose satisfies the needs of prostate brachytherapy simulation in general and can be used to mimic the soft tissues in pelvic structure. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Li, Pan; Jiang, Shan; Yang, Zhiyong] Tianjin Univ, Sch Mech Engn, Ctr Adv Mech & Robot, Tianjin 300072, Peoples R China.
   [Yu, Yan] Thomas Jefferson Univ, Dept Radiat Oncol, Kimmel Canc Ctr, Div Med Phys, Philadelphia, PA 19107 USA.
   [Yang, Jun] Tianjin Union Med Ctr, Dept Imaging, Tianjin 300121, Peoples R China.
RP Jiang, S (reprint author), Tianjin Univ, Sch Mech Engn, 92 Weijin Rd, Tianjin 300072, Peoples R China.
EM shanjmri@tju.edu.cn
FU National Natural Science Foundation of People's Republic of China
   [51175373]; New Century Educational Talents Plan of Chinese Education
   Ministry [NCET-10-0625]; Key Technology and Development Program of
   Tianjin Municipal Science and Technology Commission [12ZCDZSY10600]
FX We gratefully acknowledge the financial support from the National
   Natural Science Foundation of People's Republic of China (No. 51175373),
   the New Century Educational Talents Plan of Chinese Education Ministry
   (NCET-10-0625), and the Key Technology and Development Program of
   Tianjin Municipal Science and Technology Commission (No. 12ZCDZSY10600).
   The authors thank all staffs in Tianjin Union Medicine Center for
   clinical supervision. Technical assistance from professors in School of
   Mechanics and Centre for Advanced Mechanisms and Robotics are greatly
   acknowledged.
CR Ansari MZ, 2007, KEY ENG MATER, V345-346, P1241, DOI 10.4028/www.scientific.net/KEM.345-346.1241
   ANSARI MZ, 2006, KSME P SPRRING, P1327
   Babinski MA, 2007, BJU INT, V100, P940, DOI 10.1111/j.1464-410X.2007.07060.x
   Chang CY, 2010, EUR POLYM J, V46, P92, DOI 10.1016/j.eurpolymj.2009.04.033
   Chanthasopeephan T, 2007, IEEE T BIO-MED ENG, V54, P349, DOI 10.1109/TBME.2006.886937
   Christie M. H., 2000, ADV POLYM SCI, V153, P37
   Gerwen D.J., 2012, MED ENG PHYS, V34, P665, DOI DOI 10.1016/J.MEDENGPHY.2012.04.007
   Hing JT, 2006, IEEE INT CONF ROBOT, P619, DOI 10.1109/ROBOT.2006.1641779
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200
   Jiang S, 2014, J BIOMECH, V47, P3344, DOI 10.1016/j.jbiomech.2014.08.007
   Jiang S, 2013, MAT SCI ENG C-MATER, V33, P3768, DOI 10.1016/j.msec.2013.05.001
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Ko SY, 2013, IEEE T BIO-MED ENG, V60, P910, DOI 10.1109/TBME.2012.2227741
   Li P, 2014, J MED BIOL ENG, V34, P568, DOI 10.5405/jmbe.1804
   Locke M., 2004, TOPICS BIOMECHANICAL
   Manickam K, 2014, J MECH BEHAV BIOMED, V35, P132, DOI 10.1016/j.jmbbm.2014.03.017
   Misra S, 2010, INT J ROBOT RES, V29, P1640, DOI 10.1177/0278364910369714
   Okamura AM, 2004, IEEE T BIO-MED ENG, V51, P1707, DOI 10.1109/TBME.2004.831542
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Patil S, 2014, IEEE T ROBOT, V30, P853, DOI 10.1109/TRO.2014.2307633
   Podder T. K., 2006, P 28 IEEE EMBS INT C, P3652
   Sneddon L.N., 1965, INT J ENG SCI, V3, P47
   Stoianovici D, 2013, IEEE-ASME T MECH, V18, P914, DOI 10.1109/TMECH.2012.2195325
   Stone Nelson N, 2002, Brachytherapy, V1, P154, DOI 10.1016/S1538-4721(02)00058-2
   Vrana NE, 2008, MACROMOL SYMP, V269, P106, DOI 10.1002/masy.200850913
   Vrooijink GJ, 2014, INT J ROBOT RES, V33, P1361, DOI 10.1177/0278364914526627
   YANKELEVSKY DZ, 1989, COMPUT STRUCT, V31, P287, DOI 10.1016/0045-7949(89)90232-0
NR 28
TC 9
Z9 9
U1 3
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD SEP
PY 2015
VL 49
BP 220
EP 234
DI 10.1016/j.jmbbm.2015.05.012
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN2RQ
UT WOS:000358270000019
PM 26042767
DA 2018-10-20
ER

PT J
AU Parkes, M
   Myant, C
   Dini, D
   Cann, P
AF Parkes, Maria
   Myant, Connor
   Dini, Daniele
   Cann, Philippa
TI Tribology-optimised silk protein hydrogels for articular cartilage
   repair
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article
DE Articular cartilage; Friction; Biomaterial; Hydrogel
ID FLUID LOAD SUPPORT; UNCONFINED COMPRESSION; MECHANICAL-PROPERTIES;
   CHONDRAL DEFECTS; CONTACT AREA; PORE-SIZE; FRICTION; SCAFFOLDS; FIBROIN;
   LUBRICATION
AB Porous hydrogels were made from silk fibre as potential materials for cartilage repair. The aim was to develop materials which mimicked the tribological behaviour of cartilage, with controlled pore-sizes and optimised mechanical properties. Mechanical tests showed hydrogels had a comparable compressive modulus to cartilage, with stiffness improved by decreasing pore size. Under static loading and during shear hydrogels demonstrated significant interstitial fluid support. Friction testing showed the hydrogels had a cartilage-like frictional response, dominated by this interstitial fluid support. Silk hydrogels showed little wear, early signs of which were changes in surface morphology that did not correlate with the equilibrium friction coefficient. Consequently both wear and friction should be monitored when assessing the tribological performance of hydrogels. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Parkes, Maria; Myant, Connor; Dini, Daniele; Cann, Philippa] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, Tribol Grp, London SW7 2AZ, England.
RP Parkes, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, Tribol Grp, London SW7 2AZ, England.
EM maria.parkes04@imperial.ac.uk
RI Dini, Daniele/H-8335-2013
FU UK EPSRC [EP/H020837/1, EP/G026114/1]; Engineering and Physical Sciences
   Research Council [EP/G026114/1, EP/H020837/1]
FX The authors wish to thank the UK EPSRC for funding this research: "In
   Contact Analysis of Synovial Fluid Lubricating Film Properties"
   (EP/H020837/1) and Platform Grant "Nanotribology: Measurement and
   Modelling across the Rubbing Interface" (EP/G026114/1).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Accardi M, 2013, THESIS IMPERIAL COLL
   Accardi MA, 2013, TISSUE ENG PT A, V19, P2300, DOI [10.1089/ten.tea.2012.0580, 10.1089/ten.TEA.2012.0580]
   Accardi MA, 2011, TRIBOL INT, V44, P565, DOI 10.1016/j.triboint.2010.09.009
   Ak F, 2013, BIOMACROMOLECULES, V14, P719, DOI 10.1021/bm3018033
   Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berth.2005.09.007
   Baykal D, 2013, J MECH BEHAV BIOMED, V28, P263, DOI 10.1016/j.jmbbm.2013.07.022
   Baykal D, 2012, J MECH BEHAV BIOMED, V14, P39, DOI 10.1016/j.jmbbm.2012.05.012
   Bonnevie ED, 2012, J BIOMECH, V45, P1036, DOI 10.1016/j.jbiomech.2011.12.019
   Bonnevie ED, 2011, TRIBOL LETT, V41, P83, DOI 10.1007/s11249-010-9687-0
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   Brooks PM, 2002, CURR OPIN RHEUMATOL, V14, P573, DOI 10.1097/01.BOR.0000025200.21474.83
   Caligaris M, 2008, OSTEOARTHR CARTILAGE, V16, P1220, DOI 10.1016/j.joca.2008.02.020
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Dowson D., 1966, P I MECH ENG, V181, P45, DOI DOI 10.1243/PIME_CONF_1966_181_206_02
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gong J, 1998, J CHEM PHYS, V109, P8062, DOI 10.1063/1.477453
   Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p
   Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q
   Greene GW, 2010, BIOMATERIALS, V31, P3117, DOI 10.1016/j.biomaterials.2010.01.102
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Haddad FS, 2012, J BONE JOINT SURG BR, V94B, P297, DOI 10.1302/0301-620X.94B3.28362
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kaufman JD, 2008, J MATER RES, V23, P1472, DOI 10.1557/JMR.2008.0185
   Kim HT, 2006, J ORTHOP SPORT PHYS, V36, P765, DOI 10.2519/jospt.2006.2284
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kirsebom H, 2011, POLYM CHEM-UK, V2, P1059, DOI 10.1039/c1py00014d
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lozinsky VI, 2002, RUSS CHEM REV, V71, P489, DOI DOI 10.1070/RC2002V071N06ABEH000720
   Luong FT, 2013, J BIOMED MATER RES A, V102, P1
   Mavraki A, 2009, P I MECH ENG J-J ENG, V223, P325, DOI 10.1243/13506501JET580
   MCCUTCHEN CW, 1959, NATURE, V184, P1284, DOI 10.1038/1841284a0
   McGann ME, 2012, P I MECH ENG H, V226, P612, DOI 10.1177/0954411912447014
   Motta A, 2011, J BIOACT COMPAT POL, V26, P130, DOI 10.1177/0883911511400251
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   Park SH, 2003, J BIOMECH, V36, P1785, DOI 10.1016/S0021-9290(03)00231-8
   Radin EL, 1990, BIOMECH DIARTHRODIAL, P437
   RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   SACK RA, 1987, INVEST OPHTH VIS SCI, V28, P842
   Shekhawat VK, 2009, OSTEOARTHR CARTILAGE, V17, P1197, DOI 10.1016/j.joca.2009.03.013
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Spector T, 1992, ANN RHEUM DIS, V59, P1105
   Spiller KL, 2008, ACTA BIOMATER, V4, P17, DOI 10.1016/j.actbio.2007.09.001
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Stops AJF, 2012, J MECH BEHAV BIOMED, V14, P172, DOI 10.1016/j.jmbbm.2012.04.015
   Thomas BH, 2009, J MECH BEHAV BIOMED, V2, P588, DOI 10.1016/j.jmbbm.2008.08.001
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
NR 62
TC 9
Z9 9
U1 4
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
EI 1879-2464
J9 TRIBOL INT
JI Tribol. Int.
PD SEP
PY 2015
VL 89
SI SI
BP 9
EP 18
DI 10.1016/j.triboint.2014.11.024
PG 10
WC Engineering, Mechanical
SC Engineering
GA CM5SW
UT WOS:000357749900003
DA 2018-10-20
ER

PT J
AU Motte, JC
   Delenne, JY
   Rouau, X
   Mayer-Laigle, C
AF Motte, J. -C.
   Delenne, J. -Y.
   Rouau, X.
   Mayer-Laigle, C.
TI Mineral-vegetal co-milling: An effective process to improve
   lignocellulosic biomass fine milling and to increase interweaving
   between mixed particles
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Lignocellulosic biomass; Biomaterial; Co-grinding; Co-milling;
   Comminution
ID STATE ANAEROBIC-DIGESTION; MECHANICAL-PROPERTIES; WHEAT-STRAW; SIZE;
   COMPOSITES; CEMENT; SCALE; IMAGE; RATIO
AB Fine-milling is a crucial objective for lignocellulosic biomass valorization. Co-milling appears to be a promising technique to improve its efficiency. However, the mechanisms occurring while co-milling remain poorly understood. In this study, an experimental work was performed to produce co-milled powders from both lignocellulosic (wheat, straw or pine sawdust) and mineral materials (limestone, quartzite or tile) with very contrasted physicochemical properties. The main consequences of co-milling were studied for both materials. A two-component mixing law for the prediction of the blend properties was proposed (particle sizes and true densities) to highlight the gain of this single processing step compared to separate milling and mixing. The predicted values were compared with experimental data for co-milled powders at 7 biomass contents from 0% to 100%. In all cases, co-milling leads to a reduction in particle size of lignocellulosic materials and create strong interweaving with mineral particles. Crown Copyright (C) 2015 Published by Elsevier Ltd. All rights reserved.
C1 [Motte, J. -C.; Delenne, J. -Y.; Rouau, X.; Mayer-Laigle, C.] INRA CIRAD SupAgro Univ Montpellier, UMR Ingn Agropolymeres & Technol Emergentes 1208, F-34060 Montpellier 1, France.
RP Mayer-Laigle, C (reprint author), INRA CIRAD SupAgro Univ Montpellier, UMR Ingn Agropolymeres & Technol Emergentes 1208, 2 Pl Pierre Viala, F-34060 Montpellier 1, France.
EM claire.mayer@supagro.inra.fr
RI Delenne, Jean-Yves/D-1683-2013
OI Delenne, Jean-Yves/0000-0002-4107-0502; Mayer-Laigle,
   Claire/0000-0003-2121-7607
CR Altun O, 2013, MINER ENG, V43-44, P58, DOI 10.1016/j.mineng.2012.08.003
   Arsene M.A., 2013, MAT RES, V16, P1, DOI [10.1590/S1516-14392013005000084, DOI 10.1590/S1516-14392013005000084, 10.1590/S1516-14392013005000084.]
   Barakat A., 2013, BIORESOUR TECHNOL
   Barakat A, 2014, RSC ADV, V4, P48109, DOI 10.1039/c4ra07568d
   Barzegar-Jalali M, 2010, POWDER TECHNOL, V197, P150, DOI 10.1016/j.powtec.2009.09.008
   Bhandari B., 2013, HDB FOOD POWDERS PRO
   Boylan D, 2000, BIOMASS BIOENERG, V19, P411, DOI 10.1016/S0961-9534(00)00052-0
   Chataing T., 2013, CHATAING T, Patent No. PCT/IB20 13/050863
   Chesson A, 1997, J SCI FOOD AGR, V75, P289, DOI 10.1002/(SICI)1097-0010(199711)75:3<289::AID-JSFA879>3.3.CO;2-I
   Clark JH, 2009, BIOFUEL BIOPROD BIOR, V3, P72, DOI 10.1002/bbb.119
   Development Core Team R, 2008, R LANG ENV STAT COMP
   Doroodchi E, 2013, POWDER TECHNOL, V235, P412, DOI 10.1016/j.powtec.2012.10.054
   El-Fadaly E., 2010, J AM SCI, V6, P241
   Giry K, 2006, INT J PHARM, V321, P162, DOI 10.1016/j.ijpharm.2006.05.009
   Javadzadeh Y, 2012, POWDER TECHNOL, V218, P51, DOI 10.1016/j.powtec.2011.11.037
   Jorge FC, 2004, HOLZ ROH WERKST, V62, P370, DOI 10.1007/s00107-004-0501-2
   Kaliyan N, 2009, BIOSYST ENG, V104, P47, DOI 10.1016/j.biosystemseng.2009.05.006
   Keough M. J., 2002, EXPT DESIGN DATA ANA
   Kratky L, 2011, CHEM ENG TECHNOL, V34, P391, DOI 10.1002/ceat.201000357
   Kulu P, 2009, WEAR, V267, P1832, DOI 10.1016/j.wear.2009.02.025
   Le Bolay N, 2014, POWDER TECHNOL, V255, P36, DOI 10.1016/j.powtec.2013.10.050
   Lu CH, 2004, J MATER PROCESS TECH, V145, P336, DOI 10.1016/j.jmatprotec.2003.08.002
   Mayer-Laigle C., 2014, CHEM ENG RES DES
   Motte JC, 2014, BIORESOURCE TECHNOL, V173, P185, DOI 10.1016/j.biortech.2014.09.015
   Motte JC, 2013, BIORESOURCE TECHNOL, V144, P141, DOI 10.1016/j.biortech.2013.06.057
   Osawaru A.O., 1992, MIN PROC EXT MET REV, V11, P107
   Pan JM, 2014, J EUR CERAM SOC, V34, P249, DOI 10.1016/j.jeurceramsoc.2013.08.004
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sedan D, 2008, J EUR CERAM SOC, V28, P183, DOI 10.1016/j.jeurceramsoc.2007.05.019
   Silva GGD, 2012, BIORESOURCE TECHNOL, V103, P192, DOI 10.1016/j.biortech.2011.09.073
   Vaezi M, 2013, BIOSYST ENG, V114, P97, DOI 10.1016/j.biosystemseng.2012.11.007
   Williams RO, 1999, EUR J PHARM BIOPHARM, V48, P131, DOI 10.1016/S0939-6411(99)00027-2
   Zapata C, 2004, CHEM ENG RES DES, V82, P631, DOI 10.1205/026387604323142685
   Zapata-Massot C, 2004, POWDER TECHNOL, V143, P215, DOI 10.1016/j.powtec.2004.04.016
NR 34
TC 3
Z9 3
U1 2
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD SEP
PY 2015
VL 192
BP 703
EP 710
DI 10.1016/j.biortech.2015.06.036
PG 8
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA CM4OL
UT WOS:000357664200090
PM 26094197
DA 2018-10-20
ER

PT J
AU Mahadevaiah, S
   Robinson, KG
   Kharkar, PM
   Kiick, KL
   Akins, RE
AF Mahadevaiah, Shruthi
   Robinson, Karyn G.
   Kharkar, Prathamesh M.
   Kiick, Kristi L.
   Akins, Robert E.
TI Decreasing matrix modulus of PEG hydrogels induces a vascular phenotype
   in human cord blood stem cells
SO BIOMATERIALS
LA English
DT Article
DE Cell encapsulation; Gene expression; Stem cell; Vascular grafts; vWF
   (von Willibrand factor)
ID CUTANEOUS WOUND CLOSURE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; IN-VIVO;
   CORONARY-ARTERY; DRUG-DELIVERY; EXTRACELLULAR-MATRIX; HEMATOPOIETIC
   STEM; SUBSTRATE MODULUS; CLICK HYDROGELS
AB Adult and congenital cardiovascular diseases are significant health problems that are often managed using surgery. Bypass grafting is a principal therapy, but grafts fail at high rates due to hyperplasia, fibrosis, and atherosclerosis. Biocompatible, cellularized materials that attenuate these complications and encourage healthy microvascularization could reduce graft failure, but an improved understanding of biomaterial effects on human stem cells is needed to reach clinical utility. Our group investigates stem-cell-loaded biomaterials for placement along the adventitia of at-risk vessels and grafts. Here, the effects of substrate modulus on human CD34+ stem cells from umbilical cord blood were evaluated. Cells were isolated by immunomagnetic separation and encapsulated in 3, 4, and 6 weight% PEG hydrogels containing 0.032% gelatin and 0.0044% fibronectin. Gels reached moduli of 0.34, 4.5, and 9.1 kPa. Cell viability approached 100%. Cell morphologies appeared similar across gels, but proliferation was significantly lower in 6 wt% gels. Expression profiling using stem cell signaling arrays indicated enhanced self-renewal and differentiation into vascular endothelium among cells in the lower weight percent gels. Thus, modulus was associated with cell proliferation and function. Gels with moduli in the low kilopascal range may be useful in stimulating cell engraftment and microvascularization of graft adventitia. (c) 2015 Elsevier Ltd. All rights reserved.
C1 [Mahadevaiah, Shruthi; Robinson, Karyn G.; Akins, Robert E.] Nemours Alfred I duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA.
   [Mahadevaiah, Shruthi] Nemours Alfred I duPont Hosp Children, Crit Care Dept, Wilmington, DE 19803 USA.
   [Kharkar, Prathamesh M.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
RP Akins, RE (reprint author), Nemours Alfred I duPont Hosp Children, Ctr Pediat Clin Res & Dev, 1600 Rockland Rd, Wilmington, DE 19803 USA.
EM Robert.Akins@nemours.org
RI Kharkar, Prathamesh/L-9566-2015
OI Kharkar, Prathamesh/0000-0002-4042-0902; Akins,
   Robert/0000-0001-9706-0752
FU National Institute of General Medical Sciences [P20 GM103446, P20
   RR017716]; Nemours Foundation; University of Delaware Research
   Foundation; National Heart Lung and Blood Institute [R01 HL108110]
FX The authors thank the Histochemistry and Tissue Processing Core
   Laboratory of Nemours-A.I. duPont Hospital for Children for assistance
   with sample preparation. Chris McGann and Eric Levenson are thanked for
   their helpful discussion and suggestions. The authors also thank
   Professor April Kloxin for the use of the rheometer in her laboratory.
   This publication was made possible by support from the National
   Institute of General Medical Sciences IDeA Program (P20 GM103446 to REA
   and P20 RR017716 to KLK), by funds from the Nemours Foundation (to REA),
   the University of Delaware Research Foundation (to KLK), and by support
   from the National Heart Lung and Blood Institute (R01 HL108110 to REA).
CR Avery S, 2010, STEM CELLS, V28, P863, DOI 10.1002/stem.409
   Baldwin AD, 2013, POLYM CHEM-UK, V4, P133, DOI 10.1039/c2py20576a
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142
   DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174
   DeVolder RJ, 2010, BIOMATERIALS, V31, P6494, DOI 10.1016/j.biomaterials.2010.05.016
   Dombrowski C, 2013, STEM CELLS, V31, P2724, DOI 10.1002/stem.1514
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fischer EIC, 2006, ACTA PHYSIOL, V188, P103, DOI 10.1111/j.1748-1716.2006.01614.x
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652
   Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Grimaldi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001910
   Henshall TL, 2015, ARTERIOSCL THROM VAS, V35, P409, DOI 10.1161/ATVBAHA.114.304849
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Huang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088814
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Kanji S, 2014, J CELL MOL MED, V18, P685, DOI 10.1111/jcmm.12217
   Kanji S, 2014, STEM CELL RES, V12, P275, DOI 10.1016/j.scr.2013.11.005
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kekarainen T, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-30
   Kharkar PM, 2014, J MATER CHEM B, V2, P5511, DOI 10.1039/c4tb00496e
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Kuriyama S, 2014, J CELL BIOL, V206, P113, DOI 10.1083/jcb.201402093
   Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005
   Liu GP, 2010, TISSUE ENG PT A, V16, P971, DOI [10.1089/ten.tea.2009.0516, 10.1089/ten.TEA.2009.0516]
   Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086273
   Lu X, 2003, AM J PHYSIOL-HEART C, V285, pH1966, DOI 10.1152/ajpheart.00357.2003
   Magnusson PU, 2007, BLOOD, V110, P4214, DOI 10.1182/blood-2007-01-067314
   Mallawaarachchi CM, 2005, ARTERIOSCL THROM VAS, V25, P1383, DOI 10.1161/01.ATV.0000168415.33812.51
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219
   Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   ROBERTS AB, 1993, GROWTH FACTORS, V8, P1
   Robinson KG, 2012, J BIOMED MATER RES A, V100A, P1356, DOI 10.1002/jbm.a.34075
   Rorby E, 2012, BLOOD, V120, P4343, DOI 10.1182/blood-2012-02-408658
   Ruan JL, 2013, TISSUE ENG PART C-ME, V19, P794, DOI [10.1089/ten.tec.2012.0460, 10.1089/ten.TEC.2012.0460]
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schelte P, 2000, BIOCONJUGATE CHEM, V11, P118, DOI 10.1021/bc990122k
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Shinoka Toshiharu, 2008, Yale Journal of Biology and Medicine, V81, P161
   Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000
   Stanzel BV, 2014, STEM CELL REP, V2, P64, DOI 10.1016/j.stemcr.2013.11.005
   Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802
   Subrammaniyan R, 2011, CYTOTHERAPY, V13, P993, DOI 10.3109/14653249.2011.579961
   Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338
   Treloar LRG, 2005, PHYS RUBBER ELASTICI
   Trogdon JG, 2007, HEALTH PROMOT PRACT, V8, P234, DOI 10.1177/1524839907303794
   Valdimarsdottir G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-16
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Xia Y, 2012, BIOMATERIALS, V33, P2462, DOI 10.1016/j.biomaterials.2011.12.001
   Zhang WJ, 2007, J CELL MOL MED, V11, P945, DOI 10.1111/j.1582-4934.2007.00099.x
   Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007
NR 66
TC 7
Z9 8
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2015
VL 62
BP 24
EP 34
DI 10.1016/j.biomaterials.2015.05.021
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL8RD
UT WOS:000357240900003
PM 26016692
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Minardi, S
   Corradetti, B
   Taraballi, F
   Sandri, M
   Van Eps, J
   Cabrera, FJ
   Weiner, BK
   Tampieri, A
   Tasciotti, E
AF Minardi, Silvia
   Corradetti, Bruna
   Taraballi, Francesca
   Sandri, Monica
   Van Eps, Jeffrey
   Cabrera, Fernando J.
   Weiner, Bradley K.
   Tampieri, Anna
   Tasciotti, Ennio
TI Evaluation of the osteoinductive potential of a bio-inspired scaffold
   mimicking the osteogenic niche for bone augmentation
SO BIOMATERIALS
LA English
DT Article
DE Bone regeneration; Hydroxyapatite; Biomineralization; Biomimetic
   material; Stem cells
ID MESENCHYMAL STEM-CELLS; HUMAN TRABECULAR BONE; GROWTH-FACTOR;
   MORPHOGENETIC PROTEIN-2; GRAFT SUBSTITUTES; DRUG-DELIVERY; RAT MODEL;
   HYDROXYAPATITE; REGENERATION; BEHAVIOR
AB Augmentation of regenerative osteogenesis represents a premier clinical need, as hundreds of thousands of patients are left with insufficient healing of bony defects related to a host of insults ranging from congenital abnormalities to traumatic injury to surgically-induced deficits. A synthetic material that closely mimics the composition and structure of the human osteogenic niche represents great potential to successfully address this high demand. In this study, a magnesium-doped hydroxyapatite/type I collagen scaffold was fabricated through a biologically-inspired mineralization process and designed to mimic human trabecular bone. The composition of the scaffold was fully characterized by XRD, FTIR, ICP and TGA, and compared to human bone. Also, the scaffold microstructure was evaluated by SEM, while its nano-structure and nano-mechanical properties were evaluated by AFM. Human bone marrow-derived mesenchymal stem cells were used to test the in vitro capability of the scaffold to promote osteogenic differentiation. The cell/scaffold constructs were cultured up to 7 days and the adhesion, organization and proliferation of the cells were evaluated. The ability of the scaffold to induce osteogenic differentiation of the cells was assessed over 3 weeks and the correlate gene expression for classic genes of osteogenesis was assessed. Finally, when tested in an ectopic model in rabbit, the scaffold produced a large volume of trabecular bone in only two weeks, that subsequently underwent maturation over time as expected, with increased mature cortical bone formation, supporting its ability to promote bone regeneration in clinically-relevant scenarios. Altogether, these results confirm a high level of structural mimicry by the scaffold to the composition and structure of human osteogenic niche that translated to faster and more efficient osteoinduction in vivo - features that suggest such a biomaterial may have great utility in future clinical applications where bone regeneration is required. (c) 2015 The Authors. Published by Elsevier Ltd.
C1 [Minardi, Silvia; Sandri, Monica; Tampieri, Anna] Inst Sci & Technol Ceram CNR, I-48018 Faenza, RA, Italy.
   [Minardi, Silvia; Corradetti, Bruna; Taraballi, Francesca; Van Eps, Jeffrey; Cabrera, Fernando J.; Weiner, Bradley K.; Tasciotti, Ennio] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.
   [Corradetti, Bruna] Univ Politecn Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy.
   [Van Eps, Jeffrey] Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA.
   [Weiner, Bradley K.] Houston Methodist Hosp, Dept Orthoped & Sports Med, Houston, TX 77030 USA.
RP Tasciotti, E (reprint author), Houston Methodist Res Inst, Dept Nanomed, 6670 Bertner Ave, Houston, TX 77030 USA.
EM etasciotti@tmhs.org
RI Cabrera, Fernando/L-8483-2016
OI Cabrera, Fernando/0000-0002-8651-6790; corradetti,
   bruna/0000-0002-0345-4847; Sandri, Monica/0000-0001-5782-3137;
   Taraballi, Francesca/0000-0002-4959-1169; Tasciotti,
   Ennio/0000-0003-1187-3205; Van Eps, Jeffrey/0000-0003-2086-5119
FU Brown Foundation [18130011]; Cullen Trust for Health Care Foundation
   [18130014]; EU [SMILEY FP7-NMP-2012-SMALL-6-310637]
FX The authors acknowledge Dr. Jianhua Gu and HMRI SEM core, and Dr. Kemi
   Cui and HMRI ACTM core. Authors thank the Preclinical Catheterization
   lab of HMRI for DynaCT analysis. The authors thank Dr. Bayan Aghdasi,
   for providing the specimen of human trabecular bone utilized in this
   study. We thank Massimiliano Dapporto for the support with acquiring the
   XRD spectra. This study was supported by the Brown Foundation (Project
   ID: 18130011), by the Cullen Trust for Health Care Foundation (Project
   ID: 18130014) and by the EU through the grant SMILEY
   FP7-NMP-2012-SMALL-6-310637 (2012-15).
CR Allori AC, 2008, TISSUE ENG PART B-RE, V14, P285, DOI 10.1089/ten.teb.2008.0084
   Arrington E D, 1996, Clin Orthop Relat Res, P300, DOI 10.1097/00003086-199608000-00037
   Bahar H, 2010, J ORTHOP RES, V28, P664, DOI 10.1002/jor.21017
   Bertinetti L, 2009, LANGMUIR, V25, P5647, DOI 10.1021/la804230j
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   BUCHOLZ RW, 2002, CLIN ORTHOP FEBRUARY, V395, P44
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chiapasco M., 2008, INT J ORAL MAXILLOF, V24, P237
   Corradetti B., 2014, STEM CELLS DEV, V24, P1112, DOI DOI 10.1089/SCD.2014.0351
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   Epstein Nancy E, 2013, Surg Neurol Int, V4, pS343, DOI 10.4103/2152-7806.114813
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GREENWALD AS, 2001, J BONE JOINT SURG AM, V83, pS98
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0
   Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Kinard LA, 2014, ACTA BIOMATER, V10, P4574, DOI 10.1016/j.actbio.2014.07.011
   Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008
   Kuroda S, 2013, CLIN ORAL INVEST, V17, P131, DOI 10.1007/s00784-012-0686-4
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Levi B, 2011, PLAST RECONSTR SURG, V127, P1118, DOI 10.1097/PRS.0b013e318205f274
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu Y, 2013, ADV FUNCT MATER, V23, P1404, DOI 10.1002/adfm.201201611
   Ma DY, 2011, CLIN ORAL IMPLAN RES, V22, P1193, DOI 10.1111/j.1600-0501.2010.02091.x
   Manassero M, 2013, TISSUE ENG PT A, V19, P1554, DOI [10.1089/ten.tea.2012.0008, 10.1089/ten.TEA.2012.0008]
   Mann S., 2001, BIOMINERALIZATION
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Minardi S, 2014, SMALL, V10, P3943, DOI 10.1002/smll.201401211
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raisz LG, 1999, CLIN CHEM, V45, P1353
   Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452
   Sarahrudi K, 2011, INJURY, V42, P833, DOI 10.1016/j.injury.2011.03.055
   Schmid GJ, 2009, DEV DYNAM, V238, P766, DOI 10.1002/dvdy.21882
   Scott M.A., 2011, STEM CELLS DEV, V21, P655
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Sottile V, 2002, BONE, V30, P699, DOI 10.1016/S8756-3282(02)00674-9
   Sprio S, 2008, MAT SCI ENG C-BIO S, V28, P179, DOI 10.1016/j.msec.2006.11.009
   Sprio S.S.M., 2014, BONE SUBSTITUTES BIO
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   Taraballi F, 2012, ADV HEALTHC MATER, V1, P513, DOI 10.1002/adhm.201200043
   Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 64
TC 38
Z9 40
U1 3
U2 127
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2015
VL 62
BP 128
EP 137
DI 10.1016/j.biomaterials.2015.05.011
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL8RD
UT WOS:000357240900013
PM 26048479
OA Other Gold
DA 2018-10-20
ER

PT J
AU Aryaei, A
   Liu, J
   Jayatissa, AH
   Jayasuriya, AC
AF Aryaei, Ashkan
   Liu, Jason
   Jayatissa, Ahalapitiya H.
   Jayasuriya, A. Champa
TI Cross-linked chitosan improves the mechanical properties of calcium
   phosphate-chitosan cement
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate cement; Chitosan; Cross-linking; Mechanical
   properties; Porosity
ID COMPOSITE SCAFFOLD; BONE REGENERATION; TISSUE; INJECTABILITY; FILMS;
   HYDROXYAPATITE/CHITOSAN; BIOCOMPATIBILITY; NANOPARTICLES; PASTES; ACID
AB Calcium phosphate (CaP) cements are highly applicable and valuable materials for filling bone defects by minimally invasive procedures. The chitosan (CS) biopolymer is also considered as one of the promising biomaterial candidates in bone tissue engineering. In the present study, some key features of CaP-CS were significantly improved by developing a novel CaP-CS composite. For this purpose, CS was the first cross-linked with tripolyphosphate (TPP) and then mixed with CaP matrix. A group of CaP-CS samples without cross-linking was also prepared. Samples were fabricated and tested based on the known standards. Additionally, the effect of different powder (P) to liquid (L) ratios was also investigated. Both cross-linked and uncross-linked CaP-CS samples showed excellent washout resistance. The most significant effects were observed on Young's modulus and compressive strength in wet condition as well as surface hardness. In dry conditions, the Young's modulus of cross-linked samples was slightly improved. Based on the presented results, cross-linking does not have a significant effect on porosity. As expected, by increasing the P/L ratio of a sample, ductility and injectability were decreased. However, in the most cases, mechanical properties were enhanced. The results have shown that cross-linking can improve the mechanical properties of CaP-CS and hence it can be used for bone tissue engineering applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Aryaei, Ashkan; Jayatissa, Ahalapitiya H.] Univ Toledo, Dept Mech Engn, Toledo, OH 43606 USA.
   [Liu, Jason] Univ Toledo, Sch Med, Toledo, OH 43614 USA.
   [Jayasuriya, A. Champa] Univ Toledo, Dept Orthopaed Surg, Toledo, OH 43614 USA.
RP Jayasuriya, AC (reprint author), Univ Toledo, Dept Orthopaed Surg, 3065 Arlington Ave,Dowling Hall 2447, Toledo, OH 43614 USA.
EM a.jayasuriya@utoledo.edu
FU NIDCR NIH HHS [R01 DE023356]
CR Aryaei A, 2014, J BIOMED MATER RES A, V102, P2704, DOI 10.1002/jbm.a.34942
   Aryaei A, 2012, J MECH BEHAV BIOMED, V5, P82, DOI 10.1016/j.jmbbm.2011.08.006
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   Babaei Z., 2012, MAT SCI ENG C, V33, P370
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024
   Burguera EF, 2008, J BIOMED MATER RES B, V84B, P493, DOI 10.1002/jbm.b.30896
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Chiou MS, 2004, DYES PIGMENTS, V60, P69, DOI 10.1016/S1043-7208(03)00140-2
   CHOW LC, 1984, J DENT RES, V63, P868, DOI 10.1177/00220345840630061101
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Heinemann S., 2012, ACTA BIOMATER, V9, P6199
   Jayasuriya AC, 2010, J BIOMED MATER RES A, V93A, P1280, DOI 10.1002/jbm.a.32623
   Jayasuriya AC, 2013, MAT SCI ENG C-MATER, V33, P3688, DOI 10.1016/j.msec.2013.04.057
   Khairoun I, 1997, J BIOMED MATER RES, V38, P356, DOI 10.1002/(SICI)1097-4636(199724)38:4<356::AID-JBM8>3.0.CO;2-N
   Alves HLR, 2008, J MATER SCI-MATER M, V19, P2241, DOI 10.1007/s10856-007-3329-6
   Leroux L, 1999, BONE, V25, p31S, DOI 10.1016/S8756-3282(99)00130-1
   Liu H, 2009, POLYM ADVAN TECHNOL, V20, P613, DOI 10.1002/pat.1306
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Rajzer I, 2010, J MATER SCI-MATER M, V21, P2049, DOI 10.1007/s10856-010-4078-5
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Takagi S, 2003, J BIOMED MATER RES B, V67B, P689, DOI 10.1002/jbm.b.10065
   Takagi S, 2003, DENT MATER, V19, P797, DOI 10.1016/S0109-5641(03)00028-9
   Thai VV, 2010, J MATER SCI-MATER M, V21, P1867, DOI 10.1007/s10856-010-4058-9
   Them-Han W., 2009, ACTA BIOMATER, V5, P1182
   van de Watering F., 2012, BIODEGRADATION CALCI, P139
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
NR 36
TC 8
Z9 8
U1 3
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2015
VL 54
BP 14
EP 19
DI 10.1016/j.msec.2015.04.024
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CL1ZY
UT WOS:000356744600003
PM 26046262
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wauthle, R
   Ahmadi, SM
   Yavari, SA
   Mulier, M
   Zadpoor, AA
   Weinans, H
   Van Humbeeck, J
   Kruth, JP
   Schrooten, J
AF Wauthle, Ruben
   Ahmadi, Seyed Mohammad
   Yavari, Saber Amin
   Mulier, Michiel
   Zadpoor, Amir Abbas
   Weinans, Harrie
   Van Humbeeck, Jan
   Kruth, Jean-Pierre
   Schrooten, Jan
TI Revival of pure titanium for dynamically loaded porous implants using
   additive manufacturing
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Additive manufacturing; Selective laser melting; Titanium; Fatigue;
   Porous biomaterials
ID IN-GROWTH CONSTRUCTS; UNIT-CELL APPROACH; MECHANICAL-PROPERTIES;
   ORTHOPEDIC APPLICATIONS; BONE REGENERATION; FATIGUE BEHAVIOR;
   HEAT-TREATMENT; LASER; TANTALUM; TI-6AL-4V
AB Additive manufacturing techniques are getting more and more established as reliable methods for producing porous metal implants thanks to the almost full geometrical and mechanical control of the designed porous biomaterial. Today, Ti6Al4V ELI is still the most widely used material for porous implants, and none or little interest goes to pure titanium for use in orthopedic or load-bearing implants. Given the special mechanical behavior of cellular structures and the material properties inherent to the additive manufacturing of metals, the aim of this study is to investigate the properties of selective laser melted pure unalloyed titanium porous structures. Therefore, the static and dynamic compressive properties of pure titanium structures are determined and compared to previously reported results for identical structures made from Ti6Al4V ELI and tantalum. The results show that porous Ti6Al4V ELI still remains the strongest material for statically loaded applications, whereas pure titanium has a mechanical behavior similar to tantalum and is the material of choice for cyclically loaded porous implants. These findings are considered to be important for future implant developments since it announces a potential revival of the use of pure titanium for additively manufactured porous implants. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Wauthle, Ruben; Kruth, Jean-Pierre] Katholieke Univ Leuven, Dept Mech Engn, Sect Prod Engn Machine Design & Automat PMA, B-3001 Louvain, Belgium.
   [Wauthle, Ruben] 3D Syst LayerWise NV, B-3001 Louvain, Belgium.
   [Ahmadi, Seyed Mohammad; Yavari, Saber Amin; Zadpoor, Amir Abbas; Weinans, Harrie] Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, NL-2628 CD Delft, Netherlands.
   [Mulier, Michiel] Katholieke Univ Leuven, Dept Orthopaed, B-3212 Pellenberg, Belgium.
   [Weinans, Harrie] UMC Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Weinans, Harrie] UMC Utrecht, Dept Rheumatol, NL-3584 CX Utrecht, Netherlands.
   [Van Humbeeck, Jan; Schrooten, Jan] Katholieke Univ Leuven, Dept Mat Engn, B-3001 Louvain, Belgium.
   [Schrooten, Jan] Katholieke Univ Leuven, Prometheus, Div Skeletal Tissue Engn, B-3000 Louvain, Belgium.
RP Wauthle, R (reprint author), 3D Syst LayerWise NV, Grauwmeer 14, B-3001 Louvain, Belgium.
EM ruben.wauthle@3dsystems.com
RI Zadpoor, Amir A/A-8510-2008; Amin Yavari, Saber/E-5360-2017; Amin
   Yavari, Saber/G-9486-2013
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
FU agency for Innovation by Science and Technology (IWT) of the Flemish
   government through Baekeland mandate [IWT 100228]
FX This research was established by funding of the agency for Innovation by
   Science and Technology (IWT) of the Flemish government through Baekeland
   mandate 'IWT 100228'.
CR Ahmadi SM, 2014, J MECH BEHAV BIOMED, V34, P106, DOI 10.1016/j.jmbbm.2014.02.003
   Andani MT, 2014, ACTA BIOMATER, V10, P4058, DOI 10.1016/j.actbio.2014.06.025
   [Anonymous], 2011, 13314 ISO
   Attar H, 2014, MAT SCI ENG A-STRUCT, V593, P170, DOI 10.1016/j.msea.2013.11.038
   Barbas A, 2012, J MECH BEHAV BIOMED, V9, P34, DOI 10.1016/j.jmbbm.2012.01.008
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Brenne F, 2013, J MATER PROCESS TECH, V213, P1558, DOI 10.1016/j.jmatprotec.2013.03.013
   Brunette D. M., 2001, TITANIUM MED
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Challis VJ, 2014, MATER DESIGN, V63, P783, DOI 10.1016/j.matdes.2014.05.064
   Chan K.S., 2012, METALL MATER TRANS A, V44, P1010
   Cheng XY, 2012, J MECH BEHAV BIOMED, V16, P153, DOI 10.1016/j.jmbbm.2012.10.005
   de Wild M, 2013, TISSUE ENG PT A, V19, P2645, DOI [10.1089/ten.tea.2012.0753, 10.1089/ten.TEA.2012.0753]
   Degischer H-P, 2002, HDB CELLULAR METALS
   Edwards P, 2014, MAT SCI ENG A-STRUCT, V598, P327, DOI 10.1016/j.msea.2014.01.041
   Emmelmann C, 2011, PHYSCS PROC, V12, P375, DOI 10.1016/j.phpro.2011.03.048
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Helsen JA, 2010, BIOL MED PHYS BIOMED, P1
   Horn T.J., 2014, ADDIT MANUF, V1-4, P2, DOI DOI 10.1016/J.ADDMA.2014.05.001
   Kruth JP, 2007, CIRP ANN-MANUF TECHN, V56, P730, DOI 10.1016/j.cirp.2007.10.004
   Lampman S., 1990, ASM HDB, P592
   Leuders S., 2013, INT J FATIGUE, V48, P300, DOI DOI 10.1016/J.IJFATIGUE.2012.11.011
   Levine BR, 2010, MATERIALWISS WERKST, V41, P1002, DOI 10.1002/mawe.201000701
   Levine B, 2008, ADV ENG MATER, V10, P788, DOI 10.1002/adem.200800215
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Lewis G, 2013, J MATER SCI-MATER M, V24, P2293, DOI 10.1007/s10856-013-4998-y
   Li SJ, 2014, ACTA BIOMATER, V10, P4537, DOI 10.1016/j.actbio.2014.06.010
   Li SJ, 2012, ACTA MATER, V60, P793, DOI 10.1016/j.actamat.2011.10.051
   Lipinski P, 2013, J MECH BEHAV BIOMED, V28, P274, DOI 10.1016/j.jmbbm.2013.08.011
   Lyman W.S., 1990, ASM HDB, P1099
   Mann E, 2010, EUR ORTHOP TRAUMATOL, V1, P103
   Mullen L, 2010, J BIOMED MATER RES B, V92B, P178, DOI 10.1002/jbm.b.31504
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murr L. E., 2009, 25 SO BIOM ENG C MIA, P23
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Pyka G, 2012, ADV ENG MATER, V14, P363, DOI 10.1002/adem.201100344
   Ritchie RO, 1999, INT J FRACTURE, V100, P55, DOI 10.1023/A:1018655917051
   Sallica-Leva E, 2013, J MECH BEHAV BIOMED, V26, P98, DOI 10.1016/j.jmbbm.2013.05.011
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Sun JF, 2013, MATER DESIGN, V49, P545, DOI 10.1016/j.matdes.2013.01.038
   Thijs L, 2013, ACTA MATER, V61, P4657, DOI 10.1016/j.actamat.2013.04.036
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   Vrancken B, 2012, J ALLOY COMPD, V541, P177, DOI 10.1016/j.jallcom.2012.07.022
   Wauthle R, 2015, ADDIT MANUF, V5, P77, DOI 10.1016/j.addma.2014.12.008
   Wauthle R, 2015, ACTA BIOMATER, V14, P217, DOI 10.1016/j.actbio.2014.12.003
   Wieding J, 2012, MATERIALS, V5, P1336, DOI 10.3390/ma5081336
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 54
TC 31
Z9 31
U1 5
U2 104
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2015
VL 54
BP 94
EP 100
DI 10.1016/j.msec.2015.05.001
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA CL1ZY
UT WOS:000356744600013
PM 26046272
DA 2018-10-20
ER

PT J
AU Nalluri, SM
   Krishnan, GR
   Cheah, C
   Arzumand, A
   Yuan, Y
   Richardson, CA
   Yang, SY
   Sarkar, D
AF Nalluri, Sandeep M.
   Krishnan, G. Rajesh
   Cheah, Calvin
   Arzumand, Ayesha
   Yuan, Yuan
   Richardson, Caley A.
   Yang, Shuying
   Sarkar, Debanjan
TI Hydrophilic polyurethane matrix promotes chondrogenesis of mesenchymal
   stem cell
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polyurethane; Gel; Mesenchymal stem cell; Chondrogenic differentiation
ID TYROSINE-BASED POLYURETHANES; IN-VITRO CHONDROGENESIS; SEGMENTED
   POLYURETHANES; MECHANICAL-PROPERTIES; N-CADHERIN; BIOMATERIAL
   APPLICATIONS; RHEOLOGICAL BEHAVIOR; EXTRACELLULAR-MATRIX;
   ARTICULAR-CARTILAGE; HYDROGELS
AB Segmental polyurethanes exhibit biphasic morphology and can control cell fate by providing distinct matrix guided signals to increase the chondrogenic potential of mesenchymal stem cells (MSCs). Polyethylene glycol (PEG) based hydrophilic polyurethanes can deliver differential signals to MSCs through their matrix phases where hard segments are cell-interactive domains and PEG based soft segments are minimally interactive with cells. These coordinated communications can modulate cell-matrix interactions to control cell shape and size for chondrogenesis. Biphasic character and hydrophilicity of polyurethanes with gel like architecture provide a synthetic matrix conducive for chondrogenesis of MSCs, as evidenced by deposition of cartilage-associated extracellular matrix. Compared to monophasic hydrogels, presence of cell interactive domains in hydrophilic polyurethanes gels can balance cell-cell and cell-matrix interactions. These results demonstrate the correlation between lineage commitment and the changes in cell shape, cell-matrix interaction, and cell-cell adhesion during chondrogenic differentiation which is regulated by polyurethane phase morphology, and thus, represent hydrophilic polyurethanes as promising synthetic matrices for cartilage regeneration. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Nalluri, Sandeep M.; Sarkar, Debanjan] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Krishnan, G. Rajesh; Cheah, Calvin; Arzumand, Ayesha; Yuan, Yuan; Sarkar, Debanjan] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
   [Richardson, Caley A.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
   [Yang, Shuying] SUNY Buffalo, Dept Oral Biol, Sch Dent Med, Buffalo, NY 14260 USA.
RP Sarkar, D (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM debanjan@buffalo.edu
RI Sarkar, Debanjan/C-6093-2017
OI Sarkar, Debanjan/0000-0002-6666-3152
FU Mark Diamond Research Fund of the Graduate Student Association at the
   University at Buffalo; State University of New York
FX The authors thank William J. Nolan for SEM imaging, Michael J. Hill for
   proofreading the manuscript and Prof. Frank V. Bright for use of FTIR
   spectrometer. SMN acknowledges support from the Mark Diamond Research
   Fund of the Graduate Student Association at the University at Buffalo,
   The State University of New York. This work is supported by a faculty
   startup grant to DS from UB Foundation.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Basak S, 2012, J MATER CHEM, V22, P11658, DOI 10.1039/c2jm30711a
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Brassinne J, 2013, MACROMOLECULES, V46, P9134, DOI 10.1021/ma401657f
   Brizard AM, 2009, FARADAY DISCUSS, V143, P345, DOI 10.1039/b903806j
   Bromberg L, 1998, MACROMOLECULES, V31, P6148, DOI 10.1021/ma980523f
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chassenieux C, 2011, CURR OPIN COLLOID IN, V16, P18, DOI 10.1016/j.cocis.2010.07.007
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   CLARK AH, 1987, ADV POLYM SCI, V83, P57
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Dicesare P, 2013, J BIOMED MATER RES A, V101, P2151, DOI 10.1002/jbm.a.34515
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Flickinger GL, 1999, J NON-NEWTON FLUID, V87, P283, DOI 10.1016/S0377-0257(99)00068-3
   Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438
   Ghone NV, 2012, J CELL PHYSIOL, V227, P3701, DOI 10.1002/jcp.24078
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hall BK, 1995, INT J DEV BIOL, V39, P881
   Hao JK, 2011, MACROMOLECULES, V44, P9390, DOI 10.1021/ma202130u
   Javvaji V, 2014, BIOMATER SCI-UK, V2, P1016, DOI 10.1039/c4bm00017j
   Kim BK, 2000, J POLYM SCI POL PHYS, V38, P2652, DOI 10.1002/1099-0488(20001015)38:20<2652::AID-POLB50>3.0.CO;2-3
   Kim J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03552
   Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243
   Krishnan GR, 2014, J POLYM SCI POL CHEM, V52, P1917, DOI 10.1002/pola.27198
   Kumar R, 2007, LANGMUIR, V23, P12849, DOI 10.1021/la7028559
   LEE HS, 1987, MACROMOLECULES, V20, P2089, DOI 10.1021/ma00175a008
   Lim YB, 2000, BIOCHEM BIOPH RES CO, V273, P609, DOI 10.1006/bbrc.2000.2987
   Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Madbouly SA, 2005, MACROMOLECULES, V38, P4014, DOI 10.1021/ma050453u
   Madbouly SA, 2013, MACROMOLECULES, V46, P4606, DOI 10.1021/ma400200y
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Maji PK, 2009, J POLYM SCI POL CHEM, V47, P731, DOI 10.1002/pola.23185
   Maloney JD, 2010, ILLUSTRATIVE HANDBOOK OF GENERAL SURGERY, P99, DOI 10.1007/978-1-84882-089-0_14
   Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]
   Mattia J, 2007, MACROMOLECULES, V40, P1546, DOI 10.1021/ma0626362
   McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   Mishra A, 2011, J APPL POLYM SCI, V120, P3546, DOI 10.1002/app.33525
   Murthy NS, 2010, POLYMER, V51, P3978, DOI 10.1016/j.polymer.2010.06.024
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   OBERLENDER SA, 1994, DEVELOPMENT, V120, P177
   Palmer A, 1998, RHEOL ACTA, V37, P97, DOI 10.1007/s003970050095
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   PETROVIC ZS, 1991, PROG POLYM SCI, V16, P695, DOI 10.1016/0079-6700(91)90011-9
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Rajesh Krishnan G., 2015, MACROMOL BIOSCI
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2007, POLYM DEGRAD STABIL, V92, P1994, DOI 10.1016/j.polymdegradstab.2007.08.003
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Scardi P, 2001, ACTA CRYSTALLOGR A, V57, P604, DOI 10.1107/S0108767301008881
   Sen Gupta A, 2002, J BIOMAT SCI-POLYM E, V13, P1093
   SOLURSH M, 1982, DEV BIOL, V94, P259, DOI 10.1016/0012-1606(82)90090-2
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Tian J, 2004, MACROMOLECULES, V37, P10001, DOI 10.1021/ma049474z
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yan H, 2008, SOFT MATTER, V4, P1313, DOI 10.1039/b716966c
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yilgor I, 2006, POLYMER, V47, P4105, DOI 10.1016/j.polymer.2006.02.027
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   ZIMMERMANN B, 1984, J ANAT, V138, P351
NR 75
TC 9
Z9 9
U1 1
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2015
VL 54
BP 182
EP 195
DI 10.1016/j.msec.2015.05.043
PG 14
WC Materials Science, Biomaterials
SC Materials Science
GA CL1ZY
UT WOS:000356744600023
PM 26046282
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Frajkorova, F
   Bodisova, K
   Bohac, M
   Bartonickova, E
   Sedlacek, J
AF Frajkorova, Frantiska
   Bodisova, Katarina
   Bohac, Martin
   Bartonickova, Eva
   Sedlacek, Jaroslav
TI Preparation and characterisation of porous composite biomaterials based
   on silicon nitride and bioglass
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Sintering; Composites; Glass; Nitrides; Biomedical applications
ID BIOACTIVE GLASS 45S5; SIMULATED BODY-FLUID; TAPE CAST; IN-VITRO;
   MECHANICAL-PROPERTIES; CRYSTALLIZATION; CERAMICS; KINETICS; COATINGS;
   SBF
AB The combination of bioinert and bioactive material offers new potentialities in bone tissue engineering. The present paper deals with preparation of novel biomaterial composite based on silicon nitride (Si3N4) and bioglass (in amount of 10 and 30 wt%) by free sintering at 980 degrees C for 1 h in nitrogen atmosphere. The obtained material was characterised by differential thermal analysis (DTA) and X-ray powder diffraction (XRD), porosity and pore size distribution were evaluated by means of mercury intrusion porosimetry (MIP). The bioactivity was examined in vitro with respect to the ability of hydroxyapatite layer formation on the surface of materials as a result of contact with simulated body fluid (SBF). All composites were studied by Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) before and after immersion in SBF. The bioglass-free sample was prepared as a reference material to compare the microstructure and bioactivity to the composites. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Frajkorova, Frantiska; Bohac, Martin; Bartonickova, Eva] Brno Univ Technol, Fac Chem, Brno 61200, Czech Republic.
   [Bodisova, Katarina] Slovak Univ Technol Bratislava, Dept Ceram Glass & Cements, Fac Chem & Food Technol, Bratislava 81237, Slovakia.
   [Sedlacek, Jaroslav] Slovak Acad Sci, Inst Inorgan Chem, SK-84536 Bratislava, Slovakia.
RP Frajkorova, F (reprint author), Brno Univ Technol, Fac Chem, Purkynova 464-118, Brno 61200, Czech Republic.
OI Bartonickova, Eva/0000-0002-5866-7946
FU Excellent young researcher at Brno University of Technology, Brno, Czech
   Republic [CZ.1.07./2.3.00/30.0039, CZ.1.07/2.3.00/30.0005]
FX This work was supported by project Excellent young researcher at Brno
   University of Technology, Brno, Czech Republic Nos.
   CZ.1.07./2.3.00/30.0039 and CZ.1.07/2.3.00/30.0005.
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   Chen QZ, 2010, ACTA BIOMATER, V6, P4143, DOI 10.1016/j.actbio.2010.04.022
   Clupper DC, 2004, J EUR CERAM SOC, V24, P2929, DOI 10.1016/S0955-2219(03)00363-7
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Clupper DC, 2001, J BIOMED MATER RES, V57, P532, DOI 10.1002/1097-4636(20011215)57:4<532::AID-JBM1199>3.0.CO;2-3
   Diaz R. L., 2004, US Patent, Patent No. [0220679A1, 0220679]
   Fukura I., 1987, US Patent, Patent No. [4.636.218, 4636218]
   Gross KA, 1997, INT J ORAL MAX IMPL, V12, P589
   Gu YW, 2003, BIOMATERIALS, V24, P1603, DOI 10.1016/S0142-9612(02)00573-2
   Hampshire S, 2007, J ACHIEV MAT MANUF E, V24, P43
   Hench L. L., 1993, INTRO BIOCERAMICS, P17
   Hench L.L., 1993, INTRO BIOCERAMICS, P521
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kingery W. D., 1976, INTRO CERAMICS
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Maier H. R., 2004, BER, V81, P33
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MATUSITA K, 1980, J NON-CRYST SOLIDS, V38-9, P741, DOI 10.1016/0022-3093(80)90525-6
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Neumann A, 2004, MATERIALWISS WERKST, V35, P569, DOI 10.1002/mawe.200400778
   Olsson K., 2003, EP Patent, Patent No. 1064238
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Riley FL, 2000, J AM CERAM SOC, V83, P245
   Santos J. D., 2001, KEY ENG MATER, V192-195, P589
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Sorell C. C., 1999, P 5 M SEM IMPL SPIN, P47
   Sulzer A. G., 1977, Patent, Patent No. [GB 1463948, 1463948]
   Sung YM, 2001, J MATER RES, V16, P2039, DOI 10.1557/JMR.2001.0279
   Zhou Y. S., 1977, MAT SCI ENG C, V5, P125
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
NR 38
TC 5
Z9 5
U1 2
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD SEP
PY 2015
VL 41
IS 8
BP 9770
EP 9778
DI 10.1016/j.ceramint.2015.04.049
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA CK9GR
UT WOS:000356549100074
DA 2018-10-20
ER

PT J
AU Jiang, RZ
   Tran, DT
   McClure, JP
   Chu, D
AF Jiang, Rongzhong
   Tran, Dat T.
   McClure, Joshua P.
   Chu, Deryn
TI Nano-Structured Bio-Inorganic Hybrid Material for High Performing Oxygen
   Reduction Catalyst
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE bio-inorganic hybrid catalyst; oxygen reduction reaction; Ag-Co; hemin;
   graphene nanoplatelets
ID HIGH-AREA CARBON; AG NANOPARTICLES; ALKALINE MEDIA; HEAT-TREATMENT;
   ELECTROREDUCTION; ELECTRODES; SILVER; ELECTROCATALYST; NANOFRAMES;
   PORPHYRIN
AB In this study, we demonstrate a non-Pt nanostructured bioinorgaoic hybrid (BIH) catalyst for catalytic oxygen reduction in alkaline media. This catalyst was synthesized through biomaterial hemin, nanostructured Ag-Co alloy, and graphene nano platelets (GNP) by heat-treatment and ultrasonically processing. This hybrid catalyst has the advantages of the combined features of these bio and inorganic materials. A 10-fold improvement in catalytic activity (at 0.8 V vs RHE) is achieved in comparison of pure Ag nanoparticles (20-40 nm). The hybrid catalyst reaches 80% activity (at 0.8 V vs RHE) of the state-of-the-art catalyst (containing 40% Pt and 60% active carbon). Comparable catalytic stability for the hybrid catalyst with the Pt catalyst is observed by chronoamperometric experiment. The hybrid catalyst catalyzes 4-electron oxygen reduction to produce water with fast kinetic rate. The rate constant obtained from the hybrid catalyst (at 0.6 V vs RHE) is 4 times higher than that of pure Ag/GNP catalyst. A catalytic model is proposed to explain the oxygen reduction reaction at the BIH catalyst.
C1 [Jiang, Rongzhong; Tran, Dat T.; McClure, Joshua P.; Chu, Deryn] US Army Res Lab, Sensors & Electron Devices Directorate, Adelphi, MD 20783 USA.
RP Jiang, RZ (reprint author), US Army Res Lab, Sensors & Electron Devices Directorate, 2800 Powder Mill Rd, Adelphi, MD 20783 USA.
EM Rongzhong.jiang.civ@mail.mil
FU U.S. Department of the Army; U.S. Army Material Command
FX The authors would like to thank Dr. Wen-An Chiou and Dr. Sz-Chian Liou
   at University of Maryland for assisting TEM and STEM analyses. Thanks to
   Dr. Cynthia Lundgren for helpful discussions. Finally, thanks to the
   U.S. Department of the Army and U.S. Army Material Command for
   supporting this work.
CR BEER SZ, 1965, J ELECTROCHEM SOC, V112, P1133, DOI 10.1149/1.2423379
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061
   Chen HM, 2008, J PHYS CHEM C, V112, P7522, DOI 10.1021/jp8017698
   Choi HJ, 2001, J ELECTROANAL CHEM, V508, P105, DOI 10.1016/S0022-0728(01)00523-X
   COLLMAN JP, 1979, J ELECTROANAL CHEM, V101, P117, DOI 10.1016/S0022-0728(79)80085-6
   COLLMAN JP, 1980, J AM CHEM SOC, V102, P6027, DOI 10.1021/ja00539a009
   DONG SJ, 1987, BER BUNSEN PHYS CHEM, V91, P479, DOI 10.1002/bbpc.19870910450
   EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0
   Esmaeili A, 2014, J COLLOID INTERF SCI, V432, P19, DOI 10.1016/j.jcis.2014.06.055
   Gojkovic SL, 1999, J ELECTROANAL CHEM, V462, P63, DOI 10.1016/S0022-0728(98)00390-8
   Guo JS, 2011, J PHYS CHEM C, V115, P8494, DOI 10.1021/jp112197f
   Guo SJ, 2013, J AM CHEM SOC, V135, P13879, DOI 10.1021/ja406091p
   Holewinski A, 2014, NAT CHEM, V6, P828, DOI [10.1038/NCHEM.2032, 10.1038/nchem.2032]
   Jiang RZ, 2014, ELECTROCHIM ACTA, V127, P146, DOI 10.1016/j.electacta.2014.01.134
   Jiang RZ, 2014, J POWER SOURCES, V245, P352, DOI 10.1016/j.jpowsour.2013.06.123
   Jiang RZ, 2012, ELECTROCHIM ACTA, V75, P185, DOI 10.1016/j.electacta.2012.04.098
   Jiang RZ, 2012, ELECTROCHEM COMMUN, V19, P73, DOI 10.1016/j.elecom.2012.03.013
   Jiang RZ, 2000, J ELECTROCHEM SOC, V147, P4605, DOI 10.1149/1.1394109
   JIANG RZ, 1991, J ELECTROANAL CHEM, V305, P171, DOI 10.1016/0022-0728(91)85516-R
   Li RS, 2010, ELECTROCHEM COMMUN, V12, P901, DOI 10.1016/j.elecom.2010.04.016
   Li S, 2010, ELECTROCHIM ACTA, V55, P7346, DOI 10.1016/j.electacta.2010.07.020
   Liang ZX, 2011, J PHYS CHEM C, V115, P2604, DOI 10.1021/jp1112334
   Lima FHB, 2006, J POWER SOURCES, V161, P806, DOI 10.1016/j.jpowsour.2006.06.029
   Liu P, 2015, J POWER SOURCES, V278, P522, DOI 10.1016/j.jpowsour.2014.12.122
   Liu P, 2014, ASIAN J CHEM, V26, P2523
   Marcinkoski J, 2011, J POWER SOURCES, V196, P5282, DOI 10.1016/j.jpowsour.2011.02.035
   Maruyama J, 2006, CHEM MATER, V18, P1303, DOI 10.1021/cm0517972
   McClure JP, 2014, CARBON, V79, P457, DOI 10.1016/j.carbon.2014.08.005
   McEachran M, 2011, J AM CHEM SOC, V133, P8066, DOI 10.1021/ja111642d
   Rong C, 2010, ELECTROCHIM ACTA, V55, P6872, DOI 10.1016/j.electacta.2010.05.078
   Schulenburg H, 2003, J PHYS CHEM B, V107, P9034, DOI 10.1021/jp030349j
   Tsai YH, 2013, J PHYS CHEM C, V117, P24611, DOI 10.1021/jp4088018
   Tuaev X, 2013, ACS NANO, V7, P5666, DOI 10.1021/nn402406k
   VANVEEN JAR, 1988, ELECTROCHIM ACTA, V33, P801, DOI 10.1016/S0013-4686(98)80010-8
   Wang YJ, 2014, J MATER CHEM A, V2, P12681, DOI 10.1039/c4ta02062f
   Wu G, 2011, CARBON, V49, P3972, DOI 10.1016/j.carbon.2011.05.036
   YANG YF, 1995, J ELECTROANAL CHEM, V397, P271, DOI 10.1016/0022-0728(95)04178-7
   YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9
   Zhang R, 2014, ELECTROCHIM ACTA, V147, P343, DOI 10.1016/j.electacta.2014.09.064
   Zhou XJ, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301523
   Zhu W, 2011, ELECTROCHEM SOLID ST, V14, pB81, DOI 10.1149/1.3594097
NR 42
TC 7
Z9 7
U1 2
U2 56
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 26
PY 2015
VL 7
IS 33
BP 18530
EP 18539
DI 10.1021/acsami.5b04714
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CQ0XN
UT WOS:000360322000043
PM 26280984
DA 2018-10-20
ER

PT J
AU Mihic, A
   Cui, Z
   Wu, J
   Vlacic, G
   Miyagi, Y
   Li, SH
   Lu, S
   Sung, HW
   Weisel, RD
   Li, RK
AF Mihic, Anton
   Cui, Zhi
   Wu, Jun
   Vlacic, Goran
   Miyagi, Yasuo
   Li, Shu-Hong
   Lu, Sun
   Sung, Hsing-Wen
   Weisel, Richard D.
   Li, Ren-Ke
TI A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and
   Improves Cardiac Function After Implantation into Myocardial Infarct
SO CIRCULATION
LA English
DT Article
DE conduction; injectable biomaterials; myocardial infarction; remodeling
ID RESPONSIVE CHITOSAN HYDROGEL; EMBRYONIC STEM-CELLS; BIOMEDICAL
   APPLICATIONS; RAT HEARTS; IN-VIVO; BIOMATERIALS; TRANSPLANTATION;
   STIMULATION; INJECTION; THERAPY
AB Background Efficient cardiac function requires synchronous ventricular contraction. After myocardial infarction, the nonconductive nature of scar tissue contributes to ventricular dysfunction by electrically uncoupling viable cardiomyocytes in the infarct region. Injection of a conductive biomaterial polymer that restores impulse propagation could synchronize contraction and restore ventricular function by electrically connecting isolated cardiomyocytes to intact tissue, allowing them to contribute to global heart function.
   Methods and Results We created a conductive polymer by grafting pyrrole to the clinically tested biomaterial chitosan to create a polypyrrole (PPy)-chitosan hydrogel. Cyclic voltammetry showed that PPy-chitosan had semiconductive properties lacking in chitosan alone. PPy-chitosan did not reduce cell attachment, metabolism, or proliferation in vitro. Neonatal rat cardiomyocytes plated on PPy-chitosan showed enhanced Ca2+ signal conduction in comparison with chitosan alone. PPy-chitosan plating also improved electric coupling between skeletal muscles placed 25 mm apart in comparison with chitosan alone, demonstrating that PPy-chitosan can electrically connect contracting cells at a distance. In rats, injection of PPy-chitosan 1 week after myocardial infarction decreased the QRS interval and increased the transverse activation velocity in comparison with saline or chitosan, suggesting improved electric conduction. Optical mapping showed increased activation in the border zone of PPy-chitosan-treated rats. Echocardiography and pressure-volume analysis showed improvement in load-dependent (ejection fraction, fractional shortening) and load-independent (preload recruitable stroke work) indices of heart function 8 weeks after injection.
   Conclusions We synthesized a biocompatible conductive biomaterial (PPy-chitosan) that enhances biological conduction in vitro and in vivo. Injection of PPy-chitosan better maintained heart function after myocardial infarction than a nonconductive polymer.
C1 [Mihic, Anton; Cui, Zhi; Wu, Jun; Vlacic, Goran; Miyagi, Yasuo; Li, Shu-Hong; Lu, Sun; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada.
   [Mihic, Anton; Cui, Zhi; Wu, Jun; Vlacic, Goran; Miyagi, Yasuo; Li, Shu-Hong; Lu, Sun; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Div Cardiac Surg, Dept Surg, Toronto, ON M5S 1A1, Canada.
   [Sung, Hsing-Wen] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.
RP Li, RK (reprint author), Ctr Toronto Med Discovery Tower,101 Coll St,Rm 3-, Toronto, ON M5G 1L7, Canada.
EM renkeli@uhnresearch.ca
OI Li, Ren-Ke/0000-0002-2584-060X
FU Heart and Stroke Foundation of Ontario [G140005765]; Heart &
   Stroke/Richard Lewar Centres of Excellence in Cardiovascular Research;
   Ontario Graduate Scholarship from the province of Ontario
FX This work was supported by a grant from the Heart and Stroke Foundation
   of Ontario (G140005765). Dr Li holds a Canada Research Chair in cardiac
   regeneration. A. Mihic was supported by a studentship award from the
   Heart & Stroke/Richard Lewar Centres of Excellence in Cardiovascular
   Research, and an Ontario Graduate Scholarship from the province of
   Ontario. This work was also supported by a generous contribution by
   Eileen Mercier.
CR Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Blackburn NJR, 2015, BIOMATERIALS, V39, P182, DOI 10.1016/j.biomaterials.2014.11.004
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054
   Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lee LC, 2013, INT J CARDIOL, V168, P2022, DOI 10.1016/j.ijcard.2013.01.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Leung BM, 2015, J TISSUE ENG REGEN M, V9, P1247, DOI 10.1002/term.1724
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lu SH, 2010, TISSUE ENG PT A, V16, P1303, DOI 10.1089/ten.TEA.2009.0434
   Miller JS, 2000, CHEMPHYSCHEM, V1, P229, DOI 10.1002/1439-7641(20001215)1:4<229::AID-CPHC229>3.0.CO;2-J
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687
   Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sharma V, 2012, EXPERT OPIN PHARMACO, V13, P1153, DOI 10.1517/14656566.2012.685163
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578
   Song KD, 2010, J MATER SCI-MATER M, V21, P2835, DOI 10.1007/s10856-010-4131-4
   Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONHA.106.615385
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wei L, 2013, PACE, V36, P1138, DOI 10.1111/pace.12154
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
NR 35
TC 32
Z9 34
U1 6
U2 88
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD AUG 25
PY 2015
VL 132
IS 8
BP 772
EP 784
DI 10.1161/CIRCULATIONAHA.114.014937
PG 13
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA CP9HN
UT WOS:000360204800015
PM 26304669
OA Bronze
DA 2018-10-20
ER

PT J
AU Dumitriu, C
   Ungureanu, C
   Popescu, S
   Tofan, V
   Popescu, M
   Pirvu, C
AF Dumitriu, Cristina
   Ungureanu, Camelia
   Popescu, Simona
   Tofan, Vlad
   Popescu, Marian
   Pirvu, Cristian
TI Ti surface modification with a natural antioxidant and antimicrobial
   agent
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE TiO2 nanostructure; Torularhodin; Anodization; Antibacterial properties;
   Medical devices
ID FREE-ENERGY; BACTERIAL ADHESION; TRANSPLANT RECIPIENTS; MICROBIAL
   ADHESION; RHODOTORULA-RUBRA; BIOFILM FORMATION; MEDICAL DEVICES;
   IN-VITRO; CAROTENOIDS; INFECTIONS
AB Ti surface was modified with a natural antioxidant and antimicrobial agent, torularhodin, by its incorporation onto a Ti/TiO2 substrate via anodization process. This natural antioxidant and antimicrobial agent can be produced from waste materials, as an alternative to synthetic antimicrobial compounds.
   Scanning electron microscopy (SEM), Structural Fourier Transform Infrared (FTIR) spectroscopy, contact angle (CA) measurements, and atomic force microscopy (AFM) are employed to assess the surface properties of resulting coatings.
   Surface and electrochemical analyses highlighted that torularhodin was embedded in the TiO2 shielding layer, improving the antibacterial activity with about 65% compared to Ti/TiO2. Several species of microorganisms: Staphylococcus aureus, Candida albicans and Aspergillus fumigatus were utilized to test the antimicrobial effect Hemolysis and cytotoxicity tests were additionally performed, showing good results.
   This nanostructured Ti surface based on a natural antioxidant and antibacterial agent is a promising biomaterial for medical device purposes. (C) 2015 Published by Elsevier B.V.
C1 [Dumitriu, Cristina; Ungureanu, Camelia; Popescu, Simona; Popescu, Marian; Pirvu, Cristian] Univ Politehn Bucuresti, Bucharest 060042, Romania.
   [Popescu, Marian] Natl Inst Res & Dev Microtechnol, Bucharest 077190, Romania.
   [Tofan, Vlad] Cantacuzino Natl Inst Res Dev Microbiol & Immunol, Bucharest 050096, Romania.
RP Pirvu, C (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Gen Chem, 1-7 Polizu, Bucharest 011061, Romania.
EM c_pirvu@chim.pub.ro
OI Pirvu, Cristian/0000-0003-0339-6146
FU CNCS-UEFISCDI [PN2-253/2014-NANOCOAT]
FX This work was supported by a project of CNCS-UEFISCDI,
   PN2-253/2014-NANOCOAT.
CR Anitha VC, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/065102
   [Anonymous], 2004, F75600 ASTM
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Buergers R, 2009, DENT MATER, V25, P269, DOI 10.1016/j.dental.2008.07.011
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Cao HL, 2013, SURF COAT TECH, V233, P57, DOI 10.1016/j.surfcoat.2013.01.043
   Chan CMN, 2013, J EXP NANOSCI, V8, P859, DOI 10.1080/17458080.2011.616540
   Cowan T., 2011, J WOUND CARE, V20, P222
   Desrousseaux C, 2013, J HOSP INFECT, V85, P87, DOI 10.1016/j.jhin.2013.06.015
   Dumitriu C, 2013, J ELECTROCHEM SOC, V160, pG55, DOI 10.1149/2.035302jes
   Dumitriu C, 2015, APPL SURF SCI, V341, P157, DOI 10.1016/j.apsusc.2015.02.183
   Frengova GI, 2009, J IND MICROBIOL BIOT, V36, P163, DOI 10.1007/s10295-008-0492-9
   Gavalda J, 2005, CLIN INFECT DIS, V41, P52, DOI 10.1086/430602
   Gomes F, 2014, BIOFOULING, V30, P131, DOI 10.1080/08927014.2013.848858
   Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003
   Hahnel S, 2008, J DENT, V36, P977, DOI 10.1016/j.jdent.2008.08.004
   Hamadi F, 2008, COLLOID SURFACE B, V65, P134, DOI 10.1016/j.colsurfb.2008.03.010
   Han RM, 2012, MOLECULES, V17, P2140, DOI 10.3390/molecules17022140
   Han V, 2010, VOX SANG, V98, P116, DOI 10.1111/j.1423-0410.2009.01249.x
   Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005
   Iatta R, 2014, MED MYCOL, V52, P264, DOI 10.1093/mmy/myt004
   Iversen M, 2007, EUR J CLIN MICROBIOL, V26, P879, DOI 10.1007/s10096-007-0376-3
   Johnston JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111346
   Knorr SD, 2005, DENT MATER, V21, P272, DOI 10.1016/j.dental.2004.06.002
   Konovalova TA, 1999, J PHYS CHEM B, V103, P4672, DOI 10.1021/jp9900638
   Kummer KM, 2013, J BIOMED MATER RES B, V101B, P677, DOI 10.1002/jbm.b.32870
   Lee K, 2014, CHEM REV, V114, P9385, DOI 10.1021/cr500061m
   Liu Y, 2005, BIOPHYS CHEM, V117, P39, DOI 10.1016/j.bpc.2005.04.015
   Maurya Archana, 2012, J RES UPDATES POLYM, V1, P43, DOI DOI 10.6000/1929-5995.2012.01.01.6
   Mavor A. L., 2005, CURR DRUG TARGETS, V6, P863
   Mohan CC, 2013, ACTA BIOMATER, V9, P9568, DOI 10.1016/j.actbio.2013.08.023
   NCCLS, 2006, M2 A9 PERF STAND ANT
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pan J, 2002, J AM CHEM SOC, V124, P13949, DOI 10.1021/ja0279186
   Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689
   Pintucci JP, 2010, EUR REV MED PHARMACO, V14, P683
   Proia LA, 2004, CLIN INFECT DIS, V39, P373, DOI 10.1086/422320
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   Regonini D, 2013, MAT SCI ENG R, V74, P377, DOI 10.1016/j.mser.2013.10.001
   Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11
   Rodrigues LR, 2011, ADV EXP MED BIOL, V715, P351, DOI 10.1007/978-94-007-0940-9_22
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   Sakaki H, 2001, J BIOSCI BIOENG, V92, P294, DOI 10.1263/jbb.92.294
   Sekino T, 2010, TOP APPL PHYS, V117, P17, DOI 10.1007/978-3-642-03622-4_2
   Singh K., 2014, J NANOMED NANOTECHNO, V5, P250
   Stolarzewicz I, 2012, POSTEP MIKROBIOL, V51, P167
   Tissot F, 2014, TRANSPLANTATION, V97, P1192, DOI 10.1097/01.tp.0000441088.01723.ee
   Ungureanu C, 2012, ADV SCI LETT, V5, P1, DOI [10.1166/asl.2012.4403, DOI 10.1166/ASL.2012.4403]
   Ungureanu C, 2014, MAT SCI ENG C-MATER, V42, P726, DOI 10.1016/j.msec.2014.06.020
   Ungureanu C, 2013, BIORESOURCE TECHNOL, V132, P406, DOI 10.1016/j.biortech.2012.11.105
   Ungureanu C, 2012, REV CHIM-BUCHAREST, V63, P316
   Xia L, 2012, INT J NANOMED, V7, P4873, DOI 10.2147/IJN.S29496
   YOKOYAMA A, 1995, FEMS MICROBIOL LETT, V128, P139, DOI 10.1016/0378-1097(95)00097-O
   Zhang F, 2013, J PHYS CHEM C, V117, P14659, DOI 10.1021/jp404439p
NR 57
TC 2
Z9 2
U1 2
U2 41
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 25
PY 2015
VL 276
BP 175
EP 185
DI 10.1016/j.surfcoat.2015.06.063
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA CQ4SJ
UT WOS:000360594600022
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Lahtinen, J
   Hryniewicz, T
   Rzadkiewicz, S
AF Rokosz, Krzysztof
   Lahtinen, Jouko
   Hryniewicz, Tadeusz
   Rzadkiewicz, Slawomir
TI XPS depth profiling analysis of passive surface layers formed on
   austenitic AISI 304L and AISI 316L SS after high-current-density
   electropolishing
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE High-current-density electropolishing (HDEP); AISI 304L SS; AISI 316L
   SS; XPS depth profiling
ID STAINLESS-STEEL; TITANIUM BIOMATERIAL; MAGNETIC-FIELD; CORROSION; IRON;
   FILM; OXIDATION; BEHAVIOR; NIOBIUM; SPECTRA
AB In this paper, the XPS depth profiling results of passive surface layers formed on nickel-chromium AISI 304L and nickel-chromium-molybdenum AISI 316L austenitic stainless steels after a standard electropolishing at current density of 50 A/dm(2) (EP50), and after a high current density electropolishing at 1000 A/dm(2) (EP1000) in the mixture of sulfuric/orthophosphoric acids electrolyte in the following proportions H3PO4:H2SO4 = 1:4 and 4:1 are presented. The results have shown, that in case of nickel-chromium austenitic stainless steel (AISI 304L) there were no detected significant differences in the chemical composition of the passive layer formed after EP50 and EP1000 electrochemical treatments. In the passive layer of nickel-chromium-molybdenum austenitic stainless steel, the chromium and molybdenum enrichment was noted after EP1000 electropolishing, but was not observed after EP50 operation. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Rzadkiewicz, Slawomir] Koszalin Univ Technol, Div Surface Electrochem & Technol, Fac Mech Engn, PL-75620 Koszalin, Poland.
   [Lahtinen, Jouko] Aalto Univ, Sch Sci, Dept Appl Phys, FI-00076 Aalto, Finland.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Div Surface Electrochem & Technol, Fac Mech Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Jouko.Lahtinen@aalto.fi;
   Tadeusz.Hryniewicz@tu.koszalin.pl; rzadkiewiczs@gmail.com
RI Lahtinen, Jouko/K-6804-2012
OI Lahtinen, Jouko/0000-0002-1192-9945
CR Aronniemi M, 2005, SURF SCI, V578, P108, DOI 10.1016/j.susc.2005.01.019
   Aronniemi M, 2008, THIN SOLID FILMS, V516, P6110, DOI 10.1016/j.tsf.2007.11.011
   BARON A, 2006, J ACHIEV MAT MANUF E, V18, P55
   Biesinger MC, 2011, APPL SURF SCI, V257, P2717, DOI 10.1016/j.apsusc.2010.10.051
   Biesinger MC, 2004, SURF INTERFACE ANAL, V36, P1550, DOI 10.1002/sia.1983
   Burstein GT, 2000, NATURE, V407, P885, DOI 10.1038/35038040
   Crist B.V., 2005, ELEMENTS NATIVE OXID
   Dettner P., 1988, ELECTROLYTIC CHEM PO
   DIEPERS H, 1971, PHYS LETT A, VA 37, P139, DOI 10.1016/0375-9601(71)90095-8
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   Hiyniewicz T., 2009, 18 INT MAT RES C BIO, pS9
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2008, MATER LETT, V62, P3073, DOI 10.1016/j.matlet.2008.01.130
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2007, INTRO SURFACE FINISH
   Hryniewicz T., 2011, BIOMATERIALS, P227
   Hryniewicz T., 2014, INT LETT CHEM PHYS A, V4, P98, DOI DOI 10.18052/WWW.SCIPRESS.COM/ILCPA.23.98
   Hryniewicz T, 2013, APPL SURF SCI, V265, P931, DOI 10.1016/j.apsusc.2012.11.104
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Kuhn A., 2006, MET FINISH, V102, P80
   Lu G, 2000, SURF SCI, V458, P80, DOI 10.1016/S0039-6028(00)00420-9
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R, 2012, T I MET FINISH, V90, P188, DOI 10.1179/0020296712Z.00000000031
   Rokosz K, 2013, ADV MATER SCI, V13, P11, DOI 10.2478/adms-2013-0002
   Rokosz K., 2015, SURF INTERFACE ANAL
   Rokosz K., 2012, MONOGRAPH OFFICE POL, V219
   Rokosz K., 2010, J SCI ENG, V66
   Rokosz K, 2015, TEH VJESN, V22, P415, DOI 10.17559/TV-20140722110711
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Sainio J, 2005, APPL SURF SCI, V252, P1076, DOI 10.1016/j.apsusc.2005.02.029
   Tegart W.J.McG., 1959, ELECTROLYTIC CHEM PO
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
NR 44
TC 21
Z9 21
U1 1
U2 36
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 25
PY 2015
VL 276
BP 516
EP 520
DI 10.1016/j.surfcoat.2015.06.022
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA CQ4SJ
UT WOS:000360594600063
DA 2018-10-20
ER

PT J
AU Kheirkhah, M
   Fathi, M
   Salimijazi, HR
   Razavi, M
AF Kheirkhah, Mitra
   Fathi, Mohammadhossein
   Salimijazi, Hamid Reza
   Razavi, Mehdi
TI Surface modification of stainless steel implants using nanostructured
   forsterite (Mg2SiO4) coating for biomaterial applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Stainless steel; Implant; Coating; Bioceramic; Forsterite; Biomedical
   applications
ID BIOACTIVE GLASS; NANOCRYSTALLINE FORSTERITE; CERAMIC BIOACTIVITY; METAL
   IMPLANTS; HYDROXYAPATITE; REGENERATION; SCAFFOLDS
AB The main aim of this research was the preparation of the forsterite (Mg2SiO4) coating on the surface of 316L stainless steel (316L SS) substrate. For this purpose, the nanostructured forsterite was coated on the 316L SS substrate using the sol gel dip coating technique. Structural characterization techniques including X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy dispersive spectroscopy (EDX) were utilized to investigate the phase structure, morphology and elemental composition of the uncoated and coated samples. Corrosion properties of samples were studied using the electrochemical measurements in simulated body fluid (SBF). The in vitro bioactivity evaluation of the forsterite coated samples was conducted by soaking the samples in the SBF at the temperature of 37 degrees C. The results showed that, a crack-free and homogeneous forsterite coating with the crystallite size of around 40 nm was successfully achieved on the surface of 316L SS substrate. The corrosion current density of the forsterite coated samples was lesser than that of the uncoated ones indicating the improvement of corrosion resistance of the metallic substrate using the forsterite coating. Deposition of Ca and P-contained products on the surface of coated samples during the incubation in the SBF solution confirmed the bioactivity behavior of the forsterite coated samples. Consequently, the 316L SS substrate coated with nanostructured forsterite may be an appropriate selection for dental and orthopedic implant applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kheirkhah, Mitra; Fathi, Mohammadhossein; Razavi, Mehdi] Isfahan Univ Technol, Dept Mat Engn, Biomat Res Grp, Esfahan 8415683111, Iran.
   [Fathi, Mohammadhossein; Razavi, Mehdi] Isfahan Univ Med Sci, Dent Mat Res Ctr, Esfahan, Iran.
   [Kheirkhah, Mitra; Salimijazi, Hamid Reza] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
   [Razavi, Mehdi] Brunel Univ, Inst Mat & Mfg, London UB8 3PH, England.
   [Razavi, Mehdi] Brunel Univ, Brunel Inst Bioengn, London UB8 3PH, England.
RP Kheirkhah, M (reprint author), Isfahan Univ Technol, Dept Mat Engn, Biomat Res Grp, Esfahan 8415683111, Iran.
EM kheirkhan.mitra65@gmail.com
OI Razavi, Mehdi/0000-0002-3020-6187
CR Alkire R.C., 2006, ADV ELECTROCHEMICAL
   ALTHOFF J, 1982, HISTOCHEMISTRY, V74, P541, DOI 10.1007/BF00496668
   Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Boccaccini AR, 2010, J R SOC INTERFACE, V7, pS581, DOI 10.1098/rsif.2010.0156.focus
   Eschbach L., 2000, INJURY, V31, pD2
   Fathi MH, 2008, MATER LETT, V62, P4306, DOI 10.1016/j.matlet.2008.07.015
   Ge J, 2007, MATER CORROS, V58, P573, DOI 10.1002/maco.200604043
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Iafisco M, 2014, MAT SCI ENG C-MATER, V35, P212, DOI 10.1016/j.msec.2013.11.009
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kharaziha M, 2009, CERAM INT, V35, P2449, DOI 10.1016/j.ceramint.2009.02.001
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee KY, 2006, BIOMED MATER, V1, pR31, DOI 10.1088/1748-6041/1/2/R01
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Ni SY, 2007, CERAM INT, V33, P83, DOI 10.1016/j.ceramint.2005.07.021
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Razavi M., 2014, PHYS SCI INT J, V4, P708, DOI DOI 10.9734/PSIJ/2014/9265
   Salata O.V., 2004, J NANOBIOTECHNOL, V2, P3, DOI DOI 10.1186/1477-3155-2-3
   Standard A., 2004, STAND TEST METH DET
   Sutha S, 2013, MAT SCI ENG C-MATER, V33, P4046, DOI 10.1016/j.msec.2013.05.047
   Yazdanpanah A, 2012, CERAM INT, V38, P5007, DOI 10.1016/j.ceramint.2012.02.097
NR 31
TC 11
Z9 11
U1 1
U2 31
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 25
PY 2015
VL 276
BP 580
EP 586
DI 10.1016/j.surfcoat.2015.06.012
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA CQ4SJ
UT WOS:000360594600071
DA 2018-10-20
ER

PT J
AU Matlahov, I
   Iline-Vul, T
   Abayev, M
   Lee, EMY
   Nadav-Tsubery, M
   Keinan-Adamsky, K
   Gray, JJ
   Goobes, G
AF Matlahov, Irina
   Iline-Vul, Taly
   Abayev, Meital
   Lee, Elizabeth M. Y.
   Nadav-Tsubery, Merav
   Keinan-Adamsky, Keren
   Gray, Jeffiey J.
   Goobes, Gil
TI Interfacial Mineral-Peptide Properties of a Mineral Binding Peptide from
   Osteonectin and Bone-like Apatite
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID SOLID-STATE NMR; AMORPHOUS CALCIUM-PHOSPHATE; HYDROXYAPATITE CRYSTALS;
   MATRIX MACROMOLECULES; MOLECULAR RECOGNITION; STRUCTURE PREDICTION;
   COLLAGEN FIBRILS; AMINO-ACIDS; PROTEIN; NUCLEATION
AB Osteonectin is a regulator of bone mineralization. It interacts specifically with collagen and apatite through its N-terminal domain, inhibiting crystal growth. In this work, we investigated the interface formed between the mineral and an acidic peptide, ON29, derived from the protein's apatite binding domain. The structural properties of the peptide bound to the mineral and the mineral peptide interface are characterized using NMR and computational methods. A biomaterial complex is formed by precipitation of the mineral in the presence of the acidic peptide. The peptide gets embedded between mineral particles, which comprise a disordered hydrated coat covering apatite-like crystals. P-31 SEDRA measurements show that the peptide does not affect the overall proximity between phosphate ions in the mineral. {N-15}C-13 REDOR measurements reveal an alpha-turn in the center of the free peptide, which is unchanged when it is bound to the mineral. {P-31}C-13 REDOR and H-1-C-13 HETCOR measurements show that Glu/Asp carboxylates and Thr/Ala/Val side chains from ON29 are proximate to phosphate and hydroxyl groups in the mineral phases. Predictions of ON29's fold on and off hydroxyapatite crystal faces using ROSETTA-surface are used to model the molecular conformation of the peptide and its apatite-binding interface. The models constructed without bias from experimental results are consistent with NMR measurements and map out extensively the residues forming an interface with apatitic crystals.
C1 [Matlahov, Irina; Iline-Vul, Taly; Abayev, Meital; Nadav-Tsubery, Merav; Keinan-Adamsky, Keren; Goobes, Gil] Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel.
   [Lee, Elizabeth M. Y.; Gray, Jeffiey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
RP Goobes, G (reprint author), Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel.
EM gil.goobes@biu.ac.il
FU USA-Israel Binational Science Foundation [2008409]; Israeli Science
   Foundation [1059/09]
FX This work was supported by research grants from the USA-Israel
   Binational Science Foundation (No. 2008409) and the Israeli Science
   Foundation (No. 1059/09).
CR Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179
   BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372
   Best SM, 2008, MAGN RESON CHEM, V46, P323, DOI 10.1002/mrc.2168
   Boanini E, 2006, EUR J INORG CHEM, P4821, DOI 10.1002/ejic.200600423
   Boskey A L, 1998, J Cell Biochem Suppl, V30-31, P83
   Boskey AL, 1997, J DENT RES, V76, P1433, DOI 10.1177/00220345970760080501
   Brauniger T, 2002, MONATSH CHEM, V133, P1549, DOI 10.1007/s00706-002-0501-z
   Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y
   Davies E, 2014, P NATL ACAD SCI USA, V111, pE1354, DOI 10.1073/pnas.1315080111
   Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f
   DOI Y, 1989, CALCIFIED TISSUE INT, V44, P200, DOI 10.1007/BF02556565
   DOI Y, 1992, ARCH ORAL BIOL, V37, P15, DOI 10.1016/0003-9969(92)90147-Z
   EBRAHIMPOUR A, 1993, J COLLOID INTERF SCI, V159, P158, DOI 10.1006/jcis.1993.1307
   Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9
   Feng JQ, 2013, BONE, V54, P213, DOI 10.1016/j.bone.2013.01.046
   FERNANDEZ VL, 1992, J AM CHEM SOC, V114, P9634, DOI 10.1021/ja00050a051
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Fujisawa R, 1998, EUR J ORAL SCI, V106, P249, DOI 10.1111/j.1600-0722.1998.tb02183.x
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200
   GLIMCHER MJ, 1976, HDB PHYSIOLOGY     7, V7, P25
   Goobes G, 2007, MAGN RESON CHEM, V45, pS32, DOI 10.1002/mrc.2123
   Goobes G, 2007, PROG NUCL MAG RES SP, V50, P71, DOI 10.1016/j.pnmrs.2006.11.002
   Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103
   GULLION T, 1992, CHEM PHYS LETT, V194, P423, DOI 10.1016/0009-2614(92)86076-T
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1
   GULLION T, 1989, ADV MAGN RESON, V13, P57
   Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778
   Hu YY, 2010, P NATL ACAD SCI USA, V107, P22425, DOI 10.1073/pnas.1009219107
   HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   Iline-Vul T, 2015, BIOMACROMOLECULES, V16, P2656, DOI 10.1021/acs.biomac.5b00465
   Koblinski JE, 2005, J CELL SCI, V118, P2965, DOI 10.1242/jcs.02411
   Landis W J, 1999, Gravit Space Biol Bull, V12, P15
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LANE TF, 1994, FASEB J, V8, P163
   Liao S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025019
   Long G, 1996, J BIOL CHEM, V271, P8121
   Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   Mann S, 2001, BIOMINERALIZATION PR
   Masica DL, 2011, J PHYS CHEM C, V115, P13775, DOI 10.1021/jp202965h
   Masica DL, 2010, STRUCTURE, V18, P1678, DOI 10.1016/j.str.2010.09.013
   Matsumoto T, 2002, BIOMATERIALS, V23, P2241, DOI 10.1016/S0142-9612(01)00358-1
   MORADIANOLDAK J, 1992, P ROY SOC B-BIOL SCI, V247, P47, DOI 10.1098/rspb.1992.0008
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3
   Raghunathan V, 2006, J PHYS CHEM B, V110, P9324, DOI 10.1021/jp056644g
   Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y
   REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   ROMBERG RW, 1985, J BIOL CHEM, V260, P2728
   Schneiders W, 2007, BONE, V40, P1048, DOI 10.1016/j.bone.2006.11.019
   Shaw WJ, 2008, BIOPHYS J, V94, P3247, DOI [10.1529/biophysj.107.119636, 10.1529/biophyj.107.119636]
   Shaw WJ, 2008, J PHYS CHEM B, V112, P16975, DOI 10.1021/jp808012g
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tarasevich BJ, 2010, J STRUCT BIOL, V169, P266, DOI 10.1016/j.jsb.2009.10.007
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Veis A, 2013, CALCIFIED TISSUE INT, V93, P307, DOI 10.1007/s00223-012-9678-2
   Vinogradov E, 2000, CHEM PHYS LETT, V329, P207, DOI 10.1016/S0009-2614(00)01006-X
   Vinogradov E, 1999, CHEM PHYS LETT, V314, P443, DOI 10.1016/S0009-2614(99)01174-4
   Vyalikh A, 2011, J PHYS CHEM C, V115, P1513, DOI 10.1021/jp1082399
   Wang Y, 2013, NAT MATER, V12, P1144, DOI [10.1038/NMAT3787, 10.1038/nmat3787]
   Wang Y, 2012, NAT MATER, V11, P724, DOI [10.1038/NMAT3362, 10.1038/nmat3362]
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   Zheng G, 1997, MAGN RESON CHEM, V35, P606, DOI 10.1002/(SICI)1097-458X(199709)35:9<606::AID-OMR124>3.0.CO;2-#
NR 67
TC 7
Z9 7
U1 4
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD AUG 25
PY 2015
VL 27
IS 16
BP 5562
EP 5569
DI 10.1021/acs.chemmater.5b01696
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA CQ0YE
UT WOS:000360323700015
DA 2018-10-20
ER

PT J
AU Foster, LJR
   Ho, S
   Hook, J
   Basuki, M
   Marcal, H
AF Foster, Leslie John Ray
   Ho, Sonia
   Hook, James
   Basuki, Monica
   Marcal, Helder
TI Chitosan as a Biomaterial: Influence of Degree of Deacetylation on Its
   Physiochemical, Material and Biological Properties
SO PLOS ONE
LA English
DT Article
ID OLFACTORY ENSHEATHING CELLS; IN-VITRO; POLYHYDROXYALKANOATE FILMS;
   CELLULAR BIOCOMPATIBILITY; SURFACE-ROUGHNESS; ACETYLATION;
   TRANSPLANTATION; REGENERATION; DEGRADATION; MEMBRANES
AB Chitosan is a biomaterial with a range of current and potential biomedical applications. Manipulation of chitosan degree of deacetylation (DDA) to achieve specific properties appears feasible, but studies investigating its influence on properties are often contradictory. With a view to the potential of chitosan in the regeneration of nerve tissue, the influence of DDA on the growth and health of olfactory ensheathing cells (OECs) was investigated. There was a linear increase in OEC proliferation as the DDA increased from 72 to 85%. This correlated with linear increases in average surface roughness (0.62 to 0.78 mu m) and crystallinity (4.3 to 10.1%) of the chitosan films. Mitochondrial activity and membrane integrity of OECs was significantly different for OECs cultivated on chitosan with DDAs below 75%, while those on films with DDAs up to 85% were similar to cells in asynchronous growth. Apoptotic indices and cell cycle analysis also suggested that chitosan films with DDAs below 75% were cytocompatible but induced cellular stress, while OECs grown on films fabricated from chitosan with DDAs above 75% showed no significant differences compared to those in asynchronous growth. Tensile strength and elongation to break varied with DDA from 32.3 to 45.3 MPa and 3.6 to 7.1% respectively. DDA had no significant influence on abiotic and biotic degradation profiles of the chitosan films which showed approximately 8 and 20% weight loss respectively. Finally, perceived patterns in property changes are subject to change based on potential variations in DDA analysis. NMR examination of the chitosan samples here revealed significant differences depending upon which peaks were selected for integration; 6 to 13% in DDA values within individual samples. Furthermore, differences between DDA values determined here and those reported by the commercial suppliers were significant and this may also be a source of concern when selecting commercial chitosans for biomaterial research.
C1 [Foster, Leslie John Ray; Ho, Sonia; Basuki, Monica; Marcal, Helder] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia.
   [Hook, James] Univ New S Wales, Mark Wainwright Analyt Ctr, NMR Facil, Sydney, NSW, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia.
EM J.Foster@unsw.edu.au
RI Hook, James/D-6805-2011
OI Hook, James/0000-0002-1185-7320
FU National Health and Medical Research Council of Australia [63510]
FX This work was supported by the National Health and Medical Research
   Council of Australia, http://www.nhmrc.gov.au, (63510 to JF). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Barnett SC, 2004, J ANAT, V204, P57, DOI 10.1111/j.1469-7580.2004.00257.x
   Baxter S, 2005, FOOD HYDROCOLLOID, V19, P821, DOI 10.1016/j.foodhyd.2004.11.002
   BROUWER J, 1984, CLIN CHIM ACTA, V142, P21, DOI 10.1016/0009-8981(84)90097-4
   Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897
   Chan RTH, 2013, POLYM INT, V62, P884, DOI 10.1002/pi.4451
   Chan RTH, 2011, INT J POLYM SCI, DOI 10.1155/2011/473045
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Clasen C, 2006, BIOMACROMOLECULES, V7, P3210, DOI 10.1021/bm060486x
   Daranarong D, 2014, POLYM INT, V63, P1254, DOI 10.1002/pi.4631
   Daranarong D, 2014, BIOMED RES INT, DOI 10.1155/2014/741408
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Foster J, 2010, BIOPOLYMERS, P243
   Foster LJR, 2012, JOVE-J VIS EXP, DOI 10.3791/3527
   Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g
   Foster LJR, 2014, BIOADHESION BIOMIMET, P195
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Hoekstra A, 1998, BIOMATERIALS, V19, P1467, DOI 10.1016/S0142-9612(98)00060-X
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7
   Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Muzzarelli RAA, 1999, EXS, V87, P251
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Revi D, 2014, J BIOMED MATER RES A, V102, P3273, DOI 10.1002/jbm.a.35003
   Richter MW, 2008, EXP NEUROL, V209, P353, DOI 10.1016/j.expneurol.2007.06.011
   Ruitenberg MJ, 2006, J NEUROTRAUM, V23, P468, DOI 10.1089/neu.2006.23.468
   SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706
   Sanguanchaipaiwong V, 2004, BIOMACROMOLECULES, V5, P643, DOI 10.1021/bm0344708
   Shahbazi J, 2011, LASER SURG MED, V43, P490, DOI 10.1002/lsm.21076
   Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Venault A, 2012, AICHE J, V58, P2226, DOI 10.1002/aic.12737
   Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9
   Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444
NR 45
TC 17
Z9 17
U1 1
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2015
VL 10
IS 8
AR e0135153
DI 10.1371/journal.pone.0135153
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP6KK
UT WOS:000359995500016
PM 26305690
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chamberlain, MD
   Wells, LA
   Lisovsky, A
   Guo, HB
   Isserlin, R
   Talior-Volodarsky, I
   Mahou, R
   Emili, A
   Sefton, MV
AF Chamberlain, Michael Dean
   Wells, Laura A.
   Lisovsky, Alexandra
   Guo, Hongbo
   Isserlin, Ruth
   Talior-Volodarsky, Ilana
   Mahou, Redouan
   Emili, Andrew
   Sefton, Michael V.
TI Unbiased phosphoproteomic method identifies the initial effects of a
   methacrylic acid copolymer on macrophages
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE phosphoproteomic; material-cell interactions; macrophage; methacrylic
   acid
ID GENE-EXPRESSION; PROTEIN; REPAIR; CELLS; ANGIOGENESIS; MATRIX; BEADS;
   BIOCOMPATIBILITY; PARADIGM; PATHWAY
AB An unbiased phosphoproteomic method was used to identify biomaterial-associated changes in the phosphorylation patterns of macrophage-like cells. The phosphorylation differences between differentiated THP1 (dTHP1) cells treated for 10, 20, or 30 min with a vascular regenerative methacrylic acid (MAA) copolymer or a control methyl methacrylate (MM) copolymer were determined by MS. There were 1,470 peptides (corresponding to 729 proteins) that were differentially phosphorylated in dTHP1 cells treated with the two materials with a greater cellular response to MAA treatment. In addition to identifying pathways (such as integrin signaling and cytoskeletal arrangement) that are well known to change with cell-material interaction, previously unidentified pathways, such as apoptosis and mRNA splicing, were also discovered.
C1 [Chamberlain, Michael Dean; Wells, Laura A.; Lisovsky, Alexandra; Talior-Volodarsky, Ilana; Mahou, Redouan; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Guo, Hongbo; Isserlin, Ruth; Emili, Andrew] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3G9, Canada.
   [Sefton, Michael V.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
RI Chamberlain, Michael/A-9107-2016
OI Chamberlain, Michael/0000-0003-1813-8545
FU Natural Sciences and Engineering Research Council (NSERC); Ontario
   Research Foundation; Province of Ontario; University of Toronto; NSERC
   Collaborative Research and Training Experience Program (CREATE) in
   Manufacturing Materials; Mimetics (M3) training program; Canadian
   Institutes of Health Research (CIHR); CIHR Training Program in
   Regenerative Medicine
FX This work was supported by the Natural Sciences and Engineering Research
   Council (NSERC), the Ontario Research Foundation, scholarships from the
   Province of Ontario (to A. L.) and the University of Toronto (to A. L.),
   the NSERC Collaborative Research and Training Experience Program
   (CREATE) in Manufacturing Materials (A. L.) and Mimetics (M3) training
   program (A. L.), a fellowship from the Canadian Institutes of Health
   Research (CIHR; to L. A. W.), and the CIHR Training Program in
   Regenerative Medicine (L.A.W.).
CR Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134
   Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539
   Bock BC, 2010, J BIOL CHEM, V285, P21644, DOI 10.1074/jbc.M109.096628
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chen L, 2006, FEBS LETT, V580, P3401, DOI 10.1016/j.febslet.2006.05.012
   Conte D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052167
   Desai S, 2011, BBA-MOL CELL RES, V1813, P1190, DOI 10.1016/j.bbamcr.2011.03.007
   Eckhaus AA, 2008, PLAST RECONSTR SURG, V122, P1361, DOI 10.1097/PRS.0b013e3181882082
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fitzpatrick LE, 2012, BIOMATERIALS, V33, P5297, DOI 10.1016/j.biomaterials.2012.04.008
   Fitzpatrick LE, 2011, BIOMATERIALS, V32, P8957, DOI 10.1016/j.biomaterials.2011.08.021
   Guo HB, 2013, PROTEOMICS, V13, P1325, DOI 10.1002/pmic.201200369
   Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huynh KD, 2000, GENE DEV, V14, P1810
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538
   Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046
   Martin DC, 2010, J BIOMED MATER RES A, V93A, P484, DOI 10.1002/jbm.a.32528
   Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0
   Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126
   Rueda D, 2007, J IMMUNOL, V178, P4373, DOI 10.4049/jimmunol.178.7.4373
   Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]
   Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X
   Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29
   Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375
   Wells LA, 2014, BIOMATER SCI-UK, V2, P1768, DOI 10.1039/c4bm00159a
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007
   Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993
NR 37
TC 5
Z9 5
U1 1
U2 17
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 25
PY 2015
VL 112
IS 34
BP 10673
EP 10678
DI 10.1073/pnas.1508826112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP6NZ
UT WOS:000360005600049
PM 26261332
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Jinks, I
   Paul, P
   Wortmann, FJ
AF Jinks, Ian
   Paul, Prem
   Wortmann, Franz J.
TI The effects of esterification on the humidity-dependent glass transition
   of human hair
SO THERMOCHIMICA ACTA
LA English
DT Article
DE Human hair; Differential scanning calorimetry; Glass transition;
   Esterification; Internal plasticization
ID KERATIN; WATER; TEMPERATURE; WOOL; RELAXATION; PROTEINS; FIBERS
AB Human hair is a highly complex biomaterial. For the analysis of its mechanical and thermal properties it is, however, well described by a two-phase structure, which contains as morphological components the highly-ordered, crystalline intermediate filaments (IFs) and the less-ordered, amorphous matrix. A previous study has shown that wool compared to human hair exhibits for the whole range of water contents higher values for the glass transition temperature, T-g, as a property of the matrix. This is despite a higher content of hydrophobic, high glycine-tyrosine (HGT) proteins contained within the matrix of human hair. On this basis, the internal plasticization (IP) hypothesis was developed, stating that the composition of the matrix is the controlling factor of the glass transition and that, namely, the HGT-proteins may have a plasticization effect in the matrix. To further evaluate this hypothesis, esterifications of the hair proteins with various alcohols were carried out to introduce additional and variable hydrophobic sites into the fiber. The effects of these modifications on the humidity-dependent Tg of hair are analysed on the basis of the Fox-equation. It is shown that all esterifications lead to a systematic decrease of, the T-g-values in line with the IP-hypothesis. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Jinks, Ian; Wortmann, Franz J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
   [Paul, Prem] Unilever Res Labs, Wirral CH63 3JW, Merseyside, England.
RP Wortmann, FJ (reprint author), Univ Manchester, Sch Mat, Sackville St Bldg,C47, Manchester M13 9PL, Lancs, England.
EM franz.wortmann@manchester.ac.uk
CR Aharoni SM, 1998, POLYM ADVAN TECHNOL, V9, P169, DOI 10.1002/(SICI)1099-1581(199803)9:3<169::AID-PAT740>3.3.CO;2-Q
   ALEXANDER P, 1951, BIOCHEM J, V48, P629, DOI 10.1042/bj0480629
   Cao JN, 2005, BIOPOLYMERS, V77, P38, DOI 10.1002/bip.20186
   DIN German Institute for Standardization, 1994, 53765 DIN
   Doster W, 2010, BBA-PROTEINS PROTEOM, V1804, P3, DOI 10.1016/j.bbapap.2009.06.019
   Evans T., 2012, PRACTICAL MODERN HAI
   Feughelman M., 1997, MECH PROPERTIES STRU
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   Fukuda M., 1990, SEN-I GAKKAISHI, V46, P415
   GILLESPIE JM, 1974, COMP BIOCHEM PHYSIOL, V47, P339, DOI 10.1016/0305-0491(74)90063-7
   GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011
   IBM Corp, 2011, SPSS VERS 20
   Jansson H, 2010, BBA-PROTEINS PROTEOM, V1804, P20, DOI 10.1016/j.bbapap.2009.06.026
   Jinks I.R., 2014, P 6 INT C APPL HAIR
   Jinks I.R., 2014, THESIS U MANCHESTER
   JURDANA LE, 1992, TEXT RES J, V62, P463, DOI 10.1177/004051759206200805
   KALICHEVSKY MT, 1992, INT J BIOL MACROMOL, V14, P257, DOI 10.1016/S0141-8130(05)80038-8
   MACLAREN J, 1981, WOOL SCI CHEM REACTI
   Miyake T, 2008, SEN-I GAKKAISHI, V64, P289
   Robbins C. R., 2012, CHEM PHYS BEHAV HUMA
   Rouilly A, 2001, POLYMER, V42, P10111, DOI 10.1016/S0032-3861(01)00555-9
   WATT IC, 1968, J APPL CHEM, V18, P1
   WATT IC, 1964, J APPL POLYM SCI, V8, P1737
   Wortmann F.J., 2007, IFSCC MAG, V10, P317
   WORTMANN FJ, 1994, TEXT RES J, V64, P737, DOI 10.1177/004051759406401206
   WORTMANN FJ, 1995, TEXT RES J, V65, P669, DOI 10.1177/004051759506501107
   Wortmann FJ, 2006, BIOPOLYMERS, V81, P371, DOI 10.1002/bip.20429
   WORTMANN FJ, 1984, TEXT RES J, V54, P6, DOI 10.1177/004051758405400102
   WORTMANN FJ, 1985, TEXT RES J, V55, P750, DOI 10.1177/004051758505501207
   Wortmann FJ, 2012, J STRUCT BIOL, V177, P553, DOI 10.1016/j.jsb.2011.09.014
   Wortmann FJ, 2009, J APPL POLYM SCI, V113, P3336, DOI 10.1002/app.30336
   Zar J.H., 1996, BIOSTATISTICAL ANAL
NR 32
TC 2
Z9 2
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0040-6031
EI 1872-762X
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD AUG 20
PY 2015
VL 614
BP 33
EP 36
DI 10.1016/j.tca.2015.06.002
PG 4
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA CN9ZO
UT WOS:000358809900005
DA 2018-10-20
ER

PT J
AU Du, YZ
   Yu, M
   Ge, J
   Ma, PX
   Chen, XF
   Lei, B
AF Du, Yuzhang
   Yu, Meng
   Ge, Juan
   Ma, Peter X.
   Chen, Xiaofeng
   Lei, Bo
TI Development of a Multifunctional Platform Based on Strong, Intrinsically
   Photoluminescent and Antimicrobial Silica-Poly(citrates)-Based Hybrid
   Biodegradable Elastomers for Bone Regeneration
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID TISSUE REGENERATION; MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS;
   BIOACTIVE GLASS; OSTEOGENIC DIFFERENTIATION; STEM-CELLS; BIOMATERIALS;
   HYDROXYAPATITE; FABRICATION; STRATEGIES
AB Biodegradable biomaterials with intrinsically multifunctional properties such as high strength, photoluminescent ability (bioimaging monitoring), and antimicrobial activity (anti-infection), as well as high osteoblastic differentiation ability, play a critical role in successful bone tissue regeneration. However, fabricating a biomaterial containing all these functions is still a challenge. Here, urethane cross-linked intrinsically multifunctional silica-poly(citrate) (CMSPC)-based hybrid elastomers are developed by first one-step polymerization and further chemical crosslinked using isocyanate. CMSPC hybrid elastomers demonstrate a high modulus of 976 +/- 15 MPa, which is superior compared with most conventional poly(citrate)-based elastomers. Hybrid elastomers show strong and stable intrinsic photoluminescent ability (emission 400-600 nm) due to the incorporation of silica phase. All elastomers exhibit high inherent antibacterial properties against Staphylococcus aureus. In addition, CMSPC hybrid elastomers significantly enhance the proliferation and metabolic activity of osteoblasts (MC3T3-E1). CMSPC hybrid elastomers significantly promote the osteogenic differentiation of MC3T3-E1 by improving alkaline phosphatase activity and calcium biomineralization deposits, as well as expressions of osteoblastic genes. These hybrid elastomers also show a minimal inflammatory response indicated by subcutaneous transplantation in vivo. These optimized structure and multifunctional properties make this hybrid elastomer highly promising for bone tissue regeneration and antiinfection and bioimaging applications.
C1 [Du, Yuzhang; Yu, Meng; Ge, Juan; Lei, Bo] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710054, Peoples R China.
   [Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Chen, Xiaofeng; Lei, Bo] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
   [Lei, Bo] State Key Lab Mfg Syst Engn, Xian 710054, Peoples R China.
RP Du, YZ (reprint author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710054, Peoples R China.
EM mapx@umich.edu; rayboo@xjtu.edu.cn
FU scientific research starting foundation from Xi'an Jiaotong University;
   Natural Science Basic Research Plan in Shaanxi Province of China
   [2015JQ5165]; Fundamental Research Funds for the Central Universities
   [XJJ2014090]; National 973 Project of China [2012CB619100]; National
   Natural Science Foundation of China [51372005]
FX Y.D. and M.Y. contributed equally to this work. The valuable comments of
   potential reviewers are acknowledged. This work was supported by the
   scientific research starting foundation from Xi'an Jiaotong University,
   the Natural Science Basic Research Plan in Shaanxi Province of China
   (Program No. 2015JQ5165), the Fundamental Research Funds for the Central
   Universities (XJJ2014090), National 973 Project of China (2012CB619100),
   and National Natural Science Foundation of China (51372005).
CR Akyildiz AC, 2014, J BIOMECH, V47, P773, DOI 10.1016/j.jbiomech.2014.01.019
   Andrade F, 2013, ADV DRUG DELIVER REV, V65, P1816, DOI 10.1016/j.addr.2013.07.020
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Bliuc D, 2015, OSTEOPOROSIS INT, V26, P1331, DOI 10.1007/s00198-014-3014-9
   Carlisle E.M., 1981, P69
   Chen MJ, 2014, PROG POLYM SCI, V39, P365, DOI 10.1016/j.progpolymsci.2013.11.001
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Dawson JI, 2014, STEM CELLS, V32, P35, DOI 10.1002/stem.1559
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Dimmeler S, 2014, NAT MED, V20, P814, DOI 10.1038/nm.3627
   Du YZ, 2015, J MATER CHEM B, V3, P2986, DOI 10.1039/c4tb02089h
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Gu HJ, 2011, BIOMATERIALS, V32, P7023, DOI 10.1016/j.biomaterials.2011.06.003
   Hench LL, 2014, SPRING SER BIOMAT S, V2, P51, DOI 10.1007/978-3-642-53980-0_3
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Jacombs A, 2014, PLAST RECONSTR SURG, V133, p471E, DOI 10.1097/PRS.0000000000000020
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Lei B, 2014, MATER CHEM PHYS, V145, P397, DOI 10.1016/j.matchemphys.2013.09.057
   Lei B, 2013, J MATER CHEM B, V1, P5153, DOI 10.1039/c3tb20941e
   Lei B, 2012, J MATER CHEM, V22, P16906, DOI 10.1039/c2jm31384g
   Lei B, 2012, J AM CERAM SOC, V95, P30, DOI 10.1111/j.1551-2916.2011.04918.x
   Lipsky BA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-227
   Liu H, 2015, BIOMATERIALS, V49, P103, DOI 10.1016/j.biomaterials.2015.01.017
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Ojanen X, 2015, J BIOMECH, V48, P269, DOI 10.1016/j.jbiomech.2014.11.034
   Pereira MJN, 2013, ADV MATER, V25, P1209, DOI 10.1002/adma.201203824
   Ripamonti U, 2012, BIOMATERIALS, V33, P3813, DOI 10.1016/j.biomaterials.2012.01.050
   Shie MY, 2013, BIOMATERIALS, V34, P6589, DOI 10.1016/j.biomaterials.2013.05.075
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   Xie ZW, 2014, ADV MATER, V26, P4491, DOI 10.1002/adma.201306070
   Xue YM, 2014, CHEM ENG J, V251, P158, DOI 10.1016/j.cej.2014.04.049
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
   Zhang QW, 2012, BIOMATERIALS, V33, P5067, DOI 10.1016/j.biomaterials.2012.03.063
   Zhang QW, 2011, BIOMATERIALS, V32, P87, DOI 10.1016/j.biomaterials.2010.08.090
   Zhang Y, 2013, BIOMATERIALS, V34, P4048, DOI 10.1016/j.biomaterials.2013.02.040
   Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g
   Zhao X, 2015, J MATER CHEM B, V3, P3222, DOI 10.1039/c4tb01693a
   Zhou PY, 2014, BIOMATERIALS, V35, P10033, DOI 10.1016/j.biomaterials.2014.09.009
NR 41
TC 18
Z9 18
U1 8
U2 82
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 19
PY 2015
VL 25
IS 31
BP 5016
EP 5029
DI 10.1002/adfm.201501712
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CP4RT
UT WOS:000359870900009
DA 2018-10-20
ER

PT J
AU Shi, MQ
   Song, GH
   Yang, PP
   Chu, YQ
   Ma, CA
AF Shi, Mei-Qin
   Song, Guang-Hui
   Yang, Pian-Pian
   Chu, You-Qun
   Ma, Chun-An
TI A new biomass template to prepare multi-channel structure of WO3 and its
   application for methanol electro-oxidation
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Multi-channel WO3; Methanol electro-oxidation;
   Electro-catalyst; Microstructure
ID FUEL-CELLS; PT-RU; CATALYSTS
AB Reed was used as the template and its unique multi-channel structure was fully duplicated on the WO3 particles by simple impregnation and calcination. The prepared WO3 particles which have multi-channel structure ((mc)-WO3) were evaluated as a support for methanol electro-oxidation. 10 wt% Pt was loaded on the (mc)-WO3 support by employing microwave-assisted polyol strategy. The morphological characterizations suggest that Pt is homogeneously dispersed on (mc)-WO3 with an average size of 3.3 nm. Electrochemical studies indicate that the electro-catalytic performance of the synthesized catalyst is better for methanol electro-oxidation compared with that of commercial Pt/C. This improved activity can be attributed to the enhanced H-spillover effect caused by the increased interface between Pt and WO3 in the multi-channel structure of catalysts. It is also found that the multi-channel structure of WO3 could facilitate the electron transfer and mass transport during the electrochemical reaction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shi, Mei-Qin; Song, Guang-Hui; Yang, Pian-Pian; Chu, You-Qun; Ma, Chun-An] Zhejiang Univ Technol, Coll Chem Engn, State Key Lab Breeding Base Green Chem Synth Tech, Hangzhou 310032, Zhejiang, Peoples R China.
RP Ma, CA (reprint author), Zhejiang Univ Technol, Coll Chem Engn, State Key Lab Breeding Base Green Chem Synth Tech, Hangzhou 310032, Zhejiang, Peoples R China.
EM science@zjut.edu.cn
FU National Natural Science Foundation of China [21376220]
FX This work was supported by National Natural Science Foundation of China
   (21376220).
CR Baeck SH, 2003, ADV MATER, V15, P1269, DOI 10.1002/adma.200304669
   Cao DX, 2004, J POWER SOURCES, V134, P170, DOI 10.1016/j.jpowsour.2004.03.053
   Du Y, 2009, ELECTROCHEM COMMUN, V11, P1717, DOI 10.1016/j.elecom.2009.07.004
   Duay J, 2013, ACS NANO, V7, P1200, DOI 10.1021/nn3056077
   GASTEIGER HA, 1995, J PHYS CHEM-US, V99, P8290, DOI 10.1021/j100020a063
   Girishkumar G, 2005, LANGMUIR, V21, P8487, DOI 10.1021/la051499j
   Jayaraman S, 2005, J PHYS CHEM B, V109, P22958, DOI 10.1021/jp053053h
   Lebedeva NP, 2010, ELECTROCHIM ACTA, V55, P7659, DOI 10.1016/j.electacta.2009.12.041
   Ma CA, 2013, J POWER SOURCES, V242, P273, DOI 10.1016/j.jpowsour.2013.05.083
   Savadogo O, 1996, J ELECTROCHEM SOC, V143, P3842, DOI 10.1149/1.1837306
   Shrestha S, 2011, CATAL REV, V53, P256, DOI 10.1080/01614940.2011.596430
   Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858
   Tian BZ, 2004, J AM CHEM SOC, V126, P865, DOI 10.1021/ja037877t
   Zhou WQ, 2009, INT J HYDROGEN ENERG, V34, P9316, DOI 10.1016/j.ijhydene.2009.09.059
   Zhu KK, 2003, CHEM PHYS LETT, V377, P317, DOI 10.1016/S009-2614(03)01206-5
NR 15
TC 2
Z9 3
U1 2
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 15
PY 2015
VL 153
BP 124
EP 127
DI 10.1016/j.matlet.2015.04.014
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CM0DF
UT WOS:000357347900034
DA 2018-10-20
ER

PT J
AU Stoleru, E
   Tsekov, Y
   Kotsilkova, R
   Ivanov, E
   Vasile, C
AF Stoleru (Paslaru), Elena
   Tsekov, Yuliy
   Kotsilkova, Rumiana
   Ivanov, Evgeni
   Vasile, Cornelia
TI Mechanical behavior at nanoscale of chitosan-coated PE surface
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE coatings; polyolefins; surfaces and interfaces
ID POLYETHYLENE SURFACE; IMPROVING HEMOCOMPATIBILITY; SENSING INDENTATION;
   BLOOD-COMPATIBILITY; FILMS; NANOINDENTATION; ANTITHROMBOGENICITY;
   POLYMERIZATION; BIOMATERIAL; IMPROVEMENT
AB Chitosan coating of polyethylene (PE) was proposed as a new procedure to improve its biocompatibility and surface properties. The functionalization of the PE film surface by covalent bonding of chitosan coating and its effect on the surface mechanical properties, as surface elasticity, stiffness, and adhesion (that are important in different biological processes) were investigated by nano-indentation, scratch, and atomic force microscopy. It has been established that chitosan grafting onto corona functionalized PE surface using various coupling agents significantly improves the surface hardness and elastic modulus although they decrease in depth of the layer. Compared to the neat PE substrate, the chitosan coated samples show significant improved friction properties and tear resistance. The surface roughness features correlate with the micro-mechanical parameters. Therefore, the covalent immobilization of the chitosan onto PE leads to a stable coating with better mechanical performance being recommended as a promising material for medical applications and food packaging. (c) 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 42344.
C1 [Stoleru (Paslaru), Elena; Vasile, Cornelia] Petru Poni Inst Macromol Chem, Dept Phys Chem, Iasi 700487, Romania.
   [Tsekov, Yuliy; Kotsilkova, Rumiana; Ivanov, Evgeni] Bulgarian Acad Sci, Inst Mech, Open Lab Expt Micro & Nano Mech, BU-1113 Sofia, Bulgaria.
RP Vasile, C (reprint author), Petru Poni Inst Macromol Chem, Dept Phys Chem, 41A Gr Ghica Voda Alley, Iasi 700487, Romania.
EM cvasile@icmpp.ro
RI Paslaru, Elena/O-4402-2014; Ivanov, Evgeni/P-2496-2016
OI Paslaru, Elena/0000-0003-1409-9913; Ivanov, Evgeni/0000-0002-8337-6884
FU European Cooperation in Science and Technology (COST) action [FA0904,
   MP1202]; DNTC/India [01/10-2013]; IAEA Research Contract [17689
   (RC-17689-R0)]
FX The authors acknowledge the financial support given by the European
   Cooperation in Science and Technology (COST) action FA0904
   (Eco-Sustainable Food Packaging Based on Polymer Nanomaterials); MP1202
   (Rational design of hybrid organic-inorganic interfaces); bilateral
   project DNTC/India 01/10-2013 and IAEA Research Contract No: 17689
   (RC-17689-R0).
CR Amendola E., STUDY ADHESION SILIC
   ANDERSON GW, 1958, J AM CHEM SOC, V80, P4423, DOI 10.1021/ja01549a078
   Bandopadhay D, 2004, J APPL POLYM SCI, V92, P3046, DOI 10.1002/app.20291
   Broughton W. R., 055 NPL DEPCMPR
   Chen YS, 2004, J APPL POLYM SCI, V93, P2014, DOI 10.1002/app.20663
   Feng G, 2002, J MATER RES, V17, P660, DOI 10.1557/JMR.2002.0094
   Fischer-Cripps AC, 2011, MECH ENG SER, P77, DOI 10.1007/978-1-4419-9872-9_4
   Geng KB, 2007, POLYMER, V48, P841, DOI 10.1016/j.polymer.2006.07.075
   Ho E, 2005, DENT MATER, V21, P656, DOI 10.1016/j.dental.2004.09.002
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Ivanov E., 2012, MECH NANOMATERIALS N, P287
   Lei JX, 2001, ACTA CHIM SINICA, V59, P685
   Mao C, 2004, MAT SCI ENG C-BIO S, V24, P479, DOI 10.1016/j.msec.2003.09.168
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Marghalani HY, 2010, J APPL ORAL SCI, V18, P59, DOI 10.1590/S1678-77572010000100011
   Moghbeli M. R., 2001, P RUBB BOND C COL GE
   Munteanu BS, 2014, CELL CHEM TECHNOL, V48, P565
   Odegard GM, 2005, EXP MECH, V45, P130, DOI 10.1177/0014485105052320
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Paslaru E, 2013, J APPL POLYM SCI, V130, P2444, DOI 10.1002/app.39329
   Popelka A, 2012, CARBOHYD POLYM, V90, P1501, DOI 10.1016/j.carbpol.2012.07.021
   Robertson GL, 1993, FOOD PACKAGING PRINC
   Shan B, 2006, J APPL POLYM SCI, V101, P3697, DOI 10.1002/app.20860
   Shin GH, 2002, J AGR FOOD CHEM, V50, P4608, DOI 10.1021/jf020169r
   Sugiyama K, 2000, MACROMOL MATER ENG, V282, P5, DOI 10.1002/1439-2054(20001001)282:1<5::AID-MAME5>3.0.CO;2-H
   Theapsak S, 2012, ACS APPL MATER INTER, V4, P2474, DOI 10.1021/am300168a
   Tihminlioglu F, 2010, J FOOD ENG, V96, P342, DOI 10.1016/j.jfoodeng.2009.08.018
   Wang Z., 2014, J APPL POLYM SCI, P131
   Zhao GW, 2007, PLASMA SCI TECHNOL, V9, P202, DOI 10.1088/1009-0630/9/2/18
NR 29
TC 0
Z9 0
U1 0
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2015
VL 132
IS 31
AR 42344
DI 10.1002/app.42344
PG 10
WC Polymer Science
SC Polymer Science
GA CJ0EM
UT WOS:000355147600019
DA 2018-10-20
ER

PT J
AU Yang, Y
   Mo, FN
   Chen, YY
   Liu, YY
   Chen, SJ
   Zuo, JD
AF Yang, Yan
   Mo, Funian
   Chen, Yangyang
   Liu, Yingyi
   Chen, Shaojun
   Zuo, Jiandong
TI Preparation of 2-(dimethylamino) ethyl methacrylate copolymer micelles
   for shape memory materials
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE 2-(dimethylamino) ethyl methacrylate; biocompatible; biomaterials;
   micelles; shape memory polymers
ID BLOCK-COPOLYMERS; BIOMEDICAL APPLICATIONS; AQUEOUS-SOLUTION; GENE
   DELIVERY; POLYMERS; MEMBRANES; SIO2; PH
AB Researchers are actively developing shape memory polymers (SMPs) for smart biomaterials. This paper reports a new SMP system synthesized from biocompatible 2-(dimethylamino) ethyl methacrylate (DMAEMA), butyl acrylate (BA) and tri(ethylene glycol) divinyl ether (TDE). Preliminary results show that the DMAEMA-co-BA-co-TDE copolymers form micelles in aqueous solution due to chemical crosslinking and hydrophobicity. The micelle size decreased with the increase in the BA content since the hydrophobicity of copolymers increases with the increase of BA content. The resulting polymer films contain-N(CH3)(2) functional groups for further biomaterial applications. The thermal stability of DMAEMA-co-BA-co-TDE copolymers is determined by the DMAEMA structure and content. Moreover, the copolymers form micro-phase-separated structures containing a reversible amorphous soft phase, and the storage moduli decreases significantly around T-g. Therefore, good thermal-induced shape memory effects are achieved in the DMAEMA-co-BA-co-TDE copolymers by adjusting the BA content. This work proposes a new strategy for designing smart biomaterials using a biocompatible monomer. (c) 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 42312.
C1 [Yang, Yan; Mo, Funian; Chen, Yangyang; Liu, Yingyi; Chen, Shaojun; Zuo, Jiandong] Shenzhen Univ, Shenzhen Key Lab Special Funct Mat, Nanshan Dist Key Lab Biopolymers & Safety Evaluat, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China.
RP Chen, SJ (reprint author), Shenzhen Univ, Shenzhen Key Lab Special Funct Mat, Nanshan Dist Key Lab Biopolymers & Safety Evaluat, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China.
EM chensj@szu.edu.cn
FU National Natural Science Foundation of China [21104045]; Special
   Research Foundation of Shenzhen Oversea High-level Talents for
   Innovation and Entrepreneurship [KQCX20120807153115869]; Nanshan
   District Key Lab for Biopolymers and Safety Evaluation [KC2014ZDZJ0001A]
FX This work was financially supported by the National Natural Science
   Foundation of China (grant No. 21104045), the Special Research
   Foundation of Shenzhen Oversea High-level Talents for Innovation and
   Entrepreneurship (Grant No. KQCX20120807153115869), and the Nanshan
   District Key Lab for Biopolymers and Safety Evaluation
   (No.KC2014ZDZJ0001A).
CR Ahn SK, 2010, MACROMOLECULES, V43, P7330, DOI 10.1021/ma101145r
   Arslan H, 2014, MACROMOL BIOSCI, V14, P81, DOI 10.1002/mabi.201300290
   Bertrand O, 2014, MACROMOLECULES, V47, P183, DOI 10.1021/ma402301w
   Chen SJ, 2009, MATER LETT, V63, P1462, DOI 10.1016/j.matlet.2009.03.028
   FRISCH HL, 1980, POLYM ENG SCI, V20, P2, DOI 10.1002/pen.760200103
   Guo WJ, 2014, J POLYM SCI POL CHEM, V52, P2131, DOI 10.1002/pola.27222
   Han X, 2014, MOL PHYS, V112, P2046, DOI 10.1080/00268976.2014.882523
   Hu JL, 2010, J MATER CHEM, V20, P3346, DOI 10.1039/b922872a
   Melendez-Ortiz HI, 2014, POLYM ENG SCI, V54, P1625, DOI 10.1002/pen.23703
   Lee HC, 2014, MACROMOLECULES, V47, P3041, DOI 10.1021/ma500360a
   Li Y, 2014, MACROMOL RAPID COMM, V35, P466, DOI 10.1002/marc.201300719
   Lowe AB, 1999, MACROMOLECULES, V32, P2141, DOI 10.1021/ma980543h
   Luo YW, 2013, ADV MATER, V25, P743, DOI 10.1002/adma.201202884
   de Souza JCP, 2012, COLLOID POLYM SCI, V290, P1285, DOI 10.1007/s00396-012-2651-9
   Popescu MT, 2012, MACROMOLECULES, V45, P3523, DOI 10.1021/ma300222d
   Qian Y, 2013, BIOMATERIALS, V34, P2117, DOI 10.1016/j.biomaterials.2012.11.050
   Schepelina O, 2010, ADV FUNCT MATER, V20, P1962, DOI 10.1002/adfm.201000369
   Small W, 2010, J MATER CHEM, V20, P3356, DOI 10.1039/b923717h
   Sui KY, 2010, J POLYM SCI POL CHEM, V48, P2143, DOI 10.1002/pola.23982
   Wong YS, 2014, SCI CHINA CHEM, V57, P476, DOI 10.1007/s11426-013-5061-z
   Xie T, 2010, NATURE, V464, P267, DOI 10.1038/nature08863
   Yi Z, 2014, J MEMBRANE SCI, V463, P49, DOI 10.1016/j.memsci.2014.03.041
   Yu HP, 2013, HOLZFORSCHUNG, V67, P455, DOI 10.1515/hf-2012-0077
   Zhang Q, 2014, RSC ADV, V4, P24240, DOI 10.1039/c4ra00971a
   Zhou WZ, 2013, POWDER TECHNOL, V249, P1, DOI 10.1016/j.powtec.2013.07.018
   Zhu LJ, 2014, J MATER CHEM A, V2, P15566, DOI 10.1039/c4ta03199g
NR 26
TC 1
Z9 1
U1 4
U2 66
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2015
VL 132
IS 31
AR 42312
DI 10.1002/app.42312
PG 7
WC Polymer Science
SC Polymer Science
GA CJ0EM
UT WOS:000355147600005
DA 2018-10-20
ER

PT J
AU Baranowska, M
   Slota, AJ
   Eravuchira, PJ
   Alba, M
   Formentin, P
   Pallares, J
   Ferre-Borrull, J
   Marsal, LF
AF Baranowska, Malgorzata
   Slota, Agata J.
   Eravuchira, Pinkie J.
   Alba, Maria
   Formentin, Pilar
   Pallares, Josep
   Ferre-Borrull, Josep
   Marsal, Lluis F.
TI Protein attachment to silane-functionalized porous silicon: A comparison
   of electrostatic and covalent attachment
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Porous silicon; APTMS; GTA; Silane-PEG-NHS; Collagen; Bovine serum
   albumin; Reflection interference spectroscopy (RIfS)
ID ALUMINA RUGATE FILTERS; BOVINE SERUM-ALBUMIN; CELL-ADHESION; SURFACE
   FUNCTIONALIZATION; BIOSENSING APPLICATIONS; STRUCTURE FABRICATION;
   MACROPOROUS SILICON; DRUG-DELIVERY; REAL-TIME; MEMBRANE
AB Porous silicon (pSi) is a prosperous biomaterial, biocompatible, and biodegradable. Obtaining regularly functionalized pSi surfaces is required in many biotechnology applications. Silane-PEG-NHS (triethoxysilane-polyethylene-glycol-N-hydroxysuccinimide) is useful for single-molecule studies due to its ability to attach to only one biomolecule. We investigate the functionalization of pSi with silane-PEG-NHS and compare it with two common grafting agents: APTMS (3-aminopropylotrimethoxysilane) as electrostatic linker, and APTMS modified with glutaraldehyde as covalent spacer. We show the arrangement of two proteins (collagen and bovine serum albumin) as a function of the functionalization and of the pore size. FTIR is used to demonstrate correct functionalization while fluorescence confocal microscopy reveals that silane-PEG-NHS results in a more uniform protein distribution. Reflection interference spectroscopy (RIfS) is used to estimate the attachment of linker and proteins. The results open a way to obtain homogenous chemical modified silicon supports with a great value in biosensing, drug delivery and cell biology. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Baranowska, Malgorzata; Slota, Agata J.; Eravuchira, Pinkie J.; Alba, Maria; Formentin, Pilar; Pallares, Josep; Ferre-Borrull, Josep; Marsal, Lluis F.] Univ Rovira & Virgili, Dept Engn Elect Elect & Automat, Tarragona 43007, Spain.
RP Ferre-Borrull, J (reprint author), Univ Rovira & Virgili, Dept Engn Elect Elect & Automat, Avda Paisos Catalans 26, Tarragona 43007, Spain.
EM josep.ferre@urv.cat; Iluis.marsal@urv.cat
RI Alba, Maria/F-6604-2016; Marsal, Lluis/G-8852-2011; Ferre-Borrull,
   Josep/A-9315-2009
OI Alba, Maria/0000-0003-2119-9082; Marsal, Lluis/0000-0002-5976-1408;
   Ferre-Borrull, Josep/0000-0002-5210-5133
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [TEC2012-34397]; Catalan Government [AGAUR 2014 SGR 1433]; ICREA under
   the ICREA Academia Award
FX This work was supported in part by the Spanish Ministry of Economy and
   Competitiveness (MINECO) under Grant Number TEC2012-34397, by Catalan
   Government under project AGAUR 2014 SGR 1433 and ICREA under the ICREA
   Academia Award.
CR Alba M, 2014, RSC ADV, V4, P11409, DOI 10.1039/c3ra48062c
   Alvarez SD, 2009, ACS NANO, V3, P3301, DOI 10.1021/nn900825q
   Alvarez SD, 2009, BIOMATERIALS, V30, P26, DOI 10.1016/j.biomaterials.2008.09.005
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Bailey RC, 2005, MATER TODAY, V8, P46, DOI 10.1016/S1369-7021(05)00794-7
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Charnay C, 2004, EUR J PHARM BIOPHARM, V57, P533, DOI 10.1016/j.ejph.2003.12.007
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Ciampi S, 2010, CHEM SOC REV, V39, P2158, DOI 10.1039/b923890p
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Coffer JL, 2003, PHYS STATUS SOLIDI A, V197, P336, DOI 10.1002/pssa.200306520
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dancil KPS, 1999, J AM CHEM SOC, V121, P7925, DOI 10.1021/ja991421n
   De Stefano L, 2007, SENSORS-BASEL, V7, P214, DOI 10.3390/s7020214
   Decuzzi P, 2008, BIOMATERIALS, V29, P377, DOI 10.1016/j.biomaterials.2007.09.025
   Devouge S, 2009, J COLLOID INTERF SCI, V332, P408, DOI 10.1016/j.jcis.2008.12.045
   Dhanekar S, 2013, BIOSENS BIOELECTRON, V41, P54, DOI 10.1016/j.bios.2012.09.045
   Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384
   Gunda NSK, 2014, APPL SURF SCI, V305, P522, DOI 10.1016/j.apsusc.2014.03.130
   Hiraoui M, 2011, MATER CHEM PHYS, V128, P151, DOI 10.1016/j.matchemphys.2011.02.052
   Jane A.O., 2007, PROGR BIOMEDICAL OPT, V6799
   JORDAN GM, 1994, J PHARM PHARMACOL, V46, P182, DOI 10.1111/j.2042-7158.1994.tb03774.x
   Karnik R, 2005, NANO LETT, V5, P1638, DOI 10.1021/nl050966e
   Kawamura R, 2013, LANGMUIR, V29, P6429, DOI 10.1021/la4012229
   KIERNAN J. A., 2000, MICROSC TODAY, V8, P8
   Kilian KA, 2009, CHEM COMMUN, P630, DOI 10.1039/b815449j
   Ko CH, 2000, LANGMUIR, V16, P6906, DOI 10.1021/la000415y
   KORN AH, 1972, J MOL BIOL, V65, P525, DOI 10.1016/0022-2836(72)90206-9
   Kumeria T, 2014, ACS APPL MATER INTER, V6, P12971, DOI 10.1021/am502882d
   Kumeria T, 2014, ANAL CHEM, V86, P1837, DOI 10.1021/ac500069f
   Kumeria T, 2013, ACS APPL MATER INTER, V5, P11783, DOI 10.1021/am403465x
   Kuo CH, 2011, PHYS CHEM CHEM PHYS, V13, P15122, DOI 10.1039/c1cp20590k
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lugo JE, 2007, J NEW MAT ELECTR SYS, V10, P113
   Ma SH, 2005, LAB CHIP, V5, P74, DOI 10.1039/b405713a
   Macias G, 2013, ACS APPL MATER INTER, V5, P8093, DOI 10.1021/am4020814
   Malaisamy R, 2013, SEP PURIF TECHNOL, V115, P114, DOI 10.1016/j.seppur.2013.04.051
   Marsal LF, 2008, PHYS STATUS SOLIDI A, V205, P2437, DOI 10.1002/pssa.200723556
   Melikjanyan GA, 2012, J CONTEMP PHYS-ARME+, V47, P133, DOI 10.3103/S1068337212030061
   Mery E, 2007, SENSOR ACTUAT B-CHEM, V126, P120, DOI 10.1016/j.snb.2006.11.003
   Meskini O, 2007, TALANTA, V71, P1430, DOI 10.1016/j.talanta.2006.05.089
   Metwalli E, 2006, J COLLOID INTERF SCI, V298, P825, DOI 10.1016/j.jcis.2006.03.045
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Ng JF, 2011, J BIOMED MATER RES B, V99B, P282, DOI 10.1002/jbm.b.31897
   Norstrom AEE, 2001, J ADHES SCI TECHNOL, V15, P665, DOI 10.1163/156856101750430413
   Orosco MM, 2009, NAT NANOTECHNOL, V4, P255, DOI [10.1038/NNANO.2009.11, 10.1038/nnano.2009.11]
   Ouyang H, 2005, ADV FUNCT MATER, V15, P1851, DOI 10.1002/adfm.200500218
   Pacholski C, 2013, SENSORS-BASEL, V13, P4694, DOI 10.3390/s130404694
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Recio-Sanchez G, 2010, MATERIALS, V3, P755, DOI 10.3390/ma3020755
   Savage DJ, 2013, CURR OPIN PHARMACOL, V13, P834, DOI 10.1016/j.coph.2013.06.006
   Schlingman DJ, 2011, COLLOID SURFACE B, V83, P91, DOI 10.1016/j.colsurfb.2010.11.002
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Silverstein R., 2005, SPECTROMETRIC IDENTI
   Simion M, 2009, SUPERLATTICE MICROST, V46, P69, DOI 10.1016/j.spmi.2008.11.024
   Sin EJ, 2012, BIOMED ENG-APP BAS C, V24, P111, DOI 10.4015/S1016237212500093
   Singh S, 2009, J MATER SCI-MATER M, V20, P181, DOI 10.1007/s10856-008-3509-z
   Sweetman MJ, 2011, LANGMUIR, V27, P9497, DOI 10.1021/la201760w
   Taga K., 1990, ANAL CHIM ACTA, V240, P125
   TAYLOR DM, 1991, J COLLOID INTERF SCI, V144, P53, DOI 10.1016/0021-9797(91)90237-3
   Tembe S, 2008, IEEE SENS J, V8, P1593, DOI 10.1109/JSEN.2008.928925
   Trifonov T, 2008, SENSOR ACTUAT A-PHYS, V141, P662, DOI 10.1016/j.sna.2007.09.001
   Vaccari L, 2006, MICROELECTRON ENG, V83, P1598, DOI 10.1016/j.mee.2006.01.113
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   Wang XX, 2012, J BRAZIL CHEM SOC, V23, P2011, DOI 10.1590/S0103-50532012005000075
   Weigel C., 1989, CHEMIE, V335, P663
   Wu EC, 2011, BIOMATERIALS, V32, P1957, DOI 10.1016/j.biomaterials.2010.11.013
   Xifre-Perez E, 2006, J LUMIN, V121, P301, DOI 10.1016/j.jlumin.2006.08.008
   Xifre-Perez E, 2009, APPL PHYS B-LASERS O, V95, P169, DOI 10.1007/s00340-009-3416-0
   Yashiki S, 2001, J BIOSCI BIOENG, V92, P385, DOI 10.1263/jbb.92.385
   Ye W.W., 2013, ADV MAT RES, V631-632, P572
NR 74
TC 5
Z9 5
U1 4
U2 77
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD AUG 15
PY 2015
VL 452
BP 180
EP 189
DI 10.1016/j.jcis.2015.04.022
PG 10
WC Chemistry, Physical
SC Chemistry
GA CI9CV
UT WOS:000355068900024
PM 25942096
DA 2018-10-20
ER

PT J
AU Hsiao, CR
   Lin, CW
   Chou, CM
   Chung, CJ
   He, JL
AF Hsiao, Chaio-Ru
   Lin, Cheng-Wei
   Chou, Chia-Man
   Chung, Chi-Jen
   He, Ju-Liang
TI Surface modification of blood-contacting biomaterials by
   plasma-polymerized superhydrophobic films using hexamethyldisiloxane and
   tetrafluoromethane as precursors
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Blood contacting biomaterials; Nanoparticles; Plasma polymerization;
   Superhydrophobic; Surface modification
ID CHEMICAL-VAPOR-DEPOSITION; THIN-FILMS; COMPATIBILITY; ENHANCEMENT;
   ADSORPTION; PLATELET; ADHESION; IMPROVE; SIO2
AB This paper proposes a plasma polymerization system that can be used to modify the surface of the widely used biomaterial, polyurethane (PU), by employing low-cost hexamethyldisiloxane (HMDSO) and tetrafluoromethane (CF4) as precursors; this system features a pulsed-dc power supply. Plasma-polymerized HMDSO/CF4 (pp-HC) with coexisting micro- and nanoscale morphology was obtained as a superhydrophobic coating material by controlling the HMDSO/CF4 (f(H)) monomer flow ratio. The developed surface modification technology can be applied to medical devices, because it is non-cytotoxic and has favorable hemocompatibility, and no blood clots form when the device surface direct contacts. Experimental results reveal that the obtained pp-HC films contained SiOx nanoparticles randomly dispersed on the micron-scale three-dimensional network film surface. The -CF functional group, -CF2 bonding, and SiOx were detected on the film surface. The maximal water contact angle of the pp-HC coating was 161.2 degrees, apparently attributable to the synergistic effect of the coexisting micro- and nanoscale surface morphology featuring a low surface-energy layer. The superhydrophobic and antifouling characteristics of the coating were retained even after it was rubbed 20 times with a steel wool tester. Results of in vitro cytotoxicity, fibrinogen adsorption, and platelet adhesion tests revealed favorable myoblast cell proliferation and the virtual absence of fibrinogen adsorption and platelet adhesion on the pp-HC coated specimens. These quantitative findings imply that the pp-HC coating can potentially prevent the formation of thrombi and provide an alternative means of modifying the surfaces of blood-contacting biomaterials. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Hsiao, Chaio-Ru; He, Ju-Liang] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan.
   [Lin, Cheng-Wei; Chung, Chi-Jen] Cent Taiwan Univ Sci & Technol, Dept Dent Technol & Mat Sci, Taichung 40601, Taiwan.
   [Chou, Chia-Man] Taichung Vet Gen Hosp, Dept Surg, Taichung 40705, Taiwan.
   [Chou, Chia-Man] Natl Yang Ming Univ, Dept Med, Taipei 11221, Taiwan.
RP Chou, CM (reprint author), Feng Chia Univ, Dept Mat Sci & Engn, 100 Wenhwa Rd, Taichung 40724, Taiwan.
EM cmuhou@vghtc.gov.tw; cjchung@seed.net.tw
FU Ministry of Science and Technology, Taiwan, ROC [MOST
   102-2221-E-166-004, MOST 103-2221-E-166-005]; Taichung Veterans General
   Hospital [TCVGH-1035401C]
FX The authors sincerely thank the Ministry of Science and Technology,
   Taiwan, ROC (Contract No. MOST 102-2221-E-166-004, 103-2221-E-166-005)
   and Taichung Veterans General Hospital (Project No. TCVGH-1035401C) for
   financially supporting this research.
CR Alves P, 2014, COLLOID SURFACE B, V113, P25, DOI 10.1016/j.colsurfb.2013.08.039
   [Anonymous], 2003, G17103 ASTM
   [Anonymous], 2002, D335902 ASTM
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen L, 2011, COLLOID SURFACE B, V85, P2, DOI 10.1016/j.colsurfb.2010.10.034
   Choi Y.S., 2013, J PHYS D, V46, P501
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Cokeliler D, 2013, APPL SURF SCI, V268, P28, DOI 10.1016/j.apsusc.2012.11.136
   Corbella C, 2005, THIN SOLID FILMS, V482, P172, DOI 10.1016/j.tsf.2004.11.135
   Corbella C, 2009, J APPL PHYS, V106, DOI 10.1063/1.3183945
   Fan ZP, 2011, APPL SURF SCI, V257, P4296, DOI 10.1016/j.apsusc.2010.12.039
   Freitas SC, 2012, ACTA BIOMATER, V8, P4101, DOI 10.1016/j.actbio.2012.07.020
   Fujii T, 1999, THIN SOLID FILMS, V343, P457, DOI 10.1016/S0040-6090(98)01693-9
   Gao N, 2011, MATER LETT, V65, P2902, DOI 10.1016/j.matlet.2011.06.088
   Hurst SM, 2012, COLLOID SURFACE A, V407, P85, DOI 10.1016/j.colsurfa.2012.05.012
   ISO 10993-5, 1999, 109935 ISO
   Kim JK, 2004, J PHYS D APPL PHYS, V37, P2425, DOI 10.1088/0022-3727/37/17/013
   Kim Y, 2012, THIN SOLID FILMS, V523, P29, DOI 10.1016/j.tsf.2012.06.023
   Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Kolev I., 2013, SVC B, V20, P42
   Martinu L., 2010, HDB DEPOSITION TECHN, P394
   Merger M., 2010, J AM CHEM SOC, V132, P6735
   NYGREN H, 1995, J VAC SCI TECHNOL A, V13, P2613, DOI 10.1116/1.579459
   Qi PK, 2013, SURF COAT TECH, V233, P80, DOI 10.1016/j.surfcoat.2013.02.008
   Rauscher H., 2010, PLASMA TECHNOLOGY HY, P95
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Tsvetkova T, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012070
   Wagner C.D., 1977, HDB XRAY ULTRAVIOLET, P86
   Xu XK, 2005, APPL SURF SCI, V245, P11, DOI 10.1016/j.apsusc.2004.10.018
   Yang YW, 2014, J BIOMED MATER RES A, V102, P160, DOI 10.1002/jbm.a.34681
   Ye X, 2009, APPL SURF SCI, V255, P6686, DOI 10.1016/j.apsusc.2009.02.068
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhao XY, 2006, EUR POLYM J, V42, P2161, DOI 10.1016/j.eurpolymj.2006.03.013
NR 34
TC 13
Z9 13
U1 3
U2 122
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 15
PY 2015
VL 346
BP 50
EP 56
DI 10.1016/j.apsusc.2015.03.208
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CI8IW
UT WOS:000355017000008
DA 2018-10-20
ER

PT J
AU Tok, HY
   Hamzah, E
   Bakhsheshi-Rad, HR
AF Tok, H. Y.
   Hamzah, E.
   Bakhsheshi-Rad, H. R.
TI The role of bismuth on the microstructure and corrosion behavior of
   ternary Mg-1.2Ca-xBi alloys for biomedical applications
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Biomaterial; Magnesium alloy; Microstructure; Corrosion behavior
ID IN-VITRO DEGRADATION; SIMULATED BODY-FLUID; MG-CA ALLOYS; MAGNESIUM
   ALLOYS; BIODEGRADABLE MATERIALS; GRAIN-REFINEMENT; IMPLANT ALLOYS; ZN
   ALLOY; BONE; PERFORMANCE
AB In this study the influence of various Bi additions on the microstructure and corrosion behavior of the Mg-1.2Ca-xBi alloys (x = 0.5, 1.5, 3, 5, 12 wt.%) were evaluated by using optical and scanning electron microscopy, immersion and electrochemical tests. Microstructural observations showed that the refinement efficiency became more pronounced with increased Bi amount. Microstructural results of Mg-1.2Ca-xBi (x = 0.5, 1.5, and 3) indicated that the formation of three distinct phases-namely alpha-Mg, Mg2Ca and Mg3Bi2. However, further addition of Bi to 5 and 12 wt.% leads to evolution of a-Mg, Mg3Bi2, and Mg2Bi2Ca phases. The addition of Bi up to 0.5 wt.% enhanced corrosion resistance while further addition from 1.5 to 12 wt.% accelerated the degradation rate because of the emergence of more galvanic coupling between the a-Mg phases and secondary phases. The analyses showed that the Mg-1.2Ca-0.5Bi alloy gives the best corrosion resistance behavior, which makes it ideal for biodegradable medical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Tok, H. Y.; Hamzah, E.; Bakhsheshi-Rad, H. R.] Univ Teknol Malaysia, Fac Mech Engn, Dept Mat Mfg & Ind Engn, Johor Baharu 81310, Johor, Malaysia.
RP Hamzah, E (reprint author), Univ Teknol Malaysia, Fac Mech Engn, Dept Mat Mfg & Ind Engn, Johor Baharu 81310, Johor, Malaysia.
EM Esah@fkm.utm.my
FU Nippon Sheet Glass foundation [R.J130000.7324.4B136]; University
   Teknologi Malaysia; Ministry of Higher Education Malaysia
FX We would like to acknowledge the financial support for the research from
   Nippon Sheet Glass foundation under the Grant No. R.J130000.7324.4B136
   and Zamalah Scholarship provided by University Teknologi Malaysia and
   the Ministry of Higher Education Malaysia.
CR Ali YH, 2015, J ALLOY COMPD, V619, P639, DOI 10.1016/j.jallcom.2014.09.061
   [Anonymous], 2004, G3172 ASTM
   Bakhsheshi-Rad HR, 2014, MATER DESIGN, V53, P283, DOI 10.1016/j.matdes.2013.06.055
   Bakhsheshi-Rad HR, 2013, SURF COAT TECH, V222, P79, DOI 10.1016/j.surfcoat.2013.02.007
   Bakhsheshi-Rad HR, 2012, CORROS SCI, V64, P184, DOI 10.1016/j.corsci.2012.07.015
   Ben-Hamu G, 2008, INTERMETALLICS, V16, P860, DOI 10.1016/j.intermet.2008.03.003
   Candan S, 2011, J ALLOY COMPD, V509, P1958, DOI 10.1016/j.jallcom.2010.10.100
   Dhanapal A, 2012, J ALLOY COMPD, V523, P49, DOI 10.1016/j.jallcom.2012.01.070
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Dinodi N, 2013, J MAGNES ALLOY, V1, P201, DOI 10.1016/j.jma.2013.08.003
   Fowler BA, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P433, DOI 10.1016/B978-012369413-3/50077-X
   Kalb H, 2012, CORROS SCI, V57, P122, DOI 10.1016/j.corsci.2011.12.026
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lei T, 2012, CORROS SCI, V54, P270, DOI 10.1016/j.corsci.2011.09.027
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lu L, 2005, MATER SCI FORUM, V488-489, P299, DOI 10.4028/www.scientific.net/MSF.488-489.299
   Mohajernia S, 2015, SURF COAT TECH, V263, P54, DOI 10.1016/j.surfcoat.2014.12.059
   Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057
   Razavi M, 2010, MAT SCI ENG A-STRUCT, V527, P6938, DOI 10.1016/j.msea.2010.07.063
   Remennik S, 2011, MATER SCI ENG B-ADV, V176, P1653, DOI 10.1016/j.mseb.2011.07.011
   Ren MG, 2014, J ALLOY COMPD, V591, P34, DOI 10.1016/j.jallcom.2013.12.215
   Rosalbino F, 2013, J BIOMED MATER RES A, V101, P704, DOI 10.1002/jbm.a.34368
   Sachdeva D, 2012, CORROS SCI, V60, P18, DOI 10.1016/j.corsci.2012.04.016
   Sedighi M., 2013, EUR PHYS J APPL PHYS, V61
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song YW, 2012, CORROS SCI, V65, P322, DOI 10.1016/j.corsci.2012.08.037
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tan LL, 2013, J MATER SCI TECHNOL, V29, P503, DOI 10.1016/j.jmst.2013.03.002
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang X, 2013, MAT SCI ENG C-MATER, V33, P618, DOI 10.1016/j.msec.2012.10.006
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yao M. Y., 2013, EFFECT BIADDITION CO, V1
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
   Zhen Z, 2013, T NONFERR METAL SOC, V23, P2283, DOI 10.1016/S1003-6326(13)62730-2
   Zhou W, 2009, CORROS SCI, V51, P403, DOI 10.1016/j.corsci.2008.11.006
   Zhu L, 2013, ACTA METALL SIN, V49, P51, DOI 10.3724/SP.J.1037.2012.00378
NR 40
TC 17
Z9 17
U1 3
U2 33
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD AUG 15
PY 2015
VL 640
BP 335
EP 346
DI 10.1016/j.jallcom.2015.03.217
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA CH7DK
UT WOS:000354195600052
DA 2018-10-20
ER

PT J
AU Zhao, DP
   Chang, KK
   Ebel, T
   Nie, HM
   Willumeit, R
   Pyczak, F
AF Zhao, Dapeng
   Chang, Keke
   Ebel, Thomas
   Nie, Hemin
   Willumeit, Regine
   Pyczak, Florian
TI Sintering behavior and mechanical properties of a metal injection molded
   Ti-Nb binary alloy as biomaterial
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Metal injection molding; Ti-Nb alloy; Sintering behavior; Titanium
   carbide; Mechanical properties
ID BIOMEDICAL APPLICATIONS; POWDER-METALLURGY; HOMOGENIZATION; SYSTEM
AB Sintering behavior, microstructure and mechanical properties of a Ti-16Nb alloy processed by metal injection molding (MIM) technology using elemental powders were investigated in this work by optical microscopy, X-ray diffraction (XRD), dilatometer, scanning electron microscopy (SEM) and energy-dispersive spectroscopy (EDS). It was found that from 700 degrees C to 1500 degrees C the homogenization and densification process of MIM Ti-16Nb alloy consisted of three steps, i.e., Ti-diffusion-controlled step, Ti-Nb-diffusion step and matrix-diffusion step. Titanium carbide formation was observed in the samples sintered at 1300 degrees C and 1500 degrees C, but not in the ones sintered at 900 degrees C and 1100 degrees C. The MIM Ti-16Nb specimens sintered at 1500 degrees C exhibited a good combination of high tensile strength and low Young's modulus. However, the titanium carbide particles led to poor ductility. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhao, Dapeng; Nie, Hemin] Hunan Univ, Coll Biol, Changsha 410082, Hunan, Peoples R China.
   [Zhao, Dapeng; Ebel, Thomas; Willumeit, Regine; Pyczak, Florian] Helmholtz Zentrum Geesthacht, Inst Mat Res, D-21502 Geesthacht, Germany.
   [Chang, Keke] Rhein Westfal TH Aachen, Mat Chem, D-52056 Aachen, Germany.
RP Zhao, DP (reprint author), Hunan Univ, Coll Biol, Changsha 410082, Hunan, Peoples R China.
EM dpzhao@hotmail.com
RI Willumeit, Regine/I-8029-2013; Zhao, Dapeng/I-5984-2018; Pyczak,
   Florian/I-4331-2013; Chang, Keke/A-3203-2017
OI Willumeit, Regine/0000-0002-6004-6946; Zhao, Dapeng/0000-0001-6777-7760;
   Pyczak, Florian/0000-0002-9686-6575; Chang, Keke/0000-0001-9118-7031;
   Nie, Hemin/0000-0002-3657-7333
FU Helmholtz - CSC Fellowship Programme
FX This research was funded by Helmholtz - CSC Fellowship Programme. The
   authors are grateful to Dr. Uwe Lorenz, Wolfgang Limberg, Andreas
   Dobernowsky, Petra Fischer, Dr. Michael Oehring, Dr. Jonathan Paul,
   Martin Wolff, and Dr. Juliano Soyama from Helmholtz-Zentrum Geesthacht.
CR Bidaux J.-E., 2011, EUR CELLS MATER, V22, P32
   Chaves JM, 2014, J ALLOY COMPD, V616, P420, DOI 10.1016/j.jallcom.2014.07.159
   COBLE RL, 1958, J AM CERAM SOC, V41, P55, DOI 10.1111/j.1151-2916.1958.tb13519.x
   Ebel T., 2012, POWDER INJECTION MOU, V6, P29
   Ferri OM, 2010, MAT SCI ENG A-STRUCT, V527, P1800, DOI 10.1016/j.msea.2009.11.007
   Ferri OM, 2009, MAT SCI ENG A-STRUCT, V504, P107, DOI 10.1016/j.msea.2008.10.039
   Frisk K, 2003, CALPHAD, V27, P367, DOI 10.1016/j.calphad.2004.01.004
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   German R. M., 1984, POWDER METALLURGY SC
   German R.M., 1997, INJECTION MOLDING ME
   GERMAN R M, 1990, POWDER INJECTION MOL
   Gottlicher M, 2013, ACTA BIOMATER, V9, P9201, DOI 10.1016/j.actbio.2013.07.015
   Hanada S, 2003, MATER SCI FORUM, V426-4, P3103, DOI 10.4028/www.scientific.net/MSF.426-432.3103
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   LEBER S, 1964, T METALL SOC AIME, V230, P100
   Lee BJ, 2001, METALL MATER TRANS A, V32, P2423, DOI 10.1007/s11661-001-0033-x
   Liu YJ, 2009, J ALLOY COMPD, V476, P429, DOI 10.1016/j.jallcom.2008.09.019
   McCracken M, 1999, J Prosthodont, V8, P40, DOI 10.1111/j.1532-849X.1999.tb00006.x
   Murray J., 1981, B ALLOY PHASE DIAGRA, V2, P55
   Narasimhan KS, 2001, MATER CHEM PHYS, V67, P56, DOI 10.1016/S0254-0584(00)00420-X
   Neumann G., 2008, PERGAMON MAT SERIES, P149
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   O'Flynn J, 2015, J ALLOY COMPD, V618, P437, DOI 10.1016/j.jallcom.2014.08.134
   RAJ R, 1984, ACTA METALL MATER, V32, P1003, DOI 10.1016/0001-6160(84)90003-8
   Siqueira RP, 2009, J ALLOY COMPD, V476, P130, DOI 10.1016/j.jallcom.2008.09.004
   Terayama A, 2013, J ALLOY COMPD, V577, pS408, DOI 10.1016/j.jallcom.2011.12.166
   Weiss B., 1990, METAL POWDER REP, V45, P187
   Wojtaszek M, 2014, J ALLOY COMPD, V615, pS546, DOI 10.1016/j.jallcom.2014.01.161
   Yanbin L, 2011, J ALLOY COMPD, V509, P3592
   Zhao DP, 2013, J MECH BEHAV BIOMED, V28, P171, DOI 10.1016/j.jmbbm.2013.08.013
   Zhuravleva K, 2013, ADV ENG MATER, V15, P262, DOI 10.1002/adem.201200117
NR 31
TC 20
Z9 20
U1 5
U2 55
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD AUG 15
PY 2015
VL 640
BP 393
EP 400
DI 10.1016/j.jallcom.2015.04.039
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA CH7DK
UT WOS:000354195600060
DA 2018-10-20
ER

PT J
AU Chien, MY
   Chen, LC
   Chen, YC
   Sheu, MT
   Tsai, YC
   Ho, HO
   Su, CH
   Liu, DZ
AF Chien, Mei-Yin
   Chen, Ling-Chun
   Chen, Ying-Chen
   Sheu, Ming-Thau
   Tsai, Ya-Chi
   Ho, Hsiu-O
   Su, Ching-Hua
   Liu, Der-Zen
TI Mycelial Mattress from a Sporangia Formation-Delayed Mutant of Rhizopus
   stolonifer as Wound Healing-Enhancing Biomaterial
SO PLOS ONE
LA English
DT Article
ID FUNGAL MYCELIA; KERATINOCYTE PROLIFERATION; SKIN SUBSTITUTES; CHITOSAN;
   CHITIN; METALLOPROTEINASES; INHIBITORS
AB A mycelial mattress of Rhizopus stolonifer obtained from a liquid static culture was utilized for wound dressing and biomedical use. Following screening of mutants induced by UV radiation, F6, exhibiting delayed sporangium formation was selected because its sporangium maturation exhibited a 5-day delay without significant loss of mycelial weight compared to the wild type. The sporangium-free mycelial mattress from the sporangiospore culture of F6 was treated with 1N sodium hydroxide NaOH at 85 degrees C for 2 h to produce a sponge-like membrane named Rhizochitin. The trifluoroacetic acid hydrolysate of Rhizochitin contained 36% N-acetylglucosamine and 53% hexose respectively detected by the Elson-Morgen and phenol-sulfuric acid methods. Results indicated the wound area in rats covered with Rhizochitin was 40% less than that of the uncovered group. Rhizochitin decreased the expression of PDGF in the proliferation stage, increased the expression of TGF-beta in the inflammation and proliferation stages, and increased the expression of VEGF in the inflammation and proliferation stages. Rhizochitin inhibited secretion of matrix metalloproteinase-9 on days 1, 7, 9, and 12 and matrix metalloproteinase-2 on days 3, 7, 9, and 12. It was concluded that Rhizochitin has beneficial properties of biocompatible, biodegradable, and wound healing.
C1 [Chien, Mei-Yin] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan.
   [Chen, Ling-Chun; Chen, Ying-Chen; Sheu, Ming-Thau; Ho, Hsiu-O] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan.
   [Sheu, Ming-Thau] Taipei Med Univ Hosp, Clin Res Ctr, Taipei, Taiwan.
   [Sheu, Ming-Thau] Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan.
   [Tsai, Ya-Chi; Liu, Der-Zen] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan.
   [Su, Ching-Hua] Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan.
   [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan.
   [Chien, Mei-Yin] Ko Da Pharmaceut Co, Taoyuan, Taiwan.
RP Liu, DZ (reprint author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan.
EM tonyliu@tmu.edu.tw
FU Center of Excellence for Clinical Trials and Research in Neuroscience
   [DOH 100-TD-B-111-003]; Ministry of Science and Technology of ROC [NSC
   100-2320-B-038-004-MY3]; Ko Da Pharmaceutical Co., Taoyuan, Taiwan
FX Financial funding from the Center of Excellence for Clinical Trials and
   Research in Neuroscience (DOH 100-TD-B-111-003) and Ministry of Science
   and Technology of ROC (NSC 100-2320-B-038-004-MY3) is highly
   appreciated. Ko Da Pharmaceutical Co., Taoyuan, Taiwan provided support
   in the form of salaries for author MYC, but did not have any additional
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Baik WY, 2002, BIORESOURCE TECHNOL, V81, P167, DOI 10.1016/S0960-8524(01)00148-1
   Chen C, 1999, WOUND REPAIR REGEN, V7, P486, DOI 10.1046/j.1524-475X.1999.00486.x
   Chittoria RK, 2012, J SOC WOUND CARE RES, V5, P2
   Ferreira JA, 2012, BIORESOURCE TECHNOLO
   Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.1007/10_2010_93, 10.10007/10_2010_93]
   Franco RA, 2013, J BIOMATER APPL, V27, P605, DOI 10.1177/0885328211416527
   Gibson D., 2009, WOUNDS INT, V1, P1
   Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024
   Hung WS, 2004, J BIOMED MATER RES B, V70B, P122, DOI 10.1002/jbm.b.30028
   Jayakumar R, 2011, INT J MOL SCI, V12, P1876, DOI 10.3390/ijms12031876
   Kennedy JF, 1994, CARBOHYDRATE ANALYSI
   Moussa S, 2011, INT J BIOL MACROMOL, V48, P736, DOI 10.1016/j.ijbiomac.2011.02.022
   Rodriguez X, 2004, BIOINORGANIC CHEMIST, P1, DOI [10.1155/S1565363304000019, DOI 10.1155/S1565363304000019]
   Senevirathne M, 2012, ADV FOOD NUTR RES, V65, P495, DOI 10.1016/B978-0-12-416003-3.00032-9
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01
   Srinivasan A, 2010, BIORESOURCE TECHNOL, V101, P6594, DOI 10.1016/j.biortech.2010.03.079
   Su CH, 2005, J BIOMED MATER RES A, V72A, P220, DOI 10.1002/jbm.a.30235
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
   Tayel AA, 2010, INT J BIOL MACROMOL, V47, P454, DOI 10.1016/j.ijbiomac.2010.06.011
   Tayel AA, 2010, INT J BIOL MACROMOL, V47, P10, DOI 10.1016/j.ijbiomac.2010.04.005
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s
   Zamani A, 2013, BIOTECHNOLOGY ADVANC
   Zamani A, 2010, INT J MOL SCI, V11, P2976, DOI 10.3390/ijms11082976
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
NR 27
TC 1
Z9 1
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 14
PY 2015
VL 10
IS 8
AR e0134090
DI 10.1371/journal.pone.0134090
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO9KD
UT WOS:000359493600020
PM 26275241
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ghinea, R
   Pecho, O
   Herrera, LJ
   Ionescu, AM
   Cardona, JD
   Sanchez, MP
   Paravina, RD
   Perez, MD
AF Ghinea, Razvan
   Pecho, Oscar
   Javier Herrera, Luis
   Maria Ionescu, Ana
   de la Cruz Cardona, Juan
   Purificacion Sanchez, Maria
   Paravina, Rade D.
   del Mar Perez, Maria
TI Predictive algorithms for determination of reflectance data from
   quantity of pigments within experimental dental resin composites
SO BIOMEDICAL ENGINEERING ONLINE
LA English
DT Article
ID MECHANICAL-PROPERTIES; CAMPHORQUINONE; ACCEPTABILITY; REGRESSION
AB Background: Being able to estimate (predict) the final spectrum of reflectance of a biomaterial, especially when the final color and appearance are fundamental for their clinical success (as is the case of dental resin composites), could be a very useful tool for the industrial development of these type of materials. The main objective of this study was the development of predictive models which enable the determination of the reflectance spectrum of experimental dental resin composites based on type and quantity of pigments used in their chemical formulation.
   Methods: 49 types of experimental dental resin composites were formulated as a mixture of organic matrix, inorganic filler, photo activator and other components in minor quantities (accelerator, inhibitor, fluorescent agent and 4 types of pigments). Spectral reflectance of all samples were measured, before and after artificial chromatic aging, using a spectroradiometer. A Multiple Nonlinear Regression Model (MNLR) was used to predict the values of the Reflectance Factors values in the visible range (380 nm-780 nm), before and after aging, from % Pigment (% P1, % P2, % P3 and % P4) within the formulation.
   Results: The average value of the prediction error of the model was 3.46% (SD: 1.82) across all wavelengths for samples before aging and 3.54% (SD: 1.17) for samples after aging. The differences found between the predicted and measured values of the chromatic coordinates are smaller than the acceptability threshold and, in some cases, are even below the perceptibility threshold.
   Conclusions: Within the framework of this pilot study, the nonlinear predictive models developed allow the prediction, with a high degree of accuracy, of the reflectance spectrum of the experimental dental resin composites.
C1 [Ghinea, Razvan; Pecho, Oscar; Maria Ionescu, Ana; de la Cruz Cardona, Juan; del Mar Perez, Maria] Univ Granada, Dept Opt, E-18071 Granada, Spain.
   [Javier Herrera, Luis] Univ Granada, Dept Comp Architecture & Comp Technol, E-18071 Granada, Spain.
   [Purificacion Sanchez, Maria] Univ Granada, Dept Inorgan Chem, E-18071 Granada, Spain.
   [Paravina, Rade D.; del Mar Perez, Maria] Univ Texas Houston, Dept Restorat Dent & Prosthodont, Sch Dent, Houston Ctr Biomat & Biomimet, Houston, TX 77054 USA.
RP Ghinea, R (reprint author), Univ Granada, Dept Opt, Campus Fuentenueva S-N, E-18071 Granada, Spain.
EM rghinea@ugr.es
RI Herrera, Luis/L-2392-2014; Pecho, Oscar/N-3831-2018; CARDONA PEREZ, JUAN
   DE LA CRUZ/I-9351-2018
OI Herrera, Luis/0000-0003-3220-9389; Pecho, Oscar/0000-0001-7314-5049;
   CARDONA PEREZ, JUAN DE LA CRUZ/0000-0003-2867-9708; Ghinea,
   Razvan/0000-0001-8865-2430; Ionescu,
   Ana-Maria-Andreea/0000-0003-4114-9613
FU  [CEI BioTic 94];  [JA-TEP 1136];  [PYR-2014-12];  [MAT2013-43946-R]
FX The research presented in this study was partially funded by CEI BioTic
   94, JA-TEP 1136, PYR-2014-12 and MAT2013-43946-R research grants.
CR [Anonymous], 2000, 74912000 ISO
   [Anonymous], 2013, 489222013 ISO
   Atai M, 2004, DENT MATER, V20, P663, DOI 10.1016/j.dental.2003.08.008
   Calheiros FC, 2008, DENT MATER, V24, P1164, DOI 10.1016/j.dental.2008.01.006
   CIE, 2004, TECHN REP COL
   Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263
   Perez MD, 2011, J DENT, V39, pE37, DOI 10.1016/j.jdent.2011.09.007
   FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656
   Ghinea R, 2010, P SCAD NEWP BEACH US
   Ghinea R, 2010, J DENT, V38, pE57, DOI 10.1016/j.jdent.2010.07.008
   Haykin S., 1994, NEURAL NETWORKS COMP
   Herrera LJ, 2010, APPL OPTICS, V49, P422, DOI 10.1364/AO.49.000422
   Hoerl AE, 2000, TECHNOMETRICS, V42, P80, DOI 10.2307/1271436
   Johnston WM, 2009, J DENT, V37, pE2, DOI 10.1016/j.jdent.2009.03.011
   Lindsey DT, 2007, J DENT, V35, P593, DOI 10.1016/j.jdent.2007.03.006
   Park MY, 2007, DENT MATER, V23, P731, DOI 10.1016/j.dental.2006.06.028
   Sadowsky SJ, 2006, J PROSTHET DENT, V96, P433, DOI 10.1016/j.prosdent.2006.09.018
   Schneider LFJ, 2012, DENT MATER, V28, P392, DOI 10.1016/j.dental.2011.11.014
   Schneider LFJ, 2009, DENT MATER, V25, P369, DOI 10.1016/j.dental.2008.08.003
   Schunn CD, 2005, EVALUATING GOODNESS
   Sharma G, 2005, COLOR RES APPL, V30, P21, DOI 10.1002/col.20070
   Wee AG, 2005, DENT MATER, V21, P665, DOI 10.1016/j.dental.2004.09.003
   Zandinejad AA, 2006, DENT MATER, V22, P382, DOI 10.1016/j.dental.2005.04.027
NR 23
TC 1
Z9 1
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-925X
J9 BIOMED ENG ONLINE
JI Biomed. Eng. Online
PD AUG 13
PY 2015
VL 14
SU 2
AR S4
DI 10.1186/1475-925X-14-S2-S4
PG 14
WC Engineering, Biomedical
SC Engineering
GA DA0EQ
UT WOS:000367470100005
PM 26329369
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sarker, M
   Chen, XB
   Schreyer, DJ
AF Sarker, Md.
   Chen, X. B.
   Schreyer, D. J.
TI Experimental approaches to vascularisation within tissue engineering
   constructs
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE growth factors; vascularization; vasculogenesis; biomaterial;
   angiogenesis; scaffold
ID ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; BLOOD-VESSEL FORMATION;
   PLATELET-RICH PLASMA; HYALURONIC-ACID HYDROGELS; RESIDENT PROGENITOR
   CELLS; POROUS ALGINATE SCAFFOLDS; NONVIRAL GENE DELIVERY; ANGIOGENESIS
   IN-VITRO; EMBRYONIC STEM-CELLS
AB Tissue engineering opens up a new area to restore the function of damaged tissue or replace a defective organ. Common strategies in tissue engineering to repair and form new tissue containing a functional vascular network include the use of cells, growth factors, extracellular matrix proteins, and biophysical stimuli. Yet, formation of well-distributed, interconnected, and stable vascular network still remains challenging. In addition, anastomoses with host vasculature upon implantation and long-time survival of the new blood vessel in vivo are other critical issues to be addressed. This paper presents a brief review of recent advances in vascularization in vitro as well as in vivo for tissue engineering, along with suggestions for future research.
C1 [Sarker, Md.; Chen, X. B.; Schreyer, D. J.] Univ Saskatchewan, Coll Engn, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada.
   [Schreyer, D. J.] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon City Hosp 5800, Saskatoon, SK S7K 0M7, Canada.
   [Chen, X. B.] Univ Saskatchewan, Coll Engn, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada.
RP Sarker, M (reprint author), Univ Saskatchewan, Coll Engn, Div Biomed Engn, 1A26,57 Campus Dr, Saskatoon, SK S7N 5A9, Canada.
EM mas921@mail.usask.ca
OI Sarker, Md Ariful Islam/0000-0002-0849-8638
FU Saskatchewan Health Research Foundation [SHRF] [2784]; Natural Sciences
   and Engineering Research Council of Canada [NSERC] [RGPIN-2014-05648]
FX This work was financially supported by the Saskatchewan Health Research
   Foundation [SHRF Reference # 2784]; and the Natural Sciences and
   Engineering Research Council of Canada [NSERC RGPIN-2014-05648].
CR Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380
   Ahmad SA, 2002, SEMIN CANCER BIOL, V12, P105, DOI 10.1006/scbi.2001.0418
   Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI 10.1089/ten.TEA.2009.0708
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y
   Alajati A, 2008, NAT METHODS, V5, P439, DOI 10.1038/NMETH.1198
   [Anonymous], 2012, CC BY SA 3 0
   Aper T, 2007, EUR J VASC ENDOVASC, V33, P33, DOI 10.1016/j.ejvs.2006.08.008
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bai XP, 2013, J BIOACT COMPAT POL, V28, P126, DOI 10.1177/0883911512473230
   Baker BM, 2013, LAB CHIP, V13, P3246, DOI 10.1039/c3lc50493j
   Basire A, 2006, THROMB HAEMOSTASIS, V95, P678, DOI 10.1160/TH05-07-0511
   Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1
   Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Borschel GH, 2006, PLAST RECONSTR SURG, V117, P2235, DOI 10.1097/01.prs.0000224295.54073.49
   Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brey EM, 2008, PRINCIPLES REGENERAT, P1020
   Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9
   Brown KJ, 1996, LAB INVEST, V75, P539
   Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002
   Buyukhatipoglu K, 2010, TISSUE ENG PART C-ME, V16, P631, DOI [10.1089/ten.tec.2009.0280, 10.1089/ten.TEC.2009.0280]
   Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x
   Carmeliet P, 2000, CIRC RES, V87, P176, DOI 10.1161/01.RES.87.3.176
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chamberlain MD, 2011, TISSUE ENG PT A, V17, P151, DOI 10.1089/ten.TEA.2010.0293
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Clementi E, 1999, P NATL ACAD SCI USA, V96, P1559, DOI 10.1073/pnas.96.4.1559
   Collen A, 2003, BLOOD, V101, P1810, DOI 10.1182/blood-2002-05-1593
   Conklin BS, 2002, J SURG RES, V102, P13, DOI 10.1006/jsre.2001.6295
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Cooper TP, 2011, ACTA BIOMATER, V7, P1072, DOI 10.1016/j.actbio.2010.11.008
   Corstorphine L, 2011, J TISSUE ENG REGEN M, V5, P119, DOI 10.1002/term.296
   Coura RD, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-12
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cronin KJ, 2004, PLAST RECONSTR SURG, V113, P260, DOI 10.1097/01.PRS.0000095942.71618.9D
   Cuchiara MP, 2012, ADV FUNCT MATER, V22, P4511, DOI 10.1002/adfm.201200976
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   Davis S, 1999, CURR TOP MICROBIOL, V237, P173
   De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034
   Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276
   DICKSON MC, 1995, DEVELOPMENT, V121, P1845
   Distler JHW, 2003, Q J NUCL MED, V47, P149
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Doldere JH, 2011, PLAST RECONSTR SURG, V127, P2283, DOI 10.1097/PRS.0b013e3182131c3e
   Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022
   Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Ennett AB, 2002, EXPERT OPIN BIOL TH, V2, P805, DOI 10.1517/14712598.2.8.805
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Forster NA, 2011, ISLETS, V3, P271, DOI 10.4161/isl.3.5.15942
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   Fu RH, 2014, CELL TRANSPLANT, V23, P621, DOI 10.3727/096368914X678382
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Furukawa KS, 2002, CELL TRANSPLANT, V11, P475
   Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Gauvin R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-24
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Ghosh R, 2008, INT J CLIN PRACT, V62, P1383, DOI 10.1111/j.1742-1241.2008.01842.x
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Gomes ME, 2004, INT MATER REV, V49, P274, DOI 10.1179/095066004225021927
   Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   Hall H, 2007, CURR PHARM DESIGN, V13, P3597, DOI 10.2174/138161207782794158
   Hao X, 2004, BIOCHEM BIOPH RES CO, V315, P1058, DOI 10.1016/j.bbrc.2004.01.165
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hegen A, 2011, J TISSUE ENG REGEN M, V5, pE52, DOI 10.1002/term.336
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Hildbrand P, 2004, BLOOD, V104, P2010, DOI 10.1182/blood-2004-12-4219
   Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298
   Hiscox AM, 2008, TISSUE ENG PT A, V14, P433, DOI 10.1089/tea.2007.0099
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104502
   Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175
   Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225
   Hussey AJ, 2009, TISSUE ENG PT A, V15, P3823, DOI [10.1089/ten.tea.2008.0682, 10.1089/ten.TEA.2008.0682]
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cellbio.1.1.67
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Johnson NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063075
   Jones CP, 2009, STEM CELLS, V27, P3074, DOI 10.1002/stem.222
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   KARASEK MA, 1989, J INVEST DERMATOL, V93, pS33, DOI 10.1111/1523-1747.ep12580906
   Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Khanna O, 2010, AM J SURG, V200, P655, DOI 10.1016/j.amjsurg.2010.08.001
   Khattak SF, 2005, TISSUE ENG, V11, P974, DOI 10.1089/ten.2005.11.974
   Khondee S, 2011, MOL PHARMACEUT, V8, P788, DOI 10.1021/mp100393j
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kim S, 2008, TISSUE ENG PART B-RE, V14, P133, DOI 10.1089/teb.2007.0304
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Kitajima T, 2007, BIOMATERIALS, V28, P1989, DOI 10.1016/j.biomaterials.2006.12.022
   Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Kurita J, 2011, ANN THORAC SURG, V92, P837, DOI 10.1016/j.athoracsur.2011.04.084
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee KW, 2004, TRANSPLANT P, V36, P2464, DOI 10.1016/j.transproceed.2004.08.078
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee VK, 2011, 2011 IEEE 37 ANN NE
   Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Lim D, 2003, LAB CHIP, V3, P318, DOI 10.1039/b308452c
   Lindahl P, 1999, CURR TOPICS PATHOL, V93, P27
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Lu M, 1999, INVEST OPHTH VIS SCI, V40, P3281
   Lu TL, 2013, INT J NANOMED, V8, P337, DOI 10.2147/IJN.S38635
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MALEK A, 1992, AM J PHYSIOL, V263, pC389
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mao ZW, 2009, ACTA BIOMATER, V5, P2983, DOI 10.1016/j.actbio.2009.04.004
   MARINPADILLA M, 1985, J COMP NEUROL, V241, P237, DOI 10.1002/cne.902410210
   Markowicz M, 2005, INT J ARTIF ORGANS, V28, P1251
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Maynard HD, 2005, ACTA BIOMATER, V1, P451, DOI 10.1016/j.actbio.2005.04.004
   McGuigan AP, 2008, BIOMATERIALS, V29, P2453, DOI 10.1016/j.biomaterials.2008.02.010
   McGuigan AP, 2006, NAT PROTOC, V1, P2963, DOI 10.1038/nprot.2006.443
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6
   Mehier-Humbert S, 2005, ADV DRUG DELIVER REV, V57, P733, DOI 10.1016/j.addr.2004.12.007
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Mellott AJ, 2013, ANN BIOMED ENG, V41, P446, DOI 10.1007/s10439-012-0678-1
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   MORIN O, 1986, J CELL PHYSIOL, V129, P103, DOI 10.1002/jcp.1041290115
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Muehleder Severin, 2014, Front Bioeng Biotechnol, V2, P52, DOI 10.3389/fbioe.2014.00052
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nahmias Y, 2006, NAT PROTOC, V1, P2288, DOI 10.1038/nprot.2006.386
   Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029
   Nakada Mitsutoshi, 2011, Cancers (Basel), V3, P3242, DOI 10.3390/cancers3033242
   Narayan D, 2008, J BIOMED MATER RES A, V87A, P710, DOI 10.1002/jbm.a.31749
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   NICOSIA RF, 1995, LAB INVEST, V73, P658
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nishiyama Y, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3002759
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Nor JE, 2001, LAB INVEST, V81, P453
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   OpenStax College, 2014, AN PHYS
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Pachence JM, 1997, PRINCIPLES TISSUE EN, P273
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   PISKIN E, 1994, J BIOMAT SCI-POLYM E, V5, P451, DOI 10.1163/156856294X00149
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Popat KC, 2006, J ORTHOP RES, V24, P619, DOI 10.1002/jor.20105
   Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497
   Prabhakar V, 2003, J BIOMED MATER RES A, V67A, P303, DOI 10.1002/jbm.a.10603
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   RANGANATHAN S, 1994, MOL REPROD DEV, V38, P69, DOI 10.1002/mrd.1080380112
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662
   Richard L, 1999, Methods Mol Med, V18, P261, DOI 10.1385/0-89603-516-6:261
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Rissanen TT, 2001, EUR J CLIN INVEST, V31, P651, DOI 10.1046/j.1365-2362.2001.00864.x
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Sadr N, 2011, BIOMATERIALS, V32, P7479, DOI 10.1016/j.biomaterials.2011.06.034
   Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316
   Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14
   Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036
   SATO N, 1993, AM J PATHOL, V142, P1119
   Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18
   Sha'ban Munirah, 2008, J Orthop Surg Res, V3, P17, DOI 10.1186/1749-799X-3-17
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Shyu KG, 1998, CIRCULATION, V98, P2081, DOI 10.1161/01.CIR.98.19.2081
   Sidelmann JJ, 2000, SEMIN THROMB HEMOST, V26, P605, DOI 10.1055/s-2000-13216
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682
   Skoog SA, 2014, J MATER SCI-MATER M, V25, P845, DOI 10.1007/s10856-013-5107-y
   Skovseth DK, 2002, AM J PATHOL, V160, P1629, DOI 10.1016/S0002-9440(10)61110-8
   Slaaf D, 1993, PHYSICS HEART CIRCUL, P383
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Smith CM, 2004, TISSUE ENG, V10, P1566, DOI 10.1089/1076327042500274
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   Song J, 2000, IN VITRO CELL DEV-AN, V36, P600
   SPORN LA, 1995, BLOOD, V86, P1802
   Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Su H, 2009, INT J CARDIOL, V133, P191, DOI 10.1016/j.ijcard.2007.12.034
   Sugimori E, 2006, DENT MATER J, V25, P591, DOI 10.4012/dmj.25.591
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Sumpio BE, 1998, ARTERIOSCL THROM VAS, V18, P349, DOI 10.1161/01.ATV.18.3.349
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Tang MD, 2004, ADV MATER, V16, P1345, DOI 10.1002/adma.200400766
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.TEA.2010.0551, 10.1089/ten.tea.2010.0551]
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Therriault D, 2005, ADV MATER, V17, P395, DOI 10.1002/adma.200400481
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   Tuan TL, 1996, EXP CELL RES, V223, P127, DOI 10.1006/excr.1996.0065
   Tuin A, 2012, EUR CELLS MATER, V24, P320, DOI 10.22203/eCM.v024a23
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   UNGARI S, 1985, INVAS METAST, V5, P193
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252
   Vaiman M, 2005, ISRAEL MED ASSOC J, V7, P571
   van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02000852-0
   Vannucci L, 2013, NEW MICROBIOL, V36, P1
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002
   Wang XY, 2014, LAB CHIP, V14, P2709, DOI 10.1039/c4lc00069b
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wiethoff CM, 2003, J PHARM SCI, V92, P203, DOI 10.1002/jps.10286
   Wiggenhauser PS, 2012, CELL TISSUE RES, V347, P747, DOI 10.1007/s00441-011-1226-2
   Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042
   Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wong CS, 2013, J MATER SCI-MATER M, V24, P1865, DOI 10.1007/s10856-013-4937-y
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Wust S, 2011, J FUNCT BIOMATER, V2, P119, DOI 10.3390/jfb2030119
   Yamagishi S, 1999, MICROVASC RES, V57, P329, DOI 10.1006/mvre.1999.2145
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yang M, 2009, J BIOMED MATER RES B, V91B, P354, DOI 10.1002/jbm.b.31409
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315
   Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9
   Zhou LL, 1999, CURR EYE RES, V19, P395, DOI 10.1076/ceyr.19.5.395.5297
   Zieber L, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024102
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 339
TC 17
Z9 17
U1 2
U2 68
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD AUG 13
PY 2015
VL 26
IS 12
BP 683
EP 734
DI 10.1080/09205063.2015.1059018
PG 52
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA CM5MU
UT WOS:000357733000001
PM 26053971
DA 2018-10-20
ER

PT J
AU Zhang, F
   Li, JJ
   Zhu, T
   Zhang, SS
   Kundu, SC
   Lu, SZ
AF Zhang, Fang
   Li, Jiaojiao
   Zhu, Tian
   Zhang, Shanshan
   Kundu, Subhas C.
   Lu, Shenzhou
TI Potential of biocompatible regenerated silk fibroin/sodium N-lauroyl
   sarcosinate hydrogels
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hydrogel; surfactant; biocompatibility; silk fibroin
ID MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; SCAFFOLD; CULTURE;
   SURFACE; DIFFERENTIATION; FABRICATION; PROTEINS; CRYSTALS; DELIVERY
AB Hydrogels are becoming widely used in biomaterial applications. The available methods for the preparation of these materials are continually growing. The gelation time (GT) of silk protein fibroin is difficult to control by physical methods. The cross-linkers used in available chemical techniques are likely to impact the biocompatibility of the resultant materials. In this paper, we demonstrate that the addition of sodium N-lauroyl sarcosinate (an amino-acid-based surfactant) accelerates the formation of hydrogels from fibroin. GT, turbidity variations, changes of viscoelasticity during the gelation process, and the mechanical properties of the products are measured. The secondary structure was probed by Fourier transform infrared spectroscopy, X-ray diffraction and the morphologies of the products were investigated by scanning electron microscopy. Transformations in the beta-sheet content were monitored by the fluorescence of Thioflavine T and circular dichroism measurements. The relationship between the surface tension of sodium N-lauroyl sarcosinate and the GT was also explained. To investigate cell compatibility, fibroblast cells were seeded onto the surface of the hydrogels. The results indicate that the sodium N-lauroyl sarcosinate/fibroin GT can be controlled. This blend-hydrogel demonstrates excellent cell compatibility, good compression strength, and outstanding compression-recovery characteristics. Sodium N-lauroyl sarcosinate/silk fibroin hydrogels containing beta-sheets have considerable potential as replacement materials in addressing the tissue defects involved with repair surgery.
C1 [Zhang, Fang; Li, Jiaojiao; Zhu, Tian; Zhang, Shanshan; Lu, Shenzhou] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Lu, SZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM lushenzhou@suda.edu.cn
RI Lu, Shenzhou/P-6519-2015
OI Lu, Shenzhou/0000-0003-4188-2057; Kundu, Subhas C./0000-0002-7170-2291
FU National Natural Science Foundation of China [51203107, 51373114];
   Nature Science Foundation of Jiangsu, China [BK20131176]; PAPD
FX This work was supported by the National Natural Science Foundation of
   China [grant number 51203107], [grant number 51373114]; PAPD and Nature
   Science Foundation of Jiangsu, China [grant number. BK20131176].
CR Amin S, 2009, SCI RES ESSAYS, V4, P1175
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Chen K, 2014, J BIONIC ENG, V11, P378, DOI 10.1016/S1672-6529(14)60051-2
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Gad EAM, 1997, J AM OIL CHEM SOC, V74, P43, DOI 10.1007/s11746-997-0117-x
   Gasperini L, 2014, J R SOC INTERFACE, V11
   Ghosh S, 2011, J COLLOID INTERF SCI, V358, P208, DOI 10.1016/j.jcis.2011.02.054
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu XY, 2013, CELLULOSE, V20, P2923, DOI 10.1007/s10570-013-0075-4
   Huang YP, 2013, COMPOS SCI TECHNOL, V84, P15, DOI 10.1016/j.compscitech.2013.05.007
   Karakutuk I, 2012, BIOMACROMOLECULES, V13, P1122, DOI 10.1021/bm300006r
   Kim HH, 2014, INT J BIOL MACROMOL, V70, P516, DOI 10.1016/j.ijbiomac.2014.06.052
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Lanigan RS, 2000, INT J TOXICOL, V20, P1
   Li CM, 2015, ACTA BIOMATER, V11, P222, DOI 10.1016/j.actbio.2014.08.009
   Li P, 2014, ACS APPL MATER INTER, V6, P7948, DOI 10.1021/am501275t
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Ma YF, 2013, MAT SCI ENG C-MATER, V33, P2413, DOI 10.1016/j.msec.2013.02.006
   Marycz K, 2014, BIO-MED MATER ENG, V24, P1625, DOI 10.3233/BME-140966
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Munshi S, 2014, J PHARMACOL TOX MET, V70, P195, DOI 10.1016/j.vascn.2014.06.005
   Nagarkar S, 2010, PHYS CHEM CHEM PHYS, V12, P3834, DOI 10.1039/b916319k
   Numata K, 2014, MACROMOL BIOSCI, V14, P799, DOI 10.1002/mabi.201300482
   Numata K, 2012, BIOMACROMOLECULES, V13, P1383, DOI 10.1021/bm300089a
   Numata K, 2011, BIOMACROMOLECULES, V12, P2137, DOI 10.1021/bm200221u
   Omenetto Fiorenzo G, 2010, Biomaterials, V31, P6119
   Park CH, 2013, CARBOHYD POLYM, V98, P179
   Park CH, 2013, BIOMACROMOLECULES, V14, P2629
   Ribeiro Marta, 2014, Biomatter, V4, pe28536, DOI 10.4161/biom.28536
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   ROEHL D, 1988, J DAIRY SCI, V71, P3167, DOI 10.3168/jds.S0022-0302(88)79920-8
   Savadkoohi S, 2013, J FOOD ENG, V117, P255, DOI 10.1016/j.jfoodeng.2013.03.004
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   SUN S, 2013, BIOTECHNOLOGY, V12, P128, DOI DOI 10.3923/biotech.2013.128.134
   Sun W., 2014, J TISSUE ENG REGEN M, DOI [10.1002/term.1868, DOI 10.1002/TERM.1868]
   Szczesniak M, 2012, POLIMERY MED, V43, P29
   Thiele J, 2014, ADV MATER, V26, P125, DOI 10.1002/adma.201302958
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhong TY, 2012, J BIOMED MATER RES A, V100A, P1983, DOI 10.1002/jbm.a.33307
   Ziv K, 2014, BIOMATERIALS, V35, P3736, DOI 10.1016/j.biomaterials.2014.01.029
NR 47
TC 5
Z9 5
U1 2
U2 36
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD AUG 13
PY 2015
VL 26
IS 12
BP 780
EP 795
DI 10.1080/09205063.2015.1058576
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA CM5MU
UT WOS:000357733000005
PM 26053789
DA 2018-10-20
ER

PT J
AU Tao, H
   Wu, YH
   Li, HF
   Wang, CF
   Zhang, Y
   Li, C
   Wen, TY
   Wang, XM
   He, Q
   Wang, DL
   Ruan, DK
AF Tao, Hui
   Wu, Yaohong
   Li, Haifeng
   Wang, Chaofeng
   Zhang, Yan
   Li, Chao
   Wen, Tianyong
   Wang, Xiumei
   He, Qing
   Wang, Deli
   Ruan, Dike
TI BMP7-Based Functionalized Self-Assembling Peptides for Nucleus Pulposus
   Tissue Engineering
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE intervertebral disc; degeneration; functional peptide; self-assembly;
   hydrogel; compatibility
ID LOW-BACK-PAIN; INTERVERTEBRAL DISC DEGENERATION; WEIGHT HYALURONIC-ACID;
   EXTRACELLULAR-MATRIX; NANOFIBER SCAFFOLDS; LUMBAR FUSION; HYDROGELS;
   CELL; REPAIR; BIOSYNTHESIS
AB Nucleus pulposus (NP) tissue engineering has been demonstrated to be a feasible therapeutic strategy for intervertebral disc regeneration. In this study, we constructed a novel injectable biomaterial by conjugating three different short peptides of BMP7 to the C-terminus of the self-assembling peptide RADA16-I, and we then mixed each of these conjugates with RADA16-I at equal volumes to obtain the novel functionalized peptides RAD-SNV, RAD-KPS, and RAD-KAI. The bioactivities of these functionalized peptides for human degenerated NP cells (hdNPCs) were evaluated in vitro, and the most ideal scaffold was chosen for assessment of its in vivo degradation and the tissue reactions to it. All of the functionalized peptides self-assembled to form hydrogel scaffolds with a nanofibrous structure under physiological conditions. Compared with the RADA16-I and RAD-KAI scaffolds, the RAD-SNV and RAD-KPS scaffolds possessed better bioactivities for hdNPCs, which were characterized by their enhanced proliferation, migration, and ECM (collagen II, aggrecan, and sox-9) secretion. RAD-KPS was chosen over RAD-SNV as the most ideal scaffold material due to the cells' higher rate of expression of aggrecan both at the gene and protein level after 28 days of coculture. Moreover, in vivo analysis demonstrated that subcutaneously injected RAD-KPS degraded in vivo without invoking intense inflammation. Therefore, RAD-KPS is an ideal candidate scaffold for NP tissue engineering and holds great potential for NP regeneration.
C1 [Tao, Hui; Li, Haifeng; Wang, Chaofeng; Zhang, Yan; Li, Chao; Wen, Tianyong; He, Qing; Wang, Deli; Ruan, Dike] Navy Gen Hosp, Dept Orthopaed Surg, Beijing 100037, Peoples R China.
   [Tao, Hui] Anhui Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Hefei 230031, Anhui, Peoples R China.
   [Wu, Yaohong] Southern Med Univ, Affiliated Hosp 3, Guangzhou 510665, Guangdong, Peoples R China.
   [Wang, Xiumei] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
RP Wang, DL (reprint author), Navy Gen Hosp, Dept Orthopaed Surg, Beijing 100037, Peoples R China.
EM wangdelinavy@163.com; ruandikengh@163.com
CR Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   An H. S., 2005, SPINE, V30, P25
   Antoniou J, 1996, SPINE, V21, P1153, DOI 10.1097/00007632-199605150-00006
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Balkovec C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024285
   Bruehl S, 2014, REGION ANESTH PAIN M, V39, P120, DOI 10.1097/AAP.0000000000000058
   Bydon M, 2014, J SPINAL DISORD TECH, V27, P297, DOI 10.1097/BSD.0000000000000072
   Chen YC, 2013, ACTA BIOMATER, V9, P5181, DOI 10.1016/j.actbio.2012.09.039
   Chen YP, 2009, J BIOMED MATER RES A, V91A, P296, DOI 10.1002/jbm.a.32246
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Cheng YL, 2013, BIOMACROMOLECULES, V14, P468, DOI 10.1021/bm3017059
   Chubinskaya S, 2007, INT ORTHOP, V31, P773, DOI 10.1007/s00264-007-0423-9
   Colombier P., 2013, JT BONE SPINE, V81, P125
   Dolan P, 2001, CLIN BIOMECH, V16, pS8, DOI 10.1016/S0268-0033(00)00096-6
   Doll TAPF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0740
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Gawri R, 2013, EUR CELLS MATER, V26, P107, DOI 10.22203/eCM.v026a08
   Gelain F, 2006, PLOS ONE, V1, P1, DOI DOI 10.1371/JOURNAL.PONE.0000119
   Gillet P, 2003, J SPINAL DISORD TECH, V16, P338, DOI 10.1097/00024720-200308000-00005
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hughes SPF, 2012, J BONE JOINT SURG BR, V94B, P1298, DOI 10.1302/0301-620X.94B10.28986
   Huh H, 2010, J KOREAN NEUROSURG S, V47, P30, DOI 10.3340/jkns.2010.47.1.30
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Jeong CG, 2014, ACTA BIOMATER, V10, P3421, DOI 10.1016/j.actbio.2014.05.012
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Koutsopoulos S, 2013, ACTA BIOMATER, V9, P5162, DOI 10.1016/j.actbio.2012.09.010
   Leung VYL, 2011, ORTHOP CLIN N AM, V42, P575, DOI 10.1016/j.ocl.2011.07.003
   Liang CZ, 2013, ACTA BIOMATER, V9, P9423, DOI 10.1016/j.actbio.2013.08.019
   Liu X, 2013, ACTA BIOMATER, V9, P6798, DOI 10.1016/j.actbio.2013.01.027
   Liu X, 2012, NANOSCALE, V4, P2720, DOI [10.1039/c2nr00001, 10.1039/c2nr00001f]
   Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Maude S, 2013, NANOMEDICINE-UK, V8, P823, DOI [10.2217/NNM.13.65, 10.2217/nnm.13.65]
   Mercuri JJ, 2013, TISSUE ENG PT A, V19, P952, DOI [10.1089/ten.TEA.2012.0088, 10.1089/ten.tea.2012.0088]
   Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15
   Pye SR, 2004, J RHEUMATOL, V31, P753
   Reitmaier S, 2012, J MECH BEHAV BIOMED, V14, P67, DOI 10.1016/j.jmbbm.2012.05.010
   Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869
   Ruan DK, 2007, LANCET, V369, P993, DOI 10.1016/S0140-6736(07)60496-6
   Rubin DI, 2007, NEUROL CLIN, V25, P353, DOI 10.1016/j.ncl.2007.01.004
   Schizas C, 2010, EUR CELLS MATER, V20, P306
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   Sihawong R, 2014, EUR SPINE J, V23, P786, DOI 10.1007/s00586-014-3212-3
   Tao H, 2014, TISSUE ENG PT A, V20, P1621, DOI [10.1089/ten.tea.2013.0279, 10.1089/ten.TEA.2013.0279]
   Tsaryk R, 2015, ACTA BIOMATER, V20, P10, DOI 10.1016/j.actbio.2015.03.041
   Wang CF, 2013, J ORTHOP RES, V31, P1366, DOI 10.1002/jor.22369
   Wang CF, 2011, J ORTHOP RES, V29, P838, DOI 10.1002/jor.21310
   Wang H., 2013, TISSUE ENG PART A, V20, P908
   Zhang K, 2006, J ORTHOP SURG RES, V1, P9
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
NR 53
TC 16
Z9 19
U1 2
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 12
PY 2015
VL 7
IS 31
BP 17076
EP 17087
DI 10.1021/acsami.5b03605
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CP2BX
UT WOS:000359683600024
PM 26197234
DA 2018-10-20
ER

PT J
AU Grenho, L
   Salgado, CL
   Fernandes, MH
   Monteiro, FJ
   Ferraz, MP
AF Grenho, L.
   Salgado, C. L.
   Fernandes, M. H.
   Monteiro, F. J.
   Ferraz, M. P.
TI Antibacterial activity and biocompatibility of three-dimensional
   nanostructured porous granules of hydroxyapatite and zinc oxide
   nanoparticles-an in vitro and in vivo study
SO NANOTECHNOLOGY
LA English
DT Article
DE nanostructured hydroxyapatite; zinc oxide nanoparticles; porous
   granules; antibacterial activity; biocompatibility
ID OSTEOBLAST ADHESION; STAPHYLOCOCCUS-AUREUS; LIPID-PEROXIDATION;
   NANOPHASE CERAMICS; ZNO NANOPARTICLES; BIOFILM FORMATION; CANCER-CELLS;
   TISSUE; INFECTIONS; SCAFFOLDS
AB Ceramic scaffolds are widely studied in the bone tissue engineering field due to their potential in regenerative medicine. However, adhesion of microorganisms on biomaterials with subsequent formation of antibiotic-resistant biofilms is a critical factor in implant-related infections. Therefore, new strategies are needed to address this problem. In the present study, three-dimensional and interconnected porous granules of nanostructured hydroxyapatite (nanoHA) incorporated with different amounts of zinc oxide (ZnO) nanoparticles were produced using a simple polymer sponge replication method. As in vitro experiments, granules were exposed to Staphylococcus aureus and Staphylococcus epidermidis and, after 24 h, the planktonic and sessile populations were assessed. Cytocompatibility towards osteoblast-like cells (MG63 cell line) was also evaluated for a period of 1 and 3 days, through resazurin assay and imaging flow cytometry analysis. As in vivo experiments, nanoHA porous granules with and without ZnO nanoparticles were implanted into the subcutaneous tissue in rats and their inflammatory response after 3, 7 and 30 days was examined, as well as their antibacterial activity after 1 and 3 days of S. aureus inoculation. The developed composites proved to be especially effective at reducing bacterial activity in vitro and in vivo for a weight percentage of 2% ZnO, with a low cell growth inhibition in vitro and no differences in the connective tissue growth and inflammatory response in vivo. Altogether, these results suggest that nanoHA-ZnO porous granules have a great potential to be used in orthopaedic and dental applications as a template for bone regeneration and, simultaneously, to restrain biomaterial-associated infections.
C1 [Grenho, L.; Salgado, C. L.; Monteiro, F. J.] Univ Porto, Fac Engn, Dept Engn Met & Mat, P-4200465 Oporto, Portugal.
   [Grenho, L.; Salgado, C. L.; Monteiro, F. J.] Univ Porto, Inst Invest & Inovacao Saude i3s, P-4200465 Oporto, Portugal.
   [Grenho, L.; Salgado, C. L.; Monteiro, F. J.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Fernandes, M. H.] Univ Porto, Fac Med Dent, Lab Bone Metab & Regenerat, P-4200392 Oporto, Portugal.
   [Ferraz, M. P.] Univ Fernando Pessoa, Fac Ciencias Saude, FP ENAS CEBIMED, P-4200150 Oporto, Portugal.
RP Grenho, L (reprint author), Univ Porto, Fac Engn, Dept Engn Met & Mat, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
EM liliana.grenho@ineb.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Salgado, Christiane/0000-0002-3844-1667; Monteiro,
   Fernando/0000-0002-1361-4605
FU FEDER funds through the Programa Operacional Factores de Competitividade
   (COMPETE); Portuguese funds through FCT (Fundacao para a Ciencia e a
   Tecnologia) [PTDC/SAU-BMA/111233/2009, SFRH/BD/72866/2010]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade (COMPETE) and by Portuguese funds through
   FCT (Fundacao para a Ciencia e a Tecnologia) in the framework of the
   NaNO-Biofilm project (PTDC/SAU-BMA/111233/2009) and PhD grant
   (SFRH/BD/72866/2010) whose support is acknowledged. The authors are
   thankful to Fluidinova S.A. for the supply of NanoXIM.
CR Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129
   Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Bernhardt A, 2013, J MATER SCI-MATER M, V24, P1755, DOI 10.1007/s10856-013-4933-2
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046
   Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Geilich BM, 2013, INT J NANOMED, V8, P1177, DOI 10.2147/IJN.S42010
   Gervaso F, 2012, INT J APPL CERAM TEC, V9, P507, DOI 10.1111/j.1744-7402.2011.02662.x
   Grenho L, 2014, J BIOMED MATER RES A, V102, P3726, DOI 10.1002/jbm.a.35042
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Laranjeira M S, 2010, J BIOMED MATER RES A, P95891
   Lee HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084272
   Maschhoff PM, 2014, INT J NANOMED, V9, P257, DOI 10.2147/IJN.S54897
   MCCARTHY TJ, 1992, J CLIN PHARM THER, V17, P51, DOI 10.1111/j.1365-2710.1992.tb01265.x
   Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Ninan N, 2014, COLLOID SURFACE B, V115, P244, DOI 10.1016/j.colsurfb.2013.11.048
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   Romano CL, 2013, J CHEMOTHERAPY, V25, P67, DOI 10.1179/1973947812Y.0000000045
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Sena LA, 2009, J MATER SCI-MATER M, V20, P2395, DOI 10.1007/s10856-009-3813-2
   Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6
   Suarez-Franco JL, 2013, J NANOMATER, DOI 10.1155/2013/361249
   Taccola L, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S16581
   Teixeira S, 2008, J MATER SCI-MATER M, V19, P855, DOI 10.1007/s10856-007-3005-x
   Tommila M, 2008, ACTA BIOMATER, V4, P354, DOI 10.1016/j.actbio.2007.07.005
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Tripathi G, 2012, CERAM INT, V38, P341, DOI 10.1016/j.ceramint.2011.07.012
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   Zeelie JJ, 1998, ANALYST, V123, P503, DOI 10.1039/a704895e
   Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1
   Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 51
TC 13
Z9 13
U1 6
U2 80
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD AUG 7
PY 2015
VL 26
IS 31
AR 315101
DI 10.1088/0957-4484/26/31/315101
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA CN8FY
UT WOS:000358676300006
PM 26180062
DA 2018-10-20
ER

PT J
AU Rahemi, H
   Nigam, N
   Wakeling, JM
AF Rahemi, Hadi
   Nigam, Nilima
   Wakeling, James M.
TI The effect of intramuscular fat on skeletal muscle mechanics:
   implications for the elderly and obese
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE ageing; obesity; connective tissue stiffness; fibre pennation; muscle
   model; finite-elements
ID AGE-ASSOCIATED DIFFERENCES; IN-VIVO; TENDON PROPERTIES; ANKLE JOINT;
   STRENGTH; ARCHITECTURE; FORCE; WOMEN; MODEL; GASTROCNEMIUS
AB Skeletal muscle accumulates intramuscular fat through age and obesity. Muscle quality, a measure of muscle strength per unit size, decreases in these conditions. It is not clear how fat influences this loss in performance. Changes to structural parameters (e.g. fibre pennation and connective tissue properties) affect the muscle quality. This study investigated the mechanisms that lead to deterioration in muscle performance due to changes in intramuscular fat, pennation and aponeurosis stiffness. A finite-element model of the human gastrocnemius was developed as a fibre-reinforced composite biomaterial containing contractile fibres within the base material. The base-material properties were modified to include intramuscular fat in five different ways. All these models with fat generated lower fibre stress and muscle quality than their lean counterparts. This effect is due to the higher stiffness of the tissue in the fatty models. The fibre deformations influence their interactions with the aponeuroses, and these change with fatty inclusions. Muscles with more compliant aponeuroses generated lower forces. The muscle quality was further reduced for muscles with lower pennation. This study shows that whole-muscle force is dependent on its base-material properties and changes to the base material due to fatty inclusions result in reductions to force and muscle quality.
C1 [Rahemi, Hadi; Wakeling, James M.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Neuromuscular Mech Lab, Burnaby, BC V5A 1S6, Canada.
   [Nigam, Nilima] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada.
RP Rahemi, H (reprint author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Neuromuscular Mech Lab, Burnaby, BC V5A 1S6, Canada.
EM hrahemi@sfu.ca
FU Natural Sciences and Engineering Research Council of Canada; Canada
   Research Chairs Program
FX We gratefully acknowledge funding from Natural Sciences and Engineering
   Research Council of Canada (N.N. and J.W.) and the Canada Research
   Chairs Program (N.N.).
CR Bangerth W, 2013, DEAL 11 LIB VERSION
   Blemker SS, 2005, J BIOMECH, V38, P657, DOI 10.1016/j.jbiomech.2004.04.009
   Bol M, 2008, COMPUT METHOD BIOMEC, V11, P489, DOI 10.1080/10255840701771750
   BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369
   Carrasco DI, 1999, MOTOR CONTROL, V3, P436, DOI 10.1123/mcj.3.4.436
   Csapo R, 2014, J APPL PHYSIOL, V116, P961, DOI 10.1152/japplphysiol.01337.2013
   Csapo R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-209
   Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A
   Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465
   FUKASHIRO S, 1993, CLIN BIOMECH, V8, P25, DOI 10.1016/S0268-0033(05)80006-3
   Goodpaster BH, 2004, AM J CLIN NUTR, V79, P748
   Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4
   GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909
   Hasson CJ, 2012, ANN BIOMED ENG, V40, P1088, DOI 10.1007/s10439-011-0481-4
   Hodgson JA, 2012, J MECH BEHAV BIOMED, V9, P163, DOI 10.1016/j.jmbbm.2012.01.010
   HUBBARD RP, 1984, J BIOMECH ENG-T ASME, V106, P144, DOI 10.1115/1.3138471
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   Kelley DE, 2002, ANN NY ACAD SCI, V967, P135
   Kulmala JP, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0858
   Lerner ZF, 2014, GAIT POSTURE, V39, P978, DOI 10.1016/j.gaitpost.2013.12.020
   Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.3.CO;2-D
   Lynch NA, 1999, J APPL PHYSIOL, V86, P188
   Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2
   Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x
   Maganaris CN, 2001, J APPL PHYSIOL, V90, P865
   Malenfant P, 2001, INT J OBESITY, V25, P1316, DOI 10.1038/sj.ijo.0801733
   Metter EJ, 1999, J GERONTOL A-BIOL, V54, pB207, DOI 10.1093/gerona/54.5.B207
   NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511
   Natali AN, 2012, J MECH BEHAV BIOMED, V5, P216, DOI 10.1016/j.jmbbm.2011.08.025
   Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005
   Oomens CWJ, 2003, PHILOS T ROY SOC B, V358, P1453, DOI 10.1098/rstb.2003.1345
   Porter M. M., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P129
   Rahemi H, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00298
   Randhawa A, 2013, EUR J APPL PHYSIOL, V113, P437, DOI 10.1007/s00421-012-2448-z
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   SALE DG, 1987, J APPL PHYSIOL, V62, P1786
   Schwenzer NF, 2009, J MAGN RESON IMAGING, V29, P1346, DOI 10.1002/jmri.21789
   SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033
   Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012
   Tanner C, 2006, MED PHYS, V33, P1758, DOI 10.1118/1.2198315
   Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112
   Tomlinson DJ, 2014, J ANAT, V225, P675, DOI 10.1111/joa.12248
   Tomlinson D J, 2014, Age (Dordr), V36, P9652, DOI 10.1007/s11357-014-9652-1
   Wakeling JM, 2014, INT J BIOMED IMAGING, DOI 10.1155/2014/352910
   Wickiewicz TL, 1983, ORTHOP RELAT RES, V179, P275, DOI [10.1097/00003086-198310000-00042, DOI 10.1097/00003086-198310000-00042]
   Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8
NR 46
TC 30
Z9 30
U1 1
U2 12
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD AUG 6
PY 2015
VL 12
IS 109
AR 20150365
DI 10.1098/rsif.2015.0365
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR1KR
UT WOS:000361084200016
PM 26156300
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Basargan, T
   Nasun-Saygili, G
AF Basargan, Tugba
   Nasun-Saygili, Gulhayat
TI Spray-Dried Mesoporous Hydroxyapatite Chitosan Biocomposites
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Biomaterial; Chitosan; Hydroxyapatite; Inlet temperature; Spray-drying;
   Weight change
ID IN-VIVO TESTS; NANOCRYSTALLINE HYDROXYAPATITE; COMPOSITE MICROSPHERES;
   BIOMEDICAL APPLICATION; NANO-HYDROXYAPATITE; SURFACE-AREA;
   NANOPARTICLES; FABRICATION; SCAFFOLDS; COATINGS
AB In this study, hydroxyapatite-chitosan composites with weight ratio of 1:0.1 were produced by spray-drying technique using two different inlet temperature. Besides, the effect of weight change of hydroxyapatite on composites was investigated on composites which were spray-dried in the selected temperature. Synthesized hydroxyapatite-chitosan samples were characterized using Fourier transform infrared microscopy, scanning electron microscopy, X-ray fluorescence spectroscopy, Brunauer-Emmet-Teller method, and X-ray diffraction. Particle size measurements were also performed in this content. Simulated body fluid studies were conducted on selected samples. According to results, hydroxyapatite-chitosan sample was successfully synthesized. Spray-dried mesoporous microspheres with high surface areas could be suitable for biomedical usage.
C1 [Basargan, Tugba; Nasun-Saygili, Gulhayat] Istanbul Tech Univ, Dept Chem Engn, TR-80626 Istanbul, Turkey.
RP Basargan, T (reprint author), Istanbul Tech Univ, Chem & Met Engn Fac, Dept Chem Engn, TR-34469 Maslak, Turkey.
EM basargant@itu.edu.tr
CR Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7
   Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Arca H.C., 2008, FABAD J PHARM SCI, V33, P35
   Bianco A, 2007, J THERM ANAL CALORIM, V88, P237, DOI 10.1007/s10973-006-8011-6
   Brantley SL, 2000, AM MINERAL, V85, P1767
   Bumgardner J.D., 2007, United States Patent Application, Patent No. 20070254007
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Danilchenko S. N., 2009, Journal of Biological Physics and Chemistry, V9, P119, DOI 10.4024/22DA09A.jbpc.09.03
   Davidenko N, 2010, ACTA BIOMATER, V6, P466, DOI 10.1016/j.actbio.2009.07.029
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Ding CC, 2012, MATER LETT, V79, P72, DOI 10.1016/j.matlet.2012.03.092
   Gecer A, 2009, POLYM COMPOSITE, V30, P288, DOI 10.1002/pc.20635
   Guo YP, 2011, MATER LETT, V65, P2205, DOI 10.1016/j.matlet.2011.04.057
   Huang ZH, 2008, MATER LETT, V62, P3376, DOI 10.1016/j.matlet.2008.03.045
   Im HH, 2005, KEY ENG MAT, V284-286, P729, DOI 10.4028/www.scientific.net/KEM.284-286.729
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kern A.A., 2006, TOPAS 3
   Kim HS, 2007, MACROMOL RES, V15, P65, DOI 10.1007/BF03218754
   Klinkamnarong J, 2009, SOLID STATE SCI, V11, P1023, DOI 10.1016/j.solidstatesciences.2009.02.003
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Kumar R, 2008, J R SOC INTERFACE, V5, P427, DOI 10.1098/rsif.2007.1141
   Laurencin C., 1998, US Patent, Patent No. [5 766 618, 5766618]
   Li J. F., 2009, J FUNCT MAT, V40, P653
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li Xiang-nan, 2011, Journal of Central South University (Science and Technology), V42, P1232
   Maachoua H., 2008, TRENDS BIOMATER ARTI, V22, P16
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Mohamed K.R., 2013, J ADVERTISING RES, V1, P1
   Mohamed KR, 2011, CERAM INT, V37, P3265, DOI 10.1016/j.ceramint.2011.05.121
   Mollazadeh S, 2007, ADV APPL CERAM, V106, P165, DOI 10.1179/174367607X168996
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   Peng Q, 2006, KEY ENG MAT, V309-311, P65, DOI 10.4028/www.scientific.net/KEM.309-311.65
   Rajkumar M., 2010, INT J ENG SCI TECHNO, V2, P2437
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   Shalaby S. W., 2004, ABSORBABLE BIODEGRAD
   Shum HC, 2009, CHEM MATER, V21, P5548, DOI 10.1021/cm9028935
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sinha A, 2008, J MATER SCI-MATER M, V19, P2009, DOI 10.1007/s10856-007-3286-0
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sukhodub L, 2009, MATERIALWISS WERKST, V40, P318, DOI 10.1002/mawe.200800449
   Sun RX, 2009, MATER RES BULL, V44, P1939, DOI 10.1016/j.materresbull.2009.06.015
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang AJ, 2007, MAT SCI ENG A-STRUCT, V460, P1, DOI 10.1016/j.msea.2007.02.043
   Wang AJ, 2009, POWDER TECHNOL, V191, P1, DOI 10.1016/j.powtec.2008.10.020
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang Y, 2008, J MATER SCI-MATER M, V19, P623, DOI 10.1007/s10856-006-0047-4
NR 53
TC 3
Z9 3
U1 4
U2 31
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD AUG 5
PY 2015
VL 54
IS 11
BP 1172
EP 1183
DI 10.1080/03602559.2014.1003235
PG 12
WC Polymer Science
SC Polymer Science
GA CR8WE
UT WOS:000361634100004
DA 2018-10-20
ER

PT J
AU Cordoba, A
   Monjo, M
   Hierro-Oliva, M
   Gonazlez-Martin, ML
   Ramis, JM
AF Cordoba, Alba
   Monjo, Marta
   Hierro-Oliva, Margarita
   Luisa Gonzalez-Martin, Maria
   Maria Ramis, Joana
TI Bioinspired Quercitrin Nanocoatings: A Fluorescence-Based Method for
   Their Surface Quantification, and Their Effect on Stem Cell Adhesion and
   Differentiation to the Osteoblastic Lineage
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE flavonoids; polyphenols; biomaterial; DPBA; implant
ID IN-VITRO; FLAVONOIDS; QUERCETIN; FUNCTIONALITIES; BIOMATERIALS;
   SPECIFICITY; FATE
AB Polyphenol-based coatings have several potential applications in medical devices, such as cardiovascular stents, contrast agents, drug delivery systems, or bone implants, due to the multiple bioactive functionalities of these compounds. In a previous study, we fabricated titanium surfaces functionalized with flavonoids through covalent chemistry, and observed their osteogenic, anti-inflammatory, and antifibrotic properties in vitro. In this work, we report a fluorescence-based method for the quantification of the amount of flavonoid grafted onto the surfaces, using 2-aminoethyl diphenylborinate, a boronic ester that spontaneously forms a fluorescent complex with flavonoids. The method is sensitive, simple, rapid, and easy to perform with routine equipment, and could be applied to determine the surface coverage of other plant-derived polyphenol-based coatings. Besides, we evaluated an approach based on reductive amination to covalently graft the flavonoid quercitrin to Ti substrates, and optimized the grafting conditions. Depending on the reaction conditions, the amount of quercitrin grafted was between 64 +/- 10 and 842 +/- 361 nmol on 6.2 mm Ti coins. Finally, we evaluated the in vitro behavior of bone-marrow-derived human mesenchymal stem cells cultured on the quercitrin nanocoated Ti surfaces. The surfaces functionalized with quercitrin showed a faster stem cell adhesion than control surfaces, probably due to the presence of the catechol groups of quercitrin on the surfaces. A rapid cell adhesion is crucial for the successful performance of an implant. Furthermore, quercitrin-nanocoated surfaces enhanced the mineralization of the cells after 21 days of cell culture. These results indicate that quercitrin nanocoatings could promote the rapid osteointegration of bone implants.
C1 [Cordoba, Alba; Monjo, Marta; Maria Ramis, Joana] Univ Balearic Isl, Grp Cell Therapy & Tissue Engn, Res Inst Hlth Sci IUNICS, Palma De Mallorca 07122, Spain.
   [Cordoba, Alba; Monjo, Marta; Maria Ramis, Joana] Inst Invest Sanitaria Palma, Palma De Mallorca 07010, Spain.
   [Hierro-Oliva, Margarita; Luisa Gonzalez-Martin, Maria] Univ Extremadura, Fac Ciencias, Dept Fis Aplicada, E-06071 Badajoz, Spain.
   [Hierro-Oliva, Margarita; Luisa Gonzalez-Martin, Maria] CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza 50018, Spain.
RP Monjo, M (reprint author), Univ Balearic Isl, Grp Cell Therapy & Tissue Engn, Res Inst Hlth Sci IUNICS, Carretera Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.
EM marta.monjo@uib.es; joana.ramis@uib.es
RI Cordoba, Alba/V-2448-2017
OI Cordoba, Alba/0000-0002-2726-5119; Hierro-Oliva,
   Margarita/0000-0002-9741-4503; Monjo, Marta/0000-0002-2731-9527; Ramis,
   Joana Maria/0000-0001-9109-8362
FU Conselleria d'Educacio, Cultura i Universitats del Govern de les Illes
   Balears; European Social Fund
FX This work was supported by the Conselleria d'Educacio, Cultura i
   Universitats del Govern de les Illes Balears, and the European Social
   Fund (contract to J.M.R.). We acknowledge NANBIOSIS ICTS (CIBER-BBN) and
   SACSS-SAIUEx (UEx) for the use of the XPS facility.
CR Amic D, 2007, CURR MED CHEM, V14, P827, DOI 10.2174/092986707780090954
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barrett DG, 2014, CHEM COMMUN, V50, P7265, DOI 10.1039/c4cc02961e
   Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824
   Choi JS, 2014, MACROMOL BIOSCI, V14, P270, DOI 10.1002/mabi.201300281
   Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778
   Cordoba A, 2015, ADV HEALTHC MATER, V4, P540, DOI 10.1002/adhm.201400587
   Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dementev N, 2009, LANGMUIR, V25, P7573, DOI 10.1021/la803947q
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265
   Ernst IMA, 2010, PHARMACOL RES, V61, P253, DOI 10.1016/j.phrs.2009.10.006
   Gomez-Florit M., 2015, QUERCITRIN PER UNPUB
   Gomez-Florit M, 2014, J PERIODONTOL, V85, P966, DOI 10.1902/jop.2014.130438
   Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hong S, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400113
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim S, 2015, CHEM COMMUN, V51, P5340, DOI 10.1039/c4cc08609k
   Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898
   Lee JH, 2014, FOOD SCI BIOTECHNOL, V23, P75, DOI 10.1007/s10068-014-0010-y
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lu YC, 2014, NANOSCALE, V6, P10297, DOI 10.1039/c4nr00617h
   McArthur EA, 2004, J AM CHEM SOC, V126, P2260, DOI 10.1021/ja038062n
   Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300
   Nifli AP, 2007, J AGR FOOD CHEM, V55, P2873, DOI 10.1021/jf0632637
   Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009
   Razumovitch J, 2009, J PHYS CHEM B, V113, P8383, DOI 10.1021/jp902383m
   Satue M, 2013, ACTA BIOMATER, V9, P5759, DOI 10.1016/j.actbio.2012.11.021
   Satue M, 2013, BIOCHEM PHARMACOL, V86, P1476, DOI 10.1016/j.bcp.2013.09.009
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   Xiao LS, 2015, ACS APPL MATER INTER, V7, P6530, DOI 10.1021/am508404t
   Xing YJ, 2007, LANGMUIR, V23, P684, DOI 10.1021/la060994s
   Xu JX, 2014, NANOSCALE, V6, P1277, DOI 10.1039/c3nr04528e
   Yang ZL, 2014, ACS APPL MATER INTER, V6, P2647, DOI 10.1021/am405124z
   Yin YQ, 2013, TOXICOL APPL PHARM, V269, P89, DOI 10.1016/j.taap.2013.03.015
NR 39
TC 9
Z9 9
U1 5
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 5
PY 2015
VL 7
IS 30
BP 16857
EP 16864
DI 10.1021/acsami.5b05044
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CO6PY
UT WOS:000359279800086
PM 26167954
DA 2018-10-20
ER

PT J
AU Oliva, N
   Unterman, S
   Zhang, Y
   Conde, J
   Song, HS
   Artzi, N
AF Oliva, Nuria
   Unterman, Shimon
   Zhang, Yi
   Conde, Joao
   Song, Hyun Seok
   Artzi, Natalie
TI Personalizing Biomaterials for Precision Nanomedicine Considering the
   Local Tissue Microenvironment
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
DE hydrogels; nanomaterials; theranostics; precision medicine; tissue
   microenvironment; nanofillers; multifunctional materials
ID CONTROLLED DRUG-DELIVERY; WALLED CARBON NANOTUBES; PH-RESPONSIVE
   HYDROGELS; BAND-GAP FLUORESCENCE; IN-VIVO EVALUATION; GENE DELIVERY;
   SIRNA DELIVERY; GRAPHENE OXIDE; BIOMEDICAL APPLICATIONS; CANCER-THERAPY
AB New advances in (nano)biomaterial design coupled with the detailed study of tissue-biomaterial interactions can open a new chapter in personalized medicine, where biomaterials are chosen and designed to match specific tissue types and disease states. The notion of a one size fits all biomaterial no longer exists, as growing evidence points to the value of customizing material design to enhance (pre)clinical performance. The complex microenvironment in vivo at different tissue sites exhibits diverse cell types, tissue chemistry, tissue morphology, and mechanical stresses that are further altered by local pathology. This complex and dynamic environment may alter the implanted material's properties and in turn affect its in vivo performance. It is crucial, therefore, to carefully study tissue context and optimize biomaterials considering the implantation conditions. This practice would enable attaining predictable material performance and enhance clinical outcomes.
C1 [Oliva, Nuria; Unterman, Shimon; Zhang, Yi; Conde, Joao; Song, Hyun Seok; Artzi, Natalie] MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Conde, Joao] Queen Mary Univ London, Sch Mat Sci & Engn, London, England.
   [Artzi, Natalie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol, Boston, MA 02115 USA.
RP Artzi, N (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, E25 449, Cambridge, MA 02139 USA.
EM nartzi@mit.edu
RI Conde, Joao/F-2231-2011; Zhang, Yi/K-3340-2016; Oliva, Nuria/P-7825-2016
OI Conde, Joao/0000-0001-8422-6792; Zhang, Yi/0000-0001-8667-7829; Oliva,
   Nuria/0000-0002-6305-0801
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Agarwal P, 2013, BIOCONJUGATE CHEM, V24, P846, DOI 10.1021/bc400042a
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Arias JL, 2011, CURR DRUG TARGETS, V12, P1151
   Arias JL, 2011, EXPERT OPIN DRUG DEL, V8, P1589, DOI 10.1517/17425247.2012.634794
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Artzi N, 2011, ACTA BIOMATER, V7, P67, DOI 10.1016/j.actbio.2010.07.008
   Artzi N, 2009, ADV MATER, V21, P3399, DOI 10.1002/adma.200900340
   Artzi N, 2009, MACROMOL BIOSCI, V9, P754, DOI 10.1002/mabi.200800355
   Arunbabu D, 2013, J PHYS CHEM B, V117, P441, DOI 10.1021/jp3101688
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bae WK, 2013, BIOMATERIALS, V34, P1433, DOI 10.1016/j.biomaterials.2012.10.077
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Bardajee GR, 2014, CARBOHYD POLYM, V101, P741, DOI 10.1016/j.carbpol.2013.10.028
   Barone PW, 2005, ANAL CHEM, V77, P7556, DOI 10.1021/ac0511997
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Barrett DG, 2013, ADV HEALTHC MATER, V2, P745, DOI 10.1002/adhm.201200316
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   Bikram M, 2007, J CONTROL RELEASE, V123, P219, DOI 10.1016/j.jconrel.2007.08.013
   Blackburn WH, 2009, BIOCONJUGATE CHEM, V20, P960, DOI 10.1021/bc800547c
   Brazel CS, 2009, PHARM RES-DORD, V26, P644, DOI 10.1007/s11095-008-9773-2
   Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008
   Chaban VV, 2010, J PHYS CHEM B, V114, P13481, DOI 10.1021/jp104507g
   Chang CY, 2012, BIOMATERIALS, V33, P8026, DOI 10.1016/j.biomaterials.2012.07.058
   Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v
   Cirillo G, 2014, BIOMED RES INT, DOI 10.1155/2014/825017
   Cochran MC, 2011, ACAD RADIOL, V18, P1341, DOI 10.1016/j.acra.2011.06.013
   Conde J., 2014, NANOONCOLOGICALS NEW
   Conde J, 2012, DRUG DELIV, V2012
   Conde J, 2015, P NATL ACAD SCI USA, V112, pE1278, DOI 10.1073/pnas.1421229112
   Conde J, 2015, ADV DRUG DELIVER REV, V81, P169, DOI 10.1016/j.addr.2014.09.003
   Conde J, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00048
   Conde J, 2013, BIOMATERIALS, V34, P7744, DOI 10.1016/j.biomaterials.2013.06.041
   Conde J, 2012, ACS NANO, V6, P8316, DOI 10.1021/nn3030223
   Conde J, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/619530
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Dayani Y, 2013, BIOMACROMOLECULES, V14, P3380, DOI 10.1021/bm401155a
   de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a
   Demarchi CA, 2014, SOFT MATTER, V10, P3441, DOI 10.1039/c3sm53157k
   DeVolder RJ, 2012, TISSUE ENG PT A, V18, P1642, DOI [10.1089/ten.tea.2011.0547, 10.1089/ten.TEA.2011.0547]
   Dickerson E. B., 2010, BMC CANC, V10
   Ding D, 2011, ACS NANO, V5, P2520, DOI 10.1021/nn102138u
   Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111
   Doria G, 2012, SENSORS-BASEL, V12, P1657, DOI 10.3390/s120201657
   Dunn SS, 2012, J AM CHEM SOC, V134, P7423, DOI 10.1021/ja300174v
   El-Fiqi A, 2013, ACTA BIOMATER, V9, P9508, DOI 10.1016/j.actbio.2013.07.036
   Endres S, 2005, Z ORTHOP GRENZGEB, V143, P660, DOI 10.1055/s-2005-918191
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Fullenkamp DE, 2012, BIOMATERIALS, V33, P3783, DOI 10.1016/j.biomaterials.2012.02.027
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gao ZG, 2011, J CONTROL RELEASE, V152, P84, DOI 10.1016/j.jconrel.2011.01.021
   Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934
   Ge B, 2009, SENSOR ACTUAT B-CHEM, V137, P547, DOI 10.1016/j.snb.2009.01.030
   Gefen A, 2007, J BIOMECH ENG-T ASME, V129, P924, DOI 10.1115/1.2800830
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gupta M, 2004, J CONTROL RELEASE, V99, P157, DOI 10.1016/j.jconrel.2004.06.016
   Haase M, 2011, ANGEW CHEM INT EDIT, V50, P5808, DOI 10.1002/anie.201005159
   Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   Heffernan MJ, 2005, BIOCONJUGATE CHEM, V16, P1340, DOI 10.1021/bc050176w
   Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   Huang Y, 2014, SOFT MATTER, V10, P6121, DOI 10.1039/c4sm00871e
   Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w
   Hyon SH, 2014, J BIOMED MATER RES A, V102, P2511, DOI 10.1002/jbm.a.34923
   Ito K, 2007, POLYM J, V39, P489, DOI 10.1295/polymj.PJ2006239
   Jaiswal MK, 2014, J NANOSCI NANOTECHNO, V14, P4082, DOI 10.1166/jnn.2014.8662
   Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kang XJ, 2013, NANOSCALE, V5, P253, DOI 10.1039/c2nr33130f
   Kazusa H, 2013, J APPL BIOMATER FUNC, V11, P180, DOI 10.5301/JABFM.5000164
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim BJ, 2014, BIOMACROMOLECULES, V15, P1579, DOI 10.1021/bm4017308
   Kim H, 2013, ACS NANO, V7, P6735, DOI 10.1021/nn403096s
   Kim H, 2011, BIOCONJUGATE CHEM, V22, P2558, DOI 10.1021/bc200397j
   Kim JI, 2012, BIOMATERIALS, V33, P2251, DOI 10.1016/j.biomaterials.2011.11.083
   Kim JH, 2011, ACS NANO, V5, P7848, DOI 10.1021/nn201904t
   Kim JH, 2009, NAT CHEM, V1, P473, DOI [10.1038/NCHEM.332, 10.1038/nchem.332]
   Kim YM, 2013, BIOMATERIALS, V34, P4493, DOI 10.1016/j.biomaterials.2013.02.050
   Kim YM, 2012, ACS NANO, V6, P5757, DOI 10.1021/nn300842a
   Kojima C, 2013, NANOMED-NANOTECHNOL, V9, P767, DOI 10.1016/j.nano.2013.01.004
   Komlev VS, 2002, BIOMATERIALS, V23, P3449, DOI 10.1016/S0142-9612(02)00049-2
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Kuppusamy P, 2002, CANCER RES, V62, P307
   Kurapati R, 2013, CHEM COMMUN, V49, P734, DOI 10.1039/c2cc38417e
   Lai PS, 2007, J CONTROL RELEASE, V122, P39, DOI 10.1016/j.jconrel.2007.06.012
   Laroui H, 2014, J CONTROL RELEASE, V186, P41, DOI 10.1016/j.jconrel.2014.04.046
   Larson N, 2012, CHEM MATER, V24, P840, DOI 10.1021/cm2031569
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee MR, 2004, ANGEW CHEM INT EDIT, V43, P1675, DOI 10.1002/anie.200353204
   LeGeros R. Z., 2002, CLIN ORTHOP RELAT RE, V81
   Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049
   Lei YG, 2010, BIOMATERIALS, V31, P9106, DOI 10.1016/j.biomaterials.2010.08.016
   Lin CW, 2013, BIOMATERIALS, V34, P4387, DOI 10.1016/j.biomaterials.2013.02.058
   Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r
   Liu J, 2010, CARBOHYD POLYM, V82, P432, DOI 10.1016/j.carbpol.2010.04.084
   Liu RQ, 2012, J MATER CHEM, V22, P14160, DOI [10.1039/c2jm32541, 10.1039/c2jm32541a]
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   MacLachlan I., 2007, LIPOSOMES DRUG DELIV, P237
   Malvindi MA, 2012, NANOSCALE, V4, P486, DOI 10.1039/c1nr11269d
   Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133
   Mastronardi E, 2014, SENSORS-BASEL, V14, P3156, DOI 10.3390/s140203156
   McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008
   Medeiros SF, 2011, INT J PHARMACEUT, V403, P139, DOI 10.1016/j.ijpharm.2010.10.011
   Medintz IL, 2004, P NATL ACAD SCI USA, V101, P9612, DOI 10.1073/pnas.0403343101
   Meenach SA, 2013, J BIOMAT SCI-POLYM E, V24, P1112, DOI 10.1080/09205063.2012.741321
   Meenach SA, 2010, ACTA BIOMATER, V6, P1039, DOI 10.1016/j.actbio.2009.10.017
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Mura S, 2012, ADV DRUG DELIVER REV, V64, P1394, DOI 10.1016/j.addr.2012.06.006
   Naficy S, 2011, AUST J CHEM, V64, P1007, DOI 10.1071/CH11156
   Nair L. L. C., 2007, PROG POLYM SCI, V32, P18
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Navath RS, 2011, MOL PHARMACEUT, V8, P1209, DOI 10.1021/mp200027z
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ning JY, 2013, MACROMOLECULES, V46, P5317, DOI 10.1021/ma4009059
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Oliva N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1616
   Oliva N, 2012, LANGMUIR, V28, P15402, DOI 10.1021/la303155p
   Pan YJ, 2012, BIOMATERIALS, V33, P6570, DOI 10.1016/j.biomaterials.2012.05.062
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Perumal OP, 2008, BIOMATERIALS, V29, P3469, DOI 10.1016/j.biomaterials.2008.04.038
   Qiu L, 2014, ADV MATER, V26, P3333, DOI 10.1002/adma.201305359
   Rapoport N, 2012, INT J HYPERTHER, V28, P374, DOI 10.3109/02656736.2012.665567
   Ratner BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5371
   Ray GJ, 2014, BIOCONJUGATE CHEM, V25, P665, DOI 10.1021/bc400456g
   REBRIN K, 1992, J BIOMED ENG, V14, P33, DOI 10.1016/0141-5425(92)90033-H
   Restani RB, 2012, ANGEW CHEM INT EDIT, V51, P5162, DOI 10.1002/anie.201200362
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Ryu JH, 2010, LANGMUIR, V26, P7086, DOI 10.1021/la904437u
   Sarvestani AS, 2008, J NANOMATER, DOI 10.1155/2008/126803
   Schoener CA, 2013, J BIOMAT SCI-POLYM E, V24, P1027, DOI 10.1080/09205063.2012.731376
   Schoener CA, 2012, POLYM INT, V61, P874, DOI 10.1002/pi.4219
   Schroeder A, 2009, CHEM PHYS LIPIDS, V162, P1, DOI 10.1016/j.chemphyslip.2009.08.003
   Segovia N, 2015, ADV HEALTHC MATER, V4, P271, DOI 10.1002/adhm.201400235
   Sekine Y, 2012, ADV HEALTHC MATER, V1, P722, DOI 10.1002/adhm.201200175
   Seow WY, 2007, BIOMATERIALS, V28, P1730, DOI 10.1016/j.biomaterials.2006.11.039
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Servant A, 2014, ADV HEALTHC MATER, V3, P1334, DOI 10.1002/adhm.201400016
   Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005
   Shazly TM, 2008, BIOMATERIALS, V29, P4584, DOI 10.1016/j.biomatetials.2008.08.032
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Simson J, 2013, J ORTHOP RES, V31, P392, DOI 10.1002/jor.22247
   Simson JA, 2013, TISSUE ENG PT A, V19, P1843, DOI [10.1089/ten.tea.2012.0578, 10.1089/ten.TEA.2012.0578]
   Simson JA, 2013, BIOMACROMOLECULES, V14, P637, DOI 10.1021/bm301585e
   Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f
   Sohier J, 2010, ACTA BIOMATER, V6, P2932, DOI 10.1016/j.actbio.2010.02.013
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tao Y, 2014, BIOMATERIALS, V35, P9963, DOI 10.1016/j.biomaterials.2014.08.036
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Thorp LE, 2006, ARTHRITIS RHEUM, V54, P3842, DOI 10.1002/art.22247
   Togo Y, 2013, STEM CELLS INT, DOI 10.1155/2013/634379
   Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014
   Tsuji H, 2005, MACROMOL BIOSCI, V5, P569, DOI 10.1002/mabi.200500062
   Unterman SA, 2012, TISSUE ENG PT A, V18, P2497, DOI [10.1089/ten.TEA.2011.0711, 10.1089/ten.tea.2011.0711]
   VASHIST A, 2013, ORIENT J CHEM, V29, P861
   Wallace DG, 2001, J BIOMED MATER RES, V58, P545, DOI 10.1002/jbm.1053
   Wang SY, 2012, ACS NANO, V6, P6843, DOI 10.1021/nn301633m
   Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684
   Whitehead KA, 2011, ANNU REV CHEM BIOMOL, V2, P77, DOI 10.1146/annurev-chembioeng-061010-114133
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wiltsey C, 2013, J MATER SCI-MATER M, V24, P837, DOI 10.1007/s10856-013-4857-x
   Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004
   Wu CJ, 2013, MACROMOL BIOSCI, V13, P59, DOI 10.1002/mabi.201200362
   Wu CJ, 2010, MATERIALS, V3, P2986, DOI 10.3390/ma3052986
   Wu W, 2010, BIOMATERIALS, V31, P8371, DOI 10.1016/j.biomaterials.2010.07.061
   Wu WT, 2010, BIOMATERIALS, V31, P3023, DOI 10.1016/j.biomaterials.2010.01.011
   Xuan JJ, 2010, INT J PHARMACEUT, V395, P317, DOI 10.1016/j.ijpharm.2010.05.042
   Yan B, 2012, J AM CHEM SOC, V134, P16558, DOI 10.1021/ja308876j
   Yang J, 2009, ADV MATER, V21, P4339, DOI 10.1002/adma.200900334
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Yildirim ED, 2008, J BIOMED MATER RES B, V87B, P406, DOI 10.1002/jbm.b.31118
   Yin WY, 2014, ACS NANO, V8, P6922, DOI 10.1021/nn501647j
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zayats M, 2002, ANAL CHEM, V74, P4763, DOI 10.1021/ac020312f
   Zhang HB, 2010, BIOMATERIALS, V31, P5445, DOI 10.1016/j.biomaterials.2010.03.034
   Zhang JQ, 2014, ADV HEALTHC MATER, V3, P412, DOI 10.1002/adhm.201300033
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang L, 2012, SOFT MATTER, V8, P10439, DOI 10.1039/c2sm26102b
   Zhang Yi, 2011, Int J Biomater Res Eng, V1, P18, DOI 10.4018/ijbre.2011010102
   Zhang Y, 2013, BIOMATERIALS, V34, P4048, DOI 10.1016/j.biomaterials.2013.02.040
   Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g
   Zheng D, 2012, P NATL ACAD SCI USA, V109, P11975, DOI 10.1073/pnas.1118425109
   Zhou YL, 2013, J MATER SCI-MATER M, V24, P2277, DOI 10.1007/s10856-013-4987-1
   Zubris KAV, 2012, MOL PHARMACEUT, V9, P196, DOI 10.1021/mp200367s
NR 200
TC 17
Z9 17
U1 1
U2 85
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1584
EP 1599
DI 10.1002/adhm.201400778
PG 16
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600001
PM 25963621
OA Bronze
DA 2018-10-20
ER

PT J
AU Kerativitayanan, P
   Carrow, JK
   Gaharwar, AK
AF Kerativitayanan, Punyavee
   Carrow, James K.
   Gaharwar, Akhilesh K.
TI Nanomaterials for Engineering Stem Cell Responses
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
DE nanomaterials; stem cells; tissue engineering; drug delivery;
   nanoparticles
ID BONE MORPHOGENETIC PROTEIN-2; SEQUENTIAL BMP-2/BMP-7 DELIVERY; FOCAL
   ADHESION KINASE; MARROW STROMAL CELLS; IN-VITRO EVALUATION; OSTEOGENIC
   DIFFERENTIATION; SILVER NANOPARTICLES; CARBON NANOTUBES; NANOFIBROUS
   SCAFFOLDS; TIO2 NANOTUBES
AB Recent progress in nanotechnology has stimulated the development of multifunctional biomaterials for tissue engineering applications. Synergistic interactions between nanomaterials and stem cell engineering offer numerous possibilities to address some of the daunting challenges in regenerative medicine, such as controlling trigger differentiation, immune reactions, limited supply of stem cells, and engineering complex tissue structures. Specifically, the interactions between stem cells and their microenvironment play key roles in controlling stem cell fate, which underlines therapeutic success. However, the interactions between nanomaterials and stem cells are not well understood, and the effects of the nanomaterials shape, surface morphology, and chemical functionality on cellular processes need critical evaluation. In this Review, focus is put on recent development in nanomaterial-stem cell interactions, with specific emphasis on their application in regenerative medicine. Further, the emerging technologies based on nanomaterials developed over the past decade for stem cell engineering are reviewed, as well as the potential applications of these nanomaterials in tissue regeneration, stem cell isolation, and drug/gene delivery. It is anticipated that the enhanced understanding of nanomaterial-stem cell interactions will facilitate improved biomaterial design for a range of biomedical and biotechnological applications.
C1 [Kerativitayanan, Punyavee; Carrow, James K.; Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.
RP Gaharwar, AK (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
EM gaharwar@tamu.edu
OI Carrow, James/0000-0002-9123-9222; Gaharwar,
   Akhilesh/0000-0002-0284-0201
CR Agarwal R, 2013, P NATL ACAD SCI USA, V110, P17247, DOI 10.1073/pnas.1305000110
   Akhavan O, 2013, CARBON, V54, P419, DOI 10.1016/j.carbon.2012.11.058
   Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040
   Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Ambre AH, 2013, J BIOMED MATER RES A, V101, P2644, DOI 10.1002/jbm.a.34561
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Bang AG, 2008, SCIENCE, V320, P58, DOI 10.1126/science.1157042
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Biswas A, 2012, BIOMATERIALS, V33, P5459, DOI 10.1016/j.biomaterials.2012.04.012
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Carrow JK, 2015, MACROMOL CHEM PHYS, V216, P248, DOI 10.1002/macp.201400427
   Cha CY, 2013, ACS NANO, V7, P2891, DOI 10.1021/nn401196a
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chen YC, 2010, TOXICOL APPL PHARM, V245, P272, DOI 10.1016/j.taap.2010.03.011
   Cheng XG, 2014, ACTA BIOMATER, V10, P1360, DOI 10.1016/j.actbio.2013.11.017
   Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Deng XY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115101
   Dyondi D, 2013, INT J NANOMED, V8, P47, DOI 10.2147/IJN.S37953
   Ferreira L, 2009, J CELL BIOCHEM, V108, P746, DOI 10.1002/jcb.22303
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Florez L, 2012, SMALL, V8, P2222, DOI 10.1002/smll.201102002
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gaharwar AK, 2014, TISSUE ENG PT A, V20, P2088, DOI 10.1089/ten.tea.2013.0281
   Gaharwar AK, 2014, J CONTROL RELEASE, V187, P66, DOI 10.1016/j.jconrel.2014.04.035
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2012, MACROMOL BIOSCI, V12, P779, DOI 10.1002/mabi.201100508
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P568, DOI 10.1016/j.actbio.2010.09.015
   Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665
   Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1
   Gu M, 2014, TISSUE ENG PART B-RE, V20, P477, DOI [10.1089/ten.teb.2013.0638, 10.1089/ten.TEB.2013.0638]
   Gul H, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/15/155101
   Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001
   Haidar ZS, 2009, J BIOMED MATER RES A, V91A, P919, DOI 10.1002/jbm.a.32292
   Harush-Frenkel O, 2008, BIOMACROMOLECULES, V9, P435, DOI 10.1021/bm700535p
   Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135
   Hong SJ, 2010, J BIOMATER APPL, V24, P733, DOI 10.1177/0885328209338956
   Hongbin Z., 2013, BIOMACROMOLECULES, V14, P1299
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hu Y, 2012, ACTA BIOMATER, V8, P439, DOI 10.1016/j.actbio.2011.10.021
   Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Ilie I, 2012, INT J NANOMED, V7, P2211, DOI 10.2147/IJN.S29975
   Jiang XE, 2010, BIOMACROMOLECULES, V11, P748, DOI 10.1021/bm901348z
   Jiang X, 2012, ACTA BIOMATER, V8, P1290, DOI 10.1016/j.actbio.2011.11.019
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a
   Kittler S, 2009, MATERIALWISS WERKST, V40, P258, DOI 10.1002/mawe.200800437
   Kolambkar YM, 2010, TISSUE ENG PT A, V16, P3219, DOI [10.1089/ten.tea.2010.0004, 10.1089/ten.TEA.2010.0004]
   Kshitiz, 2011, TRENDS BIOTECHNOL, V29
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lai M, 2011, BIOMACROMOLECULES, V12, P1097, DOI 10.1021/bm1014365
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li D, 2006, J AM CERAM SOC, V89, P1861, DOI 10.1111/j.1551-2916.2006.00989.x
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Lindberg HK, 2009, TOXICOL LETT, V186, P166, DOI 10.1016/j.toxlet.2008.11.019
   Liu D, 2010, BIOCONJUGATE CHEM, V21, P1673, DOI 10.1021/bc100177v
   Liu DD, 2010, ACS NANO, V4, P2185, DOI 10.1021/nn901479w
   Liu HC, 2011, TISSUE ENG PT A, V17, P2417, DOI [10.1089/ten.tea.2010.0620, 10.1089/ten.TEA.2010.0620]
   Liu KK, 2009, BIOMATERIALS, V30, P4249, DOI 10.1016/j.biomaterials.2009.04.056
   Lo H, 1995, Tissue Eng, V1, P15, DOI 10.1089/ten.1995.1.15
   Lorenz S, 2010, MACROMOL BIOSCI, V10, P1034, DOI 10.1002/mabi.201000099
   Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r
   Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Martino S, 2009, TISSUE ENG PT A, V15, P3139, DOI [10.1089/ten.tea.2008.0552, 10.1089/ten.TEA.2008.0552]
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Meng DC, 2011, J BIOMED MATER RES A, V99A, P435, DOI 10.1002/jbm.a.33185
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mihaila SM, 2014, BIOMATERIALS, V35, P9087, DOI 10.1016/j.biomaterials.2014.07.052
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c
   Nitya G, 2012, J MATER SCI-MATER M, V23, P1749, DOI 10.1007/s10856-012-4647-x
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Park MVDZ, 2009, TOXICOL APPL PHARM, V240, P108, DOI 10.1016/j.taap.2009.07.019
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pulavendran S, 2010, IET NANOBIOTECHNOL, V4, P51, DOI 10.1049/iet-nbt.2009.0014
   Pulavendran S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-15
   Rajam M, 2011, INT J PHARMACEUT, V410, P145, DOI 10.1016/j.ijpharm.2011.02.065
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rippon HJ, 2004, CELL PROLIFERAT, V37, P23, DOI 10.1111/j.1365-2184.2004.00298.x
   Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/NNM.12.18, 10.2217/nnm.12.18]
   Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h
   Sasidharan A, 2011, NANOSCALE, V3, P2461, DOI 10.1039/c1nr10172b
   Schexnailder PJ, 2010, MACROMOL BIOSCI, V10, P1416, DOI 10.1002/mabi.201000053
   Schrand A. M., 2009, SAFETY NANOPARTICLES
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910
   Stout DA, 2012, MATER TODAY, V15, P312, DOI 10.1016/S1369-7021(12)70136-0
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Suh WH, 2009, NANO TODAY, V4, P27, DOI 10.1016/j.nantod.2008.10.013
   Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Tian LL, 2012, J MATER SCI, V47, P3272, DOI 10.1007/s10853-011-6166-4
   Tran LA, 2010, BIOMATERIALS, V31, P9482, DOI 10.1016/j.biomaterials.2010.08.034
   Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang SG, 2012, J MATER CHEM, V22, P23357, DOI 10.1039/c2jm34249a
   Wang Z, 2009, NANOSCALE RES LETT, V4, P593, DOI 10.1007/s11671-009-9292-z
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xia YN, 2008, NAT MATER, V7, P758, DOI 10.1038/nmat2277
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xing Y, 2011, ACS NANO, V5, P2376, DOI 10.1021/nn200279k
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
   Yang H, 2007, ADV MATER, V19, P3085, DOI 10.1002/adma.200702050
   Yang M, 2013, ANALYST, V138, P72, DOI 10.1039/c2an35744e
   Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535
   Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Zandi M, 2010, J BIOMED MATER RES A, V92A, P1244, DOI 10.1002/jbm.a.32452
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang S., 2009, PHARM RES, V26
   Zhang Y, 2012, ACS APPL MATER INTER, V4, P4099, DOI 10.1021/am300840p
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
   Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001
NR 162
TC 45
Z9 47
U1 6
U2 141
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1600
EP 1627
DI 10.1002/adhm.201500272
PG 28
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600002
PM 26010739
OA Bronze
DA 2018-10-20
ER

PT J
AU Groen, N
   Tahmasebi, N
   Shimizu, F
   Sano, Y
   Kanda, T
   Barbieri, D
   Yuan, HP
   Habibovic, P
   van Blitterswijk, CA
   de Boer, J
AF Groen, Nathalie
   Tahmasebi, Niloofar
   Shimizu, Fumitaka
   Sano, Yasuteru
   Kanda, Takashi
   Barbieri, Davide
   Yuan, Huipin
   Habibovic, Pamela
   van Blitterswijk, Clemens A.
   de Boer, Jan
TI Exploring the Material-Induced Transcriptional Landscape of Osteoblasts
   on Bone Graft Materials
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE bone regeneration; cell-biomaterial interactions; transcriptional
   profiling
ID CALCIUM-PHOSPHATE CERAMICS; MESENCHYMAL STROMAL CELLS; STEM-CELLS;
   OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; INORGANIC-PHOSPHATE;
   IN-VITRO; BIOMATERIALS; OSTEOINDUCTION; SCAFFOLDS
AB During the past decades, there have been major advances in the field of biomaterials, thereby generating a vast variety of materials for a broad range of tissue engineering and regeneration applications. Although gene expression profiling has been used occasionally in biomaterial research, its usefulness for understanding cell-biomaterial interactions should be further explored for it to fulfill its promise as a tool to assess and improve material properties. Here, the transcriptional landscape induced by 23 materials is explored with a variety of properties within the scope of bone regeneration. An osteoblast cell line is used to identify the gene expression profiles that can be adopted in response to biophysical and chemical cues. It is shown that TGF- and WNT signaling may be involved in the cellular response to osteoinductive materials along with differential cell adhesion kinetics via attenuated FAK signaling. The previously reported effect of calcium and phosphate on BMP2 and TGF- signaling is confirmed and the biological effect of the addition of nanohydroxyapatite in poly (d,l-lactic acid) polymer particles is studied. Together with future applications, this approach will help researchers understand cellular responses in relation to material properties, which will promote the development of more effective biomaterials for applications in tissue regeneration.
C1 [Groen, Nathalie; Tahmasebi, Niloofar; Barbieri, Davide; Yuan, Huipin; Habibovic, Pamela; van Blitterswijk, Clemens A.; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Shimizu, Fumitaka; Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Dept Neurol & Clin Neurosci, Grad Sch Med, Yamaguchi 7558505, Japan.
   [Barbieri, Davide; Yuan, Huipin] Xpand Biotechnol BV, NL-3723 MB Bilthoven, Netherlands.
   [Habibovic, Pamela; van Blitterswijk, Clemens A.; de Boer, Jan] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
RP de Boer, J (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM jan.deboer@maastrichtuniversity.nl
FU Project BONE-IP of the research program of the BioMedical Materials
   Institute [P2.04]; Dutch Ministry of Economic Affairs
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, cofunded by the Dutch
   Ministry of Economic Affairs.
CR Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203
   Baker BA, 2014, BIOMATERIALS, V35, P6716, DOI 10.1016/j.biomaterials.2014.04.075
   Barbieri D., 2014, FRONTIERS NANOBIOMED, P473
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1
   Chai Y. C., 2011, TISSUE ENG A
   Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Das RK, 2014, BIOMATERIALS, V35, P5278, DOI 10.1016/j.biomaterials.2014.03.044
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059
   Doorn J, 2013, BIOMATERIALS, V34, P3053, DOI 10.1016/j.biomaterials.2012.12.037
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Groen N, 2013, BIOMATERIALS, V34, P5552, DOI 10.1016/j.biomaterials.2013.04.001
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081
   McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370
   Moxham JP, 2007, LARYNGOSCOPE, V117, P1790, DOI 10.1097/MLG.0b013e3180ed451b
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036
   Olivares-Navarrete R, 2011, ACTA BIOMATER, V7, P2740, DOI 10.1016/j.actbio.2011.02.030
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002
   Shih Y.-R. V., 2014, P NAT AC SCI 2014 JA, V2014
   Sieg DJ, 2000, NAT CELL BIOL, V2, P249
   Sims Natalie A, 2014, Bonekey Rep, V3, P527, DOI 10.1038/bonekey.2014.22
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   van der Maaten L. J. P., 2009, P 12 INT C ART INT S, V5, P384
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang J., 2014, ACTA BIOMATER, P3254
NR 61
TC 4
Z9 4
U1 3
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1691
EP 1700
DI 10.1002/adhm.201500171
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600012
PM 26046651
DA 2018-10-20
ER

PT J
AU Sahu, N
   Baligar, P
   Midha, S
   Kundu, B
   Bhattacharjee, M
   Mukherjee, S
   Mukherjee, S
   Maushart, F
   Das, S
   Loparic, M
   Kundu, SC
   Ghosh, S
   Mukhopadhyay, A
AF Sahu, Neety
   Baligar, Prakash
   Midha, Swati
   Kundu, Banani
   Bhattacharjee, Maumita
   Mukherjee, Snehasish
   Mukherjee, Souhrid
   Maushart, Florian
   Das, Sanskrita
   Loparic, Marko
   Kundu, Subhas C.
   Ghosh, Sourabh
   Mukhopadhyay, Asok
TI Nonmulberry Silk Fibroin Scaffold Shows Superior Osteoconductivity Than
   Mulberry Silk Fibroin in Calvarial Bone Regeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biodegradation; bone graft materials; bone regeneration; calvarial bone
   defect; mulberry silk; nonmulberry silk
ID OSTEOBLAST DIFFERENTIATION; ANTHERAEA-MYLITTA; STEM-CELLS; IN-VITRO;
   BIOMATERIALS; DEFECTS; EXPRESSION; SIALOPROTEIN; DEGRADATION;
   FABRICATION
AB Recent years have witnessed the advancement of silk biomaterials in bone tissue engineering, although clinical application of the same is still in its infancy. In this study, the potential of pure nonmulberry Antheraea mylitta (Am) fibroin scaffold, without preloading with bone precursor cells, to repair calvarial bone defect in a rat model is explored and compared with its mulberry counterpart Bombyx mori (Bm) silk fibroin. After 3 months of implantation, Am scaffold culminates in a completely ossified regeneration with a progressive increase in mineralization at the implanted site. On the other hand, the Bm scaffold fails to repair the damaged bone, presumably due to its low osteoconductivity and early degradation. The deposition of bone matrix on scaffolds is evaluated by scanning electron and atomic force microscopy. These results are corroborated by in vitro studies of enzymatic degradation, colony formation, and secondary conformational features of the scaffold materials. The greater biocompatibility and mineralization in pure nonmulberry fibroin scaffolds warrants the use of these scaffolds as an ideal bone graft biomaterial for effective repair of critical size defects.
C1 [Sahu, Neety; Baligar, Prakash; Mukhopadhyay, Asok] Natl Inst Immunol, Stem Cell Biol Lab, New Delhi 110067, India.
   [Midha, Swati; Bhattacharjee, Maumita; Das, Sanskrita; Ghosh, Sourabh] Indian Inst Technol, Dept Textile Technol, New Delhi 110016, India.
   [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Maushart, Florian; Loparic, Marko] Univ Basel, Biozentrum & Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in; sghosh08@textile.iitd.ac.in;
   ashok@nii.ac.in
RI Kundu, Banani/O-9320-2016
OI Kundu, Banani/0000-0003-1251-700X; Kundu, Subhas C./0000-0002-7170-2291;
   /0000-0003-0295-5356; Baligar, Prakash/0000-0002-0553-4090
FU Department of Biotechnology, Government of India, New Delhi; Commission
   for Technology and Innovation (CTI) grant [14540.2, 1 PFNM-NM]
FX N.S. and P.B. contributed equally to this work. The work was funded by
   the Department of Biotechnology, Government of India, New Delhi, for
   which S.C.K. and A.M. are grateful. M.L. and F.M. were supported by
   Commission for Technology and Innovation (CTI) grant (Project 14540.2; 1
   PFNM-NM). A.M., S.C.K., and S.G. acknowledge NII, IIT Kharagpur, and IIT
   Delhi for providing infrastructural supports to conduct this study.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Bhattacharjee M, 2013, BIOMATERIALS, V34, P8161, DOI 10.1016/j.biomaterials.2013.07.018
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   Braccini A, 2007, J TISSUE ENG REGEN M, V1, P60, DOI 10.1002/term.11
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cebe P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01130
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Das S., 2015, ACTA BIOMATER, V1, P233
   Das S, 2013, BIOMACROMOLECULES, V14, P311, DOI 10.1021/bm301193t
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Hu JG, 2012, J MATER SCI-MATER M, V23, P711, DOI 10.1007/s10856-011-4533-y
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Jolanda R. V., 2015, ACTA BIOMATER, V13, P277
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Kuboyama N, 2013, J BIOMED MATER RES B, V101B, P295, DOI 10.1002/jbm.b.32839
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu KG, 2012, J BIOMAT SCI-POLYM E, V23, P509, DOI 10.1163/092050610X552861
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Naskar D., 2014, SCI REP, V22, P4745
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 46
TC 11
Z9 11
U1 1
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD AUG 5
PY 2015
VL 4
IS 11
BP 1709
EP 1721
DI 10.1002/adhm.201500283
PG 13
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CO7ZH
UT WOS:000359382600014
PM 26084249
DA 2018-10-20
ER

PT J
AU Ullah, MH
   Mahadi, WNL
   Latef, TA
AF Ullah, M. Habib
   Mahadi, W. N. L.
   Latef, T. A.
TI Aerogel Poly(butylene succinate) Biomaterial Substrate for RF and
   Microwave Applications
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SILICA AEROGEL; ANTENNA; BAND; ACID
AB Polybutylene succinate (PBS) has become a potential candidate, similar to polypropylene (PP) and acrylonitrile butadiene styrene (ABS), for use as an organic plastic material due to its outstanding mechanical properties as well as high thermal deformation characteristics. A new composition of silica aerogel nanoparticles extracted from rice waste with PBS is proposed for use as a dielectric (epsilon(r) = 4.5) substrate for microwave applications. A microstrip patch antenna was fabricated on the proposed dielectric substrate for multi-resonant ultra-wideband (UWB) applications. The performance characteristics of the proposed biomaterial-based antenna were investigated in a far-field measurement environment. The results indicate that the proposed biocompatible material-based antenna covered a bandwidth of 9.4 (2.3-11.7) GHz with stop bands from 5.5 GHz to 5.8 GHz and 7.0 GHz to 8.3 GHz. Peak gains of 9.82 dBi, 7.59 dBi, 8.0 dBi and 7.68 dBi were measured at resonant frequencies of 2.7 GHz, 4.6 GHz, 6.3 GHz and 9.5 GHz, respectively.
C1 [Ullah, M. Habib; Mahadi, W. N. L.; Latef, T. A.] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
RP Ullah, MH (reprint author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
EM mhullah@yahoo.com
RI Engineering, Faculty/I-7935-2015; ABDUL LATEF, TARIK/B-9927-2010
OI Engineering, Faculty/0000-0002-4848-7052; 
FU University of Malaya [FP012-2014A]
FX The authors acknowledge the assistance given by University of Malaya
   (Project: FP012-2014A).
CR Bondioli F, 2010, J AM CERAM SOC, V93, P121, DOI 10.1111/j.1551-2916.2009.03337.x
   Cao WQ, 2013, IEEE T ANTENN PROPAG, V61, P2286, DOI 10.1109/TAP.2012.2235400
   DeJean G, 2005, IEEE ANTENN WIREL PR, V4, P22, DOI 10.1109/LAWP.2004.841626
   Gurav JL, 2010, J NANOMATER, V2010, P23
   Habib Ullah M., 2014, SMART MATER STRUCT, V23
   Hall P.S., 2007, PRINTED ANTENNAS WIR
   Islam MT, 2012, PROG ELECTROMAGN RES, V129, P161, DOI 10.2528/PIER12032604
   Kaufmann T, 2012, INT J ANTENN PROPAG, DOI 10.1155/2012/972696
   Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0
   LEVY D, 1989, J NON-CRYST SOLIDS, V113, P137, DOI 10.1016/0022-3093(89)90004-5
   Lu WJ, 2014, IEEE T ANTENN PROPAG, V62, P2860, DOI 10.1109/TAP.2014.2307343
   Mobashsher AT, 2014, IEEE ANTENN WIREL PR, V13, P798, DOI 10.1109/LAWP.2014.2318035
   Oishi A, 2006, POLYM J, V38, P710, DOI 10.1295/polymj.PJ2005206
   PERI JB, 1966, J PHYS CHEM-US, V70, P2937, DOI 10.1021/j100881a037
   POELZ G, 1982, NUCL INSTRUM METHODS, V195, P491, DOI 10.1016/0029-554X(82)90010-6
   Priel A, 2006, BIOPHYS J, V90, P4639, DOI 10.1529/biophysj.105.078915
   Reppe J. W., 1949, ACETYLENE CHEM
   SCHAEFER DW, 1986, PHYS REV LETT, V56, P2199, DOI 10.1103/PhysRevLett.56.2199
   Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043
   Takahashi H, 2000, CHEM LETT, P684, DOI 10.1246/cl.2000.684
   Tserki V, 2006, POLYM DEGRAD STABIL, V91, P367, DOI 10.1016/j.polymdegradstab.2005.04.035
   Ullah MH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4833496
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Xu J, 2010, BIOTECHNOL J, V5, P1149, DOI 10.1002/biot.201000136
   Zeikus JG, 1999, APPL MICROBIOL BIOT, V51, P545, DOI 10.1007/s002530051431
NR 25
TC 4
Z9 4
U1 6
U2 37
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 4
PY 2015
VL 5
AR 12868
DI 10.1038/srep12868
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO4EQ
UT WOS:000359114000001
PM 26238975
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gupta, KA
   Mita, K
   Arunkumar, KP
   Nagaraju, J
AF Gupta, Adarsh K.
   Mita, Kazuei
   Arunkumar, Kallare P.
   Nagaraju, Javaregowda
TI Molecular architecture of silk fibroin of Indian golden silkmoth,
   Antheraea assama
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEIN SECONDARY STRUCTURE; BOMBYX-MORI; MECHANICAL-PROPERTIES;
   NEPHILA-CLAVIPES; EXPRESSED GENES; DRAGLINE SILK; CODON USAGE; SEQUENCE;
   DNA; ORGANIZATION
AB The golden silk spun by Indian golden silkmoth Antheraea assama, is regarded for its shimmering golden luster, tenacity and value as biomaterial. This report describes the gene coding for golden silk H-fibroin (AaFhc), its expression, full-length sequence and structurally important motifs discerning the underlying genetic and biochemical factors responsible for its much sought-after properties. The coding region, with biased isocodons, encodes highly repetitious crystalline core, flanked by a pair of 5' and 3' non-repetitious ends. AaFhc mRNA expression is strictly territorial, confined to the posterior silk gland, encoding a protein of size 230 kDa, which makes homodimers making the elementary structural units of the fibrous core of the golden silk. Characteristic polyalanine repeats that make tight beta-sheet crystals alternate with non-polyalanine repeats that make less orderly antiparallel beta-sheets, beta-turns and partial alpha-helices. Phylogenetic analysis of the conserved N-terminal amorphous motif and the comparative analysis of the crystalline region with other saturniid H-fibroins reveal that AaFhc has longer, numerous and relatively uniform repeat motifs with lower serine content that assume tighter beta-crystals and denser packing, which are speculated to be responsible for its acclaimed properties of higher tensile strength and higher refractive index responsible for golden luster.
C1 [Gupta, Adarsh K.; Arunkumar, Kallare P.; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad 500001, Andhra Pradesh, India.
   [Mita, Kazuei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.
RP Gupta, KA (reprint author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad 500001, Andhra Pradesh, India.
EM adarsh@cdfd.org.in; arun@cdfd.org.in
FU Department of Biotechnology, Government of India through Centre of
   Excellence grant for Genetics and Genomics of Silkmoths
   [BT/01/COE/05/12]
FX This work is sincerely dedicated in memory of Dr. J. Nagaraju. This work
   was supported by Department of Biotechnology, Government of India
   through Centre of Excellence grant for Genetics and Genomics of
   Silkmoths (grant number BT/01/COE/05/12) to JN. We are grateful to Dr.
   H. A. Nagarajaram (Laboratory of Computational Biology, CDFD) for his
   valuable inputs during computational analyses and manuscript
   preparation. We thank Dr. Rashna Bhandari (Laboratory of Cell
   Signalling, CDFD) and Dr. R. Harinarayanan (Laboratory of Bacterial
   Genetics, CDFD) for their helpful discussions during few experiments.
CR Amalendu Tikader, 2013, Plant Knowledge Journal, V2, P83
   Arunkumar KP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-338
   Bratzel G, 2012, J MECH BEHAV BIOMED, V7, P30, DOI 10.1016/j.jmbbm.2011.07.012
   Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564
   Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng1011
   Collin MA, 2010, J MOL EVOL, V70, P519, DOI 10.1007/s00239-010-9349-8
   COUBLE P, 1985, NUCLEIC ACIDS RES, V13, P1801, DOI 10.1093/nar/13.5.1801
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Higgins LE, 2007, INT J BIOL MACROMOL, V40, P201, DOI 10.1016/j.ijbiomac.2006.07.007
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Horard B, 1997, MOL CELL BIOL, V17, P1572, DOI 10.1128/MCB.17.3.1572
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Lesperon L., 1937, Archives de Zoologie Experimentale et Generale Paris, V79, P1
   Ling SJ, 2013, BIOMACROMOLECULES, V14, P1885, DOI 10.1021/bm400267m
   Lucas F., 1968, Comprehensive Biochem, V26, P475
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   MITA K, 1994, J MOL EVOL, V38, P583
   NAKAMURA T, 1991, FEBS LETT, V289, P123, DOI 10.1016/0014-5793(91)80923-Q
   Nation J. L., 2000, INSECT PHYSL BIOCH, P2485
   PAULING L, 1953, P NATL ACAD SCI USA, V39, P253, DOI 10.1073/pnas.39.4.253
   PAULSSON G, 1992, J MOL BIOL, V225, P349, DOI 10.1016/0022-2836(92)90926-B
   PEDRIXGILLOT S, 1979, BIOCHIMIE, V61, P171
   Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097
   Saravanan D. U. V., 2007, AUTEX RES J, V7, P1
   SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Sezutsu Hideki, 2009, Journal of Insect Biotechnology and Sericology, V78, P1
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shibukawa A., 1959, B SERICULT EXP STN, V15, P383
   SHIMURA K, 1982, Journal of Sericultural Science of Japan, V51, P20
   Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01
   Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645
   Talukdar B., 2011, INT J PURE APPL SCI, V7, P81
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T
   Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
NR 53
TC 2
Z9 2
U1 1
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 3
PY 2015
VL 5
AR 12706
DI 10.1038/srep12706
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0MR
UT WOS:000358846300001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Abdul-Kader, AM
   Radwan, RM
AF Abdul-Kader, A. M.
   Radwan, R. M.
TI Low-energy He-ion beam modifications the surface properties of
   biomaterial
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE surface properties; ultra-high-molecular-weight polyethylene;
   biocompatibility; ion bombardment
ID MOLECULAR-WEIGHT POLYETHYLENE; GAMMA-IRRADIATION; DIELECTRIC-PROPERTIES;
   HYDROGEN RELEASE; POLYMERS; FILMS; BOMBARDMENT; RADIATION; ELECTRON;
   COMPOSITE
AB In the present work, ultra-high-molecular-weight polyethylene (UHMWPE) films were irradiated with 130keV He ions. The fluence of the ion beam was ranged from 1x10(12) to 1x10(16)cm(-2). The chemical, morphological, and crystallite structure changes resulted from the ion bombardment were obtained using different spectroscopic techniques. These techniques were Fourier transform infrared spectrometer, scanning electron microscope, X-ray diffraction, and UV-vis spectrophotometry. The surface free energy for untreated and ion-beam-treated samples was determined by means of contact angle measurements of three different liquids. Our results showed a decrease in the crystallinity of UHMWPE and formation of C=O groups on the polymer surface for modified samples as well. A remarkable shifting in the UV-vis spectra toward lower energy and increase in the optical absorption were observed as the ion fluence increases. Measurements of the contact angle indicate remarkable increase in the surface free energy as a function of ion fluence.
C1 [Abdul-Kader, A. M.] Helwan Univ, Fac Sci, Dept Phys, Cairo, Egypt.
   [Radwan, R. M.] AEA, NCRRT, Radiat Phys Dept, Cairo, Egypt.
   [Radwan, R. M.] Jazan Univ, Dept Diagnost Radiol, Coll Appl Med Sci, Jazan, Saudi Arabia.
RP Abdul-Kader, AM (reprint author), Helwan Univ, Fac Sci, Dept Phys, Cairo, Egypt.
EM atawab2001@yahoo.com
CR Abdel Moez A, 2012, SPECTROCHIM ACTA A, V93, P203
   Abdul-Kader AM, 2009, APPL SURF SCI, V255, P7786, DOI 10.1016/j.apsusc.2009.04.176
   Abdul-Kader AM, 2005, NUCL INSTRUM METH B, V240, P152, DOI 10.1016/j.nimb.2005.06.106
   Abdul-Kader AM, 2005, VACUUM, V78, P281, DOI 10.1016/j.vacuum.2005.01.039
   Al-Qaradawi IY, 2007, RADIAT PHYS CHEM, V76, P123, DOI 10.1016/j.radphyschem.2006.03.016
   Bakshi SR, 2007, COMPOS PART A-APPL S, V38, P2493, DOI 10.1016/j.compositesa.2007.08.004
   Balabanov S, 2002, VACUUM, V69, P107, DOI 10.1016/S0042-207X(02)00316-0
   Balanzat E, 1995, NUCL INSTRUM METH B, V105, P46, DOI 10.1016/0168-583X(95)00521-8
   Balanzat E, 1996, NUCL INSTRUM METH B, V116, P159, DOI 10.1016/0168-583X(96)00121-8
   Chapiro A, 1995, NUCL INSTRUM METH B, V105, P5, DOI 10.1016/0168-583X(95)00861-6
   Clough RL, 2001, NUCL INSTRUM METH B, V185, P8, DOI 10.1016/S0168-583X(01)00966-1
   Costa L, 1997, POLYM DEGRAD STABIL, V55, P329, DOI 10.1016/S0141-3910(96)00170-X
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   Dworecki K, 2001, NUCL INSTRUM METH B, V185, P61, DOI 10.1016/S0168-583X(01)00779-0
   enkiewicz M, 2008, POLYM TEST, V27, P420, DOI [10.1016/j.polymertesting.2008.01.002, DOI 10.1016/J.POLYMERTESTING.2008.01.002]
   FAKES DW, 1987, SURF INTERFACE ANAL, V10, P416, DOI 10.1002/sia.740100807
   Fernando SS, 2007, POLYM DEGRAD STABIL, V92, P2163, DOI 10.1016/j.polymdegradstab.2007.01.032
   Goldman M, 1996, POLYMER, V37, P2909, DOI 10.1016/0032-3861(96)89386-4
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hazarika J, 2012, NUCL INSTRUM METH B, V288, P74, DOI 10.1016/j.nimb.2012.06.026
   Jagielski J, 2007, NUCL INSTRUM METH B, V261, P690, DOI 10.1016/j.nimb.2007.03.021
   Kumar PK, 2011, MATER DESIGN, V32, P1129, DOI 10.1016/j.matdes.2010.11.001
   Kumar R, 2008, NUCL INSTRUM METH B, V266, P1783, DOI 10.1016/j.nimb.2007.11.059
   Kumar V, 2012, RADIAT PHYS CHEM, V81, P652, DOI 10.1016/j.radphyschem.2012.02.027
   Lee E. H., 1996, POLYIMIDES FUNDAMENT
   Mishra R, 2001, RADIAT MEAS, V33, P845, DOI 10.1016/S1350-4487(01)00038-5
   MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pelagade SM, 2012, NUCL INSTRUM METH B, V289, P34, DOI 10.1016/j.nimb.2012.08.010
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   Qureshi A, 2009, NUCL INSTRUM METH B, V267, P3456, DOI 10.1016/j.nimb.2009.07.016
   Radwan RM, 2008, RADIAT PHYS CHEM, V77, P179, DOI 10.1016/j.radphyschem.2007.05.011
   RANDALL JN, 1983, APPL PHYS LETT, V42, P457, DOI 10.1063/1.93969
   Rosu L, 2009, POLYM TEST, V28, P296, DOI 10.1016/j.polymertesting.2009.01.004
   Siljegovic M, 2011, RADIAT PHYS CHEM, V80, P1378, DOI 10.1016/j.radphyschem.2011.08.012
   Singh NL, 2007, MAT SCI ENG B-SOLID, V137, P85, DOI 10.1016/j.mseb.2006.10.013
   Stelescu DM, 2013, POLYM TEST, V32, P187, DOI 10.1016/j.polymertesting.2012.10.010
   Suarez JCM, 2002, POLYM DEGRAD STABIL, V75, P143, DOI 10.1016/S0141-3910(01)00213-0
   Toth S, 2006, THIN SOLID FILMS, V497, P279, DOI 10.1016/j.tsf.2005.10.050
   Tretinnikov ON, 1999, J POLYM SCI POL PHYS, V37, P1503, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1503::AID-POLB16>3.0.CO;2-X
   Turos A, 2006, NUCL INSTRUM METH B, V249, P660, DOI 10.1016/j.nimb.2006.03.075
   Verma R, 2012, J PHYS CHEM SOLIDS, V73, P288, DOI 10.1016/j.jpcs.2011.10.026
   Virk HS, 1998, J PHYS D APPL PHYS, V31, P3139, DOI 10.1088/0022-3727/31/21/020
   Wang YQ, 2000, NUCL INSTRUM METH B, V161, P1027, DOI 10.1016/S0168-583X(99)00989-1
   Wielunski LS, 1997, NUCL INSTRUM METH B, V127, P698, DOI 10.1016/S0168-583X(96)01160-3
   WROBEL AM, 1978, POLYMER, V19, P908, DOI 10.1016/0032-3861(78)90197-0
   Zaki MF, 2008, J PHYS D, V41
   Ziegler J. F., 1985, STOPPING RANGES IONS, VI
NR 48
TC 0
Z9 0
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD AUG 3
PY 2015
VL 29
IS 15
BP 1607
EP 1616
DI 10.1080/01694243.2015.1038104
PG 10
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA CI1VJ
UT WOS:000354532700008
DA 2018-10-20
ER

PT J
AU Bohmler, J
   Haidara, H
   Ponche, A
   Ploux, L
AF Boehmler, Judith
   Haidara, Hamidou
   Ponche, Arnaud
   Ploux, Lydie
TI Impact of Chemical Heterogeneities of Surfaces on Colonization by
   Bacteria
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE bacterial adhesion; surface properties; functional group density;
   chemical heterogeneities; real-time confocal microscopy
ID SELF-ASSEMBLED MONOLAYERS; GRAM-POSITIVE BACTERIA; ACID-BASE PROPERTIES;
   ESCHERICHIA-COLI; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION;
   MICROBIAL ADHESION; INITIAL ADHESION; FLOW CONDITIONS; CELL-SIZE
AB An essential yet never addressed parameter for the control of bacteria on functionalized biomaterial is surely the accessibility and heterogeneity of the functional groups immobilized on the surface. In this context, we investigated the colonization (Escherichia coli K12, Staphylococcus epidermidis RP62A) of precisely engineered surfaces revealing various densities of NH2 and CH3 functional groups. We demonstrated for the first time nonlinear relationships between the NH2/CH3 surface fraction and the quantity of adhered, adhering or detaching bacteria. Plateaus and transition zones were related to the range of NH2/CH3 surface fraction offering stability or sharp variation in bacterium/surface interactions. The nonlinear behavior was attributed to the discrete distribution of positive charges revealed by the bacterial membrane in the continuum of negative charges resulting from the phospholipids, which may correlate with one single specific distribution of positive NH3+ charges on the material surface, because of electrostatic, repulsive interactions occurring at the local, molecular scale.
C1 [Boehmler, Judith; Haidara, Hamidou; Ponche, Arnaud; Ploux, Lydie] Univ Haute Alsace, Univ Strasbourg, Inst Sci Mat Mulhouse, CNRS,UMR7361, Mulhouse, France.
RP Ploux, L (reprint author), Univ Haute Alsace, Univ Strasbourg, Inst Sci Mat Mulhouse, CNRS,UMR7361, Mulhouse, France.
EM Lydie.Ploux@uha.fr
OI Ponche, Arnaud/0000-0002-8993-2896
FU French "Centre National de la Recherche Scientifique" (CNRS); Region
   Alsace (France)
FX The article has been edited and proofread by Proof-Reading-Services.org.
   All works done at Institut de Science des Materiaux de Mulhouse were
   funded by the French "Centre National de la Recherche Scientifique"
   (CNRS). The present project was also especially funded by Region Alsace
   (France). In addition, the authors sincerely thank Jules Valentin and
   Adeline Marguier for their technical help and Prof Jean-Claude Block for
   stimulating discussions.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anguita-Alonso Paloma, 2005, Expert Rev Anti Infect Ther, V3, P797, DOI 10.1586/14787210.3.5.797
   Anselme K, 2011, ACTA BIOMATER, V7, P1936, DOI 10.1016/j.actbio.2010.12.002
   Aswal DK, 2006, ANAL CHIM ACTA, V568, P84, DOI 10.1016/j.aca.2005.10.027
   Bagshaw SM, 2006, CURR OPIN INFECT DIS, V19, P67, DOI 10.1097/01.qco.0000200292.37909.e0
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Barth KA, 2008, ADV FUNCT MATER, V18, P1459, DOI 10.1002/adfm.200701246
   Basu S, 1997, J COLLOID INTERF SCI, V190, P253, DOI 10.1006/jcis.1997.4856
   BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6
   Bohmler J, 2013, ACS APPL MATER INTER, V5, P10478, DOI 10.1021/am401976g
   Burton EA, 2009, LANGMUIR, V25, P1547, DOI 10.1021/la803261b
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   COICO R, 2005, CURRENT PROTOCOLS MI
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cottenye N, 2012, ADV FUNCT MATER, V22, P4891, DOI 10.1002/adfm.201200988
   Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r
   Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Fonseca AP, 2001, J MATER SCI-MATER M, V12, P543, DOI 10.1023/A:1011227915575
   Gasol JM, 1995, MAR ECOL PROG SER, V128, P91, DOI 10.3354/meps128091
   Harkes G, 1992, Cell Biophys, V20, P17, DOI 10.1007/BF02782652
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, J MATER SCI-MATER M, V21, P963, DOI 10.1007/s10856-009-3975-y
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   KOCH AL, 1966, J GEN MICROBIOL, V45, P409, DOI 10.1099/00221287-45-3-409
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   Lee SH, 2010, J PHYS CHEM C, V114, P10512, DOI 10.1021/jp101426h
   Lin JH, 2014, LANGMUIR, V30, P10328, DOI 10.1021/la5020362
   Lin YC, 2009, J COLLOID INTERF SCI, V340, P126, DOI 10.1016/j.jcis.2009.08.014
   Liu Y, 2001, J APPL MICROBIOL, V90, P337, DOI 10.1046/j.1365-2672.2001.01244.x
   Mauclaire L, 2010, COLLOID SURFACE B, V76, P104, DOI 10.1016/j.colsurfb.2009.10.021
   Miao H, 2009, J MICROBIOL METH, V76, P111, DOI 10.1016/j.mimet.2008.09.015
   Mougin K, 2001, LANGMUIR, V17, P5952, DOI 10.1021/la0102399
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174
   Nicolau Korres A. M., 2013, SCI WORLD J, V2013
   Ploux L, 2007, COLLOID SURFACE B, V57, P174, DOI 10.1016/j.colsurfb.2007.01.018
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Poortinga AT, 2002, SURF SCI REP, V47, P3, DOI 10.1016/S0167-5729(02)00032-8
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   Rasband WS, 1997, IMAGEJ
   Roberts JA, 2004, CHEM GEOL, V212, P313, DOI 10.1016/j.chemgeo.2004.08.021
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x
   Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002
   Scherrer B., 2007, BIOSTATISTIQUE, V1
   Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018
   SHERMAN PM, 1985, INFECT IMMUN, V49, P797
   Shyue JJ, 2004, LANGMUIR, V20, P8693, DOI 10.1021/la049247q
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Terada A, 2005, COLLOID SURFACE B, V43, P99, DOI 10.1016/j.colsurfb.2005.03.016
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u
   Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043
   Wiencek KM, 1997, BIOFOULING, V11, P293, DOI 10.1080/08927019709378338
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Zhang H, 1998, APPL PHYS A-MATER, V66, pS269, DOI 10.1007/s003390051143
NR 64
TC 4
Z9 4
U1 4
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD AUG
PY 2015
VL 1
IS 8
BP 693
EP 704
DI 10.1021/acsbiomaterials.5b00151
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RP
UT WOS:000372214100010
DA 2018-10-20
ER

PT J
AU Zhang, SS
   Burda, JE
   Anderson, MA
   Zhao, ZR
   Ao, Y
   Cheng, Y
   Sun, Y
   Deming, TJ
   Sofroniew, MV
AF Zhang, Shanshan
   Burda, Joshua E.
   Anderson, Mark A.
   Zhao, Ziru
   Ao, Yan
   Cheng, Yin
   Sun, Yi
   Deming, Timothy J.
   Sofroniew, Michael V.
TI Thermoresponsive Copolypeptide Hydrogel Vehicles for Central Nervous
   System Cell Delivery
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biomaterials; hydrogel; brain; spinal cord; drug delivery; neural stem
   cells; transplantation
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; AXONAL REGENERATION;
   LOCAL-DELIVERY; RADIAL GLIA; TRACT AXONS; TISSUE; SCAR; ASTROCYTES;
   GROWTH
AB Biomaterial vehicles have the potential to facilitate cell transplantation in the central nervous system (CNS). We have previously shown that highly tunable ionic diblock copolypeptide hydrogels (DCH) can provide sustained release of hydrophilic and hydrophobic molecules in the CNS. Here, we show that recently developed nonionic and thermoresponsive DCH, called DCHT, exhibit excellent cytocompatibility. Neural stem cell (NSC) suspensions in DCHT were easily injected as liquids at room temperature. DCHT with a viscosity tuned to prevent cell sedimentation and clumping significantly through injection cannulae. At body temperature, DCHT self-assembled into hydrogels with a stiffness tuned to that of CNS tissue. After injection in vivo, DCHT significantly increased by 3-fold the survival of NSC grafted into a healthy CNS. In an injured CNS, NSC injected as suspensions in DCHT distributed well in non-neural lesion cores, integrated with healthy neural cells at lesion perimeters, and supported regrowing host nerve fibers. Our findings show that nonionic DCHT have numerous advantageous properties that make them useful tools for in vivo delivery of cells and molecules in the CNS for experimental investigations and potential therapeutic strategies.
C1 [Zhang, Shanshan; Deming, Timothy J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   [Burda, Joshua E.; Anderson, Mark A.; Zhao, Ziru; Ao, Yan; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Cheng, Yin; Sun, Yi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.
   [Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Sofroniew, MV (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
EM sofroniew@mednet.ucla.edu
OI Burda, Joshua/0000-0001-5139-348X
FU Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research
   Foundation; NIH [R01NS084030]; Microscopy Core Resource of the UCLA
   Broad Stem Cell Research Center-CIRM Laboratory
FX This study was supported by Wings for Life, The Dr. Miriam and Sheldon
   G. Adelson Medical Research Foundation, NIH R01NS084030, and the
   Microscopy Core Resource of the UCLA Broad Stem Cell Research
   Center-CIRM Laboratory.
CR Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chu TC, 2014, BRAIN RES BULL, V107, P18, DOI 10.1016/j.brainresbull.2014.05.003
   Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283
   Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682
   Deming TJ, 2005, SOFT MATTER, V1, P28, DOI 10.1039/b500307e
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340
   Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040
   Dunnett SB, 2014, NEUROBIOL DIS, V61, P79, DOI 10.1016/j.nbd.2013.05.004
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162
   Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024
   Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008
   Hoban DB, 2013, BIOMATERIALS, V34, P9420, DOI 10.1016/j.biomaterials.2013.08.073
   Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2
   Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kramer JR, 2013, SOFT MATTER, V9, P3389, DOI 10.1039/c3sm27559k
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023
   Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   McCall J, 2012, CELL TISSUE RES, V349, P27, DOI 10.1007/s00441-012-1388-6
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   NORRIS CR, 1991, J NEUROSCI, V11, P3481
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926
   Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006
   Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013
   Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Zhang SS, 2015, BIOMACROMOLECULES, V16, P1331, DOI 10.1021/acs.biomac.5b00124
   Zhang S, 2014, BIOMATERIALS, V35, P1989, DOI 10.1016/j.biomaterials.2013.11.005
   Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013
NR 49
TC 15
Z9 15
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD AUG
PY 2015
VL 1
IS 8
BP 705
EP 717
DI 10.1021/acsbiomaterials.5b00153
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RP
UT WOS:000372214100011
PM 27547820
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Khalili, AA
   Ahmad, MR
AF Khalili, Amelia Ahmad
   Ahmad, Mohd Ridzuan
TI A Review of Cell Adhesion Studies for Biomedical and Biological
   Applications
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE cell adhesion; attachment event; detachment event; adhesion strength
ID QUARTZ-CRYSTAL MICROBALANCE; ATOMIC-FORCE MICROSCOPY; OSTEOBLAST-LIKE
   CELLS; EXTRACELLULAR-MATRIX PROTEINS; BIOMIMETIC PEPTIDE SURFACES;
   RED-BLOOD-CELLS; ENDOTHELIAL-CELL; FLOW CHAMBER; LIVING CELLS;
   SHEAR-STRESS
AB Cell adhesion is essential in cell communication and regulation, and is of fundamental importance in the development and maintenance of tissues. The mechanical interactions between a cell and its extracellular matrix (ECM) can influence and control cell behavior and function. The essential function of cell adhesion has created tremendous interests in developing methods for measuring and studying cell adhesion properties. The study of cell adhesion could be categorized into cell adhesion attachment and detachment events. The study of cell adhesion has been widely explored via both events for many important purposes in cellular biology, biomedical, and engineering fields. Cell adhesion attachment and detachment events could be further grouped into the cell population and single cell approach. Various techniques to measure cell adhesion have been applied to many fields of study in order to gain understanding of cell signaling pathways, biomaterial studies for implantable sensors, artificial bone and tooth replacement, the development of tissue-on-a-chip and organ-on-a-chip in tissue engineering, the effects of biochemical treatments and environmental stimuli to the cell adhesion, the potential of drug treatments, cancer metastasis study, and the determination of the adhesion properties of normal and cancerous cells. This review discussed the overview of the available methods to study cell adhesion through attachment and detachment events.
C1 [Khalili, Amelia Ahmad; Ahmad, Mohd Ridzuan] Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Johor Baharu 81310, Malaysia.
   [Ahmad, Mohd Ridzuan] Univ Teknol Malaysia, Inst Ibnu Sina, Johor Baharu 81310, Malaysia.
RP Ahmad, MR (reprint author), Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Johor Baharu 81310, Malaysia.
EM amelia.ahmadkhalili@gmail.com; ridzuan@fke.utm.my
RI Ahmad, Mohd Ridzuan/M-9037-2016
OI Ahmad, Mohd Ridzuan/0000-0002-1331-9606
FU Ministry of Higher Education Malaysia [4L640, 4F351]; Universiti
   Teknologi Malaysia [02G46, 03H82, 03H80]
FX The research was supported by the Ministry of Higher Education Malaysia
   (grant Nos. 4L640 and 4F351) and Universiti Teknologi Malaysia, (grant
   Nos. 02G46, 03H82 and 03H80). Thanks to them for funding this project
   and for their endless support.
CR Alapan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07173
   An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x
   Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853
   Askenasy N, 2002, STEM CELLS, V20, P501, DOI 10.1634/stemcells.20-6-501
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Bearinger JP, 1997, LANGMUIR, V13, P5175, DOI 10.1021/la970101j
   Beaussart A, 2014, NAT PROTOC, V9, P1049, DOI 10.1038/nprot.2014.066
   BELLONI PN, 1990, CANCER METAST REV, V8, P353, DOI 10.1007/BF00052608
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   Bhat VD, 1998, J BIOMED MATER RES, V41, P377, DOI 10.1002/(SICI)1097-4636(19980905)41:3<377::AID-JBM6>3.3.CO;2-Q
   Bonakdar N., 2012, PLOS ONE, V7
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009
   Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0
   Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6
   Cao J, 1997, ANN BIOMED ENG, V25, P573, DOI 10.1007/BF02684196
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Castelain M, 2012, J APPL PHYS, V111, DOI 10.1063/1.4723566
   Castelain M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2772270
   Castelain M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2842078
   Cavic BA, 1999, ANALYST, V124, P1405, DOI 10.1039/a903236c
   Chan BP, 1999, BIOMATERIALS, V20, P2395, DOI 10.1016/S0142-9612(99)00167-2
   Channavajjala LS, 1997, J CELL SCI, V110, P249
   Chaw KC, 2007, LAB CHIP, V7, P1041, DOI 10.1039/b707399m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515
   Cheung LSL, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054033
   Cho Peter, 2006, Implant Dent, V15, P377, DOI 10.1097/01.id.0000247858.37697.d5
   Christ KV, 2010, J ADHES SCI TECHNOL, V24, P2027, DOI 10.1163/016942410X507911
   Christ KV, 2010, BIOMED MICRODEVICES, V12, P443, DOI 10.1007/s10544-010-9401-x
   Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001
   Correlates M., 1985, J CLIN INVEST, V76, p[1605, 1612]
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   Curtis JE, 2004, P SOC PHOTO-OPT INS, V5514, P455, DOI 10.1117/12.560049
   D'Arcangelo E., 2014, BIOTECHNIQUES, V58, P13
   Da-Silva AC, 2013, BIOTECHNOL J, V8, P690, DOI 10.1002/biot.201200320
   Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Deshpande VS, 2008, J MECH PHYS SOLIDS, V56, P1484, DOI 10.1016/j.jmps.2007.08.006
   Detry JG, 2009, BIOTECHNOL AGRON SOC, V13, P427
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698
   EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8
   EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2
   Ferreira GNM, 2009, TRENDS BIOTECHNOL, V27, P689, DOI 10.1016/j.tibtech.2009.09.003
   Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Fu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030721
   Gallant ND, 2007, J BIOMECH, V40, P1301, DOI 10.1016/j.jbiomech.2006.05.018
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Gao Z, 2008, MAT SCI ENG C-BIO S, V28, P1227, DOI 10.1016/j.msec.2007.11.003
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gerszten RE, 1998, CIRC RES, V82, P871
   Giacomello E., 1999, BIOTECHNIQUES, V26, P764
   Girdhar G, 2007, BIOPHYS J, V93, P4041, DOI 10.1529/biophysj.107.109298
   Goldstein AS, 2003, J BIOMED MATER RES A, V67A, P658, DOI 10.1002/jbm.a.10125
   Goldstein AS, 2002, J BIOMED MATER RES, V59, P665, DOI 10.1002/jbm.1276
   Goldstein AS, 1998, AICHE J, V44, P465, DOI 10.1002/aic.690440222
   Goldstein AS, 1997, BIOTECHNOL BIOENG, V55, P616, DOI 10.1002/(SICI)1097-0290(19970820)55:4<616::AID-BIT4>3.0.CO;2-K
   Gourier C, 2008, CELL MOL BIOENG, V1, P263, DOI 10.1007/s12195-008-0030-x
   Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780
   Gupta VK, 2010, BIOMECH MODEL MECHAN, V9, P613, DOI 10.1007/s10237-010-0201-2
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hansma HG, 2004, CURR OPIN STRUC BIOL, V14, P380, DOI 10.1016/j.sbi.2004.05.005
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Harbers GM, 2005, LANGMUIR, V21, P8374, DOI 10.1021/la050396y
   Hartmann A, 2014, LAB CHIP, V14, P542, DOI 10.1039/c3lc50916h
   HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Heitmann V, 2007, ANAL CHEM, V79, P3392, DOI 10.1021/ac062433b
   Heitmann V, 2007, SPRINGER SER CHEM SE, V5, P303, DOI 10.1007/5346_031
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Hirano Y, 2008, PFLUG ARCH EUR J PHY, V456, P139, DOI 10.1007/s00424-007-0431-z
   Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   Hodges SR, 2002, J FLUID MECH, V460, P381, DOI 10.1017/S0022112002008340
   Hoffmann SC, 2011, J IMMUNOL, V186, P2757, DOI 10.4049/jimmunol.1002867
   Honarmandi P, 2011, LAB CHIP, V11, P684, DOI 10.1039/c0lc00487a
   Hong S, 2006, BIOMATERIALS, V27, P5813, DOI 10.1016/j.biomaterials.2006.07.031
   HONN KV, 1992, CANCER METAST REV, V11, P353, DOI 10.1007/BF01307187
   Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68
   Huan W, 2003, J ORTHOPAED RES, V21, P88, DOI 10.1016/S0736-0266(02)00130-4
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Huynh J, 2013, CELL MOL BIOENG, V6, P138, DOI 10.1007/s12195-013-0278-7
   Hwang WC, 1997, BIOPHYS J, V72, P2669, DOI 10.1016/S0006-3495(97)78910-0
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim WS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/24/245605
   Kong D, 2008, BIOPHYS J, V95, P4034, DOI [10.1529/biophysj.108.131342, 10.1529/biophysj.l08.131342]
   Kong D, 2008, J THEOR BIOL, V250, P75, DOI 10.1016/j.jtbi.2007.09.028
   Kong D, 2010, J BIOMECH, V43, P2524, DOI 10.1016/j.jbiomech.2010.05.019
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572
   Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009
   Kreke MR, 2005, BIOMATERIALS, V26, P2975, DOI 10.1016/j.biomaterials.2004.08.013
   Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026
   Kwon KW, 2007, LAB CHIP, V7, P1461, DOI 10.1039/b710054j
   Lane W. O., 2012, JOVE-J VIS EXP, V1, P12
   LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G
   Le Guillou-Buffello D, 2005, BIOMATERIALS, V26, P4197, DOI 10.1016/j.biomaterials.2004.10.024
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Lee C. C., 2004, J MED BIOL ENG, V24, P51
   Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee MH, 2007, J BIOMED MATER RES A, V81A, P150, DOI 10.1002/jbm.a.31065
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Li F, 2007, BIOSENS BIOELECTRON, V23, P42, DOI 10.1016/j.bios.2007.03.018
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t
   Lynch L, 2005, MOL BIOL CELL, V16, P51, DOI 10.1091/mbc.E04-05-0399
   Mandal K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037548
   Marx KA, 2005, ANAL BIOCHEM, V343, P23, DOI 10.1016/j.ab.2005.05.013
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Marx KA, 2007, ANAL BIOCHEM, V361, P77, DOI 10.1016/j.ab.2006.09.023
   McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Meseke M, 2013, J BIOMED MATER RES A, V101, P1726, DOI 10.1002/jbm.a.34477
   Mianabadi M, 2004, AM J CHINESE MED, V32, P369, DOI 10.1142/S0192415X04002028
   Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076
   Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172
   Miller T, 2003, LANGMUIR, V19, P1723, DOI 10.1021/la0261500
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166
   Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x
   Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0
   Nalayanda DD, 2010, J PEDIATR SURG, V45, P45, DOI 10.1016/j.jpedsurg.2009.10.008
   Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148
   Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399
   Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445
   Palange AL, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00161
   Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2
   Park JY, 2007, J BIOMOL SCREEN, V12, P406, DOI 10.1177/1087057106299162
   Perinpanayagam H, 2001, J ORTHOPAED RES, V19, P993, DOI 10.1016/S0736-0266(01)00045-6
   Pesen D, 2005, BIOPHYS J, V88, P670, DOI 10.1529/biophysj.104.049965
   Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439
   Polio SR, 2012, ACTA BIOMATER, V8, P82, DOI 10.1016/j.actbio.2011.08.013
   Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Renshaw KM, 2005, BIOTECHNOL PROGR, V21, P538, DOI 10.1021/bp049664t
   REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 1997, ANN BIOMED ENG, V25, P190, DOI 10.1007/BF02738550
   Riahi R, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4868301
   Ronan W, 2012, J MECH BEHAV BIOMED, V14, P143, DOI 10.1016/j.jmbbm.2012.05.016
   Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Rupprecht P, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3673802
   Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Saif MTA, 2003, ANN BIOMED ENG, V31, P950, DOI 10.1114/1.1591189
   Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005
   Schluter DK, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1080
   Schwingel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054850
   Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276
   Shen YJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/11/115802
   Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046
   Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.biomed.7.060804.100423
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756
   Sordel T, 2007, BIOMATERIALS, V28, P1572, DOI 10.1016/j.biomaterials.2006.10.032
   Spangenberg C, 2006, CANCER RES, V66, P3715, DOI 10.1158/0008-5472.CAN-05-2823
   Szekanecz Z, 2000, ARTHRITIS RES, V2, P368, DOI 10.1186/ar114
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tang ZL, 2012, BIOMATERIALS, V33, P7405, DOI 10.1016/j.biomaterials.2012.06.077
   Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Ting LH, 2012, AM J PHYSIOL-HEART C, V302, pH2220, DOI 10.1152/ajpheart.00975.2011
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   Tsai JW, 2000, P SOC PHOTO-OPT INS, V4082, P213, DOI 10.1117/12.390549
   USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Vogel J, 1998, BBA-BIOMEMBRANES, V1372, P205, DOI 10.1016/S0005-2736(98)00058-3
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wang CC, 2009, J BIOMED MATER RES A, V88A, P370, DOI 10.1002/jbm.a.31604
   Warrick JW, 2013, INTEGR BIOL-UK, V5, P720, DOI 10.1039/c3ib20224k
   Weder G, 2009, BIOINTERPHASES, V4, P27, DOI 10.1116/1.3139962
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wu CC, 2005, BIOCHEM BIOPH RES CO, V329, P256, DOI 10.1016/j.bbrc.2005.01.126
   Xi J., 2013, J BIOCHIPS TISSUE CH, VS5, P001, DOI 10.4172/2153-0777.S5-001
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034
   Yang SP, 2012, MAT SCI ENG C-MATER, V32, P254, DOI 10.1016/j.msec.2011.10.026
   Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052
   Zhang X, 2008, CHEM ENG J, V135, pS82, DOI 10.1016/j.cej.2007.07.054
   Zhong Y, 2012, INT J COMPUT MAT SCI, V1, DOI 10.1142/S2047684112500327
   Zhou DW, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029210
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
   Zhu Y, 2012, AGING CELL, V11, P741, DOI 10.1111/j.1474-9726.2012.00840.x
   Zou JX, 2002, J BIOL CHEM, V277, P1824, DOI 10.1074/jbc.M103133200
NR 217
TC 96
Z9 96
U1 13
U2 86
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2015
VL 16
IS 8
BP 18149
EP 18184
DI 10.3390/ijms160818149
PG 36
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CZ0WE
UT WOS:000366826100078
PM 26251901
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Khorasani, AM
   Goldberg, M
   Doeven, EH
   Littlefair, G
AF Khorasani, Amir Mahyar
   Goldberg, Moshe
   Doeven, Egan H.
   Littlefair, Guy
TI Titanium in Biomedical Applications-Properties and Fabrication: A Review
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Biocompatibility; Bioimplants Fabrication; Mechanical Properties;
   Osseointegration; Ti-Based Biomaterial
ID COMMERCIALLY PURE TITANIUM; POROUS HYDROXYAPATITE SCAFFOLDS;
   SHAPE-MEMORY ALLOYS; DIAMOND-LIKE CARBON; CELLS IN-VITRO; SOL-GEL
   METHOD; TI-TA ALLOYS; MECHANICAL-PROPERTIES; CORROSION-RESISTANCE;
   IMPLANT MATERIALS
AB Ti and Ti-based alloys have unique properties such as high strength, low density and excellent corrosion resistance. These properties are essential for the manufacture of lightweight and high strength components for biomedical applications. In this paper, Ti properties such as metallurgy, mechanical properties, surface modification, corrosion resistance, biocompatibility and osseointegration in biomedical applications have been discussed. This paper also analyses the advantages and disadvantages of various Ti manufacturing processes for biomedical applications such as casting, powder metallurgy, cold and hot working, machining, laser engineering net shaping (LEN), superplastic forming, forging and ring rolling. The contributions of this research are twofold, firstly scrutinizing the behaviour of Ti and Ti-based alloys in-vivo and in-vitro experiments in biomedical applications to determine the factors leading to failure, and secondly strategies to achieve desired properties essential to improving the quality of patient outcomes after receiving surgical implants. Future research will be directed toward manufacturing of Ti for medical applications by improving the production process, for example using optimal design approaches in additive manufacturing and investigating alloys containing other materials in order to obtain better medical and mechanical characteristics.
C1 [Khorasani, Amir Mahyar; Goldberg, Moshe; Doeven, Egan H.; Littlefair, Guy] Deakin Univ, Sch Engn, Fac Sci Engn & Built Environm, Waurn Ponds, Vic 3216, Australia.
RP Khorasani, AM (reprint author), Deakin Univ, Sch Engn, Fac Sci Engn & Built Environm, Waurn Ponds, Vic 3216, Australia.
RI Littlefair, Guy/N-1614-2017
CR Akahori T, 1998, MAT SCI ENG A-STRUCT, V243, P237, DOI 10.1016/S0921-5093(97)00807-1
   Akahori T, 2000, METALL MATER TRANS A, V31, P1937, DOI 10.1007/s11661-000-0221-0
   Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Anawati, 2013, CORROS SCI, V70, P212, DOI 10.1016/j.corsci.2013.01.032
   Andresen P., 2000, STRESS CORROSION CRA
   Antunes RA, 2012, ACTA BIOMATER, V8, P937, DOI 10.1016/j.actbio.2011.09.012
   Appel F, 2004, INTERMETALLICS, V12, P791, DOI 10.1016/j.intermet.2004.02.042
   Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045
   Asadnia M., 2010, INT J APPL ENG RES, P5
   Au AR, 2000, J ORAL REHABIL, V27, P978, DOI 10.1046/j.1365-2842.2000.00576.x
   Bacakova L, 2001, J BIOMED MATER RES, V54, P567
   Bajpai I, 2015, J BIOMATER TISS ENG, V5, P403, DOI 10.1166/jbt.2015.1322
   Balakrishnan A., 2008, TRENDS BIOMATER ARTI, V22, P54
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Benea L, 2014, CORROS SCI, V80, P331, DOI 10.1016/j.corsci.2013.11.059
   Black G H. J., 1998, HDB BIOMATERIAL PROP
   Borgioli F, 2001, SURF COAT TECH, V141, P103, DOI 10.1016/S0257-8972(01)01164-1
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chang C. J., 2003, FUEL, V2014, P10
   Chang C. J., 2003, TECHNOL, V2005, P08
   Cheah CM, 2005, INT J ADV MANUF TECH, V25, P308, DOI 10.1007/s00170-003-1840-6
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chien CY, 2013, J BIOMED MATER RES A, V101, P740, DOI 10.1002/jbm.a.34376
   Choi M, 2014, J MECH BEHAV BIOMED, V30, P214, DOI 10.1016/j.jmbbm.2013.11.014
   Choudhury P, 2012, WOODH PUBL SER BIOM, V49, P84
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chua CK, 2010, RAPID PROTOTYPING: PRINCIPLES AND APPLICATIONS, 3RD EDITION, P1
   Chudhuri B, 2013, J BIOMATER TISS ENG, V3, P653, DOI 10.1166/jbt.2013.1126
   Chun YB, 2005, MAT SCI ENG A-STRUCT, V398, P209, DOI 10.1016/j.msea.2005.03.019
   Cooper K.G., 2001, RAPID PROTOTYPING TE
   Santos EC, 2006, INT J MACH TOOL MANU, V46, P1459, DOI 10.1016/j.ijmachtools.2005.09.005
   Courant B, 2005, J MATER PROCESS TECH, V160, P374, DOI 10.1016/j.jmatprotec.2004.06.025
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Da Silva L, 2000, J ORAL REHABIL, V27, P131, DOI 10.1046/j.1365-2842.2000.00506.x
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Fleck C, 2010, INT J FATIGUE, V32, P929, DOI 10.1016/j.ijfatigue.2009.09.009
   Froes F., 2005, DEV TITANIUM P M
   Froes FH, 2010, KEY ENG MATER, V436, P1, DOI 10.4028/www.scientific.net/KEM.436.1
   Furuta T, 2005, MATER TRANS, V46, P3001, DOI 10.2320/matertrans.46.3001
   Gale W. F., 2003, MACHINING PROSTHETIC
   Gaspar M, 2013, COMPUT AIDED DESIGN, V45, P1170, DOI 10.1016/j.cad.2013.04.007
   Geetha M, 2004, SURF ENG, V20, P68, DOI 10.1179/026708404225010595
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gibson I, 2006, VIRTUAL PHYS PROTOTY, V1, P31, DOI 10.1080/17452750500271298
   Glavicic MG, 2008, METALL MATER TRANS A, V39A, P887, DOI 10.1007/s11661-007-9376-2
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Guleryuz H, 2005, SURF COAT TECH, V192, P164, DOI 10.1016/j.surfcoat.2004.05.018
   Guttal Satyabodh, 2005, Gerodontology, V22, P242
   Hall P. C., 2005, GOOGLE PATENTS
   Hannula S.-P, 2006, Advances in Science and Technology, V49, P109, DOI 10.4028/www.scientific.net/AST.49.109
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Haslauer CM, 2010, MED ENG PHYS, V32, P645, DOI 10.1016/j.medengphy.2010.04.003
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   Heidloff AJ, 2010, JOM-US, V62, P35, DOI 10.1007/s11837-010-0075-x
   Heimann R. B., 2008, PRINCIPLES APPL
   Hertl C, 2014, MAT SCI ENG C-MATER, V41, P28, DOI 10.1016/j.msec.2014.03.018
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   Hoseini J, 2014, J BIOMATER TISS ENG, V4, P138, DOI 10.1166/jbt.2014.1150
   House K, 2008, AM J ORTHOD DENTOFAC, V133, P584, DOI 10.1016/j.ajodo.2007.03.021
   Hsu HC, 2005, J MATER SCI-MATER M, V16, P821, DOI 10.1007/s10856-005-3585-2
   Hsu HC, 2013, MAT SCI ENG A-STRUCT, V568, P1, DOI 10.1016/j.msea.2013.01.002
   Hsu HC, 2010, MATER CHARACT, V61, P851, DOI 10.1016/j.matchar.2010.05.003
   Huang HH, 2002, BIOMATERIALS, V23, P59, DOI 10.1016/S0142-9612(01)00079-5
   Huang Y, 2013, APPL SURF SCI, V271, P299, DOI 10.1016/j.apsusc.2013.01.187
   Huasheng X., 2008, SPECIAL CASTING NO S, VS1, P462
   Iijima D, 2003, BIOMATERIALS, V24, P1519, DOI 10.1016/S0142-9612(02)00533-1
   Iijima M, 2002, BIOMATERIALS, V23, P1769, DOI 10.1016/S0142-9612(01)00303-9
   Ikeda M, 2003, J JPN I MET, V67, P420, DOI 10.2320/jinstmet1952.67.9_420
   Imam MA, 2010, JOM-US, V62, P17, DOI 10.1007/s11837-010-0069-8
   Inci I, 2014, J BIOMATER TISS ENG, V4, P624, DOI 10.1166/jbt.2014.1210
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Jackson M, 2006, MATER SCI TECH-LOND, V22, P881, DOI 10.1179/174328406x111147
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jebali A, 2014, J BIOMATER TISS ENG, V4, P638, DOI 10.1166/jbt.2014.1209
   Jeffrey G. A., 1997, INTRO HYDROGEN BONDI
   Jiang XP, 2006, MAT SCI ENG A-STRUCT, V429, P30, DOI 10.1016/j.msea.2006.04.024
   KAHVECI AI, 1986, SCRIPTA METALL MATER, V20, P1287, DOI 10.1016/0036-9748(86)90050-5
   Kalpakjian S. R. S., 2003, MANUFACTURING PROCES
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Kazakeviciute-Makovska R, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.432
   Kazemi RB, 1996, ORAL SURG ORAL MED O, V81, P596, DOI 10.1016/S1079-2104(96)80055-2
   Khorasani A. Mahyar, 2012, International Journal of Computational Materials Science and Surface Engineering, V5, P68, DOI 10.1504/IJCMSSE.2012.049055
   Khorasani Amir Mahyar, 2012, International Journal of Machining and Machinability of Materials, V12, P142, DOI 10.1504/IJMMM.2012.048553
   Khorasani A. M., 2012, ARTIF INTELL, P1
   Khorasani A. M., 2014, MACHINABILITY BIOMAT
   Khorasani A. M., 2014, J MACH FORM TECHNOL, V6, P45
   Khorasani AM, 2013, ARAB J SCI ENG, V38, P1565, DOI 10.1007/s13369-013-0600-7
   Khorasani AM, 2011, INT J ADV MANUF TECH, V55, P457, DOI 10.1007/s00170-010-3060-1
   Khorasani E. G. S. A. M., 2010, J MANUFACTURING TECH, V1, P41
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kim KM, 2006, ELECTROCHIM ACTA, V51, P5636, DOI 10.1016/j.electacta.2006.02.038
   Kim SK, 2005, J ORAL REHABIL, V32, P346, DOI 10.1111/j.1365-2842.2004.01475.x
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kom M, 2015, J BIOMATER TISS ENG, V5, P396, DOI 10.1166/jbt.2015.1327
   Komotori J, 2001, WEAR, V251, P1239, DOI 10.1016/S0043-1648(01)00753-0
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kurtz S.M, 2004, CROSSLINKED THERMALL
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Faria ACL, 2011, J MECH BEHAV BIOMED, V4, P1873, DOI 10.1016/j.jmbbm.2011.06.004
   Lausmaa J., 2001, TITANIUM MED, P267
   Lee K, 2013, THIN SOLID FILMS, V549, P154, DOI 10.1016/j.tsf.2013.09.002
   Lei MK, 2011, SURF COAT TECH, V205, P4602, DOI 10.1016/j.surfcoat.2011.03.141
   Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Li SJ, 2004, BIOMATERIALS, V25, P2525, DOI 10.1016/j.biomaterials.2003.09.039
   Liu F, 2015, J BIOMATER TISS ENG, V5, P164, DOI 10.1166/jbt.2015.1297
   Lutjering G., 2003, TITANIUM
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Machado A.R., 1990, ARCH P I MECH ENG B, V204, P53
   Maeshima T, 2006, MAT SCI ENG A-STRUCT, V438, P844, DOI 10.1016/j.msea.2006.05.092
   Mareci D, 2013, T NONFERR METAL SOC, V23, P3829, DOI 10.1016/S1003-6326(13)62936-2
   Marin C, 2008, J PERIODONTOL, V79, P1942, DOI [10.1902/jop.2008.080106, 10.1902/jop.2008.080106 ]
   McCracken CG, 2010, INT J POWDER METALL, V46, P19
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Mohan L, 2012, APPL SURF SCI, V258, P6331, DOI 10.1016/j.apsusc.2012.03.032
   Mori M, 2012, PROC CIRP, V1, P22, DOI 10.1016/j.procir.2012.04.004
   Mtao Australia, 2013, KEY FACTS FIGURES 20, P8
   Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004
   Nag S, 2007, ACTA BIOMATER, V3, P369, DOI 10.1016/j.actbio.2006.08.005
   Nagiah N, 2013, J BIOMATER TISS ENG, V3, P624, DOI 10.1166/jbt.2013.1130
   Nan H., 2005, CHINA FOUNDRY, V2, P239
   Nandy AK, 2009, INT J MACH TOOL MANU, V49, P182, DOI 10.1016/j.ijmachtools.2008.08.008
   Nezafati N, 2015, J BIOMATER TISS ENG, V5, P78, DOI 10.1166/jbt.2015.1240
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M., 2005, TITANIUM ITS ALLOYS
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Nolan D, 2006, SURF COAT TECH, V200, P5698, DOI 10.1016/j.surfcoat.2005.08.110
   Nomani J, 2013, WEAR, V304, P20, DOI 10.1016/j.wear.2013.04.008
   Oak JJ, 2008, J NON-CRYST SOLIDS, V354, P1828, DOI 10.1016/j.jnoncrysol.2007.10.025
   Oberg E., 2008, MACHINERYS HDB
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Ozel T, 2010, CIRP ANN-MANUF TECHN, V59, P77, DOI 10.1016/j.cirp.2010.03.055
   Park J. B., 2002, BIOMATERIALS PRINCIP
   Park JW, 2009, ACTA BIOMATER, V5, P3272, DOI 10.1016/j.actbio.2009.04.038
   Park YJ, 2013, J DENT, V41, P1251, DOI 10.1016/j.jdent.2013.09.003
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Polishetty A., 2010, INT J MECH MECHATRON, V10, P1
   Polmear I., 2005, LIGHT ALLOYS TRADITI
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   Pramanik Alokesh, 2013, Advanced Materials Research, V651, P338, DOI 10.4028/www.scientific.net/AMR.651.338
   Prevey P. S., 2001, EFFECT LOW PLASTICIT, P1
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Qun Z., 2008, TITANIUM IND PROGR, V2, P7
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Raja KS, 2005, ELECTROCHIM ACTA, V51, P154, DOI 10.1016/j.electacta.2005.04.011
   Rajasekaran B, 2008, MATER LETT, V62, P2473, DOI 10.1016/j.matlet.2007.12.025
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Randeniya LK, 2010, DIAM RELAT MATER, V19, P329, DOI 10.1016/j.diamond.2010.01.003
   Rao TS, 2005, CORROS SCI, V47, P1071, DOI 10.1016/j.corsci.2004.07.025
   Rath PC, 2012, CERAM INT, V38, P3209, DOI 10.1016/j.ceramint.2011.12.026
   Ratner B. D., 2013, SURFACE PROPERTIES S, P34
   Ren L., 2014, J MAT SCI TECHNOL
   Rilo B, 2002, J PROSTHET DENT, V87, P407, DOI 10.1067/mpr.2002.123232
   Robin A, 2008, MATER CORROS, V59, P929, DOI 10.1002/maco.200805014
   Rodrigues DC, 2009, J BIOMED MATER RES B, V88B, P206, DOI 10.1002/jbm.b.31171
   Ribeiro ALR, 2009, J MATER SCI-MATER M, V20, P1629, DOI 10.1007/s10856-009-3737-x
   Roshanbinfar K, 2013, J BIOMATER TISS ENG, V3, P284, DOI 10.1166/jbt.2013.1093
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Saari H, 2005, INTERMETALLICS, V13, P937, DOI 10.1016/j.intermet.2004.12.006
   Sadraie SH, 2014, J BIOMATER TISS ENG, V4, P562, DOI 10.1166/jbt.2014.1203
   Saha R., 2014, DEFENCE SCI J, V36, P121
   Sanders DG, 2008, MATERIALWISS WERKST, V39, P353, DOI 10.1002/mawe.200800305
   Sanders DG, 2008, J MATER ENG PERFORM, V17, P187, DOI 10.1007/s11665-007-9186-0
   Saresh N, 2007, J MATER PROCESS TECH, V192, P83, DOI 10.1016/j.jmatprotec.2007.04.048
   Sargent GA, 2008, METALL MATER TRANS A, V39A, P2949, DOI 10.1007/s11661-008-9650-y
   Schey J. A., 2000, INTRO MANUFACTURING
   Semiatin SL, 2002, METALL MATER TRANS A, V33, P2719, DOI 10.1007/s11661-002-0394-9
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   Shi W, 2002, MAT SCI ENG A-STRUCT, V337, P104, DOI 10.1016/S0921-5093(02)00003-5
   Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Silva Maria Margareth da, 2006, Mat. Res., V9, P97, DOI 10.1590/S1516-14392006000100018
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Stack MM, 2011, TRIBOL INT, V44, P1827, DOI 10.1016/j.triboint.2011.07.009
   Stolyarov VV, 2005, PHYS MET METALLOGR+, V99, P204
   Su B, 2006, J UNIV SCI TECHNOL B, V13, P469, DOI 10.1016/S1005-8850(06)60095-9
   Sung S. Y., 2007, MELTING CASTING TITA
   Swaminathan V, 2012, BIOMATERIALS, V33, P5487, DOI 10.1016/j.biomaterials.2012.04.015
   Tan Philip L, 2008, J Prosthodont, V17, P378, DOI 10.1111/j.1532-849X.2008.00302.x
   Tay CY, 2014, ACS APPL MATER INTER, V6, P6248, DOI 10.1021/am501266a
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thair L, 2003, CORROS SCI, V45, P1951, DOI 10.1016/S0010-938X(03)00027-1
   Tian Q. M., 2014, ELECTROPHORETIC DEPO
   Tian XJ, 2010, MAT SCI ENG A-STRUCT, V527, P1821, DOI 10.1016/j.msea.2009.11.014
   Tredwin CJ, 2013, DENT MATER, V29, P521, DOI 10.1016/j.dental.2013.02.002
   Uchida M, 2005, BIOMATERIALS, V26, P6924, DOI 10.1016/j.biomaterials.2005.04.066
   Uezono M, 2013, J BIOMED MATER RES B, V101B, P1031, DOI 10.1002/jbm.b.32913
   Uta E, 2009, J MICROSC-OXFORD, V233, P451, DOI 10.1111/j.1365-2818.2009.03141.x
   Varadarajan N, 2014, J BIOMATER TISS ENG, V4, P295, DOI 10.1166/jbt.2014.1173
   Venugopal S, 2008, J MATER PROCESS TECH, V202, P201, DOI 10.1016/j.jmatprotec.2007.09.038
   Wang G, 2007, J MATER PROCESS TECH, V192, P555, DOI 10.1016/j.jmatprotec.2007.04.059
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Wang HY, 2013, CHARACTERIZATION OF BIOMATERIALS, P105, DOI 10.1016/B978-0-12-415800-9.00004-8
   Wang JW, 2007, DENT MATER, V23, P133, DOI 10.1016/j.denta1.2006.01.001
   Wang XY, 2014, IEEE T COMP PACK MAN, V4, P4, DOI 10.1109/TCPMT.2013.2280922
   Wang YB, 2009, MATER LETT, V63, P1293, DOI 10.1016/j.matlet.2009.02.062
   Wangfeng Z., 2010, CHINESE J RARE METAL, V1, P001
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wen CE, 2007, ACTA BIOMATER, V3, P403, DOI 10.1016/j.actbio.2006.10.004
   Wise D. L., 2000, HUMAN APPL
   Wu D., 2008, INVESTIGATION COLD R, V10, P016
   Wu G, 2014, J BIOMATER TISS ENG, V4, P1047, DOI 10.1166/jbt.2014.1260
   Xu LJ, 2008, J ALLOY COMPD, V453, P320, DOI 10.1016/j.jallcom.2006.11.144
   Yamazaki K, 1998, ARTIF ORGANS, V22, P466, DOI 10.1046/j.1525-1594.1998.06156.x
   Yan David Ping, 2011, International Journal of Machining and Machinability of Materials, V10, P264, DOI 10.1504/IJMMM.2011.043089
   Yan DP, 2011, TMS2011 SUPPLEMENTAL PROCEEDINGS, VOL 2: MATERIALS FABRICATION, PROPERTIES, CHARACTERIZATION, AND MODELING, P633
   Yazdi MRS, 2011, EXPERT SYST APPL, V38, P12116, DOI 10.1016/j.eswa.2011.03.002
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Yu GL, 2007, J PROSTHET DENT, V97, P157, DOI 10.1016/j.prosdent.2007.01.005
   Zavanelli RA, 2004, J ORAL REHABIL, V31, P1029, DOI 10.1111/j.1365-2842.2004.01336.x
   Zhang BB, 2011, DENT MATER, V27, P214, DOI 10.1016/j.dental.2010.10.005
   Zhang T, 2014, J BIOMATER TISS ENG, V4, P1030, DOI 10.1166/jbt.2014.1255
   Zhang XP, 2008, MAT SCI ENG A-STRUCT, V481, P170, DOI 10.1016/j.msea.2007.02.147
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   Zhu XJ, 2005, SCRIPTA MATER, V52, P651, DOI 10.1016/j.scriptamat.2004.11.017
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zielinski A, 2008, CORROS REV, V26, P1, DOI 10.1515/corrrev.2008.1
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 235
TC 23
Z9 23
U1 12
U2 122
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD AUG
PY 2015
VL 5
IS 8
BP 593
EP 619
DI 10.1166/JBT.2015.1361
PG 27
WC Cell & Tissue Engineering
SC Cell Biology
GA CX2VL
UT WOS:000365554800001
DA 2018-10-20
ER

PT J
AU Shikha, D
   Shahid, M
   Jha, U
   Sinha, SK
   Reddy, VR
   Ojha, S
   Kumar, P
   Kanjilal, D
AF Shikha, Deep
   Shahid, Md.
   Jha, Ush
   Sinha, Sanjay Kumar
   Reddy, V. Raghavendra
   Ojha, Sunil
   Kumar, P.
   Kanjilal, Dinakar
TI Corrosion, wettability and thrombogenicity investigation of ion beam
   modified HAP/Al2O3
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Coatings; Surface properties; Corrosion
ID GEL-DERIVED HYDROXYAPATITE; BIOMATERIAL ALUMINA; THIN-FILMS;
   IMPLANTATION; COATINGS; SPECTROSCOPY; GENERATION; LAYERS; TESTS; BLOOD
AB Hydroxyapatite Ca-10(PO4)(6)(OH)(2), is a biosensitive ceramic which promotes bone growth in human fluid. However due to its weak mechanical strength it is often coated on chemically inert material such as alumina. In the present work hydroxyapatite (HAP) of thickness 1 mu m is deposited on alumina using sol gel process and the stoichiometric ratio of Ca:P = 1.67 is maintained. Surface property of HAP is further improved by Ar+ ion implantation. The samples were irradiated with 1.4 MeV Ar+ ions with fluence ranging from 5 x 10(14) to 1 x 10(16) ions/cm(2). After irradiation, the surface is characterized using Atomic Force Microscope (AFM), Scanning Electron Microscope (SEM), electron dispersive X-ray spectroscopy (EDX), Glancing incidence X-ray diffraction (GXRD) and Rutherford backscattering Spectroscopy (RBS) techniques. Corrosion resistances and impedance analysis were carried out in Ringer solution. RBS and EDX were used to confirm the stoichiometric ratio of the film. Compound formation before and after ion implantation was studied using GXRD. Nanohardness, wettability and thrombogenicity of all the samples were studied. Correlation among surface morphology, improvement in corrosion resistance, hardness, wetability and thrombogenicity before and after ion implantation are discussed in this paper. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shikha, Deep; Shahid, Md.; Jha, Ush] BIT Mesra, Dept Chem, Ranchi 835215, Bihar, India.
   [Sinha, Sanjay Kumar] BIT Mesra, Dept Phys, Ranchi 835215, Bihar, India.
   [Reddy, V. Raghavendra] UGC DAE Consortium Sci Res Indore, Indore, India.
   [Ojha, Sunil; Kumar, P.; Kanjilal, Dinakar] IUAC, New Delhi, India.
RP Sinha, SK (reprint author), BIT Mesra, Dept Phys, Ranchi 835215, Bihar, India.
EM sksinha@bitmesra.ac.in
RI Jha, Usha/L-9583-2017
OI Jha, Usha/0000-0001-9033-6517; Kanjilal, Dinakar/0000-0001-9728-3147
FU Department of Science and Technology (DST), New Delhi; DST
FX The authors are grateful for the financial support from the Department
   of Science and Technology (DST), New Delhi. They also acknowledge the
   help rendered by Central Instrumentation Facility (CIF) of the
   Institute, IUAC New Delhi for ion implantation, UGC-DAE Consortium for
   Scientific Research, Indore Centre for characterization. One of the
   authors (M. Shahid) is thankful to DST for his fellowship.
CR Aksakal B, 2010, J MATER ENG PERFORM, V19, P894, DOI 10.1007/s11665-009-9559-7
   Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   Baumann H, 2002, NUCL INSTRUM METH B, V196, P286, DOI 10.1016/S0168-583X(02)01298-3
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Borruto A, 1998, WEAR, V222, P57, DOI 10.1016/S0043-1648(98)00256-7
   BRINKER CJ, 1990, SOL GEL SCI
   Delgado-Alvarado C, 2006, ACTA BIOMATER, V2, P701, DOI 10.1016/j.actbio.2006.05.012
   Dou Y, 2012, J SOL-GEL SCI TECHN, V61, P126, DOI 10.1007/s10971-011-2601-x
   Feng W, 2005, MATER LETT, V59, P916, DOI DOI 10.1016/J.MATLET.2004.08.041
   Heimke G., 1986, HDB BIOMATERIALS EVO
   Hsieh MF, 2001, BIOMATERIALS, V22, P2601, DOI 10.1016/S0142-9612(00)00448-8
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hulbert S. F., 1993, INTRO BIOCERAMIOCS
   Hwang K, 2000, SURF COAT TECH, V123, P252, DOI 10.1016/S0257-8972(99)00512-5
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   KANJILAL D, 1993, NUCL INSTRUM METH A, V328, P97, DOI 10.1016/0168-9002(93)90610-T
   Kim W, 2000, J MATER SCI, V35, P5401, DOI 10.1023/A:1004859231795
   Lapatin C.M., 1998, NUCL INSTRUM METH B, V145, P522
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Lo WJ, 1999, J BIOMED MATER RES, V46, P408, DOI 10.1002/(SICI)1097-4636(19990905)46:3<408::AID-JBM14>3.0.CO;2-Z
   Lopatin CM, 1998, NUCL INSTRUM METH B, V145, P522, DOI 10.1016/S0168-583X(98)80557-0
   Man HH, 1996, J MAGN MAGN MATER, V152, P47, DOI 10.1016/0304-8853(95)00454-8
   Mateo MP, 2009, APPL SURF SCI, V255, P5172, DOI 10.1016/j.apsusc.2008.08.040
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nayak K., 2010, INT J CHEM TECH RES, V2, P903
   PARK JB, 1992, BIOMATERIALS INTRO
   Rautray TR, 2010, THIN SOLID FILMS, V518, P3160, DOI 10.1016/j.tsf.2009.08.044
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Rompen EH, 1999, CLIN ORAL IMPLAN RES, V10, P85, DOI 10.1034/j.1600-0501.1999.100202.x
   Shikha D, 2008, INT J APPL CERAM TEC, V5, P44, DOI 10.1111/j.1744-7402.2008.02184.x
   Shikha D, 2007, NUCL INSTRUM METH B, V264, P254, DOI 10.1016/j.nimb.2007.08.093
   Shikha D, 2009, SURF COAT TECH, V203, P2541, DOI 10.1016/j.surfcoat.2009.02.071
   Sinha SK, 2000, NUCL INSTRUM METH B, V170, P120, DOI 10.1016/S0168-583X(00)00068-9
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Vigen K.M., 2002, SURF COAT TECH, V158-159, P609
   Wang MC, 2001, J MATER SCI, V36, P3283, DOI 10.1023/A:1017907024197
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
NR 40
TC 1
Z9 1
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD AUG 1
PY 2015
VL 163
BP 272
EP 278
DI 10.1016/j.matchemphys.2015.07.040
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CX0BI
UT WOS:000365361500030
DA 2018-10-20
ER

PT J
AU Zhang, Q
   Cao, P
AF Zhang, Qian
   Cao, Peng
TI Degradable porous Fe-35wt.%Mn produced via powder sintering from NH4HCO3
   porogen
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Sintering; Corrosion test; Microstructure
ID FE-MN ALLOYS; SPACE-HOLDER; PURE IRON; IN-VITRO; MAGNESIUM ALLOYS; CELL
   VIABILITY; STENTS; BIOMATERIAL; BIOCOMPATIBILITY; METALLURGY
AB In this study, a Fe-35Mn (wt.%) alloy was produced by a simple press-and-sinter process from blended elemental powders with ammonium bicarbonate as porogen (space holding). The addition of NH4HCO3 leads to an open-cell porosity of 25-31% in the sintered compacts. The predominant phases in the sintered porous samples are austenitic y and martensitic e phases. The presence of these two antiferromagnetic phases assures magnetic resonance imaging (MRI) compatibility. The degradation performance was evaluated by static immersion and electrochemical test. The degradation rate determined by potentiodynamic analysis ranges from ca. 2 to 8 mmpy in both 5% NaCl and simulated body fluid (SBF) solutions, depending on porosity in the samples. Static immersion test performed under conditions close to in vivo degradation confirms the findings from potentiodynamic test. The degradation rate decreases over time and gradually levels off after 7 days of immersion. The observed degradation rate meets the requirements for a biodegradable material. However, the mechanical properties have to be improved in order to maintain mechanical integrity for biomedical applications if the porous Fe-35Mn is used. Nevertheless, the promising degradation properties would provoke further development of biodegradable Fe-Mn alloys in the future. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhang, Qian; Cao, Peng] Univ Auckland, Dept Chem & Mat Engn, Auckland 1142, New Zealand.
RP Cao, P (reprint author), Univ Auckland, Dept Chem & Mat Engn, Private Bag 92019, Auckland 1142, New Zealand.
EM p.cao@auckland.ac.nz
OI Cao, Peng/0000-0001-6390-6852
CR Bafti H, 2010, MATER DESIGN, V31, P4122, DOI 10.1016/j.matdes.2010.04.038
   Cu X. N., 2010, FRONT MAT SCI CHINA, V4, P111
   Fontana M.G., 2005, CORROSION ENG, P53
   FONTECAVE M, 1993, BIOCHIMIE, V75, P767, DOI 10.1016/0300-9084(93)90126-D
   Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Jha N, 2013, MATER DESIGN, V47, P810, DOI 10.1016/j.matdes.2013.01.005
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li DS, 2009, J ALLOY COMPD, V474, pL1, DOI 10.1016/j.jallcom.2008.06.043
   Manonukul A, 2010, J MATER PROCESS TECH, V210, P529, DOI 10.1016/j.jmatprotec.2009.10.016
   Marinelli P, 2002, MAT SCI ENG A-STRUCT, V335, P137, DOI 10.1016/S0921-5093(01)01908-6
   Martinez J, 2005, MAT SCI ENG A-STRUCT, V408, P26, DOI 10.1016/j.msea.2005.06.019
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Nag S., 2012, ASM HDB MAT MED DEVI, V23, P1
   Nakai M, 2011, J MECH BEHAV BIOMED, V4, P1206, DOI 10.1016/j.jmbbm.2011.04.003
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   RABINKIN A, 1979, CALPHAD, V3, P77, DOI 10.1016/0364-5916(79)90008-7
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Schumann H., 1967, ARCH EISENHUTTENWES, V38, P647
   Sherif EM, 2010, ELECTROCHIM ACTA, V55, P3657, DOI 10.1016/j.electacta.2010.01.117
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witusiewicz VT, 2004, J PHASE EQUILIB DIFF, V25, P346, DOI 10.1361/15477030420115
   Xiang CS, 2012, PROCEDIA ENGINEER, V27, P768, DOI 10.1016/j.proeng.2011.12.518
   Xiong JY, 2008, J MECH BEHAV BIOMED, V1, P269, DOI 10.1016/j.jmbbm.2007.09.003
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 38
TC 6
Z9 7
U1 2
U2 27
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD AUG 1
PY 2015
VL 163
BP 394
EP 401
DI 10.1016/j.matchemphys.2015.07.056
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CX0BI
UT WOS:000365361500045
DA 2018-10-20
ER

PT J
AU Sharma, A
   McQuillan, AJ
   Sharma, LA
   Waddell, JN
   Shibata, Y
   Duncan, WJ
AF Sharma, Ajay
   McQuillan, A. James
   Sharma, Lavanya A.
   Waddell, John Neil
   Shibata, Yo
   Duncan, Warwick John
TI Spark anodization of titanium-zirconium alloy: surface characterization
   and bioactivity assessment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMPROVED BIOLOGICAL PERFORMANCE; ANODIC OXIDE-FILMS; DENTAL IMPLANTS;
   PURE TITANIUM; OXIDATION; BONE; PROLIFERATION; CA; TI; OSSEOINTEGRATION
AB Titanium (Ti) and its alloys have been popularly used as implant biomaterial for decades. Recently, titanium-zirconium (TiZr) alloy has been developed as an alternative implant material with improved strength in load bearing areas. Surface modification is one of the key factors to alter the surface properties to hasten osseointegration. Spark anodic oxidation (anodization) is one such method that is reported to enhance the bone formation around implants. This study aims to anodize TiZr and study its surface characteristics and cytocompatibility by cell culture experiments using osteoblast-like cells. Titanium (Ti) and TiZr discs were anodized in an electrolyte containing DL-alpha-glycerophosphate and calcium acetate (CA) at 300 V. The surface characteristics were analyzed by scanning electron microscopy, electron dispersive spectroscopy, X-ray diffraction (XRD), atomic force microscopy and goniometry. Using osteoblast-like cells viability, proliferation, differentiation and mineralization was assessed. The anodized surfaces demonstrated increased oxygen, entrapped calcium and phosphorous from the electrolyte used. XRD analysis confirmed the presence of anatase in the oxide layer. Average roughness increased and there was a significant decrease in contact angle (P<0.01) following anodization. The anodized TiZr (aTiZr) surfaces were more nano-porous compared to anodized Ti (aTi). No significant difference was found in the viability of cells, but after 24 h the total number of cells was significantly higher (P<0.01). Proliferation, alkaline phosphatase activity and calcium deposits were significantly higher on anodized surfaces compared to machined surfaces (P<0.05, ANOVA). Anodization of TiZr resulted in a more nanoporous and hydrophilic surface than aTi, and osteoblast biocompatibility appeared comparable to aTi.
C1 [Sharma, Ajay; Duncan, Warwick John] Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dept Oral Sci, Dunedin 9016, New Zealand.
   [McQuillan, A. James] Univ Otago, Dept Chem, Dunedin 9016, New Zealand.
   [Sharma, Lavanya A.] Univ Otago, Otago Sch Med Sci, Dunedin 9016, New Zealand.
   [Waddell, John Neil] Sir John Walsh Res Inst, Fac Dent, Dunedin, New Zealand.
   [Shibata, Yo] Showa Univ, Sch Dent, Dept Conservat Dent, Div Biomat & Engn, Tokyo 142, Japan.
RP Sharma, A (reprint author), Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dept Oral Sci, Walsh Bldg,310 Great King St, Dunedin 9016, New Zealand.
EM ajsharma.perio@gmail.com
RI Duncan, Warwick/S-2126-2016
OI Duncan, Warwick/0000-0002-5412-0089
FU Dentsply, Austarlia; Wishborne trust
FX This study was funded by Dentsply, Austarlia and Wishborne trust. We
   wish to acknowledge the assistance of Liz Girwan, Otago Centre for
   Electron Microscopy, University of Otago, for her assistance in the SEM.
   We wish to acknowledge the assistance of Andrew McNaughton, Otago Centre
   for Confocal Microscopy, University of Otago, for his assistance in the
   confocal microscopy. We acknowledge the assistance of Paul Reynolds,
   Department of Chemistry for his assistance in fabrication of electrical
   set up. We the authors of this manuscript declare that there is no
   potential conflict of interest with respect to the authorship and/or
   publication of this article.
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anil S, 2011, DENT IMPLANT SURFACE, P83
   Bai Y, 2011, SURF INTERFACE ANAL, V43, P998, DOI 10.1002/sia.3683
   Balshi SF, 2005, INT J ORAL MAX IMPL, V20, P946
   Barter S, 2012, CLIN ORAL IMPLAN RES, V23, P873, DOI 10.1111/j.1600-0501.2011.02231.x
   Bernhard N, 2009, FORUM IMPLANTOLOGICU, V5, P30
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Connor PA, 1999, LANGMUIR, V15, P2916, DOI 10.1021/la980894p
   Duncan Warwick J, 2008, Ann R Australas Coll Dent Surg, V19, P152
   El-wassefy NA, 2014, CLIN ORAL IMPLAN RES, V25, pE1, DOI 10.1111/clr.12031
   Giordano C, 2005, J MATER SCI-MATER M, V16, P1221, DOI 10.1007/s10856-005-4732-5
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, P538, DOI 10.1111/j.1708-8208.2010.00289.x
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   Ikarashi Y, 2005, MATER TRANS, V46, P2260, DOI 10.2320/matertrans.46.2260
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   KURZE P, 1986, Stomatologie der DDR, V36, P549
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Ostman PO, 2012, CLIN IMPLANT DENT R, V14, P852, DOI 10.1111/j.1708-8208.2012.00453.x
   Pae A, 2011, INT J ORAL MAX IMPL, V26, P475
   Park IS, 2008, J BIOMED MATER RES B, V84B, P422, DOI 10.1002/jbm.b.30887
   Park IS, 2011, SURF INTERFACE ANAL, V43, P1030, DOI 10.1002/sia.3686
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   SHIBUYA Y, 2009, KOBE J MED SCI, V55, pE73
   Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Teh TH, 2003, CORROS SCI, V45, P2757, DOI 10.1016/S0010-938X(03)00101-X
   Wu J, 2010, J BIOMED MATER RES B, V92B, P298, DOI 10.1002/jbm.b.31515
   Xiropaidis AV, 2005, CLIN ORAL IMPLAN RES, V16, P532, DOI 10.1111/j.1600-0501.2005.01126.x
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 41
TC 7
Z9 7
U1 2
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2015
VL 26
IS 8
AR 221
DI 10.1007/s10856-015-5555-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CR4OE
UT WOS:000361312700006
PM 26260697
DA 2018-10-20
ER

PT J
AU Ballester-Beltran, J
   Lebourg, M
   Salmeron-Sanchez, M
AF Ballester-Beltran, Jose
   Lebourg, Myriam
   Salmeron-Sanchez, Manuel
TI Sandwich-like Microenvironments to Harness Cell/Material Interactions
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 102; Sandwich culture; 3D culture; cell culture;
   physiological; cellular environment; bioengineering
ID CELL-MIGRATION; VENTRAL STIMULI; 3RD-DIMENSION; PROTEOLYSIS; MATRICES;
   DORSAL; ASSAY; FATE
AB Cell culture has been traditionally carried out on bi-dimensional (2D) substrates where cells adhere using ventral receptors to the biomaterial surface. However in vivo, most of the cells are completely surrounded by the extracellular matrix (ECM), resulting in a three-dimensional (3D) distribution of receptors. This may trigger differences in the outside-in signaling pathways and thus in cell behavior.
   This article shows that stimulating the dorsal receptors of cells already adhered to a 2D substrate by overlaying a film of a new material (a sandwich-like culture) triggers important changes with respect to standard 2D cultures. Furthermore, the simultaneous excitation of ventral and dorsal receptors shifts cell behavior closer to that found in 3D environments. Additionally, due to the nature of the system, a sandwich-like culture is a versatile tool that allows the study of different parameters in cell/material interactions, e.g., topography, stiffness and different protein coatings at both the ventral and dorsal sides. Finally, since sandwich-like cultures are based on 2D substrates, several analysis procedures already developed for standard 2D cultures can be used normally, overcoming more complex procedures needed for 3D systems.
C1 [Ballester-Beltran, Jose; Lebourg, Myriam] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia, Spain.
   [Ballester-Beltran, Jose; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Salmeron-Sanchez, M (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia, Spain.
EM manuel.salmeron-sanchez@glasgow.ac.uk
RI Salmeron-Sanchez, Manuel/E-4680-2010
OI Salmeron-Sanchez, Manuel/0000-0002-8112-2100; BALLESTER-BELTRAN,
   JOSE/0000-0002-3287-2925
FU ERC through HealInSynergy [306990]; FPU program [AP2009-3626]
FX The support from ERC through HealInSynergy (306990) and the FPU program
   AP2009-3626 are acknowledged.
CR [Anonymous], 2015, J VIS EXP
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Ballester-Beltran J, 2014, BIOMATER SCI-UK, V2, P381, DOI 10.1039/c3bm60248f
   Ballester-Beltran J., 2015, NANOMEDICINE
   Ballester-Beltran J, 2013, BIOTECHNOL BIOENG, V110, P3048, DOI 10.1002/bit.24972
   Ballester-Beltran J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0039-5
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Glass M, 2012, PATTERN RECOGN, V45, P3154, DOI 10.1016/j.patcog.2012.03.001
   Gobel U, 2012, BIOTECHNOL J, V7, P833, DOI 10.1002/biot.201200176
   Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Lee EJ, 2009, IEEE ENG MED BIO, P6034, DOI 10.1109/IEMBS.2009.5333169
   Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566
   Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124
   Schor SL, 2006, CELL MOTIL CYTOSKEL, V63, P287, DOI 10.1002/cm.20123
   WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 18
TC 1
Z9 1
U1 3
U2 6
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2015
IS 102
AR e53090
DI 10.3791/53090
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7NL
UT WOS:000361537100043
PM 26274867
OA Green Published
DA 2018-10-20
ER

PT J
AU Kaplan, J
   Grinstaff, M
AF Kaplan, Jonah
   Grinstaff, Mark
TI Fabricating Superhydrophobic Polymeric Materials for Biomedical
   Applications
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 102; Electrospinning; electrospraying;
   polycaprolactone; poly(lactide-co-glycolide); microfiber; nanofiber;
   microparticles; superhydrophobic; biomaterials; drug delivery;
   biodegradable; surface coatings
ID ELECTROSPUN POLYPHOSPHAZENE NANOFIBERS; TISSUE ENGINEERING SCAFFOLDS;
   IN-VITRO DEGRADATION; SMALL-DIAMETER; CONTROLLED-RELEASE; VASCULAR
   GRAFTS; SURFACE-TENSION; DRAG REDUCTION; DRUG-DELIVERY; PLUS WATER
AB Superhydrophobic materials, with surfaces possessing permanent or metastable non-wetted states, are of interest for a number of biomedical and industrial applications. Here we describe how electrospinning or electrospraying a polymer mixture containing a biodegradable, biocompatible aliphatic polyester (e.g., polycaprolactone and poly(lactide-co-glycolide)), as the major component, doped with a hydrophobic copolymer composed of the polyester and a stearate-modified poly(glycerol carbonate) affords a superhydrophobic biomaterial. The fabrication techniques of electrospinning or electrospraying provide the enhanced surface roughness and porosity on and within the fibers or the particles, respectively. The use of a low surface energy copolymer dopant that blends with the polyester and can be stably electrospun or electrosprayed affords these superhydrophobic materials. Important parameters such as fiber size, copolymer dopant composition and/or concentration, and their effects on wettability are discussed. This combination of polymer chemistry and process engineering affords a versatile approach to develop application-specific materials using scalable techniques, which are likely generalizable to a wider class of polymers for a variety of applications.
C1 [Kaplan, Jonah; Grinstaff, Mark] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Grinstaff, Mark] Boston Univ, Dept Chem, Boston, MA 02215 USA.
   [Grinstaff, Mark] Boston Univ, Dept Med, Boston, MA 02215 USA.
RP Grinstaff, M (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM mgrin@bu.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668
FU BU; NIH [R01CA149561]
FX Funding was provided in part by BU and the NIH R01CA149561. The authors
   wish to thank the electrospinning/electrospraying team including Stefan
   Yohe, Eric Falde, Joseph Hersey, and Julia Wang for their helpful
   discussions and contributions to the preparation and characterization of
   superhydrophobic biomaterials.
CR Azizian S, 2003, J CHEM ENG DATA, V48, P662, DOI 10.1021/je025639s
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Caracciolo PC, 2009, J MATER SCI-MATER M, V20, P2129, DOI 10.1007/s10856-009-3768-3
   Carampin P, 2007, J BIOMED MATER RES A, V80A, P661, DOI 10.1002/jbm.a.30999
   Correia DM, 2014, POLYM ENG SCI, V54, P1608, DOI 10.1002/pen.23704
   Crick CR, 2010, CHEM-EUR J, V16, P3568, DOI 10.1002/chem.200903335
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Deng D, 2013, ACS APPL MATER INTER, V5, P774, DOI 10.1021/am302338x
   Ebrahimi A, 2013, LAB CHIP, V13, P4248, DOI 10.1039/c3lc50517k
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Grafahrend D, 2008, J MATER SCI-MATER M, V19, P1479, DOI 10.1007/s10856-007-3299-8
   Greenberg James A, 2009, Rev Obstet Gynecol, V2, P146
   Gugerell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090676
   Guix M, 2012, ACS NANO, V6, P4445, DOI 10.1021/nn301175b
   HOKE BC, 1992, J CHEM ENG DATA, V37, P331, DOI 10.1021/je00007a016
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Inai R, 2005, J POLYM SCI POL PHYS, V43, P3205, DOI 10.1002/polb.20457
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jiang HL, 2007, MACROMOL BIOSCI, V7, P517, DOI 10.1002/mabi.200600277
   Jiang HL, 2006, J BIOMED MATER RES B, V79B, P50, DOI 10.1002/jbm.b.30510
   Ju GN, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.44
   Kaplan JA, 2014, BIOMACROMOLECULES, V15, P2548, DOI 10.1021/bm500410h
   Kenawy ER, 2007, MAT SCI ENG A-STRUCT, V459, P390, DOI 10.1016/j.msea.2007.01.039
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Khanam N, 2007, ACTA BIOMATER, V3, P1050, DOI 10.1016/j.actbio.2007.06.005
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kim YB, 2009, J APPL POLYM SCI, V114, P3870, DOI 10.1002/app.31091
   Ko T.-J., 2013, SOFT MATTER
   Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b
   Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815
   Leach M. K., 2011, J VIS EXP
   Lee JS, 2005, EUR J PHARM BIOPHARM, V59, P169, DOI 10.1016/j.ejpb.2004.06.006
   Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f
   Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnil171
   Lim HS, 2006, J AM CHEM SOC, V128, P14458, DOI 10.1021/ja0655901
   Lin YJ, 2010, J APPL POLYM SCI, V115, P3393, DOI 10.1002/app.30481
   Liu H, 2012, J APPL POLYM SCI, V125, pE468, DOI 10.1002/app.36757
   Lourenco B.N., 2012, BIOINTERPHASES, V7
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Macias-Montero M, 2012, LANGMUIR, V28, P15047, DOI 10.1021/la3028918
   Manna U, 2013, ADV MATER, V25, P6405, DOI 10.1002/adma.201302561
   Marmur A, 2006, BIOFOULING, V22, P107, DOI 10.1080/08927010600562328
   Mun CH, 2012, TISSUE ENG PT A, V18, P1608, DOI [10.1089/ten.tea.2011.0695, 10.1089/ten.TEA.2011.0695]
   Nagiah N, 2012, ADV ENG MATER, V14, pB138, DOI 10.1002/adem.201180041
   Nair PA, 2013, J BIOMED MATER RES A, V101, P1876, DOI 10.1002/jbm.a.34490
   Nayak BK, 2013, APPL SURF SCI, V266, P27, DOI 10.1016/j.apsusc.2012.11.052
   Niu HT, 2014, RSC ADV, V4, P11782, DOI 10.1039/c4ra00232f
   Norton FJ, 1945, US Patent, Patent No. 2386259
   Oh JH, 2012, CURR APPL PHYS, V12, pS144, DOI 10.1016/j.cap.2012.02.047
   Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030
   Ou J, 2004, PHYS FLUIDS, V16, P4635, DOI 10.1063/1.1812011
   Pant HR, 2013, APPL SURF SCI, V285, P538, DOI 10.1016/j.apsusc.2013.08.089
   Pant HR, 2013, POLYM INT, V62, P1008, DOI 10.1002/pi.4380
   Panthi G, 2013, FIBER POLYM, V14, P718, DOI 10.1007/s12221-013-0718-y
   Paun IA, 2012, APPL SURF SCI, V258, P9302, DOI 10.1016/j.apsusc.2011.10.044
   Peesan M, 2006, J BIOMAT SCI-POLYM E, V17, P547, DOI 10.1163/156856206776986251
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Ray WC, 2003, MACROMOLECULES, V36, P3557, DOI 10.1021/ma025872v
   Reneker DH, 2007, ADV APPL MECH, V41, P43, DOI 10.1016/S0065-2156(07)41002-X
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Sakai Shinji, 2006, Biotechnology Journal, V1, P958, DOI 10.1002/biot.200600054
   Sas I, 2012, J POLYM SCI POL PHYS, V50, P824, DOI 10.1002/polb.23070
   Schmitt E. E., 1967, U. S. Patent, Patent No. [3,297,033, 3297033]
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Srinivasan S, 2013, SOFT MATTER, V9, P5691, DOI 10.1039/c3sm50445j
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tong HW, 2011, POLYM ENG SCI, V51, P1325, DOI 10.1002/pen.21937
   Uykun N, 2014, J BIOACT COMPAT POL, V29, P382, DOI 10.1177/0883911514535153
   VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016
   Verplanck N, 2007, NANOSCALE RES LETT, V2, P577, DOI 10.1007/s11671-007-9102-4
   Wang SG, 2012, COLLOID SURFACE B, V89, P254, DOI 10.1016/j.colsurfb.2011.09.029
   Weldon CB, 2012, J CONTROL RELEASE, V161, P903, DOI 10.1016/j.jconrel.2012.05.021
   Welle A, 2007, BIOMATERIALS, V28, P2211, DOI 10.1016/j.biomaterials.2007.01.024
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
   Wolinsky J. B., 2012, BIOMACROMOLECULES, V13
   Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v
   Wright J., 2012, ADV DELIVERY SCI TEC, P11, DOI DOI 10.1007/978-1-4614-0554-2-2
   Wu YW, 2014, NANOSCALE, V6, P9720, DOI 10.1039/c4nr02198c
   Xie JW, 2008, J BIOMED MATER RES A, V85A, P897, DOI 10.1002/jbm.a.31499
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu XM, 2010, BIOMACROMOLECULES, V11, P2283, DOI 10.1021/bm1003509
   Xue CH, 2014, ACS APPL MATER INTER, V6, P10153, DOI 10.1021/am501371b
   Yamaguchi T, 2008, J SOL-GEL SCI TECHN, V48, P350, DOI 10.1007/s10971-008-1822-0
   Yohe ST, 2013, ADV FUNCT MATER, V23, P3628, DOI 10.1002/adfm.201203111
   Yohe ST, 2013, ADV HEALTHC MATER, V2, P1204, DOI 10.1002/adhm.201200381
   Yohe ST, 2013, CHEM COMMUN, V49, P804, DOI 10.1039/c2cc38012a
   Yohe ST, 2012, J CONTROL RELEASE, V162, P92, DOI 10.1016/j.jconrel.2012.05.047
   Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a
   You Y, 2005, J APPL POLYM SCI, V95, P193, DOI 10.1002/app.21116
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang J, 2006, ARTIF ORGANS, V30, P898, DOI 10.1111/j.1525-1594.2006.00322.x
   Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
NR 102
TC 0
Z9 0
U1 5
U2 71
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2015
IS 102
AR e53117
DI 10.3791/53117
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7NL
UT WOS:000361537100046
PM 26383018
OA Green Published
DA 2018-10-20
ER

PT J
AU Nitipir, C
   Albu, MG
   Voicu, G
   Ficai, A
   Barbu, MA
   Popa, LG
   Mirea, D
   Lazar, S
   Levai, C
   Ghica, MV
AF Nitipir, Cornelia
   Albu, Madalina Georgiana
   Voicu, Georgeta
   Ficai, Anton
   Barbu, Maria Alexandra
   Popa, Liliana Gabriela
   Mirea, Daniel
   Lazar, Stefan
   Levai, Codrina
   Ghica, Mihaela Violeta
TI Collagen - vinblastine Delivery Systems as a New Treatment for Kaposi's
   Sarcoma
SO REVISTA DE CHIMIE
LA English
DT Article
DE collagen; genipin; vinblastine; drug delivery systems
AB Collagen-vinblastine composites have been prepared by crosslinking with genipin and glutaraldehyde followed by freeze-drying in order to obtain drug delivery systems in spongious form. The resulting composites have been characterized with respect to their swelling capacity, FT-IR spectroscopy, scanning electron microscopy and vinblastine release. It was observed that the composites absorbed a high amount of water depending on the degree of crosslinking and the amount of vinblastine. They have porous structures as SEM images showed and the native collagen structure was kept for all composites. The release of vinblastine was between 67.72% and 84.91%. In the first hour of experiment, vinblastine is released faster inducing the remission of tumor cells, while during the next four hours the drug is released more slowly and gradually to maintain an appropriate concentration for remission consolidation and tumor healing. In conclusion, the obtained drug delivery systems based on collagen and vinblastine are a promising biomaterial for treatment of Kaposi's sarcoma.
C1 [Nitipir, Cornelia; Popa, Liliana Gabriela; Lazar, Stefan] Univ Med & Pharm Carol Davila, Fac Med, Bucharest 050474, Romania.
   [Nitipir, Cornelia; Barbu, Maria Alexandra; Popa, Liliana Gabriela; Mirea, Daniel] Elias Emergency Univ Hosp, Bucharest 011461, Romania.
   [Albu, Madalina Georgiana] INCDTP Leather & Footwear Res Inst, Bucharest 031215, Romania.
   [Voicu, Georgeta; Ficai, Anton] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
   [Lazar, Stefan] Infect & Trop Dis Hosp Dr Victor Babes, Bucharest 030303, Romania.
   [Levai, Codrina] Victor Babes Univ Med & Pharm, Timisoara 300041, Romania.
   [Ghica, Mihaela Violeta] Univ Med & Pharm Carol Davila, Fac Pharm, Bucharest 020956, Romania.
RP Albu, MG (reprint author), INCDTP Leather & Footwear Res Inst, 93 Ion Minulescu Str, Bucharest 031215, Romania.
EM albu_mada@yahoo.com; codrinalevai@umft.ro
OI FICAI, Anton/0000-0002-1777-0525; Nitipir, Cornelia/0000-0002-5985-3759;
   Albu, Madalina Georgiana/0000-0001-9960-2244; Voicu,
   Georgeta/0000-0001-7155-7138
CR ALBU M.G., 2011, BIOMATERIALS APPL NA
   Albu M.G., 2011, COLLAGEN GELS MATRIC
   Albu MG, 2015, FARMACIA, V63, P20
   Albu MG, 2009, REV CHIM-BUCHAREST, V60, P666
   Cassidy J, 2010, OXFORD HDB ONCOLOGY
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   FLAITZ CM, 1995, ORAL ONCOL, V31B, P280
   Ghica MV, 2013, PHARMAZIE, V68, P340, DOI 10.1691/ph.2013.2101
   Ghica MV, 2012, REV CHIM-BUCHAREST, V63, P929
   de Arriba AG, 2007, ACTAS DERMO-SIFILOGR, V98, P50
   GULLATE M.M., 2014, CLIN GUIDE ANTINEOPL
   Jridi M, 2015, INT J BIOL MACROMOL, V77, P369, DOI 10.1016/j.ijbiomac.2015.03.020
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lungu A, 2011, DIG J NANOMATER BIOS, V6, P1897
   McCormick SU, 1996, J ORAL MAXIL SURG, V54, P583, DOI 10.1016/S0278-2391(96)90637-0
   Sato H, 1996, PHARMACEUT RES, V13, P1565, DOI 10.1023/A:1016096016642
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Trookman NS, 2011, J AM ACAD DERMATOL, V64, pS16, DOI 10.1016/j.jaad.2010.11.008
NR 18
TC 11
Z9 11
U1 3
U2 11
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD AUG
PY 2015
VL 66
IS 8
BP 1169
EP 1172
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CR1ZQ
UT WOS:000361124600019
DA 2018-10-20
ER

PT J
AU Chang, Q
   Li, L
   Yang, DL
   Zhang, MY
   Minh-Tan, TT
   Hu, W
   Lu, S
AF Chang Qing
   Li Li
   Yang Dalei
   Zhang Mingyao
   Minh-Tan, Ton-That
   Hu Wei
   Lue Shuai
TI Synthesis and Characterization of Poly(omega-pentadecalactone) for Its
   Industrial-scale Production
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Article
DE Poly(omega-pentadecalactone); Polymerization; Characterization
ID RING-OPENING POLYMERIZATION; OMEGA-PENTADECALACTONE; CRYSTALLIZATION
   KINETICS; CATALYZED SYNTHESIS; CRYSTAL-STRUCTURE; MOLECULAR-WEIGHT;
   MACROLACTONES; POLYPENTADECANOLACTONE; MORPHOLOGY; POLYESTERS
AB The synthesis of biomaterial poly(omega-pentadecalactone)(PPDL) with yttrium isopropoxide as initiator in bulk was explored for its industrial-scale production. The weight-average molecular weight((M) over bar (w) ) of PPDL could be controlled by the molar ratio of monomer to initiator(M/I), polymerization temperature(T-p) and period(t(p)). The synthesis conditions were optimized, and a high (M) over bar (w) of 9.2x10(4) of PPDL could be obtained by the reaction at an M/I molar ratio of 1000/1 and 100 degrees C for only 30 min, which presented tough properties with a tensile strength of about 20 MPa and an elongation at break of about 300%. This mechanical property was comparable to that of high density polyethylene(HDPE). The melting point was about 96 degrees C, and 5% of mass loss temperature(T-5%) was as high as 340 degrees C. Thus, the PPDL with good mechanical properties and high thermal stability can be synthesized without solvent at low expenses.
C1 [Chang Qing; Yang Dalei; Zhang Mingyao; Hu Wei; Lue Shuai] Changchun Univ Technol, Inst Chem Engn, Changchun 130012, Peoples R China.
   [Li Li] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.
   [Minh-Tan, Ton-That] Natl Res Council Canada, Boucherville, PQ J4B 6Y4, Canada.
RP Hu, W (reprint author), Changchun Univ Technol, Inst Chem Engn, Changchun 130012, Peoples R China.
EM huwei@ccut.edu.cn
FU National Natural Science Foundation of China [21404013]; Science and
   Technology Development Plan of Jilin Province, China [20140204039GX];
   Changchun Science and Technology Plan Project, China [14KG105]; College
   Students' Innovation and Entrepreneurship Training Plan of Higher School
   in Jilin Province, China [201410190034]; Research Project of Science and
   Technology of the Education Department of Jilin Province During the 12th
   Five-year Plan Period, China [2015-78]
FX Supported by the National Natural Science Foundation of China(No.
   21404013), the Science and Technology Development Plan of Jilin
   Province, China(No. 20140204039GX), the Changchun Science and Technology
   Plan Project, China(No. 14KG105), the College Students' Innovation and
   Entrepreneurship Training Plan of Higher School in Jilin Province, China
   (No. 201410190034) and the Research Project of Science and Technology of
   the Education Department of Jilin Province During the 12th Five-year
   Plan Period, China(No. 2015-78).
CR Bisht KS, 1997, MACROMOLECULES, V30, P2705, DOI 10.1021/ma961869y
   Bouyahyi M, 2014, MACROMOLECULES, V47, P517, DOI 10.1021/ma402072t
   Cai JL, 2010, POLYMER, V51, P1088, DOI 10.1016/j.polymer.2010.01.007
   Cai JL, 2009, POLYM INT, V58, P944, DOI 10.1002/pi.2624
   Duda A, 2002, MACROMOLECULES, V35, P4266, DOI 10.1021/ma012207y
   Focarete ML, 2001, J POLYM SCI POL PHYS, V39, P1721
   Gazzano M, 2003, J POLYM SCI POL PHYS, V41, P1009, DOI 10.1002/polb.10419
   Hunsen M, 2008, BIOMACROMOLECULES, V9, P518, DOI 10.1021/bm701269p
   Jasinska-Walc L, 2015, MACROMOLECULES, V48, P502, DOI 10.1021/ma502262e
   Jedlinski Z, 1996, MACROMOL CHEM PHYSIC, V197, P2923, DOI 10.1002/macp.1996.021970925
   Kim E, 2005, MACROMOL BIOSCI, V5, P734, DOI 10.1002/mabi.200500038
   Kobayashi S, 2009, MACROMOL RAPID COMM, V30, P237, DOI 10.1002/marc.200800690
   NOMURA R, 1994, MACROMOLECULES, V27, P620, DOI 10.1021/ma00080a046
   Pascual A, 2013, EUR POLYM J, V49, P1601, DOI 10.1016/j.eurpolymj.2013.02.009
   Skoglund P, 1998, POLYMER, V39, P1899, DOI 10.1016/S0032-3861(97)00473-4
   Skoglund P, 1998, POLYMER, V39, P3143, DOI 10.1016/S0032-3861(97)10023-4
   Wilson JA, 2015, MACROMOLECULES, V48, P950, DOI 10.1021/ma5022049
   Yu Y, 2012, PROCESS BIOCHEM, V47, P1027, DOI 10.1016/j.procbio.2012.04.006
   Zhong ZY, 2000, MACROMOL CHEM PHYSIC, V201, P1329, DOI 10.1002/1521-3935(20000801)201:12<1329::AID-MACP1329>3.0.CO;2-8
NR 19
TC 0
Z9 0
U1 2
U2 20
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 1005-9040
EI 2210-3171
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD AUG
PY 2015
VL 31
IS 4
BP 640
EP 644
DI 10.1007/s40242-015-5092-4
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA CR1FZ
UT WOS:000361071600027
DA 2018-10-20
ER

PT J
AU Firempong, CK
   Zhang, HY
   Zhang, JJ
   Wang, Y
   Cao, X
   Omari-Siaw, E
   Tong, SS
   Yu, JN
   Xu, XM
AF Firempong, Caleb Kesse
   Zhang, Hui-Yun
   Zhang, Jia-Jia
   Wang, Yan
   Cao, Xia
   Omari-Siaw, Emmmanuel
   Tong, Shan-Shan
   Yu, Jiangnan
   Xu, Ximing
TI Lipid raft biomaterial as a mass screening affinity tool for rapid
   identification of potential antitumor Chinese herbal medicine
SO EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE
LA English
DT Article
DE Affinity system; Antitumor; Lipid raft; Mass screening; Natural products
ID ENHANCED ORAL BIOAVAILABILITY; FLAMMULINA-VELUTIPES STEROLS; TYROSINE
   KINASE INHIBITOR; PHASE-I TRIAL; STATIONARY-PHASE; CHROMATOGRAPHIC
   CHARACTERISTICS; SILICA SURFACE; CELLS; CANCER; DISCOVERY
AB Introduction: The quest for novel cancer drugs is one of the most significant studies in natural products, and Chinese herbs with its promising antitumor properties cannot be exempted from this chemotherapeutic bracket. This study was therefore aimed at piloting the use of receptor-rich lipid raft biomaterial as a mass screening tool for rapid isolation of effective antitumor components from some Chinese herbs used in the treatment of diseases consistent with cancer symptoms.
   Method: Aqueous crude extracts from 10 different Chinese herbs (Paeonia suffruticosa, Vaccaria segetalis, Terminalia chebula, Trichosanthes kirilowii, Arisaema erubescens, Morus australis, Centella asiatica, Rhematoxylon campechianum, Trachelospermum jasminoides and Taraxacum officinale) were screened using lipid raft silica beads. The identified bioactive products were separated into various fractions (petroleum ether, ethyl acetate, n-butanol and raffinate extracts) with another affinity screening analysis. Conventional MTT bioassay was employed to authenticate the susceptibility of liver cancer cells to the final bioactive isolates.
   Results: The results showed that only Vaccaria segetalis and Arisaema erubescens significantly interacted with the system. The MTT bioassay further confirmed the cytotoxicity of these plants and the data correlated very well with its reported cancer-related activities.
   Conclusion: These findings support the reliable application of the lipid raft biomaterial as a prospective mass screening technique for antitumor natural products. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Firempong, Caleb Kesse; Zhang, Hui-Yun; Zhang, Jia-Jia; Wang, Yan; Cao, Xia; Omari-Siaw, Emmmanuel; Tong, Shan-Shan; Yu, Jiangnan; Xu, Ximing] Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, Zhenjiang 212013, Peoples R China.
   [Yu, Jiangnan] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China.
RP Xu, XM (reprint author), 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
EM calebuse@yahoo.com; 472998291@qq.com; 934193740@qq.com;
   1185546956@qq.com; 841661898@qq.com; omarisiaw@gmail.com;
   877274194@qq.com; yjn@ujs.edu.cn; xmxu@ujs.edu.cn
FU National Natural Science Foundation of China [30973677, 81373371];
   Ministry of Education of China [20113227110012/2014M560410]; Ministry of
   Education of Jiangsu Province [1401023B]; Priority Academic Program
   Development of Jiangsu University [13JDG007];
   Industry-University-Research Institution Cooperation in Jiangsu province
   [GY2012049, GY2013055]; Industry-University-Research Institution
   Cooperation in Zhenjiang [GY2012049, GY2013055]
FX This work was supported by the National Natural Science Foundation of
   China (Grant 30973677, 81373371), the Doctoral Fund of Ministry of
   Education of China (Grant 20113227110012/2014M560410), Doctoral Fund of
   Ministry of Education of Jiangsu Province ((1401023B), Priority Academic
   Program Development of Jiangsu University (13JDG007) and the
   Industry-University-Research Institution Cooperation (Grants GY2012049
   and GY2013055) in Jiangsu province and Zhenjiang.
CR Astafieva AA, 2012, PEPTIDES, V36, P266, DOI 10.1016/j.peptides.2012.05.009
   Bag Anwesa, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P244, DOI 10.1016/S2221-1691(13)60059-3
   Balsevich JJ, 2012, FITOTERAPIA, V83, P170, DOI 10.1016/j.fitote.2011.10.010
   Beigi F, 1999, J CHROMATOGR A, V852, P313, DOI 10.1016/S0021-9673(99)00025-4
   Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815
   Chan E, 2008, INVEST NEW DRUG, V26, P241, DOI 10.1007/s10637-008-9118-3
   Commission CP, 2005, CHINESE PHARMACOPOEI, p[328, 547]
   Feng L, 2012, ASIAN BIOMED, V6, P683, DOI 10.5372/1905-7415.0605.108
   Firempong CK, 2015, RSC ADV, V5, P49330, DOI 10.1039/c5ra08322b
   Habicht KL, 2013, J PHARMACEUT BIOMED, V72, P159, DOI 10.1016/j.jpba.2012.10.001
   Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172
   He LC, 1999, CHINESE SCI BULL, V44, P826, DOI 10.1007/BF02885029
   He LC, 2001, CHROMATOGRAPHIA, V54, P71, DOI 10.1007/BF02491836
   Hou XF, 2009, J CHROMATOGR A, V1216, P7081, DOI 10.1016/j.chroma.2009.08.062
   Huang X, 2004, J CHROMATOGR B, V812, P71
   Idrus RBH, 2012, J ETHNOPHARMACOL, V140, P333, DOI 10.1016/j.jep.2012.01.023
   Kandil FE, 1996, PHYTOCHEMISTRY, V42, P1243, DOI 10.1016/0031-9422(95)00924-8
   Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959
   Ling CQ, 2014, J INTEGR MED-JIM, V12, P331, DOI 10.1016/S2095-4964(14)60038-8
   Marshall JL, 2005, INVEST NEW DRUG, V23, P31, DOI 10.1023/B:DRUG.0000047103.64335.b0
   Moaddel R, 2010, J PHARMACEUT BIOMED, V52, P416, DOI 10.1016/j.jpba.2009.06.035
   Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1
   NOCTOR TAG, 1992, J CHROMATOGR-BIOMED, V577, P305, DOI 10.1016/0378-4347(92)80252-L
   Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002
   Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141
   Sheu MJ, 2009, J ETHNOPHARMACOL, V126, P332, DOI 10.1016/j.jep.2009.08.019
   Su XY, 2007, J CHROMATOGR A, V1154, P132, DOI 10.1016/j.chroma.2007.03.050
   Takahashi N, 2009, INT IMMUNOPHARMACOL, V9, P508, DOI 10.1016/j.intimp.2009.01.006
   Tong S, 2014, BIOMED CHROMATOGR
   Tong SS, 2014, CHROMATOGRAPHIA, V77, P419, DOI 10.1007/s10337-014-2623-y
   Undevia SD, 2004, INVEST NEW DRUG, V22, P449, DOI 10.1023/B:DRUG.0000036687.26604.8c
   Vuignier K, 2013, J PHARMACEUT BIOMED, V74, P205, DOI 10.1016/j.jpba.2012.10.030
   Yi CX, 2013, J AGR FOOD CHEM, V61, P5961, DOI 10.1021/jf3055278
   Yi CX, 2013, INT J PHARMACEUT, V448, P44, DOI 10.1016/j.ijpharm.2013.03.020
   Yi CX, 2012, INT J NANOMED, V7, P5067, DOI 10.2147/IJN.S34612
   Zhang C, 2012, J CHROMATOGR A, V1233, P78, DOI 10.1016/j.chroma.2012.02.013
   Zhang MH, 2014, J ETHNOPHARMACOL, V151, P591, DOI 10.1016/j.jep.2013.11.015
   Zhang YH, 2014, J INTEGR MED-JIM, V12, P483, DOI 10.1016/S2095-4964(14)60057-1
NR 38
TC 1
Z9 1
U1 2
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1876-3820
EI 1876-3839
J9 EUR J INTEGR MED
JI Eur. J. Integr. Med.
PD AUG
PY 2015
VL 7
IS 4
BP 365
EP 371
DI 10.1016/j.eujim.2015.07.026
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CR0KQ
UT WOS:000361007800008
DA 2018-10-20
ER

PT J
AU Della Bona, A
   Pecho, OE
   Alessandretti, R
AF Della Bona, Alvaro
   Pecho, Oscar E.
   Alessandretti, Rodrigo
TI Zirconia as a Dental Biomaterial
SO MATERIALS
LA English
DT Review
DE biomaterials; zirconia; bonding
ID SHEAR BOND STRENGTH; FIXED PARTIAL DENTURES; ALL-CERAMIC RESTORATIONS;
   RESIN CEMENT; Y-TZP; SURFACE-TREATMENT; FLEXURAL STRENGTH; LUTING
   CEMENTS; ADHESIVE RESIN; STABILIZED ZIRCONIA
AB Ceramics are very important in the science of dental biomaterials. Among all dental ceramics, zirconia is in evidence as a dental biomaterial and it is the material of choice in contemporary restorative dentistry. Zirconia has been applied as structural material for dental bridges, crowns, inserts, and implants, mostly because of its biocompatibility, high fracture toughness, and radiopacity. However, the clinical success of restorative dentistry has to consider the adhesion to different substrates, which has offered a great challenge to dental zirconia research and development. This study characterizes zirconia as a dental biomaterial, presenting the current consensus and challenges to its dental applications.
C1 [Della Bona, Alvaro; Pecho, Oscar E.; Alessandretti, Rodrigo] Univ Passo Fundo, Sch Dent, Postgrad Program Dent, BR-99052900 Passo Fundo, RS, Brazil.
RP Della Bona, A (reprint author), Univ Passo Fundo, Sch Dent, Postgrad Program Dent, Campus 1,BR285, BR-99052900 Passo Fundo, RS, Brazil.
EM dbona@upf.br; opey@correo.ugr.es; rodrigo.alle@yahoo.com.br
RI Pecho, Oscar/N-3831-2018
OI Pecho, Oscar/0000-0001-7314-5049; Della Bona, Alvaro/0000-0002-8312-7503
FU CNPq do Brasil [304995/2013-4]; PNPD from CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) do Brasil [42009014007P4];
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)
   [396-2551/14-1]
FX This study was partially supported by CNPq do Brasil grant #
   304995/2013-4, PNPD 42009014007P4 from CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior) do Brasil, and
   396-2551/14-1 from FAPERGS (Fundacao de Amparo a Pesquisa do Estado do
   Rio Grande do Sul) scholarships.
CR Abduo J, 2010, J ORAL REHABIL, V37, P866, DOI 10.1111/j.1365-2842.2010.02113.x
   Abi-Rached FO, 2015, OPER DENT, V40, pE66, DOI 10.2341/14-013-LR1
   Aboushelib MN, 2005, DENT MATER, V21, P984, DOI 10.1016/j.dental.2005.03.013
   Aboushelib Moustafa N, 2008, J Prosthodont, V17, P9
   Aboushelib MN, 2008, J BIOMED MATER RES B, V87B, P139, DOI 10.1002/jbm.b.31083
   Aboushelib MN, 2008, DENT MATER, V24, P1268, DOI 10.1016/j.dental.2008.02.010
   Aboushelib MN, 2008, INT J PROSTHODONT, V21, P237
   Aboushelib MN, 2009, DENT MATER, V25, P989, DOI 10.1016/j.dental.2009.02.011
   Aboushelib Moustafa N, 2008, J Prosthodont, V17, P401, DOI 10.1111/j.1532-849X.2008.00306.x
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   [Anonymous], 2010, 68722010 ISO
   Atsu SS, 2006, J PROSTHET DENT, V95, P430, DOI 10.1016/j.prosdent.2006.03.016
   Attia A, 2011, DENT MATER, V27, P207, DOI 10.1016/j.dental.2010.10.004
   Batson ER, 2014, J PROSTHET DENT, V112, P770, DOI 10.1016/j.prosdent.2014.05.002
   Bavbek NC, 2014, J ADHES DENT, V16, P473, DOI 10.3290/j.jad.a32812
   BECHER PF, 1992, J AM CERAM SOC, V75, P493, DOI 10.1111/j.1151-2916.1992.tb07832.x
   Benetti P, 2010, DENT MATER, V26, P743, DOI 10.1016/j.dental.2010.03.019
   Blatz MB, 2007, QUINTESSENCE INT, V38, P745
   Blatz MB, 2004, J PROSTHET DENT, V91, P356, DOI 10.1016/j.prosdent.2004.02.001
   Boitelle P, 2014, J ORAL REHABIL, V41, P853, DOI 10.1111/joor.12205
   Bona AD, 2004, DENT MATER, V20, P956, DOI 10.1016/j.dental.2004.02.004
   Bona AD, 2007, DENT MATER, V23, P769, DOI 10.1016/j.dental.2006.06.043
   Borba M, 2011, DENT MATER, V27, P1259, DOI 10.1016/j.dental.2011.09.008
   Borba M, 2011, DENT MATER, V27, P710, DOI 10.1016/j.dental.2011.04.003
   Boscato N, 2007, AM J DENT, V20, P103
   Oyagu RC, 2009, DENT MATER, V25, P392, DOI 10.1016/j.dental.2008.09.002
   Cavalcanti AN, 2009, OPER DENT, V34, P280, DOI 10.2341/08-80
   Queiroz JRC, 2012, DENT MATER, V28, P763, DOI 10.1016/j.dental.2012.03.014
   Chen L, 2013, J PROSTHET DENT, V110, P402, DOI 10.1016/j.prosdent.2013.04.005
   Christensen RP, 2010, J AM DENT ASSOC, V141, P1317, DOI 10.14219/jada.archive.2010.0076
   Coli P, 2004, INT J PROSTHODONT, V17, P577
   Corazza PH, 2015, AM J DENT, V28, P95
   da Silva EM, 2014, J PROSTHET DENT, V112, P568, DOI 10.1016/j.prosdent.2013.12.003
   de Castro HL, 2012, DENT MATER, V28, P91, DOI 10.1016/j.dental.2012.09.003
   de Kler M, 2007, J ORAL REHABIL, V34, P841, DOI 10.1111/j.1365-2842.2006.01675.x
   Della Bona A, 2006, J DENT RES, V85, P1037
   Della Bona A, 2004, DENT MATER, V20, P338, DOI 10.1016/S0109-5641(03)00126-X
   Della Bona A, 2003, DENT MATER, V19, P693, DOI 10.1016/S0109-5641(03)00015-0
   Della Bona A, 2002, INT J PROSTHODONT, V15, P248
   Della Bona A, 2000, J Adhes Dent, V2, P305
   Della Bona A, 2002, INT J PROSTHODONT, V15, P159
   Della Bona A., 2014, CURR ORAL HLTH REP, V1, P232, DOI [10.1007/s40496-014-0030-y, DOI 10.1007/S40496-014-0030-Y]
   Della Bona A, 2009, BONDING CERAMICS SCI
   Della Bona A, 2008, J AM DENT ASSOC, V139, p8S
   Della Bona Alvaro, 2010, J Evid Based Dent Pract, V10, P35, DOI 10.1016/j.jebdp.2009.11.014
   Bona Alvaro Della, 2007, Braz. oral res., V21, P10, DOI 10.1590/S1806-83242007000100002
   Della Bona A, 2009, J ADHES SCI TECHNOL, V23, P1163, DOI 10.1163/156856109X440146
   DELLABONA A, 1995, J DENT RES, V74, P1591, DOI 10.1177/00220345950740091401
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Derand T, 2005, DENT MATER, V21, P1158, DOI 10.1016/j.dental.2005.02.005
   de Souza GMD, 2011, J PROSTHET DENT, V105, P296, DOI 10.1016/S0022-3913(11)60055-3
   Druck CC, 2015, J BIOMED MATER RES B, V103, P143, DOI 10.1002/jbm.b.33184
   Fischer J, 2009, DENT MATER, V25, P419, DOI 10.1016/j.dental.2008.09.003
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guess PC, 2009, INT J ESTHET DENT, V4, P262
   Heikkinen TT, 2009, J ADHES SCI TECHNOL, V23, P1043, DOI 10.1163/156856109X440155
   Hjerppe J, 2008, ACTA ODONTOL SCAND, V66, P262, DOI 10.1080/00016350802247123
   Janda R, 2003, DENT MATER, V19, P567, DOI 10.1016/S0109-5641(02)00106-9
   Jevnikar P, 2010, DENT MATER, V26, P688, DOI 10.1016/j.dental.2010.03.013
   Karimipour-Saryazdi M, 2014, J PROSTHET DENT, V111, P395, DOI 10.1016/j.prosdent.2013.09.034
   Kawai Y, 2010, NANO BIOMED, V2, P31
   Kelly J.R., 2004, DENT CLIN N AM, V48, P513, DOI DOI 10.1016/J.CDEN.2004.01.003
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kelly JR, 2012, DENT MATER, V28, P41, DOI 10.1016/j.dental.2011.09.001
   Kern M, 2015, DENT MATER, V31, P8, DOI 10.1016/j.dental.2014.06.007
   Kim GH, 2015, J PROSTHET DENT, V113, P603, DOI 10.1016/j.prosdent.2014.12.013
   Kim JH, 2015, OPER DENT, V40, P55, DOI 10.2341/13-303-L
   Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kumbuloglu O, 2006, OPER DENT, V31, P248, DOI 10.2341/05-22
   Liu D, 2012, J ADHES SCI TECHNOL, V26, P1249, DOI 10.1163/156856111X593586
   Liu YH, 2010, J EUR CERAM SOC, V30, P1297, DOI 10.1016/j.jeurceramsoc.2009.11.019
   Lung CYK, 2015, MAT SCI ENG C-MATER, V46, P103, DOI 10.1016/j.msec.2014.10.029
   Lung CYK, 2012, DENT MATER, V28, P863, DOI 10.1016/j.dental.2012.04.023
   Lung CYK, 2012, DENT MATER, V28, P467, DOI 10.1016/j.dental.2012.02.009
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Luthy H, 2006, DENT MATER, V22, P195, DOI 10.1016/j.dental.2005.04.016
   Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005
   Matinlinna JP, 2011, DENT MATER, V27, P273, DOI 10.1016/j.dental.2010.11.002
   Nakamura T, 2009, J PROSTHODONT RES, V53, P116, DOI 10.1016/j.jpor.2009.02.007
   Oba Y, 2014, DENT MATER J, V33, P226, DOI 10.4012/dmj.2013-346
   Oliveira-Ogliari A, 2015, DENT MATER, V31, P68, DOI 10.1016/j.dental.2014.11.011
   Pereira LD, 2015, J ADHES DENT, V17, P169, DOI 10.3290/j.jad.a33974
   Piascik JR, 2009, DENT MATER, V25, P1116, DOI 10.1016/j.dental.2009.03.008
   Piascik JR, 2012, DENT MATER, V28, P604, DOI 10.1016/j.dental.2012.01.008
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piwowarczyk A, 2005, OPER DENT, V30, P382
   Qeblawi DM, 2015, J PROSTHET DENT, V113, P122, DOI 10.1016/j.prosdent.2014.08.006
   Qeblawi DM, 2010, J PROSTHET DENT, V103, P210, DOI 10.1016/S0022-3913(10)60033-9
   Quinn GD, 2007, FRACTOGRAPHY CERAMIC
   Rekow ED, 2006, DENT MATER, V22, P125, DOI 10.1016/j.dental.2005.04.010
   Renda JJ, 2015, J PROSTHODONT, V24, P188, DOI 10.1111/jopr.12246
   Sailer I, 2007, INT J PROSTHODONT, V20, P383
   Sailer I, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2007.01468.x
   Sailer I, 2009, INT J PROSTHODONT, V22, P553
   Saito A, 2010, J PROSTHET DENT, V104, P247, DOI 10.1016/S0022-3913(10)60133-3
   Sanli S, 2015, DENT MATER, V31, P657, DOI 10.1016/j.dental.2015.03.004
   Sciasci P, 2015, J PROSTHET DENT, V113, P212, DOI 10.1016/j.prosdent.2014.09.012
   Sun T, 2014, J MECH BEHAV BIOMED, V35, P93, DOI 10.1016/j.jmbbm.2014.03.014
   Swain MV, 2009, ACTA BIOMATER, V5, P1668, DOI 10.1016/j.actbio.2008.12.016
   Taskonak B, 2005, BIOMATERIALS, V26, P3235, DOI 10.1016/j.biomaterials.2004.08.025
   Taskonak B, 2008, DENT MATER, V24, P1149, DOI 10.1016/j.dental.2008.01.004
   Tinschert J, 2008, INT J PROSTHODONT, V21, P217
   VANNOORT R, 1989, J DENT, V17, P61, DOI 10.1016/0300-5712(89)90131-0
   Von Steyern PV, 2005, J ORAL REHABIL, V32, P180, DOI 10.1111/j.1365-2842.2004.01437.x
   Wolfart M, 2007, DENT MATER, V23, P45, DOI 10.1016/j.dental.2005.11.040
   Yang B, 2008, DENT MATER, V24, P508, DOI 10.1016/j.dental.2007.04.013
   Yi YA, 2015, OPER DENT, V40, P63, DOI 10.2341/13-149-L
NR 111
TC 11
Z9 11
U1 6
U2 69
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD AUG
PY 2015
VL 8
IS 8
BP 4978
EP 4991
DI 10.3390/ma8084978
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA CQ5KX
UT WOS:000360643900025
PM 28793485
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Venkatesan, J
   Lowe, B
   Manivasagan, P
   Kang, KH
   Chalisserry, EP
   Anil, S
   Kim, DG
   Kim, SK
AF Venkatesan, Jayachandran
   Lowe, Baboucarr
   Manivasagan, Panchanathan
   Kang, Kyong-Hwa
   Chalisserry, Elna P.
   Anil, Sukumaran
   Kim, Dong Gyu
   Kim, Se-Kwon
TI Isolation and Characterization of Nano-Hydroxyapatite from Salmon Fish
   Bone
SO MATERIALS
LA English
DT Article
DE hydroxyapatite; salmon; fish; alkaline hydrolysis
ID NATURAL HYDROXYAPATITE; NANOCRYSTALLINE HYDROXYAPATITE; COLLAGEN
   SCAFFOLDS; BOVINE BONE; TISSUE; NANOPARTICLES; WASTE; APATITE;
   EXTRACTION; TEMPERATURE
AB Nano-Hydroxyapatite (nHA) was isolated from salmon bone by alkaline hydrolysis. The resulting nHA was characterized using several analytical tools, including thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction analysis (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM), to determine the purity of the nHA sample. The removal of organic matter from the raw fish was confirmed by TGA. FT-IR confirmed the presence of a carbonated group and the similarities to synthetic Sigma HA. XRD revealed that the isolated nHA was amorphous. Microscopy demonstrated that the isolated nHA possessed a nanostructure with a size range of 6-37 nm. The obtained nHA interacted with mesenchymal stem cells (MSCs) and was non-toxic. Increased mineralization was observed for nHA treated MSCs compared to the control group. These results suggest that nHA derived from salmon is a promising biomaterial in the field of bone tissue engineering.
C1 [Venkatesan, Jayachandran; Manivasagan, Panchanathan; Kang, Kyong-Hwa; Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Busan 608737, South Korea.
   [Lowe, Baboucarr] Pukyong Natl Univ, Dept Marine Bio Convergence Sci, Busan 608737, South Korea.
   [Chalisserry, Elna P.] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh 12372, Saudi Arabia.
   [Anil, Sukumaran] King Saud Univ, Dent Biomat Res Chair, Riyadh 12372, Saudi Arabia.
   [Kim, Dong Gyu] Pukyong Natl Univ, Specialized Grad Sch Sci & Technol Convergence, Busan 608739, South Korea.
RP Kim, DG (reprint author), Pukyong Natl Univ, Specialized Grad Sch Sci & Technol Convergence, Busan 608739, South Korea.
EM venkatjchem@pknu.ac.kr; babolowe@gmail.com; manimaribtech@gmail.com;
   khkang@pknu.ac.kr; paulelna@gmail.com; drsanil@gmail.com;
   dgkim@pknu.ac.kr; sknkim@pknu.ac.kr
OI Kim, Se-Kwon/0000-0001-6507-9539; Manivasagan,
   Panchanathan/0000-0002-9548-0451; /0000-0002-6440-8780
FU Pukyong National University; Marine Bioprocess Research Center of the
   Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea
FX This paper was supported by research funds from Pukyong National
   University in 2015 and a grant from the Marine Bioprocess Research
   Center of the Marine Biotechnology Program, funded by the Ministry of
   Oceans and Fisheries, Korea.
CR Bahrololoom ME, 2009, J CERAM PROCESS RES, V10, P129
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Chattanathan S., 2013, WATER AIR SOIL POLL, V224, P1
   Coelho T.M., 2007, J APPL PHYS, V101
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Guo GS, 2005, CERAM INT, V31, P869, DOI 10.1016/j.ceramint.2004.10.003
   Hoyer B, 2012, BIOMACROMOLECULES, V13, P1059, DOI 10.1021/bm201776r
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Janus AM, 2008, MICROCHIM ACTA, V161, P349, DOI 10.1007/s00604-007-0864-2
   Jarudilokkul S, 2007, COLLOID SURFACE A, V296, P149, DOI 10.1016/j.colsurfa.2006.09.038
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kim B.S., 2014, BIOMED MAT, V9
   Kongsri S, 2013, CHEM ENG J, V215, P522, DOI 10.1016/j.cej.2012.11.054
   Lima WM, 2005, MATER SCI FORUM, V498-499, P600, DOI 10.4028/www.scientific.net/MSF.498-499.600
   Matsuura A, 2009, DENT MATER J, V28, P234, DOI 10.4012/dmj.28.234
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Ozawa M, 2005, J MATER SCI, V40, P1037, DOI 10.1007/s10853-005-6529-9
   Ozawa M, 2003, J MATER SCI LETT, V22, P513, DOI 10.1023/A:1022982218727
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Ozawa M., 2007, P INT S ECOTOPIA SCI, P957
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Panda NN, 2014, BIOPROC BIOSYST ENG, V37, P433, DOI 10.1007/s00449-013-1009-0
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Prabakaran K., 2006, TRENDS BIOMATER ARTI, V20, P20
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Ruksudjarlt A, 2008, CURR APPL PHYS, V8, P270, DOI 10.1016/j.cap.2007.10.076
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shimizu K, 2007, J BIOMED MATER RES B, V82B, P471, DOI 10.1002/jbm.b.30752
   Sofronia AM, 2014, MAT SCI ENG C-MATER, V43, P153, DOI 10.1016/j.msec.2014.07.023
   Venkatesan J., 2011, BIOMED MAT, V6
   Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032
   Venkatesan J, 2010, MATERIALS, V3, P4761, DOI 10.3390/ma3104761
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
   Yunoki S., 2011, BIOMED MAT, V6
   Zainol I, 2012, ADV MATER RES-SWITZ, V545, P235, DOI 10.4028/www.scientific.net/AMR.545.235
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 46
TC 10
Z9 11
U1 1
U2 20
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD AUG
PY 2015
VL 8
IS 8
BP 5426
EP 5439
DI 10.3390/ma8085253
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA CQ5KX
UT WOS:000360643900056
PM 28793514
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, S
   Jeong, MJ
   Kang, KY
AF Lee, Sinah
   Jeong, Myung-Joon
   Kang, Kyu-Young
TI Preparation of cellulose aerogels as a nano-biomaterial from
   lignocellulosic biomass
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article
DE Cellulose; Aerogel; Fiber analysis; Microstructure; Lignocellulosic
   biomass
ID COHERENT EXPANDED AEROGELS; AEROCELLULOSE
AB Cellulose aerogels were prepared from various delignified wood fibers by using a peracetic acid pretreatment. The effect of the treatment conditions was evaluated to find the optimum condition for the production of a functional cellulose aerogel for use as a nano-biomaterial. The morphologies and the physical properties of the delignified wood fibers were analyzed and compared according to the various conditions of pretreatment. The density and the microstructure were studied for cellulose aerogels produced from delignified wood fibers. The results showed that peracetic acid pretreatment did not have a considerable effect on the average fiber length and the surface; however, acid hydrolysis caused a decrease in the viscosity of the wood fibers and an increase in their density and destroyed the microstructure. According to these results minimizing cellulose degradation while wood pulping is an important consideration in the preparation of cellulose aerogels.
C1 [Lee, Sinah; Jeong, Myung-Joon; Kang, Kyu-Young] Dongguk Univ Seoul, Dept Biol & Environm Sci, Seoul 100715, South Korea.
RP Lee, S (reprint author), Dongguk Univ Seoul, Dept Biol & Environm Sci, Seoul 100715, South Korea.
EM kykang@dongguk.edu
OI Kang, Kyu-Young/0000-0002-0457-842X
FU Korea Forest Service [S111314L010130]; Dongguk University
FX This study was carried out with the support of 'Forest Science &
   Technology Project (Project No. S111314L010130)' provided by Korea
   Forest Service. This work was also supported by the research program of
   Dongguk University, 2015.
CR Duchemin B. J. C., 2009, J APPL POLYM SCI, V115, P216
   Gavillon R, 2008, BIOMACROMOLECULES, V9, P269, DOI 10.1021/bm700972k
   Hattori M., 1998, POLYM J, V30, P44
   Hoepfner S, 2008, CELLULOSE, V15, P121, DOI 10.1007/s10570-007-9146-8
   Innerlohinger J, 2006, MACROMOL SYMP, V244, P126, DOI 10.1002/masy.200651212
   Jeong MJ, 2014, CELLULOSE, V21, P4621, DOI 10.1007/s10570-014-0455-4
   Jin H, 2004, COLLOID SURFACE A, V240, P63, DOI 10.1016/j.colsurfa.2004.03.007
   Kistler SS, 1932, J PHYS CHEM-US, V36, P52, DOI 10.1021/j150331a003
   Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0
   Lafontaine R., 1984, SILICA GEL
   Li J, 2011, BIOMACROMOLECULES, V12, P1860, DOI 10.1021/bm200205z
   Liebner F., 2007, HOLZFORSCHUNG, V63, P3
   Staudinger H., 1938, PAPIERFABRIKANT, V36, P373
   Tan CB, 2001, ADV MATER, V13, P644, DOI 10.1002/1521-4095(200105)13:9<644::AID-ADMA644>3.0.CO;2-#
   Wang ZG, 2012, CELLULOSE, V19, P393, DOI 10.1007/s10570-012-9651-2
   Yamamoto M, 2011, BIOMACROMOLECULES, V12, P3982, DOI 10.1021/bm201211z
NR 16
TC 1
Z9 1
U1 4
U2 38
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
EI 1976-8524
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD AUG
PY 2015
VL 67
IS 4
BP 738
EP 741
DI 10.3938/jkps.67.738
PG 4
WC Physics, Multidisciplinary
SC Physics
GA CQ6KE
UT WOS:000360712400024
DA 2018-10-20
ER

PT J
AU Sedaghati, T
   Seifalian, AM
AF Sedaghati, Tina
   Seifalian, Alexander M.
TI Nanotechnology and bio-functionalisation for peripheral nerve
   regeneration
SO NEURAL REGENERATION RESEARCH
LA English
DT Review
DE nanomaterial; regenerative medicine; biomaterial; peptides; nerve
   regeneration; stem cells; nanotechnology
ID PEPTIDE NANOFIBER SCAFFOLD; SPINAL-CORD-INJURY; EXTRACELLULAR-MATRIX;
   SCHWANN-CELLS; SCIATIC-NERVE; BIOMATERIALS APPROACH; NEURITE OUTGROWTH;
   RGD; CONDUITS; SURFACE
AB There is a high clinical demand for new smart biomaterials, which stimulate neuronal cell proliferation, migration and increase cell-material interaction to facilitate nerve regeneration across these critical-sized defects. This article briefly reviews several up-to-date published studies using Arginine-Glycine-Aspartic acid peptide sequence, nanocomposite based on polyhedral oligomeric silsesquioxane nanoparticle and nanofibrous scaffolds as promising strategies to enhance peripheral nerve regeneration by influencing cellular behaviour such as attachment, spreading and proliferation. The aim is to establish the potent manipulations, which are simple and easy to employ in the clinical conditions for nerve regeneration and repair.
C1 [Sedaghati, Tina; Seifalian, Alexander M.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Seifalian, Alexander M.] Royal Free NHS Trust Fdn Hosp, London, England.
   [Seifalian, Alexander M.] NanoRegMed Ltd, London, England.
RP Seifalian, AM (reprint author), UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
EM a.seifalian@gmail.com
CR Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   BARONVANEVERCOOREN A, 1982, J CELL BIOL, V93, P211, DOI 10.1083/jcb.93.1.211
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Chawla R, 2014, J SURG RES, V188, P361, DOI 10.1016/j.jss.2014.01.006
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Ghanbari H, 2011, MACROMOL RAPID COMM, V32, P1032, DOI 10.1002/marc.201100126
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hong S, 2010, J BIOMED MATER RES B, V94B, P421, DOI 10.1002/jbm.b.31670
   Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4
   Hu JP, 2011, MACROMOL RAPID COMM, V32, P1729, DOI 10.1002/marc.201100343
   Huang JF, 2013, J RECONSTR MICROSURG, V29, P77, DOI 10.1055/s-0032-1328918
   Huang JF, 2010, NEUROL INDIA, V58, P384, DOI 10.4103/0028-3886.65810
   Jell G, 2009, FUNDAMENTALS TISSUE, P469
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Liu WQ, 2009, NEUROBIOL DIS, V34, P11, DOI 10.1016/j.nbd.2008.11.012
   Masaeli E, 2014, NANOMED-NANOTECHNOL, V10, P1559, DOI 10.1016/j.nano.2014.04.008
   Matsumoto K, 2000, ASAIO J, V46, P415, DOI 10.1097/00002480-200007000-00009
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Olakowska E, 2010, FOLIA NEUROPATHOL, V48, P231
   Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Puppi D, 2011, J TISSUE ENG REGEN M, V5, P253, DOI 10.1002/term.310
   Qiu T, 2014, J BIOMED MATER RES A, V102, P3734, DOI 10.1002/jbm.a.35078
   Rafiuddin M, 2003, BRAIN RES, V993, P208, DOI 10.1016/j.brainres.2003.08.057
   Rashid ST, 2004, EUR J VASC ENDOVASC, V27, P608, DOI 10.1016/j.ejvs.2004.01.020
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sedaghati T., 2014, REGEN MED APPL ORGAN, P799
   Sedaghati T, 2014, NEW BIOTECHNOL, V31, P203, DOI 10.1016/j.nbt.2014.01.002
   Sedaghati T, 2011, BIOTECHNOL APPL BIOC, V58, P288, DOI 10.1002/bab.51
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Torabinejad B, 2014, MAT SCI ENG C-MATER, V42, P199, DOI 10.1016/j.msec.2014.05.003
   Tsintou M, 2015, NEURAL REGEN RES, V10, P726, DOI 10.4103/1673-5374.156966
   Tucker BA, 2008, CAN J NEUROL SCI, V35, P551, DOI 10.1017/S0317167100009331
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037
   Xiao W, 2013, INJURY, V44, P941, DOI 10.1016/j.injury.2013.03.029
   Yan QJ, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-36
   Yazdimamaghani M, 2014, J BIOMED NANOTECHNOL, V10, P911, DOI 10.1166/jbn.2014.1783
   Yildirimer L, 2015, TISSUE ENG PART C-ME, V21, P614, DOI [10.1089/ten.tec.2014.0270, 10.1089/ten.TEC.2014.0270]
   Yun DH, 2014, J BIOMAT SCI-POLYM E, V25, P354, DOI 10.1080/09205063.2013.861170
NR 51
TC 5
Z9 5
U1 1
U2 51
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD AUG
PY 2015
VL 10
IS 8
BP 1191
EP 1194
DI 10.4103/1673-5374.162678
PG 4
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CQ5HX
UT WOS:000360635300003
PM 26487832
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hosseini, SM
   Vasaghi, A
   Nakhlparvar, N
   Roshanravan, R
   Talaei-Khozani, T
   Razi, Z
AF Hosseini, Seyed Mojtaba
   Vasaghi, Attiyeh
   Nakhlparvar, Newsha
   Roshanravan, Reza
   Talaei-Khozani, Tahereh
   Razi, Zahra
TI Differentiation of Wharton's jelly mesenchymal stem cells into neurons
   in alginate scaffold
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; Wharton's jelly mesenchymal stem cells; mesenchymal
   stem cells; neurons; motor neurons; alginate; 3D scaffold; neural
   regeneration
ID UMBILICAL-CORD; STROMAL CELLS; BONE-MARROW; LINEAGE; ADIPOSE
AB Alginate scaffold has been considered as an appropriate biomaterial for promoting the differentiation of embryonic stem cells toward neuronal cell lineage. We hypothesized that alginate scaffold is suitable for culturing Wharton's jelly mesenchymal stem cells (WJMSCs) and can promote the differentiation of WJMSCs into neuron-like cells. In this study, we cultured WJMSCs in a three-dimensional scaffold fabricated by 0.25% alginate and 50 mM CaCl2 in the presence of neurogenic medium containing 10 mu M retinoic acid and 20 ng/mL basic fibroblast growth factor. These cells were also cultured in conventional two-dimensional culture condition in the presence of neurogenic medium as controls. After 10 days, immunofluorescence staining was performed for detecting beta-tubulin (marker for WJMSCs-differentiated neuron) and CD271 (motor neuron marker). beta-Tubulin and CD271 expression levels were significantly greater in the WJMSCs cultured in the three-dimensional alginate scaffold than in the conventional two-dimensional culture condition. These findings suggest that three-dimensional alginate scaffold cell culture system can induce neuronal differentiation of WJMSCs effectively.
C1 [Hosseini, Seyed Mojtaba; Vasaghi, Attiyeh; Nakhlparvar, Newsha] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   [Hosseini, Seyed Mojtaba; Vasaghi, Attiyeh; Nakhlparvar, Newsha; Razi, Zahra] Shiraz Univ Med Sci, Sch Med, Cell & Mol Med Student Res Grp, Shiraz, Iran.
   [Hosseini, Seyed Mojtaba] Shiraz Univ Med Sci, Dept Anat, Stem Cell Lab, Shiraz, Iran.
   [Roshanravan, Reza] Shiraz Univ Med Sci, Colorectal Res Ctr, Dept Surg, Shiraz, Iran.
   [Talaei-Khozani, Tahereh] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Tissue Engn, Tissue Engn Lab, Shiraz, Iran.
   [Talaei-Khozani, Tahereh] Shiraz Univ Med Sci, Sch Med, Dept Anat, Lab Stem Cell Res, Shiraz, Iran.
   [Razi, Zahra] Shiraz Univ Med Sci, Dept Med Phys, Shiraz, Iran.
RP Talaei-Khozani, T (reprint author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Tissue Engn, Tissue Engn Lab, Shiraz, Iran.
EM talaeit@sums.ac.ir
RI Talaei-khozani, Tahereh/N-2344-2015
OI Talaei-khozani, Tahereh/0000-0002-8425-8871
FU Shiraz University of Medical Sciences, Iran [5959]
FX We wish to thank the research deputy of Shiraz University of Medical
   Sciences, Iran for offering student research grant (No. 5959).
CR Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Balasubramanian S, 2013, CELL BIOL INT, V37, P507, DOI 10.1002/cbin.10056
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bozza A, 2014, BIOMATERIALS, V35, P4636, DOI 10.1016/j.biomaterials.2014.02.039
   Candiello J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-9
   Datta I, 2011, CYTOTHERAPY, V13, P918, DOI 10.3109/14653249.2011.579957
   Divya MS, 2012, STEM CELL RES THER, V19, P57
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x
   Frampton JP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015002
   Hosseini SM, 2013, CELL J, V15, P46
   Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604
   Khodabandeh Z, 2015, IRAN J MED IN PRESS
   Kim J, 2013, STEM CELL RES, V11, P978, DOI 10.1016/j.scr.2013.06.005
   La Rocca G, 2009, HISTOCHEM CELL BIOL, V131, P267, DOI 10.1007/s00418-008-0519-3
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Messerli M, 2013, REPROD SCI, V20, P1455, DOI 10.1177/1933719113488443
   Montanucci P, 2011, TISSUE ENG PT A, V17, P2651, DOI [10.1089/ten.TEA.2010.0587, 10.1089/ten.tea.2010.0587]
   Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Penolazzi L, 2010, TISSUE ENG PART C-ME, V16, P141, DOI [10.1089/ten.tec.2008.0582, 10.1089/ten.TEC.2008.0582]
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Ribeiro J, 2013, INT REV NEUROBIOL, V108, P79, DOI 10.1016/B978-0-12-410499-0.00004-6
   Shakhbazau AV, 2011, B EXP BIOL MED+, V150, P547, DOI 10.1007/s10517-011-1186-2
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Tantrawatpan Chairat, 2013, Journal of the Medical Association of Thailand, V96, P1208
   Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330
   Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Zhang L, 2009, NEUROCHEM RES, V34, P2030, DOI 10.1007/s11064-009-9992-x
NR 35
TC 5
Z9 5
U1 0
U2 6
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD AUG
PY 2015
VL 10
IS 8
BP 1312
EP 1316
DI 10.4103/1673-5374.162768
PG 5
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CQ5HX
UT WOS:000360635300032
PM 26487861
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ayyub, OB
   Kofinas, P
AF Ayyub, Omar B.
   Kofinas, Peter
TI Enzyme Induced Stiffening of Nanoparticle-Hydrogel Composites with
   Structural Color
SO ACS NANO
LA English
DT Article
DE hydrogel; nanoparticle; photonic crystal; self-assembly; protease
ID PHOTONIC CRYSTALS; IONIC-STRENGTH; DELIVERY; HYDROLYSIS; SENSORS; FILMS;
   PH
AB The passive monitoring of biological environments by soft materials has a variety of nanobiotechnology applications; however, invoking distinct transitions in geometric, mechanical or optical properties remains a prevalent design challenge. We demonstrate here that close-packed nanoparticle hydrogel composites can progress through a substantial shift in such properties by the use of a chemical-to-physical cross-link transition mediated by the catalytic activity of different proteases. Catalytic cleavage of the original hydrogel network structure initiates the self-assembled formation of a secondary, physically cross-linked network, causing a 1200% increase in storage modulus. Furthermore, this unique mechanism can be fabricated as a 3D photonic crystal with broad (similar to 240 nm), visible responses to the targeted enzymes. Moreover, the material provided threshold responses, requiring a certain extent of proteolytic activity before the transition occurred. This allowed for the fabrication of Boolean logic gates (OR and AND), which responded to a specific assortment of proteases. Ultimately, this mechanism enables the design of stimuli-responsive hydrogels, which can proceed through a secondary network formation, after an energetic barrier has been breached. Protease responsive hydrogel nanocomposites, described here, could offer avenues in degradation-stiffening and collapsing materials for a variety of biomaterial applications.
C1 [Ayyub, Omar B.; Kofinas, Peter] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Kofinas, P (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM kofinas@umd.edu
OI Kofinas, Peter/0000-0001-6657-3037
FU NIBIB NIH HHS [R01 EB019963]
CR Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Asher SA, 2003, J AM CHEM SOC, V125, P3322, DOI 10.1021/ja021037h
   Ayyub OB, 2011, BIOSENS BIOELECTRON, V28, P349, DOI 10.1016/j.bios.2011.07.043
   BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Holtz JH, 1997, NATURE, V389, P829
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/NCHEM.1937, 10.1038/nchem.1937]
   Kilian KA, 2009, NANO LETT, V9, P2021, DOI 10.1021/nl900283j
   Kimble KW, 2006, ANAL BIOANAL CHEM, V385, P678, DOI 10.1007/s00216-006-0453-y
   Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282
   Lee K, 2000, J AM CHEM SOC, V122, P9534, DOI 10.1021/ja002017n
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacConaghy KI, 2014, J AM CHEM SOC, V136, P6896, DOI 10.1021/ja5031062
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Orosco MM, 2009, NAT NANOTECHNOL, V4, P255, DOI [10.1038/NNANO.2009.11, 10.1038/nnano.2009.11]
   Orosco MM, 2006, ADV MATER, V18, P1393, DOI 10.1002/adma.200502420
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Plunkett KN, 2005, BIOMACROMOLECULES, V6, P632, DOI 10.1021/bm049349v
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Rose S, 2014, NATURE, V505, P382, DOI 10.1038/nature12806
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Thornton PD, 2007, ADV MATER, V19, P1252, DOI 10.1002/adma.200601784
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Xu M, 2008, J AM CHEM SOC, V130, P3113, DOI [10.1021/ja077979, 10.1021/ja077979+]
   Yetisen AK, 2014, SENSOR ACTUAT B-CHEM, V196, P156, DOI 10.1016/j.snb.2014.01.077
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Yoshida T, 2003, J POLYM SCI POL CHEM, V41, P779, DOI 10.1002/pola.10595
NR 31
TC 22
Z9 22
U1 16
U2 204
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD AUG
PY 2015
VL 9
IS 8
BP 8004
EP 8011
DI 10.1021/acsnano.5b01514
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CQ0YA
UT WOS:000360323300028
PM 26196060
DA 2018-10-20
ER

PT J
AU Brennan, MA
   Renaud, A
   Gamblin, AL
   D'Arros, C
   Nedellec, S
   Trichet, V
   Layrolle, P
AF Brennan, Meadhbh A.
   Renaud, Audrey
   Gamblin, Anne-laure
   D'Arros, Cyril
   Nedellec, Steven
   Trichet, Valerie
   Layrolle, Pierre
TI 3D cell culture and osteogenic differentiation of human bone marrow
   stromal cells plated onto jet-sprayed or electrospun micro-fiber
   scaffolds
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE micro-fiber scaffolds; electrospinning; jet-spraying; cell infiltration;
   mesenchymal stromal cells; 3D in vitro bone tissue models
ID MESENCHYMAL STEM-CELLS; IN-VITRO; INFILTRATION; ADHESION; POROSITY;
   MATRIX; MEDICINE; BIOLOGY; SHAPE
AB A major limitation of the 2D culture systems is that they fail to recapitulate the in vivo 3D cellular microenvironment whereby cell-cell and cell-extracellular matrix (ECM) interactions occur. In this paper, a biomaterial scaffold that mimics the structure of collagen fibers was produced by jet-spraying. This micro-fiber polycaprolactone (PCL) scaffold was evaluated for 3D culture of human bone marrow mesenchymal stromal cells (MSCs) in comparison with a commercially available electrospun scaffold. The jet-sprayed scaffolds had larger pore diameters, greater porosity, smaller diameter fibers, and more heterogeneous fiber diameter size distribution compared to the electrospun scaffolds. Cells on jet-sprayed constructs exhibited spread morphology with abundant cytoskeleton staining, whereas MSCs on electrospun scaffolds appeared less extended with fewer actin filaments. MSC proliferation and cell infiltration occurred at a faster rate on jet-sprayed compared to electrospun scaffolds. Osteogenic differentiation of MSCs and ECM production as measured by ALP, collagen and calcium deposition was superior on jet-sprayed compared to electrospun scaffolds. The jet-sprayed scaffold which mimics the native ECM and permits homogeneous cell infiltration is important for 3D in vitro applications such as bone cellular interaction studies or drug testing, as well as bone tissue engineering strategies.
C1 [Brennan, Meadhbh A.; Renaud, Audrey; Gamblin, Anne-laure; Trichet, Valerie; Layrolle, Pierre] Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt & Primary Bone Tumo, INSERM,UMR 957, F-44035 Nantes, France.
   [D'Arros, Cyril] IRTUN, Biomed Tissues SAS, Nantes, France.
   [Nedellec, Steven] CNRS 3556, SFR Sante Francois Bonamy, MicroPICell Platform, INSERM,UMS 016, Nantes, France.
RP Brennan, MA (reprint author), Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt & Primary Bone Tumo, INSERM,UMR 957, F-44035 Nantes, France.
EM pierre.layrolle@inserm.fr
RI Layrolle, Pierre/K-9257-2015; Brennan, Meadhbh/L-2068-2015; Trichet,
   Valerie/L-1553-2015
OI Layrolle, Pierre/0000-0001-9800-5210; Brennan, Meadhbh
   A/0000-0002-1532-9760
FU Region Pays de la Loire: Postdoctoral Fellowship; European Commission
   [241879]
FX The authors would like to acknowledge funding from Region Pays de la
   Loire: Postdoctoral Fellowship and the European Commission under the FP7
   framework, Reborne Project (#241879). We would also like to thank EFS
   Toulouse for kindly providing the MSCs.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abdal-hay A, 2014, MATER LETT, V125, P51, DOI 10.1016/j.matlet.2014.03.138
   Abdal-haya A, 2013, COLLOID SURFACE B, V102, P635, DOI 10.1016/j.colsurfb.2012.09.017
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Arumuganathar S, 2008, BIOMACROMOLECULES, V9, P759, DOI 10.1021/bm701322k
   Arumuganathar S, 2008, J APPL POLYM SCI, V107, P1215, DOI 10.1002/app.27190
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955067402003733
   Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110
   Ghasemi-Mobarakeh L, 2008, YAKHTEH, V10, P179
   Ghasemi-Mobarakeh L, 2009, INT J ARTIF ORGANS, V32, P150
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144
   Hsu SH, 2013, ACTA BIOMATER, V9, P6915, DOI 10.1016/j.actbio.2013.02.012
   Jayasinghe SN, 2013, ANALYST, V138, P2215, DOI 10.1039/c3an36599a
   Jayasinghe SN, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3328092
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470
   Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07
   Logan N, 2013, STEM CELLS INT
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1095, DOI 10.1089/ten.tec.2009.0753
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Nerurkar NL, 2011, ACTA BIOMATER, V7, P485, DOI 10.1016/j.actbio.2010.08.011
   Norgaard R, 2006, ANN NY ACAD SCI, V1067, P443, DOI 10.1196/annals.1354.063
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Sohier J, 2014, TISSUE ENG PART C-ME, V20, P285, DOI [10.1089/ten.TEC.2013.0147, 10.1089/ten.tec.2013.0147]
   Sohier J, 2014, BIOMATERIALS, V35, P1833, DOI 10.1016/j.biomaterials.2013.10.061
   Townsend-Nicholson A, 2006, BIOMACROMOLECULES, V7, P3364, DOI 10.1021/bm060649h
   Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b
   Wright LD, 2011, MAT SCI ENG C-MATER, V31, P30, DOI 10.1016/j.msec.2010.02.001
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 46
TC 16
Z9 16
U1 3
U2 47
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045019
DI 10.1088/1748-6041/10/4/045019
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600020
PM 26238732
OA Other Gold
DA 2018-10-20
ER

PT J
AU Brown, CFC
   Yan, J
   Han, TTY
   Marecak, DM
   Amsden, BG
   Flynn, LE
AF Brown, Cody F. C.
   Yan, Jing
   Han, Tim Tian Y.
   Marecak, Dale M.
   Amsden, Brian G.
   Flynn, Lauren E.
TI Effect of decellularized adipose tissue particle size and cell density
   on adipose-derived stem cell proliferation and adipogenic
   differentiation in composite methacrylated chondroitin sulphate
   hydrogels
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE adipose tissue engineering; composite scaffolds; particle size;
   extracellular matrix (ECM); chondroitin sulphate; adipose-derived stem
   cells; adipogenic differentiation
ID SCAFFOLDS; MICROENVIRONMENT; ADHESION
AB An injectable composite scaffold incorporating decellularized adipose tissue (DAT) as a bioactive matrix within a hydrogel phase capable of in situ polymerization would be advantageous for adipose-derived stem cell (ASC) delivery in the filling of small or irregular soft tissue defects. Building on previous work, the current study investigates DAT milling methods and the effects of DAT particle size and cell seeding density on the response of human ASCs encapsulated in photo-cross-linkable methacrylated chondroitin sulphate (MCS)-DAT composite hydrogels. DAT particles were generated by milling lyophilized DAT and the particle size was controlled through the processing conditions with the goal of developing composite scaffolds with a tissue-specific 3D microenvironment tuned to enhance adipogenesis. ASC proliferation and adipogenic differentiation were assessed in vitro in scaffolds incorporating small (average diameter of 38 +/- 6 mu m) or large (average diameter of 278 +/- 3 mu m) DAT particles in comparison to MCS controls over a period of up to 21 d. Adipogenic differentiation was enhanced in the composites incorporating the smaller DAT particles and seeded at the higher density of 5 x 10(5) ASCs/scaffold, as measured by glycerol-3-phosphate dehydrogenase (GPDH) enzyme activity, semi-quantitative analysis of perilipin expression and oil red O staining of intracellular lipid accumulation. Overall, this study demonstrates that decellularized tissue particle size can impact stem cell differentiation through cell-cell and cell-matrix interactions, providing relevant insight towards the rational design of composite biomaterial scaffolds for adipose tissue engineering.
C1 [Brown, Cody F. C.; Flynn, Lauren E.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
   [Yan, Jing; Han, Tim Tian Y.; Marecak, Dale M.; Amsden, Brian G.; Flynn, Lauren E.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   [Yan, Jing; Han, Tim Tian Y.; Marecak, Dale M.; Amsden, Brian G.; Flynn, Lauren E.] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON K7L 2V7, Canada.
   [Flynn, Lauren E.] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Brown, CFC (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
EM lauren.flynn@uwo.ca
RI Flynn, Lauren/C-9967-2015
OI Flynn, Lauren/0000-0001-6227-0928
FU Canadian Institutes of Health Research (CIHR); Canada Foundation for
   Innovation (CFI); Ontario Ministry of Research and Innovation (MRI)
FX Funding for this study was provided by the Canadian Institutes of Health
   Research (CIHR), with infrastructure support from the Canada Foundation
   for Innovation (CFI) and the Ontario Ministry of Research and Innovation
   (MRI). The authors would like to acknowledge Drs F Watkins, K Meathrel,
   J Davidson, D McKay, and Mrs K Martin for their clinical collaborations.
CR American Society for Aesthetic Plastic Surgery, 2013, TOP 5 PROC SURG NONS
   Ang XM, 2014, TISSUE ENG PT A, V20, P966, DOI [10.1089/ten.tea.2013.0337, 10.1089/ten.TEA.2013.0337]
   Bauer-Kreisel P, 2010, ADV DRUG DELIVER REV, V62, P798, DOI 10.1016/j.addr.2010.04.003
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197
   Flynn L, 2009, J BIOMED MATER RES A, V89A, P929, DOI 10.1002/jbm.a.32044
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Flynn Lauren, 2008, Organogenesis, V4, P228
   Gibson M, 2014, BIOMED RES INT, DOI 10.1155/2014/469120
   Hauner H, 2001, ADIPOSE TISSUE PROTO
   Hillel AT, 2011, SCI TRANSL MED, V3, P93
   Kaufman MR, 2007, PLAST RECONSTR SURG, V119, P2287, DOI 10.1097/01.prs.0000260712.44089.e7
   Korhonen H, 1998, TRENDS FOOD SCI TECH, V9, P307, DOI 10.1016/S0924-2244(98)00054-5
   KUHL M, 1994, MAR ECOL PROG SER, V105, P139, DOI 10.3354/meps105139
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   PEER L A, 1956, Plast Reconstr Surg (1946), V18, P233, DOI 10.1097/00006534-195610000-00001
   Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Saylan Ziya, 2003, Aesthet Surg J, V23, P221, DOI 10.1067/maj.2003.45
   Shenaq SM, 2002, CLIN PLAST SURG, V29, P111, DOI 10.1016/S0094-1298(03)00089-0
   SMAHEL J, 1989, BRIT J PLAST SURG, V42, P207, DOI 10.1016/0007-1226(89)90205-1
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Turner AEB, 2012, BIOMATERIALS, V33, P4490, DOI 10.1016/j.biomaterials.2012.03.026
   Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055
   Yeatts AB, 2012, BIOTECHNOL BIOENG, V109, P2381, DOI 10.1002/bit.24497
   Young DA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024104
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
   Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056
NR 33
TC 15
Z9 15
U1 1
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045010
DI 10.1088/1748-6041/10/4/045010
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600011
PM 26225549
DA 2018-10-20
ER

PT J
AU Foroutan, F
   Walters, NJ
   Owens, GJ
   Mordan, NJ
   Kim, HW
   de Leeuw, NH
   Knowles, JC
AF Foroutan, Farzad
   Walters, Nick J.
   Owens, Gareth J.
   Mordan, Nicola J.
   Kim, Hae-Won
   de Leeuw, Nora H.
   Knowles, Jonathan C.
TI Sol-gel synthesis of quaternary
   (P2O5)(55)-(CaO)(25)-(Na2O)((20-x))-(TiO2)(x) bioresorbable glasses for
   bone tissue engineering applications (x=0, 5, 10, or 15)
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE sol-gel; phosphate-based glass; bioactive glass; titanium; biomaterial;
   tissue engineering
ID PHOSPHATE-BASED GLASSES; STRUCTURAL-CHARACTERIZATION; BIOMEDICAL
   APPLICATIONS; SOLUBLE GLASSES; TITANIUM; SOLUBILITY; BULK
AB In the present study, we report a new and facile sol-gel synthesis of phosphate-based glasses with the general formula of (P2O5)(55)-(CaO)(25)-(Na2O)((20-x))-(TiO2)(x), where x = 0, 5, 10 or 15, for bone tissue engineering applications. The sol-gel synthesis method allows greater control over glass morphology at relatively low processing temperature (200 degrees C) in comparison with phosphate-based melt-derived glasses (similar to 1000 degrees C). The glasses were analyzed using several characterization techniques, including x-ray diffraction (XRD), P-31 magic angle spinning nuclear magnetic resonance (P-31 MAS-NMR), Fourier transform infrared (FTIR) spectroscopy and energy-dispersive x-ray (EDX) spectroscopy, which confirmed the amorphous and glassy nature of the prepared samples. Degradation was assessed by measuring the ion release and pH change of the storage medium. Cytocompatibility was also confirmed by culturing osteoblast-like osteosarcoma cell line MG-63 on the glass microparticles over a seven-day period. Cell attachment to the particles was imaged using scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). The results revealed the potential of phosphate-based sol-gel derived glasses containing 5 or 10 mol% TiO2, with high surface area, ideal dissolution rate for cell attachment and easily metabolized dissolution products, for bone tissue engineering applications.
C1 [Foroutan, Farzad; Owens, Gareth J.; Mordan, Nicola J.; Knowles, Jonathan C.] UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Foroutan, Farzad; de Leeuw, Nora H.] UCL, Dept Chem, London WC1H 0AJ, England.
   [Walters, Nick J.] Univ Tampere, Adult Stem Cell Grp, Tampere 33014, Finland.
   [Walters, Nick J.] BioMediTech, Tampere 33520, Finland.
   [Kim, Hae-Won; Knowles, Jonathan C.] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Kim, Hae-Won; Knowles, Jonathan C.] Dankook Univ, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Res Ctr Nanobiomed Sci, Chungnam 330714, South Korea.
   [de Leeuw, Nora H.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales.
RP Foroutan, F (reprint author), UCL Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
EM j.knowles@ucl.ac.uk
OI Walters, Nick/0000-0002-4138-9695
FU UCL Industrial Doctorate Centre in Molecular Modelling & Material
   Science; National Research Centers Program through the National Research
   Foundation (NRF), Republic of Korea [2009-0093829]; Engineering and
   Physical Sciences Research Council [EP/J008095/1, EP/J008095/2]
FX This project was supported by the UCL Industrial Doctorate Centre in
   Molecular Modelling & Material Science and in part (JCK & HWK) by
   National Research Centers Program (2009-0093829) through the National
   Research Foundation (NRF), Republic of Korea. The authors are grateful
   to Dr David Apperley for performing <SUP>31</SUP>P MAS-NMR measurements
   (EPSRC NMR Service, Department of Chemistry, Durham University).
CR Abou Neel EA, 2014, MAT SCI ENG C-MATER, V35, P307, DOI 10.1016/j.msec.2013.10.029
   Abou Neel EA, 2008, ACTA BIOMATER, V4, P523, DOI 10.1016/j.actbio.2007.11.007
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Brauer DS, 2010, J NON-CRYST SOLIDS, V356, P2626, DOI 10.1016/j.jnoncrysol.2010.03.022
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   Dricsscns F C M, 1982, MONOGRAPHS ORAL SCI, P10
   Fluck E, 1978, PHOSPHOR PHOSPHORUS, V26, P386
   Foroutan F, 2015, J SOL-GEL SCI TECHN, V73, P434, DOI 10.1007/s10971-014-3555-6
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Hu HJ, 2013, COLLOID SURFACE B, V101, P83, DOI 10.1016/j.colsurfb.2012.06.021
   Kiani A, 2012, PHILOS T R SOC A, V370, P1352, DOI 10.1098/rsta.2011.0276
   KIRKPATRICK RJ, 1995, SOLID STATE NUCL MAG, V5, P9, DOI 10.1016/0926-2040(95)00042-O
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Lakhkar NJ, 2012, ACTA BIOMATER, V8, P4181, DOI 10.1016/j.actbio.2012.07.023
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee IH, 2013, PHYS CHEM GLASSES-B, V54, P115
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   Montague L, CHEM MAT, V15, P4709
   Montchamp J.-L., 2015, PHOSPHORUS CHEM
   Navarro M, 2003, J BIOMED MATER RES A, V67A, P1009, DOI 10.1002/jbm.a.20014
   Pickup DM, 2008, J MATER SCI-MATER M, V19, P1681, DOI 10.1007/s10856-007-3342-9
   Pickup DM, 2008, J MATER SCI-MATER M, V19, P1661, DOI 10.1007/s10856-007-3259-3
   Pickup DM, 2007, J MATER CHEM, V17, P4777, DOI 10.1039/b709955j
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038
NR 28
TC 3
Z9 3
U1 1
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045025
DI 10.1088/1748-6041/10/4/045025
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600026
PM 26306553
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gumel, AM
   Razaif-Mazinah, MRM
   Anis, SNS
   Annuar, MSM
AF Gumel, Ahmad Mohammed
   Razaif-Mazinah, Mohd Rafais Mohd
   Anis, Siti Nor Syairah
   Annuar, Mohamad Suffian Mohamad
TI Poly (3-hydroxyalkanoates)-co-(6-hydroxyhexanoate) hydrogel promotes
   angiogenesis and collagen deposition during cutaneous wound healing in
   rats
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE biomaterial; biopolymer; cytokines; hydrogel; PHA; PCL; wound
ID GRANULATION-TISSUE FORMATION; RING-OPENING POLYMERIZATION;
   GROWTH-FACTOR; IN-VITRO; CELL-PROLIFERATION; DIABETIC-RATS;
   SMOOTH-MUSCLE; DELIVERY; COPOLYMER; FILMS
AB Wound management and healing in several physiological or pathological conditions, particularly when comorbidities are involved, usually proves to be difficult. This presents complications leading to socio-economic and public health burdens. The accelerative wound healing potential of biocompatible poly(3-hydroxyalkanoates)-co-(6-hydroxyhexanoate) (PHA-PCL) composite hydrogel is reported herein.
   The biosynthesized PHA-PCL macromer was cross-linked with PEGMA to give a hydrogel. Twenty-four rats weighing 200-250 g each were randomly assigned to four groups of six rats. Rats in group I (negative control) were dressed with sterilized gum acacia paste in 10% normal saline while PEGMA-alone hydrogel (PH) was used to dress group II (secondary control) rats. Group III rats were dressed with PHAs-PCL cross-linked PEGMA hydrogel (PPH). For the positive control (group IV), the rats were dressed with Intrasite (R) gel.
   Biochemical, histomorphometric and immunohistomorphometric analyses revealed a significant difference in area closure and re-epithelialization on days 7 and 14 in PPH or Intrasite (R) gel groups compared to gum acacia or PEGMA-alone groups. Furthermore, wounds dressed with PPH or Intrasite (R) gel showed evident collagen deposition, enhanced fibrosis and extensively organized angiogenesis on day 14 compared to the negative control group. While improvement in wound healing of the PH dressed group could be observed, there was no significant difference between the negative control group and the PH dressed group in any of the tests.
   The findings suggested that topical application of PPH accelerated the rats' wound healing process by improving angiogenesis attributed to the increased microvessel density (MVD) and expressions of VEGF-A in tissue samples. Thus, PPH has been demonstrated to be effective in the treatment of cutaneous wounds in rats, and could be a potential novel agent in the management and acceleration of wound healing in humans and animals.
C1 [Gumel, Ahmad Mohammed; Razaif-Mazinah, Mohd Rafais Mohd; Anis, Siti Nor Syairah; Annuar, Mohamad Suffian Mohamad] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
RP Gumel, AM (reprint author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
EM gumel@um.edu.my
RI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/B-9031-2010
OI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/0000-0003-3387-0160
FU University of Malaya [BK014-2014, UM.C/625/1/HIR/MOHE/05]
FX The authors acknowledge the University of Malaya for research grants
   BK014-2014 and UM.C/625/1/HIR/MOHE/05.
CR Abdulla MA, 2010, BIOMED RES-INDIA, V21, P241
   Agarwal PK, 2009, INDIAN J EXP BIOL, V47, P32
   Al-Bayaty F, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/468764
   Bai MY, 2014, J BIOMED MATER RES A, V102, P2324, DOI 10.1002/jbm.a.34912
   Claria J, 2006, RECENT PAT ANTI-CANC, V1, P369, DOI 10.2174/157489206778776961
   Clarke S, 2006, ULTRAVIOLET LIGHT DI
   Collins N, 2001, Adv Skin Wound Care, V14, P288, DOI 10.1097/00129334-200111000-00008
   DAVIDSON JM, 1985, J CELL BIOL, V100, P1219, DOI 10.1083/jcb.100.4.1219
   de Oliveira AP, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/472382
   Debono R, 2000, THESIS DURHAM U
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045
   Dong YX, 2012, MACROMOL RAPID COMM, V33, P120, DOI 10.1002/marc.201100534
   Dong YX, 2012, J MATER SCI-MATER M, V23, P25, DOI 10.1007/s10856-011-4496-z
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Ehrlich HP, 2006, WOUND REPAIR REGEN, V14, P625, DOI 10.1111/j.1743-6109.2006.00170.x
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305
   Fournier D, 2007, MACROMOLECULES, V40, P915, DOI 10.1021/ma062199r
   GROTENDORST GR, 1985, J CLIN INVEST, V76, P2323, DOI 10.1172/JCI112243
   Gumel A., 2013, INT J CHEM REACT ENG, V11, P609
   Gumel AM, 2013, J POLYM ENVIRON, V21, P580, DOI 10.1007/s10924-012-0527-1
   Gumel AM, 2013, INT J BIOL MACROMOL, V55, P127, DOI 10.1016/j.ijbiomac.2012.12.028
   Gumel AM, 2013, ULTRASON SONOCHEM, V20, P937, DOI 10.1016/j.ultsonch.2012.09.015
   Gumel AM, 2012, POLYM DEGRAD STABIL, V97, P1224, DOI 10.1016/j.polymdegradstab.2012.05.041
   Gumel AM, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41149
   Gumel AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045214
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Hajiaghaalipour F, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/386734
   Howdieshell TR, 2001, J SURG RES, V96, P173, DOI 10.1006/jsre.2001.6089
   Kant V, 2015, J SURG RES, V193, P978, DOI 10.1016/j.jss.2014.10.019
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Li G, 2015, J BIOMED NANOTECHNOL, V11, P105, DOI 10.1166/jbn.2015.2053
   Li J, 1999, MACROMOLECULES, V32, P2789, DOI 10.1021/ma981816b
   Ma JT, 2009, J MOL CATAL B-ENZYM, V56, P151, DOI 10.1016/j.molcatb.2008.03.012
   MAJNO G, 1971, SCIENCE, V173, P548, DOI 10.1126/science.173.3996.548
   Murthy S, 2013, BIOMED RES INT, DOI 10.1155/2013/972028
   Nguyen DT, 2009, WOODHEAD PUBL MATER, P25, DOI 10.1533/9781845695545.1.25
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Saad GR, 2012, POLYM-PLAST TECHNOL, V51, P1113, DOI 10.1080/03602559.2012.680568
   Saranya S, 2014, J BIOACT COMPAT POL, V29, P152, DOI 10.1177/0883911513520380
   SARGENT JM, 1989, BRIT J CANCER, V60, P206, DOI 10.1038/bjc.1989.252
   Sellmayer A, 1999, LIPIDS, V34, pS13, DOI 10.1007/BF02562222
   Shukla A, 1999, PHYTOTHER RES, V13, P50, DOI 10.1002/(SICI)1099-1573(199902)13:1<50::AID-PTR368>3.3.CO;2-M
   Slavin J, 1996, J PATHOL, V178, P5
   Souba W, 1999, MODERN NUTR HLTH DIS, P618
   Teramoto N, 2008, MOLECULES, V13, P1773, DOI 10.3390/molecules13081773
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
   Tsou R, 2002, WOUND REPAIR REGEN, V10, P222, DOI 10.1046/j.1524-475X.2002.10405.x
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Nguyen VC, 2013, INT J POLYM SCI, DOI 10.1155/2013/106570
   Wang K, 2010, CARBOHYD POLYM, V79, P755, DOI 10.1016/j.carbpol.2009.10.004
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Xiong YC, 2010, J BIOMAT SCI-POLYM E, V21, P127, DOI 10.1163/156856209X410283
   Xu Y, 2013, DRUG DEV IND PHARM, V40, P1
   Yao YC, 2008, BIOMATERIALS, V29, P4823, DOI 10.1016/j.biomaterials.2008.09.008
   Zhang XZ, 2005, POLYMER, V46, P9664, DOI 10.1016/j.polymer.2005.08.055
   Zhang Z, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-24
NR 62
TC 3
Z9 3
U1 1
U2 26
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045001
DI 10.1088/1748-6041/10/4/045001
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600002
PM 26154416
DA 2018-10-20
ER

PT J
AU Lorenzetti, M
   Bernardini, G
   Luxbacher, T
   Santucci, A
   Kobe, S
   Novak, S
AF Lorenzetti, M.
   Bernardini, G.
   Luxbacher, T.
   Santucci, A.
   Kobe, S.
   Novak, S.
TI Surface properties of nanocrystalline TiO2 coatings in relation to the
   in vitro plasma protein adsorption
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE anatase nanocrystalline coatings; plasma protein adsorption; UV
   photo-activation; zeta potential; proteomics; 2D-PAGE
ID UV-PHOTOFUNCTIONALIZED TITANIUM; HUMAN SERUM-ALBUMIN; BIOMATERIAL
   SURFACES; ADHESION; BLOOD; MECHANISM; HYDRATION; INSIGHTS; CONTACT;
   RUTILE
AB This study reports on the selective adsorption of whole plasma proteins on hydrothermally (HT) grown TiO2-anatase coatings and its dependence on the three main surface properties: surface charge, wettability and roughness. The influence of the photo-activation of TiO2 by UV irradiation was also evaluated. Even though the protein adhesion onto Ti-based substrates was only moderate, better adsorption of any protein (at pH = 7.4) occurred for the most negatively charged and hydrophobic substrate (Ti non-treated) and for the most nanorough and hydrophilic surface (HT Ti3), indicating that the mutual action of the surface characteristics is responsible for the attraction and adhesion of the proteins. The HT coatings showed a higher adsorption of certain proteins (albumin 'passivation' layer, apolipoproteins, vitamin D-binding protein, ceruloplasmin, alpha-2-HS-glycoprotein) and higher ratios of albumin to fibrinogen and albumin to immunoglobulin gamma-chains. The UV pre-irradiation affected the surface properties and strongly reduced the adsorption of the proteins. These results provide in-depth knowledge about the characterization of nanocrystalline TiO2 coatings for body implants and provide a basis for future studies on the hemocompatibility and biocompatibility of such surfaces.
C1 [Lorenzetti, M.; Kobe, S.; Novak, S.] Jozef Stefan Inst, Dept Nanostruct Mat, Ljubljana 1000, Slovenia.
   [Lorenzetti, M.; Kobe, S.; Novak, S.] Jozef Stefan Int Postgrad Sch, Ljubljana 1000, Slovenia.
   [Bernardini, G.; Santucci, A.] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy.
   [Luxbacher, T.] Anton Paar GmbH, A-8054 Graz, Austria.
RP Lorenzetti, M (reprint author), Jozef Stefan Inst, Dept Nanostruct Mat, Jamova Cesta 39, Ljubljana 1000, Slovenia.
EM martina.lorenzetti@ijs.si; sasa.novak@ijs.si
RI Santucci, Annalisa/K-1932-2018
OI Santucci, Annalisa/0000-0001-6976-9086; Luxbacher,
   Thomas/0000-0002-5472-8203; Lorenzetti, Martina/0000-0002-2557-7899
FU European Commission [FP7-PEOPLE-2010-ITN-264635]
FX Funding by the European Commission within the framework of the FP7-ITN
   network BioTiNet (FP7-PEOPLE-2010-ITN-264635) is acknowledged.
CR Bernardini G, 2014, MOL BIOSYST, V10, P1305, DOI 10.1039/c3mb70328b
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068086
   Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hori N, 2010, ACTA BIOMATER, V6, P4175, DOI 10.1016/j.actbio.2010.05.006
   Huang Y, 2010, ACTA BIOMATER, V6, P2083, DOI 10.1016/j.actbio.2009.12.035
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024
   Jachimska B, 2012, BIOELECTROCHEMISTRY, V87, P138, DOI 10.1016/j.bioelechem.2011.09.004
   Jansson E, 2004, COLLOID SURFACE B, V35, P45, DOI 10.1016/j.colsurfb.2004.02.007
   JONES P, 1971, T FARADAY SOC, V67, P2679, DOI 10.1039/tf9716702679
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Labarre D, 2012, POLYMERS-BASEL, V4, P986, DOI 10.3390/polym4020986
   Lazzeri M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.155409
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lorenzetti M, 2014, MAT SCI ENG C-MATER, V37, P390, DOI 10.1016/j.msec.2014.01.029
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   MAKINO K, 1987, J COLLOID INTERF SCI, V115, P65, DOI 10.1016/0021-9797(87)90009-9
   Marucco A, 2013, J PHYS CONF SER, V429, DOI 10.1088/1742-6596/429/1/012014
   MUNUERA G, 1971, DISCUSS FARADAY SOC, P205
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P285, DOI 10.1016/0021-9797(78)90306-5
   Oshida Y., 2007, BIOSCIENCE BIOENGINE, P157
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   SAROFF HA, 1963, J PHYS CHEM-US, V67, P1211, DOI 10.1021/j100800a011
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   TENGVALL P, 2001, TITANIUM MED, P457
   Tengvall P., 2011, COMPREHENSIVE BIOMAT, P63
   Textor M., 2001, TITANIUM MED, P171
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zimmermann R, 2010, CURR OPIN COLLOID IN, V15, P196, DOI 10.1016/j.cocis.2010.01.002
NR 44
TC 6
Z9 6
U1 5
U2 36
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2015
VL 10
IS 4
AR 045012
DI 10.1088/1748-6041/10/4/045012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CP9LK
UT WOS:000360215600013
PM 26225819
DA 2018-10-20
ER

PT J
AU Ajioka, I
AF Ajioka, I.
TI Understanding self-repairing potential by biological and biomaterial
   engineering approaches for brain regeneration
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
CT 25th Biennial Meeting of the International-Society-for-Neurochemistry
   Jointly with the 13th Meeting of the
   Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th
   Meeting of the Australasian-Neuroscience-Society
CY AUG 23-27, 2015
CL Cairns, AUSTRALIA
SP Int Soc Neurochemistry, Asian Pacific Soc Neurochemistry, Australasian Neuroscience Soc
C1 [Ajioka, I.] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD AUG
PY 2015
VL 134
SU 1
SI SI
MA W03-04
BP 88
EP 88
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA CP9IA
UT WOS:000360206300177
DA 2018-10-20
ER

PT J
AU Castillo-Dali, G
   Velazquez-Cayon, R
   Serrera-Figallo, MA
   Rodriguez-Gonzalez-Elipe, A
   Gutierrez-Perez, JL
   Torres-Lagares, D
AF Castillo-Dali, Gabriel
   Velazquez-Cayon, Rocio
   Angeles Serrera-Figallo, M.
   Rodriguez-Gonzalez-Elipe, Agustin
   Gutierrez-Perez, Jose-Luis
   Torres-Lagares, Daniel
TI Importance of Poly(lactic-co-glycolic acid) in Scaffolds for Guided Bone
   Regeneration: A Focused Review
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Review
DE biopolymers; scaffold; PLGA; GTR; GBR; bone; regeneration; biomaterial
ID TISSUE REGENERATION; FABRICATION; BEHAVIOR; CELLS
AB Total or partial tissue damage and loss of function in an organ are two of the most serious and costly issues in human health. Initially, these problems were approached through organ and allogenic tissue transplantation, but this option is limited by the scarce availability of donors. In this manner, new bone for restoring or replacing lost and damaged bone tissue is an important health and socioeconomic necessity. Tissue engineering has been used as a strategy during the 21st century for mitigating this need through the development of guided bone regeneration scaffold and composites. In this manner, compared with other traditional methods, bone tissue engineering offers a new and interesting approach to bone repair. The poly-alpha-hydroxy acids, which include the copolymers of lactic acid and glycolic acid, have been used commonly in the fabrication of these scaffolds. The objective of our article was to review the characteristics and functions of scaffold with biomedical applications, with special interest in scaffold construction using poly(lactic-co-glycolic acid) polymers, in order to update the current methods used for fabrication and to improve the quality of these scaffolds, integrating this information into the context of advancements made in tissue engineering based on these structures. In the future, research into bone regeneration should be oriented toward a fruitful exchange between disciplines involved in tissue engineering, which is coming very close to filling the gaps in our ability to provide implants and restoration of functionality in bone tissue. Overcoming this challenge will provide benefits to a major portion of the population and facilitate substantial improvements to quality of life.
C1 [Castillo-Dali, Gabriel; Velazquez-Cayon, Rocio; Angeles Serrera-Figallo, M.; Torres-Lagares, Daniel] Univ Seville, Seville, Spain.
   [Rodriguez-Gonzalez-Elipe, Agustin] Inst Sci Mat, Seville, Spain.
   [Gutierrez-Perez, Jose-Luis] Virgen de Rocio Hosp, Andalusian Hlth Serv, Seville, Spain.
RP Torres-Lagares, D (reprint author), Univ Seville, Seville, Spain.
EM danieltl@us.es
OI CASTILLO-DALI, GABRIEL/0000-0001-5795-9958; Gutierrez Perez, Jose
   Luis/0000-0003-2624-1454
CR Aboudzadeh N, 2010, J BIOMED MATER RES A, V94A, P137, DOI 10.1002/jbm.a.32673
   Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   Alvarez-Barreto JF, 2009, REV ESTUDIOS TRANSDI, V1, P98
   Ge ZG, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/021001
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Huang YX, 2010, J BIOMED MATER RES A, V95A, P993, DOI 10.1002/jbm.a.32922
   Hutmacher D, 1996, INT J ORAL MAXILLOF, V11, P668
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim Y, 2006, J APPL POLYM SCI, V101, P1657, DOI 10.1002/app.22196
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lopez-Santos C, 2010, ACS APPL MATER INTER, V2, P980, DOI 10.1021/am100052w
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   MELCHER AH, 1976, J PERIODONTOL, V47, P256, DOI 10.1902/jop.1976.47.5.256
   Molina-Lorenzo MJ, 2009, PLASTICS APPL MED
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   NYMAN S, 1990, International Journal of Oral and Maxillofacial Implants, V5, P9
   Okada K, 2003, KOREA-AUST RHEOL J, V15, P43
   Park JB, 2011, MED ORAL PATOL ORAL, V16, pE115, DOI 10.4317/medoral.16.e115
   PONTORIERO R, 1988, J CLIN PERIODONTOL, V15, P247, DOI 10.1111/j.1600-051X.1988.tb01578.x
   Qi RL, 2013, COLLOID SURFACE B, V110, P148, DOI 10.1016/j.colsurfb.2013.04.036
   Rojas-Cortes MG, 2008, INGENIERIA INVESTIGA, V28, P57
   Shin M, 2008, J BIOMED MATER RES A, V84A, P702, DOI 10.1002/jbm.a.31392
   Spicer PP, 2013, ACTA BIOMATER, V9, P8832, DOI 10.1016/j.actbio.2013.07.018
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zong C, 2010, EUR CELLS MATER, V20, P109
NR 28
TC 6
Z9 6
U1 5
U2 49
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2015
VL 41
IS 4
BP E152
EP E157
DI 10.1563/AAID-JOI-D-13-00225
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP8QK
UT WOS:000360159000010
PM 24552153
DA 2018-10-20
ER

PT J
AU Catros, S
   Molenberg, A
   Freilich, M
   Dard, M
AF Catros, Sylvain
   Molenberg, Aart
   Freilich, Martin
   Dard, Michel
TI Evaluation of a Polyethylene Glycol-Osteogenic Protein-1 System on
   Alveolar Bone Regeneration in the Mini-Pig
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE polyethylene glycol; osteogenic protein-1; minipig histomorphometry;
   alveolar bone regeneration; dose response
ID SINUS FLOOR AUGMENTATION; PLATELET-RICH PLASMA; MORPHOGENETIC PROTEIN-7;
   MANDIBULAR RECONSTRUCTION; PARATHYROID-HORMONE; RIDGE AUGMENTATION;
   MAXILLARY SINUS; DENTAL IMPLANTS; MINIATURE PIGS; DEFECTS
AB Alveolar bone regeneration associated with the local release of osteogenic protein-1 (OP-1) from a polyethylene glycol (PEG) scaffold was evaluated in 14 mini-pigs. Following extraction of mandibular teeth and 26-weeks of healing time, standardized bone defects were created bilaterally in the posterior mandibles (3 sites for each hemimandible) that were randomly assigned to treatment groups. Seven treatments groups were compared: 4 different concentrations of the PEG/OP-1 test system (n = 14 for each), a positive control (collagen/OP-1, n = 14), a negative control (PEG only, n = 7) and nontreated defects (n = 7). Each animal provided all test and control groups. The animals were sacrificed after 3 weeks of healing and samples were processed for histology and histomorphometry. Three weeks after implantation, there were positive clinical responses for all test groups. Earlier bone maturation was observed in the test groups that had higher concentrations of OP-1 (0.25, 0.5, or 1 mg/mL) compared to the negative control group (PEG alone), the low concentration group (0.1 mg/mL), and the positive control group (collagen/OP-1). However, histomorphometric quantitative analyses did not reveal any statistical difference between any of the groups. No residual PEG biomaterial or inflammatory responses to the biomaterial or growth factor were observed. This study confirmed the safe local delivery of OP-1 from PEG hydrogel. Alveolar bone regeneration was not statistically different between tests groups, negative control (PEG alone) or commercial positive control (collagen/OP-1). The semi-quantitative analysis, however, showed a trend in favor of the higher concentrations of OP-1 to induce faster bone maturation.
C1 [Catros, Sylvain] Bordeaux Segalen Univ, INSERM, U1026, BioTis, Bordeaux, France.
   [Catros, Sylvain] CHU Bordeaux, Pole Odontol & Sante Buccale, Bordeaux, France.
   [Molenberg, Aart; Dard, Michel] Inst Straumann AG, Basel, Switzerland.
   [Freilich, Martin] Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Biomat, Farmington, CT 06032 USA.
   [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA.
RP Catros, S (reprint author), Bordeaux Segalen Univ, INSERM, U1026, BioTis, Bordeaux, France.
EM sylvaincatros@hotmail.com
CR Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Clokie CML, 2008, J CAN DENT ASSOC, V74, P67
   Corinaldesi G, 2013, BRIT J ORAL MAX SURG, V51, P247, DOI 10.1016/j.bjoms.2012.06.004
   Dahlin C, 2014, CLIN ORAL IMPLAN RES, V25, P16, DOI 10.1111/clr.12076
   Dard M, 2012, WOODH PUBL SER BIOM, V50, P308
   Dard M, 1997, CELL ENG, V2, P1
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Grainger DW, 2012, ADV DRUG DELIVER REV, V64, P1061, DOI 10.1016/j.addr.2012.08.001
   Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013
   Howell T. H., 1997, INT J PERIODONT REST, V17, P124
   Jensen SS, 2009, J BIOMED MATER RES B, V90B, P171, DOI 10.1002/jbm.b.31271
   Joshi A, 2004, BRIT DENT J, V196, P167, DOI 10.1038/sj.bdj.4810945
   Jung RE, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2008.01270.x
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Jung RE, 2007, INT J ORAL MAX IMPL, V22, P258
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P162, DOI 10.1111/j.1600-0501.2008.01634.x
   Kaigler Darnell, 2006, Expert Opin Drug Deliv, V3, P647, DOI 10.1517/17425247.3.5.647
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mardas N, 2014, J INVEST SURG, V27, P32, DOI 10.3109/08941939.2013.817628
   Reid B, 2015, J TISSUE ENG REGEN M, V9, P315, DOI 10.1002/term.1688
   Roldan JC, 2004, CLIN ORAL IMPLAN RES, V15, P716, DOI 10.1111/j.1600-0501.2004.01070.x
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Silva Fabricio Moreira Serrae, 2006, Implant Dent, V15, P420, DOI 10.1097/01.id.0000246225.51298.67
   Susin C, 2010, J CLIN PERIODONTOL, V37, P574, DOI 10.1111/j.1600-051X.2010.01554.x
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Terheyden H, 2004, INT J ORAL MAX SURG, V33, P164, DOI 10.1016/j.ijom.2003.08.009
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008
   Thoma DS, 2014, CLIN ORAL IMPLAN RES, V25, P511, DOI 10.1111/clr.12203
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P7, DOI 10.1111/j.1600-0501.2008.01604.x
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   Wang HM, 2004, J BIOMED MATER RES A, V68A, P219, DOI 10.1002/jbm.a.10129
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Warnke PH, 2003, PLAST RECONSTR SURG, V111, P2471, DOI 10.1097/01.PRS.0000063110.10932.9B
NR 36
TC 1
Z9 1
U1 1
U2 3
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2015
VL 41
IS 4
BP E96
EP E101
DI 10.1563/AAID-JOI-D-13-00307
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP8QK
UT WOS:000360159000002
PM 24673473
DA 2018-10-20
ER

PT J
AU Havlucu, U
   Bolukbasi, N
   Yeniyol, S
   Cetin, S
   Ozdemir, T
AF Havlucu, Ugur
   Bolukbasi, Nilufer
   Yeniyol, Sinem
   Cetin, Sule
   Ozdemir, Tayfun
TI Effects of Light-Emitting Diode Photobiomodulation Therapy and BioOss as
   Single and Combined Treatment in an Experimental Model of Bone Defect
   Healing in Rats
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE light-emitting diode; photobiomodulation; deproteinized bovine bone
   graft; histomorphometry; histopathology
ID LOW-LEVEL LASER; BOVINE BONE; REPAIR; PHOTOTHERAPY; IRRADIATION;
   REGENERATION; PREVENTION; MOVEMENT; NEURONS; CELLS
AB The present study assesses histopathologically and histomorphometrically the effects of light-emitting diode (LED) photobiomodulation therapy (LPT) on bone healing in BioOss-filled femoral defects of rats. It has been reported that LPT modulates cellular metabolic processes, leading to an enhanced regenerative potential for biological tissues. Thirty-six male Wistar rats with femoral bone defects were divided into 4 groups: defect group (empty bone defect, without application of LPT), graft group (bone defect filled with BioOss, without application of LPT), (defect+LPT) group (empty bone defect, with application of LPT), and (graft+LPT) group (bone defect filled with BioOss, with application of LPT). An OsseoPulse LED device (wavelength: 618 nm; output power: 20 mW/cm(2)) was initiated 24 hours postsurgery and performed every 24 hours for 7, 14, and 21 days. The LPT-applied and BioOss-filled defects presented a higher amount of new bone formation with trabeculae formation. These defects showed statistically significant lower values of inflammation severity, and fewer remnants of biomaterial were present. Within the limitations of this study, LPT has positive effects on bone healing histopathologically and histomorphometrically for the defects filled with BioOss 3 weeks after the rats' femora injury.
C1 [Havlucu, Ugur; Bolukbasi, Nilufer; Yeniyol, Sinem; Ozdemir, Tayfun] Istanbul Univ, Fac Dent, Dept Oral Implantol, Istanbul, Turkey.
   [Cetin, Sule] Marmara Univ, Sch Med, Dept Histol & Embryol, Istanbul, Turkey.
RP Bolukbasi, N (reprint author), Istanbul Univ, Fac Dent, Dept Oral Implantol, Istanbul, Turkey.
EM dr.niluferbolukbasi@hotmail.com
CR AboElsaad NS, 2009, LASER MED SCI, V24, P527, DOI 10.1007/s10103-008-0590-y
   Brawn PR, 2007, IMPLANT DENT, V16, P204, DOI 10.1097/ID.0b013e318065a84c
   Brignardello-Petersen R, 2012, J ORAL MAXIL SURG, V70, P1789, DOI 10.1016/j.joms.2012.01.008
   Cafaro A, 2010, PHOTOMED LASER SURG, V28, DOI 10.1089/pho.2009.2655
   Cankaya AB, 2011, INT J MED SCI, V8, P667, DOI 10.7150/ijms.8.667
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Sousa MVD, 2011, PHOTOMED LASER SURG, V29, P191, DOI 10.1089/pho.2009.2652
   de Lima AG, 2012, INT J RADIAT ONCOL, V82, P270, DOI 10.1016/j.ijrobp.2010.10.012
   De Souza Thais Oricchio Fedri, 2010, Photomed Laser Surg, V28 Suppl 2, pS85, DOI 10.1089/pho.2009.2661
   Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Dortbudak O, 2002, CLIN ORAL IMPLAN RES, V13, P288, DOI 10.1034/j.1600-0501.2002.130308.x
   Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033
   Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100
   Ekizer A, 2015, LASER MED SCI, V30, P779, DOI 10.1007/s10103-013-1405-3
   Gavish L, 2004, LASER SURG MED, V35, P369, DOI 10.1002/lsm.20108
   Ghahroudi AAR, 2014, LASER MED SCI, V29, P925, DOI 10.1007/s10103-013-1403-5
   Guzzardella GA, 2003, CLIN ORAL IMPLAN RES, V14, P226, DOI 10.1034/j.1600-0501.2003.00872.x
   Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   Kamali F, 2007, J PHOTOCH PHOTOBIO B, V88, P11, DOI 10.1016/j.jphotobiol.2007.04.010
   KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015
   Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x
   Kaya GS, 2011, PHOTOMED LASER SURG, V29, P405, DOI 10.1089/pho.2010.2807
   Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x
   Kim YD, 2007, LASER SURG MED, V39, P441, DOI 10.1002/lsm.20508
   Kim YD, 2009, LASER MED SCI, V24, P577, DOI 10.1007/s10103-008-0614-7
   Kreisner PE, 2010, MED ORAL PATOL ORAL, V15, pE616, DOI 10.4317/medoral.15.e616
   Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200
   Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047
   Salmos-Brito JAL, 2013, LASER MED SCI, V28, P57, DOI 10.1007/s10103-012-1065-8
   Makhlouf M, 2012, PHOTOMED LASER SURG, V30, P160, DOI 10.1089/pho.2011.3069
   Maluf AP, 2012, LASER MED SCI, V25, P693
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Mercer C, 1996, Dent Update, V23, P74
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585
   Raghoebar GM, 2007, INT J ORAL MAX IMPL, V22, P359
   Rochkind S, 2004, PHOTOMED LASER SURG, V22, P249, DOI 10.1089/1549541041438579
   Freire MDS, 2014, CLIN ORAL INVEST, V18, P1005, DOI 10.1007/s00784-013-1058-4
   Shakouri SK, 2010, LASER MED SCI, V25, P73, DOI 10.1007/s10103-009-0670-7
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Uysal T, 2012, EUR J ORTHODONT, V34, P44, DOI 10.1093/ejo/cjq166
   Vescovi P, 2012, PHOTOMED LASER SURG, V30, P5, DOI 10.1089/pho.2010.2955
   Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200
   Yeager RL, 2006, PHOTOMED LASER SURG, V24, P29, DOI 10.1089/pho.2006.24.29
NR 47
TC 2
Z9 2
U1 1
U2 5
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2015
VL 41
IS 4
BP E110
EP E117
DI 10.1563/AAID-JOI-D-13-00310
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP8QK
UT WOS:000360159000004
PM 24766197
DA 2018-10-20
ER

PT J
AU Bencherif, SA
   Sands, RW
   Ali, OA
   Li, WA
   Lewin, SA
   Braschler, TM
   Shih, TY
   Verbeke, CS
   Bhatta, D
   Dranoff, G
   Mooney, DJ
AF Bencherif, Sidi A.
   Sands, R. Warren
   Ali, Omar A.
   Li, Weiwei A.
   Lewin, Sarah A.
   Braschler, Thomas M.
   Shih, Ting-Yu
   Verbeke, Catia S.
   Bhatta, Deen
   Dranoff, Glenn
   Mooney, David J.
TI Injectable cryogel-based whole-cell cancer vaccines
SO NATURE COMMUNICATIONS
LA English
DT Article
ID COLONY-STIMULATING FACTOR; DENDRITIC CELLS; TUMOR-IMMUNOTHERAPY;
   IN-VIVO; PHASE-I; GM-CSF; MELANOMA; SAFETY; THERAPY; RESPONSES
AB A biomaterial-based vaccination system that uses minimal extracorporeal manipulation could provide in situ enhancement of dendritic cell (DC) numbers, a physical space where DCs interface with transplanted tumour cells, and an immunogenic context. Here we encapsulate GM-CSF, serving as a DC enhancement factor, and CpG ODN, serving as a DC activating factor, into sponge-like macroporous cryogels. These cryogels are injected subcutaneously into mice to localize transplanted tumour cells and deliver immunomodulatory factors in a controlled spatio-temporal manner. These vaccines elicit local infiltrates composed of conventional and plasmacytoid DCs, with the subsequent induction of potent, durable and specific anti-tumour T-cell responses in a melanoma model. These cryogels can be delivered in a minimally invasive manner, bypass the need for genetic modification of transplanted cancer cells and provide sustained release of immunomodulators. Altogether, these findings indicate the potential for cryogels to serve as a platform for cancer cell vaccinations.
C1 [Bencherif, Sidi A.; Sands, R. Warren; Ali, Omar A.; Li, Weiwei A.; Lewin, Sarah A.; Braschler, Thomas M.; Shih, Ting-Yu; Verbeke, Catia S.; Bhatta, Deen; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Bencherif, Sidi A.; Sands, R. Warren; Ali, Omar A.; Li, Weiwei A.; Lewin, Sarah A.; Braschler, Thomas M.; Shih, Ting-Yu; Verbeke, Catia S.; Bhatta, Deen; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Bencherif, Sidi A.] Univ Technol Compiegne, Univ Sorbonne, UTC CNRS UMR 7338, Biomech & Bioengn BMBI, F-60205 Compiegne, France.
   [Sands, R. Warren] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA 15232 USA.
   [Braschler, Thomas M.] Ecole Polytech Fed Lausanne, Stn 17, LMIS4, Sch Engn, CH-1015 Lausanne, Switzerland.
   [Dranoff, Glenn] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.
   [Dranoff, Glenn] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02215 USA.
   [Dranoff, Glenn] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA.
   [Dranoff, Glenn] Harvard Univ, Sch Med, Boston, MA 02215 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Li, Aileen/0000-0002-1056-5932
FU National Institutes of Health [5R01DE019917-03, F30DK088518-03,
   T32-GM008152, 1UL1 TR001102]; Swiss National Fonds [PBELP3-133350]
FX We thank Mr Thomas Ferrante and Dr James Weaver at the Wyss Institute
   for their technical assistance with confocal microscopy and scanning
   electron microscopy, respectively. This research was financially
   supported by the National Institutes of Health grants 5R01DE019917-03,
   F30DK088518-03 and T32-GM008152, and the Swiss National Fonds (grant
   PBELP3-133350). Dr. Roger B. Davis from the Harvard Catalyst
   Biostatistical Consulting Program funded by the National Institutes of
   Health (grant 1UL1 TR001102) is acknowledged.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Ali A., 2011, BIOMATTER, V1, P66
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Becker JC, 2010, EXP DERMATOL, V19, P157, DOI 10.1111/j.1600-0625.2009.00986.x
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079
   Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694
   Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609
   Buckwalter M., 2007, J IMMUNOL, V178, P16
   Cann SAH, 2003, POSTGRAD MED J, V79, P672
   Caulfield JJ, 1999, IMMUNOLOGY, V98, P104
   Chiang CLL, 2010, SEMIN IMMUNOL, V22, P132, DOI 10.1016/j.smim.2010.02.004
   Copier J, 2010, CURR OPIN MOL THER, V12, P14
   Davis MB, 2011, CLIN CANCER RES, V17, P3984, DOI 10.1158/1078-0432.CCR-10-3262
   Dhodapkar MV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008068
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539
   Eggermont AM, 2014, J CLIN ONCOL, V32
   Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494
   Gubeli RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02610
   Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133
   Herlyn M, 2010, J INVEST DERMATOL, V130, P911, DOI 10.1038/jid.2009.441
   Hinrichs CS, 2014, AM J CLIN ONCOL-CANC, V32, P3008
   Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495
   Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294
   Kaufman HL, 2012, SEMIN ONCOL, V39, P263, DOI 10.1053/j.seminoncol.2012.02.011
   Keenan BP, 2012, SEMIN ONCOL, V39, P276, DOI 10.1053/j.seminoncol.2012.02.007
   Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817
   Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108
   Li WA, 2013, CURR OPIN IMMUNOL, V25, P238, DOI 10.1016/j.coi.2012.12.008
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Liu YR, 2014, BIOMACROMOLECULES, V15, P3836, DOI 10.1021/bm501166j
   Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X
   Mansoor W, 2005, BRIT J CANCER, V93, P1085, DOI 10.1038/sj.bjc.6602839
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258
   Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394
   Ribas A, 2014, J CLIN ONCOL, V32, P9000, DOI DOI 10.1200/JCO.2013.54.6911
   Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017
   Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x
   SHRAYER D, 1995, CANCER IMMUNOL IMMUN, V40, P277, DOI 10.1007/s002620050174
   Singh A, 2011, J CONTROL RELEASE, V155, P184, DOI 10.1016/j.jconrel.2011.06.008
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122
   Sznol M, 2014, J CLIN ONCOL, V32, pLBA
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130
   Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802
   Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5
   Wu QJ, 2011, GROWTH FACTORS, V29, P290, DOI 10.3109/08977194.2011.624517
   Zacharski LR, 2005, J THROMB HAEMOST, V3, P424, DOI 10.1111/j.1538-7836.2005.01110.x
NR 56
TC 64
Z9 64
U1 5
U2 72
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG
PY 2015
VL 6
AR 7556
DI 10.1038/ncomms8556
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ1EI
UT WOS:000360339700001
PM 26265369
OA DOAJ Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Assal, Y
   Mizuguchi, Y
   Mie, M
   Kobatake, E
AF Assal, Yasmine
   Mizuguchi, Yoshinori
   Mie, Masayasu
   Kobatake, Eiry
TI Growth Factor Tethering to Protein Nanoparticles via Coiled-Coil
   Formation for Targeted Drug Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID MOLTEN GLOBULE; POLYMER THERAPEUTICS; FLUORESCENT-PROBE; POLYPEPTIDE;
   PEPTIDES; MATRIX; STATE
AB Protein-based nanoparticles are attractive carriers for drug delivery because they are biodegradable and can be genetically designed. Moreover, modification of protein-based nanoparticles with cell-specific ligands allows for active targeting abilities. Previously, we developed protein nanoparticles comprising genetically engineered elastin-like polypeptides (ELPs) with fused polyaspartic acid tails (ELP-D). Epidermal growth factor (EGF) was displayed on the surface of the ELP-D nanoparticles via genetic design to allow for active cell-targeting abilities. Herein, we focused on the coiled-coil structural motif as a means for noncovalent tethering of growth factor to ELP-D. Specifically, two peptides known to form a heterodimer via a coiled-coil structural motif were fused to ELP-D and single-chain vascular endothelial growth factor (scVEGF(121)), to facilitate noncovalent tethering upon formation of the heterodimer coiled-coil structure. Drug-loaded growth factor-tethered ELP-Ds were found to be effective against cancer cells by provoking cell apoptosis. These results demonstrate that tethering growth factor to protein nanoparticles through coiled-coil formation yields a promising biomaterial candidate for targeted drug delivery.
C1 [Assal, Yasmine; Mizuguchi, Yoshinori; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268052, Japan.
RP Kobatake, E (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268052, Japan.
EM kobatake.e.aa@m.titech.ac.jp
RI Mie, Masayasu/C-5995-2015
OI Mie, Masayasu/0000-0003-2255-3346
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   JSPS Institutional Program for Young Researcher Overseas Visits
FX This work was financially supported by Grants-in-aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan and JSPS Institutional Program for Young Researcher
   Overseas Visits. We are also grateful to Ms. Keiko Ikeda from the
   Technical Department of the Tokyo Institute of Technology for technical
   support with the transmission electron microscope imaging.
CR Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   Boesen TP, 2002, J BIOL CHEM, V277, P40335, DOI 10.1074/jbc.M204107200
   Boucher C, 2010, BIOMATERIALS, V31, P7021, DOI 10.1016/j.biomaterials.2010.05.072
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Fujita Y, 2009, BIOMATERIALS, V30, P3450, DOI 10.1016/j.biomaterials.2009.03.012
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Kobatake E, 2011, BIOCONJUGATE CHEM, V22, P2038, DOI 10.1021/bc200249u
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   Matsumoto R, 2014, J BIOMED MATER RES B, V102, P1792, DOI 10.1002/jbm.b.33162
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Meyer DE, 2001, CANCER RES, V61, P1548
   Mie M, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015004
   Murschel F, 2013, ACTA BIOMATER, V9, P6806, DOI 10.1016/j.actbio.2013.02.032
   OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T
   OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872
   Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016
   Pechar M, 2014, BIOMACROMOLECULES, V15, P2590, DOI 10.1021/bm500436p
   Pechar M, 2011, BIOMACROMOLECULES, V12, P3645, DOI 10.1021/bm200897b
   Pola R, 2013, BIOMACROMOLECULES, V14, P881, DOI 10.1021/bm3019592
   Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X
   SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   Urry DW, 1997, ANN NY ACAD SCI, V831, P32
   VIDAL BD, 1978, J HISTOCHEM CYTOCHEM, V26, P196
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yui H, 2005, LANGMUIR, V21, P721, DOI 10.1021/la040109a
NR 28
TC 15
Z9 15
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD AUG
PY 2015
VL 26
IS 8
BP 1672
EP 1677
DI 10.1021/acs.bioconjchem.5b00266
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CP5ZA
UT WOS:000359962900033
PM 26079837
DA 2018-10-20
ER

PT J
AU Dursun, E
   Dursun, CK
   Eratalay, K
   Orhan, K
   Celik, HH
   Tozum, TF
AF Dursun, Erhan
   Dursun, Ceyda Kanli
   Eratalay, Kenan
   Orhan, Kaan
   Celik, Hakan Hamdi
   Toezuem, Tolga Fikret
TI Do Porous Titanium Granule Grafts Affect Bone Microarchitecture at
   Augmented Maxillary Sinus Sites? A Pilot Split-Mouth Human Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE sinus; bone substitute; microtomography; human; dental implant
ID RESIDUAL RIDGE RESORPTION; MICROCOMPUTED TOMOGRAPHY; AUTOGENOUS BONE;
   COMPUTED-TOMOGRAPHY; FLOOR AUGMENTATION; BOVINE BONE; DENSITY;
   QUANTIFICATION; OSTEOPOROSIS; BIOMATERIAL
AB Background:The aim of this randomized controlled clinical study was to analyze the bone microarchitecture at augmented maxillary sinus sites by using different materials in patients to compare the effect of porous titanium granules as a sinus augmentation material with bone microstructural features.Materials and Methods:Eight subjects with bilateral atrophic posterior maxilla of residual bone height <4 mm included in this study and each patient was treated with bilateral sinus augmentation procedure using xenograft with equine origin (Apatos, Osteobiol; Tecnoss Dental) and xenograft (1 g) + porous titanium (1 g) granules (Natix; Tigran Technologies AB). Sixteen human bone biopsy samples were taken from patients receiving two-stage sinus augmentation therapy during implant installation and analyzed using microcomputerized tomography. Three-dimensional bone structural parameters were analyzed in details: tissue volume, bone volume, percentage of bone volume, bone surface and bone surface density, bone specific surface, trabecular thickness trabecular separation, trabecular number, trabecular pattern factor, structural model index, fractal dimension, and bone mineral density.Results:No statistically significant differences were found between groups according to bone structural parameters.Conclusions:Porous titanium grafts may ensure a space for new bone formation in the granules, which may be a clinical advantage for long-term success.
C1 [Dursun, Erhan; Eratalay, Kenan] Hacettepe Univ, Dept Periodontol, Fac Dent, Ankara, Turkey.
   [Orhan, Kaan] Ankara Univ, Dept Dentomaxillofacial Radiol, Fac Dent, TR-06100 Ankara, Turkey.
   [Celik, Hakan Hamdi] Hacettepe Univ, Fac Med, Dept Anat, TR-06100 Ankara, Turkey.
   [Toezuem, Tolga Fikret] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60612 USA.
RP Tozum, TF (reprint author), Univ Illinois, Coll Dent, Dept Periodont, 801 South Paulina St Room 469G, Chicago, IL 60612 USA.
EM ttozum@uic.edu
OI Celik, Hakan Hamdi/0000-0002-7909-7604; Orhan, Kaan/0000-0001-6768-0176
FU Hacettepe University, Scientific Research Projects Coordination Unit,
   Ankara, Turkey [011D10201003]
FX This study is supported by Hacettepe University, Scientific Research
   Projects Coordination Unit (Grant Number: 011D10201003), Ankara, Turkey.
CR Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Carballido-Gamio Julio, 2006, Curr Osteoporos Rep, V4, P64, DOI 10.1007/s11914-006-0004-7
   Carlsson Gunnar E, 2004, Gerodontology, V21, P65, DOI 10.1111/j.1741-2358.2004.00005.x
   Caubet J, 2011, J ORAL MAXIL SURG, V69, P482, DOI 10.1016/j.joms.2010.10.037
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Davis GR, 1996, PHYSIOL MEAS, V17, P121, DOI 10.1088/0967-3334/17/3/001
   Deluiz D, 2015, CLIN IMPLANT DENT R, V17, P296, DOI 10.1111/cid.12108
   Ekfeldt A, 2001, CLIN ORAL IMPLAN RES, V12, P462, DOI 10.1034/j.1600-0501.2001.120505.x
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Gedrange T, 2005, CLIN ORAL IMPLAN RES, V16, P425, DOI 10.1111/j.1600-0501.2005.01134.x
   HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Homolka P, 2002, RADIOLOGY, V224, P247, DOI 10.1148/radiol.2241010948
   Huang HL, 2012, CLIN ORAL IMPLAN RES, V23, P1098, DOI 10.1111/j.1600-0501.2011.02273.x
   Kim YJ, 2015, CLIN IMPLANT DENT R, V17, P307, DOI 10.1111/cid.12109
   Klemetti E, 1996, J PROSTHET DENT, V75, P512, DOI 10.1016/S0022-3913(96)90455-2
   Kuhl S, 2012, INT J ORAL MAX IMPL, V27, P1541
   Misch C E, 1989, Dent Today, V8, P39
   Misch CM, 2011, ORAL MAXIL SURG CLIN, V23, P229, DOI 10.1016/j.coms.2011.01.003
   Miyamoto S, 2013, CLIN ORAL IMPLAN RES, V24, P134, DOI 10.1111/j.1600-0501.2011.02396.x
   Monje A, 2015, CLIN IMPLANT DENT R, V17, P111, DOI 10.1111/cid.12075
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Ozan O, 2011, J CRANIOFAC SURG, V22, P1755, DOI 10.1097/SCS.0b013e31822e6305
   PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P645, DOI 10.1111/j.1600-0501.2012.02439.x
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P523, DOI 10.1111/j.1600-0501.2011.02414.x
   Pietrokovski Jaime, 2007, J Prosthodont, V16, P502, DOI 10.1111/j.1532-849X.2007.00225.x
   Rebaudi A, 2010, INT J ORAL MAX IMPL, V25, P75
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Soardi CM, 2014, CLIN IMPLANT DENT R, V16, P557, DOI 10.1111/cid.12016
   Southard TE, 2000, ORAL SURG ORAL MED O, V89, P244, DOI 10.1067/moe.2000.102223
   Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031
   Tosoni GM, 2006, ORAL SURG ORAL MED O, V102, P235, DOI 10.1016/j.tripleo.2005.08.020
   Turner TM, 2007, UPSALA J MED SCI, V112, P191, DOI 10.3109/2000-1967-193
   Verket A, 2013, INT J ORAL MAX IMPL, V28, P721, DOI 10.11607/jomi.2853
   Villanueva-Alcojol L, 2013, IMPLANT DENT, V22, P380, DOI 10.1097/ID.0b013e31829afa44
   Xie QF, 1997, ACTA ODONTOL SCAND, V55, P299, DOI 10.3109/00016359709114968
NR 42
TC 5
Z9 5
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2015
VL 24
IS 4
BP 427
EP 433
DI 10.1097/ID.0000000000000275
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CP3WI
UT WOS:000359813000011
PM 26200164
DA 2018-10-20
ER

PT J
AU Zhang, M
   Zou, Y
   Zhang, FJ
   Zhang, XM
   Wang, MM
AF Zhang, Miao
   Zou, Ying
   Zhang, Fengju
   Zhang, Xuemin
   Wang, Mengmeng
TI Efficacy of Blue-Light Cross-linking on Human Scleral Reinforcement
SO OPTOMETRY AND VISION SCIENCE
LA English
DT Article
DE blue light; cross-linking; human; sclera; efficacy
ID BIOMECHANICAL PROPERTIES; ULTRAVIOLET; RIBOFLAVIN; RADIATION; FLAVINS;
   SAFETY; MYOPIA; TIME
AB Purpose To evaluate the biomechanical effects of collagen cross-linking by riboflavin/blue light (460 nm) on human sclera.
   Methods Forty-two sclera samples from donated human eyes were treated with riboflavin at 0.5% on the equatorial sclera for 20 minutes and then randomly divided into seven groups and irradiated, respectively, with blue light at different intensities (14.6, 19.5, 22.5, 26, 32.5, and 40.6 mW/cm(2)) for 20 minutes using a light-emitting diode source with an exposure area of 10 mm in diameter. The untreated samples constituted the control group. During irradiation, continuous riboflavin solution infiltration was carried out for 20 minutes. Stress-strain measurements of scleral strips were performed with a biomaterial tester. Stress data and Young modulus values in different groups were compared by one-way analysis of variance.
   Results Blue-light (460 nm) cross-linking was efficient in stiffening human sclera strips. Interestingly, eyes treated with 22.5 mW/cm(2) exhibited higher Young modulus values (19.12 [4.88] MPa) at 8% strain compared with other groups, representing a 307.68% increase over control eye values (4.69 [+/- 1.26] MPa). Stress and Young modulus increased gradually with irradiation intensity from 19.5 to 22.5 mW/cm(2) before decreasing for higher intensities.
   Conclusions The biomechanical strength of human sclera may be enhanced by collagen cross-linking with riboflavin/460 nm blue-light irradiation; the dose of 22.5 mW/cm(2) might be used for blue-light (460 nm) scleral cross-linking to achieve a higher efficacy.
C1 [Zhang, Miao; Zou, Ying; Zhang, Fengju; Zhang, Xuemin; Wang, Mengmeng] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100000, Peoples R China.
RP Zhang, FJ (reprint author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100000, Peoples R China.
EM fjz269@yahoo.com
FU National Natural Science Foundation of China [81271041]; Beijing
   Scientific Research Key Program of Beijing Municipal Commission of
   Education [KZ201310025027]; High Level Talent Fund of the Beijing
   Healthcare [2013-2-023]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81271041), Beijing Scientific Research Key Program of Beijing
   Municipal Commission of Education (KZ201310025027) and High Level Talent
   Fund of the Beijing Healthcare (2013-2-023).
CR Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8
   Edwards AM, 1999, J PHOTOCH PHOTOBIO B, V48, P36, DOI 10.1016/S1011-1344(99)00006-8
   Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011
   Goettsch W, 1998, ENVIRON HEALTH PERSP, V106, P71
   HAM WT, 1979, PHOTOCHEM PHOTOBIOL, V29, P735, DOI 10.1111/j.1751-1097.1979.tb07759.x
   HAM WT, 1982, AM J OPHTHALMOL, V93, P299, DOI 10.1016/0002-9394(82)90529-3
   Hammer A, 2014, INVEST OPHTH VIS SCI, V55, P2881, DOI 10.1167/iovs.13-13748
   Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k
   Holden B, 2014, EYE, V28, P142, DOI 10.1038/eye.2013.256
   Iseli HP, 2008, J REFRACT SURG, V24, pS752
   Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092
   Lamb LE, 2001, ARCH BIOCHEM BIOPHYS, V393, P316, DOI 10.1006/abbi.2001.2492
   Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0
   Edwards AM, 2014, METHODS MOL BIOL, V1146, P3, DOI 10.1007/978-1-4939-0452-5_1
   Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P1639
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Schumacher S, 2012, INVEST OPHTH VIS SCI, V53, P762, DOI 10.1167/iovs.11-8059
   Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410
   Spoerl E, 1999, J REFRACT SURG, V15, P711
   VANNORREN D, 1990, VISION RES, V30, P1517, DOI 10.1016/0042-6989(90)90032-G
   Wang MM, 2015, CLIN EXP OPHTHALMOL, V43, P156, DOI 10.1111/ceo.12392
   Wang MM, 2012, J REFRACT SURG, V28, P723, DOI 10.3928/1081597X-20120921-08
   Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4
   Wernli J, 2013, INVEST OPHTH VIS SCI, V54, P1176, DOI 10.1167/iovs.12-11409
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2009, ACTA OPHTHALMOL, V87, P193, DOI 10.1111/j.1755-3768.2008.01229.x
   Young TL, 2009, OPTOMETRY VISION SCI, V86, P8, DOI 10.1097/OPX.0b013e3181940655
   Zhang Y, 2014, BIOMED RES INT, V2014
NR 28
TC 2
Z9 2
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-5488
EI 1538-9235
J9 OPTOMETRY VISION SCI
JI Optom. Vis. Sci.
PD AUG
PY 2015
VL 92
IS 8
BP 873
EP 878
DI 10.1097/OPX.0000000000000642
PG 6
WC Ophthalmology
SC Ophthalmology
GA CP3YE
UT WOS:000359818100005
PM 26099056
OA Bronze
DA 2018-10-20
ER

PT J
AU Simon, TE
   Johnson, RJ
   Naig, AL
   Brockmeyer, JR
   Prasad, BM
   White, PW
AF Simon, Todd E.
   Johnson, Rebekah J.
   Naig, Anna L.
   Brockmeyer, Joel R.
   Prasad, Balakrishna M.
   White, Paul W.
TI Permacol Interposition Graft as an Alternative to Vein in Contaminated
   Wounds Using a Rabbit Model
SO ANNALS OF VASCULAR SURGERY
LA English
DT Article
ID COMPROMISED SURGICAL FIELD; ACELLULAR DERMAL ALLOGRAFT; EXTREMITY
   VASCULAR INJURY; VENTRAL HERNIA REPAIR; AUTOGENOUS VEIN; WARTIME REPORT;
   INFECTION; DACRON; BIOMATERIAL; MANAGEMENT
AB Background: Vascular injuries are common in trauma and often involve massive soft tissue injury and segmental arterial loss. Current practice uses either autogenous vein or polytetrafluorethylene (PTFE) for interposition grafting in arterial injuries. Decision making between autogenous or synthetic conduit pivots around the physiological state of the trauma patient. Vein is known to increase operative times in an already physiologically depleted patient, whereas synthetic graft can be simply pulled from the shelf. However, when used in contaminated wounds, PTFE is prone to chronic infection and subsequent graft failure. An alternative synthetic conduit resistant to infection would be ideal for such situations. Permacol (Tissue Science Laboratories, Inc, Andover, MA), a biosynthetic material, has demonstrated resistance to bacterial contamination in contaminated hernia repairs. When fashioned into a tubular structure, this material may be useful as an alternative vascular conduit in contaminated trauma wounds.
   Methods: New Zealand white rabbits were randomized to one of 4 groups: Permacol graft (P) without bacterial contamination (n = 9), Permacol graft with bacterial contamination (CP; n = 9), autogenous vein graft without bacterial contamination (V; n = 9), or autogenous vein with bacterial contamination (CV; n = 9). All groups then underwent interposition grafting of the right common carotid artery. Grafts were contaminated by applying Staphylococcus aureus (1 x 10(5) colonies/0.1 mL) directly to the exposed surface of the graft on completion of the arterial repair. Each graft was then excised at day 42, and segments were collected for histologic evaluation, bacterial counts, and real-time polymerase chain reaction.
   Results: Of the 36 rabbits used in this study, 3 animals in the CV group died within 72 hr of surgery. There was no difference in early mortality between P and V (0% vs. 0%; P = 1.0); however, early mortality was higher in the CV compared with the CP group (33% vs. 0%; P = 0.023). At 42 days, histologic evaluation of graft patency demonstrated no difference between P and V (67% vs. 33%; P = 0.157); however, patency was higher in CP than CV (56% vs. 12%; P - 0.040). In addition, no difference was found between the 2 contaminated groups in regard to the number of bacteria present on each graft material.
   Conclusions: Permacol as an interposition graft is a feasible alternative to vein in a contaminated setting and shows resistance to infection in a rabbit model. Future studies are needed to evaluate this material in larger animal models.
C1 [Simon, Todd E.; White, Paul W.] Walter Reed Natl Mil Med Ctr, Div Vasc Surg, Bethesda, MD 20889 USA.
   [Johnson, Rebekah J.; Naig, Anna L.; Brockmeyer, Joel R.] Dwight D Eisenhower Army Med Ctr, Div Vasc Surg, Ft Gordon, GA USA.
   [Prasad, Balakrishna M.] Dwight D Eisenhower Army Med Ctr, Dept Clin Invest, Ft Gordon, GA USA.
RP Simon, TE (reprint author), Walter Reed Natl Mil Med Ctr, Div Vasc Surg, 8901 Rockville Pike, Bethesda, MD 20889 USA.
EM te.simon@yahoo.com
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Ansaloni L, 2009, AM J SURG, V198, P303, DOI 10.1016/j.amjsurg.2008.09.021
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451
   BRICKER DL, 1970, CHEST, V58, P566, DOI 10.1378/chest.58.6.566
   Campanelli G, 2008, WORLD J EMERG SURG, V3, DOI 10.1186/1749-7922-3-33
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   Cheek R C, 1974, Am Surg, V40, P439
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   Clouse WD, 2006, ANN VASC SURG, V20, P429, DOI 10.1007/s10016-006-9090-3
   Diaz JJ, 2006, AM SURGEON, V72, P1181
   FOSTER JH, 1959, SURG GYNECOL OBSTET, V108, P141
   Fox CJ, 2007, SURG CLIN N AM, V87, P1193, DOI 10.1016/j.suc.2007.07.015
   Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010
   Fox CJ, 2007, SURG CLIN NORTH AM, V87, pxi
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   HARRISON JH, 1958, ARCH SURG-CHICAGO, V76, P67, DOI 10.1001/archsurg.1958.01280190069013
   KNOTT LH, 1978, J SURG RES, V24, P288, DOI 10.1016/0022-4804(78)90094-X
   Mancini GJ, 2006, AM SURGEON, V72, P1187
   MATTOX KL, 1989, ANN SURG, V209, P698, DOI 10.1097/00000658-198906000-00007
   Mattox KL, 1989, ANN SURG, V209, P706
   Milburn ML, 2008, SURG INFECT, V9, P433, DOI 10.1089/sur.2007.044
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Peck MA, 2007, J VASC SURG, V45, P1197, DOI 10.1016/j.jvs.2007.02.003
   SHAH PM, 1983, J TRAUMA, V23, P1030, DOI 10.1097/00005373-198312000-00002
   Tsai JW, 2009, ANN VASC SURG, V23, P374, DOI 10.1016/j.avsg.2008.10.004
   WILSON SE, 1975, J SURG RES, V18, P221, DOI 10.1016/0022-4804(75)90145-6
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   ZDANOWSKI Z, 1993, APMIS, V101, P926, DOI 10.1111/j.1699-0463.1993.tb00203.x
NR 29
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0890-5096
EI 1615-5947
J9 ANN VASC SURG
JI Ann. Vasc. Surg.
PD AUG
PY 2015
VL 29
IS 6
BP 1307
EP 1314
DI 10.1016/j.avsg.2015.05.001
PG 8
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA CO7BH
UT WOS:000359312000033
PM 26004967
DA 2018-10-20
ER

PT J
AU Mehta, NK
   Moynihan, KD
   Irvine, DJ
AF Mehta, Naveen K.
   Moynihan, Kelly D.
   Irvine, Darrell J.
TI Engineering New Approaches to Cancer Vaccines
SO CANCER IMMUNOLOGY RESEARCH
LA English
DT Review
ID DENDRITIC CELL-POPULATIONS; LYMPH-NODE; T-CELLS; IN-SITU; INTRANASAL
   IMMUNIZATION; ANTITUMOR IMMUNITY; PEPTIDE VACCINES; IMMUNOTHERAPY;
   VACCINATION; NANOPARTICLES
AB Recently, a number of promising approaches have been developed using synthetic chemistry, materials science, and bioengineering-based strategies to address challenges in the design of more effective cancer vaccines. At the stage of initial priming, potency can be improved by maximizing vaccine delivery to lymph nodes. Because lymphatic uptake from peripheral tissues is strongly size dependent, antigens and adjuvants packaged into optimally sized nanoparticles access the lymph node with much greater efficiency than unformulated vaccines. Once primed, T cells must home to the tumor site. Because T cells acquire the necessary surface receptors in the local lymph node draining the tissue of interest, vaccines must be engineered that reach organs, such as the lung and gut, which are common sites of tumor lesions but inaccessible by been designed that entrap or slowly release immunomodulators at the tumor site, reducing systemic exposure and improving therapeutic efficacy. Finally, lessons learned from the design of biomaterial- based scaffolds in regenerative medicine have led to the development of implantable vaccines that recruit and activate antigen-presenting cells to drive antitumor immunity. Overall, these engineering strategies represent an expanding toolkit to create safe and effective cancer vaccines.
C1 [Mehta, Naveen K.; Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Mehta, Naveen K.; Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Ragon Inst MGH, Boston, MA USA.
   [Moynihan, Kelly D.; Irvine, Darrell J.] Harvard Univ, Boston, MA 02115 USA.
   [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Irvine, DJ (reprint author), MIT, MIT Room 76-261,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM djirvine@mit.edu
OI Moynihan, Kelly/0000-0001-6200-7863
FU NIH [CA174795, CA172164]; V Foundation; Bridge Project of the Koch
   Institute; Dana-Farber/Harvard Cancer Center; Hertz Foundation; NSF
FX This work was supported by grants from the NIH (CA174795 and CA172164),
   the V Foundation, and the Bridge Project of the Koch Institute and the
   Dana-Farber/Harvard Cancer Center. K.D. Moynihan is supported by a
   graduate fellowship from the Hertz Foundation. K.D. Moynihan and N.K.
   Mehta are supported by graduate research fellowships from the NSF.
CR Ali OA, 2011, J CONTROL RELEASE, V154, P249, DOI 10.1016/j.jconrel.2011.06.021
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155
   Chua BY, 2015, BIOMATERIALS, V53, P50, DOI 10.1016/j.biomaterials.2015.02.066
   de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110
   Egilmez NK, 2000, CANCER RES, V60, P3832
   Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Fraser CC, 2014, VACCINE, V32, P2896, DOI 10.1016/j.vaccine.2014.02.024
   Fritsch EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29311
   Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8
   Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988
   Hacohen N, 2013, CANCER IMMUNOL RES, V1, P11, DOI 10.1158/2326-6066.CIR-13-0022
   Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105
   Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915
   Hodi SF, 2014, DENDRITIC CELL ACTIV
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kourtis IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061646
   Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4
   Kumamoto T, 2002, NAT BIOTECHNOL, V20, P64, DOI 10.1038/nbt0102-64
   Kwong B, 2013, CANCER RES, V73, P1547, DOI 10.1158/0008-5472.CAN-12-3343
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Mercier I, 2013, CANCER RES, V73, P4629, DOI 10.1158/0008-5472.CAN-12-3058
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Mackay CR, 2000, NEW ENGL J MED, V343, P15
   Maloy KJ, 2001, P NATL ACAD SCI USA, V98, P3299, DOI 10.1073/pnas.051630798
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859
   Matsuo K, 2011, J CONTROL RELEASE, V152, P310, DOI 10.1016/j.jconrel.2011.03.009
   McLennan Danielle N, 2005, Drug Discov Today Technol, V2, P89, DOI 10.1016/j.ddtec.2005.05.006
   Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111
   Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   MORTON DL, 1974, ANN SURG, V180, P635, DOI 10.1097/00000658-197410000-00029
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109
   Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169
   Sandoval F, 2013, SCI TRANSL MED, V5
   Schulze HJ, 2005, BRIT J DERMATOL, V152, P939, DOI 10.1111/j.1365-2133.2005.06486.x
   Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863
   Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649
   Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061
   Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373
   Stano A, 2012, VACCINE, V30, P7541, DOI 10.1016/j.vaccine.2012.10.050
   SUPERSAXO A, 1990, PHARMACEUT RES, V7, P167, DOI 10.1023/A:1015880819328
   Swartz MA, 2014, CANCER IMMUNOL RES, V2, P701, DOI 10.1158/2326-6066.CIR-14-0115
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.957994
   van Herpen CM, 2003, CLIN CANCER RES, V9, P2950
   Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237
   Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883
   Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980
   Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001
   Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095
   Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866
NR 75
TC 17
Z9 17
U1 0
U2 37
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 2326-6066
EI 2326-6074
J9 CANCER IMMUNOL RES
JI Cancer Immunol. Res.
PD AUG
PY 2015
VL 3
IS 8
BP 836
EP 843
DI 10.1158/2326-6066.CIR-15-0112
PG 8
WC Oncology; Immunology
SC Oncology; Immunology
GA CO7DH
UT WOS:000359318100002
PM 26156157
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Tong, S
   Xu, DP
   Liu, ZM
   Wang, XK
AF Tong, Shuang
   Xu, Da-Peng
   Liu, Zi-Mei
   Wang, Xu-Kai
TI Construction and in vitro characterization of three-dimensional silk
   fibroin-chitosan scaffolds
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Silk fibroin; Chitosan; Scaffolds; Bone tissue engineering; Osteoblast
   cell
ID BIOMATERIAL SCAFFOLDS; NETWORKS; DESIGN; CELL
AB The objective of this study was to discuss the construction method, characterization, and biocompatibility of three-dimensional silk fibroin-chitosan (SF-CS) scaffolds which met the requirements of bone tissue engineering scaffolds. Silk fibroin (SF) and chitosan (CS) were mixed at different ratios-3 to 7, 5 to 5, and 7 to 3- to fabricate the composite materials. To find out the optimum mixing ratio of SF and CS, parameters such as pore size, porosity, water absorption, and the mechanical properties were evaluated. Osteoblast cells hFOB1.19 were seeded on SF-CS scaffolds and pure CS scaffolds for the first time. Cell adhesion rate, cell proliferation, and cell activity were evaluated, and cell growth and formation of mineralized nodules were observed. Results showed that SF-CS scaffolds are a suitable candidate for bone tissue engineering.
C1 [Tong, Shuang; Xu, Da-Peng; Liu, Zi-Mei; Wang, Xu-Kai] China Med Univ, Liaoning Inst Dent Res, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang 110002, Liaoning Provin, Peoples R China.
RP Wang, XK (reprint author), China Med Univ, Liaoning Inst Dent Res, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang 110002, Liaoning Provin, Peoples R China.
EM wangxukai757892@sina.com
FU Science and Technology Plan Project of Liaoning Province
   [2012-B-00002012225082]
FX This work was supported by the Science and Technology Plan Project of
   Liaoning Province (Grant No. 2012-B-00002012225082).
CR Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771
   Du CH, 2006, POLYM INT, V55, P377, DOI 10.1002/pi.1995
   El Sayed K, 2013, J TISSUE ENG REGEN M, V7, P61, DOI 10.1002/term.496
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Harris SA, 1997, US Patent, Patent No. [5,681,701, 5681701]
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khang G, 2006, ENCY MED DEVICES INS, P366
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lai BQ, 2013, BIOMATERIALS, V34, P2888, DOI 10.1016/j.biomaterials.2012.12.046
   Lyons Frank, 2008, Technol Health Care, V16, P305
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Wang YL, 2012, INT J NANOMED, V7, P2315, DOI [10.2147/IJN.S30593, 10.2147/IJN.S31162]
   Woodward S, 1996, PLANT CELL TISS ORG, V44, P31, DOI 10.1007/BF00045910
NR 27
TC 5
Z9 5
U1 1
U2 16
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD AUG
PY 2015
VL 34
IS 4
BP 475
EP 484
DI 10.4012/dmj.2014-251
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA CO8CX
UT WOS:000359393700008
PM 26235712
OA Bronze
DA 2018-10-20
ER

PT J
AU Wu, PL
   Nakamura, N
   Kimura, T
   Nam, K
   Fujisato, T
   Funamoto, S
   Higami, T
   Kishida, A
AF Wu, Pingli
   Nakamura, Naoko
   Kimura, Tsuyoshi
   Nam, Kwangwoo
   Fujisato, Toshiya
   Funamoto, Seiichi
   Higami, Tetsuya
   Kishida, Akio
TI Decellularized porcine aortic intima-media as a potential cardiovascular
   biomaterial
SO INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
LA English
DT Article
DE Decellularized aortic intima-media; Tissue structure; Mechanical
   properties; Cardiovascular biomaterial
ID MECHANICAL-PROPERTIES; HUMAN PERICARDIUM; TISSUE; MATRIX; VALVE
AB OBJECTIVES: The aim of this research is to investigate the histological and mechanical properties of decellularized aortic intima-media, a promising cardiovascular biomaterial.
   METHODS: Porcine aortic intima-media was decellularized using two methods: high hydrostatic pressurization (HHP) and sodium dodecyl sulphate (SDS). The histological properties were characterized using haematoxylin and eosin staining and Elastica van Gieson staining. The mechanical properties were evaluated using a tensile strength test.
   RESULTS: The structure of the HHP-treated samples was unchanged histologically, whereas that of the SDS-treated samples appeared structurally loose. Consequently, with regard to the mechanical properties of SDS-decellularized intima-media, elastic modulus and tensile strength were significantly decreased.
   CONCLUSIONS: The decellularization method affected the structure and the mechanical properties of the biomaterial. The HHP-treated sample was structurally and mechanically similar to the untreated control. Its mechanical properties were similar to those of human heart valves and the iliac artery and vein. Our results imply that porcine aortic intima-media that is decellularized with HHP is a potential cardiovascular biomaterial.
C1 [Wu, Pingli; Nakamura, Naoko; Kimura, Tsuyoshi; Nam, Kwangwoo; Kishida, Akio] Tokyo Med & Dent Univ, Dept Mat Based Med Engn, Inst Biomat & Bioengn, Tokyo, Japan.
   [Fujisato, Toshiya] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan.
   [Funamoto, Seiichi; Higami, Tetsuya] Sapporo Med Univ, Sch Med, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan.
RP Kishida, A (reprint author), Tokyo Med & Dent Univ, Dept Mat Based Med Engn, Inst Biomat & Bioengn, Tokyo, Japan.
EM kishida.mbme@tmd.ac.jp
OI FUJISATO, Toshia/0000-0002-7206-093X
FU Japan Society for the Promotion of Science (JSPS)
FX This work was partly supported by a Grant-in-Aid from the Japan Society
   for the Promotion of Science (JSPS).
CR Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kalejs Martins, 2009, Interact Cardiovasc Thorac Surg, V8, P553, DOI 10.1510/icvts.2008.196220
   Korossis SA, 2005, J HEART VALVE DIS, V14, P408
   LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475
   Negishi J, 2015, J TISSUE ENG REGEN M, V9, pE144, DOI 10.1002/term.1662
   Negishi J, 2011, J ARTIF ORGANS, V14, P223, DOI 10.1007/s10047-011-0570-z
   Prasertsung I, 2008, J BIOMED MATER RES B, V85B, P210, DOI 10.1002/jbm.b.30938
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCOTT M, 1995, ANN THORAC SURG, V60, pS391, DOI 10.1016/0003-4975(95)00263-K
   Venkatraman S, 2008, PROG POLYM SCI, V33, P953
   Vincentelli A, 1998, J HEART VALVE DIS, V7, P24
   White JK, 2005, ANN THORAC SURG, V80, P704, DOI 10.1016/j.athoracsur.2004.08.063
   WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400
NR 19
TC 4
Z9 4
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1569-9293
EI 1569-9285
J9 INTERACT CARDIOV TH
JI Interact Cardiovasc. Thorac. Surg.
PD AUG
PY 2015
VL 21
IS 2
BP 189
EP 194
DI 10.1093/icvts/ivv113
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CP2HZ
UT WOS:000359699400011
PM 25972596
OA Bronze
DA 2018-10-20
ER

PT J
AU El-Rashidy, AA
   Gad, A
   Abu-Hussein, AG
   Habib, SI
   Badr, NA
   Hashem, AA
AF El-Rashidy, Aiah A.
   Gad, Ahmed
   Abu-Hussein, Abd El-Hay G.
   Habib, Shaymaa I.
   Badr, Nadia A.
   Hashem, Azza A.
TI Chemical and biological evaluation of Egyptian Nile Tilapia (Oreochromis
   niloticas) fish scale collagen
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Nile Tilapia; Fish scale; Type I collagen; Characterization; BHK-21
   (Baby Hamster kidney)
ID ACID-SOLUBLE COLLAGEN; REDFISH SEBASTES-MENTELLA; CROSS-LINKING; SKIN;
   PROTEINS; BONE; DENATURATION; SPECTROSCOPY; FIBROBLASTS; BIOMATERIAL
AB Collagen is considered to be one of the most useful biomaterials with different medical applications. However, collagen properties differ from one source to another. The aim of this study was to extract, purify, characterize and perform preliminary biological evaluation of type I collagen from scales of Egyptian Nile Tilapia. Pepsin-solubilized collagen (PSC) was successfully prepared from Nile Tilapia fish scale waste. Lyophilized collagen was dissolved in dilute HCl to form acidic collagen solutions (ACS) which was neutralized to form gel. To confirm the biocompatibility of the produced gel, baby hamster kidney (BHK-21) fibroblast cells were seeded onto a 3D collagen gel (0.3% and 0.5%, w/v). The results of an SDS-PAGE test showed that the extracted collagens were type I collagen, with alpha chain composition of (alpha 1)2 alpha 2. Thermal analysis showed that the denaturation temperature was 32 degrees C. X-ray diffraction (XRD) analysis and Fourier-transform infrared spectra (FTIR) showed that the extracted collagen had a triple helix structure. Active proliferation of BHK-21 cells with no signs of toxicity was evident with both collagen gel concentrations tested. The results show that Nile Tilapia scales can be an effective source of collagen extraction that could be used as a potential biomaterial in biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [El-Rashidy, Aiah A.; Habib, Shaymaa I.; Hashem, Azza A.] Cairo Univ, Fac Oral & Dent Med, Dept Biomat, Cairo 11562, Egypt.
   [Gad, Ahmed] Cairo Univ, Fac Agr, Dept Anim Prod, Cairo 12613, Egypt.
   [Gad, Ahmed; Abu-Hussein, Abd El-Hay G.] Cairo Univ, Fac Agr, CURP, Cairo 12613, Egypt.
   [Badr, Nadia A.] Umm Al Qura Univ, Fac Dent, Cairo Univ, Dept Biomat,Fac Oral & Dent Med, Mecca, Saudi Arabia.
RP El-Rashidy, AA (reprint author), Cairo Univ, Fac Oral & Dent Med, Dept Biomat, Cairo 11562, Egypt.
EM aiah.abdelwahab@dentistry.cu.edu.eg
RI Gad, Ahmed/M-7273-2013
OI Gad, Ahmed/0000-0001-9741-2105; El-Rashidy, Aiah/0000-0002-4475-0837
CR ABE Y, 1972, BIOPOLYMERS, V11, P1841, DOI 10.1002/bip.1972.360110906
   Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   AOAC, 2012, OFF METH AN AOAC INT
   Artym VV, 2010, CURRENT PROTOCOLS CE, V10, P1, DOI DOI 10.1002/0471143030.CB1018S48
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Fishery and Aquaculture Country Profiles FAO South Africa, 2010, COUNTR PROF FACT SHE
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Guzzi Plepis AMD, 1996, POLYM ENG SCI, V36, P2932, DOI DOI 10.1002/PEN.10694
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   International Agency for Research on Cancer, 2007, IPCC CLIM CHANG 2007, P1
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanza R., 2013, PRINC TISSUE ENG, P441
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li CM, 2008, EUR FOOD RES TECHNOL, V227, P1467, DOI 10.1007/s00217-008-0869-z
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Lin Wang, 2008, Food Chemistry, V108, P616, DOI 10.1016/j.foodchem.2007.11.017
   Matmaroh K, 2011, FOOD CHEM, V129, P1179, DOI 10.1016/j.foodchem.2011.05.099
   MIAN M, 1992, INT J TISSUE REACT, V14, P1
   Minh-Thuy L. T., 2014, FOOD CHEM, V149, P264, DOI DOI 10.1016/J.F00DCHEM.2013.10.094
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Najafi MF, 2008, IFMBE PROC, V21, P806
   Nalinanon S., 2012, INT P CHEM BIOL ENV, V39, P47
   NWRC (National Water Research Centre)WL/DELFT Hydraulics National Water Resources Plan for Egypt, 2000, NAT WAT RES PLAN EG
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Rochdi A, 1999, BIOPOLYMERS, V50, P690, DOI 10.1002/(SICI)1097-0282(199912)50:7<690::AID-BIP2>3.0.CO;2-P
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Sugiura H, 2009, J BIOMAT SCI-POLYM E, V20, P1353, DOI 10.1163/092050609X12457418396658
   TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Villas-Boas SG, 2003, ANAL BIOCHEM, V322, P134, DOI 10.1016/j.ab.2003.07.018
   Wang L, 2007, J FOOD SCI, V72, pE450, DOI 10.1111/j.1750-3841.2007.00478.x
   Wang L, 2008, FOOD CHEM, V108, P616, DOI 10.1016/j.foodchem.2007.11.017
   Westgate S., 2012, COLLAGEN DRESSINGS M
   Wong D. W. S., 1989, MECH THEORY FOOD CHE
   Wu C.-H., 2006, Taiwan Invent. Pat. Publ. Number I, Patent No. 263678
   Yacoub AM, 2012, INT J ENV SCI ENG, V3, P1
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Zhang FengXiang, 2011, Food and Nutrition Sciences, V2, P818, DOI 10.4236/fns.2011.28112
   Zhou T, 2015, ACS APPL MATER INTER, V7, P3253, DOI 10.1021/am507990m
NR 49
TC 11
Z9 13
U1 0
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2015
VL 79
BP 618
EP 626
DI 10.1016/j.ijbiomac.2015.05.019
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CO4YH
UT WOS:000359166300079
PM 26026980
DA 2018-10-20
ER

PT J
AU Farghali, RA
   Fekry, AM
   Ahmed, RA
   Elhakim, HKA
AF Farghali, R. A.
   Fekry, A. M.
   Ahmed, Rasha A.
   Elhakim, H. K. A.
TI Corrosion resistance of Ti modified by chitosan-gold nanoparticles for
   orthopedic implantation
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Review
DE Chitosan; AuNPs; Titanium
ID MICROBIOLOGICALLY INFLUENCED CORROSION; ELECTROCHEMICAL CORROSION;
   NANOCOMPOSITE FILMS; TITANIUM-ALLOYS; HANKS SOLUTION; BEHAVIOR; NITI;
   DEPOSITION; PREVENTION; MAGNESIUM
AB Highly uniform bionanocomposite film composed of chitosan (CS) and gold nanoparticles (AuNPs) was synthesized successfully by electrodeposition method. The influence of AuNPs/CS bionanocomposite film on corrosion resistance of Ti was investigated. Surface morphology and compositional properties of the bionanocomposite were analyzed by scanning electron microscope (SEM), energy dispersive X-ray analysis (EDX), and X-ray photoelectron spectroscopy (XPS). Moreover, cyclic voltammetry (CV), open-circuit potential measurements (OCP), electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization (R-p) were used to examine the corrosion behavior in Hanks' solution. In comparison with Ti, Nyquist and Bode plots displayed higher impedance values and phase angles for AuNPs/CS biocomposite denoting a more protective passive film on Ti with inhibition efficiency (IE%) of 98%. An electric equivalent circuit with three time constants was modeled for the bionanocomposite. In addition, the antibacterial effect revealed the high efficiencies of the bionanocomposite film for inhibiting bacterial growth. The combination of the high biocompatibility of chitosan and strong adsorption ability of AuNPs make AuNPs/CS bionanocomposite promising candidate for modifying biomaterial surfaces for medical implantation applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Farghali, R. A.; Ahmed, Rasha A.] Taif Univ, Fac Sci, Dept Chem, At Taif, Saudi Arabia.
   [Farghali, R. A.; Fekry, A. M.] Cairo Univ, Dept Chem, Fac Sci, Giza 12613, Egypt.
   [Ahmed, Rasha A.] Minist Justice, Medico Legal Dept, Forens Chem Labs, Cairo, Egypt.
   [Elhakim, H. K. A.] Cairo Univ, Dept Biochem, Fac Sci, Giza 12613, Egypt.
RP Ahmed, RA (reprint author), Taif Univ, Fac Sci, Dept Chem, Hawiya 888, At Taif, Saudi Arabia.
EM rashaauf@yahoo.com
FU Taif University, Kingdom of Saudi Arabia
FX This work was financial support by Taif University, Kingdom of Saudi
   Arabia. This research was also carried out in cooperation with Faculty
   of Science, Cairo University. The authors would like to thank Core labs
   in King Abdullah University of science and technology (KAUST) for
   performing XPS analysis.
CR Ahmed RA, 2014, APPL SURF SCI, V292, P390, DOI 10.1016/j.apsusc.2013.11.150
   Ameer MA, 2011, PROG ORG COAT, V71, P343, DOI 10.1016/j.porgcoat.2011.04.001
   Ameer MA, 2010, INT J HYDROGEN ENERG, V35, P11387, DOI 10.1016/j.ijhydene.2010.07.071
   Casaletto MP, 2006, SURF INTERFACE ANAL, V38, P215, DOI 10.1002/sia.2180
   Chen CH, 2008, SURF COAT TECH, V202, P2709, DOI 10.1016/j.surfcoat.2007.09.052
   Chudasama B., 2010, J NANOPART RES, V10, P1677
   Davies J. E., 1991, BONE BIOMATERIAL I 1
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P7
   Fadlallah S. A., 2014, ALLOYS COMPD, V583, P455
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   Fekry A. M., 2010, INT J HYDRPGEN ENERG, V351, P2945
   Fong YY, 2010, J PHYS CHEM C, V114, P15931, DOI 10.1021/jp9118315
   FRIEDMAN RJ, 1995, J APPL BIOMATER, V6, P231, DOI 10.1002/jab.770060403
   Ghoneim AA, 2010, ELECTROCHIM ACTA, V55, P6028, DOI 10.1016/j.electacta.2010.05.062
   Gu YW, 2005, APPL SURF SCI, V252, P2038, DOI 10.1016/j.apsusc.2005.03.207
   Heakal F. El-Taib, 2008, J ELECTROCHEM SOC, V155, P534
   Helsen J.A., 1998, METALS BIOMATERIALS
   Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P99, DOI 10.2106/JBJS.F.00102
   Jaramillo TF, 2003, J AM CHEM SOC, V125, P7148, DOI 10.1021/ja029800v
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kumar K, 2009, LANGMUIR, V25, P7667, DOI 10.1021/la900327v
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Lane RA, 2005, J FAIL ANAL PREV, V5, P33, DOI 10.1361/154770205X65891
   Li Y, 2008, SURF COAT TECH, V202, P3017, DOI 10.1016/j.surfcoat.2007.11.003
   LITTLE B, 1991, INT MATER REV, V36, P253, DOI 10.1179/imr.1991.36.1.253
   LITTLE B, 1992, ELECTROCHIM ACTA, V37, P2185, DOI 10.1016/0013-4686(92)85110-7
   Liu XM, 2007, APPL SURF SCI, V253, P3154, DOI 10.1016/j.apsusc.2006.07.008
   Liu ZM, 2005, SENSOR ACTUAT B-CHEM, V106, P394, DOI 10.1016/j.snb.2004.08.023
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   McKinney R. V., 1985, DENT IMPLANT TISSUE
   McLachlan D. R. C., 1983, BIOL ASPECTS METALS, P209
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   Nagarajan N, 2007, MATER CHEM PHYS, V103, P47, DOI 10.1016/j.matchemphys.2007.01.005
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Raffi M, 2008, J MATER SCI TECHNOL, V24, P192
   Rhim JW, 2006, J AGR FOOD CHEM, V54, P5814, DOI 10.1021/jf060658h
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Sun F, 2008, COLLOID SURFACE B, V67, P132, DOI 10.1016/j.colsurfb.2008.08.008
   Tondo E, 2009, SURF COAT TECH, V203, P3427, DOI 10.1016/j.surfcoat.2009.05.006
   VOGEL W, 1995, LANGMUIR, V11, P401, DOI 10.1021/la00002a005
   Wei H, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295603
   Wong MH, 2007, SCRIPTA MATER, V56, P205, DOI 10.1016/j.scriptamat.2006.10.014
   Xiao Y, 2003, SCIENCE, V299, P1877, DOI 10.1126/science.1080664
   Youssef AM, 2014, INT J BIOL MACROMOL, V69, P185, DOI 10.1016/j.ijbiomac.2014.05.047
   Zhitomirsky I, 2000, MATER LETT, V46, P1, DOI 10.1016/S0167-577X(00)00133-6
   Zhitomirsky I, 2006, J MATER SCI, V41, P8186, DOI 10.1007/s10853-006-0994-7
   Zhitomirsky I, 2004, J APPL ELECTROCHEM, V34, P235, DOI 10.1023/B:JACH.0000009965.74890.d9
NR 52
TC 6
Z9 6
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2015
VL 79
BP 787
EP 799
DI 10.1016/j.ijbiomac.2015.04.078
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CO4YH
UT WOS:000359166300099
PM 25989146
DA 2018-10-20
ER

PT J
AU Valle, J
   Burgui, S
   Langheinrich, D
   Gil, C
   Solano, C
   Toledo-Arana, A
   Helbig, R
   Lasagni, A
   Lasa, I
AF Valle, Jaione
   Burgui, Saioa
   Langheinrich, Denise
   Gil, Carmen
   Solano, Cristina
   Toledo-Arana, Alejandro
   Helbig, Ralf
   Lasagni, Andres
   Lasa, Inigo
TI Evaluation of Surface Microtopography Engineered by Direct Laser
   Interference for Bacterial Anti-Biofouling
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion; biofilm; biomaterial-associated infection; direct laser
   interference patterning; Staphylococcus aureus
ID FIBRONECTIN-BINDING PROTEINS; ATOMIC-FORCE MICROSCOPE;
   STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA;
   ADHESION; ATTACHMENT; TOPOGRAPHY; INFECTIONS; STRATEGIES
AB Modification of the biomaterial surface topography is a promising strategy to prevent bacterial adhesion and biofilm formation. In this study, we use direct laser interference patterning (DLIP) to modify polystyrene surface topography at sub-micrometer scale. The results revealed that three-dimensional micrometer structures have a profound impact on bacterial adhesion. Thus, line-and pillar-like patterns enhanced S. aureus adhesion, whereas complex lamella microtopography reduced S. aureus adhesion in static and continuous flow culture conditions. Interestingly, lamella-like textured surfaces retained the capacity to inhibit S. aureus adhesion both when the surface is coated with human serum proteins and when the material is implanted subcutaneously in a foreign-body associated infection model.
C1 [Valle, Jaione; Burgui, Saioa; Gil, Carmen; Solano, Cristina; Toledo-Arana, Alejandro; Lasa, Inigo] Univ Publ Navarra, CSIC, Gobierno Navarra, Inst Agrobiotecnol,Lab Microbial Biofilms, Pamplona, Spain.
   [Langheinrich, Denise; Lasagni, Andres] Fraunhofer Inst Mat & Beam Technol IWS Dresden, D-01277 Dresden, Germany.
   [Langheinrich, Denise; Lasagni, Andres] Tech Univ Dresden, Inst Mfg Technol, D-01069 Dresden, Germany.
   [Helbig, Ralf] Leibniz Inst Polymer Res IPF Dresden, D-01069 Dresden, Germany.
RP Valle, J (reprint author), Univ Publ Navarra, CSIC, Gobierno Navarra, Inst Agrobiotecnol,Lab Microbial Biofilms, Campus Arrosadia, Pamplona, Spain.
EM jaione.valle@unavarra.es
RI Toledo-Arana, Alejandro/F-9624-2011; Solano, Cristina/F-9607-2011;
   Lasagni, Andres/M-7476-2017; Gil, Carmen/K-3759-2017; jaione,
   valle/G-6213-2011; Lasa, Inigo/F-2947-2011; Umlauf, Ursula/D-3356-2014
OI Toledo-Arana, Alejandro/0000-0001-8148-6281; Solano,
   Cristina/0000-0002-6207-1766; Gil, Carmen/0000-0002-8867-4442; jaione,
   valle/0000-0003-3115-0207; Lasa, Inigo/0000-0002-6625-9221; 
FU Spanish Ministry of Science and Innovation; Spanish Ministry of Economy
   and Competitivity [AGL2011-23954, BIO2011-30503-C02-02]; Innovation
   Department of the Government of Navarra [IIQ14066. RI1]; Deutsche
   Forschungsgemeinschaft (DFG) [LA-2513 4-1]
FX J. Valle was supported by Spanish Ministry of Science and Innovation
   "Ramon y Cajal" contract. This research was supported by grants
   AGL2011-23954 and BIO2011-30503-C02-02 from the Spanish Ministry of
   Economy and Competitivity and IIQ14066. RI1 from Innovation Department
   of the Government of Navarra. A. Lasagni, D. Langhenirich, and R. Helbig
   thank the Deutsche Forschungsgemeinschaft (DFG) for the financial
   support of the project "Mechanically stable anti-adhesive polymer
   surfaces" (LA-2513 4-1).
CR Abban S, 2012, FOOD MICROBIOL, V31, P139, DOI 10.1016/j.fm.2012.04.003
   Basak P, 2009, J MATER SCI-MATER M, V20, P213, DOI 10.1007/s10856-008-3521-3
   Bieda M., 2014, ADV ENG MAT
   Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581
   Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014
   Graham MV, 2014, COATINGS, V4, P37, DOI 10.3390/coatings4010037
   Graham MV, 2013, SOFT MATTER, V9, P6235, DOI 10.1039/c3sm50584g
   Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kim P, 2012, NANO LETT, V12, P527, DOI 10.1021/nl200426g
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Komaromy A, 2009, MICROELECTRON ENG, V86, P1431, DOI 10.1016/j.mee.2009.01.024
   Komaromy AZ, 2012, MICROELECTRON ENG, V91, P39, DOI 10.1016/j.mee.2011.10.012
   Langheinrich D., 2011, J POLYM SCI B, V50, P415
   Lasagni AF, 2012, PLASTIC RES ONLINE, DOI [10.1002/spepro.004281, DOI 10.1002/SPEPRO.004281]
   Manabe K, 2013, ACS APPL MATER INTER, V5, P11900, DOI 10.1021/am4035762
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Modjarrad K., 2013, HDB POLYM APPL MED D
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744
   Shah SR, 2013, MATER TODAY, V16, P177, DOI 10.1016/j.mattod.2013.05.003
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
NR 43
TC 23
Z9 23
U1 3
U2 56
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG
PY 2015
VL 15
IS 8
BP 1060
EP 1069
DI 10.1002/mabi.201500107
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CP1IN
UT WOS:000359629600004
PM 25914260
DA 2018-10-20
ER

PT J
AU Goldshmid, R
   Mironi-Harpaz, I
   Shachaf, Y
   Seliktar, D
AF Goldshmid, Revital
   Mironi-Harpaz, Iris
   Shachaf, Yonatan
   Seliktar, Dror
TI A method for preparation of hydrogel microcapsules for stem cell
   bioproces sing and stem cell therapy
SO METHODS
LA English
DT Article
DE Biomaterial; Suspension bioreactor; 3D culture; Physical crosslinking;
   Chemical crosslinking; Pluronic-fibrinogen; PEG
ID DYNAMIC-MECHANICAL ANALYSIS; FULLY-SYNTHETIC SUBSTITUTE; CHONDROGENIC
   DIFFERENTIATION; POLYETHYLENE-GLYCOL; CROSS-LINKING; OSTEOGENIC
   DIFFERENTIATION; BIOMEDICAL APPLICATIONS; CLINICAL-APPLICATIONS;
   IN-VITRO; EXPANSION
AB A method for the preparation of suspension culture microcapsules used in the bioprocessing of human mesenchymal stem cells (hMSCs) is reported. The microcapsules are prepared from a semi-synthetic hydrogel comprising Pluronie (R) F127 conjugated to denatured fibrinogen. The Pluronic-fibrinogen adducts display a lower critical solubility temperature (LCST) at similar to 30 degrees C, thus enabling mild, cell-compatible physical crosslinking of the microcapsules in a warm gelation bath. Cell-laden microgels were prepared from a solution of Pluronic-fibrinogen hydrogel precursor and hMSCs; these were cultivated for up to 15 days in laboratory-scale suspension bioreactors and harvested by reducing the temperature of the microcapsules to disassemble the physical polymer network. The viability, proliferation and cell recovery yields of the hMSCs were shown to be better than photo-chemically crosslinked microcapsules made from a similar material. The cell culture yields, which exceeded 300% after 15 days in suspension culture, were comparable to other microcarrier systems used for the mass production of hMSCs. The simplicity of this methodology, both in terms of the cell inoculation and mild recovery conditions, represent distinct advantages for stem cell bioprocessing with suspension culture bioreactors. (C) 2015 Published by Elsevier Inc.
C1 [Goldshmid, Revital; Mironi-Harpaz, Iris; Shachaf, Yonatan; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Goldshmid, Revital] Technion Israel Inst Technol, Interdisciplinary Program Biotechnol, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
FU Singapore National Research Foundation (NRF)-Technion-NUS Grant for
   Regenerative Medicine Initiative in Cardiac Restoration Therapy; Lorry
   I. Lokey Interdisciplinary Center for Life Sciences and Engineering;
   EC-IP FP7 grant Angioscaff; Russell Berrie Nanotechnology Institute;
   EC-IP FP7 grant Biodesign
FX This work was supported by the Singapore National Research Foundation
   (NRF)-Technion-NUS Grant for Regenerative Medicine Initiative in Cardiac
   Restoration Therapy, the Lorry I. Lokey Interdisciplinary Center for
   Life Sciences and Engineering, Russell Berrie Nanotechnology Institute,
   as well as by EC-IP FP7 grants Angioscaff and Biodesign.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   ALTANKOV G, 1991, Journal of Biomaterials Science Polymer Edition, V2, P81, DOI 10.1163/156856291X00089
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249
   Boo L, 2011, J MATER SCI-MATER M, V22, P1343, DOI 10.1007/s10856-011-4294-7
   Cellesi F, 2004, BIOTECHNOL BIOENG, V88, P740, DOI 10.1002/bit.20264
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Chen A.K., 2010, CURR PROTOC STEM CEL
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9
   Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X
   Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fink T, 2004, STEM CELLS, V22, P1346, DOI 10.1634/stemcells.2004-0038
   Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719
   Frisman I, 2011, LANGMUIR, V27, P6977, DOI 10.1021/la104695m
   GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hewitt CJ, 2011, BIOTECHNOL LETT, V33, P2325, DOI 10.1007/s10529-011-0695-4
   Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196
   Jackson L, 2007, J POSTGRAD MED, V53, P121
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Kesselman D, 2013, ACTA BIOMATER, V9, P7630, DOI 10.1016/j.actbio.2013.04.030
   KIREMITCI M, 1990, BIOMATER ARTIF CELL, V18, P599, DOI 10.3109/10731199009117327
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Lund AW, 2008, J BIOMED MATER RES B, V87B, P213, DOI 10.1002/jbm.b.31098
   MARLCWAY BD, 2010, CELL TRANSPLANT, V19, P29
   McNiece I, 2007, SEMIN CELL DEV BIOL, V18, P839, DOI 10.1016/j.semcdb.2007.09.005
   Meyvis TKL, 2002, INT J PHARM, V244, P163, DOI 10.1016/S0378-5173(02)00328-9
   Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005
   Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309
   Parson AB, 2008, CELL, V132, P511, DOI 10.1016/j.cell.2008.02.004
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301
   RODER B, 1993, J BIOMAT SCI-POLYM E, V5, P79
   Sart S, 2013, J TISSUE ENG REGEN M, V7, P537, DOI 10.1002/term.545
   Schipani E., 2008, STEMBOOK
   Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007
   SMIT NPM, 1989, J INVEST DERMATOL, V92, P18, DOI 10.1111/1523-1747.ep13070406
   Tae SK, 2006, BIOMED MATER, V1, P63, DOI 10.1088/1748-6041/1/2/003
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Yang HS, 2010, CELL TRANSPLANT, V19, P1123, DOI 10.3727/096368910X516664
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zweigerdt R, 2009, ADV BIOCHEM ENG BIOT, V114, P201, DOI 10.1007/10_2008_27
NR 59
TC 4
Z9 4
U1 1
U2 34
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 35
EP 43
DI 10.1016/j.ymeth.2015.04.027
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100005
PM 25931428
DA 2018-10-20
ER

PT J
AU Ungerleider, JL
   Johnson, TD
   Rao, N
   Christman, KL
AF Ungerleider, J. L.
   Johnson, T. D.
   Rao, N.
   Christman, K. L.
TI Fabrication and characterization of injectable hydrogels derived from
   decellularized skeletal and cardiac muscle
SO METHODS
LA English
DT Article
DE Decellularization; Hydrogel; Extracellular matrix; Myocardial
   infarction; Peripheral artery disease
ID CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERIAL-DISEASE;
   EXTRACELLULAR-MATRIX; THERAPEUTIC ANGIOGENESIS; INTRAMUSCULAR INJECTION;
   MYOCARDIAL-INFARCTION; TISSUE-REPAIR; GROWTH-FACTOR; DOUBLE-BLIND;
   QUANTIFICATION
AB Biomaterials, which can contain appropriate biomechanical and/or biochemical cues, are increasingly being investigated as potential scaffolds for tissue regeneration and/or repair for treating myocardial infarction, heart failure, and peripheral artery disease. Specifically, injectable hydrogels are touted for their minimally invasive delivery, ability to self-assemble in situ, and capacity to encourage host tissue regeneration. Here we present detailed methods for fabricating and characterizing decellularized injectable cardiac and skeletal muscle extracellular matrix (ECM) hydrogels. The ECM derived hydrogels have low cellular and DNA content, retain sulfated glycosaminoglycans and other extracellular matrix proteins such as collagen, gel at physiologic temperature and pH, and assume a nanofibrous architecture. These injectable hydrogels are amenable to minimally invasive, tissue specific biomaterial therapies for treating myocardial infarction and peripheral artery disease. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ungerleider, J. L.; Johnson, T. D.; Rao, N.; Christman, K. L.] Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU National Institutes of Health (NIH) [R01HL113468]
FX This research was supported in part by National Institutes of Health
   (NIH) through R01HL113468. Dr. Christman is co-founder, board member,
   and holds equity interest in Ventrix, Inc.
CR Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774
   DeQuach J.A., 2013, EUR CELLS MATER, V23, P400
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hill RC, 2015, MOL CELL PROTEOMICS, V14, P961, DOI 10.1074/mcp.M114.045260
   Johnson T. D., 2014, BIOMATER SCI
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Kawamura I, 2011, J CARDIOVASC PHARM, V57, P416, DOI 10.1097/FJC.0b013e31820c9776
   Lin Y.D., 2012, SCI TRANSL MED, V4
   Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x
   Ouma GO, 2012, VASC MED, V17, P174, DOI 10.1177/1358863X12438270
   Powell RJ, 2011, J VASC SURG, V54, P1032, DOI 10.1016/j.jvs.2011.04.006
   Powell RJ, 2010, J VASC SURG, V52, P1525, DOI 10.1016/j.jvs.2010.07.044
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shigematsu H, 2010, GENE THER, V17, P1152, DOI 10.1038/gt.2010.51
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371
   Ungerleider J.L., 2014, STEM CELL TRANSL MED, V3, P1
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   White CJ, 2007, CIRCULATION, V116, P2203, DOI 10.1161/CIRCULATIONAHA.106.621391
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Young DA, 2014, J BIOMED MATER RES A, V102, P1641, DOI 10.1002/jbm.a.35109
NR 38
TC 20
Z9 20
U1 4
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 53
EP 59
DI 10.1016/j.ymeth.2015.03.024
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100007
PM 25843605
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Abbott, RD
   Raja, WK
   Wang, RY
   Stinson, JA
   Glettig, DL
   Burke, KA
   Kaplan, DL
AF Abbott, Rosalyn D.
   Raja, Waseem K.
   Wang, Rebecca Y.
   Stinson, Jordan A.
   Glettig, Dean L.
   Burke, Kelly A.
   Kaplan, David L.
TI Long term perfusion system supporting adipogenesis
SO METHODS
LA English
DT Article
DE Adipose tissue engineering; Three dimensional culture; Silk scaffold;
   Long term culture; Perfusion
ID MESENCHYMAL STEM-CELLS; ADIPOSE-TISSUE; IN-VITRO; ADIPOCYTE/ENDOTHELIAL
   COCULTURES; LIPOLYTIC FUNCTION; DIFFERENTIATION; BIOREACTORS; ADIPOCYTE;
   CULTURE; PREADIPOCYTES
AB Adipose tissue engineered models are needed to enhance our understanding of disease mechanisms and for soft tissue regenerative strategies. Perfusion systems generate more physiologically relevant and sustainable adipose tissue models, however adipocytes have unique properties that make culturing them in a perfusion environment challenging. In this paper we describe the methods involved in the development of two perfusion culture systems (2D and 3D) to test their applicability for long term in vitro adipogenic cultures. It was hypothesized that a silk protein biomaterial scaffold would provide a 3D framework, in combination with perfusion flow, to generate a more physiologically relevant sustainable adipose tissue engineered model than 2D cell culture. Consistent with other studies evaluating 20 and 3D culture systems for adipogenesis we found that both systems successfully model adipogenesis, however 3D culture systems were more robust, providing the mechanical structure required to contain the large, fragile adipocytes that were lost in 2D perfused culture systems. 3D perfusion also stimulated greater lipogenesis and lipolysis and resulted in decreased secretion of LDH compared to 2D perfusion. Regardless of culture configuration (2D or 3D) greater glycerol was secreted with the increased nutritional supply provided by perfusion of fresh media. These results are promising for adipose tissue engineering applications including long term cultures for studying disease mechanisms and regenerative approaches, where both acute (days to weeks) and chronic (weeks to months) cultivation are critical for useful insight. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Abbott, Rosalyn D.; Raja, Waseem K.; Wang, Rebecca Y.; Stinson, Jordan A.; Glettig, Dean L.; Burke, Kelly A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA.
   [Raja, Waseem K.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.
   [Glettig, Dean L.] MIT, Biol Engn, Cambridge, MA 02139 USA.
   [Burke, Kelly A.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Abbott, Rosalyn/0000-0003-3287-3175
FU NIH Tissue Engineering Resource Center [P41 EB002520]; NIH Ruth
   Kirschstein Postdoctoral Fellowship [F32-DK093194]; AFIRM
   [W81XWH-08-2-0032]
FX The authors wish to thank Dr. Sonal Pandya for providing the surgical
   specimens. The authors would also like to thank Dr. Irene Georgakoudi
   for the use of her confocal microscope. Finally, the authors would like
   to thank Francis Borowsky and Elisa Clark for technical assistance and
   Dr. Teresa DesRochers and Kiyatec for providing the 3D Kube culture
   systems. This work was funded by the NIH Tissue Engineering Resource
   Center (P41 EB002520) a NIH Ruth Kirschstein Postdoctoral Fellowship
   awarded to Kelly Burke (F32-DK093194) and AFIRM (W81XWH-08-2-0032).
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bellas E., 2013, TISSUE ENG C
   Bellas E, 2013, BIOMATERIALS, V34, P2960, DOI 10.1016/j.biomaterials.2013.01.058
   Choi JH, 2011, TISSUE ENG PT A, V17, P1437, DOI [10.1089/ten.tea.2010.0527, 10.1089/ten.TEA.2010.0527]
   Choi JH, 2010, TISSUE ENG PART C-ME, V16, P1157, DOI 10.1089/ten.TEC.2009.0760
   Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050
   Clark AM, 2010, ANAL BIOANAL CHEM, V397, P2939, DOI 10.1007/s00216-010-3897-z
   Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x
   Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5
   Gaspar Diana Alves, 2012, Biomatter, V2, P167, DOI 10.4161/biom.22170
   Gerlach JC, 2012, TISSUE ENG PART C-ME, V18, P54, DOI [10.1089/ten.tec.2011.0216, 10.1089/ten.TEC.2011.0216]
   Girandon L, 2011, FOLIA BIOL-PRAGUE, V57, P47
   GOERGEN JL, 1993, CYTOTECHNOLOGY, V11, P189, DOI 10.1007/BF00749869
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799
   Lai N, 2012, TISSUE ENG PART C-ME, V18, P958, DOI [10.1089/ten.tec.2012.0168, 10.1089/ten.TEC.2012.0168]
   Mabvuure N, 2012, CURR STEM CELL RES T, V7, P287, DOI 10.2174/157488812800793018
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Minteer Danielle M, 2014, J Diabetes Sci Technol, V8, P1227, DOI 10.1177/1932296814548215
   Ni XF, 2008, MICROELECTRON ENG, V85, P1330, DOI 10.1016/j.mee.2008.01.070
   Oragui E, 2011, OPEN ORTHOP J, V2, P267
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Salter E, 2012, TISSUE ENG PART B-RE, V18, P62, DOI [10.1089/ten.TEB.2011.0209, 10.1089/ten.teb.2011.0209]
   Sistino Joseph J, 2003, J Extra Corpor Technol, V35, P200
   Stacey DH, 2009, TISSUE ENG PT A, V15, P3389, DOI [10.1089/ten.tea.2008.0293, 10.1089/ten.TEA.2008.0293]
   Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P590, DOI 10.1021/bp034238d
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Ward A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055696
   Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h
NR 37
TC 11
Z9 11
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 84
EP 89
DI 10.1016/j.ymeth.2015.03.022
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100011
PM 25843606
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Corvelli, M
   Che, B
   Saeui, C
   Singh, A
   Elisseeff, J
AF Corvelli, Michael
   Che, Bernadette
   Saeui, Christopher
   Singh, Anirudha
   Elisseeff, Jennifer
TI Biodynamic performance of hyaluronic acid versus synovial fluid of the
   knee in osteoarthritis
SO METHODS
LA English
DT Article
DE Cartilage; Osteoarthritis; Hyaluronic acid; Lubricin; Synovial fluid
ID ARTICULAR-CARTILAGE; BOUNDARY LUBRICATION; FRICTIONAL RESPONSE;
   STRESS-RELAXATION; LUBRICIN; PRESSURIZATION; REPLACEMENT; DEGRADATION;
   INJURY; JOINTS
AB Hyaluronic acid (HA), a natural biomaterial present in healthy joints but depleted in osteoarthritis (OA), has been employed clinically to provide symptomatic relief of joint pain. Joint movement combined with a reduced joint lubrication in osteoarthritic knees can result in increased wear and tear, chondrocyte apoptosis, and inflammation, leading to cascading cartilage deterioration. Therefore, development of an appropriate cartilage model that can be evaluated for its friction properties with potential lubricants in different conditions is necessary, which can closely resemble a mechanically induced OA cartilage. Additionally, a comparison of different models with and without endogenous lubricating surface zone proteins, such as PRG4 promotes a well-rounded understanding of cartilage lubrication. In this study, we present our findings on the lubricating effects of HA on different articular cartilage model surfaces in comparison to synovial fluid, a physiological lubricating biomaterial. The mechanical testings data demonstrated that HA reduced average static and kinetic friction coefficient values of the cartilage samples by 75% and 70%, respectively. Furthermore, HA mimicked the friction characteristics of freshly harvested natural synovial fluid throughout all tested and modeled OA conditions with no statistically significant difference. These characteristics led us to exclusively identify HA as an effective boundary layer lubricant in the technology that we develop to treat OA (Singh et al., 2014). (C) 2015 Elsevier Inc. All rights reserved.
C1 [Corvelli, Michael; Che, Bernadette; Saeui, Christopher; Singh, Anirudha; Elisseeff, Jennifer] Johns Hopkins Univ, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD USA.
   [Corvelli, Michael; Che, Bernadette; Saeui, Christopher; Singh, Anirudha; Elisseeff, Jennifer] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA.
   [Singh, Anirudha] Johns Hopkins Univ, Sch Med, Dept Urol, Brady Urol Inst, Baltimore, MD 21205 USA.
RP Singh, A (reprint author), Johns Hopkins Univ, Dept Urol, Brady Urol Inst, Baltimore, MD 21218 USA.
EM anirudhasingh@gmail.com; jhe@jhu.edu
FU NIH [R01AR054005]; United States; DoD-PRORP grant; Wallace H. Coulter
   Foundation; Ort Philanthropic Fund; Jules Stein Professorship from the
   Research to Prevent Blindness Foundation
FX We thank F. Guilak (Duke University) for helpful discussions on the
   friction testing, T. Clemens (Johns Hopkins) for use of their
   laboratory, and the Johns Hopkins' Wilmer Eye Institute Microscopy Core
   Facility. Funding sources gratefully acknowledged are NIH R01AR054005,
   United States, DoD-PRORP grant, the Wallace H. Coulter Foundation, the
   Ort Philanthropic Fund for supporting the rheometer and the Jules Stein
   Professorship from the Research to Prevent Blindness Foundation.
CR ANADERE I, 1979, BIORHEOLOGY, V16, P179
   Ateshian G. A., 2005, FRICTION LUBRICATION, P447
   Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040
   Ballard Brooke L, 2012, J Bone Joint Surg Am, V94, pe64, DOI 10.2106/JBJS.K.00046
   Basalo IM, 2005, J BIOMECH, V38, P1343, DOI 10.1016/j.jbiomech.2004.05.045
   BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013
   Caligaris M, 2008, OSTEOARTHR CARTILAGE, V16, P1220, DOI 10.1016/j.joca.2008.02.020
   Chang DP, 2009, SOFT MATTER, V5, P3438, DOI 10.1039/b907155e
   Courtney P, 2014, BRIT J HOSP MED, V75, pC66, DOI 10.12968/hmed.2014.75.Sup5.C66
   Eckstein F, 2000, J BIOMECH, V33, P819, DOI 10.1016/S0021-9290(00)00034-8
   Ehlers EM, 2001, ANN ANAT, V183, P13, DOI 10.1016/S0940-9602(01)80007-8
   Elsaid KA, 2008, ARTHRITIS RHEUM, V58, P1707, DOI 10.1002/art.23495
   Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104
   Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373
   Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325
   Jones ARC, 2009, ARTHRITIS RHEUM-US, V60, P133, DOI 10.1002/art.24143
   Kersting UG, 2005, OSTEOARTHR CARTILAGE, V13, P925, DOI 10.1016/j.joca.2005.06.005
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   Kumar P, 2001, J ANAT, V199, P241, DOI 10.1046/j.1469-7580.2001.19930241.x
   Kuster MS, 1997, J BONE JOINT SURG BR, V79B, P109, DOI 10.1302/0301-620X.79B1.6978
   Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023
   MCCUTCHEN CW, 1966, FED PROC, V25, P1061
   Musumeci G, 2013, OA ANATOMY, V1, P1
   Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017
   Pickard J, 1998, P I MECH ENG H, V212, P177, DOI 10.1243/0954411981533953
   Saarakkala S, 2004, ULTRASOUND MED BIOL, V30, P783, DOI 10.1016/j.ultrasmedbio.2004.03.005
   Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005
   Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446
   Seror J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7497
   Singh A, 2014, NAT MATER, V13, P988, DOI [10.1038/NMAT4048, 10.1038/nmat4048]
   Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015
   Wong Benjamin L., 2008, Molecular & Cellular Biomechanics, V5, P197
NR 32
TC 5
Z9 5
U1 1
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2015
VL 84
BP 90
EP 98
DI 10.1016/j.ymeth.2015.03.019
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CO5DP
UT WOS:000359180100012
PM 25858258
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Sardella, E
   Fisher, ER
   Shearer, JC
   Trulli, MG
   Gristina, R
   Favia, P
AF Sardella, Eloisa
   Fisher, Ellen R.
   Shearer, Jeffrey C.
   Trulli, Marta Garzia
   Gristina, Roberto
   Favia, Pietro
TI N-2/H(2)o Plasma Assisted Functionalization of
   Poly(epsilon-caprolactone) Porous Scaffolds: Acidic/Basic Character
   versus Cell Behavior
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE absorbent polymers; plasma treatment; scaffolds; surface acid-base
   properties
ID SURFACE MODIFICATION; LACTIC-ACID; BIOMEDICAL APPLICATIONS;
   BIODEGRADABLE POLYMERS; CONTACT-ANGLE; OXYGEN PLASMA; ADHESION;
   DEPOSITION; FILMS; BIOMATERIALS
AB A primary research focus in tissue engineering addresses the factors that drive cell growth in scaffolds. Due to the inherent complexity of phenomena at the cell/biomaterial interface in cell-culture media, it is not easy to unambiguously disentangle the effects of different surface properties (e.g., chemical composition, roughness, porosity, etc.) in promoting specific cell behaviors, especially on porous scaffold materials. We have investigated fast low-pressure plasma treatments of porous PCL scaffolds for tissue engineering with neutral, acidic, and basic groups to obtain stable water absorbent materials. An increase of Saos2 cell growth was observed on plasma-treated scaffolds with respect to native samples; amphoteric surfaces were found very suitable for cell proliferation.
C1 [Sardella, Eloisa; Gristina, Roberto] CNR, Inst Inorgan Methodol & Plasmas IMIP, I-70126 Bari, Italy.
   [Fisher, Ellen R.; Shearer, Jeffrey C.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Gristina, Roberto; Favia, Pietro] Univ Bari, Dept Chem, I-70126 Bari, Italy.
RP Sardella, E (reprint author), CNR, Inst Inorgan Methodol & Plasmas IMIP, Via Orabona 4, I-70126 Bari, Italy.
EM eloisa.sardella@cnr.it; pietro.favia@uniba.it
OI Garzia Trulli, Marta/0000-0001-8644-3731; SARDELLA,
   ELOISA/0000-0002-6776-8327
FU MIUR [PON 16 02_00563_3448479]; LIPP (Apulian Industrial Plasma
   Laboratory) from Regione Puglia [51]; U.S. National Science Foundation
   [CHE-1152963]; American Chemical Society Global Research Experiences,
   Exchanges, and Training (GREET) program
FX The projects "RINOVATIS" (PON 16 02_00563_3448479) from MIUR, and LIPP
   (Apulian Industrial Plasma Laboratory, cod. 51) from Regione Puglia are
   gratefully acknowledged for funding. JCS and ERF (Colorado State
   University) acknowledge financial support for this work provided by the
   U.S. National Science Foundation (CHE-1152963) and by the American
   Chemical Society Global Research Experiences, Exchanges, and Training
   (GREET) program. Ms. F. Florio, Mr. S. Cosmai, and Mr. D. Benedetti
   (IMIP-CNR) are acknowledged for their experimental support.
CR Araujo JV, 2014, J BIOMED MATER RES A, V102, P4415, DOI 10.1002/jbm.a.35128
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Beamson G., 1992, HIGH RESOLUTION XPS
   Buttiglione M, 2007, BIOMATERIALS, V28, P2932, DOI 10.1016/j.biomaterials.2007.02.022
   Chen JL, 2006, J BIOMED MATER RES A, V79A, P307, DOI 10.1002/jbm.a.30799
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Da Ponte G, 2011, SURF COAT TECH, V205, pS525, DOI 10.1016/j.surfcoat.2011.03.112
   Da Ponte G, 2014, PLASMA PROCESS POLYM, V11, P345, DOI 10.1002/ppap.201300130
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Detomaso L, 2005, SURF COAT TECH, V200, P1022, DOI 10.1016/j.surfcoat.2005.02.002
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   Di Mundo R, 2010, PLASMA PROCESS POLYM, V7, P212, DOI 10.1002/ppap.200900112
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Eddy G., 2012, AM J BIOMED ENG, V2, P218, DOI DOI 10.5923/J.AJBE.20120206.02
   Favia P, 2006, PLASMA PROCESS POLYM, V3, P66, DOI 10.1002/ppap.200500073
   Favia P., 2006, PLASMA PROCESS POLYM, P271
   Fisher ER, 2013, ACS APPL MATER INTER, V5, P9312, DOI 10.1021/am4025966
   Gao CY, 2003, J BIOMAT SCI-POLYM E, V14, P937, DOI 10.1163/156856203322381429
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Guex AG, 2012, ACTA BIOMATER, V8, P1481, DOI 10.1016/j.actbio.2011.12.033
   Guo C, 2013, MATER LETT, V94, P11, DOI 10.1016/j.matlet.2012.11.092
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hasirci N, 2010, SURF INTERFACE ANAL, V42, P486, DOI 10.1002/sia.3247
   Heang S., 2013, BIOMED MATER, V8, P1
   HOLMESFARLEY SR, 1985, LANGMUIR, V1, P725, DOI 10.1021/la00066a016
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   Intranuovo F, 2011, SURF COAT TECH, V205, pS548, DOI 10.1016/j.surfcoat.2011.04.069
   Intranuovo F., 2014, PLASMA PROCESS POLYM, V11, P2
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Kregar Z, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145201
   Lee HU, 2011, MAT SCI ENG C-MATER, V31, P688, DOI 10.1016/j.msec.2010.12.012
   Lotz A, 2012, J MATER CHEM, V22, P19455, DOI 10.1039/c2jm30344b
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Morelli S, 2007, J MEMBRANE SCI, V302, P27, DOI 10.1016/j.memsci.2007.06.027
   Nagiah N, 2013, MAT SCI ENG C-MATER, V33, P4444, DOI 10.1016/j.msec.2013.06.042
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Park H, 2010, COLLOID SURFACE B, V77, P90, DOI 10.1016/j.colsurfb.2010.01.011
   Pegalajar-Jurado A, 2014, ACS APPL MATER INTER, V6, P12307, DOI 10.1021/am502003z
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Poll HU, 2001, SURF COAT TECH, V142, P489, DOI 10.1016/S0257-8972(01)01055-6
   Rence F., 2012, PLASMA PROCESS POLYM, V9, P491
   Rosenhahn A, 2009, BIOINTERPHASES, V4, P7, DOI 10.1116/1.3110182
   Sardella E, 2005, SURF COAT TECH, V200, P51, DOI 10.1016/j.surfcoat.2005.02.063
   Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Tanaka T, 2011, NUCL INSTRUM METH B, V269, P2130, DOI 10.1016/j.nimb.2011.07.003
   Trevino KJ, 2011, SURF INTERFACE ANAL, V43, P1257, DOI 10.1002/sia.3707
   Vaissiere G, 2000, MED BIOL ENG COMPUT, V38, P205, DOI 10.1007/BF02344778
   Wan YQ, 2006, BIOMATERIALS, V27, P2699, DOI 10.1016/j.biomaterials.2005.12.007
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Wertheimer MR, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PJ04
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272
   Yildirim ED, 2008, NATO SCI PEACE SEC A, P191
   Yildirim E. D., 2007, PLASMA PROCESS POLYM, V4, P58
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zelzer M, 2012, PLASMA PROCESS POLYM, V9, P149, DOI 10.1002/ppap.201100054
   Zelzer M, 2009, J PHYS CHEM B, V113, P8487, DOI 10.1021/jp902137y
NR 65
TC 7
Z9 7
U1 0
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD AUG
PY 2015
VL 12
IS 8
BP 786
EP 798
DI 10.1002/ppap.201400201
PG 13
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA CP1XZ
UT WOS:000359672400010
DA 2018-10-20
ER

PT J
AU Locatelli, E
   Monaco, I
   Franchini, MC
AF Locatelli, Erica
   Monaco, Ilaria
   Franchini, Mauro Comes
TI Hard and soft nanoparticles for image-guided surgery in nanomedicine
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Image-guided surgery; Soft nanoparticles; Hard nanoparticles; Biomedical
   applications
ID CANCER-TARGETED PROBES; SILICA NANOPARTICLES; ONCOLOGIC SURGERY;
   INDOCYANINE GREEN
AB The use of hard and/or soft nanoparticles for therapy, collectively called nanomedicine, has great potential in the battle against cancer. Major research efforts are underway in this area leading to development of new drug delivery approaches and imaging techniques. Despite this progress, the vast majority of patients who are affected by cancer today sadly still need surgical intervention, especially in the case of solid tumors. An important perspective for researchers is therefore to provide even more powerful tools to the surgeon for pre- and post-operative approaches. In this context, image-guided surgery, in combination with nanotechnology, opens a new strategy to win this battle. In this perspective, we will analyze and discuss the recent progress with nanoparticles of both metallic and biomaterial composition, and their use to develop powerful systems to be applied in image-guided surgery.
C1 [Locatelli, Erica; Monaco, Ilaria; Franchini, Mauro Comes] Univ Bologn, Dept Ind Chem, I-40136 Bologna, Italy.
RP Franchini, MC (reprint author), Univ Bologn, Dept Ind Chem, V Risorgimento 4, I-40136 Bologna, Italy.
EM mauro.comesfranchini@unibo.it
RI comes franchini, mauro/G-9727-2012; Locatelli, Erica/K-2632-2012
OI comes franchini, mauro/0000-0001-5765-7263; 
CR [Anonymous], 2007, N AM CONTR MED MARK
   Barone DG, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009685.PUB2
   Benezra M, 2011, J CLIN INVEST, V121, P2768, DOI 10.1172/JCI45600
   Bradbury MS, 2013, INTEGR BIOL-UK, V5, P74, DOI 10.1039/c2ib20174g
   Burns A. A., 2008, NANO LETT, V9, P442
   Cho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089968
   Hill TK, 2015, BIOCONJUGATE CHEM, V26, P294, DOI 10.1021/bc5005679
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2
   Kircher MF, 2003, CANCER RES, V63, P8122
   Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721
   Li Y, 2012, THERANOSTICS, V2, P769, DOI 10.7150/thno.4690
   Noorlander CW, 2015, NANOMEDICINE-UK, V10, P1599, DOI [10.2217/NNM.15.21, 10.2217/nnm.15.21]
   Phillips E., 2014, SCL TRANSL MED, V6, DOI DOI 10.1126/SCITRANSLMED.3009524
   Rizzo LY, 2013, CURR OPIN BIOTECH, V24, P1159, DOI 10.1016/j.copbio.2013.02.020
   Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943
   Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6
   TechNavio (Infiniti Research Ltd.), 2015, GLOB CONTR MED CONTR
   Xi L, 2014, ANN SURG ONCOL, V21, P1602, DOI 10.1245/s10434-014-3541-9
   Xiong CY, 2011, J MED CHEM, V54, P1825, DOI 10.1021/jm101477d
   Xu XY, 2015, TRENDS MOL MED, V21, P223, DOI 10.1016/j.molmed.2015.01.001
NR 21
TC 5
Z9 5
U1 0
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD AUG 1
PY 2015
VL 17
IS 8
AR 328
DI 10.1007/s11051-015-3135-x
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CO0II
UT WOS:000358833200001
DA 2018-10-20
ER

PT J
AU Wolbank, S
   Pichler, V
   Ferguson, JC
   Meinl, A
   van Griensven, M
   Goppelt, A
   Redl, H
AF Wolbank, Susanne
   Pichler, Valentin
   Ferguson, James Crawford
   Meinl, Alexandra
   van Griensven, Martijn
   Goppelt, Andreas
   Redl, Heinz
TI Non-invasive in vivo tracking of fibrin degradation by fluorescence
   imaging
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterial degradation; fibrin; fluorescence; non-invasive imaging
ID SEALANT
AB Fibrin-based sealants consist of natural coagulation factors involved in the final phase of blood coagulation, during which fibrinogen is enzymatically converted by thrombin to form a solid-phase fibrin clot. For applications in tissue regeneration, a controlled process of matrix degradation within a certain period of time is essential for optimal wound healing. Hence, it is desirable to follow the kinetics of fibrinolysis at the application site. Non-invasive molecular imaging systems enable real-time tracking of processes in the living animal. In this study, a non-invasive fluorescence based imaging system was applied to follow and quantify site-specific degradation of fibrin sealant. To enable non-invasive tracking of fibrin in vivo, fibrin-matrix was labelled by incorporation of a fluorophore-conjugated fibrinogen component. Protein degradation and release of fluorescence were, in a first step, correlated in vitro. In vivo, fluorophore-labelled fibrin was subcutaneously implanted in mice and followed throughout the experiment using a multispectral imaging system. For the fluorescent fibrin, degradation correlated with the release of fluorescence from the clots in vitro. In vivo it was possible to follow and quantify implanted fibrin clots throughout the experiment, demonstrating degradation kinetics of approximately 16days in the subcutaneous compartment, which was further confirmed by histological evaluation of the application site. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Wolbank, Susanne; Pichler, Valentin; Ferguson, James Crawford; van Griensven, Martijn; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, A-1200 Vienna, Austria.
   [Wolbank, Susanne; Pichler, Valentin; Ferguson, James Crawford; Meinl, Alexandra; van Griensven, Martijn; Redl, Heinz] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Meinl, Alexandra] Bernhard Gottlieb Univ, Sch Dent, Vienna, Austria.
   [Goppelt, Andreas] Baxter Innovat GmbH, Vienna, Austria.
RP Wolbank, S (reprint author), Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM susanne.wolbank@trauma.lbg.ac.at
RI van Griensven, Martijn/F-5808-2012
OI van Griensven, Martijn/0000-0001-5104-9881; Goppelt,
   Andreas/0000-0002-0780-1332
FU Baxter Innovations GmbH, Vienna; Lorenz Bohler Fonds; European FP7
   project Angioscaff [NMP LA 2008 214402]
FX The authors thank Baxter Innovations GmbH, Vienna and the Lorenz Bohler
   Fonds and the European FP7 project Angioscaff (NMP LA 2008 214402) for
   supporting this study.
CR Bancrofts JD, 1982, THEORY PRACTICE HIST
   Buchta C, 2005, BIOMATERIALS, V26, P6233, DOI 10.1016/j.biomaterials.2005.04.014
   DINGES HP, 1986, PATHOL RES PRACT, V181, P746, DOI 10.1016/S0344-0338(86)80051-6
   Hara T, 2012, JACC-CARDIOVASC IMAG, V5, P607, DOI 10.1016/j.jcmg.2012.01.017
   Hattori R, 2000, ANN THORAC SURG, V70, P2132, DOI 10.1016/S0003-4975(00)02126-3
   Kroez M, 2005, WOUND REPAIR REGEN, V13, P318, DOI 10.1111/j.1067-1927.2005.130315.x
   Loskutoff DJ, 2000, J CLIN INVEST, V106, P1441, DOI 10.1172/JCI11765
   Macasev D, 2011, J BIOMATER APPL, V26, P129, DOI 10.1177/0885328210369574
   Michlits W, 2007, WOUND REPAIR REGEN, V15, P360, DOI 10.1111/j.1524-475X.2007.00238.x
   Mittermayr R, 2008, WOUND REPAIR REGEN, V16, P542, DOI 10.1111/j.1524-475X.2008.00391.x
   Ntziachristoss V, 2007, TXB VIVO IMAGING VER
   Pans CP, 2010, BIOMED OPT EXPRESS, V1, P285
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Peterbauer-Scherb A, 2012, J TISSUE ENG REGEN M, V6, P434, DOI 10.1002/term.446
   Pfluger H, 1982, Z Urol Nephrol, V75, P25
   Spuentrup E, 2008, EUR RADIOL, V18, P1995, DOI 10.1007/s00330-008-0965-2
   Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030262
NR 17
TC 6
Z9 6
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD AUG
PY 2015
VL 9
IS 8
BP 973
EP 976
DI 10.1002/term.1941
PG 4
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CO6WM
UT WOS:000359297700009
PM 25044309
DA 2018-10-20
ER

PT J
AU Kumar, B
   Kumar, U
AF Kumar, Binod
   Kumar, Upendra
TI Adsorption of malachite green in aqueous solution onto sodium carbonate
   treated rice husk
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Malachite Green; Adsorption Equilibrium; Kinetic; Thermodynamic Studies;
   SEM; FTIR; COD
ID ACTIVATED CARBON; KINETICS; THERMODYNAMICS; DYE; EQUILIBRIUM; ADSORBENT;
   WASTE; SHELL
AB The feasibility of using rice husk for removing malachite green (MG) from aqueous solutions has been investigated as a low cost and an eco-friendly adsorbent. The effect of chemical treatment of rice husk by sodium carbonate was investigated through SEM and FTIR. As well, the effect of various factors like rotational speed, pH value of solution, temperature, initial concentration of dye, dose of adsorbent, contact time on the adsorption of MG was examined in batch experiments. Adsorption isotherms, kinetics, mass transfer and rate limiting steps are studied in detail. Adsorption thermodynamic parameters, activation energy and isosteric heat of adsorption were also studied. The adsorption was a spontaneous, endothermic and followed the pseudo-second-order kinetic model. The mechanism of adsorption and the COD aspect in deciding the effectiveness of the biomaterial as an adsorbent for dyes has also to be taken into account.
C1 [Kumar, Binod; Kumar, Upendra] Natl Inst Technol, Dept Civil Engn, Silchar, Assam, India.
RP Kumar, U (reprint author), Natl Inst Technol, Dept Civil Engn, Silchar, Assam, India.
EM upendra_kumar72@rediffmail.com
FU World Bank TEQIP II fund of MHRD, Govt. of India
FX The authors greatly appreciate the World Bank TEQIP II fund of MHRD,
   Govt. of India for the financial support. The authors are also grateful
   to all the Civil and Environmental Engineering teams of the National
   Institute of Technology, Silchar, Assam, India, for their support and
   encouragement.
CR Ahmad R, 2010, J ENVIRON MANAGE, V91, P1032, DOI 10.1016/j.jenvman.2009.12.016
   Anirudhan TS, 2008, J CHEM THERMODYN, V40, P702, DOI 10.1016/j.jct.2007.10.005
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Chowdhury S, 2011, DESALINATION, V265, P159, DOI 10.1016/j.desal.2010.07.047
   Ciobanu G, 2014, KOREAN J CHEM ENG, V31, P1021, DOI 10.1007/s11814-014-0040-4
   Daintith J., 2008, OXFORD DICT CHEM
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Derbyshire F, 2001, CHEM PHYS CARBON, V27, P1
   Dom&iacute;nguez G., 2010, J MEX CHEM SOC, V54, P1161
   Ghaedi M, 2011, DESALINATION, V281, P226, DOI 10.1016/j.desal.2011.07.068
   Ghoreishi SM, 2003, CHEM ENG J, V95, P163, DOI 10.1016/S1385-8947(03)00100-1
   Han XL, 2012, KOREAN J CHEM ENG, V29, P494, DOI 10.1007/s11814-011-0211-5
   Kumar PS, 2010, DESALINATION, V261, P52, DOI 10.1016/j.desal.2010.05.032
   LASZLO JA, 1994, J APPL POLYM SCI, V52, P531, DOI 10.1002/app.1994.070520408
   Linh L. P., 2012, INT J BIOMASS RENEWA, V1, P32
   Luduena L, 2011, BIORESOURCES, V6, P1440
   Lyubchik SI, 2004, COLLOID SURFACE A, V242, P151, DOI 10.1016/j.colsurfa.2004.04.066
   Naiya TK, 2008, ENVIRON PROG, V27, P313, DOI 10.1002/ep.10280
   Ngah WSW, 2008, BIORESOURCE TECHNOL, V99, P3935, DOI 10.1016/j.biortech.2007.06.011
   Rosa D., 2010, COMPOS SCI TECHNOL, V70, P116
   Sonawane GH, 2009, DESALINATION, V247, P430, DOI 10.1016/j.desal.2009.01.006
   Subbareddy Y., 2012, J ENV RES DEV, V7, p1A
   Tsai WT, 2010, J HAZARD MATER, V175, P844, DOI 10.1016/j.jhazmat.2009.10.087
   Von Oepen, 1991, CHEMOSPHERE, V22, P285
   Xin HA, 2007, J ENVIRON SCI-CHINA, V19, P1287, DOI 10.1016/S1001-0742(07)60210-1
   Yang XQ, 2009, PROCESS BIOCHEM, V44, P1185, DOI 10.1016/j.procbio.2009.06.015
NR 26
TC 8
Z9 8
U1 1
U2 15
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD AUG
PY 2015
VL 32
IS 8
BP 1655
EP 1666
DI 10.1007/s11814-014-0351-5
PG 12
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CN9CT
UT WOS:000358744700024
DA 2018-10-20
ER

PT J
AU Briquez, PS
   Hubbell, JA
   Martino, MM
AF Briquez, Priscilla S.
   Hubbell, Jeffrey A.
   Martino, Mikael M.
TI Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin
   Wound Healing
SO ADVANCES IN WOUND CARE
LA English
DT Review
ID FACTOR-BINDING DOMAIN; DIABETIC FOOT; MYOCARDIAL-INFARCTION; FACTOR
   RECEPTORS; DRUG-DELIVERY; FIBRONECTIN; INTEGRIN; PATHOPHYSIOLOGY;
   MORPHOGENESIS; BIOMATERIALS
AB Significance: Growth factors are very promising molecules for the treatment of skin wounds. However, their translation to clinical use has been seriously limited, facing issues related to safety and cost-effectiveness. These problems may derive from the fact that growth factors are used at vastly supra-physiological levels without optimized delivery systems.
   Recent Advances: The extracellular matrix (ECM) plays a fundamental role in coordinating growth factor signaling. Therefore, understanding the mechanisms by which the ECM modulates growth factor activity is key for designing efficient growth factor-based therapies. Recently, several growth factor-binding domains have been discovered within various ECM proteins, and growth factor delivery systems integrating these ECM growth factor-binding domains showed promising results in animal models of skin wound healing. Moreover, a novel strategy consisting of engineering growth factors to target endogenous ECM could substantially enhance their efficacy, even when used at low doses.
   Critical Issues: Optimal delivery of growth factors often requires complex engineered biomaterial matrices, which can face regulatory issues for clinical translation. To simplify delivery systems and render strategies more applicable, growth factors can be engineered to optimally function with clinically approved biomaterials or with endogenous ECM present at the delivery site.
   Future Directions: Further development and clinical trials will reveal whether growth factor-based therapies can be used as main therapeutic approaches for skin wound healing. The future impact of these therapies will depend on our capacity to deliver growth factors more precisely, to improve efficacy, safety, and cost-effectiveness.
C1 [Briquez, Priscilla S.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.
   [Briquez, Priscilla S.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.
   [Hubbell, Jeffrey A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA.
   [Martino, Mikael M.] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.
RP Martino, MM (reprint author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.
EM jhubbell@uchicago.edu; mmartino@ifrec.osaka-u.ac.jp
RI Martino, Mikael/N-9345-2013
OI Martino, Mikael/0000-0002-5012-4605
FU European Research Council under the Advanced Grant Cytrix; Swiss
   National Science Foundation
FX The authors would like to acknowledge Dr. Hans M. Larsson and Dr.
   Federico Tortelli for careful reading of the article. This work was
   supported in part by the European Research Council under the Advanced
   Grant Cytrix and by the Swiss National Science Foundation.
CR Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394
   Arora NS, 2009, IMPLANT DENT, V18, P303, DOI 10.1097/ID.0b013e31819e8ec6
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019
   Breitbart AS, 2003, ANN PLAS SURG, V51, P409, DOI 10.1097/01.SAP.0000084461.83554.71
   Broderick N, 2009, NURSE PRACT, V34, P16, DOI 10.1097/01.NPR.0000361299.88402.f6
   Buchberger B, 2010, IMPORTANCE GROWTH FA, V6, pDoc12
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carter K, 2003, BR J COMMUN NURS, V8, p[S15, S18, S22]
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Cugat R, 2010, EUR MUSCULOSKELET RE, V5, P32
   De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076
   Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P349, DOI 10.1097/01.ASW.0000418541.31366.a3
   Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Ferraro B, 2009, MOL THER, V17, P651, DOI 10.1038/mt.2009.12
   Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kumar V., 2009, ROBBINS COTRAN PATHO
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Lin FB, 2011, J INVEST DERMATOL, V131, P84, DOI 10.1038/jid.2010.253
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b
   Achar RAN, 2014, ACTA CIR BRAS, V29, P125, DOI 10.1590/S0102-86502014000200009
   Powers JG, 2013, DERMATOL THER, V26, P197, DOI 10.1111/dth.12055
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   Schultz G. S., 2005, EXTRACELLULAR MATRIX
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Shuttleworth L, 2005, INT J EXP PATHOL, V86, pA68
   Tokunou T, 2008, FASEB J, V22, P1886, DOI 10.1096/fj.07-100925
   Traub S, 2013, BIOMATERIALS, V34, P5958, DOI 10.1016/j.biomaterials.2013.04.050
   Traversa B, 2001, PRIM INTENTION, V9, P161
   Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148
   Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x
   Werdin F, 2009, EPLASTY, V8, P26
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66
   Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75
   Zhu J, 2014, J INVEST DERMATOL, V134, P895, DOI 10.1038/jid.2013.484
NR 61
TC 51
Z9 52
U1 4
U2 32
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2162-1918
EI 2162-1934
J9 ADV WOUND CARE
JI Adv. Wound Care
PD AUG
PY 2015
VL 4
IS 8
BP 479
EP 489
DI 10.1089/wound.2014.0603
PG 11
WC Dermatology
SC Dermatology
GA CL8YW
UT WOS:000357261900005
OA Green Published
DA 2018-10-20
ER

PT J
AU Bishai, M
   De, S
   Adhikari, B
   Banerjee, R
AF Bishai, Moumita
   De, Swarnalok
   Adhikari, Basudam
   Banerjee, Rintu
TI A platform technology of recovery of lactic acid from a fermentation
   broth of novel substrate Zizyphus oenophlia
SO 3 BIOTECH
LA English
DT Article
DE Lactic acid; Purification; Ion exchange resin; Amberlite IRA 96;
   Amberlite IR 120
ID ANION-EXCHANGE RESINS; CIRCULAR-DICHROISM; L(+)-LACTIC ACID;
   PURIFICATION; ADSORPTION
AB Lactic acid, a biologically derived compound, exists ubiquitously in nature. Its existence ranges from human being to microorganisms. Having paramount industrial significance, lactic acid should be highly pure, devoid of any contaminants. Hence, development of minimum steps of platform technologies to purify it needs urgent attention. The article proposed a novel and simple process for separation of lactic acid from a potential substrate Zizyphus oenophlia, based on ion exchange chromatography. The process herein involves two steps of purification; firstly a weak anion exchange resin was used to separate lactic acid from other anions present in the broth. This was followed by use of strong cation exchanger which washes out the target molecule (lactic acid) while trapped other cations present in the solution. The selected ion exchangers were Amberlite IRA 96 and Amberlite IR 120. Amberlite IRA 96 retained the lactic acid from the broth while washing away other anions. Maximum binding capacity of the resin was found to 210.46 mg lactic acid/g bead. After the simple two-step purification process, the purity of lactic acid improves up to 99.17 % with a recovery yield of 98.9 %. Upon characterization, formation of only levo rotatory form of lactic acid confirms its easy metabolism by the human system, thus triggering its application towards biomaterial sector.
C1 [Bishai, Moumita; De, Swarnalok; Banerjee, Rintu] Indian Inst Technol, Microbial Biotechnol & Downstream Proc Lab, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.
   [Adhikari, Basudam] Indian Inst Technol, Ctr Mat Sci, Kharagpur 721302, W Bengal, India.
RP Banerjee, R (reprint author), Indian Inst Technol, Microbial Biotechnol & Downstream Proc Lab, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.
EM rb@iitkgp.ac.in
FU Department of Biotechnology, India
FX The authors would like to acknowledge Department of Biotechnology, India
   for providing funds for this research.
CR ANAND RD, 1967, CHEM COMMUN, P421, DOI 10.1039/c19670000421
   Beavers EM, 2005, THESIS EMPORIA STATE
   Bishai M, 2013, BIORESOURCE TECHNOL, V133, P627, DOI 10.1016/j.biortech.2012.12.049
   Bishai M, 2013, FOOD SCI BIOTECHNOL, V22, P73, DOI 10.1007/s10068-013-0051-7
   Caboche JJ, 2000, CHEM ENG PROCESS, Patent No. US6280985
   Cao XJ, 2002, BIOCHEM ENG J, V11, P189, DOI 10.1016/S1369-703X(02)00024-4
   Chendake YJ, 2014, J MEMBRANE SCI, V451, P243, DOI 10.1016/j.memsci.2013.10.014
   Choi JI, 1999, J CHEM ENG JPN, V32, P184, DOI 10.1252/jcej.32.184
   Dechow F J., 1989, SEPARATION PURIFICAT
   Deyl Z, 1984, NEW COMPREHENSIVE BI, V8
   EVANGELISTA RL, 1994, APPL BIOCHEM BIOTECH, V45-6, P131, DOI 10.1007/BF02941793
   Gargely A, 2000, IDENTIFICATION DETER
   Gonzalez MI, 2007, J FOOD ENG, V80, P553, DOI 10.1016/j.jfoodeng.2006.06.021
   Groot W, 2010, POLY LACTIC ACID SYN
   Guo Q, 2012, CHEM-EUR J, V18, P13854, DOI 10.1002/chem.201201319
   John RP, 2008, BRAZ ARCH BIOL TECHN, V51, P1241, DOI 10.1590/S1516-89132008000600020
   KAUFMAN EN, 1995, APPL BIOCHEM BIOTECH, V51-2, P605, DOI 10.1007/BF02933462
   Kimberley AC, 1996, APPL BIOCHEM BIOTECH, V56, P49
   Kulprathipanja S, 1991, US Patent, Patent No. [US5068419 A, 6280985, US6280985]
   Kulprathipanja S., 1991, US Patent, Patent No. 5068419
   Losada M, 2007, PHYS CHEM CHEM PHYS, V9, P3127, DOI 10.1039/b703368k
   Madzingaidzo L, 2002, J BIOTECHNOL, V96, P223, DOI 10.1016/S0168-1656(02)00049-4
   MARIA HJ, 1972, J MOL SPECTROSC, V42, P177, DOI 10.1016/0022-2852(72)90153-1
   Moldes AB, 2003, BIOPROC BIOSYST ENG, V25, P357, DOI 10.1007/s00449-002-0316-7
   Moldes AB, 2001, APPL BIOCHEM BIOTECH, V95, P69, DOI 10.1385/ABAB:95:2:069
   Myhre CEL, 2004, ATMOS CHEM PHYS DISC, V4, P3013
   Negi S, 2011, FOOD TECHNOL BIOTECH, V49, P310
   Quintero J, 2012, REV FAC ING-UNIV ANT, P139
   Raya-Tonetti G, 1998, LAT AM APPL RES, V28, P89
   Rincon J, 2007, SOLVENT EXTR ION EXC, V15, P329
   Sosa AV, 2000, BIOSEPARATION, V9, P283, DOI 10.1023/A:1011165810823
   Subramanian G., 1995, QUALITY ASSURANCE EN
   Tong WY, 2004, BIOCHEM ENG J, V18, P89, DOI 10.1016/S1369-703X(03)00170-0
   Wee YJ, 2006, FOOD TECHNOL BIOTECH, V44, P163
   Zheng YZ, 1996, APPL BIOCHEM BIOTECH, V57-8, P627, DOI 10.1007/BF02941743
NR 35
TC 5
Z9 6
U1 1
U2 19
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5738
EI 2190-572X
J9 3 BIOTECH
JI 3 Biotech
PD AUG
PY 2015
VL 5
IS 4
BP 455
EP 463
DI 10.1007/s13205-014-0240-y
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CN9NL
UT WOS:000358775700010
PM 28324548
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Muanprasat, C
   Wongkrasant, P
   Satitsri, S
   Moonwiriyakit, A
   Pongkorpsakol, P
   Mattaveewong, T
   Pichyangkura, R
   Chatsudthipong, V
AF Muanprasat, Chatchai
   Wongkrasant, Preedajit
   Satitsri, Saravut
   Moonwiriyakit, Aekkacha
   Pongkorpsakol, Pawin
   Mattaveewong, Tharinee
   Pichyangkura, Rath
   Chatsudthipong, Varanuj
TI Activation of AMPK by chitosan oligosaccharide in intestinal epithelial
   cells: Mechanism of action and potential applications in intestinal
   disorders
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE Chitosan oligosaccharide; Intestinal epithelial cells; AMP-activated
   protein kinase; Diarrhea; Colorectal cancer
ID PROTEIN-KINASE; LIFE-SPAN; TIGHT JUNCTIONS; COLON-CANCER; METFORMIN;
   CHITOOLIGOSACCHARIDES; PHOSPHORYLATION; INFLAMMATION; RESVERATROL;
   HEALTHSPAN
AB Chitosan oligosaccharide (COS), a biomaterial derived from chitin, is absorbed by intestinal epithelia without degradation and has diverse biological activities including intestinal epithelial function. However, the mode of action is still unclear. This study aimed to investigate the effect of COS on AMP-activated protein kinase (AMPK) in intestinal epithelial cells (IEC) and its potential applications in the intestinal diseases benefited from AMPK activation. COS with molecular weights (MW) from 5,000 Da to 14,000 Da induced AMPK activation in T84 cells. That with MW of 5,000-Da was the most potent polymer and was used in the subsequent experiments. COS also activated AMPK in other IEC including HT-29 and Caco-2 cells. Mechanism of COS-induced AMPK activation in T84 cells involves calcium-sensing receptor (CaSR)-phospholipase C (PLC)-IP3 receptor channel-mediated calcium release from endoplasmic reticulum (ER). In addition, COS promoted tight junction assembly in T84 cells in an AMPK-dependent manner. COS also inhibited NF-kappa B transcriptional activity and NF-kappa B-mediated inflammatory response and barrier disruption via AMPK-independent mechanisms. Interestingly, luminal exposure to COS suppressed cholera toxin-induced intestinal fluid secretion by similar to 30% concurrent with AMPK activation in a mouse closed loop model. Importantly, oral administration of COS prevented the development of aberrant crypt foci in a mouse model of colitis-associated colorectal cancer (CRC) via a mechanism involving AMPK activation-induced beta-catenin suppression and caspase-3 activation. Collectively, this study reveals a novel action of COS in activating AMPK via CaSR-PLC-IP3 receptor channel-mediated calcium release from ER. COS may be beneficial in the treatment of secretory diarrheas and CRC chemoprevention. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Muanprasat, Chatchai; Wongkrasant, Preedajit; Satitsri, Saravut; Moonwiriyakit, Aekkacha; Pongkorpsakol, Pawin; Mattaveewong, Tharinee; Chatsudthipong, Varanuj] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok 10400, Thailand.
   [Pichyangkura, Rath] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok 10330, Thailand.
RP Muanprasat, C (reprint author), Mahidol Univ, Dept Physiol, Fac Sci, Bangkok 10400, Thailand.
EM chatchai.mua@mahidol.ac.th
RI Satitsri, Saravut/I-6616-2013
OI Satitsri, Saravut/0000-0002-1555-4917
FU Agricultural Research Development Agency (ARDA); Thailand Research Fund
   (TRF); Mahidol University [RSA5680006]; National Research Council of
   Thailand (NRCT); Faculty of Science, Mahidol University; Office of the
   Higher Education Commission; Mahidol University under the National
   Research Universities Initiative; TRF through the Royal Golden Jubilee
   Ph.D. Program [PHD/0105/2556]
FX This work is supported by grants from the Agricultural Research
   Development Agency (ARDA), Thailand Research Fund (TRF) and Mahidol
   University (grant RSA5680006), and National Research Council of Thailand
   (NRCT) (to C.M.). Financial supports from the Faculty of Science,
   Mahidol University, and the Office of the Higher Education Commission
   and Mahidol University under the National Research Universities
   Initiative are also gratefully acknowledged (to C.M.). C.M. is TRF
   Research Scholar. SS is supported by TRF through the Royal Golden
   Jubilee Ph.D. Program (Grant PHD/0105/2556). Authors thank Professor
   Chumpol Prolpramool for critical reading of the manuscript.
CR Almabrouk TAM, 2014, BRIT J PHARMACOL, V171, P595, DOI 10.1111/bph.12479
   Anwar MA, 2014, J CANCER, V5, P736, DOI 10.7150/jca.9726
   Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151
   Caplan MJ, 2008, CURR OPIN NEPHROL HY, V17, P506, DOI 10.1097/MNH.0b013e32830baaae
   Chi Y, 2011, J PHARMACOL EXP THER, V339, P257, DOI 10.1124/jpet.111.183020
   Dai XL, 2013, NEUROSCI LETT, V554, P64, DOI 10.1016/j.neulet.2013.08.046
   Fan XD, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0450-z
   Gama L, 1997, AM J PHYSIOL-CELL PH, V273, pC1168
   Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244
   Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010
   Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013
   Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327
   Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535
   Je JY, 2012, ADV FOOD NUTR RES, V65, P321, DOI 10.1016/B978-0-12-416003-3.00021-4
   Jouret F, 2013, J CELL SCI, V126, P5132, DOI 10.1242/jcs.127555
   Ju CX, 2010, BIOL PHARM BULL, V33, P1511, DOI 10.1248/bpb.33.1511
   Kim JN, 2009, ISLETS, V1, P111, DOI 10.4161/isl.1.2.9143
   King JD, 2009, AM J PHYSIOL-CELL PH, V297, pC94, DOI 10.1152/ajpcell.00677.2008
   Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435
   Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6655, DOI 10.1016/j.bmcl.2009.10.007
   Li W, 2014, MOL CARCINOG
   Lodhi G, 2014, BIOMED RES INT, DOI 10.1155/2014/654913
   Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Muanprasat C, 2013, FUTURE MED CHEM, V5, P781, DOI [10.4155/fmc.13.42, 10.4155/FMC.13.42]
   Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rogers AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069050
   Saidak Z, 2009, MOL PHARMACOL, V76, P1131, DOI 10.1124/mol.109.058784
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800
   Szkudelski T, 2014, BIOCH BIOPHYS ACTA
   Thadathil N, 2014, FOOD CHEM, V150, P392, DOI 10.1016/j.foodchem.2013.10.083
   Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061
   Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
   Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103
   Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104
   Zulato E, 2014, BRIT J CANCER, V111, P25, DOI 10.1038/bjc.2014.274
NR 40
TC 25
Z9 29
U1 6
U2 48
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD AUG 1
PY 2015
VL 96
IS 3
BP 225
EP 236
DI 10.1016/j.bcp.2015.05.016
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CN5JJ
UT WOS:000358465300008
PM 26047848
DA 2018-10-20
ER

PT J
AU Chyasnavichyus, M
   Young, SL
   Tsukruk, VV
AF Chyasnavichyus, Marius
   Young, Seth L.
   Tsukruk, Vladimir V.
TI Recent advances in micromechanical characterization of polymer,
   biomaterial, and cell surfaces with atomic force microscopy
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 22nd International Colloquium on Scanning Probe Microscopy (ICSPM22)
CY DEC 11-13, 2014
CL JAPAN
SP Japan Soc Appl Phys
ID SCANNING PROBE MICROSCOPY; ORGANIC THIN-FILMS; MECHANICAL-PROPERTIES;
   VISCOELASTIC PROPERTIES; NANOMECHANICAL PROPERTIES; TAPPING-MODE; SOFT
   MATTER; AFM NANOINDENTATION; ELASTIC PROPERTIES; RELATIVE-HUMIDITY
AB Probing of micro- and nanoscale mechanical properties of soft materials with atomic force microscopy (AFM) gives essential information about the performance of the nanostructured polymer systems, natural nanocomposites, ultrathin coatings, and cell functioning. AFM provides efficient and is some cases the exclusive way to study these properties nondestructively in controlled environment. Precise force control in AFM methods allows its application to variety of soft materials and can be used to go beyond elastic properties and examine temperature and rate dependent materials response. In this review, we discuss experimental AFM methods currently used in the field of soft nanostructured composites and biomaterials. We discuss advantages and disadvantages of common AFM probing techniques, which allow for both qualitative and quantitative mappings of the elastic modulus of soft materials with nanosacle resolution. We also discuss several advanced techniques for more elaborate measurements of viscoelastic properties of soft materials and experiments on single cells. (C) 2015 The Japan Society of Applied Physics
C1 [Chyasnavichyus, Marius; Young, Seth L.; Tsukruk, Vladimir V.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Chyasnavichyus, M (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM vladimir@mse.gatech.edu
RI Chyasnavichyus, Marius/D-8173-2016
OI Chyasnavichyus, Marius/0000-0003-3640-7200
FU National Science Foundation, Division of Materials Research Award
   [DMR-1209332, DMR-1505234, CBET-1402712]; Air Force Office of Scientific
   Research [FA9550-14-1-0269]; Georgia Tech Microanalysis Center
FX The authors would like to acknowledge financial support which funds the
   AFM work in SEMA lab from: National Science Foundation, Division of
   Materials Research Awards DMR-1209332 and DMR-1505234, and CBET-1402712
   project; Air Force Office of Scientific Research, FA9550-14-1-0269, and
   Georgia Tech Microanalysis Center.
CR Arinero R, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432264
   Arnold W., 2012, ENCY NANOTECHNOLOGY
   Beaussart A, 2014, ACS NANO, V8, P10723, DOI 10.1021/nn5044383
   Beaussart A, 2014, NAT PROTOC, V9, P1049, DOI 10.1038/nprot.2014.066
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Braunsmann C, 2014, POLYMER, V55, P219, DOI 10.1016/j.polymer.2013.11.029
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Buzio R., 2013, SCANNING PROBE MICRO, V3
   Campbell SE, 2012, ACTA BIOMATER, V8, P4389, DOI 10.1016/j.actbio.2012.07.042
   Canetta E, 2005, BIORHEOLOGY, V42, P321
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Cappella B, 2011, POLYMERS-BASEL, V3, P1091, DOI 10.3390/polym3031091
   Cartagena A, 2014, BIOPHYS J, V106, P1033, DOI 10.1016/j.bpj.2013.12.037
   Chakraborty I, 2014, POLYMER, V55, P1609, DOI 10.1016/j.polymer.2014.02.027
   Chawla G, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3626847
   Chen YY, 2009, LANGMUIR, V25, P4607, DOI 10.1021/la8036346
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Choi I, 2013, LANGMUIR, V29, P9761, DOI 10.1021/la401597p
   Choi T, 2006, ADV FUNCT MATER, V16, P1324, DOI 10.1002/adfm.200500693
   Chyasnavichyus M, 2014, POLYMER, V55, P6091, DOI 10.1016/j.polymer.2014.09.053
   Chyasnavichyus M, 2014, LANGMUIR, V30, P10566, DOI 10.1021/la404925h
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   Clifford CA, 2005, APPL SURF SCI, V252, P1915, DOI 10.1016/j.apsusc.2005.08.090
   Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003
   Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019
   Dinelli F, 1999, SURF INTERFACE ANAL, V27, P562, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<562::AID-SIA538>3.3.CO;2-B
   Dongmo LS, 2000, ULTRAMICROSCOPY, V85, P141, DOI 10.1016/S0304-3991(00)00051-6
   Dufrene YF, 2013, NAT METHODS, V10, P847, DOI [10.1038/NMETH.2602, 10.1038/nmeth.2602]
   Ebeling D, 2013, ACS NANO, V7, P10387, DOI 10.1021/nn404845q
   Enning R, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3575322
   Fichtner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093123
   Fischer H, 2013, J MICROSC-OXFORD, V250, P210, DOI 10.1111/jmi.12036
   Fischer-Cripps AC, 2004, MAT SCI ENG A-STRUCT, V385, P74, DOI 10.1016/j.msea.2004.04.070
   Franz C. M., 2012, ATOMIC FORCE MICROSC, V1st
   Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006
   Fukuma T., 2012, ATOMIC FORCE MICROSC
   Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005
   Gadelrab KR, 2013, LANGMUIR, V29, P2200, DOI 10.1021/la3044413
   Ganser C, 2014, HOLZFORSCHUNG, V68, P53, DOI 10.1515/hf-2013-0014
   Garcia R, 2014, NAT NANOTECHNOL, V9, P577, DOI [10.1038/NNANO.2014.157, 10.1038/nnano.2014.157]
   Garcia R, 2013, EUR POLYM J, V49, P1897, DOI 10.1016/j.eurpolymj.2013.03.037
   Garcia R, 2012, NAT NANOTECHNOL, V7, P217, DOI [10.1038/nnano.2012.38, 10.1038/NNANO.2012.38]
   Gorelik J, 2002, BIOPHYS J, V83, P3296, DOI 10.1016/S0006-3495(02)75330-7
   Grant CA, 2013, MICRON, V44, P174, DOI 10.1016/j.micron.2012.06.004
   Griepentrog M, 2013, POLYM TEST, V32, P455, DOI 10.1016/j.polymertesting.2013.01.011
   Guillaume-Gentil O, 2014, TRENDS BIOTECHNOL, V32, P381, DOI 10.1016/j.tibtech.2014.04.008
   HABERLE W, 1991, J VAC SCI TECHNOL B, V9, P1210, DOI 10.1116/1.585206
   Haugstad G., 2013, SCANNING PROBE MICRO
   Hazel JL, 1998, J TRIBOL-T ASME, V120, P814, DOI 10.1115/1.2833784
   Hazel JL, 1999, THIN SOLID FILMS, V339, P249, DOI 10.1016/S0040-6090(98)00961-4
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Herruzo ET, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4126
   Huey BD, 2007, ANNU REV MATER RES, V37, P351, DOI 10.1146/annurev.matsci.37.052506.084331
   Hurley DC, 2006, APPL SURF SCI, V253, P1274, DOI 10.1016/j.apsusc.2006.01.072
   Hurley D. C., 2013, SCANNING PROBE MICRO
   Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n
   Jimenez-Palomar I, 2012, J MECH BEHAV BIOMED, V5, P149, DOI 10.1016/j.jmbbm.2011.08.018
   Karagiannidis PG, 2011, THIN SOLID FILMS, V519, P4105, DOI 10.1016/j.tsf.2011.01.196
   Kasas S, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/13/133001
   Kashef J, 2015, DEV BIOL, V401, P165, DOI 10.1016/j.ydbio.2014.11.002
   Katan AJ, 2011, CELL, V147, P979, DOI 10.1016/j.cell.2011.11.017
   Killgore JP, 2011, LANGMUIR, V27, P13983, DOI 10.1021/la203434w
   Kovalev A, 2004, J MATER RES, V19, P716, DOI 10.1557/jmr.2004.19.3.716
   Liu JX, 2011, COLLOID SURFACE A, V380, P175, DOI 10.1016/j.colsurfa.2011.02.037
   Longo G, 2013, J MICROBIOL METH, V93, P80, DOI 10.1016/j.mimet.2013.01.022
   Luzinov I, 2000, MACROMOLECULES, V33, P1043, DOI 10.1021/ma990926v
   Luzinov I, 2000, MACROMOLECULES, V33, P7629, DOI 10.1021/ma000523r
   Magonov S., 2013, NANOSCALE APPL INFOR
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Maivald P., 1991, Nanotechnology, V2, P103, DOI 10.1088/0957-4484/2/2/004
   Martinez-Martin D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.198101
   Martinez-Tong DE, 2014, COMPOS SCI TECHNOL, V104, P34, DOI 10.1016/j.compscitech.2014.08.030
   Mazeran PE, 1997, TRIBOL LETT, V3, P125, DOI 10.1023/A:1019123525610
   McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255
   Medalsy I, 2011, ANGEW CHEM INT EDIT, V50, P12103, DOI 10.1002/anie.201103991
   MEYER E, 1988, J MICROSC-OXFORD, V152, P269, DOI 10.1111/j.1365-2818.1988.tb01388.x
   Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008
   Nguyen HK, 2014, MACROMOLECULES, V47, P7971, DOI 10.1021/ma501562q
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   OVERNEY RM, 1994, LANGMUIR, V10, P1281, DOI 10.1021/la00016a049
   Pakzad A, 2012, COMPOS SCI TECHNOL, V72, P314, DOI 10.1016/j.compscitech.2011.11.020
   Prokhorov VV, 2011, NANOTECHNOL RUSS, V6, P286, DOI 10.1134/S199507801103013X
   Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003
   Rabe U, 2002, SURF INTERFACE ANAL, V33, P65, DOI 10.1002/sia.1163
   RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4
   Raghavan D, 2000, LANGMUIR, V16, P9448, DOI 10.1021/la991694w
   Rebelo LM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055102
   Rheinlaender J, 2013, SOFT MATTER, V9, P3230, DOI 10.1039/c2sm27412d
   Rheinlaender J, 2010, SCANNING PROBE MICROSCOPY OF FUNCTIONAL MATERIALS: NANOSCALE IMAGING AND SPECTROSCOPY, P433, DOI 10.1007/978-1-4419-7167-8_15
   Rheinlaender J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3122007
   Robert W. S., 2010, HDB NANOPHYSICS
   Rodriguez BJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475504
   Rodriguez TR, 2004, APPL PHYS LETT, V84, P449, DOI 10.1063/1.1642273
   RosaZeiser A, 1997, MEAS SCI TECHNOL, V8, P1333, DOI 10.1088/0957-0233/8/11/020
   Schaffer TE, 2013, ANAL CHEM, V85, P6988, DOI 10.1021/ac400686k
   Schon P, 2011, EUR POLYM J, V47, P692, DOI 10.1016/j.eurpolymj.2010.09.029
   Schwarz UD, 2003, J COLLOID INTERF SCI, V261, P99, DOI 10.1016/S0021-9797(03)00049-3
   SCHWARZL F, 1952, J APPL PHYS, V23, P838, DOI 10.1063/1.1702316
   Silbernagl D, 2010, SCANNING, V32, P282, DOI 10.1002/sca.20196
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Stan G, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245702
   Stan G, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/21/215703
   Tranchida D, 2011, J PHYS CHEM B, V115, P3385, DOI 10.1021/jp112211c
   Tranchida D, 2011, ADV ENG MATER, V13, pB369, DOI 10.1002/adem.201080129
   Tsou AH, 2008, J APPL POLYM SCI, V107, P1362, DOI 10.1002/app.27184
   Tsukruk VV, 2000, POLYMER, V41, P5541, DOI 10.1016/S0032-3861(00)00004-5
   Tsukruk VV, 2012, SCANNING PROBE MICROSCOPY OF SOFT MATTER: FUNDAMENTALS AND PRACTICES, P1
   TSUKRUK VV, 1995, POLYMER, V36, P1791, DOI 10.1016/0032-3861(95)90925-R
   Tsukruk VV, 1998, LANGMUIR, V14, P446, DOI 10.1021/la970367q
   Tsukruk VV, 2000, POLYM INT, V49, P441, DOI 10.1002/(SICI)1097-0126(200005)49:5<441::AID-PI240>3.0.CO;2-U
   Turner JA, 1997, J APPL PHYS, V82, P966, DOI 10.1063/1.365935
   Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08
   VANDERWERF KO, 1994, APPL PHYS LETT, V65, P1195, DOI 10.1063/1.112106
   Verdier C, 2003, J POLYM SCI POL PHYS, V41, P3139, DOI 10.1002/polb.10470
   Wang D, 2010, MACROMOLECULES, V43, P5521, DOI 10.1021/ma100799s
   Xu X, 2012, J APPL PHYS, V111, DOI 10.1063/1.3689815
   Yablon DG, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/5/055402
   Young SL, 2014, ACTA BIOMATER, V10, P4832, DOI 10.1016/j.actbio.2014.07.023
   Young SL, 2012, BIOMACROMOLECULES, V13, P3189, DOI 10.1021/bm300964h
   Young TJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/12/125703
   Yu M, 2015, BEILSTEIN J NANOTECH, V6, P157, DOI 10.3762/bjnano.6.15
   Yuya PA, 2008, J APPL PHYS, V104, DOI 10.1063/1.2996259
   Zauscher S., 2014, HDB NANOMATERIALS PR
   Zhang J, 2012, BEILSTEIN J NANOTECH, V3, P464, DOI 10.3762/bjnano.3.53
   Zhao J, 2008, APPL SURF SCI, V255, P2295, DOI 10.1016/j.apsusc.2008.07.099
   ZHONG Q, 1993, SURF SCI, V290, pL688, DOI 10.1016/0167-2584(93)90906-Y
NR 128
TC 21
Z9 21
U1 8
U2 123
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD AUG
PY 2015
VL 54
IS 8
SI 2
AR 08LA02
DI 10.7567/JJAP.54.08LA02
PG 13
WC Physics, Applied
SC Physics
GA CN8BX
UT WOS:000358663300003
OA Bronze
DA 2018-10-20
ER

PT J
AU Basu, B
   Sabareeswaran, A
   Shenoy, SJ
AF Basu, Bikramjit
   Sabareeswaran, A.
   Shenoy, S. J.
TI Biocompatibility property of 100% strontium-substituted
   SiO2-Al2O3-P2O5-CaO-CaF2 glass ceramics over 26 weeks implantation in
   rabbit model: Histology and micro-Computed Tomography analysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE in vivo; micro-CT; orthopedic; strontium; glass ceramics; implant
   stability
ID BIOACTIVE-GLASS; BONE-FORMATION; IONOMER CEMENTS; IN-VITRO;
   HYDROXYAPATITE; INTERFACE; RANELATE; REPLICATION; REACTIVITY; BEHAVIOR
AB One of the desired properties for any new biomaterial composition is its long-term stability in a suitable animal model and such property cannot be appropriately assessed by performing short-term implantation studies. While hydroxyapatite (HA) or bioglass coated metallic biomaterials are being investigated for in vivo biocompatibility properties, such study is not extensively being pursued for bulk glass ceramics. In view of their inherent brittle nature, the implant stability as well as impact of long-term release of metallic ions on bone regeneration have been a major concern. In this perspective, the present article reports the results of the in vivo implantation experiments carried out using 100% strontium (Sr)-substituted glass ceramics with the nominal composition of 4.5 SiO2-3Al(2)O(3)-1.5P(2)O(5)-3SrO-2SrF(2) for 26 weeks in cylindrical bone defects in rabbit model. The combination of histological and micro-computed tomography analysis provided a qualitative and quantitative understanding of the bone regeneration around the glass ceramic implants in comparison to the highly bioactive HA bioglass implants (control). The sequential polychrome labeling of bone during in vivo osseointegration using three fluorochromes followed by fluorescence microscopy observation confirmed homogeneous bone formation around the test implants. The results of the present study unequivocally confirm the long-term implant stability as well as osteoconductive property of 100% Sr-substituted glass ceramics, which is comparable to that of a known bioactive implant, that is, HA-based bioglass. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1168-1179, 2015.
C1 [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Basu, Bikramjit] Indian Inst Sci, Interdisciplinary Bioengn Program, Bangalore 560012, Karnataka, India.
   [Sabareeswaran, A.] Sree Chitra Tirunal Inst Med Sci & Technol, Histopathol Lab, Trivandrum, Kerala, India.
   [Shenoy, S. J.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Vivo Models & Testing, Trivandrum 695012, Kerala, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
FU Department of Science and Technology, Government of India
FX Contract grant sponsor: Department of Science and Technology, Government
   of India
CR Acharya NK, 2010, J SPINAL DISORD TECH, V23, P266, DOI 10.1097/BSD.0b013e3181a990fc
   Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031
   Barros VMD, 2002, BIOMATERIALS, V23, P2895, DOI 10.1016/S0142-9612(01)00417-3
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P273, DOI 10.1007/BF00122280
   BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   Boss JH, 1999, J LONG-TERM EFF MED, V9, P1
   Boyd D, 2006, J MATER SCI-MATER M, V17, P397, DOI 10.1007/s10856-006-8465-x
   Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x
   Brentegani LG, 1997, BIOMATERIALS, V18, P137, DOI 10.1016/S0142-9612(96)00110-X
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Davidson Carel Leon, 2006, J. Appl. Oral Sci., V14, P3, DOI 10.1590/S1678-77572006000700002
   Devi ND, 2012, J AM CERAM SOC, V95, P2700
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Freeman CO, 2006, J MATER SCI-MATER M, V17, P465, DOI 10.1007/s10856-006-8474-9
   FRIEDMAN S, 1995, J ENDODONT, V21, P384, DOI 10.1016/S0099-2399(06)80976-3
   Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Goel A, 2011, ACTA BIOMATER, V7, P4071, DOI [10.1016/Lactbio.2011.06.047, 10.1016/j.actbio.2011.06.047]
   Guida A, 2003, J MATER SCI LETT, V22, P1401, DOI 10.1023/A:1025794927195
   Hill R, 2004, J PHYS CHEM-US, V45, P127
   Hill RG, 2004, J NON-CRYST SOLIDS, V336, P223, DOI 10.1016/j.jnoncrysol.2004.02.005
   Hill R, 2007, J AM CERAM SOC, V90, P763, DOI 10.1111/j.1551-2916.2006.01474.x
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Nair MB, 2008, ACTA BIOMATER, V4, P173, DOI 10.1016/j.actbio.2007.07.004
   Nair MB, 2010, TISSUE ENG PT A, V16, P385, DOI [10.1089/ten.tea.2009.0207, 10.1089/ten.TEA.2009.0207]
   Ni GX, 2006, BIOMATERIALS, V27, P5127, DOI 10.1016/j.biomaterials.2006.05.030
   O'Donnell MD, 2008, ACTA BIOMATER, V4, P1455, DOI 10.1016/j.actbio.2008.04.018
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   Rafferty A, 2000, J AM CERAM SOC, V83, P2833
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Sabareeswaran A, 2013, BIOMATERIALS, V34, P9278, DOI 10.1016/j.biomaterials.2013.08.070
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   Vestermark MT, 2011, DAN MED BULL, V58
   Vogel M, 2004, J BIOMED MATER RES A, V70A, P370, DOI 10.1002/jbm.a.30048
   Wheeler DL, 2001, J BIOMED MATER RES, V55, P603, DOI 10.1002/1097-4636(20010615)55:4<603::AID-JBM1054>3.0.CO;2-N
   Zhao YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069339
NR 46
TC 6
Z9 6
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2015
VL 103
IS 6
BP 1168
EP 1179
DI 10.1002/jbm.b.33270
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN5QQ
UT WOS:000358484700004
PM 25303146
DA 2018-10-20
ER

PT J
AU Shaked, E
   Shani, Y
   Zilberman, M
   Scheinowitz, M
AF Shaked, Eliav
   Shani, Yoav
   Zilberman, Meital
   Scheinowitz, Mickey
TI Poly(methyl methacrylate) particles for local drug delivery using shock
   wave lithotripsy: In vitro proof of concept experiment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE local drug release; poly(methyl methacrylate) double emulsion; shock
   wave lithotripsy
ID HORSERADISH-PEROXIDASE; POLYMERS; THERAPY; PERMEABILIZATION;
   NANOPARTICLES; MICROSPHERES; PROTEINS; RELEASE
AB To leverage current local drug delivery systems methodology, there is vast use of polymeric particles serving as drug carriers to assure minimal invasive therapy with little systemic distribution of the released drug. There is an increasing interest in poly(methyl methacrylate) (PMMA) serving as carriers in drug delivery. The study aims to develop PMMA carriers for localized drug delivery and release system, combining innovative biomaterial technology and shock wave lithotripsy (SWL), and to study the effect of SWL on various concentrations of PMMA particles. We prepared PMMA particles that contain horseradish peroxidase (HRP) using a double emulsion technique, and investigated the mechanism of in vitro drug release from the carriers following exposure to SWL. We investigated the correlation between production method modifications, concentrations of the carriers subjected to SWL, and shock wave patterns. We successfully produced PMMA particles as drug carriers and stimulated the release of their contents by SWL; their polymeric shell can be shattered externally by SWL treatment, leading to release of the encapsulated drug. HRP enzyme activity was maintained following the encapsulation process and exposure to high dose of SWL pulses. Increased shock wave number results in increased shattering and greater fragmentation of PMMA particles. The results demonstrate a dose-response release of HRP; quantitation of the encapsulated HRP from the carriers rises with the number of SWL. Moreover, increased concentration of particles subjected to the same dose of SWL results in a significant increase of the total HRP release. Our research offers novel technique and insights into new, site-specific drug delivery and release systems. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1228-1237, 2015.
C1 [Shaked, Eliav; Shani, Yoav; Zilberman, Meital; Scheinowitz, Mickey] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
RP Scheinowitz, M (reprint author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
EM mickeys@post.tau.ac.il
FU DIP (Deutsch-Israel-Program Project); Ela Kodesz Institute for Medical
   Engineering and Physical Sciences
FX Contract grant sponsor: DIP (Deutsch-Israel-Program Project); Ela Kodesz
   Institute for Medical Engineering and Physical Sciences
CR Bainor A, 2011, ANAL BIOCHEM, V410, P310, DOI 10.1016/j.ab.2010.11.015
   Bettencourt A, 2012, J MICROENCAPSUL, V29, P353, DOI 10.3109/02652048.2011.651500
   Brewer E, 2011, J NANOMATER, DOI 10.1155/2011/408675
   Chen W, 2002, POLYM TEST, V21, P113, DOI 10.1016/S0142-9418(01)00055-1
   Cleveland RO, 2005, J ACOUST SOC AM, V118, P2667, DOI 10.1121/1.2032187
   Deckers R, 2010, J CONTROL RELEASE, V148, P25, DOI 10.1016/j.jconrel.2010.07.117
   Delius M, 1999, CANCER RES, V59, P5227
   Dick A, 1999, CARDIOVASC INTER RAD, V22, P389, DOI 10.1007/s002709900413
   Eisenmenger W, 2001, ULTRASOUND MED BIOL, V27, P683, DOI 10.1016/S0301-5629(01)00345-3
   Esser-Kahn AP, 2011, MACROMOLECULES, V44, P5539, DOI 10.1021/ma201014n
   Foldager CB, 2012, ULTRASOUND MED BIOL, V38, P1673, DOI 10.1016/j.ultrasmedbio.2012.06.004
   GAMBIHLER S, 1994, J MEMBRANE BIOL, V141, P267
   Hu SH, 2008, LANGMUIR, V24, P11811, DOI 10.1021/la801138e
   Khalil W., 2012, CLIN RESULTS CELLWAV, P1
   Khattab AA, 2007, INT J CARDIOL, V121, P84, DOI 10.1016/j.ijcard.2006.08.030
   Klein SM, 2003, COLLOID POLYM SCI, V282, P7, DOI 10.1007/s00396-003-0915-0
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Markovsky E, 2012, J CONTROL RELEASE, V161, P446, DOI 10.1016/j.jconrel.2011.12.021
   McAteer J A, 2012, PHYS SHOCK WAVE LITH, P527
   Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e
   Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033
   Ravi S, 2008, INDIAN J PHARM SCI, V70, P303, DOI 10.4103/0250-474X.42978
   Sagi A, 2008, J AM CHEM SOC, V130, P5434, DOI 10.1021/ja801065d
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Thiel M, 2001, CLIN ORTHOP RELAT R, P18
   Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022
   Vilar G, 2012, CURR DRUG DELIV, V9, P367, DOI 10.2174/156720112801323053
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
   Zhou YF, 2004, J UROLOGY, V172, P349, DOI 10.1097/01.ju.0000132356.97888.8b
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zilberman M, 2006, J BIOMED MATER RES A, V79A, P370, DOI 10.1002/jbm.a.30775
NR 33
TC 1
Z9 1
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2015
VL 103
IS 6
BP 1228
EP 1237
DI 10.1002/jbm.b.33301
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CN5QQ
UT WOS:000358484700010
PM 25350479
DA 2018-10-20
ER

PT J
AU Subhan, F
   Ikram, M
   Shehzad, A
   Ghafoor, A
AF Subhan, Fazli
   Ikram, Muhammad
   Shehzad, Adeeb
   Ghafoor, Abdul
TI Marine Collagen: An Emerging Player in Biomedical applications
SO JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE
LA English
DT Review
DE Collagen; Extraction; Biomaterial; Marine
ID JELLYFISH COLLAGEN; SCAFFOLDS; SKIN; GEL
AB Mammalian collagen is a multifactorial biomaterial that is widely used for beneficial purposes in the advanced biomedical technologies. Generally, biomedical applicable collagen is extracted from the mammalian body, but it can also be derived from marine species. Recently, mammalian tissues collagen proteins are considered a great pathological risk for transmitted diseases, because purification of such protein is very challenging and needs efficient tool to avoid structure alteration. Thus, difficult extraction process and high cost decreased mammalian collagen demands for beneficial effects compared to marine collagen. In contrast, marine collagen is safe and easy to extract, however this potential source of collagen is hindered by low denaturing temperature, which is considered a main hurdle in the beneficial effects of marine collagen. Characterization and biomedical applications of marine collagen are in transition state and yet to be discovered. Therefore, an attempt was made to summarize the recent knowledge regarding different aspects of marine collagen applications in the biomedical engineering field.
C1 [Subhan, Fazli; Ikram, Muhammad] Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, South Korea.
   [Shehzad, Adeeb] Natl Univ Sci & Technol, Sch Mech & Mfg Engn, Dept Biomed Engn, Islamabad, Pakistan.
   [Ghafoor, Abdul] Natl Agr Res Ctr, Islamabad, Pakistan.
RP Subhan, F (reprint author), Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, South Korea.
EM fazlisubhan93@gmail.com
OI Ikram, Muhammad/0000-0003-0114-7963
CR Addad S, 2011, MAR DRUGS, V9, P967, DOI 10.3390/md9060967
   Bermueller C, 2013, TISSUE ENG PT A, V19, P2201, DOI [10.1089/ten.tea.2012.0650, 10.1089/ten.TEA.2012.0650]
   Braco GE, 1995, FOOD BIOCH, V19, P285, DOI [10.1111/j.1745-4514.1995.tb00535.x, DOI 10.1111/J.1745-4514.1995.TB00535.X]
   Chai HJ, 2010, BIOMED BIOTECHNOL, V2010, DOI [10.1155/2010/757301, DOI 10.1155/2010/757301]
   Cho JK, 2014, FOOD CHEM, V159, P200, DOI 10.1016/j.foodchem.2014.03.012
   Fernandes-Silva S, 2013, MACROMOL BIOSCI, V13, P1621, DOI 10.1002/mabi.201300228
   Ho HO, 1997, J CONTROL RELEASE, V44, P103, DOI 10.1016/S0168-3659(96)01513-1
   Hoyer B, 2014, ACTA BIOMATER, V10, P883, DOI 10.1016/j.actbio.2013.10.022
   Jayathilakan K, 2012, J FOOD SCI TECH MYS, V49, P278, DOI 10.1007/s13197-011-0290-7
   Pallela R, 2012, J BIOMED MATER RES A, V100A, P486, DOI 10.1002/jbm.a.33292
   Phanat Kittiphattanabawon, 2010, European Food Research and Technology, V230, P475
   Potaros R, 2009, NAT SCI, V43, P584
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x
   Sivakumar P, 2000, J FISH BIOL, V56, P999, DOI 10.1006/jfbi.1999.1225
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Tan CC, 2013, FOOD RES, V20, P3013, DOI [10.1093/bioinformatics/bth351, DOI 10.1093/BIOINFORMATICS/BTH351]
   Veeruraj A, 2013, PROCESS BIOCHEM, V48, P1592, DOI 10.1016/j.procbio.2013.07.011
   Yamamoto K., 2014, BIOMED RES INT, V2014, DOI [10. 1155/2014/630757 24809058, DOI 10.1155/2014/63075724809058]
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang ZF, 2011, J SCI FOOD AGR, V91, P2173, DOI 10.1002/jsfa.4435
NR 21
TC 13
Z9 14
U1 3
U2 48
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0022-1155
EI 0975-8402
J9 J FOOD SCI TECH MYS
JI J. Food Sci. Technol.-Mysore
PD AUG
PY 2015
VL 52
IS 8
BP 4703
EP 4707
DI 10.1007/s13197-014-1652-8
PG 5
WC Food Science & Technology
SC Food Science & Technology
GA CN8CR
UT WOS:000358665800004
PM 26243892
OA Green Published
DA 2018-10-20
ER

PT J
AU Magrys, A
   Paluch-Oles, J
   Bogut, A
   Kielbus, M
   Plewik, D
   Koziol-Montewka, M
AF Magrys, Agnieszka
   Paluch-Oles, Jolanta
   Bogut, Agnieszka
   Kielbus, Michal
   Plewik, Dorota
   Koziol-Montewka, Maria
TI The role of programmed death ligand 1 pathway in persistent
   biomaterial-associated infections
SO JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE PD-L1; Staphylococcus epidermidis; small colony variants;
   biomaterial-associated infections
ID SMALL-COLONY VARIANTS; STAPHYLOCOCCUS-EPIDERMIDIS; INTERFERON-GAMMA;
   MACROPHAGES; AUREUS; PD-1
AB Staphylococcus epidermidis is commonly involved in biomaterial-associated infections. Bacterial small colony variants (SCV) seem to be well adapted to persist intracellularly in professional phagocytes evading the host immune response. We studied the expression of PD-L1/L2 on macrophages infected with clinical isolates of S. epidermidis SCV and their parent wild type (WT) strains. The cytokine pattern which is triggered by the examined strains was also analysed. In the study, we infected macrophages with S. epidermidis WT and SCV strains. Persistence and release from macrophages were monitored via lysostaphin protection assays. Moreover, the effect of IFN-gamma pre-treatment on bacterial internalisation was investigated. Expression of PD-L1/L2 molecules was analysed with the use of FACS. Inflammatory reaction was measured by IL-10, TNF-alpha ELISAs, and transcriptional induction of TNF-alpha. Our study revealed that clinical SCV isolates were able to persist and survive in macrophages for at least 3 days with a low cytotoxic effect and a reduced proinflammatory response as compared to WT strains. Bacteria upregulated PD-L1/L2 expression on macrophages as compared to non-stimulated cells. The results demonstrated that the ability of S. epidermidis SCVs to induce elevated levels of anti-inflammatory cytokine, IL-10, and reduced transcriptional induction of TNF-alpha, together with expression of PD-L1 on macrophages and the ability to persist intracellularly without damaging the host cell could be the key factor contributing to chronicity of SCV infections.
C1 [Magrys, Agnieszka; Paluch-Oles, Jolanta; Bogut, Agnieszka; Koziol-Montewka, Maria] Med Univ Lublin, Chair & Dept Med Microbiol, Ul Chodzki 1, PL-20093 Lublin, Poland.
   [Kielbus, Michal] Med Univ Lublin, Chair & Dept Biochem & Mol Biol, PL-20093 Lublin, Poland.
   [Plewik, Dorota] Pope John Paul II State Sch Higher Educ Biala Pod, Res Ctr Innovat, PL-21500 Biala Podlaska, Poland.
RP Magrys, A (reprint author), Med Univ Lublin, Chair & Dept Med Microbiol, Ul Chodzki 1, PL-20093 Lublin, Poland.
EM agnieszka.magrys@umlub.pl
RI Koziol-Montewka, Maria/B-6615-2017
CR Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07
   Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bogut A, 2014, J MED MICROBIOL, V63, P176, DOI 10.1099/jmm.0.066068-0
   Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043
   Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987
   Hofmeyer KA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/451694
   Jones KJ, 2005, J MED MICROBIOL, V54, P315, DOI 10.1099/jmm.0.45872-0
   Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331
   Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210
   Mack D, 2013, BIOMATERIALS ASS INF, P25, DOI 10.1007/9781-46141031-7
   McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421
   Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327
   Rowe JH, 2012, J IMMUNOL, V189, P876, DOI 10.4049/jimmunol.1103227
   Sakai S, 2010, INT IMMUNOL, V22, P915, DOI 10.1093/intimm/dxq446
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Shi SF, 2012, EXP THER MED, V3, P367, DOI 10.3892/etm.2011.423
   Singh R, 2009, J MED MICROBIOL, V58, P1067, DOI 10.1099/jmm.0.009720-0
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551
   Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang J., 2012, SCI REP, V2, P10, DOI DOI 10.1038/SREP00606
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zahra M, 2013, J CLIN MICROBIOL, V51, P3228, DOI 10.1128/JCM.01337-13
NR 30
TC 4
Z9 4
U1 0
U2 8
PU MICROBIOLOGICAL  SOCIETY KOREA
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER 803, 635-4 YEOGSAM-DONG, KANGNAM-KU,
   SEOUL 135-703, SOUTH KOREA
SN 1225-8873
EI 1976-3794
J9 J MICROBIOL
JI J. Microbiol.
PD AUG
PY 2015
VL 53
IS 8
BP 544
EP 552
DI 10.1007/s12275-015-5022-7
PG 9
WC Microbiology
SC Microbiology
GA CN9JG
UT WOS:000358762500008
PM 26224457
DA 2018-10-20
ER

PT J
AU Niknejad, H
   Yazdanpanah, G
   Kakavand, M
AF Niknejad, Hassan
   Yazdanpanah, Ghasem
   Kakavand, Mona
TI Extract of fetal membrane would inhibit thrombosis and hemolysis
SO MEDICAL HYPOTHESES
LA English
DT Article
ID AMNIOTIC EPITHELIAL-CELLS; FIBROBLAST-GROWTH-FACTOR; IN-VITRO;
   ENDOTHELIAL-CELLS; EXTRACORPOREAL-CIRCULATION; PRESERVATION PROCEDURES;
   PLATELET ACTIVATION; VASCULAR GRAFTS; INNATE IMMUNITY; OCULAR SURFACE
AB The innermost layer of fetal membranes is amnion which has anti-adhesive, anti-inflammation and vis-coelastic properties, as well as low immunogenicity. Amniotic membrane has been employed in variety of clinical fields as a natural biomaterial. Amniotic epithelial cells possess stem cell characteristics and capability to differentiate into endothelial cells. The basement membrane of amnion is an extracellular matrix enriched scaffold to support adhesion of endothelial cells. The matrix of amniotic membrane contains two kinds of glycosaminoglycans including perlecan (a heparan sulfate proteoglycan) and hyaluronic acid which both inhibit blood coagulation. Moreover, the other ingredients of amniotic membrane such as pigment-epithelium derived factor (PEDF), IL-10, MMP-9 inhibit platelet aggregation. Based on some biochemical and biomechanical evidences, we hypothesized in this paper that amniotic membrane could prevent thrombosis and hemolysis; therefore, has the capability to be applied in blood contacting devices and implants. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Niknejad, Hassan; Yazdanpanah, Ghasem; Kakavand, Mona] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn, Tehran, Iran.
   [Niknejad, Hassan] Shahid Beheshti Univ Med Sci, Nanomed & Tissue Engn Res Ctr, Tehran, Iran.
RP Niknejad, H (reprint author), Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn, POB 1985711151, Tehran, Iran.
EM niknejad@sbmu.ac.ir
RI Yazdanpanah, Ghasem/B-1347-2018
FU Nanomedicine and Tissue Engineering Research Center of Shahid Beheshti
   University of Medical Sciences
FX We would like to thank Prof. H. Peirovi for his critical comments. This
   work was supported by Nanomedicine and Tissue Engineering Research
   Center of Shahid Beheshti University of Medical Sciences.
CR Ahmadi M, 2013, BLOOD PURIFICAT, V35, P305, DOI 10.1159/000350613
   Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11
   AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Bachleda P, 2010, BIOMED PAP, V154, P13, DOI 10.5507/bp.2010.005
   Barbucci R, 1998, J THROMB THROMBOLYS, V6, P109, DOI 10.1023/A:1008841303634
   Ben-Hadj-Khalifa S, 2012, EUR CYTOKINE NETW, V23, P87, DOI 10.1684/ecn.2012.0315
   Ben-Hadj-Khalifa S, 2011, J THROMB THROMBOLYS, V32, P311, DOI 10.1007/s11239-011-0618-1
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/1076327042500427
   BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   Choi G, 2006, SWISS MED WKLY, V136, P139
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   CLARK RE, 1976, SURG FORUM, V27, P208
   De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Garfias Y, 2011, IMMUNOL INVEST, V40, P183, DOI 10.3109/08820139.2010.532266
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hieber AD, 1997, PLACENTA, V18, P301, DOI 10.1016/S0143-4004(97)80065-3
   Hinds MT, 2006, J BIOMED MATER RES A, V77A, P458, DOI 10.1002/jbm.a.30571
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Jiang A, 2006, CORNEA, V25, pS36, DOI 10.1097/01.ico.0000247211.78391.af
   Keelan JA, 1998, AM J REPROD IMMUNOL, V40, P332
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Lee PH, 2012, ACTA BIOMATER, V8, P3342, DOI 10.1016/j.actbio.2012.05.012
   Lee YM, 2006, EUR J PHARMACOL, V537, P52, DOI 10.1016/j.ejphar.2006.03.031
   Libera RD, 2008, ARQ BRAS OFTALMOL, V71, P669, DOI 10.1590/S0004-27492008000500011
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Magatti M., 2014, CELL TRANSPLANT
   Mall JW, 2004, NEPHROL DIAL TRANSPL, V19, P61, DOI 10.1093/ndt/gfg319
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Nightingale MJ, 2008, TRANSFUSION MED, V18, P281, DOI 10.1111/j.1365-3148.2008.00888.x
   Niknejad H, 2013, PLACENTA, V34, P340, DOI 10.1016/j.placenta.2013.02.001
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Niknejad H, 2014, CYTOTHERAPY, V16, P33, DOI 10.1016/j.jcyt.2013.07.005
   Niknejad H, 2013, MED HYPOTHESES, V81, P862, DOI 10.1016/j.mehy.2013.08.018
   Niknejad H, 2012, NEUROSCI LETT, V506, P22, DOI 10.1016/j.neulet.2011.10.038
   Niknejad H, 2011, CRYOBIOLOGY, V63, P145, DOI 10.1016/j.cryobiol.2011.08.003
   Niknejad H, 2010, EUR CELLS MATER, V19, P22, DOI 10.22203/eCM.v019a03
   Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006
   Peirovi H, 2012, J VASC SURG, V56, P1098, DOI 10.1016/j.jvs.2012.02.036
   Russo A, 2012, CELL TISSUE BANK, V13, P353, DOI 10.1007/s10561-011-9261-5
   Schulz C, 2013, J THROMB HAEMOST, V11, P233, DOI 10.1111/jth.12261
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Shao CK, 2004, INVEST OPHTH VIS SCI, V45, P1758, DOI 10.1167/iovs.03-0882
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804
   Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017
   Tagarakis Georgios I, 2009, Recent Pat Cardiovasc Drug Discov, V4, P177
   Takashima S, 2004, CELL STRUCT FUNCT, V29, P73, DOI 10.1247/csf.29.73
   Tehrani FA, 2013, CRYOBIOLOGY, V67, P293, DOI 10.1016/j.cryobiol.2013.08.010
   TRELFORDSAUDER M, 1978, J MED, V9, P273
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5
   VANDERPUYE OA, 1993, INT ARCH ALLERGY IMM, V101, P376, DOI 10.1159/000236480
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Willett NJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4476
   Xiao Le, 2004, Chin J Traumatol, V7, P312
   Xiao XY, 2013, EXP EYE RES, V115, P31, DOI 10.1016/j.exer.2013.06.005
   Yamagishi SI, 2009, DIABETES-METAB RES, V25, P266, DOI 10.1002/dmrr.906
   Zaga-Clavellina V, 2014, J MATERN-FETAL NEO M, V27, P1320, DOI 10.3109/14767058.2013.857397
   Zelen CM, 2014, INT WOUND J
   Zhang X, 2011, J BIOMED MATER RES A, V97A, P145, DOI 10.1002/jbm.a.33040
   Zimmermann AK, 2004, ASAIO J, V50, P193, DOI 10.1097/01.MAT.0000123638.41808.59
NR 70
TC 6
Z9 6
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD AUG
PY 2015
VL 85
IS 2
BP 197
EP 202
DI 10.1016/j.mehy.2015.04.030
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CN5KQ
UT WOS:000358468600018
PM 25997985
DA 2018-10-20
ER

PT J
AU Heffernan, JM
   Overstreet, DJ
   Le, LD
   Vernon, BL
   Sirianni, RW
AF Heffernan, John M.
   Overstreet, Derek J.
   Le, Long D.
   Vernon, Brent L.
   Sirianni, Rachael W.
TI Bioengineered Scaffolds for 3D Analysis of Glioblastoma Proliferation
   and Invasion
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Tumor microenvironment; Cell tracking; Three-dimensional cell culture;
   Biomaterial hydrogels; Hyaluronic acid; Gelatin; Poly(ethylene glycol)
ID HYALURONAN-GELATIN HYDROGEL; TUMOR-CELL INVASION; EXTRACELLULAR-MATRIX;
   IN-VITRO; GLIOMA INVASION; ACID; BRAIN; MIGRATION; MICROENVIRONMENT;
   CULTURE
AB The invasion of malignant glioblastoma (GBM) cells into healthy brain is a primary cause of tumor recurrence and associated morbidity. Here, we describe a high-throughput method for quantitative measurement of GBM proliferation and invasion in three-dimensional (3D) culture. Optically clear hydrogels composed of thiolated hyaluronic acid and gelatin were chemically crosslinked with thiol-reactive poly(ethylene glycol) polymers to form an artificial 3D tumor microenvironment. Characterization of the viscoelasticity and aqueous stability indicated the hydrogels were mechanically tunable with stiffness ranging from 18 Pa to 18.2 kPa and were resistant to hydrolysis for at least 30 days. The proliferation, dissemination and subsequent invasion of U118 and U87R GBM spheroids cultured on the hydrogels were tracked in situ with repeated fluorescence confocal microscopy. Using custom automated image processing, cells were identified and quantified through 500 A mu m of gel over 14 days. Proliferative and invasive behaviors were observed to be contingent on cell type, gel stiffness, and hepatocyte growth factor availability. These measurements highlight the utility of this platform for performing quantitative, fluorescence imaging analysis of the behavior of malignant cells within an artificial, 3D tumor microenvironment.
C1 [Heffernan, John M.; Overstreet, Derek J.; Sirianni, Rachael W.] Barrow Neurol Inst, Barrow Brain Tumor Res Ctr, Phoenix, AZ 85013 USA.
   [Heffernan, John M.; Le, Long D.; Vernon, Brent L.; Sirianni, Rachael W.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.
RP Sirianni, RW (reprint author), Barrow Neurol Inst, Barrow Brain Tumor Res Ctr, 350 W Thomas Rd, Phoenix, AZ 85013 USA.
EM jmh325@glink.drexel.edu; derek.overstreet@gmail.com; ldle2@asu.edu;
   brent.vernon@asu.edu; rachael.sirianni@dignityhealth.org
OI Sirianni, Rachael/0000-0002-9196-0239
FU Arizona State University; Barrow Neurological Institute
FX <SUP>1</SUP>H NMR experiments were performed at Arizona State University
   at the Magnetic Resonance Research Center. The authors would like to
   acknowledge our colleagues Mike Berens, Nhan Tran, and Harshil Dhruv at
   the Translational Genomic Institute (TGen) in Phoenix, AZ for providing
   cell lines and advice, and Luis Laitano at Arizona State University for
   performing rheological analysis. The authors also acknowledge Arizona
   State University and Barrow Neurological Institute for providing funding
   support during this project.
CR Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   ARIZA A, 1995, HUM PATHOL, V26, P1144, DOI 10.1016/0046-8177(95)90278-3
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319
   Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013
   Beucher S., 1992, P 10 PFEFF C SIGN IM, P299
   Bin Kim J, 2004, BREAST CANCER RES TR, V85, P281
   BULLARD DE, 1981, J NEUROPATH EXP NEUR, V40, P410, DOI 10.1097/00005072-198107000-00005
   Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006
   Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70
   DELPECH B, 1993, EUR J CANCER, V29A, P1012, DOI 10.1016/S0959-8049(05)80214-X
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075
   Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001
   Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Guzman A, 2014, BIOMATERIALS, V35, P6954, DOI 10.1016/j.biomaterials.2014.04.086
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jiglaire CJ, 2014, EXP CELL RES, V321, P99, DOI 10.1016/j.yexcr.2013.12.010
   Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Lawyer T., 2012, INT J CELL BIOL, V1-9, P2012
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089
   MERZAK A, 1994, CANCER RES, V54, P3988
   Morpurgo M, 1996, BIOCONJUGATE CHEM, V7, P363, DOI 10.1021/bc9600224
   Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5
   Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Petrecca K, 2013, J NEURO-ONCOL, V111, P19, DOI 10.1007/s11060-012-0983-4
   PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465
   Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
NR 41
TC 17
Z9 17
U1 1
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2015
VL 43
IS 8
BP 1965
EP 1977
DI 10.1007/s10439-014-1223-1
PG 13
WC Engineering, Biomedical
SC Engineering
GA CN2KM
UT WOS:000358249800022
PM 25515315
DA 2018-10-20
ER

PT J
AU Fang, HW
   Kao, WY
   Lin, PI
   Chang, GW
   Hung, YJ
   Chen, RM
AF Fang, Hsu-Wei
   Kao, Wei-Yu
   Lin, Pei-I
   Chang, Guang-Wei
   Hung, Ya-Jung
   Chen, Ruei-Ming
TI Effects of Polypropylene Carbonate/Poly(D,L-lactic) Acid/Tricalcium
   Phosphate Elastic Composites on Improving Osteoblast Maturation
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE PPC/PLA/TCP elastic composites; Bone regeneration; Osteoblasts; Cell
   proliferation and maturation; Osteopontin
ID INDUCED APOPTOTIC INSULTS; OF-THE-LITERATURE; GENE-EXPRESSION; BONE;
   DIFFERENTIATION; CELLS; MINERALIZATION; OSTEOPONTIN; ACTIVATION;
   MATRICES
AB Bone tissue engineering utilizing biomaterials to improve osteoblast growth has provided de novo consideration for therapy of bone diseases. Polypropylene carbonate (PPC) is a polymer with a low glass transition temperature but high elasticity. In this study, we developed a new PPC-derived composite by mixing poly-lactic acid (PLA) and tricalcium phosphate (TCP), called PPC/PLA/TCP elastic (PPTE) scaffolds. We also evaluated the beneficial effects of PPTE composites on osteoblast growth and maturation and the possible mechanisms. Compared to PPC polymers, PPTE composites had similar pore sizes and porosities but possessed better hydrophilic surface structures. Biological evaluations further revealed that PPTE composites attracted adhesion of mouse osteoblasts, and these bone cells extended along the porous scaffolds to produce accurate fibroblast-like morphologies. In parallel, seeding mouse osteoblasts onto PPTE composites time-dependently increased cell growth. Sequentially, PPTE composites augmented DNA replication and cell proliferation. Consequently, PPTE composites significantly improved osteoblast mineralization. As to the mechanism, treatment with PPTE composites induced osteopontin (OPN) mRNA and protein expression and alkaline phosphatase activity. Taken together, this study showed that PPTE composites with porous and hydrophilic surfaces can stimulate osteoblast adhesion, proliferation, and maturation through an OPN-dependent mechanism. Therefore, the de novo PPTE scaffolds may have biomaterial potential for bone regeneration.
C1 [Fang, Hsu-Wei; Chang, Guang-Wei; Hung, Ya-Jung] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei 106, Taiwan.
   [Fang, Hsu-Wei; Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei 110, Taiwan.
   [Kao, Wei-Yu; Lin, Pei-I; Chen, Ruei-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan.
   [Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthet & Toxicol Res Ctr, Taipei, Taiwan.
RP Chen, RM (reprint author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.
EM rmchen@tmu.edu.tw
FU Taipei Medical University; National Taipei University of Technology
   [NTUT-TMU-100-06, NTUT-TMU-101-15]; Wan-Fang Hospital [102-wf-eva-20];
   National Science Council, Taipei, Taiwan [NSC101-2314-B-038-008-MY3,
   NSC101-2314-B-038-003-MY3]
FX This study was supported by Taipei Medical University and National
   Taipei University of Technology (NTUT-TMU-100-06 and NTUT-TMU-101-15),
   Wan-Fang Hospital (102-wf-eva-20), and National Science Council
   (NSC101-2314-B-038-008-MY3; NSC101-2314-B-038-003-MY3), Taipei, Taiwan.
   We wish to confirm that there are no known conflicts of interest
   associated with this publication and there has been no significant
   financial support for this work that could have influenced its outcome.
CR Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Chatakun P, 2014, CELL MOL LIFE SCI, V71, P113, DOI 10.1007/s00018-013-1326-0
   Chen RM, 2013, SURGERY, V154, P58, DOI 10.1016/j.surg.2013.02.003
   Chen RM, 2010, J BONE MINER RES, V25, P2193, DOI 10.1002/jbmr.121
   Cheng YX, 2014, J BIOMED NANOTECHNOL, V10, P287, DOI 10.1166/jbn.2014.1753
   Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8
   COLLINOSDOBY P, 1995, J CELL BIOCHEM, V57, P399, DOI 10.1002/jcb.240570305
   Du LC, 2004, J APPL POLYM SCI, V92, P1840, DOI 10.1002/app.20165
   Feng JQ, 2013, BONE, V54, P213, DOI 10.1016/j.bone.2013.01.046
   Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036
   Gorter EA, 2014, BONE, V64, P288, DOI 10.1016/j.bone.2014.04.026
   Hamlekhan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096213
   Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365.2141.2006.06218.x
   Ho WP, 2009, J CELL BIOCHEM, V108, P1084, DOI 10.1002/jcb.22338
   Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006
   Huang Z, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055005
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   Liao MH, 2014, BRIT J NUTR, V111, P55, DOI 10.1017/S0007114513002043
   Lin PL, 2007, MATER LETT, V61, P3009, DOI 10.1016/j.matlet.2006.10.064
   Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783
   Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200
   Nam D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040044
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Patntirapong S, 2015, J BIOMED MATER RES A, V103, P658, DOI 10.1002/jbm.a.35214
   Rani VVD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195101
   Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037
   RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Sheng Matilda H C, 2014, J Bone Metab, V21, P41, DOI 10.11005/jbm.2014.21.1.41
   Shrivats AR, 2014, DRUG DISCOV TODAY, V19, P781, DOI 10.1016/j.drudis.2014.04.010
   Stein GS, 1996, PHYSIOL REV, V76, P593
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wei JD, 2012, J ORTHOP RES, V30, P1058, DOI 10.1002/jor.22046
   Wu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072404
   Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398
   ZHOU H, 1994, J BONE MINER RES, V9, P1489
NR 39
TC 4
Z9 4
U1 2
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2015
VL 43
IS 8
BP 1999
EP 2009
DI 10.1007/s10439-014-1236-9
PG 11
WC Engineering, Biomedical
SC Engineering
GA CN2KM
UT WOS:000358249800025
PM 25549776
DA 2018-10-20
ER

PT J
AU Pucciani, F
   Altomare, DF
   Dodi, G
   Falletto, E
   Frasson, A
   Giani, I
   Martelluci, J
   Naldini, G
   Piloni, V
   Sciaudone, G
   Bove, A
   Bocchini, R
   Bellini, M
   Alduini, P
   Battaglia, E
   Galeazzi, F
   Rossitti, P
   Satta, PU
AF Pucciani, Filippo
   Altomare, Donato Francesco
   Dodi, Giuseppe
   Falletto, Ezio
   Frasson, Alvise
   Giani, Iacopo
   Martelluci, Jacopo
   Naldini, Gabriele
   Piloni, Vittorio
   Sciaudone, Guido
   Bove, Antonio
   Bocchini, Renato
   Bellini, Massimo
   Alduini, Pietro
   Battaglia, Edda
   Galeazzi, Francesca
   Rossitti, Piera
   Satta, Paolo Usai
CA Italian Soc Colorectal Surg SICCR
   Italian Assoc Hosp Gastroenterolog
TI Diagnosis and treatment of faecal incontinence: Consensus statement of
   the Italian Society of Colorectal Surgery and the Italian Association of
   Hospital Gastroenterologists
SO DIGESTIVE AND LIVER DISEASE
LA English
DT Article
DE Anorectal manometry; Biofeedback; Endoanal ultrasonography; Faecal
   incontinence; Post anal repair; Rectopexy; Sphincteroplasty
ID SACRAL NERVE-STIMULATION; ANAL-SPHINCTER REPAIR; QUALITY-OF-LIFE;
   RANDOMIZED CONTROLLED-TRIAL; INTERNAL RECTAL PROLAPSE; PELVIC ORGAN
   PROLAPSE; LAPAROSCOPIC VENTRAL RECTOPEXY; GRACILIS MUSCLE TRANSPOSITION;
   DOUBLE-BLIND CROSSOVER; INJECTABLE SILICONE BIOMATERIAL
AB Faecal incontinence is a common and disturbing condition, which leads to impaired quality of life and huge social and economic costs. Although recent studies have identified novel diagnostic modalities and therapeutic options, the best diagnostic and therapeutic approach is not yet completely known and shared among experts in this field.
   The Italian Society of Colorectal Surgery and the Italian Association of Hospital Gastroenterologists selected a pool of experts to constitute a joint committee on the basis of their experience in treating pelvic floor disorders. The aim was to develop a position paper on the diagnostic and therapeutic aspects of faecal incontinence, to provide practical recommendations for a cost-effective diagnostic work-up and a tailored treatment strategy. The recommendations were defined and graded on the basis of levels of evidence in accordance with the criteria of the Oxford Centre for Evidence-Based Medicine, and were based on currently published scientific evidence. Each statement was drafted through constant communication and evaluation conducted both online and during face-to-face working meetings. A brief recommendation at the end of each paragraph allows clinicians to find concise responses to each diagnostic and therapeutic issue. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
C1 [Pucciani, Filippo] Univ Florence, Dept Surg & Translat Med, I-50134 Florence, Italy.
   [Altomare, Donato Francesco] Univ Bari, Dept Emergency & Organ Transplantat, I-70121 Bari, Italy.
   [Dodi, Giuseppe; Frasson, Alvise] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35100 Padua, Italy.
   [Falletto, Ezio] Univ Turin, Citta Salute & Sci Hosp, Div Surg Sci 1, I-10124 Turin, Italy.
   [Giani, Iacopo; Naldini, Gabriele] Univ Hosp Pisa, Proctol & Perineal Surg Unit, Pisa, Italy.
   [Martelluci, Jacopo] Careggi Univ Hosp, Gen Emergency & Minimally Invas Surg, Florence, Italy.
   [Piloni, Vittorio] Villa Igea Clin, Diagnost Imaging Ctr, Ancona, Italy.
   [Sciaudone, Guido] Univ Naples 2, Sch Med, Gen & Geriatr Surg Unit, Naples, Italy.
   [Bove, Antonio] Dept Gastroenterol AORN A Cardarelli, Gastroenterol & Endoscopy Unit, Naples, Italy.
   [Bocchini, Renato] Malatesta Novello Private Hosp, Gastrointestinal Physiopathol Gastroenterol Dept, Cesena, Italy.
   [Bellini, Massimo] Univ Pisa, Dept Gastroenterol, Gastrointestinal Unit, I-56100 Pisa, Italy.
   [Alduini, Pietro] San Luca Hosp, Digest Endoscopy Unit, Lucca, Italy.
   [Battaglia, Edda] Cardinal Massaia Hosp, Gastroenterol & Endoscopy Unit, Asti, Italy.
   [Galeazzi, Francesca] Padua Univ Hosp, Gastroenterol Unit, Padua, Italy.
   [Rossitti, Piera] SM della Misericordia Univ Hospi, Gastroenterol Unit, Udine, Italy.
   [Satta, Paolo Usai] Brotzu Hosp, Gastroenterol Unit, Cagliari, Italy.
RP Pucciani, F (reprint author), Univ Florence, Dept Surg & Translat Med, Piazza Brambilla 3, I-50134 Florence, Italy.
EM pucciani@unifi.it
RI Frasson, Alvise/D-4245-2014
OI Frasson, Alvise/0000-0002-0287-1278; bellini,
   massimo/0000-0002-6387-6443; Altomare, Donato
   Francesco/0000-0001-8980-2752; PUCCIANI, FILIPPO/0000-0002-9890-5558;
   SCIAUDONE, Guido/0000-0003-4221-8502; Usai-Satta,
   Paolo/0000-0003-3344-927X
CR Abbas MA, 2012, DIS COLON RECTUM, V55, P605, DOI 10.1097/DCR.0b013e3182415406
   Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870
   Adams FJ, 2007, MANAGEMENT 3 4 DEGRE, V29, P1
   Adusumilli S, 2013, COLORECTAL DIS, V15, pE680, DOI 10.1111/codi.12367
   Agachan F, 1996, DIS COLON RECTUM, V39, P899, DOI 10.1007/BF02053989
   Ahmad M, 2012, COLORECTAL DIS, V14, P19, DOI 10.1111/codi.12045
   Altomare DF, 2013, COLORECTAL DIS, V15, pE741, DOI 10.1111/codi.12418
   Altomare DF, 2011, COLORECTAL DIS, V13, P198, DOI 10.1111/j.1463-1318.2009.02088.x
   Altomare D F, 2007, Tech Coloproctol, V11, P268, DOI 10.1007/s10151-007-0363-9
   Altomare DF, 2004, DIS COLON RECTUM, V47, P853, DOI 10.1007/s10350-004-0524-0
   Altomare DF, 2004, BRIT J SURG, V91, P1352, DOI 10.1002/bjs.4600
   Altomare DF, 2004, INT J COLORECTAL DIS, V19, P203, DOI 10.1007/s00384-003-0523-y
   Altomare DF, 2007, DIAGNOSIS CLIN MAN A, P53
   Altomare DF, 2007, RECTAL PROLAPSE DIAG, P97
   Altomare Donato F, 2005, Chir Ital, V57, P153
   Altomare DF, 2007, DIS COLON RECTUM, V50, P1023, DOI 10.1007/s10350-006-0863-0
   Altomare DF, 2010, WORLD J GASTROENTERO, V16, P5267, DOI 10.3748/wjg.v16.i42.5267
   Amoroso L, 2005, RADIOL MED, V109, P421
   Andromanakos Nikolaos, 2006, J Gastrointestin Liver Dis, V15, P41
   [Anonymous], 2007, FEC INC 2007
   Appalaneni V, 2010, GASTROINTEST ENDOSC, V72, P1117, DOI 10.1016/j.gie.2010.04.022
   Ausili E, 2010, SPINAL CORD, V48, P560, DOI 10.1038/sc.2009.186
   Ayabaca SM, 2002, DIS COLON RECTUM, V45, P63, DOI 10.1007/s10350-004-6115-2
   Azpiroz F, 2002, AM J GASTROENTEROL, V97, P232
   BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646
   Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   Baig MK, 2000, BRIT J SURG, V87, P1316, DOI 10.1046/j.1365-2168.2000.01592.x
   Bari Ausaf A, 2012, Surg Neurol Int, V3, pS260, DOI 10.4103/2152-7806.103016
   Barisic GI, 2006, INT J COLORECTAL DIS, V21, P52, DOI 10.1007/s00384-004-0737-7
   Bartlett L, 2011, DIS COLON RECTUM, V54, P846, DOI 10.1007/DCR.0b013e3182148fef
   BARTOLO DCC, 1983, J NEUROL NEUROSUR PS, V46, P1115, DOI 10.1136/jnnp.46.12.1115
   Bellini M, 2010, DIGEST LIVER DIS, V42, P99, DOI 10.1016/j.dld.2009.04.008
   Bharucha AE, 2006, AM J GASTROENTEROL, V101, P2679, DOI 10.1111/j.1572-0241.2006.00900.x
   Bharucha AE, 2006, GASTROENTEROLOGY, V130, P1510, DOI 10.1053/j.gastro.2005.11.064
   Bharucha AE, 2015, AM J GASTROENTEROL, V110, P127, DOI 10.1038/ajg.2014.396
   Bharucha AE, 2014, GASTROENTEROLOGY, V146, P37, DOI 10.1053/j.gastro.2013.10.062
   Bharucha AE, 2012, AM J PHYSIOL-GASTR L, V303, pG256, DOI 10.1152/ajpgi.00099.2012
   Bharucha AE, 2012, AM J GASTROENTEROL, V107, P902, DOI 10.1038/ajg.2012.45
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Bharucha AE, 2010, AM J GASTROENTEROL, V105, P786, DOI 10.1038/ajg.2010.70
   Bharucha AE, 2005, GUT, V54, P546, DOI 10.1136/gut.2004.047696
   Bharucha AE, 2003, GASTROENTEROLOGY, V124, P1672, DOI 10.1016/S0016-5085(03)00329-9
   Birnbaum EH, 1996, DIS COLON RECTUM, V39, P1215, DOI 10.1007/BF02055111
   Boenicke L, 2012, COLORECTAL DIS, V14, P480, DOI 10.1111/j.1463-1318.2011.02648.x
   Bols EM, 2010, ACTA OBSTET GYNECOL, V89, P302
   Bond C, 2007, J CLIN GASTROENTEROL, V41, P45, DOI 10.1097/MCG.0b013e31802dcba5
   Bordeianou L, 2008, DIS COLON RECTUM, V51, P1010, DOI 10.1007/s10350-008-9230-7
   Bordeianou L, 2011, DIS COLON RECTUM, V54, P60, DOI 10.1007/DCR.0b013e3181fd2373
   Bourguignon J, 1998, PRESSE MED, V27, P1702
   Boyle R, 2012, COCHRANE DB SYST REV, V10
   Bresler L, 2002, ANN CHIR, V127, P520, DOI 10.1016/S0003-3944(02)00828-3
   Briel JW, 1998, DIS COLON RECTUM, V41, P209, DOI 10.1007/BF02238250
   BROWNING GGP, 1983, BRIT MED J, V286, P1873, DOI 10.1136/bmj.286.6381.1873
   Cera Susan M, 2005, Clin Colon Rectal Surg, V18, P46, DOI 10.1055/s-2005-864081
   Chan MKY, 2008, DIS COLON RECTUM, V51, P1015, DOI 10.1007/s10350-008-9326-0
   Chassagne P, 2000, AGE AGEING, V29, P159, DOI 10.1093/ageing/29.2.159
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   CHEONG DMO, 1995, MUSCLE NERVE, V18, P612, DOI 10.1002/mus.880180608
   Chermansky CJ, 2012, CURR OPIN UROL, V22, P287, DOI 10.1097/MOU.0b013e32835480b2
   CHIARIONI G, 1993, GUT, V34, P1576, DOI 10.1136/gut.34.11.1576
   Choi JS, 2001, AM J GASTROENTEROL, V96, P740
   Christensen AF, 2005, BRIT J RADIOL, V78, P308, DOI 10.1259/bjr/720389963
   Christensen P, 2006, GASTROENTEROLOGY, V131, P738, DOI 10.1053/j.gastro.2006.06.004
   Christensen P, 2008, J SPINAL CORD MED, V31, P560, DOI 10.1080/10790268.2008.11754571
   Christensen P, 2009, DIS COLON RECTUM, V52, P286, DOI 10.1007/DCR.0b013e3181979341
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   CHRISTIANSEN J, 1990, BRIT J SURG, V77, P1039, DOI 10.1002/bjs.1800770928
   Chung CP, 2013, INT UROGYNECOL J, V24, P349, DOI 10.1007/s00192-012-1816-x
   Cohen BL, 2006, J UROLOGY, V175, P2178, DOI 10.1016/S0022-5347(06)00315-6
   Collins Brigitte, 2013, Br J Nurs, V22, P575
   Collinson R, 2010, GASTROEN CLIN BIOL, V34, P584, DOI 10.1016/j.gcb.2010.09.007
   Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x
   Collinson R, 2009, COLORECTAL DIS, V11, P11, DOI 10.1111/j.1463-1318.2008.01565.x
   Comiter CV, 1999, UROLOGY, V54, P454, DOI 10.1016/S0090-4295(99)00165-X
   Cook, 1999, Colorectal Dis, V1, P263, DOI 10.1046/j.1463-1318.1999.00083.x
   CORMAN ML, 1985, BRIT J SURG, V72, pS21, DOI 10.1002/bjs.1800721314
   CTERCTEKO G C, 1988, Australian and New Zealand Journal of Surgery, V58, P703, DOI 10.1111/j.1445-2197.1988.tb01100.x
   Cundiff GW, 1998, AM J OBSTET GYNECOL, V179, P1451, DOI 10.1016/S0002-9378(98)70009-2
   Curry JI, 1999, J PEDIATR SURG, V34, P338, DOI 10.1016/S0022-3468(99)90204-X
   D'Hoore A, 2006, SURG ENDOSC, V20, P1919, DOI 10.1007/s00464-005-0485-y
   D'Hoore A, 2004, BRIT J SURG, V91, P1500, DOI 10.1002/bjs.4779
   da Silva GM, 2006, AM J OBSTET GYNECOL, V195, P1742, DOI 10.1016/j.ajog.2006.07.034
   Damon H, 2008, INT J COLORECTAL DIS, V23, P845, DOI 10.1007/s00384-008-0489-x
   Damon H, 2013, INT J COLORECTAL DIS, V28, P227, DOI 10.1007/s00384-012-1558-8
   Daube JR, 1996, CLIN NEUROPHYSIOL, V46, P257
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de Miguel M, 2011, COLORECTAL DIS, V13, P72, DOI 10.1111/j.1463-1318.2009.02066.x
   de Tayrac R, 2013, INT UROGYNECOL J, V24, P1859, DOI 10.1007/s00192-013-2177-9
   DEEN KI, 1994, BRIT J SURG, V81, P302, DOI 10.1002/bjs.1800810253
   Deffieux X, 2012, EUR J OBSTET GYN R B, V165, P170, DOI 10.1016/j.ejogrb.2012.09.001
   Del Popolo G, 2008, SPINAL CORD, V46, P517, DOI 10.1038/sj.sc.3102167
   Deutekom M, 2005, DIS COLON RECTUM, V48, P2294, DOI 10.1007/s10350-005-0162-1
   Deutekom M, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005086.PUB3
   Deutekom M, 2007, AM J GASTROENTEROL, V102, P351, DOI 10.1111/j.1572-0241.2006.00927.x
   Devesa JM, 2011, TECH COLOPROCTOL, V15, P17, DOI 10.1007/s10151-010-0673-1
   Devesa JM, 1997, DIS COLON RECTUM, V40, P883, DOI 10.1007/BF02051193
   Devroede G, 2012, FEMALE PELVIC MED RE, V18, P103, DOI 10.1097/SPV.0b013e3182486e60
   Diamant NE, 1999, GASTROENTEROLOGY, V116, P735, DOI 10.1016/S0016-5085(99)70195-2
   Dietz HP, 2007, ULTRASOUND OBST GYN, V29, P329, DOI 10.1002/uog.3951
   Dietz HP, 2005, ULTRASOUND OBST GYN, V25, P580, DOI 10.1002/uog.1899
   Dobben AC, 2007, INT J COLORECTAL DIS, V22, P783, DOI 10.1007/s00384-006-0217-3
   Douard R, 2003, DIS COLON RECTUM, V46, P1089, DOI 10.1097/01.DCR.0000080169.97231.A2
   Dudding TC, 2008, COLORECTAL DIS, V10, P249, DOI 10.1111/j.1463-1318.2007.01319.x
   Dudding TC, 2011, COLORECTAL DIS, V13, pE187, DOI 10.1111/j.1463-1318.2011.02650.x
   Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4
   Duelund-Jakobsen J, 2012, COLORECTAL DIS, V14, P753, DOI 10.1111/j.1463-1318.2011.02800.x
   Dulucq JL, 2007, SURG ENDOSC, V21, P2226, DOI 10.1007/s00464-007-9350-5
   Dvorkin LS, 2005, DIS COLON RECTUM, V48, P824, DOI 10.1007/s10350-004-0834-2
   Ehrenpreis ED, 2007, DIS COLON RECTUM, V50, P641, DOI 10.1007/s10350-006-0778-9
   El-Gazzaz G, 2009, INT J COLORECTAL DIS, V24, P1377, DOI 10.1007/s00384-009-0745-8
   Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078
   Eltomey MA, 2008, AM J ROENTGENOL, V191, P1469, DOI 10.2214/AJR.07.3773
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, BRIT J SURG, V81, P1231, DOI 10.1002/bjs.1800810853
   EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229
   Faaborg PM, 2009, SPINAL CORD, V47, P545, DOI 10.1038/sc.2008.159
   Falletto E, 2014, TECH COLOPROCTOL, V18, P53, DOI 10.1007/s10151-013-1002-2
   Faltin DL, 2000, OBSTET GYNECOL, V95, P643, DOI 10.1016/S0029-7844(99)00631-6
   Chia B, 2008, REV ASSOC MED BRAS, V54, P142, DOI 10.1590/S0104-42302008000200017
   Farnsworth B, 2010, PELVIPERINEOLOGY, V29, P116
   FAROUK R, 1994, BRIT J SURG, V81, P743, DOI 10.1002/bjs.1800810542
   Farrell SA, 2012, OBSTET GYNECOL, V120, P803, DOI 10.1097/AOG.0b013e31826ac4bb
   Felt-Bersma RJF, 2008, GASTROENTEROL CLIN N, V37, P645, DOI 10.1016/j.gtc.2008.06.001
   Felt-Bersma RJ, 2008, GASTROENTEROL CLIN N, V37, pix
   Felt-Bersma RJF, 2001, GASTROENTEROL CLIN N, V30, P199, DOI 10.1016/S0889-8553(05)70174-6
   FELTBERSMA RJF, 1989, DIS COLON RECTUM, V32, P112, DOI 10.1007/BF02553822
   FELTBERSMA RJF, 1990, DIS COLON RECTUM, V33, P479, DOI 10.1007/BF02052142
   Fernando RJ, 2006, OBSTET GYNECOL, V107, P1261, DOI 10.1097/01.AOG.0000218693.24144.bd
   Fernando RJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002866.pub3
   Fielding JR, 2002, RADIOGRAPHICS, V22, P295, DOI 10.1148/radiographics.22.2.g02mr25295
   Finlay IG, 2004, BRIT J SURG, V91, P1485, DOI 10.1002/bjs.4721
   Fitzpatrick M, 2000, AM J OBSTET GYNECOL, V183, P1220, DOI 10.1067/mob.2000.108880
   FLESHMAN JW, 1991, DIS COLON RECTUM, V34, P739, DOI 10.1007/BF02051061
   FLESHMAN JW, 1991, DIS COLON RECTUM, V34, P1061, DOI 10.1007/BF02050062
   Food and Drug Administration Safety Communication, 2011, UPD SER COMPL UNPUB
   Frascio M, 2014, COLORECTAL DIS, V16, P167, DOI 10.1111/codi.12403
   FRENCKNER B, 1976, GUT, V17, P147, DOI 10.1136/gut.17.2.147
   Fynes MM, 1999, DIS COLON RECTUM, V42, P753, DOI 10.1007/BF02236930
   GABRIEL WB, 1948, P ROY SOC MED, V41, P467
   Galandiuk S, 2009, LANGENBECK ARCH SURG, V394, P425, DOI 10.1007/s00423-008-0332-4
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   George AT, 2013, BRIT J SURG, V100, P330, DOI 10.1002/bjs.9000
   Giamundo P, 2007, Tech Coloproctol, V11, P310, DOI 10.1007/s10151-007-0371-9
   Giamundo P, 2002, AM J GASTROENTEROL, V97, P2328
   Giani I, 2011, ANN SURG, V254, P90, DOI 10.1097/SLA.0b013e3182196ff4
   Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299
   Giordano P, 2002, DIS COLON RECTUM, V45, P635, DOI 10.1007/s10350-004-6260-7
   Glasgow SC, 2006, DIS COLON RECTUM, V49, P1052, DOI 10.1007/s10350-006-0538-x
   Glasgow SC, 2012, DIS COLON RECTUM, V55, P482, DOI 10.1097/DCR.0b013e3182468c22
   Gottesman L., 1995, PRACTICAL GUIDE ANOR, P207
   Govaert B, 2009, DIS COLON RECTUM, V52, P1688, DOI 10.1007/DCR.0b013e3181b55595
   Govaert B, 2009, DIS COLON RECTUM, V52, P1423, DOI 10.1007/DCR.0b013e3181a91241
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Grassini M, 2008, GASTROINTEST ENDOSC, V67, P88, DOI 10.1016/j.gie.2007.05.019
   Grassini M, 2007, WORLD J GASTROENTERO, V13, P1816, DOI 10.3748/wjg.v13.i12.1816
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Harmston C, 2011, COLORECTAL DIS, V13, P791, DOI 10.1111/j.1463-1318.2010.02266.x
   Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359
   Hassan C, 2011, J GASTROINTEST LIVER, V20, P279
   Haverfield ME, 2007, PELVIPERINEOLOGY, V26, P108
   Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798
   Hetzer F H, 2005, Tech Coloproctol, V9, P25, DOI 10.1007/s10151-005-0188-3
   Hetzer FH, 2007, ARCH SURG-CHICAGO, V142, P8, DOI 10.1001/archsurg.142.1.8
   Heymen S, 2001, DIS COLON RECTUM, V44, P728, DOI 10.1007/BF02234575
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Hoekstra LT, 2011, J PEDIATR SURG, V46, P1603, DOI 10.1016/j.jpedsurg.2011.04.050
   Hollingshead JRF, 2009, BRIT J SURG, V96, P1082, DOI 10.1002/bjs.6664
   Holzer B, 2008, J GASTROINTEST SURG, V12, P921, DOI 10.1007/s11605-008-0485-z
   Hosker G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001310.pub2
   Hultman CS, 2006, ANN PLAS SURG, V56, P65, DOI 10.1097/01.sap.0000186513.75052.29
   IHRE T, 1974, SCAND J GASTROENTERO, V9, P1
   Indinnimeo M, 2010, DIS COLON RECTUM, V53, P1661, DOI 10.1007/DCR.0b013e3181f46309
   INFANTINO A, 1995, DIS COLON RECTUM, V38, P27, DOI 10.1007/BF02053853
   Jarrett MED, 2005, INT J COLORECTAL DIS, V20, P446, DOI 10.1007/s00384-004-0729-7
   Jarrett MED, 2004, BRIT J SURG, V91, P755, DOI 10.1002/bjs.4545
   Jelovsek JE, 2005, AM J OBSTET GYNECOL, V193, P2105, DOI 10.1016/j.ajog.2005.07.016
   Jensen LL, 1997, DIS COLON RECTUM, V40, P197, DOI 10.1007/BF02054988
   Johnson E, 2003, EUR J SURG S, V588, P51
   Jones MP, 2007, AM J GASTROENTEROL, V102, P850, DOI 10.1111/j.1572-0241.2007.01069.x
   Jones OM, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7099
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Keller J, 2009, BEST PRACT RES CL GA, V23, P407, DOI 10.1016/j.bpg.2009.02.012
   Kellokumpu IH, 2000, SURG ENDOSC-ULTRAS, V14, P634, DOI 10.1007/s004640000017
   Kenefick NJ, 2003, BRIT J SURG, V90, P1256, DOI 10.1002/bjs.4196
   KIFF ES, 1984, BRIT J SURG, V71, P614, DOI 10.1002/bjs.1800710817
   Koch SM, 2010, COLORECTAL DIS, V12, P334, DOI 10.1111/j.1463-1318.2009.01792.x
   Konsten J, 2001, DIS COLON RECTUM, V44, P581, DOI 10.1007/BF02234333
   Kouraklis G, 2004, SURG TODAY, V34, P304, DOI 10.1007/s00595-003-2704-2
   KUMAR D, 1995, BRIT J SURG, V82, P1645, DOI 10.1002/bjs.1800821219
   Laforest A, 2012, COLORECTAL DIS, V14, P1231, DOI 10.1111/j.1463-1318.2012.02956.x
   Lam TJ, 2012, COLORECTAL DIS, V14, P214, DOI 10.1111/j.1463-1318.2011.02548.x
   Lau CW, 2000, DIS COLON RECTUM, V43, P478, DOI 10.1007/BF02237190
   LAURBERG S, 1988, ARCH NEUROL-CHICAGO, V45, P1250, DOI 10.1001/archneur.1988.00520350088021
   Lauretta A, 2012, TECH COLOPROCTOL, V16, P477, DOI 10.1007/s10151-012-0918-2
   LAW PJ, 1990, DIS COLON RECTUM, V33, P370, DOI 10.1007/BF02156260
   Lazorthes F, 1998, DIS COLON RECTUM, V41, P602, DOI 10.1007/BF02235267
   Lee Byoung Hwan, 2010, J Neurogastroenterol Motil, V16, P177, DOI 10.5056/jnm.2010.16.2.177
   Lefaucheur JP, 2006, MUSCLE NERVE, V33, P324, DOI 10.1002/mus.20387
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Leroi AM, 2009, COLORECTAL DIS, V11, P572, DOI 10.1111/j.1463-1318.2009.01914.x
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Liberman H, 2000, DIS COLON RECTUM, V43, P188, DOI 10.1007/BF02236980
   Lindsay I, 2006, COLORECTAL DIS, V8, pS2
   Loening-Baucke V, 2002, CURR OPIN PEDIATR, V14, P570, DOI 10.1097/01.MOP.0000028541.37171.EF
   LOENINGBAUCKE V, 1990, DIGEST DIS, V8, P112, DOI 10.1159/000171245
   Lombardi G, 2010, SPINAL CORD, V48, P154, DOI 10.1038/sc.2009.101
   LONDONOSCHIMMER EE, 1994, INT J COLORECTAL DIS, V9, P110, DOI 10.1007/BF00699424
   Loos M, 2013, ANN SURG ONCOL, V20, P1816, DOI 10.1245/s10434-012-2827-z
   Pereira PL, 2010, J PEDIATR UROL, V6, P134, DOI 10.1016/j.jpurol.2009.07.004
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Madoff RD, 2009, INCONTINENCE, P1387
   Madsen Mari A, 2008, Clin Colon Rectal Surg, V21, P100, DOI 10.1055/s-2008-1075858
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2008, DIS COLON RECTUM, V51, P436, DOI 10.1007/s10350-007-9157-4
   Maeda Y, 2010, DIS COLON RECTUM, V53, P995, DOI 10.1007/DCR.0b013e3181d64207
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Maher C, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004014.PUB2, 10.1002/14651858.CD004014.pub2]
   Mahony RT, 2004, AM J OBSTET GYNECOL, V191, P885, DOI 10.1016/j.ajog.2004.07.006
   Malouf AJ, 2000, AM J ROENTGENOL, V175, P741, DOI 10.2214/ajr.175.3.1750741
   Marcello PW, 1998, DIS COLON RECTUM, V41, P336, DOI 10.1007/BF02237488
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Maris A, 2013, COLORECTAL DIS, V15, pE67, DOI 10.1111/codi.12036
   Matzel KE, 2007, ACTA NEUROCHIR SUPPL, V97, P351
   Matzel KE, 2002, INT J COLORECTAL DIS, V17, P430, DOI 10.1007/s00384-002-0412-9
   Matzel KE, 2001, CHIR GASTROENTEROL, V17, P230
   Matzel KE, 2001, DIS COLON RECTUM, V44, P1427, DOI 10.1007/BF02234593
   Mavrantonis C, 1999, DIS COLON RECTUM, V42, P497, DOI 10.1007/BF02234176
   Melenhorst J, 2008, COLORECTAL DIS, V10, P257, DOI 10.1111/j.1463-1318.2007.01375.x
   Melenhorst J, 2007, COLORECTAL DIS, V9, P725, DOI 10.1111/j.1463-1318.2007.01241.x
   MELLGREN A, 1994, DIS COLON RECTUM, V37, P1133, DOI 10.1007/BF02049817
   Mercer-Jones MA, 2014, COLORECTAL DIS, V16, P82, DOI 10.1111/codi.12415
   Meschia M, 2002, OBSTET GYNECOL, V100, P719, DOI 10.1016/S0029-7844(02)02215-9
   Mevik K, 2009, SCAND J SURG, V98, P234, DOI 10.1177/145749690909800408
   Michelsen HB, 2006, DIS COLON RECTUM, V49, P1039, DOI 10.1007/s10350-006-0548-8
   Michot F, 2003, ANN SURG, V237, P52, DOI 10.1097/00000658-200301000-00008
   Milani R, 2003, P 33 ANN M INT CONT, P189
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   Mitrani C, 1998, J CLIN GASTROENTEROL, V26, P175, DOI 10.1097/00004836-199804000-00005
   Morris OJ, 2013, TECH COLOPROCTOL, V17, P517, DOI 10.1007/s10151-013-1000-4
   Moscovitz I, 2002, COLORECTAL DIS, V4, P275
   Mouritsen L, 2005, BEST PRACT RES CL OB, V19, P895, DOI 10.1016/j.pbobgyn.2005.08.007
   Mouritsen L, 2003, INT UROGYNECOL J PEL, V14, P122, DOI 10.1007/s00192-002-1024-1
   Moya P, 2012, TECH COLOPROCTOL, V16, P263, DOI 10.1007/s10151-012-0823-8
   Nichols CM, 2005, OBSTET GYNECOL, V106, P1266, DOI 10.1097/01.AOG.0000187303.43011.12
   Nikiteas N, 1996, DIS COLON RECTUM, V39, P1164, DOI 10.1007/BF02081420
   Noelting J, 2012, AM J GASTROENTEROL, V107, P1530, DOI 10.1038/ajg.2012.221
   Nordenstam J, 2008, BJOG-INT J OBSTET GY, V115, P857, DOI 10.1111/j.1471-0528.2008.01726.x
   Norton C, 2001, Colorectal Dis, V3, P323, DOI 10.1046/j.1463-1318.2001.00257.x
   Norton C, 2010, NEUROUROL URODYNAM, V29, P199, DOI 10.1002/nau.20803
   Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x
   Norton C, 2012, COCHRANE DB SYST REV, V7
   Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   OLIVER GC, 1994, DIS COLON RECTUM, V37, P461, DOI 10.1007/BF02076192
   Omar MI, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD002116.PUB2
   Oom DMJ, 2012, DIS COLON RECTUM, V55, P646, DOI 10.1097/DCR.0b013e318251dca1
   Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862
   PALMER KR, 1980, GASTROENTEROLOGY, V79, P1272
   Palsson OS, 2004, APPL PSYCHOPHYS BIOF, V29, P153, DOI 10.1023/B:APBI.0000039055.18609.64
   Patton V, 2013, BRIT J SURG, V100, P959, DOI 10.1002/bjs.9114
   Pehl C, 2012, DIGESTION, V86, P78, DOI 10.1159/000338954
   PESCATORI M, 1992, DIS COLON RECTUM, V35, P482, DOI 10.1007/BF02049407
   Pescatori M, 1998, INT J COLORECTAL DIS, V13, P223, DOI 10.1007/s003840050165
   Petros P, 2013, TECH COLOPROCTOL, V17, P449, DOI 10.1007/s10151-013-0980-4
   Pfrommer W, 2000, EUR J PEDIATR SURG, V10, P186, DOI 10.1055/s-2008-1072354
   Pilini V, 1988, COLOPROCTOLOGY, V10, P297
   Piloni V, 1999, INT J COLORECTAL DIS, V14, P131, DOI 10.1007/s003840050198
   Piloni V, 2014, FECAL INCONTINENCE C, P71
   Piloni V, 1995, TECHN COLOPROCT, V2, P70
   Piloni VI, 2013, RECONSTRUCTIVE SURG, P13
   Portier G, 2011, COLORECTAL DIS, V13, P914, DOI 10.1111/j.1463-1318.2010.02327.x
   Portier G, 2006, DIS COLON RECTUM, V49, P1136, DOI 10.1007/s10350-006-0616-0
   Pradal-Prat D, 1998, Electromyogr Clin Neurophysiol, V38, P491
   Pucciani F, 2003, Tech Coloproctol, V7, P139, DOI 10.1007/s10151-003-0025-5
   Pucciani F, 2013, COLORECTAL DIS, V15, P987, DOI 10.1111/codi.12236
   Pucciani F, 2013, TECH COLOPROCTOL, V17, P299, DOI 10.1007/s10151-012-0923-5
   Pucciani F., 2007, FECAL INCONTINENCE D, P167
   Pucciani F, 2008, DIS COLON RECTUM, V51, P1552, DOI 10.1007/s10350-008-9312-6
   Quander CR, 2005, AM J GASTROENTEROL, V100, P905, DOI 10.1111/j.1572-0241.2005.30511.x
   Rajindrajith S, 2013, ALIMENT PHARM THER, V37, P37, DOI 10.1111/apt.12103
   Rao SSC, 2010, CLIN GASTROENTEROL H, V8, P910, DOI 10.1016/j.cgh.2010.06.004
   Rao SSC, 2002, NEUROGASTROENT MOTIL, V14, P553, DOI 10.1046/j.1365-2982.2002.00352.x
   Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x
   Rasmussen OO, 2000, DIS COLON RECTUM, V43, P633, DOI 10.1007/BF02235577
   Ratto C, 2005, DIS COLON RECTUM, V48, P1027, DOI 10.1007/s10350-004-0884-5
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ratto C, 2010, DIS COLON RECTUM, V53, P264, DOI 10.1007/DCR.0b013e3181c7642c
   Retzke F, 2013, PELVIPERINEOLOGY, V32, P59
   REX DK, 1992, DIS COLON RECTUM, V35, P1040, DOI 10.1007/BF02252993
   Ricciardi R, 2006, DIS COLON RECTUM, V49, P852, DOI 10.1007/s10350-006-0529-y
   Rink AD, 2010, COLORECTAL DIS, V12, P342, DOI 10.1111/j.1463-1318.2009.01790.x
   Robert-Yap J, 2010, DIS COLON RECTUM, V53, P428, DOI 10.1007/DCR.0b013e3181ca74b4
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   ROIG JV, 1995, DIS COLON RECTUM, V38, P952, DOI 10.1007/BF02049731
   Romano G, 1996, BRIT J RADIOL, V69, P6, DOI 10.1259/0007-1285-69-817-6
   Romano G, 2000, DIAGNOSIS TREATMENT, P129
   Rongen MJGM, 2003, DIS COLON RECTUM, V46, P716, DOI 10.1097/01.DCR.0000070035.45378.BD
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   Rothenhoefer S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-155
   Rygh AB, 2010, ACTA OBSTET GYN SCAN, V89, P1256, DOI 10.3109/00016349.2010.512073
   Sander P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P177, DOI 10.1007/s001920050041
   Sansoni J, 2006, REFINIG CONTINENCE M
   Sansoni J, 2013, DIS COLON RECTUM, V56, P652, DOI 10.1097/DCR.0b013e318279c2ac
   Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848
   Santoro GA, 2012, DIS COLON RECTUM, V55, P797, DOI 10.1097/DCR.0b013e3182538f14
   SATO Y, 1988, RADIOLOGY, V168, P157, DOI 10.1148/radiology.168.1.3380953
   Scarlett Y, 2004, GASTROENTEROLOGY, V126, pS55, DOI 10.1053/j.gastro.2003.10.007
   Schultz I, 2000, DIS COLON RECTUM, V43, P35, DOI 10.1007/BF02237241
   Schwandner T, 2011, DTSCH ARZTEBL INT, V108, P653, DOI 10.3238/arztebl.2011.0653
   Senapati A, 2013, COLORECTAL DIS, V15, P858, DOI 10.1111/codi.12177
   Sentovich SM, 1997, DIS COLON RECTUM, V40, P1430, DOI 10.1007/BF02070707
   Shafik A, 2007, AM SURGEON, V73, P6
   Shah BJ, 2012, AM J GASTROENTEROL, V107, P1635, DOI 10.1038/ajg.2012.284
   Sheldon R, 2005, BRIT J SURG, V92, P1423, DOI 10.1002/bjs.5111
   Sielezneff I, 1999, DIS COLON RECTUM, V42, P367, DOI 10.1007/BF02236355
   Sielezneff I, 1996, INT J COLORECTAL DIS, V11, P15, DOI 10.1007/BF00418849
   Sileri P, 2012, J GASTROINTEST SURG, V16, P622, DOI 10.1007/s11605-011-1793-2
   SIMMANG C, 1994, DIS COLON RECTUM, V37, P1065, DOI 10.1007/BF02049804
   Singh K, 2001, AM J OBSTET GYNECOL, V185, P71, DOI 10.1067/mob.2001.113876
   Sinha CK, 2008, PEDIATR SURG INT, V24, P685, DOI 10.1007/s00383-008-2130-z
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Sitzler PJ, 1996, DIS COLON RECTUM, V39, P1356, DOI 10.1007/BF02054524
   SLADE MS, 1977, DIS COLON RECTUM, V20, P33, DOI 10.1007/BF02587449
   Slawik S, 2008, COLORECTAL DIS, V10, P138, DOI 10.1111/j.1463-1318.2007.01259.x
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Smart NJ, 2013, COLORECTAL DIS, V15, P650, DOI 10.1111/codi.12219
   Soligo M, 2003, AM J OBSTET GYNECOL, V189, P438, DOI 10.1067/S0002-9378(03)00466-6
   SORENSEN M, 1991, GUT, V32, P1031, DOI 10.1136/gut.32.9.1031
   Stabile G, 1994, Minerva Chir, V49, P1187
   SULTAN AH, 1994, BRIT J SURG, V81, P463, DOI 10.1002/bjs.1800810349
   SUN WM, 1992, GUT, V33, P807, DOI 10.1136/gut.33.6.807
   Talley NJ, 2008, AM J GASTROENTEROL, V103, P820, DOI 10.1111/j.1572-0241.2008.01832.x
   Tan E, 2011, INT J COLORECTAL DIS, V26, P275, DOI 10.1007/s00384-010-1119-y
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   Ternent CA, 1997, DIS COLON RECTUM, V40, P462, DOI 10.1007/BF02258393
   Thiersch C, 1988, Dis Colon Rectum, V31, P154
   Thin NN, 2013, BRIT J SURG, V100, P1430, DOI 10.1002/bjs.9226
   Thomas GP, 2013, COLORECTAL DIS, V15, P519, DOI 10.1111/codi.12093
   Thomas S, 2006, CONTINENCE OUTCOMES
   Tjandra JJ, 2008, COLORECTAL DIS, V10, P681, DOI 10.1111/j.1463-1318.2007.01467.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Tou S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001758.pub2
   Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364
   Tsiaoussis J, 2005, DIS COLON RECTUM, V48, P838, DOI 10.1007/s10350-004-0850-2
   Uludag O, 2011, COLORECTAL DIS, V13, P1162, DOI 10.1111/j.1463-1318.2010.02447.x
   Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292
   Vaizey CJ, 2004, DIS COLON RECTUM, V47, P858, DOI 10.1007/s10350-003-0112-8
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Vaizey CJ, 1998, BRIT J SURG, V85, P596
   van der Hagen SJ, 2012, COLORECTAL DIS, V14, P1398, DOI 10.1111/j.1463-1318.2012.03023.x
   van Geelen JM, 2013, INT UROGYNECOL J, V24, P707, DOI 10.1007/s00192-012-2025-3
   Van Koughnett JAM, 2013, WORLD J GASTROENTERO, V19, P9216, DOI 10.3748/wjg.v19.i48.9216
   Van WM, 2006, J UROLOGY, V176, P342
   Varma M, 2011, DIS COLON RECTUM, V54, P1339, DOI 10.1097/DCR.0b013e3182310f75
   Velluti Farina A, 2013, PELVIPERINEOLOGY, V32, P9
   VENKATESH KS, 1989, DIS COLON RECTUM, V32, P1039, DOI 10.1007/BF02553877
   Vitton V, 2013, COLORECTAL DIS, V15, pE726, DOI 10.1111/codi.12397
   von Papen M, 2007, DIS COLON RECTUM, V50, P50, DOI 10.1007/s10350-006-0781-1
   Wagenlehner FM, 2012, PELVIPERINEOLOGY, V31, P101
   Wald A, 2007, NEW ENGL J MED, V356, P1648, DOI 10.1056/NEJMcp067041
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Weber AM, 1998, AM J OBSTET GYNECOL, V179, P1446, DOI 10.1016/S0002-9378(98)70008-0
   West RL, 2005, INT J COLORECTAL DIS, V20, P328, DOI 10.1007/s00384-004-0693-2
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Whitehead W E, 2001, Dis Colon Rectum, V44, P131, DOI 10.1007/BF02234835
   Wijffels NAT, 2013, COLORECTAL DIS, V15, P368, DOI 10.1111/j.1463-1318.2012.03183.x
   Williams A, 2006, BJOG-INT J OBSTET GY, V113, P201, DOI 10.1111/j.1471-0528.2006.00806.x
   Withagen MI, 2012, BJOG-INT J OBSTET GY, V119, P354, DOI 10.1111/j.1471-0528.2011.03231.x
   Wong RK, 2012, AM J GASTROENTEROL, V107, P1157, DOI 10.1038/ajg.2012.23
   Yakut M, 1998, INT SURG, V83, P53
   Yip B, 2002, DIS COLON RECTUM, V45, P184, DOI 10.1007/s10350-004-6142-z
   Zbar AP, 2003, INT J COLORECTAL DIS, V18, P369, DOI 10.1007/s00384-003-0478-z
   Zutshi M, 2009, DIS COLON RECTUM, V52, P1089, DOI 10.1007/DCR.0b013e3181a0a79c
NR 380
TC 4
Z9 6
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1590-8658
EI 1878-3562
J9 DIGEST LIVER DIS
JI Dig. Liver Dis.
PD AUG
PY 2015
VL 47
IS 8
BP 628
EP 645
DI 10.1016/j.dld.2015.03.028
PG 18
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CN0FA
UT WOS:000358088300004
PM 25937624
DA 2018-10-20
ER

PT J
AU Aguayo, S
   Donos, N
   Spratt, D
   Bozec, L
AF Aguayo, S.
   Donos, N.
   Spratt, D.
   Bozec, L.
TI Nanoadhesion of Staphylococcus aureus onto Titanium Implant Surfaces
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE atomic force microscopy; biophysics; nanomechanics; microbiology; dental
   implants; bacterial adhesion
ID ATOMIC-FORCE MICROSCOPY; FIBRONECTIN-BINDING PROTEINS; ADHESION FORCES;
   STATISTICAL-ANALYSIS; BACTERIAL ADHESION; POISSON ANALYSIS;
   SILICON-NITRIDE; SPECTROSCOPY; EPIDERMIDIS; FIBRINOGEN
AB Adhesion of bacteria to dental implant surfaces is the critical initial step in the process of biofilm colonization; however, the specific nanoadhesive interactions occurring during the first contact between bacterial cells and biomaterial substrates remain poorly understood. In this report, we utilize single-cell force spectroscopy to characterize the dynamics of the initial interaction between living Staphylococcus aureus cells and machined titanium surfaces at the nanoscale. Values for maximum adhesion force were found to increase from 0-s (-0.27 +/- 0.30 nN) to 60-s (-9.15 +/- 0.78 nN) surface delays, with similar results observed for total adhesion work (7.39 +/- 2.38 and 988.06 +/- 117.08 aJ, respectively). Single unbinding events observed at higher surface delays were modeled according to the wormlike chain model, obtaining molecular contour-length predictions of 314.06 +/- 9.27 nm. Average single-bond rupture forces of -0.95 +/- 0.04 nN were observed at increased contact times. Short- and long-range force components of bacterial adhesion were obtained by Poisson analysis of single unbinding event peaks, yielding values of -0.75 +/- 0.04 and -0.58 +/- 0.15 nN, respectively. Addition of 2-mg/mL chlorhexidine to the buffer solution resulted in the inhibition of specific adhesive events but an increased overall adhesion force and work. These results suggest that initial attachment of S. aureus to smooth titanium is mostly mediated by short-range attractive forces observed at higher surface delays.
C1 [Aguayo, S.; Bozec, L.] UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, London WC1X 8LD, England.
   [Donos, N.] UCL, UCL Eastman Dent Inst, Periodontol Unit, London WC1X 8LD, England.
   [Spratt, D.] UCL, Div Microbial Dis, UCL Eastman Dent Inst, London WC1X 8LD, England.
RP Aguayo, S (reprint author), UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, 256 Grays Inn Rd, London WC1X 8LD, England.
EM Sebastian.aguayo.13@ucl.ac.uk
OI Aguayo, Sebastian/0000-0003-0900-1993
FU BecasChile PhD Scholarship Programme
FX We thank the BecasChile PhD Scholarship Programme for funding this
   research. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Abu-Lail NI, 2006, LANGMUIR, V22, P7296, DOI 10.1021/la0533415
   Aguayo S, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062001
   Beaussart A, 2013, NANOSCALE, V5, P10894, DOI 10.1039/c3nr03272h
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u
   Chan Y, 2010, J THEOR BIOL, V262, P498, DOI 10.1016/j.jtbi.2009.10.009
   Chen Y, 2014, APPL ENVIRON MICROB, V80, P637, DOI 10.1128/AEM.02745-13
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Esposito M, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003815.PUB3
   Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   Gordesli FP, 2012, ENVIRON SCI TECHNOL, V46, P10089, DOI 10.1021/es300653w
   Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x
   Herman P, 2014, MOL MICROBIOL, V93, P356, DOI 10.1111/mmi.12663
   Herman P, 2013, LANGMUIR, V29, P13018, DOI 10.1021/la4029172
   Izquierdo-Barba I, 2015, ACTA BIOMATER, V15, P20, DOI 10.1016/j.actbio.2014.12.023
   Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x
   Kishen A, 2008, J ENDODONT, V34, P850, DOI 10.1016/j.joen.2008.04.006
   Lee A, 2010, IMPLANT DENT, V19, P387, DOI 10.1097/ID.0b013e3181effa53
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   Logan N, 2015, J BIOMED MATER RES A, V103, P1208, DOI 10.1002/jbm.a.35264
   Mei L, 2009, J DENT RES, V88, P841, DOI 10.1177/0022034509342523
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Meyer RL, 2010, ULTRAMICROSCOPY, V110, P1349, DOI 10.1016/j.ultramic.2010.06.010
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006
   Setzer FC, 2014, J DENT RES, V93, P19, DOI 10.1177/0022034513504782
   Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906
   Sullan RMA, 2014, NANOSCALE, V6, P1134, DOI 10.1039/c3nr05462d
   Taubenberger A V, 2013, TISSUE ENG PART B-RE, V20, P40
   UHLEN M, 1984, J BIOL CHEM, V259, P1695
   Valderrama P, 2013, INT J DENT, V2013, DOI DOI 10.1155/2013/740680
   Webb HK, 2011, J MICROBIOL METH, V86, P131, DOI 10.1016/j.mimet.2011.05.021
   Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012
   Younes JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036917
   Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001
NR 40
TC 9
Z9 9
U1 1
U2 33
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD AUG
PY 2015
VL 94
IS 8
BP 1078
EP 1084
DI 10.1177/0022034515591485
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN1LR
UT WOS:000358182000009
PM 26130256
DA 2018-10-20
ER

PT J
AU Shao, K
   Han, BQ
   Gao, JN
   Song, FL
   Yang, Y
   Liu, WS
AF Shao Kai
   Han Baoqin
   Gao Jinning
   Song Fulai
   Yang Yan
   Liu Wanshun
TI Synthesis and characterization of a hydroxyethyl derivative of chitosan
   and evaluation of its biosafety
SO JOURNAL OF OCEAN UNIVERSITY OF CHINA
LA English
DT Article
DE hydroxyethyl chitosan; biomaterial; cytotoxicity; biocompatibility;
   biodegradability
ID IN-VITRO EVALUATION; CHITIN; POLYMERS; VIVO; CYTOTOXICITY; CONJUGATE;
   RELEASE; SAFETY; PH
AB Hydroxyethyl chitosan (HE-chitosan) is a water-soluble derivative of chitosan with many apparent biological properties. For example, it is non-toxic and rapidly biodegradable. Moreover, HE-chitosan has advantages in water-solubility, moisture retention and gelling property due to its hydroxyethyl group. However, the biocompatibility and biodegradability of this multifunctional derivative have rarely been documented although they are critical for its application in biomedical and clinical treatments. The purpose of this work was to evaluate the biosafety of HE-chitosan, and draw important clues for its diverse applications. HE-chitosan was synthesized and characterized its chemical structure with FTIR. Its molecular weight (MW) was determined by gel permeation chromatography (GPC), and its deacetylation degree (DD) was investigated through potentiometric analysis. The cytotoxicity of HE-chitosan on mouse fibroblast cell L929 was tested. The biocompatibility and biodegradability of HE-chitosan in rat and rabbit were evaluated. The FTIR results indicated that the hydroxyethyl groups were linked to C6 of chitosan. The GPC analysis confirmed that its Mw was about 90.01 kDa. It was also demonstrated that HE-chitosan had excellent biocompatibility and biodegradability in vivo and had no cytotoxicity on L929. These findings indicated that HE-chitosan can potentially be applied as a biomaterial in tissue engineering, drug delivery, and other biomedical fields.
C1 [Shao Kai; Han Baoqin; Gao Jinning; Song Fulai; Yang Yan; Liu Wanshun] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
RP Han, BQ (reprint author), Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
EM baoqinh@ouc.edu.cn
FU National Key Technology R&D Program of the Ministry of Science and
   Technology [2013BAB01B02]
FX This work is supported by the National Key Technology R&D Program of the
   Ministry of Science and Technology (2013BAB01B02).
CR Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Carreira AS, 2010, CARBOHYD POLYM, V80, P618, DOI 10.1016/j.carbpol.2009.12.047
   Chen Y, 2010, J APPL POLYM SCI, V117, P2233, DOI 10.1002/app.32141
   Chow KS, 2002, CARBOHYD POLYM, V47, P357, DOI 10.1016/S0144-8617(01)00190-4
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Dong W, 2010, BIOMACROMOLECULES, V11, P1527, DOI 10.1021/bm100158p
   Dong YM, 2001, ACTA POLYM SIN, P172
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   El-Sherbiny IM, 2009, EUR POLYM J, V45, P199, DOI 10.1016/j.eurpolymj.2008.10.042
   Gomaa YA, 2010, CARBOHYD POLYM, V81, P234, DOI 10.1016/j.carbpol.2010.02.024
   He XK, 2012, THERANOSTICS, V2, P1054, DOI 10.7150/thno.3705
   HUANG R, 2003, CARBOHYD POLYM, V51, P431
   Huang RH, 2005, INT J BIOL MACROMOL, V36, P120, DOI 10.1016/j.ijbiomac.2005.05.001
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Li DH, 2007, CARBOHYD POLYM, V67, P40, DOI 10.1016/j.carbpol.2006.04.022
   Li MY, 2011, J MATER SCI-MATER M, V22, P2745, DOI 10.1007/s10856-011-4455-8
   Liang Y, 2011, J MATER SCI-MATER M, V22, P175, DOI 10.1007/s10856-010-4190-6
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Liu WG, 2004, J MATER SCI-MATER M, V15, P1199, DOI 10.1007/s10856-004-5672-1
   Liu XF, 2007, J APPL POLYM SCI, V103, P3521, DOI 10.1002/app.25421
   MUZZARELLI RAA, 1984, CARBOHYD RES, V126, P225, DOI 10.1016/0008-6215(84)85380-X
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Nanaki SG, 2012, CARBOHYD POLYM, V87, P1286, DOI 10.1016/j.carbpol.2011.09.013
   Rasad MSBA, 2010, CARBOHYD POLYM, V79, P1094, DOI 10.1016/j.carbpol.2009.10.048
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Takei T, 2012, ACTA BIOMATER, V8, P686, DOI 10.1016/j.actbio.2011.10.005
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wan Y, 2004, J POLYM SCI POL PHYS, V42, P1379, DOI 10.1002/polb.20007
   Xie YJ, 2007, CARBOHYD POLYM, V69, P142, DOI 10.1016/j.carbpol.2006.09.010
   Xu XL, 2010, CARBOHYD POLYM, V81, P541, DOI 10.1016/j.carbpol.2010.03.011
   Yuan ZX, 2011, J DRUG TARGET, V19, P540, DOI 10.3109/1061186X.2010.521158
   Zhang C, 2005, J APPL POLYM SCI, V97, P2161, DOI 10.1002/app.21975
   Zhao YQ, 2008, CARBOHYD POLYM, V74, P828, DOI 10.1016/j.carbpol.2008.04.042
   Zheng ML, 2011, CARBOHYD POLYM, V86, P231, DOI 10.1016/j.carbpol.2011.04.038
NR 40
TC 3
Z9 6
U1 2
U2 31
PU OCEAN UNIV CHINA
PI QINGDAO
PA 5 YUSHAN RD, QINGDAO, 266003, PEOPLES R CHINA
SN 1672-5182
EI 1993-5021
J9 J OCEAN U CHINA
JI J. OCEAN UNIV.
PD AUG
PY 2015
VL 14
IS 4
BP 703
EP 709
DI 10.1007/s11802-015-2544-x
PG 7
WC Oceanography
SC Oceanography
GA CN3OJ
UT WOS:000358335900017
DA 2018-10-20
ER

PT J
AU Chandrasekaran, N
   Dimartino, S
   Janmale, T
   Gieseg, SP
   Fee, CJ
AF Chandrasekaran, Neha
   Dimartino, Simone
   Janmale, Tejraj
   Gieseg, Steven P.
   Fee, Conan J.
TI Adsorption of chemically synthesized mussel adhesive peptide sequences
   containing DOPA on stainless steel
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE adhesive peptides; DOPA; stainless steel; QCM-D; mushroom tyrosinase
ID QUARTZ-CRYSTAL MICROBALANCE; MARINE MUSSEL; CROSS-LINKING;
   INFRARED-SPECTROSCOPY; MYTILUS-EDULIS; QCM-D; PROTEIN;
   3,4-DIHYDROXYPHENYLALANINE; TYROSINASE; INTERFACES
AB The adsorption of proteins at solid-liquid interfaces is important in biosensor and biomaterial applications. Marine mussels affix themselves to surfaces using a highly cross-linked, protein-based adhesive containing a high proportion of L-3,4-dihydroxyphenylalanine (DOPA) residues. In this work, the effect of DOPA residues on protein adhesion on stainless steel surfaces was studied using a quartz crystal microbalance with dissipation system. The adsorption of two repetitive peptide motifs, KGYKYYGGSS and KGYKYY, from the mussel Mytilus edulis foot protein 5 on stainless steel was studied before and after chemo-enzymatic modification of tyrosine residues to DOPA using mushroom tyrosinase. Conversion from tyrosine to DOPA, evaluated by HPLC, was in the range 70-99%. DOPA-modified sequences showed fourfold greater adhesion than unmodified M. edulis foot protein 5 motifs. Copyright (c) 2015 European Peptide Society and John Wiley & Sons, Ltd.
C1 [Chandrasekaran, Neha; Dimartino, Simone; Fee, Conan J.] Univ Canterbury, Dept Chem & Proc Engn, Christchurch 1, New Zealand.
   [Dimartino, Simone; Fee, Conan J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.
   [Janmale, Tejraj; Gieseg, Steven P.] Univ Canterbury, Free Radical Biochem, Sch Biol Sci, Christchurch 1, New Zealand.
   [Gieseg, Steven P.] Univ Otago Christchurch, Dept Radiol, Christchurch, New Zealand.
RP Fee, CJ (reprint author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.
EM conan.fee@canterbury.ac.nz
RI Dimartino, Simone/I-3392-2012
OI Dimartino, Simone/0000-0002-9695-1278
FU University of Canterbury
FX N. Chandrasekaran is grateful to the University of Canterbury for a UC
   Doctoral Scholarship.
CR Anand G, 2010, LANGMUIR, V27, P1830
   ARWIN H, 1990, LANGMUIR, V6, P1551, DOI 10.1021/la00100a005
   Bandara N, 2013, J ADHES SCI TECHNOL, V18-19, P2139
   Baty AM, 1997, LANGMUIR, V13, P5702, DOI 10.1021/la9610720
   BENEDICT CV, 1989, ACS SYM SER, V385, P465, DOI 10.1021/bk-1989-0385.ch033
   BI RC, 1984, BIOPOLYMERS, V23, P391, DOI DOI 10.1002/BIP.360230302
   Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v
   Chandrasekaran N, 2012, P CHEM C WELL NZ, P23
   Chandrasekaran N, 2013, CHEM ENG RES DES, V91, P1674, DOI 10.1016/j.cherd.2013.07.017
   Creton C, 2003, MRS BULL, V28, P419, DOI 10.1557/mrs2003.121
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Dimartino S, 2013, BIOL BIOMIMETIC ADHE, P117
   Fant C, 2000, BIOFOULING, V16, P119, DOI 10.1080/08927010009378437
   Fant C, 2010, J ADHESION, V86, P25, DOI 10.1080/00218460903417768
   Flammang P, 2006, BIOLOGICAL ADHESIVES, P183, DOI 10.1007/978-3-540-31049-5_10
   Gao ZH, 2007, APPL SPECTROSC, V61, P55, DOI 10.1366/000370207779701398
   GIESEG SP, 1993, BIOCHEMISTRY-US, V32, P4780, DOI 10.1021/bi00069a012
   Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Irwin EF, 2005, LANGMUIR, V21, P5529, DOI 10.1021/la0470737
   ITO S, 1984, BIOCHEM J, V222, P407, DOI 10.1042/bj2220407
   Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019
   Lee BP, 2006, BIOLOGICAL ADHESIVES, P257, DOI 10.1007/978-3-540-31049-5_13
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Malmstrom J, 2007, LANGMUIR, V23, P9760, DOI 10.1021/la701233y
   MARUMO K, 1986, BIOCHIM BIOPHYS ACTA, V872, P98, DOI 10.1016/0167-4838(86)90152-4
   Monahan J, 2003, CHEM COMMUN, P1672, DOI 10.1039/b301052j
   OLIVIERI MP, 1992, BIOMATERIALS, V13, P1000, DOI 10.1016/0142-9612(92)90150-M
   Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h
   Rischka K, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P201, DOI 10.1007/978-3-7091-0286-2_13
   Sauerbrey G., 1959, J PHYS, V155, p206~222
   Schreiber L, 2005, PLANTA, V220, P520, DOI 10.1007/s00425-004-1364-9
   Sever MJ, 2004, ANGEW CHEM, V116, P454
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Stengel G, 2005, ANAL CHEM, V77, P3709, DOI 10.1021/ac048302x
   Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256
   Voigt D, 2008, J EXP BIOL, V211, P2647, DOI 10.1242/jeb.019273
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1984, ANAL CHEM, V56, P1935, DOI 10.1021/ac00275a040
   Wilke P, 2012, ACS MACRO LETT, V1, P871, DOI 10.1021/mz300258m
NR 43
TC 2
Z9 2
U1 2
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD AUG
PY 2015
VL 21
IS 8
BP 630
EP 635
DI 10.1002/psc.2776
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA CN4AD
UT WOS:000358369300002
PM 25854691
DA 2018-10-20
ER

PT J
AU Magazzu, A
   Spadaro, D
   Donato, MG
   Sayed, R
   Messina, E
   D'Andrea, C
   Foti, A
   Fazio, B
   Iati, MA
   Irrera, A
   Saija, R
   Gucciardi, PG
   Marago, OM
AF Magazzu, A.
   Spadaro, D.
   Donato, M. G.
   Sayed, R.
   Messina, E.
   D'Andrea, C.
   Foti, A.
   Fazio, B.
   Iati, M. A.
   Irrera, A.
   Saija, R.
   Gucciardi, P. G.
   Marago, O. M.
TI Optical tweezers: a non-destructive tool for soft and biomaterial
   investigations
SO RENDICONTI LINCEI-SCIENZE FISICHE E NATURALI
LA English
DT Article
DE Optical trapping; Optofluidics; Nanospectroscopy; Biosensors
ID ULTRA-SENSITIVE SPECTROSCOPY; SINGLE-PARTICLE DYNAMICS; CYLINDRICAL
   VECTOR BEAMS; T-MATRIX FORMALISM; RED-BLOOD-CELLS; NONSPHERICAL
   PARTICLES; RAMAN-SPECTROSCOPY; GOLD NANOPARTICLES; BIOLOGICAL
   APPLICATIONS; SILVER NANOPARTICLES
AB Optical tweezers are a key technique for trapping and contactless manipulation of particles at the micro- and nanoscale that can exert and sense forces from hundreds of piconewton down to few femtonewton. In their simplest implementation, they are based on a single laser beam tightly focused to a high-intensity diffraction-limited spot. Here, after reviewing the general theoretical background on optical forces, we focus on their calibration and show a comparison between frequency and time domain methods. Then, we show novel measurements and calculations of optical forces on gold nanoparticles discussing their size scaling behavior. Finally, we describe recent applications of chiral optical trapping to soft materials, and integration of optical tweezers with Raman spectroscopy for ultra-sensitive spectroscopy of biomolecules in liquids.
C1 [Magazzu, A.; Spadaro, D.; Donato, M. G.; Sayed, R.; Messina, E.; D'Andrea, C.; Foti, A.; Fazio, B.; Iati, M. A.; Irrera, A.; Gucciardi, P. G.; Marago, O. M.] CNR, IPCF Ist Proc Chim Fis, I-98158 Messina, Italy.
   [Magazzu, A.; Foti, A.; Saija, R.] Univ Messina, Dipartimento Fis & Sci Terra, I-98166 Messina, Italy.
RP Marago, OM (reprint author), CNR, IPCF Ist Proc Chim Fis, Vle F Stagno DAlcontres 37, I-98158 Messina, Italy.
EM marago@me.cnr.it
RI Donato, Maria/A-9645-2018; Gucciardi, Pietro Giuseppe/B-8188-2014;
   Magazzo, Alessandro/J-2476-2016; Marago, Onofrio/J-9827-2016; Irrera,
   Alessia/O-2387-2015; D'Andrea, Cristiano/Q-1095-2018; Fazio,
   Barbara/O-2841-2015
OI Donato, Maria/0000-0002-7580-3137; Gucciardi, Pietro
   Giuseppe/0000-0003-1826-9174; Magazzo, Alessandro/0000-0003-1247-2702;
   Marago, Onofrio/0000-0002-7220-8527; Irrera,
   Alessia/0000-0002-3057-1328; D'Andrea, Cristiano/0000-0001-5807-3067;
   Fazio, Barbara/0000-0002-1947-1123; IATI', MARIA
   ANTONIA/0000-0002-3576-8656; IATI', MARIA ANTONIA/0000-0003-0467-8049
FU Programma Operativo Nazionale Ricerca e Competitivita; Project PANREX
   [PON01_01322]; Project SOCIAL-NANO [PAC02L3_00087]; MPNS COST Action
   "Advances in Optofluidics: Integration of Optical Control and Photonics
   with Microfluidics'' [1205]
FX We acknowledge support from "Programma Operativo Nazionale Ricerca e
   Competitivita'' 2007-2013, Project PON01_01322 PANREX, Project
   PAC02L3_00087 SOCIAL-NANO, and the MPNS COST Action 1205 "Advances in
   Optofluidics: Integration of Optical Control and Photonics with
   Microfluidics''.
CR Ajito K, 2002, LAB CHIP, V2, P11, DOI 10.1039/b108744b
   Albaladejo S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.113602
   ASHKIN A, 1992, BIOPHYS J, V61, P569, DOI 10.1016/S0006-3495(92)81860-X
   ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156
   BarZiv R, 1997, PHYS REV LETT, V78, P154, DOI 10.1103/PhysRevLett.78.154
   Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654
   Borghese F, 2007, PHYS EARTH SPACE ENV, P1, DOI 10.1007/978-3-540-37414-5
   Borghese F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.163903
   Borghese F, 2007, OPT EXPRESS, V15, P11984, DOI 10.1364/OE.15.011984
   Borghese F, 2006, OPT EXPRESS, V14, P9508, DOI 10.1364/OE.14.009508
   Bosanac L, 2008, NANO LETT, V8, P1486, DOI 10.1021/nl080490+
   Buosciolo A, 2004, OPT COMMUN, V230, P357, DOI 10.1016/j.optcom.2003.11.062
   Callegari A, 2014, ARXIV14025439
   Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761
   Chaumet PC, 2000, OPT LETT, V25, P1065, DOI 10.1364/OL.25.001065
   Cipparrone G, 2011, ADV MATER, V23, P5773, DOI 10.1002/adma.201102828
   Coffey WT, 2004, LANGEVIN EQUATION
   Cojoc D, 2005, P SOC PHOTO-OPT INS, V5930, P59300
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   De Luca AC, 2007, HAEMATOL-HEMATOL J, V92, P174
   De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943
   Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301
   Dholakia K, 2011, NAT PHOTONICS, V5, P335, DOI [10.1038/nphoton.2011.80, 10.1038/NPHOTON.2011.80]
   Dienerowitz M, 2008, OPT EXPRESS, V16, P4991, DOI 10.1364/OE.16.004991
   Donato MG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4656
   Donato MG, 2012, OPT LETT, V37, P3381, DOI 10.1364/OL.37.003381
   DRAINE BT, 1988, ASTROPHYS J, V333, P848, DOI 10.1086/166795
   Fazal FM, 2011, NAT PHOTONICS, V5, P318, DOI 10.1038/nphoton.2011.100
   Florin EL, 1997, J STRUCT BIOL, V119, P202, DOI 10.1006/jsbi.1997.3880
   Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566
   Friese MEJ, 1996, PHYS REV A, V54, P1593, DOI 10.1103/PhysRevA.54.1593
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   GHISLAIN LP, 1993, OPT LETT, V18, P1678, DOI 10.1364/OL.18.001678
   GORDON JP, 1973, PHYS REV A, V8, P14, DOI 10.1103/PhysRevA.8.14
   Hamden KE, 2005, J VIROL METHODS, V129, P145, DOI 10.1016/j.jviromet.2005.05.018
   Hansen PM, 2005, NANO LETT, V5, P1937, DOI 10.1021/nl051289r
   Henderson S, 2001, COLLOID SURFACE A, V190, P81, DOI 10.1016/S0927-7757(01)00667-7
   Hernandez RJ, 2013, LAB CHIP, V13, P459, DOI 10.1039/c2lc40703e
   Irrera A, 2011, NANO LETT, V11, P4879, DOI 10.1021/nl202733j
   Jones PH, 2007, J OPT A-PURE APPL OP, V9, pS278, DOI 10.1088/1464-4258/9/8/S23
   Jones PH, 2009, ACS NANO, V3, P3077, DOI 10.1021/nn900818n
   Jones PH, 2015, OPTICAL TWEEZERS
   Kyrsting A, 2011, NANO LETT, V11, P888, DOI 10.1021/nl104280c
   Lankers M, 1997, CHEM PHYS LETT, V277, P331, DOI 10.1016/S0009-2614(97)00894-4
   Maier S A, 2007, PLASMONICS FUNDAMENT
   Marago OM, 2008, NANO LETT, V8, P3211, DOI 10.1021/nl8015413
   Marago OM, 2010, NANOSCI TECHNOL, P23, DOI 10.1007/978-3-642-03535-7_2
   Marago OM, 2013, NAT NANOTECHNOL, V8, P807, DOI [10.1038/NNANO.2013.208, 10.1038/nnano.2013.208]
   Marago OM, 2010, ACS NANO, V4, P7515, DOI 10.1021/nn1018126
   Marques MI, 2014, OPT LETT, V39, P5122, DOI 10.1364/OL.39.005122
   Messina E, 2012, J QUANT SPECTROSC RA, V113, P220, DOI 10.1016/j.jqsrt.2012.06.023
   Messina E, 2011, J PHYS CHEM C, V115, P5115, DOI 10.1021/jp109405j
   Messina E, 2011, ACS NANO, V5, P905, DOI 10.1021/nn102101a
   Mishchenko MI, 2001, J QUANT SPECTROSC RA, V70, P811, DOI 10.1016/S0022-4073(01)00047-4
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Nieminen TA, 2001, J QUANT SPECTROSC RA, V70, P627, DOI 10.1016/S0022-4073(01)00034-6
   Nieminen TA, 2014, J QUANT SPECTROSC RA, V146, P59, DOI 10.1016/j.jqsrt.2014.04.003
   Nieminen TA, 2011, J MOD OPTIC, V58, P528, DOI 10.1080/09500340.2010.528565
   Ohlinger A, 2011, NANO LETT, V11, P1770, DOI 10.1021/nl2003544
   Olof SN, 2012, NANO LETT, V12, P6018, DOI 10.1021/nl303585w
   Padgett M, 2011, NAT PHOTONICS, V5, P343, DOI [10.1038/NPHOTON.2011.81, 10.1038/nphoton.2011.81]
   Palima D, 2013, LASER PHOTONICS REV, V7, P478, DOI 10.1002/lpor.201200030
   Pesce G, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/38002
   Petrov DV, 2007, J OPT A-PURE APPL OP, V9, pS139, DOI 10.1088/1464-4258/9/8/S06
   Phillips DB, 2014, NAT PHOTONICS, V8, P400, DOI 10.1038/nphoton.2014.74
   Phillips DB, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285503
   Ploschner M, 2012, NANO LETT, V12, P1923, DOI 10.1021/nl204378r
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Prikulis J, 2004, NANO LETT, V4, P115, DOI 10.1021/nl0349606
   Rao S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431628
   Reece PJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3225148
   Saija R, 2005, J QUANT SPECTROSC RA, V94, P163, DOI 10.1016/j.jqsrt.2004.09.006
   Saija R, 2009, OPT EXPRESS, V17, P10231, DOI 10.1364/OE.17.010231
   Seol Y, 2006, OPT LETT, V31, P2429, DOI 10.1364/OL.31.002429
   Simpson SH, 2014, J QUANT SPECTROSC RA, V146, P81, DOI 10.1016/j.jqsrt.2014.04.012
   Simpson SH, 2007, J OPT SOC AM A, V24, P430, DOI 10.1364/JOSAA.24.000430
   Skelton SE, 2013, OPT LETT, V38, P28, DOI 10.1364/OL.38.000028
   Skelton SE, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/7/075706
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930
   Swartzlander GA, 2011, NAT PHOTONICS, V5, P48, DOI [10.1038/nphoton.2010.266, 10.1038/NPHOTON.2010.266]
   Tan SD, 2004, NANO LETT, V4, P1415, DOI 10.1021/nl049347g
   Tkachenko G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4577
   Wang F, 2013, NANO LETT, V13, P1185, DOI 10.1021/nl304607v
   Wang F, 2011, NANO LETT, V11, P4149, DOI 10.1021/nl2020262
   Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607
   Wood BR, 2001, BBA-MOL CELL RES, V1539, P58, DOI 10.1016/S0167-4889(01)00089-1
   Xie CG, 2002, OPT LETT, V27, P249, DOI 10.1364/OL.27.000249
NR 91
TC 2
Z9 2
U1 5
U2 43
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 2037-4631
EI 1720-0776
J9 REND LINCEI-SCI FIS
JI Rend. Lincei.-Sci. Fis. Nat.
PD AUG
PY 2015
VL 26
SU 2
BP 203
EP 218
DI 10.1007/s12210-015-0395-4
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN3QQ
UT WOS:000358341800008
DA 2018-10-20
ER

PT J
AU de Olyveira, GM
   dos Santos, ML
   Riccardi, CD
   Costa, LMM
   Daltro, PB
   Basmaji, P
   Daltro, GD
   Guastaldi, AC
AF de Olyveira, Gabriel Molina
   dos Santos, Marcio Luiz
   Riccardi, Carla dos Santos
   Manzine Costa, Ligia Maria
   Daltro, Paula Braga
   Basmaji, Pierre
   Daltro, Gildasio de Cerqueira
   Guastaldi, Antonio Carlos
TI Physically Modified Bacterial Cellulose Biocomposites for Guided Tissue
   Regeneration
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Bacterial Cellulose; Nanoskin (R); Nanocomposites; Scaffolds; Dental
   Materials
ID SURFACE MODIFICATION; BIOMEDICAL APPLICATIONS; NANOCOMPOSITES;
   BIOMATERIALS; POLYMERS; COLLAGEN; PLASMA
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process was modified by the addition of chondroitin sulfate to the culture medium before the bacteria was inoculated. Besides, the potential of gamma irradiation treatment for the modification of the BC surface properties, in enhancing its potential for biomedical applications, was also analyzed. For guided tissue regeneration purposes, biomimetic precipitation of calcium phosphate of biological interest from simulated body fluid on bacterial cellulose was studied. The influence of chondroitin sulfate on bacterial cellulose was analyzed by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM) and thermogravimetric analysis (TGA), as well as after CaP coatings produced by a biomimetic route. FTIR analysis showed interaction between bacterial cellulose nanobiocomposites and calcium phosphate. XRD demonstrated formation of amorphous calcium phosphate and sodium chloride on bacterial cellulose nanobiocomposites. SEM images proved faster calcium phosphate deposition in non-irradiated samples. The different samples showed significant variation in thermal properties.
C1 [de Olyveira, Gabriel Molina; dos Santos, Marcio Luiz; Riccardi, Carla dos Santos; Daltro, Paula Braga; Guastaldi, Antonio Carlos] UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
   [Manzine Costa, Ligia Maria] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09210170 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex COM HUPES, BR-40110910 Salvador, BA, Brazil.
RP de Olyveira, GM (reprint author), UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
EM gabriel.ufabc@gmail.com
RI dos Santos, Marcio/D-9905-2014; Guastaldi, Antonio/O-7379-2014; Manzine
   Costa, Ligia Maria/N-1780-2015
OI dos Santos, Marcio/0000-0002-3385-7516; Guastaldi,
   Antonio/0000-0002-6433-3555; Manzine Costa, Ligia
   Maria/0000-0001-6483-7633
CR Alvarez VA, 2006, POLYM DEGRAD STABIL, V91, P3156, DOI 10.1016/j.polymdegradstab.2006.07.011
   Aoki H., 1999, SCI MED APPL HYDROXY
   Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0
   Basmaji P, 2014, J BIOMATER TISS ENG, V4, P59, DOI 10.1166/jbt.2014.1133
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chan C. M, 1994, POLYM SURFACE MODIFI
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   Deepa B, 2011, BIORESOURCE TECHNOL, V102, P1988, DOI 10.1016/j.biortech.2010.09.030
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Filho L. X., 2013, J NANOSCI NANOTECHNO, V13, P1
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gois P. B. P., 2013, INT REV BIOPHYSICAL, V3, P48
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Kaczmarek H, 2002, SURF SCI, V507, P883, DOI 10.1016/S0039-6028(02)01367-5
   Kondo T., 1998, POLYSACCHARIDES STRU, P131
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Manfredi B.L., 2006, POLYM DEGRAD STABIL, V91, P255
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Olyveira G., 2014, SCI ADV MATER, V6, P1
   Olyveira G. M., 2011, J NANOTECH ENG MED, V2, P34001
   Olyveira G. M., 2014, J BIOMATER TISS ENG, V4, P1
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P665, DOI 10.1166/jbt.2013.1127
   Ouajai S., 2006, POLYM DEGRAD STABIL, V13, P131
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Salmen L., 2005, POLYSACCHARIDES STRU, P159
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   SINACORE MS, 1989, BIO-TECHNOL, V7, P1275
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun Y, 2008, BIORESOURCES, V3, P297
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Willians D. F., 1991, CONCISE ENCY MED DEN
   Willians D. F., 1981, BIOCOMPATIBILITY CLI
   Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P117, DOI 10.2174/1574888X08666131124135654
NR 43
TC 2
Z9 2
U1 5
U2 44
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD AUG
PY 2015
VL 7
IS 8
BP 1657
EP 1664
DI 10.1166/sam.2015.2283
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA CN2RK
UT WOS:000358269400034
DA 2018-10-20
ER

PT J
AU Gaston, J
   Bartlett, S
   Klemuk, SA
   Thibeault, SL
AF Gaston, J.
   Bartlett, S.
   Klemuk, S. A.
   Thibeault, S. L.
TI Formulation and characterization of a porous, elastomeric biomaterial
   for vocal fold tissue engineering research (vol 123, pg 866, 2014)
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Correction
CR Gaston J, 2014, ANN OTO RHINOL LARYN, V123, P866, DOI 10.1177/0003489414539131
NR 1
TC 0
Z9 0
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD AUG
PY 2015
VL 124
IS 8
BP 675
EP 675
DI 10.1177/0003489415593945
PG 1
WC Otorhinolaryngology
SC Otorhinolaryngology
GA CM8NG
UT WOS:000357957900014
OA Bronze
DA 2018-10-20
ER

PT J
AU Sravanthi, V
   Pallavi, MCP
   Bonam, SR
   Sathyabama, S
   Kumar, HMS
AF Sravanthi, Vemireddy
   Pallavi, M. C. Preethi
   Bonam, Srinivasa Reddy
   Sathyabama, Sathyaseelan
   Kumar, Halmuthur M. Sampath
TI Oleic acid nanoemulsion for nasal vaccination: Impact on adjuvanticity
   based immune response
SO JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Oleic acid nanoemulsion; Nasal vaccination; Antibody class switch;
   Dendritic cell activation
ID PROTECTIVE IMMUNITY; CELLS; VACCINES; ANTIGEN; GENERATION;
   IMMUNOGENICITY; FORMULATIONS; ANTIBODIES; MECHANISM; ROUTE
AB Subunit vaccine formulations with enhanced potency are vital to improve immune response against weak antigens and also promote dose sparing of adjuvant and antigens that may cause undesirable side effects. Recently particulate delivery systems are under exploration to enhance antigen specific immunity. Oleic acid a potential biomaterial in terms of penetration is used for formulating nanoemulsion for nasal vaccination. In this study influence of oleic acid nanoemulsion on antigen uptake and role in dendritic cells activation is studied. Formulation conditions were optimized to produce a stable nanoemulsion at lowest surfactant concentration (2%). Penetration enhancement of oleic acid nanoemulsion was evaluated using cell uptake study by Fluorescein isothiocyanate conjugated OVA on A549 cell line. Here, we report strong class switched, high avidity humoral and cellular (cytokine) immune response elicited by vaccine delivery system with antigen and adjuvant. Flowcytometry analysis showed enhanced expression of activated dendritic cells on 45th day compared to soluble antigen. These data suggest that oleic acid formulation enhances penetration, sustain release of antigen and stimulates both cellular and humoral immune response. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Sravanthi, Vemireddy; Pallavi, M. C. Preethi; Bonam, Srinivasa Reddy; Sathyabama, Sathyaseelan; Kumar, Halmuthur M. Sampath] CSIR Indian Inst Chem Technol, NPC Div, Vaccine Immunol Lab, Hyderabad 500007, Andhra Pradesh, India.
RP Kumar, HMS (reprint author), CSIR Indian Inst Chem Technol, NPC Div, Vaccine Immunol Lab, Hyderabad 500007, Andhra Pradesh, India.
EM sampath@iict.res.in
RI BONAM, SRINIVASA REDDY/I-1342-2016
OI BONAM, SRINIVASA REDDY/0000-0002-2888-2418
FU CSIR-New Delhi [CSC0205]
FX Authors thank CSIR-New Delhi for the support under the 12th FYP supra
   institutional project DENOVA (CSC0205).
CR Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912
   Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020
   Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466
   Bernardi DS, 2011, J NANOBIOTECHNOL, V9, P1
   Borrebaeck C.A., 2002, J IMMUNOL, V168, P3165
   Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399
   Copland MJ, 2005, IMMUNOL CELL BIOL, V83, P97, DOI 10.1111/j.1440-1711.2005.01315.x
   Eck SC, 1999, CANCER IMMUNOL IMMUN, V48, P336, DOI 10.1007/s002620050583
   Ejima D, 2005, ANAL BIOCHEM, V345, P250, DOI 10.1016/j.ab.2005.07.004
   Fox CB, 2012, CLIN VACCINE IMMUNOL, V19, P1633, DOI 10.1128/CVI.00235-12
   Gonipeta B., 2013, ISRN ALLERGY, V20, P1
   GRANFORS K, 1979, J CLIN MICROBIOL, V9, P336
   Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111
   Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057
   Jain J, 2010, AAPS PHARMSCITECH, V11, P826, DOI 10.1208/s12249-010-9440-x
   Kaser M. R., 2013, MAKING USE ANTIBODIE
   Kim YU, 2013, ANTIBODIES, V2, P554, DOI 10.3390/antib2040554
   Kobayashi S, 1996, EUR J PHARM SCI, V4, P267, DOI 10.1016/0928-0987(96)00169-8
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Patil HP, 2014, J CONTROL RELEASE, V174, P51, DOI 10.1016/j.jconrel.2013.11.013
   Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485
   Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729
   Slutter B, 2010, J CONTROL RELEASE, V148, P117, DOI 10.1016/j.jconrel.2010.06.009
   Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531
   WANG LY, 1994, PHARMACEUT RES, V11, P513, DOI 10.1023/A:1018906330308
   Welch RJ, 2010, J CLIN LAB ANAL, V24, P160, DOI 10.1002/jcla.20382
   Wilson NS, 2012, IMMUNOL CELL BIOL, V90, P540, DOI 10.1038/icb.2011.71
NR 27
TC 2
Z9 2
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1773-2247
J9 J DRUG DELIV SCI TEC
JI J. Drug Deliv. Sci. Technol.
PD AUG
PY 2015
VL 28
BP 56
EP 63
DI 10.1016/j.jddst.2015.05.007
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CM4AR
UT WOS:000357627100008
DA 2018-10-20
ER

PT J
AU Zhang, S
   Cheng, X
   Yao, Y
   Wei, YH
   Han, CJ
   Shi, YS
   Wei, QS
   Zhang, Z
AF Zhang, Sheng
   Cheng, Xian
   Yao, Yao
   Wei, Yehui
   Han, Changjun
   Shi, Yusheng
   Wei, Qingsong
   Zhang, Zhen
TI Porous niobium coatings fabricated with selective laser melting on
   titanium substrates: Preparation, characterization, and cell behavior
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Niobium; Titanium; Selective laser melting; Coatings; Biocompatibility
ID ORTHOPEDIC APPLICATIONS; MECHANICAL-PROPERTIES; SURFACE; BONE; IMPLANTS;
   METALS; ALLOY; BIOACTIVITY; SCAFFOLDS; ADHESION
AB Nb, an expensive and refractory element with good wear resistance and biocompatibility, is gaining more attention as a new metallic biomaterial. However, the high price of the raw material, as well as the high manufacturing costs because of Nb's strong oxygen affinity and high melting point have limited the widespread use of Nb and its compounds. To overcome these disadvantages, porous Nb coatings of various thicknesses were fabricated on Ti substrate via selective laser melting (SLM), which is a 3D printing technique that uses computer-controlled high-power laser to melt the metal. The morphology and microstructure of the porous Nb coatings, which had pores ranging from 15 to 50 pm in size, were characterized with scanning electron microscopy (SEM). The average hardness of the coating, which was measured with the linear intercept method, was 392 +/- 37 HV. In vitro tests of the porous Nb coating which was monitored with SEM, immunofluorescence, and CCK-8 counts of cells, exhibited excellent cell morphology, attachment, and growth. The simulated body fluid test also proved the bioactivity of the Nb coating. Therefore, these new porous Nb coatings could potentially be used for enhanced early biological fixation to bone tissue. In addition, this study has shown that SLM technique could be used to fabricate coatings with individually tailored shapes and/or porosities from group IVB and VB biomedical metals and their alloys on stainless steel, Co-Cr, and other traditional biomedical materials without wasting raw materials. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhang, Sheng] Beijing Aeronaut Mfg Technol Res Inst, Sci & Technol Power Beam Proc Lab, Beijing 100024, Peoples R China.
   [Zhang, Sheng; Han, Changjun; Shi, Yusheng; Wei, Qingsong; Zhang, Zhen] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
   [Cheng, Xian; Yao, Yao; Wei, Yehui; Zhang, Zhen] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Stomatol, Wuhan 430022, Peoples R China.
RP Wei, QS (reprint author), Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
EM wqs_xn@163.com; zhangzhentitanium@163.com
FU National Key Technology R&D Program of Ministry of Science and
   Technology of China [2012BAF08B03]; National Natural Science Foundation
   of China [81300920, 51375189]
FX This work has been supported by the National Key Technology R&D Program
   of Ministry of Science and Technology of China (Grant No. 2012BAF08B03),
   the National Natural Science Foundation of China (No. 81300920) and the
   National Natural Science Foundation of China (Grant No. 51375189).
CR Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Davenport R. W., 1993, SENSORY ROLE NEURONA
   Eremeev SV, 2008, PHYS SOLID STATE+, V50, P543, DOI 10.1134/S1063783408030256
   Fox P, 2008, SURF COAT TECH, V202, P5001, DOI 10.1016/j.surfcoat.2008.05.003
   Gristina R, 2009, J BIOMED MATER RES B, V88B, P139, DOI 10.1002/jbm.b.31160
   Hoshikawa Y, 2008, KEY ENG MATER, V361-363, P693, DOI 10.4028/www.scientific.net/KEM.361-363.693
   Jang JS, 2000, J MATER SCI, V35, P2297, DOI 10.1023/A:1004791313979
   Jevremovic D, 2012, METALURGIJA, V51, P171
   Johansson CB, 1991, CLIN ORAL IMPLAN RES, V2, P24, DOI 10.1034/j.1600-0501.1991.020103.x
   Kamber BS, 2003, PRECAMBRIAN RES, V126, P289, DOI 10.1016/S0301-9268(03)00100-1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kruth JP, 2004, J MATER PROCESS TECH, V149, P616, DOI 10.1016/j.jmatprotec.2003.11.051
   Lei SY, 2014, RAPID PROTOTYPING J, V20, P390, DOI 10.1108/RPJ-10-2012-0095
   Lindner M, 2011, J BIOMED MATER RES A, V97A, P466, DOI 10.1002/jbm.a.33058
   Medellin-Castillo H. I., 2009, ASME 2009 INT MECH E, P609
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mumtaz KA, 2007, J MATER SCI, V42, P7647, DOI 10.1007/s10853-007-1661-3
   Pauline SA, 2014, MAT SCI ENG C-MATER, V36, P194, DOI 10.1016/j.msec.2013.12.016
   Podrezov YN, 2009, POWDER METALL MET C+, V48, P201, DOI 10.1007/s11106-009-9111-1
   Qin LG, 2014, J MATER SCI, V49, P2662, DOI 10.1007/s10853-013-7972-7
   Ramirez G, 2011, APPL SURF SCI, V257, P2555, DOI 10.1016/j.apsusc.2010.10.021
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Seifert HJ, 1996, J PHASE EQUILIB, V17, P24, DOI 10.1007/BF02648366
   Sun J., 2012, ADV MECH ENG, V2012
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   van Elsen M, 2008, RAPID PROTOTYPING J, V14, P15, DOI 10.1108/13552540810841526
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   Wang XJ, 2008, ACTA BIOMATER, V4, P1530, DOI 10.1016/j.actbio.2008.04.005
   Yasa E, 2011, PROCEDIA ENGINEER, V19, DOI 10.1016/j.proeng.2011.11.130
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
NR 35
TC 8
Z9 9
U1 3
U2 108
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2015
VL 53
BP 50
EP 59
DI 10.1016/j.msec.2015.04.005
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CN0HB
UT WOS:000358093600009
PM 26042690
DA 2018-10-20
ER

PT J
AU Borkowski, L
   Pawlowska, M
   Radzki, RP
   Bienko, M
   Polkowska, I
   Belcarz, A
   Karpinski, M
   Slowik, T
   Matuszewski, L
   Slosarczyk, A
   Ginalska, G
AF Borkowski, Leszek
   Pawlowska, Marta
   Radzki, Radoslaw P.
   Bienko, Marek
   Polkowska, Izabela
   Belcarz, Anna
   Karpinski, Miroslaw
   Slowik, Tymoteusz
   Matuszewski, Lukasz
   Slosarczyk, Anna
   Ginalska, Grazyna
TI Effect of a carbonated HAP/beta-glucan composite bone substitute on
   healing of drilled bone voids in the proximal tibial metaphysis of
   rabbits
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bone; Composite; Implantation; Rabbit; Osseointegration; Mineralization
ID HYDROXYAPATITE-FIBRIN IMPLANTS; IN-SITU; TISSUE; PHOSPHATE; BIOACTIVITY;
   COLLAGEN; REPAIR; BIOMATERIALS; DEFECTS; CELLS
AB A novel elastic hydroxyapatite-based composite of high surgical handiness has been developed. Its potential application in orthopedics as a filler of bone defects has been studied. The biomaterial was composed of carbonated hydroxyapatite (CHAP) granules and polysaccharide polymer (beta-1,3-glucan). Cylinders of 4 mm in diameter and 6 mm in length were implanted into bone cavities created in the proximal metaphysis of tibiae of 24 New Zealand white rabbits. 18 sham-operated animals were used as controls. After 1, 3 or 6 months, the rabbits were euthanized, the bones were harvested and subjected to analysis. Radiological images and histological sections revealed integration of implants with bone tissue with no signs of graft rejection. Peripheral quantitative computed tomography (pQCT) indicated the stimulating effect of the biomaterial on bone formation and mineralization. Densitometry (DXA) analysis suggested that biomineralization of bones was preceded by bioresorption and gradual disappearance of porous ceramic granules. The findings suggest that the CHAP-glucan composite material enables regeneration of bone tissue and could serve as a bone defect filler. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Borkowski, Leszek; Belcarz, Anna; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, PL-20093 Lublin, Poland.
   [Pawlowska, Marta; Radzki, Radoslaw P.; Bienko, Marek] Univ Life Sci Lublin, Dept Anim Physiol, PL-20033 Lublin, Poland.
   [Polkowska, Izabela] Univ Life Sci Lublin, Dept & Clin Anim Surg, PL-20612 Lublin, Poland.
   [Karpinski, Miroslaw] Univ Life Sci Lublin, Dept Compan & Wildlife Anim, PL-20950 Lublin, Poland.
   [Slowik, Tymoteusz] Lublin Small Anim Med Ctr, Independent Radiol Unit, PL-20151 Lublin, Poland.
   [Matuszewski, Lukasz] Med Univ Lublin, Childrens Orthopaed Clin, PL-20093 Lublin, Poland.
   [Matuszewski, Lukasz] Med Univ Lublin, Rehabil Dept, PL-20093 Lublin, Poland.
   [Slosarczyk, Anna] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Borkowski, L (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1, PL-20093 Lublin, Poland.
EM leszek.borkowski@umlub.pl
RI Bienko, Marek/V-7116-2017
OI Bienko, Marek/0000-0002-9706-6676; Radzki, Radoslaw/0000-0002-5439-2420;
   Belcarz, Anna/0000-0001-9899-5314; Ginalska, Grazyna/0000-0002-9961-4226
FU European Regional Development Fund within the Innovative Economy
   Operational Program [UDA-POIG 01.03.01-00-005/09-01]; Medical University
   in Lublin [DS2/12]; National Science Centre [5824/B/P01/2011/40]
FX The authors would like to acknowledge that the financial assistance for
   this research was provided by the European Regional Development Fund
   within the Innovative Economy Operational Program, grant no. UDA-POIG
   01.03.01-00-005/09-01, the DS2/12 of Medical University in Lublin, and
   by the National Science Centre grant no. 5824/B/P01/2011/40. The
   experiments were conducted using the equipment purchased within the
   agreement no. POWP.01.03.00-06-010/09-00 Operational Program Development
   of Eastern Poland 2007-2013. The authors would especially like to
   express their gratitude to Mgr Tomasz Piersiak for his assistance in
   histological preparations.
CR Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Belcarz A, 2010, European Patent, Patent No. [EP 107266397, 107266397]
   Belcarz A., 2005, ENG BIOMATER, V9, P34
   Belcarz A, 2013, INT J PHARMACEUT, V454, P285, DOI 10.1016/j.ijpharm.2013.06.076
   Belcarz A, 2013, CENT EUR J BIOL, V8, P534, DOI 10.2478/s11535-013-0169-2
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Bonucci E, 1997, EUR J ORAL SCI, V105, P557, DOI 10.1111/j.1600-0722.1997.tb00217.x
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002
   Goto T, 2001, J Orthop Sci, V6, P444, DOI 10.1007/s007760170013
   Guo YP, 2012, MICROPOR MESOPOR MAT, V155, P245, DOI 10.1016/j.micromeso.2012.01.037
   Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460
   Hong ZK, 2007, J BIOMED MATER RES A, V81A, P515, DOI 10.1002/jbm.a.31038
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Iooss P, 2001, BIOMATERIALS, V22, P2785, DOI 10.1016/S0142-9612(01)00022-9
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Li B, 2012, MAT SCI ENG C-MATER, V32, P929, DOI 10.1016/j.msec.2012.02.014
   Li QL, 2008, J BIOACT COMPAT POL, V23, P520, DOI 10.1177/0883911508097370
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017
   MARINI E, 1994, CELL MATER, V4, P231
   Meskinfam M, 2011, J BIOMED NANOTECHNOL, V7, P455, DOI 10.1166/jbn.2011.1306
   Neumann M, 2006, EUR J TRAUMA, V32, P125, DOI DOI 10.1007/S00068-006-6044-Y
   Paszkiewicz Z., 2011, European Patent, Patent No. [EP 2338531, 2338531]
   Pieters IY, 2010, ACTA BIOMATER, V6, P1561, DOI 10.1016/j.actbio.2009.11.002
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P483, DOI 10.1016/j.ijbiomac.2010.07.002
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   Trotter JF, 2003, J BONE JOINT SURG AM, V85A, P2215, DOI 10.2106/00004623-200311000-00026
   Ueda H, 2002, BIOMATERIALS, V23, P1003, DOI 10.1016/S0142-9612(01)00211-3
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
   Yaylao lu M.B., 1999, BIOMATERIALS, V20, P711
   Yoshida A, 2006, J BIOMATER APPL, V21, P179, DOI 10.1177/0885328206059796
   Zagury R, 2007, IMPLANT DENT, V16, P290, DOI 10.1097/ID.0b013e3180e9d9ed
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 49
TC 16
Z9 16
U1 2
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2015
VL 53
BP 60
EP 67
DI 10.1016/j.msec.2015.04.009
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CN0HB
UT WOS:000358093600010
PM 26042691
DA 2018-10-20
ER

PT J
AU Wright, B
   Parmar, N
   Bozec, L
   Aguayo, SD
   Day, RM
AF Wright, Bernice
   Parmar, Nina
   Bozec, Laurent
   Aguayo, Sebastian D.
   Day, Richard M.
TI A simple and robust method for pre-wetting poly (lactic-co-glycolic)
   acid microspheres
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Poly (lactic-co-glycolic) acid microspheres; thermally induced phase
   separation; thermally induced phase separation microspheres; serum
   protein adsorption; human skeletal myoblasts and thermally induced phase
   separation microspheres; poly (lactic-co-glycolic) acid microsphere
   surface topography; wetting poly (lactic-co-glycolic) acid microspheres
ID HUMAN-ENDOTHELIAL CELLS; WETTABILITY GRADIENT; PROTEIN ADSORPTION;
   PLASMA TREATMENT; DRUG-DELIVERY; SURFACES; ADHESION; SCAFFOLDS;
   FISTULAS; STRESS
AB Poly (lactic-co-glycolic) acid microspheres are amenable to a number of biomedical procedures that support delivery of cells, drugs, peptides or genes. Hydrophilisation or wetting of poly (lactic-co-glycolic) acid are an important pre-requisites for attachment of cells and can be achieved via exposure to plasma oxygen or nitrogen, surface hydrolysis with NaOH or chloric acid, immersion in ethanol and water, or prolonged incubation in phosphate buffered saline or cell culture medium. The aim of this study is to develop a simple method for wetting poly (lactic-co-glycolic) acid microspheres for cell delivery applications. A one-step ethanol immersion process that involved addition of serum-supplemented medium and ethanol to PLGA microspheres over 30min-24h is described in the present study. This protocol presents a more efficient methodology than conventional two-step wetting procedures. Attachment of human skeletal myoblasts to poly (lactic-co-glycolic) acid microspheres was dependent on extent of wetting, changes in surface topography mediated by ethanol pre-wetting and serum protein adsorption. Ethanol, at 70% (v/v) and 100%, facilitated similar levels of wetting. Wetting with 35% (v/v) ethanol was only achieved after 24h. Pre-wetting (over 3h) with 70% (v/v) ethanol allowed significantly greater (p0.01) serum protein adsorption to microspheres than wetting with 35% (v/v) ethanol. On serum protein-loaded microspheres, greater numbers of myoblasts attached to constructs wetted with 70% ethanol than those partially wetted with 35% (v/v) ethanol. Microspheres treated with 70% (v/v) ethanol presented a more rugose surface than those treated with 35% (v/v) ethanol, indicating that more efficient myoblast adhesion to the former may be at least partially attributed to differences in surface structure. We conclude that our novel protocol for pre-wetting poly (lactic-co-glycolic) acid microspheres that incorporates biochemical and structural features into this biomaterial can facilitate myoblast delivery for use in clinical settings.
C1 [Wright, Bernice; Parmar, Nina; Day, Richard M.] UCL, Div Med, Appl Biomed Engn Grp, London WC1E 6BT, England.
   [Bozec, Laurent; Aguayo, Sebastian D.] UCL, UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1E 6BT, England.
RP Day, RM (reprint author), UCL, Div Med, Appl Biomed Engn Grp, London WC1E 6BT, England.
EM r.m.day@ucl.ac.uk
OI Aguayo, Sebastian/0000-0003-0900-1993
FU UK Medical Research Council [MR/L002752/1]; Sir Halley Stewart Trust;
   Department of Health's NIHR as a Comprehensive Biomedical Research
   Centre; Medical Research Council [MR/L002752/1]
FX This project was supported by grants from the UK Medical Research
   Council (MR/L002752/1) and Sir Halley Stewart Trust. The research was
   undertaken at UCL/UCLH which receives funding from the Department of
   Health's NIHR as a Comprehensive Biomedical Research Centre.
CR Ahmadi R, 2011, ACTA BIOMATER, V7, P1542, DOI 10.1016/j.actbio.2010.12.022
   BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360
   Blaker JJ, 2008, ALIMENT PHARM THER, V28, P614, DOI 10.1111/j.1365-2036.2008.03773.x
   Blaker JJ, 2008, ACTA BIOMATER, V4, P264, DOI 10.1016/j.actbio.2007.09.011
   Chang J, 2012, PHARM RES-DORDR, V29, P1495, DOI 10.1007/s11095-011-0624-1
   Esposito AR, 2013, MATER RES-IBERO-AM J, V16, P695, DOI [10.1590/S1516-14392013000400002, 10.1590/S1516-14392013005000056]
   Foong KS, 2010, TISSUE ENG PART C-ME, V16, P855, DOI [10.1089/ten.tec.2009.0599, 10.1089/ten.TEC.2009.0599]
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Luck M, 1998, J CONTROL RELEASE, V55, P107, DOI 10.1016/S0168-3659(98)00030-3
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Safinia L, 2007, MACROMOL BIOSCI, V7, P315, DOI 10.1002/mabi.200600175
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tran VT, 2012, EUR J PHARM SCI, V45, P128, DOI 10.1016/j.ejps.2011.10.030
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vasita R, 2012, INT J NANOMED, V7, P61, DOI 10.2147/IJN.S26453
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
NR 30
TC 1
Z9 2
U1 2
U2 21
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2015
VL 30
IS 2
BP 147
EP 159
DI 10.1177/0885328215577297
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CM5PH
UT WOS:000357740000002
PM 25791685
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Yang, LL
   Zhang, JM
   He, JS
   Zhang, J
   Gan, ZH
AF Yang, Lili
   Zhang, Jinming
   He, Jiasong
   Zhang, Jun
   Gan, Zhihua
TI Homogeneous synthesis of amino-reserved chitosan-graft-polycaprolactone
   in an ionic liquid and the application in cell cultivation
SO POLYMER INTERNATIONAL
LA English
DT Article
DE chitosan; polycaprolactone; aminosaccharide unit; microsphere; cell
   culture
ID EPSILON-CAPROLACTONE; ORGANIC CATALYST; IN-VITRO; TISSUE; BIOMATERIAL;
   SCAFFOLDS
AB The homogeneous preparation of amino-reserved chitosan-graft-polycaprolactone copolymer (ACS-g-PCL) was achieved in 1-butyl-3-methylimidazolium acetate via a protection - ring-opening graft polymerization - deprotection procedure. The molar substitution of PCL (MSPCL) in ACS-g-PCL copolymers was in the range 17.1 - 45.6 and could be well controlled by altering reaction conditions. The resultant ACS-g-PCL copolymers were soluble in some common organic solvents such as dimethylsulfoxide, ethanol and toluene. As the increment of MSPCL increased, the hydrophilicity of the ACS-g-PCL copolymers decreased. Eventually, ACS-g-PCL microspheres with a diameter of 100-200 mu m were fabricated by an emulsion evaporation method. Among them, the ACS-g-PCL copolymer with an MSPCL of 26.8 formed into porous microspheres. The fluorescence microscopy and cytotoxicity results suggested that all of the microspheres, especially the ACS-g-PCL microspheres with MSPCL of 17.1 and 26.8, showed high cell adhesion and cytocompatibility to the human osteosarcoma cell line (MG-63), indicating their great prospects in tissue engineering. (c) 2015 Society of Chemical Industry
C1 [Yang, Lili; Zhang, Jinming; He, Jiasong; Zhang, Jun] Chinese Acad Sci, Beijing Natl Lab Mol Sci, Inst Chem, Key Lab Engn Plast, Beijing 100190, Peoples R China.
   [Yang, Lili] Univ Chinese Acad Sci, Beijing 100039, Peoples R China.
   [Gan, Zhihua] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Organ Inorgan Composites, Beijing Lab Biomat, Beijing 100029, Peoples R China.
RP Zhang, J (reprint author), Chinese Acad Sci, Beijing Natl Lab Mol Sci, Inst Chem, Key Lab Engn Plast, Beijing 100190, Peoples R China.
EM jzhang@iccas.ac.cn; zhgan@mail.buct.edu.cn
FU National Science Foundation of China [51425307]
FX This work was supported by the National Science Foundation of China (No.
   51425307).
CR Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Changerath R, 2009, J BIOMED MATER RES B, V89B, P65, DOI 10.1002/jbm.b.31188
   Chen MX, 2014, CARBOHYD POLYM, V111, P298, DOI 10.1016/j.carbpol.2014.04.038
   Chen XG, 2006, BIOCHEM ENG J, V27, P269, DOI 10.1016/j.bej.2005.08.021
   Custodio CA, 2014, ADV FUNCT MATER, V24, P1391, DOI 10.1002/adfm.201301516
   Duan KR, 2010, CARBOHYD POLYM, V80, P498, DOI 10.1016/j.carbpol.2009.12.013
   Feng H, 2007, CARBOHYD POLYM, V70, P258, DOI 10.1016/j.carbpol.2007.04.004
   Feng H, 2006, J POLYM SCI POL CHEM, V44, P5353, DOI 10.1002/pola.21625
   Ho STB, 2010, POLYM INT, V59, P808, DOI 10.1002/pi.2792
   Kim S, 2014, J BIOMED MATER RES B, V102, P1393, DOI 10.1002/jbm.b.33118
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Liu L, 2005, BIOPOLYMERS, V78, P163, DOI 10.1002/bip.20261
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Setoguchi T, 2012, POLYMER, V53, P4977, DOI 10.1016/j.polymer.2012.08.060
   She ZD, 2010, POLYM INT, V59, P55, DOI 10.1002/pi.2688
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tsai WB, 2013, J TAIWAN INST CHEM E, V44, P1, DOI 10.1016/j.jtice.2012.09.003
   Wang ZD, 2013, CARBOHYD POLYM, V94, P505, DOI 10.1016/j.carbpol.2013.01.090
NR 21
TC 6
Z9 6
U1 2
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD AUG
PY 2015
VL 64
IS 8
SI SI
BP 1045
EP 1052
DI 10.1002/pi.4912
PG 8
WC Polymer Science
SC Polymer Science
GA CL9YI
UT WOS:000357334600015
DA 2018-10-20
ER

PT J
AU Imhof, T
   Gruenewald, N
   Schwarz, G
   Noack, MJ
   Koch, M
AF Imhof, Thomas
   Gruenewald, Nora
   Schwarz, Guenter
   Noack, Michael J.
   Koch, Manuel
TI Modified amelogenin is a new and versatile nanomaterial for biomedical
   applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE amelogenin; functionalization; fusion protein; RGD tripeptide;
   nanoparticle
ID IN-VITRO
AB Amelogenin self-assembly is crucial for tooth biomineralization and crystallite enamel orientation. Amelogenin forms stable nanoparticles under physiological conditions. Here, we tested whether the surface properties and binding characteristics of these particles could be modified to enhance amelogenin function as a biomaterial. We evaluated different amelogenin fusion proteins for their ability to form hybrid nanoparticles. As a proof-of-concept, the integrin-binding tripeptide Arg-Gly-Asp (RGD) sequence from fibronectin was integrated into mouse amelogenin (rM179) at three different positions. Dynamic light scattering (DLS) measurements revealed that these amelogenin fusion proteins still form nanospheres. Additional DLS and isothermal titration calorimetry measurements showed that the mixtures of RGD-modified amelogenin and wild-type amelogenin form stable particles. We determined that insertion of the RGD-loop at the amelogenin C-terminus converts the nanoparticle into a cell-binding substrate. Calvarial osteoblasts efficiently attached and spread on modified amelogenin, whereas almost no binding was observed on wild-type amelogenin. These results establish amelogenin as a new versatile biomaterial that can be easily modified to add additional functions. Biotechnol. Bioeng. 2015;112: 1708-1713. (c) 2015 Wiley Periodicals, Inc.
C1 [Imhof, Thomas; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany.
   [Gruenewald, Nora; Schwarz, Guenter] Univ Cologne, Ctr Mol Med, Inst Biochem, Dept Chem, D-50674 Cologne, Germany.
   [Noack, Michael J.] Univ Cologne, Sch Dent, Dept Operat Dent, D-50931 Cologne, Germany.
   [Koch, Manuel] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal.
RP Koch, M (reprint author), Univ Cologne, Fac Med, Ctr Biochem, Inst Dent Res & Oral Musculoskeletal Biol, Kerpener Str 32, D-50931 Cologne, Germany.
EM Manuel.Koch@uni-koeln.de
CR AICHMAYER B, 2009, BIOMACROMOLECULES, V11, P369
   Almqvist S, 2010, J MATER SCI-MATER M, V21, P947, DOI 10.1007/s10856-009-3952-5
   AOBA T, 1987, CALCIFIED TISSUE INT, V41, P86, DOI 10.1007/BF02555250
   Bonde JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033269
   Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751
   Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108
   Fincham AG, 1995, CONNECT TISSUE RES, V32, P119, DOI 10.3109/03008209509013713
   Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]
   Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713
   MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006
   SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956
   Smith C E, 1996, Adv Dent Res, V10, P159
   Tarasevich BJ, 2009, BIOPOLYMERS, V91, P103, DOI 10.1002/bip.21095
   Veit G, 2011, J BIOL CHEM, V286, P27804, DOI 10.1074/jbc.M111.220046
   Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007
NR 15
TC 2
Z9 2
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG
PY 2015
VL 112
IS 8
BP 1708
EP 1713
DI 10.1002/bit.25576
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CL5AO
UT WOS:000356971500020
PM 25728989
DA 2018-10-20
ER

PT J
AU Borde, B
   Grunert, P
   Hartl, R
   Bonassar, LJ
AF Borde, Brandon
   Grunert, Peter
   Haertl, Roger
   Bonassar, Lawrence J.
TI Injectable, high-density collagen gels for annulus fibrosus repair: An
   in vitro rat tail model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; crosslinking; intervertebral disc; riboflavin; tissue
   engineering
ID INTERVERTEBRAL DISC DEGENERATION; NEEDLE PUNCTURE INJURY; NUCLEUS
   REPLACEMENT; CROSS-LINKING; ANULUS FIBROSUS; ANIMAL-MODELS; LUMBAR DISC;
   SCAFFOLDS; CONSEQUENCES; CHALLENGES
AB A herniated intervertebral disc often causes back pain when disc tissue is displaced through a damaged annulus fibrosus. Currently, the only methods available for annulus fibrosus repair involve mechanical closure of defect, which does little to address biological healing in the damaged tissue. Collagen hydrogels are injectable and have been used to repair annulus defects in vivo. In this study, high-density collagen hydrogels at 5, 10, and 15mg/mL were used to repair defects made to intact rat caudal intervertebral discs in vitro. A group of gels at 15mg/mL were also cross-linked with riboflavin at 0.03mM, 0.07mM, or 0.10mM. These cross-linked, high-density collagen gels maintained their presence in the defect under loading and contributed positively to the mechanical response of damaged discs. Discs exhibited increases to 95% of undamaged effective equilibrium and instantaneous moduli as well as up to fourfold decreases in effective hydraulic permeability from the damaged discs. These data suggest that high-density collagen gels may be effective at restoring mechanical function of injured discs as well as potential vehicles for the delivery of biological agents such as cells or growth factors that may aid in the repair of the annulus fibrosus. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2571-2581, 2015.
C1 [Borde, Brandon; Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.
   [Grunert, Peter; Haertl, Roger] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA.
   [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Bonassar, LJ (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.
EM lb244@cornell.edu
RI Bonassar, Lawrence/C-2103-2016
OI Bonassar, Lawrence/0000-0003-1094-6433
FU AO Foundation; AO Spine International; NFL Medical Charities; Howard
   Hughes Medical Institute [NIH F31AR064695-02]
FX Contract grant sponsors: The AO Foundation, AO Spine International, NFL
   Medical Charities, and the Howard Hughes Medical Institute; contract
   grant number: NIH F31AR064695-02
CR Ahearne M, 2008, BRIT J OPHTHALMOL, V92, P268, DOI 10.1136/bjo.2007.130104
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0
   Bowles RD, 2011, NATL ACAD SCI US, V108
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bron JL, 2012, J MATER SCI-MATER M, V23, P813, DOI 10.1007/s10856-011-4545-7
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chiang CJ, 2010, SPINE, V36, P1
   Connor DE, 2012, J CLIN NEUROSCI, V19, P1706, DOI 10.1016/j.jocn.2012.03.026
   Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072
   Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005
   Dai LY, 2005, SURG NEUROL, V64, P226, DOI 10.1016/j.surneu.2004.11.003
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Fawzy A, 2012, J DENT RES, V91, P1049, DOI 10.1177/0022034512459053
   Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010
   Gorensek M, 2006, SPINE J, V6, p143S
   Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Hussain M, 2011, MED ENG PHYS, V33, P438, DOI 10.1016/j.medengphy.2010.11.011
   Iatridis JC, 1998, J BIOMECH, V31, P535, DOI 10.1016/S0021-9290(98)00046-3
   Ibusuki S, 2007, TISSUE ENG, V13, P1995, DOI 10.1089/ten.2006.0153
   Keorochana G, 2010, SPINE J, V10, P1014, DOI 10.1016/j.spinee.2010.08.013
   Kim Y, 1995, J BIOMECH, P28
   Korecki CL, 2008, SPINE, V33, P235, DOI 10.1097/BRS.0b013e3181624504
   LATHAM JM, 1994, CLIN BIOMECH, V9, P211, DOI 10.1016/0268-0033(94)90001-9
   Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9
   Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20
   Michalek AJ, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004915
   Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z
   Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Rohlmann A, 2001, ERGONOMICS, V44, P781, DOI 10.1080/00140130110047657
   Roy R, 2010, J BIOMED MATER RES A, V93A, P843, DOI 10.1002/jbm.a.32231
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schroeder Y, 2008, J ORTHOP RES, V26, P1141, DOI 10.1002/jor.20632
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Singh K, 2010, CONT SPINE SURG, V11, P1
   Thompson RE, 2004, CLIN BIOMECH, V19, P448, DOI 10.1016/j.clinbiomech.2004.01.012
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015
NR 53
TC 13
Z9 14
U1 4
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2571
EP 2581
DI 10.1002/jbm.a.35388
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500007
PM 25504661
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Taylor, J
   Anyango, JO
   Potgieter, M
   Kallmeyer, K
   Naidoo, V
   Pepper, MS
   Taylor, JRN
AF Taylor, Janet
   Anyango, Joseph O.
   Potgieter, Marnie
   Kallmeyer, Karlien
   Naidoo, Vinny
   Pepper, Michael S.
   Taylor, John R. N.
TI Biocompatibility and biodegradation of protein microparticle and film
   scaffolds made from kafirin (sorghum prolamin protein) subcutaneously
   implanted in rodent models
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE microparticle; kafirin; histology; film; biocompatibility
ID BONE MORPHOGENETIC PROTEIN-2; POROUS ZEIN SCAFFOLDS;
   MECHANICAL-PROPERTIES; IN-VITRO; DIGESTIBILITY; ENCAPSULATION;
   BIOMATERIAL; RELEASE; TISSUE; FOOD
AB Kafirin, the sorghum prolamin protein, like its maize homologue zein, can be made into microparticles and films and potentially used as a biomaterial. Zein has good bio- and cyto-compatibility. Kafirin could be advantageous as it is more hydrophobic, more crosslinked, more slowly digested by mammalian proteases than zein and is non-allergenic. The safety and biocompatibility of kafirin implants in two forms was determined in rodent models. One week post subcutaneous injection of kafirin microparticles (size 5-mu m diameter) in mice, chronic inflammation, abnormal red blood cells, and gross fibrin formation were observed. This chronic inflammatory response was possibly caused by the release of hydrolysis products such as glutamate during the degradation of the kafirin microparticles. In contrast, films made from kafirin microparticles (50-mu m thick, folded into 1 cm(3)) implanted in rats showed no abnormal inflammatory reactions and were only partially degraded by day 28. The slower degradation of the kafirin films was probably due to their far smaller surface area when compared to kafirin microparticles. Thus, kafirin films appear to have potential as a biomaterial. This study also raises awareness that the form of prolamin based biomaterials, (kafirin and zein) should be considered when assessing the safety of such materials. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2582-2590, 2015.
C1 [Taylor, Janet; Anyango, Joseph O.; Taylor, John R. N.] Univ Pretoria, Inst Food Nutr & Well Being, ZA-0028 Hatfield, South Africa.
   [Taylor, Janet; Anyango, Joseph O.; Taylor, John R. N.] Univ Pretoria, Dept Food Sci, ZA-0028 Hatfield, South Africa.
   [Anyango, Joseph O.] Egerton Univ, Dept Dairy & Food Sci & Technol, Nakuru, Kenya.
   [Potgieter, Marnie; Kallmeyer, Karlien; Pepper, Michael S.] Univ Pretoria, Fac Hlth Sci, Dept Immunol, ZA-0002 Pretoria, South Africa.
   [Potgieter, Marnie; Kallmeyer, Karlien; Pepper, Michael S.] Univ Pretoria, Fac Hlth Sci, Inst Cellular & Mol Med, ZA-0002 Pretoria, South Africa.
   [Naidoo, Vinny] Univ Pretoria, Fac Vet Sci, Biomed Res Ctr, ZA-0002 Pretoria, South Africa.
RP Taylor, JRN (reprint author), Univ Pretoria, Inst Food Nutr & Well Being, Private Bag X20, ZA-0028 Hatfield, South Africa.
EM Janet.taylor@up.ac.za
RI Naidoo, Vinny/A-1508-2008
OI Naidoo, Vinny/0000-0003-2740-5983; Potgieter,
   Marnie/0000-0002-2184-2755; Taylor, Janet/0000-0001-7148-5437; Taylor,
   John/0000-0002-9714-2093
CR Adebowale AA, 2011, J CEREAL SCI, V54, P360
   Anyango JO, 2012, J AGR FOOD CHEM, V60, P8419, DOI 10.1021/jf302533e
   Anyango JO, 2011, J AGR FOOD CHEM, V59, P12674, DOI 10.1021/jf203273y
   Belton PS, 2006, J CEREAL SCI, V44, P272, DOI 10.1016/j.jcs.2006.05.004
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Boonkong W, 2013, J MATER SCI-MATER M, V24, P1581, DOI 10.1007/s10856-013-4864-y
   Brahatheeswaren D, 2012, BIOMED MATER, V7, P04500
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Ciacci C, 2007, CLIN NUTR, V26, P799, DOI 10.1016/j.clnu.2007.05.006
   DEROSE RT, 1989, PLANT MOL BIOL, V12, P245, DOI 10.1007/BF00043202
   DesSousa FO, 2012, J BIOMATER APPL, V27, P187
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X
   Emmambux NM, 2003, J SCI FOOD AGR, V83, P402, DOI 10.1002/jsfa.1379
   Gleneich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Lin T, 2011, AAPS PHARMSCITECH, V12, P172, DOI 10.1208/s12249-010-9565-y
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Nag S., 2012, ASM HDB, V23, P6
   Oberholzer HM, 2009, INT J MORPHOL, V27, P955, DOI 10.4067/S0717-95022009000300049
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Pontieri P, 2013, J AGR FOOD CHEM, V61, P2565, DOI 10.1021/jf304882k
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   ROTHENBUHLER E, 1985, J AGR FOOD CHEM, V33, P433, DOI 10.1021/jf00063a027
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   Taylor J., 2009, J CEREAL SCI, V50, P90
   Taylor J, 2009, J AGR FOOD CHEM, V57, P7523, DOI 10.1021/jf901592q
   TOBARI C, 1988, CANCER RES, V48, P1543
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Weiler A, 1996, J BONE JOINT SURG BR, V78B, P369
   Withold W, 1996, CLIN CHEM, V42, P210
   Xiao D, 2011, J AGR FOOD CHEM, V59, P7393, DOI 10.1021/jf200774v
   Xue AS, 2014, CRANIOMAX TRAUM REC, V7, P27, DOI 10.1055/s-0033-1364199
   Zhang BC, 2011, FOOD CHEM, V124, P210, DOI 10.1016/j.foodchem.2010.06.019
NR 38
TC 4
Z9 4
U1 0
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2582
EP 2590
DI 10.1002/jbm.a.35394
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500008
PM 25524818
DA 2018-10-20
ER

PT J
AU Mohtaram, NK
   Ko, J
   King, C
   Sun, L
   Muller, N
   Jun, MBG
   Willerth, SM
AF Mohtaram, Nima Khadem
   Ko, Junghyuk
   King, Craig
   Sun, Lin
   Muller, Nathan
   Jun, Martin Byung-Guk
   Willerth, Stephanie M.
TI Electrospun biomaterial scaffolds with varied topographies for neuronal
   differentiation of human-induced pluripotent stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human-induced pluripotent stem cells; melt electrospinning; solution
   electrospinning; scaffold topography; neural tissue engineering
ID SPINAL-CORD-INJURY; POLYMER MELTS; MODEL; TRANSPLANTATION; REGENERATION;
   RECOVERY
AB In this study, we investigated the effect of micro and nanoscale scaffold topography on promoting neuronal differentiation of human induced pluripotent stem cells (iPSCs) and directing the resulting neuronal outgrowth in an organized manner. We used melt electrospinning to fabricate poly (epsilon-caprolactone) (PCL) scaffolds with loop mesh and biaxial aligned microscale topographies. Biaxial aligned microscale scaffolds were further functionalized with retinoic acid releasing PCL nanofibers using solution electrospinning. These scaffolds were then seeded with neural progenitors derived from human iPSCs. We found that smaller diameter loop mesh scaffolds (43.7 +/- 3.9 mu m) induced higher expression of the neural markers Nestin and Pax6 compared to thicker diameter loop mesh scaffolds (85 +/- 4 mu m). The loop mesh and biaxial aligned scaffolds guided the neurite outgrowth of human iPSCs along the topographical features with the maximum neurite length of these cells being longer on the biaxial aligned scaffolds. Finally, our novel bimodal scaffolds also supported the neuronal differentiation of human iPSCs as they presented both physical and chemical cues to these cells, encouraging their differentiation. These results give insight into how physical and chemical cues can be used to engineer neural tissue. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2591-2601, 2015.
C1 [Mohtaram, Nima Khadem; Ko, Junghyuk; Muller, Nathan; Jun, Martin Byung-Guk; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [King, Craig] Univ Victoria, Dept Biomed Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [Sun, Lin; Willerth, Stephanie M.] Univ Victoria, Div Med Sci, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [Willerth, Stephanie M.] ICORD, Vancouver, BC V5Z 1M9, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Dept Mech Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
OI Muller, Nathan/0000-0002-5893-7870; Willerth,
   Stephanie/0000-0002-1665-7723
FU Natural Sciences and Engineering Research Council
FX Contract grant sponsor: Natural Sciences and Engineering Research
   Council's Discovery
CR Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Cordie T, 2014, CELL MOL BIOENG, V7, P379, DOI 10.1007/s12195-014-0341-z
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   Dalton PD, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034109
   Dalton PD, 2006, BIOMACROMOLECULES, V7, P686, DOI 10.1021/bm050777q
   Detta N, 2010, POLYM INT, V59, P1558, DOI 10.1002/pi.2954
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Jiang X, 2012, ACTA BIOMATER, V8, P1290, DOI 10.1016/j.actbio.2011.11.019
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mohtaram N, 2014, J BIOMATER IN PRESS
   Mohtaram NK, 2013, BIOMED MAT, V8
   Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Nutt SE, 2013, EXP NEUROL, V248, P491, DOI 10.1016/j.expneurol.2013.07.010
   Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104
   Pan F, 2013, BIOMATERIALS, V34, P8131, DOI 10.1016/j.biomaterials.2013.07.025
   Qin J, 2013, NEUROSCI LETT, V548, P95, DOI 10.1016/j.neulet.2013.05.007
   Saadai P, 2013, J PEDIATR SURG, V48, P158, DOI 10.1016/j.jpedsurg.2012.10.034
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sun YB, 2013, INTEGR BIOL-UK, V5, P450, DOI 10.1039/c2ib20256e
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Turksen K, 2012, METHOD MOL BIOL, V873
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 41
TC 22
Z9 23
U1 1
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2591
EP 2601
DI 10.1002/jbm.a.35392
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500009
PM 25524598
DA 2018-10-20
ER

PT J
AU Meyer, RA
   Meyer, RS
   Green, JJ
AF Meyer, Randall A.
   Meyer, Randall S.
   Green, Jordan J.
TI An automated multidimensional thin film stretching device for the
   generation of anisotropic polymeric micro- and nanoparticles
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE anisotropic; particle shape; biomimetic; automation; microparticles;
   nanoparticles
ID ANTIGEN-PRESENTING CELLS; NONVIRAL GENE DELIVERY; DRUG-DELIVERY; SHAPE;
   PARTICLES; MICROPARTICLES; MONODISPERSE; TUMOR
AB Anisotropic polymeric particles are of growing interest for biomaterials applications due to their unique properties. These include the ability for these particles to evade nonspecific cellular uptake and to have enhanced targeted cellular uptake and interaction. One of the most widely used methods for generating anisotropic polymeric particles is the thin film stretching procedure. Despite its theoretical simplicity, this procedure, as it has been implemented to date, can be difficult due to the inconsistent nature of the manual operation of machinery used to stretch the film. We have constructed an automated thin film stretcher for control over biomaterials via thin film stretching in 1D and 2D and as a result, have enabled precise generation of anisotropic polymeric particles. We demonstrate that this device can be utilized to produce anisotropic biodegradable particles of different size, shape, and material consistency. Furthermore, we show that this machine has enabled the scaled up and rapid production of anisotropic polymeric particles, including polymeric microparticles that mimic the shape of red blood cells. Further application of this automated thin film stretching device could allow for significant impact to diverse biomaterial and biomedical applications such as biomimetic particles for immunoengineering and long-circulating particles for controlled release of drugs. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2747-2757, 2015.
C1 [Meyer, Randall A.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Meyer, Randall A.; Meyer, Randall S.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Meyer, Randall A.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Mat Sci & Engn, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU NIH [R01-EB016721]; NIH Cancer Nanotechnology Training Center
   [R25CA153952]; JHU Institute for Nanobiotechnology; Johns Hopkins
   University
FX Contract grant sponsor: NIH; contract grant number: R01-EB016721;
   Contract grant sponsor: NIH Cancer Nanotechnology Training Center;
   contract grant number: R25CA153952; Contract grant sponsors: JHU
   Institute for Nanobiotechnology; Johns Hopkins University
CR Adriani G, 2012, BIOMATERIALS, V33, P5504, DOI 10.1016/j.biomaterials.2012.04.027
   Aryal S, 2013, NANOMEDICINE-UK, V8, P1271, DOI [10.2217/NNM.12.153, 10.2217/nnm.12.153]
   Barreto-Ortiz SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081061
   Barua S, 2013, P NATL ACAD SCI USA, V110, P3270, DOI 10.1073/pnas.1216893110
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104
   Chen K, 2012, BIOMACROMOLECULES, V13, P2748, DOI 10.1021/bm3007242
   Chou LYT, 2014, NAT NANOTECHNOL, V9, P148, DOI [10.1038/nnano.2013.309, 10.1038/NNANO.2013.309]
   Chu KS, 2014, NANO LETT, V14, P1472, DOI 10.1021/nl4046558
   Chu KS, 2013, NANOMED-NANOTECHNOL, V9, P686, DOI 10.1016/j.nano.2012.11.008
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Fields RJ, 2012, J CONTROL RELEASE, V164, P41, DOI 10.1016/j.jconrel.2012.09.020
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Florez L, 2012, SMALL, V8, P2222, DOI 10.1002/smll.201102002
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Guo BL, 2014, SCI CHINA CHEM, V57, P490, DOI 10.1007/s11426-014-5086-y
   Hasan W, 2012, NANO LETT, V12, P287, DOI 10.1021/nl2035354
   HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Jang SG, 2013, J AM CHEM SOC, V135, P6649, DOI 10.1021/ja4019447
   Jiang X, 2013, ADV MATER, V25, P227, DOI 10.1002/adma.201202932
   Jiang X, 2011, PHARM RES-DORDR, V28, P1317, DOI 10.1007/s11095-011-0436-3
   Karagoz B, 2014, POLYM CHEM-UK, V5, P350, DOI 10.1039/c3py01306e
   Kim HN, 2013, ADV DRUG DELIVER REV, V65, P536, DOI 10.1016/j.addr.2012.07.014
   Kolhar P, 2013, P NATL ACAD SCI USA, V110, P10753, DOI 10.1073/pnas.1308345110
   Kozielski KL, 2013, CHEM COMMUN, V49, P5319, DOI 10.1039/c3cc40718g
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Luo GS, 2011, PARTICUOLOGY, V9, P545, DOI 10.1016/j.partic.2011.06.004
   Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108
   Morton SW, 2013, ADV MATER, V25, P4707, DOI 10.1002/adma.201302025
   Petzetakis N, 2011, CHEM SCI, V2, P955, DOI 10.1039/c0sc00596g
   Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j
   Rao JP, 2011, PROG POLYM SCI, V36, P887, DOI 10.1016/j.progpolymsci.2011.01.001
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Sharma G, 2010, J CONTROL RELEASE, V147, P408, DOI 10.1016/j.jconrel.2010.07.116
   Shum HC, 2010, MACROMOL RAPID COMM, V31, P108, DOI 10.1002/marc.200900590
   Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Tao L, 2011, EXP BIOL MED, V236, P20, DOI 10.1258/ebm.2010.010243
   Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Wang YP, 2011, LANGMUIR, V27, P524, DOI 10.1021/la1045095
   Xu J, 2013, MOL PHARMACEUT, V10, P3366, DOI 10.1021/mp400190z
   Yang SK, 2012, LAB CHIP, V12, P2097, DOI 10.1039/c2lc90046g
   Yoo JW, 2010, P NATL ACAD SCI USA, V107, P11205, DOI 10.1073/pnas.1000346107
   Zhou ZM, 2013, ADV MATER, V25, P2723, DOI 10.1002/adma.201300220
NR 50
TC 10
Z9 10
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2747
EP 2757
DI 10.1002/jbm.a.35399
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500025
PM 25641799
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gudmundsdottir, S
   Lieder, R
   Sigurjonsson, OE
   Petersen, PH
AF Gudmundsdottir, Steinunn
   Lieder, Ramona
   Sigurjonsson, Olafur E.
   Petersen, Petur H.
TI Chitosan leads to downregulation of YKL-40 and inflammasome activation
   in human macrophages
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitin; chitosan; inflammation; chitinase; YKL-40
ID HUMAN CARTILAGE GLYCOPROTEIN-39; BINDING PROPERTIES;
   CHITOOLIGOSACCHARIDES; CHITINASE; CELLS; ANGIOGENESIS; ENDOTOXINS;
   THP-1; DIFFERENTIATION; CHITOTRIOSIDASE
AB Chitosan, the deacetylated derivative of chitin, is used as biomaterial in diverse settings. It is also found on pathogens and can be proinflammatory. Shorter derivatives of chitosan can be generated chemically or enzymatically, chitosan oligosaccharides (ChOS). There is variation in the chemical composition of ChOS, including size distribution, but in general, they have been described as inert or anti-inflammatory. Active human chitinases can cleave chitin and chitosan, while inactive chitinases bind both but do not cleave. Both active and inactive chitinases have important roles in the immune response. The inactive chitinase YKL-40 is expressed highly during inflammation and has been proposed as a marker of poor prognosis. YKL-40 acts as a negative regulator of the inflammasome and as a positive regulator of angiogenesis. Levels of YKL-40 can therefore regulate levels of inflammation, the extent of angiogenesis, and the process of inflammation resolution. This study shows that chitosan leads to reduced secretion of YKL-40 by primary human macrophages and that this is concomitant with inflammasome activation. This was most pronounced with a highly deacetylated ChOS. No effect on the secretion of the active chitinase Chit-1 was detected. Smaller and more acetylated ChOS did not affect YKL-40 levels nor inflammasome activation. We conclude that this effect on the levels of YKL-40 is a part of the proinflammatory mechanisms of chitosan and its derivatives. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2778-2785, 2015.
C1 [Gudmundsdottir, Steinunn; Petersen, Petur H.] Univ Iceland, Dept Anat, Biomed Ctr, Fac Med,Sch Hlth Sci, IS-101 Reykjavik, Iceland.
   [Lieder, Ramona; Sigurjonsson, Olafur E.] Landspitali Univ Hosp, Blood Bank, IS-105 Reykjavik, Iceland.
   [Lieder, Ramona; Sigurjonsson, Olafur E.] Reykjavik Univ, Sch Sci & Engn, IS-101 Reykjavik, Iceland.
   [Sigurjonsson, Olafur E.; Petersen, Petur H.] Univ Iceland, Biomed Ctr, IS-101 Reykjavik, Iceland.
RP Petersen, PH (reprint author), Univ Iceland, Dept Anat, Biomed Ctr, Fac Med,Sch Hlth Sci, IS-101 Reykjavik, Iceland.
EM phenry@hi.is
OI Sigurjonsson, Olafur/0000-0002-4968-842X
FU Landspitali University Hospital Research Fund; Icelandic Student
   Innovation Fund [1323410091]
FX Contract grant sponsor: Landspitali University Hospital Research Fund;
   Contract grant sponsor: Icelandic Student Innovation Fund; contract
   grant number: 1323410091
CR Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482
   Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06
   Barone R, 2003, J TROP PEDIATRICS, V49, P63, DOI 10.1093/tropej/49.1.63
   Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x
   Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936
   Cederkvist FH, 2008, CARBOHYD POLYM, V74, P41, DOI 10.1016/j.carbpol.2008.01.020
   Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017
   Di Rosa M, 2013, INFLAMMATION, V36, P482, DOI 10.1007/s10753-012-9569-8
   Einarsson JM, 2013, BIOCHEM BIOPH RES CO, V434, P298, DOI 10.1016/j.bbrc.2013.02.122
   Fernandes JC, 2010, MAR DRUGS, V8, P1763, DOI 10.3390/md8061763
   Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200
   Goldman DL, 2012, CLIN EXP ALLERGY, V42, P523, DOI 10.1111/j.1365-2222.2011.03886.x
   Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   JOHANSEN JS, 1995, EUR J CANCER, V31A, P1437, DOI 10.1016/0959-8049(95)00196-P
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Labadaridis I, 2005, ARCH DIS CHILD-FETAL, V90, pF531, DOI 10.1136/adc.2004.051284
   Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250
   Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271
   Lieder R, 2012, J TISSUE ENG REGEN M, V6, P356
   Lieder R, 2013, TISSUE ENG PART B-RE, V19, P391, DOI [10.1089/ten.teb.2012.0636, 10.1089/ten.TEB.2012.0636]
   Lieder R, 2013, ACTA BIOMATER, V9, P4771, DOI 10.1016/j.actbio.2012.08.043
   Maess MB, 2014, J IMMUNOL METHODS, V402, P76, DOI 10.1016/j.jim.2013.11.006
   Mathieu C, 2013, OSTEOARTHR CARTILAGE, V21, P849, DOI 10.1016/j.joca.2013.03.012
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Porporatto C, 2004, INT IMMUNOL, V16, P433, DOI 10.1093/intimm/dxh051
   Prakash M, 2013, CELL SIGNAL, V25, P1567, DOI 10.1016/j.cellsig.2013.03.016
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075
   Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377
   Schultz Nicolai A, 2010, Cancers (Basel), V2, P1453, DOI 10.3390/cancers2031453
   Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328
   Weecharangsan W, 2008, INT J PHARMACEUT, V348, P161, DOI 10.1016/j.ijpharm.2007.07.011
   Wu HG, 2012, CARBOHYD POLYM, V89, P511, DOI 10.1016/j.carbpol.2012.03.037
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
NR 43
TC 8
Z9 9
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2015
VL 103
IS 8
BP 2778
EP 2785
DI 10.1002/jbm.a.35417
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL5VG
UT WOS:000357029500028
PM 25684555
DA 2018-10-20
ER

PT J
AU Hameed, N
   Glattauer, V
   Ramshaw, JAM
AF Hameed, Nishar
   Glattauer, Veronica
   Ramshaw, John A. M.
TI Evaluation of polyvinyl alcohol composite membranes containing collagen
   and bone particles
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Polyvinyl alcohol; Bone; Demineralised bone; Thermal properties;
   Mechanical properties; Cell culture
ID POLY(VINYL ALCOHOL); ALCOHOL/COLLAGEN HYDROGEL; MORPHOGENETIC PROTEINS;
   GROWTH-FACTORS; IN-VIVO; MATRIX; BIOMATERIALS; BLENDS; FILMS;
   OSTEOINDUCTIVITY
AB Composite biomaterials provide alternative materials that improve on the properties of the individual components and can be used to replace or restore damaged or diseased tissues. Typically, a composite biomaterial consists of a matrix, often a polymer, with one or more fillers that can be made up of particles, sheets or fibres. The polymer matrix can be chosen from a wide range of compositions and can be fabricated easily and rapidly into complex shapes and structures. In the present study we have examined three size fractions of collagen-containing particles embedded at up to 60% w/w in a poly(vinyl alcohol) (PVA) matrix. The particles used were bone particles, which are a mineral-collagen composite and demineralised bone, which gives naturally cross-linked collagen particles. SEM showed well dispersed particles in the PVA matrix for all concentrations and sizes of particles, with FTIR suggesting collagen to PVA hydrogen bonding. T-g of membranes shifted to a slightly lower temperature with increasing collagen content, along with a minor amount of melting point depression. The modulus and tensile strength of membranes were improved with the addition of both particles up to 10 wt%, and were clearly strengthened by the addition, although this effect decreased with higher collagen loadings. Elongation at break decreased with collagen content. Cell adhesion to the membranes was observed associated with the collagen particles, indicating a lack of cytotoxicity. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Hameed, Nishar] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3216, Australia.
   [Glattauer, Veronica; Ramshaw, John A. M.] CSIRO Mfg Flagship, Clayton, Vic 3169, Australia.
RP Hameed, N (reprint author), Deakin Univ, Inst Frontier Mat, Pigdons Rd, Geelong, Vic 3216, Australia.
EM nishar.hameed@deakin.edu.au; veronica.glattauer@csiro.au;
   john.ramshaw@csiro.au
RI Glattauer, veronica/A-9435-2018
FU Alfred Deakin Research Fellowship
FX This work was funded in part by an Alfred Deakin Research Fellowship to
   NH.
CR Alexy P, 2003, POLYM TEST, V22, P801, DOI 10.1016/S0142-9418(03)00016-3
   Bae HW, 2006, SPINE, V31, P1299, DOI 10.1097/01.brs.0000218581.92992.b7
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Blum B, 2004, ORTHOPEDICS, V27, pS161
   Figueiredo A, 2013, MAT SCI ENG C-MATER, V33, P3506, DOI 10.1016/j.msec.2013.04.047
   FISCHER EG, 1990, J IMMUNOL METHODS, V128, P235, DOI 10.1016/0022-1759(90)90215-H
   Glattauer V, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P261
   Glattauer V, 2010, J BIOMED MATER RES A, V92A, P1301, DOI 10.1002/jbm.a.32468
   Gupta A, 2009, J APPL POLYM SCI, V111, P1400, DOI 10.1002/app.28990
   Ivanovic A, 2014, CLIN ORAL INVEST, V18, P1319, DOI 10.1007/s00784-013-1089-x
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Jiang YJ, 2010, J BIOMED MATER RES B, V93B, P275, DOI 10.1002/jbm.b.31585
   Kobayashi M, 2001, J BIOMED MATER RES, V58, P344
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Peng ZY, 2012, J MACROMOL SCI B, V51, P1934, DOI 10.1080/00222348.2012.660060
   Peng ZY, 2011, POLYM-PLAST TECHNOL, V50, P245, DOI 10.1080/03602559.2010.531438
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P645, DOI 10.1111/j.1600-0501.2012.02439.x
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   SARTI B, 1995, BIOMATERIALS, V16, P785, DOI 10.1016/0142-9612(95)99641-X
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Sharaf F, 1999, POLYM DEGRAD STABIL, V66, P173, DOI 10.1016/S0141-3910(98)00101-3
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sionkowska A, 2009, J MOL LIQ, V144, P71, DOI 10.1016/j.molliq.2008.09.007
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Weis C, 2004, J BIOMED MATER RES B, V70B, P191, DOI 10.1002/jbm.b.30007
   Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Yi F, 2006, J BIOMAT SCI-POLYM E, V17, P1015, DOI 10.1163/156856206778365997
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
NR 35
TC 6
Z9 6
U1 0
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2015
VL 48
BP 38
EP 45
DI 10.1016/j.jmbbm.2015.04.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK4QO
UT WOS:000356208500004
PM 25913606
DA 2018-10-20
ER

PT J
AU Arahira, T
   Maruta, M
   Matsuya, S
   Todo, M
AF Arahira, T.
   Maruta, M.
   Matsuya, S.
   Todo, M.
TI Development and characterization of a novel porous beta-TCP scaffold
   with a three-dimensional PLLA network structure for use in bone tissue
   engineering
SO MATERIALS LETTERS
LA English
DT Article
DE Composite scaffold; beta-TCP; PLLA; Biomaterial; Bone regeneration
ID MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLD; DIFFERENTIATION;
   PROLIFERATION; CELLS; FOAM
AB In the field of bone regenerative medicine, the need for artificial bone substitutes has been rapidly increasing, and various porous bioactive ceramics have been developed for use as bone substitutes. While materials such as beta-tricalcium phosphate (beta-TCP) have good oseteoconductivity, poly (L-lactide acid) (PLLA) has been shown to have good mechanical and physical properties. Therefore, the primary aim of this study was to fabricate a porous beta-TCP scaffold with a PLLA network structure (beta-TCP/PLLA) for use in bone tissue engineering. The fabricated beta-TCP/PLLA scaffolds were characterized,by their surface microstructures and compressive moduli. The results demonstrated that the structure of the PLLA membrane, such as pore size and thickness of membrane, could be changed by varying the concentration of PLEA. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Arahira, T.; Maruta, M.; Matsuya, S.] Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, Fukuoka 8140193, Japan.
   [Todo, M.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan.
RP Arahira, T (reprint author), Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM arahira@college.fdcnet.ac.jp
RI U-ID, Kyushu/C-5291-2016; Kyushu, RIAM/F-4018-2015
OI Kyushu, RIAM/0000-0002-3518-444X
FU Japan Society for the Promotion of Science, Japan [25893284]
FX This work was supported by a Japan Society for the Promotion of Science,
   Japan Grant-in-Aid for Research Activity Start-up Grant number 25893284.
CR Arahira T, 2014, J MECH BEHAV BIOMED, V39, P218, DOI 10.1016/j.jmbbm.2014.07.013
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   Gerard C, 2010, J BIOMED MATER RES A, V93A, P615, DOI 10.1002/jbm.a.32568
   He XM, 2010, TISSUE ENG PART C-ME, V16, P329, DOI [10.1089/ten.tec.2008.0703, 10.1089/ten.TEC.2008.0703]
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Munar GM, 2013, DENT MATER J, V32, P608, DOI 10.4012/dmj.2013-031
   Nikaido T, 2013, KEY ENG MATER, V529-530, P15, DOI 10.4028/www.scientific.net/KEM.529-530.15
   Park JE, 2011, J MATER SCI-MATER M, V22, P1171, DOI 10.1007/s10856-011-4289-4
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009
   Tiwari Akshay, 2012, J Clin Orthop Trauma, V3, P4, DOI 10.1016/j.jcot.2012.04.004
   Todo M, 2009, J MATER SCI, V44, P4191, DOI 10.1007/s10853-009-3546-0
   Udoh K, 2010, DENT MATER J, V29, P154, DOI 10.4012/dmj.2009-079
   Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457
   Zhang X, 2011, J MATER SCI-MATER M, V22, P371, DOI 10.1007/s10856-010-4198-y
NR 17
TC 6
Z9 7
U1 1
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 1
PY 2015
VL 152
BP 148
EP 150
DI 10.1016/j.matlet.2015.03.128
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CK4IS
UT WOS:000356188100040
DA 2018-10-20
ER

PT J
AU Rajendran, V
   Prabhu, M
   Suriyaprabha, R
AF Rajendran, V.
   Prabhu, M.
   Suriyaprabha, R.
TI Synthesis of TiO2-doped mesoporous nanobioactive glass particles and
   their cytocompatibility against osteoblast cell line
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID TITANIUM-DOPED BIOGLASS; PHOSPHATE-BASED GLASS; SIMULATED BODY-FLUID;
   IN-VITRO; CRYSTALLIZATION BEHAVIOR; BIOMEDICAL APPLICATIONS; APATITE
   FORMATION; BIOACTIVE GLASS; ION RELEASE; THIN-FILMS
AB To obtain medically important mesoporous biomaterial, we prepared titanium-doped nanobioactive glass (NBG) particles 55SiO(2)-(36 - x) CaO-9P(2)O(5)-xTiO(2) (x = 0, 1, 2, and 3 mol%) were prepared by simple sol-gel method. The physicochemical properties of the prepared nanocomposites were analyzed using different characterization techniques. The developed mesoporous nanocomposites showed amorphous nature with globular morphology, with a particle size of approximately 50 nm. The specific surface area of glass nanocomposites doped with TiO2 at different concentrations, namely SCPT0 (0 %), SCPT1 (1 %), SCPT2 (2 %), and SCPT3 (3 %) samples, was 129, 186, 105, and 129 m(2) g(-1), respectively. In addition, the average pore diameter of the glass series was 33, 18, 27, and 25 nm. The in vitro bioactivity of hydroxyapatite layer formation was confirmed using simulated body fluid. Further, antibacterial property of mesoporous nanocomposites was investigated against Escherichia coli and Staphylococcus aureus. The diameter of the inhibition zone of TiO2-doped nanocomposites against E. coli was found to be 16, 18, and 20 mm. No significant inhibition was found for Ti-free samples against E. coli and S. aureus. The cytotoxicity assay revealed that the prepared NBG particles doped with 1 % TiO2 were nontoxic and showed better cell viability in osteoblast cell line (MG-63) at a concentration of 125 A mu g ml(-1). Therefore, the addition of biomimic metal oxide dopant such as TiO2 in NBGs is an effective approach to develop a highly biocompatible material for bone implant applications.
C1 [Rajendran, V.; Prabhu, M.; Suriyaprabha, R.] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
RP Rajendran, V (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com; prabhubpt16@gmail.com; rsuriyaprabha@gmail.com
FU Department of Science and Technology (DST), New Delhi
   [SR/S2/CMP-0054/2009]
FX The authors acknowledge the financial support (SR/S2/CMP-0054/2009 dt.
   27.09.2010) provided by the Department of Science and Technology (DST),
   New Delhi, to carry out this research project.
CR Abou Neel EA, 2009, J NON-CRYST SOLIDS, V355, P991, DOI 10.1016/j.jnoncrysol.2009.04.016
   Asif IM, 2014, J MATER SCI-MATER M, V25, P1865, DOI 10.1007/s10856-014-5230-4
   Barbieri L, 1997, MATER RES BULL, V32, P637, DOI 10.1016/S0025-5408(97)00029-9
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Bielby RC, 2004, TISSUE ENG, V10, P1018, DOI 10.1089/1076327041887664
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Caballero L, 2009, J PHOTOCH PHOTOBIO A, V202, P92, DOI 10.1016/j.jphotochem.2008.11.005
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   Dhayal M, 2014, MAT SCI ENG C-MATER, V37, P99, DOI 10.1016/j.msec.2013.12.035
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   FitzGerald V, 2009, J BIOMED MATER RES A, V91A, P76, DOI 10.1002/jbm.a.32206
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Kim YS, 2012, POWDER TECHNOL, V215-16, P195, DOI 10.1016/j.powtec.2011.09.047
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lakhkar NJ, 2012, ACTA BIOMATER, V8, P4181, DOI 10.1016/j.actbio.2012.07.023
   Li ZS, 2009, ACTA BIOMATER, V5, P2189, DOI 10.1016/j.actbio.2009.02.013
   Martin RA, 2012, PHYS CHEM CHEM PHYS, V14, P15807, DOI 10.1039/c2cp43032k
   Mohammadi MS, 2014, COLLOID SURFACE B, V121, P82, DOI 10.1016/j.colsurfb.2014.05.037
   Monem AS, 2008, J MATER SCI-MATER M, V19, P1097, DOI 10.1007/s10856-007-3044-3
   NAN Y, 1992, J AM CERAM SOC, V75, P1641, DOI 10.1111/j.1151-2916.1992.tb04237.x
   Ni SY, 2008, J MATER SCI-MATER M, V19, P359, DOI 10.1007/s10856-007-3186-3
   Pena J, 2006, SOLID STATE SCI, V8, P513, DOI 10.1016/j.solidstatesciences.2005.11.003
   Prabhu M, 2013, J NANOSCI NANOTECHNO, V13, P5327, DOI 10.1166/jnn.2013.7474
   Prabhu M, 2013, CERAM INT, V39, P1683, DOI 10.1016/j.ceramint.2012.08.011
   Rajendran V, 2010, J AM CERAM SOC, V93, P4053, DOI 10.1111/j.1551-2916.2010.04009.x
   Rouquerol F, 1999, GEN CONCLUSIONS RECO, P439
   Saravanakumar B, 2015, INT J APPL CERAM TEC, V12, P95, DOI 10.1111/ijac.12124
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Shahadat M, 2015, COLLOID SURFACE B, V126, P121, DOI 10.1016/j.colsurfb.2014.11.049
   Socrates G., 2004, INFRARED RAMAN CHARA
   Talos F, 2013, CORROS SCI, V72, P41, DOI 10.1016/j.corsci.2013.03.003
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Vasconcelos HC, 2010, J SOL-GEL SCI TECHN, V55, P126, DOI 10.1007/s10971-010-2223-8
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
   Yu BB, 2012, LANGMUIR, V28, P17465, DOI 10.1021/la303768b
   Yun HS, 2010, MATER LETT, V64, P1850, DOI 10.1016/j.matlet.2010.04.053
NR 40
TC 3
Z9 3
U1 3
U2 62
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD AUG
PY 2015
VL 50
IS 15
BP 5145
EP 5156
DI 10.1007/s10853-015-9047-4
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA CI7RH
UT WOS:000354961400004
DA 2018-10-20
ER

PT J
AU Linh, NTB
   Jang, DW
   Lee, BT
AF Nguyen Thuy Ba Linh
   Jang, Dong-Woo
   Lee, Byong-Taek
TI Collagen immobilization of multi-layered BCP-ZrO2 bone substitutes to
   enhance bone formation
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Porous scaffolds; Multi layered BCP-ZrO2; Collagen immobilization;
   Surface modification; Bone substitutes
ID BIPHASIC CALCIUM-PHOSPHATE; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION;
   MARROW-CELLS; IN-VITRO; SCAFFOLDS; BIOMATERIAL; ZIRCONIA; HYDROGELS;
   ADHESION
AB A porous microstructure of multi-layered BCP-ZrO2 bone substitutes was fabricated using the sponge replica method in which the highly interconnected structure was immobilized with collagen via ethyl(dimethylaminopropypcarbodiimide/N-hydroxysuccinimide crosslinking. Their struts are combined with a three-layered BCP/BCP-ZrO2/ZrO2 microstructure. Collagen fibers were firmly attached to the strut surface of the BCP-ZrO2 scaffolds. With control of the three-layered microstructure and collagen immobilization, the compressive strength of the scaffolds increased significantly to 6.8 MPa compared to that of the monolithic BCP scaffolds (1.3 MPa). An in vitro study using MU, confocal observation, and real-time polymer chain reaction analysis demonstrated that the proliferation and differentiation of the pre-osteoblast-like MC3T3-E1 cells was improved due to the collagen incorporation. Remarkable enhancement of bone regeneration was observed without any immunological reaction in the femurs of rabbits during 1 and 5 months of implantation. Furthermore, the interfaces between new bone and the scaffold struts bonded directly without any gaps. (C) 2015 Published by Elsevier B.V.
C1 [Nguyen Thuy Ba Linh; Jang, Dong-Woo; Lee, Byong-Taek] Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan 330090, South Korea.
   [Nguyen Thuy Ba Linh; Lee, Byong-Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan 330090, South Korea.
RP Lee, BT (reprint author), Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan 330090, South Korea.
EM lbt@sch.ac.kr
FU Business for Academic-industrial Cooperative establishments [C0247339]
FX This work (Grants No. C0247339) was supported by Business for
   Academic-industrial Cooperative establishments funded Korea Small and
   Medium Business Administration in 2014.
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Charles PT, 2009, SENSORS-BASEL, V9, P645, DOI 10.3390/s90100645
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHEVALIER J, 1997, BIOCERAMICS, V10
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   CUDKOWICZ G, 1971, J EXP MED, V134, P83, DOI 10.1084/jem.134.1.83
   Donegan M, 2013, PLASMA PROCESS POLYM, V10, P526, DOI 10.1002/ppap.201200078
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Goldberg M.M., 1992, BONE IMPLANT GRAFTIN, P9
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hamed E, 2012, J R SOC INTERFACE, V9, P1654, DOI 10.1098/rsif.2011.0814
   He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jager M, 2013, J BIOMED MATER RES A, V101, P2905, DOI 10.1002/jbm.a.34590
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Jun IK, 2006, MATER LETT, V60, P2507, DOI 10.1016/j.matlet.2006.01.031
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim M, 2010, KOREAN J MAT RES, V20, P331
   Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019
   Kim RY, 2014, BIOMATERIALS, V35, P1869, DOI 10.1016/j.biomaterials.2013.11.029
   Kim Y. - H., 2012, SCI TECHNOL ADV MAT, V12
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   McLaren EA, 2005, QDT, V28, P99
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Nettles Dana L., 2002, TISSUE ENG PART A, V8, P1009
   Linh NTB, 2013, J BIOMED MATER RES A, V101, P2412, DOI 10.1002/jbm.a.34533
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pires MM, 2009, ANGEW CHEM INT EDIT, V48, P7813, DOI 10.1002/anie.200902375
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Richard F., 2008, BIOCHEM SOC T, V36, P241
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122
   SILBERMANN M, 1983, ANAT REC, V206, P373, DOI 10.1002/ar.1092060404
   STEIN GS, 1990, FASEB J, V4, P3111
   STRAUSS PG, 1990, J CELL BIOL, V110, P1369, DOI 10.1083/jcb.110.4.1369
   Taubenberger A. V., 2013, TISSUE ENG B
   VandeVord PJ, 2005, J ORTHOP RES, V23, P1059, DOI 10.1016/j.orthres.2004.12.004
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Wang B., 2012, ACCOUNTS CHEM RES, V46, P761
   Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025
NR 50
TC 4
Z9 4
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 1
PY 2015
VL 345
BP 238
EP 248
DI 10.1016/j.apsusc.2015.03.126
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CH1SY
UT WOS:000353803000031
DA 2018-10-20
ER

PT J
AU Kang, BM
   Jeong, WJ
   Park, GC
   Yoon, DJ
   Ahn, HG
   Lim, YS
AF Kang, Byeong-Mo
   Jeong, Woon-Jo
   Park, Gye-Choon
   Yoon, Dong-Joo
   Ahn, Ho-Geun
   Lim, Yeong-Seog
TI The Characteristics of an Antibacterial TiAgN Thin Film Coated by
   Physical Vapor Deposition Technique
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE TiAgN; Nanoconnposite; Nanoparticle; Thin Film; Antibacterial
   Biomaterial; PVD
ID BACTERIAL ADHESION; STAINLESS-STEEL; TITANIUM; INFECTIONS
AB In this work, we found the characteristics of an antibacterial TiAgN thin film coated on the pure titanium specimen via the physical vapor deposition process (PVD). TiAgN thin films were coated using TiAg alloy targets by arc ion plating method. Changing the process parameters, the surface analysis of TiAgN thin film was observed by FE-SEM and the force of adhesion was measured with Scratch Tester. The proliferation of human gingival fibroblast (HGF) cells was examined by XTT test assay and the antibacterial properties were investigated by culturing Streptococus Mutans (KCTC 3065) using paper disk techniques. At the result of experiment, cytotoxic effects were not found and the antibacterial effects against Streptococus Mutans were appeared over 5 wt% TiAgN specimens.
C1 [Kang, Byeong-Mo; Lim, Yeong-Seog] Chonnam Natl Univ, Dept Elect & Comp Engn, Kwangju 500757, South Korea.
   [Jeong, Woon-Jo] OT&T Inc, Kwangju 500706, South Korea.
   [Park, Gye-Choon] Mokpo Natl Univ, Dept Elect Engn, Muan 534729, Jeonnam, South Korea.
   [Yoon, Dong-Joo] Sunchon Natl Univ, Ctr Pract Use Rate Mat, Sunchon 540742, Jeonnam, South Korea.
   [Ahn, Ho-Geun] Sunchon Natl Univ, Dept Chem Engn, Sunchon 540742, Jeonnam, South Korea.
RP Kang, BM (reprint author), Chonnam Natl Univ, Dept Elect & Comp Engn, Kwangju 500757, South Korea.
FU Ministry of Trade, Industry and Energy (MOTIE); Korea Institute for
   Advancement of Technology (KIAT); Honam Institute for Regional Program
   Evaluation through the Leading Industry Development for Economic Region
FX This research was financially supported by the Ministry of Trade,
   Industry and Energy (MOTIE), Korea Institute for Advancement of
   Technology (KIAT) and Honam Institute for Regional Program Evaluation
   through the Leading Industry Development for Economic Region.
CR Bahna P, 2007, INT J ANTIMICROB AG, V29, P593, DOI 10.1016/j.ijantimicag.2006.12.013
   Berry C W, 1992, Implant Dent, V1, P59, DOI 10.1097/00008505-199200110-00006
   Dan ZG, 2005, THIN SOLID FILMS, V492, P93, DOI 10.1016/j.tsf.2005.06
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   ELAGLI K, 1992, BIOMATERIALS, V13, P25, DOI 10.1016/0142-9612(92)90090-B
   Elias C. N., 2008, BIOL MAT SCI JOM, V3, P46
   Hsieh JH, 2008, SURF COAT TECH, V202, P5586, DOI 10.1016/j.surfcoat.2008.06.107
   Jeyachandran YL, 2007, MAT SCI ENG C-BIO S, V27, P35, DOI 10.1016/j.msec.2006.01.004
   Joo YK, 2009, MATERIALS, V2, P699, DOI 10.3390/ma2020699
   JOSHI RI, 1988, J MED MICROBIOL, V27, P105, DOI 10.1099/00222615-27-2-105
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Wang HF, 2011, J MATER SCI TECHNOL, V27, P309, DOI 10.1016/S1005-0302(11)60067-4
   Zhang W, 2008, SURF COAT TECH, V203, P909, DOI 10.1016/j.surfcoat.2008.08.023
   Zhao Q, 2007, APPL SURF SCI, V253, P7254, DOI 10.1016/j.apsusc.2007.03.011
NR 14
TC 3
Z9 3
U1 1
U2 34
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2015
VL 15
IS 8
BP 6020
EP 6023
DI 10.1166/jnn.2015.10417
PG 4
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC3RW
UT WOS:000350268100083
PM 26369190
DA 2018-10-20
ER

PT J
AU Nagasawa, D
   Azuma, T
   Noguchi, H
   Uosaki, K
   Takai, M
AF Nagasawa, Daiki
   Azuma, Tomoyuki
   Noguchi, Hidenori
   Uosaki, Kohei
   Takai, Madoka
TI Role of Interfacial Water in Protein Adsorption onto Polymer Brushes as
   Studied by SFG Spectroscopy and QCM
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; SUM-FREQUENCY GENERATION; QUARTZ-CRYSTAL
   MICROBALANCE; TRANSFER RADICAL POLYMERIZATION; ISOTOPIC DILUTION
   SPECTROSCOPY; MOLECULAR SIMULATION; VIBRATIONAL SPECTROSCOPY;
   ZWITTERIONIC POLYMERS; PHOSPHOLIPID POLYMERS; SURFACE INTERACTIONS
AB The adsorption of large biomolecules such as proteins is of high relevance in medicine; adsorbed proteins can initiate undesirable biOlogice reactions such as blood coagulation or immune responses, which adversely affect the human body and the functioning of medical devices. Thus, the suppression of protein adsorption onto material surfaces is essential for medical and biomedical applications. Interfacial water molecules may play a key role in protein adsorption. In this context, in this study, we prepare various types of surfaces (hydrophobic, hydrophilic, anionic, cationic, and zwitterionic) using polymer brushes with different molecular structures. We analyze the adsorption of negatively and positively charged proteins using a quartz crystal microbalance (QCM) to quantitatively investigate protein adsorption onto the polymer brush surfaces. The structure of the interface between the polymer brushes and water media is investigated using sum frequency generation (SFG) spectroscopy. Our comparison of the protein adsorption characteristics with the properties of the interfacial water molecules of each polymer brush indicates that the interfacial water molecules, which strongly interact with polymer brushes, are important for suppressing protein adsorption. The findings can significantly contribute to the functional biomaterial design.
C1 [Nagasawa, Daiki; Azuma, Tomoyuki; Takai, Madoka] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Noguchi, Hidenori; Uosaki, Kohei] NIMS, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan.
   [Noguchi, Hidenori; Uosaki, Kohei] NIMS, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan.
RP Takai, M (reprint author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM takai@bis.t.u-tokyo.ac.jp
OI Uosaki, Kohei/0000-0001-8886-3270
FU World Premier International Research Center (WPI) Initiative on
   Materials Nanoarchitectonics from the Ministry of Education, Culture,
   Sports, Science and Technology of Japan
FX This work was supported by the Grant-in-Aid for Scientific Research on
   Innovative Areas "Molecular Soft-Interface Science" and World Premier
   International Research Center (WPI) Initiative on Materials
   Nanoarchitectonics from the Ministry of Education, Culture, Sports,
   Science and Technology of Japan. The authors thank K. Kushiro from the
   University of Tokyo for helpful discussions and comments.
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Anderson A, 2009, LANGMUIR, V25, P11549, DOI 10.1021/la901459b
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bednarek M, 2007, J POLYM SCI POL CHEM, V45, P333, DOI 10.1002/pola.21784
   Bharti B, 2011, LANGMUIR, V27, P9823, DOI 10.1021/la201898v
   Bonn M, 2012, BIOINTERPHASES, V7, P1
   Carter D. C., 1994, ADV PROTEIN CHEM
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313
   Feiler AA, 2007, J COLLOID INTERF SCI, V315, P475, DOI 10.1016/j.jcis.2007.07.029
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Ghi PY, 2002, BIOMACROMOLECULES, V3, P991, DOI 10.1021/bm0200332
   Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kitano H, 2005, MACROMOL BIOSCI, V5, P314, DOI 10.1002/mabi.200400212
   Kitano K, 2009, COLLOID SURFACE B, V74, P350, DOI 10.1016/j.colsurfb.2009.08.004
   Kondo T, 2012, COLLOID SURFACE B, V100, P126, DOI 10.1016/j.colsurfb.2012.05.008
   Kondo T, 2012, COLLOID SURFACE B, V91, P215, DOI 10.1016/j.colsurfb.2011.11.012
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Leng C, 2015, J PHYS CHEM C, V119, P8775, DOI 10.1021/acs.jpcc.5b01649
   Leung BO, 2012, LANGMUIR, V28, P5724, DOI 10.1021/la204805x
   Li GZ, 2008, BIOMATERIALS, V29, P4592, DOI 10.1016/j.biomaterials.2008.08.021
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   McDonald S, 2001, MACROMOLECULES, V34, P8600, DOI 10.1021/ma0115186
   Mondal JA, 2012, J AM CHEM SOC, V134, P7842, DOI 10.1021/ja300658h
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998
   Pyun J, 2003, MACROMOL RAPID COMM, V24, P1043, DOI 10.1002/marc.200300078
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodriguez O, 2003, POLYMER, V44, P6323, DOI 10.1016/S0032-3861(03)00654-2
   Shao Q, 2010, J PHYS CHEM B, V114, P16625, DOI 10.1021/jp107272n
   Shen YR, 2006, CHEM REV, V106, P1140, DOI 10.1021/cr040377d
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Sovago M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173901
   Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173
   Tajima N, 2011, ANAL CHEM, V83, P1969, DOI 10.1021/ac1026786
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tian CS, 2009, CHEM PHYS LETT, V470, P1, DOI 10.1016/j.cplett.2009.01.016
   Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063
   Tsuruta T, 2010, J BIOMAT SCI-POLYM E, V21, P1831, DOI 10.1163/092050610X488269
   Uosaki K, 2010, J AM CHEM SOC, V132, P17271, DOI 10.1021/ja107265q
   Wu J, 2012, LANGMUIR, V28, P7436, DOI 10.1021/la300394c
   Xie Y, 2012, APPL SURF SCI, V258, P8153, DOI 10.1016/j.apsusc.2012.05.013
   Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242
   Yu GB, 2014, J PHYS CHEM B, V118, P4451, DOI 10.1021/jp409326f
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhao C, 2013, BIOMATERIALS, V34, P4714, DOI 10.1016/j.biomaterials.2013.03.028
   Zheng J, 2004, LANGMUIR, V20, P8931, DOI 10.1021/la036345n
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
NR 57
TC 28
Z9 28
U1 7
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD JUL 30
PY 2015
VL 119
IS 30
BP 17193
EP 17201
DI 10.1021/acs.jpcc.5b04186
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CO3BP
UT WOS:000359031900018
DA 2018-10-20
ER

PT J
AU Wang, Y
   Zhang, DM
   Wen, CE
   Li, YC
AF Wang, Yu
   Zhang, Dongmei
   Wen, Cuie
   Li, Yuncang
TI Processing and Characterization of SrTiO3-TiO2 Nanoparticle-Nanotube
   Heterostructures on Titanium for Biomedical Applications
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE TiO2 nanotube; SeTiO3-TiO2 nanoparticle-nanotube heterostructure;
   surface energy; biocompatibility; SaOS2 cell
ID SUBSTITUTED HYDROXYAPATITE COATINGS; TIO2 NANOTUBES; HYDROTHERMAL
   SYNTHESIS; STRONTIUM RANELATE; CELL RESPONSE; IN-VITRO; SURFACE;
   OSTEOBLAST; ALLOYS; ARRAYS
AB Surface properties such as physicochemical characteristics and topographical parameters of biomaterials, essentially determining the interaction between the biological cells and the biomaterial, are important considerations in the design of implant materials. In this study, a layer of SrTiO3TiO2 nanoparticlenanotube heterostructures on titanium has been fabricated via anodization combined with a hydrothermal process. Titanium was anodized to create a layer of titania (TiO2) nanotubes (TNTs), which was then decorated with a layer of SrTiO3 nanoparticles via hydrothermal processing. SrTiO3-TiO2 heterostructures with high and low volume fraction of SrTiO3 nanoparticle (denoted by 6.3-Sr/TNTs and 1.4-Sr/TNTs) were achieved by using a hydrothermal processing time of 12 and 3 h, respectively. The in vitro biocompatibility of the SrTiO3-TiO2 heterostructures was assessed by using osteoblast cells (SaOS(2)). Our results indicated that the SrTiO3-TiO2 heterostructures with different volume fractions of SrTiO3 nanoparticles exhibited different Sr ion release in cell culture media and different surface energies. An appropriate volume fraction of SrTiO3 in the heterostructures stimulated the secretion of cell filopodia, leading to enhanced biocompatibility in terms of cell attachment, anchoring, and proliferation on the heterostructure surface.
C1 [Wang, Yu; Zhang, Dongmei] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia.
   [Wen, Cuie; Li, Yuncang] RIMET Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
RP Li, YC (reprint author), RIMET Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
EM yuncang.li@rmit.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772
FU NHMRC [GNT1087290]
FX The authors are grateful to Paul Morrison, School of Applied Sciences,
   RMIT University, for his technical support in the ion concentration
   analysis using ICP-MS. C.W. and Y.L. acknowledge the support for this
   research by NHMRC through Grant GNT1087290.
CR Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013
   Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Carre A, 2007, J ADHES SCI TECHNOL, V21, P961, DOI 10.1163/156856107781393875
   Cheng H, 2014, J BIOMED MATER RES A, V102, P3488, DOI 10.1002/jbm.a.35019
   Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Davies John E, 2003, J Dent Educ, V67, P932
   Eckert JO, 1996, J AM CERAM SOC, V79, P2929, DOI 10.1111/j.1151-2916.1996.tb08728.x
   Fu Y.F., 2005, J ORAL TISSUE ENG, V2, P76
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Gum D., 2007, J PHYS CHEM C, V111, P13393
   Jiao ZB, 2014, CHEM-EUR J, V20, P2654, DOI 10.1002/chem.201304135
   Kabaso D, 2011, COMPUT METHOD BIOMEC, V14, P469, DOI 10.1080/10255842.2010.534986
   LENCKA MM, 1995, CHEM MATER, V7, P18, DOI 10.1021/cm00049a006
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopez MCB, 2000, J EUR CERAM SOC, V20, P107
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Narayanan R, 2011, MATER CHEM PHYS, V125, P510, DOI 10.1016/j.matchemphys.2010.10.024
   Ni GX, 2012, J BIOMED MATER RES B, V100B, P562, DOI 10.1002/jbm.b.31986
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Pors Nielsen S., 2004, BONE, V35, P583, DOI DOI 10.1016/J.B0NE.2004.04.026
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Schmidt-Stein F, 2009, ELECTROCHEM COMMUN, V11, P2077, DOI 10.1016/j.elecom.2009.08.036
   Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027
   Sekine K, 2013, IEEE ENG MED BIO, P858, DOI 10.1109/EMBC.2013.6609636
   Shrestha N. K, 2009, ANGEW CHEM, V121, P987
   Song YY, 2009, J AM CHEM SOC, V131, P4230, DOI 10.1021/ja810130h
   Textor M, 2001, ENG MAT SER, P171
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang Y, 2014, J BIOMED MATER RES A, V102, P743, DOI 10.1002/jbm.a.34738
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xin YC, 2009, ACS NANO, V3, P3228, DOI 10.1021/nn9007675
   Yin P, 2014, J BIOMED MATER RES A, V102, P621, DOI 10.1002/jbm.a.34723
   Zhang J, 2010, ACS NANO, V4, P387, DOI 10.1021/nn901087c
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
NR 47
TC 14
Z9 14
U1 6
U2 87
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUL 29
PY 2015
VL 7
IS 29
BP 16018
EP 16026
DI 10.1021/acsami.5b04304
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CO1ES
UT WOS:000358897200039
PM 26136139
DA 2018-10-20
ER

PT J
AU Song, X
   Wang, L
   Niinomi, M
   Nakai, M
   Liu, Y
AF Song, Xiu
   Wang, Lei
   Niinomi, Mitsuo
   Nakai, Masaaki
   Liu, Yang
TI Fatigue characteristics of a biomedical beta-type titanium alloy with
   titanium boride
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Biomaterial; beta-type titanium alloy; Fatigue strength; Titanium boride
ID MECHANICAL-PROPERTIES; TI-29NB-13TA-4.6ZR ALLOY; CORROSION BEHAVIOR;
   TI-6AL-4V ELI; MICROSTRUCTURE; COMPOSITES; FIXATION; DESIGN; FLUID;
   BORON
AB A beta-type Ti-29Nb-13Ta-4.6Zr (TNTZ) alloy containing various amounts of TiB reinforcements has been developed to achieve higher fatigue strength for biomedical applications. Fatigue tests were performed at room temperature, and the effects of TiB on fatigue crack initiation and propagation were investigated. The results indicate that the fatigue limit of the TNTZ alloy was substantially improved by the TiB reinforcements. However, the fatigue strength first increased and subsequently decreased as the B concentration increased. TNTZ alloy with 0.10% B has the largest fatigue limit, which is 67% greater than that of the TNTZ alloy. The effects of TiB on the improvement of the fatigue properties are due to the following two factors. First, sliding of the dislocations can be blocked by TiB particles, which results in resistance to fatigue crack initiation. In addition, the crack deflection and crack bridging by the TiB particles could delay the crack propagation. Conversely, debonding of some larger TiB particles may occur, especially when the B concentration is higher than 0.20%. Therefore, the crack initiates from the debonding of the TiB particles and easily propagates along the voids from the interfacial decohesion, which could exert a deleterious influence on the fatigue strength. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Song, Xiu; Wang, Lei; Liu, Yang] Northeastern Univ, Sch Met & Mat, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Peoples R China.
   [Niinomi, Mitsuo; Nakai, Masaaki] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Wang, L (reprint author), Northeastern Univ, Sch Met & Mat, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Peoples R China.
EM wanglei@mail.neu.edu.cn
FU National Natural Science Foundation of China, China [51301037];
   Fundamental Research Funds for the Central Universities [N140204001];
   Doctoral Fund of Liaoning Province, China [20131036]
FX This research work was financially supported by the National Natural
   Science Foundation of China, China (51301037) and the Fundamental
   Research Funds for the Central Universities (N140204001), and the
   Doctoral Fund of Liaoning Province, China (20131036).
CR Akahori T, 1998, MAT SCI ENG A-STRUCT, V243, P237, DOI 10.1016/S0921-5093(97)00807-1
   Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Chen W, 2010, INT J FATIGUE, V32, P799, DOI 10.1016/j.ijfatigue.2009.06.002
   Dai SJ, 2013, T NONFERR METAL SOC, V23, P3027, DOI 10.1016/S1003-6326(13)62829-0
   Diomidis N, 2011, WEAR, V271, P1093, DOI 10.1016/j.wear.2011.05.010
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Huang LJ, 2009, SCRIPTA MATER, V60, P996, DOI 10.1016/j.scriptamat.2009.02.032
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Laheurte P, 2010, J MECH BEHAV BIOMED, V3, P565, DOI 10.1016/j.jmbbm.2010.07.001
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Narita K, 2012, J MECH BEHAV BIOMED, V9, P207, DOI 10.1016/j.jmbbm.2012.01.011
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Quast JP, 2008, MAT SCI ENG A-STRUCT, V497, P1, DOI 10.1016/j.msea.2008.07.045
   Sarkar R, 2011, MAT SCI ENG A-STRUCT, V528, P4819, DOI 10.1016/j.msea.2011.03.014
   Song X, 2011, MAT SCI ENG A-STRUCT, V528, P5600, DOI 10.1016/j.msea.2011.03.108
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   Wang LQ, 2010, MAT SCI ENG A-STRUCT, V527, P1058, DOI 10.1016/j.msea.2009.09.022
   Xie LC, 2014, INT J FATIGUE, V66, P127, DOI 10.1016/j.ijfatigue.2014.03.019
   Yilbas BS, 2009, J MATER PROCESS TECH, V209, P1199, DOI 10.1016/j.jmatprotec.2008.03.024
   Zhang XH, 2003, MAT SCI ENG A-STRUCT, V348, P41
NR 25
TC 6
Z9 7
U1 3
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUL 29
PY 2015
VL 640
BP 154
EP 164
DI 10.1016/j.msea.2015.05.078
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA CN7PN
UT WOS:000358626600017
DA 2018-10-20
ER

PT J
AU Raftery, RM
   Tierney, EG
   Curtin, CM
   Cryan, SA
   O'Brien, FJ
AF Raftery, Rosanne M.
   Tierney, Erica G.
   Curtin, Caroline M.
   Cryan, Sally-Ann
   O'Brien, Fergal J.
TI Development of a gene-activated scaffold platformfor tissue engineering
   applications using chitosan-pDNA nanoparticles on collagen-based
   scaffolds
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Chitosan nanoparticles; Gene delivery; Mesenchymal stem cells (MSCs);
   Gene-activated scaffold; Tissue engineering
ID IN-VIVO; TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; DNA NANOPARTICLES;
   DELIVERY-SYSTEM; GAG SCAFFOLDS; BONE REGENERATION; NONVIRAL VECTORS;
   PROTON SPONGE; THERAPY
AB Biomaterial scaffolds that support cell infiltration and tissue formation can also function as platforms for the delivery of therapeutics such as drugs, proteins, and genes. As burst release of supraphysiological quantities of recombinant proteins can result in adverse side effects, the objective of this study was to explore the potential of a series of collagen-based scaffolds, developed in our laboratory, as gene-activated scaffold platforms with potential in a range of tissue engineering applications. The potential of chitosan, a biocompatible material derived from the shells of crustaceans, as a gene delivery vector was assessed using mesenchymal stem cells (MSCs). A transfection efficiency of >45% is reported which is similar to what is achieved with polyethyleneimine (PEI), a non-viral gold standard vector, without causing cytotoxic side effects. When the optimised chitosan nanoparticles were incorporated into a series of collagen-based scaffolds, sustained transgene expression from MSCs seeded on the scaffolds was maintained for up to 28 days and interestingly the composition of the scaffold had an effect on transfection efficiency. These results demonstrate that by simply varying the scaffold composition and the gene (or combinations thereof) chosen; the systemhas potential for amyriad of therapeutic applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; Cryan, Sally-Ann; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Dublin, Ireland.
   [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; Cryan, Sally-Ann; O'Brien, Fergal J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Dublin, Ireland.
   [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; O'Brien, Fergal J.] RCSI, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland.
   [Raftery, Rosanne M.; Tierney, Erica G.; Curtin, Caroline M.; O'Brien, Fergal J.] TCD, Dublin, Ireland.
   [Cryan, Sally-Ann] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Dublin, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Dublin, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Raftery,
   Rosanne/0000-0001-7820-0246; Cryan, Sally-Ann/0000-0002-3941-496X
FU Science Foundation Ireland (SFI) Research Frontiers Programme
   [11/RFP/ENM/3053]; European Research Council under the European
   Community's Seventh Framework Programme (FP7)/ERC [239685]
FX This work was funded by Science Foundation Ireland (SFI) Research
   Frontiers Programme (Grant No. 11/RFP/ENM/3053) and the European
   Research Council under the European Community's Seventh Framework
   Programme (FP7/2007-2013)/ERC grant agreement No. 239685. Collagen
   materials were provided by Integra Life Sciences, Inc. through a
   Material Transfer Agreement. We also thank Dr. M. Sawkins and the Centre
   for Research on Adaptive Nanostructures and Nanodevices (CRANN), Trinity
   College Dublin, for their help with SEM and AFM imaging.
CR Agirre M, 2014, POLYMERS-BASEL, V6, P1727, DOI 10.3390/polym6061727
   Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Behr JP, 1997, CHIMIA, V51, P34
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Djurovic S, 2004, MOL BIOTECHNOL, V28, P21, DOI 10.1385/MB:28:1:21
   Garaiova Z, 2012, INT J BIOL MACROMOL, V51, P1043, DOI 10.1016/j.ijbiomac.2012.08.016
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616
   Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Ishii T, 2001, BBA-BIOMEMBRANES, V1514, P51, DOI 10.1016/S0005-2736(01)00362-5
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Klausner EA, 2010, BIOMATERIALS, V31, P1814, DOI 10.1016/j.biomaterials.2009.10.031
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Lee RJ, 2000, CIRCULATION, V102, P898
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lundstrom K, 2003, TECHNOL CANCER RES T, V2, P471, DOI 10.1177/153303460300200513
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Malakooty Poor E., 2013, ARTIF CELL NANOMED B, V1, P1
   Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/s0939-641(03)00155-3
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   Miyazaki M, 2009, EUR SPINE J, V18, P783, DOI 10.1007/s00586-009-0924-x
   Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021
   Mumper R.J., 1995, P INT S CONTR REL BI, V22, P178
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Puras G, 2013, EUR J PHARM BIOPHARM, V83, P131, DOI 10.1016/j.ejpb.2012.09.010
   Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021
   Regnstrom K, 2006, PHARM RES, V23, P475, DOI 10.1007/s11095-006-9563-7
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Romoren K, 2003, INT J PHARM, V261, P115, DOI 10.1016/S0378-5173(03)00301-6
   Sambrook J, 1989, MOL CLONING LAB MANU, P6
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Schaffert D, 2008, GENE THER, V15, P1131, DOI 10.1038/gt.2008.105
   Strand SP, 2010, BIOMATERIALS, V31, P975, DOI 10.1016/j.biomaterials.2009.09.102
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Tierney EG, 2012, J CONTROL RELEASE, V158, P304, DOI 10.1016/j.jconrel.2011.11.026
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
NR 60
TC 26
Z9 26
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 28
PY 2015
VL 210
BP 84
EP 94
DI 10.1016/j.jconrel.2015.05.005
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CK5CC
UT WOS:000356238700010
PM 25982680
DA 2018-10-20
ER

PT J
AU Gammon, JM
   Tostanoski, LH
   Adapa, AR
   Chiu, YC
   Jewell, CM
AF Gammon, Joshua M.
   Tostanoski, Lisa H.
   Adapa, Arjun R.
   Chiu, Yu-Chieh
   Jewell, Christopher M.
TI Controlled delivery of a metabolic modulator promotes regulatory T cells
   and restrains autoimmunity
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Nanoparticle; Tolerance; Biomaterial; Immunotherapy; Metabolism;
   Autoimmunity; Immunology; Vaccine
ID METABOTROPIC GLUTAMATE-RECEPTOR; TOLEROGENIC DENDRITIC CELLS;
   CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ADAPTIVE IMMUNITY; MYELIN;
   ANTIGEN; ENCEPHALOMYELITIS; MICE; NANOPARTICLES
AB Autoimmune disorders occur when the immune system abnormally recognizes and attacks self-molecules. Dendritic cells (DCs) play a powerful role in initiating adaptive immune response, and are therefore a recent target for autoimmune therapies. N-Phenyl-7-(hydroxyimino) cyclopropa[ b] chromen-1a-carboxamide (PHCCC), a small molecule glutamate receptor enhancer, alters how DCs metabolize glutamate, skewing cytokine secretion to bias T cell function. These effects provide protection in mouse models of multiple sclerosis (MS) by polarizing T cells away from inflammatory T(H)17 cells and toward regulatory T cells (T-REG) when mice receive daily systemic injections of PHCCC. However, frequent, continued treatment is required to generate and maintain therapeutic benefits. Thus, the use of PHCCC is limited by poor solubility, the need for frequent dosing, and cell toxicity. We hypothesized that controlled release of PHCCC from degradable nanoparticles (NPs) might address these challenges by altering DC function to maintain efficacy with reduced treatment frequency and toxicity. This idea could serve as a new strategy for harnessing biomaterials to polarize immune function through controlled delivery of metabolic modulators. PHCCC was readily encapsulated in nanoparticles, with controlled release of 89% of drug into media over three days. Culture of primary DCs or DC and T cell co-cultures with PHCCC NPs reduced DC activation and secretion of pro-inflammatory cytokines, while shifting T cells away from T(H)17 and toward T-REG phenotypes. Importantly, PHCCC delivered to cells in NPs was 36-fold less toxic compared with soluble PHCCC. Treatment of mice with PHCCC NPs every three days delayed disease onset and decreased disease severity compared with mice treated with soluble drug at the same dose and frequency. These results highlight the potential to promote tolerance through controlled delivery of metabolic modulators that alter DC signaling to polarize T cells, and suggest future gains that could be realized by engineering materials that provide longer term release. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Gammon, Joshua M.; Tostanoski, Lisa H.; Adapa, Arjun R.; Chiu, Yu-Chieh; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
RP Jewell, CM (reprint author), Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
OI Tostanoski, Lisa/0000-0001-9255-5684; Jewell,
   Christopher/0000-0002-6668-6928
FU NSF CAREER Award [1351688]; National Multiple Sclerosis Society
   [PP2103]; Pharmaceutics division of the PhRMA Foundation [13071672];
   Damon Runyon Foundation [DDR3415]; Alliance for Cancer Gene Therapy
   [15051543]; Melanoma Research Alliance [348963];  [DGE1322106]
FX This work was supported in part by NSF CAREER Award # 1351688, the
   National Multiple Sclerosis Society # PP2103, and the Pharmaceutics
   division of the PhRMA Foundation # 13071672. CMJ is a Damon
   Runyon-Rachleff Innovator supported by the Damon Runyon Foundation (#
   DDR3415), a Young Investigator supported by the Alliance for Cancer Gene
   Therapy (# 15051543), and a Young Investigator support by the Melanoma
   Research Alliance (# 348963). LHT is a NSF Graduate Research Fellow
   supported by grant # DGE1322106.
CR Andorko J.I., 2014, AAPS J, V17, P323
   Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603
   Comabella M, 2012, CLIN IMMUNOL, V142, P2, DOI 10.1016/j.clim.2011.03.004
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Fallarino F, 2010, NAT MED, V16, P897, DOI 10.1038/nm.2183
   Fazio F, 2014, NEUROPHARMACOLOGY, V81, P237, DOI 10.1016/j.neuropharm.2014.02.011
   Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011
   Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036
   Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358
   Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168
   Lutterotti A, 2014, EXPERT OPIN INV DRUG, V23, P9, DOI 10.1517/13543784.2014.844788
   Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5
   Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111
   McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507
   MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Niswender CM, 2008, MOL PHARMACOL, V74, P1345, DOI 10.1124/mol.108.049551
   Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163
   Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555
   Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Spampinato Simona Federica, 2014, Front Cell Neurosci, V8, P462, DOI 10.3389/fncel.2014.00462
   Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1
   Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
NR 34
TC 15
Z9 17
U1 3
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 28
PY 2015
VL 210
BP 169
EP 178
DI 10.1016/j.jconrel.2015.05.277
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CK5CC
UT WOS:000356238700018
PM 26002150
OA Other Gold
DA 2018-10-20
ER

PT J
AU Yang, WK
   Chang, EJ
   Lee, WK
AF Yang, Won-Kyue
   Chang, Eun-Ju
   Lee, Woo-Kul
TI Alendronate-calcium phosphate hybrid films promoted the osteoblast
   differentiation and inhibited osteoclastogenic activity
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Calcium phosphate; Alendronate; Proliferation; Differentiation;
   Osteoblast; Osteoclast
ID NITROGEN-CONTAINING BISPHOSPHONATES; MESENCHYMAL STEM-CELLS; MARROW
   STROMAL CELLS; IN-VITRO; BONE; PROLIFERATION; HYDROXYAPATITE;
   NANOPARTICLES; OSTEOPOROSIS; MODULATION
AB Surface property of biomaterials is a crucial factor determining the biocompatibility of a biomaterial. In this study, we aimed at evaluating the feasibility of alendronate (ALN) and CP hybrid films (CPAs) to promote bone regeneration. Experimental analysis elucidated that ALN incorporation promoted osteoblast proliferation and differentiation, phenotype gene expression, phase shift from differentiation into mineralization, and bone-like nodule formation. Inhibitory effect on the formation of multinucleated osteoclast was substantial. Therefore, the hybrid films can enhance osteogenic responses while inducing anti-osteoclastic effects. We expect the hybrid films can be potentially utilized for the promotion of bone regeneration. (C) 2015 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Yang, Won-Kyue; Lee, Woo-Kul] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Coll Engn, Dept Chem Engn, Cheonan, South Korea.
   [Chang, Eun-Ju] Univ Ulsan, Coll Med, Dept Biomed Sci, Ulsan 680749, South Korea.
   [Chang, Eun-Ju] Univ Ulsan, Man Med Ctr, Ulsan 680749, South Korea.
RP Lee, WK (reprint author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Coll Engn, Dept Chem Engn, Cheonan, South Korea.
EM leewo@dankook.ac.kr
CR Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Boanini E, 2012, BONE, V51, P944, DOI 10.1016/j.bone.2012.07.020
   Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897
   Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022
   Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217
   Coleman R, 2011, ANN NY ACAD SCI, V1218, P3, DOI 10.1111/j.1749-6632.2010.05766.x
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
   Duque G, 2007, J BONE MINER RES, V22, P1603, DOI 10.1359/JBMR.070701
   Elliott Susan N., 1998, Life Sciences, V62, P77
   Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7
   Haynes DR, 2004, BIOMATERIALS, V25, P4877, DOI 10.1016/j.biomaterials.2004.01.003
   Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024
   Inoue Y, 2010, EXP CLIN ENDOCR DIAB, V118, P719, DOI 10.1055/s-0030-1249084
   Jung JY, 2009, J MATER SCI-MATER M, V20, P2441, DOI 10.1007/s10856-009-3817-y
   Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lourwood DL, 1998, PHARMACOTHERAPY, V18, P779
   Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Monkkonen J., 1998, LIFE SCI, V62, pL95
   Moon HJ, 2011, BIOCHEM BIOPH RES CO, V413, P194, DOI 10.1016/j.bbrc.2011.08.057
   Moreau J.L., 2009, BIOMATERIALS, V30, P675
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800
   Price P.A., 1988, ANNU REV NUTR, V8, P865
   Ringe JD, 2001, J CLIN ENDOCR METAB, V86, P5252, DOI 10.1210/jc.86.11.5252
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640
   Schnitzler V, 2011, ACTA BIOMATER, V7, P759, DOI 10.1016/j.actbio.2010.09.017
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122
   Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502
   VANBEEK E, 1994, J BONE MINER RES, V9, P1875, DOI 10.1002/jbmr.5650091206
   von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059
   Xiong Y, 2009, J INT MED RES, V37, P407, DOI 10.1177/147323000903700216
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Zhu Y, 2013, BIOMACROMOLECULES, V14, P342, DOI 10.1021/bm301523p
NR 41
TC 5
Z9 5
U1 5
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
EI 1876-794X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD JUL 25
PY 2015
VL 27
BP 391
EP 397
DI 10.1016/j.jiec.2015.01.019
PG 7
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CL8LC
UT WOS:000357225200050
DA 2018-10-20
ER

PT J
AU Matos, AC
   Marques, CF
   Pinto, RV
   Ribeiro, IAC
   Goncalves, LM
   Vaz, MA
   Ferreira, JMF
   Almeida, AJ
   Bettencourt, AF
AF Matos, Ana C.
   Marques, Catarina F.
   Pinto, Rosana V.
   Ribeiro, Isabel A. C.
   Goncalves, Ldia M.
   Vaz, Mario A.
   Ferreira, J. M. F.
   Almeida, Antonio J.
   Bettencourt, Ana F.
TI Novel doped calcium phosphate-PMMA bone cement composites as
   levofloxacin delivery systems
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Poly(methylmethacrylate); Biphasic calcium phosphate; Fluoroquinolone;
   Controlled release; Osteomyelitis; Biocompatibility; Drug delivery
   system
ID DRUG-DELIVERY; ANTIBIOTIC DELIVERY; HYDROXYAPATITE; RELEASE;
   REPLACEMENT; INFECTIONS; SURVIVAL; COATINGS
AB Antibiotic-loaded acrylic bone cements (ALABCs) are well-established and cost-effective materials to control the occurrence of bone and joint infections. However, the inexistence of alternative antibiotics other than those already commercially available and the poor ability to bind to bone tissue hampering its biological function are still major drawbacks of ALABCs clinical application. The concept of this research work is to develop a novel bone cement (BC) drug delivery system composed by Mg- and Sr-doped calcium phosphate (CaP) particles as drug carriers loaded into a lactose-modified acrylic BC, which, to the best of our knowledge, has never been reported. CaP particles are known to promote bone ingrowth and current research is focused on using these carriers as antibiotic delivery systems for the treatment of bone infections, like osteomyelitis. Levofloxacin is a fluoroquinolone with anti-staphylococcal activity and adequate penetration into osteoarticular tissues and increasingly being recommended to manage bone-related infections. Also, the lactose-modified BC matrix, with a more porous structure, has already proved to enhance antibiotic release from the BC inner matrix. This novel BC composite biomaterial has shown improved mechanical integrity, biocompatibility maintenance, and sustained release of levofloxacin, with concentrations over the minimum inhibitory concentration values after a 48 h while maintaining antibacterial activity over an 8-week period against Staphyloccocus aureus and Staphyloccocus epidermidis, common pathogens associated with bone infections. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Matos, Ana C.; Pinto, Rosana V.; Ribeiro, Isabel A. C.; Goncalves, Ldia M.; Almeida, Antonio J.; Bettencourt, Ana F.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, IMed ULisboa, P-1649003 Lisbon, Portugal.
   [Marques, Catarina F.; Ferreira, J. M. F.] Univ Aveiro, CICECO, Dept Mat & Ceram Engn, P-3810193 Aveiro, Portugal.
   [Vaz, Mario A.] Univ Porto, Fac Engn, INEGI, P-4200465 Oporto, Portugal.
RP Bettencourt, AF (reprint author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, IMed ULisboa, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.
EM asimao@ff.ulisboa.pt
RI Bettencourt, Ana/M-4219-2013; Vaz, Mario/I-5613-2015; iMed.ULisboa,
   CBT/B-4215-2014; Almeida, Antonio/I-6590-2012; iMed.ULisboa,
   NanoBB/B-5393-2014; Ribeiro, Isabel/A-6098-2014; iMed.ULisboa,
   iMed.ULisboa/C-6292-2014
OI Bettencourt, Ana/0000-0002-8498-5892; Vaz, Mario/0000-0002-6347-9608;
   Almeida, Antonio/0000-0002-7807-4726; Ribeiro,
   Isabel/0000-0002-7110-6393; Ferreira, Jose/0000-0002-7520-2809; Pinto,
   Flavia/0000-0002-8523-5479; Goncalves, Lidia/0000-0002-6799-2740;
   Marques, Catarina/0000-0002-3650-1830
FU CICECO; Portuguese government through the "Fundacao para a Ciencia e
   Tecnologia (FCT), Portugal" [EXCL/CTM-NAN/0166/2012,
   PEst-OE/SAU/UI4013/2011, SFRH/BD/78355/2011]
FX The authors gratefully acknowledge to Professor Jose Esteves from
   INEGI/FEUP, U. Porto, for the helpful availability throughout all the
   mechanical assays and to Nuno Monge for image on graphical artwork. The
   support of CICECO is also acknowledged. Authors thank the Portuguese
   government through the "Fundacao para a Ciencia e Tecnologia (FCT),
   Portugal" for financial support in the frame of the research project
   EXCL/CTM-NAN/0166/2012 and strategic project PEst-OE/SAU/UI4013/2011 and
   the Ph.D. grant SFRH/BD/78355/2011.
CR [Anonymous], 2009, 109935 ISO
   Bettencourt A, 2002, INT J PHARM, V241, P97, DOI 10.1016/S0378-5173(02)00136-9
   Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8
   Bettencourt AF, 2007, FREE RADICAL BIO MED, V43, pS44
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08
   Canul-Chuil A, 2003, J BIOMED MATER RES B, V64B, P27, DOI 10.1002/jbm.b.10486
   Clinical and Laboratory Standards Institute [CLSI], 2007, M100S17 CLSI
   Clinical Laboratory Standards Institute (CLSI), 2012, M07M09 CLSI, pM07
   Dall'Oca C, 2014, EUR J HISTOCHEM, V58, P95, DOI 10.4081/ejh.2014.2255
   de Lima IR, 2011, J BIOMED MATER RES A, V98A, P351, DOI 10.1002/jbm.a.33126
   Frutos G, 2010, ACTA BIOMATER, V6, P804, DOI 10.1016/j.actbio.2009.08.028
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057
   Hosseinzadeh H. R. S., 2013, ACRYLIC BONE CEMENT
   Hurst M, 2002, DRUGS, V62, P2127, DOI 10.2165/00003495-200262140-00013
   *ISO, 2002, 5833 ISO
   Jameson SS, 2015, ACTA ORTHOP, V86, P7, DOI 10.3109/17453674.2014.972256
   Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Lewis G, 2009, J BIOMED MATER RES B, V89B, P558, DOI 10.1002/jbm.b.31220
   Lin Y., 2014, J ANTIBIOT, P1
   Liu S, 2014, CARBOHYD POLYM, V102, P869, DOI 10.1016/j.carbpol.2013.10.076
   Lopez-Heredia MA, 2012, ACTA BIOMATER, V8, P3120, DOI 10.1016/j.actbio.2012.05.007
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI DOI 10.2174/1877610801002010040
   Matos AC, 2015, INT J PHARMACEUT, V485, P317, DOI 10.1016/j.ijpharm.2015.03.035
   Matos AC, 2014, MAT SCI ENG C-MATER, V38, P218, DOI 10.1016/j.msec.2014.02.002
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Pina S, 2010, EUR CELLS MATER, V20, P162
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   Sa Y, 2015, J BIOMED MATER RES B, V103, P548, DOI 10.1002/jbm.b.33233
   Shi M, 2010, BIOMATERIALS, V31, P4146, DOI 10.1016/j.biomaterials.2010.01.112
   Siepmann J, 2012, ADV DEL SCI TECHNOL, P127, DOI 10.1007/978-1-4614-0881-9_6
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Uskokovic V, 2015, CRIT REV THER DRUG, V32, P1
   Uskokovic V, 2014, MAT SCI ENG C-MATER, V37, P210, DOI 10.1016/j.msec.2014.01.008
   WU S, 1971, J POLYM SCI POL SYM, P19
   Zebarjad S. M., 2011, ENGINEERING, V3, P795, DOI DOI 10.4236/ENG.2011.38096
   Zhou Y, 2014, COLLOID SURFACE B, V115, P237, DOI 10.1016/j.colsurfb.2013.11.045
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zimmerli W., 2015, BONE JOINT INFECT MI
NR 45
TC 11
Z9 12
U1 1
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JUL 25
PY 2015
VL 490
IS 1-2
BP 200
EP 208
DI 10.1016/j.ijpharm.2015.05.038
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CL3FV
UT WOS:000356836700023
PM 26002570
DA 2018-10-20
ER

PT J
AU Neufurth, M
   Wang, XH
   Tolba, E
   Dorweiler, B
   Schroder, HC
   Link, T
   Diehl-Seifert, B
   Muller, WEG
AF Neufurth, Meik
   Wang, Xiaohong
   Tolba, Emad
   Dorweiler, Bernhard
   Schroeder, Heinz C.
   Link, Thorben
   Diehl-Seifert, Baerbel
   Mueller, Werner E. G.
TI Modular Small Diameter Vascular Grafts with Bioactive Functionalities
SO PLOS ONE
LA English
DT Article
ID POLYELECTROLYTE MULTILAYER FILMS; ENDOTHELIAL-CELLS; INORGANIC
   POLYPHOSPHATE; IN-VIVO; CALCIUM POLYPHOSPHATE; ALKALINE-PHOSPHATASE;
   BLOOD-VESSEL; VE-CADHERIN; STEM-CELLS; ALGINATE
AB We report the fabrication of a novel type of artificial small diameter blood vessels, termed biomimetic tissue-engineered blood vessels (bTEBV), with a modular composition. They are composed of a hydrogel scaffold consisting of two negatively charged natural polymers, alginate and a modified chitosan, N,O-carboxymethyl chitosan (N,O-CMC). Into this biologically inert scaffold two biofunctionally active biopolymers are embedded, inorganic polyphosphate (polyP) and silica, as well as gelatin which exposes the cell recognition signal, Arg-Gly-Asp (RGD). These materials can be hardened by exposure to Ca2+ through formation of Ca2+ bridges between the polyanions, alginate, N, O-CMC, and polyP (alginate-Ca2+-N,O-CMC-polyP). The bTEBV are formed by pressing the hydrogel through an extruder into a hardening solution, containing Ca2+. In this universal scaffold of the bTEBV biomaterial, polycations such as poly(L-Lys), poly(D-Lys) or a His/Gly-tagged RGD peptide (three RGD units) were incorporated, which promote the adhesion of endothelial cells to the vessel surface. The mechanical properties of the biopolymer material (alginate-Ca2+-N,O-CMC-polyP-silica) revealed a hardness (elastic modulus) of 475 kPa even after a short incubation period in CaCl2 solution. The material of the artificial vascular grafts (bTEBVs with an outer size 6 mm and 1.8 mm, and an inner diameter 4 mm and 0.8 mm, respectively) turned out to be durable in 4-week pulsatile flow experiments at an alternating pressure between 25 and 100 mbar (18.7 and 75.0 mm Hg). The burst pressure of the larger (smaller) vessels was 850 mbar (145 mbar). Incorporation of polycationic poly(L-Lys), poly(D-Lys), and especially the His/Gly-tagged RGD peptide, markedly increased the adhesion of human, umbilical vein/vascular endothelial cells, EA.HY926 cells, to the surface of the hydrogel. No significant effect of the polyP samples on the clotting of human plasma is measured. We propose that the metabolically degradable polymeric scaffold bTEBV is a promising biomaterial for future prosthetic vascular grafts.
C1 [Neufurth, Meik; Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Link, Thorben; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, D-55128 Mainz, Germany.
   [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Cardiothorac & Vasc Surg, Div Vasc Surg, D-55131 Mainz, Germany.
   [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, D-55128 Mainz, Germany.
RP Muller, WEG (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wang013@uni-mainz.de; wmueller@uni-mainz.de
RI Neufurth, Meik/N-4297-2015
OI Neufurth, Meik/0000-0002-2383-6412; Tolba, Emad/0000-0002-3422-2344
FU NanotecMARIN GmbH; European Research Council (ERC) Advanced Investigator
   Grant ("BIOSILICA") [268476]; ERC-PoC Grant ("MorphoVES-PoC") [662486];
   Deutsche Forschungsgemeinschaft [Schr 277/10-3]; European Commission
   [604036, 311848]; International Human Frontier Science Program
FX NanotecMARIN GmbH provided support in the form of salaries for the
   author BDS, but did not have any additional role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section. WEGM is a holder of a European Research
   Council (ERC) Advanced Investigator Grant ("BIOSILICA": No. 268476) and
   the ERC-PoC Grant ("MorphoVES-PoC": No. 662486). This work was supported
   by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-3), the
   European Commission ("Bio-Scaffolds": No. 604036 and "BlueGenics": No.
   311848), and the International Human Frontier Science Program.
CR AHN K, 1995, LIFE SCI, V56, P2331, DOI 10.1016/0024-3205(95)00227-W
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Anitha A., 2011, J BIOMAT SCI-POLYM E, V23, P1381, DOI DOI 10.1163/092050611X581534
   [Anonymous], 2013, REPORT A270
   [Anonymous], 2010, HEART DISEASE AND ST
   BARSTAD RM, 1995, BLOOD, V86, P212
   Bergmeister H, 2013, EUR SURG, V45, P187, DOI 10.1007/s10353-013-0224-x
   Biswas R, 2010, SEMIN DIALYSIS, V23, P105, DOI 10.1111/j.1525-139X.2009.00684.x
   Boura C, 2006, BIO-MED MATER ENG, V16, pS115
   Boura C, 2006, CELL BIOCHEM BIOPHYS, V44, P223, DOI 10.1385/CBB:44:2:223
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   BREWSTER DC, 2000, VASCULAR SURG, P559
   Brini Marisa, 2013, Met Ions Life Sci, V13, P81, DOI 10.1007/978-94-007-7500-8_4
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4
   Campos DFD, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015003
   Catto V, 2014, ISRN VASC MED, V2014, P1, DOI [10.1155/2014/923030, DOI 10.1155/2014/923030]
   Chavan D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766959
   Chavan D, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3579496
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811
   Comeau PA, 2012, J BIOMATER APPL, V27, P267, DOI 10.1177/0885328211401933
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Demirkhanyan L, 2014, BIOPHYS J, V106, p753A, DOI 10.1016/j.bpj.2013.11.4145
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062
   Embi A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-51
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870
   Faxalv L, 2013, BLOOD, V122, P3818, DOI 10.1182/blood-2013-05-499384
   Felner JM, 1990, CLINICAL METHODS THE, P57
   Fischer-Cripps AC, 2011, MECH ENG SER, P21, DOI 10.1007/978-1-4419-9872-9_2
   Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100
   Gu ZP, 2014, RSC ADV, V4, P2783, DOI 10.1039/c3ra44323j
   Hanson SR, 2006, ANN NY ACAD SCI, V516, P453
   He W, 2013, CELL BIOCHEM BIOPHYS, V66, P855, DOI 10.1007/s12013-013-9528-5
   Heng BC, 2011, BIOTECHNOL BIOPROC E, V16, P127, DOI 10.1007/s12257-010-0141-9
   Hojo K, 2013, PROTEIN PEPTIDE LETT, V20, P1122
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kader KN, 2000, TISSUE ENG, V6, P241, DOI 10.1089/10763270050044425
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Kulaev IS, 2004, THE BIOCHEMISTRY OF, P1
   KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Lee KY, 1997, J APPL POLYM SCI, V63, P425, DOI 10.1002/(SICI)1097-4628(19970124)63:4<425::AID-APP3>3.0.CO;2-T
   Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803
   Linderman S, 2014, FASEB J SUPPL 546 9, V28, P5469
   Loh SA, 2013, ANN VASC SURG, V27, P208, DOI 10.1016/j.avsg.2012.04.018
   Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5
   MacQuarrie JL, 2011, BLOOD, V117, P4134, DOI 10.1182/blood-2010-07-290551
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823
   Mori K, 2007, ONCOL REP, V18, P1365
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Muller WEG, 2015, J TISSUE ENG REGEN M, V9, pE39, DOI 10.1002/term.1745
   Muller WEG, 2015, J MATER CHEM B, V3, P1722, DOI 10.1039/c4tb01586j
   Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j
   Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007
   Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001
   Muller WEG, 2014, Patent application, Patent No. [1413154. 4, 14131544]
   Neufurth M, 2014, BIOMATERIALS, V35, P8810, DOI 10.1016/j.biomaterials.2014.07.002
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Nikolova-Krstevski V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-240
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Pradeepa R, 2012, DIABETES TECHNOL THE, V14, pS59, DOI 10.1089/dia.2012.0065
   Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200
   Sachs L, 1984, ANGEW STAT, P242
   Sakairi N, 1998, CARBOHYD POLYM, V37, P409, DOI 10.1016/S0144-8617(97)00226-9
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Santos MF, 1997, AM J PHYSIOL-GASTR L, V273, pG175
   Sarkar S, 2006, J VASC SURG, V44, P846, DOI 10.1016/j.jvs.2006.07.023
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Schroder HC, 2003, PROG MOLEC, V33, P249
   Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108
   Smith PJ, 2004, CURR PROTOC CYTOM, V7, P725, DOI [10.1002/0471142956.cy0725s28, DOI 10.1002/0471142956.CY0725S28]
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Takei Takayuki, 2006, Biotechnology Journal, V1, P1014, DOI 10.1002/biot.200600055
   Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   VANDERLUGT A, 1995, EUR J VASC ENDOVASC, V9, P394, DOI 10.1016/S1078-5884(05)80006-1
   VANSON JAM, 1990, J THORAC CARDIOV SUR, V99, P703
   Varty K, 1996, BRIT J SURG, V83, P1375, DOI 10.1002/bjs.1800831015
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100
   Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131
   Welschoff J, 2014, FASEB J, V28, P2281, DOI 10.1096/fj.13-246348
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   YOSHIKI S, 1970, HISTOCHEMISTRY, V21, P249, DOI 10.1007/BF00304216
   Zidi M, 2003, COMPUT BIOL MED, V33, P65, DOI 10.1016/S0010-4825(02)00059-8
   Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29
NR 95
TC 5
Z9 5
U1 2
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 23
PY 2015
VL 10
IS 7
AR e0133632
DI 10.1371/journal.pone.0133632
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN7NJ
UT WOS:000358621000034
PM 26204529
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Serpooshan, V
   Mahmoudi, M
   Zhao, MM
   Wei, K
   Sivanesan, S
   Motamedchaboki, K
   Malkovskiy, AV
   Goldstone, AB
   Cohen, JE
   Yang, PC
   Rajadas, J
   Bernstein, D
   Woo, YJ
   Ruiz-Lozano, P
AF Serpooshan, Vahid
   Mahmoudi, Morteza
   Zhao, Mingming
   Wei, Ke
   Sivanesan, Senthilkumar
   Motamedchaboki, Khatereh
   Malkovskiy, Andrey V.
   Goldstone, Andrew B.
   Cohen, Jeffrey E.
   Yang, Phillip C.
   Rajadas, Jayakumar
   Bernstein, Daniel
   Woo, Y. Joseph
   Ruiz-Lozano, Pilar
TI Protein Corona Influences Cell-Biomaterial Interactions in
   Nanostructured Tissue Engineering Scaffolds
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE collagen; in situ biosensors; nanostructures; personalized biomaterials;
   protein corona; tissue engineering; scaffolds
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; POST MYOCARDIAL-INFARCTION;
   NANOPARTICLE INTERACTIONS; HYDRAULIC PERMEABILITY; PLASTIC COMPRESSION;
   STEM-CELLS; BIOMARKERS; SECRETOME; PROMOTES; DISEASE
AB Biomaterials are extensively used to restore damaged tissues, in the forms of implants (e.g., tissue engineered scaffolds) or biomedical devices (e.g., pacemakers). Once in contact with the physiological environment, nanostructured biomaterials undergo modifications as a result of endogenous proteins binding to their surface. The formation of this macromolecular coating complex, known as protein corona, onto the surface of nanoparticles and its effect on cell-particle interactions are currently under intense investigation. In striking contrast, protein corona constructs within nanostructured porous tissue engineering scaffolds remain poorly characterized. As organismal systems are highly dynamic, it is conceivable that the formation of distinct protein corona on implanted scaffolds might itself modulate cell-extracellular matrix interactions. Here, it is reported that corona complexes formed onto the fibrils of engineered collagen scaffolds display specific, distinct, and reproducible compositions that are a signature of the tissue microenvironment as well as being indicative of the subject's health condition. Protein corona formed on collagen matrices modulated cellular secretome in a context-specific manner ex vivo, demonstrating their role in regulating scaffold-cellular interactions. Together, these findings underscore the importance of custom-designing personalized nanostructured biomaterials, according to the biological milieu and disease state. The use of protein corona as in situ biosensor of temporal and local biomarkers is proposed.
C1 [Serpooshan, Vahid; Mahmoudi, Morteza; Yang, Phillip C.; Rajadas, Jayakumar; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Serpooshan, Vahid; Zhao, Mingming; Bernstein, Daniel; Ruiz-Lozano, Pilar] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.
   [Mahmoudi, Morteza; Yang, Phillip C.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Wei, Ke] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.
   [Sivanesan, Senthilkumar; Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.
   [Motamedchaboki, Khatereh] Sanford Burnham Med Res Inst, Prote Facil, La Jolla, CA 92037 USA.
   [Goldstone, Andrew B.; Cohen, Jeffrey E.; Woo, Y. Joseph] Stanford Univ, Med Ctr, Dept Cardiothorac Surg, Stanford, CA 94305 USA.
RP Serpooshan, V (reprint author), Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
EM mahmoudi@stanford.edu; prlozano@stanford.edu
RI Mahmoudi, Morteza/L-5332-2017
OI Mahmoudi, Morteza/0000-0002-2575-9684
FU National Institutes of Health [HL65484, HL086879, NIH R01 HL095571]; NIG
   [HL061535]
FX V.S. and M.M. contributed equally to this work. This work was supported
   by National Institutes of Health grants HL65484 and HL086879 (to
   P.R.-L.) and NIH R01 HL095571 (to Y.J.W.). V.S. was an Oak Foundation
   postdoctoral fellow at Stanford. D.B. was supported by NIG grant
   HL061535. K.W. was a SBMRI California Institute for Regenerative
   Medicine postdoctoral fellow (TG2-01162).
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Artym VV, 2010, CURRENT PROTOCOLS CE, V10, P1, DOI DOI 10.1002/0471143030.CB1018S48
   Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577
   Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001
   Breuls Roel G M, 2008, Open Orthop J, V2, P103, DOI 10.2174/1874325000802010103
   Brill LM, 2009, METHODS, V48, P311, DOI 10.1016/j.ymeth.2009.02.023
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652
   Chen HP, 2014, EXP CELL RES, V323, P346, DOI 10.1016/j.yexcr.2014.02.028
   de la Cuesta Fernando, 2013, Methods Mol Biol, V1005, P237, DOI 10.1007/978-1-62703-386-2_19
   Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Duffy PA, 2007, EJC SUPPL, V5, P143, DOI 10.1016/S1359-6349(07)70034-4
   Ghavami M., 2012, RSC ADV, V3, P1119
   Kelly PM, 2015, NAT NANOTECHNOL, V10, P472, DOI [10.1038/nnano.2015.47, 10.1038/NNANO.2015.47]
   Laurent S, 2013, J COLLOID INTERF SCI, V392, P431, DOI 10.1016/j.jcis.2012.10.005
   Li X, 2014, J PROTEOMICS, V98, P138, DOI 10.1016/j.jprot.2013.12.025
   Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248
   Mahmoudi M, 2014, NANO LETT, V14, P6, DOI 10.1021/nl403419e
   Mahmoudi M, 2013, ACS NANO, V7, P8379, DOI 10.1021/nn403844q
   Mahmoudi M, 2012, NANOSCALE, V4, P5461, DOI 10.1039/c2nr31185b
   Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g
   Mahmoudi M, 2011, NANOSCALE, V3, P1127, DOI 10.1039/c0nr00733a
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h
   Monopoli MP, 2011, NAT NANOTECHNOL, V6, P11, DOI 10.1038/nnano.2011.267
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Panahloo A, 2003, ATHEROSCLEROSIS, V168, P297, DOI 10.1016/S0021-9150(03)00095-9
   Serpooshan V, 2014, BIOENGINEERED, V5, DOI 10.4161/bioe.27751
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Serpooshan V, 2013, ACTA BIOMATER, V9, P4673, DOI 10.1016/j.actbio.2012.08.031
   Serpooshan V, 2011, SOFT MATTER, V7, P2918, DOI 10.1039/c0sm00691b
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028
   Shimano M, 2012, CIRCULATION, V126, pE327, DOI 10.1161/CIRCULATIONAHA.112.150656
   Spector M, 2002, TISSUE ENG, V8, P351, DOI 10.1089/107632702760184628
   Tardif JC, 2006, CIRCULATION, V113, P2936, DOI 10.1161/CIRCULATIONAHA.105.598987
   Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Vivanco F, 2005, J PROTEOME RES, V4, P1181, DOI 10.1021/pr0500197
   Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
NR 42
TC 13
Z9 13
U1 1
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUL 22
PY 2015
VL 25
IS 28
BP 4379
EP 4389
DI 10.1002/adfm.201500875
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CN5WR
UT WOS:000358504000001
PM 27516731
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Schultz, KM
   Kyburz, KA
   Anseth, KS
AF Schultz, Kelly M.
   Kyburz, Kyle A.
   Anseth, Kristi S.
TI Measuring dynamic cell-material interactions and remodeling during 3D
   human mesenchymal stem cell migration in hydrogels
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE PEG-peptide hydrogels; human mesenchymal stem cells; cell migration;
   microrheology
ID PARTICLE TRACKING MICRORHEOLOGY; ENGINEERED PEG HYDROGELS;
   CROSS-LINKING; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; DEGRADATION;
   ANGIOGENESIS; PROTEOLYSIS; TRANSITION; MICROSCOPY
AB Biomaterials that mimic aspects of the extracellular matrix by presenting a 3D microenvironment that cells can locally degrade and remodel are finding increased applications as wound-healing matrices, tissue engineering scaffolds, and even substrates for stem cell expansion. In vivo, cells do not simply reside in a static microenvironment, but instead, they dynamically reengineer their surroundings. For example, cells secrete proteases that degrade extracellular components, attach to the matrix through adhesive sites, and can exert traction forces on the local matrix, causing its spatial reorganization. Although biomaterials scaffolds provide initially well-defined microenvironments for 3D culture of cells, less is known about the changes that occur over time, especially local matrix remodeling that can play an integral role in directing cell behavior. Here, we use microrheology as a quantitative tool to characterize dynamic cellular remodeling of peptide-functionalized poly(ethylene glycol) (PEG) hydrogels that degrade in response to cell-secreted matrix metalloproteinases (MMPs). This technique allows measurement of spatial changes in material properties during migration of encapsulated cells and has a sensitivity that identifies regions where cells simply adhere to the matrix, as well as the extent of local cell remodeling of the material through MMP-mediated degradation. Collectively, these microrheological measurements provide insight into microscopic, cellular manipulation of the pericellular region that gives rise to macroscopic tracks created in scaffolds by migrating cells. This quantitative and predictable information should benefit the design of improved biomaterial scaffolds for medically relevant applications.
C1 [Schultz, Kelly M.] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.
   [Kyburz, Kyle A.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Kyburz, Kyle A.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Schultz, KM (reprint author), Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.
EM kes513@lehigh.com; Kristi.Anseth@colorado.edu
FU Howard Hughes Medical Institute; National Science Foundation [CTS
   1236662]; National Institutes of Health [RO1DE016523]
FX We acknowledge Dr. Jennifer Leight for helpful discussion. Funding for
   this work was provided by Howard Hughes Medical Institute, the National
   Science Foundation (CTS 1236662), and the National Institutes of Health
   (RO1DE016523).
CR ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026
   Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Alkhouli N, 2013, AM J PHYSIOL-ENDOC M, V305, pE1427, DOI 10.1152/ajpendo.00111.2013
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738
   Crocker J. C., 2011, PARTICLE TRACKING US
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Guvendiren M, 2013, CURR OPIN BIOTECH, V24, P841, DOI 10.1016/j.copbio.2013.03.009
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.3.CO;2-V
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kyburz KA, 2013, ACTA BIOMATER, V9, P6381, DOI 10.1016/j.actbio.2013.01.026
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mascall KS, 2012, J CELL SCI, V125, P2267, DOI 10.1242/jcs.099044
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975
   Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reed MJ, 2003, MICROVASC RES, V65, P9, DOI 10.1016/S0026-2862(02)00026-2
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Schultz KM, 2013, SOFT MATTER, V9, P1570, DOI 10.1039/c2sm27303a
   Schultz KM, 2012, ACS MACRO LETT, V1, P706, DOI 10.1021/mz300106y
   Schultz KM, 2012, SOFT MATTER, V8, P6198, DOI 10.1039/c2sm25187f
   Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/nmat3025, 10.1038/NMAT3025]
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tseng Q, 2014, PIV PARTICLE IMAGE V
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
NR 48
TC 43
Z9 43
U1 4
U2 97
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 21
PY 2015
VL 112
IS 29
BP E3757
EP E3764
DI 10.1073/pnas.1511304112
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN2BJ
UT WOS:000358225100005
PM 26150508
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Shiwaku, Y
   Neff, L
   Nagano, K
   Takeyama, KI
   de Bruijn, J
   Dard, M
   Gori, F
   Baron, R
AF Shiwaku, Yukari
   Neff, Lynn
   Nagano, Kenichi
   Takeyama, Ken-Ichi
   de Bruijn, Joost
   Dard, Michel
   Gori, Francesca
   Baron, Roland
TI The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the
   Composition and Structure of Biphasic Calcium Phosphates
SO PLOS ONE
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; BONE-FORMATION; SPHINGOSINE 1-PHOSPHATE;
   SEALING ZONE; RESORPTION; HYDROXYAPATITE; DIFFERENTIATION; ACTIVATION;
   TISSUE; CELLS
AB Biphasic calcium phosphates (BCPs), consisting of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), exhibit good biocompatibility and osteoconductivity, maintaining a balance between resorption of the biomaterial and formation of new bone. We tested whether the chemical composition and/or the microstructure of BCPs affect osteoclasts (OCs) differentiation and/or their ability to crosstalk with osteoblasts (OBs). To this aim, OCs were cultured on BCPs with HA content of 5, 20 or 60% and their differentiation and activity were assessed. We found that OC differentiation is partially impaired by increased HA content, but not by the presence of micropores within BCP scaffolds, as indicated by TRAP staining and gene profile expression. We then investigated whether the biomaterial-induced changes in OC differentiation also affect their ability to crosstalk with OBs and regulate OB function. We found that BCPs with low percentage of HA favored the expression of positive coupling factors, including sphingosine-kinase 1 (SPHK1) and collagen triple helix repeat containing 1 (Cthrc1). In turn, the increase of these secreted coupling factors promotes OB differentiation and function. All together our studies suggest that the chemical composition of biomaterials affects not only the differentiation and activity of OCs but also their potential to locally regulate bone formation.
C1 [Shiwaku, Yukari; Neff, Lynn; Nagano, Kenichi; Takeyama, Ken-Ichi; Gori, Francesca; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.
   [Baron, Roland] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA USA.
   [de Bruijn, Joost] Xpand Biotechnol BV, Bilthoven, Netherlands.
   [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY 10003 USA.
RP Baron, R (reprint author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.
EM Roland_Baron@hsdm.harvard.edu
FU Straumann
FX This work was supported by Straumann in the form of research support for
   Dr. Baron's laboratory at Harvard.
CR Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Benahmed MD, 1996, J HISTOCHEM CYTOCHEM, V44, P1131, DOI 10.1177/44.10.8813078
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954
   Ghanaati S, 2012, BIOMEDICAL MAT, V7
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Gonda Y, 2009, BIOMATERIALS, V30, P4390, DOI 10.1016/j.biomaterials.2009.05.002
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7
   Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008
   Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840
   Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187
   Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621
   Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489
   Okuda T, 2007, BIOMATERIALS, V28, P2612, DOI 10.1016/j.biomaterials.2007.01.040
   Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106
   Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037
   Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001
   Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215
   Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493
   Tanaka T, 2010, J BIOMED MATER RES A, V93A, P469, DOI 10.1002/jbm.a.32560
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012
NR 48
TC 12
Z9 12
U1 4
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 20
PY 2015
VL 10
IS 7
AR e0132903
DI 10.1371/journal.pone.0132903
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN6LN
UT WOS:000358546400042
PM 26193362
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Premnath, P
   Tan, B
   Venkatakrishnan, K
AF Premnath, P.
   Tan, B.
   Venkatakrishnan, K.
TI Engineering functionalized multi-phased silicon/silicon oxide
   nano-biomaterials to passivate the aggressive proliferation of cancer
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; LASER; CELL;
   NANOSTRUCTURES; FABRICATION; DOXORUBICIN; RELEASE; SURFACE; SIZE
AB Currently, the use of nano silicon in cancer therapy is limited as drug delivery vehicles and markers in imaging, not as manipulative/controlling agents. This is due to limited properties that native states of nano silicon and silicon oxides offers. We introduce nano-functionalized multi-phased silicon/silicon oxide biomaterials synthesized via ultrashort pulsed laser synthesis, with tunable properties that possess inherent cancer controlling properties that can passivate the progression of cancer. This nanostructured biomaterial is composed of individual functionalized nanoparticles made of a homogenous hybrid of multiple phases of silicon and silicon oxide in increasing concentration outwards from the core. The chemical properties of the proposed nanostructure such as number of phases, composition of phases and crystal orientation of each functionalized nanoparticle in the three dimensional nanostructure is defined based on precisely tuned ultrashort pulsed laser-material interaction mechanisms. The amorphous rich phased biomaterial shows a 30 fold (95%) reduction in number of cancer cells compared to bulk silicon in 48 hours. Further, the size of the cancer cells reduces by 76% from 24 to 48 hours. This method exposes untapped properties of combination of multiple phases of silicon oxides and its applications in cancer therapy.
C1 [Premnath, P.; Venkatakrishnan, K.] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Tan, B.] Ryerson Univ, Dept Aerosp Engn, Toronto, ON M5B 2K3, Canada.
RP Venkatakrishnan, K (reprint author), Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
EM venkat@ryerson.ca
OI Venkatakrishnan, Krishnan/0000-0002-6491-3971; Tan,
   Bo/0000-0001-8141-4819
FU NSERC
FX The authors thanks Nabila Abraham and Dhruv Patel for assistance in
   imaging and analysis. This study was supported by NSERC.
CR Biserni E, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2461-8
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Dalby M. J., 2003, EXP CELL RES, V284, P272
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dekker RJ, 2005, BIOMATERIALS, V26, P5231, DOI 10.1016/j.biomaterials.2005.01.057
   Dey PP, 2014, APPL SURF SCI, V307, P77, DOI 10.1016/j.apsusc.2014.03.168
   Erogbogbo F, 2010, ACS NANO, V5, P413, DOI [DOI 10.1021/NN1018945, 10.1021/nn1018945]
   Erogbogbo F, 2008, ACS NANO, V2, P873, DOI 10.1021/nn700319z
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Jin CY, 2008, CHEM RES TOXICOL, V21, P1871, DOI 10.1021/tx800179f
   Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524
   Li L, 2014, BIOSENS BIOELECTRON, V61, P76, DOI 10.1016/j.bios.2014.05.012
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m
   Meseguer-Olmo L, 2006, J ORTHOP RES, V24, P454, DOI 10.1002/jor.20064
   Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Monem AS, 2014, INT J PHARMACEUT, V470, P1, DOI 10.1016/j.ijpharm.2014.04.067
   Nisbet D. R., 2008, J BIOMATER APPL, V27, P269
   Odachi G, 2013, APPL SURF SCI, V282, P525, DOI 10.1016/j.apsusc.2013.06.005
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   Ravichandran R, 2013, J BIOMAT SCI-POLYM E, V24, P1988, DOI 10.1080/09205063.2013.816930
   Rosenholm JM, 2008, ACS NANO, V3, P197
   Shi L, 2014, J MATER CHEM B, V2, P2658, DOI 10.1039/c4tb00016a
   Sivayoganathan M, 2012, OPT MATER EXPRESS, V2, P987, DOI 10.1364/OME.2.000987
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Srinivasan S, 2014, J PHOTOCH PHOTOBIO B, V136, P81, DOI 10.1016/j.jphotobiol.2014.04.012
   Tavangar A, 2013, J APPL PHYS, V113, DOI 10.1063/1.4771667
   Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087
   Ullmann M, 2002, J NANOPART RES, V4, P499, DOI 10.1023/A:1022840924336
   Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333
   Xiao L, 2011, ACS NANO, V5, P3651, DOI 10.1021/nn1035262
   Zhang Q, 2012, ADV FUNCT MATER, V22, P5144, DOI 10.1002/adfm.201201316
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138
NR 35
TC 5
Z9 5
U1 0
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 20
PY 2015
VL 5
AR 12141
DI 10.1038/srep12141
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1HU
UT WOS:000358170300001
PM 26190009
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nakajima, K
   Fujita, J
   Matsui, M
   Tohyama, S
   Tamura, N
   Kanazawa, H
   Seki, T
   Kishino, Y
   Hirano, A
   Okada, M
   Tabei, R
   Sano, M
   Goto, S
   Tabata, Y
   Fukuda, K
AF Nakajima, Kazuaki
   Fujita, Jun
   Matsui, Makoto
   Tohyama, Shugo
   Tamura, Noriko
   Kanazawa, Hideaki
   Seki, Tomohisa
   Kishino, Yoshikazu
   Hirano, Akinori
   Okada, Marina
   Tabei, Ryota
   Sano, Motoaki
   Goto, Shinya
   Tabata, Yasuhiko
   Fukuda, Keiichi
TI Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes
   and Angiogenesis to Ameliorate Cardiac Function after Myocardial
   Infarction
SO PLOS ONE
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; HEART;
   THERAPY; INTRACORONARY; BIOMATERIALS; REGENERATION; MYOCYTES; TRIAL
AB Cell transplantation therapy will mean a breakthrough in resolving the donor shortage in cardiac transplantation. Cardiomyocyte (CM) transplantation, however, has been relatively inefficient in restoring cardiac function after myocardial infarction (MI) due to low engraftment of transplanted CM. In order to ameliorate engraftment of CM, the novel transplantation strategy must be invented. Gelatin hydrogel (GH) is a biodegradable water-soluble polymer gel. Gelatin is made of collagen. Although we observed that collagen strongly induced the aggregation of platelets to potentially cause coronary microembolization, GH did not enhance thrombogenicity. Therefore, GH is a suitable biomaterial in the cell therapy after heart failure. To assess the effect of GH on the improvement of cardiac function, fetal rat CM (5x10(6) or 1x10(6) cells) were transplanted with GH (10 mg/ml) to infarcted hearts. We compared this group with sham operated rats, CM in phosphate buffered saline (PBS), only PBS, and only GH-transplanted groups. Three weeks after transplantation, cardiac function was evaluated by echocardiography. The echocardiography confirmed that transplantation of 5x10(6) CM with GH significantly improved cardiac systolic function, compared with the CM+PBS group (fractional area change: 75.1 +/- 3.4% vs. 60.7 +/- 5.9%, p<0.05), only PBS, and only GH groups (60.1 +/- 6.5%, 65.0 +/- 2.8%, p<0.05). Pathological analyses demonstrated that in the CM+GH group, CM were efficiently engrafted in infarcted myocardium (p<0.01) and angiogenesis was significantly enhanced (p<0.05) in both central and peripheral areas of the scar. Moreover, quantitative RT-PCR revealed that angiogenic cytokines, such as basic fibroblast growth factor, vascular endothelial growth factor, and hepatocyte growth factor, were significantly enriched in the CM+GH group (p<0.05). Here, we report that GH confined the CM effectively in infarcted myocardium after transplantation, and that CM transplanted with GH improved cardiac function with a direct contraction effect and enhanced angiogenesis.
C1 [Nakajima, Kazuaki; Fujita, Jun; Tohyama, Shugo; Kanazawa, Hideaki; Seki, Tomohisa; Kishino, Yoshikazu; Okada, Marina; Tabei, Ryota; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.
   [Hirano, Akinori] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan.
   [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Field Tissue Engn,Sakyo Ku, Kyoto, Japan.
   [Tamura, Noriko; Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan.
   [Tohyama, Shugo] Japan Soc Promot Sci, Tokyo, Japan.
RP Fujita, J (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.
EM jfujita@a6.keio.jp
RI Fukuda, Keiichi/L-3777-2013
FU Highway Program for Realization of Regenerative Medicine from Japan
   Science and Technology Agency
FX The present work was supported by the Highway Program for Realization of
   Regenerative Medicine from Japan Science and Technology Agency (to KF,
   http://www.jst.go.jp/saisei-nw/highway/research/b.html).
CR Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Fujita J, 2012, AM J PHYSIOL-HEART C, V303, pH1169, DOI 10.1152/ajpheart.00376.2012
   Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198
   Goto SY, 2002, CIRCULATION, V106, P266, DOI 10.1161/01.CIR.0000021427.87256.7E
   Hato N, 2012, OTOLARYNG HEAD NECK, V146, P641, DOI 10.1177/0194599811431661
   Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Hemmi N, 2014, STEM CELL TRANSL MED, V3, P1473, DOI 10.5966/sctm.2014-0072
   Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137
   Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552
   Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016
   Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Van Belle E, 1998, CIRCULATION, V97, P381
   van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001
   YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
NR 27
TC 13
Z9 13
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 17
PY 2015
VL 10
IS 7
AR e0133308
DI 10.1371/journal.pone.0133308
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RV
UT WOS:000358198700123
PM 26186362
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wickham, A
   Sjolander, D
   Bergstrom, G
   Wang, EG
   Rajendran, V
   Hildesjo, C
   Skoglund, K
   Nilsson, KPR
   Aili, D
AF Wickham, Abeni
   Sjolander, Daniel
   Bergstrom, Gunnar
   Wang, Ergang
   Rajendran, Vijayalakshmi
   Hildesjo, Camilla
   Skoglund, Karin
   Nilsson, K. Peter R.
   Aili, Daniel
TI Near-Infrared Emitting and Pro-Angiogenic Electrospun Conjugated Polymer
   Scaffold for Optical Biomaterial Tracking
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; IN-VIVO; STEM-CELLS; CONDUCTING
   POLYMERS; NEURAL INTERFACES; SURFACE-ENERGY; SOLAR-CELLS; MICROSCOPY;
   COLLAGEN; DIFFERENTIATION
AB Noninvasive tracking of biomaterials is vital for determining the fate and degradation of an implant in vivo, and to show its role in tissue regeneration. Current biomaterials have no inherent capacity to enable tracing but require labeling with, for example, fluorescent dyes, or nanoparticles. Here a novel biocompatible fully conjugated electrospun scaffold is described, based on a semiconducting luminescent polymer that can be visualized in situ after implantation using fluorescence imaging. The polymer, poly [2,3-bis-(3-octyloxyphenyl)quinoxaline-5,8-diyl-alt -thiophene-2,5-diyl] (TQ1), is electrospun to form a fibrous mat. The fibers display fluorescence emission in the near-infrared region with lifetimes in the sub-nanosecond range, optimal for in situ imaging. The material shows no cytotoxic behaviors for embryonic chicken cardiomyocytes and mouse myoblasts, and cells migrate onto the TQ1 fibers even in the presence of a collagen substrate. Subcutaneous implantations of the material in rats show incorporation of the TQ1 fibers within the tissue, with limited inflammation and a preponderance of small capillaries around the fibers. The fluorescent properties of the TQ1 fibers are fully retained for up to 90 d following implantation and they can be clearly visualized in tissue using fluorescence and lifetime imaging, thus making it both a pro-angiogenic and traceable biomaterial.
C1 [Wickham, Abeni; Aili, Daniel] Linkoping Univ, Div Mol Phys, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
   [Sjolander, Daniel; Nilsson, K. Peter R.] Linkoping Univ, Div Organ Chem, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
   [Bergstrom, Gunnar] Linkoping Univ, Div Biotechnol, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
   [Wang, Ergang] Chalmers, Dept Chem & Chem Engn Polymer Technol, SE-41296 Gothenburg, Sweden.
   [Rajendran, Vijayalakshmi] Linkoping Univ, Integrat Regenerat Med IGEN Ctr, SE-58183 Linkoping, Sweden.
   [Rajendran, Vijayalakshmi] Linkoping Univ, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden.
   [Hildesjo, Camilla; Skoglund, Karin] Linkoping Univ Hosp, Dept Clin Pathol, Council Ostergotland, SE-58183 Linkoping, Sweden.
RP Wickham, A (reprint author), Linkoping Univ, Div Mol Phys, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
EM daniel.aili@liu.se
RI Aili, Daniel/L-2668-2013; Sjolander, Daniel/B-7813-2011; Wang,
   Ergang/F-8157-2010
OI Aili, Daniel/0000-0002-7001-9415; Sjolander, Daniel/0000-0003-2274-4062;
   Wang, Ergang/0000-0002-4942-3771; Wickham, Abeni/0000-0002-2106-0665
FU Linkoping University; Swedish Foundation for Strategic Research; Swedish
   Research Council
FX Thanks to Prof. Torkel Erhardsson for statistical guidance, to Jonas
   Bergqvist for help with photoluminescent data acquisition, Anders
   Elfwing, Dr. Luigi Petrone, Dr. Koen Vandewal, Dr. Naresh Polsetti,
   Prof. Klas I. Udekwu, and Prof. Olle Inganas for help with initial
   experiments. Also, thanks to Dr. Staffan Danmark for reviewing the
   manuscript. Prof. Jordi Altimiras kindly provided the ECCM (Linkoping
   University, Sweden). D.A. and A.W. gratefully acknowledge financial
   support from Linkoping University and the Swedish Foundation for
   Strategic Research. K.P.R.N. and D.S. acknowledge the support by the
   Swedish Foundation for Strategic Research. E.W. thanks the Swedish
   Research Council for financial support. During this study, A.W. was
   enrolled in the graduate school Forum Scientium.
CR Achelle S, 2013, DYES PIGMENTS, V98, P575, DOI 10.1016/j.dyepig.2013.03.030
   Akins RE, 2010, TISSUE ENG PT A, V16, P629, DOI 10.1089/ten.tea.2009.0458
   Appel A. A., 2021, BIOMATERIALS, V34, P6615
   Arja K, 2013, MACROMOL RAPID COMM, V34, P723, DOI 10.1002/marc.201200817
   Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v
   Bai C, 2013, CELL PROLIFERAT, V46, P232, DOI 10.1111/cpr.12024
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Biswas T, 2010, J MOL BIOL, V397, P495, DOI 10.1016/j.jmb.2010.01.053
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Burattini S, 2004, EUR J HISTOCHEM, V48, P223
   Cui MC, 2011, BIOORG MED CHEM LETT, V21, P4193, DOI 10.1016/j.bmcl.2011.05.079
   Ding D, 2011, NANOSCALE, V3, P1997, DOI 10.1039/c0nr00950d
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Fomina N, 2010, J AM CHEM SOC, V132, P9540, DOI 10.1021/ja102595j
   Formigli L, 2005, AM J PHYSIOL-CELL PH, V288, pC795, DOI 10.1152/ajpcell.00345.2004
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Harris JR, 2007, MICRON, V38, P513, DOI 10.1016/j.micron.2006.07.026
   Hedstrom S, 2012, J PHYS CHEM C, V116, P26700, DOI 10.1021/jp308063u
   Heinrich L., 2006, J BIOMED MATER RES P, V81B, P153
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278
   Hou LT, 2011, ADV FUNCT MATER, V21, P3169, DOI 10.1002/adfm.201100566
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   Kim SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014110
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Laforgue A, 2010, MACROMOLECULES, V43, P4194, DOI 10.1021/ma9027678
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]
   Nwaneshiudu A, 2012, J INVEST DERMATOL, V132, P1, DOI 10.1038/jid.2012.429
   Ostuni E, 2003, LANGMUIR, V19, P1861, DOI 10.1021/la020649c
   Petrone L, 2011, BIOFOULING, V27, P1043, DOI 10.1080/08927014.2011.625474
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Shen Y., 2014, BIOMED MATER, V9, P1
   Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326
   Stachewicz U, 2011, LANGMUIR, V27, P3024, DOI 10.1021/la1046645
   Toshima K, 2002, CHEM COMMUN, P212, DOI 10.1039/b107829c
   Tromholt T, 2012, J MATER CHEM, V22, P7592, DOI 10.1039/c2jm16340c
   Wang EG, 2010, ADV MATER, V22, P5240, DOI 10.1002/adma.201002225
   Weber K. T., 1989, MOL CELL BIOCHEM, V96, P1
   Wegenast-Braun BM, 2012, AM J PATHOL, V181, P1953, DOI 10.1016/j.ajpath.2012.08.031
   Whatmore Jacqueline L., 2002, Angiogenesis, V5, P45, DOI 10.1023/A:1021528628524
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xie J, 2014, ACTA BIOMATER, V10, P2463, DOI 10.1016/j.actbio.2014.01.031
   Yuan YY, 2014, SMALL, V10, P1967, DOI 10.1002/smll.201302765
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
NR 61
TC 9
Z9 9
U1 4
U2 64
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUL 15
PY 2015
VL 25
IS 27
BP 4274
EP 4281
DI 10.1002/adfm.201500351
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CM9AG
UT WOS:000357996600011
DA 2018-10-20
ER

PT J
AU Mahdis, S
   Youngjae, C
AF Mahdis, Shayan
   Youngjae, Chun
TI An overview of thin film nitinol endovascular devices
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Thin film nitinol; Endovascular device; Sputtering deposition;
   Hemocompatibility; Stent graft
ID SHAPE-MEMORY ALLOY; PULSED-LASER DEPOSITION; GUINIER-PRESTON ZONES;
   SPUTTER-DEPOSITION; HEART-VALVE; MECHANICAL-PROPERTIES; MEDICAL
   APPLICATIONS; FLASH EVAPORATION; PLATELET-ADHESION; SURFACE OXIDATION
AB Thin film nitinol has unique mechanical properties (e.g., superelasticity), excellent biocompatibility, and ultra-smooth surface, as well as shape memory behavior. All these features along with its low-profile physical dimension (i.e., a few micrometers thick) make this material an ideal candidate in developing low-profile medical devices (e.g., endovascular devices). Thin film nitinol-based devices can be collapsed and inserted in remarkably smaller diameter catheters for a wide range of catheter-based procedures; therefore, it can be easily delivered through highly tortuous or narrow vascular system. A high-quality thin film nitinol can be fabricated by vacuum sputter deposition technique. Micromachining techniques were used to create micro patterns on the thin film nitinol to provide fenestrations for nutrition and oxygen transport and to increase the device's flexibility for the devices used as thin film nitinol covered stent. In addition, a new surface treatment method has been developed for improving the hemocompatibility of thin film nitinol when it is used as a graft material in endovascular devices. Both in vitro and in vivo test data demonstrated a superior hemocompatibility of the thin film nitinol when compared with commercially available endovascular graft materials such as ePTFE or Dacron polyester. Promising features like these have motivated the development of thin film nitinol as a novel biomaterial for creating endovascular devices such as stent grafts, neurovascular flow diverters, and heart valves. This review focuses on thin film nitinol fabrication processes, mechanical and biological properties of the material, as well as current and potential thin film nitinol medical applications. (C) 2015 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mahdis, Shayan; Youngjae, Chun] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA.
   [Youngjae, Chun] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
RP Youngjae, C (reprint author), Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA.
EM yjchun@pitt.edu
CR Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   Bourantas CV, 2013, INT J CARDIOL, V168, P11, DOI 10.1016/j.ijcard.2013.03.065
   Brisman JL, 2005, AM J NEURORADIOL, V26, P1237
   Buehler W. J., 1962, T ASM, V55, P269
   BUSCH JD, 1990, J APPL PHYS, V68, P6224, DOI 10.1063/1.346914
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Cha JO, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-37
   Chen P, 2001, THIN SOLID FILMS, V398, P597, DOI 10.1016/S0040-6090(01)01325-6
   Chu JP, 2000, MAT SCI ENG A-STRUCT, V277, P11, DOI 10.1016/S0921-5093(99)00560-2
   Chun Y, 2011, J INTEL MAT SYST STR, V22, P1
   Chun YJ, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/105021
   Chun Y, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/5/055021
   Chun Y, 2009, MAT SCI ENG C-MATER, V29, P2436, DOI 10.1016/j.msec.2009.07.004
   Chun YJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118769
   Ciabattari F, 1997, APPL PHYS A-MATER, V64, P623, DOI 10.1007/s003390050528
   Collen KR, 1991, STRUCTURAL ELECT PRO
   de Miranda RL, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/10/104010
   Dinca VC, 2006, APPL SURF SCI, V252, P4619, DOI 10.1016/j.apsusc.2005.07.093
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2
   Gu HD, 1998, THIN SOLID FILMS, V330, P196, DOI 10.1016/S0040-6090(98)00603-8
   Gupta V, 2003, P INT C SHAP MEM SUP
   Gyobu A, 1996, HEAT TREAT, V139, P340
   Habijan T, 2012, MAT SCI ENG C-MATER, V32, P2523, DOI 10.1016/j.msec.2012.07.035
   He JL, 2000, THIN SOLID FILMS, V359, P46, DOI 10.1016/S0040-6090(99)00720-8
   Ho KK, 2002, THIN SOLID FILMS, V413, P1, DOI 10.1016/S0040-6090(02)00339-5
   Ho KK, 2000, THIN SOLID FILMS, V370, P18, DOI 10.1016/S0040-6090(00)00947-0
   Huang XY, 2003, NAT MATER, V2, P307, DOI 10.1038/nmat884
   Ikuta K., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P355, DOI 10.1109/MEMSYS.1994.556166
   Ishida A, 1999, MAT SCI ENG A-STRUCT, V273, P754, DOI 10.1016/S0921-5093(99)00410-4
   Ishida A, 1995, MATER T JIM, V36, P1349, DOI 10.2320/matertrans1989.36.1349
   Ishida A, 1997, METALL MATER TRANS A, V28, P1985, DOI 10.1007/s11661-997-0155-x
   Ishida A, 2003, ACTA MATER, V51, P5571, DOI 10.1016/S1359-6454(03)00420-8
   Ishida A, 2001, MATER TRANS, V42, P1060, DOI 10.2320/matertrans.42.1060
   ISHIDA A, 1993, THIN SOLID FILMS, V228, P210, DOI 10.1016/0040-6090(93)90600-T
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Jarrige I, 2004, THIN SOLID FILMS, V458, P314, DOI 10.1016/j.tsf.2003.12.039
   Kajiwara S, 1996, PHIL MAG LETT, V74, P395, DOI 10.1080/095008396179922
   Kauffman GB, 1997, CHEM ED, V21, P1, DOI DOI 10.1007/S00897970111A]
   Kealey CP, 2010, BIOMATERIALS, V31, P8864, DOI 10.1016/j.biomaterials.2010.08.014
   Kikuchi T, 1998, PHILOS MAG A, V78, P467
   KIM JJ, 1986, SCRIPTA METALL MATER, V20, P243, DOI 10.1016/0036-9748(86)90135-3
   Kuribayashi K, 2006, MAT SCI ENG A-STRUCT, V419, P131, DOI 10.1016/j.msea.2005.12.016
   Lee HJ, 2009, SCRIPTA MATER, V60, P1133, DOI 10.1016/j.scriptamat.2009.02.054
   Lee HJ, 2006, MATER TRANS, V47, P527, DOI 10.2320/matertrans.47.527
   Lee YJ, 2005, NEURORADIOLOGY, V47, P680, DOI 10.1007/s00234-005-1402-8
   Lehnert T, 2002, J MATER SCI, V37, P1523, DOI 10.1023/A:1014904415916
   Lehnert T, 1999, MAT SCI ENG A-STRUCT, V273, P713, DOI 10.1016/S0921-5093(99)00402-5
   Levi DS, 2008, ASAIO J, V54, P221, DOI 10.1097/MAT.0b013e31816b43b0
   Machado LG, 2003, BRAZ J MED BIOL RES, V36, P683, DOI 10.1590/S0100-879X2003000600001
   Makino E, 1999, SENSOR ACTUAT A-PHYS, V75, P156, DOI 10.1016/S0924-4247(99)00003-5
   Makino E, 1998, SENSOR ACTUAT A-PHYS, V71, P187, DOI 10.1016/S0924-4247(98)00180-0
   Malisch TW, 1997, J NEUROSURG, V87, P176, DOI 10.3171/jns.1997.87.2.0176
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   MIYAZAKI S, 1994, MATER T JIM, V35, P14, DOI 10.2320/matertrans1989.35.14
   Mohanchandra KP, 2008, MATER LETT, V62, P3481, DOI 10.1016/j.matlet.2008.03.028
   Mohanchandra KP, 2011, MATER LETT, V65, P1184, DOI 10.1016/j.matlet.2011.01.037
   Nair K, 2003, SADHANA-ACAD P ENG S, V28, P575, DOI 10.1007/BF02706448
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Petrini L, 2011, J METALL, V2011, P41
   Qian LM, 2005, TRIBOL LETT, V18, P463, DOI 10.1007/s11249-005-3606-9
   Quandt E, 1996, SENSOR ACTUAT A-PHYS, V53, P434, DOI 10.1016/0924-4247(96)01147-8
   Rigberg D, 2009, J VASC SURG, V50, P375, DOI 10.1016/j.jvs.2009.03.028
   Saatci I, 2004, AM J NEURORADIOL, V25, P1742
   Samaroo HD, 2008, INT J NANOMED, V3, P75
   Sanjabi S, 2005, THIN SOLID FILMS, V491, P190, DOI 10.1016/j.tsf.2005.06.004
   Sanjabi S, 2009, SCI IRAN TRANS B, V16, P248
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SEKIGUCHI Y, 1983, P 32 M JAP SOC MAT, P65
   Serruys Patrick W., 2002, HDB CORONARY STENTS
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Simka W, 2010, ELECTROCHIM ACTA, V55, P2437, DOI 10.1016/j.electacta.2009.11.097
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SRINIVASAN S, 1970, J COLLOID INTERF SCI, V32, P456, DOI 10.1016/0021-9797(70)90131-1
   Stepan LL, 2007, J BIOMED MATER RES A, V82A, P768, DOI 10.1002/jbm.a.31192
   Stepan LL, 2005, J BIOMECH ENG-T ASME, V127, P915, DOI 10.1115/1.2049311
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Stone GW, 2012, J AM COLL CARDIOL, V60, P1975, DOI 10.1016/j.jacc.2012.09.004
   Szold A, 2006, SURG ENDOSC, V20, P1493, DOI 10.1007/s00464-005-0867-1
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Tulloch AW, 2011, J SURG RES, V171, P317, DOI 10.1016/j.jss.2010.01.014
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   WALKER JA, 1990, SENSOR ACTUAT A-PHYS, V21, P243, DOI 10.1016/0924-4247(90)85047-8
   Wang X, 2006, SCRIPTA MATER, V54, P925, DOI 10.1016/j.scriptamat.2005.10.061
   Zhang JX, 2003, ACTA MATER, V51, P3121, DOI 10.1016/S1359-6454(03)00124-1
   Zhang JX, 2001, ACTA MATER, V49, P3001, DOI 10.1016/S1359-6454(01)00204-X
NR 87
TC 13
Z9 13
U1 4
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 15
PY 2015
VL 21
BP 20
EP 34
DI 10.1016/j.actbio.2015.03.025
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK9FR
UT WOS:000356546500002
DA 2018-10-20
ER

PT J
AU Shi, MC
   Zhou, YH
   Shao, J
   Chen, ZT
   Song, BT
   Chang, J
   Wu, CT
   Xiao, Y
AF Shi, Mengchao
   Zhou, Yinghong
   Shao, Jin
   Chen, Zetao
   Song, Botao
   Chang, Jiang
   Wu, Chengtie
   Xiao, Yin
TI Stimulation of osteogenesis and angiogenesis of hBMSCs by delivering Si
   ions and functional drug from mesoporous silica nanospheres
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mesoporous silica nanospheres; Osteogenesis; Angiogenesis;
   Multifunction; Bone regeneration
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BIOACTIVE GLASS SCAFFOLDS;
   BONE TISSUE REGENERATION; CONTROLLED-RELEASE; IN-VITRO; NANOPARTICLES;
   DIFFERENTIATION; BIOCOMPATIBILITY; PROLIFERATION
AB Multifunctional bioactive materials with the ability to stimulate osteogenesis and angiogenesis of stem cells play an important role in the regeneration of bone defects. However, how to develop such biomaterials remains a significant challenge. In this study, we prepared mesoporous silica nanospheres (MSNs) with uniform sphere size (similar to 90 nm) and mesopores (similar to 2.7 nm), which could release silicon ions (Si) to stimulate the osteogenic differentiation of human bone marrow stromal cells (hBMSCs) via activating their ALP activity, bone-related gene and protein (OCN, RUNX2 and OPN) expression. Hypoxia-inducing therapeutic drug, dimethyloxaloylglycine (DMOG), was effectively loaded in the mesopores of MSNs (D-MSNs). The sustained release of DMOG from D-MSNs could stabilize HIF-la and further stimulated the angiogenic differentiation of hBMSCs as indicated by the enhanced VEGF secretion and protein expression. Our study revealed that D-MSNs could combine the stimulatory effect on both osteogenic and angiogenic activity of hBMSCs. The potential mechanism of D-MSN-stimulated osteogenesis and angiogenesis was further elucidated by the supplementation of cell culture medium with pure Si ions and DMOG. Considering the easy handling characteristics of nanospheres, the prepared D-MSNs may be applied in the forms of injectable spheres for minimally invasive surgery, or MSNs/polymer composite scaffolds for bone defect repair. The concept of delivering both stimulatory ions and functional drugs may offer a new strategy to construct a multifunctional biomaterial system for bone tissue regeneration. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shi, Mengchao; Song, Botao; Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Zhou, Yinghong; Shao, Jin; Chen, Zetao; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn; chengtiewu@mail.sic.ac.cn
OI SHAO, JIN/0000-0002-3864-0391; Xiao, Yin/0000-0003-1785-3491; Zhou,
   Yinghong/0000-0001-9757-7735
FU Recruitment Program of Global Young Talent, China; Natural Science
   Foundation of China [31370963, 81190132]; QCAS Biotechnology Fund
   [GJHZ1505]; Key Research Program of Chinese Academy of Sciences
   [KGZD-EW-T06]; Innovative Project of SIC; CAS; ARC [DP120103697]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (C.W.), Natural Science Foundation of China (Grant
   31370963, 81190132), the QCAS Biotechnology Fund (Grant No GJHZ1505),
   Key Research Program of Chinese Academy of Sciences (Grant KGZD-EW-T06),
   Innovative Project of SIC, CAS and ARC (DP120103697).
CR Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944
   Asikainen TM, 2007, AM J PHYSIOL-LUNG C, V293, pL555, DOI 10.1152/ajplung.00251.2007
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292
   Ding H, 2014, STEM CELLS DEV, V23, P990, DOI 10.1089/scd.2013.0486
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang DM, 2008, TOXICOL APPL PHARM, V231, P208, DOI 10.1016/j.taap.2008.04.009
   Jensen T, 2011, J BIOMED MATER RES A, V99A, P94, DOI 10.1002/jbm.a.33166
   Kamarudin NHN, 2014, J COLLOID INTERF SCI, V421, P6, DOI 10.1016/j.jcis.2014.01.034
   Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Li XY, 2014, ACS NANO, V8, P1309, DOI 10.1021/nn4046985
   Lindfors NC, 2008, J BIOMED MATER RES B, V87B, P73, DOI 10.1002/jbm.b.31070
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Neumann A, 2013, RSC ADV, V3, P24222, DOI 10.1039/c3ra44734k
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146
   Ravichandran R, 2014, MICROPOR MESOPOR MAT, V187, P53, DOI 10.1016/j.micromeso.2013.12.018
   Ravichandran R, 2013, J BIOMAT SCI-POLYM E, V24, P1988, DOI 10.1080/09205063.2013.816930
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105
   Slane J, 2014, J MECH BEHAV BIOMED, V29, P451, DOI 10.1016/j.jmbbm.2013.10.008
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Song BT, 2012, ACTA BIOMATER, V8, P1901, DOI 10.1016/j.actbio.2012.01.020
   Stucki U, 2001, CLIN ORAL IMPLAN RES, V12, P121, DOI 10.1034/j.1600-0501.2001.012002121.x
   Suzuki O, 2004, MICROSURG, V24, P85, DOI 10.1002/micr.10190
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tomoaia G, 2014, MAT SCI ENG C-MATER, V37, P37, DOI 10.1016/j.msec.2013.12.027
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]
   Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12
   Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026
   Wu CT, 2013, ACTA BIOMATER, V9, P9159, DOI 10.1016/j.actbio.2013.06.026
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022
   Xia LU, 2013, MICROPOR MESOPOR MAT, V173, P155, DOI 10.1016/j.micromeso.2013.02.020
   Zhao YN, 2009, J AM CHEM SOC, V131, P8398, DOI 10.1021/ja901831u
   Zhou YH, 2015, J TISSUE ENG REGEN M, V9, P118, DOI 10.1002/term.1619
   Zhu YF, 2005, NANOTECHNOLOGY, V16, P2633, DOI 10.1088/0957-4484/16/11/027
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 46
TC 46
Z9 47
U1 16
U2 181
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 15
PY 2015
VL 21
BP 178
EP 189
DI 10.1016/j.actbio.2015.04.019
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK9FR
UT WOS:000356546500016
PM 25910640
DA 2018-10-20
ER

PT J
AU Facin, BR
   Moret, B
   Baretta, D
   Belfiore, LA
   Paulino, AT
AF Facin, Bruno R.
   Moret, Bruna
   Baretta, Dilmar
   Belfiore, Laurence A.
   Paulino, Alexandre T.
TI Immobilization and controlled release of beta-galactosidase from
   chitosan-grafted hydrogels
SO FOOD CHEMISTRY
LA English
DT Article
DE beta-Galactosidase; Immobilization; Hydrogel; Chitosan; Lactose; Food
ID LACTOSE-INTOLERANCE; MAGNETIC BIOMATERIAL; POTENTIAL DEVICE; HYDROLYSIS;
   ENTRAPMENT; PROTEIN
AB Chitosan-grafted hydrogels were employed for immobilization and controlled released of beta-galactosidase. These hydrogels containing immobilized enzymes were employed to simulate the production of lactose-free food and controlled release of beta-galactosidase into lactose-intolerant individuals. The degree of swelling, efficiency of immobilization (i.e., fractional uptake of enzyme), and controlled release were studied as a function of pH and temperature. The degrees of swelling decreased in acidic media: 49.4 g absorbed water per g hydrogel at pH 7.0, and 8.4 g absorbed water per g hydrogel at pH 3.5. The immobilization efficiency was 19%, indicating that chitosan-grafted hydrogels are promising matrices for enzyme adsorption and immobilization. Cyclic experiments reveal that chitosan-grafted hydrogels containing immobilized enzymes can be reused several times without introducing additional enzyme prior to each cycle. There is no significant decrease in the activity of the immobilized enzyme during reutilization studies. All results were conducted in triplicate by considering t-tests at a 95% significance level. Analysis of beta-galactosidase activity and controlled release reveals that chitosan-grafted hydrogels containing immobilized enzymes are useful for the production of lactose-free food and controlled enzyme release with high performance. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Facin, Bruno R.; Moret, Bruna; Baretta, Dilmar; Paulino, Alexandre T.] Santa Catarina State Univ, Higher Educ Ctr West, Dept Food Engn, BR-89870000 Chapeco Pinhalzinho, SC, Brazil.
   [Belfiore, Laurence A.; Paulino, Alexandre T.] Colorado State Univ, Dept Chem & Biol Engn, Polymer Phys & Engn Lab, Ft Collins, CO 80523 USA.
RP Paulino, AT (reprint author), Santa Catarina State Univ, Higher Educ Ctr West, Dept Food Engn, BR-89870000 Chapeco Pinhalzinho, SC, Brazil.
EM atpaulino10@gmail.com
RI Paulino, Alexandre/B-8075-2013
OI Paulino, Alexandre/0000-0001-7076-2797; Baretta,
   Dilmar/0000-0001-8219-1362
FU CNPq - Brazil [479402/2013-2]; CAPES - Brazil; UDESC - Brazil; CSU -
   United States
FX ATP acknowledges the CNPq - Brazil (Process No 479402/2013-2) for
   financial support. The authors also gratefully acknowledge the CAPES -
   Brazil, UDESC - Brazil and CSU - United States for research support.
CR Ansari S, 2012, J ROY ASIATIC SOC, V22, P1, DOI 10.1017/S1356186312000090
   Aralijo W. A. G., 2007, NUTRITIME, V4, P395
   Bezerra SS, 2011, LAT AM J PHARM, V30, P1833
   Bortolin A, 2012, POLIMEROS, V22, P311, DOI 10.1590/S0104-14282012005000046
   Brena B. M., 2006, METHODS BIOTECHNOLOG, P15
   Flood MT, 2004, REGUL TOXICOL PHARM, V40, P281, DOI 10.1016/j.yrtph.2004.07.011
   Freitas FF, 2011, BIOCHEM ENG J, V58-59, P33, DOI 10.1016/j.bej.2011.08.011
   Grosova Z, 2009, FOOD CHEM, V116, P96, DOI 10.1016/j.foodchem.2009.02.011
   Grosova Z, 2008, BIOTECHNOL LETT, V30, P763, DOI 10.1007/s10529-007-9606-0
   Ha EJ, 2013, MACROMOL RES, V21, P5, DOI 10.1007/s13233-013-1007-8
   Haider T, 2007, INT J BIOL MACROMOL, V41, P72, DOI 10.1016/j.ijbiomac.2007.01.001
   Horn MM, 2010, POLIMEROS, V20, P201, DOI 10.1590/S0104-14282010005000025
   Jurado E, 2002, ENZYME MICROB TECH, V31, P300, DOI 10.1016/S0141-0229(02)00107-2
   Kim MH, 2012, J MOL CATAL B-ENZYM, V75, P68, DOI 10.1016/j.molcatb.2011.11.011
   Kjeldahl J., 1883, Z ANAL CHEM, V22, P366, DOI [DOI 10.1007/BF01338151, 10.1007/BF01338151]
   Klein M. P., 2010, THESIS FEDERAL U RIO
   Klein MP, 2012, BIOMACROMOLECULES, V13, P2456, DOI 10.1021/bm3006984
   Kronska H., 2009, J FOOD NUTR RES, V48, P87
   Mattar R., 2010, REV ASS MED BRASILEI, V56
   Montalto M, 2006, WORLD J GASTROENTERO, V12, P187, DOI 10.3748/wjg.v12.i2.187
   Moura M. R., 2008, POLIMEROS, V18, P132, DOI DOI 10.1590/S0104-14282008000200010
   Paulino AT, 2012, CARBOHYD POLYM, V90, P1216, DOI 10.1016/j.carbpol.2012.06.051
   Paulino AT, 2011, POLYM INT, V60, P1324, DOI 10.1002/pi.3084
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Rebros M, 2007, FOOD CHEM, V102, P784, DOI 10.1016/j.foodchem.2006.06.020
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   SaloVaananen PP, 1996, FOOD CHEM, V57, P27, DOI 10.1016/0308-8146(96)00157-4
   Santiago P. A., 2004, Ciencia e Tecnologia de Alimentos, V24, P567, DOI 10.1590/S0101-20612004000400015
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stefano M. Di., 2002, GASTROENTEROLOGY, V122, P1793
   Suarez FL, 1995, ALIMENT PHARM THER, V9, P589
   Torres P, 2012, J MOL CATAL B-ENZYM, V83, P57, DOI 10.1016/j.molcatb.2012.07.004
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vesa TH, 2000, J AM COLL NUTR, V19, p165S, DOI 10.1080/07315724.2000.10718086
   Vonk RJ, 2003, EUR J CLIN INVEST, V33, P70, DOI 10.1046/j.1365-2362.2003.01099.x
   White A, 1976, BIOCH PRINCIPLES
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 39
TC 15
Z9 15
U1 3
U2 167
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD JUL 15
PY 2015
VL 179
BP 44
EP 51
DI 10.1016/j.foodchem.2015.01.088
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA CF9ZM
UT WOS:000352926400006
PM 25722137
DA 2018-10-20
ER

PT J
AU Seo, BB
   Choi, H
   Koh, JT
   Song, SC
AF Seo, Bo-Bae
   Choi, Hyuck
   Koh, Jeong-Tae
   Song, Soo-Chang
TI Sustained BMP-2 delivery and injectable bone regeneration using
   thermosensitive polymeric nanoparticle hydrogel bearing dual
   interactions with BMP-2
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Polymeric nanoparticles; Dual interactions; Injectable hydrogel; Bone
   morphogenetic protein-2 (BMP-2); Sustained BMP-2 release
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY; BIOMEDICAL
   APPLICATIONS; BIOMATERIAL CARRIERS; IN-VITRO; POLYPHOSPHAZENES; RHBMP-2;
   PHARMACOKINETICS; SYSTEMS
AB Localized and continuous osteogenic stimulation to defected sites is required for effective bone regeneration. Here, we suggest an injectable and sustained bone morphogenetic protein-2 (BMP-2) release system using thermosensitive polymeric nanoparticles bearing dual interacting forces with BMP-2. For sustained BMP-2 release, hydrophobic and ionic interactions were introduced to thermosensitive poly(phosphazene). Hydrophobic isoleucine ethyl ester and hydrophilic poly-ethylene glycol were mainly substituted to the poly(phosphazene) back bone for amphiphilicity and hydrophobic interaction with BMP-2. Carboxylic acid moiety was additionally substituted to the back bone for ionic interaction with BMP-2. These dual interacting polymeric nanoparticles (D-NPs) formed compact nanocomplexes with BMP-2. The aqueous solution of BMP-2/D-NP nanocomplexes was transformed to hydrogel when the temperature of the solution increased. Loaded BMP-2 was sustain-released for three weeks from the BMP-2/D-NP nanocomplex hydrogel. The extended BMP-2 exposure caused higher osteocalcin secretion in C2C12 cells. Significant bone generations were observed at the target site by single injection of BMP-2/D-NP nanocomplexes in vivo. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Seo, Bo-Bae; Song, Soo-Chang] Korea Inst Sci & Technol, Ctr Biomat, Seoul 130650, South Korea.
   [Seo, Bo-Bae; Song, Soo-Chang] Univ Sci & Technol, Dept Biomol Sci, Seoul 136791, South Korea.
   [Choi, Hyuck; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju 500757, South Korea.
   [Choi, Hyuck; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Gwangju 500757, South Korea.
RP Song, SC (reprint author), Korea Inst Sci & Technol, Ctr Biomat, Seoul 130650, South Korea.
EM scsong@kist.re.kr
OI Song, Soo-Chang/0000-0001-9344-0686
FU Korea Institute of Science and Technology (KIST); National Research
   Foundation of Korea
FX This research is financially supported by Korea Institute of Science and
   Technology (KIST) and National Research Foundation of Korea.
CR Asamura S, 2010, ANN PLAS SURG, V64, P496, DOI 10.1097/SAP.0b013e31819b6c52
   Bergman K., 2009, J BIOMED MATER RES A, V91, P111
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bromberg L, 1999, LANGMUIR, V15, P8633, DOI 10.1021/la990946q
   Chan JM, 2010, METHODS MOL BIOL, V624, P163, DOI 10.1007/978-1-60761-609-2_11
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Greenstein J.D., 1961, CHEM AMINO ACIDS, P925
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hernandez A, 2012, ACTA BIOMATER, V8, P781, DOI 10.1016/j.actbio.2011.10.008
   Jill D., 2009, J ENDODONT, V35, P321
   Kang G.D., 2008, INT J PHARMACEUT, V249, P1
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kim YM, 2012, ACS NANO, V6, P5757, DOI 10.1021/nn300842a
   KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133
   Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lemmouchi Y, 1998, J BIOACT COMPAT POL, V13, P4, DOI 10.1177/088391159801300102
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   SOHN YS, 1995, MACROMOLECULES, V28, P7566, DOI 10.1021/ma00126a039
   Tillmann U., 2011, LANGMUIR, V27, P1314
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
NR 34
TC 40
Z9 40
U1 4
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 10
PY 2015
VL 209
BP 67
EP 76
DI 10.1016/j.jconrel.2015.04.023
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CJ7KQ
UT WOS:000355674300008
PM 25910579
DA 2018-10-20
ER

PT J
AU Choi, DJ
   Choi, SM
   Kang, HY
   Min, HJ
   Lee, R
   Ikram, M
   Subhan, F
   Jin, SW
   Jeong, YH
   Kwak, JY
   Yoon, S
AF Choi, Da Jeong
   Choi, Seung Mi
   Kang, Hae Yeong
   Min, Hye-Jin
   Lee, Rira
   Ikram, Muhammad
   Subhan, Fazli
   Jin, Song Wan
   Jeong, Young Hun
   Kwak, Jong-Young
   Yoon, Sik
TI Bioactive fish collagen/polycaprolactone composite nanofibrous scaffolds
   fabricated by electrospinning for 3D cell culture
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Electrospun nanofiber; Composite scaffold; Fish collagen; Thymic
   epithelial cells; 3D cell culture
ID TISSUE ENGINEERING APPLICATIONS; I COLLAGEN; PROLIFERATION; GROWTH;
   BIOCOMPATIBILITY; BIOMATERIAL; FIBROBLASTS; PHENOTYPES; MIGRATION;
   GUIDANCE
AB One of the most challenging objectives of 3D cell culture is the development of scaffolding materials with outstanding biocompatibility and favorable mechanical strength. In this study, we fabricated a novel nanofibrous scaffold composed of fish collagen (FC) and polycaprolactone (PCL) blends by using the electrospinning method. Nanofibrous scaffolds were characterized using a scanning electron microscope (SEM), and it was revealed that the diameter of nanofibers decreased as FC content was increased in the FC/PCL composite nanofibers. The cytocompatibility of the FC/PCL scaffolds was evaluated by SEM, WST-1 assay, confocal microscopy, western blot, and RT-PCR. It was found that the scaffolds not only facilitated the adhesion, spreading, protrusions, and proliferation of thymic epithelial cells (TECs), but also stimulated the expression of genes and proteins involved in cell adhesion and T-cell development. Thus, these results suggest that the FC/PCL composite nanofibrous scaffolds will be a useful model of 3D cell culture for TECs and may have wide applicability in the future for engineering tissues or organs. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Choi, Da Jeong; Choi, Seung Mi; Kang, Hae Yeong; Min, Hye-Jin; Lee, Rira; Ikram, Muhammad; Subhan, Fazli; Yoon, Sik] Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, Gyeongsangnam D, South Korea.
   [Jin, Song Wan] Korea Polytech Univ, Dept Mech Engn, Shihung 429793, South Korea.
   [Jeong, Young Hun] Kyungpook Natl Univ, Dept Mech Engn, Taegu 702701, South Korea.
   [Kwak, Jong-Young] Dong A Univ, Sch Med, Dept Biochem, Busan 602714, South Korea.
   [Choi, Da Jeong; Choi, Seung Mi; Kang, Hae Yeong; Min, Hye-Jin; Lee, Rira; Ikram, Muhammad; Subhan, Fazli; Jin, Song Wan; Jeong, Young Hun; Kwak, Jong-Young; Yoon, Sik] Pioneer Res Ctr, Seoul, South Korea.
RP Yoon, S (reprint author), Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 626870, Gyeongsangnam D, South Korea.
EM sikyoon@pusan.ac.kr
RI Tarsitano, Elisa/D-6611-2015
OI Ikram, Muhammad/0000-0003-0114-7963
FU Pioneer Research Center Program through the National Research Foundation
   of Korea - Ministry of Science, ICT & Future Planning [201210130003]
FX This work was supported by the Pioneer Research Center Program through
   the National Research Foundation of Korea funded by the Ministry of
   Science, ICT & Future Planning (201210130003).
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Bae I, 2008, FOOD CHEM, V108, P49, DOI 10.1016/j.foodchem.2007.10.039
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Chakrapani VY, 2012, J APPL POLYM SCI, V125, P3221, DOI 10.1002/app.36504
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Dufour S, 2013, CELL ADHES MIGR, V7, P345, DOI 10.4161/cam.25139
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Gendron R, 2012, MACROMOL BIOSCI, V12, P360, DOI 10.1002/mabi.201100341
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Haslauer CM, 2011, J BIOMAT SCI-POLYM E, V22, P1695, DOI 10.1163/092050610X521595
   He SW, 2011, J NANOSCI NANOTECHNO, V11, P1052, DOI 10.1166/jnn.2011.3080
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Ingavle GC, 2014, TISSUE ENG PART B-RE, V20, P277, DOI [10.1089/ten.TEB.2013.0276, 10.1089/ten.teb.2013.0276]
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   KIMURA S, 1983, COMP BIOCHEM PHYS B, V74, P525, DOI 10.1016/0305-0491(83)90222-5
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Laco F, 2013, J BIOMED MATER RES A, V101, P1787, DOI 10.1002/jbm.a.34468
   Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z
   Lei K.F., 2013, IEEE ENG MED BIOL SO, V2013, P180
   Li CL, 2008, ONCOL REP, V20, P1465, DOI 10.3892/or_00000167
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8
   Nagai N, 2008, J BIOMED MATER RES B, V87B, P432, DOI 10.1002/jbm.b.31121
   Papiernik M, 1992, Eur Cytokine Netw, V3, P89
   Pati F, 2012, J BIOMED MATER RES A, V100A, P1068, DOI 10.1002/jbm.a.33280
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Solouk Atefeh, 2011, Iranian Biomedical Journal, V15, P6
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Sugiura H, 2009, J BIOMAT SCI-POLYM E, V20, P1353, DOI 10.1163/092050609X12457418396658
   Venugopal JR, 2006, ARTIF ORGANS, V30, P440, DOI 10.1111/j.1525-1594.2006.00239.x
   Yamada S, 2014, BIOMED RES INT, DOI 10.1155/2014/302932
   Zhang YZ, 2007, INT J NANOMED, V2, P623
NR 41
TC 19
Z9 19
U1 2
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JUL 10
PY 2015
VL 205
BP 47
EP 58
DI 10.1016/j.jbiotec.2015.01.017
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CI2BV
UT WOS:000354550600006
PM 25617682
DA 2018-10-20
ER

PT J
AU Tallawi, M
   Rosellini, E
   Barbani, N
   Cascone, MG
   Rai, R
   Saint-Pierre, G
   Boccaccini, AR
AF Tallawi, Marwa
   Rosellini, Elisabetta
   Barbani, Niccoletta
   Cascone, Maria Grazia
   Rai, Ranjana
   Saint-Pierre, Guillaume
   Boccaccini, Aldo R.
TI Strategies for the chemical and biological functionalization of
   scaffolds for cardiac tissue engineering: a review
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE biofunctionalization; cardiac tissue engineering; biomimetic scaffolds;
   chemical modification; biological modification
ID ENDOTHELIAL-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; MOLECULARLY IMPRINTED
   POLYMERS; ASSEMBLING PEPTIDE NANOFIBERS; BIOTIN BINDING SYSTEM;
   RGD-MODIFIED ALGINATE; EXTRACELLULAR-MATRIX COMPONENTS; LEFT-VENTRICULAR
   FUNCTION; RAT INFARCT MODEL; MYOCARDIAL-INFARCTION
AB The development of biomaterials for cardiac tissue engineering (CTE) is challenging, primarily owing to the requirement of achieving a surface with favourable characteristics that enhances cell attachment and maturation. The biomaterial surface plays a crucial role as it forms the interface between the scaffold (or cardiac patch) and the cells. In the field of CTE, synthetic polymers ( polyglycerol sebacate, polyethylene glycol, polyglycolic acid, poly-L-lactide, polyvinyl alcohol, polycaprolactone, polyurethanes and poly(N-isopropyl-acrylamide)) have been proven to exhibit suitable biodegradable and mechanical properties. Despite the fact that they show the required biocompatible behaviour, most synthetic polymers exhibit poor cell attachment capability. These synthetic polymers are mostly hydrophobic and lack cell recognition sites, limiting their application. Therefore, biofunctionalization of these biomaterials to enhance cell attachment and cell material interaction is being widely investigated. There are numerous approaches for functionalizing a material, which can be classified as mechanical, physical, chemical and biological. In this review, recent studies reported in the literature to functionalize scaffolds in the context of CTE, are discussed. Surface, morphological, chemical and biological modifications are introduced and the results of novel promising strategies and techniques are discussed.
C1 [Tallawi, Marwa; Rai, Ranjana; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
   [Rosellini, Elisabetta; Barbani, Niccoletta; Cascone, Maria Grazia] Univ Pisa, Dept Civil & Ind Engn, I-56126 Pisa, Italy.
   [Saint-Pierre, Guillaume] Inspiralia, Mat Lab, Madrid 28049, Spain.
RP Tallawi, M (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
EM marwa.tallawi@ww.uni-erlangen.de; aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
FU EU FP-7 BIOSCENT project [214539]
FX The authors acknowledge partial funding from the EU FP-7 BIOSCENT
   project (ID 214539).
CR Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120
   AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Amsden BG, 2010, J CONTROL RELEASE, V145, P109, DOI 10.1016/j.jconrel.2010.03.029
   Anamelechi CC, 2005, BIOMATERIALS, V26, P6887, DOI 10.1016/.biomaterials.2005.04.027
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Bai XP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045002
   Bakowsky U, 2002, BIOCHEMISTRY-US, V41, P4704, DOI 10.1021/bi0117596
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Bauer SM, 2005, J VASC SURG, V41, P699, DOI 10.1016/j.jvs.2005.01.015
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Bhat VD, 1998, J BIOMED MATER RES, V41, P377, DOI 10.1002/(SICI)1097-4636(19980905)41:3<377::AID-JBM6>3.3.CO;2-Q
   Bhatia SK, 2010, BIOTECHNOL J, V5, P1309, DOI 10.1002/biot.201000230
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   BOGDANOV AA, 1991, J CELL PHYSIOL, V147, P182, DOI 10.1002/jcp.1041470123
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069
   Brown DA, 2005, J BIOMED MATER RES A, V74A, P419, DOI 10.1002/jbm.a.30344
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100
   Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127
   Cao Y, 2004, BIOPOLYMER METHODS T, V238, P87
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Chapanian R, 2010, J CONTROL RELEASE, V143, P53, DOI 10.1016/j.jconrel.2009.11.025
   Charlotte KW., 2007, CHEM SOC REV, V36, P1573, DOI [10.10391b614342n, DOI 10.1039/B614342N]
   Chen JL, 2006, J BIOMED MATER RES A, V79A, P307, DOI 10.1002/jbm.a.30799
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chew SY, 2006, NANOTECHNOLOGY, V17, P3880, DOI 10.1088/0957-4484/17/15/045
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3
   Chiono V, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0045
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi S, 2013, CELLS TISSUES ORGANS, V198, P349, DOI 10.1159/000358755
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chua KN, 2007, EXP HEMATOL, V35, P771, DOI 10.1016/j.exphem.2007.02.002
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Cormack PAG, 1999, REACT FUNCT POLYM, V41, P115, DOI 10.1016/S1381-5148(99)00024-3
   Cristallini C, 2004, MACROMOL BIOSCI, V4, P31, DOI 10.1002/mabi.200300026
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Duan Y, 2007, J BIOMAT SCI-POLYM E, V18, P1153, DOI 10.1163/156856207781554019
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Fukuda K, 2003, BONE MARROW TRANSPL, V32, pS25, DOI 10.1038/sj.bmt.1703940
   Fukuda K, 2002, CR BIOL, V325, P1027, DOI 10.1016/S1631-0691(02)01524-X
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI200113713
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Gandaglia A, 2012, TISSUE ENG PT A, V18, P725, DOI [10.1089/ten.tea.2011.0254, 10.1089/ten.TEA.2011.0254]
   Gao J, 2011, TISSUE ENG PT A, V17, P2739, DOI [10.1089/ten.tea.2011.0105, 10.1089/ten.TEA.2011.0105]
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gerhardt WW, 2006, BIOMACROMOLECULES, V7, P1735, DOI 10.1021/bm060024j
   Giraud M. N., 2012, CARDIOL RES PRACT, V2012, DOI DOI 10.1155/2012/971614
   Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Hakuno D, 2002, CIRCULATION, V105, P380, DOI 10.1161/hc0302.102593
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hart BR, 2001, J AM CHEM SOC, V123, P2072, DOI 10.1021/ja005661
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   Hein S, 2001, J NUCL CARDIOL, V8, P188, DOI 10.1067/mnc.2001.113331
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61
   Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   HIRD B, 1993, J POLYM SCI POL CHEM, V31, P1377, DOI 10.1002/pola.1993.080310604
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866
   Improvement P, 2010, ANN INTERN MED, V152, pITC61
   Inagaki N, 2003, J APPL POLYM SCI, V89, P96, DOI [10.1002/app.12160, DOI 10.1002/APP.12160]
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Janorkar AV, 2006, J POLYM SCI POL CHEM, V44, P6534, DOI 10.1002/pola.21700
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jia XL, 2011, J BIOMAT SCI-POLYM E, V22, P1811, DOI 10.1163/092050610X528534
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kanematsu A, 2004, J CONTROL RELEASE, V99, P281, DOI 10.1016/j.jconrel.2004.07.008
   KEMPE M, 1995, J CHROMATOGR A, V691, P317, DOI 10.1016/0021-9673(94)00820-Y
   Khang G, 2001, TISSUE ENG, V7, P236
   Kim D, 2012, ANAL CHEM, V84, P2533, DOI 10.1021/ac3000013
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kojima N, 2006, BIOMATERIALS, V27, P4904, DOI 10.1016/j.biomaterials.2006.05.026
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kubies D, 2003, J MATER SCI-MATER M, V14, P143, DOI 10.1023/A:1022019813078
   Kutryk MJB, 2003, MICROSC RES TECHNIQ, V60, P138, DOI 10.1002/jemt.10252
   LADOUX A, 1993, BIOCHEM BIOPH RES CO, V195, P1005, DOI 10.1006/bbrc.1993.2144
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   LaNasa SM, 2009, ACTA BIOMATER, V5, P2929, DOI 10.1016/j.actbio.2009.05.011
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lanza R., 2011, PRINCIPLES TISSUE EN
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Lavik E, 2015, APPL MICROBIOL BIOT, V65, P1
   Layman H, 2009, ACTA BIOMATER, V5, P230, DOI 10.1016/j.actbio.2008.07.024
   Lchek M, 1990, METHOD ENZYMOL, V184, P5
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee J, 2009, J CONTROL RELEASE, V137, P196, DOI 10.1016/j.jconrel.2009.04.008
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Lee KB, 2003, J PHARM SCI, V92, P933, DOI 10.1002/jps.10556
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Li RK, 1999, CIRCULATION, V100, P63
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Losi P, 2010, BIOMATERIALS, V31, P5336, DOI 10.1016/j.biomaterials.2010.03.033
   LUNDGREN E, 1985, EXP CELL RES, V158, P371, DOI 10.1016/0014-4827(85)90462-8
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Maitra N, 2000, CARDIOVASC RES, V47, P715, DOI 10.1016/S0008-6363(00)00140-1
   Maretschek S, 2008, J CONTROL RELEASE, V127, P180, DOI 10.1016/j.jconrel.2008.01.011
   Marra KG, 2008, PLAST RECONSTR SURG, V121, P1153, DOI 10.1097/01.prs.0000305517.93747.72
   Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895
   Mathieu HJ, 2001, SURF INTERFACE ANAL, V32, P3, DOI 10.1002/sia.995
   Mathur AB, 2003, J BIOMED MATER RES A, V66A, P729, DOI 10.1002/jbm.a.10581
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miskon A, 2009, J ARTIF ORGANS, V12, P111, DOI 10.1007/s10047-009-0449-4
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163
   Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pons J, 2009, J GENE MED, V11, P743, DOI 10.1002/jgm.1362
   Porter AM, 2011, BIOMACROMOLECULES, V12, P242, DOI 10.1021/bm101220b
   Rachkov A, 2001, BBA-PROTEIN STRUCT M, V1544, P255, DOI 10.1016/S0167-4838(00)00226-0
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rocher P, 2002, BIOMATERIALIEN, V3, P14, DOI 10.1515/BIOMAT.2002.3.1.14
   Rosellini E, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065007
   Rosellini E, 2010, J APPL POLYM SCI, V118, P3236, DOI 10.1002/app.32622
   Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sanders EH, 2003, MACROMOLECULES, V36, P3803, DOI 10.1021/ma021771l
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182
   Schussler O, 2009, NAT CLIN PRACT CARD, V6, P240, DOI 10.1038/ncpcardio1451
   SELLERGREN B, 1993, J CHROMATOGR A, V654, P17, DOI 10.1016/0021-9673(93)83061-V
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Silvestri A, 2014, J BIOMED MATER RES B, V102, P1002, DOI 10.1002/jbm.b.33081
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   Silvestri D, 2005, ANAL CHIM ACTA, V542, P3, DOI 10.1016/j.aca.2004.12.005
   Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682
   Singh S, 2011, BIOMATERIALS, V32, P2059, DOI 10.1016/j.biomaterials.2010.11.038
   Sivagnanam V, 2009, ANAL CHEM, V81, P6509, DOI 10.1021/ac9009319
   Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904
   Sondermeijer HP, 2008, CIRCULATION, V118, pS322
   Spadaccio C, 2011, J CELL MOL MED, V15, P1096, DOI 10.1111/j.1582-4934.2010.01100.x
   Steinke J, 1995, ADV POLYM SCI, V123, P80
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Svenson J, 2001, ANAL CHIM ACTA, V435, P19, DOI 10.1016/S0003-2670(00)01396-9
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   Taguchi T, 2000, J BIOACT COMPAT POL, V15, P309, DOI 10.1106/U857-BGYG-UP8G-C6T3
   Taipale J, 1997, FASEB J, V11, P51
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Takano H, 2003, CURR PHARM DESIGN, V9, P1121, DOI 10.2174/1381612033455008
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Tsai WB, 2005, MACROMOL BIOSCI, V5, P214, DOI 10.1002/mabi.200400144
   Tsai WB, 2005, BIOMATERIALS, V26, P3141, DOI 10.1016/j.biomaterials.2004.08.014
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   VANBILSEN M, 1993, CARDIOVASC RES, V27, P1140
   Ventura C, 2000, CIRC RES, V87, P189, DOI 10.1161/01.RES.87.3.189
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   vonSegesser LK, 1996, ANN THORAC SURG, V61, P330, DOI 10.1016/0003-4975(95)01011-4
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HY, 1996, LANGMUIR, V12, P4850, DOI 10.1021/la960243y
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507
   Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Wulff G, 2002, BIOSEPARATION, V10, P257, DOI DOI 10.1023/A:1021585518592
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   YAMAGISHI H, 1995, J MEMBRANE SCI, V105, P249, DOI 10.1016/0376-7388(95)00064-J
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9
   Zhong Z, 2005, BIOMACROMOLECULES, V6, P2998, DOI [10.1021/bm050318p, DOI 10.1021/BM050318P]
   Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051
   Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zou YZ, 2003, CIRCULATION, V108, P748, DOI 10.1161/01.CIR.0000081773.76337.44
NR 280
TC 52
Z9 52
U1 8
U2 116
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUL 6
PY 2015
VL 12
IS 108
AR 20150254
DI 10.1098/rsif.2015.0254
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0FD
UT WOS:000358824600001
PM 26109634
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Mayer, S
   Decaluwe, H
   Ruol, M
   Manodoro, S
   Kramer, M
   Till, H
   Deprest, J
AF Mayer, Steffi
   Decaluwe, Herbert
   Ruol, Michele
   Manodoro, Stefano
   Kramer, Manuel
   Till, Holger
   Deprest, Jan
TI Diaphragm Repair with a Novel Cross-Linked Collagen Biomaterial in a
   Growing Rabbit Model
SO PLOS ONE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL DEFECTS; HERNIA REPAIR; PATCH
   REPAIR; TRACHEAL OCCLUSION; ANIMAL-MODEL; MESHES; RECONSTRUCTION;
   METAANALYSIS; MANAGEMENT
AB Background
   Neonates with congenital diaphragmatic hernia and large defects often require patch closure. Acellular collagen matrices (ACM) have been suggested as an alternative to synthetic durable patches as they are remodeled by the host or could also be used for tissue engineering purposes.
   Materials and Methods
   2.0x1.0 cm diaphragmatic defects were created in 6-weeks old New-Zealand white rabbits. We compared reconstruction with a purpose-designed cross-linked ACM (Matricel) to 4-layer non-cross-linked small intestinal submucosa (SIS) and a 1-layer synthetic Dual Mesh (Gore-Tex). Unoperated animals or animals undergoing primary closure (4/0 polyglecaprone) served as age-matched controls. 60 (n = 25) resp. 90 (n = 17) days later, animals underwent chest x-ray and obduction for gross examination of explants, scoring of adhesion and inflammatory response. Also, uniaxial tensiometry was done, comparing explants to contralateral native diaphragmatic tissue.
   Results
   Overall weight nearly doubled from 1,554 +/- 242 g at surgery to 2,837 +/- 265 g at obduction (+ 84%). X-rays did show rare elevation of the left diaphragm (SIS = 1, Gore-Tex = 1, unoperated control = 1), but no herniation of abdominal organs. 56% of SIS and 10% of Matricel patches degraded with visceral bulging in four (SIS = 3, Matricel = 1). Adhesion scores were limited: 0.5 (Matricel) to 1 (SIS, Gore-Tex) to the left lung (p = 0.008) and 2.5 (Gore-Tex), 3 (SIS) and 4 (Matricel) to the liver (p<0.0001). Tensiometry revealed a reduced bursting strength but normal compliance for SIS. Compliance was reduced in Matricel and Gore-Tex (p<0.01). Inflammatory response was characterized by a more polymorphonuclear cell (SIS) resp. macrophage (Matricel) type of infiltrate (p<0.05). Fibrosis was similar for all groups, except there was less mature collagen deposited to Gore-Tex implants (p<0.05).
   Conclusions
   Matricel induced a macrophage-dominated inflammatory response, more adhesions, had appropriate strength but a lesser compliance compared to native tissue. The herein investigated ACM is not a viable option for CDH repair.
C1 [Mayer, Steffi; Ruol, Michele; Manodoro, Stefano; Deprest, Jan] Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium.
   [Decaluwe, Herbert] Katholieke Univ Leuven, Dept Thorac Surg, Univ Hosp Gasthuisberg, Leuven, Belgium.
   [Ruol, Michele] Univ Hosp Padua, Dept Pediat Surg, Padua, Italy.
   [Manodoro, Stefano] Univ Hosp Monza, Dept Obstet & Gynecol, Monza, Italy.
   [Kramer, Manuel] Univ Erlangen Nurnberg, Dept Radiol, D-91054 Erlangen, Germany.
   [Till, Holger] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany.
   [Deprest, Jan] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, Leuven, Belgium.
RP Deprest, J (reprint author), Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium.
EM jan.deprest@uzleuven.be
RI Decaluwe, Herbert/A-2436-2009
OI Decaluwe, Herbert/0000-0002-0877-7717
FU European Commission (EuroSTEC) [LSHC-CT-2006-037409]; Instituut voor
   Wetenschap en Technologie (I.W.T.); Flanders Research Foundation (FWO
   Vlaanderen) [1801207N]
FX This work was supported by the European Commission in its 6th Framework
   Program (EuroSTEC, LSHC-CT-2006-037409) and the Instituut voor
   Wetenschap en Technologie (I.W.T.). Jan Deprest is a clinical researcher
   for the Flanders Research Foundation (FWO Vlaanderen; 1801207N). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aikawa M, 2013, SURG TODAY, V43, P1298, DOI 10.1007/s00595-012-0414-3
   ATKINSON JB, 1992, J PEDIATR SURG, V27, P754, DOI 10.1016/S0022-3468(05)80109-5
   BAX NMA, 1984, J PEDIATR SURG, V19, P484, DOI 10.1016/S0022-3468(84)80281-X
   Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Claerhout F, 2008, AM J OBSTET GYNECOL, V198, pe91
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   De Coppi P, 2012, EUR J PEDIATR SURG, V22, P393, DOI 10.1055/s-0032-1329410
   DeKoninck P, 2011, EARLY HUM DEV, V87, P619, DOI 10.1016/j.earlhumdev.2011.08.001
   Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2
   Deprest J, 2010, J UROLOGY, V183, P2249, DOI 10.1016/j.juro.2010.02.008
   Deprest J, 2009, J UROLOGY, V182, P2362, DOI 10.1016/j.juro.2009.07.043
   Fauza DO, 2014, SEMIN PEDIATR SURG, V23, P135, DOI 10.1053/j.sempedsurg.2014.04.004
   Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034
   Feola A, 2015, AM J OBSTET GYNECOL, V212, p[474, e1], DOI [10.1016/j.ajog.2014.11.008, DOI 10.1016/J.AJ0G.2014.11.008]
   Gasior AC, 2012, PEDIATR SURG INT, V28, P327, DOI 10.1007/s00383-012-3059-9
   Gonzalez R, 2011, J LAPAROENDOSC ADV S, V21, P449, DOI 10.1089/lap.2010.0409
   Grethel EJ, 2006, J PEDIATR SURG, V41, P29, DOI 10.1016/j.jpedsurg.2005.10.005
   Gucciardo L, 2014, J PEDIATR SURG, V49, P1458, DOI 10.1016/j.jpedsurg.2014.01.058
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Jones KA, 2009, INT UROGYNECOL J, V20, P847, DOI 10.1007/s00192-008-0781-x
   Laituri CA, 2010, EUR J PEDIATR SURG, V20, P363, DOI 10.1055/s-0030-1261939
   Lally KP, 2007, PEDIATRICS, V120, pE651, DOI 10.1542/peds.2006-3040
   LALLY KP, 1992, ANN SURG, V216, P569, DOI 10.1097/00000658-199211000-00008
   Lammers G, 2010, BIOMATERIALS, V31, P8299, DOI 10.1016/j.biomaterials.2010.07.055
   Lantis JC, 2000, J INVEST SURG, V13, P319
   Loff S, 2005, J PEDIATR SURG, V40, P1701, DOI 10.1016/j.jpedsurg.2005.07.007
   Mayer S, 2011, PRENATAL DIAG, V31, P1086, DOI 10.1002/pd.2839
   Mayer S, 2011, SEMIN PEDIATR SURG, V20, P161, DOI 10.1053/j.sempedsurg.2011.03.006
   Montzka K, 2011, BJU INT, V107, P1974, DOI 10.1111/j.1464-410X.2010.09680.x
   MOVAT HZ, 1955, ARCH PATHOL, V60, P289
   Ozog Y, 2011, INT UROGYNECOL J, V22, P1099, DOI 10.1007/s00192-011-1440-1
   Ozog Y, 2009, INT UROGYNECOL J, V20, P435, DOI 10.1007/s00192-008-0793-6
   Peeters E, 2013, J SURG RES, V180, P274, DOI 10.1016/j.jss.2013.01.025
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Romao RLP, 2012, J PEDIATR SURG, V47, P1496, DOI 10.1016/j.jpedsurg.2012.01.009
   Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068
   Sinha CK, 2009, J PEDIATR SURG, V44, P312, DOI 10.1016/j.jpedsurg.2008.10.078
   Slack M, 2012, INT UROGYNECOL J, V23, pS15, DOI 10.1007/s00192-012-1678-2
   St Peter SD, 2007, J SURG RES, V140, P234, DOI 10.1016/j.jss.2007.03.018
   Steinau G, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-5
   Tsai J, 2012, J PEDIATR SURG, V47, P637, DOI 10.1016/j.jpedsurg.2011.11.054
   Tsao K, 2011, FETAL DIAGN THER, V29, P46, DOI 10.1159/000320244
   TSUKADA T, 1986, ARTERIOSCLEROSIS, V6, P601, DOI 10.1161/01.ATV.6.6.601
   Turner CG, 2011, J PEDIATR SURG, V46, P57, DOI 10.1016/j.jpedsurg.2010.09.063
   Verbelen T, 2013, EUR J CARDIO-THORAC, V44, P263, DOI 10.1093/ejcts/ezt001
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
   Zuhlke H V, 1990, Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir, P1009
NR 48
TC 4
Z9 4
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2015
VL 10
IS 7
AR e0132021
DI 10.1371/journal.pone.0132021
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1DQ
UT WOS:000358157600181
PM 26147985
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, J
   Deng, AP
   Zhou, AM
   Yang, Y
   Gao, LH
   Zhong, ZC
   Yang, SL
AF Zhang, Jing
   Deng, Aipeng
   Zhou, Aimei
   Yang, Yang
   Gao, Lihu
   Zhong, Zhaocai
   Yang, Shulin
TI Comparison of two proanthocyanidin cross-linked recombinant human
   collagen-peptide (RHC) - chitosan scaffolds
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE recombinant human collagen; chitosan; proanthocyanidin; hydrogen
   bonding; HUVECs viability
ID BIOMATERIAL SCAFFOLDS; POROUS SCAFFOLDS; DRUG-DELIVERY; SILK FIBROIN;
   IN-VITRO; TISSUE; CARTILAGE; GELATIN; LINKING; MATRIX
AB Cross-linking plays an important role in tissue engineering, which involves the alternative of cross-linker and the way of components interaction. We compared two proanthocyanidin (PA) cross-linked recombinant human collagen-peptide - chitosan scaffolds: immerse cross-linking (I-CLS) and premix cross-linking (P-CLS). Both of the scaffolds presented homogeneous pore structure with mean pore size of 110-115m. The swelling ratio was decreased to 29.6 in I-CLS, but increased to 37.1 in P-CLS while porosity of the two scaffolds was reduced about 8% comparing to 94.3% before cross-linking. The cross-linked scaffolds exhibited enhanced resistance to enzyme degradation and improved compressive modulus (I-CLS>P-CLS). The scaffolds transformed from elastic region to plastic region until the strain reached 60%, and the stress was 40.5, 133.2 and 84.1kPa of uncross-linking scaffold, I-CLS and P-CLS individually. Thermal stability indicated molecular bonding between PA and the scaffold components, simultaneously, Fourier transform infrared spectroscopy mainly presented hydrogen bonding between the protein amide carbonyl and the phenolic hydroxyl with a particular transform due to pyrrolidine rings of proline in P-CLS. Both of the I-CLS and P-CLS could promote human umbilical vein endothelial cells attachment and proliferation. The characterization suggested in situ biodegradable application of P-CLS, while a potential long-term utilization of I-CLS in tissue engineering.
C1 [Zhang, Jing; Deng, Aipeng; Zhou, Aimei; Gao, Lihu; Zhong, Zhaocai; Yang, Shulin] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China.
   [Yang, Yang] Univ Nottingham, Fac Engn, Nottingham NG7 2RD, England.
RP Yang, SL (reprint author), Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China.
EM yshulin@njust.edu.cn
RI 南京理工大学, 环境与生物工程学院/N-7361-2016
FU National High Technology Research and Development Program of China
   [2014AA022107]; Science and Technology Project of Jiangsu province,
   China [BE 2011837]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD)
FX This work was financially supported by the National High Technology
   Research and Development Program of China [No: 2014AA022107], Science
   and Technology Project of Jiangsu province, China [No: BE 2011837], as
   well as A Project Funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD).
CR Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Bedran-Russo AKB, 2008, J BIOMED MATER RES B, V86B, P330, DOI 10.1002/jmb.b.31022
   Botta SB, 2012, J BIOMED MATER RES B, V100B, P1009, DOI 10.1002/jbm.b.32666
   Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.tea.2012.0721, 10.1089/ten.TEA.2012.0721]
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen Y, 2015, ACTA BIOMATER, V11, P435, DOI 10.1016/j.actbio.2014.09.028
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Covington AD, 2005, J AM LEATHER CHEM AS, V100, P325
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Epasinghe DJ, 2012, J DENT, V40, P173, DOI 10.1016/j.jdent.2011.11.013
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Friess W, 2003, ADV DRUG DELIVER REV, V55, P1529, DOI 10.1016/j.addr.2003.08.001
   Geiger M., 2002, PHARM TECH EUROPE, V14, P58
   Geiger M, 2002, PHARM TECHNOL EUR, V14, P48
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494
   Han B, 2003, J BIOMED MATER RES A, V65A, P118, DOI 10.1002/jbm.a.10460
   Hartwell R, 2011, ACTA BIOMATER, V7, P3060, DOI 10.1016/j.actbio.2011.04.024
   Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+
   He LR, 2011, INT J BIOL MACROMOL, V48, P354, DOI 10.1016/j.ijbiomac.2010.12.012
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   Horn MM, 2009, CARBOHYD POLYM, V77, P239, DOI 10.1016/j.carbpol.2008.12.039
   Huang CH, 2012, MAT SCI ENG C-MATER, V32, P2476, DOI 10.1016/j.msec.2012.07.029
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Ku CS, 2007, CHEMOSPHERE, V67, P1618, DOI 10.1016/j.chemosphere.2006.11.037
   LEATRESE DH, 1998, J BIOMED MATER RES, V42, P396
   Liu B., 2012, CHEM SCI T, V1, P347
   Liu BS, 2008, J BIOMED MATER RES A, V87A, P1092, DOI 10.1002/jbm.a.31916
   Liu B, 2011, ADV MATER RES-SWITZ, V236-238, P2905, DOI 10.4028/www.scientific.net/AMR.236-238.2905
   Liu Y, 2013, J DENT, V41, P535, DOI 10.1016/j.jdent.2013.03.007
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   McFadden TM, 2013, ACTA BIOMATER, V9, P9303, DOI 10.1016/j.actbio.2013.08.014
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Sagliyan A, 2012, REV MED VET-TOULOUSE, V163, P11
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shinjiro Takata AS, 2004, J MED INVEST, V51, P133
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tiyaboonchai W, 2011, FIBER POLYM, V12, P324, DOI 10.1007/s12221-011-0324-9
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhu YJ, 2014, J MECH BEHAV BIOMED, V36, P32, DOI 10.1016/j.jmbbm.2014.04.003
NR 47
TC 2
Z9 3
U1 1
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUL 3
PY 2015
VL 26
IS 10
BP 585
EP 599
DI 10.1080/09205063.2015.1047667
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA CK9WG
UT WOS:000356589600002
PM 26053645
DA 2018-10-20
ER

PT J
AU Darwis, D
   Abbas, EB
   Nurlidar, F
   Putra, DP
AF Darwis, Darmawan
   Abbas, Erizal B.
   Nurlidar, Farah
   Putra, D. Pribadi
TI Radiation Processing of Polymers for Medical and Pharmaceutical
   Applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Conference on Innovation in Polymer Science and Technology
   (IPST)
CY OCT 07-10, 2013
CL Yogyakarta, INDONESIA
DE biomaterial; crosslinking; degradation; electron beam; gamma
   irradiation; polymer; radiation processing; sterilizationbiomaterial
ID HYDROGELS
AB The use of ionizing radiation for the preparation of polymeric biomaterials is one of the examples of the application of atomic energy for the benefit of humanity. Radiation processing is based on the use of high energy ionizing radiation to induce chemical and biological changes in irradiated systems. High energy electron (EB) under 10 keV and gamma irradiation are the most frequently used of ionizing radiation for synthesis, modification of polymers, and sterilization of medical devices. Potential biomedical and pharmaceutical applications of these polymers are implants, topical dressings, injectable formulations, drug delivery devices, diagnostic assays, and immobilized enzyme. Through radiation crosslinking or degradation processes, polymers with specific characteristics can be prepared. The advantages of radiation processing include the absent of any chemical residues (since no chemical additives are requires to initiate the reactions), can be used at all temperatures, can be limited to the surface only and in certain cases, the synthesis/modification of materials can be combined with sterilization.
C1 [Darwis, Darmawan; Abbas, Erizal B.; Nurlidar, Farah; Putra, D. Pribadi] Natl Nucl Energy Agcy, Ctr Applicat Isotopes & Radiat Technol, Jl Lebak Bulus Raya 49, Jakarta 12070, Indonesia.
RP Darwis, D (reprint author), Natl Nucl Energy Agcy, Ctr Applicat Isotopes & Radiat Technol, Jl Lebak Bulus Raya 49, Jakarta 12070, Indonesia.
EM darmawan_p3tir@batan.go.id
CR Australian Government Department of Agriculture Fisheries and Forestry, 2013, GAMM IRR TREATM ADDR, P16
   Caliceti P, 2001, J CONTROL RELEASE, V75, P173, DOI 10.1016/S0168-3659(01)00380-7
   Chapiro A., 1962, RAD CHEM POLYM SYSTE, P354
   Chmielewski A. G., 2008, TRENDS RAD STERILIZA, P29
   Chmielewski A. G., 2008, TRENDS RAD STERILIZA, P49
   Cleland M. R., 2005, CERN ACC SCH SMALL A
   Council on Ionizing Radiation Measurements and Standards, 2004, 4 REP NEEDS ION RAD, P78
   Aquino KAD, 2012, GAMMA RADIATION, P171
   DARMAWAN D., 1999, P NAT SEM IND CHEM S, P324
   Darmawan D., 2004, P NAT SEM IND MED PL, P539
   Darwis D, 2009, AT INDONES, V35, P85, DOI 10.17146/aij.2009.12
   Dziedzic-Goclawska A., 1997, ADV TISSUE BANKING, V1, P266
   Gueven O., 2004, ADV RAD CHEM POLYM, P33
   Gupta B, 2010, INDIAN J FIBRE TEXT, V35, P174
   Hammad A., 2008, TRENDS RAD STERILIZA, P119
   Hammad A. A., 2008, TRENDS RAD STERILIZA, P120
   Hansen JM, 2001, DISINFECTION STERILI, P729
   Hoffman P., 2004, DISINFECTION HEALTHC, P115
   International Atomic Energy Agency, 2004, IAEATECDOC1384, P1
   International Atomic Energy Agency (IAEA), 2001, GAMM IRR RAD PROC, P3
   International Brotherhood of Teamsters, 2008, TRI COUNC POL STAT E, P1
   Joshi G, 2011, INT J PHARM PHARM SC, V3, P200
   Kashyap N., 2004, DRUG DEV DELIVERY, V4, P32
   Kovac A., 2003, P TECHN M VIENN, P85
   Mehta K, 2008, TRENDS RAD STERILIZA, P5
   Minister of Public Works and Government Services Canada, 2012, INTR RAD, P6
   Nather A., 2007, RAD TISSUE BANKING B, P3
   Nikita T. S., 1963, EFFECT IONIZING RAD, P7
   Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030
   Patel A., 2011, BIOMEDICAL ENG FRONT, P280
   Razzak MT, 2001, RADIAT PHYS CHEM, V62, P107, DOI 10.1016/S0969-806X(01)00427-3
   Rosiak J. M., 2002, IAEATECDOC1324, P5
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Saha N., 2011, J BIOMATER NANOBIOTE, V2, P85, DOI DOI 10.4236/JBNB.2011.21011
   Sarma K. S. S., 2004, IAEA TECDOC 1386 EME, P74
   Silindir M., 2009, FABAD J PHARM SCI, V34, P43
   Singh A., 1994, ISOTOPE RAD TECHNOLO, P2
   Singh A., 1992, RAD PROCESSING POLYM, P2
   Wayne R., 2005, STERILISATION POLYM, P1
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   Yusof N, 2007, RAD TISSUE BANKING B, P99
   Yusof N., 2001, ADV TISSUE BANKING, V5, P342
   Yusof N., 2007, RAD TISSUE BANKING B, P109
   Yusof N., 2007, RAD TISSUE BANKING, P121
   Zaman K., 2001, ADV TISSUE BANKING, V5, P309
NR 45
TC 3
Z9 3
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2015
VL 353
IS 1
SI SI
BP 15
EP 23
DI 10.1002/masy.201550302
PG 9
WC Polymer Science
SC Polymer Science
GA DN7SV
UT WOS:000377279700003
DA 2018-10-20
ER

PT J
AU Nurlidar, F
   Budianto, E
   Darwis, D
   Sugiarto
AF Nurlidar, Farah
   Budianto, Emil
   Darwis, Darmawan
   Sugiarto
TI Hydroxyapatite Deposition on Modified Bacterial Cellulose Matrix
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Conference on Innovation in Polymer Science and Technology
   (IPST)
CY OCT 07-10, 2013
CL Yogyakarta, INDONESIA
DE bacterial cellulose; biopolymers; citric acid; coconut water;
   hydroxyapatite
ID BONE REGENERATION; COMPOSITES
AB Bacterial cellulose (BC), biosynthesized by bacteria, is an attractive biomaterial for bone regeneration due to its biocompatibility and good mechanical properties. However, BC is devoid of inorganic elements which are necessary for formation of chemical bonds with bone. Incorporation of inorganic phases such as hydroxyapatite (HA) into BC matrix may enhance bone regeneration. The aim of this study was to develop BC as a matrix for HA deposition. Absorption capacity is a key to incorporate calcium ion into BC and induces HA deposition. To enhance its absorption capacity, BC was modified using citric acid. The results showed that the incorporation of carboxylate groups into BC via reaction with citric acid improved its absorption capacity. X-ray diffraction (XRD) patterns of the modified BC after soaking treatments showed HA deposition with diffractions attributed to low crystalline HA at 2 theta = 11.7 degrees; 26.2 degrees; 29.4 degrees; 32.0 degrees; 33.0 degrees; 34.2 degrees; and 46.6 degrees. Furthermore, energy dispersive spectroscopy (EDS) analysis showed that the average Ca/P ratio was 1.12.
C1 [Nurlidar, Farah; Darwis, Darmawan; Sugiarto] Ctr Applicat Isotopes & Radiat Technol, Ps Jumat 12070, Jakarta Selatan, Indonesia.
   [Budianto, Emil] Univ Indonesia, Depok 16421, Jawa Barat, Indonesia.
RP Nurlidar, F (reprint author), Ctr Applicat Isotopes & Radiat Technol, Ps Jumat 12070, Jakarta Selatan, Indonesia.
EM farah@batan.go.id
CR Bielecki S., 2002, BIOPOLYMERS, V5, P37, DOI 10.1002/3527600035.bpol5003
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Darwis D., 2009, J ILMIAH A I R, V5, P83
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Kawai T, 2004, BIOMATERIALS, V25, P4529, DOI 10.1016/j.biomaterials.2003.11.039
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Salam A, 2011, CARBOHYD POLYM, V84, P1221, DOI 10.1016/j.carbpol.2011.01.008
   Salam A, 2010, BIOMACROMOLECULES, V11, P1453, DOI 10.1021/bm1000235
   Strange DGT, 2011, ACTA BIOMATER, V7, P3586, DOI 10.1016/j.actbio.2011.06.025
   Nge TT, 2010, BIOPOLYMERS, P345
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 16
TC 0
Z9 0
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2015
VL 353
IS 1
SI SI
BP 128
EP 132
DI 10.1002/masy.201550317
PG 5
WC Polymer Science
SC Polymer Science
GA DN7SV
UT WOS:000377279700018
DA 2018-10-20
ER

PT J
AU Othman, Z
   Hashim, K
   Sabariah, K
   Abd Nasir, MH
   Hassan, A
AF Othman, Zainon
   Hashim, K.
   Sabariah, K.
   Abd Nasir, M. H.
   Hassan, A.
TI Synthesis and Characterization of Carboxymethyl Derivatives of Sago
   (Metroxylon sagu) Starch
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT International Conference on Innovation in Polymer Science and Technology
   (IPST)
CY OCT 07-10, 2013
CL Yogyakarta, INDONESIA
DE carboxymethyl sago starch; degree of substitution; sago starch
ID POTATO STARCH
AB Synthesis of carboxymethyl starch (CMSS) from sago (Metroxylon sagu), an important agricultural commodity of Malaysia, was conducted in 30 L reactor vessel using isopropanol as the non-aqueous medium. CMSS of degree of substitution (DS) 0.24, 0.40, 0.54 and 0.80 was prepared by varying the molar ratio of sodium hydroxide and sodium monochloroacetate to anhydroglucose units including reaction time. Substitution of the hydroxyl groups on the native starch with carboxymethyl group was confirmed using Fourier transform infrared. All prepared samples were water-soluble at room temperature, producing high paste clarity. Carboxymethylation markedly reduced viscosity of CMSS compared to native sago. The particle size distribution also displayed increase in the granule size range compared to native sago. However X-ray diffractometry of CMSS revealed loss of crystallinity. Scanning electron microscopy showed that the granular smooth appearance of native starch was mostly distorted after carboxymethylation process at higher DS values. The synthesis of carboxymethyl sago starch with different degrees of substitution will add value to the sago industry as new functional biomaterial with potential application in the food and non-food industry.
C1 [Othman, Zainon; Hashim, K.; Sabariah, K.; Abd Nasir, M. H.; Hassan, A.] Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia.
RP Othman, Z (reprint author), Agensi Nuklear Malaysia, Kajang 43000, Selangor, Malaysia.
EM zainon@nuclearmalaysia.gov.my
CR Ahmad FB, 1999, CARBOHYD POLYM, V38, P361, DOI 10.1016/S0144-8617(98)00123-4
   American Standard of Test Method, 1992, ASTM, V6, P24939
   Kittipongpatana OS, 2006, CARBOHYD POLYM, V63, P105, DOI 10.1016/j.carbpol.2005.08.024
   Liu J, 2012, FOOD CHEM, V133, P1196, DOI 10.1016/j.foodchem.2011.05.061
   Noor Fadzlina Z. A., 2005, J FOOD SCI, V70, P9
   Qiu HY, 1999, POLYM ADVAN TECHNOL, V10, P468, DOI 10.1002/(SICI)1099-1581(199907)10:7<468::AID-PAT898>3.3.CO;2-N
   Singhal RS, 2008, CARBOHYD POLYM, V72, P1, DOI 10.1016/j.carbpol.2007.07.043
   Tijsen CJ, 2001, CARBOHYD POLYM, V45, P219, DOI 10.1016/S0144-8617(00)00243-5
   Wang YL, 2009, CARBOHYD RES, V344, P1764, DOI 10.1016/j.carres.2009.06.014
   Yaacob B, 2011, IRAN POLYM J, V20, P195
NR 10
TC 1
Z9 1
U1 2
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2015
VL 353
IS 1
SI SI
BP 139
EP 146
DI 10.1002/masy.201550319
PG 8
WC Polymer Science
SC Polymer Science
GA DN7SV
UT WOS:000377279700020
DA 2018-10-20
ER

PT J
AU Moloney, TC
   Fhlathartaigh, MN
   Kulkarni, M
   Pandit, A
   Dowd, E
AF Moloney, Teresa C.
   Fhlathartaigh, Mary Ni
   Kulkarni, Mangesh
   Pandit, Abhay
   Dowd, Eilis
TI Fibrin As a Scaffold for Delivery of GDNF Overexpressing Stem Cells to
   the Adult Rat Brain
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biomaterial; neurotrophic factors; stem cells; neurodegeneration; fibrin
ID SPINAL-CORD-INJURY; NIGRAL DOPAMINERGIC-NEURONS; MARROW STROMAL CELLS;
   NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE;
   BONE-MARROW; CONTROLLED-RELEASE; SUBACUTE MODEL; CLOT STRUCTURE
AB Treatment of neurodegenerative disease is entering a new era where direct intracerebral delivery of therapeutic factors aims to restore normality to dysfunctional circuits. Cell-based therapeutic approaches, where virally manipulated mesenchymal stem cells (MSCs) overexpressing glial cell line derived neurotrophic factor (GDNF) are utilized as vehicles to deliver neurotrophic support to the Parkinsonian brain, have shown promising preclinical results at preserving dopaminergic neuron integrity. However, poor cell survival following transplantation will hinder clinical progression. One approach to improve MSCs survival following transplantation is to couple the cell engraftment procedure with a scaffold thereby providing a physical substrate upon which to eventually complex pro-survival factors. Evaluation of commercially available, clinically accepted materials with an established safety profile will expedite clinical translation. Therefore, this study sought to determine if a clinically used fibrin scaffold can be utilized as an adjunct to intracerebral cell transplantation without evoking an adverse host or stem cell response. Sixteen male Sprague Dawley rats received bilateral intrastriatal transplants of 30 000 GDNF-transduced MSCs delivered in either control transplantation medium or a fibrin scaffold. Rats were sacrificed 1, 4, 7, and 14 days post-transplantation. Brains were analyzed to determine in situ polymerization and biodegradability of the fibrin scaffold, GDNF release from transplanted GDNF-MSCs, survival of the GDNF-MSC graft and the host's immune response to the transplant. This study found that fibrin scaffold was adaptable to intracerebral delivery with successful polymerization of the fibrin scaffold in situ. Inclusion of the fibrin scaffold was not detrimental to cell survival nor did it impede neurotrophin release from entrapped cells. Importantly, the inclusion of the fibrin scaffold was associated with a reduced host astroglial and microglial response compared to cells alone indicative of a favorable biocompatibility profile. Overall, fibrin represents an adaptable scaffold for inclusion in a minimally invasive cell-based therapeutic approach for neurodegenerative diseases.
C1 [Moloney, Teresa C.; Fhlathartaigh, Mary Ni; Dowd, Eilis] Natl Univ Ireland, Dept Pharmacol, Galway, Ireland.
   [Moloney, Teresa C.; Fhlathartaigh, Mary Ni; Dowd, Eilis] Natl Univ Ireland, Dept Therapeut, Galway, Ireland.
   [Moloney, Teresa C.; Fhlathartaigh, Mary Ni; Kulkarni, Mangesh; Pandit, Abhay; Dowd, Eilis] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
RP Dowd, E (reprint author), Natl Univ Ireland, Dept Pharmacol, Galway, Ireland.
EM eilis.dowd@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Dowd, Eilis/0000-0002-2668-539X
FU Science Foundation Ireland Strategic Research Cluster grant
   [07/SRC/B1163]
FX We acknowledge BAXTER for their kind gift of the TISSEEL used in this
   project. We thank Doczyk Design for the generation of the schematic.
   This research was funded by a Science Foundation Ireland Strategic
   Research Cluster grant (07/SRC/B1163).
CR Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Bartmann C, 2007, TRANSFUSION, V47, P1426, DOI 10.1111/j.1537-2995.2007.01219.x
   Breen A, 2006, J BIOMED MATER RES A, V78A, P702, DOI 10.1002/jbm.a.30735
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Breen A, 2009, J BIOMED MATER RES A, V89A, P876, DOI 10.1002/jbm.a.32039
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   De Faveri Sara, 2014, Front Neuroeng, V7, P7, DOI 10.3389/fneng.2014.00007
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Hoban DB, 2013, BIOMATERIALS, V34, P9420, DOI 10.1016/j.biomaterials.2013.08.073
   Ito T, 2001, J AM SOC NEPHROL, V12, P2625
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Johnson SJ, 2013, MOVEMENT DISORD, V28, P319, DOI 10.1002/mds.25328
   Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P252
   Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P250
   Kassam Amin, 2004, Ear Nose Throat J, V83, P246
   Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x
   Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292
   Kulkarni M, 2014, BIOMATERIALS, V35, P2001, DOI 10.1016/j.biomaterials.2013.11.003
   Kulkarni M, 2009, BIOMACROMOLECULES, V10, P1650, DOI 10.1021/bm900248n
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737
   LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557
   Liu JB, 2013, CELLS TISSUES ORGANS, V198, P35, DOI 10.1159/000351665
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Love S, 2005, NAT MED, V11, P703, DOI 10.1038/nm0705-703
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Moloney TC, 2010, BRAIN RES, V1359, P33, DOI 10.1016/j.brainres.2010.08.040
   Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745
   Moore AM, 2010, J HAND SURG-AM, V35A, P2008, DOI 10.1016/j.jhsa.2010.08.016
   Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ren ZH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02786
   Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260
   Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]
   Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x
   Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x
   Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861
   Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216
   Sullivan AM, 1998, EUR J NEUROSCI, V10, P57
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   Winkler C, 1996, J NEUROSCI, V16, P7206
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wood MD, 2008, J BIOMED MATER RES A, V84A, P300, DOI 10.1002/jbm.a.31269
   Wood MD, 2013, REGEN MED, V8, P27, DOI [10.2217/RME.12.105, 10.2217/rme.12.105]
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Zhang ZQ, 2008, IN VITRO CELL DEV-AN, V44, P169, DOI 10.1007/s11626-008-9093-1
NR 58
TC 1
Z9 1
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUL
PY 2015
VL 1
IS 7
BP 559
EP 566
DI 10.1021/acsbiomaterials.5b00049
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RN
UT WOS:000372213900009
DA 2018-10-20
ER

PT J
AU Appavu, R
   Chesson, CB
   Koyfman, AY
   Snook, JD
   Kohlhapp, FJ
   Zloza, A
   Rudra, JS
AF Appavu, Rajagopal
   Chesson, Charles B.
   Koyfman, Alexey Y.
   Snook, Joshua D.
   Kohlhapp, Frederick J.
   Zloza, Andrew
   Rudra, Jai S.
TI Enhancing the Magnitude of Antibody Responses through Biomaterial
   Stereochemistry
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE adjuvant; enantiomer; nanofiber; peptide; stereochemistry; self-assembly
ID D-AMINO ACIDS; SELF-ASSEMBLING PEPTIDES; CELL RESPONSES; NALP3
   INFLAMMASOME; IMMUNE-RESPONSES; DENDRITIC CELLS; VACCINE; ADJUVANT;
   BETA; IMMUNOMODULATION
AB D-Amino acid analogs of peptides and proteins are attractive for applications in biotechnology and medicine due to their reduced proteolytic sensitivity. Here, we report that self-assembling peptide nanofibers composed of D-amino acids act as immune adjuvants, and investigate their ability to induce antibody responses in comparison to their L-amino acid counterparts. The model antigenic peptide OVA (chicken egg ovalbumin as 323-339) from chicken egg ovalbumin, known to elicit antibody responses in mice, was linked to an L- or D-amino acid self-assembling peptide domain to generate enantiomeric nanofibers displaying the same epitope. The chiral nature of the fusion peptides was confirmed by circular dichrosim spectroscopy and transmission electron microscopy studies indicated that OVA-bearing enantiomers self-assembled into nanofibers with similar morphologies. In mice, D-amino acid peptide nanofibers displaying OVA elicited stronger antibody responses, equivalent levels of CD4+ T cell responses, and long-term antigen-presentation in vivo compared to L-amino acid nanofibers. Our findings indicate that self-assembling peptides composed of D-amino acids are strong immune adjuvants and that biomaterial stereochemistry can be used as a design tool to program adaptive immune responses for vaccine development.
C1 [Appavu, Rajagopal; Koyfman, Alexey Y.; Snook, Joshua D.; Rudra, Jai S.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Chesson, Charles B.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Chesson, Charles B.; Rudra, Jai S.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Kohlhapp, Frederick J.; Zloza, Andrew] Rush Univ, Med Ctr, Dept Microbiol Immunol, Chicago, IL 60612 USA.
   [Kohlhapp, Frederick J.; Zloza, Andrew] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.
RP Rudra, JS (reprint author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM jarudra@utmb.edu
FU Sealy Center for Vaccine Development, and the Department of Pharmacology
   and Toxicology, UTMB
FX This study was supported by funds from the Sealy Center for Vaccine
   Development, and the Department of Pharmacology and Toxicology, UTMB
   (J.S.R/). TEM studies were conducted at the Sealy Center for Structural
   Biology Cryo-electron Microscopy core lab and we thank Dr. Misha Sherman
   and Michael Woodson for assistance with imaging. Flow cytometry was
   conducted at the Flow Cytometry and Cell Sorting Facility at UTMB and we
   thank Mark Griffin for his expertise. SPR studies were conducted at the
   Solution Biophysics Research Core Lab at the Sealy Center for Structural
   Biology and we thank Dr. Luis Marcelo F. Holthauzen for his expertise
   and assistance. We thank Dr. Rebecca Pompano for helpful discussions and
   Heather Lander for assistance with editing the manuscript.
CR Anderson RJ, 2014, NAT CHEM BIOL, V10, P943, DOI [10.1038/NCHEMBIO.1640, 10.1038/nchembio.1640]
   ARMSTRONG DW, 1993, CHIRALITY, V5, P375, DOI 10.1002/chir.530050519
   Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020
   Billard JM, 2012, AMINO ACIDS, V43, P1851, DOI 10.1007/s00726-012-1346-3
   Bowerman CJ, 2012, BIOPOLYMERS, V98, P169, DOI 10.1002/bip.22058
   Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063
   Chesson CB, 2014, VACCINE, V32, P1174, DOI 10.1016/j.vaccine.2013.11.047
   Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   FISHER GH, 1991, BRAIN RES BULL, V26, P983, DOI 10.1016/0361-9230(91)90266-M
   Friedman M, 2012, AMINO ACIDS, V42, P1553, DOI 10.1007/s00726-011-0915-1
   Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225
   Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636
   Huang ZH, 2012, J AM CHEM SOC, V134, P8730, DOI 10.1021/ja211725s
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hudalla GA, 2013, ADV HEALTHC MATER, V2, P1114, DOI 10.1002/adhm.201200435
   Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Khan TA, 2014, ACTA BIOMATER, V10, P1720, DOI 10.1016/j.actbio.2013.12.011
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Lewis JS, 2014, MRS BULL, V39, P25, DOI 10.1557/mrs.2013.310
   Li XM, 2012, LANGMUIR, V28, P13512, DOI 10.1021/la302583a
   Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373
   Luo ZL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002364
   Luo ZL, 2008, MACROMOL BIOSCI, V8, P785, DOI 10.1002/mabi.200800003
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Malyala P, 2008, J PHARM SCI-US, V97, P2041, DOI 10.1002/jps.21152
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Maude S, 2013, NANOMEDICINE-UK, V8, P823, DOI [10.2217/NNM.13.65, 10.2217/nnm.13.65]
   Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003
   Montero A, 2011, CHEM BIOL, V18, P1453, DOI 10.1016/j.chembiol.2011.08.017
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009
   Pradhan P, 2014, BIOMATERIALS, V35, P5491, DOI 10.1016/j.biomaterials.2014.03.039
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Sun TL, 2007, J AM CHEM SOC, V129, P1496, DOI 10.1021/ja0686155
   Swanekamp RJ, 2012, J AM CHEM SOC, V134, P5556, DOI 10.1021/ja301642c
   Thomas SN, 2011, BIOMATERIALS, V32, P2194, DOI 10.1016/j.biomaterials.2010.11.037
   Tsutsumi H, 2013, MOL BIOSYST, V9, P609, DOI 10.1039/c3mb25442a
   Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523
   ZAGON J, 1994, NUTR RES, V14, P445, DOI 10.1016/S0271-5317(05)80182-4
NR 51
TC 10
Z9 11
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUL
PY 2015
VL 1
IS 7
BP 601
EP 609
DI 10.1021/acsbiomaterials.5b00139
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DG6RN
UT WOS:000372213900014
DA 2018-10-20
ER

PT J
AU Naves, MM
   Menezes, HHM
   Magalhaes, D
   Ferreira, JA
   Ribeiro, SF
   de Mello, JDB
   Costa, HL
AF Naves, Marina Melo
   Machado Menezes, Helder Henrique
   Magalhaes, Denildo
   Ferreira, Jessica Afonso
   Ribeiro, Sara Ferreira
   Biasoli de Mello, Jose Daniel
   Costa, Henara Lillian
TI Effect of Macrogeometry on the Surface Topography of Dental Implants
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE dental implants; implant design; osseointegration; surface texturing;
   surface topography; titanium
ID TITANIUM IMPLANTS; RETROSPECTIVE ANALYSIS; EARLY OSSEOINTEGRATION; BONE
   INTEGRATION; MINIATURE PIGS; ROUGHNESS; PARAMETERS; SURVIVAL; ADHESION;
   CONTACT
AB Purpose: Because the microtopography of titanium implants influences the biomaterial-tissue interaction, surface microtexturing treatments are frequently used for dental implants. However, surface treatment alone may not determine the final microtopography of a dental implant, which can also be influenced by the implant macrogeometry. This work analyzed the effects on surface roughness parameters of the same treatment applied by the same manufacturer to implants with differing macro-designs. Materials and Methods: Three groups of titanium implants with different macro-designs were investigated using laser interferometry and scanning electron microscopy. Relevant surface roughness parameters were calculated for different regions of each implant. Two flat disks (treated and untreated) were also investigated for comparison. Results: The tops of the threads and the nonthreaded regions of all implants had very similar roughness parameters, independent of the geometry of the implant, which were also very similar to those of flat disks treated with the same process. In contrast, the flanks and valleys of the threads presented larger irregularities (Sa) with higher slopes (Sdq) and larger developed surface areas (Sdr) on all implants, particularly for implants with threads with smaller heights. The flanks and valleys displayed stronger textures (Str), particularly on the implants with threads with larger internal angles. Conclusion: Parameters associated with the height of the irregularities (Sa), the slope of the asperities (Sdq), the presence of a surface texture (Str), and the developed surface area of the irregularities (Sdr) were significantly affected by the macrogeometry of the implants. Flat disks subjected to the same surface treatment as dental implants reproduced only the surface topography of the flat regions of the implants.
C1 [Naves, Marina Melo; Magalhaes, Denildo; Ferreira, Jessica Afonso] Univ Fed Uberlandia, Sch Dent, Uberlandia, MG, Brazil.
   [Naves, Marina Melo; Machado Menezes, Helder Henrique; Magalhaes, Denildo] HD Ensinos Odontol, Uberlandia, MG, Brazil.
   [Ribeiro, Sara Ferreira; Biasoli de Mello, Jose Daniel; Costa, Henara Lillian] Univ Fed Uberlandia, Lab Tribol & Mat, Campus Sta Monica,Bl 5K, BR-38400901 Uberlandia, MG, Brazil.
RP Costa, HL (reprint author), Univ Fed Uberlandia, Lab Tribol & Mat, Campus Sta Monica,Bl 5K, BR-38400901 Uberlandia, MG, Brazil.
EM ltm-henara@ufu.br
RI Costa, Henara/H-1746-2014
OI Costa, Henara/0000-0002-0412-4436
FU Fundacao de Apoio a Pesquisa no Estado de Minas Gerais (Fapemig),
   Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), Brazil
FX The authors are grateful to Neodent for providing all the samples used
   in this work and to Fundacao de Apoio a Pesquisa no Estado de Minas
   Gerais (Fapemig), Brazil, and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil, for financial support. The
   authors reported no conflicts of interest related to this study.
CR Abron A, 2001, J PROSTHET DENT, V85, P40, DOI 10.1067/mpr.2001.112415
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   [Anonymous], 1993, 11562 ISOIS
   [Anonymous], 1997, 4287 ISO
   Bennett J, 1999, INTRO SURFACE ROUGHN
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cardoso MV, 2013, CLIN IMPLANT DENT RE
   Chuang SK, 2006, J DENT RES, V85, P1147, DOI 10.1177/154405910608501216
   Coelho PG, 2011, J MECH BEHAV BIOMED, V27, P1974
   Degidi Marco, 2005, J Oral Implantol, V31, P25, DOI 10.1563/0-730.1
   Deporter D, 2009, INT J PERIODONT REST, V29, P625
   Dong SP, 1994, 3 DIMENSIONAL SURFAC, P3
   DONG WP, 1994, WEAR, V178, P29, DOI 10.1016/0043-1648(94)90127-9
   DONG WP, 1993, WEAR, V167, P9, DOI 10.1016/0043-1648(93)90050-V
   DUNNETT CW, 1992, STAT MED, V11, P1057, DOI 10.1002/sim.4780110807
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   Elias CN, 2010, EXPERT REV MED DEVIC, V7, P241, DOI [10.1586/erd.09.74, 10.1586/ERD.09.74]
   Goncalves Jr JL, 2012, P 3 INT C METR 21 23
   Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x
   Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Levine RA, 2002, INT J ORAL MAX IMPL, V17, P550
   Novaes AB, 2002, INT J ORAL MAX IMPL, V17, P377
   Rizzi M, 2014, J PROSTHET DENT, V112, P1103, DOI 10.1016/j.prosdent.2014.04.010
   Rosa MB, 2013, INT J ORAL MAX IMPL, V28, P358, DOI 10.11607/jomi.2791
   Rosa MB, 2012, J APPL ORAL SCI, V20, P550, DOI 10.1590/S1678-77572012000500010
   SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204
   Shibli JA, 2007, J BIOMED MATER RES B, V80B, P377, DOI 10.1002/jbm.b.30608
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   Stout K. J., 1993, DEV METHODS CHARACTE
   Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945
   Valverde GB, 2013, CLIN ORAL IMPLAN RES, V24, P238, DOI 10.1111/j.1600-0501.2011.02392.x
   Vercaigne S, 1998, BIOMATERIALS, V19, P1093, DOI 10.1016/S0142-9612(98)00039-8
   Vroom MG, 2009, CLIN ORAL IMPLAN RES, V20, P1231, DOI 10.1111/j.1600-0501.2009.01768.x
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Zupnik J, 2011, J PERIODONTOL, V82, P1390, DOI 10.1902/jop.2011.100685
NR 40
TC 2
Z9 3
U1 2
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JUL-AUG
PY 2015
VL 30
IS 4
BP 789
EP 799
DI 10.11607/jomi.3934
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DD0SH
UT WOS:000369629200007
PM 26252030
OA Bronze
DA 2018-10-20
ER

PT J
AU Ramos-Murguialday, M
   Caubet, J
   Ramis, JM
   Monjo, M
AF Ramos-Murguialday, Mikel
   Caubet, Jorge
   Maria Ramis, Joana
   Monjo, Marta
TI Evaluation of the Ideal Implant Insertion Time in Human Bone Biopsies
   After Sinus Elevation Using a Combination of Autologous Bone and Graft
   Substitute
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE clinical study; composite graft; dental implant; gene expression;
   microcomputed tomography (microCT); sinus lift (SL)
ID RESONANCE FREQUENCY-ANALYSIS; PROSPECTIVE CLINICAL-TRIAL; AUTOGENOUS
   ILIAC CREST; FLOOR AUGMENTATION; STABILITY MEASUREMENTS;
   HISTOMORPHOMETRIC ANALYSIS; MEMBRANE PERFORATIONS; LIFT PROCEDURES;
   MAXILLARY; SURVIVAL
AB Purpose: To evaluate the ideal implant insertion time in human bone biopsies after sinus elevation with a composite graft consisting of an equal amount of biomaterial and autologous bone, by comparing the bone regeneration obtained 4 to 5 months after surgery with that obtained after 6 to 8 months, and using the adjacent native bone as reference. Materials and Methods: Twenty-six biopsy specimens of 11 patients were analyzed. Two groups were created depending on the time of implant insertion: group t1 at 4 to 5 months (n = 13) and group t2 at 6 to 8 months (n = 13). The same volume of grafted bone and native bone were analyzed for each biopsy with microcomputed tomography (microCT) and gene expression analysis. Results: Statistically significant differences were found in bone mineral density (BMD), bone volume fraction, and trabecular separation (TbSp) between native and grafted bone in both groups, with higher grafted bone values, except for the variable TbSp, which was lower in the grafted bone. This decrease in TbSp in the grafted bone in both groups can be explained by the significant increase in trabecular thickness in group t2 and the trabecular number in group t1, compared with native bone. No significant differences were found between the two groups in the morphometric parameters and BMD of the grafted bone. Also, no significant changes in the messenger RNA (mRNA) levels of bone formation, bone resorption, and inflammatory markers were found between both groups, with the exception that alkaline phosphatase mRNA levels were significantly lower in group t1 relative to native bone. Conclusion: This composite graft showed no differences in three-dimensional microstructure, BMD, or at the molecular level between 4 to 5 months and 6 to 8 months of healing time. Thus, this time can be shortened to 4 months with the security of a grafted area of mature bone.
C1 [Ramos-Murguialday, Mikel] Son Espases Hosp, Dept Oral & Maxillofacial Surg, Palma De Mallorca, Spain.
   [Ramos-Murguialday, Mikel; Caubet, Jorge] Clin GBCOM, Unit Oral & Maxillofacial Surg, Palma De Mallorca, Spain.
   [Maria Ramis, Joana; Monjo, Marta] Univ Illes Balears, Dept Fundamental Biol & Hlth Sci, Res Inst Hlth Sci, Palma De Mallorca, Spain.
   [Maria Ramis, Joana; Monjo, Marta] Inst Invest Sanitaria Palma, Palma De Mallorca, Spain.
   [Monjo, Marta] Univ Oslo, Inst Clin Dent, Dept Biomat, Oslo, Norway.
RP Monjo, M (reprint author), UIB, Dept Fundamental Biol & Hlth Sci, Res Inst Hlth Sci IUNICS, Cra Valldemossa,Km 7-5, E-07122 Palma De Mallorca, Spain.
EM marta.monjo@uib.es
OI Monjo, Marta/0000-0002-2731-9527; Ramis, Joana Maria/0000-0001-9109-8362
FU Ministry of Science and Innovation of Spain (Torres Quevedo contract);
   Conselleria de Salut i Consum from the Balearic government; Mateu Orfila
   Foundation; Ministry of Science and Innovation of Spain (Ramon y Cajal
   contract)
FX This work was supported by the Ministry of Science and Innovation of
   Spain (Torres Quevedo contract to J.M. Ramis, and Ramon y Cajal contract
   to M. Monjo), by the Conselleria de Salut i Consum from the Balearic
   government, and by the Mateu Orfila Foundation. The authors thank the
   Department of Biomaterials (University of Oslo, Norway) for the use of
   the micro-CT scanner and all the patients who participated in this
   study. The authors reported no conflicts of interest related to this
   study.
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Becker W, 2005, J PERIODONTOL, V76, P391, DOI 10.1902/jop.2005.76.3.391
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Caubet J, 2015, CLIN ORAL IMPLAN RES, V26, P727, DOI 10.1111/clr.12380
   Caubet J, 2011, J ORAL MAXIL SURG, V69, P482, DOI 10.1016/j.joms.2010.10.037
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   Consolo U, 2007, CLIN ORAL IMPLAN RES, V18, P252, DOI 10.1111/j.1600-0501.2006.01330.x
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Crespi R, 2007, INT J ORAL MAX IMPL, V22, P527
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P7
   Fugazzotto PA, 2003, J PERIODONTOL, V74, P1534, DOI 10.1902/jop.2003.74.10.1534
   Galindo-Moreno P, 2008, CLIN ORAL IMPLAN RES, V19, P755, DOI 10.1111/j.1600-0501.2008.01536.x
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Gerressen M, 2009, CLIN ORAL IMPLAN RES, V20, P109, DOI 10.1111/j.1600-0501.2008.01619.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman Mats, 2004, Clin Implant Dent Relat Res, V6, P82, DOI 10.1111/j.1708-8208.2004.tb00030.x
   Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x
   Hirsch JM, 1991, CLIN ORAL IMPLAN RES, V2, P91, DOI 10.1034/j.1600-0501.1991.020207.x
   Huang HL, 2013, CLIN ORAL INVEST, V17, P535, DOI 10.1007/s00784-012-0725-1
   Hurzeler M B, 1996, Int J Oral Maxillofac Implants, V11, P466
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kessler-Liechti G, 2008, INT J ORAL MAX IMPL, V23, P353
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Nkenke E, 2002, INT J ORAL MAX IMPL, V17, P557
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Raghoebar GM, 2005, CLIN ORAL IMPLAN RES, V16, P349, DOI 10.1111/j.1600-0501.2005.01115.x
   Rodrigo D, 2010, CLIN ORAL IMPLAN RES, V21, P255, DOI 10.1111/j.1600-0501.2009.01820.x
   Roze J, 2009, CLIN ORAL IMPLAN RES, V20, P1140, DOI 10.1111/j.1600-0501.2009.01745.x
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schwartz-Arad D, 2004, J PERIODONTOL, V75, P511, DOI 10.1902/jop.2004.75.4.511
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Shlomi B, 2004, INT J ORAL MAX IMPL, V19, P559
   Sittitavornwong S, 2010, ORAL MAXIL SURG CLIN, V22, P317, DOI 10.1016/j.coms.2010.04.006
   Stricker A, 2003, CLIN ORAL IMPLAN RES, V14, P207, DOI 10.1034/j.1600-0501.2003.140211.x
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   ten Bruggenkate CM, 1998, PERIODONTOL 2000, V17, P176
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P256, DOI 10.1034/j.1600-0501.2000.011003256.x
   Zaffe D, 2007, CLIN ORAL IMPLAN RES, V18, P525, DOI 10.1111/j.1600-0501.2007.01368.x
NR 45
TC 0
Z9 0
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JUL-AUG
PY 2015
VL 30
IS 4
BP 891
EP 899
DI 10.11607/jomi.3945
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DD0SH
UT WOS:000369629200019
PM 26252041
OA Bronze
DA 2018-10-20
ER

PT J
AU Seyyedi, K
   Mahdiyar, A
AF Seyyedi, K.
   Mahdiyar, A.
TI DECOLORIZATION OF CONTAMINATED WATER CONTAINING CI DIRECT BLUE 53 BY
   MACROALGAE CHARA SP AND OPTIMIZATION OF DECOLORIZATION PROCESS
SO LATIN AMERICAN APPLIED RESEARCH
LA English
DT Article
DE Biodegradation; Macroalgae Chara; Direct blue53; Decolorization
ID DYE SOLUTION; BIOLOGICAL DECOLORIZATION; OPERATIONAL PARAMETERS;
   MALACHITE-GREEN; REMOVAL; BIOSORPTION; TIO2
AB Dye wastewater is considered as a major pollutant of surface water. In recent years, biological treatment with the use of micro and macro organisms has been used as a good method for removing various organic and inorganic pollutants. In the present study, the potential of a macroalgae Chara sp., was investigated as a viable biomaterial for the biological treatment of Direct Blue 53 solution. The effects of operational parameters such as temperature, pH, initial dye concentration, the amount of algae, salinity, and light-darkness on the efficiency of biological decolorization were studied. In optimal conditions, with an initial value for live algae of 3.5 g, temperature of 25 degrees C, pH = 2, for a solution containing 15 ppm of Direct blue 53, the dye removal efficiency obtained was of 63%. Dye removal increased with an increase in the amount of biomass. The efficiency of the biological treatment of Direct Blue 53 decreased as the temperature and initial dye concentration increased. The salinity of the solution had an inverse relationship with the decolorization efficiency, and the dye was removed more easily in darkness. The results of FTIR and GC-Mass spectroscopy showed that the decolorization mechanism of the solution in the presence of live algae was biodegradation.
C1 [Seyyedi, K.] Islamic Azad Univ, Tabriz Branch, Dept Appl Chem, Tabriz, Iran.
   [Seyyedi, K.] Islamic Azad Univ, East Azarbaijan Sci & Res Branch, Dept Chem, Tabriz, Iran.
   [Mahdiyar, A.] Islamic Azad Univ, Tabriz Branch, Dept Chem Engn Biotechnol, Tabriz, Iran.
   [Mahdiyar, A.] Islamic Azad Univ, East Azarbaijan Sci & Res Branch, Dept Chem Engn Biotechnol, Tabriz, Iran.
RP Seyyedi, K (reprint author), Islamic Azad Univ, Tabriz Branch, Dept Appl Chem, Tabriz, Iran.
EM ka_seyyedi@yahoo.com
CR Aksu Z, 2005, PROCESS BIOCHEM, V40, P1347, DOI 10.1016/j.procbio.2004.06.007
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014
   Bakker N. V. J., 2001, PLANT ECOL, V154, P237
   Celekli A, 2011, CHEM ENG J, V169, P166, DOI 10.1016/j.cej.2011.02.077
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Daneshvar N, 2007, J HAZARD MATER, V143, P214, DOI 10.1016/j.jhazmat.2006.09.016
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2
   Donmez GC, 1999, PROCESS BIOCHEM, V34, P885
   Erden E., 2011, ELECTRON J BIOTECHN, V14, P1
   Khatace A. R., 2009, Chinese Journal of Applied and Environmental Biology, V15, P110, DOI 10.3724/SP.J.1145.2009.00110
   Khataee AR, 2011, CHEM ENG RES DES, V89, P172, DOI 10.1016/j.cherd.2010.05.009
   Khataee AR, 2010, BIORESOURCE TECHNOL, V101, P2252, DOI 10.1016/j.biortech.2009.11.079
   Khataee AR, 2009, ENVIRON TECHNOL, V30, P1155, DOI 10.1080/09593330903133911
   Khataee AR, 2009, J HAZARD MATER, V161, P1225, DOI 10.1016/j.jhazmat.2008.04.075
   Mittal A, 2005, J HAZARD MATER, V117, P171, DOI 10.1016/j.jhazmat.2004.09.016
   Orfao JJM, 2006, J COLLOID INTERF SCI, V296, P480, DOI 10.1016/j.jcis.2005.09.063
   Peta A., 2009, SCI TOTAL ENVIRON, V407, P1164
   Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047
   RAMMEL R.S, 2011, J U CHEM TECHNOL MET, V46, P283
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Vashishta B.R., 2005, BOT DEGREE STUDENTS
   Velis CA, 2009, BIORESOURCE TECHNOL, V100, P2747, DOI 10.1016/j.biortech.2008.12.026
   Zarei M, 2009, ELECTROCHIM ACTA, V54, P6651, DOI 10.1016/j.electacta.2009.06.060
NR 25
TC 1
Z9 1
U1 2
U2 3
PU PLAPIQUI(UNS-CONICET)
PI BAHIA BLANCA
PA CAMINO LA CARRINDANGA, KM 7, C C 717, 8000 BAHIA BLANCA, ARGENTINA
SN 0327-0793
EI 1851-8796
J9 LAT AM APPL RES
JI Latin Am. Appl. Res.
PD JUL
PY 2015
VL 45
IS 3
BP 193
EP 198
PG 6
WC Engineering, Chemical
SC Engineering
GA CZ6LW
UT WOS:000367213800008
DA 2018-10-20
ER

PT J
AU Schutgens, EM
   Tryfonidou, MA
   Smit, TH
   Oner, FC
   Krouwels, A
   Ito, K
   Creemers, LB
AF Schutgens, E. M.
   Tryfonidou, M. A.
   Smit, T. H.
   Oner, F. Cumhur
   Krouwels, A.
   Ito, K.
   Creemers, L. B.
TI BIOMATERIALS FOR INTERVERTEBRAL DISC REGENERATION: PAST PERFORMANCE AND
   POSSIBLE FUTURE STRATEGIES
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Intervertebral disc degeneration; nucleus pulposus cells; annulus
   fibrosus cells; regeneration; hydrogels; synthetic polymers; natural
   hydrogels; delivery; cell-biomaterial interactions
ID MESENCHYMAL STEM-CELLS; NUCLEUS PULPOSUS REGENERATION; SMALL-INTESTINAL
   SUBMUCOSA; TISSUE ENGINEERING APPLICATIONS; GELATIN HYDROGEL
   MICROSPHERES; PEPTIDE NANOFIBER HYDROGEL; HYALURONIC-ACID HYDROGELS;
   IN-VITRO CHARACTERIZATION; ANNULUS FIBROSUS CELL; DRUG-DELIVERY SYSTEM
AB Intervertebral disc (IVD) degeneration is associated with most cases of cervical and lumbar spine pathologies, amongst which chronic low back pain has become the number one cause of loss of quality-adjusted life years. In search of alternatives to the current less than optimal and usually highly invasive treatments, regenerative strategies are being devised, none of which has reached clinical practice as yet. Strategies include the use of stem cells, gene therapy, growth factors and biomaterial carriers. Biomaterial carriers are an important component in musculoskeletal regenerative medicine techniques. Several biomaterials, both from natural and synthetic origin, have been used for regeneration of the IVD in vitro and in vivo. Aspects such as ease of use, mechanical properties, regenerative capacity, and their applicability as carriers for regenerative and anti-degenerative factors determine their suitability for IVD regeneration. The current review provides an overview of the biomaterials used with respect to these properties, including their drawbacks. In addition, as biomaterial application until now appears to have been based on a mix of mere availability and intuition, a more rational design is proposed for future use of biomaterials for IVD regeneration. Ideally, high-throughput screening is used to identify optimally effective materials, or alternatively medium content comparative studies should be carried out to determine an appropriate reference material for future studies on novel materials.
C1 [Schutgens, E. M.; Oner, F. Cumhur; Krouwels, A.; Ito, K.; Creemers, L. B.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.
   [Tryfonidou, M. A.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, NL-3508 TC Utrecht, Netherlands.
   [Smit, T. H.] Vrije Univ Amsterdam, Med Ctr, Dept Orthopaed, Amsterdam, Netherlands.
   [Ito, K.] Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, NL-5600 MB Eindhoven, Netherlands.
RP Creemers, LB (reprint author), Dept Orthopaed G05 228, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.
EM l.b.creemers@umcutrecht.nl
RI Ito, Keita/A-8592-2017
OI Ito, Keita/0000-0002-7372-4072
FU Project P2.01 IDiDAS of the research program of the BioMedical Materials
   Institute; Dutch Ministry of Economic Affairs, Agriculture and
   Innovation; Dutch Arthritis Foundation [LLP12, LLP22]; Dutch Government
   [FES0908]
FX Authors gratefully acknowledge funding as part of the Project P2.01
   IDiDAS of the research program of the BioMedical Materials Institute,
   co-funded by the Dutch Ministry of Economic Affairs, Agriculture and
   Innovation. In addition, the financial contribution of the Dutch
   Arthritis Foundation (LLP12 and LLP22) and the Dutch Government to the
   Netherlands Institute for Regenerative Medicine (NIRM, grant no FES0908)
   is acknowledged. We wish to confirm that there are no known conflicts of
   interest associated with this publication and there has been no
   significant financial support for this work that could have influenced
   its outcome.
CR Acosta FL, 2011, TISSUE ENG PT A, V17, P3045, DOI 10.1089/ten.tea.2011.0229
   Adams MA, 2014, CLIN ANAT, V28, P195
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anderson D Greg, 2005, Spine J, V5, p297S, DOI 10.1016/j.spinee.2005.02.019
   Ashley GW, 2013, P NATL ACAD SCI USA, V110, P2318, DOI 10.1073/pnas.1215498110
   Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Benz K, 2012, EUR SPINE J, V21, P1758, DOI 10.1007/s00586-012-2443-4
   Benz K, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-54
   Bertolo Alessandro, 2012, Eur Spine J, V21 Suppl 6, pS826, DOI 10.1007/s00586-011-1975-3
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bron JL, 2009, J ORTHOP RES, V27, P620, DOI 10.1002/jor.20789
   Bron JL, 2012, J MATER SCI-MATER M, V23, P813, DOI 10.1007/s10856-011-4545-7
   Bron JL, 2011, J MECH BEHAV BIOMED, V4, P1196, DOI 10.1016/j.jmbbm.2011.04.002
   Buckley CT, 2012, TISSUE ENG PT A, V18, P382, DOI [10.1089/ten.tea.2011.0145, 10.1089/ten.TEA.2011.0145]
   Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   CARTER DR, 2004, CLIN ORTHOP RE S OCT, pS69, DOI DOI 10.1097/01.BLO.0000144970.05107.7E
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chee AV, 2014, SPINE J, V14, P491, DOI 10.1016/j.spinee.2013.06.095
   Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008
   Chen YC, 2013, ACTA BIOMATER, V9, P5181, DOI 10.1016/j.actbio.2012.09.039
   Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI 10.1089/ten.TEA.2009.0229
   Cheng YH, 2013, CARBOHYD POLYM, V92, P1512, DOI 10.1016/j.carbpol.2012.10.074
   Cheng YH, 2011, BIOMATERIALS, V32, P6953, DOI 10.1016/j.biomaterials.2011.03.065
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Colombini A, 2014, TISSUE ENG PART B-RE, V20, P713, DOI [10.1089/ten.teb.2014.0158, 10.1089/ten.TEB.2014.0158]
   Cortes DH, 2014, J BIOMECH, V47, P2088, DOI 10.1016/j.jbiomech.2013.12.021
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Dahl MC, 2010, SPINE, V35, P1445, DOI 10.1097/BRS.0b013e3181bef192
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Diederichs S, 2012, TISSUE ENG PT A, V18, P1140, DOI [10.1089/ten.TEA.2011.0426, 10.1089/ten.tea.2011.0426]
   Ding AG, 2008, PHARM RES-DORD, V25, P2041, DOI 10.1007/s11095-008-9594-3
   Dodo CG, 2013, BIOFOULING, V29, P549, DOI 10.1080/08927014.2013.787416
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Drira Z, 2013, J MECH BEHAV BIOMED, V18, P20, DOI 10.1016/j.jmbbm.2012.09.015
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Ella V, 2005, J MATER SCI-MATER M, V16, P655, DOI 10.1007/s10856-005-2537-1
   Endres M, 2010, BIOMATERIALS, V31, P5836, DOI 10.1016/j.biomaterials.2010.03.078
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Etebar S, 1999, J NEUROSURG, V90, P163, DOI 10.3171/spi.1999.90.2.0163
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Feng GJ, 2011, BIOMATERIALS, V32, P8182, DOI 10.1016/j.biomaterials.2011.07.049
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Foss BL, 2014, J MECH BEHAV BIOMED, V29, P56, DOI 10.1016/j.jmbbm.2013.08.020
   Francisco AT, 2014, ACTA BIOMATER, V10, P1102, DOI 10.1016/j.actbio.2013.11.013
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157
   Ghosh P, 2012, J NEUROSURG-SPINE, V16, P479, DOI 10.3171/2012.1.SPINE11852
   Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343
   Gloria A, 2007, J MATER SCI-MATER M, V18, P2159, DOI 10.1007/s10856-007-3003-z
   Gorth DJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3932
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Guillaume O, 2015, J BIOMATER APPL, V29, P1230, DOI 10.1177/0885328214557905
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Gupta A, 2014, TISSUE ENG PT A, V20, P3101, DOI [10.1089/ten.TEA.2013.0702, 10.1089/ten.tea.2013.0702]
   Heathfield SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2468
   Hegewald AA, 2010, J TISSUE ENG REGEN M, V5, P275
   Helgeson MD, 2013, SPINE J, V13, P342, DOI 10.1016/j.spinee.2012.12.009
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Higashino K, 2010, SPINE, V35, pE1144, DOI 10.1097/BRS.0b013e3181e504d3
   Ho STB, 2010, BIOMATERIALS, V31, P38, DOI 10.1016/j.biomaterials.2009.09.021
   Hu JG, 2012, J MATER SCI-MATER M, V23, P711, DOI 10.1007/s10856-011-4533-y
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hung KC, 2014, ADV HEALTHC MATER, V3, P1578, DOI 10.1002/adhm.201400018
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x
   Hutton WC, 2004, J SPINAL DISORD TECH, V17, P53, DOI 10.1097/00024720-200402000-00011
   Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Isaacs JL, 2014, J MECH BEHAV BIOMED, V40, P75, DOI 10.1016/j.jmbbm.2014.08.012
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   Jacobs WCH, 2013, BEST PRACT RES CL RH, V27, P673, DOI 10.1016/j.berh.2013.09.009
   Jeong CG, 2014, ACTA BIOMATER, V10, P3421, DOI 10.1016/j.actbio.2014.05.012
   Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003
   Jonsson L, 2011, EUR SURG RES, V46, P169, DOI 10.1159/000324401
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Kenne L, 2013, CARBOHYD POLYM, V91, P410, DOI 10.1016/j.carbpol.2012.08.066
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim HY, 2017, J TISSUE ENG REGEN M, V11, P44, DOI 10.1002/term.1856
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim JH, 2009, SPINE, V34, P2486, DOI 10.1097/BRS.0b013e3181b26ed1
   Kim SH, 2014, J TISSUE ENG REGEN M, V8, P279, DOI 10.1002/term.1520
   Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397
   Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kota DJ, 2014, INT J BIOCHEM CELL B, V55, P1, DOI 10.1016/j.biocel.2014.07.022
   Lai P, 2014, COLLOID SURFACE B, V118, P154, DOI 10.1016/j.colsurfb.2014.03.017
   LARSEN B, 1971, CARBOHYD RES, V17, P287, DOI 10.1016/S0008-6215(00)82536-7
   Lazebnik M, 2011, J TISSUE ENG REGEN M, V5, pE179, DOI 10.1002/term.412
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leone G, 2008, J BIOMED MATER RES A, V84A, P391, DOI 10.1002/jbm.a.31334
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Li ZS, 2008, J BIOMED MATER RES A, V86A, P552, DOI 10.1002/jbm.a.31596
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liang CZ, 2012, J MATER SCI-MATER M, V23, P1097, DOI 10.1007/s10856-012-4563-0
   Liang CZ, 2013, ACTA BIOMATER, V9, P9423, DOI 10.1016/j.actbio.2013.08.019
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007
   Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004
   Lopez A, 2010, J BIOMED MATER RES B, V95B, P75, DOI 10.1002/jbm.b.31685
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028
   Malhotra NR, 2012, SPINE, V37, pE1099, DOI 10.1097/BRS.0b013e31825cdfb7
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Martin JT, 2014, ACTA BIOMATER, V10, P2473, DOI 10.1016/j.actbio.2014.02.024
   Martin Michael D, 2002, Neurosurg Focus, V13, pE1
   Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z
   Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03
   Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128
   Mehlhorn AT, 2009, TISSUE ENG PT A, V15, P1159, DOI 10.1089/ten.tea.2008.0069
   Melrose J, 2001, CELLS TISSUES ORGANS, V168, P137, DOI 10.1159/000047829
   Mercuri J, 2014, J BIOMED MATER RES A, V102, P4380, DOI 10.1002/jbm.a.35104
   MILLER JAA, 1988, SPINE, V13, P173, DOI 10.1097/00007632-198802000-00008
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Nakki A, 2014, EUR SPINE J, V23, pS354, DOI 10.1007/s00586-013-2878-2
   Neidlinger-Wilke C, 2009, SPINE, V34, P663, DOI 10.1097/BRS.0b013e318194e20c
   Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414
   Nguyen QT, 2012, BIOMATERIALS, V33, P6682, DOI 10.1016/j.biomaterials.2012.06.005
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275
   Oliveira MB, 2014, TISSUE ENG PART C-ME, V20, P851, DOI [10.1089/ten.tec.2013.0738, 10.1089/ten.TEC.2013.0738]
   Park HS, 2013, ACTA BIOMATER, V9, P8962, DOI 10.1016/j.actbio.2013.07.013
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Park SH, 2012, J TISSUE ENG REGEN M, V6, ps24, DOI 10.1002/term.541
   Park SH, 2011, TISSUE ENG PT A, V17, P2999, DOI [10.1089/ten.TEA.2010.0747, 10.1089/ten.tea.2010.0747]
   Patel MP, 2010, J PHARM PHARM SCI, V13, P536, DOI 10.18433/J3JC7C
   PEARLSTEIN E, 1980, MOL CELL BIOCHEM, V29, P103
   Pereira CL, 2014, BIOMATERIALS, V35, P8144, DOI 10.1016/j.biomaterials.2014.06.017
   Peroglio M, 2012, EUR SPINE J, V21, P839, DOI DOI 10.1007/S00586-011-1976-2
   Pirvu T, 2015, BIOMATERIALS, V42, P11, DOI 10.1016/j.biomaterials.2014.11.049
   Purmessur D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4302
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Radcliff KE, 2013, SPINE J, V13, P1339, DOI 10.1016/j.spinee.2013.03.020
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Richardson SM, 2008, CURR PAIN HEADACHE R, V12, P83, DOI 10.1007/s11916-008-0016-3
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6
   Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI 10.1089/ten.TEA.2009.0770
   Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sasson A, 2012, J MECH BEHAV BIOMED, V8, P143, DOI 10.1016/j.jmbbm.2011.12.008
   Sawamura K, 2009, TISSUE ENG PT A, V15, P3719, DOI 10.1089/ten.TEA.2008.0697
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Scholz B, 2010, EUR CELLS MATER, V20, P24
   Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sharma MB, 2012, HAEMATOL-HEMATOL J, V97, P651, DOI 10.3324/haematol.2011.050500
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sillat T, 2013, ACTA ORTHOP, V84, P585, DOI 10.3109/17453674.2013.854666
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P4, DOI 10.1002/term.2
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Smith LJ, 2014, TISSUE ENG PT A, V20, P1841, DOI [10.1089/ten.tea.2013.0516, 10.1089/ten.TEA.2013.0516]
   Stern S, 2000, ACTA ORTHOP SCAND, V71, P496, DOI 10.1080/000164700317381207
   STERN S, 2004, CLIN ORTHOP RELA FEB, P238
   Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003
   Su WY, 2010, ACTA BIOMATER, V6, P3044, DOI 10.1016/j.actbio.2010.02.037
   Sun W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093570
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   Tan B, 2012, J SURG RES, V182, P40
   Tao H, 2014, TISSUE ENG PT A, V20, P1621, DOI [10.1089/ten.tea.2013.0279, 10.1089/ten.TEA.2013.0279]
   Thavaneswaran P, 2014, ANZ J SURG, V84, P121, DOI 10.1111/ans.12315
   Tilwani Reshma K, 2012, J Funct Biomater, V3, P23, DOI 10.3390/jfb3010023
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403
   Tsuchida AI, 2013, REGEN MED, V8, P583, DOI 10.2217/rme.13.44
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101
   van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018
   van Tienen TG, 2009, CLIN SPORT MED, V28, P143, DOI 10.1016/j.csm.2008.08.003
   Wang BC, 2012, J BIOMED MATER RES A, V100A, P646, DOI 10.1002/jbm.a.33300
   Wang H, 2014, TISSUE ENG PT A, V20, P908, DOI [10.1089/ten.tea.2012.0703, 10.1089/ten.TEA.2012.0703]
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Willems N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0727-x
   Williams FM, 2012, ANN RHEUM DIS, V72, P1141
   Wu SC, 2013, J APPL PHYSIOL, V114, P1610, DOI 10.1152/japplphysiol.01132.2012
   Xu BY, 2014, J BIOSCI BIOENG, V117, P624, DOI 10.1016/j.jbiosc.2013.10.018
   Xu L, 2013, STEM CELLS DEV, V22, P1657, DOI 10.1089/scd.2012.0605
   Xu T, 2012, BIOFABRICATION, V5, P15001
   Yan J, 2013, J BIOMATER APPL, V29, P72
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Yang JJ, 2010, TISSUE ENG PT A, V16, P2529, DOI 10.1089/ten.TEA.2009.0647
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8
   Yeganegi M, 2010, ACTA BIOMATER, V6, P3847, DOI 10.1016/j.actbio.2010.05.003
   Yim RLH, 2014, STEM CELLS DEV, V23, P2553, DOI 10.1089/scd.2014.0203
   Zeng C, 2014, MAT SCI ENG C-MATER, V37, P232, DOI 10.1016/j.msec.2014.01.012
   Zhang LM, 2012, CARBOHYD POLYM, V88, P1445, DOI 10.1016/j.carbpol.2012.02.050
   Zhang ZC, 2014, CHINESE MED J-PEKING, V127, P314, DOI 10.3760/cma.j.issn.0366-6999.20130584
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 231
TC 7
Z9 6
U1 0
U2 29
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2015
VL 30
BP 210
EP 231
DI 10.22203/eCM.v030a15
PG 22
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA CY1BM
UT WOS:000366141600015
PM 27227695
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Hakim, JS
   Rad, ME
   Grahn, PJ
   Chen, BK
   Knight, AM
   Schmeichel, AM
   Isaq, NA
   Dadsetan, M
   Yaszemski, MJ
   Windebank, AJ
AF Hakim, Jeffrey S.
   Rad, Melika Esmaeili
   Grahn, Peter J.
   Chen, Bingkun K.
   Knight, Andrew M.
   Schmeichel, Ann M.
   Isaq, Nasro A.
   Dadsetan, Mahrokh
   Yaszemski, Michael J.
   Windebank, Anthony J.
TI Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold
   Implantation Results in a Permissive Lesion Environment after Spinal
   Cord Injury in Rat
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MYELIN-ASSOCIATED GLYCOPROTEIN; FOREIGN-BODY REACTION; NEURITE
   OUTGROWTH; IN-VIVO; WALLERIAN DEGENERATION; AXONAL REGENERATION;
   MICROGLIAL RESPONSE; MONOCLONAL-ANTIBODY; REACTIVE ASTROCYTES;
   MULTIPLE-SCLEROSIS
AB Positively charged oligo[poly(ethylene glycol) fumarate] (OPF+) scaffolds loaded with Schwann cells bridge spinal cord injury (SCI) lesions and support axonal regeneration in rat. The regeneration achieved is not sufficient for inducing functional recovery. Attempts to increase regeneration would benefit from understanding the effects of the scaffold and transplanted cells on lesion environment. We conducted morphometric and stereological analysis of lesions in rats implanted with OPF+ scaffolds with or without loaded Schwann cells 1, 2, 3, 4, and 8 weeks after thoracic spinal cord transection. No differences were found in collagen scarring, cyst formation, astrocyte reactivity, myelin debris, or chondroitin sulfate proteoglycan (CSPG) accumulation. However, when scaffold-implanted animals were compared with animals with transection injuries only, these barriers to regeneration were significantly reduced, accompanied by increased activated macrophages/microglia. This distinctive and regeneration permissive tissue reaction to scaffold implantation was independent of Schwann cell transplantation. Although the tissue reaction was beneficial in the short term, we observed a chronic fibrotic host response, resulting in scaffolds surrounded by collagen at 8 weeks. This study demonstrates that an appropriate biomaterial scaffold improves the environment for regeneration. Future targeting of the host fibrotic response may allow increased axonal regeneration and functional recovery.
C1 [Hakim, Jeffrey S.; Dadsetan, Mahrokh; Yaszemski, Michael J.; Windebank, Anthony J.] Mayo Clin, Coll Med, Rochester, MN 55905 USA.
   [Hakim, Jeffrey S.; Rad, Melika Esmaeili; Grahn, Peter J.; Isaq, Nasro A.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA.
   [Chen, Bingkun K.; Knight, Andrew M.; Schmeichel, Ann M.; Windebank, Anthony J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Dadsetan, Mahrokh; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Yaszemski, Michael J.; Windebank, Anthony J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA.
RP Windebank, AJ (reprint author), Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA.
EM windebank.anthony@mayo.edu
FU NIH [EB02390, UL1TR000135]; Morton Foundation; Kipnis Foundation; Mayo
   Foundation
FX We thank Professor Charles Howe for critical reading of the article. We
   thank James Tarara for his help with imaging and microscopy. We thank
   Jarred Nesbit and Bret Ball for their help with animal care and
   surgeries. We thank Jane Meyer for her administrative role in article
   preparation. This work was supported by grants from the NIH (EB02390,
   UL1TR000135), and the Morton, Kipnis, and Mayo Foundations (AJW).
CR Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3
   Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010
   Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Dadsetan M, 2007, BIOMACROMOLECULES, V8, P1702, DOI 10.1021/bm070052h
   Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012
   Dadsetan M, 2010, BIOMATERIALS, V31, P8051, DOI 10.1016/j.biomaterials.2010.06.054
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Daly WT, 2013, BIOMATERIALS, V34, P8630, DOI 10.1016/j.biomaterials.2013.07.086
   Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884
   Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110
   Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165
   Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014
   Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190
   Imai M, 2008, J NEUROSURG-SPINE, V8, P58, DOI 10.3171/SPI-08/01/058
   Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim J, 2010, J BIOMED MATER RES A, V95A, P191, DOI 10.1002/jbm.a.32810
   Kinard LA, 2012, NAT PROTOC, V7, P1219, DOI 10.1038/nprot.2012.055
   Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   Lin SX, 2011, ASN NEURO, V3
   LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395
   Linker RA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0394-8
   Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Pertici V., 2014, BIOMATERIALS
   Petter-Puchner AH, 2007, EXP TOXICOL PATHOL, V58, P237, DOI 10.1016/j.etp.2006.07.004
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Ritfeld GJ, 2014, BIOMATERIALS, V35, P1924, DOI 10.1016/j.biomaterials.2013.11.062
   Rooney GE, 2008, SPINE, V33, pE914, DOI 10.1097/BRS.0b013e318186b2b1
   Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260
   Rooney GE, 2011, TISSUE ENG PT A, V17, P1287, DOI [10.1089/ten.tea.2010.0396, 10.1089/ten.TEA.2010.0396]
   Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109
   RUDGE JS, 1990, J NEUROSCI, V10, P3594
   Runge MB, 2010, BIOMACROMOLECULES, V11, P2845, DOI 10.1021/bm100526a
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113
   Shi Q, 2014, SCI CHINA LIFE SCI, V57, P232, DOI 10.1007/s11427-014-4612-7
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013
   South SA, 2000, GLIA, V29, P81, DOI 10.1002/(SICI)1098-1136(20000101)29:1<81::AID-GLIA8>3.0.CO;2-O
   Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J
   Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523
   Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701
NR 74
TC 10
Z9 10
U1 3
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL 1
PY 2015
VL 21
IS 13-14
BP 2099
EP 2114
DI 10.1089/ten.tea.2015.0019
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CV0ZP
UT WOS:000363982900014
PM 25891264
OA Green Published
DA 2018-10-20
ER

PT J
AU Jung, AR
   Kim, RY
   Kim, HW
   Shrestha, KR
   Jeon, SH
   Cha, KJ
   Park, YH
   Kim, DS
   Lee, JY
AF Jung, Ae Ryang
   Kim, Richard Y.
   Kim, Hyung Woo
   Shrestha, Kshitiz Raj
   Jeon, Seung Hwan
   Cha, Kyoung Je
   Park, Yong Hyun
   Kim, Dong Sung
   Lee, Ji Youl
TI Nanoengineered Polystyrene Surfaces with Nanopore Array Pattern Alters
   Cytoskeleton Organization and Enhances Induction of Neural
   Differentiation of Human Adipose-Derived Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ADULT SKELETAL-MUSCLE; REGENERATIVE MEDICINE; NEURONAL LINEAGE; STROMAL
   CELLS; IN-VITRO; ADHESION; TOPOGRAPHY; SUBSTRATE; NANOSCALE; PROTEIN
AB Human adipose-derived stem cells (hADSCs) can differentiate into various cell types depending on chemical and topographical cues. One topographical cue recently noted to be successful in inducing differentiation is the nanoengineered polystyrene surface containing nanopore array-patterned substrate (NP substrate), which is designed to mimic the nanoscale topographical features of the extracellular matrix. In this study, efficacies of NP and flat substrates in inducing neural differentiation of hADSCs were examined by comparing their substrate-cell adhesion rates, filopodia growth, nuclei elongation, and expression of neural-specific markers. The polystyrene nano Petri dishes containing NP substrates were fabricated by a nano injection molding process using a nickel electroformed nano-mold insert (Diameter: 200nm. Depth of pore: 500nm. Center-to-center distance: 500nm). Cytoskeleton and filopodia structures were observed by scanning electron microscopy and F-actin staining, while cell adhesion was tested by vinculin staining after 24 and 48h of seeding. Expression of neural specific markers was examined by real-time quantitative polymerase chain reaction and immunocytochemistry. Results showed that NP substrates lead to greater substrate-cell adhesion, filopodia growth, nuclei elongation, and expression of neural specific markers compared to flat substrates. These results not only show the advantages of NP substrates, but they also suggest that further study into cell-substrate interactions may yield great benefits for biomaterial engineering.
C1 [Jung, Ae Ryang; Kim, Richard Y.; Shrestha, Kshitiz Raj; Jeon, Seung Hwan; Park, Yong Hyun; Lee, Ji Youl] Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul 137040, South Korea.
   [Kim, Hyung Woo; Cha, Kyoung Je; Kim, Dong Sung] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea.
RP Lee, JY (reprint author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, 505 Banpo Dong, Seoul 137040, South Korea.
EM smkds@postech.ac.kr; uroljy@catholic.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2011-0030075]; National Research Foundation of Korea (NRF) grant
   - Korea goverment (MSIP) [2014R1A2A1A01006527]
FX This work was partially supported by the National Research Foundation of
   Korea (NRF) grant funded by the Korea government (MSIP) (No.
   2011-0030075) and partially supported by the National Research
   Foundation of Korea (NRF) grant funded by the Korea goverment (MSIP)
   (No. 2014R1A2A1A01006527).
CR Ahmadi N, 2012, TISSUE CELL, V44, P87, DOI 10.1016/j.tice.2011.11.006
   Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037
   ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Anghileri E, 2008, STEM CELLS DEV, V17, P909, DOI 10.1089/scd.2007.0197
   Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Cha KJ, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/5/055002
   Cha KJ, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025007
   Cha KJ, 2011, MACROMOL BIOSCI, V11, P1357, DOI 10.1002/mabi.201100134
   Chalut KJ, 2010, SOFT MATTER, V6, P1675, DOI 10.1039/b921206j
   Choi MJ, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045006
   Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Jeon K, 2012, BIOMATERIALS, V33, P5206, DOI 10.1016/j.biomaterials.2012.04.011
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Kshitiz, 2012, INTEGR BIOL-UK, V4, P1008, DOI 10.1039/c2ib20080e
   Kwon EB, 2011, KOREAN J UROL, V52, P852, DOI 10.4111/kju.2011.52.12.852
   Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Ning HX, 2008, DIFFERENTIATION, V76, P488, DOI 10.1111/j.1432-0436.2007.00240.x
   Ning HX, 2006, DIFFERENTIATION, V74, P510, DOI 10.1111/j.1432-0436.2006.00081.x
   Pan F, 2013, BIOMATERIALS, V34, P8131, DOI 10.1016/j.biomaterials.2013.07.025
   Park KS, 2012, MACROMOL BIOSCI, V12, P1480, DOI 10.1002/mabi.201200225
   Piao S, 2012, J SEX MED, V9, P1968, DOI 10.1111/j.1743-6109.2012.02760.x
   Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027
   Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3
   Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022
   Taha MF, 2014, J BIOTECHNOL, V172, P1, DOI 10.1016/j.jbiotec.2013.11.028
   Teo BKK, 2010, METHOD CELL BIOL, V98, P241, DOI 10.1016/S0091-679X(10)98011-4
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121
   Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 49
TC 10
Z9 10
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL 1
PY 2015
VL 21
IS 13-14
BP 2115
EP 2124
DI 10.1089/ten.tea.2014.0346
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CV0ZP
UT WOS:000363982900015
PM 25919423
DA 2018-10-20
ER

PT J
AU Branisteanu, DE
   Nichifor, M
   Dorobat, CM
   Branisteanu, DC
   Petrariu, FD
   Molodoi, AD
   Radu, DC
   Boda, D
AF Branisteanu, Daciana Elena
   Nichifor, Marieta
   Dorobat, Carmen Mihaela
   Branisteanu, Daniel Constantin
   Petrariu, Florin Dumitru
   Molodoi, Andreea Dana
   Radu, Doru Cezar
   Boda, Daniel
TI Use of textile biomaterials for the topic treatment of chronic venous
   disease
SO ROMANIAN BIOTECHNOLOGICAL LETTERS
LA English
DT Article
DE biomaterial; biopolymer; elastic compression; chronic venous disease;
   troxerutin
ID LASER-SCANNING MICROSCOPY; WALL; LOCALIZATION; TROXERUTIN
AB This scientific work summarizes and concludes the efforts of three regional research centers having regard to discovering an innovating topic treatment for the chronic venous disease.
   New textile biomaterials have been prepared, by chemical or physical application of biopolymers on the textile material, and the load of the biopolymers and biomaterials with rutin, troxerutin and heparine have been tested using physical or chemical methods. The pharmacologically active substance was then gradually released, in a controlled way, at the level of venous endothelium, as a consequence of the prolonged contact of the biomaterial with the skin. There have been performed in vitro and in vivo animal studies, in order to choose the most efficient biomaterial. The textile material chosen must keep intact both the chemical structure and the shape of the grafted polymer, as well as the structure of the drug included in it.
   Finally the efficiency, tolerance and safety of the applied treatments have been analyzed in a rigorous, scientific manner on the patients in different stages of the chronic venous disease.
C1 [Branisteanu, Daciana Elena] Gr T Popa Univ Med & Pharm, Discipline Dermatol, Iasi, Romania.
   [Nichifor, Marieta] P Poni Inst Macromol Chem, Dept Bioact & Biocompatible Polymers, Iasi, Romania.
   [Dorobat, Carmen Mihaela] Gr T Popa Univ Med & Pharm, Discipline Infect Dis, Iasi, Romania.
   [Branisteanu, Daniel Constantin] Gr T Popa Univ Med & Pharm, Discipline Ophthalmol, Iasi, Romania.
   [Petrariu, Florin Dumitru] Gr T Popa Univ Med & Pharm, Discipline Primary Hlth Care & Epidemiol, Iasi, Romania.
   [Molodoi, Andreea Dana] Municipal Hosp, Dept Dermatol, Roman, Romania.
   [Radu, Doru Cezar] Gh Asachi Tech Univ, Fac Text & Leather Engn, Iasi, Romania.
   [Boda, Daniel] Carol Davila Univ Med & Pharm Bucharest, Dermatol Res Lab, Bucharest, Romania.
RP Radu, DC (reprint author), Gh Asachi Tech Univ, Fac Text & Leather Engn, Iasi, Romania.
EM dradu@tex.tuiasi.ro
OI PETRARIU, FLORIN DUMITRU/0000-0003-4538-9809
CR Allegra C., 2006, PHLEBOLYMPHOLOGY, V2, P48
   Andercou A., 2005, RJ ANN VASC SURG, V7, P2
   Andercou A., 2005, RJ ANN VASC SURG, V7, P3
   Andreozzi G. M., 2006, PHLEBOLYMPHOLOGY, V1, P28
   Branisteanu D. E., 2010, DERMATOVENEROL BUC, V3, P197
   Carlsson K, 1996, J MAL VASCUL, V21, P270
   Garde C, 2005, PHLEBOLYMPHOLOGY, P384
   Knittel D., 2003, EXOGENOUS DERMATOLOG, V2, P11
   Lee MH, 2000, J APPL POLYM SCI, V78, P1986, DOI 10.1002/1097-4628(20001209)78:11<1986::AID-APP190>3.0.CO;2-7
   Lim S. H., REV CHITOSAN ITS DER
   Lim SH, 2003, J MACROMOL SCI-POL R, VC43, P223, DOI 10.1081/MC-120020161
   NEUMANN HAM, 1992, EUR J CLIN PHARMACOL, V43, P423, DOI 10.1007/BF02220620
   Nichifor M, 2009, J MATER SCI-MATER M, V20, P975, DOI 10.1007/s10856-008-3653-5
   PATWARDHAN A, 1995, J CARDIOVASC SURG, V36, P381
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ARS DOCENDI
PI BUCHAREST
PA SOS PANDURI 90, SECT 5, BUCHAREST, RO-050663, ROMANIA
SN 1224-5984
J9 ROM BIOTECH LETT
JI Rom. Biotech. Lett.
PD JUL-AUG
PY 2015
VL 20
IS 4
BP 10618
EP 10625
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CR6TX
UT WOS:000361481700008
DA 2018-10-20
ER

PT J
AU Petrovic, MM
   Radovic, MD
   Kostic, MM
   Mitrovic, JZ
   Bojic, DV
   Zarubica, AR
   Bojic, AL
AF Petrovic, Milica M.
   Radovic, Miljana D.
   Kostic, Milos M.
   Mitrovic, Jelena Z.
   Bojic, Danijela V.
   Zarubica, Aleksandra R.
   Bojic, Aleksandar Lj.
TI A Novel Biosorbent Lagenaria vulgaris Shell - ZrO2 for the Removal of
   Textile Dye From Water
SO WATER ENVIRONMENT RESEARCH
LA English
DT Article
DE biomaterial; modification; ZrO2; removal; dye
ID AQUEOUS-SOLUTION; ADSORPTION
AB A new biosorbent, abbreviated as LVB-ZrO2, was synthesized by chemically modifying Lagenaria vulgaris shell with ZrO2. The removal of textile dye RB19 from aqueous solution by LVB-ZrO2 was studied. Characterization by SEM, FTIR and XRD confirmed the chemical modification of the biomaterial, which showed significant improvement of removal efficiency compared with unmodified Lagenaria vulgaris shell. LVB-ZrO2 point of zero charge is 5.49. The biosorption process is highly pH dependent and the optimal pH is 2.0, at which complete dye removal was attained. The results are the best by a pseudo-second order kinetic model. The optimal adsorbent dosage is 4 mg/dm(3). The RB19 biosorption follows the Langmuir isotherm model (R-2 = 0.9978), with the maximum sorption capacity of 75.12 mg/g. LVB-ZrO2 is a mechanically stable, easy to synthesize, cost-effective, biocompatible and environmentally-friendly biosorbent with the high potential for the removal of RB19 from aqueous solution.
C1 [Petrovic, Milica M.; Radovic, Miljana D.; Kostic, Milos M.; Mitrovic, Jelena Z.; Bojic, Danijela V.; Zarubica, Aleksandra R.; Bojic, Aleksandar Lj.] Univ Nis, Fac Sci & Math, Dept Chem, Nish 18000, Serbia.
RP Petrovic, MM (reprint author), Univ Nis, Fac Sci & Math, Dept Chem, Visegradska 33, Nish 18000, Serbia.
EM milicabor84@gmail.com
FU Ministry of Education, Science and Technological development of the
   Republic of Serbia [TR34008]
FX This work was supported by the Ministry of Education, Science and
   Technological development of the Republic of Serbia, Grant No. TR34008.
CR Akar ST, 2009, DESALINATION, V249, P757, DOI 10.1016/j.desal.2008.09.012
   Aksu Z, 2006, J HAZARD MATER, V137, P418, DOI 10.1016/j.jhazmat.2006.02.019
   Alencar WS, 2012, CHEM ENG J, V209, P577, DOI 10.1016/j.cej.2012.08.053
   Barka N, 2013, J TAIWAN INST CHEM E, V44, P52, DOI 10.1016/j.jtice.2012.09.007
   Cardoso NF, 2011, J ENVIRON MANAGE, V92, P1237, DOI 10.1016/j.jenvman.2010.12.010
   Chen H, 2010, J HAZARD MATER, V177, P228, DOI 10.1016/j.jhazmat.2009.12.022
   Copello GJ, 2011, J HAZARD MATER, V186, P932, DOI 10.1016/j.jhazmat.2010.11.097
   Gupta VK, 2012, CHEM ENG J, V180, P81, DOI 10.1016/j.cej.2011.11.006
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mahmoodi NM, 2011, DESALINATION, V275, P93, DOI 10.1016/j.desal.2011.02.034
   Mitic-Stojanovic D. L., 2011, WATER SA, V37, P1
   Noh HJ, 2003, MATER LETT, V57, P2425, DOI 10.1016/S0167-577X(02)01248-X
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Sahu HR, 2000, B MATER SCI, V23, P349, DOI 10.1007/BF02708383
   Sarkar D, 2007, CERAM INT, V33, P1275, DOI 10.1016/j.ceramint.2006.05.002
   Shah B. N., 2010, Asian Journal of Plant Sciences, V9, P152
   Shore J., 1995, CELLULOSIC DYEING
   Singanan M., 2003, WATER ENV WASTEWATER
   Stankovic MN, 2013, AUST J CHEM, V66, P227, DOI 10.1071/CH12422
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yang YN, 2004, LANGMUIR, V20, P6736, DOI 10.1021/la049363t
   Zollinger H., 2003, COLOR CHEM
NR 23
TC 1
Z9 1
U1 1
U2 7
PU WATER ENVIRONMENT FEDERATION
PI ALEXANDRIA
PA 601 WYTHE ST, ALEXANDRIA, VA 22314-1994 USA
SN 1061-4303
EI 1554-7531
J9 WATER ENVIRON RES
JI Water Environ. Res.
PD JUL
PY 2015
VL 87
IS 7
BP 635
EP 643
DI 10.2175/106143015X14212658614838
PG 9
WC Engineering, Environmental; Environmental Sciences; Limnology; Water
   Resources
SC Engineering; Environmental Sciences & Ecology; Marine & Freshwater
   Biology; Water Resources
GA CR6YT
UT WOS:000361495200007
PM 26163499
DA 2018-10-20
ER

PT J
AU Mo, XH
   Cen, J
   Gibson, E
   Wang, R
   Percival, SL
AF Mo, Xiaohui
   Cen, John
   Gibson, Elaine
   Wang, Robin
   Percival, Steven L.
TI An open multicenter comparative randomized clinical study on chitosan
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID CHRONIC NONHEALING WOUNDS; AUTOLOGOUS PLATELET GEL; HEALING FACTORS;
   RICH PLASMA; TRIAL; CLASSIFICATION; ULCERS
AB Chitosan, a natural polysaccharide derivate from chitin, offers a promising alternative biomaterial for use in wound dressings. In this work, the safety and efficacy of a next-generation KA01 chitosan wound dressing in facilitating the healing of nonhealing chronic wounds was studied. This open multicenter comparative prospective randomized clinical study was conducted at three medical centers in China. A total of 90 patients (45 in test group and 45 in control group) with unhealed chronic wounds including pressure ulcers, vascular ulcers, diabetic foot ulcers, and wounds with minor infections, or at risk of infection, were treated with the next generation chitosan wound dressing as the test article or traditional vaseline gauze as a control. Baseline assessments were undertaken with the primary end point being wound area reduction. The secondary end points included pain reduction (using the NRS11 pain scale) at dressing change, wound exudate levels, wound depth and duration of the treatment. After 4 weeks treatment, the wound area reduction was significantly greater in the test group (65.97+/-4.48%) than the control group (39.95+/-4.48%). The average pain level in the test group was 1.12+/-0.23 and 2.30+/-0.23 in the control group. The wound depth was also lower in the test group 0.30+/-0.48 cm than the control group 0.54+/-0.86 cm. The level of exudate fell and the dressing could be removed integrally in both the test and control groups. The mean duration of the test group was 27.31+/-5.37 days and control group 27.09+/-6.44 days. No adverse events were reported in either group. In conclusion this open multicenter comparative prospective randomized clinical study has provided compelling evidence that the next generation chitosan wound dressing can enhance wound progression towards healing by facilitating wound reepithelialization and reducing the patients pain level. Furthermore the dressing was shown to be clinically safe and effective in the management of chronic wounds.
C1 [Mo, Xiaohui; Cen, John] Foshan United Med Technol Ltd, Foshan, Guangdong, Peoples R China.
   [Gibson, Elaine] Aspen Med Europe Ltd, Redditch, England.
   [Wang, Robin] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.
   [Percival, Steven L.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.
   [Percival, Steven L.] Univ Liverpool, Surface Sci Res Ctr, Liverpool L69 3BX, Merseyside, England.
RP Percival, SL (reprint author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.
EM steven.percival@liverpool.ac.uk
OI Percival, Steven/0000-0002-7752-5935
CR Autologel Diabetic Foot Ulcer Study Group, 2006, OSTOMY WOUND MANAG, V52, p[68, 72, 74]
   Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
   Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491
   Caceres M, 2012, CLIN ORAL IMPLAN RES, V23, P1104, DOI 10.1111/j.1600-0501.2011.02274.x
   Chen LH, 2013, J DIABETES RES, DOI 10.1155/2013/269527
   Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004
   Friese G, 2007, 5 INT S DIAB FOOT
   [何利平 He Liping], 2012, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V43, P757
   International Working Group on the Diabetic Foot (IWGDF) Editorial Board, 2008, DIABETES-METAB RES S, V24, pS181
   Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573
   Jiang X, 2008, W CHIN MED J, V01, P114
   KNIGHTON DR, 1986, ANN SURG, V204, P322, DOI 10.1097/00000658-198609000-00011
   KRUPSKI WC, 1991, J VASC SURG, V14, P526, DOI 10.1016/0741-5214(91)90247-R
   Nikolidakis D, 2008, TISSUE ENG PART B-RE, V14, P249, DOI 10.1089/ten.teb.2008.0062
   Pietramaggiori G, 2008, WOUND REPAIR REGEN, V16, P218, DOI 10.1111/j.1524-475X.2008.00362.x
   Saad SH, 2011, INT WOUND J, V8, P307
   Saldalamacchia G, 2004, NUTR METAB CARDIOVAS, V14, P395, DOI 10.1016/S0939-4753(04)80029-2
   Senet P, 2003, J VASC SURG, V38, P1342, DOI 10.1016/S0741-5214(03)00908-X
   Treece KA, 2004, DIABETIC MED, V21, P987, DOI 10.1111/j.1464-5491.2004.01275.x
   Vogrin M, 2010, EUR SURG RES, V45, P77, DOI 10.1159/000318597
   Wang Y, 2008, CHIN J REPARATIVE RE, V05, P563
   Wrotniak Maciej, 2007, Ortop Traumatol Rehabil, V9, P227
   Yang Yanzhi, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P571
   Yuan Nan-bing, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P292
   Yuan Nan-bing, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P900
   Yuan Nanbing, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P468
NR 26
TC 5
Z9 5
U1 1
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
EI 1524-475X
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD JUL-AUG
PY 2015
VL 23
IS 4
BP 518
EP 524
DI 10.1111/wrr.12298
PG 7
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA CQ7EG
UT WOS:000360765100175
PM 25845544
DA 2018-10-20
ER

PT J
AU Ye, F
   Jiang, J
   Chang, HL
   Xie, L
   Deng, JJ
   Ma, ZB
   Yuan, WZ
AF Ye, Fang
   Jiang, Jin
   Chang, Honglong
   Xie, Li
   Deng, Jinjun
   Ma, Zhibo
   Yuan, Weizheng
TI Improved single-cell culture achieved using micromolding in capillaries
   technology coupled with poly (HEMA)
SO BIOMICROFLUIDICS
LA English
DT Article
ID SURFACE; BIOLOGY; PATTERN; GROWTH
AB Cell studies at the single-cell level are becoming more and more critical for understanding the complex biological processes. Here, we present an optimization study investigating the positioning of single cells using micromolding in capillaries technology coupled with the cytophobic biomaterial poly (2-hydroxyethyl methacrylate) (poly (HEMA)). As a cytophobic biomaterial, poly (HEMA) was used to inhibit cells, whereas the glass was used as the substrate to provide a cell adhesive background. The poly (HEMA) chemical barrier was obtained using micromolding in capillaries, and the microchannel networks used for capillarity were easily achieved by reversibly bonding the polydimethylsiloxane mold and the glass. Finally, discrete cell adhesion regions were presented on the glass surface. This method is facile and low cost, and the reagents are commercially available. We validated the cytophobic abilities of the poly (HEMA), optimized the channel parameters for higher quality and more stable poly (HEMA) patterns by investigating the effects of changing the aspect ratio and the width of the microchannel on the poly (HEMA) grid pattern, and improved the single-cell occupancy by optimizing the dimensions of the cell adhesion regions. (C) 2015 AIP Publishing LLC.
C1 [Ye, Fang; Jiang, Jin; Chang, Honglong; Deng, Jinjun; Ma, Zhibo; Yuan, Weizheng] Northwestern Polytech Univ, Minist Educ, Key Lab Micro Nano Syst Aerosp, Xian 710072, Peoples R China.
   [Ye, Fang; Jiang, Jin; Chang, Honglong; Deng, Jinjun; Ma, Zhibo; Yuan, Weizheng] Northwestern Polytech Univ, Sch Mech Engn, Xian 710072, Peoples R China.
   [Xie, Li] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China.
RP Yuan, WZ (reprint author), Northwestern Polytech Univ, Minist Educ, Key Lab Micro Nano Syst Aerosp, Xian 710072, Peoples R China.
EM yuanwz@nwpu.edu.cn
OI Chang, Honglong/0000-0003-0400-3658
FU National Key Scientific Instrument and Equipment Development Project
   [2013YQ190467]; 111 project [B13044]; National Natural Science
   Foundation of China [51375398, 50775188, 51475384]
FX We thank Mr. Yanpeng Hao for drawing the flowcharts, and Mrs. Jianping
   Bai for directing cell experiments. This work was supported by the
   National Key Scientific Instrument and Equipment Development Project
   (2013YQ190467), 111 project (Grant No. B13044), and the National Natural
   Science Foundation of China (Grant Nos. 51375398, 50775188, and
   51475384). All cell culture experiments were performed at the Fourth
   Military Medical University.
CR Cheng Q, 2009, BIOMATERIALS, V30, P4203, DOI 10.1016/j.biomaterials.2009.04.023
   Chien HW, 2009, BIOMATERIALS, V30, P2209, DOI 10.1016/j.biomaterials.2008.12.060
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318
   Jing GS, 2011, ACTA BIOMATER, V7, P1094, DOI 10.1016/j.actbio.2010.09.040
   Kawashima T, 2010, MICROELECTRON ENG, V87, P704, DOI 10.1016/j.mee.2009.12.066
   Leclair AM, 2011, BIOMATERIALS, V32, P1351, DOI 10.1016/j.biomaterials.2010.10.051
   Lee JH, 2008, COLLOID SURFACE B, V64, P126, DOI 10.1016/j.colsurfb.2008.01.015
   Liu WW, 2009, CHINESE J ANAL CHEM, V37, P943, DOI 10.1016/S1872-2040(08)60113-9
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Nakanishi J, 2008, ANAL SCI, V24, P67, DOI 10.2116/analsci.24.67
   Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e
   Shim HW, 2007, BIOSENS BIOELECTRON, V22, P3188, DOI 10.1016/j.bios.2007.02.016
   Shim HW, 2009, J NANOSCI NANOTECHNO, V9, P1204, DOI 10.1166/jnn.2009.C120
   Situ Z. Q., 2007, CELL CULTURE, P6
   Tabatabaei M, 2013, BIOMATERIALS, V34, P10065, DOI 10.1016/j.biomaterials.2013.09.070
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Thibault C., 2005, J NANOBIOTECHNOL, V3
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Ye F., J BIOMED MA IN PRESS
NR 23
TC 3
Z9 4
U1 2
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD JUL
PY 2015
VL 9
IS 4
AR 044106
DI 10.1063/1.4926807
PG 9
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA CQ0UD
UT WOS:000360311900008
PM 26339307
OA Green Published
DA 2018-10-20
ER

PT J
AU Hirata, HH
   Munhoz, MAS
   Plepis, AMG
   Martins, VCA
   Santos, GR
   Galdeano, EA
   Cunha, MR
AF Hirata, H. H.
   Munhoz, M. A. S.
   Plepis, A. M. G.
   Martins, V. C. A.
   Santos, G. R.
   Galdeano, E. A.
   Cunha, M. R.
TI Feasibility study of collagen membranes derived from bovine pericardium
   and intestinal serosa for the repair of cranial defects in
   ovariectomised rats
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Biomaterial; Collagen; Osseointegration; Osteoporosis; Ovariectomy
ID BONE DEFECTS; MATRIX; SCAFFOLDS; BIOMATERIALS; REGENERATION; IMPLANTS
AB The indication of biomaterials has increased substantially in the regenerative therapy of bone defects. However, in addition to evaluating the physicochemical properties of biomaterials, the quality of the recipient tissue is also essential for the osseointegration of implants, as abnormalities in bone metabolism, such as gonadal hormone deficiency, can influence bone healing. This study evaluated the osteoregenerative capacity of collagen membranes derived from bovine pericardium and intestinal serosa in the repair of cranial defects in ovariectomised rats. Thirty female Wistar rats were submitted to surgical creation of a 5-mm cranial bone defect. The rats were divided into a control group (not ovariectomised) and an ovariectomised group. The non-ovariectomised group was divided into three subgroups: control (G1) in which the defect was not filled with the biomaterial, and two subgroups (G2 and G3) that received the bovine pericardium- and serosa-derived collagen membranes, respectively. The ovariectomised group was divided into the same subgroups (G4, G5, and G6). The animals were sacrificed 8 weeks after surgery. The calvaria were removed for macroscopic and radiographic photodocumentation and processed for histomorphometric analysis of bone healing at the surgical site. Macroscopic, radiological, and microscopic analyses demonstrated the biocompatibility of the implanted collagen membranes, as indicated by the absence of infiltration and signs of inflammation at the surgical site. Histologically, discrete immature bone neoformation projecting from the margins of the defect was observed at the surgical site in ovariectomised groups when compared to the non-ovariectomised groups. The volume of newly formed bone was significantly higher in the non-ovariectomised groups (G1: 7.83% +/- 1.32; G2: 21.33% +/- 1.96; and G3: 22.83% +/- 0.98) compared to the respective ovariectomised subgroups (G4: 3.16% +/- 0.75; G5: 16.83% +/- 0.98; and G6: 16.16% +/- 0.75), thus demonstrating the deleterious effects of ovariectomy on bone homeostasis. Higher volumes of newly formed bone were observed in the groups receiving the membrane grafts (G2, G3, G5, and G6) compared to the control groups (G1 and G4). In conclusion, the bilateral ovariectomy compromises the ability to repair bone lesions grafted with osteoconductive biomaterials as in the case of collagen membranes derived from both bovine pericardium and intestinal serosa. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Hirata, H. H.; Munhoz, M. A. S.; Plepis, A. M. G.; Cunha, M. R.] Univ Sao Paulo, Programa Posgrad Interunidades Bioengn, BR-13566590 Sao Carlos, SP, Brazil.
   [Hirata, H. H.; Munhoz, M. A. S.; Santos, G. R.; Galdeano, E. A.; Cunha, M. R.] Fac Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil.
   [Plepis, A. M. G.; Martins, V. C. A.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
RP Cunha, MR (reprint author), Fac Med Jundiai, Dept Morphol & Pathol, Rua Francisco Telles 250, BR-13202550 Jundiai, SP, Brazil.
EM hiratahh@gmail.com; masmunhoz@me.com; amplepis@iqsc.usp.br;
   virginia@iqsc.usp.br; geovanerib.santos@gmail.com;
   eagaldeano@yahoo.com.br; cunhamr@hotmail.com
RI Plepis, Ana/J-2559-2012; Martins, Virginia/H-5832-2012
OI Plepis, Ana/0000-0002-4360-8433; Martins, Virginia/0000-0001-7565-9641;
   Alexandre Galdeano, Ewerton/0000-0002-1922-8430
CR Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Camilli JA, 2004, ARCH ORAL BIOL, V49, P747, DOI 10.1016/j.archoralbio.2004.02.009
   Cho Peter, 2004, Implant Dent, V13, P79, DOI 10.1097/01.ID.0000116456.76235.BC
   Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y
   de Batista TM, 2009, J THERM ANAL CALORIM, V95, P945, DOI 10.1007/s10973-007-8897-7
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   GOISSIS G., 1999, REV BRASILEIRA ENGEN, V15, P55
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Lane NE, 1999, J BONE MINER RES, V14, P206, DOI 10.1359/jbmr.1999.14.2.206
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Mandarim de Lacerda CA, 1999, BRAZ J MORPHOL, V16, P131
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Miguel FB, 2013, J MATER SCI-MATER M, V24, P2567, DOI 10.1007/s10856-013-4980-8
   Moreira PD, 2013, J BIOMED MATER RES B, V101B, P18, DOI 10.1002/jbm.b.32804
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Pereira NT, 2012, MICROSC RES TECHNIQ, V75, P36, DOI 10.1002/jemt.21019
   Ramesh S, 2007, P SOC PHOTO-OPT INS, V6423
   RAMSHAW J. A. M., 2001, BIOMEDICAL ENG APPL, V13, P14
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Shalaby SW, 2003, ADV POLYM MAT
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Sun Zhe, 2014, Hua Xi Kou Qiang Yi Xue Za Zhi, V32, P134
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang Jian-wei, 2005, Chin J Traumatol, V8, P111
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 31
TC 7
Z9 7
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUL
PY 2015
VL 46
IS 7
BP 1215
EP 1222
DI 10.1016/j.injury.2015.03.039
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA CP8EK
UT WOS:000360124800005
PM 25920373
DA 2018-10-20
ER

PT J
AU Istrate, B
   Mareci, D
   Munteanu, C
   Stanciu, S
   Luca, D
   Crimu, CI
   Kamel, E
AF Istrate, B.
   Mareci, D.
   Munteanu, C.
   Stanciu, S.
   Luca, D.
   Crimu, C. I.
   Kamel, E.
TI In vitro electrochemical properties of biodegradable ZrO2-CaO coated
   MgCa alloy using atmospheric plasma spraying
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Mg-Ca alloy; ZrO2-CaO-coated; plasma spraying; EIS; SEM
ID LOW-POWER PLASMA; CORROSION BEHAVIOR; MAGNESIUM; ZIRCONIA; COATINGS;
   CALCIUM; BONE
AB ZrO2-CaO 95%-5% as a ceramic biomaterial facilitates the osteoconductivity in new bone formation around implant. Surface characterization before and after electrochemical testing was performed used scanning electron microscopy (SEM). ZrO2-CaO coating was performed using a Sulzer Metco 9MCE Atmospheric Plasma Spraying facility. The electrochemical properties of the calcium oxide stabilized zirconium oxide coated and uncoated MgCa sample at the open circuit potential at different immersion time in Ringer's solution were studied by electrochemical impedance spectroscopy (EIS). Equivalent circuit (EC) was used to modeling EIS data, in order to characterize ZrO2-CaO coated and uncoated MgCa surface.
C1 [Istrate, B.; Munteanu, C.; Crimu, C. I.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
   [Mareci, D.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Stanciu, S.; Luca, D.] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Iasi 700050, Romania.
   [Kamel, E.] Dunarea de Jos Univ Galati, Dept Dent Med, Fac Med, Galati, Romania.
RP Munteanu, C (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Bd D Mangeron 6, Iasi 700050, Romania.
EM cornelmun@gmail.com
RI Bogdan, Istrate/P-5182-2014; Luca, Dorin/Q-3616-2016
OI Bogdan, Istrate/0000-0003-0817-3523; Luca, Dorin/0000-0003-3502-2018;
   Mareci, Daniel/0000-0002-5859-1996
CR Bozzini B, 2011, J MATER SCI-MATER M, V22, P193, DOI 10.1007/s10856-010-4187-1
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Deville S, 2004, KEY ENG MAT, V264-268, P2013, DOI 10.4028/www.scientific.net/KEM.264-268.2013
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Li T, 2015, MATER CORROS, V66, P7, DOI 10.1002/maco.201307528
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Mareci D, 2012, J OPTOELECTRON ADV M, V14, P112
   Mareci D, 2010, J OPTOELECTRON ADV M, V12, P1590
   Mareci D, 2010, J MATER SCI-MATER M, V21, P2907, DOI 10.1007/s10856-010-4147-9
   Morks MF, 2006, MATER LETT, V60, P1049, DOI 10.1016/j.matlet.2005.10.073
   Morks MF, 2005, SURF COAT TECH, V199, P66, DOI 10.1016/j.surfcoat.2005.02.159
   Papatoiu C, 2014, J OPTOELECTRON ADV M, V16, P1093
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Zhang JS, 2015, MATER CORROS, V66, P542, DOI 10.1002/maco.201407696
NR 23
TC 1
Z9 1
U1 0
U2 11
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD JUL-AUG
PY 2015
VL 17
IS 7-8
BP 1186
EP 1192
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA CP6AV
UT WOS:000359967600044
DA 2018-10-20
ER

PT J
AU Johansson, P
   Jimbo, R
   Kozai, Y
   Sakurai, T
   Kjellin, P
   Currie, F
   Wennerberg, A
AF Johansson, Par
   Jimbo, Ryo
   Kozai, Yusuke
   Sakurai, Takashi
   Kjellin, Per
   Currie, Fredrik
   Wennerberg, Ann
TI Nanosized Hydroxyapatite Coating on PEEK Implants Enhances Early Bone
   Formation: A Histological and Three-Dimensional Investigation in Rabbit
   Bone
SO MATERIALS
LA English
DT Article
DE polyether ether ketone; HA; biomaterial; histology
ID IN-VITRO; TENSILE PROPERTIES; REMOVAL TORQUE; POLYETHERETHERKETONE;
   TITANIUM; SURFACE; LUMBAR; FUSION; TIBIA; RESPONSES
AB Polyether ether ketone (PEEK) has been frequently used in spinal surgery with good clinical results. The material has a low elastic modulus and is radiolucent. However, in oral implantology PEEK has displayed inferior ability to osseointegrate compared to titanium materials. One idea to reinforce PEEK would be to coat it with hydroxyapatite (HA), a ceramic material of good biocompatibility. In the present study we analyzed HA-coated PEEK tibial implants via histology and radiography when following up at 3 and 12 weeks. Of the 48 implants, 24 were HA-coated PEEK screws (test) and another 24 implants served as uncoated PEEK controls. HA-coated PEEK implants were always osseointegrated. The total bone area (BA) was higher for test compared to control implants at 3 (p < 0.05) and 12 weeks (p < 0.05). Mean bone implant contact (BIC) percentage was significantly higher (p = 0.024) for the test compared to control implants at 3 weeks and higher without statistical significance at 12 weeks. The effect of HA-coating was concluded to be significant with respect to early bone formation, and HA-coated PEEK implants may represent a good material to serve as bone anchored clinical devices.
C1 [Johansson, Par; Jimbo, Ryo; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prostodont, S-21421 Malmo, Sweden.
   [Kozai, Yusuke; Sakurai, Takashi] Kanagawa Dent Univ, Dept Radiopraxis Sci, Yokosuka, Kanagawa 2388580, Japan.
   [Kjellin, Per; Currie, Fredrik] Promimic AB, S-41292 Gothenburg, Sweden.
RP Johansson, P (reprint author), Malmo Univ, Fac Odontol, Dept Prostodont, S-21421 Malmo, Sweden.
EM par.johansson@mah.se; ryo.jimbo@mah.se; kozai@kdu.ac.jp;
   sakurait@kdcnet.ac.jp; per@promimic.se; fredrik@promimic.se;
   ann.wennerberg@mah.se
FU Swedish Knowledge Foundation
FX This study was supported by grants received from the Swedish Knowledge
   Foundation.
CR Abrahamsson I, 2013, CLIN ORAL IMPLAN RES, V24, P57, DOI 10.1111/j.1600-0501.2012.02424.x
   Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Ahn YH, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044101
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Anandjiwala J, 2011, EUR SPINE J, V20, P1951, DOI 10.1007/s00586-011-1917-0
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Branemark P. I., 1977, J PLAST RECONSTR SUR, V16, P1, DOI DOI 10.3109/02844316909036699
   Chou WK, 2015, J SPINAL DISORD TECH, V28, pE121, DOI 10.1097/BSD.0000000000000176
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Eom TG, 2012, OR SURG OR MED OR PA, V114, P411, DOI 10.1016/j.oooo.2011.10.036
   Fan JP, 2004, BIOMATERIALS, V25, P5363, DOI 10.1016/j.biomaterials.2003.12.050
   Fontana F, 2011, CLIN ORAL IMPLAN RES, V22, P760, DOI 10.1111/j.1600-0501.2010.02056.x
   Gobbato L, 2012, IMPLANT DENT, V21, P454, DOI 10.1097/ID.0b013e3182611cd7
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911
   Johansson P, 2014, INT J NANOMED, V9, P3903, DOI 10.2147/IJN.S60387
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kim Dong-Seok, 2009, J Adv Prosthodont, V1, P10, DOI 10.4047/jap.2009.1.1.10
   Kim MC, 2013, J SPINAL DISORD TECH, V26, P87, DOI 10.1097/BSD.0b013e318237b9b1
   Kim PD, 2012, SPINE, V37, pE1155, DOI 10.1097/BRS.0b013e318257f14d
   Kjellin P., 2012, US Pantent, Patent No. [8206813 B2, 8206813, US 8206813 B2]
   Kruger T, 1998, Aktuelle Radiol, V8, P81
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lee JH, 2010, TISSUE ENG REGEN MED, V7, P540
   Lee JH, 2005, BIOMATERIALS, V26, P3249, DOI 10.1016/j.biomaterials.2004.08.033
   Mantripragada VP, 2013, J BIOMED MATER RES A, V101, P3349, DOI 10.1002/jbm.a.34605
   Meirelles L, 2008, J BIOMED MATER RES A, V87A, P299, DOI 10.1002/jbm.a.31744
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Nakada H, 2008, J HARD TISSUE BIOL, V17, P99, DOI 10.2485/jhtb.17.99
   Nemoto O, 2014, EUR SPINE J, V23, P2150, DOI 10.1007/s00586-014-3466-9
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Park P, 2004, SPINE, V29, P1938, DOI 10.1097/01.brs.0000137069.88904.03
   Peraire C, 2006, J BIOMED MATER RES A, V77A, P370, DOI 10.1002/jbm.a.30556
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Rao PJ, 2014, ORTHOP SURG, V6, P81, DOI 10.1111/os.12098
   Reigstad O, 2011, J BIOMED MATER RES B, V99B, P14, DOI 10.1002/jbm.b.31866
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Stein IC, 2015, EUR SPINE J, V24, pS555, DOI 10.1007/s00586-014-3704-1
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Treves C, 2010, J BIOMED MATER RES A, V92A, P1623, DOI 10.1002/jbm.a.32507
   Voor MJ, 2008, J BIOMECH, V41, P186, DOI 10.1016/j.jbiomech.2007.06.028
   Weiner BK, 1998, SPINE, V23, P634, DOI 10.1097/00007632-199803010-00020
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Williams D, 2008, MED DEVICE TECHNOL, V19, P10
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
NR 47
TC 10
Z9 10
U1 3
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2015
VL 8
IS 7
BP 3815
EP 3830
DI 10.3390/ma8073815
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP5CG
UT WOS:000359898300003
PM 28793409
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Capanema, NSV
   Mansur, AAP
   Carvalho, SM
   Silva, ARP
   Ciminelli, VS
   Mansur, HS
AF Capanema, Nadia S. V.
   Mansur, Alexandra A. P.
   Carvalho, Sandhra M.
   Silva, Alexandra R. P.
   Ciminelli, Virginia S.
   Mansur, Herman S.
TI Niobium-Doped Hydroxyapatite Bioceramics: Synthesis, Characterization
   and In Vitro Cytocompatibility
SO MATERIALS
LA English
DT Article
DE biomaterial; bioceramic; bioactive ceramic; calcium phosphate; doped
   hydroxyapatite; bone tissue engineering
ID BONE-GRAFT SUBSTITUTES; CALCIUM-PHOSPHATE; THERMAL-DECOMPOSITION; HYBRID
   SCAFFOLDS; GLASS; ATMOSPHERE; TISSUE; IONS
AB Doping calcium phosphates with ionic species can play an important role in biological responses promoting alkaline phosphatase activity, and, therefore inducing the generation of new bone. Thus, in this study, the synthesis of niobium-doped hydroxyapatite (Nb-HA) nanosize particles obtained by the precipitation process in aqueous media followed by thermal treatment is presented. The bioceramics were extensively characterized by X-ray diffraction, wavelength dispersive X-ray fluorescence spectrometry, Fourier transform infrared spectroscopy, scanning electron microscopy/energy dispersive X-ray spectroscopy analysis, transmission electron microscopy, atomic force microscopy and thermal analysis regarding their chemical composition, structure and morphology. The results showed that the precipitate dried at 110 degrees C was composed of amorphous calcium phosphate and HA, with polidisperse particles ranging from micro to nano dimensions. After the thermal treatment at 900 degrees C, the bioceramic system evolved predominantly to HA crystalline phase, with evident features of particle sintering and reduction of surface area. Moreover, the addition of 10 mol% of niobium salt precursor during the synthesis indicated the complete incorporation of the Nb(V) species in the HA crystals with detectable changes in the original lattice parameters. Furthermore, the incorporation of Nb ions caused a significant refinement on the average particle size of HA. Finally, the preliminary cytocompatibility response of the biomaterials was accessed by human osteoblast cell culture using MTT and resazurin assays, which demonstrated no cytotoxicity of the Nb-alloyed hydroxyapatite. Thus, these findings seem promising for developing innovative Nb-doped calcium phosphates as artificial biomaterials for potential use in bone replacements and repair.
C1 [Capanema, Nadia S. V.; Mansur, Alexandra A. P.; Carvalho, Sandhra M.; Silva, Alexandra R. P.; Ciminelli, Virginia S.; Mansur, Herman S.] Univ Fed Minas Gerais, Ctr Nanosci Nanotechnol & Innovat CeNano2I, Escola Engn, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Ctr Nanosci Nanotechnol & Innovat CeNano2I, Escola Engn, Dept Met & Mat Engn, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM nsvnadia@gmail.com; aapiscitelli@uol.com.br; sandhra.carvalho@gmail.com;
   alebiomat@gmail.com; ciminelli@demet.ufmg.br; hmansur@demet.ufmg.br
RI Capanema, Nadia/C-5888-2018
OI Mansur, Alexandra/0000-0003-1526-2508; Mansur,
   Herman/0000-0002-3032-495X
FU CAPES; FAPEMIG; CNPq; INCT-ACQUA
FX The authors acknowledge the financial support from the CAPES, FAPEMIG,
   CNPq and INCT-ACQUA. The authors express their gratitude to the staff of
   the Microscopy Center/UFMG for TEM analysis, Emilio O. Neto for the EDX
   analysis, Isabel de Sousa Batista Carvalho for XRF analysis, and to
   Dagoberto B. Santos and Patricia Trigueiro for SEM/EDX analysis.
CR Alqap ASF, 2011, IFMBE PROC, V35, P108, DOI 10.1007/978-3-642-21729-6_30
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Compton OC, 2009, J PHYS CHEM C, V113, P479, DOI 10.1021/jp807839b
   Costa HS, 2008, J MATER SCI, V43, P510, DOI 10.1007/s10853-007-1849-6
   Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015
   da Rocha DN, 2013, J MATER RES TECHNOL, V2, P24, DOI 10.1016/j.jmrt.2013.03.007
   Demirtas TT, 2015, MAT SCI ENG C-MATER, V49, P713, DOI 10.1016/j.msec.2015.01.057
   Denry IL, 2005, J BIOMED MATER RES B, V75B, P18, DOI 10.1002/jbm.b.30295
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Elliott J. C., 1994, STUDIES INORGANIC CH, V18, P389
   Etoubleau J, 1999, GEOSTANDARD NEWSLETT, V23, P187, DOI 10.1111/j.1751-908X.1999.tb00573.x
   Farzadi A, 2014, CERAM INT, V40, P6021, DOI 10.1016/j.ceramint.2013.11.051
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JARCHO M, 1977, J BIOENG, V1, P79
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Lafon JP, 2003, J THERM ANAL CALORIM, V72, P1127, DOI 10.1023/A:1025036214044
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   LeGeros R. Z., 1993, INTRO BIOCERAMICS
   Legeros R. Z., 1991, MONOGRAPHS ORAL SCI, V15, P200
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Mansur HS, 2008, CHEM ENG J, V137, P72, DOI 10.1016/j.cej.2007.09.036
   Mansur HS, 2012, MAT SCI ENG C-MATER, V32, P404, DOI 10.1016/j.msec.2011.11.012
   Meejoo S, 2006, THERMOCHIM ACTA, V447, P115, DOI 10.1016/j.tca.2006.04.013
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Oliveira LCA, 2014, APPL CATAL B-ENVIRON, V152, P403, DOI 10.1016/j.apcatb.2014.01.025
   Ramesh S, 2013, CERAM INT, V39, P111, DOI 10.1016/j.ceramint.2012.05.103
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Rueger JM, 1998, ORTHOPADE, V27, P72
   RUYS AJ, 1995, J MATER SCI-MATER M, V6, P297, DOI 10.1007/BF00120274
   Santos MH, 2007, BIOMED MATER, V2, P135, DOI 10.1088/1748-6041/2/2/012
   Santos MH, 2008, MAT SCI ENG C-BIO S, V28, P563, DOI 10.1016/j.msec.2007.07.002
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   Tamai M, 2007, J ARTIF ORGANS, V10, P22, DOI 10.1007/s10047-006-0363-y
   Uysal I, 2014, PROG NAT SCI-MATER, V24, P340, DOI 10.1016/j.pnsc.2014.06.004
NR 44
TC 16
Z9 16
U1 4
U2 31
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2015
VL 8
IS 7
BP 4191
EP 4209
DI 10.3390/ma8074191
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA CP5CG
UT WOS:000359898300028
PM 28793433
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gray, A
   Maguire, T
   Schloss, R
   Yarmush, ML
AF Gray, Andrea
   Maguire, Timothy
   Schloss, Rene
   Yarmush, Martin L.
TI Identification of IL-1 and LPS as optimal activators of monolayer and
   alginate-encapsulated mesenchymal stromal cell immunomodulation using
   design of experiments and statistical methods
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE mesenchymal stromal cells; fractional factorial design; alginate
   encapsulation; immunomodulation
ID MOLECULAR-WEIGHT CUTOFF; FACTOR-KAPPA-B; STEM-CELLS; TNF-ALPHA; IN-VIVO;
   INTERFERON-GAMMA; POLYLYSINE MICROCAPSULES; BINDING-PROTEIN; SOLUBLE
   CD14; NITRIC-OXIDE
AB Induction of therapeutic mesenchymal stromal cell (MSC) function is dependent upon activating factors present in diseased or injured tissue microenvironments. These functions include modulation of macrophage phenotype via secreted molecules including prostaglandin E2 (PGE2). Many approaches aim to optimize MSC-based therapies, including preconditioning using soluble factors and cell immobilization in biomaterials. However, optimization of MSC function is usually inefficient as only a few factors are manipulated in parallel. We utilized fractional factorial design of experiments to screen a panel of 6 molecules (lipopolysaccharide [LPS], polyinosinic-polycytidylic acid [poly(I:C)], interleukin [IL]-6, IL-1, interferon [IFN]-, and IFN-), individually and in combinations, for the upregulation of MSC PGE2 secretion and attenuation of macrophage secretion of tumor necrosis factor (TNF)-, a pro-inflammatory molecule, by activated-MSC conditioned medium (CM). We used multivariable linear regression (MLR) and analysis of covariance to determine differences in functions of optimal factors on monolayer MSCs and alginate-encapsulated MSCs (eMSCs). The screen revealed that LPS and IL-1 potently activated monolayer MSCs to enhance PGE2 production and attenuate macrophage TNF-. Activation by LPS and IL-1 together synergistically increased MSC PGE2, but did not synergistically reduce macrophage TNF-. MLR and covariate analysis revealed that macrophage TNF- was strongly dependent on the MSC activation factor, PGE2 level, and macrophage donor but not MSC culture format (monolayer versus encapsulated). The results demonstrate the feasibility and utility of using statistical approaches for higher throughput cell analysis. This approach can be extended to develop activation schemes to maximize MSC and MSC-biomaterial functions prior to transplantation to improve MSC therapies. (c) 2015 American Institute of Chemical Engineers Biotechnol. Prog., 31:1058-1070, 2015
C1 [Gray, Andrea; Maguire, Timothy; Schloss, Rene; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Yarmush, ML (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
EM yarmush@rci.rutgers.edu
FU New Jersey Commission for Spinal Cord Injury [10-2947-SCR-R-0]; New
   Jersey Commission for Brain Injury Research [CBIR12IRG019]; National
   Institutes of Health (Ruth L. Kirschstein National Research Service
   Award from the National Institute of General Medical Sciences) [T32
   GM8339]; National Science Foundation [0801620]; United States Department
   of Education [P200A100096]
FX The authors thank Dr. Serom Lee and Dr. Mehdi Ghodbane for critical
   review and comments on the manuscript. Support for this work came from
   grants from the New Jersey Commission for Spinal Cord Injury
   (10-2947-SCR-R-0), the New Jersey Commission for Brain Injury Research
   (CBIR12IRG019), the National Institutes of Health (Ruth L. Kirschstein
   National Research Service Award T32 GM8339 from the National Institute
   of General Medical Sciences), the National Science Foundation
   (Integrative Graduate Education and Research Traineeship Award 0801620),
   and the United States Department of Education (Graduate Assistance in
   Areas of National Need Award P200A100096). The authors report no
   conflicts of interest.
CR Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627
   Babiarz J, NANO LIFE
   Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631
   Barminko J, 2011, BIOTECHNOL BIOENG, V108, P2747, DOI 10.1002/bit.23233
   Barminko JA, 2014, BIOTECHNOL BIOENG, V111, P2239, DOI 10.1002/bit.25282
   Bartosh TJ, 2013, STEM CELLS, V31, P2443, DOI 10.1002/stem.1499
   Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247
   Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9
   Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135
   COROMILI V, 1993, BIOMAT ARTIF CELL IM, V21, P427, DOI 10.3109/10731199309117382
   Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007
   Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2007.0037
   de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6
   Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352
   Dong J, 2008, CYTOTECHNOLOGY, V57, P251, DOI 10.1007/s10616-008-9168-6
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698
   Dumitru CA, 2014, FASEB J, V28, P3855
   English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   Gazdic M., 2015, STEM CELL REV
   GOOSEN MFA, 1989, J MEMBRANE SCI, V41, P323, DOI 10.1016/S0376-7388(00)82412-6
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Herrmann JL, 2011, SHOCK, V35, P512, DOI 10.1097/SHK.0b013e31820b2fb9
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Jakobsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096615
   Jaynes J, 2013, STAT MED, V32, P307, DOI 10.1002/sim.5526
   Jiang YF, 2011, NEUROL RES, V33, P331, DOI 10.1179/016164110X12816242542571
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x
   Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108
   Kurachi Maki, 2005, Journal of Infection and Chemotherapy, V11, P199, DOI 10.1007/s10156-005-0392-0
   Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.013909.105812
   Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209
   Lei JX, 2011, CELL IMMUNOL, V271, P147, DOI 10.1016/j.cellimm.2011.06.014
   Li Q, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt213
   Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197
   Luo Y, 2012, SURGERY, V151, P353, DOI 10.1016/j.surg.2011.09.033
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748
   Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI [10.1002/btpr.67, 10.1021/bp.67]
   Matsuura H, 1999, J BIOL CHEM, V274, P29138, DOI 10.1074/jbc.274.41.29138
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   MONTGOMERY D. C., 2008, DESIGN ANAL EXPT
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Mundra V, 2012, MOL PHARM, V10, P77
   Nakamoto N, 2006, INT J ONCOL, V29, P625
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105
   Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7
   Orive G, 2014, ADV DRUG DELIVER REV, V67-68, P3, DOI 10.1016/j.addr.2013.07.009
   OTTERLEI M, 1993, INFECT IMMUN, V61, P1917
   Perdana Arif, 2014, International Journal of Business Information Systems, V16, P247, DOI 10.1504/IJBIS.2014.063767
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Roldan-Valadez E, 2013, ANAT REC, V296, P1913, DOI 10.1002/ar.22817
   Roldan-Valadez E, 2013, EUR J RADIOL, V82, pE697, DOI 10.1016/j.ejrad.2013.07.012
   Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864
   Sarrafzadegan N, 2011, J RES MED SCI, V16, P254
   Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
   Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3
   Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682
   Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563
   Treffkorn L, 2004, PROSTAG OTH LIPID M, V74, P113, DOI 10.1016/j.prostaglandins.2004.07.005
   Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52
   van den Berk LCJ, 2010, J LEUKOCYTE BIOL, V87, P283, DOI 10.1189/jlb.0709467
   VANDENBOSSCHE GMR, 1991, J PHARM PHARMACOL, V43, P275, DOI 10.1111/j.2042-7158.1991.tb06683.x
   VANDENBOSSCHE GMR, 1993, BIOTECHNOL BIOENG, V42, P381, DOI 10.1002/bit.260420316
   Waterman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045590
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
   Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191
   Ylostalo JH, 2014, CYTOTHERAPY, V16, P1486, DOI 10.1016/j.jcyt.2014.07.010
   Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x
   Yu B, 1996, J BIOL CHEM, V271, P4100
   Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008
   Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588
   Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004
NR 83
TC 8
Z9 8
U1 1
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2015
VL 31
IS 4
BP 1058
EP 1070
DI 10.1002/btpr.2103
PG 13
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA CP0YM
UT WOS:000359602900022
PM 25958832
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yang, J
   Wang, S
   Lee, JH
AF Yang, Jaechang
   Wang, Semyung
   Lee, Jong Hyun
TI Photovoltaic Detection of Hydrogen Peroxide over a Wide Range of
   Concentrations for Agricultural Applications
SO JOURNAL OF CHEMICAL ENGINEERING OF JAPAN
LA English
DT Article
DE Hydrogen Peroxide; Photovoltaic Detection; Chemiluminescence; Capacitor
   Filter; Reflective Plate
ID CARBON-PASTE; ELECTRODE; SENSOR; NANOPARTICLES; HEMOGLOBIN; BIOSENSOR;
   MEMBRANE
AB Detection methods to broaden the measurable range of hydrogen peroxide (H2O2) concentrations are suggested for agricultural applications. Photovoltaic detection is based on the chemiluminescence (CL) of luminol with potassium ferricyanide as a catalyst. The use of potassium ferricyanide (non-biomaterial) enables the sensor to be stored for a long period at room temperature and can lower the manufacturing cost. In this study, the measurement range was broadened down to 3x10(-5)% by improving the stability and enhancing the sensitivity of the sensor. To improve the stability in the time domain, a low pass filter (LPF) was connected, reducing noise caused by ambient light. To enhance sensitivity, a reflective plate was employed to redirect diverging emitted light toward the photodiode. The highest possible detection level was also elevated up to 0.5% by preparing the mixture of luminol and catalysts (MLC) at high concentration. As a result, the performance index, IMR (Index of Measurable Range=maximum/minimum ratio of detectable concentration) of the system grew to over 16,000, which is about 16 times larger than previous results. All of the experimental results were confirmed to be in good agreement with calculated theoretical output voltages from chemiluminescence. The proposed device is intended to replace hazardous pesticides or antibiotics which have been used for agricultural applications.
C1 [Yang, Jaechang; Wang, Semyung; Lee, Jong Hyun] Gwangju Inst Sci & Technol, Chool Mechatron, Gwangju 500712, South Korea.
   [Lee, Jong Hyun] Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju 500712, South Korea.
RP Lee, JH (reprint author), Gwangju Inst Sci & Technol, Chool Mechatron, Gwangju 500712, South Korea.
EM jonghyun@gist.ac.kr
FU Institute of Medical System Engineering (iMSE) in the GIST, Korea
FX This research was supported by a Grant from the Institute of Medical
   System Engineering (iMSE) in the GIST, Korea.
CR AIZAWA M, 1984, ANAL LETT PT B, V17, P555, DOI 10.1080/00032718408066489
   Bruno D. W., 1994, Aquaculture International, V2, P10, DOI 10.1007/BF00118529
   Byun HongJu, 2003, Journal of the Korean Society for Horticultural Science, V44, P859
   Choi I., 2009, J BIOENVIRON CONTROL, V18, P297
   FORZANI ES, 1995, J ELECTROANAL CHEM, V382, P33, DOI 10.1016/0022-0728(94)03640-O
   Kim HJ, 2008, SENSORS-BASEL, V8, P4110, DOI 10.3390/s8074110
   Kim Hyung-Il, 2003, Journal of the Korean Physical Society, V42, P336
   KULYS J, 1994, J ELECTROANAL CHEM, V372, P49, DOI 10.1016/0022-0728(93)03262-N
   KULYS J, 1993, ANAL CHIM ACTA, V274, P53, DOI 10.1016/0003-2670(93)80604-J
   Li JJ, 2010, MICROCHIM ACTA, V171, P125, DOI 10.1007/s00604-010-0383-4
   Luo FB, 2009, MICROCHIM ACTA, V165, P23, DOI 10.1007/s00604-008-0091-5
   Miyasaka T, 1998, J CHEM ENG JPN, V31, P29, DOI 10.1252/jcej.31.29
   Ozaki K, 2009, J PLANT PHYSIOL, V166, P569, DOI 10.1016/j.jplph.2008.08.007
   Rach JJ, 2000, J AQUAT ANIM HEALTH, V12, P267, DOI 10.1577/1548-8667(2000)012<0267:EOHPTC>2.0.CO;2
   Rameshkumar P, 2013, J APPL ELECTROCHEM, V43, P1005, DOI 10.1007/s10800-013-0589-3
   Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003
   Tan XC, 2009, SENSORS-BASEL, V9, P6185, DOI 10.3390/s90806185
   Tensha K., 2006, B YAMAGUCHI PREF FIS, V4, P167
   Tian L, 2012, MICROCHIM ACTA, V177, P39, DOI 10.1007/s00604-011-0746-5
   Uchida A, 2009, J AGR SCI, V64, P415
   Vanninen I, 1998, CROP PROT, V17, P547, DOI 10.1016/S0261-2194(98)00060-X
   Wang Q, 2009, MICROCHIM ACTA, V167, P153, DOI 10.1007/s00604-009-0236-1
   Wolfbeis OS, 2003, MICROCHIM ACTA, V143, P221, DOI 10.1007/s00604-003-0090-5
   Yan ZK, 2013, MICROCHIM ACTA, V180, P145, DOI 10.1007/s00604-012-0916-0
   Yang JC, 2008, JPN J APPL PHYS, V47, P6943, DOI 10.1143/JJAP.47.6943
   Zhang KY, 2010, MICROCHIM ACTA, V171, P139, DOI 10.1007/s00604-010-0409-y
   Zhang Y, 2011, BIOPROC BIOSYST ENG, V34, P215, DOI 10.1007/s00449-010-0463-1
   Zheng J., 2012, ADV OPTICAL MAT, V24, P194
NR 28
TC 0
Z9 1
U1 1
U2 6
PU SOC CHEMICAL ENG JAPAN
PI BUNKYO KU TOKYO
PA KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN
SN 0021-9592
J9 J CHEM ENG JPN
JI J. Chem. Eng. Jpn.
PD JUL
PY 2015
VL 48
IS 7
BP 575
EP 583
DI 10.1252/jcej.14we276
PG 9
WC Engineering, Chemical
SC Engineering
GA CP4EH
UT WOS:000359834300010
DA 2018-10-20
ER

PT J
AU Levin, BP
AF Levin, Barry P.
TI The Dual Function of a Dermal Allograft in Immediate Implant Therapy
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID BEAM COMPUTED-TOMOGRAPHY; ANTERIOR SINGLE IMPLANTS; FACIAL BONE WALL;
   BIOLOGIC WIDTH; AESTHETIC OUTCOMES; TITANIUM IMPLANTS; TISSUE STABILITY;
   PLACEMENT; DIMENSION; DOGS
AB Immediate implant placement often requires tissue augmentation simultaneously. Both hard and soft tissue grafting can improve long-term physiologic and esthetic outcomes. Bone replacement grafts are frequently combined with barrier membranes (guided bone regeneration [GBR]). When these materials are resorbable, they are often composed of collagen or synthetic polymers. These techniques do not address the need for soft tissue augmentation, and harvesting of autogenous soft tissue grafts is required. The use of a dermal allograft composed of natural, non-cross-linked collagen eliminates the need for the second surgical site to harvest autogenous soft tissue. This article demonstrates the dual functionality of a dermal allograft serving as both a GBR membrane and a biologically incorporated soft tissue biomaterial in immediate implant therapy.
C1 [Levin, Barry P.] Univ Penn, Dept Grad Periodontol & Implant Surg, Philadelphia, PA 19104 USA.
RP Levin, BP (reprint author), 509 York Rd, Jenkintown, PA 19046 USA.
EM aperiodoc@verizon.net
CR Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Braut V, 2011, INT J PERIODONT REST, V31, P125
   Caneva M, 2012, CLIN ORAL IMPLAN RES, V00, P1
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P891, DOI 10.1111/j.1600-0501.2010.01946.x
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Chen ST, 2009, J PERIODONTOL, V80, P163, DOI [10.1902/jop.2009.080243, 10.1902/jop.2009.080243 ]
   Cochran DL, 1997, J PERIODONTOL, V68, P186, DOI 10.1902/jop.1997.68.2.186
   Covani U, 2010, INT J PERIODONT REST, V30, P601
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   Fernandez-Botran R, 2002, TRANSPLANTATION, V74, P623, DOI 10.1097/00007890-200209150-00007
   GARGIULO AW, 1961, J PERIODONTOL, V32, P261, DOI 10.1902/jop.1961.32.3.261
   Grunder U, 2011, INT J PERIODONT REST, V31, P9
   Hermann JS, 2000, CLIN ORAL IMPLAN RES, V11, P1, DOI 10.1034/j.1600-0501.2000.011001001.x
   Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   Kan JYK, 2011, INT J ORAL MAX IMPL, V26, P179
   Linkevicius T, 2010, J ORAL MAXIL SURG, V68, P2272, DOI 10.1016/j.joms.2009.08.018
   Martins MC, 2004, INT J ORAL MAX IMPL, V19, P839
   Nisapakultorn K, 2010, CLIN ORAL IMPLAN RES, V21, P662, DOI 10.1111/j.1600-0501.2009.01887.x
   Roe P, 2012, INT J ORAL MAX IMPL, V27, P393
   Romanos GE, 2010, J PERIODONTOL, V81, P70, DOI 10.1902/jop.2009.090364
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Spray J R, 2000, Ann Periodontol, V5, P119, DOI 10.1902/annals.2000.5.1.119
   Vervaeke S, 2014, CLIN IMPLANT DENT R, V16, P1
   Wennstrom JL, 2012, CLIN ORAL IMPLAN RES, V23, P136, DOI 10.1111/j.1600-0501.2012.02540.x
NR 27
TC 0
Z9 0
U1 0
U2 1
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUL-AUG
PY 2015
VL 35
IS 4
BP 507
EP 513
DI 10.11607/prd.2095
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN5IE
UT WOS:000358462200008
PM 26133140
OA Bronze
DA 2018-10-20
ER

PT J
AU Ntounis, A
   Pitman, LM
   Pollini, A
   Vidal, R
   Lin, WS
   Madigan, MP
   Greenwell, H
AF Ntounis, Athanasios
   Pitman, Lillie M.
   Pollini, Adrien
   Vidal, Ricardo
   Lin, Wei-Shao
   Madigan, Michael P.
   Greenwell, Henry
TI The ABC Protocol in the Esthetic Zone: A Comprehensive Surgical and
   Prosthetic Approach
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; SINGLE TOOTH EXTRACTION; IMPLANT PLACEMENT;
   SINUS AUGMENTATION; FOLLOW-UP; BONE; STABILITY; ABUTMENT; CONTOUR
AB The purpose of this article is to present a surgical and restorative protocol for the replacement of missing teeth in the esthetic zone. The ABC protocol consists of digitally guided implantation, autogenous bone graft (A), followed by bovine bone xenograft (B) and connective tissue graft (C). Autogenous bone is placed in contact with the implant surface to induce osseointegration; bovine bone xenograft is then applied to augment the ridge dimension and provide long-term stability. Connective tissue is used to provide additional volume. The ABC biomaterial sequence offers favorable hard and soft tissue dimensions and immediate provisional restoration predictably leads to an esthetically pleasing definitive prosthesis.
C1 [Ntounis, Athanasios; Pollini, Adrien; Vidal, Ricardo; Lin, Wei-Shao; Greenwell, Henry] Univ Louisville, Sch Dent, Dept Oral Hlth & Rehabil, Louisville, KY 40202 USA.
RP Ntounis, A (reprint author), Univ Louisville, Sch Dent, Dept Oral Hlth & Rehabil, 501 South Preston,Room 312, Louisville, KY 40202 USA.
EM perio.ntounis@louisville.edu
CR Arte S, 2001, J DENT RES, V80, P1445, DOI 10.1177/00220345010800051201
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 2013, J PERIODONTOL, V84, P1517, DOI 10.1902/jop.2013.120635
   Buser D, 2011, J PERIODONTOL, V82, P342, DOI 10.1902/jop.2010.100408
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P820, DOI 10.1111/j.1600-0501.2010.02060.x
   Degidi M, 2013, INT J PERIODONT REST, V33, P559, DOI 10.11607/prd.1795
   Fu JH, 2014, CLIN ORAL IMPLAN RES, V25, P458, DOI 10.1111/clr.12171
   Grunder U, 2011, INT J PERIODONT REST, V31, P9
   Hultin M, 2012, CLIN ORAL IMPLAN RES, V23, P124, DOI 10.1111/j.1600-0501.2012.02545.x
   Jemt T, 1999, Int J Periodontics Restorative Dent, V19, P20
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   Linkevicius T., 2013, CLIN IMPLANT DENT RE
   Ntounis A, 2012, CLIN ADV PERIODONTIC, V2, P200, DOI 10.1902/cap.2012.110093
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schneider D, 2011, CLIN ORAL IMPLAN RES, V22, P28, DOI 10.1111/j.1600-0501.2010.01987.x
   SEIBERT JS, 1987, DENT CLIN N AM, V31, P529
   Su HA, 2010, INT J PERIODONT REST, V30, P335
   Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1016/S0889-5406(00)70173-9
NR 19
TC 0
Z9 0
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUL-AUG
PY 2015
VL 35
IS 4
BP 561
EP 569
DI 10.11607/prd.2170
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CN5IE
UT WOS:000358462200014
PM 26133146
OA Bronze
DA 2018-10-20
ER

PT J
AU Kulkarni, M
   Mrak-Poljsak, K
   Flasker, A
   Mazare, A
   Schmuki, P
   Kos, A
   Cucnik, S
   Sodin-Semrl, S
   Iglic, A
AF Kulkarni, Mukta
   Mrak-Poljsak, Katjusa
   Flasker, Ajda
   Mazare, Anca
   Schmuki, Patrik
   Kos, Andrej
   Cucnik, Sasa
   Sodin-Semrl, Snezna
   Iglic, Ales
TI FABRICATION OF TiO2 NANOTUBES FOR BIOAPPLICATIONS
SO MATERIALI IN TEHNOLOGIJE
LA English
DT Article
DE TiO2; nanotubes; electrochemical anodization; protein binding
ID TITANIUM; SURFACE; OSTEOBLASTS; ADHESION; ALLOYS; LAYERS
AB Titanium (Ti), due its most promising biomaterial properties, can be used in the medical devices that interact with the body tissue, specifically to evaluate, treat, augment or replace any tissue, organ or function of the body. In the present work, we prepared titanium dioxide (TiO2) nanotubes with different diameters in the same electrolyte by tailoring different parameters of electrochemical anodization. These structures have more nanorough regions and more surface area that can promote protein binding and cell adhesion in order to increase the lifetime of implants and other medical devices. As an example, we showed the differences in the protein binding of human acute-phase serum amyloid A (SAA) to the TiO2 nanotubes of different diameters, specifically of 50 nm and 15 nm, as well as comparing it with the binding to the foil alone. We found that SAA binds most prevalently to the nanotubes 50 nm, as opposed to the nanotubes 15 nm or the foil.
C1 [Kulkarni, Mukta; Flasker, Ajda; Kos, Andrej; Iglic, Ales] Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia.
   [Mrak-Poljsak, Katjusa; Cucnik, Sasa; Sodin-Semrl, Snezna] Univ Med Ctr, Dept Rheumatol, Ljubljana, Slovenia.
   [Mazare, Anca; Schmuki, Patrik] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91054 Erlangen, Germany.
   [Cucnik, Sasa; Sodin-Semrl, Snezna] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.
   [Sodin-Semrl, Snezna] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.
RP Kulkarni, M (reprint author), Univ Ljubljana, Fac Elect Engn, Trzaska Cesta 25, Ljubljana 1000, Slovenia.
EM mukta.kulkarni@fe.uni-lj.si
OI Mazare, Anca/0000-0002-4836-946X
CR Awitor KO, 2008, J PHOTOCH PHOTOBIO A, V199, P250, DOI 10.1016/j.jphotochem.2008.05.023
   Bakir M, 2012, J BIOMATER APPL, V27, P3, DOI 10.1177/0885328212439615
   Bauer S., 2010, EUROP CELLS MAT, V20, P16
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   D F, 2009, BIOMATERIALS, V30, P5897, DOI DOI 10.1016/J.BIOMATERIALS.2009.07.027
   D F, 2008, BIOMATERIALS, V20, P2941, DOI DOI 10.1016/J.BIOMATERIALS.2008.04.023
   Dale GR, 2009, J NANOSCI NANOTECHNO, V9, P4215, DOI 10.1166/jnn.2009.M35
   Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607
   Gongadze E, 2013, MINI-REV MED CHEM, V13, P194
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Kowalski D, 2013, NANO TODAY, V8, P235, DOI 10.1016/j.nantod.2013.04.010
   Lakota K, 2010, RECENT PATENTS ENDOC, V4, P89, DOI DOI 10.4155/PPA.12.26
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Macak JM, 2007, SMALL, V3, P300, DOI 10.1002/smll.200600426
   Mihov D, 2010, TRAKIA J SCI, V8, P119
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Ross AP, 2013, INT J NANOMED, V8, P109, DOI 10.2147/IJN.S36203
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Sasaki K, 2006, ANN ANAT, V188, P137, DOI 10.1016/j.aanat.2005.10.003
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
NR 21
TC 0
Z9 0
U1 1
U2 14
PU INST ZA KOVINSKE MATERIALE I IN TEHNOLOGIE
PI LJUBJANA
PA LEPI POT 11, LJUBJANA, 10000, SLOVENIA
SN 1580-2949
EI 1580-3414
J9 MATER TEHNOL
JI Mater. Tehnol.
PD JUL-AUG
PY 2015
VL 49
IS 4
BP 635
EP 637
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA CN6RB
UT WOS:000358560800026
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tay, CY
   Wu, YL
   Cai, PQ
   Tan, NS
   Venkatraman, SS
   Chen, XD
   Tan, LP
AF Tay, Chor Yong
   Wu, Yun-Long
   Cai, Pingqiang
   Tan, Nguan Soon
   Venkatraman, Subbu S.
   Chen, Xiaodong
   Tan, Lay Poh
TI Bio-inspired micropatterned hydrogel to direct and deconstruct
   hierarchical processing of geometry-force signals by human mesenchymal
   stem cells during smooth muscle cell differentiation
SO NPG ASIA MATERIALS
LA English
DT Article
ID GROWTH-FACTOR-BETA; STRESS FIBERS; ADIPOSE-TISSUE; ACTIN; TENSION;
   EXPRESSION; MATRIX; SHAPE; FATE; MIGRATION
AB Micropatterned biomaterial-based hydrogel platforms allow the recapitulation of in vivo-like microstructural and biochemical features that are critical physiological regulators of stem cell development. Herein, we report the use of muscle mimicking geometries patterned on polyacrylamide hydrogels as an effective strategy to induce smooth muscle cell (SMC) differentiation of human mesenchymal stem cells (hMSCs). hMSCs were systemically coerced to elongate with varying aspect ratios (AR) (that is, 1:1, 5:1, 10:1 and 15:1) at a fixed projection area of similar to 7000 mu m(2). The results showed engineered cellular anisotropy with an intermediate AR 5: 1 and AR 10: 1, promoting the expression of alpha smooth muscle actin (alpha-SMA) and enhancement of contractile output. Further mechanistic studies indicated that a threshold cell traction force of similar to 3.5 mu N was required for SMC differentiation. Beyond the critical cytoskeleton tension, hMSCs respond to higher intracellular architectural cues such as the stress fiber (SF) alignment, SF subtype expression and diphosphorylated myosin regulatory light-chain activity to promote the expression and incorporation of a-SMA to the SF scaffold. These findings underscore the importance of exploiting biomimetic geometrical cues as an effective strategy to guide hMSC differentiation and are expected to guide the rational design of advanced tissue-engineered vascular grafts.
C1 [Tay, Chor Yong] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117585, Singapore.
   [Wu, Yun-Long] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China.
   [Cai, Pingqiang; Venkatraman, Subbu S.; Chen, Xiaodong; Tan, Lay Poh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
   [Tan, Nguan Soon] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore.
RP Tay, CY (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore.
EM chetcy@nus.edu.sg; lptan@ntu.edu.sg
RI Chen, Xiaodong/A-4537-2009; Tan, LP/A-2229-2011; Tay, Chor
   Yong/C-1999-2016; ASTAR, IMCB/E-2320-2012; Venkatraman,
   Subramanian/A-2228-2011
OI Chen, Xiaodong/0000-0002-3312-1664; Tan, LP/0000-0002-0172-1569;
   Venkatraman, Subramanian/0000-0002-8693-1070; Tan, Nguan
   Soon/0000-0003-0136-7341; Wu, Yun-Long/0000-0001-6426-6340
FU Ministry of Education Academic Research [R-279-000-376-112]; Nanyang
   Technological University Tier 1 grant [RGT24/13]; Lee Kuan Yew
   Postdoctoral Fellowship
FX The authors gratefully acknowledge financial support from the Ministry
   of Education Academic Research Grants (R-279-000-376-112 to CYT) and
   Nanyang Technological University Tier 1 grant (RGT24/13). CYT thankfully
   acknowledges support from the Lee Kuan Yew Postdoctoral Fellowship.
CR Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81
   Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Harris LJ, 2011, J SURG RES, V168, P306, DOI 10.1016/j.jss.2009.08.001
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319
   Lam CRI, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.339
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   Leong David Tai, 2008, Curr Drug Discov Technol, V5, P319, DOI 10.2174/157016308786733537
   Leong DT, 2006, CELLS TISSUES ORGANS, V182, P1, DOI 10.1159/000091713
   Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mizutani T, 2006, J CELL PHYSIOL, V209, P726, DOI 10.1002/jcp.20773
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   ROMAN J, 1992, AM J RESP CELL MOL, V6, P472, DOI 10.1165/ajrcmb/6.5.472
   Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445
   Tay CY, 2014, NANO LETT, V14, P83, DOI 10.1021/nl4032549
   Tay CY, 2013, NANOMEDICINE-UK, V8, P623, DOI [10.2217/NNM.13.31, 10.2217/nnm.13.31]
   Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001
   Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786
   Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.TEA.2011.0172, 10.1089/ten.tea.2011.0172]
   Yang Y, 1999, DEVELOPMENT, V126, P3027
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103
NR 38
TC 19
Z9 19
U1 11
U2 46
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD JUL
PY 2015
VL 7
AR e199
DI 10.1038/am.2015.66
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA CN9PS
UT WOS:000358781900004
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Coburn, JM
   Kaplan, DL
AF Coburn, Jeannine M.
   Kaplan, David L.
TI Engineering Biomaterial-Drug Conjugates for Local and Sustained
   Chemotherapeutic Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Review
ID PERCUTANEOUS ETHANOL INJECTION; ENHANCED ANTITUMOR EFFICACY; SOLID LIPID
   NANOPARTICLES; BREAST-CANCER CELLS; IN-VIVO; HEPATOCELLULAR-CARCINOMA;
   TRANSARTERIAL CHEMOEMBOLIZATION; COMBINATION CHEMOTHERAPY;
   MULTIDRUG-RESISTANCE; LAPONITE NANODISKS
AB The standard of care for cancer patients includes surgical resection, radiation, and chemotherapy with cytotoxic chemotherapy drugs usually part of the treatment. However, these drugs are commonly associated with cardiotoxicity, ototoxicity, nephrotoxicity, peripheral neuropathy, and myelosuppression. Strategies to deliver cytotoxic chemotherapy drugs while reducing secondary toxicity and increasing tumor dosing would therefore be desirable. This goal can be achieved through the use of controlled release drug carrier systems. The aim of this review is to provide an overview of clinically used drug carrier systems and recently developed approaches for drug biomaterial conjugation.
C1 [Coburn, Jeannine M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Coburn, Jeannine M./0000-0001-6354-5436
FU NIH [P41 EB002520]
FX We thank the NIH (P41 EB002520) for support of various aspects of this
   work.
CR Aboutaleb E, 2014, J BIOMED MATER RES A, V102, P2125, DOI 10.1002/jbm.a.34890
   Albert M, 2011, CANCER-AM CANCER SOC, V117, P343, DOI 10.1002/cncr.25387
   Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745
   Aryal S, 2009, ACS NANO, V4, P251, DOI DOI 10.1021/NN9014032
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Berghammer P, 1998, CARDIOVASC INTER RAD, V21, P214, DOI 10.1007/s002709900247
   Boyette-Davis JA, 2013, CANCER CHEMOTH PHARM, V71, P619, DOI 10.1007/s00280-012-2047-z
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Chitkara D, 2013, BIOCONJUGATE CHEM, V24, P1161, DOI 10.1021/bc400032x
   Chiu B, 2014, BRIT J CANCER, V111, P708, DOI 10.1038/bjc.2014.324
   CSERHATI T, 1994, INT J PHARM, V108, P69, DOI 10.1016/0378-5173(94)90417-0
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036
   DEUTSCH JC, 1989, ARCH BIOCHEM BIOPHYS, V274, P327, DOI 10.1016/0003-9861(89)90446-3
   DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611
   Dinarvand R., 2012, P WORLD ACAD SCI ENG, V6, P611
   Dong L, 2010, BIOMATERIALS, V31, P6309, DOI 10.1016/j.biomaterials.2010.04.049
   El-Dakdouki MH, 2014, ACS APPL MATER INTER, V6, P697, DOI 10.1021/am404946v
   El-Dakdouki MH, 2012, BIOMACROMOLECULES, V13, P1144, DOI 10.1021/bm300046h
   Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093
   Feng Z, 2010, CANCER SCI, V101, P2476, DOI 10.1111/j.1349-7006.2010.01708.x
   Gale R., 1984, EXP HEMATOL, V13, P3
   Goncalves M, 2014, ACTA BIOMATER, V10, P300, DOI 10.1016/j.actbio.2013.09.013
   Gooch JL, 1998, CANCER RES, V58, P4199
   Goszcz-yfiski T. M., 2014, PHARM RES PERSPECT, V2
   Hanigan Marie H, 2003, Cancer Ther, V1, P47
   Haxton KJ, 2008, DALTON T, P5872, DOI 10.1039/b809949a
   Haxton KJ, 2009, J PHARM SCI-US, V98, P2299, DOI 10.1002/jps.21611
   Hellmers F, 2013, BIOCHEM ENG J, V75, P72, DOI 10.1016/j.bej.2013.03.019
   Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI [10.1111/j.1582-4934.2007.00189.x, 10.1111/j.1582-4934.2008.00189.x]
   Huynh NT, 2009, INT J PHARMACEUT, V379, P201, DOI 10.1016/j.ijpharm.2009.04.026
   Jager E, 2013, J CONTROL RELEASE, V165, P153, DOI 10.1016/j.jconrel.2012.11.009
   Janknegt R, 1996, SUPPORT CARE CANCER, V4, P298, DOI 10.1007/BF01358884
   John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002
   Kaminskas LM, 2012, MOL PHARMACEUT, V9, P422, DOI 10.1021/mp200522d
   Kaminskas LM, 2012, NANOMED-NANOTECHNOL, V8, P103, DOI 10.1016/j.nano.2011.05.013
   Kaminskas LM, 2011, J CONTROL RELEASE, V152, P241, DOI 10.1016/j.jconrel.2011.02.005
   Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712
   Khdair A, 2010, J CONTROL RELEASE, V141, P137, DOI 10.1016/j.jconrel.2009.09.004
   Khdair A, 2009, EUR J PHARM BIOPHARM, V71, P214, DOI 10.1016/j.ejpb.2008.08.017
   Kim GO, 2012, MOLECULES, V17, P13704, DOI 10.3390/molecules171213704
   Kim H, 2014, MACROMOL RES, V22, P805, DOI 10.1007/s13233-014-2118-6
   Kintzel PE, 2001, ANN PHARMACOTHER, V35, P1114
   Kirchhoff T, 1998, EUR J GASTROEN HEPAT, V10, P907, DOI 10.1097/00042737-199811000-00001
   Kirikoshi H, 2009, HEPATOL RES, V39, P553, DOI 10.1111/j.1872-034X.2009.00490.x
   Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7
   Laurent A, 2007, TECH VASC INTERV RAD, V10, P248, DOI 10.1053/j.tvir.2008.03.010
   Lee CC, 2006, BIOCONJUGATE CHEM, V17, P1364, DOI 10.1021/bc060117y
   Lee E, 2008, J MED CHEM, V51, P6442, DOI 10.1021/jm800767c
   Lencioni R, 2012, CARDIOVASC INTER RAD, V35, P980, DOI 10.1007/s00270-011-0287-7
   Li K, 2014, ACS APPL MATER INTER, V6, P12328, DOI 10.1021/am502094a
   Li S.-D., 2009, MOL PHARM, V7, P280
   Ling GX, 2010, J CONTROL RELEASE, V148, P241, DOI 10.1016/j.jconrel.2010.08.010
   Luo F., 2014, NANOSCALE RES LETT, V9, P1
   Flores ML, 2012, BREAST CANCER RES TR, V133, P917, DOI 10.1007/s10549-011-1864-9
   Ma P, 2009, J BIOMED NANOTECHNOL, V5, P151, DOI 10.1166/jbn.2009.1021
   Maciel D, 2013, BIOMACROMOLECULES, V14, P3140, DOI 10.1021/bm400768m
   MACKA M, 1991, J CHROMATOGR, V586, P291, DOI 10.1016/0021-9673(91)85135-3
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Malagari K, 2014, CARDIOVASC INTER RAD, V37, P165, DOI 10.1007/s00270-013-0777-x
   Manju S, 2011, J COLLOID INTERF SCI, V359, P318, DOI 10.1016/j.jcis.2011.03.071
   Manocha B, 2010, J NANOMATER, DOI 10.1155/2010/780171
   Miele E, 2009, INT J NANOMED, V4, P99
   Mirakabad FST, 2014, ASIAN PAC J CANCER P, V15, P517, DOI 10.7314/APJCP.2014.15.2.517
   MORSTYN G, 1984, J NATL CANCER I, V73, P801
   Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759
   Namgung R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4702
   OBIRI NI, 1994, CLIN EXP IMMUNOL, V95, P148
   Paraskar AS, 2010, P NATL ACAD SCI USA, V107, P12435, DOI 10.1073/pnas.1007026107
   Perez-Arnaiz C, 2014, J PHYS CHEM B, V118, P1288, DOI 10.1021/jp411429g
   RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda
   Sampath, 1998, Cancer Control, V5, P130
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Seib FP, 2013, ADV FUNCT MATER, V23, P58, DOI 10.1002/adfm.201201238
   Seib FP, 2012, BIOMATERIALS, V33, P8442, DOI 10.1016/j.biomaterials.2012.08.004
   Sengupta P, 2012, P NATL ACAD SCI USA, V109, P11294, DOI 10.1073/pnas.1203129109
   Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794
   Silverman JA, 2013, CANCER CHEMOTH PHARM, V71, P555, DOI 10.1007/s00280-012-2042-4
   Strickley RG, 2004, PHARM RES, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23
   Sui BW, 2014, MOLECULES, V19, P11915, DOI 10.3390/molecules190811915
   TADAVARTHY SM, 1975, AM J ROENTGENOL, V125, P609, DOI 10.2214/ajr.125.3.609
   Tauro JR, 2005, BIOCONJUGATE CHEM, V16, P1133, DOI 10.1021/bc0501303
   Tiwari G, 2010, J PHARM BIOALLIED SC, V2, P72, DOI 10.4103/0975-7406.67003
   TOI M, 1992, CANCER RES, V52, P275
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Upadhyay KK, 2010, BIOMATERIALS, V31, P2882, DOI 10.1016/j.biomaterials.2009.12.043
   Van Ha Thuong G, 2009, Semin Intervent Radiol, V26, P270, DOI 10.1055/s-0029-1225672
   Vogel SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1512
   Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z
   Wang SG, 2013, LANGMUIR, V29, P5030, DOI 10.1021/la4001363
   Wei X, 2013, BIOCONJUGATE CHEM, V24, P658, DOI 10.1021/bc300632w
   Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283
   Yan XD, 2005, J LIPOSOME RES, V15, P109, DOI 10.1081/LPR-200064971
   Ye HF, 2006, BIOMATERIALS, V27, P5958, DOI 10.1016/j.biomaterials.2006.08.016
   Yousefpour P, 2011, INT J NANOMED, V6, P1487, DOI 10.2147/IJN.S18535
   Zhang P, 2012, NANOMED-NANOTECHNOL, V8, P185, DOI 10.1016/j.nano.2011.06.007
   Zhang T, 2013, INT J NANOMED, V8, P1185, DOI 10.2147/IJN.S41775
   Zhu Q, 2014, MOL PHARMACEUT, V11, P3269, DOI 10.1021/mp4007776
NR 104
TC 12
Z9 12
U1 4
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1212
EP 1223
DI 10.1021/acs.bioconjchem.5b00046
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500007
PM 25689115
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ryan, CNM
   Sorushanova, A
   Lomas, AJ
   Mullen, AM
   Pandit, A
   Zeugolis, DI
AF Ryan, Christina N. M.
   Sorushanova, Anna
   Lomas, Alex J.
   Mullen, Anne Maria
   Pandit, Abhay
   Zeugolis, Dimitrios I.
TI Glycosaminoglycans in Tendon Physiology, Pathophysiology, and Therapy
SO BIOCONJUGATE CHEMISTRY
LA English
DT Review
ID COLLAGEN-GAG SCAFFOLDS; MESENCHYMAL STEM-CELLS; THERMORESPONSIVE
   HYALURONAN HYDROGELS; THERMALLY RESPONSIVE POLYMERS; HEPARAN-SULFATE
   PROTEOGLYCANS; DIGITAL FLEXOR TENDON; ROTATOR CUFF TENDONS; MODEL
   IN-VITRO; CHONDROITIN SULFATE; EXTRACELLULAR-MATRIX
AB Although glycosaminoglycans constitute a minor portion of native tissues, they play a crucial role in various physiological processes, while their abnormal expression is associated with numerous pathophysiologies. Glycosaminoglycans have become increasingly prevalent in biomaterial design for tendon repair, given their low immunogenicity and their inherent capacity to stimulate the regenerative processes, while maintaining resident cell phenotype and function. Further, their incorporation into three-dimensional scaffold conformations significantly improves their mechanical properties, while reducing the formation of peritendinous adhesions. Herein, we discuss the role of glycosaminoglycans in tendon physiology and pathophysiology and the advancements achieved to date using glycosaminoglycan-functionalized scaffolds for tendon repair and regeneration. It is evidenced that glycosaminoglycan functionalization has led to many improvements in tendon tissue engineering and it is anticipated to play a pivotal role in future reparative therapies.
C1 [Ryan, Christina N. M.; Sorushanova, Anna; Lomas, Alex J.; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway NUI Galway, Regenerat Modular & Dev Engn Lab REMODEL, Galway, Ireland.
   [Ryan, Christina N. M.; Sorushanova, Anna; Lomas, Alex J.; Pandit, Abhay; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway NUI Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Ryan, Christina N. M.; Sorushanova, Anna; Lomas, Alex J.; Pandit, Abhay; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway NUI Galway, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Mullen, Anne Maria] Teagasc Food Res Ctr, Ashtown, Ireland.
RP Zeugolis, DI (reprint author), Natl Univ Ireland Galway NUI Galway, Regenerat Modular & Dev Engn Lab REMODEL, Biosci Res Bldg, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
RI Mullen, Anne M/E-5779-2016; Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; zeugolis,
   dimitrios/0000-0002-7599-5191
FU EU [251385, 263289]; Health Research Board [HRA_POR/2011/84]; Teagasc
   Walsh Fellowship [2014045]; ReValueProtein Research Project [11/F/043];
   Department of Agriculture, Food and the Marine (DAFM) under the National
   Development Plan - Irish Government
FX The authors would like to thank Maciek Doczyk for the preparation of
   Figure 2. This work is supported by the: EU FP7/2007-2013, Marie Curie,
   IAPP award, part of the People programme, Tendon Regeneration Project
   (Grant Agreement Number: 251385) to D.Z.; EU FP7/2007-2013, NMP award,
   Green Nano Mesh Project (Grant Agreement Number: 263289) to D.Z.; Health
   Research Board, Health Research Awards Programme, under the grant
   agreement number HRA_POR/2011/84 to D.Z. This work forms part of the
   Teagasc Walsh Fellowship (Grant Award No: ref 2014045) and the
   ReValueProtein Research Project (Grant Award No. 11/F/043) supported by
   the Department of Agriculture, Food and the Marine (DAFM) under the
   National Development Plan2007-2013 funded by the Irish Government to
   A.M.M. and D.Z. We thank NW Tex Net for hosting CNMR and Vornia
   Biomaterials for hosting D.Z.
CR Abate M, 2014, BIOMED RES INT, DOI 10.1155/2014/783632
   Abbah SA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt426
   Ahmadzadeh H, 2013, J BIOMECH, V46, P2497, DOI 10.1016/j.jbiomech.2013.07.008
   Akasaka T, 2006, CLIN BIOMECH, V21, P810, DOI 10.1016/j.clinbiomech.2006.04.007
   AMADIO PC, 1988, J HAND SURG-AM, V13A, P559, DOI 10.1016/S0363-5023(88)80095-9
   AMIEL D, 1989, J HAND SURG-AM, V14A, P837, DOI 10.1016/S0363-5023(89)80085-1
   ANDERSON JC, 1972, BIOCHEM J, V127, P179, DOI 10.1042/bj1270179
   Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1
   Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091
   Attia M, 2014, BRIT J SPORT MED, V48, P469, DOI 10.1136/bjsports-2013-092633
   Attia M, 2012, J ORTHOP RES, V30, P61, DOI 10.1002/jor.21479
   Baeurle SA, 2009, POLYMER, V50, P1805, DOI 10.1016/j.polymer.2009.01.066
   BALAZS EA, 1986, BIOCHEM J, V235, P903, DOI 10.1042/bj2350903
   Barbosa I, 2005, J CELL SCI, V118, P253, DOI 10.1242/jcs.01607
   Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082
   Barritault D., 2006, Annales Pharmaceutiques Francaises, V64, P135
   Baymurat AC, 2015, J BIOMED MATER RES A, V103, P84, DOI 10.1002/jbm.a.35151
   Berenson MC, 1996, J ORTHOP RES, V14, P518, DOI 10.1002/jor.1100140404
   Bhavsar D, 2010, J SURG RES, V159, P765, DOI 10.1016/j.jss.2009.10.010
   Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x
   Blanquaert F, 1995, BONE, V17, P499, DOI 10.1016/8756-3282(95)00402-5
   Bonnaffe D, 2011, CR CHIM, V14, P59, DOI 10.1016/j.crci.2010.06.002
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Buchanan CI, 2001, J APPL PHYSIOL, V90, P164
   BURD DAR, 1991, BRIT J PLAST SURG, V44, P579, DOI 10.1016/0007-1226(91)90093-Y
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   BURG MA, 1994, J NEUROBIOL, V25, P1, DOI 10.1002/neu.480250102
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277
   Chaubet F, 1999, POLYM INT, V48, P313, DOI 10.1002/(SICI)1097-0126(199904)48:4<313::AID-PI151>3.0.CO;2-H
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436
   Chen SH, 2014, INT J NANOMED, V9, P4079, DOI 10.2147/IJN.S67931
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chevalier F, 2014, STEM CELL RES, V12, P703, DOI 10.1016/j.scr.2014.03.001
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chou WY, 2010, J SHOULDER ELB SURG, V19, P557, DOI 10.1016/j.jse.2009.08.006
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Comerford EJ, 2004, AM J VET RES, V65, P1136, DOI 10.2460/ajvr.2004.65.1136
   Costantino Cosimo, 2009, Acta Biomed, V80, P225
   CRIBB AM, 1995, J ANAT, V187, P423
   CURWIN SL, 1988, J APPL PHYSIOL, V65, P2297
   D'Este M, 2012, CARBOHYD POLYM, V90, P1378, DOI 10.1016/j.carbpol.2012.07.007
   DANIELSEN CC, 1981, MECH AGEING DEV, V15, P269, DOI 10.1016/0047-6374(81)90135-4
   de Wit T, 2009, J ORTHOP RES, V27, P408, DOI 10.1002/jor.20730
   Desgranges P, 1999, FASEB J, V13, P761
   Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764
   Dvash R, 2013, J CONTROL RELEASE, V170, P295, DOI 10.1016/j.jconrel.2013.05.042
   EGG D, 1983, PHARMACOL RES COMMUN, V15, P709
   ELLIOTT DH, 1965, BIOL REV, V40, P392, DOI 10.1111/j.1469-185X.1965.tb00808.x
   Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Ericsson YB, 2009, OSTEOARTHR CARTILAGE, V17, P565, DOI 10.1016/j.joca.2008.10.009
   Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011
   Fakhari A, 2013, ACTA BIOMATER, V9, P7081, DOI 10.1016/j.actbio.2013.03.005
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Feitosa Vera Lucia Correa, 2005, Brazilian Journal of Morphological Sciences, V22, P113
   Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007
   Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002
   Foldager CB, 2012, INT ORTHOP, V36, P1507, DOI 10.1007/s00264-011-1479-0
   Franchi M, 2010, THESCIENTIFICWORLDJO, V10, P1932, DOI [10.1100/tsw.2010.192, 1100/tsw.2010.192]
   Frazier Sarah B, 2008, Open Glycosci, V1, P31, DOI 10.2174/1875398100801010031
   Frescaline G, 2013, TISSUE ENG PT A, V19, P1641, DOI [10.1089/ten.tea.2012.0377, 10.1089/ten.TEA.2012.0377]
   Frescaline G, 2012, STEM CELL RES, V8, P180, DOI 10.1016/j.scr.2011.09.005
   Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f
   Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951
   FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634
   Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Garcia-Filipe S, 2007, J BIOMED MATER RES A, V80A, P75, DOI 10.1002/jbm.a.30874
   Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023
   GILLARD GC, 1977, BIOCHEM J, V163, P145, DOI 10.1042/bj1630145
   Gudemez E, 2002, J HAND SURG-AM, V27A, P293, DOI 10.1053/jhsu.2002.31161
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Ha DI, 2006, MACROMOL RES, V14, P87, DOI 10.1007/BF03219073
   HAGBERG L, 1992, J HAND SURG-BRIT EUR, V17B, P167, DOI 10.1016/0266-7681(92)90081-C
   HAMM D, 1984, VET MED SM ANIM CLIN, V79, P811
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013
   HOOK M, 1984, ANNU REV BIOCHEM, V53, P847
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hu S, 2009, PROTEOM CLIN APPL, V3, P148, DOI 10.1002/prca.200800153
   Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Ikeda Y, 2011, BIOMATERIALS, V32, P769, DOI 10.1016/j.biomaterials.2010.09.043
   Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019
   Ishikawa M, 2014, OSTEOARTHR CARTILAGE, V22, P1902, DOI 10.1016/j.joca.2014.08.002
   Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540290114478
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JARVINEN M, 1991, EXP MOL PATHOL, V55, P230, DOI 10.1016/0014-4800(91)90003-G
   Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kang HJ, 2015, CELL TISSUE BANK, V16, P123, DOI 10.1007/s10561-014-9448-7
   Kappler J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3514639
   KATO Y, 1995, J RHEUMATOL, V22, P158
   Katrana F, 2008, J HAND SURG-EUR VOL, V33E, P800, DOI 10.1177/1753193408096021
   Katta J, 2009, OSTEOARTHR CARTILAGE, V17, P1001, DOI 10.1016/j.joca.2009.02.010
   Kershaw-Young CM, 2009, THERIOGENOLOGY, V72, P251, DOI 10.1016/j.theriogenology.2009.02.018
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kinneberg KRC, 2010, J ORTHOP RES, V28, P1092, DOI 10.1002/jor.21095
   KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303
   Kobayashi A, 1999, J COMP PATHOL, V120, P403, DOI 10.1053/jcpa.1998.0288
   Konig U, 2014, J MATER SCI-MATER M, V25, P607, DOI 10.1007/s10856-013-5098-8
   Kolodzinskyi MN, 2013, J HAND SURG-AM, V38A, P231, DOI 10.1016/j.jhsa.2012.11.012
   Kremer M, 2001, LANGENBECK ARCH SURG, V386, P357, DOI 10.1007/s004230100227
   Kumai T, 2014, J ORTHOP SCI, V19, P603, DOI 10.1007/s00776-014-0579-2
   Kumar P., 2015, TISSUE ENG C
   Kumar P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08729
   Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002
   KVIST M, 1987, PATHOLOGY, V19, P1
   Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004
   Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007
   LAM R, 1978, BIOPHYS J, V24, P613, DOI 10.1016/S0006-3495(78)85408-3
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Liang JI, 2014, J MATER SCI-MATER M, V25, P217, DOI 10.1007/s10856-013-5036-9
   Liao J, 2007, J BIOMECH, V40, P390, DOI 10.1016/j.jbiomech.2005.12.011
   LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551
   LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8
   Lippiello L, 2007, EVID-BASED COMPL ALT, V4, P219, DOI 10.1093/ecam/nel081
   Liu S, 2012, BIOMACROMOLECULES, V13, P3611, DOI 10.1021/bm301022p
   Liu YC, 2008, J ORTHOP RES, V26, P562, DOI 10.1002/jor.20499
   Loebel C, 2015, CARBOHYD POLYM, V115, P325, DOI 10.1016/j.carbpol.2014.08.097
   Lomas AJ, 2015, ADV DRUG DELIVER REV, V84, P257, DOI 10.1016/j.addr.2014.11.022
   LONGAKER MT, 1991, PLAST RECONSTR SURG, V87, P788, DOI 10.1097/00006534-199104000-00032
   LONGAKER MT, 1989, ANN SURG, V210, P667, DOI 10.1097/00000658-198911000-00016
   Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351
   Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09
   Maffulli N, 2000, AM J SPORT MED, V28, P857, DOI 10.1177/03635465000280061401
   Malcarney HL, 2003, SPORTS MED, V33, P993, DOI 10.2165/00007256-200333130-00004
   Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   Marxen S, 2004, ARQ BRAS MED VET ZOO, V56, P701, DOI 10.1590/S0102-09352004000600002
   Meddahi A, 1996, INT J BIOL MACROMOL, V18, P141, DOI 10.1016/0141-8130(95)01074-2
   Meloni F, 2008, EUR J RADIOL, V68, P170, DOI 10.1016/j.ejrad.2007.11.001
   Melrose J, 2012, HISTOCHEM CELL BIOL, V138, P461, DOI 10.1007/s00418-012-0968-6
   Menderes A, 2004, ANN PLAS SURG, V53, P560, DOI 10.1097/01.sap.0000134507.00053.1a
   MERKEL KHH, 1982, PATHOL RES PRACT, V173, P303, DOI 10.1016/S0344-0338(82)80092-7
   Merolla G, 2013, Musculoskelet Surg, V97 Suppl 1, P49, DOI 10.1007/s12306-013-0259-y
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   MEYERS SA, 1989, J ORTHOP RES, V7, P683, DOI 10.1002/jor.1100070508
   Muneta T, 2012, J ORTHOP SCI, V17, P425, DOI 10.1007/s00776-012-0225-9
   Necas J, 2008, VET MED-CZECH, V53, P397
   Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353
   Nishida J, 2004, J BONE JOINT SURG BR, V86B, P918, DOI 10.1302/0301-620x.86b6.14329
   NYSKA M, 1987, ARCH ORTHOP TRAUM SU, V106, P192, DOI 10.1007/BF00452209
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ohya S, 2005, BIOMATERIALS, V26, P655, DOI 10.1016/j.biomaterials.2004.03.002
   Olsson L, 1996, PIGM CELL RES, V9, P5, DOI 10.1111/j.1600-0749.1996.tb00081.x
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Oryan A, 2008, CONNECT TISSUE RES, V49, P351, DOI 10.1080/03008200802325169
   Ozgen M, 2012, RHEUMATOL INT, V32, P137, DOI 10.1007/s00296-010-1577-0
   Ozgenel GY, 2012, ULUS TRAVMA ACIL CER, V18, P11, DOI [10.5505/tjtes.2012.95530, 10.5505/tjtes.2011.95530]
   Ozgenel GY, 2001, J HAND SURG-AM, V26A, P332, DOI 10.1053/jhsu.2001.22524
   Papy-Garcia D, 2005, MACROMOLECULES, V38, P4647, DOI 10.1021/ma048485p
   PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Petrella Robert J, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P4, DOI 10.1186/1758-2555-2-4
   Piacquadio D, 1997, J AM ACAD DERMATOL, V36, P544, DOI 10.1016/S0190-9622(97)70241-X
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RADHAKRISHNAMUR.B, 1964, ARCH BIOCHEM BIOPHYS, V104, P19, DOI 10.1016/S0003-9861(64)80029-1
   Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7
   Redding WR, 1999, VET COMP ORTHOPAED, V12, P48
   Riccio M, 2010, J HAND SURG-EUR VOL, V35E, P130, DOI 10.1177/1753193409342044
   RICKETTS CR, 1952, BIOCHEM J, V51, P129, DOI 10.1042/bj0510129
   Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448
   RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367
   Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363
   RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369
   RYDELL N, 1970, ACTA ORTHOP SCAND, V41, P307, DOI 10.3109/17453677008991516
   Sakamoto K, 2011, TRENDS GLYCOSCI GLYC, V23, P212, DOI 10.4052/tigg.23.212
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Sames K, 2001, J HISTOCHEM CYTOCHEM, V49, P19, DOI 10.1177/002215540104900103
   Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001
   Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745
   Satyam A, 2014, J TISSUE ENG REGEN M, V8, P233, DOI 10.1002/term.1522
   Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428
   Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026
   Schnabelrauch M, 2013, CURR MED CHEM, V20, P2501, DOI 10.2174/0929867311320200001
   SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573
   Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179
   SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313
   SCOTT JE, 1984, BIOCHEM J, V218, P229, DOI 10.1042/bj2180229
   Scott JE, 2001, PATHOL BIOL, V49, P284, DOI 10.1016/S0369-8114(01)00152-3
   Screen HRC, 2005, ANN BIOMED ENG, V33, P1090, DOI 10.1007/s10439-005-5777-9
   Seelbach RJ, 2014, ACTA BIOMATER, V10, P4340, DOI 10.1016/j.actbio.2014.06.028
   Serfozo Z, 2009, BRAIN STRUCT FUNCT, V214, P67, DOI 10.1007/s00429-009-0229-1
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Shabafrooz V, 2014, J BIOMED MATER RES A, V102, P3130, DOI 10.1002/jbm.a.34984
   Shepherd JH, 2013, J BIOMED MATER RES A, V101, P176, DOI 10.1002/jbm.a.34317
   Shibita Y, 2001, J SHOULDER ELB SURG, V10, P209, DOI 10.1067/mse.2001.113501
   Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540290114450
   SMALL JO, 1989, J HAND SURG-BRIT EUR, V14B, P383, DOI 10.1016/0266-7681(89)90152-6
   Spanoudes K, 2014, TRENDS BIOTECHNOL, V32, P474, DOI 10.1016/j.tibtech.2014.06.009
   Spilker MH, 2001, BIOMATERIALS, V22, P1085, DOI 10.1016/S0142-9612(00)00345-8
   Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024
   Stamov D, 2008, BIOMATERIALS, V29, P1, DOI 10.1016/j.biomaterials.2007.09.009
   STONGE R, 1980, CLIN ORTHOP RELAT R, P269
   Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451
   Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024
   Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540290114441
   Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569
   SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318
   Taguchi M, 2009, J HAND SURG-AM, V34A, P1276, DOI 10.1016/j.jhsa.2009.04.011
   Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tanaka T, 2006, J ORTHOP RES, V24, P1555, DOI 10.1002/jor.20205
   Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935
   Tatati H, 2004, ARCH PHYS MED REHAB, V85, P1470, DOI 10.1016/j.apmr.2003.09.022
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   VAILAS AC, 1985, J APPL PHYSIOL, V58, P1572
   VAILAS AC, 1985, COMP BIOCHEM PHYS B, V82, P283, DOI 10.1016/0305-0491(85)90242-1
   Verolino P, 2008, BURNS, V34, P284, DOI 10.1016/j.burns.2006.11.016
   Villanueva I, 2010, MATRIX BIOL, V29, P51, DOI 10.1016/j.matbio.2009.08.004
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   VOGEL KG, 1988, J ORTHOPAED RES, V6, P434, DOI 10.1002/jor.1100060315
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   WEBBON PM, 1977, EQUINE VET J, V9, P61, DOI 10.1111/j.2042-3306.1977.tb03981.x
   Wennink JWH, 2011, MACROMOL SYMP, V309-310, P213, DOI 10.1002/masy.201100032
   Whitelock J, 2008, J CHEM TECHNOL BIOT, V83, P496, DOI 10.1002/jctb.1835
   Wilder RP, 2004, CLIN SPORT MED, V23, P55, DOI 10.1016/S0278-5919(03)00085-1
   Wodewotzky TI, 2012, BRAZ J MED BIOL RES, V45, P1157, DOI 10.1590/S0100-879X2012007500149
   WOO SLY, 1981, ACTA ORTHOP SCAND, V52, P615, DOI 10.3109/17453678108992156
   Wu QJ, 2014, INT J NANOMED, V9, P727, DOI 10.2147/IJN.S55497
   Wuillemin WA, 1997, J IMMUNOL, V159, P1953
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Yang C, 2004, J BIOMED MATER RES B, V68B, P15, DOI 10.1002/jbm.b.10074
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yannas IV, 1975, POLYM PREPR AM CH PC, V16, P209
   Yokota A, 2005, J SHOULDER ELB SURG, V14, p72S, DOI 10.1016/j.jse.2004.09.021
   Yokoyama M, 2002, DRUG DISCOV TODAY, V7, P426, DOI 10.1016/S1359-6446(02)02216-X
   Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22
   Yoshihara Y, 2001, J ORTHOP RES, V19, P573, DOI 10.1016/S0736-0266(00)00063-2
   Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016
   Zhao CF, 2013, J ORTHOP RES, V31, P969, DOI 10.1002/jor.22305
   Zhao CF, 2012, J ORTHOP RES, V30, P1940, DOI 10.1002/jor.22177
   Zhu CH, 2014, MAT SCI ENG C-MATER, V34, P393, DOI 10.1016/j.msec.2013.09.044
   Ziebell MR, 2001, CHEM BIOL, V8, P1081, DOI 10.1016/S1074-5521(01)00078-3
NR 255
TC 7
Z9 7
U1 1
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1237
EP 1251
DI 10.1021/acs.bioconjchem.5b00091
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500009
PM 25970130
DA 2018-10-20
ER

PT J
AU Cahill, EM
   O'Cearbhaill, ED
AF Cahill, Ellen M.
   O'Cearbhaill, Eoin D.
TI Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Review
ID POLYMER MICRONEEDLES; DISSOLVING MICRONEEDLES; PERCUTANEOUS-ABSORPTION;
   TRANSDERMAL DELIVERY; INSULIN DELIVERY; FLUID EXTRACTION; VACCINE
   DELIVERY; ELECTRODE ARRAY; SYSTEMS; FABRICATION
AB Microneedles have recently been adopted for use as a painless and safe method of transdermal therapeutic delivery through physically permeating the stratum corneum. While microneedles create pathways to introduce drugs, they can also act as conduits for biosignal sensing. Here, we explore the development of microneedles as both biosensing and drug delivery platforms. Microneedle sensors are being developed for continuous monitoring of biopotentials and bioanalytes through the use of conductive and electrochemically reactive biomaterials. The range of therapeutics being delivered through microneedle devices has diversified, while novel bioabsorbable microneedles are undergoing first-in-human clinical studies. We foresee that future microneedle platform development will focus on the incorporation of biofunctional materials, designed to deliver therapeutics in a stimulus responsive fashion. Biofunctional microneedle patches will require improved methods of attaching to and conforming to epithelial tissues in dynamic environments for longer periods of time and thus present an assortment of new design challenges. Through the evolution of biomaterial development and microneedle design, biofunctional microneedles are proposed as a next generation of stimulus responsive drug delivery systems.
C1 [Cahill, Ellen M.; O'Cearbhaill, Eoin D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.
   [Cahill, Ellen M.; O'Cearbhaill, Eoin D.] Univ Coll Dublin, UCD Ctr Biomed Engn, Dublin 4, Ireland.
   [O'Cearbhaill, Eoin D.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
RP O'Cearbhaill, ED (reprint author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.
EM eoin.ocearbhaill@ucd.ie
OI O'Cearbhaill, Eoin/0000-0002-4666-5863
FU Naughton Foundation; Marie Sklodowska-Curie Individual Fellowship
FX The authors would like to thank the Naughton Foundation (E.M.C.) and a
   Marie Sklodowska-Curie Individual Fellowship (E.D.O) for their financial
   support. Illustrations provided by Glen Oomen Medical Scientific
   Graphics.
CR ABI Research, 2012, WEAR DEV MARK SHAR F
   Aggarwal P, 2004, SENSOR ACTUAT B-CHEM, V102, P226, DOI 10.1016/j.snb.2004.04.024
   Akhtar N., 2014, INT J PHARM PHARM SC, V6, P18
   Ameri M, 2010, J PHARM SCI-US, V99, P2123, DOI 10.1002/jps.21985
   Aoyagi S, 2008, SENSOR ACTUAT A-PHYS, V143, P20, DOI 10.1016/j.sna.2007.06.007
   Bediz B., 2013, PHARM RES, V31, P117
   Binkley PF, 2003, IEEE ENG MED BIOL, V22, P23, DOI 10.1109/MEMB.2003.1213623
   Bystrova S, 2011, MICROELECTRON ENG, V88, P1681, DOI 10.1016/j.mee.2010.12.067
   Chang H. C., 2013, BIOMICROFLUIDICS, V7, P1
   Chu LY, 2011, J CONTROL RELEASE, V149, P242, DOI 10.1016/j.jconrel.2010.10.033
   Chua B, 2014, IEEE SENS J, V14, P333, DOI 10.1109/JSEN.2013.2283301
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Damiano ER, 2013, DIABETES CARE, V36, P251, DOI 10.2337/dc12-0070
   Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010
   Demir Y. K., 2013, PLOS ONE, V10, P1
   Donnelly R F., 2014, PLOS ONE, V9
   Donnelly RF, 2014, PHOTOCHEM PHOTOBIOL, V90, P641, DOI 10.1111/php.12209
   Donnelly RF, 2012, ADV FUNCT MATER, V22, P4879, DOI 10.1002/adfm.201200864
   Donnelly RF, 2010, DRUG DELIV, V17, P187, DOI 10.3109/10717541003667798
   El-Laboudi A, 2013, DIABETES TECHNOL THE, V15, P101, DOI 10.1089/dia.2012.0188
   Fernandez L. J., 2009, J MICROMECH MICROENG, V19
   Food and Drug Administration, 2013, GUID IND FDA STAFF T
   Forvi E, 2012, SENSOR ACTUAT A-PHYS, V180, P177, DOI 10.1016/j.sna.2012.04.019
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gestel M. S., 1976, U. S. patent, Patent No. [3,964,482, 3964482, US3,964,482]
   Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017
   Ginsberg B H, 1999, Diabetes Technol Ther, V1, P203, DOI 10.1089/152091599317431
   Guo L, 2013, IEEE T BIOMED CIRC S, V7, P1, DOI 10.1109/TBCAS.2012.2192932
   Guo L, 2011, I IEEE EMBS C NEUR E, P562, DOI 10.1109/NER.2011.5910610
   Hench L. L., 2010, J R SOC INTERFACE, V7, pS379
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Hong XY, 2014, NANO-MICRO LETT, V6, P191, DOI 10.5101/nml140021r
   Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401
   Hsu LS, 2014, SENSORS-BASEL, V14, P12370, DOI 10.3390/s140712370
   Huang CJ, 2007, SENSOR ACTUAT B-CHEM, V122, P461, DOI 10.1016/j.snb.2006.06.015
   Ikeno F, 2004, CATHETER CARDIO INTE, V63, P222, DOI 10.1002/ccd.20167
   Ito Y, 2007, J DRUG TARGET, V15, P323, DOI 10.1080/10611860701349794
   Ito Y, 2006, EUR J PHARM SCI, V29, P82, DOI 10.1016/j.ejps.2006.05.011
   Jiang J., 2007, INVEST OPHTH VIS SCI, V48, P4038
   Jin CY, 2009, BIOMED MICRODEVICES, V11, P1195, DOI 10.1007/s10544-009-9337-1
   Jung PG, 2008, SENSOR MATER, V20, P45
   Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005
   Kudva YC, 2014, DIABETES CARE, V37, P1184, DOI 10.2337/dc13-2066
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Lee JH, 2007, ENVIRON SCI TECHNOL, V41, P7857, DOI 10.1021/es070969o
   Lee S, 2003, FOOD CHEM, V82, P521, DOI 10.1016/S0308-8146(02)00592-7
   Li GH, 2009, INT J PHARM, V368, P109, DOI 10.1016/j.ijpharm.2008.10.008
   Martanto W., 2004, PHARM RES, V21, P947
   McCrudden MTC, 2015, DRUG DELIV TRANSL RE, V5, P3, DOI 10.1007/s13346-014-0211-1
   Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4
   Miller PR, 2012, TALANTA, V88, P739, DOI 10.1016/j.talanta.2011.11.046
   Moon SJ, 2005, MICROSYST TECHNOL, V11, P311, DOI [10.1007/s00542-004-0446-8, 10.1007/S00542-004-0446-8]
   Morales JO, 2014, DRUG DEV IND PHARM, V40, P579, DOI 10.3109/03639045.2014.892960
   Mukerjee E, 2004, SENSOR ACTUAT A-PHYS, V114, P267, DOI 10.1016/j.sna.2003.11.008
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Nordquist L, 2007, PHARM RES, V24, P1381, DOI 10.1007/s11095-007-9256-x
   Norman JJ, 2013, PEDIATR DIABETES, V14, P459, DOI 10.1111/pedi.12031
   O'Mahony C, 2012, SENSOR ACTUAT A-PHYS, V186, P130, DOI 10.1016/j.sna.2012.04.037
   Omatsu T, 2010, OPT EXPRESS, V18, P17967, DOI 10.1364/OE.18.017967
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Park JH, 2007, IEEE T BIO-MED ENG, V54, P903, DOI 10.1109/TBME.2006.889173
   Park JH, 2010, J KOREAN PHYS SOC, V56, P1223, DOI 10.3938/jkps.56.1223
   Patel SR, 2011, PHARM RES-DORDR, V28, P166, DOI 10.1007/s11095-010-0271-y
   Peng Q, 2013, ACTA BIOMATER, V9, P5063, DOI 10.1016/j.actbio.2012.09.034
   PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225
   Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18
   Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023
   Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024
   Reed ML, 1998, J PHARM SCI-US, V87, P1387, DOI 10.1021/js980085q
   Rynd F., 1845, DUBLIN MED PRESS, V13, P167
   Sakaguchi K, 2012, DIABETES TECHNOL THE, V14, P485, DOI 10.1089/dia.2011.0255
   Senapati S, 2011, TOP CURR CHEM, V304, P153, DOI 10.1007/128_2011_142
   Suh H, 2014, CLIN EXP VACCINE RES, V3, P42, DOI 10.7774/cevr.2014.3.1.42
   Traverso G, 2015, J PHARM SCI-US, V104, P362, DOI 10.1002/jps.24182
   Tuan-Mahmood TM, 2013, EUR J PHARM SCI, V50, P623, DOI 10.1016/j.ejps.2013.05.005
   Valdes-Ramirez G, 2014, ELECTROCHEM COMMUN, V47, P58, DOI 10.1016/j.elecom.2014.07.014
   Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077
   van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042
   Vrdoljak A, 2013, VACCINE DEV THERAPY, V3, P47, DOI DOI 10.2147/VDT.S34682
   Wang Ping M, 2005, Diabetes Technol Ther, V7, P131, DOI 10.1089/dia.2005.7.131
   Wilke N, 2005, SENSOR ACTUAT A-PHYS, V123-24, P319, DOI 10.1016/j.sna.2005.05.017
   Windmiller JR, 2011, ELECTROANAL, V23, P2302, DOI 10.1002/elan.201100361
   Windmiller JR, 2011, ANALYST, V136, P1846, DOI 10.1039/c1an00012h
   World Health Organization, 2015, WHO GUID US SAF ENG
   Yan K, 2010, INT J PHARMACEUT, V397, P77, DOI 10.1016/j.ijpharm.2010.06.052
   Yang SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2715
NR 86
TC 12
Z9 12
U1 2
U2 98
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1289
EP 1296
DI 10.1021/acs.bioconjchem.5b00211
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500013
PM 26020359
DA 2018-10-20
ER

PT J
AU Samorezov, JE
   Morlock, CM
   Alsberg, E
AF Samorezov, Julia E.
   Morlock, Colin M.
   Alsberg, Eben
TI Dual Ionic and Photo-Crosslinked Alginate Hydrogels for Micropatterned
   Spatial Control of Material Properties and Cell Behavior
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID HYALURONIC-ACID HYDROGELS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   INTERPENETRATING NETWORKS; SUBSTRATE FLEXIBILITY; MECHANICAL-PROPERTIES;
   PROLIFERATION; GROWTH; LINKING; FATE
AB Biomaterial properties such as mechanics, degradation rate, and cell adhesivity affect cell behaviors including spreading, proliferation, and differentiation. To engineer complex tissues, it is often desirable to achieve precise spatial control over these properties. Here, methacrylated alginate (MA-ALG) was used to create hydrogels comprising a single base material with regions of different types and levels of crosslinking and subsequently different material properties. Ionic and ultraviolet light crosslinking mechanisms were combined to create dual-crosslinked hydrogels with significantly increased stiffness and decreased swelling compared to calcium-crosslinked or UV-crosslinked hydrogels. MC3T3 cells showed significantly enhanced proliferation on the surface of dual-crosslinked hydrogels compared with calcium-crosslinked hydrogels. Photomasks were then used to create patterned hydrogels with precise spatial control over regions that were only calcium-crosslinked versus dual-crosslinked. This spatial variation in crosslinking mechanism permitted local regulation of the hydrogel physical properties and alignment of cells seeded on their surface. Photomasks were also used to create hydrogels with patterned presentation of cell adhesion ligands, leading to spatial control over cell attachment and proliferation. This biomaterial system can be useful for providing patterned, instructive cues to guide cell behavior for engineering complex tissues.
C1 [Samorezov, Julia E.; Morlock, Colin M.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Div Gen Med Sci, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Div Gen Med Sci, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Natl Ctr Regenerat Med, Div Gen Med Sci, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Div Gen Med Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU National Institutes of Health [R01AR063194, R21AR061265, R56DE022376];
   NDSEG; NSF Graduate Fellowships
FX The authors thank Michael Hill for providing the acrylated RGD and Oju
   Jeon for creating the crosslinking chemistry schematic, and gratefully
   acknowledge funding support from the National Institutes of Health
   (R01AR063194, R21AR061265, and R56DE022376; EA) and NDSEG and NSF
   Graduate Fellowships (JES).
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Alsberg E, 2006, EXPERT OPIN BIOL TH, V6, P847, DOI 10.1517/14712598.6.9.847
   Bajpai SK, 2004, REACT FUNCT POLYM, V59, P129, DOI 10.1016/j.reactfunctpolym.2004.01.002
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Cha C, 2012, BIOTECHNOL BIOENG, V109, P63, DOI 10.1002/bit.23258
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chueh BH, 2010, BIOMED MICRODEVICES, V12, P145, DOI 10.1007/s10544-009-9369-6
   CORY AH, 1991, CANCER COMMUN, V3, P207
   Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Jeon O, 2013, ADV FUNCT MATER, V23, P4765, DOI 10.1002/adfm.201300529
   Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004
   Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.tea.2012.0581, 10.1089/ten.TEA.2012.0581]
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mihaila SM, 2013, ADV HEALTHC MATER, V2, P895, DOI 10.1002/adhm.201200317
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Rouillard AD, 2010, BIOMACROMOLECULES, V11, P2184, DOI 10.1021/bm1001312
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schade R, 2010, INT J ARTIF ORGANS, V33, P219
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Shilpa A, 2003, J MACROMOL SCI-POL R, VC43, P187, DOI 10.1081/MC-120020160
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Tan HP, 2011, J TISSUE ENG REGEN M, V5, P790, DOI 10.1002/term.378
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Thorpe SD, 2008, BIOCHEM BIOPH RES CO, V377, P458, DOI 10.1016/j.bbrc.2008.09.154
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
   Zhang XZ, 2004, BIOMATERIALS, V25, P4719, DOI 10.1016/j.biomaterials.2003.11.040
   Zhao XH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3343265
NR 54
TC 9
Z9 9
U1 8
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL
PY 2015
VL 26
IS 7
BP 1339
EP 1347
DI 10.1021/acs.bioconjchem.5b00117
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CN1NK
UT WOS:000358186500018
PM 25799217
DA 2018-10-20
ER

PT J
AU Yu, H
   Yang, JL
   Sun, YX
AF Yu, Hui
   Yang, Jialing
   Sun, Yuxin
TI Energy Absorption of Spider Orb Webs During Prey Capture: A Mechanical
   Analysis
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE silk; spider webs; energy dissipation; finite element
ID NATURALLY COMPLIANT STRUCTURES; DRAGLINE SILK; PERFORMANCE; BIOMATERIAL;
   DESIGN; BIOMECHANICS; EVOLUTION; ROLES
AB When the spider orb web stops a prey, the web dissipates impact energy by three routes: internal dissipation within the radial silk, internal dissipation within the spiral silk and aerodynamic dissipation. This paper investigates the energy dissipation mechanism of spider orb webs from the mechanics point of view. Firstly, the dynamic response and energy dissipation of a single spider silk under transverse impact are studied analytically and numerically. The congruence of dynamic response curve validates the accuracy of finite element analysis. Then the whole web is modeled using the finite element method and the respective contribution of each route to total energy dissipation during the simulated prey impact is obtained, which agrees with published experimental results. Finally, the influence of initial impact kinetic energy on the fraction distribution of three routes is demonstrated based on the finite element model. The mechanical mechanism of energy dissipation of spider orb webs is discussed and the reason for the differences among the existing opinions is speculated.
C1 [Yu, Hui; Yang, Jialing; Sun, Yuxin] Beihang Univ, Inst Solid Mech, Beijing 100191, Peoples R China.
RP Sun, YX (reprint author), Beihang Univ, Inst Solid Mech, Beijing 100191, Peoples R China.
EM yxsun@buaa.edu.cn
FU National Natural Science Foundation of China [11032001]
FX The work described in this paper is fmancially supported by the National
   Natural Science Foundation of China (No. 11032001).
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Alam MS, 2005, INT J DAMAGE MECH, V14, P365, DOI [10.1177/1056789505054313, 10.1177/105678950504313]
   Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Bratzel G, 2012, BIOPOLYMERS, V97, P408, DOI 10.1002/bip.21729
   DENNY M, 1976, J EXP BIOL, V65, P483
   Elices M., 2000, STRUCTURAL BIOL MAT
   Foelix R. F, 1996, BIOL SPIDERS
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Harmer AMT, 2011, J R SOC INTERFACE, V8, P457, DOI 10.1098/rsif.2010.0454
   Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341
   Hesselberg T, 2012, J EXP BIOL, V215, P3362, DOI 10.1242/jeb.068890
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lin L, 1998, STRUCTURAL ENG, V76, P59
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013
   Tarakanova A, 2012, J R SOC INTERFACE, V9, P3240, DOI 10.1098/rsif.2012.0473
   Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309
   Vollrath F, 2010, NATURE, V466, P319, DOI 10.1038/466319a
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
   Wise D. H., 1993, SPIDERS ECOLOGICAL W
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
NR 38
TC 2
Z9 2
U1 2
U2 36
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD JUL
PY 2015
VL 12
IS 3
BP 453
EP 463
DI 10.1016/S1672-6529(14)60136-0
PG 11
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA CN2RN
UT WOS:000358269700012
DA 2018-10-20
ER

PT J
AU Yang, YW
   Wu, JY
   Liu, CT
   Liao, GC
   Cheng, KY
   Chiang, MH
   Wu, JS
AF Yang, Yi-Wei
   Wu, Jane-Yii
   Liu, Chih-Tung
   Liao, Guo-Chun
   Cheng, Kuang-Yao
   Chiang, Ming-Hung
   Wu, Jong-Shinn
TI An Optimized Two-Step Nitrogen-Based Plasma Treatment Procedure under
   Atmospheric-Pressure Condition and its Surface Amination Mechanism
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE amide; amine; atmospheric-pressure plasma; biomedical; biomaterial;
   carbamate; DBD; nitrogen-containing group; PLA
ID MESENCHYMAL STEM-CELLS; POLYMER FILMS; DEPOSITION; DISCHARGE; ADHESION;
   IMMOBILIZATION; ADSORPTION; ALLYLAMINE; COATINGS; BEHAVIOR
AB Atmospheric pressure nitrogen-based dielectric barrier discharge (DBD) jet with two-step plasma treatment procedure has been verified to be very effective in facilitating nitrogen-containing group incorporation on Polylactide (PLA) surface. It includes: 1) pretreatment plasma treatment by a nitrogen discharge with a trace amount of oxygen, and 2) ammonia plasma treatment by a nitrogen discharge with a small amount of ammonia. In this study, the optimized operation condition of two-step plasma procedure is investigated under different concentrations of added gases (0-1% oxygen; 0-10% ammonia). XPS analysis shows that approximate to 0.19 of N/C ratio can be achieved by means of the optimized two-step plasma procedures. Furthermore, a surface amination mechanism is proposed based on the observations of Optical Emission Spectra (OES), Atomic Force Microscope (AFM), and X-ray Photoelectron Spectra (XPS) analyses.
C1 [Yang, Yi-Wei; Liu, Chih-Tung; Liao, Guo-Chun; Cheng, Kuang-Yao; Chiang, Ming-Hung; Wu, Jong-Shinn] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.
   [Wu, Jane-Yii] Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Wu, JS (reprint author), Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.
EM chongsin@faculty.nctu.edu.tw
FU Ministry of Science and Technology of Taiwan [NSC-01-2221-E-009-041-MY3]
FX The authors would like to express their sincere gratitude to the
   financial support of Ministry of Science and Technology of Taiwan
   through the grant, NSC-01-2221-E-009-041-MY3.
CR Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   Cheng K. -W., 2012, THESIS NATL CHIAO TU, p[16, 1]
   Chiang MH, 2010, SURF COAT TECH, V204, P3729, DOI 10.1016/j.surfcoat.2010.04.057
   Crespin M, 2011, J MATER SCI-MATER M, V22, P671, DOI 10.1007/s10856-011-4245-3
   Dilecce G, 2010, PURE APPL CHEM, V82, P1201, DOI 10.1351/PAC-CON-09-08-19
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hiratsuka A, 1999, ELECTROANAL, V11, P1098, DOI 10.1002/(SICI)1521-4109(199911)11:15<1098::AID-ELAN1098>3.0.CO;2-N
   Hu WJ, 2009, THIN SOLID FILMS, V517, P4268, DOI 10.1016/j.tsf.2009.02.043
   Kim KS, 2010, APPL SURF SCI, V257, P398, DOI 10.1016/j.apsusc.2010.06.092
   Klages CP, 2008, PLASMA PROCESS POLYM, V5, P368, DOI 10.1002/ppap.200700142
   Lerouge S, 2007, BIOMATERIALS, V28, P1209, DOI 10.1016/j.biomaterials.2006.10.033
   Mangindaan D, 2011, SURF COAT TECH, V206, P1299, DOI 10.1016/j.surfcoat.2011.08.046
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Mortensen H, 2006, JPN J APPL PHYS 1, V45, P8506, DOI 10.1143/JJAP.45.8506
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Mwale F, 2006, TISSUE ENG, V12, P2639, DOI 10.1089/ten.2006.12.2639
   Nakamura R, 1997, ANAL CHEM, V69, P4649, DOI 10.1021/ac970571i
   Nakanishi K, 1996, ANAL CHEM, V68, P1695, DOI 10.1021/ac950756u
   Nardulli M, 2010, J BIOMED MATER RES B, V94B, P97, DOI 10.1002/jbm.b.31629
   Ogino A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF06
   Panousis E, 2006, J PHYS D APPL PHYS, V39, P2140, DOI 10.1088/0022-3727/39/10/026
   Panousis E, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205201
   Pintassilgo CD, 2005, J PHYS D APPL PHYS, V38, P417, DOI 10.1088/0022-3727/38/3/011
   PIPER LG, 1988, J CHEM PHYS, V88, P231, DOI 10.1063/1.454649
   Pointu A. -M., 2005, J PHYS APPL PHYS, P38
   Ruelle B, 2012, POLYMERS-BASEL, V4, P296, DOI 10.3390/polym4010296
   Sharma H, 2012, SENSOR ACTUAT B-CHEM, V173, P569, DOI 10.1016/j.snb.2012.07.040
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Song H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HE01
   Thomaz JC, 1999, J PHYS D APPL PHYS, V32, P3208, DOI 10.1088/0022-3727/32/24/317
   Truica-Marasescu F, 2008, PLASMA PROCESS POLYM, V5, P44, DOI 10.1002/ppap.200700077
   Volcke C, 2010, BIOSENS BIOELECTRON, V25, P1875, DOI 10.1016/j.bios.2009.12.034
   Yang LZ, 2010, SURF COAT TECH, V205, pS345, DOI 10.1016/j.surfcoat.2010.08.008
   Yang YW, 2014, J BIOMED MATER RES A, V102, P160, DOI 10.1002/jbm.a.34681
NR 38
TC 3
Z9 3
U1 2
U2 28
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUL
PY 2015
VL 12
IS 7
BP 678
EP 690
DI 10.1002/ppap.201400095
PG 13
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA CN2ML
UT WOS:000358255500006
DA 2018-10-20
ER

PT J
AU Hsu, CW
   Poche, RA
   Saik, JE
   Ali, S
   Wang, S
   Yosef, N
   Calderon, GA
   Scott, L
   Vadakkan, TJ
   Larina, IV
   West, JL
   Dickinson, ME
AF Hsu, Chih-Wei
   Poche, Ross A.
   Saik, Jennifer E.
   Ali, Saniya
   Wang, Shang
   Yosef, Nejla
   Calderon, Gisele A.
   Scott, Larry, Jr.
   Vadakkan, Tegy J.
   Larina, Irina V.
   West, Jennifer L.
   Dickinson, Mary E.
TI Improved Angiogenesis in Response to Localized Delivery of
   Macrophage-Recruiting Molecules
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; OPTICAL COHERENCE TOMOGRAPHY;
   COLONY-STIMULATING FACTOR; THERAPEUTIC ANGIOGENESIS;
   MYOCARDIAL-ISCHEMIA; CARDIAC-FUNCTION; PROTEIN THERAPY; MYELOID CELLS;
   PDGFR-BETA; VEGF-A
AB Successful engineering of complex organs requires improved methods to promote rapid and stable vascularization of artificial tissue scaffolds. Toward this goal, tissue engineering strategies utilize the release of pro-angiogenic growth factors, alone or in combination, from biomaterials to induce angiogenesis. In this study we have used intravital microscopy to define key, dynamic cellular changes induced by the release of pro-angiogenic factors from polyethylene glycol diacrylate hydrogels transplanted in vivo. Our data show robust macrophage recruitment when the potent and synergistic angiogenic factors, PDGFBB and FGF2 were used as compared with VEGF alone and intravital imaging suggested roles for macrophages in endothelial tip cell migration and anastomosis, as well as pericyte-like behavior. Further data from in vivo experiments show that delivery of CSF1 with VEGF can dramatically improve the poor angiogenic response seen with VEGF alone. These studies show that incorporating macrophage-recruiting factors into the design of pro-angiogenic biomaterial scaffolds is a key strategy likely to be necessary for stable vascularization and survival of implanted artificial tissues.
C1 [Hsu, Chih-Wei; Poche, Ross A.; Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.
   [Hsu, Chih-Wei; Poche, Ross A.; Wang, Shang; Yosef, Nejla; Calderon, Gisele A.; Scott, Larry, Jr.; Vadakkan, Tegy J.; Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.
   [Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA.
   [Saik, Jennifer E.; Ali, Saniya; West, Jennifer L.; Dickinson, Mary E.] Rice Univ, Dept Bioengn, Houston, TX USA.
   [Ali, Saniya; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC USA.
RP Dickinson, ME (reprint author), Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.
EM mdickins@bcm.edu
FU National Institute of Health [R01HL097520-01A1, R21EY020632,
   F32EY019436, R01HL120140]; Cancer Prevention Research Institute of Texas
   [RP120713-P3]; American Heart Association Predoctoral Fellowship
   [12PRE12030410]
FX This work was supported by: 1. National Institute of Health
   (http://www.nih.gov) R01HL097520-01A1 (MED, JLW); 2. National Institute
   of Health (http://www.nih.gov) R21EY020632 (MED); 3. Cancer Prevention
   Research Institute of Texas (http://www.cprit.state.tx.us) RP120713-P3
   (MED); 4. American Heart Association Predoctoral Fellowship
   (http://www.heart.org) 12PRE12030410 (CWH); 5. National Institute of
   Health (http://www.nih.gov) F32EY019436 (RAP); 6. National Institute of
   Health (http://www.nih.gov) R01HL120140 (IVL). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241
   Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Andres G, 2009, J CELL MOL MED, V13, P2083, DOI 10.1111/j.1582-4934.2008.00415.x
   Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255
   Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chu HH, 2012, THER DELIV, V3, P693, DOI 10.4155/TDE.12.50
   des Rieux A, 2011, J CONTROL RELEASE, V150, P272, DOI 10.1016/j.jconrel.2010.11.028
   Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3
   DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   FLEMING TJ, 1993, J IMMUNOL, V151, P2399
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x
   Hedman M, 2003, CIRCULATION, V107, P2677, DOI 10.1161/01.CIR.0000070540.80780.92
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721
   Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593
   Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483
   Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI [10.1016/S0076-6879(08)021105-3, 10.1016/S0076-6879(08)02005-3]
   LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I
   Larina IV, 2009, ANAT REC, V292, P333, DOI 10.1002/ar.20821
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928
   Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104
   Mahmud MS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050901
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530
   Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Moldovan NI, 2000, CIRC RES, V87, P378
   Molin D, 2007, CURR OPIN PHARMACOL, V7, P158, DOI 10.1016/j.coph.2006.10.006
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016
   Poche R. A., 2010, COLD SPRING HARB PRO
   Poche RA, 2015, DEV BIOL
   Poche RA, 2009, DEV DYNAM, V238, P2318, DOI 10.1002/dvdy.21886
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-1569
   SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519
   Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085
   Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107
   Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445
   Sudheendran N, 2011, LASER PHYS LETT, V8, P247, DOI 10.1002/lapl.201010120
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
   Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609
   Wang S, 2014, BIOMED OPT EXPRESS, V5, P1980, DOI 10.1364/BOE.5.001980
   Wang Y, 2011, NEUROINFORMATICS, V9, P193, DOI 10.1007/s12021-011-9110-5
   Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jeb.21116
   Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860
   Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479
NR 77
TC 17
Z9 17
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2015
VL 10
IS 7
AR e0131643
DI 10.1371/journal.pone.0131643
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1CG
UT WOS:000358153000132
PM 26132702
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tsou, CH
   Lee, HT
   De Guzman, M
   Tsai, HA
   Wang, PN
   Cheng, HJ
   Suen, MC
AF Tsou, Chi-Hui
   Lee, Hsun-Tsing
   De Guzman, Manuel
   Tsai, Hui-An
   Wang, Pin-Ning
   Cheng, Hsiang-Jung
   Suen, Maw-Cherng
TI Synthesis of biodegradable polycaprolactone/polyurethane by curing with
   H2O
SO POLYMER BULLETIN
LA English
DT Article
DE Biodegradable; Polycaprolactone diol; Hydrolytic degradation;
   Polyurethane
ID TYROSINE-BASED POLYURETHANES; BIOMATERIAL APPLICATIONS; ELASTOMERS;
   CURE; COMPOSITES; BEHAVIOR
AB To prepare a pre-polymer in this study, the following materials were used: 4,4'-diphenylmethane diisocyanate, poly(e-caprolactone) diol (PCL), and polytetramethylene ether glycol. The pre-polymer was then cured using H2O to form a new type of polyurethane (PU), PCL/H2O-PU. Fourier transform infrared analysis confirmed the successful synthesis of PCL/H2O-PU. Results from thermal gravimetric analysis, differential scanning calorimetry, and dynamic mechanical analysis showed that the thermal resistance and glass transition temperature of PCL/H2O-PU increased with the H2O and the hard segment content. Stress-strain curves for the PCL/H2O-PU specimens showed that with increasing H2O content, the tensile strength and Young's modulus increased, but the elongation at break decreased. WAXD patterns indicated that with a higher H2O content, the polymer chains were in a more ordered arrangement, although the morphology was still amorphous. The degree of swelling in an aqueous ethanol solution and the hydrolytic degradation rate increased with the PCL content. Scanning electron microscopic images showed that during the degradation period, the original wrinkled surface of PCL/H2O-PU became smooth, and then cracks were formed. The cracks became more severe when the degradation was at a higher temperature.
C1 [Tsou, Chi-Hui] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan.
   [Tsou, Chi-Hui; De Guzman, Manuel] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Dept Chem Engn, Taoyuan 32023, Taiwan.
   [Lee, Hsun-Tsing] Vanung Univ, Nanomat Applicat R&D Ctr, Taoyuan 32091, Taiwan.
   [Tsai, Hui-An; Wang, Pin-Ning; Suen, Maw-Cherng] Taoyuan Innovat Inst Technol, Dept Creat Fash Design, Taoyuan 32091, Taiwan.
   [Cheng, Hsiang-Jung] Taoyuan Innovat Inst Technol, Grad Sch Mat Appl Technol, Taoyuan 32091, Taiwan.
RP Suen, MC (reprint author), Taoyuan Innovat Inst Technol, Dept Creat Fash Design, Taoyuan 32091, Taiwan.
EM sun@tiit.edu.tw
FU Everlight Chemical Industrial Corporation; Far Eastern New Century
   Corporation; Apex Nanotek Corporation; Grabio Greentech Corporation;
   Ching-Yung Trading Co. Ltd.; Fabric King Textile Co. Ltd.; Ministry of
   Economic Affairs [100-EC-17-A-10-S1-186]; National Science Council [NSC
   102-2221-E-161-011, NSC 100-3113-E-033-001, NSC 102-2221-E-003-065]
FX The authors express their appreciation to Everlight Chemical Industrial
   Corporation, Far Eastern New Century Corporation, Apex Nanotek
   Corporation, Grabio Greentech Corporation, Ching-Yung Trading Co. Ltd.,
   Fabric King Textile Co. Ltd., the Ministry of Economic Affairs
   (100-EC-17-A-10-S1-186), and the National Science Council (NSC
   102-2221-E-161-011, NSC 100-3113-E-033-001, and NSC 102-2221-E-003-065)
   for supporting this work.
CR Chattopadhyay DK, 2006, POLYMER, V47, P3814, DOI 10.1016/j.polymer.2006.03.092
   Chattopadhyay DK, 2005, PROG ORG COAT, V54, P296, DOI 10.1016/j.porgcoat.2005.07.004
   Datta J, 2008, J THERM ANAL CALORIM, V93, P753, DOI 10.1007/s10973-008-9140-x
   Datta J, 2007, PRZEM CHEM, V86, P624
   Datta J, 2010, J ELASTOM PLAST, V42, P117, DOI 10.1177/0095244309354368
   Datta J, 2008, POLIMERY-W, V53, P871
   GARDNER G, 1996, J PROT COAT LININGS, V13, P81
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Hatakeyama T, 2002, POLYMER, V43, P1177, DOI 10.1016/S0032-3861(01)00714-5
   Heijkants GJC, 2005, BIOMATERIALS, V26, P4219
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee HT, 2014, POLYM BULL, V71, P2749, DOI 10.1007/s00289-014-1222-2
   Lee SI, 2001, POLYM DEGRAD STABIL, V72, P1
   Modesti M, 2002, POLYM DEGRAD STABIL, V78, P341, DOI 10.1016/S0141-3910(02)00184-2
   Moore T, 2005, BIOMATERIALS, V26, P3771, DOI 10.1016/j.biomaterials.2004.10.002
   Ni H, 2000, PROG ORG COAT, V40, P175, DOI 10.1016/S0300-9440(00)00116-8
   Ren DK, 2012, INT J ADHES ADHES, V34, P55, DOI 10.1016/j.ijadhadh.2011.12.009
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Shah PN, 2009, POLYMER, V50, P2281, DOI 10.1016/j.polymer.2009.02.048
   Shah PN, 2012, J BIO APPL, P1
   Tsou CH, 2014, MATER RES INNOV, V18, P372, DOI 10.1179/1432891714Z.000000000435
   Tsou CH, 2014, MATER SCI-MEDZG, V20, P446
   Tsou CH, 2014, MATERIALS, V7, P5617, DOI 10.3390/ma7085617
   Tsou CH, 2013, POLYM DEGRAD STABIL, V98, P643, DOI 10.1016/j.polymdegradstab.2012.11.010
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   Yeganeh H, 2007, POLYM INT, V56, P41, DOI 10.1002/pi.2107
   Yukihiro N, 2007, J POLYM SCI A, V45, P2689
NR 29
TC 8
Z9 8
U1 3
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JUL
PY 2015
VL 72
IS 7
BP 1545
EP 1561
DI 10.1007/s00289-015-1356-x
PG 17
WC Polymer Science
SC Polymer Science
GA CN4PZ
UT WOS:000358413700001
DA 2018-10-20
ER

PT J
AU Wang, M
   Abbah, SA
   Hu, T
   Lam, RWM
   Toh, SY
   Liu, T
   Cool, SM
   Bhakoo, K
   Li, J
   Goh, JCH
   Wong, HK
AF Wang, Ming
   Abbah, Sunny Akogwu
   Hu, Tao
   Lam, Raymond Wing Moon
   Toh, Soo Yein
   Liu, Tong
   Cool, Simon M.
   Bhakoo, Kishore
   Li, Jun
   Goh, James Cho Hong
   Wong, Hee-Kit
TI Polyelectrolyte Complex Carrier Enhances Therapeutic Efficiency and
   Safety Profile of Bone Morphogenetic Protein-2 in Porcine Lumbar
   Interbody Fusion Model
SO SPINE
LA English
DT Article
DE BMP-2; interbody fusion; heterotopic ossification; polyelectrolyte
   complexes; alginate microbeads; heparin; porcine model; biomaterial
ID SPINAL RECONSTRUCTIVE SURGERY; HEPARIN-CONJUGATED FIBRIN;
   LARGE-ANIMAL-MODEL; IN-VIVO; HETEROTOPIC OSSIFICATION; RETROGRADE
   EJACULATION; POSTEROLATERAL FUSION; INCORPORATING HEPARIN; CANCELLOUS
   BONE; STROMAL CELLS
AB Study Design. Porcine lumbar interbody fusion model.
   Objective. This study evaluates the effect of polyelectrolyte complex (PEC) carrier in enhancing the therapeutic efficiency and safety profile of bone morphogenetic protein-2 (BMP-2) in a large animal model.
   Summary of Background Data. Extremely large amounts of BMP-2 are administered to achieve consistent spinal fusion, which has led to complications. Heparin-modified PEC carrying reduced BMP-2 doses of 0.5 g was demonstrated to achieve consistent spinal fusion with reduction of complications in rodent model. The purpose of this study was to evaluate whether PEC could improve the therapeutic efficiency of BMP-2 in porcine model.
   Methods. Three-segment (L3-L6) anterior lumbar interbody fusions with instrumentation were performed on 6 pigs using 3 different doses of BMP-2, namely, (1) 50 g, (2) 150 g, and (3) 300 g. The BMP-2 was delivered using heparin-modified alginate microbeads loaded into biodegradable cage. Fusion performance was evaluated after 3 months.
   Results. Manual palpation and micro-computed tomography showed consistent fusion in all experimental groups. Heterotopic bone formation beyond the cage implant area was more evident in group 2 and group 3 than in group 1. Similarly, superior bone microstructure was observed in the new bone with the lowered BMP-2 dose. Biomechanical evaluation revealed enhanced stiffness of the operated segments compared with nonoperated segments (P < 0.05). Mechanical stability was maintained despite dose reduction of BMP-2. Although the mineral apposition rate was higher in group 3, unsatisfactory bony microstructure with decreased trabecular number was observed in group 3 compared with group 1.
   Conclusion. PEC carrying low doses of BMP-2 achieved consistent interbody fusion. We observed dose-related reduction in heterotopic ossification without compromising the stability of the fused segments. PEC carrier reduces the efficacious doses of BMP-2. This could enhance the safety profile of BMP-2 and reduce dose- and carrier-related complications. Level of Evidence: N/A
C1 [Wang, Ming; Abbah, Sunny Akogwu; Hu, Tao; Lam, Raymond Wing Moon; Toh, Soo Yein; Cool, Simon M.; Goh, James Cho Hong; Wong, Hee-Kit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117595, Singapore.
   [Liu, Tong] ASTAR, Singapore Inst Mfg Technol, Singapore, Singapore.
   [Cool, Simon M.] ASTAR, Inst Med Biol, Singapore, Singapore.
   [Bhakoo, Kishore] ASTAR, Singapore Bioimaging Consortium, Singapore, Singapore.
   [Li, Jun] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Li, Jun; Goh, James Cho Hong] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore 117548, Singapore.
RP Wong, HK (reprint author), Univ Orthopaed Hand & Reconstruct Microsurg Clust, Level 11,NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore.
EM heekit_wong@nuhs.edu.sg
RI Li, Jun/B-5308-2008
OI Li, Jun/0000-0003-2982-7960; Abbah, Sunny/0000-0001-6053-6673
FU A*STAR BMRC [09/1/21/19/601]
FX A*STAR BMRC grant 09/1/21/19/601 funds were received to support this
   work.
CR Abbah SA, 2011, TISSUE ENG PT A, V17, P809, DOI [10.1089/ten.tea.2010.0255, 10.1089/ten.TEA.2010.0255]
   Abbah SA, 2011, SPINE, V36, P1752, DOI 10.1097/BRS.0b013e31822576a4
   Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Abbah SA, 2013, TISSUE ENG PT A, V19, P350, DOI [10.1089/ten.TEA.2012.0274, 10.1089/ten.tea.2012.0274]
   Abbah SA, 2014, TISSUE ENG PT A, V20, P1679, DOI [10.1089/ten.tea.2013.0593, 10.1089/ten.TEA.2013.0593]
   Abbah SA, 2012, J CONTROL RELEASE, V162, P364, DOI 10.1016/j.jconrel.2012.07.027
   Anderson CL, 2012, SPINE, V37, pE502, DOI 10.1097/BRS.0b013e318238870b
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   Bitton R, 2014, SMALL, V10, P500, DOI 10.1002/smll.201300254
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   Brower RS, 2008, SPINE, V33, pE653, DOI 10.1097/BRS.0b013e31817c4f1c
   Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Carragee EJ, 2011, SPINE J, V11, P511, DOI 10.1016/j.spinee.2011.02.013
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carragee EJ, 2009, SPINE J, V9, P873, DOI 10.1016/j.spinee.2009.09.001
   Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876
   Deyo RA, 2012, SPINE, V37, P222, DOI 10.1097/BRS.0b013e31821bfa3a
   Dougherty R, 2007, MICROSC MICROANAL S2, V13, P1678, DOI DOI 10.1017/S1431927607074430
   Fluhr H, 2011, MOL HUM REPROD, V17, P354, DOI 10.1093/molehr/gar001
   Foldager C, 2009, BONE, V45, P267, DOI 10.1016/j.bone.2009.04.240
   Foldager C, 2008, SPINE, V33, P2683, DOI 10.1097/BRS.0b013e31817fce91
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Haid Jr RW, 2004, SPINE J, V4, P38
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Helgeson MD, 2011, SPINE J, V11, P507, DOI 10.1016/j.spinee.2011.01.017
   Joseph V, 2007, SPINE, V32, P2885, DOI 10.1097/BRS.0b013e31815b7596
   King Gaston N., 2001, Current Pharmaceutical Biotechnology, V2, P131, DOI 10.2174/1389201013378716
   Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078551
   Knox JB, 2011, SPINE, V36, P672, DOI 10.1097/BRS.0b013e3181e030e0
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Koo KH, 2012, ARTIF ORGANS, V36, P629, DOI 10.1111/j.1525-1594.2012.01444.x
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   Li HS, 2004, EUR SPINE J, V13, P354, DOI 10.1007/s00586-003-0647-3
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730
   Mok JM, 2008, SPINE, V33, P1668, DOI 10.1097/BRS.0b013e31817b6229
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Pollari S, 2012, MOL CANCER RES, V10, P597, DOI 10.1158/1541-7786.MCR-11-0482
   Reid JJ, 2011, J BIOMECH, V44, P213, DOI 10.1016/j.jbiomech.2010.10.021
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9
   Shen HX, 2010, SPINE, V35, P747, DOI 10.1097/BRS.0b013e3181bc3420
   Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Singh K, 2006, J SPINAL DISORD TECH, V19, P416, DOI 10.1097/00024720-200608000-00008
   Singh K, 2013, SPINE J, V13, P1118, DOI 10.1016/j.spinee.2013.07.028
   Smoljanovic T, 2008, SPINE, V33, P224, DOI 10.1097/BRS.0b013e31816068e2
   Smoljanovic T, 2010, SPINE, V35, pE622, DOI 10.1097/BRS.0b013e3181e15edf
   Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060
   Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534
   Wang M, 2013, SPINE, V38, P1452, DOI 10.1097/BRS.0b013e31828a3504
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
NR 61
TC 6
Z9 6
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD JUL 1
PY 2015
VL 40
IS 13
BP 964
EP 973
DI 10.1097/BRS.0000000000000935
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA CM8JJ
UT WOS:000357946000002
PM 25893351
DA 2018-10-20
ER

PT J
AU Hulsart-Billstrom, G
   Bergman, K
   Andersson, B
   Hilborn, J
   Larsson, S
   Jonsson, KB
AF Hulsart-Billstrom, Gry
   Bergman, Kristoffer
   Andersson, Brittmarie
   Hilborn, Jons
   Larsson, Sune
   Jonsson, Kenneth B.
TI A uni-cortical femoral defect model in the rat: evaluation using
   injectable hyaluronan hydrogel as a carrier for bone morphogenetic
   protein-2
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE large femoral bone defect; rat model; hydrogel; in vivo; osteogenesis;
   bone regeneration; 3R
ID CELL-SURFACE RECEPTOR; COLLAGEN SPONGES; BOVINE COLLAGEN; CLINICAL USE;
   IN-VIVO; ACID; REGENERATION; POLYSACCHARIDE; DELIVERY; REPAIR
AB The development of biomaterial for bone regeneration requires animal models that are reliable and designed to mimic clinically relevant situations. We have previously investigated hydrogels comprised of modified hyaluronic acid and polyvinyl alcohol in models of ectopic bone formation. This hydrogel induces bone regeneration when loaded with bone morphogenetic proteins (BMPs). To allow further optimization of hydrogels, we developed a new, femoral, non-critical-sized cortical defect model. In the rat femur, we drilled standardized, elongated unilateral cortical defects that did not require stabilization and that could be created bilaterally to allow paired comparisons of biomaterials. After optimizing the defect size, subsequent stress fractures occurred in only 8% and the defect healed partially over the 40 day study period. In a time-course experiment, we treated bone defects with the previously studied hyaluronan hydrogel loaded with 10 mu g hydroxyapatite and 6 mu g BMP-2. The shape of the defect allowed controlled containment of the material within the defect. The defect in the right leg was left untreated, while the left defect was filled with 40 mu l of the BMP hydrogel. As determined by pQCT analysis, the treated defects had a higher bone mineral content, bone area and bone density than control defects. The relative difference was greatest between the groups at 10 and 20 days and diminished as the defect healed in the untreated legs. We conclude that this animal model allows facile and rapid screening of biomaterials for bone regeneration in cortical femoral defects without requiring external fixation. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Hulsart-Billstrom, Gry; Andersson, Brittmarie; Larsson, Sune; Jonsson, Kenneth B.] Uppsala Univ, Dept Surg Sci, Unit Orthopaed, SE-75185 Uppsala, Sweden.
   [Bergman, Kristoffer; Hilborn, Jons] Uppsala Univ, Angstrom Lab, Dept Mat Chem, SE-75185 Uppsala, Sweden.
RP Jonsson, KB (reprint author), Uppsala Univ, Dept Surg Sci, Unit Orthopaed, SE-75185 Uppsala, Sweden.
EM kenneth.jonsson@surgsci.uu.se
OI Hilborn, Jons/0000-0001-6947-9601
FU Biodesign
FX Biodesign is gratefully acknowledged for financial support.
CR An YH, 2003, HDB HIST METHODS BON
   Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x
   Arosarena OA, 2005, OTOLARYNG HEAD NECK, V132, P592, DOI 10.1016/j.otohns.2004.09.137
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   BAY BK, 1993, BONE, V14, P225, DOI 10.1016/8756-3282(93)90145-Z
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303
   Dimitriou R, 2011, INJURY, V42, pS3, DOI 10.1016/j.injury.2011.06.015
   Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Hilborn J., 2011, WILEY INTERDISCIP RE, V11, P471
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   LAURENT TC, 1992, FASEB J, V6, P2397
   Leibold RA, 2002, AM J ROENTGENOL, V179, P198, DOI 10.2214/ajr.179.1.1790198
   Manes S, 2000, IUBMB LIFE, V49, P89
   MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   MELCHER AH, 1962, J BONE JOINT SURG BR, V44, P928
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Ossipov DA, 2007, J APPL POLYM SCI, V106, P60, DOI 10.1002/app.26455
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   RAY RD, 1957, J BONE JOINT SURG AM, V39, P1119, DOI 10.2106/00004623-195739050-00012
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TRAUTINGER F, 1991, ARCH DERMATOL RES, V283, P395, DOI 10.1007/BF00371822
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Wang YL, 2011, ARCH ORTHOP TRAUM SU, V131, P991, DOI 10.1007/s00402-011-1269-6
   Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   ZHENG SX, 2004, BIOMATERIALS, V25, P1339, DOI DOI 10.1016/J.BIOMATERIALS.2003.08.014
NR 42
TC 6
Z9 7
U1 2
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUL
PY 2015
VL 9
IS 7
BP 799
EP 807
DI 10.1002/term.1655
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CM7NV
UT WOS:000357881900006
PM 23225778
DA 2018-10-20
ER

PT J
AU Secker, C
   Brosnan, SM
   Luxenhofer, R
   Schlaad, H
AF Secker, Christian
   Brosnan, Sarah M.
   Luxenhofer, Robert
   Schlaad, Helmut
TI Poly(alpha-Peptoid)s Revisited: Synthesis, Properties, and Use as
   Biomaterial
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE amino acid N-carboxyanhydride (NCA); biomaterials; peptides; properties;
   ring-opening polymerization
ID ALPHA-AMINO-ACIDS; RING-OPENING POLYMERIZATION; PHOSGENE-FREE SYNTHESIS;
   MEDIATED ZWITTERIONIC POLYMERIZATION; ACTIVATED URETHANE DERIVATIVES;
   SEQUENCE-SPECIFIC POLYPEPTOIDS; GLYCINE N-CARBOXYANHYDRIDES;
   POLY-BETA-PEPTOIDS; INITIATED POLYMERIZATION; DIBLOCK COPOLYPEPTOIDS
AB Polypeptoids have been of great interest in the polymer science community since the early half of the last century; however, they had been basically forgotten materials until the last decades in which they have enjoyed an exciting revival. In this mini-review, we focus on the recent developments in polypeptoid chemistry, with particular focus on polymers synthesized by the ring-opening polymerization (ROP) of amino acid N-carboxyanhydrides (NCAs). Specifically, we will review traditional monomer synthesis (such as Leuchs, Katchalski, and Kricheldorf) and recent advances in polymerization methods to yield both linear, cyclic, and functional polymers, solution and bulk thermal properties, and preliminary results on the use of polypeptoids as biomaterials (i.e immunogenicity, biodistribution, degradability, and drug delivery).
C1 [Secker, Christian; Brosnan, Sarah M.] Max Planck Inst Colloids & Interfaces, Dept Colloid Chem, D-14424 Potsdam, Germany.
   [Luxenhofer, Robert] Univ Wurzburg, Chair Chem Technol Mat Synth, Dept Chem & Pharm, D-97070 Wurzburg, Germany.
   [Schlaad, Helmut] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
RP Schlaad, H (reprint author), Univ Potsdam, Inst Chem, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany.
EM schlaad@uni-potsdam.de
RI Luxenhofer, Robert/C-2825-2008
OI Luxenhofer, Robert/0000-0001-5567-7404; Brosnan, Sarah
   M./0000-0002-0881-889X
FU Max Planck Society; National Science Foundation Postdoctoral Research
   Fellowship in Biology [DBI-1308104]
FX Financial support was given by the Max Planck Society and National
   Science Foundation Postdoctoral Research Fellowship in Biology under
   grant no. DBI-1308104.
CR Aseyev V, 2011, ADV POLYM SCI, V242, P29, DOI 10.1007/12_2010_57
   BALLARD DGH, 1958, J CHEM SOC, P355, DOI 10.1039/jr9580000355
   Bamford C. H., 1976, COMPREHENSIVE CHEM K, V15, P583
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Becer CR, 2009, ANGEW CHEM INT EDIT, V48, P4900, DOI 10.1002/anie.200900755
   Birke A, 2014, BIOMACROMOLECULES, V15, P548, DOI 10.1021/bm401542z
   Brosnan SM, 2014, POLYMER, V55, P5511, DOI 10.1016/j.polymer.2014.08.067
   Chen XP, 2011, J POLYM SCI POL CHEM, V49, P3030, DOI 10.1002/pola.24739
   Chen XP, 2010, MACROMOLECULES, V43, P1341, DOI 10.1021/ma902427m
   Connor EF, 2002, J AM CHEM SOC, V124, P914, DOI 10.1021/ja0173324
   Darensbourg DJ, 2004, J AM CHEM SOC, V126, P13808, DOI 10.1021/ja046225h
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Diehl C, 2010, SOFT MATTER, V6, P3784, DOI 10.1039/c0sm00114g
   Dimitrov I, 2007, PROG POLYM SCI, V32, P1275, DOI 10.1016/j.progpolymsci.2007.07.001
   DOUY A, 1986, MAKROMOL CHEM, V187, P465
   EHLER KW, 1976, BIOCHIM BIOPHYS ACTA, V434, P233, DOI 10.1016/0005-2795(76)90055-6
   Fetsch C, 2015, MACROMOL CHEM PHYS, V216, P547, DOI 10.1002/macp.201400534
   Fetsch C, 2013, POLYMERS-BASEL, V5, P112, DOI 10.3390/polym5010112
   Fetsch C, 2012, MACROMOL RAPID COMM, V33, P1708, DOI 10.1002/marc.201200189
   Fetsch C, 2011, MACROMOLECULES, V44, P6746, DOI 10.1021/ma201015y
   Fuchs F., 1922, CHEM BER, V55, P2943
   Fujita Y, 2007, J POLYM SCI POL CHEM, V45, P5365, DOI 10.1002/pola.22281
   Gangloff N, 2013, MACROMOL RAPID COMM, V34, P997, DOI 10.1002/marc.201300269
   Grossmann A., 2014, THESIS TU DRESDEN
   Grossmann A, 2012, MACROMOL RAPID COMM, V33, P1714, DOI 10.1002/marc.201200263
   Guo L, 2012, J AM CHEM SOC, V134, P9163, DOI 10.1021/ja210842b
   Guo L, 2011, BIOPOLYMERS, V96, P596, DOI 10.1002/bip.21597
   Guo L, 2009, J AM CHEM SOC, V131, P18072, DOI 10.1021/ja907380d
   Hadjichristidis N, 2009, CHEM REV, V109, P5528, DOI 10.1021/cr900049t
   Hara E, 2014, J PEPT SCI, V20, P570, DOI 10.1002/psc.2655
   Hara E, 2012, INT IMMUNOPHARMACOL, V14, P261, DOI 10.1016/j.intimp.2012.07.011
   Heller P, 2015, MACROMOL BIOSCI, V15, P63, DOI 10.1002/mabi.201400417
   Heller P, 2015, MACROMOL RAPID COMM, V36, P38, DOI 10.1002/marc.201400466
   Heller P, 2014, MACROMOL BIOSCI, V14, P1380, DOI 10.1002/mabi.201400167
   HENDERSON DC, 1987, INT ARCH ALLER A IMM, V82, P208, DOI 10.1159/000234188
   Ishida T, 2008, INT J PHARM, V354, P56, DOI 10.1016/j.ijpharm.2007.11.005
   Jia L, 2002, J AM CHEM SOC, V124, P7282, DOI 10.1021/ja0263691
   Kamei Y, 2008, MACROMOLECULES, V41, P7913, DOI 10.1021/ma801315r
   Kamei Y, 2008, J POLYM SCI POL CHEM, V46, P2525, DOI 10.1002/pola.22584
   KATCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243, DOI 10.1016/S0065-3233(08)60600-2
   Kidchob T, 1996, J CONTROL RELEASE, V40, P285, DOI 10.1016/0168-3659(95)00196-4
   Kidchob T, 1998, J CONTROL RELEASE, V51, P241, DOI 10.1016/S0168-3659(97)00176-4
   Kidchob T, 1998, J CONTROL RELEASE, V50, P205, DOI 10.1016/S0168-3659(97)00135-1
   Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303
   Koga K, 2010, J POLYM SCI POL CHEM, V48, P4351, DOI 10.1002/pola.24213
   Koga K, 2009, J POLYM SCI POL CHEM, V47, P3839, DOI 10.1002/pola.23450
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   KRICHELDORF HR, 1976, MAKROMOL CHEM, V177, P1243
   Lahasky SH, 2014, POLYM CHEM-UK, V5, P1418, DOI 10.1039/c3py01356a
   Lahasky SH, 2011, MACROMOLECULES, V44, P9063, DOI 10.1021/ma201948u
   Lau KHA, 2012, LANGMUIR, V28, P2288, DOI 10.1021/la203905g
   Lau KHA, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201400225
   Lau KHA, 2012, LANGMUIR, V28, P16099, DOI 10.1021/la302131n
   Laufer B, 2009, J PEPT SCI, V15, P141, DOI 10.1002/psc.1076
   Lee CU, 2013, MACROMOLECULES, V46, P8213, DOI 10.1021/ma401067f
   Lee CU, 2013, ACS MACRO LETT, V2, P436, DOI 10.1021/mz300667n
   Lee CU, 2011, MACROMOLECULES, V44, P9574, DOI 10.1021/ma2020936
   Leuchs H, 1906, BER DTSCH CHEM GES, V39, P857, DOI 10.1002/cber.190603901133
   LEVY AL, 1950, NATURE, V165, P152, DOI 10.1038/165152a0
   Luxenhofer R, 2013, J POLYM SCI POL CHEM, V51, P2731, DOI 10.1002/pola.26687
   Luxenhofer R, 2012, MACROMOL RAPID COMM, V33, P1613, DOI 10.1002/marc.201200354
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   Makino A, 2009, BIOMATERIALS, V30, P5156, DOI 10.1016/j.biomaterials.2009.05.046
   MOBASHERY S, 1985, J ORG CHEM, V50, P2200, DOI 10.1021/jo00212a042
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Patch J.A., 2004, PSEUDOPEPTIDES DRUG, P1
   Robinson JW, 2013, MACROMOLECULES, V46, P580, DOI 10.1021/ma302412v
   Robinson JW, 2012, CHEM COMMUN, V48, P7835, DOI 10.1039/c2cc33881e
   Rosales AM, 2010, MACROMOLECULES, V43, P5627, DOI 10.1021/ma1002563
   SARID S, 1959, J BIOL CHEM, V234, P1740
   Schlaad H, 2010, MACROMOL RAPID COMM, V31, P511, DOI 10.1002/marc.200900683
   Schneider M, 2013, LANGMUIR, V29, P6983, DOI 10.1021/la4009174
   Schulz A, 2014, ACS NANO, V8, P2686, DOI 10.1021/nn406388t
   Secker C., 2015, THESIS U POTSDAM
   Secker C, 2015, EUR POLYM J, V62, P394, DOI 10.1016/j.eurpolymj.2014.08.028
   SELA M, 1959, ADV PROTEIN CHEM, V14, P391, DOI 10.1016/S0065-3233(08)60614-2
   SELA MICHAEL, 1966, ADVANCE IMMUNOL, V5, P29, DOI 10.1016/S0065-2776(08)60272-2
   Sigmund F, 1926, H-S Z PHYSIOL CHEM, V157, P91, DOI 10.1515/bchm2.1926.157.1-3.91
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   SISIDO M, 1977, MAKROMOL CHEM, V178, P3107
   Statz AR, 2008, SOFT MATTER, V4, P131, DOI 10.1039/b711944e
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Sun J, 2013, ACS NANO, V7, P4715, DOI 10.1021/nn4015714
   Surman F, 2015, MACROMOL BIOSCI, V15, P636, DOI 10.1002/mabi.201400470
   Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96
   Szwarc M., 1965, ADV POLYM SCI, V4, P1
   Tanisaka H, 2008, BIOCONJUGATE CHEM, V19, P109, DOI 10.1021/bc7001665
   Tao XF, 2014, MACROMOLECULES, V47, P6173, DOI 10.1021/ma501131t
   Tao XF, 2014, MACROMOL RAPID COMM, V35, P875, DOI 10.1002/marc.201400066
   Tischer T, 2014, ADV MATER, V26, P4087, DOI 10.1002/adma.201401006
   TONELLI AE, 1976, BIOPOLYMERS, V15, P1615, DOI 10.1002/bip.1976.360150814
   Ulbricht J, 2014, BIOMATERIALS, V35, P4848, DOI 10.1016/j.biomaterials.2014.02.029
   WALEY SG, 1949, PROC R SOC LON SER-A, V199, P499, DOI 10.1098/rspa.1949.0151
   WESSELY F, 1950, MONATSH CHEM, V81, P861, DOI 10.1007/BF00899328
   Wessely F., 1926, Z PHYSL CHEM, V159, P102
   Wong S, 2015, J POLYM SCI POL CHEM, V53, P280, DOI 10.1002/pola.27320
   Yamada S, 2014, RSC ADV, V4, P29890, DOI 10.1039/c4ra03315a
   Yamada S, 2013, J POLYM SCI POL CHEM, V51, P3726, DOI 10.1002/pola.26775
   Yamada S, 2012, J POLYM SCI POL CHEM, V50, P2527, DOI 10.1002/pola.26052
   Zhang DH, 2012, MACROMOLECULES, V45, P5833, DOI 10.1021/ma202319g
   Zhou MY, 2011, J MATER CHEM, V21, P693, DOI 10.1039/c0jm01266a
   Zuckermann RN, 2011, BIOPOLYMERS, V96, P545, DOI 10.1002/bip.21573
NR 103
TC 25
Z9 25
U1 5
U2 107
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL
PY 2015
VL 15
IS 7
BP 881
EP 891
DI 10.1002/mabi.201500023
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CM9GN
UT WOS:000358015600001
PM 25851782
DA 2018-10-20
ER

PT J
AU Zhang, SQ
   Karaca, BT
   VanOosten, SK
   Yuca, E
   Mahalingam, S
   Edirisinghe, M
   Tamerler, C
AF Zhang, Siqi
   Karaca, Banu Taktak
   VanOosten, Sarah Kay
   Yuca, Esra
   Mahalingam, Suntharavathanan
   Edirisinghe, Mohan
   Tamerler, Candan
TI Coupling Infusion and Gyration for the Nanoscale Assembly of Functional
   Polymer Nanofibers Integrated with Genetically Engineered Proteins
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE genetically engineered proteins; gyration; infusion; nanofibers;
   peptides
ID PRESSURIZED GYRATION; BINDING PEPTIDE; FIBERS; IMMOBILIZATION;
   MORPHOLOGY; BIOSENSORS; BEHAVIOR
AB Nanofibers featuring functional nanoassemblies show great promise as enabling constituents for a diverse range of applications in areas such as tissue engineering, sensing, optoelectronics, and nanophotonics due to their controlled organization and architecture. An infusion gyration method is reported that enables the production of nanofibers with inherent biological functions by simply adjusting the flow rate of a polymer solution. Sufficient polymer chain entanglement is obtained at Berry number > 1.6 to make bead-free fibers integrated with gold nanoparticles and proteins, in the diameter range of 117-216 nm. Integration of gold nanoparticles into the nanofiber assembly is followed using a gold-binding peptide tag genetically conjugated to red fluorescence protein (DsRed). Fluorescence microscopy analysis corroborated with Fourier transform infrared spectroscopy (FTIR) data confirms the integration of the engineered red fluorescence protein with the nanofibers. The gold nanoparticle decorated nanofibers having red fluorescence protein as an integral part keep their biological functionality including copper-induced fluorescence quenching of the DsRed protein due to its selective Cu+2 binding. Thus, coupling the infusion gyration method in this way offers a simple nanoscale assembly approach to integrate a diverse repertoire of protein functionalities into nanofibers to generate biohybrid materials for imaging, sensing, and biomaterial applications.
C1 [Zhang, Siqi; Mahalingam, Suntharavathanan; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Karaca, Banu Taktak; VanOosten, Sarah Kay; Yuca, Esra; Tamerler, Candan] Univ Kansas, Bioengn Res Ctr BERC, Dept Mech Engn, Lawrence, KS 66045 USA.
RP Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk; ctamerler@ku.edu
OI Mahalingam, Dr Suntharavathanan/0000-0002-9617-8449; Tamerler,
   Candan/0000-0002-1960-2218
FU Engineering and Physical Science Research Council (EPSRC, UK)-University
   College London (UCL); EPSRC [EP/L023059/1]; University of Kansas; NFRFG;
   TUBITAK-2214-International Doctoral Research Fellowship; Engineering and
   Physical Sciences Research Council [EP/L023059/1]
FX UK authors are grateful for an Engineering and Physical Science Research
   Council (EPSRC, UK)-University College London (UCL) Knowledge Exchange
   Programme Award, which initiated this work and helped to attract
   privately funded researcher S.Z.; S.M. is supported by EPSRC grant
   EP/L023059/1. USA authors greatly appreciate University of Kansas Start
   Up and NFRFG Funds, also a TUBITAK-2214-International Doctoral Research
   Fellowship for Banu Taktak Karaca.
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328
   Fan JZ, 2014, RSC ADV, V4, P27683, DOI 10.1039/c4ra03669g
   Hattori T, 2012, BIOCONJUGATE CHEM, V23, P1934, DOI 10.1021/bc300316p
   He JH, 2008, FIBER POLYM, V9, P140, DOI 10.1007/s12221-008-0023-3
   Hnilova M, 2008, LANGMUIR, V24, P12440, DOI 10.1021/la801468c
   Hnilova M, 2012, J COLLOID INTERF SCI, V365, P97, DOI 10.1016/j.jcis.2011.09.006
   Hsieh YT, 2011, POLYM J, V43, P762, DOI 10.1038/pj.2011.63
   Kacar T, 2009, BIOTECHNOL BIOENG, V103, P696, DOI 10.1002/bit.22282
   Karaca B. T., 2014, MRS ONLINE P LIB, V1621, P155
   Krauland EM, 2007, BIOTECHNOL BIOENG, V97, P1009, DOI 10.1002/bit.21341
   Liu JZ, 2014, MACROMOL RAPID COMM, V35, P1503, DOI 10.1002/marc.201400274
   Mahalingam S, 2015, LANGMUIR, V31, P659, DOI 10.1021/la502181g
   Mahalingam S, 2013, MACROMOL RAPID COMM, V34, P1134, DOI 10.1002/marc.201300339
   Mellado P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662015
   Nochomovitz R, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145305
   Padron S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4769886
   Park TJ, 2006, ANAL CHEM, V78, P7197, DOI 10.1021/ac060976f
   Saquing CD, 2009, SMALL, V5, P944, DOI 10.1002/smll.200801273
   Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Uzun SD, 2014, ACS APPL MATER INTER, V6, P5235, DOI 10.1021/am5005927
   Wang HX, 2009, CHEMBIOCHEM, V10, P2560, DOI 10.1002/cbic.200900249
   Wannatong L, 2004, POLYM INT, V53, P1851, DOI 10.1002/pi.1599
   Wongsasulak S, 2007, POLYMER, V48, P448, DOI 10.1016/j.polymer.2006.11.025
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yuan XY, 2004, POLYM INT, V53, P1704, DOI 10.1002/pi.1538
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zhong H, 1999, J PHYS CHEM B, V103, P3947, DOI 10.1021/jp984518p
NR 29
TC 30
Z9 30
U1 7
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD JUL
PY 2015
VL 36
IS 14
BP 1322
EP 1328
DI 10.1002/marc.201500174
PG 7
WC Polymer Science
SC Polymer Science
GA CN0DT
UT WOS:000358084300002
PM 26033345
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Crimu, C
   Bolat, G
   Munteanu, C
   Mareci, D
AF Crimu, C.
   Bolat, G.
   Munteanu, C.
   Mareci, D.
TI Degradation characteristics of Mg0.8Ca in saline solution with and
   without albumin protein investigated by electrochemical impedance
   spectroscopy
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; CORROSION BEHAVIOR; MAGNESIUM ALLOY; IMPLANT
   ALLOYS; TITANIUM-ALLOY; BONE; MICROSTRUCTURE
AB Biodegradable magnesium-calcium (MgCa) alloy is a very attractive biomaterial. Binary Mg0.8Ca alloy was fabricated. X-ray diffraction (XRD) analysis and optical microscopy observed showed that Mg0.8Ca alloy was composed of alpha(Mg) phase. The electrochemical impedance spectroscopy (EIS) technique was used for the study on the degradation characteristics of Mg0.8Ca alloy. Because the proteins have a role on the passivation of metals, the effect of albumin protein addition in NaCl solution on the electrochemical behaviour of Mg0.8Ca alloy was studied. It has been shown that in 0.9wt% NaCl solution the impedance was mainly characterised by one capacitive and one inductive effect, which related to the alloy charge transfer reaction and the relaxation of the absorbed corrosion compounds. The addition of 37.5 mg/mL albumin protein to 0.9wt% NaCl solution increased the impedance compared to that without albumin protein. The equivalent circuits simulating the electrochemical behaviour of Mg0.8Ca alloy in 0.9wt% NaCl solution with and without albumin protein were proposed. The surface morphology of the Mg0.8Ca samples after 1-week immersion in Mg0.8Ca alloy in 0.9wt% NaCl solution with albumin protein was studied using scanning electron microscopy (SEM). The electrochemical mechanism for degradation of Mg0.8Ca alloy in 0.9wt% NaCl solution is related to the albumin protein addition.
C1 [Crimu, C.; Munteanu, C.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
   [Bolat, G.; Mareci, D.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
RP Mareci, D (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, 73 Prof Dr Doc Mangeron St, Iasi 700050, Romania.
EM danmareci@yahoo.com
OI Mareci, Daniel/0000-0002-5859-1996
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-ID-PCE-2011-3-0218]
FX This work was supported by a grant from the Romanian National Authority
   for Scientific Research, CNCS-UEFISCDI, project number
   PN-II-ID-PCE-2011-3-0218.
CR [Anonymous], 1999, G190 ASTM
   Barbinta AC, 2014, MATER CORROS, V65, P1017, DOI 10.1002/maco.201307294
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Dilea M, 2013, MATER CORROS, V64, P493, DOI 10.1002/maco.201206526
   Dragan-Raileanu LA, 2014, MATER CORROS, V65, P828, DOI 10.1002/maco.201307126
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Li T, 2015, MATER CORROS, V66, P7, DOI 10.1002/maco.201307528
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Mareci D, 2010, MATER CORROS, V61, P768, DOI 10.1002/maco.200905527
   Mindroiu M, 2013, MATER CORROS, V64, P926, DOI 10.1002/maco.201106480
   Moreno JMC, 2014, MATER CORROS, V65, P703, DOI 10.1002/maco.201307053
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M., 1998, J JPN SOC MECH ENG A, V64, P312
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Shaw B.A., 2003, CORROSION RESISTANCE
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Vasilescu C, 2014, MATER CORROS, V65, P715, DOI 10.1002/maco.201206952
   Von Der Hoh N., 2007, ADV ENG MATER, V11, pB47
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Yang S, 2013, MATER CORROS, V64, P402, DOI 10.1002/maco.201106478
   Zhang JS, 2015, MATER CORROS, V66, P542, DOI 10.1002/maco.201407696
NR 30
TC 3
Z9 3
U1 2
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-5117
EI 1521-4176
J9 MATER CORROS
JI Mater. Corros.
PD JUL
PY 2015
VL 66
IS 7
BP 649
EP 655
DI 10.1002/maco.201407980
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CL9XR
UT WOS:000357332900005
DA 2018-10-20
ER

PT J
AU Barrioni, BR
   de Carvalho, SM
   Orefice, RL
   de Oliveira, AAR
   Pereira, MD
AF Barrioni, Breno Rocha
   de Carvalho, Sandhra Maria
   Orefice, Rodrigo Lambert
   Rocha de Oliveira, Agda Aline
   Pereira, Marivalda de Magalhaes
TI Synthesis and characterization of biodegradable polyurethane films based
   on HDI with hydrolyzable crosslinked bonds and a homogeneous structure
   for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biodegradable polyurethane; Films; Crosslinked polyurethane;
   Biomaterial; Biodegradable polymer; Mechanical tests
ID TISSUE ENGINEERING APPLICATIONS; IN-VITRO DEGRADATION; SEGMENTED
   POLYURETHANES; CHAIN EXTENDERS; POLY(ETHYLENE GLYCOL); POLY(ESTER
   URETHANE)S; MECHANICAL-PROPERTIES; THERMAL-PROPERTIES; HARD SEGMENT;
   ELASTOMERS
AB Synthetic biodegradable polymers are considered strategic in the biomaterials field and are used in various applications. Among the polymers used as biomaterials, polyurethanes (Pus) feature prominently due to their versatility and the ability to obtain products with a wide range of physical and mechanical properties. In this work, new biodegradable polyurethane films were developed based on hexamethylene diisocyanate (HDI) and glycerol as the hard segment (HS), and poly(caprolactone) trial (PCL triol) and low-molecular-weight poly( ethylene glycol) PEG as the soft segment (SS) without the use of a catalyst. The films obtained were characterized by structural, mechanical and biological testing. A highly connected network with a homogeneous PU structure was obtained due to crosslinked bonds. The films showed amorphous structures, high water uptake, hydrogel behavior, and susceptibility to hydrolytic degradation. Mechanical tests indicated that the films reached a high deformation at break of up to 425.4%, an elastic modulus of 1.6 MPa and a tensile strength of 3.6 MPa. The materials presented a moderate toxic effect on MTT assay and can be considered potential materials for biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Barrioni, Breno Rocha; de Carvalho, Sandhra Maria; Orefice, Rodrigo Lambert; Rocha de Oliveira, Agda Aline; Pereira, Marivalda de Magalhaes] Univ Fed Minas Gerais, Dept Met Engn & Mat, Sch Engn, BR-31270901 Belo Horizonte, MG, Brazil.
RP Barrioni, BR (reprint author), Univ Fed Minas Gerais, Dept Met Engn & Mat, Sch Engn, Av Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM brenobarrionibh@hotmail.com; sandhra_carvalho@yahoo.com.br;
   rorefice@demet.ufmg.br; agdalinero@yahoo.com; mpereira@demet.ufmg.br
RI Orefice, Rodrigo/N-8055-2018; Barrioni, Breno/H-4769-2018
OI Orefice, Rodrigo/0000-0002-6046-4056; Barrioni,
   Breno/0000-0002-8681-6451
FU CNPq; CAPES; FAPEMIG/Brazil
FX The authors gratefully acknowledge financial support from CNPq, CAPES
   and FAPEMIG/Brazil.
CR Allan D, 2013, POLYM DEGRAD STABIL, V98, P535, DOI 10.1016/j.polymdegradstab.2012.12.002
   Bil M, 2010, ACTA BIOMATER, V6, P2501, DOI 10.1016/j.actbio.2009.08.037
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Caridade SG, 2013, J MECH BEHAV BIOMED, V20, P173, DOI 10.1016/j.jmbbm.2012.11.012
   Cauich-rodriguez J. V., 2012, DEGRADATION POLYURET
   Chan-Chan LH, 2010, ACTA BIOMATER, V6, P2035, DOI 10.1016/j.actbio.2009.12.010
   Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Chiou BS, 2002, J APPL POLYM SCI, V83, P212, DOI 10.1002/app.10056
   da Silva GR, 2011, MAT SCI ENG C-MATER, V31, P414, DOI 10.1016/j.msec.2010.10.019
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   Fu HG, 2011, SOFT MATTER, V7, P3546, DOI 10.1039/c0sm01350a
   Guelcher SA, 2005, ACTA BIOMATER, V1, P471, DOI 10.1016/j.actbio.2005.02.007
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gupta T, 2003, THERMOCHIM ACTA, V402, P169, DOI 10.1016/S0040-6031(02)00571-3
   Hood MA, 2010, POLYMER, V51, P2191, DOI 10.1016/j.polymer.2010.03.027
   Jia WJ, 2006, MATER LETT, V60, P3686, DOI 10.1016/j.matlet.2006.03.089
   Kim HI, 2011, BIOMATERIALS, V32, P2241, DOI 10.1016/j.biomaterials.2010.11.067
   Krol P, 2007, J APPL POLYM SCI, V104, P1464, DOI 10.1002/app.25011
   Krol P, 2007, PROG MATER SCI, V52, P915, DOI 10.1016/j.pmatsci.2006.11.001
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351
   Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001
   Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Lonnroth EC, 2003, ACTA ODONTOL SCAND, V61, P52
   Lonnroth Emma Christin, 2005, Int J Occup Saf Ergon, V11, P131
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   Oprea S, 2012, J APPL POLYM SCI, V124, P1059, DOI 10.1002/app.35196
   Oprea S, 2010, POLYM BULL, V65, P753, DOI 10.1007/s00289-009-0242-9
   Orefice RL, 2005, MACROMOLECULES, V38, P4058, DOI 10.1021/ma050213e
   Patel A, 2007, MACROMOL BIOSCI, V7, P727, DOI 10.1002/mabi.200600272
   Perez-Liminana MA, 2005, INT J ADHES ADHES, V25, P507, DOI 10.1016/j.ijadhadh.2005.02.002
   Piao LH, 2003, POLYMER, V44, P2025, DOI 10.1016/S0032-3861(03)00087-9
   Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006
   Reddy TT, 2008, BIOMACROMOLECULES, V9, P1313, DOI 10.1021/bm701390f
   de Oliveira AAR, 2012, J BIOMED MATER RES B, V100B, P1387, DOI 10.1002/jbm.b.32710
   Rogulska M, 2013, J THERM ANAL CALORIM, V114, P903, DOI 10.1007/s10973-013-3007-5
   Rychly J, 2011, POLYM DEGRAD STABIL, V96, P462, DOI 10.1016/j.polymdegradstab.2011.01.012
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Spirkova M, 2011, EUR POLYM J, V47, P959, DOI 10.1016/j.eurpolymj.2011.01.001
   Talakesh MM, 2012, J MEMBRANE SCI, V415, P469, DOI 10.1016/j.memsci.2012.05.033
   Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035
   Teramoto N, 2010, J APPL POLYM SCI, V115, P3199, DOI 10.1002/app.30019
   Trovati G., 2009, CHARACTERIZATION POL, P1
   van der Schuur M, 2006, POLYMER, V47, P1091, DOI 10.1016/j.polymer.2005.11.074
   Wang J, 2013, J APPL POLYM SCI, V128, P4047, DOI 10.1002/app.38613
   Wessler K, 2006, MACROMOL SYMP, V245, P161, DOI 10.1002/masy.200651322
   Yao DG, 2006, J BIOMED MATER RES B, V77B, P287, DOI 10.1002/jbm.b.30419
   Yu TL, 1999, J POLYM SCI POL PHYS, V37, P2673, DOI 10.1002/(SICI)1099-0488(19990915)37:18<2673::AID-POLB11>3.0.CO;2-N
   Yuan Y., 2013, SURFACE SCI TECHNIQU, V51
   Zhang Q, 2013, COLLOID SURFACE B, V102, P354, DOI 10.1016/j.colsurfb.2012.07.037
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 58
TC 54
Z9 56
U1 2
U2 111
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 22
EP 30
DI 10.1016/j.msec.2015.03.027
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100004
PM 25953536
DA 2018-10-20
ER

PT J
AU Siqueira, L
   Passador, FR
   Costa, MM
   Lobo, AO
   Sousa, E
AF Siqueira, L.
   Passador, F. R.
   Costa, M. M.
   Lobo, A. O.
   Sousa, E.
TI Influence of the addition of beta-TCP on the morphology, thermal
   properties and cell viability of poly (lactic acid) fibers obtained by
   electrospinning
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Scaffolds; Electrospinning; Polylactic acid; Tricalcium phosphate
ID POLY(L-LACTIC ACID); BEHAVIOR; FABRICATION; SCAFFOLDS; NANOFIBERS;
   MAGNESIUM; STRENGTH
AB Electrospinning is a simple and low-cost way to fabricate fibers. Among the various polymers used in electrospinning process, the poly (lactic acid) (PLA) stands out due to its excellent biodegradability and biocompatibility. Calcium phosphate ceramics has been recognized as an attractive biomaterial because their chemical composition is similar to the mineral component of the hard tissue in the body. Furthermore, they are bioactive and osteoinductive and some are even quite biodegradable. The beta-tricalcium phosphate (beta-TCP) particles were synthesized by solid state reaction. Different contents of beta-TCP particles were incorporated in polymer matrices to form fibers of PLA/beta-TCP composites by electrospinning aiming a possible application as a scaffold for tissue engineering. The fibers were characterized by scanning electron microscopy (SEM), infrared (FTIR), differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA). The average diameter of the fibers varied in the range of 260-519.6 +/- 50 nm. The presence of beta-TCP particles promoted changes on thermal properties of the fibers. The composite with B wt-% of beta-TCP showed a low degree of crystallinity and can be used for application in tissue engineering. The cell viability was analyzed by reduction of the methyl tetrazolium salt by the pyruvate dehydrogenase enzymatic complex present in the matrix of mitochondria (MTT test). All PLA fiber groups, with different contents of beta-TCP, showed cytocompatibility ability with non-cytotoxicity effect and bioactive properties using SBF assay. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Siqueira, L.; Sousa, E.] UNIFESP, Inst Sci & Technol, Lab Bioceram, Sao Jose Dos Campos, SP, Brazil.
   [Passador, F. R.] UNIFESP, Inst Sci & Technol, Lab Polymer Proc, Sao Jose Dos Campos, SP, Brazil.
   [Costa, M. M.; Lobo, A. O.] UNIVAP, Dev Res Inst IP&D, Lab Biomed Nanotechnol, Sao Jose Dos Campos, SP, Brazil.
RP Lobo, AO (reprint author), 2911 Ave Shishima Hifumi,2911 Urbanova, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
EM aolobo@pq.cnpq.br; eliandra.sousa@unifesp.br
RI Lobo, Anderson/B-2893-2011
OI Lobo, Anderson/0000-0002-2544-0438
FU Sao Paulo Research Foundation (FAPESP) [2011/17877-7]; Brazilian
   Innovation Agency (FINEP) [01.13.0428.00]; National Counsel of
   Technological and Scientific Development (CNPq) [474090/2013-2];
   Coordination for the Improvement of Higher Education Personnel (CAPES)
FX The authors would like to thank The Sao Paulo Research Foundation
   (FAPESP) (grant number 2011/17877-7), Brazilian Innovation Agency
   (FINEP) (grant number 01.13.0428.00) National Counsel of Technological
   and Scientific Development (CNPq) (grant number: 474090/2013-2) and
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   for the financial support, Joao Paulo Barros Machado, PhD from the
   Laboratory of Sensors and Materials (LAS) of the National Institute of
   Space Research (INPE) for permitting XRD analysis and Ana Paula Lemes,
   PhD from University Federal of Sao Paulo (UNIFESP) for thermal analyses.
CR Auras R., 2004, MACROMOL BIOSCI, V4, P835
   Barbanti Samuel H., 2005, Polímeros, V15, P13, DOI 10.1590/S0104-14282005000100006
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Branciforti MC, 2009, J MACROMOL SCI B, V48, P1222, DOI 10.1080/10408390903060970
   Cardoso H. A. I., 2012, Cerâmica, V58, P225, DOI 10.1590/S0366-69132012000200013
   Favaro MM, 2009, POLYM ADVAN TECHNOL, V20, P940, DOI 10.1002/pat.1343
   FISHER EW, 1973, KOLLOID Z Z POLYM, V251, P980
   Garkhal K, 2007, J POLYM SCI POL CHEM, V45, P2755, DOI 10.1002/pola.22031
   Geneva S.H., 1992, TEST CYTOTOXICITY 5
   Haroosh HJ, 2012, J APPL POLYM SCI, V124, P3930, DOI 10.1002/app.35448
   Hoveizi E, 2014, CELL BIOL INT, V38, P41, DOI 10.1002/cbin.10178
   Jiang L, 2006, BIOMACROMOLECULES, V7, P199, DOI 10.1021/bm050581q
   Kawachi EY, 2000, QUIM NOVA, V23, P518, DOI 10.1590/S0100-40422000000400015
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mackle JN, 2011, MACROMOL BIOSCI, V11, P1272, DOI 10.1002/mabi.201100029
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pan PJ, 2008, MACROMOLECULES, V41, P4296, DOI 10.1021/ma800343g
   Pereira C.S., 1998, EMULS CELL MAT, P193
   Pereira RB, 2014, POLIMEROS, V24, P198, DOI 10.4322/polimeros.2014.042
   Pirani S, 2013, J APPL POLYM SCI, V130, P3345, DOI 10.1002/app.39576
   Neto WAR, 2012, POLYM DEGRAD STABIL, V97, P2037, DOI 10.1016/j.polymdegradstab.2012.03.048
   Sparatu M., 2008, REV ROUM CHIM, V53, P955
   Sun B., 2013, PROG POLYM SCI, V29
   Tammaro L, 2014, BIONANOMATERIALS, V15, P9
   Torres-Giner S, 2011, J APPL POLYM SCI, V122, P914, DOI 10.1002/app.34208
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wang FM, 2006, INT ENDOD J, V39, P477, DOI 10.1111/j.1365-2591.2006.01114.x
   Yasuniwa M, 2004, J POLYM SCI POL PHYS, V42, P25, DOI 10.1002/polb.10674
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhou H, 2013, MAT SCI ENG C-MATER, V33, P2302, DOI 10.1016/j.msec.2013.01.058
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 34
TC 12
Z9 13
U1 2
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 135
EP 143
DI 10.1016/j.msec.2015.03.055
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100018
PM 25953550
DA 2018-10-20
ER

PT J
AU Grzesiak, J
   Marycz, K
   Szarek, D
   Bednarz, P
   Laska, J
AF Grzesiak, Jakub
   Marycz, Krzysztof
   Szarek, Dariusz
   Bednarz, Paulina
   Laska, Jadwiga
TI Polyurethane/polylactide-based biomaterials combined with rat olfactory
   bulb-derived glial cells and adipose-derived mesenchymal stromal cells
   for neural regenerative medicine applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Polyurethane; Polylactide; Glial cells; Mesenchymal stem
   cells
ID PERIPHERAL-NERVE REGENERATION; BIODEGRADABLE SYNTHETIC-POLYMERS;
   STEM-CELLS; ENSHEATHING CELLS; IN-VITRO; SCHWANN-CELLS; SILK FIBROIN;
   ADHESION; BEHAVIOR; POLYLACTIDE
AB Research concerning the elaboration and application of biomaterial which may support the nerve tissue regeneration is currently one of the most promising directions. Biocompatible polymer devices are noteworthy group among the numerous types of potentially attractive biomaterials for regenerative medicine application. Polylactides and polyurethanes may be utilized for developing devices for supporting the nerve regeneration, like nerve guide conduits or bridges connecting the endings of broken nerve tracts. Moreover, the combination of these biomaterial-devices with regenerative-cell populations, like stem or precursor cells should significantly improve the final therapeutic effect. Therefore, the composition and structure of final device should support the proper adhesion and growth of cells destined for clinical application. In current research, the three polymer mats elaborated for connecting the broken nerve tracts, made from polylactide, polyurethane and their blend were evaluated both for physical properties and in vitro, using the olfactory-bulb glial cells and mesenchymal stem cells. The evaluation of Young's modulus, wettability and roughness of obtained materials showed the differences between analyzed samples. The analysis of cell adhesion, proliferation and morphology showed that the polyurethane-polylactide blend was the most neutral for cells in culture, while in the pure polymer samples there were significant alterations observed. Our results indicated that polyurethane-polylactide blend is an optimal composition for culturing and delivery of glial and mesenchymal stem cells. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Grzesiak, Jakub; Marycz, Krzysztof] Univ Environm & Life Sci, Electron Microscopy Lab, PL-51631 Wroclaw, Poland.
   [Szarek, Dariusz] Lower Silesia Specialist Hosp T Marciniak, Ctr Emergency Med, Dept Neurosurg, PL-50420 Wroclaw, Poland.
   [Bednarz, Paulina] State Higher Vocat Sch Tarnow, PL-33100 Tarnow, Poland.
   [Laska, Jadwiga] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Grzesiak, J (reprint author), Univ Environm & Life Sci, Electron Microscopy Lab, Kozuchowska 5b, PL-51631 Wroclaw, Poland.
EM grzesiak.kuba@gmail.com
RI Marycz, Krzysztof/A-2249-2017
OI Bednarz, Paulina/0000-0002-8286-9556
FU National Center of Science, Poland [2011/01/B/STB8/07795]
FX This research was financially supported by the National Center of
   Science, Poland (grant no. 2011/01/B/STB8/07795). Authors declare no
   conflict of interest in this manuscript.
CR Benavente JJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090189
   Boyle CC, 1997, CANCER RES, V57, P2404
   Burke A, 2004, ADV EXP MED BIOL, V553, P83
   Czarnecki J.S., 2014, TISSUE ENG A
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35
   de Guzman RC, 2008, J BIOMED MATER RES A, V85A, P14, DOI 10.1002/jbm.a.31516
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Feng F, 2011, J MACROMOL SCI B, V50, P1500, DOI 10.1080/00222348.2010.518889
   Feng F, 2011, J APPL POLYM SCI, V119, P2778, DOI 10.1002/app.32863
   Gajowy J., 2009, ENG BIOMATER, V13, P89
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Grzesiak J, 2011, INT J MORPHOL, V29, P1012, DOI 10.4067/S0717-95022011000300059
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gurunathan T, 2014, J MATER SCI, V49, P8016, DOI 10.1007/s10853-014-8509-4
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Han JJ, 2011, J APPL POLYM SCI, V120, P3217, DOI 10.1002/app.33338
   Hausner T, 2007, ACTA NEUROCHIR SUPPL, V100, P69
   Hilmer K., US Patent, Patent No. [US 8633283 B2, 8633283]
   Honore A, 2012, GLIA, V60, P404, DOI 10.1002/glia.22274
   Keatch RP, 2012, CURR OPIN BIOTECH, V23, P579, DOI 10.1016/j.copbio.2012.01.017
   Khaidoyanidi S, 2008, CELL STEM CELL, V2, P198, DOI 10.1016/j.stem.2008.02.012
   Kueh JL, 2012, NANOMEDICINE-UK, V7, P1211, DOI 10.2217/nnm.11.180
   Lakard S., 2004, BIOELECTROCHEMISTRY, V23, P579
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee OJ, 2014, J BIOMED NANOTECHNOL, V10, P1294, DOI 10.1166/jbn.2014.1818
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li XN, 1997, NEUROSURGERY, V40, P1250, DOI 10.1097/00006123-199706000-00027
   Liu GC, 2014, POLYM CHEM-UK, V5, P2530, DOI 10.1039/c3py01649h
   Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400
   Marycz K, 2014, BIO-MED MATER ENG, V24, P1625, DOI 10.3233/BME-140966
   Marycz K, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065004
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Mi HY, 2013, MAT SCI ENG C-MATER, V33, P4767, DOI 10.1016/j.msec.2013.07.037
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Szarek D, 2013, SCANNING, V35, P232, DOI 10.1002/sca.21056
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Walsh MF, 2003, CELL PHYSIOL BIOCHEM, V13, P135, DOI 10.1159/000071864
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Willerth SM, 2008, COMBINING STEM CELLS
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zhu YL, 2010, GLIA, V58, P716, DOI 10.1002/glia.20957
NR 58
TC 24
Z9 24
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 163
EP 170
DI 10.1016/j.msec.2015.03.050
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100022
PM 25953554
OA Other Gold
DA 2018-10-20
ER

PT J
AU Cecchinato, F
   Karlsson, J
   Ferroni, L
   Gardin, C
   Galli, S
   Wennerberg, A
   Zavan, B
   Andersson, M
   Jimbo, R
AF Cecchinato, Francesca
   Karlsson, Johan
   Ferroni, Letizia
   Gardin, Chiara
   Galli, Silvia
   Wennerberg, Ann
   Zavan, Barbara
   Andersson, Martin
   Jimbo, Ryo
TI Osteogenic potential of human adipose-derived stromal cells on
   3-dimensional mesoporous TiO2 coating with magnesium impregnation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE 3-D nanostructure; Magnesium; Osteogenesis; Osteogenic markers;
   Osteopontin
ID MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; IUPAC RECOMMENDATIONS
   2001; OSTEOBLAST-LIKE CELLS; HUMAN BONE-MARROW; GENE-EXPRESSION;
   COMPOSITIONAL CHARACTERISTICS; INORGANIC HOSTS; TITANIUM-ALLOY; IN-VITRO
AB The aim of this study was to evaluate the osteogenic response of human adipose-derived stromal cells (ADScs) to mesoporous titania (TiO2) coatings produced with evaporation-induced self-assembly method (EISA) and loaded with magnesium. Our emphasis with the magnesium release functionality was to modulate progenitor cell osteogenic differentiation under standard culture conditions. Osteogenic properties of the coatings were assessed for stromal cells by means of scanning electron microscopy (SEM) imaging, colorimetric mitochondrial viability assay (MTT), colorimetric alkaline phosphates activity (ALP) assay and real time RT-polymerase chain reaction (PCR). Using atomic force microscopy (AFM) it was shown that the surface expansion area (S-dr) was strongly enhanced by the presence of magnesium. From MTT results it was shown that ADSc viability was significantly increased on mesoporous surfaces compared to the non-porous one at a longer cell culture time. However, no differences were observed between the magnesium impregnated and non-impregnated surfaces. The alkaline phosphatase activity confirmed that ADSc started to differentiate into the osteogenic phenotype after 2 weeks of culturing. The gene expression profile at 2 weeks of cell growth showed that such coatings were capable to incorporate specific osteogenic markers inside their interconnected nano-pores and, at 3 weeks, ADSc differentiated into osteoblasts. Interestingly, magnesium significantly promoted the osteopontin gene expression, which is an essential gene for the early biomaterial-cell osteogenic interaction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Cecchinato, Francesca; Galli, Silvia; Wennerberg, Ann; Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
   [Karlsson, Johan; Andersson, Martin] Chalmers Univ Technol, Dept Chem & Biol Engn Appl Surface Chem, S-41296 Gothenburg, Sweden.
   [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy.
   [Jimbo, Ryo] Nagasaki Univ, Dept Appl Prosthodont, Grad Sch Biomed Sci, Nagasaki 852, Japan.
RP Cecchinato, F (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
EM francesca.cecchinato@mah.se
OI , Martin/0000-0003-1523-4697; Gardin, Chiara/0000-0003-3817-0032
FU People Programme (Marie Curie Actions) of the European Union's under REA
   [n289163]
FX The research leading to these results has received funding from the
   People Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme FP7/2007-2013/under REA grant agreement no. n289163.
CR [Anonymous], 2012, NANOMEDICINE-UK, V7, P20
   [Anonymous], 2009, J DENT IMPLANTOL, P250
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Bressan E, 2013, INT J MOL SCI, V14, P1918, DOI 10.3390/ijms14011918
   CARPENTER TO, 1992, AM J PHYSIOL, V263, pE107
   Cecchinato F., 2013, J BIOMEDICAL MAT R A, V102, P3862
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Flammang BE, 2011, INTEGR COMP BIOL, V51, P128, DOI 10.1093/icb/icr014
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   Galli S., 2013, CLIN IMPLANT DENT RE
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Grosso D, 2004, ADV FUNCT MATER, V14, P309, DOI 10.1002/adfm.200305036
   Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986
   Karlsson J, 2012, ACTA BIOMATER, V8, P4438, DOI 10.1016/j.actbio.2012.07.035
   Katagiri YU, 1999, CANCER RES, V59, P219
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Lin Z, 2011, J PERIODONTOL, V82, P1007, DOI 10.1902/jop.2010.100577
   McCusker LB, 2003, MICROPOR MESOPOR MAT, V58, P3, DOI 10.1016/S1387-1811(02)00545-0
   McCusker LB, 2001, PURE APPL CHEM, V73, P381, DOI 10.1351/pac200173020381
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   MERRY K, 1993, J CELL SCI, V104, P1013
   Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058
   OWEN M, 1988, J CELL SCI, P63
   OWEN M, 1988, CIBA F SYMP, V136, P42
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ryu HH, 2012, J VET MED SCI, V74, P1617, DOI 10.1292/jvms.12-0065
   SODEK J, 1977, ARCH ORAL BIOL, V22, P647, DOI 10.1016/0003-9969(77)90094-2
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Wu CW, 2006, J AM CHEM SOC, V128, P4544, DOI 10.1021/ja060453p
   Xia W, 2012, J BIOMED MATER RES B, V100B, P82, DOI 10.1002/jbm.b.31925
   Zhang Y., 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/793823
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 45
TC 6
Z9 7
U1 4
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2015
VL 52
BP 225
EP 234
DI 10.1016/j.msec.2015.03.026
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CM5TH
UT WOS:000357751100030
PM 25953562
DA 2018-10-20
ER

PT J
AU Ferroni, L
   Della Puppa, A
   D'Avella, D
   Isola, M
   Scienza, R
   Gardin, C
   Zavan, B
AF Ferroni, Letizia
   Della Puppa, Alessandro
   D'Avella, Domenico
   Isola, Maurizio
   Scienza, Renato
   Gardin, Chiara
   Zavan, Barbara
TI Tissue Engineering Strategies as Tools for Personalized Meningioma
   Treatment
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Tissue engineering; Solid cancer; Drug screening; Personalized medicine;
   Biomaterial
ID COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; SKIN-CANCER;
   STEM-CELLS; PHARMACOGENOMICS; TUMOR; HYALURONAN; GENES; ABNORMALITIES;
   EXPRESSION
AB Pharmacogenomics, the science of how genetic makeup influences an individual's reaction to drugs, is an innovative tool for providing critical insights into how a patient will respond to a particular treatment. In the present work, we constructed cancer-like tissues to be used as tools for determining the most effective drug for an individual patient. Using tissue engineering strategies, we generated two different solid tumor-like tissues in vitro, a neuronal tumor (meningioma) and a nonmelanoma skin cancer. Samples were tested by both histological and genetic approaches (using a comparative genomic hybridization array, and the relative World Health Organization classification of the samples was compared with the results obtained by the molecular analyses. Our data confirmed the ability of the cells to maintain their phenotype in three-dimensional scaffolds as well as the strong relationship between chromosomal alterations and histological malignancy grades. We then validated the in vitro construction of tumor-like tissues as a potential tool for developing personalized drug treatments.
C1 [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy.
   [Della Puppa, Alessandro; D'Avella, Domenico; Scienza, Renato] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
   [Isola, Maurizio] Univ Padua, Dept Anim Med Prod & Hlth MAPS, I-35100 Padua, Italy.
RP Zavan, B (reprint author), Univ Padua, Dept Biomed Sci, Via G Colombo 3, I-35100 Padua, Italy.
EM barbara.zavan@unipd.it
OI Gardin, Chiara/0000-0003-3817-0032; Della Puppa,
   Alessandro/0000-0001-8058-092X
FU University of Padova, Progetto di Ateneo
FX This research was supported by funds from University of Padova, Progetto
   di Ateneo to Barbara Zavan.
CR Aarhus M, 2008, J NEURO-ONCOL, V88, P251, DOI 10.1007/s11060-008-9569-6
   Ahmad A, 2012, CURR MED CHEM, V19, P3739, DOI 10.2174/092986712801661121
   Angstadt AY, 2013, CANCER-AM CANCER SOC, V119, P2477, DOI 10.1002/cncr.28009
   Espinosa AB, 2008, EUR J HUM GENET, V16, P1450, DOI 10.1038/ejhg.2008.128
   Brady PD, 2012, PRENATAL DIAG, V32, P336, DOI 10.1002/pd.2933
   Braude I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-138
   Chen AC, 2013, PATHOLOGY, V45, P331, DOI 10.1097/PAT.0b013e32835f515c
   de Clare M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-24
   Della Puppa A, 2011, J NEURO-ONCOL, V102, P167, DOI 10.1007/s11060-010-0300-z
   Dickschen K, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00092
   Tabernero MD, 2012, GENE CHROMOSOME CANC, V51, P606, DOI 10.1002/gcc.21948
   Tabernero MD, 2009, BRAIN PATHOL, V19, P409, DOI 10.1111/j.1750-3639.2008.00191.x
   Fan YJ, 2014, TISSUE ENG PT A, V20, P588, DOI 10.1089/ten.TEA.2013.0219
   Fathi AR, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0337-4
   Gardin C, 2011, INT J MOL SCI, V12, P6749, DOI 10.3390/ijms12106749
   Greinert R, 2009, PATHOBIOLOGY, V76, P64, DOI 10.1159/000201675
   Karyadi DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003409
   Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002
   Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239
   Laika B, 2010, PHARMACOGENOMICS J, V10, P20, DOI 10.1038/tpj.2009.32
   Maillo A, 2007, NEURO-ONCOLOGY, V9, P438, DOI 10.1215/15228517-2007-026
   Matsuura Tomokazu, 2006, Hum Cell, V19, P11, DOI 10.1111/j.1749-0774.2005.00002.x
   McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139
   Oliveria SA, 2013, PSYCHO-ONCOLOGY, V22, P106, DOI 10.1002/pon.2059
   Pachow D, 2013, CLIN CANCER RES, V19, P1180, DOI 10.1158/1078-0432.CCR-12-1904
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704
   Preskorn SH, 2013, J PSYCHIATR PRACT, V19, P142, DOI 10.1097/01.pra.0000428559.01953.73
   Rassekh SR, 2013, PEDIATR DRUGS, V15, P71, DOI 10.1007/s40272-013-0021-9
   Ruano Y, 2010, METHODS MOL BIOL, V653, P35, DOI 10.1007/978-1-60761-759-4_3
   Sanoudou D, 2012, PHARMACOGENOMICS J, V12, P185, DOI 10.1038/tpj.2011.53
   Santelli L, 2010, ACTA NEUROCHIR, V152, P1315, DOI 10.1007/s00701-010-0657-y
   Serna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067291
   Stamoulis C, 2009, IEEE ENG MED BIO, P6973, DOI 10.1109/IEMBS.2009.5333851
   Todorovic-Rakovic N, 2011, J BIOSCIENCES, V36, P719, DOI 10.1007/s12038-011-9099-9
   Ueno T, 2012, EXPERT OPIN THER TAR, V16, pS31, DOI 10.1517/14728222.2011.636739
   Van Haren R, 2009, BRIT J DERMATOL, V161, P1278, DOI 10.1111/j.1365-2133.2009.09338.x
   Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972
   Woo KS, 2008, CANCER GENET CYTOGEN, V180, P56, DOI 10.1016/j.cancergencyto.2007.09.012
   Yadav Dinesh, 2012, Recent Pat DNA Gene Seq, V6, P127
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Zhou KY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0458-2
   Zhou PZ, 2013, NEUROL INDIA, V61, P40, DOI 10.4103/0028-3886.107928
NR 43
TC 3
Z9 3
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD JUL
PY 2015
VL 39
IS 7
BP E114
EP E126
DI 10.1111/aor.12483
PG 13
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA CM0XH
UT WOS:000357402300003
PM 25894852
DA 2018-10-20
ER

PT J
AU Paquette, IM
   Varma, MG
   Kaiser, AM
   Steele, SR
   Rafferty, JF
AF Paquette, Ian M.
   Varma, Madhulika G.
   Kaiser, Andreas M.
   Steele, Scott R.
   Rafferty, Janice F.
CA Amer Soc Colon Rectal Surg
TI The American Society of Colon and Rectal Surgeons' Clinical Practice
   Guideline for the Treatment of Fecal Incontinence
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
ID ARTIFICIAL BOWEL SPHINCTER; SACRAL NERVE-STIMULATION; QUALITY-OF-LIFE;
   INJECTABLE SILICONE BIOMATERIAL; LONG-TERM OUTCOMES; MAGNETIC
   ANAL-SPHINCTER; UNILATERAL PUDENDAL NEUROPATHY; RANDOMIZED
   CONTROLLED-TRIAL; PELVIC FLOOR INJURY; DYNAMIC GRACILOPLASTY
CR Abbas SM, 2005, ANZ J SURG, V75, P783, DOI 10.1111/j.1445-2197.2005.03520.x
   Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Altomare DF, 2010, WORLD J GASTROENTERO, V16, P5267, DOI 10.3748/wjg.v16.i42.5267
   [Anonymous], 2014, COLORECTAL DIS, DOI DOI 10.1111/C0DI.12874
   BAETEN CGMI, 1991, LANCET, V338, P1163, DOI 10.1016/0140-6736(91)92030-6
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Becmeur F, 2008, J PEDIATR SURG, V43, P1853, DOI 10.1016/j.jpedsurg.2008.03.043
   Beco J, 2004, BMC SURG, V4, P15
   Beggs AD, 2010, COLORECTAL DIS, V12, P935, DOI 10.1111/j.1463-1318.2009.01927.x
   Bharucha AE, 2010, ALIMENT PHARM THER, V32, P681, DOI 10.1111/j.1365-2036.2010.04391.x
   Bharucha AE, 2006, AM J GASTROENTEROL, V101, P2679, DOI 10.1111/j.1572-0241.2006.00900.x
   Bharucha AE, 2014, CLIN GASTROENTEROL H, V12, P843, DOI 10.1016/j.cgh.2013.06.035
   Bharucha AE, 2012, AM J GASTROENTEROL, V107, P902, DOI 10.1038/ajg.2012.45
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Bharucha AE, 2006, J CLIN GASTROENTEROL, V40, P96, DOI 10.1097/01.mcg.0000196190.42296.a9
   Bharucha AE, 2004, GASTROENTEROLOGY, V126, pS90, DOI 10.1053/j.gastro.2003.10.014
   Bliss DZ, 2011, NURS RES, V60, pS58, DOI 10.1097/NNR.0b013e3182186d8c
   Bliss DZ, 2010, AM J NURS, V110, P30, DOI 10.1097/01.NAJ.0000388262.72298.f5
   Bliss DZ, 2001, NURS RES, V50, P203, DOI 10.1097/00006199-200107000-00004
   Bock S, 2010, TECH COLOPROCTOL, V14, P41, DOI 10.1007/s10151-009-0554-7
   Bordeianou L, 2008, DIS COLON RECTUM, V51, P1010, DOI 10.1007/s10350-008-9230-7
   Brouwer R, 2010, DIS COLON RECTUM, V53, P273, DOI 10.1007/DCR.0b013e3181ceeb22
   Brown HW, 2012, INT J CLIN PRACT, V66, P1101, DOI 10.1111/ijcp.12018
   Buie WD, 2001, DIS COLON RECTUM, V44, P1255
   Byrne CM, 2005, DIS COLON RECTUM, V48, P2281, DOI 10.1007/s10350-005-0198-2
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   Chen ASH, 1998, DIS COLON RECTUM, V41, P1005, DOI 10.1007/BF02237391
   Chereau N, 2011, COLORECTAL DIS, V13, pE238, DOI 10.1111/j.1463-1318.2011.02651.x
   Chiarioni G, 2002, AM J GASTROENTEROL, V97, P109
   Choe JH, 2008, J UROLOGY, V179, P214, DOI 10.1016/j.juro.2007.08.151
   Colquhoun P, 2006, OSTOMY WOUND MANAG, V52, P68
   Cotterill N, 2011, DIS COLON RECTUM, V54, P1235, DOI 10.1097/DCR.0b013e3182272128
   Croswell E, 2010, J WOUND OSTOMY CONT, V37, P677, DOI 10.1097/WON.0b013e3181feb017
   Damon H, 2014, DIGEST LIVER DIS, V46, P237, DOI 10.1016/j.dld.2013.11.002
   Danielson J, 2013, TECH COLOPROCTOL, V17, P389, DOI 10.1007/s10151-012-0949-8
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Deutekom M, 2007, AM J GASTROENTEROL, V102, P351, DOI 10.1111/j.1572-0241.2006.00927.x
   Devesa JM, 2002, DIS COLON RECTUM, V45, P1154, DOI 10.1007/s10350-004-6382-y
   Ditah I, 2014, CLIN GASTROENTEROL H, V12, P636, DOI 10.1016/j.cgh.2013.07.020
   Edden Y, 2009, EXPERT REV MED DEVIC, V6, P307, DOI [10.1586/erd.09.10, 10.1586/ERD.09.10]
   Efron Jonathan E, 2004, Surg Technol Int, V13, P107
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Fitzpatrick M, 2003, AM J OBSTET GYNECOL, V189, P730, DOI 10.1067/S0002-9378(03)00817-2
   Frascio M, 2014, COLORECTAL DIS, V16, P167, DOI 10.1111/codi.12403
   George AT, 2012, COLORECTAL DIS, V14, P98, DOI 10.1111/j.1463-1318.2010.02485.x
   George AT, 2012, DIS COLON RECTUM, V55, P302, DOI 10.1097/DCR.0b013e3182401ecd
   Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299
   Giordano P, 2002, DIS COLON RECTUM, V45, P635, DOI 10.1007/s10350-004-6260-7
   Glasgow SC, 2012, DIS COLON RECTUM, V55, P482, DOI 10.1097/DCR.0b013e3182468c22
   Goode PS, 2005, J AM GERIATR SOC, V53, P629, DOI 10.1111/j.1532-5415.2005.53211.x
   Gooneratne ML, 2007, DIS COLON RECTUM, V50, P449, DOI 10.1007/510350-006-0839-0
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174
   Hachiro Y, 2007, DIS COLON RECTUM, V50, P1996, DOI 10.1007/s10350-007-9060-z
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Holbrook C, 2012, SURG LAPARO ENDO PER, V22, pE58, DOI 10.1097/SLE.0b013e318244eb42
   Hollingshead JRF, 2011, COLORECTAL DIS, V13, P1030, DOI 10.1111/j.1463-1318.2010.02383.x
   Hong KD, 2013, J AM COLL SURGEONS, V217, P718, DOI 10.1016/j.jamcollsurg.2013.04.028
   Hull T, 2013, DIS COLON RECTUM, V56, P234, DOI 10.1097/DCR.0b013e318276b24c
   Hussain ZI, 2012, UPDATES SURG-ITALY, V64, P289, DOI 10.1007/s13304-012-0176-x
   Jensen LL, 1997, DIS COLON RECTUM, V40, P197, DOI 10.1007/BF02054988
   Johnson BL, 2015, J GASTROINTEST SURG, V19, P15, DOI 10.1007/s11605-014-2611-4
   Johnson E, 2010, ACTA OBSTET GYN SCAN, V89, P1466, DOI 10.3109/00016349.2010.519019
   Johnson JK, 2007, J MATERN-FETAL NEO M, V20, P547, DOI 10.1080/14767050701412917
   Kaiser AM, 2014, SURG ENDOSC, V28, P2277, DOI 10.1007/s00464-014-3464-3
   Kang SB, 2013, J KOREAN SURG SOC, V84, P216, DOI 10.4174/jkss.2013.84.4.216
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kim DW, 2009, AM J SURG, V197, P14, DOI 10.1016/j.amjsurg.2007.11.023
   Kwon S, 2005, DIS COLON RECTUM, V48, P323, DOI 10.1007/s10350-004-0899-y
   Lacima G, 2010, COLORECTAL DIS, V12, P742, DOI 10.1111/j.1463-1318.2009.01881.x
   Lam TJ, 2012, COLORECTAL DIS, V14, P214, DOI 10.1111/j.1463-1318.2011.02548.x
   Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x
   Lefebure B, 2008, INT J COLORECTAL DIS, V23, P993, DOI 10.1007/s00384-008-0514-0
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   LEITE Fernando Rocha, 2013, Arq. Gastroenterol., V50, P163, DOI 10.1590/S0004-28032013000200029
   Liberman H, 2001, DIS COLON RECTUM, V44, P1567, DOI 10.1007/BF02234373
   Lundby L, 2011, DIS COLON RECTUM, V54, P318, DOI 10.1007/DCR.0b013e31820348ac
   Mackey P, 2010, COLORECTAL DIS, V12, P367, DOI 10.1111/j.1463-1318.2009.01800.x
   Macmillan AK, 2008, DIS COLON RECTUM, V51, P1502, DOI 10.1007/s10350-008-9301-9
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, ABDOM IMAGING, V26, P76, DOI 10.1007/s002610000100
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Markland AD, 2010, J AM GERIATR SOC, V58, P1341, DOI 10.1111/j.1532-5415.2010.02908.x
   Maslekar S, 2013, DIS COLON RECTUM, V56, P354, DOI 10.1097/DCR.0b013e3182805276
   Matsuoka H, 2000, DIS COLON RECTUM, V43, P1561, DOI 10.1007/BF02236739
   Matzel KE, 2009, COLORECTAL DIS, V11, P636, DOI 10.1111/j.1463-1318.2008.01673.x
   Melenhorst J, 2008, INT J COLORECTAL DIS, V23, P107, DOI 10.1007/s00384-007-0357-0
   Mellgren A, 2010, SURG CLIN N AM, V90, P185, DOI 10.1016/j.suc.2009.10.006
   Meurette G, 2009, COLORECTAL DIS, V11, P631, DOI 10.1111/j.1463-1318.2008.01633.x
   Michelsen HB, 2010, DIS COLON RECTUM, V53, P414, DOI 10.1007/DCR.0b013e3181ca7dc2
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Norton C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub2
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Norton C, 2005, DIS COLON RECTUM, V48, P1062, DOI 10.1007/s10350-004-0868-5
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub3
   Omar MI, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD002116.PUB2
   Ommer A, 2008, INT J COLORECTAL DIS, V23, P1023, DOI 10.1007/s00384-008-0524-y
   Onishi K, 1989, Acta Chir Plast, V31, P56
   Oom DMJ, 2010, DIS COLON RECTUM, V53, P150, DOI 10.1007/DCR.0b013e3181bb059f
   Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862
   Ortiz H, 2003, INT J COLORECTAL DIS, V18, P349, DOI 10.1007/s00384-002-0472-x
   Ortiz H, 2001, REV ESP ENFERM DIG, V93, P130
   Osterberg A, 2000, DIS COLON RECTUM, V43, P1256, DOI 10.1007/BF02237432
   Pager CK, 2002, DIS COLON RECTUM, V45, P997, DOI 10.1097/01.DCR.0000019495.92696.34
   Pares D, 2010, COLORECTAL DIS, V12, P605, DOI 10.1111/j.1463-1318.2010.02202.x
   Pinsk I, 2009, COLORECTAL DIS, V11, P933, DOI 10.1111/j.1463-1318.2008.01730.x
   Qureshi MS, 2011, INT J COLORECTAL DIS, V26, P1589, DOI 10.1007/s00384-011-1273-x
   Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x
   Rasmussen OO, 2000, DIS COLON RECTUM, V43, P633, DOI 10.1007/BF02235577
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ratto C, 2010, DIS COLON RECTUM, V53, P264, DOI 10.1007/DCR.0b013e3181c7642c
   Raza N, 2009, DIGEST DIS SCI, V54, P2503, DOI 10.1007/s10620-008-0631-1
   Remes-Troche JM, 2008, INT J COLORECTAL DIS, V23, P189, DOI 10.1007/s00384-007-0391-y
   Ricciardi R, 2006, DIS COLON RECTUM, V49, P852, DOI 10.1007/s10350-006-0529-y
   Rieger NA, 1997, AUST NZ J SURG, V67, P566, DOI 10.1111/j.1445-2197.1997.tb02040.x
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   Rosen HR, 1998, AM J SURG, V175, P187, DOI 10.1016/S0002-9610(97)00289-4
   Rosen HR, 1999, CHIRURG, V70, P469, DOI 10.1007/s001040050674
   Rosier PFWM, 2010, NEUROUROL URODYNAM, V29, P146, DOI 10.1002/nau.20763
   Rothbarth J, 2000, DIGEST SURG, V17, P390, DOI 10.1159/000018883
   Carmona MDR, 2009, COLORECTAL DIS, V11, P831, DOI 10.1111/j.1463-1318.2008.01652.x
   Ruiz D, 2010, DIS COLON RECTUM, V53, P1041, DOI 10.1007/DCR.0b013e3181defff8
   Ruthmann O, 2006, CHIRURG, V77, P926, DOI 10.1007/s00104-006-1217-0
   Sangwan YP, 1996, DIS COLON RECTUM, V39, P686, DOI 10.1007/BF02056951
   Sansoni J, 2013, DIS COLON RECTUM, V56, P652, DOI 10.1097/DCR.0b013e318279c2ac
   SHAFIK A, 1993, INT SURG, V78, P159
   Shatari T, 2004, SURG TODAY, V34, P463, DOI 10.1007/s00595-003-2700-6
   Siddiqui AA, 2011, J PEDIATR GASTR NUTR, V52, P574, DOI 10.1097/MPG.0b013e3181ff6042
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Smith S, 2007, BRIT J SURG, V94
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Soffer EE, 2000, AM J GASTROENTEROL, V95, P1873
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Stone Anthony R, 2004, ScientificWorldJournal, V4 Suppl 1, P330
   Suilleabhain CBO, 2001, DIS COLON RECTUM, V44, P666
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Tan EK, 2008, COLORECTAL DIS, V10, P577, DOI 10.1111/j.1463-1318.2007.01418.x
   Terra MP, 2006, DIS COLON RECTUM, V49, P1149, DOI 10.1007/s10350-006-0569-3
   Thekkinkattil DK, 2008, BRIT J SURG, V95, P222, DOI 10.1002/bjs.5933
   Thin NN, 2013, BRIT J SURG, V100, P1430, DOI 10.1002/bjs.9226
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tillin T, 2006, BRIT J SURG, V93, P1402, DOI 10.1002/bjs.5393
   Titi MA, 2008, COLORECTAL DIS, V10, P131, DOI 10.1111/j.1463-1318.2007.01312.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364
   Tries J, 2004, GASTROENTEROLOGY, V126, pS152, DOI 10.1053/j.gastro.2003.10.039
   Trudinger A, 2008, OBSTET GYNECOL, V111, P1058, DOI 10.1097/AOG.0b013e31816c4433
   Ullah S, 2011, JCPSP-J COLL PHYSICI, V21, P227, DOI 04.2011/JCPSP.227229
   Vaizey CJ, 2004, DIS COLON RECTUM, V47, P858, DOI 10.1007/s10350-003-0112-8
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Vande Velde S, 2013, SPINAL CORD, V51, P873, DOI 10.1038/sc.2013.123
   Vergara-Fernandez O, 2011, Rev Gastroenterol Mex, V76, P384
   Vonthein R, 2013, INT J COLORECTAL DIS, V28, P1567, DOI 10.1007/s00384-013-1739-0
   Wald A, 2007, NEW ENGL J MED, V356, P1648, DOI 10.1056/NEJMcp067041
   Wald A, 2006, AM J GASTROENTEROL, V101, P2681, DOI 10.1111/j.1572-0241.2006.00900_2.x
   WALKER J, 1989, Z KINDERCHIR, V44, P44
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wasserberg N, 2011, COLORECTAL DIS, V13, P449, DOI 10.1111/j.1463-1318.2010.02208.x
   Watson NFS, 2012, COLORECTAL DIS, V14, P29, DOI 10.1111/codi.12047
   Wexner SD, 2009, DIS COLON RECTUM, V52, P1550, DOI 10.1007/DCR.0b013e3181af62f8
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   Wong MTC, 2012, COLORECTAL DIS, V14, pE323, DOI 10.1111/j.1463-1318.2012.02995.x
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   Yamana T, 2004, DIS COLON RECTUM, V47, P1982, DOI 10.1007/s10350-004-0675-z
   Yamout SZ, 2009, PEDIATR SURG INT, V25, P1081, DOI 10.1007/s00383-009-2496-6
   Zutshi M, 2010, INT J COLORECTAL DIS, V25, P277, DOI 10.1007/s00384-009-0830-z
NR 186
TC 28
Z9 30
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0012-3706
EI 1530-0358
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD JUL
PY 2015
VL 58
IS 7
BP 623
EP 636
DI 10.1097/DCR.0000000000000397
PG 14
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA CL7YN
UT WOS:000357189000002
PM 26200676
OA Bronze
DA 2018-10-20
ER

PT J
AU Roman, A
   Cioban, C
   Stratul, SI
   Schwarz, F
   Muste, A
   Petrutiu, SA
   Zaganescu, R
   Mihatovic, I
AF Roman, Alexandra
   Cioban, Cosmin
   Stratul, Stefan-Ioan
   Schwarz, Frank
   Muste, Aurel
   Petrutiu, Stefan-Adrian
   Zaganescu, Raluca
   Mihatovic, Ilja
TI Ridge preservation using a new 3D collagen matrix: a preclinical study
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Bone; Collagen membrane; Socket preservation; Wound healing; Animal
ID GUIDED BONE REGENERATION; CORONALLY ADVANCED FLAP; GINGIVAL RECESSION
   DEFECTS; CONTROLLED CLINICAL-TRIAL; MILLER CLASS-I; TOOTH EXTRACTION;
   ALVEOLAR RIDGE; SOCKET PRESERVATION; KERATINIZED MUCOSA;
   CONNECTIVE-TISSUE
AB Objectives The success of ridge preservation techniques in reducing bone resorption is well documented, but no clear guidelines have been provided regarding the type of the biomaterial or technique to be used. This experimental animal study aimed at comparing the effectiveness of two ridge preservation techniques.
   Materials and methods Following the extraction of the distal roots of the mandibular second and fourth premolars of four dogs, the sockets were preserved using a combination of a collagen membrane intimately covering the socket plus a collagen matrix or a collagen membrane alone. The mandibular quadrants were randomly assigned to one of the treatment groups. Histomorphometrical analyses as well as microscopic observations were performed.
   Results After 5 months of healing, the histological analysis revealed a similar picture of bone formation in both groups. No significant differences between the buccal and lingual dimensions were calculated between the two treatment groups. The mucosa covering the alveolar ridges is significantly more abundant in post-extraction sockets preserved with the double-layered approach.
   Conclusions The double-layered approach used to treat post-extraction sockets may result in a better preservation of the mucosal seal than the single-layered approach.
   Clinical relevance The use of the new collagen matrix associated with a collagen membrane could be a clinical option to preserve post-extraction ridges, especially when an improvement in soft tissue dimension and quality is desired. However, the cost-benefit ratio of this approach should be thoroughly evaluated in further studies.
C1 [Roman, Alexandra; Cioban, Cosmin; Petrutiu, Stefan-Adrian] Iuliu Hatieganu Univ Med & Pharm, Dept Periodontol, Cluj Napoca 400012, Romania.
   [Stratul, Stefan-Ioan] Victor Babes Univ Med & Pharm, Dept Periodontol, Timisoara 300014, Romania.
   [Schwarz, Frank; Mihatovic, Ilja] Univ Dusseldorf, Westdeutsche Kieferklin, Dept Oral Surg, D-40225 Dusseldorf, Germany.
   [Muste, Aurel] Univ Vet Med & Agr Sci, Dept Surg, Cluj Napoca 400372, Romania.
   [Zaganescu, Raluca] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca 400012, Romania.
RP Stratul, SI (reprint author), Victor Babes Univ Med & Pharm, Dept Periodontol, Bv Revolutiei 9, Timisoara 300014, Romania.
EM sbs@online.ro
OI Stratul, Stefan-Ioan/0000-0002-9154-9511; Roman,
   Alexandra/0000-0002-0649-9426
CR Al-Asfour A, 2013, INT J PERIODONT REST, V33, P177, DOI 10.11607/prd.1552
   Al-Hezaimi K, 2013, J ORAL IMPLANTOL
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2011, OSTEOLOGY GUIDELINES, P123
   Artzi Z, 2006, CLIN ORAL IMPLAN RES, V17, P85, DOI 10.1111/j.1600-0501.2005.01178.x
   Barone A, 2014, J PERIODONTOL, V85, P14, DOI 10.1902/jop.2013.120711
   Bashara H, 2012, CLIN ORAL IMPLAN RES, V23, P911, DOI 10.1111/j.1600-0501.2011.02240.x
   Bornstein MM, 2007, J PERIODONTOL, V78, P1943, DOI 10.1902/jop.2007.070102
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Bragger U, 1997, CLIN ORAL IMPLAN RES, V8, P412, DOI 10.1034/j.1600-0501.1997.080508.x
   Brownfield LA, 2012, J PERIODONTOL, V83, P581, DOI 10.1902/jop.2011.110365
   Camelo M, 2012, INT J PERIODONT REST, V32, P167
   Cardaropoli D, 2012, J PERIODONTOL, V83, P321, DOI 10.1902/jop.2011.110215
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Cioban C, 2013, ROM J MORPHOL EMBRYO, V54, P125
   COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037//0003-066X.49.12.997
   Cook DC, 2013, J PERIODONTOL, V84, P585, DOI 10.1902/jop.2012.120219
   Darby I, INT J ORAL MAXIL S24, P260
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630
   Faggion CM, 2011, J CLIN PERIODONTOL, V38, P1154, DOI 10.1111/j.1600-051X.2011.01783.x
   Horowitz Robert, 2012, J Evid Based Dent Pract, V12, P149, DOI 10.1016/S1532-3382(12)70029-5
   Ivanovic A, 2013, CLIN ORAL INVESTIG
   Jung RE, 2013, J CLIN PERIODONTOL, V40, P90, DOI 10.1111/jcpe.12027
   Jung RE, 2011, J CLIN PERIODONTOL, V38, P173, DOI 10.1111/j.1600-051X.2010.01640.x
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kim SH, 2009, CLIN ORAL IMPLAN RES, V20, P1124, DOI 10.1111/j.1600-0501.2009.01744.x
   Lambert F, 2012, J CLIN PERIODONTOL, V39, P887, DOI 10.1111/j.1600-051X.2012.01900.x
   Leblebicioglu B, 2013, J CLIN PERIODONTOL, V40, P387, DOI 10.1111/jcpe.12065
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   Lin GH, 2013, J PERIODONTOL, V84, P1755, DOI 10.1902/jop.2013.120688
   McGuire MK, 2010, J PERIODONTOL, V81, P1108, DOI 10.1902/jop.2010.090698
   Molnar B, 2013, QUINTESSENCE INT, V44, P17, DOI 10.3290/j.qi.a28739
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Nevins M, 2010, INT J PERIODONT REST, V30, P151
   Orgeas GV, 2013, INT J ORAL MAX IMPL, V28, P1049, DOI 10.11607/jomi.2670
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Poulias E, 2013, J PERIODONTOL, V84, P1567, DOI 10.1902/jop.2013.120585
   Reichert C, 2011, J OROFAC ORTHOP, V72, P45, DOI 10.1007/s00056-010-0006-z
   Rothamel D, 2008, INT J ORAL MAX SURG, V37, P741, DOI 10.1016/j.ijom.2008.04.017
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schmitt CM, 2013, J PERIODONTOL, V84, P914, DOI 10.1902/jop.2012.120084
   Schwarz F, 2012, CLIN ORAL IMPLAN RES, V23, P83, DOI 10.1111/j.1600-0501.2011.02187.x
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Tarnow D P, 1996, J Esthet Dent, V8, P12, DOI 10.1111/j.1708-8240.1996.tb00904.x
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Thoma DS, 2012, J CLIN PERIODONTOL, V39, P157, DOI 10.1111/j.1600-051X.2011.01823.x
   Thoma DS, 2011, J CLIN PERIODONTOL, V38, P1063, DOI 10.1111/j.1600-051X.2011.01786.x
   Thomson D, 2011, CAN J EDUC ADM POLIC, P1, DOI 10.1111/j.1600-0501.2011.02356.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Vignoletti F, 2011, J CLIN PERIODONTOL, V38, P847, DOI 10.1111/j.1600-051X.2011.01767.x
   Zigdon H, 2008, CLIN ORAL IMPLAN RES, V19, P387, DOI 10.1111/j.1600-0501.2007.01492.x
NR 56
TC 6
Z9 6
U1 0
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD JUL
PY 2015
VL 19
IS 6
BP 1527
EP 1536
DI 10.1007/s00784-014-1368-1
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CL2LA
UT WOS:000356774100040
PM 25418353
DA 2018-10-20
ER

PT J
AU D'Mello, S
   Elangovan, S
   Hong, L
   Ross, RD
   Sumner, DR
   Salem, AK
AF D'Mello, Sheetal
   Elangovan, Satheesh
   Hong, Liu
   Ross, Ryan D.
   Sumner, D. Rick
   Salem, Aliasger K.
TI Incorporation of copper into chitosan scaffolds promotes bone
   regeneration in rat calvarial defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitosan; copper; biodegradable scaffolds; tissue engineering; bone
   regeneration
ID GROWTH-FACTOR; METAL-IONS; RABBITS; BIODEGRADATION; PROLIFERATION;
   ANGIOGENESIS; BIOMATERIAL; MEMBRANE; CHITIN
AB The objective of this study was to investigate the effects of a copper loaded chitosan scaffold on bone regeneration in critical-sized calvarial defects in rats. Chitosan scaffolds and copper-chitosan scaffolds were fabricated and characterized by scanning electron microscopy (SEM). Chitosan and copper-chitosan scaffolds were implanted into 5 mm diameter critical-sized calvarial defects in Fisher 344 male rats. Empty defects (no scaffolds) were included as a control. After 4 weeks, the rats were sacrificed for microcomputed tomography (micro-CT) and histological analysis of new bone tissue development. Microscopy images revealed the uniformly porous structure of chitosan and copper-chitosan scaffolds. Significant bone regeneration was noted in the defects treated with copper-chitosan scaffolds when evaluated using micro-CT and histological analysis, when compared with other groups tested. On analysis of the micro-CT scans, an eleven-fold and a two-fold increase in the new bone volume/total volume (BV/TV) % was found in defects treated with the copper-chitosan scaffolds, when compared to empty defects and chitosan scaffolds, respectively. This study demonstrated the suitability of copper-crosslinked chitosan scaffolds for bone tissue engineering and provides the first evidence that inclusion of copper ions in scaffolds can enhance tissue regeneration. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1044-1049, 2015.
C1 [D'Mello, Sheetal; Salem, Aliasger K.] Univ Iowa, Coll Pharm, Div Pharmaceut & Translat Therapeut, Iowa City, IA 52242 USA.
   [Elangovan, Satheesh; Salem, Aliasger K.] Univ Iowa, Dept Periodont, Coll Dent, Iowa City, IA 52242 USA.
   [Hong, Liu] Univ Iowa, Dept Prosthodont, Coll Dent, Iowa City, IA 52242 USA.
   [Ross, Ryan D.; Sumner, D. Rick] Rush Med Coll, Dept Anat & Cell Biol, Chicago, IL 60612 USA.
RP Salem, AK (reprint author), Univ Iowa, Coll Pharm, Div Pharmaceut & Translat Therapeut, Iowa City, IA 52242 USA.
EM satheesh-elangovan@uiowa.edu; aliasger-salem@uiowa.edu
OI Salem, Aliasger/0000-0002-1923-6633
FU ITI Foundation for the Promotion of Implantology, Switzerland [855
   2012]; American Cancer Society [RSG-09-015-01-CDD]; National Cancer
   Institute, National Institutes of Health
   [1R21CA13345-01/R21CA128414-01A2/UI]; Mayo Clinic Lymphoma SPORE;
   University of Iowa Start-up Grant; Osteology Foundation, Switzerland;
   Osseointegration Foundation, USA; Lyle and Sharon Bighley Professorship
FX Contract grant sponsor: ITI Foundation for the Promotion of
   Implantology, Switzerland; contract grant number: 855 2012; Contract
   grant sponsor: American Cancer Society; contract grant number:
   RSG-09-015-01-CDD; Contract grant sponsor: National Cancer Institute,
   National Institutes of Health; contract grant number:
   1R21CA13345-01/R21CA128414-01A2/UI Mayo Clinic Lymphoma SPORE; Contract
   grant sponsors: University of Iowa Start-up Grant, the Osteology
   Foundation, Switzerland, the Osseointegration Foundation, USA, the Lyle
   and Sharon Bighley Professorship
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917
   Borkow G., 2004, COPPERS ROLE WOUND H
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang PC, 2010, GENE THER, V17, P95, DOI 10.1038/gt.2009.117
   Connolly J F, 1989, J Orthop Trauma, V3, P276, DOI 10.1097/00005131-198912000-00002
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035
   HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x
   Hermann J, 1995, CURR OPIN PERIODONT, V3, P168
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   Jegoux F, 2009, J BIOMED MATER RES A, V91A, P1160, DOI 10.1002/jbm.a.32274
   Kofuji K, 2005, INT J PHARM, V303, P95, DOI 10.1016/j.ijpharm.2005.07.011
   Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595
   LANE JM, 1999, CLIN ORTHOP S, V367, pS107
   Lim HC, 2010, J BIOMED MATER RES B, V95B, P47, DOI 10.1002/jbm.b.31681
   MCAUSLAN BR, 1980, EXP CELL RES, V130, P147, DOI 10.1016/0014-4827(80)90051-8
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   RAJU KS, 1982, J NATL CANCER I, V69, P1183
   Rhazi M, 2002, EUR POLYM J, V38, P1523, DOI 10.1016/S0014-3057(02)00026-5
   SCHLICK S, 1986, MACROMOLECULES, V19, P192, DOI 10.1021/ma00155a030
   Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wongrakpanich A, 2014, MOL PHARMACEUT, V11, P1022, DOI 10.1021/mp400689r
   Worthington KLS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/39/395101
   Yang C, 2014, J BIOMED MATER RES B, V102, P80, DOI 10.1002/jbm.b.32984
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 33
TC 15
Z9 15
U1 3
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2015
VL 103
IS 5
BP 1044
EP 1049
DI 10.1002/jbm.b.33290
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL0ZO
UT WOS:000356671800011
PM 25230382
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kim, JE
   Kim, SH
   Jung, Y
AF Kim, Ji Eun
   Kim, Soo Hyun
   Jung, Youngmee
TI In situ chondrogenic differentiation of bone marrow stromal cells in
   bioactive self-assembled peptide gels
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Collagen mimetic peptide; Self-assembled peptide; In situ chondrogenic
   differentiation; Bioactive; Bone marrow stromal cells
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING SCAFFOLDS; CARTILAGE TISSUE;
   NANOFIBER SCAFFOLDS; CONTROLLED-RELEASE; PROGENITOR CELLS; HYDROGELS;
   REGENERATION; CULTURES; DESIGN
AB Articular cartilage is a specific tissue that lacks nerves and blood vessels and has limited self-repair abilities. Accordingly, it is necessary to develop new technology for the regeneration of cartilage to overcome therapeutic limitations. Recently, there have been several studies investigating the use of peptide hydrogel scaffolds, which are biocompatible and have low immunogenicity, for cartilage tissue engineering. In this study, we used self-assembled peptide hydrogels with repeating peptide sequences and bioactive motifs at the end of repeating sequences, which are collagen mimetic peptides (CMPs). CMPs that have a unique collagen-like triple helical conformation have been shown to associate with collagen molecules and fibers via a strand invasion process. In order to confirm the biological activities of the modified bioactive peptide hydrogels, the role of functional motifs in in situ chondrogenic differentiation of rabbit bone marrow stromal cells (rBMSCs) was examined. To compensate for the weaker mechanical properties of peptide hydrogels, we used poly (L-lactide-co-caprolactone) (PLCL) scaffolds, which were loaded with the self-assembled peptides into which the bioactive motifs had been incorporated. Then, we performed in vitro and in vivo analyses with the rBMSC/PLCL-peptide hydrogel complexes. The results indicated that the secretion of a cartilage-specific extracellular matrix and gene expression concerned with chondrogenic differentiation were increased by CMP motifs. In conclusion, it was confirmed that CMP-modified self-assembled peptide hydrogels could effectively enhance chondrogenic differentiation in situ, and, consequently, they could be a good biomaterial for cartilage tissue engineering. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.
C1 [Kim, Ji Eun; Kim, Soo Hyun; Jung, Youngmee] Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 136791, South Korea.
   [Kim, Ji Eun; Kim, Soo Hyun] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136705, South Korea.
   [Kim, Soo Hyun; Jung, Youngmee] Univ Sci & Technol, Dept Biomed Engn, Seoul 136791, South Korea.
RP Jung, Y (reprint author), Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 136791, South Korea.
EM cantata7@gmail.com; soohkim@kist.re.kr; winnie97@kist.re.kr
OI Kim, Soo Hyun/0000-0002-8391-3686; Jung, Youngmee/0000-0002-4778-4629
FU Korea Institute of Science and Technology Institutional Program
   [2E25119, 2E24680]
FX This study was supported by the Korea Institute of Science and
   Technology Institutional Program (2E25119 and 2E24680).
CR Appleton CTG, 2007, ANN NY ACAD SCI, V1117, P165, DOI 10.1196/annals.1402.022
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Cassiede P, 1996, J BONE MINER RES, V11, P1264
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsu L, 2008, J AM CHEM SOC, V130, P3892, DOI 10.1021/ja076553s
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034
   Jung Y, 2008, BIOMATERIALS, V29, P4630, DOI 10.1016/j.biomaterials.2008.08.031
   Kim HJ, 2009, TISSUE ENG PT A, V15, P1543, DOI 10.1089/ten.tea.2008.0368
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4
   Kopesky PW, 2010, TISSUE ENG PT A, V16, P465, DOI [10.1089/ten.tea.2009.0158, 10.1089/ten.TEA.2009.0158]
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057
   Merceron C, 2008, JOINT BONE SPINE, V75, P672, DOI 10.1016/j.jbspin.2008.07.007
   Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Roberts S, 2011, REGEN MED, V6, P351, DOI [10.2217/RME.11.21, 10.2217/rme.11.21]
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Xie J, 2006, TISSUE ENG, V12, P449, DOI 10.1089/ten.2006.12.449
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
NR 42
TC 11
Z9 11
U1 1
U2 46
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2015
VL 120
IS 1
BP 91
EP 98
DI 10.1016/j.jbiosc.2014.11.012
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA CL2ES
UT WOS:000356757000016
PM 25540912
DA 2018-10-20
ER

PT J
AU Park, HJ
   Lee, OJ
   Lee, MC
   Moon, BM
   Ju, HW
   Lee, JM
   Kim, JH
   Kim, DW
   Park, CH
AF Park, Hyun Jung
   Lee, Ok Joo
   Lee, Min Chae
   Moon, Bo Mi
   Ju, Hyung Woo
   Lee, Jung Min
   Kim, Jung-Ho
   Kim, Dong Wook
   Park, Chan Hum
TI Fabrication of 3D porous silk scaffolds by particulate (salt/sucrose)
   leaching for bone tissue reconstruction
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk fibroin; Hydroxyapatite; Particulate leaching; Bone reconstruction
ID MESENCHYMAL STEM-CELLS; IN-VITRO; FIBROIN; SALT; BIOCOMPATIBILITY;
   BIOMATERIALS; CARTILAGE; POLYMER; VIVO
AB Silk fibroin is a biomaterial being actively studied in the field of bone tissue engineering. In this study, we aimed to select the best strategy for bone reconstruction on scaffolds by changing various conditions. We compared the characteristics of each scaffold via structural analysis using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), the swelling ratio, water uptake, porosity, compressive strength, cell infiltration and cell viability (CCK-8). The scaffolds had high porosity with good inter pore connectivity and showed high compressive strength and modulus. In addition, to confirm bone reconstruction, animal studies were conducted in which samples were implanted in rat calvaria and investigated by micro-CT scans. In conclusion, the presented study indicates that using sucrose produces scaffolds showing better pore interconnectivity and cell infiltration than scaffolds made by using a salt process. In addition, in vivo experiments showed that hydroxyapatite accelerates bone reconstruction on implanted scaffolds. Accordingly, our scaffold will be expected to have a useful application in bone reconstruction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Park, Hyun Jung; Lee, Ok Joo; Lee, Min Chae; Moon, Bo Mi; Ju, Hyung Woo; Lee, Jung Min; Kim, Jung-Ho; Kim, Dong Wook; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, Chunchon 200702, Gangwon, South Korea.
   [Park, Chan Hum] Hallym Univ Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200704, Gangwon, South Korea.
RP Park, CH (reprint author), Hallym Univ Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 153 Kyo Dong, Chunchon 200704, Gangwon, South Korea.
EM hlpch@paran.com
RI 이, 옥주/B-8523-2016; Park, Chan Hum/C-6848-2016
FU Hallym University Research Fund; Technology Commercialization Support
   Program, Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea [814005-03-1-HD030]
FX This work was supported by a grant from Hallym University Research Fund
   and Technology Commercialization Support Program (814005-03-1-HD030),
   Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea.
CR Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   El Mhammedi M.A., 2007, J PRACT TECHNOL, V6, P1
   Fosso F., 2004, J CELL PHYSL, V199, P174
   Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Park HJ, 2014, MACROMOL RES, V22, P592, DOI 10.1007/s13233-014-2083-0
   Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3
   PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110
   Purohit K.M., 2011, BIOPROCES BIOTECHNIQ, V1, P1
   Reignier J, 2006, POLYMER, V47, P4703, DOI 10.1016/j.polymer.2006.04.029
   Sheikh F. A., 2015, J TISSUE ENG REGEN M
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Soliman S, 2011, J BIOMED MATER RES A, V96A, P566, DOI 10.1002/jbm.a.33010
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang XH, 2012, J MATER SCI-MATER M, V23, P315, DOI 10.1007/s10856-011-4476-3
   Zhao Y., 2011, J BIOMED SCI ENG, V4, P397, DOI [10.4236/jbise.2011.45050, DOI 10.4236/JBISE.2011.45050]
NR 29
TC 24
Z9 24
U1 2
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL
PY 2015
VL 78
BP 215
EP 223
DI 10.1016/j.ijbiomac.2015.03.064
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CK4LN
UT WOS:000356195400029
PM 25849999
DA 2018-10-20
ER

PT J
AU Linh, NTB
   Padalhin, AR
   Lee, BY
   Lee, BT
AF Nguyen Thuy Ba Linh
   Padalhin, Andrew R.
   Lee, Byung-Yeol
   Lee, Byong-Taek
TI Bilayer electrospun poly(vinyl alcohol)-gelatin mat and biphasic calcium
   phosphate-pectin-gelatin hydrogel for application in bone hemorrhage
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Bilayer hemostatic scaffold; biphasic calcium phosphate-pectin-gelatin;
   electrospun poly(vinyl alcohol)-gelatin; bone hemorrhage application;
   hemostatic agent
ID TOPICAL HEMOSTATIC AGENTS; ANIMAL-MODEL; LOCAL AGENTS; FABRICATION;
   MORTALITY; SURGICEL; COLLAGEN; POLYMER; SKIN; WAX
AB A bilayer composite scaffold consisting of a biphasic calcium phosphate-pectin-gelatin hydrogel and an electrospun poly(vinyl alcohol)-gelatin matrix was developed and investigated for application in bone hemorrhage. The aim of this research is to develop a new biomaterial system that provides a hemostatic effect on bone hemorrhage and does not interfere with native bone regeneration. The role of electrospun poly(vinyl alcohol)-gelatin in scaffolds is to provide the covering of the wound, while encapsulation and absorption of red blood cells are attributed to the biphasic calcium phosphate-pectin-gelatin hydrogel. Cell viability and cell proliferation were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, Live/Dead assay, and immunofluorescence assay using pre-osteoblast MC3T3-E1 cells. The effects with and without hemostatic bilayer scaffolds on rat calvaria were compared at 1 and 3weeks. The hemostatic bilayer agent showed good blood absorption behavior and efficient bone healing properties after 3weeks, as observed by micro-computed tomography and hematoxylin and eosin staining.
C1 [Nguyen Thuy Ba Linh; Padalhin, Andrew R.; Lee, Byong-Taek] Soonchunhyang Univ, Dept Regenerat Med, Coll Med, Cheonan 330721, South Korea.
   [Nguyen Thuy Ba Linh; Lee, Byong-Taek] Soonchunhyang Univ, Inst Tissue Regenerat, Coll Med, Cheonan 330721, South Korea.
   [Lee, Byung-Yeol] Soonchunhyang Univ, InoBone Corp R&D Ctr, Asan, South Korea.
RP Lee, BT (reprint author), Soonchunhyang Univ, Dept Regenerat Med, Coll Med, Cheonan 330721, South Korea.
EM lbt@sch.ac.kr
FU Business for Academic-industrial Cooperative establishments [C0247339]
FX This work (Grants No. C0247339) was supported by Business for
   Academic-industrial Cooperative establishments funded Korea Small and
   Medium Business Administration in 2014.
CR Armstrong JK, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-37
   Brightmore T G, 1975, Langenbecks Arch Chir, VSuppl, P39
   Byong-Taek Lee, 2007, Materials Chemistry & Physics, V104, P249, DOI 10.1016/j.matchemphys.2007.02.009
   CARSON JL, 1988, LANCET, V1, P727
   Cheng CM, 2009, CLIN THER, V31, P32, DOI 10.1016/j.clinthera.2009.01.005
   COBDEN RH, 1976, J BONE JOINT SURG AM, V58, P70, DOI 10.2106/00004623-197658010-00012
   Groenewold MD, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-15
   Hattori H, 2010, ANN BIOMED ENG, V38, P3724, DOI 10.1007/s10439-010-0121-4
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x
   Linh NTB, 2010, J BIOMED MATER RES B, V95B, P184, DOI 10.1002/jbm.b.31701
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Magyar CE, 2008, NEUROSURGERY, V63, P373, DOI 10.1227/01.NEU.0000316859.03788.44
   Murat FJL, 2004, J UROLOGY, V172, P1119, DOI 10.1097/01.ju.0000136001.99920.97
   NAPPI JF, 1980, CLEFT PALATE J, V17, P291
   Linh NTB, 2013, J MATER SCI, V48, P4233, DOI 10.1007/s10853-013-7236-6
   Linh NTB, 2013, J BIOMAT SCI-POLYM E, V24, P520, DOI 10.1080/09205063.2012.697696
   Nguyen TBL, 2012, J BIOMATER APPL, V27, P255, DOI 10.1177/0885328211401932
   Ostomel TA, 2007, LANGMUIR, V23, P11233, DOI 10.1021/la701281t
   Pal K, 2007, AAPS PHARMSCITECH, V8
   Palm MD, 2008, DERMATOL SURG, V34, P431, DOI 10.1111/j.1524-4725.2007.34090.x
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Peng Tao, 2010, TRENDS BIOMATER ARTI, V24, P27
   Sabel M, 2004, EUR SPINE J, V13, pS97, DOI 10.1007/s00586-004-0735-z
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   So-Ra S, 2013, SCI TECHNOL ADV MAT, V14
   SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9
   Tadeusz W, 2006, J CRANIOFAC SURG, V17, P420, DOI 10.1097/00001665-200605000-00006
   Nguyen TBL, 2015, TISSUE ENG PT A, V21, P1376, DOI [10.1089/ten.TEA.2014.0313, 10.1089/ten.tea.2014.0313]
   Wellisz T, 2008, ANN THORAC SURG, V85, P1776, DOI 10.1016/j.athoracsur.2007.11.042
NR 31
TC 1
Z9 1
U1 5
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2015
VL 30
IS 4
BP 424
EP 435
DI 10.1177/0883911515578762
PG 12
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA CK7NO
UT WOS:000356419400006
DA 2018-10-20
ER

PT J
AU Laffleur, F
   Psenner, J
   Suchaoin, W
AF Laffleur, Flavia
   Psenner, Julia
   Suchaoin, Wongsakorn
TI Permeation Enhancement via Thiolation: In Vitro and Ex Vivo Evaluation
   of Hyaluronic Acid-Cysteine Ethyl Ester
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE biomaterial; Caco-2 cells; mucosal drug delivery; oral drug delivery;
   permeation enhancers
ID DRUG-DELIVERY; MUCOADHESIVE POLYMERS; ENHANCING PROPERTIES; NONINVASIVE
   PEPTIDE; THIOMERS; POLYCARBOPHIL; SYSTEMS; PROTEIN
AB It was the aim of this study to evaluate the permeation-enhancing effect of synthesized thiolated hyaluronic acid (HA). HA, a naturally found polysaccharide, was chemically modified with l-cysteine ethyl ether (C) via amide bond formation. In vitro permeation enhancement was tested on Caco-2 cells with two compounds, sulforhodamine (SR) and fluorescein isothiocyanate-dextran (FD4). Cytotoxicity assays as lactate dehydrogenase and thiazolyl blue tetrazolium bromide (MTT) were performed on colon carcinoma cell line. Transepithelial electrical resistance (TEER) measurements were conducted. Ex vivo evaluation was accomplished on rat intestinal mucosa in order to predict the permeation enhancing effect with SR, sodium fluorescein (SF), and FD4, respectively. The MTT as well as lactate dehydrogenase revealed no toxicity over time periods of 3 and 12 h, respectively. The bioconjugate is biocompatible and safe to use. Furthermore, TEER measurements showed the integrity of tight junctions. The in vitro permeation studies on cell studies exhibit 1.28-fold enhancement for SR and 1.47-fold enhancement for FD4 with hyaluronic acid-cysteine ethyl ester (HAC) in comparison to unmodified one. The ex vivo transport studies exhibit 1.9-fold enhancement for SF, 1.31-fold enhancement for Rhodamine123, and 1.3-fold enhancement for FD4 with HAC in comparison to unmodified one, respectively. Thus, the promising results encourage further investigations and exploitation of this versatile polysaccharide. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2153-2160, 2015
C1 [Laffleur, Flavia; Psenner, Julia; Suchaoin, Wongsakorn] Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Pharm, Dept Pharmaceut Technol, A-6020 Innsbruck, Austria.
RP Laffleur, F (reprint author), Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Pharm, Dept Pharmaceut Technol, A-6020 Innsbruck, Austria.
EM Flavia.Laffleur@uibk.ac.at
FU FWF (Fonds zur Forderung der wissenschaftlichen Forschung) [ZFP 235150]
FX The authors wish to thank the slaughterhouse Josef Mayr in Natters for
   providing the porcine mucosa. This work was supported by the FWF (Fonds
   zur Forderung der wissenschaftlichen Forschung) project No. ZFP 235150.
CR Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J
   Bernkop-Schnurch A, 2003, J CONTROL RELEASE, V93, P95, DOI 10.1016/j.jconrel.2003.05.001
   Bernkop-Schnurch A, 2004, EUR J PHARM BIOPHARM, V58, P253, DOI 10.1016/j.ejpb.2004.03.032
   Bernkop-Schnurch A, 2000, EXPERT OPIN THER PAT, V10, P1357, DOI 10.1517/13543776.10.9.1357
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   Clausen AE, 2002, PHARMACEUT RES, V19, P602, DOI 10.1023/A:1015345827091
   Clausen AE, 2000, J PHARM SCI, V89, P1253, DOI 10.1002/1520-6017(200010)89:10<1253::AID-JPS3>3.0.CO;2-8
   Guggi D, 2005, INT J PHARM, V288, P141, DOI 10.1016/j.ijpharm.2004.09.023
   Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019
   Laffleur F, 2012, DRUG DEV IND PHARM, V39, P1531
   Laffleur F, 2014, J PHARM SCI-US, V103, P2414, DOI 10.1002/jps.24060
   Laffleur F, 2014, DRUG DEV IND PHARM, V40, P591, DOI 10.3109/03639045.2014.892959
   Laffleur F, 2013, NANOMEDICINE-UK, V8, P2061, DOI 10.2217/nnm.13.178
   Laffleur F, 2012, FUTURE MED CHEM, V4, P2205, DOI [10.4155/FMC.12.165, 10.4155/fmc.12.165]
   Leitner VM, 2004, J PHARM SCI-US, V93, P1682, DOI 10.1002/jps.20069
   Mero A, 2014, POLYMERS-BASEL, V6, P346, DOI 10.3390/polym6020346
   Necas J, 2008, VET MED-CZECH, V53, P397
   Nowak J, 2014, INT J PHARMACEUT, V478, P383
   Rahmat D, 2012, INT J PHARMACEUT, V422, P40, DOI 10.1016/j.ijpharm.2011.10.024
   Sarti F, 2012, EUR J PHARM BIOPHARM, V84, P132
   Schmitz T, 2008, DRUG DELIV, V15, P245, DOI 10.1080/10717540802006708 
   Shahnaz G, 2013, EUR J PHARM BIOPHARM, V85, P346, DOI 10.1016/j.ejpb.2013.02.010
   Siissalo S, 2009, EUR J PHARM BIOPHARM, V71, P332, DOI 10.1016/j.ejpb.2008.08.010
   Wang XQ, 2012, INT J PHARMACEUT, V438, P217, DOI 10.1016/j.ijpharm.2012.08.045
   Werle M, 2009, J PHARM SCI-US, V98, P1643, DOI 10.1002/jps.21550
NR 25
TC 10
Z9 11
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD JUL
PY 2015
VL 104
IS 7
BP 2153
EP 2160
DI 10.1002/jps.24456
PG 8
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA CL1LT
UT WOS:000356705500005
PM 25900642
DA 2018-10-20
ER

PT J
AU Gonzalez, LM
   Moeser, AJ
   Blikslager, AT
AF Gonzalez, Liara M.
   Moeser, Adam J.
   Blikslager, Anthony T.
TI Porcine models of digestive disease: the future of large animal
   translational research
SO TRANSLATIONAL RESEARCH
LA English
DT Review
ID ISCHEMIA-REPERFUSION INJURY; ACUTE MESENTERIC ISCHEMIA; SMALL-BOWEL
   RESECTION; PROSTAGLANDIN-INDUCED RECOVERY; MUCOSAL BARRIER FUNCTION;
   HUMANIZED MOUSE MODELS; NECROTIZING ENTEROCOLITIS; INTESTINAL ISCHEMIA;
   PRETERM PIGS; PANETH CELLS
AB There is increasing interest in nonrodent translational models for the study of human disease. The pig, in particular, serves as a useful animal model for the study of pathophysiological conditions relevant to the human intestine. This review assesses currently used porcine models of gastrointestinal physiology and disease and provides a rationale for the use of these models for future translational studies. The pig has proven its utility for the study of fundamental disease conditions such as ischemia-reperfuion injury, stress-induced intestinal dysfunction, and short bowel syndrome. Pigs have also shown great promise for the study of intestinal barrier function, surgical tissue manipulation and intervention, as well as biomaterial implantation and tissue transplantation. Advantages of pig models highlighted by these studies include the physiological similarity to human intestine and mechanisms of human disease. Emerging future directions for porcine models of human disease include the fields of transgenics and stem cell biology, with exciting implications for regenerative medicine.
C1 N Carolina State Univ, Ctr Comparat Med & Translat Res, Dept Clin Sci, Raleigh, NC 27695 USA.
   N Carolina State Univ, Ctr Comparat Med & Translat Res, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.
RP Gonzalez, LM (reprint author), Coll Vet Med, 1060 William Moore Dr, Raleigh, NC 27607 USA.
EM Lmgonza4@ncsu.edu
OI Blikslager, Anthony/0000-0002-0867-7310; Moeser,
   Adam/0000-0003-3068-627X
FU NICHD NIH HHS [R01 HD072968]; NIH HHS [T35 OD011070, T32 OD011130];
   NIDDK NIH HHS [P30 DK034987]
CR Abu-Elmagd KM, 2012, ANN SURG, V256, P494, DOI 10.1097/SLA.0b013e318265f310
   Acosta S, 2007, J SURG RES, V143, P320, DOI 10.1016/j.jss.2007.02.003
   Acosta S, 2012, J EMERG MED, V42, P635, DOI 10.1016/j.jemermed.2011.03.036
   Ahdieh N, 1998, PEDIATR RES, V43, P227, DOI 10.1203/00006450-199802000-00012
   Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9
   [Anonymous], 2007, SWINE LAB SURG ANEST
   ARGENZIO RA, 1990, GASTROENTEROLOGY, V98, P1129, DOI 10.1016/0016-5085(90)90325-U
   Avansino JR, 2006, J SURG RES, V132, P74, DOI 10.1016/j.jss.2005.09.009
   Azcarate-Peril M Andrea, 2011, Gut Microbes, V2, P234, DOI 10.4161/gmic.2.4.16332
   Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009
   BELLAMY JEC, 1973, CAN J COMP MED, V37, P56
   Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004
   Benhamou PH, 1997, J PEDIATR SURG, V32, P1332, DOI 10.1016/S0022-3468(97)90315-8
   Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953
   Bicakci Unal, 2013, Afr J Paediatr Surg, V10, P91, DOI 10.4103/0189-6725.115030
   BIJLSMA PB, 1995, GASTROENTEROLOGY, V108, P687, DOI 10.1016/0016-5085(95)90440-9
   Bines JE, 2002, J GASTROEN HEPATOL, V17, P1170, DOI 10.1046/j.1440-1746.2002.02872.x
   Bitar KN, 2012, NEUROGASTROENT MOTIL, V24, P7, DOI 10.1111/j.1365-2982.2011.01843.x
   Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006
   Blikslager AT, 1997, SURGERY, V121, P526, DOI 10.1016/S0039-6060(97)90107-0
   Blikslager AT, 1999, SURGERY, V125, P186, DOI 10.1016/S0039-6060(99)70264-3
   Blikslager AT, 1999, AM J PHYSIOL-GASTR L, V276, pG28, DOI 10.1152/ajpgi.1999.276.1.G28
   Block T, 2011, EUR J VASC ENDOVASC, V41, P281, DOI 10.1016/j.ejvs.2010.09.012
   Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094
   BOROS M, 1995, J SURG RES, V59, P311, DOI 10.1006/jsre.1995.1170
   Brehm MA, 2010, CURR OPIN ENDOCRINOL, V17, P120, DOI 10.1097/MED.0b013e328337282f
   Brown DR, 1997, COMP BIOCHEM PHYS A, V118, P309, DOI 10.1016/S0300-9629(96)00311-8
   Brown DR, 2004, NEUROGASTROENT MOTIL, V16, P50, DOI 10.1111/j.1743-3150.2004.00475.x
   Bruhn RS, 2013, INVEST RADIOL, V48, P231, DOI 10.1097/RLI.0b013e3182809143
   Burrin DG, 2000, AM J PHYSIOL-GASTR L, V279, pG1249
   Burton J, 2014, VET CLIN N AM-SMALL, V44, P977, DOI 10.1016/j.cvsm.2014.05.006
   Butler JE, 2013, J LEUKOCYTE BIOL, V94, P259, DOI 10.1189/jlb.0313120
   Casley-Smith JR, 1984, PHYSL INTESTINAL CIR, P9
   Chen CS, 2006, EUR J PHARMACOL, V539, P116, DOI 10.1016/j.ejphar.2006.03.081
   Chen DC, 2006, J SURG RES, V134, P52, DOI 10.1016/j.jss.2006.03.029
   Chen YM, 2003, WORLD J GASTROENTERO, V9, P795, DOI 10.3748/wjg.v9.i4.795
   Chung S. K., 1997, Hong Kong Medical Journal, V3, P201
   Cilieborg MS, 2011, BRIT J NUTR, V106, P852, DOI 10.1017/S000711451100047X
   Cilieborg MS, 2011, J NUTR, V141, P223, DOI 10.3945/jn.110.128561
   CRISSINGER KD, 1989, PEDIATR RES, V25, P612, DOI 10.1203/00006450-198906000-00012
   Deglaire A, 2012, BRIT J NUTR, V108, pS273, DOI 10.1017/S0007114512002346
   Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008
   Dekaney CM, 1997, ANAT RECORD, V249, P517
   DELAHUNTY T, 1987, COMP BIOCHEM PHYS A, V86, P565, DOI 10.1016/0300-9629(87)90542-1
   Derikx JPM, 2011, J SURG RES, V166, P222, DOI 10.1016/j.jss.2009.09.046
   Deshmukh DR, 1997, AM J PHYSIOL-CELL PH, V273, pC1130
   DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167
   Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014
   Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031
   Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110
   FLORES CA, 1992, NUTRITION, V8, P418
   Foster DM, 2012, GASTROENTEROLOGY, V143, P133, DOI 10.1053/j.gastro.2012.03.030
   Gayle J, 2002, SURGERY, V132, P461, DOI 10.1067/msy.2002.125320
   Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465
   Gookin JL, 2006, AM J PHYSIOL-GASTR L, V290, pG164, DOI 10.1152/ajpgi.00460.2004
   Gookin JL, 2003, AM J PHYSIOL-GASTR L, V285, pG967, DOI 10.1152/ajpgi.00532.2002
   Gootenberg DB, 2011, J ANIM SCI, V89, P1531, DOI 10.2527/jas.2010-3371
   Gotthardt DN, 2013, CLIN TRANSPLANT, V27, P49, DOI 10.1111/ctr.12161
   Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039
   GRAHAM H, 1987, SCAND J GASTROENTERO, V22, P55, DOI 10.3109/00365528709095851
   GRANGER DN, 1986, GASTROENTEROLOGY, V90, P80, DOI 10.1016/0016-5085(86)90078-8
   GRANGER DN, 1989, AM J PHYSIOL, V257, pG683
   GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47
   Gregory Katherine E, 2011, Adv Neonatal Care, V11, P155, DOI 10.1097/ANC.0b013e31821baaf4
   GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567
   Guan XF, 2006, GASTROENTEROLOGY, V130, P150, DOI 10.1053/j.gastro.2005.11.005
   Guan XF, 2003, GASTROENTEROLOGY, V125, P136, DOI 10.1016/S0016-5085(03)00667-X
   Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR
   HAGLIND E, 1985, ACTA CHIR SCAND, V151, P147
   HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0
   Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x
   Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152
   HERNANDEZ LA, 1987, AM J PHYSIOL, V253, pH699
   Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3
   Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139
   Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x
   Jacobi SK, 2012, J NUTR, V142, P1266, DOI 10.3945/jn.111.150995
   Jeppesen PB, 2011, GUT, V60, P902, DOI 10.1136/gut.2010.218271
   Jeppesen PB, 2012, GASTROENTEROLOGY, V143, P1473, DOI 10.1053/j.gastro.2012.09.007
   Jeppesen PB, 2001, GASTROENTEROLOGY, V120, P806, DOI 10.1053/gast.2001.22555
   Jung Camille, 2010, Int J Inflam, V2010, P823710, DOI 10.4061/2010/823710
   KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502
   Kirk AD, 2003, IMMUNOL REV, V196, P176, DOI 10.1046/j.1600-065X.2003.00081.x
   Klein HM, 1996, J COMPUT ASSIST TOMO, V20, P254, DOI 10.1097/00004728-199603000-00016
   Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127
   Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8
   KUBES P, 1992, GASTROENTEROLOGY, V103, P807, DOI 10.1016/0016-5085(92)90010-V
   Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103
   Le Bas-Bernardet S, 2008, GENE THER, V15, P1247, DOI 10.1038/gt.2008.119
   Lee HT, 2013, AM J PHYSIOL-GASTR L, V304, pG12, DOI 10.1152/ajpgi.00201.2012
   Lee H, 2014, MOL IMMUNOL, V58, P151, DOI 10.1016/j.molimm.2013.11.012
   LEHR HA, 1994, CIRCULATION, V90, P1580, DOI 10.1161/circ.90.3.8087970
   Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb
   Lennon D, 2011, LAB ANIMAL, V40, P253, DOI 10.1038/laban0811-253
   Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002
   Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463
   Little D, 2003, AM J PHYSIOL-GASTR L, V284, pG46, DOI 10.1152/ajpgi.00121.2002
   Low MJ, 2012, GASTROENTEROLOGY, V143, P1410, DOI 10.1053/j.gastro.2012.10.011
   Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91
   Meyers SN, 2005, GENOMICS, V86, P739, DOI 10.1016/j.ygeno.2005.04.010
   MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045
   Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006
   Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006
   Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006
   Moeser AJ, 2006, GASTROENTEROLOGY, V130, pA89
   Moeser AJ, 2006, AM J PHYSIOL-GASTR L, V291, pG885, DOI 10.1152/ajpgi.00380.2005
   Moeser AJ, 2004, GASTROENTEROLOGY, V127, P802, DOI 10.1053/j.gastro.2004.06.004
   Montgomery RK, 1999, GASTROENTEROLOGY, V116, P702, DOI 10.1016/S0016-5085(99)70193-9
   Moughan P J, 1992, World Rev Nutr Diet, V67, P40
   Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387
   MYER MS, 1982, J S AFR VET ASSOC, V53, P69
   MYER MS, 1982, ONDERSTEPOORT J VET, V49, P131
   Nagy ES, 2004, J PEDIATR GASTR NUTR, V39, P487, DOI 10.1097/00005176-200411000-00008
   Nankervis CA, 2008, SEMIN PERINATOL, V32, P83, DOI 10.1053/j.semperi.2008.01.003
   National Institute of Diabetes and Digestive and Kidney Diseases, 2009, OPP CHALL DIG DIS RE
   National Institute of Health, 2012, NIH S IMPR AN MOD RE
   Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935
   Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23
   Paral J, 2007, SURG LAPARO ENDO PER, V17, P291, DOI 10.1097/SLE.0b013e3180dc9376
   Paris MC, 2004, DIGEST DIS SCI, V49, P1688, DOI 10.1023/B:DDAS.0000043388.52260.2f
   PARK PO, 1992, CRIT CARE MED, V20, P135, DOI 10.1097/00003246-199201000-00026
   PARKS DA, 1982, GASTROENTEROLOGY, V82, P9
   PARKS DA, 1986, AM J PHYSIOL, V250, pG749
   Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262
   Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002
   Pereira-Fantini PM, 2008, JPEN-PARENTER ENTER, V32, P266, DOI 10.1177/0148607108316197
   Pereira-Fantini PM, 2008, J PEDIATR GASTR NUTR, V46, P20, DOI 10.1097/01.mpg.0000304449.46434.06
   Pereira-Fantini PM, 2011, HISTOCHEM CELL BIOL, V135, P195, DOI 10.1007/s00418-011-0778-2
   Petersen YM, 2003, J NUTR, V133, P1781
   Petersen YM, 2002, PEDIATR RES, V52, P498, DOI [10.1203/01.PDR.0000030884.86822.E4, 10.1203/01.0000030884.86822.E4]
   Phillips KA, 2006, NAT REV DRUG DISCOV, V5, P463, DOI 10.1038/nrd2033
   Pierson RN, 2009, XENOTRANSPLANTATION, V16, P263, DOI 10.1111/j.1399-3089.2009.00534.x
   Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638
   Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653
   Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871
   Reginelli A, 2013, CRIT ULTRASOUND J, V5, DOI 10.1186/2036-7902-5-S1-S7
   Rhoads JM, 1997, AM J PHYSIOL-GASTR L, V272, pG943
   Rizk P, 2012, WIRES SYST BIOL MED, V4, P475, DOI 10.1002/wsbm.1176
   Rogan MP, 2010, P NATL ACAD SCI USA, V107, P20571, DOI 10.1073/pnas.1015281107
   Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773
   Rosow DE, 2005, J GASTROINTEST SURG, V9, P1262, DOI 10.1016/j.gassur.2005.07.034
   Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016
   Ruiz P, 2004, TRANSPLANT P, V36, P335, DOI 10.1016/j.transproceed.2004.01.079
   Sala FG, 2009, J SURG RES, V156, P205, DOI 10.1016/j.jss.2009.03.062
   Sangild PT, 2006, J PEDIATR GASTR NUTR, V43, P160, DOI 10.1097/01.mpg.0000228122.82723.1b
   Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359
   Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026
   Sangild PT, 2002, J NUTR, V132, P3785, DOI 10.1093/jn/132.9.2673
   Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391
   Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637
   SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109
   Scheer N, 2013, DRUG DISCOV TODAY, V18, P1200, DOI 10.1016/j.drudis.2013.07.007
   Schmidt LD, 2007, J NEUROIMMUNOL, V185, P20, DOI 10.1016/j.jneuroim.2006.10.028
   Schreiber KL, 2005, STRESS, V8, P185, DOI 10.1080/10253890500188732
   Schwartz CA, 2012, ROFO-FORTSCHR RONTG, V184, P520, DOI 10.1055/s-0031-1299414
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Siggers RH, 2008, J NUTR, V138, P1437
   Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002
   Sinkora M, 2011, J IMMUNOL, V187, P5150, DOI 10.4049/jimmunol.1101879
   Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009
   SMITH SM, 1987, GASTROENTEROLOGY, V92, P950, DOI 10.1016/0016-5085(87)90969-3
   Spurrier RG, 2013, CLIN GASTROENTEROL H, V11, P354, DOI 10.1016/j.cgh.2013.01.028
   STEVENS CE, 1986, CLIN GASTROENTEROL, V15, P763
   Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867
   SUZUKI M, 1989, AM J PHYSIOL, V257, pH1740
   Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11
   Tang ZH, 2010, ACAD RADIOL, V17, P1146, DOI 10.1016/j.acra.2010.04.014
   Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858
   Thompson JS, 1996, DIGEST DIS SCI, V41, P1760, DOI 10.1007/BF02088742
   Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009
   Trautmann A, 1884, FUNDAMENTALS HISTOLO
   Trompeter M, 2002, EUR RADIOL, V12, P1179, DOI 10.1007/00330-001-1220-2
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   UDASSIN R, 1994, J SURG RES, V56, P221, DOI 10.1006/jsre.1994.1035
   Van Haver ER, 2009, J PEDIATR GASTR NUTR, V49, P90, DOI 10.1097/MPG.0b013e31818de393
   Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011
   Vegge A, 2013, AM J PHYSIOL-GASTR L, V305, pG277, DOI 10.1152/ajpgi.00064.2013
   Wagner SJ, 2013, INFLAMM BOWEL DIS, V19, P1285, DOI 10.1097/MIB.0b013e318281f573
   Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Weih S, 2011, J SURG RES, V171, P709, DOI 10.1016/j.jss.2011.07.052
   Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149
   Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333
   Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320
   Wolvekamp MCJ, 1996, DIGEST DIS, V14, P59, DOI 10.1159/000171539
   Yandza T, 2012, J SURG RES, V178, P807, DOI 10.1016/j.jss.2012.07.025
   Yasuhara H, 2005, SURG TODAY, V35, P185, DOI 10.1007/s00595-004-2924-0
   Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695
   Zabielski R, 1999, REPROD NUTR DEV, V39, P5, DOI 10.1051/rnd:19990101
   ZIMMERMAN BJ, 1990, AM J PHYSIOL, V258, pG185
NR 192
TC 30
Z9 29
U1 2
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1931-5244
EI 1878-1810
J9 TRANSL RES
JI Transl. Res.
PD JUL
PY 2015
VL 166
IS 1
BP 12
EP 27
DI 10.1016/j.trsl.2015.01.004
PG 16
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA CK6DC
UT WOS:000356317700002
PM 25655839
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jones, CH
   Gollakota, A
   Chen, MF
   Chung, TC
   Ravikrishnan, A
   Zhang, GJ
   Pfeifer, BA
AF Jones, Charles H.
   Gollakota, Akhila
   Chen, Mingfu
   Chung, Tai-Chun
   Ravikrishnan, Anitha
   Zhang, Guojian
   Pfeifer, Blaine A.
TI Influence of molecular weight upon mannosylated bio-synthetic hybrids
   for targeted antigen presenting cell gene delivery
SO BIOMATERIALS
LA English
DT Article
DE Gene therapy; Nonviral vector; Cationic polymers; Antigen presenting
   cells; Bactofection
ID MANNOSE RECEPTOR; POLYANHYDRIDE NANOPARTICLES; POLY(BETA-AMINO ESTERS);
   MICROBIAL ADHESION; LECTIN RECEPTORS; IMMUNE-RESPONSE; RICIN TOXIN;
   MACROPHAGES; CAVEOLAE; LIBRARY
AB Given the rise of antibiotic resistant microbes, genetic vaccination is a promising prophylactic strategy that enables rapid design and manufacture. Facilitating this process is the choice of vector, which is often situationally-specific and limited in engineering capacity. Furthermore, these shortcomings are usually tied to an incomplete understanding of the structure function relationships driving vector-mediated gene delivery. Building upon our initial report of a hybrid bacterial-biomaterial gene delivery vector, a comprehensive structure function assessment was completed using a class of mannosylated poly(beta-amino esters). Through a top-down screening methodology, an ideal polymer was selected on the basis of gene delivery efficacy and then used for the synthesis of a stratified molecular weight polymer library. By eliminating contributions of polymer chemical background, we were able to complete an in-depth assessment of gene delivery as a function of (1) polymer molecular weight, (2) relative mannose content, (3) polymer-membrane biophysical properties, (4) APC uptake specificity, and (5) serum inhibition. In summary, the flexibility and potential of the hybrid design featured in this work highlights the ability to systematically probe vector-associated properties for the development of translational gene delivery candidates. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Jones, Charles H.; Gollakota, Akhila; Chen, Mingfu; Chung, Tai-Chun; Ravikrishnan, Anitha; Zhang, Guojian; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
OI Chen, Mingfu/0000-0002-0169-613X
FU NIH [AI088485]; SUNY-Buffalo Schomburg fellowship
FX The authors recognize support from NIH award AI088485 (BAP) and a
   SUNY-Buffalo Schomburg fellowship (CHJ).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Canine BF, 2010, ADV DRUG DELIVER REV, V62, P1524, DOI 10.1016/j.addr.2010.04.001
   Carrillo-Conde B, 2011, MOL PHARMACEUT, V8, P1877, DOI 10.1021/mp200213r
   Chavez-Santoscoy AV, 2012, BIOMATERIALS, V33, P4762, DOI 10.1016/j.biomaterials.2012.03.027
   Chung TC, 2015, MOL PHARM
   Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   Jones CH, 2015, BIOMACROMOLECULES
   Jones CH, 2015, MOL PHARMACEUT, V12, P846, DOI 10.1021/mp500683c
   Jones CH, 2015, BIOMATERIALS, V37, P333, DOI 10.1016/j.biomaterials.2014.10.037
   Jones CH, 2014, J MATER CHEM B, V2, P8053, DOI [10.1039/C4TB01058B, 10.1039/c4tb01058b]
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Mena MA, 2006, NAT BIOTECHNOL, V24, P1569, DOI 10.1038/nbt1264
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Parsa S, 2008, PHARM RES, V25, P1202, DOI 10.1007/s11095-008-9563-x
   Parsa S, 2007, MOL PHARMACEUT, V4, P4, DOI 10.1021/mp0600889
   Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122
   Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x
   Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2
   Rehman ZU, 2013, J CONTROL RELEASE, V166, P46, DOI 10.1016/j.jconrel.2012.12.014
   Rosenberg M, 2006, FEMS MICROBIOL LETT, V262, P129, DOI 10.1111/j.1574-6968.2006.00291.x
   Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614
   Shin JS, 2001, SCIENCE, V293, P1447, DOI 10.1126/science.1061079
   SIMMONS BM, 1986, J BIOL CHEM, V261, P7912
   STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X
   Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9
   STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543
   Zhu CL, 2013, ADV MATER, V25, P1203, DOI 10.1002/adma.201204550
NR 37
TC 4
Z9 4
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 58
BP 103
EP 111
DI 10.1016/j.biomaterials.2015.04.033
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK3ND
UT WOS:000356121900011
PM 25941787
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nunome, S
   Kanetaka, H
   Kudo, T
   Endoh, K
   Hosoda, H
   Igarashi, K
AF Nunome, Shoko
   Kanetaka, Hiroyasu
   Kudo, Tada-aki
   Endoh, Kazuki
   Hosoda, Hideki
   Igarashi, Kaoru
TI Invitro evaluation of biocompatibility of Ti-Mo-Sn-Zr superelastic alloy
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Biocompatibility; Ti-Mo-Sn-Zr alloy; shape memory alloy;
   superelasticity; invitro evaluation
ID SHAPE-MEMORY ALLOY; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   ORTHODONTIC WIRES; STAINLESS-STEEL; ACTIVE CATHETER; TITANIUM-ALLOYS;
   NICKEL-TITANIUM; CELLS; BEHAVIOR
AB Shape memory alloys (SMAs) including superelastic alloys have unique properties such as shape memory and superelasticity, thus they are recognized as very useful biomaterials. These properties are very advantageous for medical use, and actually the SMA wires have been widely used in medical field. However, biocompatibility of nickel-titanium (Ni-Ti) alloy, which is the only practical SMA at present, has been questioned because of its high nickel content. The aim of this study was to evaluate the biocompatibility of a newly developed Ni-free Ti-based SMA for medical use. The newly developed SMA made of Ti-Mo-Sn-Zr system was processed into a disk of 15.1mm in diameter. Pure titanium of the same shape was prepared as control. All the disk surfaces were polished using emery papers, #120, #400, and #600. Scanning electron microscopy and a 3D optics profiler were used to evaluate the surface of the materials. Invitro evaluations included colony examination for evaluation of the cell cytotoxicity, DNA quantification for the cell proliferation, Alamar blue assay for metabolic activity, FDA staining for the live cell imaging, and cell cycle analysis, using Chinese hamster fibroblastic V-79 cells and mouse osteoblastic MC3T3-E1 cells. In colony examination and DNA quantification, there was no significant difference between the Ti-Mo-Sn-Zr and the pure titanium. In FDA staining, cultured cells on the Ti-Mo-Sn-Zr alloy showed the same biocompatibility as those on the pure titanium. The present results suggest that the newly developed Ti-Mo-Sn-Zr alloy showed the high biocompatibility comparable to pure titanium and can be used as efficient biomaterial for medical use.
C1 [Nunome, Shoko; Igarashi, Kaoru] Tohoku Univ, Grad Sch Dens, Div Oral Dysfunct Sci, Sendai, Miyagi 9808575, Japan.
   [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dens, Liaison Ctr Innovat Dent, Sendai, Miyagi 9808575, Japan.
   [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Diag & Treatment, Sendai, Miyagi 9808575, Japan.
   [Kudo, Tada-aki] Tohoku Univ, Grad Sch Dens, Div Oral Physiol, Sendai, Miyagi 9808575, Japan.
   [Endoh, Kazuki; Hosoda, Hideki] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.
RP Kanetaka, H (reprint author), Tohoku Univ, Grad Sch Dens, Liaison Ctr Innovat Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM kanetaka@dent.tohoku.ac.jp
FU Funding Program for Next Generation World-Leading Researchers [LR015];
   Japan Society for the Promotion of Science [26220907]
FX Authors would like to thank the financial support for the material
   development by Funding Program for Next Generation World-Leading
   Researchers (No. LR015) and Grant-in-Aid for Scientific Research (S)
   (No.26220907) from Japan Society for the Promotion of Science.
CR Abou Neel EA, 2010, J TISSUE ENG, V1, P1
   Acerbi F, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181faaa86
   Arciniegas M, 2013, J BIOMED MATER RES B, V101B, P709, DOI 10.1002/jbm.b.32873
   Arciniegas M, 2008, PHILOS MAG, V88, P2529, DOI 10.1080/14786430802375667
   BAGOT M, 1995, EUR J DERMATOL, V5, P614
   Barrera JM, 2013, MED ORAL PATOL ORAL, V18, pE547, DOI 10.4317/medoral.18291
   Camelia S, 2010, WSEAS T BIOL BIOMED, V3, P277
   Chen Y, 2012, J NANOMATER, V2012, P1
   Coen N, 2003, BRIT J CANCER, V88, P548, DOI 10.1038/sj.bjc.6600758
   Darel EH, 1990, ASM HDB, P897
   Diego M, 2010, JOM, V52, P36
   Endoh Kazuki, 2014, Advanced Materials Research, V922, P137, DOI 10.4028/www.scientific.net/AMR.922.137
   Espinar E, 2011, J MATER SCI-MATER M, V22, P1119, DOI 10.1007/s10856-011-4292-9
   Franklin NM, 2001, ENVIRON TOXICOL CHEM, V20, P160, DOI 10.1897/1551-5028(2001)020<0160:DOFCBA>2.0.CO;2
   Gonzalez M, 2014, MAT SCI ENG C-MATER, V42, P691, DOI 10.1016/j.msec.2014.06.010
   Gonzalez M, 2011, J MATER ENG PERFORM, V20, P653, DOI 10.1007/s11665-011-9917-0
   Gonzalez M, 2009, J MATER ENG PERFORM, V18, P506, DOI 10.1007/s11665-009-9393-y
   Haga Y, 2001, INTERV NEURORADIOL, V7, P125, DOI 10.1177/15910199010070S118
   Horev-Azaria L, 2011, TOXICOL SCI, V122, P489, DOI 10.1093/toxsci/kfr124
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Hosoda H, 2010, MATER SCI FORUM, V654-656, P2150, DOI 10.4028/www.scientific.net/MSF.654-656.2150
   Hosoda N, 2001, PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS AND PROCESSING, VOLS I AND II, P1623
   Iijima M, 2010, DENT MATER J, V29, P53, DOI 10.4012/dmj.2009-069
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Isama K, 2002, MATER TRANS, V43, P3155, DOI 10.2320/matertrans.43.3155
   Ishigaki T, 2007, INT C SHAP MEM SUP T, P559
   Jia-can S, 2009, INT ORTHOP, V34, P369
   Kanetaka H, 2010, MATER TRANS, V51, P1944, DOI 10.2320/matertrans.M2010038
   Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021
   Kassab EJ, 2013, ANGLE ORTHOD, V83, P864, DOI 10.2319/091712-740.1
   Kawakita Eiji, 2012, Open Orthop J, V6, P239, DOI 10.2174/1874325001206010239
   Kawashita M, 2014, J BIOMED MATER RES A, V102, P1880, DOI 10.1002/jbm.a.34861
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kodama C, 1998, B RES I MINERAL DRES, V43, P179
   Li HF, 2014, J MATER SCI-MATER M, V25, P1249, DOI 10.1007/s10856-014-5158-8
   Liu YX, 2011, J NANOPART RES, V13, P199, DOI 10.1007/s11051-010-0019-y
   Maeshima T, 2006, MAT SCI ENG A-STRUCT, V438, P844, DOI 10.1016/j.msea.2006.05.092
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Marcin M, 2010, BIOL TRACE ELEM RES, V146, P272
   Miaolei Z., 2013, APPL MATH, V2013, P1
   Michiardi A, 2006, J BIOMED MATER RES B, V77B, P249, DOI 10.1002/jbm.b.30441
   Mineta T, 2001, SENSOR ACTUAT A-PHYS, V88, P112, DOI 10.1016/S0924-4247(00)00510-0
   Moharamzadeh K, 2009, MATERIALS, V2, P514, DOI 10.3390/ma2020514
   Nakagawa M, 2001, Dent Mater J, V20, P305
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347
   Robin KP, 2009, ANN CLIN MICROB ANTI, V8, P1
   Saito H, 2007, INT C SHAP MEM SUP T, P565
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Sasano H, 1984, 5 INT C TIT FRANKF G, P1667
   Schiff N, 2006, EUR J ORTHODONT, V28, P298, DOI 10.1093/ejo/cji102
   Sfondrini MF, 2010, AM J ORTHOD DENTOFAC, V137, P809, DOI 10.1016/j.ajodo.2008.07.021
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Sivaraj Aravind, 2013, J Int Oral Health, V5, P1
   Taniguchi M, 2014, FEBS OPEN BIO, V4, P328, DOI 10.1016/j.fob.2014.03.004
   Tripuraneni SC, 2011, TRENDS BIOMATER, V25, P51
   Verstrynge A, 2006, AM J ORTHOD DENTOFAC, V130, P460, DOI 10.1016/j.ajodo.2004.12.030
   Villa R, 2002, MATER TRANS, V43, P2991, DOI 10.2320/matertrans.43.2991
   Xiaohua Y, 2013, BIOMED RES INT, V2013, P1
   Xinwei L, 2013, INT ORTHOP, V34, P1033
   Zhang Y, 2009, BIOMED MATER, V4, DOI [10.1088/1748-6041/25/1/012001, 10.1088/1748-6041/4/1/012001]
NR 69
TC 1
Z9 1
U1 1
U2 32
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2015
VL 30
IS 1
BP 119
EP 130
DI 10.1177/0885328215569892
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK5CL
UT WOS:000356239600011
PM 25659946
DA 2018-10-20
ER

PT J
AU Cardwell, RD
   Kluge, JA
   Thayer, PS
   Guelcher, SA
   Dahlgren, LA
   Kaplan, DL
   Goldstein, AS
AF Cardwell, Robyn D.
   Kluge, Jonathan A.
   Thayer, Patrick S.
   Guelcher, Scott A.
   Dahlgren, Linda A.
   Kaplan, David L.
   Goldstein, Aaron S.
TI Static and Cyclic Mechanical Loading of Mesenchymal Stem Cells on
   Elastomeric, Electrospun Polyurethane Meshes
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE bioreactor; confocal microscopy; polyurethane; mechanical properties;
   C3H10T1/2; electrospinning; cell morphology; cyclic stretch
ID ANTERIOR CRUCIATE LIGAMENT; GENE-EXPRESSION; FIBER DIAMETER; IN-VITRO;
   TENDON; FIBROBLAST; ALIGNMENT; SCAFFOLD; RECONSTRUCTION; MATRIX
AB Biomaterial substrates composed of semi-aligned electrospun fibers are attractive supports for the regeneration of connective tissues because the fibers are durable under cyclic tensile loads and can guide cell adhesion, orientation, and gene expression. Previous studies on supported electrospun substrates have shown that both fiber diameter and mechanical deformation can independently influence cell morphology and gene expression. However, no studies have examined the effect of mechanical deformation and fiber diameter on unsupported meshes. Semi-aligned large (1.75 mu m) and small (0.60 mu m) diameter fiber meshes were prepared from degradable elastomeric poly(esterurethane urea) (PEUUR) meshes and characterized by tensile testing and scanning electron microscopy (SEM). Next, unsupported meshes were aligned between custom grips (with the stretch axis oriented parallel to axis of fiber alignment), seeded with C3H10T1/2 cells, and subjected to a static load (50 mN, adjusted daily), a cyclic load (4% strain at 0.25 Hz for 30 min, followed by a static tensile loading of 50 mN, daily), or no load. After 3 days of mechanical stimulation, confocal imaging was used to characterize cell shape, while measurements of deoxyribonucleic acid (DNA) content and messenger ribonucleic acid (mRNA) expression were used to characterize cell retention on unsupported meshes and expression of the connective tissue phenotype. Mechanical testing confirmed that these materials deform elastically to at least 10%. Cells adhered to unsupported meshes under all conditions and aligned with the direction of fiber orientation. Application of static and cyclic loads increased cell alignment. Cell density and mRNA expression of connective tissue proteins were not statistically different between experimental groups. However, on large diameter fiber meshes, static loading slightly elevated tenomodulin expression relative to the no load group, and tenascin-C and tenomodulin expression relative to the cyclic load group. These results demonstrate the feasibility of maintaining cell adhesion and alignment on semi-aligned fibrous elastomeric substrates under different mechanical conditions. The study confirms that cell morphology is sensitive to the mechanical environment and suggests that expression of select connective tissue genes may be enhanced on large diameter fiber meshes under static tensile loads.
C1 [Cardwell, Robyn D.; Thayer, Patrick S.; Goldstein, Aaron S.] Virginia Tech, Dept Biomed Engn, Blacksburg, VA 24061 USA.
   [Kluge, Jonathan A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Chem & Biomol Engn, Nashville, TN 37235 USA.
   [Dahlgren, Linda A.] Virginia Maryland Reg Coll Vet Med, Large Anim Clin Sci, Blacksburg, VA 24061 USA.
   [Goldstein, Aaron S.] Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Tech, Dept Biomed Engn, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
FU National Institutes of Health [AR 055872]
FX The authors would like to thank the Tissue Engineering Resource Center
   (P41 EB002520) at Tufts University for providing equipment and
   facilities to perform this work. This publication was made possible by
   Grant No. AR 055872 to R.D.C. from the National Institutes of Health.
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arnoczky SP, 2007, INT J EXP PATHOL, V88, P217, DOI 10.1111/j.1365-2613.2007.00548.x
   Balestrini JL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049527
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Cardwell RD, 2014, J TISSUE ENG REGEN M, V8, P937, DOI 10.1002/term.1589
   Chaurey V, 2012, ACTA BIOMATER, V8, P3982, DOI 10.1016/j.actbio.2012.06.041
   Chen JS, 2006, TISSUE ENG, V12, P3085, DOI 10.1089/ten.2006.12.3085
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Freeman JW, 2009, J BIOMAT SCI-POLYM E, V20, P1709, DOI 10.1163/156856208X386282
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Guo L, 2012, ARTHROSCOPY, V28, P211, DOI 10.1016/j.arthro.2011.08.314
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Iatridis JC, 2005, J BIOMECH, V38, P557, DOI 10.1016/j.jbiomech.2004.03.038
   Kahn CJF, 2013, J BIOMAT SCI-POLYM E, V24, P899, DOI 10.1080/09205063.2012.727265
   Kaneko D, 2009, CONNECT TISSUE RES, V50, P263, DOI 10.1080/03008200902846270
   Kidoaki S, 2006, J BIOMED MATER RES B, V76B, P219, DOI 10.1002/jbm.b.30336
   Kluge JA, 2011, ANN BIOMED ENG, V39, P1390, DOI 10.1007/s10439-010-0243-8
   KWON K, 2005, BIOMATERIALS, V26, P3929
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Teh TKH, 2013, TISSUE ENG PT A, V19, P1360, DOI [10.1089/ten.tea.2012.0279, 10.1089/ten.TEA.2012.0279]
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
   West RV, 2005, J AM ACAD ORTHOP SUR, V13, P197, DOI 10.5435/00124635-200505000-00006
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
NR 29
TC 4
Z9 4
U1 2
U2 28
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JUL
PY 2015
VL 137
IS 7
AR 071010
DI 10.1115/1.4030404
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA CK2VX
UT WOS:000356073400011
PM 25902471
OA Green Published
DA 2018-10-20
ER

PT J
AU Meyer, M
   Prade, I
   Leppchen-Frohlich, K
   Felix, A
   Herdegen, V
   Haseneder, R
   Repke, JU
AF Meyer, Michael
   Prade, Ina
   Leppchen-Froehlich, Kathrin
   Felix, Alexander
   Herdegen, Volker
   Haseneder, Roland
   Repke, Jens-Uwe
TI Sterilisation of collagen materials using hydrogen peroxide doted
   supercritical carbon dioxide and its effects on the materials properties
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE Supercritical carbondioxide; Hydrogen peroxide; Collagen; Sterilisation
ID BIOMATERIAL; INACTIVATION; OXIDATION; DEVICES; SPORES
AB Collagen sponges and membranes which are used as medical device and in tissue engineering (TE) were sterilised by using supercritical carbon dioxide (CO2sc) which was doted with hydrogen peroxide (300 mg/L). Sterilisation was achieved by pressure change treatment (20.5-10 MPa). Neither physical nor structural and biological parameters of the materials were negatively affected. In contrast, sterilisation by gamma-irradiation led to increased solubility and decreased physical stability. As H2O2 is a common chemical used in collagen processing in industrial scale this could become a sterilisation technique for medical devices and TE materials on collagen basis. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Meyer, Michael; Prade, Ina; Leppchen-Froehlich, Kathrin] Forschungsinst Leder & Kunststoffbahnen, Freiberg, Germany.
   [Felix, Alexander; Herdegen, Volker; Haseneder, Roland; Repke, Jens-Uwe] Tech Univ Bergakad Freiberg, ITUN, D-09596 Freiberg, Germany.
RP Meyer, M (reprint author), Forschungsinst Leder & Kunststoffbahnen, Freiberg, Germany.
EM michael.meyer@filkfreiberg.de
RI Meyer, Michael/A-6227-2016
OI Meyer, Michael/0000-0003-2934-9962
FU DFG [PAK 731]; German Ministry of Economy and Technology [VF110002]
FX We thank Ines Zenker for performing the microbiological tests, Sascha
   Adler for the amino acid analyses and Sabine Kleinwechter for the DSC
   measurements. The investigation was funded by the DFG (PAK 731) and the
   German Ministry of Economy and Technology (VF110002). We thank for the
   financial support.
CR Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca
   Berg A., 1982, Patent, Patent No. [US 4320201 A, 4320201]
   Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
   Bloch A., 1961, Purification of Collagen, Patent No. [US 2973302, 2973302]
   BOWES JH, 1962, RADIAT RES, V16, P211, DOI 10.2307/3571153
   Chvapil M, 1972, INT REV CONNECTIVE T, V6, P1
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   COURTS A, 1961, BIOCHEM J, V81, P356, DOI 10.1042/bj0810356
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   FRASER D, 1951, NATURE, V167, P33, DOI 10.1038/167033b0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GRANT RA, 1973, J ANAT, V115, P29
   Heimann L., Process for the production of collagen material, Patent No. [EP 2098255 A2, 2098255]
   Hemmer JD, 2007, J BIOMED MATER RES B, V80B, P511, DOI 10.1002/jbm.b.30625
   Herdegen V, 2014, CHEM ENG TECHNOL, V37, P1891, DOI 10.1002/ceat.201300679
   Hood L.L., 1987, ADV MEAT RES, V4, P109
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   Kramer A, 2008, WALLHAUSSERS PRAXIS, P719
   Matthews I. P., 1994, Clinical Materials, V15, P191, DOI 10.1016/0267-6605(94)90082-5
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Perrut M, 2012, J SUPERCRIT FLUID, V66, P359, DOI 10.1016/j.supflu.2011.07.007
   RUDAKOVA TE, 1987, POLYM DEGRAD STABIL, V18, P271, DOI 10.1016/0141-3910(87)90015-2
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.tec.2011.0201, 10.1089/ten.TEC.2011.0201]
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G
   White A, 2006, J BIOTECHNOL, V123, P504, DOI 10.1016/j.jbiotec.2005.12.033
   Zhang J, 2006, J SUPERCRIT FLUID, V38, P354, DOI 10.1016/j.supflu.2005.05.005
   Zhang J, 2006, J SUPERCRIT FLUID, V38, P268, DOI 10.1016/j.supflu.2006.02.015
NR 36
TC 7
Z9 7
U1 4
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
EI 1872-8162
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JUL
PY 2015
VL 102
BP 32
EP 39
DI 10.1016/j.supflu.2015.04.006
PG 8
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA CK3LJ
UT WOS:000356117300005
DA 2018-10-20
ER

PT J
AU Kwon, MS
   Oh, SY
   Cho, SA
AF Kwon, Min-Seok
   Oh, Sang-Yeob
   Cho, Sung-Am
TI Two-body wear comparison of zirconia crown, gold crown, and enamel
   against zirconia
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Zirconia; Wear; Enamel; Fixed partial dentures
ID FIXED PARTIAL DENTURES; BITE FORCE; IN-VITRO; FRACTURE-RESISTANCE;
   CERAMIC MATERIALS; DENTAL CERAMICS; PORCELAIN; BIOMATERIAL; DENTITION;
   SURFACES
AB Problem statement: Full zirconia crowns have recently been used for dental restorations because of their mechanical properties. However, there is little information about their wear characteristics against enamel, gold, and full zirconia crowns.
   Purpose: The purpose of this study was to compare the wear rate of enamel, gold crowns, and zirconia crowns against zirconia blocks using an in vitro wear test.
   Materials and methods: Upper specimens were divided into three groups: 10 enamels (group 1), 10 gold crowns (group 2, Type III gold), and 10 zirconia crowns (group 3, Prettau (R) Zirkon 9H, Zirkonzahn, Italy). Each of these specimens was wear tested against a zirconia block (40 x 30 x 3 mm(3)) as a lower specimen (30 total zirconia blocks). Each specimen of the groups was abraded against the zirconia block for 600 cycles at 1 Hz with 15 mm front-toback movement on an abrading machine. Moreover, the load applied during the abrading test was 50 N, and the test was performed in a normal saline emulsion for 10 min. Threedimensional images were taken before and after the test, and the statistical analysis was performed using the Krushal Wallis test and Mann Whitney test (p=0.05).
   Results: The mean volume loss of group 1 was 0.47 mm(3), while that of group 2 and group 3 was 0.01 mm(3).
   Conclusion: The wear volume loss of enamels against zirconia was higher than that of gold and zirconia crowns. Moreover, according to this result, zirconia crowns are not recommended for heavy bruxers. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Kwon, Min-Seok; Cho, Sung-Am] Kyungpook Natl Univ, Sch Dent, Dept Prosthodont, Sangju 742711, Gyung Buk, South Korea.
   [Oh, Sang-Yeob] Kyungpook Natl Univ, Sch Automot Engn, Sangju 742711, Gyung Buk, South Korea.
RP Oh, SY (reprint author), Kyungpook Natl Univ, Sch Automot Engn, 2559 Gyeongsang Daero, Sangju 742711, Gyung Buk, South Korea.
EM syoh@knu.ac.kr; sungamcho@gmail.com
FU Kyung-Pook National University ResearchFund [2013]
FX This research was supported by the Kyung-Pook National University
   ResearchFund, (Grant no. 2013).
CR Albashaireh ZSM, 2010, J PROSTHET DENT, V104, P105, DOI 10.1016/S0022-3913(10)60102-3
   ANDERSON D. J., 1956, I JOUR DENTAL RES, V35, P664
   Ashkanani HM, 2008, J PROSTHET DENT, V100, P274, DOI 10.1016/S0022-3913(08)60206-1
   Att W, 2007, ACTA ODONTOL SCAND, V65, P14, DOI 10.1080/00016350600856232
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Christensen G, 2008, CLIN REPORT, V1, P1
   Christensen GJ, 2009, J AM DENT ASSOC, V140, P1036, DOI 10.14219/jada.archive.2009.0316
   Christensen RP, 2010, J AM DENT ASSOC, V141, P1317, DOI 10.14219/jada.archive.2010.0076
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   Elmaria A, 2006, J PROSTHET DENT, V96, P345, DOI 10.1016/j.prosdent.2006.09.002
   GIBBS CH, 1981, J PROSTHET DENT, V46, P443, DOI 10.1016/0022-3913(81)90455-8
   Heintze SD, 2008, DENT MATER, V24, P433, DOI 10.1016/j.dental.2007.06.016
   HELKIMO E, 1977, ACTA ODONTOL SCAND, V35, P297, DOI 10.3109/00016357709064128
   HUDSON JD, 1995, J PROSTHET DENT, V74, P647, DOI 10.1016/S0022-3913(05)80319-1
   JACOBI R, 1991, J PROSTHET DENT, V66, P303, DOI 10.1016/0022-3913(91)90254-T
   JAGGER DC, 1994, J PROSTHET DENT, V72, P320, DOI 10.1016/0022-3913(94)90347-6
   Jang GW, 2011, PROCEDIA ENGINEER, V10, P1556, DOI 10.1016/j.proeng.2011.04.260
   Janyavula S, 2013, J PROSTHET DENT, V109, P22, DOI 10.1016/S0022-3913(13)60005-0
   Jung YS, 2010, J ADV PROSTHODONT, V2, P111, DOI 10.4047/jap.2010.2.3.111
   Kadokawa A, 2006, J PROSTHET DENT, V96, P258, DOI 10.1016/j.prosdent.2006.08.016
   Kim MJ, 2012, J DENT, V40, P979, DOI 10.1016/j.jdent.2012.08.004
   KREJCI I, 1993, J PROSTHET DENT, V69, P425, DOI 10.1016/0022-3913(93)90192-Q
   KREJCI I, 1994, J DENT RES, V73, P1228, DOI 10.1177/00220345940730061501
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Mitov G, 2012, DENT MATER, V28, P909, DOI 10.1016/j.dental.2012.04.010
   de Abreu RAM, 2014, ARCH ORAL BIOL, V59, P1065, DOI 10.1016/j.archoralbio.2014.05.005
   Morneburg TR, 2002, INT J PROSTHODONT, V15, P20
   Oh WS, 2002, J PROSTHET DENT, V87, P451, DOI 10.1067/mpr.2002.123851
   Owais AI, 2013, EUR J ORTHODONT, V35, P427, DOI 10.1093/ejo/cjs021
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Raigrodski AJ, 2004, J PROSTHET DENT, V92, P557, DOI 10.1016/j.prosdent.2004.09.015
   Sabrah AHA, 2013, DENT MATER, V29, P666, DOI 10.1016/j.dental.2013.03.008
   SEGHI RR, 1991, J DENT RES, V70, P221, DOI 10.1177/00220345910700031301
   Serra CM, 2013, J ORAL REHABIL, V40, P563, DOI 10.1111/joor.12068
   Stober T, 2014, J ORAL REHABIL, V41, P314, DOI 10.1111/joor.12139
   Tinschert J, 2001, INT J PROSTHODONT, V14, P231
   van der Bilt A, 2008, EUR J ORAL SCI, V116, P217, DOI 10.1111/j.1600-0722.2008.00531.x
   Wang L, 2012, J EUR CERAM SOC, V32, P2599, DOI 10.1016/j.jeurceramsoc.2012.03.021
NR 39
TC 5
Z9 5
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2015
VL 47
BP 21
EP 28
DI 10.1016/j.jmbbm.2014.11.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK0IB
UT WOS:000355887800003
PM 25837341
DA 2018-10-20
ER

PT J
AU Brennan, O
   Stenson, B
   Widaaa, A
   O'Gorman, DM
   O'Brien, FJ
AF Brennan, Orlaith
   Stenson, Barry
   Widaaa, Amro
   O'Gorman, Denise M.
   O'Brien, Fergal J.
TI Incorporation of the natural marine multi-mineral dietary supplement
   Aquamin enhances osteogenesis and improves the mechanical properties of
   a collagen-based bone graft substitute
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Bone regeneration; Calcium; Collagen; Osteogenesis; Scaffold
ID GLYCOSAMINOGLYCAN SCAFFOLDS; PORE-SIZE; KNEE OSTEOARTHRITIS; GAG
   SCAFFOLDS; PROLIFERATION; FORMULA; CELLS
AB Aquamin is a commercially-available supplement derived from the algae species Lithothamnion, which has proven osteogenic potential. By harnessing this potential and combining Aquamin with a collagen scaffold, with architecture and composition optimised for bone repair, the aim of this study was to develop a natural osteo-stimulative bone graft substitute. A fabrication process was developed to incorporate Aquamin into scaffolds to produce collagen Aquamin (CollAqua) scaffolds at two different Aquamin concentrations, 100 F or 500 F (equivalent weight% of collagen or five times the weight of collagen respectively). CollAqua constructs had improved mechanical properties which were achieved without reducing the scaffold's permeability or porosity below the minimum level required for successful bone tissue engineering. The fabrication process produced a homogenous Aquamin distribution throughout the scaffold. Release kinetics revealed that in the first 12 h, the entire Aquamin content was released from the 100 F however, less than half of Aquamin in the 500 F was released with the remainder released approximately 21 days later giving an initial burst release followed by a delayed release. Osteoblasts cultured on the CollAqua scaffolds showed improved osteogenesis as measured by alkaline phosphatase, osteopontin and osteocalcin expression. This was confirmed by increased mineralisation as determined by von Kossa and Alizarin red staining.
   In conclusion, a cell and growth factor free collagen-based bone graft substitute with enhanced mechanical properties has been developed. The addition of Aquamin to the collagen biomaterial significantly improved mineralisation by osteoblasts and results in a new product which may be capable of enhancing osteogenesis to facilitate bone repair in vivo. (C) 2015 Elsevier Ltd. An rights reserved.
C1 [Brennan, Orlaith; Stenson, Barry; Widaaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, TERG, Dublin 2, Ireland.
   [Brennan, Orlaith; Stenson, Barry; O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Brennan, Orlaith; Widaaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dublin 2, Ireland.
   [Brennan, Orlaith; Widaaa, Amro; O'Brien, Fergal J.] Trinity Coll Dublin, Adv Mat & Bioengn Res Ctr AMBER, Dublin 2, Ireland.
RP Brennan, O (reprint author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.
EM obrennan1@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Brennan,
   Orlaith/0000-0001-6271-7590
FU Science Foundation Ireland [08/RFP/ENMF487 TIDA]
FX The authors thank Marigot Ltd. for providing Aquamin. This study was
   funded by Science Foundation Ireland, Grant no. 08/RFP/ENMF487 TIDA.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Alhag M, 2011, ORAL MAXILLOFAC SURG, V15, P31, DOI 10.1007/s10006-010-0241-x
   Aslam MN, 2010, CALCIFIED TISSUE INT, V86, P313, DOI 10.1007/s00223-010-9340-9
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Frestedt JL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-9
   Frestedt JL, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-7
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Nielsen BD, 2010, J EQUINE VET SCI, V30, P419, DOI 10.1016/j.jevs.2010.07.003
   O'Brien F.J., 2011, MATER TODAY, V14, P3
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   O'Gorman DM, 2012, PHYTOTHER RES, V26, P375, DOI 10.1002/ptr.3561
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Widaa A, 2014, PHYTOTHER RES, V28, P678, DOI 10.1002/ptr.5038
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
NR 29
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2015
VL 47
BP 114
EP 123
DI 10.1016/j.jmbbm.2015.03.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CK0IB
UT WOS:000355887800013
PM 25884141
DA 2018-10-20
ER

PT J
AU Sridharan, R
   Cameron, AR
   Kelly, DJ
   Kearney, CJ
   O'Brien, FJ
AF Sridharan, Rukmani
   Cameron, Andrew R.
   Kelly, Daniel J.
   Kearney, Cathal J.
   O'Brien, Fergal J.
TI Biomaterial based modulation of macrophage polarization: a review and
   suggested design principles
SO MATERIALS TODAY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; FOREIGN-BODY REACTION; IN-VIVO; ALTERNATIVE
   ACTIVATION; TOPOGRAPHICAL CONTROL; MECHANICAL-PROPERTIES; SURFACE;
   PHENOTYPE; SCAFFOLDS; SUBSTRATE
AB Macrophages have long been known for their phagocytic capabilities and immune defence; however, their role in healing is being increasingly recognized in recent years due to their ability to polarize into pro-inflammatory and anti-inflammatory phenotypes. Historically, biomaterials were designed to be inert to minimize the host response. More recently, the emergence of tissue engineering and regenerative medicine has led to the design of biomaterials that interact with the host through tailored mechanical, chemical and temporal characteristics. Due to such advances in biomaterial functionality and an improved understanding of macrophage responses to implanted materials, it is now possible to identify biomaterial design characteristics that dictate the host response and contribute to successful tissue integration. Herein, we begin by briefly reviewing macrophage cell origin and the key cytokine/chemokine markers of macrophage polarization and then describe which responses are favorable for both replacement and regenerative biomaterials. The body of the review focuses on macrophage polarization in response to inherent cues directly provided by biomaterials and the consequent cues that result from events related to biomaterial implantation. To conclude, a section on potential design principles for both replacement and regenerative biomaterials is presented. An in depth understanding of biomaterial cues to selectively polarize macrophages may prove beneficial in the design of a new generation of immuno-informed' biomaterials that can positively interact with the immune system to dictate a favorable macrophage response following implantation.
C1 [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; Kearney, Cathal J.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
   [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; O'Brien, Fergal J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; Kearney, Cathal J.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res Ctr AMBER, Dublin 2, Ireland.
   [Sridharan, Rukmani; Cameron, Andrew R.; Kelly, Daniel J.; Kearney, Cathal J.; O'Brien, Fergal J.] Univ Dublin Trinity Coll, Dublin 2, Ireland.
   [Kelly, Daniel J.] Univ Dublin Trinity Coll, Sch Engn, Dept Mech & Mfg Engn, Dublin 2, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Cameron,
   Andrew/0000-0002-6341-0379; Sridharan, Rukmani/0000-0001-6368-396X;
   Kelly, Daniel/0000-0003-4091-0992
FU Science Foundation Ireland (SFI) [SFI/12/RC/2278]; European Research
   Council (ERC) [239685]; Enterprise Ireland (EI) [CF20144003]; Irish
   Research Council Postdoctoral Fellowship (Government of Ireland)
   [GOIPD/2013/269]
FX This review has emanated from research supported in part by a research
   grant from Science Foundation Ireland (SFI) under Grant number
   SFI/12/RC/2278, European Research Council (ERC) under Grant number
   239685 (FP7/2007-2013), Enterprise Ireland (EI) under Project Code
   CF20144003 and an Irish Research Council Postdoctoral Fellowship
   (Government of Ireland), Grant Number GOIPD/2013/269.
CR Adutler-Lieber S, 2014, J AUTOIMMUN, V54, P100, DOI 10.1016/j.jaut.2014.05.003
   ALBINA JE, 1995, J IMMUNOL, V155, P4391
   Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Beningo KA, 2002, J CELL SCI, V115, P849
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gardner A.B., 2013, BIOMED RES INT, V2013, P82
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Hoogduijn MJ, 2010, INT IMMUNOPHARMACOL, V10, P1496, DOI 10.1016/j.intimp.2010.06.019
   Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jones GE, 1998, CELL ADHES COMMUN, V6, P237, DOI 10.3109/15419069809004479
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McEvoy A, 2002, BONE, V30, P171
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pixley F.J., 2012, INT J CELL BIOL, V2012, P5019
   Prockop DJ, 2013, STEM CELLS, V31, P2042, DOI 10.1002/stem.1400
   Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889
   Rees AJ, 2010, SEMIN NEPHROL, V30, P216, DOI [10.1016/j.semnephrol.2010.03.002, 10.1016/j.seminephrol.2010.03.002]
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Steward AJ, 2012, ACTA BIOMATER, V8, P2153, DOI 10.1016/j.actbio.2012.03.016
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001
   Waterfield JD, 2010, J BIOMED MATER RES A, V95A, P837, DOI 10.1002/jbm.a.32857
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Zaveri TD, 2014, BIOMATERIALS, V35, P3504, DOI 10.1016/j.biomaterials.2014.01.007
NR 96
TC 107
Z9 108
U1 6
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUL-AUG
PY 2015
VL 18
IS 6
BP 313
EP 325
DI 10.1016/j.mattod.2015.01.019
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CK4HK
UT WOS:000356184700013
OA Green Published, Other Gold
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Bai, SM
   Han, HY
   Huang, XW
   Xu, WA
   Kaplan, DL
   Zhu, HS
   Lu, Q
AF Bai, Shumeng
   Han, Hongyan
   Huang, Xiaowei
   Xu, Weian
   Kaplan, David L.
   Zhu, Hesun
   Lu, Qiang
TI Silk scaffolds with tunable mechanical capability for cell
   differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin; Nanofibrous scaffolds; Cell differentiation; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; SELF-ASSEMBLY PROCESS; BETA-SHEET CONTENT;
   IN-VITRO; FIBROIN SCAFFOLDS; OSTEOGENIC-DIFFERENTIATION; NANOFIBROUS
   SCAFFOLDS; COLLAGEN SCAFFOLDS; MATRIX; ELASTICITY
AB Bombyx mori silk fibroin is a promising biomaterial for tissue regeneration and is usually considered an "inert" material with respect to actively regulating cell differentiation due to few specific cell signaling peptide domains in the primary sequence and the generally stiffer mechanical properties due to crystalline content formed in processing. In the present study, silk fibroin porous 3D scaffolds with nanostructures and tunable stiffness were generated via a silk fibroin nanofiber-assisted lyophilization process. The silk fibroin nanofibers with high beta-sheet content were added into the silk fibroin solutions to modulate the self-assembly, and to directly induce water-insoluble scaffold formation after lyophilization. Unlike previously reported silk fibroin scaffold formation processes, these new scaffolds had lower overall beta-sheet content and softer mechanical properties for improved cell compatibility. The scaffold stiffness could be further tuned to match soft tissue mechanical properties, which resulted in different differentiation outcomes with rat bone marrow-derived mesenchymal stem cells toward myogenic and endothelial cells, respectively. Therefore, these silk fibroin scaffolds regulate cell differentiation outcomes due to their mechanical features. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bai, Shumeng; Huang, Xiaowei; Kaplan, David L.; Lu, Qiang] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Bai, Shumeng; Huang, Xiaowei; Kaplan, David L.; Lu, Qiang] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China.
   [Bai, Shumeng; Huang, Xiaowei; Lu, Qiang] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215123, Peoples R China.
   [Han, Hongyan; Xu, Weian] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn
FU National Basic Research Program of China (973 Program) [2013CB934400];
   NSFC [21174097, 81272106]; NIH [R01 DE017207, P41 EB002520]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD); Excellent Youth Foundation of Jiangsu Province [BK2012009];
   Natural Science Foundation of Jiangsu Province [BK20140397]; Key Natural
   Science Foundation of the Jiangsu Higher Education Institutions of China
   [11KGA430002]
FX We thank the National Basic Research Program of China (973 Program
   2013CB934400), NSFC (21174097, 81272106) and the NIH (R01 DE017207, P41
   EB002520) for support of this work. We also thank the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   Excellent Youth Foundation of Jiangsu Province (BK2012009), the Natural
   Science Foundation of Jiangsu Province (Grants No BK20140397), and the
   Key Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China (11KGA430002) for support of this work.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033
   Bai SM, 2014, J MATER CHEM B, V2, P6590, DOI 10.1039/c4tb00878b
   Bai SM, 2014, BIOMACROMOLECULES, V15, P3044, DOI 10.1021/bm500662z
   Bardouille C, 2001, APPL MICROBIOL BIOT, V55, P556, DOI 10.1007/s002530100595
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cristallini C, 2014, BIOMATERIALS, V35, P92, DOI 10.1016/j.biomaterials.2013.09.058
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dunne LW, 2014, ACTA BIOMATER, V10, P3630, DOI 10.1016/j.actbio.2014.05.005
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Florczyk SJ, 2011, J BIOMED MATER RES A, V98A, P614, DOI 10.1002/jbm.a.33153
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gong PY, 2013, ADV FUNCT MATER, V23, P42, DOI 10.1002/adfm.201201275
   Han F, 2014, ACTA BIOMATER, V10, P921, DOI 10.1016/j.actbio.2013.09.026
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huang CC, 2014, BIOMATERIALS, V35, P5316, DOI 10.1016/j.biomaterials.2014.03.035
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HN, 2013, ADV DRUG DELIVER REV, V65, P536, DOI 10.1016/j.addr.2012.07.014
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Li A, 2014, BIOMATERIALS, V35, P8780, DOI 10.1016/j.biomaterials.2014.06.049
   Lin SS, 2014, J MATER CHEM B, V2, P2622, DOI 10.1039/c4tb00019f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X
   McNamara SL, 2014, BIOMATERIALS, V35, P6941, DOI 10.1016/j.biomaterials.2014.05.013
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Peloquin J, 2011, J BIOMECH, V44, P815, DOI 10.1016/j.jbiomech.2010.12.018
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Solanki A, 2013, ADV MATER, V25, P5477, DOI 10.1002/adma.201302219
   Song YH, 2013, INT J NANOMED, V8, P2745, DOI 10.2147/IJN.S44885
   Sun J, 2014, BIOMATERIALS, V35, P4759, DOI 10.1016/j.biomaterials.2014.02.041
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Valarmathi MT, 2009, BIOMATERIALS, V30, P1098, DOI 10.1016/j.biomaterials.2008.10.044
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Wu XL, 2012, ACTA BIOMATER, V8, P2185, DOI 10.1016/j.actbio.2012.03.007
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 58
TC 29
Z9 29
U1 7
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2015
VL 20
BP 22
EP 31
DI 10.1016/j.actbio.2015.04.004
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ7VJ
UT WOS:000355708200003
PM 25858557
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Oh, DX
   Kim, S
   Lee, D
   Hwang, DS
AF Oh, Dongyeop X.
   Kim, Sangsik
   Lee, Dohoon
   Hwang, Dong Soo
TI Tunicate-mimetic nanofibrous hydrogel adhesive with improved wet
   adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tunicates; Underwater adhesives; Chitin nanofibers; Pyrogallol;
   Nanofibrous hydrogels
ID GALLIC ACID; IONIC-LIQUID; MUSSEL; CHITOSAN; PROTEIN; CHITIN; PH;
   TUNICHROMES; ANTIOXIDANT; MECHANICS
AB The main impediment to medical application of biomaterial-based adhesives is their poor wet adhesion strength due to hydration-induced softening and dissolution. To solve this problem, we mimicked the wound healing process found in tunicates, which use a nanofiber structure and pyrogallol group to heal any damage on its tunic under sea water. We fabricated a tunicate-mimetic hydrogel adhesive based on a chitin nanofiber/gallic acid (a pyrogallol acid) composite. The pyrogallol group-mediated cross-linking and the nanofibrous structures improved the dissolution resistance and cohesion strength of the hydrogel compared to the amorphous polymeric hydrogels in wet condition. The tunicate-mimetic adhesives showed higher adhesion strength between fully hydrated skin tissues than did fibrin glue and mussel-mimetic adhesives. The tunicate mimetic hydrogels were produced at low cost from recyclable and abundant raw materials. This tunicate-mimetic adhesive system is an example of how natural materials can be engineered for biomedical applications. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oh, Dongyeop X.; Lee, Dohoon; Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Ocean Sci & Technol Inst, Pohang 790784, South Korea.
   [Kim, Sangsik; Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci, Pohang 790784, South Korea.
   [Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.
RP Hwang, DS (reprint author), Pohang Univ Sci & Technol POSTECH, Sch Environm Sci, Pohang 790784, South Korea.
EM dshwang@postech.ac.kr
RI Hwang, Dong Soo/C-7291-2011
OI Hwang, Dong Soo/0000-0002-2487-2255; Oh, Dongyeop/0000-0003-3665-405X
FU Marine Biomaterials Research Center under Marine Biotechnology Program,
   Ministry of Oceans and Fisheries Affairs, Korea; National Research
   Foundation of Korea - Ministry of Science, ICT and Future Planning
   (MSIP) [NRF-2014R1A2A2A01006724, NRF-C1ABA001-2011-0029960]
FX This work was supported by the Marine Biomaterials Research Center under
   Marine Biotechnology Program, Ministry of Oceans and Fisheries Affairs,
   Korea. We also acknowledge the National Research Foundation of Korea
   Grant funded by the Ministry of Science, ICT and Future Planning (MSIP)
   (NRF-2014R1A2A2A01006724 & NRF-C1ABA001-2011-0029960, NRF-2013-Fostering
   Core Leaders of the Future Basic Science Program).
CR Arnow LE, 1937, J BIOL CHEM, V118, P531
   Barrett DG, 2014, CHEM COMMUN, V50, P7265, DOI 10.1039/c4cc02961e
   BAYER E, 1992, ANGEW CHEM INT EDIT, V31, P52, DOI 10.1002/anie.199200521
   Bicchieri M, 2013, ANAL BIOANAL CHEM, V405, P2713, DOI 10.1007/s00216-012-6681-4
   Burke SA, 2007, BIOMED MATER, V2, P203, DOI 10.1088/1748-6041/2/4/001
   Byun E, 2014, CHEM COMMUN, V50, P2869, DOI 10.1039/c3cc49043b
   Cai MM, 2008, COMP BIOCHEM PHYS B, V151, P110, DOI 10.1016/j.cbpb.2008.06.004
   Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307
   Cha HJ, 2009, BIOFOULING, V25, P99, DOI 10.1080/08927010802563108
   Claudio AFM, 2014, GREEN CHEM, V16, P259, DOI 10.1039/c3gc41999a
   Clay FSH, 2011, AM J OBSTET GYNECOL, V204, P378, DOI 10.1016/j.ajog.2010.11.018
   Das P, 2012, BIOMACROMOLECULES, V13, P4205, DOI 10.1021/bm3014796
   Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265
   Fichman G, 2014, ACS NANO, V8, P7220, DOI 10.1021/nn502240r
   Giano MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5095
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Holten-Andersen N, 2014, J MATER CHEM B, V2, P2467, DOI 10.1039/c3tb21374a
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d
   Je JY, 2006, BIOMACROMOLECULES, V7, P3448, DOI 10.1021/bm060373d
   Kamata H, 2014, SCIENCE, V343, P873, DOI 10.1126/science.1247811
   Kim BJ, 2015, J MATER CHEM B, V3, P112, DOI 10.1039/c4tb01496k
   Kim BJ, 2014, BIOMACROMOLECULES, V15, P1579, DOI 10.1021/bm4017308
   KIMEHUNT E, 1991, J INORG BIOCHEM, V41, P125, DOI 10.1016/0162-0134(91)80006-4
   Kimura S, 2001, PROTOPLASMA, V216, P71, DOI 10.1007/BF02680133
   Krogsgaard M, 2013, BIOMACROMOLECULES, V14, P297, DOI 10.1021/bm301844u
   Kumamoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P126, DOI 10.1271/bbb.65.126
   Kumari H, 2012, ANGEW CHEM INT EDIT, V51, P9263, DOI 10.1002/anie.201204776
   KUSTIN K, 1974, J AM CHEM SOC, V96, P7410, DOI 10.1021/ja00831a600
   Lee AS, 2006, VIB SPECTROSC, V41, P170, DOI 10.1016/j.vibspec.2005.11.006
   Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lim S, 2010, BIOMATERIALS, V31, P3715, DOI 10.1016/j.biomaterials.2010.01.063
   Lu Q., 2013, ANGEW CHEM INT EDIT, V125, P4036
   Lu Q., 2013, J R SOC INTERFACE, V10
   Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759
   MCMANUS JP, 1985, J CHEM SOC PERK T 2, P1429, DOI 10.1039/p29850001429
   Meng H, 2015, ACTA BIOMATER, V17, P160, DOI 10.1016/j.actbio.2015.02.002
   Moses DN, 2006, J BIOL CHEM, V281, P34826, DOI 10.1074/jbc.M603429200
   Oh DX, 2013, MATERIALS, V6, P3826, DOI 10.3390/ma6093826
   Oh DX, 2013, BIOTECHNOL PROGR, V29, P505, DOI 10.1002/btpr.1691
   Ohkawa K, 2004, BIOFOULING, V20, P101, DOI 10.1080/08927010410001681246
   PAPATHEOFANIS FJ, 1989, J BIOMED MATER RES, V23, P661, DOI 10.1002/jbm.820230609
   Pasanphan W, 2008, J APPL POLYM SCI, V109, P38, DOI 10.1002/app.27953
   Pasanphan W, 2008, CARBOHYD POLYM, V72, P169, DOI 10.1016/j.carbpol.2007.08.002
   Ryu JH, 2011, J CONTROL RELEASE, V152, P236
   Shafiq Z., 2012, ANGEW CHEM, V124, P4408, DOI DOI 10.1021/JA9074562
   Shao H, 2010, ADV MATER, V22, P729, DOI 10.1002/adma.200902380
   Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922
   Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x
   Tajiri R, 2014, RSC ADV, V4, P5542, DOI 10.1039/c3ra46285d
   Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z
   Taylor SW, 1995, ARCH BIOCHEM BIOPHYS, V324, P228, DOI 10.1006/abbi.1995.0035
   Taylor SW, 1997, CHEM REV, V97, P333, DOI 10.1021/cr940467q
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   White JD, 2011, MACROMOLECULES, V44, P5085, DOI 10.1021/ma201044x
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   WILSON TC, 1990, J AGR FOOD CHEM, V38, P1678, DOI 10.1021/jf00098a011
   Yu SH, 2011, CARBOHYD POLYM, V84, P794, DOI 10.1016/j.carbpol.2010.04.035
   Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107
NR 60
TC 29
Z9 29
U1 14
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2015
VL 20
BP 104
EP 112
DI 10.1016/j.actbio.2015.03.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ7VJ
UT WOS:000355708200011
PM 25841348
DA 2018-10-20
ER

PT J
AU Andrukhov, O
   Gemperli, AC
   Tang, Y
   Howald, N
   Dard, M
   Falkensammer, F
   Moritz, A
   Rausch-Fan, X
AF Andrukhov, Oleh
   Gemperli, Anja C.
   Tang, Yan
   Howald, Nadia
   Dard, Michel
   Falkensammer, Frank
   Moritz, Andreas
   Rausch-Fan, Xiaohui
TI Effect of different enamel matrix derivative proteins on behavior and
   differentiation of endothelial cells
SO DENTAL MATERIALS
LA English
DT Article
DE Endothelial cells; EMD; Cell culture; Migration; Differentiation
ID PERIODONTAL-LIGAMENT CELLS; HUMAN GINGIVAL FIBROBLASTS; IN-VITRO;
   GROWTH-FACTOR; ADHESION MOLECULES; ANGIOGENIC ACTIVITY; VEGF RECEPTOR;
   EXPRESSION; REGENERATION; MODEL
AB Objectives. Enamel matrix derivative (EMD) is an effective biomaterial for periodontal tissue regeneration and might stimulate angiogenesis. In order to clarify mechanisms underlying its biological activity, we separated two EMD fractions with different molecular weight protein components and investigated their effects on human umbilical vein endothelial cells (HUVECs) in vitro.
   Methods. Fraction Low-Molecular Weight (LMW) included proteins with a molecular weight (M.W.) <8 kDa. Fraction LMW-depleted included proteins with M.W. >8 kDa and lower than approximately 55 kDa. The effect of EMD fractions on proliferation/viability, apoptosis, migration and expression of angiopoetin-2 (ang-2), von Willebrand factor (vWF), E-selectin, intracellular adhesion molecules 1 (ICAM-1), vascular endothelial growth factor (VEGF) receptors Flt-1 and KDR was investigated.
   Results. The proliferation/viability of HUVECs was inhibited by both LMW and LMW-depleted at concentrations 100 mu g/ml, whereas EMD slightly increased cell proliferation/viability. The expression of all investigated proteins was up-regulated by EMD. However, differences in the effect of EMD fractions on the protein expression were observed. The effect of LMW-depleted on the expression of ICAM-1 and E-selectin was markedly higher compared to LMW. In contrast, the expression of vWF and VEGF receptors Flt-1 and KDR was primarily affected LMW than by LMW depleted. The expression of ang-2 was not influenced by LMW and LMW-depleted. HUVECs migration was stimulated more strongly by LMW than by EMD and LMW-depleted.
   Conclusion. Our in vitro study shows that the proteins composing EMD have different and specific biological activities and consequently have the ability to cover different aspects of EMD's biological and clinical effects. (C) 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Andrukhov, Oleh; Tang, Yan; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Competence Ctr Periodontal Res, A-1090 Vienna, Austria.
   [Gemperli, Anja C.; Howald, Nadia; Dard, Michel] Inst Straumann AG, Basel, Switzerland.
   [Tang, Yan] Capital Med Univ, Xuanwu Hosp, Dept Stomatol, Beijing, Peoples R China.
   [Dard, Michel] NYU, Coll Dent, Dept Periodontol & Implant Dent, New York, NY USA.
   [Falkensammer, Frank] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Orthodont, A-1090 Vienna, Austria.
   [Andrukhov, Oleh; Moritz, Andreas; Rausch-Fan, Xiaohui] Med Univ Vienna, Bernhard Gottlieb Sch Dent, Div Conservat Dent Periodontol & Prophylaxis, A-1090 Vienna, Austria.
RP Andrukhov, O (reprint author), Med Univ Vienna, Bernhard Gottlieb Sch Dent, Sensengasse 2a, A-1090 Vienna, Austria.
EM oleh.andrukhov@meduniwien.ac.at; xiaohui.rausch-fan@meduniwien.ac.at
OI Rausch-Fan, Xiaohui/0000-0002-8010-1914; Andrukhov,
   Oleh/0000-0002-0485-2142
FU ITI Foundation [781_2011]
FX The study was supported by the ITI Foundation (Research Grant No.
   781_2011). The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   authors acknowledge the help of Mrs. Phuong Quynh Nguyen and Mrs. Hedwig
   Rutschek for excellent technical assistance.
CR ALBELDA SM, 1994, FASEB J, V8, P504
   Amin HD, 2014, ACTA BIOMATER, V10, P1930, DOI 10.1016/j.actbio.2013.11.027
   Amin HD, 2013, ACTA BIOMATER, V9, P4796, DOI 10.1016/j.actbio.2012.09.008
   An N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096942
   Andrukhov O, 2015, ODONTOLOGY, V103, P19, DOI 10.1007/s10266-013-0146-x
   Andrukhov O, 2014, ACTA ODONTOL SCAND, V72, P337, DOI 10.3109/00016357.2013.834535
   Andrukhov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090301
   Aspriello SD, 2011, J PERIODONTOL, V82, P606, DOI 10.1902/jop.2010.100180
   Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Bertl K, 2009, J PERIODONTOL, V80, P1622, DOI 10.1902/jop.2009.090157
   Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001
   Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P247
   Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x
   Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]
   Johnson DL, 2009, J PERIODONTOL, V80, P648, DOI 10.1902/jop.2009.070420
   Kasaj A, 2012, J PERIODONTAL RES, V47, P479, DOI 10.1111/j.1600-0765.2011.01456.x
   Kauvar AS, 2010, J PERIODONTOL, V81, P1196, DOI 10.1902/jop.2010.090441
   Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Maycock J, 2002, CONNECT TISSUE RES, V43, P472, DOI 10.1080/03008200290000880
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mumulidu A, 2007, J CHROMATOGR B, V857, P210, DOI 10.1016/j.jchromb.2007.07.017
   Murota SI, 2000, ANN NY ACAD SCI, V902, P208
   Murota SI, 2000, ANN NY ACAD SCI, V902, P12
   Nokhbehsaim M, 2011, J PERIODONTOL, V82, P1725, DOI 10.1902/jop.2011.100678
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Pasceri V, 2000, CIRCULATION, V102, P2165
   PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Qu Z, 2010, ORAL SURG ORAL MED O, V109, P924, DOI 10.1016/j.tripleo.2010.01.007
   Riss T. L, 2004, ASSAY GUIDANCE MANUA
   Sakoda K, 2012, EUR J ORAL SCI, V120, P513, DOI 10.1111/j.1600-0722.2012.00999.x
   Schlueter SR, 2007, J PERIODONTOL, V78, P141, DOI 10.1902/jop.2007.060111
   Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9
   Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006
   Thoma DS, 2011, J CLIN PERIODONTOL, V38, P253, DOI 10.1111/j.1600-051X.2010.01656.x
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605
   Yao NH, 2011, MOL CELL BIOCHEM, V355, P91, DOI 10.1007/s11010-011-0842-1
   Yau TM, 2005, ANN THORAC SURG, V79, P2056, DOI 10.1016/j.athorascur.2004.10.06
   Yuan K, 2003, J CLIN PERIODONTOL, V30, P732, DOI 10.1034/j.1600-051X.2003.00413.x
NR 48
TC 2
Z9 2
U1 2
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 2015
VL 31
IS 7
BP 822
EP 832
DI 10.1016/j.dental.2015.04.004
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA CJ9HA
UT WOS:000355811900009
PM 25982018
DA 2018-10-20
ER

PT J
AU Bakhsh, TA
   Sadr, A
   Mandurah, MM
   Shimada, Y
   Zakaria, O
   Tagami, J
AF Bakhsh, Turki A.
   Sadr, Alireza
   Mandurah, Mona M.
   Shimada, Yasushi
   Zakaria, Osama
   Tagami, Junji
TI In situ characterization of resin-dentin interfaces using conventional
   vs. cryofocused ion-beam milling
SO DENTAL MATERIALS
LA English
DT Article
DE FIB; TEM; Resin composite; Collagen; Dental adhesive; Teeth, dentin,
   nano-interaction zone; Cryo; Hybrid layer
ID TEM SPECIMEN PREPARATION; TRANSMISSION ELECTRON-MICROSCOPY;
   ULTRASTRUCTURAL EXAMINATION; COMPARATIVE SEM; TOMOGRAPHY; SAMPLES; TOOL
AB Objective. The introduction of focused ion beam (FIB) milling has facilitated preparation of hard tissue samples for transmission electron microscope (TEM). However, this technique generates high temperature that may alter or damage morphological features in biological tissue. Therefore, the aim of this study was to determine the effects of cryogenic cooling on the morphological features of dentin interfaces with dental restorative materials in samples prepared by FIB for TEM examination.
   Methods. After preparation of a cylindrical-shaped cavities in extracted, non-carious premolar teeth, the specimens were restored with dental adhesive/composite and categorized into two restorative materials groups; (PB) a combination of Clearfil Protect Bond (Kuraray Noritake Dental, Japan)/Estelite Sigma Quick composite (Tokuyama Dental, Japan), and (SB) Filtek Silorane restorative system (3M ESPE, USA). The specimens were subjected to interfacial cross-sectioning, followed by observation and area selection using confocal laser microscopy. Later, ultrathin sections were prepared using FIB with cryogenic cooling (PB-C) and (SB-C), or without cooling (PB-NC) and (SB-NC) that all were examined under TEM.
   Results. Resulting TEM images of the ultra-morphological features at the resin-dentin nano-interaction zone were improved when FIB preparation was conducted in the cryogenic condition and no sign of artifacts were detected.
   Significance. Conducting ion beam milling with cryogenic cooling was advantageous in minimizing the elevation in specimen temperature. This led to preservation of dentin microstructures that revealed additional information about substrates that are necessary for advanced characterization of tooth-biomaterial interactions. (C) 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Bakhsh, Turki A.] King Abdulaziz Univ, Fac Dent, Dept Operat Dent, Jeddah 21589, Saudi Arabia.
   [Sadr, Alireza; Mandurah, Mona M.; Shimada, Yasushi; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Cardiol & Operat Dent Dept, Bunkyo Ku, Tokyo 1138549, Japan.
   [Sadr, Alireza] Univ Washington, Sch Dent, Seattle, WA 98195 USA.
   [Zakaria, Osama] Pharos Univ, Fac Dent, Oral Surg, Alexandria, Egypt.
RP Bakhsh, TA (reprint author), King Abdulaziz Univ, Fac Dent, Dept Operat Dent, POB 80209, Jeddah 21589, Saudi Arabia.
EM taabakhsh@kau.edu.sa
OI Bakhsh, Turki/0000-0002-5953-4109; Sadr, Alireza/0000-0001-7658-0572
FU Deanship of Scientific Research (DSR), King Abdulaziz University,
   Jeddah, Saudi Arabia
FX This work was funded by the Deanship of Scientific Research (DSR), King
   Abdulaziz University, Jeddah, Saudi Arabia. The authors, therefore,
   acknowledge with thanks DSR technical and financial support.
CR Bakhsh TA, 2013, J DENT, V41, P60, DOI 10.1016/j.jdent.2012.10.003
   Bakhsh TA, 2011, DENT MATER, V27, P915, DOI 10.1016/j.dental.2011.05.003
   Breschi L, 2003, AM J DENT, V16, P267
   Coutinho E, 2009, DENT MATER, V25, P1325, DOI 10.1016/j.dental.2009.06.002
   CROWELL CD, 1934, J DENT RES, V14, P251
   Desbois G, 2008, GEOFLUIDS, V8, P60, DOI 10.1111/j.1468-8123.2007.00205.x
   Desbois G, 2013, J MICROSC-OXFORD, V249, P215, DOI 10.1111/jmi.12011
   Dolph MC, 2014, NUCL INSTRUM METH B, V328, P33, DOI 10.1016/j.nimb.2014.02.126
   Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024
   Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0
   Giannuzzi LA, 1998, MICROSC RES TECHNIQ, V41, P285, DOI 10.1002/(SICI)1097-0029(19980515)41:4<285::AID-JEMT1>3.0.CO;2-Q
   Grandfield K, 2012, ADV MATER SCI ENG, V2012, P6
   Hauert R, 2012, ACTA BIOMATER, V8, P3170, DOI 10.1016/j.actbio.2012.04.016
   Kalin C, 1998, J DENT, V26, P511, DOI 10.1016/S0300-5712(98)00005-0
   Li J, 2006, MATER CHARACT, V57, P64, DOI 10.1016/j.matchar.2005.12.007
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Nalla RK, 2005, MICRON, V36, P672, DOI 10.1016/j.micron.2005.05.011
   Nishimura Kozo, 2005, Journal of Medical and Dental Sciences, V52, P9
   Nomoto R, 1994, Dent Mater J, V13, P198
   Nurrohman H, 2012, DENT MATER, V28, pE89, DOI 10.1016/j.dental.2012.04.025
   Phaneuf MW, 1999, MICRON, V30, P277, DOI 10.1016/S0968-4328(99)00012-8
   Rykaczewski K, 2012, ACS NANO, V6, P9326, DOI 10.1021/nn304250e
   SANO H, 1995, OPER DENT, V20, P160
   Tay F R, 1999, J Adhes Dent, V1, P103
   Thompson GB, 2004, ULTRAMICROSCOPY, V100, P25, DOI 10.1016/j.ultramic.2004.01.010
   Thompson LE, 2006, MICROSC MICROANAL, V12, P156, DOI 10.1017/S1431927606060041
   VANMEERBEEK B, 1995, DENT MATER, V11, P87, DOI 10.1016/0109-5641(95)80039-5
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   YU JE, 1991, J ELECTRON MICR TECH, V18, P315, DOI 10.1002/jemt.1060180314
NR 30
TC 4
Z9 4
U1 2
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 2015
VL 31
IS 7
BP 833
EP 844
DI 10.1016/j.dental.2015.04.010
PG 12
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA CJ9HA
UT WOS:000355811900010
PM 25986333
DA 2018-10-20
ER

PT J
AU Grecchi, F
   Perale, G
   Candotto, V
   Busato, A
   Pascali, M
   Carinci, F
AF Grecchi, F.
   Perale, G.
   Candotto, V.
   Busato, A.
   Pascali, M.
   Carinci, F.
TI RECONSTRUCTION OF THE ZYGOMATIC BONE WITH SMARTBONE (R): CASE REPORT
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE alloplastic implants; bone reconstruction; injury; SmartBone (R)
ID MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; SUBSTITUTES;
   SCAFFOLDS; CERAMICS
AB The repair of complex craniofacial bone defects is challenging and a successful result depends on the defect size, the quality of the soft tissue covering the defect and the choice of reconstructive method. Autologous bone grafts are the gold standard for bone replacement. Tissue engineered constructs are temporary substitutes developed to treat damaged or lost tissue. Recent advances in materials science have provided an abundance of innovations, underlining the increasing importance of polymer in this field. The Galeazzi Orthopedical institute of Milan received a Serbian soldier who reported a deep wound, due to the explosion of a grenade, during former-Yugoslavia's war. His left cheekbone was completely lost, together with the floor of the left eye. SmartBone (R) technology allowed the realization of custom-made grafts which perfectly fitted the bone defect thanks to mechanical strength, also at small thicknesses, and the ability to be shaped without powder formation or unpredicted fractures. Tissue engineering approaches to regeneration utilize 3-dimensional (3D) biomaterial matrices that interact favorably with cells. The potential benefits of using a tissue engineering approach include reduced donor site morbidity, shortened operative time, decreased technical difficulty of the repair, ability to closely mimic the in vivo microenvironment in an attempt to recapitulate normal craniofacial development: this 36-month case study allowed to prove that SmartBone (R) custom-made bone grafts are an effective solution, gathering such benefits and being available now for daily routine.
C1 [Grecchi, F.] Galeazzi Hosp, Dept Maxillofacial Surg, Milan, Italy.
   [Perale, G.] Ind Biomed Insubri SA, Mezzovico Vira, Switzerland.
   [Perale, G.] Univ Appl Sci & Art Southern Switzerland, Dept Innovat Technol, Manno, Switzerland.
   [Candotto, V.; Carinci, F.] Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
   [Pascali, M.] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
EM crc@unife.it
CR ADAMS SS, 1981, AGENTS ACTIONS, V11, P471
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Arosarena Oneida A, 2006, Oral Maxillofac Surg Clin North Am, V18, P521, DOI 10.1016/j.coms.2006.06.005
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Cordonnier T, 2011, TISSUE ENG PART C-ME, V17, P249, DOI [10.1089/ten.tec.2010.0387, 10.1089/ten.TEC.2010.0387]
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Gronthos S, 2004, LANCET, V364, P735, DOI 10.1016/S0140-6736(04)16948-1
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   Kumar A, 1996, AM J HEMATOL, V53, P92, DOI 10.1002/(SICI)1096-8652(199610)53:2<92::AID-AJH6>3.0.CO;2-Z
   Louis PJ, 2011, ORAL MAXIL SURG CLIN, V23, P209, DOI 10.1016/j.coms.2011.01.002
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Van Lieshout EMM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-34
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 19
TC 2
Z9 2
U1 0
U2 1
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JUL-SEP
PY 2015
VL 29
IS 3
SU S
BP 42
EP 47
PG 6
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA DS4EG
UT WOS:000380733600010
PM 26511180
DA 2018-10-20
ER

PT J
AU Lopez, MA
   Bassi, MA
   Confalone, L
   Lico, S
   Carinci, F
AF Lopez, M. A.
   Bassi, M. Andreasi
   Confalone, L.
   Lico, S.
   Carinci, F.
TI CRESTAL SINUS LIFT USING A FLUIDO-DYNAMIC COMPUTER GUIDED PRECISE AND
   ATRAUMATIC TECHNIQUE
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE computer guided surgery; graft; maxillary; Schneiderian; sinus
ID MAXILLARY MOLAR EXTRACTION; FLOOR AUGMENTATION; IMPLANTS; SUCCESS;
   PLACEMENT; ELEVATION; RATES; TIME
AB One of the most frequent reasons for failure during the maxillary sinus floor lift operation is connected to the possibility of a rupture of the Schneiderian membrane which, if lacerated, cannot perform the function of graft containment. In order to reduce the incidence of complications it is necessary to cut the hard tissue with extreme accuracy and as little trauma as possible, while saving the soft tissue. The precision of pre-operation measures obtained through endoral x-rays, dental-scans and cone-beam CT allows us to approach and cut with delicacy the sinus cortical floor. The recent development of computer guided surgery gives the possibility of planning the operation, which reduces the risk of failure. The cortical of the maxillary sinus is reduced through the use of calibrated burs and a profiler to obtain a hole that enables both access to the maxillary sinus and, subsequently, the lifting of the Schneiderian membrane. Each stage of the operation is monitored and all the devices used pass through a custom-made template, which acts as a surgical guide. The sinus was filled using fluid biomaterial distributed through a dispenser, which had been created specifically for this technique. Due to the reduction in trauma and the fact that the process is much less invasive, this technique could be a valid alternative to the techniques known and carried out to date. Work time is reduced to less than 3 minutes in the cortical thinning operation and percussive trauma is avoided.
C1 [Carinci, F.] Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Luigi Borsari 46, Ferrara, Italy.
EM crc@unife.it
CR Andreasi Bassi M, 2010, J OSTEOL BIOMAT, V1, P93
   Chen L, 2005, J PERIODONTOL, V76, P482, DOI 10.1902/jop.2005.76.3.482
   Chiapasco M, 2003, IMPLANT PROSTHESIS R
   Cosci F, 2000, Implant Dent, V9, P363, DOI 10.1097/00008505-200009040-00014
   Danza Matteo, 2010, Stomatologija, V12, P35
   Danza M, 2009, J ORAL MAXIL SURG, V67, P2460, DOI 10.1016/j.joms.2009.04.041
   Engelke W, 2005, INT J ORAL MAX IMPL, V20, P891
   Favero GA, 1994, STOMATOL ORTHOGNATOD
   Fugazzotto P A, 2001, Implant Dent, V10, P259
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P52
   Fugazzotto PA, 2002, INT J ORAL MAX IMPL, V17, P113
   Fugazzotto PA, 2002, J PERIODONTOL, V73, P39, DOI 10.1902/jop.2002.73.1.39
   Fugazzotto PA, 1999, INT J ORAL MAX IMPL, V14, P536
   Grecchi F, 2009, J OSSEOINTEGRATION
   Guarnieri R, 2014, VALUTAZIONE VITRO AC, P11
   HORTON JE, 1981, ORAL SURG ORAL MED O, V51, P236, DOI 10.1016/0030-4220(81)90051-7
   Lopez MA, 2014, J CRANIOFAC SURG, V25, pE127, DOI 10.1097/SCS.0000000000000457
   Malchiodi L, 2003, IMPLANT SURG, P219
   Marchetti E, 2010, J OSSEOINTEGRATION
   McFALL T. A., 1961, JOUR ORAL SURG, V19, P200
   Pozzi A, 2011, Oral Implantol (Rome), V4, P4
   Summers R B, 1994, Compendium, V15, P702
   Summers R B, 1994, Compendium, V15, P154
   Summers R B, 1995, Compend Contin Educ Dent, V16, P1094
   Summers R. B., 1994, COMPENDIUM, V15, P162
   SUMMERS RB, 1994, COMPENDIUM, V15, P710
   Summers RB, 1994, COMPENDIUM, V15, P158
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1098
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1099
   Summers RB, 1995, COMPEND CONTIN ED DE, V16, P1092
   Summers RB, 1994, COMPENDIUM, V15, P154
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1094
   SUMMERS RB, 1994, COMPENDIUM, V15, P700
   Vercellotti T, 2004, Minerva Stomatol, V53, P207
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   Vercellotti T., 2003, MODERN DENT, V5, P21
   Vercellotti T., 2004, ODONTOIATRY J
   Winter AA, 2002, INT J ORAL MAX IMPL, V17, P687
   Zaninari A, 1987, Dent Cadmos, V55, P63
NR 39
TC 2
Z9 2
U1 3
U2 4
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JUL-SEP
PY 2015
VL 29
IS 3
SU S
BP 67
EP 73
PG 7
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA DS4EG
UT WOS:000380733600014
PM 26511183
DA 2018-10-20
ER

PT J
AU Li, Y
   Chen, SK
   Li, L
   Qin, L
   Wang, XL
   Lai, YX
AF Li, Ye
   Chen, Shu-Kui
   Li, Long
   Qin, Ling
   Wang, Xin-Luan
   Lai, Yu-Xiao
TI Bone defect animal models for testing efficacy of bone substitute
   biomaterials
SO JOURNAL OF ORTHOPAEDIC TRANSLATION
LA English
DT Review
DE animal models; bone defect; bone regeneration; bone substitutes
ID BETA-TRICALCIUM PHOSPHATE; TOTAL KNEE ARTHROPLASTY; MESENCHYMAL
   STEM-CELLS; CRITICAL SIZE DEFECT; CALCIUM-PHOSPHATE; CALVARIAL DEFECT;
   SEGMENTAL DEFECT; MORPHOGENETIC PROTEIN-2; GRAFT SUBSTITUTES; TRABECULAR
   BONE
AB Large bone defects are serious complications that are most commonly caused by extensive trauma, tumour, infection, or congenital musculoskeletal disorders. If nonunion occurs, implantation for repairing bone defects with biomaterials developed as a defect filler, which can promote bone regeneration, is essential. In order to evaluate biomaterials to be developed as bone substitutes for bone defect repair, it is essential to establish clinically relevant in vitro and in vivo testing models for investigating their biocompatibility, mechanical properties, degradation, and interactional with culture medium or host tissues. The results of the in vitro experiment contribute significantly to the evaluation of direct cell response to the substitute biomaterial, and the in vivo tests constitute a stepmidway between in vitro tests and human clinical trials. Therefore, it is essential to develop or adopt a suitable in vivo bone defect animal model for testing bone substitutes for defect repair. This review aimed at introducing and discussing the most available and commonly used bone defect animal models for testing specific substitute biomaterials. Additionally, we reviewed surgical protocols for establishing relevant preclinical bone defect models with various animal species and the evaluation methodologies of the bone regeneration process after the implantation of bone substitute biomaterials. This review provides an important reference for preclinical studies in translational orthopaedics. Copyright (C) 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Li, Ye; Chen, Shu-Kui; Li, Long; Qin, Ling; Wang, Xin-Luan; Lai, Yu-Xiao] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Translat Med Res & Dev, 1068 Xueyuan Ave,Shenzhen Univ Town, Shenzhen 518055, Peoples R China.
   [Li, Ye] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China.
   [Qin, Ling; Wang, Xin-Luan] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.
   [Lai, Yu-Xiao] Fudan Univ, State Key Lab Mol Engn Polymers, Shanghai, Peoples R China.
RP Wang, XL (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Translat Med Res & Dev, 1068 Xueyuan Ave,Shenzhen Univ Town, Shenzhen 518055, Peoples R China.
EM xl.wang@siat.ac.cn; yx.lai@siat.ac.cn
RI Qin, Ling/J-9047-2018
OI Qin, Ling/0000-0001-6173-6167
FU NSFC-DG-RTD Joint Scheme [51361130034]; European Union's
   [NMP3-SL-2013-604517]; NSFC [51203178]; Shenzhen Fundamental Research
   Foundation [JCYJ20120617114912864]
FX The authors are grateful for the financial support from NSFC-DG-RTD
   Joint Scheme (Project No. 51361130034), the European Union's 7th
   Framework Program under grant agreement No. NMP3-SL-2013-604517, NSFC
   grant (Project No. 51203178), and Shenzhen Fundamental Research
   Foundation (Project No. JCYJ20120617114912864).
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   An YH, 1998, ANIMAL MODELS ORTHOP
   Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x
   Blumenfeld I, 2002, EXP GERONTOL, V37, P553, DOI 10.1016/S0531-5565(01)00215-7
   Calvo-Guirado JL, 2012, CLIN ORAL IMPLAN RES, V23, P667, DOI 10.1111/j.1600-0501.2011.02193.x
   CAMPANACCI M, 1979, J BONE JOINT SURG BR, V61, P455
   Carstens MH, 2005, J CRANIOFAC SURG, V16, P1033, DOI 10.1097/01.scs.0000186307.09171.20
   Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   Chavassieux P, 1987, J BONE MINER RES  S1, V2, P359
   Chen SH, 2013, ACTA BIOMATER, V9, P6711, DOI 10.1016/j.actbio.2013.01.024
   Chen SH, 2014, J ORTHOP TRANSL, V2, P91, DOI 10.1016/j.jot.2014.01.002
   Cheng CX, 2013, MOL IMAGING BIOL, V15, P336, DOI 10.1007/s11307-012-0592-9
   Clements JR, 2008, J FOOT ANKLE SURG, V47, P350, DOI 10.1053/j.jfas.2008.04.006
   Dai CL, 2011, BIOMATERIALS, V32, P8506, DOI 10.1016/j.biomaterials.2011.07.090
   Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779
   DEKLEER V, 2006, BONE CLIN ORTHOPEDIC, P1
   Delgado-Ruiz RA, 2014, INT J ORAL SCI, V6, P105, DOI 10.1038/ijos.2014.6
   den Boer FC, 1999, J ORTHOPAED RES, V17, P654, DOI 10.1002/jor.1100170506
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   EITEL F, 1981, ARCH ORTHOP TRAUM SU, V99, P59, DOI 10.1007/BF00400911
   Engh GA, 1997, J BONE JOINT SURG AM, V79A, P1030, DOI 10.2106/00004623-199707000-00009
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Ghazavi MT, 1997, J BONE JOINT SURG AM, V79A, P17, DOI 10.2106/00004623-199701000-00002
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Gugala Z, 2007, MACROMOL SYMP, V253, P147, DOI 10.1002/masy.200750722
   Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142
   He DW, 2014, J MATER SCI-MATER M, V25, P1415, DOI 10.1007/s10856-014-5183-7
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hussain I., 2012, INT J DENT, V2012
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Jang BJ, 2008, J VET SCI, V9, P387, DOI 10.4142/jvs.2008.9.4.387
   Kim A, 2012, CYTOTHERAPY, V14, P296, DOI 10.3109/14653249.2011.627915
   Kim HW, 2008, J BIOMATER APPL, V22, P485, DOI 10.1177/0885328207078075
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kobayashi H, 2010, J BIOMED MATER RES A, V92A, P596, DOI 10.1002/jbm.a.32397
   Koeter S, 2009, J BIOMED MATER RES B, V90B, P116, DOI 10.1002/jbm.b.31260
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Kraay M J, 1992, J Arthroplasty, V7, P7, DOI 10.1016/0883-5403(92)90025-L
   Kropil P, 2012, ACAD RADIOL, V19, P320, DOI 10.1016/j.acra.2011.10.022
   Kumar S, 2012, BONE, V50, P1012, DOI 10.1016/j.bone.2012.01.027
   Lee EH, 2010, ORAL SURG ORAL MED O, V109, pE33, DOI 10.1016/j.tripleo.2009.12.043
   Lee J, 2009, J CLIN PERIODONTOL, V36, P1067, DOI 10.1111/j.1600-051X.2009.01487.x
   Li R, 2012, J ORTHOP TRAUMA, V26, P689, DOI 10.1097/BOT.0b013e318266eb7e
   Li X, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/07/C07010
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Lim HP, 2013, J MATER SCI-MATER M, V24, P1895, DOI 10.1007/s10856-013-4939-9
   Lindsey RW, 2006, J ORTHOP RES, V24, P1438, DOI 10.1002/jor.20154
   Lippens E, 2010, TISSUE ENG PT A, V16, P617, DOI [10.1089/ten.tea.2009.0418, 10.1089/ten.TEA.2009.0418]
   Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3
   Liu YJ, 2014, BRAZ J MED BIOL RES, V47, P715, DOI 10.1590/1414-431X20144009
   Maissen O, 2006, J ORTHOP RES, V24, P1670, DOI 10.1002/jor.20231
   Mohan BG, 2013, J BIOMED MATER RES A, V101, P261, DOI 10.1002/jbm.a.34324
   MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9
   MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693
   Muscolo DL, 2006, ORTHOP CLIN N AM, V37, P65, DOI 10.1016/j.ocl.2005.08.003
   Nafei A, 2000, J BONE JOINT SURG BR, V82B, P910, DOI 10.1302/0301-620X.82B6.9836
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Neyt J G, 1998, Iowa Orthop J, V18, P118
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Pastoureau P, 1989, J BONE MINER RES  S1, V4, P477
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018
   RAAB DM, 1991, J BONE MINER RES, V6, P741
   Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497
   Reichert JC, 2010, TISSUE ENG PART B-RE, V16, P93, DOI [10.1089/ten.teb.2009.0455, 10.1089/ten.TEB.2009.0455]
   Richards RG, 2013, J ORTHOP TRANSL, V1, P11, DOI 10.1016/j.jot.2013.07.009
   Riegger C, 2012, SKELETAL RADIOL, V41, P531, DOI 10.1007/s00256-011-1203-6
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Schlegel KA, 2006, ORAL SURG ORAL MED O, V102, P7, DOI 10.1016/j.tripleo.2005.09.011
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schneider G, 2010, J MATER SCI-MATER M, V21, P2853, DOI 10.1007/s10856-010-4143-0
   Skaliczki G, 2012, ACTA PHYSIOL HUNG, V99, P223, DOI 10.1556/APhysiol.99.2012.2.16
   Smith MR, 2012, J BIOMED MATER RES B, V100B, P206, DOI 10.1002/jbm.b.31940
   Springer ING, 2005, BONE, V37, P563, DOI 10.1016/j.bone.2005.05.010
   STOCKLEY I, 1992, J BONE JOINT SURG BR, V74, P393
   Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077
   Takigami H, 2007, J ORTHOP RES, V25, P1333, DOI 10.1002/jor.20411
   Theos C, 2008, ARCH ORTHOP TRAUM SU, V128, P179, DOI 10.1007/s00402-007-0301-3
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Tielinen L, 2001, ARCH ORTHOP TRAUM SU, V121, P191, DOI 10.1007/s004020000206
   Upman PJ, 2006, BONEZONE, V5, P50
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang XD, 1998, BIO-MED MATER ENG, V8, P1
   Wang XL, 2013, J ORTHOP RES, V31, P164, DOI 10.1002/jor.22188
   Wehrhan F, 2012, CLIN ORAL IMPLAN RES, V23, P805, DOI 10.1111/j.1600-0501.2011.02223.x
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Yang HL, 2012, J BIOMED MATER RES B, V100B, P1911, DOI 10.1002/jbm.b.32758
   Yano K, 2012, J ORTHOP SCI, V17, P484, DOI 10.1007/s00776-012-0235-7
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Yoshii T, 2014, J TISSUE ENG REGEN M, V8, P589, DOI 10.1002/term.1547
   Young S, 2008, J BIOMED MATER RES A, V86A, P182, DOI 10.1002/jbm.a.31639
   Yu D, 2008, INT J ORAL MAX SURG, V37, P929, DOI 10.1016/j.ijom.2008.07.012
   Zanchetta P, 2012, J CRANIO MAXILL SURG, V40, P783, DOI 10.1016/j.jcms.2012.02.011
   Zhang G, 2008, PRACT MAN MUSCULOSKE, V30, P495
   Zhang W, 2012, ASIAN PAC J TROP MED, V5, P310, DOI 10.1016/S1995-7645(12)60045-5
   Zhang X, 2012, INT J ORAL MAX SURG, V41, P1330, DOI 10.1016/j.ijom.2012.05.014
   Zhu XS, 2011, J MATER SCI-MATER M, V22, P159, DOI 10.1007/s10856-010-4191-5
   Zwingenberger S, 2013, J SURG RES, V181, pE7, DOI 10.1016/j.jss.2012.06.039
NR 108
TC 37
Z9 39
U1 4
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-031X
J9 J ORTHOP TRANSL
JI J. Orthop. Transl.
PD JUL
PY 2015
VL 3
IS 3
BP 95
EP 104
DI 10.1016/j.jot.2015.05.002
PG 10
WC Orthopedics
SC Orthopedics
GA V35EA
UT WOS:000215882700001
PM 30035046
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kumar, A
   Young, C
   Farina, J
   Witzl, A
   Marks, ED
AF Kumar, Arun
   Young, Chelsea
   Farina, Juliana
   Witzl, Ashley
   Marks, Edward D.
TI Novel nanocomposite biomaterial to differentiate bone marrow mesenchymal
   stem cells to the osteogenic lineage for bone restorationz
SO JOURNAL OF ORTHOPAEDIC TRANSLATION
LA English
DT Article
DE chitosan; crosslinking; mineralization; nanocomposite; three-point
   analysis
ID IN-VITRO; CHITOSAN; SCAFFOLD; LEADS
AB Background/Objective: As the bone engineering field moves away from nonviable implants to more biocompatible and natural structures, nanomedicine has emerged as a superior tool for developing implantable materials.
   Methods: Here, we describe the fabrication and testing of a nanocomposite structure composed of chitosan and a biocompatible thermoplastic (PMMA).
   Results: Our nanocomposite material displayed morphologically similar characteristics to an extracted murine femur during microscopic and spectroscopic analysis as seen through SEM and FTIR. Crosslinking our nanocomposite enhanced structural and strength characteristics significantly above the noncrosslinked sample, mimicking the strength of an extracted mammalian bone. When cocultured with bone marrow mesenchymal stem cells, the composite material proved to be osteoinductive and osteogenic via DAPI and actin staining, differentiating BMSCs into the osteogenic lineage and promoting mineral deposition. Nodule formation, indicative of mineralization during BMSC differentiation, was confirmed spectroscopically via FTIR and autofluorescence of the nodule.
   Conclusion: These encouraging results show promise for in vivo implantation of our novel scaffold that is both biocompatible and biomimetic in strength and composition. Copyright (C) 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Kumar, Arun; Marks, Edward D.] Univ Delaware, Coll Hlth Sci, Dept Med Lab Sci, Nanomed Res Lab, 305C Willard Hall,16 West Main St, Newark, DE 19716 USA.
   [Young, Chelsea] Univ Delaware, Coll Engn, Dept Chem Engn, Newark, DE 19716 USA.
   [Farina, Juliana; Witzl, Ashley] Univ Delaware, Coll Hlth Sci, Dept Biol Sci, Newark, DE 19716 USA.
RP Kumar, A (reprint author), Univ Delaware, Coll Hlth Sci, Dept Med Lab Sci, Nanomed Res Lab, 305C Willard Hall,16 West Main St, Newark, DE 19716 USA.
EM arunk@udel.edu
FU University of Delaware
FX Dr. Kumar would like to acknowledge the startup funding and UDRF
   (University of Delaware Research Foundation) Award he received from the
   University of Delaware.
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Ashori A, 2013, INT J BIOL MACROMOL, V58, P343, DOI 10.1016/j.ijbiomac.2013.04.056
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791
   Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013
   Flores-Ramirez N, 2008, J BIOMAT SCI-POLYM E, V19, P259, DOI 10.1163/156856208783432525
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717
   Lee JW, 1999, J APPL POLYM SCI, V73, P113
   Lee MJ, 2010, CLIN ORTHOP SURG, V2, P90, DOI 10.4055/cios.2010.2.2.90
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Messora MR, 2013, CLIN ORAL IMPLAN RES, V24, P1347, DOI 10.1111/clr.12008
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Morgado J, 2013, EXPRESS POLYM LETT, V7, P960, DOI 10.3144/expresspolymlett.2013.94
   Rosa AL, 2014, J CELL BIOCHEM, V115, P540, DOI 10.1002/jcb.24688
   Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/JBMR.090316, 10.1359/jbmr.090316]
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Struszczyk H, 1991, ADV CHITIN CHITOSAN
   Su N, 2013, J BONE MINER RES, V28, P660, DOI 10.1002/jbmr.1778
   Towler Dwight A, 2008, Curr Osteoporos Rep, V6, P67, DOI 10.1007/s11914-008-0012-x
   Tsao CW, 2007, LAB CHIP, V7, P499, DOI 10.1039/b618901f
   Wang TJ, 2012, MOL VIS, V18, P255
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-031X
J9 J ORTHOP TRANSL
JI J. Orthop. Transl.
PD JUL
PY 2015
VL 3
IS 3
BP 105
EP 113
DI 10.1016/j.jot.2015.03.002
PG 9
WC Orthopedics
SC Orthopedics
GA V35EA
UT WOS:000215882700002
PM 30035047
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Yang, WX
   Both, SK
   Zuo, Y
   Birgani, ZT
   Habibovic, P
   Li, YB
   Jansen, JA
   Yang, F
AF Yang, Wanxun
   Both, Sanne K.
   Zuo, Yi
   Birgani, Zeinab Tahmasebi
   Habibovic, Pamela
   Li, Yubao
   Jansen, John A.
   Yang, Fang
TI Biological evaluation of porous aliphatic polyurethane/hydroxyapatite
   composite scaffolds for bone tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone regeneration; biomaterial; polyurethane; hydroxyapatite; ectopic
   bone formation
ID OF-THE-ART; CELL-CULTURE; HYDROXYAPATITE; POLYURETHANES; BIOMATERIALS;
   MECHANISMS; IMPLANTS; TITANIUM
AB Biomaterial scaffolds meant to function as supporting structures to osteogenic cells play a pivotal role in bone tissue engineering. Recently, we synthesized an aliphatic polyurethane (PU) scaffold via a foaming method using non-toxic components. Through this procedure a uniform interconnected porous structure was created. Furthermore, hydroxyapatite (HA) particles were introduced into this process to increase the bioactivity of the PU matrix. To evaluate the biological performances of these PU-based scaffolds, their influence on in vitro cellular behavior and in vivo bone forming capacity of the engineered cell-scaffold constructs was investigated in this study. A simulated body fluid test demonstrated that the incorporation of 40 wt % HA particles significantly promoted the biomineralization ability of the PU scaffolds. Enhanced in vitro proliferation and osteogenic differentiation of the seeded mesenchymal stem cells were also observed on the PU/HA composite. Next, the cell-scaffold constructs were implanted subcutaneously in a nude mice model. After 8 weeks, a considerable amount of vascularized bone tissue with initial marrow stroma development was generated in both PU and PU/HA40 scaffold. In conclusion, the PU/HA composite is a potential scaffold for bone regeneration applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2251-2259, 2015.
C1 [Yang, Wanxun; Both, Sanne K.; Jansen, John A.; Yang, Fang] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Dent 309, NL-6525 ED Nijmegen, Netherlands.
   [Yang, Wanxun] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China.
   [Yang, Wanxun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China.
   [Zuo, Yi; Li, Yubao] Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
   [Birgani, Zeinab Tahmasebi; Habibovic, Pamela] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
RP Yang, F (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Dent 309, NL-6525 ED Nijmegen, Netherlands.
EM fang.yang@radboudumc.nl
RI Yang, Fang/E-1937-2011; Jansen, John/H-8055-2014
OI Yang, Fang/0000-0002-4022-7643; 
FU Royal Netherlands Academy of Arts and Sciences (KNAW) [PSA 08-PSA-M-02];
   China Scholarship Council [2010627030]
FX Contract grant sponsor: Royal Netherlands Academy of Arts and Sciences
   (KNAW); contract grant number: PSA 08-PSA-M-02; Contract grant sponsor:
   China Scholarship Council; contract grant number: 2010627030
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Correia RN, 1996, J MATER SCI-MATER M, V7, P501, DOI 10.1007/BF00705432
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Huang M. N., 2009, J BIOMED SCI ENG, V2, P36
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kavlock KD, 2007, ACTA BIOMATER, V3, P475, DOI 10.1016/j.actbio.2007.02.001
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2010, ACTA BIOMATER, V6, P2020, DOI 10.1016/j.actbio.2009.12.004
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Liu HH, 2009, J APPL POLYM SCI, V112, P2968, DOI 10.1002/app.29862
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schweitzer P. A., 2004, CORROSION RESISTANCE
   Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vaquette C, 2013, BIOMATERIALS, V34, P5538, DOI 10.1016/j.biomaterials.2013.03.088
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025003
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
NR 30
TC 17
Z9 18
U1 8
U2 87
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2015
VL 103
IS 7
BP 2251
EP 2259
DI 10.1002/jbm.a.35365
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ1LZ
UT WOS:000355246400005
PM 25370308
DA 2018-10-20
ER

PT J
AU Santhanam, S
   Liang, J
   Baid, R
   Ravi, N
AF Santhanam, Sruthi
   Liang, Jue
   Baid, Rinku
   Ravi, Nathan
TI Investigating thiol-modification on hyaluronan via carbodiimide
   chemistry using response surface methodology
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronan; thiol; carbodiimide crosslinking; response surface
   methodology; side reaction
ID IN-VITRO EVALUATION; CHEMICAL-MODIFICATION; GOLD NANOPARTICLES; ACID
   HYDROGELS; DRUG-DELIVERY; OPTIMIZATION; DESIGN; SCAFFOLDS; PROTEINS;
   COMPLEX
AB Hyaluronan (HA) is a naturally occurring glycosaminoglycan widely researched for its use as a biomaterial in tissue engineering, drug delivery, angiogenesis, and ophthalmic surgeries. The mechanical properties of this biomaterial can be altered to a required extent by chemically modifying the pendant reactive groups. However, derivatizing these polymers to a predetermined extent has been the Achilles heel for this process. In this study, we have investigated the factors controlling the derivatization of the carboxyl moieties of HA with amine containing thiol, cystamine dihydrochloride (Cys), via carbodiimide crosslinking chemistry. We used fractional factorial design to screen and identify the significant factor(s) affecting the reaction, and response surface methodology (RSM) to develop a model equation for predicting the degree of thiolation of HA. Also, we analyzed the reaction mechanism for potential side reactions. We observed that N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) (mole ratio with repeat unit of HA) is the significant factor controlling the degree of amidation. The quadratic equations developed from RSM predict the formulation for a desired degree of amidation of HA and percentage of potential side product. Hence, derivatizing HA to a predetermined extent with minimal side product can be achieved using the statistical design of experiments. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2300-2308, 2015.
C1 [Santhanam, Sruthi; Ravi, Nathan] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.
   [Liang, Jue; Baid, Rinku; Ravi, Nathan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.
   [Ravi, Nathan] Vet Affairs Healthcare Syst, Dept Res, St Louis, MO USA.
RP Ravi, N (reprint author), Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.
EM ravi@vision.wustl.edu
FU Department of Veterans Affairs Rehab Merit Review [RX000657-01]; NIH
   [EY021620, P30 EY02687]; Research to Prevent Blindness, Inc.
FX Contract grant sponsor: Department of Veterans Affairs Rehab Merit
   Review; contract grant number: RX000657-01; Contract grant sponsor: NIH;
   contract grant number: EY021620; Contract grant sponsor: NIH Core Grant;
   contract grant number: P30 EY02687; Contract grant sponsor: Research to
   Prevent Blindness, Inc.
CR Abul Kalam M, 2013, J BIOMED MATER RES A, V101, P1813, DOI 10.1002/jbm.a.34453
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Elia R, 2010, BIOMATERIALS, V31, P4630, DOI 10.1016/j.biomaterials.2010.02.043
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Eng D, 2010, ACTA BIOMATER, V6, P2407, DOI 10.1016/j.actbio.2009.12.049
   Everaerts F, 2007, J BIOMED MATER RES A, V83A, P1176, DOI 10.1002/jbm.a.31398
   Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019
   Kim WJ, 2003, NAT MATER, V2, P815, DOI 10.1038/nmat1021
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187
   Lee H, 2014, ACS NANO, V8, P4790, DOI 10.1021/nn500685h
   Lee MY, 2012, ACS NANO, V6, P9522, DOI 10.1021/nn302538y
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma Y, 2012, J BIOMED MATER RES A, V100A, P989, DOI 10.1002/jbm.a.34032
   Motealleh B, 2014, J BIOMED MATER RES B, V102, P977, DOI 10.1002/jbm.b.33078
   Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Narayan PM, 2001, J BIOMED MATER RES, V56, P333, DOI 10.1002/1097-4636(20010905)56:3<333::AID-JBM1101>3.0.CO;2-K
   Nottelet B, 2009, J BIOMED MATER RES A, V89A, P865, DOI 10.1002/jbm.a.32023
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Palazon F, 2014, LANGMUIR, V30, P4545, DOI 10.1021/la5004269
   Papasani MR, 2012, NANOMED-NANOTECHNOL, V8, P804, DOI 10.1016/j.nano.2012.01.008
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Peng HT, 2009, J BIOMED MATER RES B, V89B, P199, DOI 10.1002/jbm.b.31206
   SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144
   Taguchi T, 2002, J BIOMED MATER RES, V61, P330, DOI 10.1002/jbm.10147
   THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115
   Valencia P, 2013, FOOD BIOPROCESS TECH, V6, P290, DOI 10.1007/s11947-011-0628-1
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
NR 35
TC 7
Z9 7
U1 4
U2 75
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2015
VL 103
IS 7
BP 2300
EP 2308
DI 10.1002/jbm.a.35366
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ1LZ
UT WOS:000355246400010
PM 25369214
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ghavimi, SAA
   Ebrahimzadeh, MH
   Solati-Hashjin, M
   Abu Osman, NA
AF Ghavimi, Soheila Ali Akbari
   Ebrahimzadeh, Mohammad H.
   Solati-Hashjin, Mehran
   Abu Osman, Noor Azuan
TI Polycaprolactone/starch composite: Fabrication, structure, properties,
   and applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polycaprolactone; starch; polymeric composite; tissue engineering;
   degradation
ID POLY-EPSILON-CAPROLACTONE; TISSUE ENGINEERING APPLICATIONS; STARCH-BASED
   BIOMATERIALS; RING-OPENING POLYMERIZATION; FIBER-MESH SCAFFOLDS; MARROW
   STROMAL CELLS; DRUG-DELIVERY SYSTEMS; FOOD-PACKAGING APPLICATIONS; FLOW
   PERFUSION BIOREACTOR; NATURAL ORIGIN SCAFFOLDS
AB Interests in the use of biodegradable polymers as biomaterials have grown. Among the different polymeric composites currently available, the blend of starch and polycaprolactone (PCL) has received the most attention since the 1980s. Novamont is the first company that manufactured a PCL/starch (SPCL) composite under the trademark Mater-Bi (R). The properties of PCL (a synthetic, hydrophobic, flexible, expensive polymer with a low degradation rate) and starch (a natural, hydrophilic, stiff, abundant polymer with a high degradation rate) blends are interesting because of the composite components have completely different structures and characteristics. PCL can adjust humidity sensitivity of starch as a biomaterial; while starch can enhance the low biodegradation rate of PCL. Thus, by appropriate blending, SPCL can overcome important limitations of both PCL and starch components and promote controllable behavior in terms of mechanical properties and degradation which make it suitable for many biomedical applications. This article reviewed the different fabrication and modification methods of the SPCL composite; different properties such as structural, physical, and chemical as well as degradation behavior; and different applications as biomaterials. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2482-2498, 2015.
C1 [Ghavimi, Soheila Ali Akbari; Solati-Hashjin, Mehran; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Ebrahimzadeh, Mohammad H.] Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Iran.
   [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Dept Biomed Engn, Tehran 15914, Iran.
RP Ghavimi, SAA (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM ghavimi@aut.ac.ir
RI Engineering, Faculty/I-7935-2015; ABU OSMAN, NOOR AZUAN/B-9265-2010
OI Engineering, Faculty/0000-0002-4848-7052; ABU OSMAN, NOOR
   AZUAN/0000-0002-2853-4421; Solati-Hashjin, Mehran/0000-0002-1187-1237
FU High Impact Research Grant from the University of Malaya
   [UM.C/HIR/MOHE/ENG/10 D000010-16001]
FX Contract grant sponsor: High Impact Research Grant from the University
   of Malaya; contract grant number: UM.C/HIR/MOHE/ENG/10 D000010-16001
CR Abbasi Z, 2014, INT J NANO DIMENS, V5, P549, DOI 10.7508/ijnd.2014.06.006
   Aee LH, 1998, THERMOCHIM ACTA, V322, P39
   Ajili SH, 2009, ACTA BIOMATER, V5, P1519, DOI 10.1016/j.actbio.2008.12.014
   Ali SFA, 2014, J POLYM ENVIRON, V22, P359, DOI 10.1007/s10924-014-0675-6
   AliAkbari Ghavimi S, 2012, J TISSUE ENG REGE S1, P12
   Aliakbari Ghavimi S., 2012, MODARES J MED SCI PA, V15, P37
   Alix S, 2013, EUR POLYM J, V49, P1234, DOI 10.1016/j.eurpolymj.2013.03.016
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Arvanitoyannis I, 1997, STARCH-STARKE, V49, P306, DOI 10.1002/star.19970490712
   Avella M, 2000, POLYMER, V41, P3875, DOI 10.1016/S0032-3861(99)00663-1
   Averous L, 2004, J MACROMOL SCI-POL R, VC44, P231, DOI 10.1081/mc-200029326
   Averous L, 2001, POLYM ENG SCI, V41, P727, DOI 10.1002/pen.10768
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Azevedo HS, 2009, ACTA BIOMATER, V5, P3021, DOI 10.1016/j.actbio.2009.04.039
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Balmayor ER, 2009, ACTA BIOMATER, V5, P1035, DOI 10.1016/j.actbio.2008.11.006
   BASTIOLI C, 1995, J ENVIRON POLYM DEGR, V3, P81, DOI 10.1007/BF02067484
   Bastioli C, 1998, MACROMOLECULAR S
   Belard L, 2009, POLYM ENG SCI, V49, P1177, DOI 10.1002/pen.21342
   Beneke CE, 2009, MOLECULES, V14, P2602, DOI 10.3390/molecules14072602
   Cai J, 2014, CARBOHYD POLYM, V102, P746, DOI 10.1016/j.carbpol.2013.10.095
   Campos A, 2012, POLYM DEGRAD STABIL, V97, P1948, DOI 10.1016/j.polymdegradstab.2011.11.010
   Campos A, 2012, J REINF PLAST COMP, V31, P573, DOI 10.1177/0731684412441092
   Carmona VB, 2014, J THERM ANAL CALORIM, V115, P153, DOI 10.1007/s10973-013-3259-0
   Carvalho PP, 2014, J BIOMED MATER RES A, V102, P3102, DOI 10.1002/jbm.a.34983
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chang PR, 2009, J APPL POLYM SCI, V113, P2973, DOI 10.1002/app.30369
   Chen L, 2005, CARBOHYD POLYM, V60, P103, DOI 10.1016/j.carbpol.2004.11.028
   Chivrac F, 2009, MAT SCI ENG R, V67, P1, DOI 10.1016/j.mser.2009.09.002
   Cho HS, 2011, WASTE MANAGE, V31, P475, DOI 10.1016/j.wasman.2010.10.029
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Choi EJ, 1999, J POLYM SCI POL PHYS, V37, P2430, DOI 10.1002/(SICI)1099-0488(19990901)37:17<2430::AID-POLB14>3.0.CO;2-4
   Costa SA, 2004, J MATER SCI-MATER M, V15, P335, DOI 10.1023/B:JMSM.0000021098.75103.3a
   Cyras VP, 2002, J THERMOPLAST COMPOS, V15, P253, DOI [10.1106/089270502021454, 10.1006/089270502021454]
   Cyras VP, 2001, POLYM ENG SCI, V41, P1521, DOI 10.1002/pen.10851
   da Silva M. A., 2008, TISSUE ENG PART A, V15, P377
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Desevaux C, 2002, J BIOMED MATER RES, V63, P772, DOI 10.1002/jbm.10451
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   di Franco CR, 2004, POLYM DEGRAD STABIL, V86, P95, DOI 10.1016/j.polymdegradstab.2004.02.009
   Dole P, 2004, CARBOHYD POLYM, V58, P335, DOI 10.1016/j.carbpol.2004.08.002
   Duarte ARC, 2010, POLYM DEGRAD STABIL, V10, P2110
   Dubois P, 1999, POLYMER, V40, P3091, DOI 10.1016/S0032-3861(98)00110-4
   Ebrahimzadeh MH, 2011, IRAN J ORTHOPED SURG, V4, P185
   Ebrahimzadeh MH, 2011, INT BON TISS ENG C B
   Eisenberg A, 2002, DIBLOCK COPOLYMER US
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fei P, 2013, J APPL POLYM SCI, V130, P4129, DOI 10.1002/app.39695
   Fu X, 2012, J BIOMED MATER RES B, V100B, P314, DOI 10.1002/jbm.b.31916
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   Gaspar M, 2005, POLYM DEGRAD STABIL, V90, P563, DOI 10.1016/j.polymdegradstab.2005.03.012
   Ghanaati S, 2011, J TISSUE ENG REGEN M, V5, pE136, DOI 10.1002/term.373
   Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P411, DOI 10.1016/j.biopha.2004.08.001
   Gibson JW, 2012, ZERO ORDER PROLONGED
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Grignard B, 2008, BIOMACROMOLECULES, V9, P3141, DOI 10.1021/bm800730m
   Habibi Y, 2008, BIOMACROMOLECULES, V9, P1974, DOI 10.1021/bm8001717
   Hermanova S, 2013, J APPL POLYM SCI, V127, P4726, DOI 10.1002/app.38078
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z
   Jones I, 2000, BIOMATERIALS UK, V7, P713
   Jukola H, 2008, J BIOMED MATER RES B, V87B, P197, DOI 10.1002/jbm.b.31093
   Kalambur S, 2006, POLYM ENG SCI, V46, P650, DOI 10.1002/pen.20508
   Kalambur S, 2006, J PLAST FILM SHEET, V22, P39, DOI 10.1177/8756087906062729
   Kaur Lovedeep, 2007, P83, DOI 10.1007/978-1-4020-6289-6_5
   Kazimoglu C, 2003, INT J ARTIF ORGANS, V26, P804
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kim EG, 2007, J APPL POLYM SCI, V103, P928, DOI 10.1002/app.25239
   Kim JJ, 2014, J BIOMATER APPL, V28, P1069, DOI 10.1177/0885328213495903
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kweon DK, 2004, J APPL POLYM SCI, V92, P1716, DOI 10.1002/app.20130
   Kweon DK, 2001, J APPL POLYM SCI, V81, P2197, DOI 10.1002/app.1656
   Kweon DK, 2000, J APPL POLYM SCI, V78, P986, DOI 10.1002/1097-4628(20001031)78:5<986::AID-APP70>3.0.CO;2-T
   Labet M, 2007, BIOMACROMOLECULES, V8, P2916, DOI 10.1021/brn700468f
   Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Liao JJ, 2014, NEW J CHEM, V38, P2522, DOI 10.1039/c3nj01647a
   Lim SW, 1999, EUR POLYM J, V35, P1875, DOI 10.1016/S0014-3057(98)00273-0
   Lima MJ, 2014, BIOMED MICRODEVICES, V16, P69, DOI 10.1007/s10544-013-9806-4
   Link DP, 2013, J BIOMED MATER RES A, V101, P3059, DOI 10.1002/jbm.a.34614
   Liu FJ, 2009, CARBOHYD POLYM, V78, P146, DOI 10.1016/j.carbpol.2009.03.021
   Liu HS, 2009, PROG POLYM SCI, V34, P1348, DOI 10.1016/j.progpolymsci.2009.07.001
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Liu MX, 2012, COLLOID SURFACE A, V395, P131, DOI 10.1016/j.colsurfa.2011.12.017
   Loercks J., 1998, POLYM DEGRAD STABIL, V59, P245
   Mahkam M, 2010, J BIOMED MATER RES A, V92A, P1392, DOI 10.1002/jbm.a.32490
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Mariani PDSC, 2009, POLYM TEST, V28, P824, DOI 10.1016/j.polymertesting.2009.07.004
   Marques AP, 2005, J MATER SCI-MATER M, V16, P1029, DOI 10.1007/s10856-005-4757-9
   Marques AP, 2005, MACROMOL BIOSCI, V5, P775, DOI 10.1002/mabi.200500010
   Marques AP, 2005, J MATER SCI-MATER M, V16, P833, DOI 10.1007/s10856-005-3580-7
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132
   Martins AM, 2012, J BIOMED MATER RES A, V100A, P599, DOI 10.1002/jbm.a.33261
   Martins AM, 2010, J BIOMED MATER RES A, V94A, P1061, DOI 10.1002/jbm.a.32785
   Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004
   Massardier-Nageotte V, 2006, POLYM DEGRAD STABIL, V91, P620, DOI 10.1016/j.polymdegradstab.2005.02.029
   Matzinos P, 2002, POLYM DEGRAD STABIL, V77, P17, DOI 10.1016/S0141-3910(02)00072-1
   Matzinos P, 2002, EUR POLYM J, V38, P1713, DOI 10.1016/S0014-3057(02)00061-7
   Mauricio MR, 2015, CARBOHYD POLYM, V115, P715, DOI 10.1016/j.carbpol.2014.07.063
   Mendes S, 2003, TISSUE ENG S1, V4, P91
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Meneguin AB, 2014, CARBOHYD POLYM, V99, P140, DOI 10.1016/j.carbpol.2013.07.077
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Miner MR, 2006, J ENDODONT, V32, P683, DOI 10.1016/j.joen.2006.01.008
   Myllymaki O., 1998, PACKAG TECHNOL SCI, V11, P265
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Odusanya OS, 2003, J APPL POLYM SCI, V87, P877, DOI 10.1002/app.11295
   Oliveira JT, 2007, J MATER SCI-MATER M, V18, P295, DOI 10.1007/s10856-006-0692-7
   Pashkuleva I, 2008, MACROMOL BIOSCI, V8, P210, DOI 10.1002/mabi.200700076
   Pavlov MP, 2004, MACROMOL BIOSCI, V4, P776, DOI 10.1002/mabi.200400002
   Pena J, 2006, POLYM DEGRAD STABIL, V91, P1424, DOI 10.1016/j.polymdegradstab.2005.10.016
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Pereira JDAS, 2014, MAT SCI ENG C-MATER, V36, P226, DOI 10.1016/j.msec.2013.12.008
   Perez CJ, 2008, MAT SCI ENG A-STRUCT, V480, P259, DOI 10.1016/j.msea.2007.07.031
   Perez E, 2013, CARBOHYD POLYM, V97, P269, DOI 10.1016/j.carbpol.2013.04.099
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Pranamuda H, 1996, J ENVIRON POLYM DEGR, V4, P1, DOI 10.1007/BF02083877
   Ratto JA, 1999, POLYMER, V40, P6777, DOI 10.1016/S0032-3861(99)00014-2
   Reed CR, 2009, ANN PLAS SURG, V62, P505, DOI 10.1097/SAP.0b013e31818e48bf
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Remya KR, 2013, J BIOMED NANOTECHNOL, V9, P1483, DOI 10.1166/jbn.2013.1640
   Requicha JF, 2014, J ORTHOP RES, V32, P904, DOI 10.1002/jor.22609
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Rodrigues AI, 2011, BIOENG ENBENG IEEE 1
   Rodrigues A, 2012, CARBOHYD POLYM, V87, P987, DOI 10.1016/j.carbpol.2011.09.044
   Rodrigues MT, 2012, BIOMATERIALS, V33, P6069, DOI 10.1016/j.biomaterials.2012.05.016
   Rodrigues MT, 2011, J TISSUE ENG REGEN M, V5, P41, DOI 10.1002/term.287
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Rosa DS, 2007, J MATER SCI, V42, P2323, DOI 10.1007/s10853-006-1105-5
   Rosa DD, 2003, J APPL POLYM SCI, V89, P3539, DOI 10.1002/app.12537
   Rosa DS, 2004, MAT SCI ENG C-BIO S, V24, P663, DOI 10.1016/j.msec.2004.08.045
   Rosa DS, 2005, POLYM TEST, V24, P756, DOI 10.1016/j.polymertesting.2005.03.014
   Ruseckaite RA, 2001, J APPL POLYM SCI, V82, P3275, DOI 10.1002/app.2186.abs
   Rutot D, 2000, COMPOS INTERFACE, V7, P215, DOI 10.1163/156855400300185324
   Saez A, 2000, EUR J PHARM BIOPHARM, V50, P379, DOI 10.1016/S0939-6411(00)00125-9
   Salgado AJ, 2007, J BIOMED MATER RES A, V80A, P983, DOI 10.1002/jbm.a.30946
   Salgado AJ, 2009, J BIOACT COMPAT POL, V24, P235, DOI 10.1177/0883911509104081
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Santos TC, 2010, ACTA BIOMATER, V6, P4314, DOI 10.1016/j.actbio.2010.06.020
   Sarazin P, 2008, POLYMER, V49, P599, DOI 10.1016/j.polymer.2007.11.029
   Sarka E, 2011, CZECH J FOOD SCI, V29, P232, DOI 10.17221/292/2010-CJFS
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Schantz J-T, 2003, TISSUE ENG, V9, P127
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shen Z, 2014, DESALIN WATER TREAT, V52, P1
   Shen ZQ, 2011, BIORESOURCE TECHNOL, V102, P8835, DOI 10.1016/j.biortech.2011.06.090
   Shenoy DB, 2005, INT J PHARM, V293, P261, DOI 10.1016/j.ijpharm.2004.12.010
   Shin BY, 2004, POLYM ENG SCI, V44, P1429, DOI 10.1002/pen.20139
   Silva GA, 2005, J BIOMED MATER RES A, V73A, P234, DOI 10.1002/jbm.a.30287
   Silva NA, 2009, TISSUE ENG PART A, V1, P45
   Silva NA, 2012, J BIOMED MATER RES A, V100A, P470, DOI 10.1002/jbm.a.33289
   Singh RP, 2003, CARBOHYD RES, V338, P1759, DOI 10.1016/S0008-6215(03)00236-2
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Slattery CJ, 2000, TRENDS PLANT SCI, V5, P291, DOI 10.1016/S1360-1385(00)01657-5
   Solati-Hashjin M, 2013, ARTIF ORGANS, V7, pA27
   Solati-Hashjin M, 2012, 10 INT SEM POL SCI T
   Song SS, 1996, BIODEGRADABLE HYDROG
   Spevacek J, 2007, EUR POLYM J, V43, P1866, DOI 10.1016/j.eurpolymj.2007.02.021
   Su J, 2012, AFR J BIOTECHNOL, V11, P694
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Tabassi SAS, 2014, J SOL-GEL SCI TECHN, V69, P166, DOI 10.1007/s10971-013-3200-9
   Taghizadeh A, 2013, CARBOHYD POLYM, V98, P189, DOI 10.1016/j.carbpol.2013.05.024
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Tuzlakoglu K, 2010, J BIOMED MATER RES A, V92A, P369, DOI 10.1002/jbm.a.32358
   VAIDYA UR, 1994, J APPL POLYM SCI, V52, P617, DOI 10.1002/app.1994.070520505
   Van Natta FJ, 1934, J AM CHEM SOC, V56, P455, DOI 10.1021/ja01317a053
   Vertuccio L, 2009, CARBOHYD POLYM, V75, P172, DOI 10.1016/j.carbpol.2008.07.020
   Vikman M, 1999, J APPL POLYM SCI, V74, P2594, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2594::AID-APP5>3.0.CO;2-R
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Wang XL, 2003, J MACROMOL SCI-POL R, VC43, P385, DOI 10.1081/MC-120023911
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   Wu C, 2011, INT J PHARMACEUT, V403, P162, DOI 10.1016/j.ijpharm.2010.09.040
   Wu CS, 2003, POLYM DEGRAD STABIL, V80, P127, DOI 10.1016/S0141-3910(02)00393-2
   Wu CS, 2003, J APPL POLYM SCI, V89, P2888, DOI 10.1002/app.12475
   Wu KJ, 2007, PROCESS BIOCHEM, V42, P669, DOI 10.1016/j.procbio.2006.12.009
   Xie FW, 2013, PROG POLYM SCI, V38, P1590, DOI 10.1016/j.progpolymsci.2013.05.002
   Xue JX, 2013, BIOMATERIALS, V34, P2624, DOI 10.1016/j.biomaterials.2012.12.011
   Yang CH, 2009, LAB CHIP, V9, P961, DOI 10.1039/b814952f
   Yao DG, 2006, J BIOMED MATER RES B, V77B, P287, DOI 10.1002/jbm.b.30419
   Yavuz H, 2003, J POLYM ENVIRON, V11, P107, DOI 10.1023/A:1024635130991
   Zeleznak K, 1987, CEREAL CHEM, V2, P121
   Zeng JB, 2011, CARBOHYD POLYM, V83, P762, DOI 10.1016/j.carbpol.2010.08.051
   Zhang Y, 2012, CARBOHYD POLYM, V88, P1208, DOI 10.1016/j.carbpol.2012.01.092
   Zhou N, 2013, CARBOHYD POLYM, V94, P420, DOI 10.1016/j.carbpol.2013.01.014
NR 206
TC 18
Z9 18
U1 5
U2 108
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2015
VL 103
IS 7
BP 2482
EP 2498
DI 10.1002/jbm.a.35371
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ1LZ
UT WOS:000355246400026
PM 25407786
DA 2018-10-20
ER

PT J
AU Won, JE
   Yun, YR
   Jang, JH
   Yang, SH
   Kim, JH
   Chrzanowski, W
   Wall, IB
   Knowles, JC
   Kim, HW
AF Won, Jong-Eun
   Yun, Ye-Rang
   Jang, Jun-Hyeog
   Yang, Sung-Hee
   Kim, Joong-Hyun
   Chrzanowski, Wojciech
   Wall, Ivan B.
   Knowles, Jonathan C.
   Kim, Hae-Won
TI Multifunctional and stable bone mimic proteinaceous matrix for bone
   tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Bone mimetic; Protein engineering; Cell adhesion; Osteogenic
   differentiation; Multi-functional
ID COLLAGEN TYPE-I; CELL-ADHESION; HUMAN FIBRONECTIN; STEM-CELLS;
   DIFFERENTIATION; SCAFFOLDS; LAMELLIPODIA; FILOPODIA; RESPONSES; TITANIUM
AB Biomaterial surface design with biomimetic proteins holds great promise for successful regeneration of tissues including bone. Here we report a novel proteinaceous hybrid matrix mimicking bone extracellular matrix that has multifunctional capacity to promote stem cell adhesion and osteogenesis with excellent stability. Osteocalcin-fibronectin fusion protein holding collagen binding domain was networked with fibrillar collagen, featuring bone extracellular matrix mimic, to provide multifunctional and structurallys-table biomatrices. The hybrid protein, integrated homogeneously with collagen fibrillar networks, preserved structural stability over a month. Biological efficacy of the hybrid matrix was proven onto tethered surface of biopolymer porous scaffolds. Mesenchymal stem cells quickly anchored to the hybrid matrix, forming focal adhesions, and substantially conformed to cytoskeletal extensions, benefited from the fibronectin adhesive domains. Cells achieved high proliferative capacity to reach confluence rapidly and switched to a mature and osteogenic phenotype more effectively, resulting in greater osteogenic matrix syntheses and mineralization, driven by the engineered osteocalcin. The hybrid biomimetic matrix significantly improved in vivo bone formation in calvarial defects over 6 weeks. Based on the series of stimulated biological responses in vitro and in vivo the novel hybrid proteinaceous composition will be potentially useful as stem cell interfacing matrices for osteogenesis and bone regeneration. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Won, Jong-Eun; Yun, Ye-Rang; Yang, Sung-Hee; Kim, Joong-Hyun; Chrzanowski, Wojciech; Wall, Ivan B.; Knowles, Jonathan C.; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Won, Jong-Eun; Yun, Ye-Rang; Yang, Sung-Hee; Kim, Joong-Hyun; Chrzanowski, Wojciech; Wall, Ivan B.; Knowles, Jonathan C.; Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan 330714, South Korea.
   [Won, Jong-Eun; Yun, Ye-Rang; Yang, Sung-Hee; Kim, Joong-Hyun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
   [Jang, Jun-Hyeog] Inha Univ, Coll Med, Dept Biochem, Inchon, South Korea.
   [Chrzanowski, Wojciech] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.
   [Wall, Ivan B.] UCL, Dept Biochem Engn, London WC1H 0AH, England.
   [Knowles, Jonathan C.] UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, London WC1X 8LD, England.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
EM kimhw@dku.edu
FU Priority Research Centers Program, National Research Foundation, South
   Korea [2009-0093829]
FX This study was supported by grants from the Priority Research Centers
   Program (grant no. 2009-0093829), National Research Foundation, South
   Korea.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Chrzanowski W, 2015, ADV FUNCT MATER, V25, P193, DOI 10.1002/adfm.201401696
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   Dorj B, 2014, ACTA BIOMATER, V10, P1238, DOI 10.1016/j.actbio.2013.11.002
   Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026
   Harris JR, 2007, MICRON, V38, P513, DOI 10.1016/j.micron.2006.07.026
   HEINEGARD D, 1989, FASEB J, V3, P2042
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   INGRAM RT, 1993, J BONE MINER RES, V8, P1019
   Jeon E, 2014, J BIOMED MATER RES A, V102, P1, DOI 10.1002/jbm.a.34689
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Krawetz RJ, 2012, TISSUE ENG PT A, V18, P1014, DOI [10.1089/ten.tea.2011.0174, 10.1089/ten.TEA.2011.0174]
   Kruger TE, 2013, SCI WORLD J, DOI 10.1155/2013/812718
   Lee JH, 2012, ACTA BIOMATER, V23, P2203
   Lee JH, 2013, J MATER CHEM B, V1, P11
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Oh SA, 2011, J TISSUE ENG, V2010
   OLDBERG A, 1983, J BIOL CHEM, V258, P193
   Pitt C G, 1981, NIDA Res Monogr, V28, P232
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sun WJ, 2007, GROWTH FACTORS, V25, P309, DOI 10.1080/08977190701803885
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   You RC, 2014, J BIOMED MATER RES A, V102, P4206, DOI 10.1002/jbm.a.35097
NR 30
TC 14
Z9 14
U1 1
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 56
BP 46
EP 57
DI 10.1016/j.biomaterials.2015.03.022
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI8SI
UT WOS:000355041600006
PM 25934278
DA 2018-10-20
ER

PT J
AU Mitchell, MJ
   Castellanos, CA
   King, MR
AF Mitchell, Michael J.
   Castellanos, Carlos A.
   King, Michael R.
TI Surfactant functionalization induces robust, differential adhesion of
   tumor cells and blood cells to charged nanotube-coated biomaterials
   under flow
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Halloysite; Surfactant; Circulating tumor cell; Leukocyte;
   Metastasis
ID CANCER-CELLS; E-SELECTIN; NEUTROPHIL ACTIVATION; CLAY NANOTUBES;
   SHEAR-STRESS; METASTASIS; NANOPARTICLES; INFLAMMATION; RECEPTOR; BIOLOGY
AB The metastatic spread of cancer cells from the primary tumor to distant sites leads to a poor prognosis in cancers originating from multiple organs. Increasing evidence has linked selectin-based adhesion between circulating tumor cells (CTCs) and endothelial cells of the microvasculature to metastatic dissemination, in a manner similar to leukocyte adhesion during inflammation. Functionalized biomaterial surfaces hold promise as a diagnostic tool to separate CTCs and potentially treat metastasis, utilizing antibody and selectin-mediated interactions for cell capture under flow. However, capture at high purity levels is challenged by the fact that CTCs and leukocytes both possess selectin ligands. Here, a straightforward technique to functionalize and alter the charge of naturally occurring halloysite nanotubes using surfactants is reported to induce robust, differential adhesion of tumor cells and blood cells to nanotube-coated surfaces under flow. Negatively charged sodium dodecanoate-functionalized nanotubes simultaneously enhanced tumor cell capture while negating leukocyte adhesion, both in the presence and absence of adhesion proteins, and can be utilized to isolate circulating tumor cells regardless of biomarker expression. Conversely, diminishing nanotube charge via functionalization with decyltrimethylammonium bromide both abolished tumor cell capture while promoting leukocyte adhesion. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Mitchell, Michael J.; Castellanos, Carlos A.; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Mitchell, Michael J.] MIT, Dept Chem Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
RP King, MR (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
EM mike.king@cornell.edu
RI Mitchell, Michael/K-8420-2014
OI Mitchell, Michael/0000-0002-3628-2244; Castellanos,
   Carlos/0000-0001-7337-487X
FU Cornell Center on the Microenvironment and Metastasis through National
   Cancer Institute [U54CA143876]
FX The authors gratefully acknowledge Jeff Mattison for work with blood
   sample collection and donor recruitment. The work described was
   supported by the Cornell Center on the Microenvironment and Metastasis
   through Award Number U54CA143876 from the National Cancer Institute. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Cancer
   Institute or the National Institutes of Health.
CR Abdullayev E, 2012, ACS NANO, V6, P7216, DOI 10.1021/nn302328x
   Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378
   Bajpai S, 2014, TECHNOLOGY, V2, P101, DOI 10.1142/S2339547814200015
   Ball CJ, 2011, BLOOD CELL MOL DIS, V46, P246, DOI 10.1016/j.bcmd.2010.12.010
   BUTLER TP, 1975, CANCER RES, V35, P512
   Cao TM, 2013, SENSORS-BASEL, V13, P12516, DOI 10.3390/s130912516
   Cavallaro G, 2012, J PHYS CHEM C, V116, P21932, DOI 10.1021/jp307961q
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608
   Chen WQ, 2013, ACS NANO, V7, P566, DOI 10.1021/nn304719q
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824
   Gassmann P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-177
   Greene BT, 2012, FRONT ONCOL, V2, P1
   HOPWOOD JJ, 1977, J BIOL CHEM, V252, P4777
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Hughes AD, 2013, CANC LETT, V352, P28
   Hughes AD, 2012, CLIN CHEM, V58, P846, DOI 10.1373/clinchem.2011.176669
   Hughes AD, 2010, LANGMUIR, V26, P12155, DOI 10.1021/la101179y
   Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006
   Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139
   Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267
   Kim MB, 2003, MICROCIRCULATION, V10, P167, DOI 10.1038/sj.mn.7800182
   Lawrence MB, 1993, J IMMUNOL, V151, P6339
   Liu MX, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455703
   Luo X, 2014, CELL REP, V7, P645, DOI 10.1016/j.celrep.2014.03.039
   Lvov YM, 2008, ACS NANO, V2, P814, DOI 10.1021/nn800259q
   Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002
   Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283
   McDonald B, 2009, INT J CANCER, V125, P1298, DOI 10.1002/ijc.24409
   Miller MC, 2010, J ONCOL, V2010, DOI DOI 10.1155/2010/617421
   Mitchell MB, 2012, J AGING RES, V2012, DOI DOI 10.1155/2012/461592
   Mitchell MJ, 2014, EXPERT REV ANTICANC, V14, P641, DOI 10.1586/14737140.2014.916619
   Mitchell MJ, 2014, BIOPHYS J, V106, P2243, DOI 10.1016/j.bpj.2014.04.001
   Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111
   Mitchell MJ, 2014, AM J PHYSIOL-CELL PH, V306, pC89, DOI 10.1152/ajpcell.00285.2013
   Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008
   Mitchell MJ, 2012, J CONTROL RELEASE, V160, P609, DOI 10.1016/j.jconrel.2012.02.018
   Mitchell MJ, 2012, BIOPHYS J, V102, P1804, DOI 10.1016/j.bpj.2012.03.053
   Mitchell MJ, 2013, FRONT ONCOL, V3, P1
   Mitchell MJ, 2014, EXPERT OPIN DRUG DEL, P1
   Myung JH, 2011, ANAL CHEM, V83, P1078, DOI 10.1021/ac102901e
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Parodi A, 2012, NAT NANOTECHNOL, V8, P61
   Rahn JJ, 2005, CLIN EXP METASTAS, V22, P475, DOI 10.1007/s10585-005-3098-x
   Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825
   SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X
   Silberberg MS., 2008, CHEM MOL NATURE MATT
   Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192
   van Ginhoven TM, 2010, J SURG ONCOL, V102, P348, DOI 10.1002/jso.21649
   Veerabadran NG, 2007, NANO, V2, P115, DOI 10.1142/S1793292007000441
   Vorobyov I, 2010, BIOPHYS J, V98, P2904, DOI 10.1016/j.bpj.2010.03.046
   Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028
   Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021
   Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2
   Zhang Y, 2009, SMALL, V5, P1990, DOI 10.1002/smll.200900520
NR 56
TC 18
Z9 20
U1 1
U2 66
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 56
BP 179
EP 186
DI 10.1016/j.biomaterials.2015.03.045
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI8SI
UT WOS:000355041600018
PM 25934290
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bygd, HC
   Forsmark, KD
   Bratlie, KM
AF Bygd, Hannah C.
   Forsmark, Kiva D.
   Bratlie, Kaitlin M.
TI Altering in vivo macrophage responses with modified polymer properties
SO BIOMATERIALS
LA English
DT Article
DE Macrophage phenotype; In vivo test; Surface modification; Polymer
   properties; Biocompatibility; Biomedical applications
ID TUMOR-ASSOCIATED MACROPHAGES; PROTEIN ADSORPTION; ALTERNATIVE
   ACTIVATION; INFLAMMATORY RESPONSES; IMPLANTED BIOMATERIALS; NEUTROPHIL
   GRANULES; NECROSIS-FACTOR; CATHEPSIN-D; POLARIZATION; CANCER
AB Macrophage reprogramming has long been the focus of research in disease therapeutics and biomaterial implantation. With different chemical and physical properties of materials playing a role in macrophage polarization, it is important to investigate and categorize the activation effects of material parameters both in vitro and in vivo. In this study, we have investigated the effects of material surface chemistry on in vivo polarization of macrophages. The library of materials used here include poly(N-iso-propylacrylamide-co-acrylic acid) (p(NIPAm-co-AAc)) nanoparticles (similar to 600 nm) modified with various functional groups. This study also focuses on the development of a quantitative structure activity relationship method (QSAR) as a predictive tool for determining the macrophage polarization in response to particular biomaterial surface chemistries. Here, we successfully use in vivo imaging and histological analysis to identify the macrophage response and activation. We demonstrate the ability to induce a spectrum of macrophage phenotypes with a change in material functionality as well as identify certain material parameters that seem to correlate with each phenotype. This suggests the potential to develop materials for a variety of applications and predict the outcome of macrophage activation in response to new surface chemistries. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Bygd, Hannah C.; Bratlie, Kaitlin M.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   [Forsmark, Kiva D.; Bratlie, Kaitlin M.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Ames Natl Lab, Ames, IA 50011 USA.
RP Bratlie, KM (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
EM kbratlie@iastate.edu
FU National Science Foundation [CBET 1227867]; Roy J. Carver Charitable
   Trust [13-4265]; NSF ARI-R2 [CMMI-0963224]
FX The authors thank Rebecca Steinlage and Samuel Spar land for their
   assistance in imaging H&E sections. This work was supported by the
   National Science Foundation under Grant No. CBET 1227867 and the Roy J.
   Carver Charitable Trust Grant No. 13-4265. The authors also acknowledge
   support from NSF ARI-R2 (CMMI-0963224) for funding the renovation of the
   research laboratories used for these studies.
CR Akilbekova D, 2015, J BIOMED MATER RES A, V103, P262, DOI 10.1002/jbm.a.35169
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Bartneck M, 2013, MAT SCI ENG C-MATER, V33, P5109, DOI 10.1016/j.msec.2013.08.028
   Beningo KA, 2002, J CELL SCI, V115, P849
   Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745
   Bicerano J., 2002, PREDICTION POLYM PRO
   Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Bridges AW, 2008, BIOMATERIALS, V29, P4605, DOI 10.1016/j.biomaterials.2008.08.015
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bygd HC, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0041-2
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   De Vos P, 2006, J BIOMED MATER RES A, P813
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   DIMENT S, 1988, J BIOL CHEM, V263, P6901
   Dimitrijevic M, 2014, AGE OMAHA, V36
   Doshi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010051
   DUNN WJ, 1989, CHEMOMETR INTELL LAB, V6, P181, DOI 10.1016/0169-7439(89)80083-8
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gonzalez-Leal IJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003194
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Guo X, 2008, MUCOSAL IMMUNOL, V1, P139, DOI 10.1038/mi.2007.18
   Hansch C, 2003, J CHEM INF COMP SCI, V43, P120, DOI 10.1021/ci020378b
   Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hollinger J. O., 2011, INTRO BIOMATERIALS
   Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kubinyi H, 1997, DRUG DISCOV TODAY, V2, P457, DOI 10.1016/S1359-6446(97)01079-9
   Kubinyi H, 1993, METHODS PRINCIPLES M
   Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001
   LEVINSON SS, 1978, CLIN CHEM, V24, P2199
   Li X, 2011, ACS COMB SCI, V13, P50, DOI 10.1021/co100019d
   Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Petersen LK, 2011, BIOMATERIALS, V32, P6815, DOI 10.1016/j.biomaterials.2011.05.063
   Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069
   Quatromoni JG, 2012, AM J TRANSL RES, V4, P376
   Ramanathan S, 2014, IRAN J CANCER PREV, V7, P1
   Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010
   Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177
   Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111
   Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385
   Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   VANOSS CJ, 1978, ANNU REV MICROBIOL, V32, P19, DOI 10.1146/annurev.mi.32.100178.000315
   Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463
   Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338
   Wang D, 2014, BIOMACROMOLECULES
   Wang D, 2015, ACS BIOMATER SCI ENG, V1, P166, DOI 10.1021/ab5001063
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644
   Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x
   Wynn TA, 2011, CURR PROTOC ESSENT L, V2011, P1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75
NR 91
TC 18
Z9 18
U1 4
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2015
VL 56
BP 187
EP 197
DI 10.1016/j.biomaterials.2015.03.042
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI8SI
UT WOS:000355041600019
PM 25934291
DA 2018-10-20
ER

PT J
AU Oechsle, AM
   Haupler, M
   Gibis, M
   Kohlus, R
   Weiss, J
AF Oechsle, Anja Maria
   Haeupler, Michaela
   Gibis, Monika
   Kohlus, Reinhard
   Weiss, Jochen
TI Modulation of the rheological properties and microstructure of collagen
   by addition of co-gelling proteins
SO FOOD HYDROCOLLOIDS
LA English
DT Article
DE Filled collagen type I gel; Soy protein isolate; Whey protein isolate;
   Gluten; Blood plasma protein
ID THERMAL-PROPERTIES; GELS; PARTICLES; BIOMATERIAL; STABILITY; DELIVERY;
   ISOLATE; CASINGS; PLASMA; BONDS
AB Collagen gels were modified by addition of co-gelling proteins to obtain gels with new functionalities. Microstructure and rheology of these mixed telopeptide-poor collagen gels were assessed. It was assumed that proteins with a low molecular weight strengthen the collagen structure by embedding themselves in the matrix, while high molecular weight proteins weaken the structure by interfering with the assembly of the network.
   Different combinations of collagen (2.8-5.19% (w/w)) and co-gelling protein concentrations (0.36-2.14% (w/w)) were applied. Blood plasma protein, soy protein isolate, whey protein isolate, and gluten were used as co-gelling proteins. The storage modulus was measured as an indicator of the gel strength. Frequency sweeps (0.1-10 Hz) at 1% strain were conducted in the linear viscoelastic region. The position of the co-gelling proteins in the collagen matrix was examined via both confocal laser scanning and scanning electron microscopy.
   The results showed weakening effects for whey protein isolate. The addition of blood plasma protein did not affect the rheology, but the microstructure was influenced, featuring more fibrillar structures in the pores compared to the reference gels. Gluten seemed to lead to phase separation, forming a separate layer without interacting with the collagen matrix. The greatest impact was found for soy protein isolate, with a strengthening effect indicated by increased storage moduli and well distributed and embedded soy protein isolate in the collagen network.
   In conclusion, co-gelling proteins display a suitable approach to modify collagen strength in order to create matrices with new functionalities, such as co-extruded sausage casings with modified knack or snap. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Oechsle, Anja Maria; Haeupler, Michaela; Gibis, Monika; Weiss, Jochen] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Phys & Meat Sci, D-70599 Stuttgart, Germany.
   [Haeupler, Michaela] Tech Univ Berlin, Chair Food Proc Engn, Dept Food Technol & Food Chem, D-14195 Berlin, Germany.
   [Kohlus, Reinhard] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Proc Engn & Food Powders, D-70599 Stuttgart, Germany.
RP Weiss, J (reprint author), Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Phys & Meat Sci, Garbenstr 21-25, D-70599 Stuttgart, Germany.
EM j.weiss@uni-hohenheim.de
OI Oechsle, Anja/0000-0003-2500-9063
FU German Ministry of Economics and Energy (via AiF); FEI (Forschungskreis
   der Ernahrungsindustrie e.V., Bonn) [AiF 17478 N]
FX This research project was supported by the German Ministry of Economics
   and Energy (via AiF) and the FEI (Forschungskreis der
   Ernahrungsindustrie e.V., Bonn): Project AiF 17478 N.
CR Almdal K., 1993, POLYM GELS NETW, V1, P5, DOI DOI 10.1016/0966-7822(93)90020-I
   Banerjee S, 2012, CRIT REV FOOD SCI, V52, P334, DOI 10.1080/10408398.2010.500234
   Barbut S, 2010, ITAL J FOOD SCI, V22, P126
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   Bueker M., 2009, COLLAGEN CONCENTRATE
   Chen JS, 1999, COLLOID SURFACE B, V12, P373, DOI 10.1016/S0927-7765(98)00091-5
   Davila E, 2007, MEAT SCI, V76, P216, DOI 10.1016/j.meatsci.2006.11.002
   Dekker M., 1997, FOOD PROTEINS THEIR, P341
   Denavi GA, 2009, FOOD HYDROCOLLOID, V23, P2094, DOI 10.1016/j.foodhyd.2009.03.007
   Foegeding EA, 2011, FOOD HYDROCOLLOID, V25, P1853, DOI 10.1016/j.foodhyd.2011.05.008
   Freudenberg U, 2007, BIOPHYS J, V92, P2108, DOI 10.1529/biophysj.106.094284
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Harper BA, 2012, FOOD RES INT, V49, P494, DOI 10.1016/j.foodres.2012.07.043
   Haurowitz F., 2014, PROTEINS BLOOD SERUM
   Highberger J. H., 1939, J AM CHEM SOC, V61, P2302
   Hurtado S, 2012, MEAT SCI, V90, P624, DOI 10.1016/j.meatsci.2011.10.004
   Jaramillo DP, 2011, FOOD RES INT, V44, P911, DOI 10.1016/j.foodres.2011.01.057
   Klein M, 2010, COLLOID SURFACE B, V79, P377, DOI 10.1016/j.colsurfb.2010.04.021
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205
   Montero P, 2000, FOOD HYDROCOLLOID, V14, P455, DOI 10.1016/S0268-005X(00)00025-4
   Nicoleti JF, 2009, FOOD BIOPHYS, V4, P135, DOI 10.1007/s11483-009-9110-2
   Nordqvist P, 2010, INT J ADHES ADHES, V30, P72, DOI 10.1016/j.ijadhadh.2009.09.002
   Oechsle AM, 2014, EUR POLYM J, V58, P144, DOI 10.1016/j.eurpolymj.2014.06.015
   Pang ZH, 2014, FOOD HYDROCOLLOID, V35, P484, DOI 10.1016/j.foodhyd.2013.07.007
   PETRUCCELLI S, 1995, J AGR FOOD CHEM, V43, P1762, DOI 10.1021/jf00055a004
   REISER K, 1992, FASEB J, V6, P2439
   Saglam D, 2014, FOOD HYDROCOLLOID, V38, P163, DOI 10.1016/j.foodhyd.2013.11.015
   Sarbon NM, 2015, FOOD HYDROCOLLOID, V45, P83, DOI 10.1016/j.foodhyd.2014.10.008
   Shewry PR, 1997, J CEREAL SCI, V25, P207, DOI 10.1006/jcrs.1996.0100
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Sun XD, 2011, COMPR REV FOOD SCI F, V10, P33, DOI 10.1111/j.1541-4337.2010.00137.x
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   Phan-Xuan T, 2013, BIOMACROMOLECULES, V14, P1980, DOI 10.1021/bm400347d
   VANVLIET T, 1988, COLLOID POLYM SCI, V266, P518, DOI 10.1007/BF01420762
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang P, 2014, FOOD HYDROCOLLOID, V35, P324, DOI 10.1016/j.foodhyd.2013.06.015
   Zanaboni G, 2000, MATRIX BIOL, V19, P511, DOI 10.1016/S0945-053X(00)00096-2
NR 42
TC 12
Z9 12
U1 3
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-005X
EI 1873-7137
J9 FOOD HYDROCOLLOID
JI Food Hydrocolloids
PD JUL
PY 2015
VL 49
BP 118
EP 126
DI 10.1016/j.foodhyd.2015.03.013
PG 9
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA CH1QR
UT WOS:000353796900014
DA 2018-10-20
ER

PT J
AU Celen, S
AF Celen, Serap
TI A novel strain energy density algorithm for laser-induced micro-hollows
SO OPTICS AND LASERS IN ENGINEERING
LA English
DT Article
DE Lotus effect; Laser-induced 3D frozen melted droplets shaping; Surface
   skin micro-machining
ID BONE ADAPTATION; INTENSITY; TITANIUM; IMPLANTS; PROPOSAL
AB Mechanical adaptation and stability of implants are dependent on strain energy density algorithms of their surfaces. These applications are in their early stage, but theoretical predictions show us that we can manufacture very strong, flexible biomaterial surface which has a shock absorbing ability. Laser micro-machining is a clean tool for biomedical industry. The purpose of this manuscript is to consolidate a laser micro-machining method for imitating lotus effect on commercially pure titanium specimen surfaces and to develop a novel strain energy density algorithm. Novel 3D nelumbo leafs were prepared using a fiber laser (lambda=1060 nm) with 200-250 ns pulse durations and optimum operation parameters were suggested. (C) 2015 Elsevier Ltd. All rights reserved.
C1 Ege Univ, Fac Engn, Dept Mech Engn, TR-35100 Izmir, Turkey.
RP Celen, S (reprint author), Ege Univ, Fac Engn, Dept Mech Engn, TR-35100 Izmir, Turkey.
EM seracelen@hotmail.com
CR ALBREKTSSON T, 1987, ACTA ORTHOP SCAND, V58, P567, DOI 10.3109/17453678709146401
   Alexander H, 2009, J BIOMED MATER RES B, V88B, P306, DOI 10.1002/jbm.b.30845
   Anisimov SI, 1995, INSTABILITIES LASER
   Bachmann F., 2007, P SOC PHOTO-OPT INS, V6735, P1
   Bachmann F, 2005, NOV MAT PROC ADV EL
   Barthlott W, 2004, BOLOGIE UNSERER Z, V34, P290
   Barthlott W, 1990, SYSTEMATICS ASS, V41, P69
   Barthlott W., 1977, TROPISCHE SUBTROPISC, V19, P367
   Breme J, 2008, METALLIC BIOMATERIAL, P271
   Burger EH, 1999, FASEB J, V13, P101
   Burger EH, 2001, BONE MECH HDB, V28, P1
   CARTER DR, 1991, J BIOMECH, V24, P3, DOI 10.1016/0021-9290(91)90373-U
   Celen S, 2011, THESIS EGE U IZMIR
   Celen S., 2009, P 19 INT C PHOT EUR, P459
   Celen S., 2013, P SURF MOD MAT ION B, P138
   Celen S, 2012, APPL SURF SCI, V263, P579, DOI 10.1016/j.apsusc.2012.09.112
   Celen S, 2011, PHYSCS PROC, V12, P245, DOI 10.1016/j.phpro.2011.03.130
   COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P
   Dahotre NB, 2008, LASER FABRICATION MA, P558
   DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304
   Doblare M., ADV FRACTURE DAMAGE, VIV, P471
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Gyorgy E, 2002, SURF COAT TECH, V154, P63, DOI 10.1016/S0257-8972(01)01699-1
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Karacs A, 2003, MAT SCI ENG C-BIO S, V23, P431, DOI 10.1016/S0928-4931(02)00316-8
   Lane WC, 1970, SCANNING ELECT MICRO, V1, P43
   Lawrence J, 2006, SURF COAT TECH, V200, P5581, DOI 10.1016/j.surfcoat.2005.07.107
   MARTIN RB, 1972, J BIOMECH, V5, P447, DOI 10.1016/0021-9290(72)90003-6
   McNamara LM, 2007, J BIOMECH, V40, P1381, DOI 10.1016/j.jbiomech.2006.05.007
   Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6
   MULLENDER MG, 1995, J ORTHOPAED RES, V13, P503, DOI 10.1002/jor.1100130405
   Oers RFM, 2008, BONE, V43, P476
   Oshida Y., 2007, BIOSCIENCE BIOENGINE
   Prendergast P J, 1995, BONE STRUCTURE REMOD, P213
   PRENDERGAST PJ, 1994, J BIOMECH, V27, P1067, DOI 10.1016/0021-9290(94)90223-2
   Schulte FA, 2013, BONE, V52, P485, DOI 10.1016/j.bone.2012.09.008
   Smit TH, 2000, J BONE MINER RES, V15, P301, DOI 10.1359/jbmr.2000.15.2.301
   Stratakis E, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3553235
   Turner CH, 1999, CALCIFIED TISSUE INT, V65, P466, DOI 10.1007/s002239900734
   Voisey KT, 2003, MAT SCI ENG A-STRUCT, V356, P414, DOI 10.1016/S0921-5093(03)00155-2
NR 40
TC 5
Z9 5
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-8166
EI 1873-0302
J9 OPT LASER ENG
JI Opt. Lasers Eng.
PD JUL
PY 2015
VL 70
BP 45
EP 50
DI 10.1016/j.optlaseng.2015.02.002
PG 6
WC Optics
SC Optics
GA CG3KB
UT WOS:000353178000007
DA 2018-10-20
ER

PT J
AU Duhring, S
   Germerodt, S
   Skerka, C
   Zipfel, PF
   Dandekar, T
   Schuster, S
AF Duehring, Sybille
   Germerodt, Sebastian
   Skerka, Christine
   Zipfel, Peter F.
   Dandekar, Thomas
   Schuster, Stefan
TI Host-pathogen interactions between the human innate immune system and
   Candida albicans - understanding and modeling defense and evasion
   strategies
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Candida albicans; human immune system; host-pathogen interaction;
   computational systems biology; defense and evasion strategies;
   immunological cross-talk
ID AGENT-BASED MODEL; BETA-LACTAMASE INHIBITION; IN-VITRO; ANTIMICROBIAL
   PEPTIDES; BIOMATERIAL SURFACES; BIOFILM FORMATION; FUNGAL PATHOGENS;
   DENDRITIC CELLS; INFECTION; RESISTANCE
AB The diploid, polymorphic yeast Candida albicans is one of the most important human pathogenic fungi. C. albicans can grow, proliferate and coexist as a commensal on or within the human host for a long time. However, alterations in the host environment can render C. albicans virulent. In this review, we describe the immunological cross-talk between C. albicans and the human innate immune system. We give an overview in form of pairs of human defense strategies including immunological mechanisms as well as general stressors such as nutrient limitation, pH, fever etc. and the corresponding fungal response and evasion mechanisms. Furthermore, Computational Systems Biology approaches to model and investigate these complex interactions are highlighted with a special focus on game-theoretical methods and agent-based models. An outlook on interesting questions to be tackled by Systems Biology regarding entangled defense and evasion mechanisms is given.
C1 [Duehring, Sybille; Germerodt, Sebastian; Schuster, Stefan] Univ Jena, Dept Bioinformat, D-07743 Jena, Germany.
   [Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Dept Infect Biol, Jena, Germany.
   [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany.
   [Dandekar, Thomas] Univ Wurzburg, Biozentrum, Dept Bioinformat, D-97070 Wurzburg, Germany.
RP Schuster, S (reprint author), Univ Jena, Dept Bioinformat, Ernst Abbe Pl 2, D-07743 Jena, Germany.
EM stefan.schu@uni-jena.de
RI Dandekar, Thomas/A-4431-2017
OI Dandekar, Thomas/0000-0003-1886-7625
FU Deutsche Forschungsgemeinschaft (DFG) [CRC/Transregio 124]
FX Deutsche Forschungsgemeinschaft (DFG) CRC/Transregio 124 "Pathogenic
   fungi and their human host: Networks of interaction" subproject B1 (SD,
   TD, and SS), subproject C4 (CS), and subproject C6 (PFZ).
CR Abt C. C, 1987, SERIOUS GAMES
   Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019
   Audretsch C, 2013, MOL BIOSYST, V9, P2665, DOI 10.1039/c3mb70117d
   AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396
   Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Bain JM, 2012, FUNGAL GENET BIOL, V49, P677, DOI 10.1016/j.fgb.2012.01.008
   Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006
   Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012
   Borkowski M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S14
   Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6
   Broom M, 2011, B MATH BIOL, V73, P683, DOI 10.1007/s11538-010-9546-z
   Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091
   Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110
   Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064
   Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chavali AK, 2008, TRENDS IMMUNOL, V29, P589, DOI 10.1016/j.it.2008.08.006
   Chen B.-S., 2014, METHOD MOL BIOL, P403
   Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11
   Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702
   Cheng SC, 2010, J IMMUNOL, V185, P2450, DOI 10.4049/jimmunol.1000756
   Chin VK, 2014, BIOMED REP, V2, P869, DOI 10.3892/br.2014.365
   Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007
   Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x
   d'Enfert C, 2009, CURR OPIN MICROBIOL, V12, P358, DOI 10.1016/j.mib.2009.05.008
   d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661
   Dancik GM, 2010, J THEOR BIOL, V262, P398, DOI 10.1016/j.jtbi.2009.10.007
   de Figueiredo LF, 2008, BIOINFORMATICS, V24, P2615, DOI 10.1093/bioinformatics/btn500
   de Lima TM, 2014, MOL IMMUNOL, V60, P8, DOI 10.1016/j.molimm.2014.03.010
   De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22
   DeAngelis Donald L, 2014, F1000Prime Rep, V6, P39, DOI 10.12703/P6-39
   Dementhon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032621
   den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099
   Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197
   Faro-Trindade I, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P437
   Filler SG, 2013, TRENDS MICROBIOL, V21, P389, DOI 10.1016/j.tim.2013.05.006
   Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475
   Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39
   Forrest S, 2007, IMMUNOL REV, V216, P176
   Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x
   Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001
   Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711
   Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023
   Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019
   Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019
   Hahn S, 2013, SEMIN IMMUNOPATHOL, V35, P439, DOI 10.1007/s00281-013-0380-x
   Hamad M, 2012, MYCOSES, V55, P205, DOI 10.1111/j.1439-0507.2011.02078.x
   Havas KA, 2014, ZOONOSES PUBLIC HLTH, V61, P260, DOI 10.1111/zph.12066
   Heinrich R., 1996, REGULATION CELLULAR
   Hofbauer J, 1998, EVOLUTIONARY GAMES P
   Horn H, 2014, ADV BIOCHEM ENG BIOT, V146, P53, DOI 10.1007/10_2014_275
   Hummert S, 2010, J THEOR BIOL, V264, P312, DOI 10.1016/j.jtbi.2010.01.022
   Hummert S, 2014, MOL BIOSYST, V10, P3044, DOI 10.1039/c3mb70602h
   Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]
   Jimenez-Lopez C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003741
   Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153
   Klipp E., 2011, SYSTEMS BIOL TXB
   KNOWLES JR, 1985, ACCOUNTS CHEM RES, V18, P97, DOI 10.1021/ar00112a001
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Kreft JU, 2013, P NATL ACAD SCI USA, V110, P18027, DOI 10.1073/pnas.1317472110
   Krysan DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004139
   Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012
   Kwak MK, 2014, FEBS LETT, V588, P1144, DOI 10.1016/j.febslet.2014.02.042
   Laskowski M, 2011, IEEE T INF TECHNOL B, V15, P877, DOI 10.1109/TITB.2011.2163414
   Leach MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032467
   Li R, 2013, ANTIMICROB AGENTS CH, V57, P1832, DOI 10.1128/AAC.02295-12
   Li YJ, 2008, INT J ANTIMICROB AG, V31, P369, DOI 10.1016/j.ijantimicag.2007.11.015
   Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090042
   Liu YP, 2015, GENOME RES, V25, P679, DOI 10.1101/gr.187427.114
   Lopez C. M., 2013, THESIS FRIEDRICH SCH
   Lu Y, 2014, P NATL ACAD SCI USA, V111, P1975, DOI 10.1073/pnas.1318690111
   Luo SS, 2013, MOL IMMUNOL, V56, P161, DOI 10.1016/j.molimm.2013.05.218
   Macal CM, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-124
   Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127
   Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913
   Mech F, 2014, CYTOM PART A, V85, P126, DOI 10.1002/cyto.a.22418
   Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6
   Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005
   Miramon P, 2013, MED MICROBIOL IMMUN, V202, P183, DOI 10.1007/s00430-013-0288-z
   Moyes D. L., 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/346307
   Naseem M, 2012, PLANT CELL, V24, P1793, DOI 10.1105/tpc.112.098335
   Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815
   Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007
   Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x
   Peer X, 2014, J PHARMACOKINET PHAR, V41, P493, DOI 10.1007/s10928-014-9381-1
   Pollmacher J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111630
   Pruchniak MP, 2012, CENT EUR J IMMUNOL, V37, P81
   Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120
   Qiao YL, 2013, NAT GENET, V45, P330, DOI 10.1038/ng.2525
   Quintin J, 2014, EUR J IMMUNOL, V44, P2405, DOI 10.1002/eji.201343828
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Ramirez-Ortiz ZG, 2012, VIRULENCE, V3, P635, DOI 10.4161/viru.22295
   READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852
   RENAUD F, 1991, J THEOR BIOL, V152, P319, DOI 10.1016/S0022-5193(05)80197-3
   Sansregret R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003435
   Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217
   Schlatter R, 2012, BRIEF BIOINFORM, V13, P365, DOI 10.1093/bib/bbr065
   SCHUSTER S, 2006, DISCOVERING BIOMOLEC, P95
   Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33
   Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x
   Shankar J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08131
   Siegismund D, 2014, BIOFOULING, V30, P1023, DOI 10.1080/08927014.2014.958999
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh A, 2013, OMICS, V17, P84, DOI 10.1089/omi.2012.0075
   Smith LM, 2013, BIOCHEM SOC T, V41, P475, DOI 10.1042/BST20130014
   Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025
   Stark HU, 2010, EVOLUTION, V64, P2458, DOI 10.1111/j.1558-5646.2010.00986.x
   Stavrum AK, 2013, J BIOL CHEM, V288, P34555, DOI 10.1074/jbc.M113.474908
   Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Swidergall M, 2013, ANTIMICROB AGENTS CH, V57, P3917, DOI 10.1128/AAC.00862-13
   Szafranski-Schneider E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002501
   Tavanti A, 2006, MICROBES INFECT, V8, P791, DOI 10.1016/j.micinf.2005.09.016
   Tian Y, 2013, HEALTH EDUC BEHAV, V40, p98S, DOI 10.1177/1090198113493910
   Tierney L., 2014, HUMAN FUNGAL PATHOGE, P45
   Tierney Lanay, 2012, Front Microbiol, V3, P85, DOI 10.3389/fmicb.2012.00085
   Tokarski C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00129
   Tyc K. M., 2011, J COMPUT SCI SYST S, VS1, DOI [10.4172/jcsb.s1-001, DOI 10.4172/JCSB.S1-001]
   Tyc KM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00041
   Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639
   Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14
   Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934
   van de Veerdonk FL, 2015, IMMUNOL REV, V265, P172, DOI 10.1111/imr.12280
   VazquezTorres A, 1996, INFECT IMMUN, V64, P3127
   Vialas V, 2014, J PROTEOMICS, V97, P62, DOI 10.1016/j.jprot.2013.06.020
   Voigt J., 2013, THESIS FRIEDRICH SCH
   Vylkova S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003995
   Wellington M, 2014, EUKARYOT CELL, V13, P329, DOI 10.1128/EC.00336-13
   Westerhoff HV, 2000, EUR J BIOCHEM, V267, P5355, DOI 10.1046/j.1432-1327.2000.01559.x
   Whittington A., 2014, HUMAN FUNGAL PATHOGE, V2nd, P3
   Williams JD, 1997, CLIN INFECT DIS, V24, P494, DOI 10.1093/clinids/24.3.494
   Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x
   Yan L, 2013, MICROBIOL RES, V168, P389, DOI 10.1016/j.micres.2013.02.008
   Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636
   Zelante T, 2011, EUR J IMMUNOL, V41, P270, DOI 10.1002/eji.201041246
   Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001
   Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222
   Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010
NR 140
TC 26
Z9 27
U1 2
U2 29
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 30
PY 2015
VL 6
AR 625
DI 10.3389/fmicb.2015.00625
PG 18
WC Microbiology
SC Microbiology
GA CL9ME
UT WOS:000357302000001
PM 26175718
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Alvarez, LM
   Rivera, JJ
   Stockdale, L
   Saini, S
   Lee, RT
   Griffith, LG
AF Alvarez, Luis M.
   Rivera, Jaime J.
   Stockdale, Linda
   Saini, Sunil
   Lee, Richard T.
   Griffith, Linda G.
TI Tethering of Epidermal Growth Factor (EGF) to Beta Tricalcium Phosphate
   (beta TCP) via Fusion to a High Affinity, Multimeric beta TCP-Binding
   Peptide: Effects on Human Multipotent Stromal Cells/Connective Tissue
   Progenitors
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; ACID-RICH SEQUENCES; IN-VIVO;
   FACTOR RECEPTOR; FILAMENTOUS BACTERIOPHAGE; HYDROXYAPATITE CRYSTALS;
   ADSORPTION PROTEIN; TITANIUM SURFACES; COLONY FORMATION
AB Transplantation of freshly-aspirated autologous bone marrow, together with a scaffold, is a promising clinical alternative to harvest and transplantation of autologous bone for treatment of large defects. However, survival proliferation, and osteogenic differentiation of the marrow-resident stem and progenitor cells with osteogenic potential can be limited in large defects by the inflammatory microenvironment. Previous studies using EGF tethered to synthetic polymer substrates have demonstrated that surface-tethered EGF can protect human bone marrow-derived osteogenic stem and progenitor cells from pro-death inflammatory cues and enhance their proliferation without detriment to subsequent osteogenic differentiation. The objective of this study was to identify a facile means of tethering EGF to clinically-relevant beta TCP scaffolds and to demonstrate the bioactivity of EGF tethered to beta TCP using stimulation of the proliferative response of human bone-marrow derived mesenchymal stem cells (hBMSC) as a phenotypic metric. We used a phage display library and panned against beta TCP and composites of beta TCP with a degradable polyester biomaterial, together with orthogonal blocking schemes, to identify a 12-amino acid consensus binding peptide sequence, LLADTTHHRPWT, with high affinity for beta TCP. When a single copy of this beta TCP-binding peptide sequence was fused to EGF via a flexible peptide tether domain and expressed recombinantly in E. coli together with a maltose-binding domain to aid purification, the resulting fusion protein exhibited modest affinity for beta TCP. However, a fusion protein containing a linear concatamer containing 10 repeats of the binding motif the resulting fusion protein showed high affinity stable binding to beta TCP, with only 25% of the protein released after 7 days at 37 degrees C. The fusion protein was bioactive, as assessed by its abilities to activate kinase signaling pathways downstream of the EGF receptor when presented in soluble form, and to enhance the proliferation of hBMSC when presented in tethered form on commercial beta TCP bone regeneration scaffolds.
C1 [Alvarez, Luis M.; Rivera, Jaime J.; Stockdale, Linda; Griffith, Linda G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Saini, Sunil] Integra Life Sci, Plainsboro, NJ USA.
   [Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Alvarez, Luis M.] US Mil Acad, Dept Chem & Life Sci, West Point, NY 10996 USA.
   [Alvarez, Luis M.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA.
RP Griffith, LG (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM griff@mit.edu
FU NIH [R01DE019523, 1R01HL117986]; Armed Forces Institute for Regenerative
   Medicine (AFIRM); NIH Biotechnology Training Program [T32 GM008334];
   Hertz Foundation
FX Funding: Funding for this work was provided by NIH R01DE019523 (LGG),
   the Armed Forces Institute for Regenerative Medicine (AFIRM) (LGG), NIH
   Biotechnology Training Program T32 GM008334 fellowship (JR), NIH
   1R01HL117986 (RTL), and a Hertz Foundation Pre-doctoral Fellowship
   (LMA).
CR Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100
   Arap MA, 2005, GENET MOL BIOL, V28, P1, DOI 10.1590/S1415-47572005000100001
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P11
   Brodke D, 2006, J ORTHOP RES, V24, P857, DOI 10.1002/jor.20094
   Brounts SH, 2013, MOL PHARMACEUT, V10, P2086, DOI 10.1021/mp300662r
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Caralla T, 2013, TISSUE ENG PT A, V19, P125, DOI 10.1089/ten.tea.2011.0622
   CARMONA P, 1987, BIOPHYS CHEM, V28, P161, DOI 10.1016/0301-4622(87)80085-6
   Clackson T, 2004, PHAGE DISPLAY A PRAC
   COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129
   Damron TA, 2007, NANOMEDICINE-UK, V2, P763, DOI 10.2217/17435889.2.6.763
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Giannoni P, 2010, TISSUE ENG PT A, V16, P489, DOI [10.1089/ten.tea.2009.0041, 10.1089/ten.TEA.2009.0041]
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GOLDSMITH ME, 1977, BIOCHEMISTRY-US, V16, P2686, DOI 10.1021/bi00631a016
   Greenwald S, 77TH ANUAL MEETING
   GRONTHOS S, 1995, BLOOD, V85, P929
   Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32
   Heylman Christopher M, 2013, J Regen Med Tissue Eng, V2, DOI 10.7243/2050-1218-2-7
   Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071
   HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Hunter GK, 1996, NUCLEATION AND INHIB
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Jay SM, 2011, J BIOL CHEM, V286, P27729, DOI 10.1074/jbc.M111.221093
   Kai T, 2003, SPINE, V28, P1653, DOI 10.1097/00007632-200308010-00005
   Kang J, 2013, BIOMATERIALS, V34, P9747, DOI 10.1016/j.biomaterials.2013.09.004
   Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936
   Kitajima T, 2009, ACTA BIOMATER, V5, P2623, DOI 10.1016/j.actbio.2009.03.022
   KOZLOWSKI H, 1981, ACTA BIOCHIM POL, V28, P1
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kriplani U, 2005, CURR OPIN BIOTECH, V16, P470, DOI 10.1016/j.copbio.2005.07.001
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   LIN TC, 1980, J BIOL CHEM, V255, P331
   Liu Bin, 2012, Orthop Surg, V4, P139, DOI 10.1111/j.1757-7861.2012.00189.x
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Luangphakdy V, 2013, TISSUE ENG PT A, V19, P634, DOI [10.1089/ten.tea.2012.0289, 10.1089/ten.TEA.2012.0289]
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Malik P, 1996, GENE, V171, P49, DOI 10.1016/0378-1119(96)00070-4
   Marcantonio NA, 2009, BIOMATERIALS, V30, P4629, DOI 10.1016/j.biomaterials.2009.05.061
   MARTINEAUDOIZE B, 1988, ENDOCRINOLOGY, V123, P841, DOI 10.1210/endo-123-2-841
   Meyers SR, 2007, ADV MATER, V19, P2492, DOI 10.1002/adma.200700029
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Muschler GF, 2003, J BIOMED BIOTECHNOL, P170
   Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012
   Muschler GF, 2002, CLIN ORTHOP RELAT R, P66, DOI 10.1097/00003086-200202000-00008
   Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b
   Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758
   Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716
   Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428
   Orii Hisaya, 2005, Journal of Medical and Dental Sciences, V52, P51
   Patterson TE, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.G.01572
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Roberts TT, 2012, ORGANOGENESIS, V8, P114, DOI 10.4161/org.23306
   Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215
   Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171
   Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322
   Saini S, 2006, THE EFFECT OF BONE G
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Santana H, 2013, INT J PHARMACEUT, V452, P52, DOI 10.1016/j.ijpharm.2013.04.054
   Satomura K, 1998, J CELL PHYSIOL, V177, P426, DOI 10.1002/(SICI)1097-4652(199812)177:3<426::AID-JCP6>3.0.CO;2-F
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028
   Seker UOS, 2009, BIOMACROMOLECULES, V10, P250, DOI 10.1021/bm8009895
   Seker UOS, 2007, LANGMUIR, V23, P7895, DOI 10.1021/la700446g
   Seker UOS, 2011, MOLECULES, V16, P1426, DOI 10.3390/molecules16021426
   Smith G P, 1991, Curr Opin Biotechnol, V2, P668, DOI 10.1016/0958-1669(91)90032-Z
   Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176
   Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385
   Urresti S, 2012, J BIOL CHEM, V287, P24649, DOI 10.1074/jbc.M112.368191
   Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591
   Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200
   Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833
   Webster MPJ, 2012, NUCLEIC ACIDS RES, V40, P8743, DOI 10.1093/nar/gks633
   Weiger MC, 2010, BIOMATERIALS
   WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263
   Whaley SR, 2000, NATURE, V405, P665
   WOOLFORD JL, 1977, BIOCHEMISTRY-US, V16, P2694, DOI 10.1021/bi00631a017
   Wu S, 2011, BIOMATERIALS, V32, P7524, DOI 10.1016/j.biomaterials.2011.06.050
   Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
NR 94
TC 4
Z9 4
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2015
VL 10
IS 6
AR e0129600
DI 10.1371/journal.pone.0129600
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1BL
UT WOS:000358150400023
PM 26121597
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sambu, S
AF Sambu, Sammy
TI A Bayesian approach to optimizing cryopreservation protocols
SO PEERJ
LA English
DT Article
DE Decision-tree learning (DTL); Sugars; Meta-data; Naive Bayes Classifier
   (NBC); 3D cryopreservation; Mouse embryonic stem cells; Cell attachment;
   Modified alginates; Encapsulation; CPA loading
ID EMBRYONIC STEM-CELLS; SURVIVAL RATE; ALGINATE; CRYOPROTECTANTS;
   STABILIZATION; RECOVERY
AB Cryopreservation is beset with the challenge of protocol alignment across a wide range of cell types and process variables. By taking a cross-sectional assessment of previously published cryopreservation data (sample means and standard errors) as preliminary meta-data, a decision tree learning analysis (DTLA) was performed to develop an understanding of target survival using optimized pruning methods based on different approaches. Briefly, a clear direction on the decision process for selection of methods was developed with key choices being the cooling rate, plunge temperature on the one hand and biomaterial choice, use of composites (sugars and proteins as additional constituents), loading procedure and cell location in 3D scaffolding on the other. Secondly, using machine learning and generalized approaches via the Naive Bayes Classification (NBC) method, these metadata were used to develop posterior probabilities for combinatorial approaches that were implicitly recorded in the metadata. These latter results showed that newer protocol choices developed using probability elicitation techniques can unearth improved protocols consistent with multiple unidimensionally-optimized physical protocols. In conclusion, this article proposes the use of DTLA models and subsequently NBC for the improvement of modern cryopreservation techniques through an integrative approach.
EM Sambu@post.harvard.edu
CR Ahmad HF, 2013, ACTA BIOMATER, V9, P6814, DOI 10.1016/j.actbio.2013.03.002
   ANCHORDOGUY TJ, 1987, CRYOBIOLOGY, V24, P324, DOI 10.1016/0011-2240(87)90036-8
   ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033
   ARAKAWA T, 1990, CRYOBIOLOGY, V27, P401, DOI 10.1016/0011-2240(90)90017-X
   Benson CMK, 2008, CRYOBIOLOGY, V56, P120, DOI 10.1016/j.cryobiol.2007.12.002
   Cui ZF, 2002, BIOTECHNOL PROGR, V18, P354, DOI 10.1021/bp0101886
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Furnkranz J, 1997, MACH LEARN, V27, P139, DOI 10.1023/A:1007329424533
   Gibson MI, 2009, BIOMACROMOLECULES, V10, P328, DOI 10.1021/bm801069x
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Heng BC, 2004, J MICROENCAPSUL, V21, P455, DOI 10.1080/02652040410001729250
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Li N, 2015, BIOTECHNOL APPL BIOC, V62, P530, DOI 10.1002/bab.1295
   Liu Y, 2007, THESIS OXFORD U
   MACGREGO.WS, 1967, ANN NY ACAD SCI, V141, P3, DOI 10.1111/j.1749-6632.1967.tb34860.x
   MARTINSEN A, 1992, BIOTECHNOL BIOENG, V39, P186, DOI 10.1002/bit.260390210
   Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x
   Miszta-Lane H, 2007, CELL PRESERV TECHNOL, V5, P16, DOI 10.1089/cpt.2006.9990
   Mitchell T.M., 1997, MACHINE LEARNING, V45
   Muldrew K, 2000, CRYOBIOLOGY, V40, P102, DOI 10.1006/cryo.2000.2236
   Pongsawatmanit R, 1999, FOOD SCI TECHNOLOGY, V5, P183, DOI 10.3136/fstr.5.183
   PRESTRELSKI SJ, 1993, ARCH BIOCHEM BIOPHYS, V303, P465, DOI 10.1006/abbi.1993.1310
   ROOS YH, 1991, INT J FOOD SCI TECH, V26, P553
   Rubinstein YD, 1997, KDD, V5, P49
   RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1
   Sambu S, 2011, P I MECH ENG H, V225, P1092, DOI 10.1177/0954411911418568
   Sambu S, 2011, CRYOLETTERS, V32, P389
   Santis LD, 2007, HUMAN REPROD, V22, P2776, DOI [10.1093/humrep/dem240, DOI 10.1093/HUMREP/DEM240]
   Sato Y, 2004, FOOD HYDROCOLLOID, V18, P527, DOI 10.1016/j.foodhyd.2003.09.001
   Selmer-Olsen E, 1999, J IND MICROBIOL BIOT, V23, P79, DOI 10.1038/sj.jim.2900693
   Serra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023212
   Shirakashi R., 2003, Heat Transfer-Asian Research, V32, P511, DOI 10.1002/htj.10105
   Terry C, 2007, CELL TRANSPLANT, V16, P639, DOI 10.3727/000000007783465000
   Therneau T, 2015, PORT BR AUTHOR INITI
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
NR 35
TC 2
Z9 2
U1 0
U2 2
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JUN 25
PY 2015
VL 3
AR e1039
DI 10.7717/peerj.1039
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL9TF
UT WOS:000357320300003
PM 26131379
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chen, W
   Wu, YX
   Li, L
   Yang, MC
   Shen, L
   Liu, G
   Tan, J
   Zeng, W
   Zhu, CH
AF Chen, Wen
   Wu, Yangxiao
   Li, Li
   Yang, Mingcan
   Shen, Lei
   Liu, Ge
   Tan, Ju
   Zeng, Wen
   Zhu, Chuhong
TI Adenosine accelerates the healing of diabetic ischemic ulcers by
   improving autophagy of endothelial progenitor cells grown on a
   biomaterial
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FOOT ULCERS; ANGIOGENESIS; COMPLICATIONS; RECEPTORS; PROMOTE; MICE
AB Endothelial progenitor cells (EPCs) seeded on biomaterials can effectively promote diabetic ischemic wound healing. However, the function of transplanted EPCs is negatively affected by a high-glucose and ischemic microenvironment. Our experiments showed that EPC autophagy was inhibited and mitochondrial membrane potential (MMP) was increased in diabetic patients, while adenosine treatment decreased the energy requirements and increased the autophagy levels of EPCs. In animal experiments, we transplanted a biomaterial seeded with EPCs onto the surface of diabetic wounds and found that adenosine-stimulated EPCs effectively promoted wound healing. Increased microvascular genesis and survival of the transplanted cells were also observed in the adenosine-stimulated groups. Interestingly, our study showed that adenosine increased the autophagy of the transplanted EPCs seeded onto the biomaterial and maintained EPC survival at 48 and 96 hours. Moreover, we observed that adenosine induced EPC differentiation through increasing the level of autophagy. In conclusion, our study indicated that adenosine-stimulated EPCs seeded onto a biomaterial significantly improved wound healing in diabetic mice; mechanistically, adenosine might maintain EPC survival and differentiation by increasing high glucose-inhibited EPC autophagy and maintaining cellular energy metabolism.
C1 [Chen, Wen; Wu, Yangxiao; Li, Li; Yang, Mingcan; Liu, Ge; Tan, Ju; Zeng, Wen; Zhu, Chuhong] Third Mil Med Univ, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Key Lab Biomech & Tissue Engn Chongqing, Chongqing 400038, Peoples R China.
   [Shen, Lei] Qiqihar Med Univ, Dept Anat, Qiqihar, Peoples R China.
RP Zhu, CH (reprint author), Third Mil Med Univ, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Key Lab Biomech & Tissue Engn Chongqing, Chongqing 400038, Peoples R China.
EM 302507008@qq.com; zhuch99@yahoo.com
OI zhu, chuhong/0000-0003-4146-5405
FU Training Program of the Major Research Plan of the National Natural
   Science Foundation of China [91439116]; National Science Foundation of
   China [31470928]; Natural Science Foundation Project of CQ CSTC
   [cstc2011jjjq0016]; Military Twelfth Five-year Key Project [BWS11C056];
   National High Technology Research and Development Program 863
   [2012AA020504]; research project of the Ministry of Education and
   Guangdong Province [2012B091000043]
FX This work was supported by the Training Program of the Major Research
   Plan of the National Natural Science Foundation of China (No. 91439116),
   the National Science Foundation of China (No: 31470928), the Natural
   Science Foundation Project of CQ CSTC (cstc2011jjjq0016), the Military
   Twelfth Five-year Key Project (BWS11C056), the National High Technology
   Research and Development Program 863 (2012AA020504) and the research
   project of the Ministry of Education and Guangdong Province
   (2012B091000043).
CR Altavilla D, 2011, SURGERY, V149, P253, DOI 10.1016/j.surg.2010.04.024
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Elsharawy MA, 2012, INTERACT CARDIOV TH, V14, P288, DOI 10.1093/icvts/ivr068
   Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285
   Gershater MA, 2009, DIABETOLOGIA, V52, P398, DOI 10.1007/s00125-008-1226-2
   Hou CL, 2013, BIOMATERIALS, V34, P112, DOI 10.1016/j.biomaterials.2012.09.022
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Montesinos MC, 2002, AM J PATHOL, V160, P2009, DOI 10.1016/S0002-9440(10)61151-0
   Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005
   SCHRADER J, 1990, CIRCULATION, V81, P389, DOI 10.1161/01.CIR.81.1.389
   Shen L, 2013, CELL TRANSPLANT, V22, P1011, DOI 10.3727/096368912X657495
   Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217
   Ulicna M, 2010, BRATISL MED J, V111, P138
   Valls MD, 2009, BIOCHEM PHARMACOL, V77, P1117, DOI 10.1016/j.bcp.2008.11.002
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005
NR 26
TC 7
Z9 10
U1 0
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 25
PY 2015
VL 5
AR 11594
DI 10.1038/srep11594
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3OS
UT WOS:000356860200001
PM 26108983
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cha, YJ
   Gim, MJ
   Oh, K
   Yoon, DK
AF Cha, Yun Jeong
   Gim, Min-Jun
   Oh, Kyunghwan
   Yoon, Dong Ki
TI In-Plane Switching Mode for Liquid Crystal Displays Using a DNA
   Alignment Layer
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE DNA; biomaterial; liquid crystal; alignment layer; IPS LCD
ID PHASE; FILM; NANO
AB We successfully fabricated the in-plane switching mode (IPS) LC display (LCD) based on a double stranded DNA (dsDNA) alignment layer. As widely known, the DNA has the right-handed double helical structure that has naturally grown grooves with a very regular period, which can be used as an alignment layer to control the orientation of liquid crystal (LC) molecules. The LC molecules on this topographical layer of DNA material align obliquely at a specific angle with respect to the direction of DNA chains, providing an instant and convenient tool for the fabrication of the IPS display compared to the conventional ways such as rubbing and mechanical shearing methods. The electro-optical performance and response time of this device were also investigated. Our result will be of great use in further exploration of the electro-optical properties of the other biomaterials.
C1 [Cha, Yun Jeong; Gim, Min-Jun; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
   [Cha, Yun Jeong; Gim, Min-Jun; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, KINC, Taejon 305701, South Korea.
   [Oh, Kyunghwan] Yonsei Univ, Inst Phys & Appl Phys, Photon Device Phys Lab, Seoul 120749, South Korea.
RP Yoon, DK (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, 291 Daehak Ro, Taejon 305701, South Korea.
EM nandk@kaist.ac.kr
RI Yoon, Dong Ki/C-9670-2011
OI Yoon, Dong Ki/0000-0002-9383-8958
FU National Research Foundation (NRF); Korean Government (MSIP)
   [2012M3A7B4049802, 2014M3C1A3052537]
FX This was supported by a grant from the National Research Foundation
   (NRF) and funded by the Korean Government (MSIP) (2012M3A7B4049802 and
   2014M3C1A3052537).
CR Becerril HA, 2009, CHEM SOC REV, V38, P329, DOI 10.1039/b718440a
   BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347
   Chen J., 2011, HDB VISUAL DISPLAY T
   Grote J., 2008, SPIE NEWSROOM, V1082
   Hwang SJ, 2007, J DISP TECHNOL, V3, P259, DOI 10.1109/JDT.2007.900920
   Katarzyna M., 2012, J NANOPHOTONICS, V6
   Kim SJ, 2013, ACS APPL MATER INTER, V5, P10715, DOI 10.1021/am402857w
   Kung H. C., 1995, J MAGN RESON SER B, V109, P323
   Lagerwall JPF, 2012, CURR APPL PHYS, V12, P1387, DOI 10.1016/j.cap.2012.03.019
   Lee Y.-J., 2013, J PHYS D, V46, P1
   Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0
   Lowe AM, 2012, CHEM MATER, V24, P746, DOI 10.1021/cm202632m
   Malone SM, 2011, LANGMUIR, V27, P11767, DOI 10.1021/la202640a
   Masahito Oh-E., 1997, LIQ CRYST, V22, P391
   Nakao H, 2003, NANO LETT, V3, P1391, DOI 10.1021/nl034620k
   Nakata M, 2008, LANGMUIR, V24, P10390, DOI 10.1021/la800639x
   Ohe M, 1996, APPL PHYS LETT, V69, P623, DOI 10.1063/1.117927
   Ohe M, 1995, APPL PHYS LETT, V67, P3895, DOI 10.1063/1.115309
   Ohzono T., 2014, NAT COMMUN, V5, P1
   Smalyukh II, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177801
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Wang YJ, 2002, J MATER SCI-MATER EL, V13, P173, DOI 10.1023/A:1014337518120
   Xu H, 2014, J PHYS CHEM B, V118, P4151, DOI 10.1021/jp501175h
   Yoon DK, 2012, LIQ CRYST, V39, P571, DOI 10.1080/02678292.2012.666809
NR 26
TC 15
Z9 15
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 24
PY 2015
VL 7
IS 24
BP 13627
EP 13632
DI 10.1021/acsami.5b03321
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CL6FO
UT WOS:000357063200061
PM 26066312
DA 2018-10-20
ER

PT J
AU Weaver, CL
   Cui, XT
AF Weaver, Cassandra L.
   Cui, Xinyan Tracy
TI Directed Neural Stem Cell Differentiation with a Functionalized Graphene
   Oxide Nanocomposite
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE graphene oxide; conducting polymer; neural stem cell; surface
   functionalization; neural biomaterial
ID GROWTH-FACTOR-AA; IN-VITRO; POLY(3,4-ETHYLENEDIOXYTHIOPHENE) PEDOT;
   NEURONAL DIFFERENTIATION; CONDUCTING POLYMERS; ELECTROCHEMICAL
   DEPOSITION; ENHANCED DIFFERENTIATION; LINEAGE DIFFERENTIATION;
   ELECTRICAL-ACTIVITY; ADULT HIPPOCAMPUS
AB Neural stem cell (NSC) transplantation has the potential to restore function to diseased or damaged nervous tissue, but poor control over cell survival, differentiation, and maturation limits therapeutic prospects. Engineered scaffolds that have the ability to drive neural stem cell behavior can address these limitations facing cell transplantation. Conducting polymers, which have the ability to electrically interface with cells, are attractive scaffolding candidates, but they lack the capacity for simple covalent modification, which would enable surface patterning of biomolecules. In this work, the NSC scaffolding performance of a nanocomposite composed of conducting polymer poly(3,4-ethylenedioxythiophene) (PEDOT) and graphene oxide (GO) nanosheets (GO/PEDOT) is investigated. The GO/PEDOT material is nontoxic and improves NSC differentiation toward the neuronal lineage. Biomolecules interferon- (IFN) and platelet-derived growth factor (PDGF) that selectively promote neuronal or oligodendrocyte lineage differentiation, respectively, are covalently cross-linked to the surface of the GO/PEDOT nanocomposite via carboxylic acid functional groups provided by GO using carbodiimide chemistry. The surfaces support a larger population of neurons when modified with IFN and a larger population of oligodendrocytes when modified by PDGF. This work demonstrates the customizability of GO/PEDOT for cell scaffolding applications and underlines its potential for controlling NSC behavior to improve therapeutic potential.
C1 [Weaver, Cassandra L.; Cui, Xinyan Tracy] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.
   [Weaver, Cassandra L.; Cui, Xinyan Tracy] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA.
   [Weaver, Cassandra L.; Cui, Xinyan Tracy] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.
RP Cui, XT (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.
EM xic11@pitt.edu
OI Cui, Xinyan/0000-0002-0470-2005
FU NSF [0748001, DGE-0549352]; University of Pittsburgh Provost's
   Development Fund
FX This work was supported by NSF Grant Nos. 0748001 and DGE-0549352 and
   the University of Pittsburgh Provost's Development Fund. Special thanks
   are given to the Nanoscale Fabrication and Characterization Facility at
   the University of Pittsburgh for access to material characterization
   instrumentation, the Center for Biological Imaging at the University of
   Pittsburgh for access to the scanning electron microscope, Lacey
   Cirinelli for assistance with cortical tissue dissection, and Jonathan
   Callan and Jaclyn LaRosa for assistance with cell culture.
CR Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Akhavan O, 2014, CARBON, V66, P395, DOI 10.1016/j.carbon.2013.09.015
   Alvarez-Buylla A., 2002, NEUROSCIENCE, V22, P629
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   Andressen C, 2013, CURR PHARM BIOTECHNO, V14, P20
   Asplund M, 2008, BIOINTERPHASES, V3, P83, DOI 10.1116/1.2998407
   BARRES BA, 1993, DEVELOPMENT, V118, P283
   Barreto JA, 2011, ADV MATER, V23, pH18, DOI 10.1002/adma.201100140
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Bianco A, 2013, ANGEW CHEM INT EDIT, V52, P4986, DOI 10.1002/anie.201209099
   BREDAS JL, 1985, ACCOUNTS CHEM RES, V18, P309, DOI 10.1021/ar00118a005
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Cul XT, 2007, IEEE T NEUR SYS REH, V15, P502, DOI 10.1109/TNSRE.2007.909811
   Deng M, 2011, SENSOR ACTUAT B-CHEM, V158, P176, DOI 10.1016/j.snb.2011.05.062
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002
   Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Han DH, 2005, ELECTROCHIM ACTA, V50, P3085, DOI 10.1016/j.electacta.2004.10.085
   Heo C, 2011, BIOMATERIALS, V32, P19, DOI 10.1016/j.biomaterials.2010.08.095
   Hong S. W., 2014, BIOMED RES INT, V2014
   Hu JG, 2008, NEUROSCIENCE, V151, P138, DOI 10.1016/j.neuroscience.2007.10.050
   Ibrahim M, 2005, INDIAN J PURE AP PHY, V43, P911
   Kandel E. R., 2013, PRINCIPLES NEURAL SC, P11709
   Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203
   Kennedy HJ, 2012, JARO-J ASSOC RES OTO, V13, P437, DOI 10.1007/s10162-012-0325-4
   Keung AJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01817
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x
   Kim SM, 2013, J BIOMED NANOTECHNOL, V9, P403, DOI 10.1166/jbn.2013.1511
   King ZA, 2011, POLYMER, V52, P1302, DOI 10.1016/j.polymer.2011.01.042
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Li N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01604
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Liu Y., 2013, SCI REP, V3, P3469
   Lu CH, 2013, BBA-GEN SUBJECTS, V1830, P4321, DOI 10.1016/j.bbagen.2012.08.028
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Luo XL, 2013, J MATER CHEM B, V1, P1340, DOI 10.1039/c3tb00006k
   Murugan AV, 2005, J MATER CHEM, V15, P902, DOI 10.1039/b414922j
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Niu L, 2001, SYNTHETIC MET, V122, P425, DOI 10.1016/S0379-6779(00)00562-2
   Osterholm A, 2012, ELECTROCHIM ACTA, V83, P463, DOI 10.1016/j.electacta.2012.07.121
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211
   Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Salto C, 2008, LANGMUIR, V24, P14133, DOI 10.1021/la8028337
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Shah S, 2014, ADV MATER, V26, P3673, DOI 10.1002/adma.201400523
   Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f
   Solanki A, 2013, ADV MATER, V25, P5477, DOI 10.1002/adma.201302219
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Song SH, 2002, NATURE, V417, P39
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tang ML, 2013, BIOMATERIALS, V34, P6402, DOI 10.1016/j.biomaterials.2013.05.024
   Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378
   Tian HC, 2014, BIOMATERIALS, V35, P2120, DOI 10.1016/j.biomaterials.2013.11.058
   Tu Q, 2013, ACS APPL MATER INTER, V5, P13188, DOI 10.1021/am4042004
   Tu Q, 2014, ANALYST, V139, P105, DOI 10.1039/c3an01796f
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   Vishwakarma SK, 2014, J ADV RES, V5, P277, DOI 10.1016/j.jare.2013.04.005
   Wade A, 2014, BBA-GEN SUBJECTS, V1840, P2520, DOI 10.1016/j.bbagen.2014.01.017
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   WARREN LF, 1989, J ELECTROCHEM SOC, V136, P2286, DOI 10.1149/1.2097303
   Weaver CL, 2014, ACS NANO, V8, P1834, DOI 10.1021/nn406223e
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009
   Yamamoto N, 2012, EUR J NEUROSCI, V35, P1595, DOI 10.1111/j.1460-9568.2012.08101.x
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zanden C, 2014, NANOMED-NANOTECHNOL, V10, P949, DOI 10.1016/j.nano.2014.01.010
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
   Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176
   Zhou K, 2012, ACS APPL MATER INTER, V4, P4524, DOI 10.1021/am3007565
   Zhu CZ, 2012, J MATER CHEM, V22, P6300, DOI 10.1039/c2jm16699b
NR 86
TC 27
Z9 28
U1 4
U2 101
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 24
PY 2015
VL 4
IS 9
BP 1408
EP 1416
DI 10.1002/adhm.201500056
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CL3EV
UT WOS:000356834000016
PM 25943251
OA Bronze
DA 2018-10-20
ER

PT J
AU Teodorescu, M
   Bercea, M
AF Teodorescu, Mirela
   Bercea, Maria
TI Poly(vinylpyrrolidone) - A Versatile Polymer for Biomedical and Beyond
   Medical Applications
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Drug-delivery; Membrane; Hydrogel; Poly(vinylpyrrolidone); Biomaterial;
   Film
ID ELECTRON-BEAM LITHOGRAPHY; LINKED POLYVINYLPYRROLIDONE NANOPARTICLES;
   LAYERED SILICATE NANOCOMPOSITES; GAS SEPARATION PROPERTIES;
   POVIDONE-IODINE; DRUG-DELIVERY; POLY(VINYL PYRROLIDONE); THIN-FILMS;
   SILVER NANOPARTICLES; NICKEL NANOPARTICLES
AB The high versatility of poly(vinylpyrrolidone) (PVP) can be explained by its diverse properties including its solubility in water and in a broad range of liquid media, high chemical and thermal resistance, and unique wetting, binding, and film-forming properties. Thanks to biocompatibility, absence of toxicity and high capacity to form interpolymer complexes, PVP is widely used for designing materials for different applications, such as biomaterials for medical and nonmedical uses. This review summarizes a vast diversity of applicative examples showing the tremendous opportunities for future research and developments of PVP based biomaterials.
C1 [Teodorescu, Mirela; Bercea, Maria] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
RP Teodorescu, M (reprint author), Petru Poni Inst Macromol Chem, 41-A Grigore Ghica Voda Alley, Iasi 700487, Romania.
EM teodorescu.mirela@icmpp.ro
RI Bercea, Maria/C-8378-2011
OI Bercea, Maria/0000-0003-0962-0372; Teodorescu,
   Mirela/0000-0002-6748-4789
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-ID-PCE-2011-3-0199, 300/2011]; European Union [264115 - STREAM]
FX This work was supported by a grant of the Romanian National Authority
   for Scientific Research, CNCS-UEFISCDI, Project Number
   PN-II-ID-PCE-2011-3-0199 (contract 300/2011), European Union's Seventh
   Framework Program (FP7/2007-2013) under grant agreement No. 264115 -
   STREAM.
CR Abbaszadeh F, 2014, J IND ENG CHEM, V20, P2895, DOI 10.1016/j.jiec.2013.11.025
   Abd El-Rehim HA, 2013, EUR POLYM J, V49, P601, DOI 10.1016/j.eurpolymj.2012.12.002
   ABDELAZIM AAA, 1993, POLYM J, V25, P671, DOI 10.1295/polymj.25.671
   Ahmed MA, 2013, J ALLOY COMPD, V578, P121, DOI 10.1016/j.jallcom.2013.04.182
   Al Malek SA, 2012, DESALINATION, V288, P31, DOI 10.1016/j.desal.2011.12.006
   Albrecht W, 2007, J MEMBRANE SCI, V291, P10, DOI 10.1016/j.memsci.2006.12.014
   Ali MS, 2010, COLLOID SURFACE B, V75, P590, DOI 10.1016/j.colsurfb.2009.10.002
   Alpatova A, 2013, J MEMBRANE SCI, V444, P449, DOI 10.1016/j.memsci.2013.05.034
   Altecor A, 2014, CERAM INT, V40, P5073, DOI 10.1016/j.ceramint.2013.09.067
   ANDERSON CC, 1979, J APPL POLYM SCI, V23, P2453, DOI 10.1002/app.1979.070230823
   APT L, 1984, ARCH OPHTHALMOL-CHIC, V102, P728, DOI 10.1001/archopht.1984.01040030584025
   APT L, 1989, OPHTHALMOLOGY, V96, P289, DOI 10.1016/S0161-6420(89)32897-1
   Ashot M, 1967, U.S. Patent, Patent No. [3350366 A, 3350366]
   Aytimur A, 2013, POLYM-PLAST TECHNOL, V52, P661, DOI 10.1080/03602559.2012.762662
   Babcock DE, 2013, BIOMATERIALS, V34, P3196, DOI 10.1016/j.biomaterials.2013.01.040
   Bailly N, 2012, BIOMACROMOLECULES, V13, P4109, DOI 10.1021/bm301410d
   Banerjee S, 2014, INT J ADHES ADHES, V50, P70, DOI 10.1016/j.ijadhadh.2014.01.001
   Barzin J, 2004, J APPL POLYM SCI, V92, P3804, DOI 10.1002/app.20395
   BENEVENTO WJ, 1990, AM J OPHTHALMOL, V109, P329, DOI 10.1016/S0002-9394(14)74560-X
   Bharali DJ, 2003, J COLLOID INTERF SCI, V258, P415, DOI 10.1016/S0021-9797(02)00099-1
   Bian FL, 2009, CARBOHYD POLYM, V76, P454, DOI 10.1016/j.carbpol.2008.11.008
   Blosi M, 2012, DYES PIGMENTS, V94, P355, DOI 10.1016/j.dyepig.2012.01.006
   Bolong N, 2009, J MEMBRANE SCI, V331, P40, DOI 10.1016/j.memsci.2009.01.008
   Brandrup J., 1999, POLYM HDB
   Buhler V., 2008, KOLLIDON POLYVINYLPY
   Burkert S, 2007, J APPL POLYM SCI, V106, P534, DOI 10.1002/app.26592
   Burks RI, 1998, PHYS THER, V78, P212, DOI 10.1093/ptj/78.2.212
   Buttini F, 2008, J PHARM SCI-US, V97, P1257, DOI 10.1002/jps.21126
   Chakrabarty B, 2008, J MEMBRANE SCI, V315, P36, DOI 10.1016/j.memsci.2008.02.027
   Chan K, 2006, POLYMER, V47, P6941, DOI 10.1016/j.polymer.2006.07.068
   Chao S, 2012, MATER RES BULL, V47, P907, DOI 10.1016/j.materresbull.2011.09.012
   Chaudhary U, 1998, J Indian Med Assoc, V96, P202
   Chen MJ, 2012, POLYMER, V53, P4501, DOI 10.1016/j.polymer.2012.07.046
   Cheng YT, 2011, MICROELECTRON ENG, V88, P929, DOI 10.1016/j.mee.2010.12.020
   Choi S, 2013, CARBON, V60, P254, DOI 10.1016/j.carbon.2013.04.034
   Choi S, 2013, MATER LETT, V90, P87, DOI 10.1016/j.matlet.2012.09.035
   Chun MK, 2005, INT J PHARM, V288, P295, DOI 10.1016/j.ijpharm.2004.10.016
   Chun MK, 2004, J APPL POLYM SCI, V94, P2390, DOI 10.1002/app.21176
   Chun MK, 2002, J CONTROL RELEASE, V81, P327, DOI 10.1016/S0168-3659(02)00078-0
   Ciulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5
   Couto GG, 2007, J COLLOID INTERF SCI, V311, P461, DOI 10.1016/j.jcis.2007.03.045
   Covaliu CI, 2013, POWDER TECHNOL, V237, P415, DOI 10.1016/j.powtec.2012.12.037
   Dafader NC, 2005, POLYM-PLAST TECHNOL, V44, P1339, DOI 10.1080/03602550500208202
   Dafader NC, 2005, POLYM-PLAST TECHNOL, V44, P243, DOI 10.1081/PTE-200048678
   Dai XY, 2012, J MATER SCI-MATER M, V23, P2709, DOI 10.1007/s10856-012-4728-x
   Das S. K., 2008, J INDIAN MED ASSOC, V106, P592
   Das Sibes Kumar, 2008, J Indian Med Assoc, V106, P589
   del Consuelo ID, 2007, J CONTROL RELEASE, V122, P135, DOI 10.1016/j.jconrel.2007.05.017
   Du ZH, 2009, J SOLID STATE CHEM, V182, P1780, DOI 10.1016/j.jssc.2009.04.021
   ELIAS HG, 1961, MAKROMOLEKUL CHEM, V50, P1
   Farm E, 2010, J ELECTROCHEM SOC, V157, pK10, DOI 10.1149/1.3250936
   Fechine GJM, 2004, POLYMER, V45, P4705, DOI 10.1016/j.polymer.2004.05.006
   Feng XM, 2010, CHINESE J CHEM, V28, P1359, DOI 10.1002/cjoc.201090232
   Feng Y, 2013, CERAM INT, V39, P7551, DOI 10.1016/j.ceramint.2013.03.007
   FLORY PJ, 1951, J AM CHEM SOC, V73, P1904, DOI 10.1021/ja01149a002
   Folttmann B.H., 2008, DRUG DELIV TECHNOL, V8, P22
   FOSTER A, 1995, NEW ENGL J MED, V332, P600, DOI 10.1056/NEJM199503023320911
   FRANK HP, 1953, J POLYM SCI, V10, P371, DOI 10.1002/pol.1953.120100402
   Frank Y.X., 2011, US Patent, Patent No. [WO2011094672 A2, 2011094672]
   Furukawa Kiyonori, 2004, Journal of Nippon Medical School, V71, P190, DOI 10.1272/jnms.71.190
   Ganesan S, 2003, MODERN PATHOL, V16, P286, DOI 10.1097/01.MP.0000062653.65441.DA
   Gatti S, 1998, ANTIMICROB AGENTS CH, V42, P2232, DOI 10.1128/AAC.42.9.2232
   Gokmese F, 2013, POLYM-PLAST TECHNOL, V52, P1259, DOI 10.1080/03602559.2013.814144
   Gong K, 2005, J PHARM SCI-US, V94, P2583, DOI 10.1002/jps.20474
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   HAAF F, 1985, POLYM J, V17, P143, DOI 10.1295/polymj.17.143
   Halake K., 2014, J IND ENG CHEM, V1843, P1
   Han MJ, 2002, J MEMBRANE SCI, V202, P55, DOI 10.1016/S0376-7388(01)00718-9
   HARPER BG, 1972, Patent No. 3669103
   Hayama M, 2004, BIOMATERIALS, V25, P1019, DOI 10.1016/S0142-9612(03)00629-X
   He TC, 2009, PHYS LETT A, V373, P592, DOI 10.1016/j.physleta.2008.12.002
   HENGLEIN A, 1959, J PHYS CHEM-US, V63, P1852, DOI 10.1021/j150581a016
   Hida Y, 2005, THIN SOLID FILMS, V476, P264, DOI 10.1016/j.tsf.2004.09.063
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Hita-Iglesias P, 2006, INT J ORAL MAX SURG, V35, P514, DOI 10.1016/j.ijom.2005.12.004
   Hosono H, 2006, NANOMATERIALS RES AP
   Hossen MK, 2008, POLYM-PLAST TECHNOL, V47, P662, DOI 10.1080/03602550802129528
   Howe KS, 2013, INT J HYDROGEN ENERG, V38, P1731, DOI 10.1016/j.ijhydene.2012.08.105
   Huang CC, 2011, BIOMATERIALS, V32, P556, DOI 10.1016/j.biomaterials.2010.08.114
   Huang JH, 2006, CRYST GROWTH DES, V6, P1528, DOI 10.1021/cg050310z
   Huang Z, 2008, TECHNOL CANCER RES T, V7, P309, DOI 10.1177/153303460800700405
   Ibrahim NA, 2013, CARBOHYD POLYM, V94, P612, DOI 10.1016/j.carbpol.2013.01.040
   ILIOPOULOS I, 1991, MACROMOLECULES, V24, P2566, DOI 10.1021/ma00009a066
   Ishiduki K, 1997, LANGMUIR, V13, P1587, DOI 10.1021/la960804l
   Ismail AF, 2007, SEP PURIF TECHNOL, V55, P98, DOI 10.1016/j.seppur.2006.11.002
   Jain P, 2010, INT J PHARMACEUT, V394, P68, DOI 10.1016/j.ijpharm.2010.04.042
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Jin WJ, 2005, MACROMOL RAPID COMM, V26, P1903, DOI 10.1002/marc.200500569
   Jing CB, 2007, J NON-CRYST SOLIDS, V353, P4128, DOI 10.1016/j.jnoncrysol.2007.06.040
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 2005, BIOMATERIALS, V26, P2013, DOI 10.1016/j.biomaterials.2004.06.001
   Jones SA, 2006, J PHARM SCI-US, V95, P1060, DOI 10.1002/jps.20608
   Jung YJ, 2011, SYNTHETIC MET, V161, P1991, DOI 10.1016/j.synthmet.2011.07.009
   Kadlubowski S, 2007, POLYMER, V48, P4974, DOI 10.1016/j.polymer.2007.06.033
   Kadlubowski S, 2014, RADIAT PHYS CHEM, V102, P29, DOI 10.1016/j.radphyschem.2014.04.016
   Kalimuthan Ramanujam, 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P1989
   Kamada H, 2003, NAT BIOTECHNOL, V21, P399, DOI 10.1038/nbt798
   Kaneda Y, 2004, BIOMATERIALS, V25, P3259, DOI 10.1016/j.biomaterials.2003.10.003
   Kang JS, 2002, J APPL POLYM SCI, V85, P57, DOI 10.1002/app.10569
   Kang K, 2011, TOXICOL LETT, V205, P227, DOI 10.1016/j.toxlet.2011.05.1033
   Kang N, 2004, POLYMER, V45, P8967, DOI 10.1016/j.polymer.2004.10.081
   Kariduraganavar MY, 2014, NATURAL AND SYNTHETIC BIOMEDICAL POLYMERS, P1
   Kaynar MB, 2013, POWDER TECHNOL, V233, P331, DOI 10.1016/j.powtec.2012.09.009
   Khan WS, 2013, INT J THERM SCI, V71, P74, DOI 10.1016/j.ijthermalsci.2013.03.006
   Kim JW, 2011, MICROELECTRON ENG, V88, P797, DOI 10.1016/j.mee.2010.07.002
   Kim YK, 2005, J MEMBRANE SCI, V251, P159, DOI 10.1016/j.memsci.2004.11.011
   Kim YK, 2004, J MEMBRANE SCI, V243, P9, DOI 10.1016/j.memsci.2004.05.001
   KIRSH YE, 1979, EUR POLYM J, V15, P223, DOI 10.1016/0014-3057(79)90166-6
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kodaira H, 2004, BIOMATERIALS, V25, P4309, DOI 10.1016/j.biomaterials.2003.01.097
   Koga S, 2010, J MEMBRANE SCI, V355, P208, DOI 10.1016/j.memsci.2010.03.032
   Koo CM, 2003, POLYMER, V44, P681, DOI 10.1016/S0032-3861(02)00803-0
   Kopolow L.S., 2003, US Patent, Patent No. [US6641259, 66412592003]
   Koseoglu-Imer DY, 2013, DESALINATION, V316, P110, DOI 10.1016/j.desal.2013.02.011
   Kozuka H, 2004, J EUR CERAM SOC, V24, P1585, DOI 10.1016/S0955-2219(03)00402-3
   Kubin A, 2008, PHARMAZIE, V63, P263, DOI 10.1691/ph.2008.7292
   Kubota S, 2014, J SUPERCRIT FLUID, V86, P33, DOI 10.1016/j.supflu.2013.11.013
   Kudaibergenov SE, 2000, POLYM ADVAN TECHNOL, V11, P506
   Lachapelle JM, 2005, CONTACT DERMATITIS, V52, P9, DOI 10.1111/j.0105-1873.2005.00479.x
   Laforgue A, 2011, J POWER SOURCES, V196, P559, DOI 10.1016/j.jpowsour.2010.07.007
   LAFRENIERE LY, 1987, IND ENG CHEM RES, V26, P2385, DOI 10.1021/ie00071a035
   Lee BM, 2011, J NANOSCI NANOTECHNO, V11, P7390, DOI 10.1166/jnn.2011.4803
   Lee HJ, 2007, J MEMBRANE SCI, V296, P139, DOI 10.1016/j.memsci.2007.03.025
   Leiva A, 2007, J COLLOID INTERF SCI, V310, P136, DOI 10.1016/j.jcis.2007.01.013
   Lele BS, 2002, MACROMOLECULES, V35, P6714, DOI 10.1021/ma020433h
   Lin H, 2013, J SOLID STATE CHEM, V204, P266, DOI 10.1016/j.jssc.2013.06.020
   Liu C, 2012, INT J ELECTROCHEM SC, V7, P7152
   LOFTSSON T, 1994, INT J PHARM, V110, P169, DOI 10.1016/0378-5173(94)90155-4
   Lopes CMA, 2003, BIOMATERIALS, V24, P1279, DOI 10.1016/S0142-9612(02)00448-9
   Lu CM, 2007, POLYM ENG SCI, V47, P830, DOI 10.1002/pen.20763
   Lu XF, 2005, MACROMOL RAPID COMM, V26, P1325, DOI 10.1002/marc.200500300
   Luo YL, 2010, J BIOACT COMPAT POL, V25, P292, DOI 10.1177/0883911510362459
   Luo YP, 2013, FORENSIC SCI INT, V229, P75, DOI 10.1016/j.forsciint.2013.03.045
   Madaeni SS, 2011, DESALINATION, V280, P305, DOI 10.1016/j.desal.2011.07.020
   Matatagui D, 2014, TALANTA, V120, P408, DOI 10.1016/j.talanta.2013.12.027
   Matsuda M, 2008, J MEMBRANE SCI, V310, P219, DOI 10.1016/j.memsci.2007.10.054
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Messager S, 2004, J HOSP INFECT, V58, P115, DOI 10.1016/j.jhin.2004.06.001
   Mestre S, 2012, J EUR CERAM SOC, V32, P2825, DOI 10.1016/j.jeurceramsoc.2011.12.006
   MEZA R, 1977, EUR POLYM J, V13, P235, DOI 10.1016/0014-3057(77)90119-7
   Misra N., 2013, ADV MAT LETT, V4, P458
   Moga KA, 2013, ADV MATER, V25, P5060, DOI 10.1002/adma.201300526
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Momesso RGRAP, 2010, RADIAT PHYS CHEM, V79, P283, DOI 10.1016/j.radphyschem.2009.08.039
   Montazer M, 2012, PROG ORG COAT, V75, P379, DOI 10.1016/j.porgcoat.2012.07.011
   Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036
   Morozov VN, 2012, J MEMBRANE SCI, V403, P110, DOI 10.1016/j.memsci.2012.02.028
   Narayanan M, 2010, MATER LETT, V64, P22, DOI 10.1016/j.matlet.2009.09.059
   Neiva EGC, 2014, SENSOR ACTUAT B-CHEM, V196, P574, DOI 10.1016/j.snb.2014.02.041
   Ng SL, 2011, BIOMATERIALS, V32, P6277, DOI 10.1016/j.biomaterials.2011.05.011
   Nischala K, 2011, COLLOID SURFACE B, V82, P203, DOI 10.1016/j.colsurfb.2010.08.039
   Noh H, 2012, POLYM-KOREA, V36, P190, DOI 10.7317/pk.2012.36.2.190
   NPCS Board of Consultants & Engineers, 2009, COMPL BOOK WAT SOL P
   Oechsner M, 1999, EUR J PHARM BIOPHARM, V47, P113, DOI 10.1016/S0939-6411(98)00070-8
   Ohm A, 2000, EUR J PHARM BIOPHARM, V49, P183, DOI 10.1016/S0939-6411(99)00080-6
   Omastova M, 2014, ELECTROCHIM ACTA, V122, P296, DOI 10.1016/j.electacta.2013.11.037
   Onlaor K., 2014, ORG ELECTRON, V15, P1
   Park JY, 2012, COLOR TECHNOL, V128, P184, DOI 10.1111/j.1478-4408.2012.00370.x
   Park JG, 2012, ELECTROCHIM ACTA, V85, P600, DOI 10.1016/j.electacta.2012.07.110
   Park O., 2003, FUNCTION FOUNTAIN SO
   Park SH, 2014, THIN SOLID FILMS, V550, P575, DOI 10.1016/j.tsf.2013.11.075
   Patel HA, 2011, APPL CLAY SCI, V51, P126, DOI 10.1016/j.clay.2010.11.013
   Pawar IA, 2014, ULTRASON SONOCHEM, V21, P1108, DOI 10.1016/j.ultsonch.2013.12.013
   Penjweini R, 2014, BBA-MOL CELL RES, V1843, P855, DOI 10.1016/j.bbamcr.2014.01.016
   Penjweini R, 2013, J PHOTOCH PHOTOBIO B, V120, P120, DOI 10.1016/j.jphotobiol.2012.12.013
   Pinteala M, 2005, POLYMER, V46, P7047, DOI 10.1016/j.polymer.2005.05.099
   Qiao JL, 2010, POLYMER, V51, P4850, DOI 10.1016/j.polymer.2010.08.018
   Quan J, 2011, COLLOID SURFACE B, V88, P304, DOI 10.1016/j.colsurfb.2011.07.006
   Raghavan SL, 2001, INT J PHARM, V212, P213, DOI 10.1016/S0378-5173(00)00610-4
   Raimi-Abraham BT, 2014, MAT SCI ENG C-MATER, V39, P168, DOI 10.1016/j.msec.2014.02.016
   Rajeswari N, 2011, J NON-CRYST SOLIDS, V357, P3751, DOI 10.1016/j.jnoncrysol.2011.07.037
   RAO VVRN, 1987, POLYMER, V28, P648, DOI 10.1016/0032-3861(87)90482-4
   Ravi M, 2011, MATER CHEM PHYS, V130, P442, DOI 10.1016/j.matchemphys.2011.07.006
   Reddy CVS, 2006, MICROELECTRON ENG, V83, P281, DOI 10.1016/j.mee.2005.08.010
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Rodriguez J, 2013, J POWER SOURCES, V237, P270, DOI 10.1016/j.jpowsour.2013.03.043
   Ruecha N, 2014, BIOSENS BIOELECTRON, V52, P13, DOI 10.1016/j.bios.2013.08.018
   Saxena A, 2006, BIOMATERIALS, V27, P5596, DOI 10.1016/j.biomaterials.2006.06.029
   Schildknecht C. E., 1953, U. S. Patent, Patent No. [2658045A, 2658045]
   Schmidt T, 2006, MACROMOL MATER ENG, V291, P755, DOI 10.1002/mame.200600057
   Schulz M, 2010, EUR J PHARM SCI, V41, P675, DOI 10.1016/j.ejps.2010.09.011
   Schwartz J.A., 2004, DEKKER ENCY NANOSCIE, V2
   Schwarz W., 1990, PVP CRITICAL REV KIN
   Scoutaris N, 2011, J CONTROL RELEASE, V156, P179, DOI 10.1016/j.jconrel.2011.07.033
   Seabra AB, 2004, BIOMATERIALS, V25, P3773, DOI 10.1016/j.biomaterials.2003.10.035
   Sebe I, 2013, INT J PHARMACEUT, V458, P99, DOI 10.1016/j.ijpharm.2013.10.011
   Sequaris JM, 2000, J COLLOID INTERF SCI, V230, P73, DOI 10.1006/jcis.2000.7046
   Immich APS, 2011, J APPL POLYM SCI, V119, P2560, DOI 10.1002/app.32980
   Immich APS, 2011, POLYM ENG SCI, V51, P445, DOI 10.1002/pen.21845
   Sheng LF, 2011, BIOSENS BIOELECTRON, V26, P3494, DOI 10.1016/j.bios.2011.01.032
   Shi ZQ, 2010, SYNTHETIC MET, V160, P2121, DOI 10.1016/j.synthmet.2010.07.042
   Shuping J., 2005, EUR POLYM J, V41, P2406
   Singh R, 2012, J MATER SCI-MATER M, V23, P2649, DOI 10.1007/s10856-012-4730-3
   Slistan-Grijalva A, 2008, MATER RES BULL, V43, P90, DOI 10.1016/j.materresbull.2007.02.013
   Smith LE, 2006, BIOMATERIALS, V27, P2806, DOI 10.1016/j.biomaterials.2005.12.018
   Sneader W, 2005, DRUG DISCOVERY: A HISTORY, P1, DOI 10.1002/0470015535
   Song JF, 2011, MAT SCI ENG A-STRUCT, V528, P5421, DOI 10.1016/j.msea.2011.03.078
   Svanholm E., 2007, THESIS KARLSTAD U KA
   Szczerba M, 2010, APPL CLAY SCI, V47, P235, DOI 10.1016/j.clay.2009.10.015
   Tan CKI, 2012, CERAM INT, V38, P2513, DOI 10.1016/j.ceramint.2011.11.021
   Tan HB, 2011, T NONFERR METAL SOC, V21, P1563, DOI 10.1016/S1003-6326(11)60897-2
   Traini D, 2012, INT J PHARMACEUT, V438, P150, DOI 10.1016/j.ijpharm.2012.08.036
   Traynor MJ, 2011, INT J PHARMACEUT, V410, P9, DOI 10.1016/j.ijpharm.2011.02.053
   Tseng TT, 2009, CERAM INT, V35, P2837, DOI 10.1016/j.ceramint.2009.03.028
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Ummartyotin S, 2012, CR PHYS, V13, P994, DOI 10.1016/j.crhy.2012.09.008
   Uslu I, 2012, J APPL POLYM SCI, V124, P3520, DOI 10.1002/app.35525
   Vakalopoulos KA, 2013, J SURG RES, V180, P290, DOI 10.1016/j.jss.2012.12.043
   Vatsha B, 2014, PHYS CHEM EARTH, V67-69, P125, DOI 10.1016/j.pce.2013.09.021
   Veeren A, 2013, EUR POLYM J, V49, P3034, DOI 10.1016/j.eurpolymj.2013.06.020
   Venkatathri N, 2007, SOLID STATE COMMUN, V143, P493, DOI 10.1016/j.ssc.2007.06.017
   Verma RK, 2003, INT J PHARMACEUT, V263, P9, DOI 10.1016/S0378-5173(03)00360-0
   Vigh T, 2013, EUR J PHARM SCI, V49, P595, DOI 10.1016/j.ejps.2013.04.034
   Wahyudiono, 2014, CHEM ENG PROCESS, V77, P1, DOI 10.1016/j.cep.2013.12.007
   Wang BL, 2012, CARBOHYD POLYM, V90, P8, DOI 10.1016/j.carbpol.2012.03.080
   Wang GR, 2013, INT J ADHES ADHES, V41, P198, DOI 10.1016/j.ijadhadh.2012.11.010
   Wang HT, 2009, FIBER POLYM, V10, P1, DOI 10.1007/s12221-009-0001-4
   Wang L, 2009, COLLOID SURFACE B, V74, P284, DOI 10.1016/j.colsurfb.2009.07.032
   Wang MC, 2014, POLYMER, V55, P2188, DOI 10.1016/j.polymer.2014.02.035
   Wang SB, 2007, MATER CHEM PHYS, V102, P255, DOI 10.1016/j.matchemphys.2006.12.014
   Wei SF, 2009, APPL SURF SCI, V255, P6978, DOI 10.1016/j.apsusc.2009.03.023
   Wiesner VL, 2014, J EUR CERAM SOC, V34, P453, DOI 10.1016/j.jeurceramsoc.2013.08.017
   Yadav PS, 2013, SAUDI PHARM J, V21, P77, DOI 10.1016/j.jsps.2011.12.007
   Yamazaki K, 2012, J MEMBRANE SCI, V396, P38, DOI 10.1016/j.memsci.2011.12.016
   Yan E, 2006, MATER LETT, V60, P2969, DOI 10.1016/j.matlet.2006.02.045
   Yanai Ryoji, 2006, Cont Lens Anterior Eye, V29, P85, DOI 10.1016/j.clae.2006.02.006
   Yanez F, 2008, EUR J PHARM BIOPHARM, V69, P1094, DOI 10.1016/j.ejpb.2008.01.023
   Yang MY, 2014, INT J PHARMACEUT, V465, P187, DOI [10.1016/i.ijpharm.2014.02.021, 10.1016/j.ijpharm.2014.02.021]
   Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904
   Zabska M, 2011, RADIAT PHYS CHEM, V80, P1125, DOI 10.1016/j.radphyschem.2011.02.019
   Zhai DD, 2013, COLLOID SURFACE A, V424, P1, DOI 10.1016/j.colsurfa.2013.01.055
   Zhang H, 2007, J CRYST GROWTH, V304, P206, DOI 10.1016/j.jcrysgro.2007.01.043
   Zhang JY, 2014, J SOLID STATE CHEM, V213, P210, DOI 10.1016/j.jssc.2014.03.004
   Zhang L, 2008, OPT LASER TECHNOL, V40, P282, DOI 10.1016/j.optlastec.2007.05.002
   Zhang YF, 2007, SCRIPTA MATER, V56, P409, DOI 10.1016/j.scriptamat.2006.10.032
   Zhang ZH, 2011, DESALINATION, V269, P239, DOI 10.1016/j.desal.2010.10.066
   Zhi X, 2013, BIOMATERIALS, V34, P5254, DOI 10.1016/j.biomaterials.2013.03.024
   Zhu YF, 2005, MICROPOR MESOPOR MAT, V84, P218, DOI 10.1016/j.micromeso.2005.05.001
   Zhu ZS, 2010, J CONTROL RELEASE, V142, P438, DOI 10.1016/j.jconrel.2009.11.002
NR 239
TC 20
Z9 21
U1 6
U2 65
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-2559
EI 1525-6111
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PD JUN 23
PY 2015
VL 54
IS 9
BP 923
EP 943
DI 10.1080/03602559.2014.979506
PG 21
WC Polymer Science
SC Polymer Science
GA CJ5AW
UT WOS:000355500800001
DA 2018-10-20
ER

PT J
AU Da Silva, GR
   Lima, TH
   Orefice, RL
   Fernandes-Cunha, GM
   Silva-Cunha, A
   Zhao, M
   Behar-Cohen, F
AF Da Silva, Gisele Rodrigues
   Lima, Tadeu Henrique
   Orefice, Rodrigo Lambert
   Fernandes-Cunha, Gabriella Maria
   Silva-Cunha, Armando
   Zhao, Min
   Behar-Cohen, Francine
TI In vitro and in vivo ocular biocompatibility of electrospun
   poly(epsilon-caprolactone) nanofibers
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Poly(epsilon-caprolactone) nanofibers; Electrospinning; In vitro and in
   vivo ocular biocompatibility; Retinal pigment epithelial cells (ARPE-19
   cells); Muller glial cells (MIO-M1 cells)
ID POLY-EPSILON-CAPROLACTONE; STEM-CELLS; SCAFFOLDS; FABRICATION;
   DIFFERENTIATION; EXPRESSION; GROWTH
AB Biocompatibility is a requirement for the development of nanofibers for ophthalmic applications. In this study, nanofibers were elaborated using poly(epsilon-caprolactone) via electrospinning. The ocular biocompatibility of this material was investigated. MIO-M1 and ARPE-19 cell cultures were incubated with nanofibers and cellular responses were monitored by viability and morphology. The in vitro biocompatibility revealed that the nanofibers were not cytotoxic to the ocular cells. These cells exposed to the nanofibers proliferated and formed an organized monolayer. ARPE-19 and MIO-M1 cells were capable of expressing GFAP, respectively, demonstrating their functionality. Nanofibers were inserted into the vitreous cavity of the rat's eye for 10 days and the in vivo biocompatibility was investigated using Optical Coherence Tomography (OCT), histology and measuring the expression of pro-inflammatory genes (IL-1 beta, TNF-alpha, VEGF and iNOS) (real-time PCR). The OCT and the histological analyzes exhibited the preserved architecture of the tissues of the eye. The biomaterial did not elicit an inflammatory reaction and pro-inflammatory cytokines were not expressed by the retinal cells, and the other posterior tissues of the eye. Results from the biocompatibility studies indicated that the nanofibers exhibited a high degree of cellular biocompatibility and short-term intraocular tolerance, indicating that they might be applied as drug carrier for ophthalmic use. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Da Silva, Gisele Rodrigues] Fed Univ Sao Joao del Rey, Sch Pharm, BR-35501296 Divinopolis, MG, Brazil.
   [Lima, Tadeu Henrique; Orefice, Rodrigo Lambert] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
   [Fernandes-Cunha, Gabriella Maria; Silva-Cunha, Armando] Univ Fed Minas Gerais, Fac Pharm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Zhao, Min; Behar-Cohen, Francine] INSERM, Ctr Rech Cordeliers, Team 17, U872, F-75006 Paris, France.
   [Zhao, Min; Behar-Cohen, Francine] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.
   [Behar-Cohen, Francine] Hotel Dieu Paris, AP HP, F-75004 Paris, France.
RP Da Silva, GR (reprint author), Ave Sebastiao Goncalves Coelho 400, BR-35500296 Divinopolis, MG, Brazil.
EM giselersilva@ufsj.edu.br; thenriquel@yahoo.com; rorefice@demet.ufmg.br;
   gabriellafcunha@gmail.com; armando@farmacia.ufmg.br; elodiecn@gmail.com;
   francine.behar@gmail.com
RI Cunha, Armando/G-1157-2012; Orefice, Rodrigo/N-8055-2018
OI Cunha, Armando/0000-0002-1161-8936; Orefice, Rodrigo/0000-0002-6046-4056
FU UFSJ (Brazil); CNPq/MCT (Brazil); Fapemig (Brazil); CAPES (Bolsistas da
   CAPES-Brasilia/Brazil)
FX The authors wish to thank the UFSJ (Brazil), CNPq/MCT (Brazil), Fapemig
   (Brazil) and CAPES (Bolsistas da CAPES-Brasilia/Brazil) for the
   financial support.
CR Bakhshandeh H, 2011, INT J NANOMED, V6, P1509, DOI 10.2147/IJN.S19011
   Bernards DA, 2013, J OCUL PHARMACOL TH, V29, P249, DOI 10.1089/jop.2012.0152
   Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001
   Buchtova N, 2013, J MATER SCI-MATER M, V24, P1875, DOI 10.1007/s10856-013-4951-0
   Chaturvedi T.P., 2013, METHOD MOL BIOL, V1014, P187
   Ding XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007410
   Du J, 2014, CARBOHYD POLYM, V99, P483, DOI 10.1016/j.carbpol.2013.08.050
   Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507
   Ford KM, 2012, MOL VIS, V18, P519
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   He XM, 2013, REGEN MED, V8, P425, DOI 10.2217/rme.13.29
   Holan Vladimir, 2013, Methods Mol Biol, V1014, P187, DOI 10.1007/978-1-62703-432-6_13
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Hwang Y.S., 2013, PLOS ONE, V1-8
   Ishii D, 2009, MATERIALS, V2, P1520, DOI 10.3390/ma2041520
   Kim JY, 2009, MICROELECTRON ENG, V86, P1447, DOI 10.1016/j.mee.2008.11.026
   Kocabey S, 2013, ACTA BIOMATER, V9, P9075, DOI 10.1016/j.actbio.2013.07.007
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864
   Liu JF, 2014, INT J NANOMED, V9, P197, DOI 10.2147/IJN.S55875
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003
   Moriarty P, 2001, REP PROG PHYS, V64, P297, DOI 10.1088/0034-4885/64/3/201
   Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1016/CIRCULATIONAHA.104.503706
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Shabani I, 2014, ACS APPL MATER INTER, V6, P72, DOI 10.1021/am404500c
   Shao-Fen L, 2013, INT J OPHTHALMOL, V6, P559
   Sharma S, 2011, MOL VIS, V17, P2898
   Silva G.R., 2011, INT J ARTIF ORGANS, V34, P198
   Sohrabi A, 2013, POLYMER, V54, P2699, DOI 10.1016/j.polymer.2013.03.046
   Son YJ, 2014, ARCH PHARM RES, V37, P69, DOI 10.1007/s12272-013-0284-2
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Subramanian A, 2012, J MATER SCI-MATER M, V23, P1797, DOI 10.1007/s10856-012-4654-y
   Touseef A., 2013, MAT SCI ENG C, V33, P707
   TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867
   Wang F, 2013, J BIOMAT SCI-POLYM E, V24, P769, DOI 10.1080/09205063.2012.712029
NR 38
TC 15
Z9 15
U1 2
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JUN 20
PY 2015
VL 73
BP 9
EP 19
DI 10.1016/j.ejps.2015.03.003
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CI8NT
UT WOS:000355029700002
PM 25797289
DA 2018-10-20
ER

PT J
AU Silva, MBR
   Gallego, J
   Cabrera, JM
   Balancin, O
   Jorge, AM
AF Silva, M. B. R.
   Gallego, J.
   Cabrera, J. M.
   Balancin, O.
   Jorge, A. M., Jr.
TI Interaction between recrystallization and strain-induced precipitation
   in a high Nb- and N-bearing austenitic stainless steel: Influence of the
   interpass time
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Hot mechanical behavior; Recrystallization; Grain refinement; Niobium;
   Precipitation; Stainless steel
ID NIOBIUM MICROALLOYED STEEL; DYNAMIC RECRYSTALLIZATION; HIGH-NITROGEN;
   DEFORMATION CONDITIONS; HOT; TEMPERATURE; BIOMATERIAL; COLD
AB In this work, we studied the influence of the interpass time (20 and 5 s) on the interaction between recrystallization and strain-induced precipitation occurring during multiple passes' deformations under continuous cooling conditions in a high niobium- and nitrogen-bearing austenitic stainless steel (ISO 5832-9). The correlation between microstructure evolution and hot mechanical properties was performed by physical simulation using hot torsion tests. The microstructure evolution was analyzed by optical microscopy, transmission electron microscopy and electron back scattered diffraction (EBSD). This technique indicated that dynamic recrystallization occurred at the first passes promoting an excellent grain refinement. On the other hand, shorter interpass time (5 s) allowed higher volume fraction of smallest precipitates than larger interpass time (20 s). After soaking, only TiNbN precipitates were found, whereas, Z-phase (CrNbN) and NbN were formed during thermomechanical processing. Particles with sizes between 20 and 50 nm were effective to pin grain boundaries and dislocations. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Silva, M. B. R.; Balancin, O.; Jorge, A. M., Jr.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   [Gallego, J.] UNESP, Dept Mech Engn, BR-15385000 Ilha Solteira, SP, Brazil.
   [Cabrera, J. M.] Univ Politecn Cataluna, Dept Mat Sci & Met Engn, E-08028 Barcelona, Spain.
   [Cabrera, J. M.] Fundacio CTM Ctr Tecnol, Manresa 08243, Spain.
RP Silva, MBR (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Via Washington Luis,Km 235, BR-13565905 Sao Carlos, SP, Brazil.
EM marianabdrs@gmail.com; moreira@dema.ufscar.br
RI Gallego, Juno/G-1908-2012; Jorge Junior, Alberto/B-2566-2012
OI Gallego, Juno/0000-0002-5477-8139; Jorge Junior,
   Alberto/0000-0002-8121-9834
FU CNPq, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
   [506440/2013-3]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) [179/09]; CNPq (Brazil) [179/09]; Ministerio de Educacion
   (Spain) [179/09]
FX The authors are grateful to CNPq, (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) under the grant CNPq# 506440/2013-3, FAPESP
   (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), under the
   grant CAPES#179/09 for the financial support received in involved
   projects and Villares Metals, Sao Paulo-Brazil, that supplied the steel.
   As well authors are grateful to CNPq (Brazil) and Ministerio de
   Educacion (Spain) for funding a bilateral cooperation, under the
   cooperation project CAPES#179/09.
CR Abad R, 2001, ISIJ INT, V41, P1373, DOI 10.2355/isijinternational.41.1373
   Boratto F., 1988, INT C PHYS MET THERM, P383
   Chilukuru H, 2009, MAT SCI ENG A-STRUCT, V510-11, P81, DOI 10.1016/j.msea.2008.04.088
   DeArdo AJ, 2001, IRONMAK STEELMAK, V28, P138, DOI 10.1179/030192301678055
   Giordani EJ, 2005, MATER SCI FORUM, V500-501, P179, DOI 10.4028/www.scientific.net/MSF.500-501.179
   GLADMAN T, 1966, PROC R SOC LON SER-A, V294, P298, DOI 10.1098/rspa.1966.0208
   Gomez M, 2005, ISIJ INT, V45, P1711, DOI 10.2355/isijinternational.45.1711
   Hanninen H, 2001, J MATER PROCESS TECH, V117, P424, DOI 10.1016/S0924-0136(01)00804-4
   Hellman P., 1975, SCAND J METALL, V4, P211
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Manohar PA, 1998, ISIJ INT, V38, P913, DOI 10.2355/isijinternational.38.913
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Miao CL, 2010, MAT SCI ENG A-STRUCT, V527, P4985, DOI 10.1016/j.msea.2010.04.039
   Morales EV, 2003, PHIL MAG LETT, V83, P79, DOI 10.1080/0950083021000056632
   Oh YJ, 2000, J NUCL MATER, V278, P242, DOI 10.1016/S0022-3115(99)00255-X
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   SAKAI T, 1995, J MATER PROCESS TECH, V53, P349, DOI 10.1016/0924-0136(95)01992-N
   Sakai T, 2014, PROG MATER SCI, V60, P130, DOI 10.1016/j.pmatsci.2013.09.002
   Seher R. J., 1971, S AM SOC TEST MAT, P119
   Simmons JW, 1996, MAT SCI ENG A-STRUCT, V207, P159, DOI 10.1016/0921-5093(95)09991-3
   Souza RC, 2013, MAT SCI ENG A-STRUCT, V582, P96, DOI 10.1016/j.msea.2013.06.037
   SUN WP, 1993, ACTA METALL MATER, V41, P3595, DOI 10.1016/0956-7151(93)90240-S
   Vervynckt S, 2012, INT MATER REV, V57, P187, DOI 10.1179/1743280411Y.0000000013
NR 23
TC 5
Z9 5
U1 3
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 18
PY 2015
VL 637
BP 189
EP 200
DI 10.1016/j.msea.2015.04.049
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA CK4QF
UT WOS:000356207600023
DA 2018-10-20
ER

PT J
AU Corno, M
   Delle Piane, M
   Monti, S
   Moreno-Couranjou, M
   Choquet, P
   Ugliengo, P
AF Corno, Marta
   Delle Piane, Massimo
   Monti, Susanna
   Moreno-Couranjou, Maryline
   Choquet, Patrick
   Ugliengo, Piero
TI Computational Study of Acidic and Basic Functionalized Crystalline
   Silica Surfaces as a Model for Biomaterial Interfaces
SO LANGMUIR
LA English
DT Article
ID PERIODIC AB-INITIO; DRUG-DELIVERY; MOLECULAR SIMULATION; AMORPHOUS
   SILICA; MESOPOROUS MATERIALS; PROTEIN ADSORPTION; ALKYL MONOLAYERS;
   CHEMISTRY; DYNAMICS; MCM-41
AB In silico modeling of acidic (CH2COOH) or basic (CH2NH2) functionalized silica surfaces has been carried out by means of a density functional approach based on a gradient-corrected functional to provide insight into the characterization of experimentally functionalized surfaces via a plasma method. Hydroxylated surfaces of crystalline cristobalite (sporting 4.8 OH/nm(2)) mimic an amorphous silica interface as unsubstituted material. To functionalize the silica surface we transformed the surface Si OH groups into Si CH2COOH and Si CH2NH2 moieties to represent acidic/basic chemical character for the substitution. Structures, energetics, electronic, and vibrational properties were computed and compared as a function of the increasing loading of the functional groups (from 1 to 4 per surface unit cell). Classical molecular dynamics simulations of selected cases have been performed through a Rear-FE reactive force field to assess the mobility of the surface added chains. Both DFT and force field calculations identify the CH2NH2 moderate surface loading (1 group per unit cell) as the most stable functionalization, at variance with the case of the CH2COOH group, where higher loadings are preferred (2 groups per unit cell). The vibrational fingerprints of the surface functionalities, which are the v(C=O) stretching and delta(NH2) bending modes for acidic/basic cases, have been characterized as a function of substitution percentage in order to guide the assignment of the experimental data. The final results highlighted the different behavior of the two types of functionalization. On the one hand, the frequency associated with the v(C=O) mode shifts to lower wavenumbers as a function of the H-bond strength between the surface functionalities (both COOH and SiOH groups), and on the other hand, the 5(NH2) frequency shift seems to be caused by a subtle balance between the H-bond donor and acceptor abilities of the NH2 moiety. Both sets of data are in general agreement with experimental measurements on the corresponding silica-functionalized materials and provide finer details for a deeper interpretation of experimental spectra.
C1 [Corno, Marta; Delle Piane, Massimo; Ugliengo, Piero] Univ Turin, Dipartimento Chim, I-10125 Turin, Italy.
   [Corno, Marta; Delle Piane, Massimo; Ugliengo, Piero] Univ Turin, NIS Nanostruct Interfaces & Surfaces Ctr, I-10125 Turin, Italy.
   [Monti, Susanna] CNR Inst Chem Organometall Cpds, I-56124 Pisa, Italy.
   [Moreno-Couranjou, Maryline; Choquet, Patrick] Luxembourg Inst Sci & Technol LIST, Mat Res & Technol Dept MRT, L-4362 Esch Sur Alzette, Luxembourg.
RP Corno, M (reprint author), Univ Turin, Dipartimento Chim, Via P Giuria 7, I-10125 Turin, Italy.
EM marta.corno@unito.it
RI Corno, Marta/I-4310-2012; Delle Piane, Massimo/K-5153-2012; ugliengo,
   piero/H-6373-2015
OI Corno, Marta/0000-0001-7248-2705; Delle Piane,
   Massimo/0000-0001-8522-9047; ugliengo, piero/0000-0001-8886-9832;
   choquet, patrick/0000-0001-8696-5812; Monti, Susanna/0000-0002-3419-7118
FU Luxembourgish agency "Fonds National de la Recherche"
   [FNR-INER/MAT/11/01]; Progetti di Ricerca di Ateneo-Compagnia di San
   Paolo-Linea 1A [ORTO11RRT5]
FX This research was carried out in the framework of the European M-ERA.NET
   BioADBD project funded by the Luxembourgish agency "Fonds National de la
   Recherche" (FNR-INER/MAT/11/01). M.C. and P.U. acknowledge Progetti di
   Ricerca di Ateneo-Compagnia di San Paolo-2011-Linea 1A, progetto
   ORTO11RRT5 for funding. S.M. is grateful to Adri C. T. van Duin for the
   serial version of the reactive dynamics program (ReaxFF) and for his
   useful comments and suggestions. A fruitful discussion with Barbara
   Onida (Politecnico of Torino) is also acknowledged.
CR Allen MP, 1989, COMPUTER SIMULATIONS
   Baerends E. J., 2012, ADF2012 01A SCM THEO
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Brunel D, 2002, STUD SURF SCI CATAL, V142, P1395
   Builes S, 2012, J PHYS CHEM C, V116, P10150, DOI 10.1021/jp301947v
   Builes S, 2013, LANGMUIR, V29, P199, DOI 10.1021/la3038507
   Builes S, 2012, J PHYS CHEM C, V116, P3017, DOI 10.1021/jp210494f
   Calvo A, 2008, CHEM MATER, V20, P4661, DOI 10.1021/cm800597k
   CATTI M, 1993, PHYS REV B, V47, P9189, DOI 10.1103/PhysRevB.47.9189
   Civalleri B, 1998, CHEM PHYS LETT, V292, P394, DOI 10.1016/S0009-2614(98)00749-0
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Csogor Z, 2003, MAT SCI ENG C-BIO S, V23, P93
   Datt A, 2012, J PHYS CHEM C, V116, P18358, DOI 10.1021/jp3063959
   Dkhissi A, 2005, J AM CHEM SOC, V127, P9776, DOI 10.1021/ja040246u
   Doadrio JC, 2006, J MATER CHEM, V16, P462, DOI 10.1039/b510101h
   Dovesi R, 2005, REV COMP CH, V21, P1, DOI 10.1002/0471720895.ch1
   Dovesi R, 2005, Z KRISTALLOGR, V220, P571, DOI 10.1524/zkri.220.5.571.65065
   Dovesi R., 2009, CRYSTAL09 USERS MANU
   Ewing CS, 2014, LANGMUIR, V30, P5133, DOI 10.1021/la500422p
   Fiorilli S, 2011, PHYS CHEM CHEM PHYS, V13, P1201, DOI 10.1039/c0cp01260b
   GATTI C, 1994, J CHEM PHYS, V101, P10686, DOI 10.1063/1.467882
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   Iler R.K., 1979, CHEM SILICA SOLUBILI
   Jang YH, 2005, J AM CHEM SOC, V127, P4959, DOI 10.1021/ja0444762w
   Kasemo B, 1999, Adv Dent Res, V13, P8
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lecoq E., 2014, 14 INT C PLASM SURF
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Mauchauffe R, 2014, J MATER CHEM B, V2, P5168, DOI 10.1039/c4tb00503a
   Meder F, 2013, LANGMUIR, V29, P12502, DOI 10.1021/la402093j
   Musso F, 2009, J PHYS CHEM C, V113, P17876, DOI 10.1021/jp905325m
   Noel Y., 2001, PHYS REV B, V65
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Pei Y, 2003, LANGMUIR, V19, P7652, DOI 10.1021/la0341198
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Puddu V, 2014, LANGMUIR, V30, P227, DOI 10.1021/la403242f
   Pujari SP, 2014, ANGEW CHEM INT EDIT, V53, P2
   Rimola A, 2013, CHEM REV, V113, P4216, DOI 10.1021/cr3003054
   Rosenholm JM, 2008, J CONTROL RELEASE, V128, P157, DOI 10.1016/j.jconrel.2008.02.013
   SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096
   Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943
   Soto-Cantu E, 2012, LANGMUIR, V28, P5562, DOI 10.1021/la204981b
   Tielens F, 2008, CHEM MATER, V20, P3336, DOI 10.1021/cm8001173
   Tsai HHG, 2008, J AM CHEM SOC, V130, P11566, DOI 10.1021/ja802051a
   UGLIENGO P, 1993, Z KRISTALLOGR, V208, P383, DOI 10.1524/zkri.1993.208.Part-2.383
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Williams JJ, 2011, J PHYS CHEM C, V115, P10651, DOI 10.1021/jp112073z
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhang LZ, 2001, LANGMUIR, V17, P6275, DOI 10.1021/la0106337
   Zhu YJ, 2012, CATAL TODAY, V194, P53, DOI 10.1016/j.cattod.2012.02.022
   Zhuravlev LT, 2000, COLLOID SURFACE A, V173, P1, DOI 10.1016/S0927-7757(00)00556-2
   ZHURAVLEV LT, 1987, LANGMUIR, V3, P316, DOI 10.1021/la00075a004
NR 53
TC 5
Z9 5
U1 0
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 16
PY 2015
VL 31
IS 23
BP 6321
EP 6331
DI 10.1021/acs.langmuir.5b01828
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA CL2EB
UT WOS:000356755300008
PM 26010674
DA 2018-10-20
ER

PT J
AU Layer, R
   Aimetti, A
   Podell, P
   Moore, S
   Ulich, T
AF Layer, Richard
   Aimetti, Alex
   Podell, Pamela
   Moore, Simon
   Ulich, Thomas
TI BIODEGRADABLE NEURO-SPINAL SCAFFOLD PRESERVES SPINAL CORD ARCHITECTURE
   FOLLOWING SPINAL CONTUSION INJURY IN RATS
SO JOURNAL OF NEUROTRAUMA
LA English
DT Meeting Abstract
CT 33rd Annual National Neurotrauma Symposium
CY JUN 28-JUL 01, 2015
CL Santa Fe, NM
DE biomaterial; tissue engineering; scaffold; implantation; biodegradable
C1 [Layer, Richard; Aimetti, Alex; Podell, Pamela; Moore, Simon; Ulich, Thomas] InVivo Therapeut, Res, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
EI 1557-9042
J9 J NEUROTRAUM
JI J. Neurotrauma
PD JUN 15
PY 2015
VL 32
IS 12
MA D8-06
BP A115
EP A115
PG 1
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA CV0OB
UT WOS:000363949000313
DA 2018-10-20
ER

PT J
AU Mina, A
   Castano, A
   Caicedo, JC
   Caicedo, HH
   Aguilar, Y
AF Mina, A.
   Castano, A.
   Caicedo, J. C.
   Caicedo, H. H.
   Aguilar, Y.
TI Determination of physical properties for beta-TCP plus chitosan
   biomaterial obtained on metallic 316L substrates
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Composite materials; Chemical synthesis; Mechanical testing; Elastic
   properties; Wear
ID WO3 THIN-FILMS; MECHANICAL-PROPERTIES; TRIBOLOGICAL PROPERTIES;
   MULTILAYER COATINGS; SCRATCH ADHESION; TUNGSTEN-OXIDE; HYDROXYAPATITE;
   SURFACES; BIOCOMPATIBILITY; ELECTROCHROMISM
AB Material surface modification, particularly the deposition of special coatings on the surface of surgical implants, is extensively used in bone tissue engineering applications. beta-Tricalcium phosphate/Chitosan (beta-TCP/Ch) coatings were deposited on 316L stainless steel (316L SS) substrates by a cathodic electro-deposition technique at different coating compositions. The crystal lattice arrangements were analyzed by X-Ray diffraction (XRD), and the results indicated that the crystallographic structure of beta-TCP was affected by the inclusion of the chitosan content. The changes in the surface morphology as a function of increasing chitosan in the coatings via scanning electron microscopy (SEM) and atomic force microscopy (AFM) showed that root-mean square values of the beta-TCP/Ch coatings decreased by further increasing chitosan percentage. The elastic plastic characteristics of the coatings were determined by conducting nanoindentation test, indicating that increase of chitosan percentage is directly related to increase of hardness and elastic modulus of the beta-TCP/Ch coatings. Tribological characterization was performed by scratch test and pin-on-disk test to analyze the changes in the surface wear of beta-TCP/Ch coatings. Finally, the results indicated an improvement in the mechanical and tribological properties of the beta-TCP/Ch coatings as a function of increasing of the chitosan percentage. This new class of coatings, comprising the bioactive components, is expected not only to enhance the bioactivity and biocompatibility, but also to protect the surface of metallic implants against wear and corrosion. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mina, A.; Castano, A.; Caicedo, J. C.; Aguilar, Y.] Univ Valle, Tribol Powder Met & Proc Solid Recycled Res Grp, Cali, Colombia.
   [Caicedo, H. H.] Johnson & Johnson, Pharmaceut Co, Janssen R&D LLC, Biol Res,Biotechnol Ctr Excellence, Spring House, PA 19477 USA.
   [Caicedo, H. H.] Natl Biotechnol & Pharmaceut Assoc, Chicago, IL 60606 USA.
   [Mina, A.] Tecnoacad ASTIN SENA Reginal Valle, Bogota, Colombia.
RP Caicedo, JC (reprint author), Univ Valle, Tribol Powder Met & Proc Solid Recycled Res Grp, Cali, Colombia.
EM julio.cesar.caicedo@correo.univalle.edu.co
FU Universidad Militar Nueva Granada, Bogota-Colombia; Excellence Center
   for Novel Materials (CENM) at Universidad del valle in Colombia [RC-
   043-2005]; Colciencias
FX This research was supported by Universidad Militar Nueva Granada,
   Bogota-Colombia and the Excellence Center for Novel Materials (CENM) at
   Universidad del valle in Colombia under Contract RC- 043-2005 with
   Colciencias.
CR ABE Y, 1990, MAT MED, V1, P233
   [Anonymous], 2010, 59905 ASTM
   [Anonymous], G17103 ASTM
   [Anonymous], G19513A ASTM
   [Anonymous], C162405 ASTM
   ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448
   Bamwenda GR, 1999, J PHOTOCH PHOTOBIO A, V122, P175, DOI 10.1016/S1010-6030(99)00026-X
   Banerjee SS, 2010, ACTA BIOMATER, V6, P4167, DOI 10.1016/j.actbio.2010.05.012
   BOHNKE O, 1982, SOLID STATE IONICS, V6, P121, DOI 10.1016/0167-2738(82)90076-5
   Brunski J. B., 2004, BIOMATERIALS SCI INT, P137
   BULL SJ, 1988, SURF COAT TECH, V36, P503, DOI 10.1016/0257-8972(88)90178-8
   BURNETT PJ, 1987, THIN SOLID FILMS, V154, P403, DOI 10.1016/0040-6090(87)90382-8
   Cabrera G, 2011, MATER CHEM PHYS, V125, P576, DOI 10.1016/j.matchemphys.2010.10.014
   Caicedo JC, 2010, APPL SURF SCI, V256, P5898, DOI 10.1016/j.apsusc.2010.03.071
   Caicedo JC, 2007, PHYS STATUS SOLIDI C, V4, P4127, DOI 10.1002/pssc.200675912
   Castro EM, 2007, SCI TECHNICA, V13, P36
   Cross MJ, 2005, J BONE JOINT SURG BR, V87B, P1073, DOI 10.1302/0301-620X.87B8.15772
   DAVAZOGLOU D, 1988, SOL ENERG MATER, V17, P379, DOI 10.1016/0165-1633(88)90020-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Ding SJ, 2006, DENT MATER J, V25, P706, DOI 10.4012/dmj.25.706
   Gangopadhyay S, 2010, TRIBOL LETT, V37, P487, DOI 10.1007/s11249-009-9544-1
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   Hajek V, 1997, WEAR, V213, P80, DOI 10.1016/S0043-1648(97)00176-2
   HURDITCH R, 1975, ELECTRON LETT, V11, P142, DOI 10.1049/el:19750109
   Inamdar AI, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/32/325706
   Ipaz L, 2012, APPL SURF SCI, V258, P3805, DOI 10.1016/j.apsusc.2011.12.033
   Jinno T, 2002, J ARTHROPLASTY, V17, P902, DOI 10.1054/arth.2002.34821
   Karim B, 1996, BIOMATERIALS, V17, P491
   Kim GS, 2003, SURF COAT TECH, V171, P91, DOI 10.1016/S0257-8972(03)00244-5
   Kucharska M, 2003, PROGR CHEM APPL CHIT, V3, P69
   Lackner JM, 2011, B POL ACAD SCI-TECH, V59, P343, DOI 10.2478/v10175-011-0042-x
   Lee KD, 1997, THIN SOLID FILMS, V302, P84, DOI 10.1016/S0040-6090(96)09556-9
   Martinez R, 2007, SCI TECHNICA, V36, P36
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   MONK PMS, 1993, ELECTROCHIM ACTA, V38, P1521, DOI 10.1016/0013-4686(93)80284-7
   Mozafari M, 2013, INT J NANOMED, V8, P1665, DOI 10.2147/IJN.S42659
   Naghib SM, 2012, INT J ELECTROCHEM SC, V7, P2890
   Nledengvist P., 1997, TRIBOL INT, V30, P507
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PANG X, 2009, COLLOID INTERFACE SC, V330, P323, DOI DOI 10.1016/J.JCIS.2008.10.070
   Pena D. Y. Ballesteros, 2010, REV FAC ING-UNIV ANT, V54, P15
   Pighinelli L, 2013, J BIOMATER NANOBIOTE, V4, P20
   Romero J., 2003, APPL PHYS A, V77, P419
   Salahinejad E, 2013, J BIOMED NANOTECHNOL, V9, P1327, DOI 10.1166/jbn.2013.1619
   Salahinejad E, 2012, MATER LETT, V88, P5, DOI 10.1016/j.matlet.2012.08.013
   Salahinejad E., 2013, PLOS ONE, V8, P1
   Tejada A., 2004, REV MEX FIS, V5, P187
   Tomoaia G, 2014, MAT SCI ENG C-MATER, V37, P37, DOI 10.1016/j.msec.2013.12.027
   Wang JW, 2006, J BIOMED MATER RES A, V76A, P503, DOI 10.1002/jbm.a.30542
   Zhang JT, 2014, ACTA BIOMATER, V10, P1035, DOI 10.1016/j.actbio.2013.11.001
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 51
TC 4
Z9 4
U1 0
U2 28
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUN 15
PY 2015
VL 160
BP 296
EP 307
DI 10.1016/j.matchemphys.2015.04.041
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA CK4RF
UT WOS:000356210200038
DA 2018-10-20
ER

PT J
AU Le, M
   Choi, H
   Choi, MK
   Cho, H
   Kim, JH
   Seo, HG
   Cha, SY
   Seo, K
   Dadi, H
   Park, C
AF MinhThong Le
   Choi, Hojun
   Choi, Min-Kyeung
   Cho, Hyesun
   Kim, Jin-Hoi
   Seo, Han Geuk
   Cha, Se-Yeon
   Seo, Kunho
   Dadi, Hailu
   Park, Chankyu
TI Development of a simultaneous high resolution typing method for three
   SLA class II genes, SLA-DQA, SLA-DQB1, and SLA-DRB1 and the analysis of
   SLA class II haplotypes
SO GENE
LA English
DT Article
DE SLA; DQA; DQB1 and DRB1; Swine
ID MAJOR HISTOCOMPATIBILITY COMPLEX; SEXUAL SELECTION; ANIMAL-MODEL;
   GENOMIC DNA; SWINE; MHC; PIG; AMPLIFICATION; ALLELES; SYSTEM
AB The characterization of the genetic variations of major histocompatibility complex (MHC) is essential to understand the relationship between the genetic diversity of MHC molecules and disease resistance and susceptibility in adaptive immunity. We previously reported the development of high-resolution individual locus typing methods for three of the most polymorphic swine leukocyte antigens (SEA) class Mod, namely, SLA-DQA, SLA-DQB1, and SLA-DRB1. In this study, we extensively modified our previous protocols and developed a method for the simultaneous amplification of the three SLA class II genes and subsequent analysis of individual loci using direct sequencing. The unbiased and simultaneous amplification of alleles from the all three hyper-polymorphic and pseudogene containing genes such as MHC genes is extremely challenging. However, using this method, we demonstrated the successful typing of SLA-DQA, SLA-DQB1, and SLA-DRB1 for 31 selected individuals comprising 26 different SLA class II haplotypes which were identified from 700 animals using the single locus typing methods. The results were identical to the known genotypes from the individual locus typing. The new method has significant benefits over the individual locus typing, including lower typing cost, use of less biomaterial, less effort and fewer errors in handling large samples for multiple loci. We also extensively characterized the haplotypes of SLA class II genes and reported three new haplotypes. Our results should serve as a basis to investigate the possible association between polymorphisms of MHC class II and differences in immune responses to exogenous antigens. (C) 2015 Elsevier B.V. All rights reserved.
C1 [MinhThong Le; Choi, Hojun; Choi, Min-Kyeung; Cho, Hyesun; Kim, Jin-Hoi; Seo, Han Geuk; Dadi, Hailu; Park, Chankyu] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea.
   [Cha, Se-Yeon] Chonbuk Natl Univ, Coll Vet Med, Jeonju, South Korea.
   [Seo, Kunho] Konkuk Univ, Coll Vet Med, Seoul 143701, South Korea.
RP Dadi, H (reprint author), Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea.
EM edenhailu@yahoo.com; chankyu@konkuk.ac.kr
FU Next-Generation BioGreen 21 Program [PJ011130]; Cooperative Research
   Program for Agriculture Science & Technology Development of the Rural
   Development Administration, Republic of Korea [PJ009103]
FX This work was supported by grants from the Next-Generation BioGreen 21
   Program (No. PJ011130) and the "Cooperative Research Program for
   Agriculture Science & Technology Development (PJ009103)" of the Rural
   Development Administration, Republic of Korea.
CR Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x
   Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x
   CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141
   GAUTSCHI C, 1990, ANIM GENET, V21, P161, DOI 10.1111/j.1365-2052.1990.tb03221.x
   Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622
   HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643
   Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x
   HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958
   Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03
   Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x
   Le MT, 2012, TISSUE ANTIGENS, V80, P528, DOI 10.1111/tan.12017
   LECHLER R, 1991, IMMUNOL LETT, V29, P41, DOI 10.1016/0165-2478(91)90197-I
   Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111
   LUMSDEN JS, 1993, CAN J VET RES, V57, P14
   Lunney JK, 2009, DEV COMP IMMUNOL, V33, P362, DOI 10.1016/j.dci.2008.07.002
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Mezrich JD, 2003, TRANSPLANTATION, V75, P904, DOI 10.1097/01.TP.0000054839.43852.BF
   Middelton Derek, 2005, Iran J Allergy Asthma Immunol, V4, P53
   MUTTER GL, 1995, NUCLEIC ACIDS RES, V23, P1411
   Park K, 2010, TISSUE ANTIGENS, V76, P301, DOI 10.1111/j.1399-0039.2010.01522.x
   Park K, 2009, J ANIM BREED GENET, V126, P127, DOI 10.1111/j.1439-0388.2008.00765.x
   Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x
   POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O
   Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547
   SETCAVAGE TM, 1976, INFECT IMMUN, V13, P600
   Smith DM, 2005, TISSUE ANTIGENS, V66, P623, DOI 10.1111/j.1399-0039.2005.00492.x
   TAKAHATA N, 1990, GENETICS, V124, P967
   Thong LM, 2011, TISSUE ANTIGENS, V77, P572, DOI 10.1111/j.1399-0039.2011.01662.x
   Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/j.annals.1334.015
   Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293
NR 30
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JUN 15
PY 2015
VL 564
IS 2
BP 228
EP 232
DI 10.1016/j.gene.2015.03.049
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA CI8SX
UT WOS:000355043100016
PM 25824383
DA 2018-10-20
ER

PT J
AU Shi, XJ
   Zhan, WJ
   Chen, GJ
   Yu, Q
   Liu, Q
   Du, H
   Cao, LM
   Liu, XL
   Yuan, L
   Chen, H
AF Shi, Xiujuan
   Zhan, Wenjun
   Chen, Gaojian
   Yu, Qian
   Liu, Qi
   Du, Hui
   Cao, Limin
   Liu, Xiaoli
   Yuan, Lin
   Chen, Hong
TI Regulation of Protein Binding Capability of Surfaces via Host-Guest
   Interactions: Effects of Localized and Average Ligand Density
SO LANGMUIR
LA English
DT Article
ID FUNCTIONALIZED POLYMER BRUSHES; BIOMEDICAL APPLICATIONS; PLASMON
   RESONANCE; GRAFTING DENSITY; PLASMINOGEN; IMPACT; IMMOBILIZATION;
   ADSORPTION; INTERFACES; MOLECULES
AB The protein binding capability of biomaterial surfaces can significantly affect subsequent biological responses, and appropriate ligand presentation is often required to guarantee the best functions. Herein, a new facile method for regulating this capability by varying the localized and average ligand density is presented. Binding between lysine and plasminogen relevant to a fibrinolysis system was chosen as a model. We integrated different lysine-modified beta-cydodextrin (beta-CD) derivatives Onto bioinert copolymer brushes via host-guest interactions. The localized and average lysine density can be conveniently modulated by changing the lysine valency on beta-CD scaffolds and by diluting lysine-perSubstituted beta-CD with pure beta-CD, respectively. Both the plasminogen adsorption and the plasminogen binding affinity were enhanced by lysine-persubstituted beta-CD compared with those of lysine-monosubstituted beta-CD, which is possibly due to the higher localized lysine density and the multivalent binding of plasminogen on lysine-persubstituted beta-CD surfaces. With a change in the ratio of lysine-persubstituted beta-CD to beta-CD, the average lysine density can be tuned, leading to the linear regulation of the adsorption of plasminogen on surfaces.
C1 [Shi, Xiujuan; Zhan, Wenjun; Chen, Gaojian; Yu, Qian; Liu, Qi; Du, Hui; Cao, Limin; Liu, Xiaoli; Yuan, Lin; Chen, Hong] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
   [Chen, Gaojian] Soochow Univ, Ctr Soft Condensed Matter Phys & Interdisciplinar, Suzhou 215006, Peoples R China.
RP Chen, GJ (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM gchen@suda.edu.cn; chenh@suda.edu.cn
RI Chen, Gaojian/C-2802-2008
OI Chen, Gaojian/0000-0002-5877-3159; , Lin/0000-0001-6966-8584; Liu,
   Xiaoli/0000-0003-1686-3292
FU National Natural Science Foundation of China [21125418, 21374069,
   21334004, 21304062]; Natural Science Foundation of the Jiangsu Higher
   Education Institutions of China [13KJA430006]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This work was supported by the National Natural Science Foundation of
   China (21125418, 21374069, 21334004, and 21304062), the Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   (13KJA430006), and the Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD).
CR Costa P, 2014, ACTA BIOMATER, V10, P2415, DOI 10.1016/j.actbio.2014.01.029
   Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919
   Elias DR, 2013, NANOMED-NANOTECHNOL, V9, P194, DOI 10.1016/j.nano.2012.05.015
   Enrico D. C., 1995, THERMODYNAMIC THEORY, P57
   FLEURY V, 1991, BIOCHEMISTRY-US, V30, P7630, DOI 10.1021/bi00244a035
   Harris DC, 2011, J AM CHEM SOC, V133, P7676, DOI 10.1021/ja2017366
   Hu WH, 2010, ADV FUNCT MATER, V20, P3497, DOI 10.1002/adfm.201001159
   Ishida N, 2010, MACROMOLECULES, V43, P7269, DOI 10.1021/ma101113g
   Jiang H, 2013, CHEM SOC REV, V42, P3394, DOI 10.1039/c2cs35453e
   Jung HS, 2008, BIOPHYS J, V94, P3094, DOI 10.1529/biophysj.107.115519
   Katrlik J, 2011, COLLOID SURFACE A, V382, P198, DOI 10.1016/j.colsurfa.2011.01.020
   Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u
   Lee EJ, 2014, RSC ADV, V4, P31581, DOI 10.1039/c4ra03795b
   Li D, 2011, ACTA BIOMATER, V7, P954, DOI 10.1016/j.actbio.2010.10.021
   Li DD, 2013, LANGMUIR, V29, P14101, DOI 10.1021/la4033332
   Li HQ, 2014, BIOMACROMOLECULES, V15, P43, DOI 10.1021/bm4012562
   Li X, 2013, LANGMUIR, V29, P1122, DOI 10.1021/la3044472
   Liu T, 2014, ACTA BIOMATER, V10, P1940, DOI 10.1016/j.actbio.2013.12.013
   Loh XJ, 2014, MATER HORIZ, V1, P185, DOI 10.1039/c3mh00057e
   Ma X, 2015, CHEM REV, V115, P7794, DOI 10.1021/cr500392w
   MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500
   MARKUS G, 1978, J BIOL CHEM, V253, P727
   Martinez A, 2013, CHEM SOC REV, V42, P4746, DOI 10.1039/c2cs35424a
   McClung WG, 2003, J BIOMED MATER RES A, V66A, P795, DOI 10.1002/jdm.a.10017
   Meng XL, 2012, LANGMUIR, V28, P13616, DOI 10.1021/la302389e
   Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880
   Rodda AE, 2014, PROG POLYM SCI, V39, P1312, DOI 10.1016/j.progpolymsci.2013.11.006
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Sato Y, 2012, LANGMUIR, V28, P1846, DOI 10.1021/la2030044
   Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w
   Shi XJ, 2013, LANGMUIR, V29, P14188, DOI 10.1021/la4037748
   Shi XJ, 2014, MATER HORIZONS, V1, P540, DOI 10.1039/c4mh00081a
   Trmcic-Cvitas J, 2009, BIOMACROMOLECULES, V10, P2885, DOI 10.1021/bm900706r
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Wang LS, 2013, ANAL CHEM, V85, P6505, DOI 10.1021/ac401105p
   Wang X, 2010, ANAL CHEM, V82, P9082, DOI 10.1021/ac102114z
   Wei KC, 2013, ACS MACRO LETT, V2, P278, DOI 10.1021/mz400036t
   Wu ZQ, 2009, LANGMUIR, V25, P2900, DOI 10.1021/la8037523
   Yang H, 2014, ACCOUNTS CHEM RES, V47, P2106, DOI 10.1021/ar500105t
   Yu K, 2013, ANAL CHEM, V85, P7786, DOI 10.1021/ac401306b
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   Yu Q, 2010, COLLOID SURFACE B, V76, P468, DOI 10.1016/j.colsurfb.2009.12.006
   Zhang YR, 2011, ANAL CHEM, V83, P9651, DOI 10.1021/ac202517x
   Zhang YX, 2013, ANAL CHEM, V85, P1106, DOI 10.1021/ac302874s
NR 44
TC 13
Z9 14
U1 1
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 9
PY 2015
VL 31
IS 22
BP 6172
EP 6178
DI 10.1021/acs.langmuir.5b01380
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA CK4OE
UT WOS:000356202300025
PM 25986051
DA 2018-10-20
ER

PT J
AU Nikkola, L
   Morton, T
   Balmayor, ER
   Jukola, H
   Harlin, A
   Redl, H
   van Griensven, M
   Ashammakhi, N
AF Nikkola, Lila
   Morton, Tatjana
   Balmayor, Elizabeth R.
   Jukola, Hanna
   Harlin, Ali
   Redl, Heinz
   van Griensven, Martijn
   Ashammakhi, Nureddin
TI Fabrication of electrospun poly(D,L lactide-co-glycolide)80/20 scaffolds
   loaded with diclofenac sodium for tissue engineering
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE Electrospinning; Poly(D,L lactide-co-glycolide); Scaffold; Drug release;
   Diclofenac sodium; Biodegradable
ID ULTRAFINE FIBERS; ACID); DEXAMETHASONE; EFFICACY; DELIVERY; NANOMATS;
   RELEASE; MATS
AB Background: Adaptation of nanotechnology into materials science has also advanced tissue engineering research. Tissues are basically composed of nanoscale structures hence making nanofibrous materials closely resemble natural fibers. Adding a drug release function to such material may further advance their use in tissue repair.
   Methods: In the current study, bioabsorbable poly(D,L lactide-co-glycolide) 80/20 (PDLGA80/20) was dissolved in a mixture of acetone/dimethylformamide. Twenty percent of diclofenac sodium was added to the solution. Nanofibers were manufactured using electrospinning. The morphology of the obtained scaffolds was analyzed by scanning electron microscopy (SEM). The release of the diclofenac sodium was assessed by UV/Vis spectroscopy. Mouse fibroblasts (MC3T3) were seeded on the scaffolds, and the cell attachment was evaluated with fluorescent microscopy.
   Results: The thickness of electrospun nanomats was about 1 mm. SEM analysis showed that polymeric nanofibers containing drug particles formed very interconnected porous nanostructures. The average diameter of the nanofibers was 500 nm. Drug release was measured by means of UV/Vis spectroscopy. After a high start peak, the release rate decreased considerably during 11 days and lasted about 60 days. During the evaluation of the release kinetics, a material degradation process was observed. MC3T3 cells attached to the diclofenac sodium-loaded scaffold.
   Conclusions: The nanofibrous porous structure made of PDLGA polymer loaded with diclofenac sodium is feasible to develop, and it may help to improve biomaterial properties for controlled tissue repair and regeneration.
C1 [Nikkola, Lila; Jukola, Hanna; Ashammakhi, Nureddin] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Morton, Tatjana; Redl, Heinz; van Griensven, Martijn] Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Balmayor, Elizabeth R.; van Griensven, Martijn] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, D-81675 Munich, Germany.
   [Harlin, Ali] Tampere Univ Technol, Inst Fiber Mat Sci, FIN-33101 Tampere, Finland.
   [Ashammakhi, Nureddin] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England.
RP Balmayor, ER (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, Ismaninger Str 22, D-81675 Munich, Germany.
EM Elizabeth.Rosado-Balmayor@tum.de
RI Rosado Balmayor, Elizabeth/N-9283-2015; van Griensven,
   Martijn/F-5808-2012
OI Rosado Balmayor, Elizabeth/0000-0002-0484-4847; van Griensven,
   Martijn/0000-0001-5104-9881
FU scope of the EU project EXPERTISSUES [NMP3-CT-2004-500283]
FX This study was performed under the scope of the EU project EXPERTISSUES
   (NMP3-CT-2004-500283). The authors would like to thank Fritz Seidl, M.A.
   for English linguistic corrections.
CR Ashammakhi N, 2006, J NANOSCI NANOTECHNO, V6, P2693, DOI 10.1166/jnn.2006.485
   Ashammakhi N, 2007, J CRANIOFAC SURG, V18, P3, DOI 10.1097/01.scs.0000236444.05345.53
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Choi JS, 2004, INT J BIOL MACROMOL, V34, P249, DOI 10.1016/j.ijbiomac.2004.06.001
   Chua KN, 2007, ACTA BIOMATER, V3, P643, DOI 10.1016/j.actbio.2007.03.012
   da Silva MA, 2009, TISSUE ENG PT A, V15, P377, DOI 10.1089/ten.tea.2007.0327
   Esposito A.R., 2013, BIORES OPEN ACCESS, V2, P138, DOI DOI 10.1089/BIORES.2012.0293
   FDA U.S.F.D.U.S., IN INGR SEARCH APPR
   Fiorani A, 2014, J MATER SCI-MATER M, V25, P2313, DOI 10.1007/s10856-014-5196-2
   Hassanzadeh-Khayyat M, 2011, J WATER RESOURCE PRO, V3, P643, DOI DOI 10.4236/JWARP.2011.39074
   Ignatova M, 2013, MACROMOL BIOSCI, V13, P860, DOI 10.1002/mabi.201300058
   Jahani H, 2012, CELL J, V14, P31
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kong LY, 2013, CARBOHYD POLYM, V92, P1416, DOI 10.1016/j.carbpol.2012.09.026
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Li JR, 2014, PHARM RES-DORDR, V31, P1632, DOI 10.1007/s11095-013-1266-2
   Nakano A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011801
   Ndreu A, 2008, NANOMEDICINE-UK, V3, P45, DOI 10.2217/17435889.3.1.45
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Nikkola L, 2006, J NANOSCI NANOTECHNO, V6, P3290, DOI 10.1166/jnn.2006.467
   Parwe SP, 2014, INT J NANOMED, V9, P1463, DOI 10.2147/IJN.S54971
   Perumcherry SR, 2011, TISSUE ENG PART C-ME, V17, P1121, DOI [10.1089/ten.tec.2010.0734, 10.1089/ten.TEC.2010.0734]
   Piras AM, 2006, J NANOSCI NANOTECHNO, V6, P3310, DOI 10.1166/jnn.2006.486
   Sekiya N, 2013, J PLAST SURG HAND SU, V47, P498, DOI 10.3109/2000656X.2013.788507
   Sequeira SJ, 2012, BIOMATERIALS, V33, P3175, DOI 10.1016/j.biomaterials.2012.01.010
   Shen XB, 2014, J NANOSCI NANOTECHNO, V14, P5258, DOI 10.1166/jnn.2014.8706
   Sun R, 1999, OPHTHALMIC SURG LAS, V30, P382
   TODD PA, 1988, DRUGS, V35, P244, DOI 10.2165/00003495-198835030-00004
   Viitanen P, 2006, J MATER SCI-MATER M, V17, P1267, DOI 10.1007/s10856-006-0601-0
   Xu XL, 2006, J CONTROL RELEASE, V114, P307, DOI 10.1016/j.jconrel.2006.05.031
   Zupanc M, 2013, ULTRASON SONOCHEM, V20, P1104, DOI 10.1016/j.ultsonch.2012.12.003
NR 31
TC 4
Z9 4
U1 1
U2 26
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD JUN 5
PY 2015
VL 20
AR 54
DI 10.1186/s40001-015-0145-1
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CK2JT
UT WOS:000356037300001
PM 26044589
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Izumi, R
   Komada, S
   Ochi, K
   Karasawa, L
   Osaki, T
   Murahata, Y
   Tsuka, T
   Imagawa, T
   Itoh, N
   Okamoto, Y
   Izawa, H
   Morimoto, M
   Saimoto, H
   Azuma, K
   Ifuku, S
AF Izumi, Ryotaro
   Komada, Shuntaro
   Ochi, Kosuke
   Karasawa, Lisa
   Osaki, Tomohiro
   Murahata, Yusuke
   Tsuka, Takeshi
   Imagawa, Tomohiro
   Itoh, Norihiko
   Okamoto, Yoshiharu
   Izawa, Hironori
   Morimoto, Minoru
   Saimoto, Hiroyuki
   Azuma, Kazuo
   Ifuku, Shinsuke
TI Favorable effects of superficially deacetylated chitin nanofibrils on
   the wound healing process
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Superficially deacetylated chitin nanofibrils; Chitin nanofibrils; Wound
   healing; Re-epithelium; Biomaterials
ID CHITOSAN NANOFIBERS; ALPHA-CHITIN; BIOMEDICAL APPLICATIONS; DRESSING
   APPLICATIONS; IN-VITRO; SKIN; FIBROBLASTS; DERIVATIVES; SURFACE;
   CHITIN/CHITOSAN
AB Previous reports indicate that the beneficial effect of chitin nanofibrils (CNFs), and chitosan nanofibrils (CSNFs) for wound healing. In this study, the wound healing effects of superficially deacetylated chitin nanofibrils (SDACNFs) were evaluated using an experimental model. In the experiments using circular excision wound model, SDACNFs induced re-epithelium and proliferation of the fibroblasts and collagen tissue. In the chitin, CNFs, and CSNFs, on the other hand, the e-epithelium and proliferation of the fibroblasts and collagen tissue were not induced perfectly compared with the SDACNFs group. In particular, re-epithelization was observed on day 4 in the only SDACNF group. Moreover, SDACNFs did not induce severe systemic inflammation in the linear incision wound model. The data indicated that SDACNFs effectively induced the proliferation and re-modeling phases compared with chitin, CNFs, and CSNFs in the wound. These data indicate that SDACNFs can be beneficial as a new biomaterial for wound healing. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Izumi, Ryotaro; Izawa, Hironori; Saimoto, Hiroyuki; Ifuku, Shinsuke] Tottori Univ, Grad Sch Engn, Tottori 6808533, Japan.
   [Komada, Shuntaro; Ochi, Kosuke; Karasawa, Lisa; Osaki, Tomohiro; Murahata, Yusuke; Tsuka, Takeshi; Imagawa, Tomohiro; Itoh, Norihiko; Okamoto, Yoshiharu; Azuma, Kazuo] Tottori Univ, Dept Vet Clin Med, Tottori 6808533, Japan.
   [Morimoto, Minoru] Tottori Univ, Res Ctr Biosci & Technol, Div Instrumental Anal, Tottori 6808550, Japan.
RP Azuma, K (reprint author), Tottori Univ, Dept Vet Clin Med, 4-101 Koyama Minami, Tottori 6808533, Japan.
EM kazu-azuma@muses.tottori-u.ac.jp; sifuku@chem.tottori-u.ac.jp
RI Izawa, Hironori/M-7037-2014
OI Izawa, Hironori/0000-0002-8715-8462
FU Creating STart-ups from Advanced Research and Technology (START) project
   of JST; KAKENHI of JSPS [26708026]
FX This work was financially supported by the Creating STart-ups from
   Advanced Research and Technology (START) project of JST and KAKENHI
   (26708026) of JSPS.
CR Azuma K, 2015, BIOMATERIALS, V42, P20, DOI 10.1016/j.biomaterials.2014.11.043
   Azuma K, 2013, J CHITIN CHITOSAN SC, V1, P144, DOI 10.1166/jcc.2013.1020
   Azuma K, 2014, J BIOMED NANOTECHNOL, V10, P2891, DOI 10.1166/jbn.2014.1882
   Azuma K, 2012, CARBOHYD POLYM, V90, P197, DOI 10.1016/j.carbpol.2012.05.023
   Azuma K, 2012, CARBOHYD POLYM, V87, P1399, DOI 10.1016/j.carbpol.2011.09.036
   Bean DB, 2003, EMERG MED PRACT, V5, P1
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g
   Dutta AK, 2013, J CHITIN CHITOSAN SC, V1, P192, DOI 10.1166/jcc.2013.1024
   Dutta AK, 2013, CARBOHYD POLYM, V97, P363, DOI 10.1016/j.carbpol.2013.05.010
   Erba P, 2011, J TRAUMA, V71, pS187, DOI 10.1097/TA.0b013e318225583c
   Fan YM, 2010, CARBOHYD POLYM, V79, P1046, DOI 10.1016/j.carbpol.2009.10.044
   Getie M, 2002, PHARMAZIE, V57, P320
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Ifuku S, 2014, RSC ADV, V4, P19246, DOI 10.1039/c4ra01975j
   Ifuku S, 2014, MOLECULES, V19, P18367, DOI 10.3390/molecules191118367
   Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c
   Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d
   Ito I, 2014, CARBOHYD POLYM, V101, P464, DOI 10.1016/j.carbpol.2013.09.074
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kelechi TJ, 2012, J AM ACAD DERMATOL, V66, pE209, DOI 10.1016/j.jaad.2011.01.031
   Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009
   Lindner HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018996
   Minagawa T, 2007, CARBOHYD POLYM, V67, P640, DOI 10.1016/j.carbpol.2006.07.007
   Minanni S, 2014, J CHITIN CHITOSAN SC, V2, P163, DOI 10.1166/jcc.2014.1073
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153, DOI DOI 10.1016/B978-
   Muzzarelli RAA, 2014, MAR DRUGS, V12, P5468, DOI 10.3390/md12115468
   Muzzarelli RAA, 2011, TOP GEOBIOL, V34, P1, DOI 10.1007/978-90-481-9684-5_1
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   NISHIMURA S, 1985, INT J BIOL MACROMOL, V7, P100, DOI 10.1016/0141-8130(85)90038-8
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Shetty S, 2008, EVID-BASED COMPL ALT, V5, P95, DOI 10.1093/ecam/nem004
   Suntar I, 2011, J ETHNOPHARMACOL, V135, P63, DOI 10.1016/j.jep.2011.02.023
   Suntar IP, 2010, J ETHNOPHARMACOL, V127, P468, DOI 10.1016/j.jep.2009.10.011
   Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x
NR 39
TC 18
Z9 18
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 5
PY 2015
VL 123
BP 461
EP 467
DI 10.1016/j.carbpol.2015.02.005
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CH1AR
UT WOS:000353754000053
PM 25843880
OA Other Gold
DA 2018-10-20
ER

PT J
AU Trofimov, BA
   Zhuravleva, IY
   Oparina, LA
   Sukhikh, AS
   Vysotskaya, OV
   Borisov, VV
   Gusarova, NK
AF Trofimov, B. A.
   Zhuravleva, I. Yu.
   Oparina, L. A.
   Sukhikh, A. S.
   Vysotskaya, O. V.
   Borisov, V. V.
   Gusarova, N. K.
TI Penta-O-{1-[2-(glycidyloxy)ethoxy]ethyl}-D-glucopyranose: synthesis and
   application for the preservation of cardiovascular bioprostheses
SO RUSSIAN CHEMICAL BULLETIN
LA English
DT Article
DE xenogenic biomaterials; preservation; epoxy compounds; IR spectroscopy;
   scanning electron microscopy
ID GLUTARALDEHYDE
AB Conditions for the atom-economical synthesis of penta-O-{1-[2-(glycidyloxy)ethoxy]ethyl}-d-glucopyranose by the reaction of exhaustive electrophilic addition of alpha-d-glucose to 2-vinyloxyethyl glycidyl ether were elaborated. Scanning electron microscopy and IR spectroscopy were used to study the effect of penta-O-{1-[2-(glycidyloxy)ethoxy]ethyl}-d-glucopyranose on the surface of the biological tissue under conditions of the base preservation of xenogenic biomaterial. The results obtained indicate an improvement of morphological characteristics of the biomaterial surface and a high density of intermolecular bonds of the collagen fibres.
C1 [Trofimov, B. A.; Oparina, L. A.; Vysotskaya, O. V.; Gusarova, N. K.] Russian Acad Sci, Siberian Branch, AE Favorsky Irkutsk Inst Chem, 1 Ul Favorskogo, Irkutsk 664033, Russia.
   [Zhuravleva, I. Yu.] EN Meshalkin Novosibirsk Res Inst Circulat Patol, Novosibirsk 630055, Russia.
   [Sukhikh, A. S.] Hlth Minist Russian Federat, Kemerovo State Med Acad, Kemerovo 650029, Russia.
   [Borisov, V. V.] Res Inst Complex Problems Cardiovasc Dis, Kemerovo 650002, Russia.
RP Trofimov, BA (reprint author), Russian Acad Sci, Siberian Branch, AE Favorsky Irkutsk Inst Chem, 1 Ul Favorskogo, Irkutsk 664033, Russia.
EM boris_trofimov@irioch.irk.ru; juravl_irina@mail.ru
FU Russian Federation Council for Grants (Program for State Support of
   Leading Scientific Schools of the Russian Federation) [NSh-156.2014.3]
FX This work was financially supported by the President of the Russian
   Federation Council for Grants (Program for State Support of Leading
   Scientific Schools of the Russian Federation, Grant NSh-156.2014.3).
CR [Anonymous], 1994, [Byul. isobret., Invention Bull.], Patent No. [RF 2008767, 2008767]
   [Anonymous], 1984, [Byul. isobret., Invention Bull.], Patent No. [A.c. USSR 1074881, 1074881]
   Barbarash L.S., 2012, COMPLEX PROBLEMS CAR, V1, P4
   Barbarash L. S., 2002, VESTN TRANSPLANTOLOG, V2, P42
   Barbarash L. S., 1996, BIOL PROTEZY ARTERII
   Barbarash L. S., 2013, GRUDNAYA SERD SOSUD, V6, P25
   Barbarash L. S., 2012, GRUDNAYA SERD SOSUD, V2, P12
   Bockeriya L. A., 2014, SERDECHNO SOSUDISTAY
   Brodsky-Doyle B, 1975, BIOPOLYMERS, V14, P937
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   HASLAM E, 1979, COMPREHENSIVE ORGANI, V5
   Herrebout W, 2003, SPECTROCHIM ACTA A, V59, P47, DOI 10.1016/S1386-1425(02)00112-9
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Kudryavtseva Yu. A., 2008, PATOLOGIYA KROVOOBRA, V1, P79
   Stankevich V. K., 2004, NAUKA PROIZVODSTVU, V1, P19
   TROFIMOV BA, 1993, REV HETEROATOM CHEM, V9, P205
   WOODROOF EA, 1978, J BIOENG, V2, P1
   Zhuravleva I. Yu., 1994, BIOSOVMESTIMOST, V1, P13
NR 19
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1066-5285
EI 1573-9171
J9 RUSS CHEM B+
JI Russ. Chem. Bull.
PD JUN
PY 2015
VL 64
IS 6
BP 1451
EP 1457
DI 10.1007/s11172-015-1031-2
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA DF4JN
UT WOS:000371313900028
DA 2018-10-20
ER

PT J
AU Colletta, A
   Wu, JF
   Wo, YQ
   Kappler, M
   Chen, H
   Xi, CW
   Meyerhoff, ME
AF Colletta, Alessandro
   Wu, Jianfeng
   Wo, Yaqi
   Kappler, Michael
   Chen, Hao
   Xi, Chuanwu
   Meyerhoff, Mark E.
TI S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley
   Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated
   Urinary Tract Infections
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE nitric oxide; SNAP-impregnated Foley catheters; long-term NO release;
   antibiofilm; biocompatibility
ID BACTERIAL BIOFILM FORMATION; NITRIC-OXIDE RELEASE; PROTEUS-MIRABILIS;
   STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; URETHRAL CATHETERS;
   ESCHERICHIA-COLI; RESISTANCE; PENETRATION; DEVICES
AB Urinary Foley catheters are utilized for management of hospitalized patients and are associated with high rates of urinary tract infections (UTIs). Nitric oxide (NO) potently inhibits microbial biofilm formation, which is the primary cause of catheter associated UTIs (CAUTIs). Herein, commercial silicone Foley catheters are impregnated via a solvent swelling method with S-nitroso-N-acetyl-D-penicillamine (SNAP), a synthetic NO donor that exhibits long-term NO release and stability when incorporated into low water-uptake polymers. The proposed catheters generate NO surface-fluxes >0.7 x 10(-10) mol min(-1) cm(-2) for over one month under physiological conditions, with minimal SNAP leaching. These biomedical devices are demonstrated to significantly decrease formation of biofilm on the surface of the catheter tubings over 3, 7, and 14 day periods by microbial species (Staphylococcus epidermidis and Proteus mirabilis) commonly causing CAUTIs. Toxicity assessment demonstrates that the SNAP-impregnated catheters are fully biocompatible, as extracts of the catheter tubings score 0 on a 3-point grading scale using an accepted mouse fibroblast cell-line toxicity model. Consequently, SNAP-impregnated silicone Foley catheters can likely provide an efficient strategy to greatly reduce the occurrence of nosocomial CAUTIs.
C1 [Colletta, Alessandro; Wo, Yaqi; Meyerhoff, Mark E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   [Wu, Jianfeng; Xi, Chuanwu] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   [Kappler, Michael; Chen, Hao] Biocrede Inc, Plymouth, MI 48170 USA.
RP Xi, CW (reprint author), Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
EM cxi@umich.edu; mmeryho@umich.edu
OI Colletta, Alessandro/0000-0002-3865-1015
FU National Institutes of Health [NIH-R42-DK100161-02]
FX We thank the National Institutes of Health for supporting these studies
   via grant # NIH-R42-DK100161-02.
CR Aiassa V, 2010, BIOCHEM BIOPH RES CO, V393, P84, DOI 10.1016/j.bbrc.2010.01.083
   Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   Cabrera-Contreras R., 2013, ISRN MICROBIOL, V2013
   Cai WY, 2012, BIOMATERIALS, V33, P7933, DOI 10.1016/j.biomaterials.2012.07.027
   Cai WY, 2011, BIOMATERIALS, V32, P7774, DOI 10.1016/j.biomaterials.2011.06.075
   Carpenter AW, 2011, ACS NANO, V5, P7235, DOI 10.1021/nn202054f
   Darouiche RO, 1999, UROLOGY, V54, P976, DOI 10.1016/S0090-4295(99)00288-5
   Davenport K, 2005, J HOSP INFECT, V60, P298, DOI 10.1016/j.jhin.2005.01.026
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Elliott TSJ, 1999, J ANTIMICROB CHEMOTH, V43, P441, DOI 10.1093/jac/43.4.441
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Gilmore BF, 2010, J BIOMED MATER RES B, V93B, P128, DOI 10.1002/jbm.b.31567
   Hachem R, 2009, ANTIMICROB AGENTS CH, V53, P5145, DOI 10.1128/AAC.00718-09
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hofler L, 2012, RSC ADV, V2, P6765, DOI 10.1039/c2ra20853a
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1118/AAC.49.6.2467-2473.2005
   Jones BV, 2005, J MED MICROBIOL, V54, P807, DOI 10.1099/JMM.0.46123-0
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   Lu Y, 2013, SMALL, V9, P2189, DOI 10.1002/smll.201201798
   Mack D, 2013, BIOMATERIALS ASS INF, P25, DOI 10.1007/9781-46141031-7
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Nicolle LE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-23
   Oman KS, 2012, AM J INFECT CONTROL, V40, P548, DOI 10.1016/j.ajic.2011.07.018
   Pickard R, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI [10.3310/jta16470, 10.3310/hta16470]
   Privett BJ, 2010, MOL PHARMACEUT, V7, P2289, DOI 10.1021/mp100248e
   Ren H, 2014, ACS APPL MATER INTER, V6, P3779, DOI 10.1021/am406066a
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P1, DOI 10.1111/j.1574-695X.2007.00284.x
   SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x
   Shishido SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P273, DOI 10.1562/0031-8655(2000)071<0273:PGMRTR>2.0.CO;2
   STEPHENS AD, 1971, Q J MED, V40, P355
   Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231
   Stickler DJ, 2006, J MED MICROBIOL, V55, P489, DOI 10.1099/jmm.0.46404-0
   Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964
   Tapiainen T, 2014, EUR J CLIN MICROBIOL, V33, P111, DOI 10.1007/s10096-013-1935-4
   Tenke P, 2014, CURR OPIN INFECT DIS, V27, P102, DOI 10.1097/QCO.0000000000000031
   Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003
   Wang HZ, 2011, ANTIMICROB AGENTS CH, V55, P4469, DOI 10.1128/AAC.00126-11
   Wojtyczka RD, 2014, INT J ENV RES PUB HE, V11, P4619, DOI 10.3390/ijerph110504619
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
   Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012
   Zunino P, 2007, FEMS IMMUNOL MED MIC, V51, P125, DOI 10.1111/j.1574-695X.2007.00285.x
NR 56
TC 19
Z9 19
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUN
PY 2015
VL 1
IS 6
BP 416
EP 424
DI 10.1021/acsbiomaterials.5b00032
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RO
UT WOS:000369347500008
PM 26462294
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Marchioli, G
   van Gurp, L
   van Krieken, PP
   Stamatialis, D
   Engelse, M
   van Blitterswijk, CA
   Karperien, MBJ
   de Koning, E
   Alblas, J
   Moroni, L
   van Apeldoorn, AA
AF Marchioli, G.
   van Gurp, L.
   van Krieken, P. P.
   Stamatialis, D.
   Engelse, M.
   van Blitterswijk, C. A.
   Karperien, M. B. J.
   de Koning, E.
   Alblas, J.
   Moroni, L.
   van Apeldoorn, A. A.
TI Fabrication of three-dimensional bioplotted hydrogel scaffolds for
   islets of Langerhans transplantation
SO BIOFABRICATION
LA English
DT Article
DE type 1 diabetes; beta cells; bioplotting; tissue engineering; islets of
   Langerhans
ID ALGINATE-BASED MICROCAPSULES; PANCREATIC BETA-CELLS;
   EXTRACELLULAR-MATRIX; INSULIN-SECRETION; TISSUE; APOPTOSIS; CULTURE;
   GLUCOSE; CONSTRUCTS; METABOLISM
AB In clinical islet transplantation, allogeneic islets of Langerhans are transplanted into the portal vein of patients with type 1 diabetes, enabling the restoration of normoglycemia. After intra-hepatic transplantation several factors are involved in the decay in islet mass and function mainly caused by an immediate blood mediated inflammatory response, lack of vascularization, and allo-and autoimmunity. Bioengineered scaffolds can potentially provide an alternative extra-hepatic transplantation site for islets by improving nutrient diffusion and blood supply to the scaffold. This would ultimately result in enhanced islet viability and functionality compared to conventional intra portal transplantation. In this regard, the biomaterial choice, the three-dimensional (3D) shape and scaffold porosity are key parameters for an optimal construct design and, ultimately, transplantation outcome. We used 3D bioplotting for the fabrication of a 3D alginate-based porous scaffold as an extra-hepatic islet delivery system. In 3D-plotted alginate scaffolds the surface to volume ratio, and thus oxygen and nutrient transport, is increased compared to conventional bulk hydrogels. Several alginate mixtures have been tested for INS1E beta-cell viability. Alginate/gelatin mixtures resulted in high plotting performances, and satisfactory handling properties. INS1E beta-cells, human and mouse islets were successfully embedded in 3D-plotted constructs without affecting their morphology and viability, while preventing their aggregation. 3D plotted scaffolds could help in creating an alternative extra-hepatic transplantation site. In contrast to microcapsule embedding, in 3D plotted scaffold islets are confined in one location and blood vessels can grow into the pores of the construct, in closer contact to the embedded tissue. Once revascularization has occurred, the functionality is fully restored upon degradation of the scaffold.
C1 [Marchioli, G.; Karperien, M. B. J.; van Apeldoorn, A. A.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands.
   [van Gurp, L.; van Krieken, P. P.; de Koning, E.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.
   [van Gurp, L.; van Krieken, P. P.; de Koning, E.] Univ Med Ctr Utrecht, Utrecht, Netherlands.
   [Engelse, M.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
   [Alblas, J.] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
   [Marchioli, G.; Karperien, M. B. J.; Moroni, L.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Stamatialis, D.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM a.a.vanapeldoorn@utwente.nl
RI Moroni, Lorenzo/D-2826-2014; van Gurp, Leon/M-1218-2016
OI Moroni, Lorenzo/0000-0003-1298-6025; van Gurp, Leon/0000-0002-6281-5964;
   Alblas, Jacqueline/0000-0002-2996-9697
FU Dutch Diabetes research foundation; Ministry of economical affairs (FES
   program) of the Netherlands
FX This research is part of the Diabetes Cell Therapy Initiative (DCTI) and
   funded by the Dutch Diabetes research foundation and the Ministry of
   economical affairs (FES program) of the Netherlands. The authors
   acknowledge Dr Paul the Vos for kindly providing the ultrapure alginate.
CR Benhamou PY, 2001, DIABETOLOGIA, V44, P859
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   BILLAUDEL B, 1982, J ENDOCRINOL, V95, P315, DOI 10.1677/joe.0.0950315
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Buitinga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064772
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Daoud JT, 2011, BIOMATERIALS, V32, P1536, DOI 10.1016/j.biomaterials.2010.10.036
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2473, DOI [10.1089/ten.tea.2011.0001, 10.1089/ten.TEA.2011.0001]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Fraga DW, 1998, TRANSPLANTATION, V65, P1060, DOI 10.1097/00007890-199804270-00009
   HALES CN, 1968, J PHYSIOL-LONDON, V199, P177, DOI 10.1113/jphysiol.1968.sp008647
   HANNOUN BJM, 1986, BIOTECHNOL BIOENG, V28, P829, DOI 10.1002/bit.260280609
   Hockaday L A, 2012, BIOFABRICATION, V4, P1758
   Hunt NC, 2009, BIOMATERIALS, V30, P6435, DOI 10.1016/j.biomaterials.2009.08.014
   Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65
   Lee W, 2009, NEUROREPORT, V20, P798, DOI 10.1097/WNR.0b013e32832b8be4
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108
   Lin CC, 2009, BIOMACROMOLECULES, V10, P2460, DOI 10.1021/bm900420f
   LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065
   Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110
   Mallett AG, 2009, TISSUE ENG PT A, V15, P1301, DOI 10.1089/ten.tea.2008.0118
   Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030
   Masuda K, 2003, J ORTHOPAED RES, V21, P922, DOI 10.1016/S0736-0266(03)00037-8
   Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099
   Nyqvist D, 2011, DIABETES, V60, P2571
   Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008
   Park SA, 2011, BIOPROC BIOSYST ENG, V34, P505, DOI 10.1007/s00449-010-0499-2
   Pedraza E, 2013, CELL TRANSPLANT, V22, P1123, DOI 10.3727/096368912X657440
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   PROKS P, 1995, J PHYSIOL-LONDON, V487, P465, DOI 10.1113/jphysiol.1995.sp020893
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rutherford SW, 1997, ADSORPTION, V3, P283, DOI 10.1007/BF01653631
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomatei-ials.2007.09.032
   Seyednejad H, 2011, ACTA BIOMATER, V7, P1999, DOI 10.1016/j.actbio.2011.01.018
   Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Simpson NE, 2006, BIOMATERIALS, V27, P2577, DOI 10.1016/j.biomaterials.2005.11.042
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118
   Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1016/S0039-6060(99)70169-8
   Turco G, 2001, BIOMACROMOLECULES, V12, P1272
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   Xu T, 2009, TISSUE ENG PT A, V15, P95, DOI 10.1089/ten.tea.2008.0095
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 61
TC 37
Z9 40
U1 2
U2 42
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2015
VL 7
IS 2
AR 025009
DI 10.1088/1758-5090/7/2/025009
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CZ1WJ
UT WOS:000366896300009
PM 26019140
DA 2018-10-20
ER

PT J
AU Othman, R
   Morris, GE
   Shah, DA
   Hall, S
   Hall, G
   Wells, K
   Shakesheff, KM
   Dixon, JE
AF Othman, Rebeen
   Morris, Gavin E.
   Shah, Disheet A.
   Hall, Stephen
   Hall, Graham
   Wells, Keith
   Shakesheff, Kevin M.
   Dixon, James E.
TI An automated fabrication strategy to create patterned tubular
   architectures at cell and tissue scales
SO BIOFABRICATION
LA English
DT Article
DE vessel; fabrication; multilayer; tissue; patterning; PNIPAAM
ID ARTIFICIAL BLOOD-VESSEL; PLURIPOTENT STEM-CELLS; AIRWAY SMOOTH-MUSCLE;
   IN-VITRO; MECHANICAL-PROPERTIES; VASCULAR-SURGERY; TIGHT JUNCTION;
   SHEETS; ARTERIES; DISEASE
AB The use of materials to impose tissue-like architecture at cell resolution will be important if engineered functional replacements for damaged cardiovascular, pulmonary, renal or digestive tissues are to be authentically engineered. Here, we demonstrate a coordinated system for the fabrication and subsequent culture of tubular tissues composed of multiple layers, cell-types and materials with physiological dimensions and defined architectures at cell resolution. We developed an automated tube fabricator that rolls 2D-matrices into 3D-tubular constructs directly from cells, hydrogels and scaffold biomaterials. Coordinated use of surface modification strategies allows 2D cell sheets and cell/biomaterial composites (i.e. hydrogels or electrospun scaffolds) to be fabricated which may be transferred into a perfusion bioreactor in a rapid and standardized procedure. To exemplify our strategy we fabricated structures resembling human mammary artery and gut; these can be imaged in situ and real-time electrical resistance measurements performed of the vessel walls, allowing non-invasive assessment of viability and functionality. Our system allows patterning at cellular resolution with variable tissue thickness, length, luminal diameter, and constituent biomaterial. This inherent flexibility will allow the recapitulation of the complex hierarchical biological architectures and generate functionality found natively in vivo.
C1 [Othman, Rebeen; Morris, Gavin E.; Shah, Disheet A.; Shakesheff, Kevin M.; Dixon, James E.] Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling ST, Sch Pharm, Nottingham NG7 2RD, England.
   [Hall, Stephen] Univ Nottingham, Sch Med, Med Engn Unit, Nottingham NG7 2RD, England.
   [Hall, Graham] Tannlin Ltd, Irvine KA1 2DJ, Scotland.
   [Wells, Keith] Trent Thermal Technol, Nottingham NG7 2QP, England.
RP Othman, R (reprint author), Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling ST, Sch Pharm, Nottingham NG7 2RD, England.
EM kevin.shakesheff@nottingham.ac.uk
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Shah, Disheet/0000-0002-8229-0835
FU ERC; UKRMP; Biotechnology and Biological Sciences Research Council
   [BB/F020619/1]
FX This work was funded by the ERC and UKRMP. We thank Tannlin Ltd for
   stencil manufacture and the University of Nottingham Medical Engineering
   Unit (MEU) in the design and manufacture of the ATF and accessories. We
   thank WPI Ltd for helpful discussions to develop real-time tube
   resistance measurements.
CR Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC
   CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   Dixon JE, 2014, P NATL ACAD SCI USA, V111, P5580, DOI 10.1073/pnas.1319685111
   Dixon JE, 2011, MOL THER, V19, P1695, DOI 10.1038/mt.2011.125
   DOBRIN PB, 1978, PHYSIOL REV, V58, P397
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163
   Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319
   Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Karaman B, 2012, DIAGN INTERV RADIOL, V18, P215, DOI 10.4261/1305-3825.DIR.4788-11.1
   Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC
   Kheirabadi BS, 2006, J INVEST SURG, V19, P387, DOI 10.1080/08941930600985744
   Kim MJ, 2008, MACROMOL RES, V16, P345, DOI 10.1007/BF03218527
   Kubo H, 2007, BIOMATERIALS, V28, P3508, DOI 10.1016/j.biomaterials.2007.04.016
   Kwak YK, 2012, INFECT IMMUN, V80, P1670, DOI 10.1128/IAI.00001-12
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   McAllister TN, 2006, USPatent, Patent No. [7744526 B2, 7744526]
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Morris GE, 2014, AM J PHYSIOL-LUNG C, V307, pL38, DOI 10.1152/ajplung.00318.2013
   Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Paik I, 2012, BIOTECHNOL BIOENG, V109, P2630, DOI 10.1002/bit.24529
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Patterson JT, 2012, REGEN MED, V7, P409, DOI [10.2217/RME.12.12, 10.2217/rme.12.12]
   Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406
   Rhodin R A J, 1980, HDB PHYSL CARDIOVASC, P1
   Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Shum- Tim D, 1999, ANN THORAC SURG, V68, P2305
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   Wang S, 2013, INT J NANOMED, V8, P2131, DOI 10.2147/IJN.S44956
   Williams C, 2011, BIOMATERIALS, V32, P5625, DOI 10.1016/j.biomaterials.2011.04.050
   Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027
   Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
NR 49
TC 2
Z9 3
U1 5
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2015
VL 7
IS 2
AR 025003
DI 10.1088/1758-5090/7/2/025003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CZ1WJ
UT WOS:000366896300003
PM 25869447
DA 2018-10-20
ER

PT J
AU Hazra, S
   Chowdhury, S
   Guha, R
   Naskar, D
   Pradhan, N
   Kundu, S
   Konar, A
AF Hazra, Sarbani
   Chowdhury, Sushovan
   Guha, Rajdeep
   Naskar, Deboki
   Pradhan, Nirparaj
   Kundu, Subhas
   Konar, Aditya
TI Antheraea mylitta silk films with natural RGD sequence supports corneal
   cell proliferation: A promising new biomaterial for corneal regeneration
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Hazra, Sarbani; Pradhan, Nirparaj] West Bengal Univ Anim & Fishery Sci, Vet Surg & Radiol, Kolkata, India.
   [Chowdhury, Sushovan; Guha, Rajdeep; Konar, Aditya] CSIR IICB, Kolkata, India.
   [Naskar, Deboki; Kundu, Subhas] IIT Kharagpur, Kharagpur, W Bengal, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 3470
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5ZY
UT WOS:000362891101109
DA 2018-10-20
ER

PT J
AU Griffith, GL
   Wirostko, BM
   Lee, HK
   Zamora, DO
   Johnson, AJ
AF Griffith, Gina L.
   Wirostko, Barbara M.
   Lee, Hee-Kyoung
   Zamora, David O.
   Johnson, Anthony James
TI Model development: Use of a biocompatible thiolated hyaluronic acid
   biomaterial for the treatment of corneal epithelial wounds
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Griffith, Gina L.; Zamora, David O.; Johnson, Anthony James] US Army Inst Surg Res, Ocular Trauma, Ft Sam Houston, TX USA.
   [Wirostko, Barbara M.; Lee, Hee-Kyoung] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA.
   [Wirostko, Barbara M.; Lee, Hee-Kyoung] Jade Therapeut Inc, Salt Lake City, UT USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 3089
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882207252
DA 2018-10-20
ER

PT J
AU Mehta, JS
   Thompson, B
   Konstantopoulos, A
   Goh, G
   Setiawan, M
   Tan, D
   Khor, K
AF Mehta, Jodhbir S.
   Thompson, Brianna
   Konstantopoulos, Aris
   Goh, Gwen
   Setiawan, Melina
   Tan, Donald
   Khor, K.
TI Biocompatibility of Graphene as Candidate Biomaterial for Synthetic
   Keratoprosthesis Skirt
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 1124
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882203033
DA 2018-10-20
ER

PT J
AU Tse, HM
   Padgett, LE
   Kozlovskaya, V
   Kharlampieva, E
   Burg, AR
AF Tse, Hubert M.
   Padgett, Lindsey E.
   Kozlovskaya, Veronika
   Kharlampieva, Eugenia
   Burg, Ashley R.
TI Islet Encapsulation with Immunomodulatory Nanothin Biomaterial Coatings
SO DIABETES
LA English
DT Meeting Abstract
CT 75th Scientific Sessions of the American-Diabetes-Association
CY JUN 05-09, 2015
CL Boston, MA
SP Amer Diabet Assoc
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD JUN
PY 2015
VL 64
SU 1
MA 1844-P
BP A476
EP A477
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CO9GN
UT WOS:000359482702367
DA 2018-10-20
ER

PT J
AU Mehdikhani, B
   Borhani, GH
AF Mehdikhani, Behzad
   Borhani, Gholam Hossein
TI Synthesis nano bio-ceramic powder beta-Ca2P2O7
SO JOURNAL OF CERAMIC PROCESSING RESEARCH
LA English
DT Article
DE biomaterial; nano powder; beta-pyro calcium phosphate; Sol gel; FTIR
   spectroscopy
ID BETA-TRICALCIUM PHOSPHATE; CALCIUM-PHOSPHATE; PROSTHETIC APPLICATIONS;
   HYDROXYAPATITE; BONE; NANOPARTICLES; BEHAVIOR; TCP
AB Nano-size beta calcium pyrophosphate(beta-Ca2P2O7) powders with average grain size of 80 nm were prepared by sol gel method with calcium nitrate 4-hydrateCa(NO3)(2)center dot 4H(2)O and different amount of diammonium hydrogen phosphate (NH4)(2)HPO4(0.4 and 0.6 molar) as calcium and phosphorus precursors. The pH of the system was maintained up to (pH = 10) by the adding of sodium hydroxide. The white precipitate stirred for 2 hour and washed with distilled water and filtered. Filtered cake was dried at 80 degrees C and calcined at 600 degrees C. The dried and calcined powders were characterized for phase composition using X-ray diffractrometry (XRD) and Fourier transform-infrared spectroscopy (FTIR). The particle size and morphology was studied using scanning electron microscopy (SEM).
C1 [Mehdikhani, Behzad; Borhani, Gholam Hossein] Malek Ashtar Ind Univ, Dept Mat, Tehran, Iran.
   [Mehdikhani, Behzad] Standard Res Inst, Bldg & Construct Dept, Tehran, Iran.
RP Mehdikhani, B (reprint author), Malek Ashtar Ind Univ, Dept Mat, Tehran, Iran.
EM mehdikhani@standard.ac.ir
FU ceramic department (International University of Iran)
FX The authors are indebted to ceramic laboratory in institute of standard
   and industrial research of Iran, that supplied the raw materials for the
   development of this research and to ceramic department (International
   University of Iran) for its financial support.
CR Aili W., 2007, J MAT SC ENG, P865
   AKAO M, 1982, J MATER SCI, V17, P343, DOI 10.1007/BF00591468
   Albee FH, 1920, ANN SURG, V71, P32
   Amjad Z, 1998, CALCIUM PHOSPHATES B, P145
   Azaroff L. A., 1968, ELEMENTS XRAY CRYSTA, P38
   Bigi A, 1997, J INORG BIOCHEM, V66, P259, DOI 10.1016/S0162-0134(96)00219-X
   Dasgupta S., 2008, NANOSTRUCTURE HYDROX
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   Deepak K., 2007, J MAT SCI ENG C, P684
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   Elliot J. C., 1998, MATERIAUX PHOSPHATE, V5, P25
   Elliott J.C., 1994, STUDIES INORGANIC CH, V18, P112
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   ITATANI K, 1994, J AM CERAM SOC, V77, P801, DOI 10.1111/j.1151-2916.1994.tb05368.x
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   KITSUGI T, 1993, BIOMATERIALS, V14, P216, DOI 10.1016/0142-9612(93)90026-X
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Legeros R.Z., 1991, CLACIUM PHOSPHATES O, P85
   Lemos A. F., 2005, J KEY ENG MAT, P284
   Levitt G. W., 1969, J BIOMEDICAL MAT RES, P683
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li W., 2009, J NANOPART RES, P691
   Liou SC, 2002, BIOMATERIALS, V23, P4541, DOI 10.1016/S0142-9612(02)00198-9
   Martin CL, 2006, J AM CERAM SOC, V89, P3379, DOI 10.1111/j.1551-2916.2006.01249.x
   MARTIN RI, 1994, J MATER SCI-MATER M, V5, P96, DOI 10.1007/BF00121697
   Mehdikhani B, 2012, J CERAM PROCESS RES, V13, P486
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Pan Y, 2003, J MATER SCI, V38, P1049, DOI 10.1023/A:1022354015226
   RADIN SR, 1994, J BIOMED MATER RES, V28, P1303, DOI 10.1002/jbm.820281108
   Ratner B. D, 1996, BIOMATERIALS SCI INT, P81
   Rautaray D, 2005, LANGMUIR, V21, P5185, DOI 10.1021/la048541f
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Uota M, 2005, LANGMUIR, V21, P4724, DOI 10.1021/la050029m
   Vallet-Regy M., 2004, J SOLID STATE IONICS, P445
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Yokogawa Y., 1991, J CERAM SOC JPN, P28
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zyman Z, 2001, J BIOMED MATER RES, V54, P256, DOI 10.1002/1097-4636(200102)54:2<256::AID-JBM13>3.3.CO;2-2
   ZYMAN Z, 1994, BIOMATERIALS, V15, P151, DOI 10.1016/0142-9612(94)90265-8
NR 43
TC 4
Z9 4
U1 0
U2 6
PU KOREAN ASSOC CRYSTAL GROWTH, INC
PI SEOUL
PA SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA
SN 1229-9162
J9 J CERAM PROCESS RES
JI J. Ceram. Process. Res.
PD JUN
PY 2015
VL 16
IS 3
BP 308
EP 312
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA CQ8BV
UT WOS:000360832100006
DA 2018-10-20
ER

PT J
AU Wetie, AGN
   Wormwood, KL
   Russell, S
   Ryan, JP
   Darie, CC
   Woods, AG
AF Wetie, Armand G. Ngounou
   Wormwood, Kelly L.
   Russell, Stefanie
   Ryan, Jeanne P.
   Darie, Costel C.
   Woods, Alisa G.
TI A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum
   Disorder
SO AUTISM RESEARCH
LA English
DT Article
DE ASD; proteomics; biomarker signature; early detection; diagnosis
ID INTENSIVE BEHAVIORAL INTERVENTION; PROTEIN-PROTEIN INTERACTIONS;
   MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; CLINICAL-IMPLICATIONS;
   INTERACTION NETWORKS; CHILDREN; IDENTIFICATION; RECEPTOR; MARKERS
AB Autism spectrum disorder (ASD) prevalence is increasing, with current estimates at 1/68-1/50 individuals diagnosed with an ASD. Diagnosis is based on behavioral assessments. Early diagnosis and intervention is known to greatly improve functional outcomes in people with ASD. Diagnosis, treatment monitoring and prognosis of ASD symptoms could be facilitated with biomarkers to complement behavioral assessments. Mass spectrometry (MS) based proteomics may help reveal biomarkers for ASD. In this pilot study, we have analyzed the salivary proteome in individuals with ASD compared to neurotypical control subjects, using MS-based proteomics. Our goal is to optimize methods for salivary proteomic biomarker discovery and to identify initial putative biomarkers in people with ASDs. The salivary proteome is virtually unstudied in ASD, and saliva could provide an easily accessible biomaterial for analysis. Using nano liquid chromatography-tandem mass spectrometry, we found statistically significant differences in several salivary proteins, including elevated prolactin-inducible protein, lactotransferrin, Ig kappa chain C region, Ig gamma-1 chain C region, Ig lambda-2 chain C regions, neutrophil elastase, polymeric immunoglobulin receptor and deleted in malignant brain tumors 1. Our results indicate that this is an effective method for identification of salivary protein biomarkers, support the concept that immune system and gastrointestinal disturbances may be present in individuals with ASDs and point toward the need for larger studies in behaviorally-characterized individuals. (C) 2015 International Society for Autism Research, Wiley Periodicals, Inc.
C1 [Wetie, Armand G. Ngounou; Wormwood, Kelly L.; Darie, Costel C.; Woods, Alisa G.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.
   [Russell, Stefanie; Ryan, Jeanne P.; Woods, Alisa G.] SUNY Coll Plattsburgh, Neuropsychol Clin, Plattsburgh, NY 12901 USA.
   [Russell, Stefanie; Ryan, Jeanne P.; Woods, Alisa G.] SUNY Coll Plattsburgh, Psychoeduc Serv, Plattsburgh, NY 12901 USA.
RP Woods, AG (reprint author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, 8 Clarkson Ave, Potsdam, NY 13699 USA.
EM awoods@clarkson.edu
FU Shire Development, LLC; Redcay Foundation; David A. Walsh fellowship;
   U.S. Army research office [W911NF-11-1-0304]; Sci-Fund Challenge 3
   Donors
FX This study was supported by a grant from Shire Development, LLC, the
   Redcay Foundation, the David A. Walsh fellowship, the U.S. Army research
   office (DURIP grant #W911NF-11-1-0304) and the generosity of Sci-Fund
   Challenge 3 Donors. Special thanks to ICare4Autism, Chris McDonough,
   PhD, BCBA, Douglas Barnaby, MD, and Jonathan Rubin, MD for their
   continued support. The authors appreciate the assistance of Patricia
   Egan, PhD, BCBA-D, of the SUNY Plattburgh Autism Intervention Programs.
   The authors would like to give special thanks to the families and
   individuals who participated in this study. All authors declare that
   they have no conflicts of interest related to this work.
CR Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22
   Andreescu S, 2011, ACS SYM SER, V1083, P1, DOI 10.1021/bk-2011-1083
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Aubert Y, 2013, J SEX MED, V10, P1461, DOI 10.1111/jsm.12131
   Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017
   Blumberg S. J., 2013, NATL HLTH STAT REPOR, V65, P1
   Braunschweig D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.50
   Broek JAC, 2014, INT J NEUROPSYCHOPH, V17, P651, DOI 10.1017/S146114571300117X
   Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088
   Chen CL, 2013, J PROTEOMICS, V85, P28, DOI 10.1016/j.jprot.2013.04.024
   Conciatori M, 2004, BIOL PSYCHIAT, V55, P413, DOI 10.1016/j.biopsych.2003.10.005
   Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943
   Darie CC, 2011, PROTEOMICS, V11, P4514, DOI 10.1002/pmic.201000819
   Dawson G, 2010, CURR OPIN NEUROL, V23, P95, DOI 10.1097/WCO.0b013e3283377644
   Dereu M, 2012, EUR CHILD ADOLES PSY, V21, P541, DOI 10.1007/s00787-012-0280-y
   Donadio E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071874
   DORING G, 1994, AM J RESP CRIT CARE, V150, pS114
   Eikeseth S, 2012, RES AUTISM SPECT DIS, V6, P829, DOI 10.1016/j.rasd.2011.09.002
   Eldevik S, 2009, J CLIN CHILD ADOLESC, V38, P439, DOI 10.1080/15374410902851739
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P169, DOI 10.1007/s00787-009-0076-x
   Gesundheit B, 2013, J AUTOIMMUN, V44, P1, DOI 10.1016/j.jaut.2013.05.005
   Hassan MI, 2009, CELL MOL LIFE SCI, V66, P447, DOI 10.1007/s00018-008-8463-x
   Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775
   Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37
   Katz R., 2004, J AM SOC EXPT NEUROT, V1, P189, DOI DOI 10.1602/NEURORX.1.2.189
   Loo JA, 2010, J DENT RES, V89, P1016, DOI 10.1177/0022034510380414
   LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3
   Martirosian G, 2011, ANAEROBE, V17, P43, DOI 10.1016/j.anaerobe.2010.12.003
   Momeni N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.19
   Momeni N., 2012, AUTISM RES TREAT, V2012
   Mu YB, 2013, ELECTROPHORESIS, V34, P1679, DOI 10.1002/elps.201200596
   Muller H, 2012, ARTERIOSCL THROM VAS, V32, P442, DOI 10.1161/ATVBAHA.111.239830
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Noriega DB, 2014, EUR J PEDIATR, V173, P33, DOI 10.1007/s00431-013-2183-4
   O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989
   Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102
   Sokolowska I, 2013, J MOL PSYCHIAT, V1, P8, DOI DOI 10.1186/2049-9256-1-8
   Sokolowska I., J NEURAL TRANSMISSIO
   Sokolowska I, 2013, CELL MOL LIFE SCI, V70, P2835, DOI 10.1007/s00018-012-1185-0
   Sokolowska I, 2012, FEBS J, V279, P2579, DOI 10.1111/j.1742-4658.2012.08641.x
   State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924
   Steeb H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-4
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Talkowski ME, 2014, HARVARD REV PSYCHIAT, V22, P65, DOI 10.1097/HRP.0000000000000002
   Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199
   Theoharides TC, 2013, CLIN THER, V35, P584, DOI 10.1016/j.clinthera.2013.04.009
   Van Schalkwyk G. I., J AUTISM DEV DISORDE
   Walker EF, 2013, BIOL PSYCHIAT, V74, P410, DOI 10.1016/j.biopsych.2013.02.016
   Wetie AGN, 2014, ELECTROPHORESIS, V35, P2046, DOI 10.1002/elps.201300370
   Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1
   Wetie AGN, 2013, JALA-J LAB AUTOM, V18, P19, DOI 10.1177/2211068212454738
   Wetie AGN, 2013, PROTEOMICS, V13, P538, DOI 10.1002/pmic.201200328
   Wilcken B, 2012, PATHOLOGY, V44, P73, DOI 10.1097/PAT.0b013e32834e843f
   Wingate M, 2014, MMWR SURVEILL SUMM, V63, P1
   Woods Alisa G, 2013, J Mol Psychiatry, V1, P6, DOI 10.1186/2049-9256-1-6
   Woods AG, 2012, J CELL MOL MED, V16, P1184, DOI 10.1111/j.1582-4934.2012.01543.x
   Woods AG, 2012, BIOCHEM BIOPH RES CO, V419, P305, DOI 10.1016/j.bbrc.2012.02.016
   Wu S, 2014, PROTEOMICS, V14, P1211, DOI 10.1002/pmic.201300378
   Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024
   Zwaigenbaum L, 2010, CURR OPIN NEUROL, V23, P97, DOI 10.1097/WCO.0b013e3283372430
NR 61
TC 26
Z9 26
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-3792
EI 1939-3806
J9 AUTISM RES
JI Autism Res.
PD JUN
PY 2015
VL 8
IS 3
BP 338
EP 350
DI 10.1002/aur.1450
PG 13
WC Behavioral Sciences; Psychology, Developmental
SC Behavioral Sciences; Psychology
GA CQ2QQ
UT WOS:000360446600010
PM 25626423
DA 2018-10-20
ER

PT J
AU Aperador, W
   Delgado, A
   Vera, E
AF Aperador, W.
   Delgado, A.
   Vera, E.
TI Tribological and Corrosion Behaviors of Titanium Carbonitride Coatings
   in Simulated Biological Fluid
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE titanium carbonitride; wear; corrosion; biomaterial
ID NITRIDE; WEAR; EROSION; ALLOY; FILMS
AB This article contributes to the study of the behavior of the hard coating titanium carbonitride (TiCN) obtained by the technique physical vapor deposition (PVD), using as substrate Bio-medical grade stainless steel 316LVM. The evaluation was conducted using a tribometer, subsequently the electrochemical properties were evaluated by techniques of electrochemical impedance spectroscopy and polarization curves, Finally, a test is made tribocorrosion, by combining these two trials and in a simulated biological fluid. Techniques of scanning electron microscopy and XRD were used to characterize the coatings. TiCN coatings, showed improved performance against corrosion phenomena and abrasive wear than steel 316LVM.
C1 [Aperador, W.; Delgado, A.] Univ Militar Nueva Granada, Sch Engn, Bogota, Colombia.
   [Vera, E.] Univ Pedagog & Tecnol Colombia, Tunja, Colombia.
RP Aperador, W (reprint author), Univ Militar Nueva Granada, Sch Engn, Bogota, Colombia.
EM g.ing.materiales@gmail.com
OI Vera Lopez, Enrique/0000-0003-4150-9308
FU Universidad Militar Nueva Granada [ING-1775-2015]
FX Thanks the financial support from the Universidad Militar Nueva Granada,
   contract number ING-1775-2015.
CR Abd El-Rahman AM, 2014, SURF COAT TECH, V258, P320, DOI 10.1016/j.surfcoat.2014.09.006
   Ajikumar PK, 2014, CERAM INT, V40, P10523, DOI 10.1016/j.ceramint.2014.03.027
   Ajikumar PK, 2012, CERAM INT, V38, P2253, DOI 10.1016/j.ceramint.2011.10.075
   Aperador William, 2014, Advanced Materials Research, V1016, P320, DOI 10.4028/www.scientific.net/AMR.1016.320
   Bansal DG, 2011, WEAR, V271, P2006, DOI 10.1016/j.wear.2010.11.021
   Borkar T, 2014, J ALLOY COMPD, V617, P933, DOI 10.1016/j.jallcom.2014.08.049
   Buchholz S, 2012, INT J REFRACT MET H, V33, P44, DOI 10.1016/j.ijrmhm.2012.02.008
   Cai F, 2015, WEAR, V324, P27, DOI 10.1016/j.wear.2014.11.008
   Caicedo JC, 2011, THIN SOLID FILMS, V519, P6362, DOI 10.1016/j.tsf.2011.04.035
   Calderon V. S., 2015, J MECH BEHAV BIOMED, V41, P83
   Forn A, 2001, INT J REFRACT MET H, V19, P507, DOI 10.1016/S0263-4368(01)00027-0
   Guu YY, 1996, SURF COAT TECH, V85, P146, DOI 10.1016/0257-8972(95)02737-8
   Guu YY, 1996, THIN SOLID FILMS, V287, P16, DOI 10.1016/S0040-6090(95)08496-7
   Hassani S, 2010, SURF COAT TECH, V205, P1426, DOI 10.1016/j.surfcoat.2010.07.098
   Hogmark S, 2000, WEAR, V246, P20, DOI 10.1016/S0043-1648(00)00505-6
   Munteanu D, 2011, TRIBOL INT, V44, P820, DOI 10.1016/j.triboint.2011.02.004
   Wei CH, 2001, THIN SOLID FILMS, V381, P104, DOI 10.1016/S0040-6090(00)01541-8
   Zhang J, 2013, APPL SURF SCI, V280, P626, DOI 10.1016/j.apsusc.2013.05.037
   Zhang XH, 2014, J ALLOY COMPD, V617, P81, DOI 10.1016/j.jallcom.2014.08.009
NR 19
TC 1
Z9 1
U1 0
U2 37
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JUN
PY 2015
VL 10
IS 6
BP 4473
EP 4481
PG 9
WC Electrochemistry
SC Electrochemistry
GA CN5OF
UT WOS:000358477900001
DA 2018-10-20
ER

PT J
AU Nitta, S
   Kaketani, S
   Iwamoto, H
AF Nitta, Sachiko
   Kaketani, Shinobu
   Iwamoto, Hiroyuki
TI Development of chitosan-nanofiber-based hydrogels exhibiting high
   mechanical strength and pH-responsive controlled release
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Chitosan; Nanofiber; Hydrogel; pH-responsive controlled release
ID CONTROLLED DRUG-DELIVERY; BIOMATERIAL; ELASTICITY; CELLULOSE; SYSTEM;
   POLYSACCHARIDE; COPOLYMER; MATRIX; CELLS
AB Developing naturally derived polymer-based hydrogels with high mechanical strength and a controlled release of loaded bioactive substances is essential in biomedicine and tissue engineering. Here, we report the fabrication of chitosan nanofiber (CNF)-based hydrogels (CNF-poly(ethylene glycol) (PEG) hydrogel) with a semi-penetrating network structure comprising CNF and chemically-crosslinkable PEG diacrylate (PEGDA). Scanning electron microscopy revealed a micro-porous structure, resulting from PEGDA gelation aligned with the bundles of CNF. CNF addition enhanced compressive rupture stress and Young's modulus, indicating that it strengthened the PEGDA hydrogels. Bovine serum albumin (BSA) was encapsulated in CNF-PEG hydrogels probably via the hydrophobic interaction between CNF and BSA. A pH decrease from 7.4 to 5.6 caused accelerated BSA release from the hydrogels due to the difference in their swelling degrees. These results indicated that CNF-PEG hydrogels could be utilized as a carrier for bioactive substances that demonstrates controlled release behavior and improved mechanical properties. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Nitta, Sachiko; Kaketani, Shinobu; Iwamoto, Hiroyuki] Fukuyama Univ, Dept Biotechnol, Fukuyama, Hiroshima 7290292, Japan.
RP Nitta, S (reprint author), Fukuyama Univ, Dept Biotechnol, 1 Sanzo,Gakuen Cho, Fukuyama, Hiroshima 7290292, Japan.
EM nitta@fubac.fukuyama-u.ac.jp
FU MEXT-Supported Program for the Strategic Research Foundation; Japan
   Society for the Promotion of Science Research Fellowships for Young
   Scientist
FX This work was supported by MEXT-Supported Program for the Strategic
   Research Foundation at Private Universities. S.N. was supported by a
   Japan Society for the Promotion of Science Research Fellowships for
   Young Scientist.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Aouada FA, 2011, J AGR FOOD CHEM, V59, P9433, DOI 10.1021/jf202347h
   Banquy X, 2009, SOFT MATTER, V5, P3984, DOI 10.1039/b821583a
   Bekale L, 2015, COLLOID SURFACE B, V125, P309, DOI 10.1016/j.colsurfb.2014.11.037
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chu XH, 2009, BIOTECHNOL LETT, V31, P347, DOI 10.1007/s10529-008-9892-1
   Dan K., 2012, NANOTECHNOLOGY, V23
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dutta AK, 2013, CARBOHYD POLYM, V97, P363, DOI 10.1016/j.carbpol.2013.05.010
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   Iwamoto S, 2014, COMPOS PART A-APPL S, V59, P26, DOI 10.1016/j.compositesa.2013.12.011
   Li W, 2008, EUR POLYM J, V44, P3688, DOI 10.1016/j.eurpolymj.2008.08.020
   Li XM, 2012, COLLOID SURFACE B, V92, P136, DOI 10.1016/j.colsurfb.2011.11.030
   Ohkawa K, 2006, BIOMACROMOLECULES, V7, P3291, DOI 10.1021/bm0604395
   Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0
   Omidian H, 2005, J CONTROL RELEASE, V102, P3, DOI 10.1016/j.jconrel.2004.09.028
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Qiu B, 2003, BIOMATERIALS, V24, P11, DOI 10.1016/S0142-9612(02)00227-2
   Rajam M, 2011, INT J PHARMACEUT, V410, P145, DOI 10.1016/j.ijpharm.2011.02.065
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Roldo M, 2004, EUR J PHARM BIOPHARM, V57, P115, DOI 10.1016/S0939-6411(03)00157-7
   Sehaqui H, 1824, SOFT MATTER, V2010, P6
   Shi JF, 2011, LANGMUIR, V27, P14425, DOI 10.1021/la2033862
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Watanabe Y, 2011, BIOPOLYMERS, V95, P833, DOI 10.1002/bip.21686
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Yang JJ, 2010, J BIOMED MATER RES A, V95A, P531, DOI 10.1002/jbm.a.32875
NR 33
TC 11
Z9 13
U1 4
U2 58
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD JUN
PY 2015
VL 67
BP 50
EP 56
DI 10.1016/j.eurpolymj.2015.03.053
PG 7
WC Polymer Science
SC Polymer Science
GA CM5TF
UT WOS:000357750900006
DA 2018-10-20
ER

PT J
AU Takamura, T
   Ko, PJ
   Sharma, J
   Yukino, R
   Ishizawa, S
   Sandhu, A
AF Takamura, Tsukasa
   Ko, Pil Ju
   Sharma, Jaiyam
   Yukino, Ryoji
   Ishizawa, Shunji
   Sandhu, Adarsh
TI Magnetic-Particle-Sensing Based Diagnostic Protocols and Applications
SO SENSORS
LA English
DT Review
DE magnetic particles; medical diagnosis; magnetic sensor; self-assembly;
   porous silicon
ID BEADS; PLATFORM
AB Magnetic particle-labeled biomaterial detection has attracted much attention in recent years for a number of reasons; easy manipulation by external magnetic fields, easy functionalization of the surface, and large surface-to-volume ratio, to name but a few. In this review, we report on our recent investigations into the detection of nano-sized magnetic particles. First, the detection by Hall magnetic sensor with lock-in amplifier and alternative magnetic field is summarized. Then, our approach to detect sub-200 nm diameter target magnetic particles via relatively large micoro-sized "columnar particles" by optical microscopy is described. Subsequently, we summarize magnetic particle detection based on optical techniques; one method is based on the scattering of the magnetically-assembled nano-sized magnetic bead chain in rotating magnetic fields and the other one is based on the reflection of magnetic target particles and porous silicon. Finally, we report recent works with reference to more familiar industrial products (such as smartphone-based medical diagnosis systems and magnetic removal of unspecific-binded nano-sized particles, or "magnetic washing").
C1 [Takamura, Tsukasa; Sandhu, Adarsh] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Tempa Ku, Toyohashi, Aichi 4418580, Japan.
   [Ko, Pil Ju; Sandhu, Adarsh] Univ Electrocommun, Res Promot Ctr, Chofu, Tokyo 1828585, Japan.
   [Sharma, Jaiyam; Yukino, Ryoji; Ishizawa, Shunji] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Tempa Ku, Toyohashi, Aichi 4418580, Japan.
   [Sandhu, Adarsh] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan.
RP Takamura, T (reprint author), Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Tempa Ku, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM takamura@eiiris.tut.ac.jp; pjko77@uec.ac.jp; jaiyam@eiiris.tut.ac.jp;
   yukino@eiiris.tut.ac.jp; ishizawa@eiiris.tut.ac.jp; sandhu@uec.ac.jp
FU A-STEP from Japan Science and Technology Agency
FX This research was partly funded by the A-STEP grant from Japan Science
   and Technology Agency.
CR Bando M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074513
   Ko PJ, 2011, NANOSCI NANOTECH LET, V3, P612, DOI 10.1166/nnl.2011.1236
   Kumagai Y, 2006, IEEE T MAGN, V42, P3893, DOI 10.1109/TMAG.2006.879613
   Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/NMAT2815, 10.1038/nmat2815]
   Morimoto Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556957
   Morimoto Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3352584
   Morimoto Y, 2009, IEEE T MAGN, V45, P2871, DOI 10.1109/TMAG.2009.2018861
   Morimoto Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DL07
   Nishio K, 2008, COLLOID SURFACE B, V64, P162, DOI 10.1016/j.colsurfb.2008.01.013
   Ohashi T, 2008, IEEE T MAGN, V44, P3252, DOI 10.1109/TMAG.2008.2001621
   Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001
   Park SY, 2010, NANO LETT, V10, P446, DOI 10.1021/nl9030488
   Primadani Z, 2007, J APPL PHYS, V101, DOI 10.1063/1.2712962
   Sandhu A, 2004, JPN J APPL PHYS 2, V43, pL868, DOI 10.1143/JJAP.43.L868
   Togawa K, 2006, J APPL PHYS, V99, DOI 10.1063/1.2162041
   van Reenen A, 2014, LAB CHIP, V14, P1966, DOI 10.1039/c3lc51454d
NR 16
TC 4
Z9 4
U1 8
U2 40
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUN
PY 2015
VL 15
IS 6
BP 12983
EP 12998
DI 10.3390/s150612983
PG 16
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA CM7JX
UT WOS:000357869200048
PM 26053747
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Huyer, LD
   Montgomery, M
   Zhao, YM
   Xiao, Y
   Conant, G
   Korolj, A
   Radisic, M
AF Huyer, Locke Davenport
   Montgomery, Miles
   Zhao, Yimu
   Xiao, Yun
   Conant, Genevieve
   Korolj, Anastasia
   Radisic, Milica
TI Biomaterial based cardiac tissue engineering and its applications
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE cardiac tissue engineering; biomaterials; host response; in vitro drug
   screening
ID PLURIPOTENT STEM-CELL; LONG-QT SYNDROME; LEFT-VENTRICULAR FUNCTION;
   ELECTRICAL-STIMULATION; EXTRACELLULAR-MATRIX; IN-VITRO; HEART-FAILURE;
   CARDIOMYOCYTE DIFFERENTIATION; DEGRADATION CHARACTERISTICS;
   MYOCARDIAL-INFARCTION
AB Cardiovascular disease is a leading cause of death worldwide, necessitating the development of effective treatment strategies. A myocardial infarction involves the blockage of a coronary artery leading to depletion of nutrient and oxygen supply to cardiomyocytes and massive cell death in a region of the myocardium. Cardiac tissue engineering is the growth of functional cardiac tissue in vitro on biomaterial scaffolds for regenerative medicine application. This strategy relies on the optimization of the complex relationship between cell networks and biomaterial properties. In this review, we discuss important biomaterial properties for cardiac tissue engineering applications, such as elasticity, degradation, and induced host response, and their relationship to engineered cardiac cell environments. With these properties in mind, we also emphasize in vitro use of cardiac tissues for high-throughput drug screening and disease modelling.
C1 [Huyer, Locke Davenport; Montgomery, Miles; Zhao, Yimu; Xiao, Yun; Conant, Genevieve; Korolj, Anastasia; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Huyer, Locke Davenport; Montgomery, Miles; Zhao, Yimu; Xiao, Yun; Conant, Genevieve; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Radisic, Milica] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada.
   [Radisic, Milica] Univ Toronto, IBBME, Toronto, ON, Canada.
RP Huyer, LD (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
EM m.radisic@utoronto.ca
RI Xiao, Yun/N-9949-2015
FU Heart and Stoke Foundation [GIA T6946]; Canadian Institutes of Health
   Research (CIHR) Operating Grant [MOP-126027]; NSERC Discovery Grant
   [RGPIN 326982-10]; National Institutes of Health [2R01 HL076485]; Canada
   Research Chair (Tier 2); Steacie Fellowship
FX This work is funded by the Heart and Stoke Foundation GIA T6946, the
   Canadian Institutes of Health Research (CIHR) Operating Grant
   (MOP-126027), NSERC Discovery Grant (RGPIN 326982-10), and National
   Institutes of Health grant 2R01 HL076485. MR is supported by Canada
   Research Chair (Tier 2) and Steacie Fellowship.
CR Ahadian S, 2013, ORGANOGENESIS, V9, P87, DOI 10.4161/org.25121
   Badie N, 2009, BIOPHYS J, V96, P3873, DOI 10.1016/j.bpj.2009.02.019
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Barrett DG, 2010, SOFT MATTER, V6, P5026, DOI 10.1039/c0sm00476f
   Barrett DG, 2010, POLYM CHEM-UK, V1, P296, DOI 10.1039/b9py00226j
   Bellis AD, 2013, BIOTECHNOL BIOENG, V110, P563, DOI 10.1002/bit.24718
   Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.tea.2011.0341, 10.1089/ten.TEA.2011.0341]
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004
   Brutsaert DL, 1998, CARDIOVASC RES, V38, P281, DOI 10.1016/S0008-6363(98)00044-3
   Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005
   Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chan YC, 2013, J CARDIOVASC TRANSL, V6, P989, DOI 10.1007/s12265-013-9510-z
   Chen A, 2014, BIOMATERIALS, V35, P675, DOI 10.1016/j.biomaterials.2013.10.007
   Chen MX, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-93
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chitcholtan K, 2013, EXP CELL RES, V319, P75, DOI 10.1016/j.yexcr.2012.09.012
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chiu LLY, 2011, J CONTROL RELEASE, V155, P376, DOI 10.1016/j.jconrel.2011.05.026
   Chiu LLY, 2011, TISSUE ENG PT A, V17, P1465, DOI 10.1089/ten.tea.2007.0244
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   CHUONG CJ, 1991, AM J PHYSIOL, V260, pH1224
   Clements M, 2014, TOXICOL SCI, V140, P445, DOI 10.1093/toxsci/kfu084
   Clifford DM, 2012, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD006536.pub3, DOI 10.1002/14651858.CD006536.PUB3]
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Dykens JA, 2007, EXPERT REV MOL DIAGN, V7, P161, DOI 10.1586/14737159.7.2.161
   Eschenhagen T, 2006, CIRC RES, V98, P573, DOI 10.1161/01.RES.0000215627.13049.5d
   Fleischer S, 2014, NANOSCALE, V6, P9410, DOI 10.1039/c4nr00300d
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Frobel J, 2014, STEM CELL REP, V3, P414, DOI 10.1016/j.stemcr.2014.07.003
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531
   Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a
   Guo L, 2013, TOXICOL SCI, V136, P581, DOI 10.1093/toxsci/kft205
   Guo L, 2013, IEEE T BIOMED CIRC S, V7, P1, DOI 10.1109/TBCAS.2012.2192932
   Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hoshi RA, 2009, ADV MATER, V21, P188, DOI 10.1002/adma.200801132
   Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747
   Iyer RK, 2012, TISSUE ENG PT A, V18, P1771, DOI [10.1089/ten.tea.2011.0468, 10.1089/ten.TEA.2011.0468]
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Johnston ID, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035017
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04670
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799
   Kimura T, 1985, Kokubyo Gakkai Zasshi, V52, P558
   Lamore SD, 2013, TOXICOL SCI, V135, P402, DOI 10.1093/toxsci/kft167
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lasher R. A., 2012, J TISSUE ENG, V3
   Lee J H, 2012, J DRUG DELIV, V2012
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Levine E, 2008, CLEV CLIN J MED, V75, P591, DOI 10.3949/ccjm.75.8.591
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883
   Liau B, 2012, REGEN MED, V7, P187, DOI [10.2217/rme.11.122, 10.2217/RME.11.122]
   Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041
   Lovitt Carrie J, 2014, Biology (Basel), V3, P345, DOI 10.3390/biology3020345
   Ma DR, 2013, INT J CARDIOL, V168, P5277, DOI 10.1016/j.ijcard.2013.08.015
   Ma Z, 2014, BIOMATERIALS, V35, P1367, DOI 10.1016/j.biomaterials.2013.10.052
   MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4
   Maeda H, 2003, J CONTROL RELEASE, V90, P59, DOI 10.1016/S0168-3659(03)00158-5
   Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378
   Mendias CL, 2005, FASEB J, V19, pA1118
   Mooney E, 2012, BIOMATERIALS, V33, P6132, DOI 10.1016/j.biomaterials.2012.05.032
   Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679
   Mukherjee S, 2011, J MATER SCI-MATER M, V22, P1689, DOI 10.1007/s10856-011-4351-2
   Mullard A, 2014, NAT REV DRUG DISCOV, V13, P873, DOI 10.1038/nrd4487
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Natarajan A, 2011, BIOMATERIALS, V32, P4267, DOI 10.1016/j.biomaterials.2010.12.022
   Nelson DM, 2014, BIOMACROMOLECULES, V15, P1, DOI 10.1021/bm4010639
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pahnke A., 2015, BIOMATERIALS CARDIAC, P71
   Piccini JP, 2009, AM HEART J, V158, P317, DOI 10.1016/j.ahj.2009.06.007
   Prabhakaran MP, 2011, MAT SCI ENG C-MATER, V31, P503, DOI 10.1016/j.msec.2010.12.017
   Qian L, 2013, NAT PROTOC, V8, P1204, DOI 10.1038/nprot.2013.067
   Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1
   Ramade A, 2014, METHOD CELL BIOL, V121, P191, DOI 10.1016/B978-0-12-800281-0.00013-0
   Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005
   Reis LA, 2016, J TISSUE ENG REGEN M, V10, P11, DOI 10.1002/term.1944
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Riegler J, 2014, CIRCULATION, V130, pS77, DOI 10.1161/CIRCULATIONAHA.113.007920
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sniadecki NJ, 2007, METHOD CELL BIOL, V83, P313, DOI 10.1016/S0091-679X(07)83013-5
   Song HN, 2011, TISSUE ENG PT A, V17, P1869, DOI [10.1089/ten.tea.2010.0617, 10.1089/ten.TEA.2010.0617]
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197
   Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   TUNG L, 1992, BIOPHYS J, V63, P371, DOI 10.1016/S0006-3495(92)81632-6
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vieira AC, 2009, J BIOMECH, V42, P2421, DOI 10.1016/j.jbiomech.2009.07.019
   Vyner MC, 2014, BIOMATERIALS, V35, P9041, DOI 10.1016/j.biomaterials.2014.07.023
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157
   Xiao Y, 2014, LAB CHIP, V14, P869, DOI 10.1039/c3lc51123e
   Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855
   Yulin X, 2012, FOLIA BIOL-PRAGUE, V58, P221
   Zhang BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494003
   Zhao YM, 2014, CAN J CARDIOL, V30, P1307, DOI 10.1016/j.cjca.2014.08.027
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zwi-Dantsis L, 2013, EUR HEART J, V34, P1575, DOI 10.1093/eurheartj/ehs096
NR 151
TC 19
Z9 19
U1 5
U2 70
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034004
DI 10.1088/1748-6041/10/3/034004
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000006
PM 25989939
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ledda, M
   De Bonis, A
   Bertani, FR
   Cacciotti, I
   Teghil, R
   Lolli, MG
   Ravaglioli, A
   Lisi, A
   Rau, JV
AF Ledda, Mario
   De Bonis, Angela
   Bertani, Francesca Romana
   Cacciotti, Ilaria
   Teghil, Roberto
   Lolli, Maria Grazia
   Ravaglioli, Antonio
   Lisi, Antonella
   Rau, Julietta V.
TI Interdisciplinary approach to cell-biomaterial interactions:
   biocompatibility and cell friendly characteristics of RKKP glass-ceramic
   coatings on titanium
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE glass-ceramics; RKKP films; CaCo-2 cell line; pulsed laser deposition;
   regenerative medicine; tissue engineering
ID INTESTINAL ALKALINE-PHOSPHATASE; BIOACTIVE GLASSES; CACO-2; MODEL; LINE;
   DIFFERENTIATION; ABSORPTION; PROTEINS; GENE
AB In this work, titanium (Ti) supports have been coated with glass-ceramic films for possible applications as biomedical implant materials in regenerative medicine. For the film preparation, a pulsed laser deposition (PLD) technique has been applied. The RKKP glass-ceramic material, used for coating deposition, was a sol-gel derived target of the following composition: Ca-19.4, P-4.6, Si-17.2, O-43.5, Na-1.7, Mg-1.3, F-7.2, K-0.2, La-0.8, Ta-4.1 (all in wt%). The prepared coatings were compact and uniform, characterised by a nanometric average surface roughness. The biocompatibility and cell-friendly properties of the RKKP glass-ceramic material have been tested. Cell metabolic activity and proliferation of human colon carcinoma CaCo-2 cells seeded on RKKP films showed the same exponential trend found in the control plastic substrates. By the phalloidin fluorescence analysis, no significant modifications in the actin distribution were revealed in cells grown on RKKP films. Moreover, in these cells a high mRNA expression of markers involved in protein synthesis, proliferation and differentiation, such as villin (VIL1), alkaline phosphatase (ALP1), beta-actin (beta-ACT), Ki67 and RPL34, was recorded. In conclusion, the findings, for the first time, demonstrated that the RKKP glass-ceramic material allows the adhesion, growth and differentiation of the CaCo-2 cell line.
C1 [Ledda, Mario; Lolli, Maria Grazia; Lisi, Antonella] Inst Translat Pharmacol IFT CNR, I-00133 Rome, Italy.
   [De Bonis, Angela; Teghil, Roberto] Univ Basilicata, Dipartimento Sci, I-85100 Potenza, Italy.
   [Bertani, Francesca Romana] ISC CNR, I-00133 Rome, Italy.
   [Cacciotti, Ilaria] Univ Roma Niccolo Cusano, I-00166 Rome, Italy.
   [Cacciotti, Ilaria] Univ Roma Tor Vergata, Dipartimento Ingn Impresa, I-00133 Rome, Italy.
   [Cacciotti, Ilaria] UdR INSTM Roma Tor Vergata, I-00133 Rome, Italy.
   [Ravaglioli, Antonio] Ceram Sci & Technol, I-48018 Faenza, Italy.
   [Rau, Julietta V.] ISM CNR, I-00133 Rome, Italy.
RP Ledda, M (reprint author), Inst Translat Pharmacol IFT CNR, Via Fosso Cavaliere 100, I-00133 Rome, Italy.
EM antonella.lisi@ift.cnr.it; giulietta.rau@ism.cnr.it
RI Rau, Julietta/E-6598-2017; Ledda, Mario/B-5656-2015; Cacciotti,
   Ilaria/K-9941-2016; Bertani, Francesca/I-5968-2016; Lisi,
   Antonella/C-7024-2015
OI Rau, Julietta/0000-0002-7953-1853; Ledda, Mario/0000-0002-0349-8938;
   Bertani, Francesca/0000-0001-6529-8993; Lisi,
   Antonella/0000-0002-5465-9500; De Bonis, Angela/0000-0002-1177-2896;
   TEGHIL, ROBERTO/0000-0002-8528-8669; Cacciotti,
   Ilaria/0000-0002-3478-6510
CR Basson MD, 1996, EXP CELL RES, V225, P301, DOI 10.1006/excr.1996.0180
   Bellucci D, 2010, SCI SINTER, V42, P307, DOI 10.2298/SOS1003307B
   BRETSCHER A, 1979, P NATL ACAD SCI USA, V76, P2321, DOI 10.1073/pnas.76.5.2321
   Cacciotti I, 2012, J MATER SCI-MATER M, V23, P1849, DOI 10.1007/s10856-012-4667-6
   Delie F, 1997, CRIT REV THER DRUG, V14, P221
   Farooq I., 2012, WORLD J DENT, V3, P199, DOI DOI 10.5005/JP-JOURNALS-10015-1156
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2013, NEW J GLASS CERAM, V3, P67, DOI DOI 10.4236/NJGC.2013.32011
   HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234
   HENTHORN PS, 1988, J BIOL CHEM, V263, P12011
   HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jones J. R, 2012, BIOGLASSES INTRO
   Krajewski A, 2005, J MATER SCI-MATER M, V16, P119, DOI 10.1007/s10856-005-5913-y
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   Ledda M, 2011, EUR REV MED PHARMACO, V15, P61
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lombardi M, 2014, CERAM INT, V41, P3371
   Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003
   Pelton AD, 1999, J NON-CRYST SOLIDS, V253, P178, DOI 10.1016/S0022-3093(99)00352-X
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rau JV, 2012, MATER RES BULL, V47, P1130, DOI 10.1016/j.materresbull.2012.02.011
   Ravaglioli A, 2008, ADV APPL CERAM, V107, P268, DOI 10.1179/174367608X341488
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025
   Zhang XH, 2003, SURGERY, V133, P429, DOI 10.1067/msy.2003.107
NR 26
TC 6
Z9 7
U1 0
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 035005
DI 10.1088/1748-6041/10/3/035005
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000019
PM 26040849
DA 2018-10-20
ER

PT J
AU Shevach, M
   Zax, R
   Abrahamov, A
   Fleischer, S
   Shapira, A
   Dvir, T
AF Shevach, Michal
   Zax, Rotem
   Abrahamov, Alona
   Fleischer, Sharon
   Shapira, Assaf
   Dvir, Tal
TI Omentum ECM-based hydrogel as a platform for cardiac cell delivery
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; COLLAGEN; DISEASE; FIBROBLASTS; CLEARANCE;
   SCAFFOLDS; HEALTH
AB Cardiovascular diseases remain the number one killer in Western countries. Despite recent advances and promising results in cardiac cell-based therapy, one of the remaining challenges is poor cell retention in the desired site. As a solution, cell delivery systems are developed to ensure that a sufficient number of viable cells reach the infarct area. These delivery systems are based on biomaterials that provide a surrogate microenvironment for the encapsulated cells, retaining them in the desired location post-delivery. Injectable thermoresponsive ECM-based hydrogels have been developed to achieve this goal. Unfortunately, the use of allogeneic or xenogeneic ECM may hamper the treatment due to an immune response to residual cellular content from the host. In this work, we have developed an omentum-based hydrogel capable of self-assembly under physiological conditions. Although in this study the omentum was obtained from porcine sources, it can be easily and safely extracted from the patient, serving as an autologous protective vehicle for the transported cells. We have characterized the biochemical composition, mechanical properties, and gelation and degradation kinetics of the processed biomaterial. Furthermore, the ability of the hydrogel to encapsulate cardiac cells and support their culture was evaluated. We envision that the newly developed platform may open new opportunities for personalized cell delivery to the heart and other tissues.
C1 [Shevach, Michal; Zax, Rotem; Abrahamov, Alona; Fleischer, Sharon; Shapira, Assaf; Dvir, Tal] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Lab Tissue Engn & Regenerat Med, IL-69978 Tel Aviv, Israel.
   [Shevach, Michal; Fleischer, Sharon; Dvir, Tal] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel.
   [Dvir, Tal] Tel Aviv Univ, Dept Mat Sci & Engn, IL-69978 Tel Aviv, Israel.
RP Shevach, M (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Lab Tissue Engn & Regenerat Med, IL-69978 Tel Aviv, Israel.
EM tdvir@post.tau.ac.il
FU Moxie Foundation; European Union; Alon Fellowship; Israel Science
   Foundation; Nicholas and Elizabeth Slezak Super Center for Cardiac
   Research and Biomedical Engineering at Tel Aviv University; NA'AMAT
   women's organization, Israel
FX T D acknowledges support from the Moxie Foundation, European Union FP7
   program (Marie Curie, CIG), Alon Fellowship, Israel Science Foundation
   and the Nicholas and Elizabeth Slezak Super Center for Cardiac Research
   and Biomedical Engineering at Tel Aviv University. M S thanks the
   NA'AMAT women's organization, Israel, for the NA'AMAT women's
   organization scholarship. This work is part of the doctoral thesis of M
   S. We would like to thank Dr Boaz Mizrahi and Ms Regina Kelmansky for
   their initial help with the rheology experiments.
CR Abe T, 2012, INT J SURG CASE REP, V3, P100, DOI 10.1016/j.ijscr.2011.11.004
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Benedicto HG, 2011, MICROSC RES TECHNIQ, V74, P1018, DOI 10.1002/jemt.20988
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Chan RW, 1998, LARYNGOSCOPE, V108, P725, DOI 10.1097/00005537-199805000-00019
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   Graham HK, 2008, ACTA PHYSIOL, V194, P3, DOI 10.1111/j.1748-1716.2008.01881.x
   Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Johnston N, 2007, LARYNGOSCOPE, V117, P1036, DOI 10.1097/M1LG.0b013e31804154c3
   Keane T J, 2014, J TISSUE ENG REGEN M, V9, P504
   Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Merenda Marcin, 2013, Pol Przegl Chir, V85, P323, DOI 10.2478/pjs-2013-0048
   Radic M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00365
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Shevach M, 2014, NANO LETT, V14, P5792, DOI 10.1021/nl502673m
   Shevach M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024101
   Shevach M, 2013, J MATER CHEM B, V1, P5210, DOI 10.1039/c3tb20584c
   Soffer-Tsur N, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035023
   Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871
   WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
NR 34
TC 11
Z9 11
U1 1
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034106
DI 10.1088/1748-6041/10/3/034106
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000014
PM 25970726
DA 2018-10-20
ER

PT J
AU Stoppel, WL
   Hu, DJ
   Domian, IJ
   Kaplan, DL
   Black, LD
AF Stoppel, Whitney L.
   Hu, Dongjian
   Domian, Ibrahim J.
   Kaplan, David L.
   Black, Lauren D., III
TI Anisotropic silk biomaterials containing cardiac extracellular matrix
   for cardiac tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE cardiomyocytes; integrins; cell infiltration; acellular scaffold
ID AMERICAN-HEART-ASSOCIATION; MESENCHYMAL STEM-CELLS; RANDOMIZED PHASE-1
   TRIAL; MYOCARDIAL-INFARCTION; SKELETAL MYOBLASTS; IN-VITRO;
   CARDIOMYOCYTES; REPAIR; REGENERATION; SCAFFOLDS
AB Cardiac malformations and disease are the leading causes of death in the United States in live-born infants and adults, respectively. In both of these cases, a decrease in the number of functional cardiomyocytes often results in improper growth of heart tissue, wound healing complications, and poor tissue repair. The field of cardiac tissue engineering seeks to address these concerns by developing cardiac patches created from a variety of biomaterial scaffolds to be used in surgical repair of the heart. These scaffolds should be fully degradable biomaterial systems with tunable properties such that the materials can be altered to meet the needs of both in vitro culture (e.g. disease modeling) and in vivo application (e.g. cardiac patch). Current platforms do not utilize both structural anisotropy and proper cell-matrix contacts to promote functional cardiac phenotypes and thus there is still a need for critically sized scaffolds that mimic both the structural and adhesive properties of native tissue. To address this need, we have developed a silk-based scaffold platform containing cardiac tissue-derived extracellular matrix (cECM). These silk-cECM composite scaffolds have tunable architectures, degradation rates, and mechanical properties. Subcutaneous implantation in rats demonstrated that addition of the cECM to aligned silk scaffold led to 99% endogenous cell infiltration and promoted vascularization of a critically sized scaffold (10 x 5 x 2.5 mm) after 4 weeks in vivo. In vitro, silk-cECM scaffolds maintained the HL-1 atrial cardiomyocytes and human embryonic stem cell-derived cardiomyocytes and promoted a more functional phenotype in both cell types. This class of hybrid silk-cECM anisotropic scaffolds offers new opportunities for developing more physiologically relevant tissues for cardiac repair and disease modeling.
C1 [Stoppel, Whitney L.; Kaplan, David L.; Black, Lauren D., III] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Hu, Dongjian; Domian, Ibrahim J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.
   [Domian, Ibrahim J.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
   [Black, Lauren D., III] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Cellular Mol & Dev Biol Program, Boston, MA 02111 USA.
RP Stoppel, WL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM lauren.black@tufts.edu
OI Black, Lauren/0000-0002-7486-5811
FU National Institutes of Health Institutional Research and Academic Career
   Development Awards program at Tufts University [K12GM074869]; NIH
   [EB002520]
FX The authors would like to acknowledge Dr William Claycomb, professor in
   the Department of Biochemistry and Molecular Biology at the Louisiana
   State University School of Medicine for his kind donation of HL-1 cells
   for use in this work. In addition, WLS would like to acknowledge funding
   from the National Institutes of Health Institutional Research and
   Academic Career Development Awards program at Tufts University
   (K12GM074869, Training in Education and Critical Research Skills
   (TEACRS)). We also thank the NIH P41 (EB002520) for support of this
   work.
CR Atmanli A, 2014, ADV HEALTHC MATER, V3, P1759, DOI 10.1002/adhm.201400010
   Black LD, 2009, TISSUE ENG PT A, V15, P3099, DOI [10.1089/ten.tea.2008.0502, 10.1089/ten.TEA.2008.0502]
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Brown JW, 2007, J THORAC CARDIOV SUR, V133, P1336, DOI 10.1016/j.jtcvs.2006.12.045
   Buckberg G, 2008, CIRCULATION, V118, P2571, DOI 10.1161/CIRCULATIONAHA.107.754424
   Buikema JW, 2013, DEVELOPMENT, V140, P4165, DOI 10.1242/dev.099325
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979
   Durrani S, 2010, REGEN MED, V5, P919, DOI [10.2217/rme.10.65, 10.2217/RME.10.65]
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Fink C, 2000, FASEB J, V14, P669
   Formigli L, 2010, CURR PHARM DESIGN, V16, P915, DOI 10.2174/138161210790883390
   French K M, 2012, FASEB J S, V26
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Gershlaka JR, 2015, EXP CELL RES, V330, P311, DOI 10.1016/j.yexcr.2014.09.007
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hauser M, 2013, HEART ASIA, V5, P106, DOI 10.1136/heartasia-2013-010319
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Johnson Todd D, 2014, Methods Mol Biol, V1181, P109, DOI 10.1007/978-1-4939-1047-2_10
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kreutziger KL, 2011, PEDIATR CARDIOL, V32, P334, DOI 10.1007/s00246-011-9888-9
   Lan JY, 2014, CELL MOL BIOENG, V7, P432, DOI 10.1007/s12195-014-0346-7
   Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Morgan KY, 2014, TISSUE ENG PT A, V20, P1654, DOI [10.1089/ten.tea.2013.0355, 10.1089/ten.TEA.2013.0355]
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]
   Osterziel KJ, 2007, EUR HEART J, V28, P638, DOI 10.1093/eurheartj/ehl515
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Pok S, 2014, TISSUE ENG PT A, V20, P1877, DOI [10.1089/ten.tea.2013.0620, 10.1089/ten.TEA.2013.0620]
   Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seif-Naraghi S, 2010, JOVE-J VIS EXP, P2109
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sullivan KE, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt403
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tran N, 2006, CELL TRANSPLANT, V15, P351, DOI 10.3727/000000006783981918
   Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003
   Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037
   Williams C, 2015, ACTA BIOMATER, V14, P84, DOI 10.1016/j.actbio.2014.11.035
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Ye K Y, 2011, JOVE-J VIS EXP, P3251
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 57
TC 18
Z9 19
U1 0
U2 58
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034105
DI 10.1088/1748-6041/10/3/034105
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000013
PM 25826196
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, Q
   Wang, MH
   Wang, KF
   Liu, YL
   Zhang, HP
   Lu, X
   Zhang, XD
AF Wang, Qun
   Wang, Meng-hao
   Wang, Ke-feng
   Liu, Yaling
   Zhang, Hong-ping
   Lu, Xiong
   Zhang, Xing-dong
TI Computer simulation of biomolecule-biomaterial interactions at surfaces
   and interfaces
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE biomaterials; biomolecules; computer simulation; hydroxyapatite;
   titanium oxide; graphene and graphene oxide
ID DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS SIMULATION; HYDROXYAPATITE
   001 SURFACE; TITANIUM-OXIDE SURFACES; METAL-DOPED GRAPHENE; AB-INITIO;
   PEPTIDE ADSORPTION; CARBON NANOTUBES; CITRIC-ACID; CHEMICAL
   FUNCTIONALIZATION
AB Biomaterial surfaces and interfaces are intrinsically complicated systems because they involve biomolecules, implanted biomaterials, and complex biological environments. It is difficult to understand the interaction mechanism between biomaterials and biomolecules through conventional experimental methods. Computer simulation is an effective way to study the interaction mechanism at the atomic and molecular levels. In this review, we summarized the recent studies on the interaction behaviors of biomolecules with three types of the most widely used biomaterials: hydroxyapatite (HA), titanium oxide (TiO2), and graphene(G)/graphene oxide(GO). The effects of crystal forms, crystallographic planes, surface defects, doping atoms, and water environments on biomolecules adsorption are discussed in detail. This review provides valuable theoretical guidance for biomaterial designing and surface modification.
C1 [Wang, Qun; Wang, Meng-hao; Lu, Xiong] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Sichuan, Peoples R China.
   [Wang, Qun] MianYang Normal Univ, Coll Life Sci & Technol, Mianyang 621000, Sichuan, Peoples R China.
   [Wang, Ke-feng; Zhang, Xing-dong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610065, Sichuan, Peoples R China.
   [Liu, Yaling] Lehigh Univ, Dept Mech Engn & Mech, Bioengn Program, Bethlehem, PA USA.
   [Zhang, Hong-ping] Southwest Univ Sci & Technol, Sch Mat Sci & Engn, Engn Res Ctr Biomass Mat, Minist Educ, Mianyang 621010, Sichuan, Peoples R China.
RP Wang, Q (reprint author), Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ, Chengdu 610031, Sichuan, Peoples R China.
EM carlcili@163.com; wangmenghao@gmail.com; fencal@163.com;
   zhp1006@126.com; luxiong_2004@163.com; zhangxd@scu.edu.cn
RI LU, xiong/B-3092-2010
OI LU, xiong/0000-0001-6367-430X
FU 863 Program [2015AA034202]; NSFC [51202152]; Sichuan Youth
   Science-Technology Foundation [2011JQ0010]; Construction Program for
   Innovative Research Team of University in Sichuan Province [14TD0050]
FX This project was financially supported by 863 Program (2015AA034202),
   NSFC (51202152), Sichuan Youth Science-Technology Foundation
   (2011JQ0010), Construction Program for Innovative Research Team of
   University in Sichuan Province (14TD0050).
CR Abergel DSL, 2010, ADV PHYS, V59, P261, DOI 10.1080/00018732.2010.487978
   Akdim B, 2013, ACS APPL MATER INTER, V5, P7470, DOI 10.1021/am401731c
   Al-Aqtash N, 2009, J PHYS CHEM C, V113, P12970, DOI 10.1021/jp902280f
   Almora-Barrios N, 2010, LANGMUIR, V26, P14535, DOI 10.1021/la101151e
   Almora-Barrios N, 2010, CRYSTENGCOMM, V12, P960, DOI 10.1039/b917179g
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Azzopardi PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009330
   Barinov A, 2009, J PHYS CHEM C, V113, P9009, DOI 10.1021/jp902051d
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Baweja L, 2013, LANGMUIR, V29, P14230, DOI 10.1021/la4033805
   Becton M, 2013, CHEM PHYS LETT, V584, P135, DOI 10.1016/j.cplett.2013.08.027
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Biswas S, 2013, J BIOMATER NANOBIOTE, V4, P351
   Boukhvalov DW, 2008, NANO LETT, V8, P4373, DOI 10.1021/nl802098g
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Cazorla C, 2010, THIN SOLID FILMS, V518, P6951, DOI 10.1016/j.tsf.2010.06.068
   Chen X, 2008, BIOMATERIALS, V29, P2423, DOI 10.1016/j.biomaterials.2008.02.002
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Cortes-Arriagada D, 2013, J MOL MODEL, V19, P3569, DOI 10.1007/s00894-013-1872-2
   Costa D, 2011, LANGMUIR, V27, P2747, DOI 10.1021/la104317j
   Costa D, 2013, J BIOMED MATER RES A, V101, P1210, DOI 10.1002/jbm.a.34416
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   de Pablo JJ, 2014, CURR OPIN SOLID ST M, V18, P99, DOI 10.1016/j.cossms.2014.02.003
   Denis PA, 2013, J PHYS CHEM C, V117, P19048, DOI 10.1021/jp4061945
   Diebold U, 2003, APPL PHYS A-MATER, V76, P681, DOI 10.1007/s00339-002-2004-5
   Ding N, 2012, COMP MATER SCI, V51, P141, DOI 10.1016/j.commatsci.2011.07.045
   Dong XL, 2011, MOL SIMULAT, V37, P1097, DOI 10.1080/08927022.2011.582108
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Friesner RA, 2005, P NATL ACAD SCI USA, V102, P6648, DOI 10.1073/pnas.0408036102
   [傅强 FU Qiang], 2009, [科学通报, Chinese Science Bulletin], V54, P2657, DOI 10.1360/972009-1537
   Ghaderi N, 2010, J PHYS CHEM C, V114, P21625, DOI 10.1021/jp108688m
   Guo TL, 2014, MOLECULES, V19, P149, DOI 10.3390/molecules19010149
   Guo YN, 2013, J PHYS CHEM C, V117, P5708, DOI 10.1021/jp310088e
   Guo YN, 2011, J PHYS CHEM C, V115, P18572, DOI 10.1021/jp200598t
   Hartree DR, 1928, P CAMB PHILOS SOC, V24, P89
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Ingolfsson HI, 2014, WIRES COMPUT MOL SCI, V4, P225, DOI 10.1002/wcms.1169
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Kang HS, 2005, J AM CHEM SOC, V127, P9839, DOI 10.1021/ja0509681
   Kang Y, 2010, J PHYS CHEM C, V114, P14496, DOI 10.1021/jp1037156
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kavathekar RS, 2011, MOL PHYS, V109, P1649, DOI 10.1080/00268976.2011.582051
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kim SN, 2011, J AM CHEM SOC, V133, P14480, DOI 10.1021/ja2042832
   Lai ZB, 2014, J MECH BEHAV BIOMED, V36, P12, DOI 10.1016/j.jmbbm.2014.04.002
   Landis WJ, 2009, CELLS TISSUES ORGANS, V189, P20, DOI 10.1159/000151454
   Larson RG, 2004, MOL PHYS, V102, P341, DOI 10.1080/00268970310001640102
   Li DC, 2009, INT J APPL MECH, V1, P113, DOI 10.1142/S1758825109000034
   Li M, 2014, ADV FUNCT MATER, V24, P1631, DOI 10.1002/adfm.201302242
   Liao CY, 2014, RSC ADV, V4, P15759, DOI 10.1039/c3ra47381c
   Liu J, 2013, J PHYS CHEM C, V117, P13037, DOI 10.1021/jp4001972
   Liu XY, 2014, APPL SURF SCI, V293, P216, DOI 10.1016/j.apsusc.2013.12.137
   Liu Y, 2013, BIOMACROMOLECULES, V14, P3321, DOI 10.1021/bm400930k
   Lou ZY, 2012, APPL SURF SCI, V258, P4911, DOI 10.1016/j.apsusc.2012.01.116
   Lu X, 2011, CRYSTENGCOMM, V13, P3741, DOI 10.1039/c0ce00971g
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   Miao W, 2013, BIOMATERIALS, V34, P9638, DOI 10.1016/j.biomaterials.2013.08.058
   Monti S, 2011, J PHYS CHEM C, V115, P24238, DOI 10.1021/jp207950p
   Muir JMR, 2014, SURF SCI, V624, P8, DOI 10.1016/j.susc.2014.01.005
   Muir JMR, 2013, SURF SCI, V617, P60, DOI 10.1016/j.susc.2013.07.009
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Ogiso M, 1998, J BIOMED MATER RES, V43, P318, DOI 10.1002/(SICI)1097-4636(199823)43:3<318::AID-JBM13>3.0.CO;2-B
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rajesh C, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3079096
   Ramachandran A, 2011, J PHYS CHEM B, V115, P6138, DOI 10.1021/jp101052x
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   Rhee SH, 1999, BIOMATERIALS, V20, P2155, DOI 10.1016/S0142-9612(99)00118-0
   Rimola A, 2012, PHILOS T R SOC A, V370, P1478, DOI 10.1098/rsta.2011.0236
   Saikia N, 2013, J COMPUT AID MOL DES, V27, P807, DOI 10.1007/s10822-013-9681-3
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sayyar S, 2013, CARBON, V52, P296, DOI 10.1016/j.carbon.2012.09.031
   Seitz R, 2005, APPL SURF SCI, V252, P154, DOI 10.1016/j.apsusc.2005.02.012
   SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X
   Streeter I, 2011, P ROY SOC A-MATH PHY, V467, P2084, DOI 10.1098/rspa.2010.0559
   Szieberth D, 2010, PHYS CHEM CHEM PHYS, V12, P11033, DOI 10.1039/c004155f
   Taylor WR, 2010, J MOL GRAPH MODEL, V29, P266, DOI 10.1016/j.jmgm.2010.06.004
   Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w
   Vovusha H, 2013, J PHYS CHEM LETT, V4, P3710, DOI 10.1021/jz401929h
   Wang CC, 2006, J PHYS CHEM B, V110, P10266, DOI 10.1021/jp060412f
   Wang KF, 2012, J MATER SCI-MATER M, V23, P1045, DOI 10.1007/s10856-012-4570-1
   Wang MH, 2014, CHEM PHYS LETT, V599, P86, DOI 10.1016/j.cplett.2014.03.024
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Wu CY, 2010, LANGMUIR, V26, P15972, DOI 10.1021/la103010c
   Xu H, 2013, BIOSENS BIOELECTRON, V50, P251, DOI 10.1016/j.bios.2013.06.039
   Xu LY, 2014, J COLLOID INTERF SCI, V418, P66, DOI 10.1016/j.jcis.2013.12.005
   Yang J, 2013, BIOSENS BIOELECTRON, V47, P530, DOI 10.1016/j.bios.2013.03.051
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Zaib Q, 2012, WATER AIR SOIL POLL, V223, P3281, DOI 10.1007/s11270-012-1109-5
   Zhang HP, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044110
   Zhang HP, 2008, J MATER SCI-MATER M, V19, P3437, DOI 10.1007/s10856-008-3498-y
   Zhang HP, 2014, PHYSICA E, V61, P83, DOI 10.1016/j.physe.2014.03.017
   Zhang HP, 2013, APPL SURF SCI, V283, P559, DOI 10.1016/j.apsusc.2013.06.145
   Zhang HP, 2011, J BIOMED MATER RES A, V96A, P466, DOI 10.1002/jbm.a.33003
   Zhang HP, 2009, ACTA BIOMATER, V5, P1169, DOI 10.1016/j.actbio.2008.11.014
   Zhang T, 2012, NANO TODAY, V7, P180, DOI 10.1016/j.nantod.2012.04.006
   Zhang ZX, 2011, J MOL MODEL, V17, P649, DOI 10.1007/s00894-010-0760-2
   Zhou H, 2007, BIOCHEM BIOPH RES CO, V361, P91, DOI 10.1016/j.bbrc.2007.06.169
NR 104
TC 8
Z9 8
U1 11
U2 107
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 032001
DI 10.1088/1748-6041/10/3/032001
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000002
PM 26065541
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Kuraitis, D
   Burgon, PG
   Crowe, S
   Vulesevic, B
   Beanlands, RS
   Dekemp, RA
   DaSilva, JN
   Ruel, M
   Suuronen, EJ
AF Zhang, Yan
   Kuraitis, Drew
   Burgon, Patrick G.
   Crowe, Suzanne
   Vulesevic, Branka
   Beanlands, Rob S.
   Dekemp, Robert A.
   DaSilva, Jean N.
   Ruel, Marc
   Suuronen, Erik J.
TI Development of reporter gene imaging techniques for long-term assessment
   of human circulating angiogenic cells
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE circulating angiogenic cells; reporter gene imaging; lentiviral vectors;
   cell function; biomatrix
ID MYOCARDIAL-INFARCTION; COLLAGEN MATRIX; LIVING SUBJECTS; THERAPY;
   DELIVERY; SYSTEMS; REGENERATION; SURVIVAL; VECTORS; HEART
AB The use of biomaterials and tracking the long-term fate of the transplanted cells is expected to help improve the clinical translation of cell therapies for cardiac regeneration. To this end, reporter gene strategies are promising for monitoring the fate of cells transplanted with or without a delivery biomaterial; however, their application with primary adult progenitor cells (such as human circulating angiogenic cells (CACs)) has not been extensively evaluated. In this study, human CACs were transduced with reporter genes via one of two lentiviral (LV) vectors: LV-GFP-iresTK or LV-Fluc-RFP-tTK. The mean transduction efficiency was 15% (LV-GFP-iresTK) and 13% (LV-Fluc-RFP-tTK) at multiplicities of infection (MOI) of 10 and 50, respectively. Western blot analysis confirmed HSV1-tk protein expression in transduced CACs. There was no significant difference in viability between the transduced CACs and the untreated controls at a MOI of 50 or below. However, a reduction was observed in cell viability of CACs transduced with LV-Fluc-RFP-tTK at an MOI of 100. Cell migration and angiogenic potential were not affected by transduction protocol. After 4 weeks, 80.3 +/- 8.4% of the labeled cells continued to express the reporters and could be visualized when embedded within a collagen matrix scaffold. Therefore, quiescent human CACs can be stably transduced to express reporter genes without affecting their function. This reporter gene technique is a promising approach to be further tested for tracking transplanted CACs (+/- delivery matrix) noninvasively and longitudinally.
C1 [Zhang, Yan; Kuraitis, Drew; Crowe, Suzanne; Vulesevic, Branka; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Beanlands, Rob S.; Dekemp, Robert A.; DaSilva, Jean N.] Univ Ottawa, Inst Heart, Natl Cardiac PET Ctr, Ottawa, ON K1Y 4W7, Canada.
   [Burgon, Patrick G.; Beanlands, Rob S.; Dekemp, Robert A.; DaSilva, Jean N.] Univ Ottawa, Inst Heart, Dept Med, Div Cardiol, Ottawa, ON K1Y 4W7, Canada.
   [Zhang, Yan; Kuraitis, Drew; Burgon, Patrick G.; Vulesevic, Branka; Beanlands, Rob S.; DaSilva, Jean N.; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
   [DaSilva, Jean N.] Univ Montreal Hosp, Res Ctr, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ H2X 0A9, Canada.
   [Zhang, Yan] Cent Hosp, Shenyang Med Coll, Dept Med, Div Cardiol, Shenyang 110024, Peoples R China.
RP Zhang, Y (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
EM mruel@ottawaheart.ca; esuuronen@ottawaheart.ca
RI Beanlands, Rob/M-2105-2017
OI Beanlands, Rob/0000-0001-7857-8169; Burgon, Patrick/0000-0003-4771-023X;
   RUEL, MARC/0000-0002-0487-1319
FU Canadian Institutes of Health Research [MOP-77536]; Heart and Stroke
   Foundation of Ontario [PRG 6242, NA6121]; Heart and Stroke Foundation of
   Canada; Canadian Institutes of Health Research Canadian Graduate
   Scholarships
FX The authors would like to thank Dr Joseph Wu, Stanford University, for
   kindly providing the plasmid vector for pUb-Fluc-RFP-tTK. This work was
   supported by the Canadian Institutes of Health Research (to Drs Ruel and
   Suuronen, grant MOP-77536), and the Heart and Stroke Foundation of
   Ontario (to Dr Beanlands, program grant PRG 6242; to Dr Suuronen,
   grant-in-aid NA6121). Dr Beanlands is a Career Investigator of the Heart
   and Stroke Foundation of Ontario; Dr Zhang was supported by a Heart and
   Stroke Foundation of Canada Doctoral Research Award, and Drs Kuraitis
   and Vulesevic by Canadian Institutes of Health Research Canadian
   Graduate Scholarships.
CR Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Ahmadi A, 2015, BIOMATERIALS, V49, P18, DOI 10.1016/j.biomaterials.2015.01.016
   Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028
   Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONHA.105.588954
   Choi HS, 2013, NAT BIOTECHNOL, V31, P148, DOI 10.1038/nbt.2468
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Furukawa T, 2006, NUCL MED BIOL, V33, P145, DOI 10.1016/j.nucmedbio.2005.07.013
   Gil JS, 2013, MOL IMAGING BIOL, V15, P273, DOI 10.1007/s11307-012-0596-5
   Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Katz MG, 2013, HUM GENE THER, V24, P914, DOI 10.1089/hum.2013.2517
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y
   Leyva FJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-13
   McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53
   McNeill B, 2014, FASEB J
   Niu G, 2012, THERANOSTICS, V2, P413, DOI 10.7150/thno.3940
   Ponomarev V, 2007, J NUCL MED, V48, P819, DOI 10.2967/jnumed.106.036962
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816
   Ray P, 2011, J BIOSCIENCES, V36, P499, DOI 10.1007/s12038-011-9079-0
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Sheikh Ahmad Y, 2006, Curr Cardiol Rep, V8, P147, DOI 10.1007/s11886-006-0026-x
   Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291
   Zhang Ya-Ping, 2010, Zoological Research, V31, P1
NR 26
TC 0
Z9 0
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2015
VL 10
IS 3
AR 034104
DI 10.1088/1748-6041/10/3/034104
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CL6QV
UT WOS:000357093000012
PM 25782444
DA 2018-10-20
ER

PT J
AU Jimenez, RA
   Millan, D
   Suesca, E
   Sosnik, A
   Fontanilla, MR
AF Jimenez, Ronald A.
   Millan, Diana
   Suesca, Edward
   Sosnik, Alejandro
   Fontanilla, Marta R.
TI Controlled release of an extract of Calendula officinalis flowers from a
   system based on the incorporation of gelatin-collagen microparticles
   into collagen I scaffolds: design and in vitro performance
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Wound healing; Collagen I scaffolds; Calendula officinalis L. flowers
   extract; Polyphenols; Gelatin-collagen microparticle-loaded skin
   dressings
ID ARTIFICIAL CONNECTIVE-TISSUE; FIBROBLAST-GROWTH-FACTOR; CONTROLLED
   DRUG-RELEASE; ENGINEERING APPLICATIONS; OXIDATIVE STRESS; MICROSPHERES;
   REGENERATION; DEXAMETHASONE; BIOMATERIAL; HYDROGELS
AB Aiming to develop biological skin dresses with improved performance in the treatment of skin wounds, acellular collagen I scaffolds were modified with polymeric microparticles and the subsequent loading of a hydroglycolic extract of Calendula officinalis flowers. Microparticles made of gelatin-collagen were produced by a water-in-oil emulsion/crosslinking method. Thereafter, these microparticles were mixed with collagen suspensions at three increasing concentrations and the resulting mixtures lyophilized to make microparticle-loaded porous collagen scaffolds. Resistance to enzymatic degradation, ability to associate with the C. officinalis extract, and the extract release profile of the three gelatin-collagen microparticle-scaffold prototypes were assessed in vitro and compared to collagen scaffolds without microparticles used as control. Data indicated that the incorporation of gelatin-collagen microparticles increased the resistance of the scaffolds to in vitro enzymatic degradation, as well as their association with the C. officinalis flower extract. In addition, a sharp decrease in cytotoxicity, as well as more prolonged release of the extract, was attained. Overall results support the potential of these systems to develop innovative dermal substitutes with improved features. Furthermore, the gelatin-collagen mixture represents a low-cost and scalable alternative with high clinical transferability, especially appealing in developing countries.
C1 [Jimenez, Ronald A.; Millan, Diana; Suesca, Edward; Fontanilla, Marta R.] Univ Nacl Colombia, Dept Pharm, Tissue Engn Grp, Bogota, Colombia.
   [Millan, Diana] Univ El Bosque, Fac Med, Bogota, Colombia.
   [Sosnik, Alejandro] Technion Israel Inst Technol, Dept Mat Sci & Engn, Haifa, Israel.
RP Fontanilla, MR (reprint author), Univ Nacl Colombia, Dept Pharm, Tissue Engn Grp, AveCarrera 30 45-10, Bogota, Colombia.
EM mrfontanillad@unal.edu.co
FU Universidad Nacional de Colombia; Colombian Department of Science,
   Technology and Innovation (COLCIENCIAS) [1101-521-28661,
   1101-452-21387]; Faculty of Science at Universidad Nacional de Colombia
FX This work was supported by Universidad Nacional de Colombia and the
   Colombian Department of Science, Technology and Innovation (COLCIENCIAS)
   (grants 1101-521-28661 and 1101-452-21387). We would like to thank
   Gabriel Zea Jimenez for his contribution to the preliminary experiments
   and "Fundacion Instituto de Inmunologia de Colombia" for lending us
   facilities to make the microparticles. Ronald Jimenez was financed by
   the Faculty of Science at Universidad Nacional de Colombia (teaching
   assistant scholarship) and by COLCIENCIAS (grant 1101-521-28661). Edward
   Suesca and Diana Millan were also supported by COLCIENCIAS (grants
   1101-452-21387 and 1101-521-28661).
CR Basch Ethan, 2006, Journal of Herbal Pharmacotherapy, V6, P135, DOI 10.1300/J157v06n03_08
   Brown DJ, 1998, ARCH DERMATOL, V134, P1401, DOI 10.1001/archderm.134.11.1401
   DeFail AJ, 2006, J BIOMED MATER RES A, V79A, P954, DOI 10.1002/jbm.a.30865
   Espinosa L, 2010, TISSUE ENG PT A, V16, P1667, DOI [10.1089/ten.tea.2008.0571, 10.1089/ten.TEA.2008.0571]
   Fonseca YM, 2010, J ETHNOPHARMACOL, V127, P596, DOI 10.1016/j.jep.2009.12.019
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Galeska I, 2005, AAPS J, V7, pE231, DOI 10.1208/aapsj070122
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Bustos RH, 2014, ANAL CHEM, V86, P2421, DOI 10.1021/ac4033164
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   International Organization for Standardization, 2009, 109935 ISO, P1
   Ju YM, 2010, J BIOMED MATER RES A, V93A, P200, DOI 10.1002/jbm.a.32512
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kikkinides ES, 1998, J CONTROL RELEASE, V51, P313, DOI 10.1016/S0168-3659(97)00182-X
   Kimura Y, 2010, J TISSUE ENG REGEN M, V4, P55, DOI 10.1002/term.218
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   MURPHY GF, 1990, LAB INVEST, V62, P305
   Preethi KC, 2009, INDIAN J EXP BIOL, V47, P113
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Fontanilla MR, 2012, TISSUE ENG PT A, V18, P1857, DOI [10.1089/ten.TEA.2011.0421, 10.1089/ten.tea.2011.0421]
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004
   Shah VP, 1998, PHARMACEUT RES, V15, P889, DOI 10.1023/A:1011976615750
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   USP, 2013, BIOL REACT TESTS IN, V87, P36
   USP, 2013, BIOL REACT TESTS IN, P1832
   Tran VT, 2011, INT J PHARMACEUT, V407, P1, DOI 10.1016/j.ijpharm.2011.01.027
   Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
NR 34
TC 5
Z9 5
U1 0
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD JUN
PY 2015
VL 5
IS 3
BP 209
EP 218
DI 10.1007/s13346-015-0217-3
PG 10
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA CM0MG
UT WOS:000357371500002
PM 25787728
DA 2018-10-20
ER

PT J
AU Suzawa, Y
   Kubo, N
   Iwai, S
   Yura, Y
   Ohgushi, H
   Akashi, M
AF Suzawa, Yoshika
   Kubo, Norihiko
   Iwai, Soichi
   Yura, Yoshiaki
   Ohgushi, Hajime
   Akashi, Mitsuru
TI Biomineral/Agarose Composite Gels Enhance Proliferation of Mesenchymal
   Stem Cells with Osteogenic Capability
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
ID ALTERNATE SOAKING PROCESS; ALCOHOL) HYDROGEL MATRICES; IMPROVES
   CARDIAC-FUNCTION; BONE-GRAFTING MATERIAL; ON/IN AGAROSE-GEL;
   CALCIUM-CARBONATE; APATITE FORMATION; STROMAL CELLS; GLA PROTEIN;
   HYDROXYAPATITE
AB Hydroxyapatite (HA) or calcium carbonate (CaCO3) formed on an organic polymer of agarose gel is a biomaterial that can be used for bone tissue regeneration. However, in critical bone defects, the regeneration capability of these materials is limited. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into bone forming osteoblasts. In this study, we loaded MSCs on HA- or CaCO3-formed agarose gel and cultured them with dexamethasone, which triggers the osteogenic differentiation of MSCs. High alkaline phosphatase activity was detected on both the HA- and CaCO3-formed agarose gels; however, basal activity was only detected on bare agarose gel. Bone-specific osteocalcin content was detected on CaCO3-formed agarose gel on Day 14 of culture, and levels subsequently increased over time. Similar osteocalcin content was detected on HA-formed agarose on Day 21 and levels increased on Day 28. In contrast, only small amounts of osteocalcin were found on bare agarose gel. Consequently, osteogenic capability of MSCs was enhanced on CaCO3-formed agarose at an early stage, and both HA- and CaCO3-formed agarose gels well supported the capability at a later stage. Therefore, MSCs loaded on either HA- or CaCO3-formed agarose could potentially be employed for the repair of critical bone defects.
C1 [Suzawa, Yoshika; Iwai, Soichi; Yura, Yoshiaki] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofcial Surg 2, Suita, Osaka 5650871, Japan.
   [Kubo, Norihiko] Miyata Dent Clin, Miyazaki 8800902, Japan.
   [Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Amagasaki, Hyogo 6610974, Japan.
   [Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Div Appl Chem, Osaka 5620871, Japan.
RP Ohgushi, H (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Amagasaki, Hyogo 6610974, Japan.
EM suzawa@dent.osaka-u.ac.jp; Norihiko0409@ybb.ne.jp;
   s-iwai@dent.osaka-u.ac.jp; yura@dent.osaka-u.ac.jp;
   hajime-ohgushi@aist.go.jp; akashi@chem.eng.osaka-u.ac.jp
CR Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Hamadouche M, 2001, J BONE JOINT SURG BR, V83B, P979, DOI 10.1302/0301-620X.83B7.11478
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hirose M, 2004, MAT SCI ENG C-BIO S, V24, P355, DOI 10.1016/j.msec.2003.12.011
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Matsumoto T, 2011, TISSUE ENG PT A, V17, P171, DOI [10.1089/ten.tea.2010.0077, 10.1089/ten.TEA.2010.0077]
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   Mizuta N, 2013, J TISSUE ENG REGEN M, V7, P51, DOI 10.1002/term.495
   Muraki K, 2006, TISSUE ENG, V12, P1711, DOI 10.1089/ten.2006.12.1711
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Ogomi D, 2005, J CONTROL RELEASE, V103, P315, DOI 10.1016/j.jconrel.2004.11.032
   Ogomi D, 2003, J BIOMED MATER RES A, V67A, P1360, DOI 10.1002/jbm.a.20053
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   Ohgushi H, 2014, EXPERT OPIN BIOL TH, V14, P197, DOI 10.1517/14712598.2014.866086
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Overgaard S, 1997, CLIN ORTHOP RELAT R, P286
   Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   PRICE PA, 1985, VITAM HORM, V42, P65
   Suzawa Y, 2010, J BIOMED MATER RES A, V93A, P965, DOI 10.1002/jbm.a.32518
   Tabata M, 2005, J BIOMED MATER RES B, V75B, P378, DOI 10.1002/jbm.b.30316
   Tabata M, 2003, J BIOMED MATER RES B, V67B, P680, DOI 10.1002/jbm.b.10063
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P795, DOI 10.1163/156856299X00883
   TAGUCHI T, 1998, CHEM LETT, V8, P711
   Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435
NR 32
TC 8
Z9 8
U1 0
U2 22
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2015
VL 16
IS 6
BP 14245
EP 14258
DI 10.3390/ijms160614245
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CM2EO
UT WOS:000357492800134
PM 26110392
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhou, ZH
   Huang, HH
   Huang, TL
   Peng, C
   Zhou, H
   Liu, QQ
   Zeng, WN
   Liu, LH
   Cao, DF
   He, SL
   Xiang, LJ
   Yan, H
AF Zhou, Zhihua
   Huang, Huihua
   Huang, Tianlong
   Peng, Cheng
   Zhou, Hu
   Liu, Qingquan
   Zeng, Wennan
   Liu, Lihua
   Cao, Dafu
   He, Siliang
   Xiang, Liujiao
   Yan, Hua
TI Synthesis and characterization of novel maleated
   poly(D,L-lactide-co-glycolide) by direct melt copolymerization
SO POLYMER BULLETIN
LA English
DT Article
DE D,L-Lactide; Glycolide; Maleic anhydride;
   Poly(D,L-lactide-co-glycolide); Modification
ID MALEIC-ANHYDRIDE; REACTIVE EXTRUSION; MECHANICAL-PROPERTIES;
   PHYSICAL-PROPERTIES; POLYLACTIDE PLA; POLYPROPYLENE; COMPOSITES;
   POLYMERS; FILMS; ACID)
AB Novel maleated poly(D,L-lactide-co-glycolide) (MPLGA) was melt copolymerized directly from maleic anhydride, D, L-lactide and glycolide monomers with stannous octoate as catalyst and benzoyl peroxide as initiator. FTIR, H-1 NMR, GPC and maleation content were employed to qualitatively characterize the synthesized MPLGA. The effects of the catalyst dosage, reaction time and reaction temperature on weight average molecular mass, polydispersity index and maleation content of MPLGA were also investigated. The results indicated that the novel MPLGA was successfully obtained using melting-copolymerization method. MPLGA, with a weight average molecular mass of about 5.39 x 10(4) Da, a polydispersity index of 1.51 and a maleation content of 7.1 wt%, was obtained when polymerization was conducted with catalyst dosage of 0.03 wt% for 36 h at 140 degrees C. The results indicated that the introduction of maleic anhydride into PLGA may offer new and important options for biomaterial applications.
C1 [Zhou, Zhihua; Huang, Huihua; Zhou, Hu; Liu, Qingquan; Zeng, Wennan; Liu, Lihua; Cao, Dafu; He, Siliang; Xiang, Liujiao; Yan, Hua] Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Xiangtan, Peoples R China.
   [Zhou, Zhihua] Hunan Univ Sci & Technol, Minist Educ, Key Lab Theoret Chem & Mol Simulat, Xiangtan, Peoples R China.
   [Zhou, Zhihua] Hunan Univ Sci & Technol, Hunan Prov Coll Key Lab QSAR QSPR, Xiangtan, Peoples R China.
   [Huang, Tianlong] Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China.
   [Peng, Cheng] Cent S Univ, Xiangya Hosp 3, Dept Burns & Plast Surg, Changsha, Hunan, Peoples R China.
RP Zhou, ZH (reprint author), Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Xiangtan, Peoples R China.
EM zhou7381@126.com
FU National Natural Science Fund of China [51273062, 51443002]; Hunan
   Provincial Natural Science Fund of China [12JJA003]; Aid Program for
   Science and Technology Innovative Research Team in Higher Educational
   Institutions of Hunan Province
FX This work was financially supported by the National Natural Science Fund
   of China (No. 51273062 and No. 51443002), the Hunan Provincial Natural
   Science Fund of China (No. 12JJA003) and the Aid Program for Science and
   Technology Innovative Research Team in Higher Educational Institutions
   of Hunan Province.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P41
   Carlson D, 1999, J APPL POLYM SCI, V72, P477, DOI 10.1002/(SICI)1097-4628(19990425)72:4<477::AID-APP3>3.0.CO;2-Q
   Chen C, 2003, J APPL POLYM SCI, V88, P659, DOI 10.1002/app11771
   Coombes A. G. A., 1994, Clinical Materials, V17, P35, DOI 10.1016/0267-6605(94)90046-9
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   GAYLORD NG, 1983, J POLYM SCI POL LETT, V21, P23, DOI 10.1002/pol.1983.130210104
   GAYLORD NG, 1988, J POLYM SCI POL CHEM, V26, P1903, DOI 10.1002/pola.1988.080260716
   Hassouna F, 2012, EUR POLYM J, V48, P404, DOI 10.1016/j.eurpolymj.2011.12.001
   He ZQ, 2011, J MACROMOL SCI B, V50, P1154, DOI 10.1080/00222348.2010.503106
   Hwang SW, 2012, POLYM TEST, V31, P333, DOI 10.1016/j.polymertesting.2011.12.005
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Kortaberria G, 2006, J NON-CRYST SOLIDS, V352, P5087, DOI 10.1016/j.jnoncrysol.2006.01.153
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   Ma GL, 2011, J CONTROL RELEASE, V152, pe133
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Pamula E, 2008, J MATER SCI-MATER M, V19, P2063, DOI 10.1007/s10856-007-3292-2
   Raquez JM, 2008, MACROMOL MATER ENG, V293, P447, DOI 10.1002/mame.200700395
   Rozman HD, 2000, EUR POLYM J, V36, P1483, DOI 10.1016/S0014-3057(99)00200-1
   Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Todo M, 2007, ENG FRACT MECH, V74, P1872, DOI 10.1016/j.engfracmech.2006.05.021
   Wu L, 2004, BIOMATERIALS, V25, P821
   Zhang JF, 2004, BIOMACROMOLECULES, V5, P1446, DOI 10.1021/bm0400022
   Zhou ZH, 2008, INT J POLYM MATER, V57, P532, DOI 10.1080/00914030701816110
NR 26
TC 4
Z9 4
U1 2
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JUN
PY 2015
VL 72
IS 6
BP 1531
EP 1543
DI 10.1007/s00289-015-1354-z
PG 13
WC Polymer Science
SC Polymer Science
GA CM2UP
UT WOS:000357538100019
DA 2018-10-20
ER

PT J
AU Song, JR
   Fan, CC
   Ma, HS
   Wei, YG
AF Song, Jingru
   Fan, Cuncai
   Ma, Hansong
   Wei, Yueguang
TI Hierarchical structure observation and nanoindentation size effect
   characterization for a limnetic shell
SO ACTA MECHANICA SINICA
LA English
DT Article
DE Biomaterial; Hierarchical structure; Mechanical property;
   Nanoindentation size effect; Trans-scale mechanics
ID DYNAMIC-MECHANICAL RESPONSE; BIOLOGICAL-MATERIALS; FRACTURE-TOUGHNESS;
   ELASTIC-MODULUS; STROMBUS-GIGAS; NACRE; BONE; INDENTATION; STRENGTH;
   BEHAVIOR
AB In the present research, hierarchical structure observation and mechanical property characterization for a type of biomaterial are carried out. The investigated biomaterial is Hyriopsis cumingii, a typical limnetic shell, which consists of two different structural layers, a prismatic "pillar" structure and a nacreous "brick and mortar" structure. The prismatic layer looks like a "pillar forest" with variation-section pillars sized on the order of several tens of microns. The nacreous material looks like a "brick wall" with bricks sized on the order of several microns. Both pillars and bricks are composed of nanoparticles. The mechanical properties of the hierarchical biomaterial are measured by using the nanoindentation test. Hardness and modulus are measured for both the nacre layer and the prismatic layer, respectively. The nanoindentation size effects for the hierarchical structural materials are investigated experimentally. The results show that the prismatic nanostructured material has a higher stiffness and hardness than the nacre nanostructured material. In addition, the nanoindentation size effects for the hierarchical structural materials are described theoretically, by using the trans-scalemechanics theory considering both strain gradient effect and the surface/interface effect. The modeling results are consistent with experimental ones.
C1 [Song, Jingru; Fan, Cuncai; Ma, Hansong; Wei, Yueguang] Chinese Acad Sci, Inst Mech, LNM, Beijing 100190, Peoples R China.
RP Wei, YG (reprint author), Chinese Acad Sci, Inst Mech, LNM, Beijing 100190, Peoples R China.
EM Songjingru@LNM.imech.ac.cn; Ywei@LNM.imech.ac.cn
CR Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   Barthelata F., 2006, J MECH PHYS SOLIDS, V55, P306
   Bechtle S, 2010, BIOMATERIALS, V31, P6378, DOI 10.1016/j.biomaterials.2010.05.044
   Brandt K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02322
   Bruet BJF, 2005, J MATER RES, V20, P2400, DOI 10.1557/JMR.2005.0273
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   CURREY JD, 1974, J ZOOL, V173, P395
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   Fleischli FD, 2008, ACTA BIOMATER, V4, P1694, DOI 10.1016/j.actbio.2008.05.029
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   Ji BH, 2010, ANNU REV MATER RES, V40, P77, DOI 10.1146/annurev-matsci-070909-104424
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Kamat S, 2000, NATURE, V405, P1036
   Katti KS, 2006, J MATER RES, V21, P1237, DOI 10.1557/JMR.2006.0147
   Katti KS, 2005, J MATER RES, V20, P1097, DOI 10.1557/JMR.2005.0171
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k
   Menig R, 2001, MAT SCI ENG A-STRUCT, V297, P203, DOI 10.1016/S0921-5093(00)01228-4
   Menig R, 2000, ACTA MATER, V48, P2383, DOI 10.1016/S1359-6454(99)00443-7
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Shao Y, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1016
   Song F, 2003, J MATER RES, V18, P1741, DOI 10.1557/JMR.2003.0239
   Song F., 2003, BIOMATERIALS, V24, P3621
   Song JR, 2014, CR MECANIQUE, V342, P315, DOI 10.1016/j.crme.2014.03.004
   Sun JY, 2007, J BIONIC ENG, V4, P11, DOI 10.1016/S1672-6529(07)60007-9
   TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73
   Tesch W, 2001, CALCIFIED TISSUE INT, V69, P147, DOI 10.1007/s00223-001-2012-z
   WANG RZ, 1995, J MATER SCI, V30, P2299, DOI 10.1007/BF01184577
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   Wei YG, 2005, INT J PLASTICITY, V21, P2123, DOI 10.1016/j.ijplas.2005.04.003
   Wei YG, 1997, J MECH PHYS SOLIDS, V45, P1253, DOI 10.1016/S0022-5096(97)00018-5
   Wei YG, 2001, SCI CHINA SER A, V44, P74, DOI 10.1007/BF02872285
   Wei YG, 2006, EUR J MECH A-SOLID, V25, P897, DOI 10.1016/j.euromechsol.2006.03.001
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096
   Wu B, 2012, COMP MATER SCI, V57, P2, DOI 10.1016/j.commatsci.2011.03.045
   Xie ZQ, 2014, INT J APPL MECH, V6, DOI 10.1142/S1758825114500173
   Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04239
   Zuo SC, 2008, ACTA MECH SINICA, V24, P83, DOI 10.1007/s10409-007-0125-y
   Zuo SC, 2007, ACTA MECH SOLIDA SIN, V20, P198, DOI 10.1007/s10338-007-0723-z
NR 43
TC 2
Z9 3
U1 1
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0567-7718
EI 1614-3116
J9 ACTA MECH SINICA-PRC
JI Acta Mech. Sin.
PD JUN
PY 2015
VL 31
IS 3
SI SI
BP 364
EP 372
DI 10.1007/s10409-015-0405-x
PG 9
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA CM1NV
UT WOS:000357448500007
OA Green Published
DA 2018-10-20
ER

PT J
AU Aziz, G
   Cools, P
   De Geyter, N
   Declercq, H
   Cornelissen, R
   Morent, R
AF Aziz, Gaelle
   Cools, Pieter
   De Geyter, Nathalie
   Declercq, Heidi
   Cornelissen, Ria
   Morent, Rino
TI Dielectric barrier discharge plasma treatment of ultrahigh molecular
   weight polyethylene in different discharge atmospheres at medium
   pressure: A cell-biomaterial interface study
SO BIOINTERPHASES
LA English
DT Article
ID DIAMOND-LIKE CARBON; SURFACE MODIFICATION; ADHESION IMPROVEMENT; POLYMER
   SURFACES; ARGON-PLASMA; WETTABILITY; SPECTROSCOPY; ADSORPTION; MEMBRANE;
   HELIUM
AB Nonthermal plasma activation of ultrahigh molecular weight polyethylene (UHMWPE) is performed in different discharge atmospheres (helium, nitrogen, argon, and air) using a parallel-plate dielectric barrier discharge reactor at medium pressure. Obtained samples are characterized via water contact angle, x-ray photoelectron spectroscopy (XPS), and atomic force microscopy. Plasma treatments were found to significantly alter the samples' surface chemical and physical characteristics. Before conducting a biocompatibility study, the influence of postplasma sterilization processes (ethanol rinsing/UV exposure) on the plasma treatment effects were studied. XPS studies showed that samples' surface chemical composition is least affected by UV exposure, thus making this process the most adequate for sterilization. In-vitro evaluation of biocompatibility was carried out by studying human foreskin fibroblast interaction with untreated and plasma treated surfaces. Cell attachment and viability on all plasma treated UHMWPE were found to be significantly higher in comparison to plain UHMWPE; this was further confirmed by the overall cell morphology. This increased cell viability on treated samples can be explained by the increased wettability on these samples. In this study, a somewhat higher cell proliferation was observed on argon plasma treated surface (water contact angle - 52 degrees) after 7 days culture. (C) 2015 American Vacuum Society.
C1 [Aziz, Gaelle; Cools, Pieter; De Geyter, Nathalie; Declercq, Heidi; Morent, Rino] Univ Ghent, Res Unit Plasma Technol RUPT, Dept Appl Phys, Fac Engn & Architecture, B-9000 Ghent, Belgium.
   [Declercq, Heidi; Cornelissen, Ria] Univ Ghent, Dept Basic Med Sci, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.
RP Aziz, G (reprint author), Univ Ghent, Res Unit Plasma Technol RUPT, Dept Appl Phys, Fac Engn & Architecture, St Pietersnieuwstr 41 B4, B-9000 Ghent, Belgium.
EM Gaelle.Aziz@Ugent.be
RI Morent, Rino/K-7435-2015
OI Morent, Rino/0000-0001-6336-1485; Cools, Pieter/0000-0003-1649-284X
FU Research Foundation Flanders (FWO) [G.0516.13N]; European Research
   Council (ERC) under the European Union's Seventh Framework Program
   (FP)/ERC [279022]
FX This research was supported by a grant (G.0516.13N) from the Research
   Foundation Flanders (FWO) and has also received funding from the
   European Research Council (ERC) under the European Union's Seventh
   Framework Program (FP/2007-2013)/ERC Grant Agreement No. 279022
   (PLASMAPOR).
CR Agraharam S, 2001, J ELECTROCHEM SOC, V148, pF102, DOI 10.1149/1.1366629
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bhoj A. N., 2005, IEEE T PLASMA SCI, V33, P205
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chiper AS, 2011, ROM J PHYS, V56, P126
   Choi DM, 1997, POLYMER, V38, P6243, DOI 10.1016/S0032-3861(97)00175-4
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   De Geyter N, 2008, SURF INTERFACE ANAL, V40, P608, DOI 10.1002/sia.2611
   De Geyter N, 2007, SURF COAT TECH, V201, P7066, DOI 10.1016/j.surfcoat.2007.01.008
   De Geyter N, 2010, SURF COAT TECH, V204, P3272, DOI 10.1016/j.surfcoat.2010.03.037
   De Geyter N., 2008, THESIS U GHENT
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Duca MD, 1998, POLYM DEGRAD STABIL, V61, P65, DOI 10.1016/S0141-3910(97)00130-4
   Fozza A. C., 1999, Plasmas and Polymers, V4, P183, DOI 10.1023/A:1021853026619
   Hegemann D, 2003, NUCL INSTRUM METH B, V208, P281, DOI 10.1016/S0168-583X(03)00644-X
   Idage SB, 1998, LANGMUIR, V14, P2780, DOI 10.1021/la9711286
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Jacobs T, 2011, SURF COAT TECH, V205, pS543, DOI 10.1016/j.surfcoat.2011.02.012
   Jacobs T, 2011, SURF COAT TECH, V205, pS511, DOI 10.1016/j.surfcoat.2011.01.029
   Junkar I., 2010, VACUUM, V84, P83
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Kim KS, 2002, J MEMBRANE SCI, V199, P135, DOI 10.1016/S0376-7388(01)00686-X
   Kurtz SM, 2016, PDL HANDB SER, P1, DOI 10.1016/B978-0-12-374721-1.00001-8
   Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Liu HJ, 2010, APPL SURF SCI, V256, P3941, DOI 10.1016/j.apsusc.2010.01.054
   Loh FC, 1996, SURF INTERFACE ANAL, V24, P597, DOI 10.1002/(SICI)1096-9918(19960916)24:9<597::AID-SIA163>3.0.CO;2-2
   Lotfi M., 2013, ADV BIOMATERIALS SCI, P207
   Ozeki K, 2007, BIO-MED MATER ENG, V17, P175
   Puertolas JA, 2010, WEAR, V269, P458, DOI 10.1016/j.wear.2010.04.033
   Rhodes NP, 2007, BIOMATERIALS, V28, P4561, DOI 10.1016/j.biomaterials.2007.07.008
   Riekerink M. O., 2001, THESIS U TWENTE
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   Vesel A., 2008, VACUUM, V82, P248
   Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zeng H., 2013, POLYM ADHESION FRICT, P210
   Zhu X, 2005, J BIOMED MATER RES A, V73A, P264, DOI 10.1002/jbm.a.30211
NR 41
TC 6
Z9 6
U1 2
U2 61
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2015
VL 10
IS 2
AR 029502
DI 10.1116/1.4907755
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA CL8AY
UT WOS:000357195600020
DA 2018-10-20
ER

PT J
AU Buxadera-Palomero, J
   Canal, C
   Torrent-Camarero, S
   Garrido, B
   Gil, FJ
   Rodriguez, D
AF Buxadera-Palomero, Judit
   Canal, Cristina
   Torrent-Camarero, Sergi
   Garrido, Beatriz
   Javier Gil, Francisco
   Rodriguez, Daniel
TI Antifouling coatings for dental implants: Polyethylene glycol-like
   coatings on titanium by plasma polymerization
SO BIOINTERPHASES
LA English
DT Article
ID DIELECTRIC BARRIER DISCHARGES; BACTERIAL ADHESION; ANTIBACTERIAL
   ACTIVITY; POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION; COVALENT
   IMMOBILIZATION; PERI-IMPLANTITIS; SURFACE-ANALYSIS; ETHYLENE-OXIDE;
   LOW-PRESSURE
AB Titanium dental implants are commonly used for the replacement of lost teeth, but they present a considerable number of failures due to the infection on surrounding tissues. The aim of this paper is the development of a polyethylene glycol-like (PEG-like) coating on the titanium surface by plasma polymerization to obtain a novel improved surface with suitable low bacterial adhesion and adequate cell response. Surface analysis data of these coatings are presented, in particular, water contact angle, surface roughness, and film chemistry, demonstrating the presence of a PEG-like coating. Streptococcus sanguinis and Lactobacillus salivarius bacterial adhesion assays showed a decreased adhesion on the plasma polymerized samples, while cell adhesion of fibroblasts and osteoblasts on the treated surfaces was similar to control surfaces. Thus, the PEG-like antifouling coating obtained by plasma polymerization on Ti confers this biomaterial's highly suitable properties for dental applications, as they reduce the possibility of infection while allowing the tissue integration around the implant. (C) 2015 American Vacuum Society.
C1 [Buxadera-Palomero, Judit; Rodriguez, Daniel] Tech Univ Catalonia UPC, Biomat Biomech & Tissue Engn Grp, EU Engn Tecn Ind Barcelona, Barcelona 08036, Spain.
   [Buxadera-Palomero, Judit; Canal, Cristina; Javier Gil, Francisco; Rodriguez, Daniel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Zaragoza 50118, Spain.
   [Buxadera-Palomero, Judit; Canal, Cristina; Torrent-Camarero, Sergi; Garrido, Beatriz; Javier Gil, Francisco; Rodriguez, Daniel] Ctr Res NanoEngn CRNE UPC, Barcelona 08028, Spain.
   [Canal, Cristina; Torrent-Camarero, Sergi; Garrido, Beatriz; Javier Gil, Francisco] Tech Univ Catalonia UPC, Biomat Biomech & Tissue Engn Grp, ETS Engn Ind Barcelona, Dept Mat Sci & Met, Barcelona 08028, Spain.
RP Rodriguez, D (reprint author), Tech Univ Catalonia UPC, Biomat Biomech & Tissue Engn Grp, EU Engn Tecn Ind Barcelona, C Comte Urgell 187, Barcelona 08036, Spain.
EM daniel.rodriguez.rius@upc.edu
OI Torrent Camarero, Sergi/0000-0002-1399-066X
FU Technical University of Catalonia; Fundacion Ramon Areces; Fundacion
   Ramon Areces through project "Biosellado"; Spanish Government through
   Ramon y Cajal fellowship of CC; EU through European Regional Development
   Funds; European Cooperation in Science and Technology, COST action
   [MP1101];  [MAT2012-2012-30706]
FX The authors acknowledge financial support of Technical University of
   Catalonia and Fundacion Ramon Areces through the fellowship of J.B.-P.
   Financial support for the project is acknowledged to Fundacion Ramon
   Areces through project "Biosellado," the Spanish Government through
   Ramon y Cajal fellowship of CC and Project MAT2012-2012-30706, cofunded
   by the EU through European Regional Development Funds, and the European
   Cooperation in Science and Technology, COST action MP1101. The authors
   also wish to express their gratitude to Montserrat Dominguez, for her
   useful comments and advices regarding the XPS analysis.
CR Abou Neel EA, 2005, BIOMATERIALS, V26, P2247, DOI 10.1016/j.biomaterials.2004.07.024
   Al-Bataineh SA, 2009, LANGMUIR, V25, P7432, DOI 10.1021/la900334w
   Algraffee H, 2012, BRIT J ORAL MAX SURG, V50, P689, DOI 10.1016/j.bjoms.2011.11.020
   Almstahl A, 2008, ORAL DIS, V14, P541, DOI 10.1111/j.1601-0825.2007.01416.x
   Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Bretagnol F, 2006, ACTA BIOMATER, V2, P165, DOI 10.1016/j.actbio.2005.11.002
   Burm KTAL, 2007, CONTRIB PLASM PHYS, V47, P177, DOI 10.1002/ctpp.200710025
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Chaid B. T., 2013, INT J RECENT RES REV, VV, P17
   Cools P, 2014, PLASMA CHEM PLASMA P, V34, P917, DOI 10.1007/s11090-014-9552-2
   Cumpson PJ, 2000, SURF INTERFACE ANAL, V29, P403, DOI 10.1002/1096-9918(200006)29:6<403::AID-SIA884>3.0.CO;2-8
   Da Ponte G, 2011, SURF COAT TECH, V205, pS525, DOI 10.1016/j.surfcoat.2011.03.112
   Da Ponte G, 2012, PLASMA PROCESS POLYM, V9, P1176, DOI 10.1002/ppap.201100201
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Dufour D, 2010, ENDOD TOPICS, V22, P2, DOI DOI 10.1111/J.1601-1546.2012.00277.X
   Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4
   Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x
   Godoy-Gallardo M., CLIN ORAL IMPL UNPUB
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   Gour N, 2014, MACROMOL MATER ENG, V299, P648, DOI 10.1002/mame.201300285
   Hadjesfandiari N, 2014, J MATER CHEM B, V2, P4968, DOI 10.1039/c4tb00550c
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Harder S, 2013, CLIN ORAL INVEST, V17, P1135, DOI 10.1007/s00784-012-0805-2
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Hu XF, 2010, BIOMATERIALS, V31, P8854, DOI 10.1016/j.biomaterials.2010.08.006
   Johnston EE, 2005, LANGMUIR, V21, P870, DOI 10.1021/la036274s
   Kane SR, 2010, J MATER SCI-MATER M, V21, P1037, DOI 10.1007/s10856-009-3935-6
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   KOLENBRANDER PE, 1990, APPL ENVIRON MICROB, V56, P3890
   KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993
   Kumar DS, 2007, J MATER SCI-MATER M, V18, P1831, DOI 10.1007/s10856-007-3033-6
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Li YL, 2014, APPL SURF SCI, V288, P288, DOI 10.1016/j.apsusc.2013.10.022
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Manso M, 2005, ACTA BIOMATER, V1, P431, DOI 10.1016/j.actbio.2005.03.003
   Mayanagi G, 2005, INT C SER, V1284, P195
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Michelmore A, 2013, LANGMUIR, V29, P2595, DOI 10.1021/la304713b
   Morris H F, 2001, J Oral Implantol, V27, P180, DOI 10.1563/1548-1336(2001)027<0180:AMCIID>2.3.CO;2
   Mouhyi J, 2012, CLIN IMPLANT DENT R, V14, P170, DOI 10.1111/j.1708-8208.2009.00244.x
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Mutlu S, 2007, J FOOD ENG, V78, P494, DOI 10.1016/j.jfoodeng.2005.10.028
   Nie LH, 2007, PLASMA PROCESS POLYM, V4, P574, DOI 10.1002/ppap.200600212
   Nisol B, 2014, SURF COAT TECH, V252, P126, DOI 10.1016/j.surfcoat.2014.04.056
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   PACE JD, 1973, J PHYS D APPL PHYS, V6, P1525, DOI 10.1088/0022-3727/6/12/315
   Petasch W, 1997, SURF COAT TECH, V97, P176, DOI 10.1016/S0257-8972(97)00143-6
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pham LC, 2009, ARCH ORAL BIOL, V54, P132, DOI 10.1016/j.archoralbio.2008.09.007
   Pier-Francesco A, 2006, CLIN ORAL IMPLAN RES, V17, P633, DOI 10.1111/j.1600-0501.2006.01274.x
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Radin S, 2007, BIOMATERIALS, V28, P1721, DOI 10.1016/j.biomaterials.2006.11.035
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schlapak R, 2006, LANGMUIR, V22, P277, DOI 10.1021/la0521793
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Smentkowski VS, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4822516
   Smith HB, 2003, PHYS PLASMAS, V10, P875, DOI 10.1063/1.1531615
   Song DH, 2011, THIN SOLID FILMS, V519, P7079, DOI 10.1016/j.tsf.2011.01.385
   Tanaka Y, 2010, J BIOMED MATER RES A, V95A, P1105, DOI 10.1002/jbm.a.32932
   Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wells GP, 2013, PLASMA PROCESS POLYM, V10, P119, DOI 10.1002/ppap.201200066
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zoulalian V, 2010, LANGMUIR, V26, P74, DOI 10.1021/la902110j
NR 78
TC 14
Z9 14
U1 3
U2 59
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2015
VL 10
IS 2
AR 029505
DI 10.1116/1.4913376
PG 11
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA CL8AY
UT WOS:000357195600023
PM 25766480
DA 2018-10-20
ER

PT J
AU Annich, GM
AF Annich, G. M.
TI Extracorporeal life support: the precarious balance of hemostasis
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Review
DE blood coagulation; blood coagulation tests; extracorporeal membrane
   oxygenation; platelets; thrombosis
ID NITRIC-OXIDE RELEASE; MEMBRANE-OXYGENATION; CARDIOPULMONARY BYPASS;
   COAGULATION; ANTICOAGULATION; ACTIVATION; CIRCUITS; SYSTEM; MODEL;
   BIVALIRUDIN
AB Extracorporeal life support is by far the most extraordinary and complex form of extracorporeal technology used in the practice of critical care medicine. It is used to support critically ill patient who suffer acute respiratory or cardiac failure unresponsive to conventional support. As extracorporeal technologies have refined the pathophysiologic reaction that occurs at the blood/biomaterial interface has not been conquered; a new set of physiologic responses/derangements occur with the patient's exposure to the artificial circuit. Without this support mortality is near certain and with support if management is not precise and judicious the complications can be catastrophic. The management of a patient on ECLS is the same as for any critically ill patient with the added need for anticoagulation to maintain patency of the extracorporeal circuit without causing bleeding within the patient and thrombosis within the circuitry or the patient. This is the precarious balance of hemostasis during ECLS.
C1 Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada.
RP Annich, GM (reprint author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM gail.annich@sickkids.ca
CR Amoako KA, 2012, ASAIO J, V58, P238, DOI 10.1097/MAT.0b013e31824abed5
   Annich G, 2013, PEDIATR CRIT CARE ME, V14, pS37, DOI 10.1097/PCC.0b013e318292dfa7
   Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Annich GM, 2012, ECMO EXTRACORPOREAL, P91
   Barstad RM, 1996, BRIT J HAEMATOL, V94, P517, DOI 10.1111/j.1365-2141.1996.tb08989.x
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Bembea MM, 2013, PEDIATR CRIT CARE ME, V14, pE77, DOI 10.1097/PCC.0b013e31827127e4
   Fortenberry JD, 1996, J PEDIATR-US, V128, P670, DOI 10.1016/S0022-3476(96)80133-8
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HATTERSLEY PG, 1966, J AMER MED ASSOC, V196, P436, DOI 10.1001/jama.196.5.436
   Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2
   HUMMEL M, 1994, CLIN TRANSPLANT, V8, P59
   Lequier L, 2014, ELSO ANTICOAGULATION, P3
   Lequier L, 2012, ECMO EXTRACORPOREAL, P137
   Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   MARCOLIN R, 1995, INT J ARTIF ORGANS, V18, P624
   MCMANUS ML, 1995, J PEDIATR-US, V126, P900, DOI 10.1016/S0022-3476(95)70205-9
   Nagle EL, 2013, PEDIATR CRIT CARE ME, V14, pE182, DOI 10.1097/PCC.0b013e31827200b6
   Palatianos GM, 2003, ANN THORAC SURG, V76, P129, DOI 10.1016/S0003-4975(03)00338-2
   Peek GJ, 1999, ASAIO J, V45, P250, DOI 10.1097/00002480-199907000-00003
   Ranucci M, 2011, CRIT CARE, V15, DOI 10.1186/cc10556
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Tayama E, 2000, ARTIF ORGANS, V24, P618, DOI 10.1046/j.1525-1594.2000.06615.x
   Urlesberger B, 1996, J PEDIATR-US, V129, P264, DOI 10.1016/S0022-3476(96)70252-4
   Valhonart H, 1999, ASAIO J, V45, P113
   VANE JR, 1990, NEW ENGL J MED, V323, P27
   Volk HD, 2000, CHEM IMMUNOL, V74, P162
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   WOODMAN RC, 1990, BLOOD, V76, P1680
NR 30
TC 28
Z9 28
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD JUN
PY 2015
VL 13
SU 1
SI SI
BP S336
EP S342
DI 10.1111/jth.12963
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CL1BN
UT WOS:000356677500045
PM 26149045
OA Bronze
DA 2018-10-20
ER

PT J
AU Jaffer, IH
   Fredenburgh, JC
   Hirsh, J
   Weitz, JI
AF Jaffer, I. H.
   Fredenburgh, J. C.
   Hirsh, J.
   Weitz, J. I.
TI Medical device-induced thrombosis: what causes it and how can we prevent
   it?
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Review
DE catheters; factor XI; factor XII; medical devices; thrombosis
ID ELASTIN-LIKE POLYPEPTIDES; ACUTE CORONARY SYNDROMES; MECHANICAL
   HEART-VALVES; STAINLESS-STEEL STENT; IN-VIVO ASSESSMENT;
   PLATELET-ADHESION; FACTOR-XI; COMPLEMENT ACTIVATION; CATHETER
   THROMBOSIS; CELL-ADHESION
AB Blood-contacting medical devices, such as vascular grafts, stents, heart valves, and catheters, are often used to treat cardiovascular diseases. Thrombus formation is a common cause of failure of these devices. This study (i) examines the interface between devices and blood, (ii) reviews the pathogenesis of clotting on blood-contacting medical devices, (iii) describes contemporary methods to prevent thrombosis on blood-contacting medical devices, (iv) explains why some anticoagulants are better than others for prevention of thrombosis on medical devices, and (v) identifies future directions in biomaterial research for prevention of thrombosis on blood-contacting medical devices.
C1 [Jaffer, I. H.; Fredenburgh, J. C.; Hirsh, J.; Weitz, J. I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada.
   [Jaffer, I. H.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.
   [Fredenburgh, J. C.; Hirsh, J.; Weitz, J. I.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Weitz, J. I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.
RP Weitz, JI (reprint author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.
EM weitzj@taari.ca
CR Alibeik S, 2012, J BIOMAT SCI-POLYM E, V23, P1981, DOI 10.1163/092050611X603250
   Alibeik S, 2012, J BIOMED MATER RES A, V100A, P856, DOI 10.1002/jbm.a.34022
   Alibeik S, 2011, ACTA BIOMATER, V7, P4177, DOI 10.1016/j.actbio.2011.07.022
   AlKhaffaf H, 1996, J VASC SURG, V23, P686, DOI 10.1016/S0741-5214(96)80050-4
   Amara U, 2008, CURRENT TOPICS COMPL, VII, P68
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bane CE, 2014, DRUG DISCOV TODAY, V19, P1454, DOI 10.1016/j.drudis.2014.05.018
   Bluestein D, 2013, J BIOMECH, V46, P338, DOI 10.1016/j.jbiomech.2012.11.033
   BOWERS VM, 1989, J BIOMED MATER RES, V23, P1453, DOI 10.1002/jbm.820231208
   Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760
   Chan WS, 2000, ARCH INTERN MED, V160, P191, DOI 10.1001/archinte.160.2.191
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   Crosby JR, 2013, ARTERIOSCL THROM VAS, V33, P1670, DOI 10.1161/ATVBAHA.113.301282
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   Deng J, 2014, ACS APPL MATER INTER, V6, P21603, DOI 10.1021/am506249r
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   Edmunds LH, 2006, ANN THORAC SURG, V82, P2315, DOI 10.1016/j.athoracsur.2006.06.072
   Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Galli M, 2000, J INVASIVE CARDIOL, V12, P452
   Gao WQ, 2013, INT J CLIN EXP MED, V6, P259
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Jordan SW, 2006, BIOMATERIALS, V27, P3473, DOI 10.1016/j.biomaterials.2006.01.009
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KAZATCHKINE MD, 1989, ADV EXP MED BIOL, V260, P19
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   Kim YH, 2005, AM HEART J, V149, P336, DOI 10.1016/j.ahj.2004.02.018
   Klement P, 2006, BIOMATERIALS, V27, P5107, DOI 10.1016/j.biomaterials.2006.05.005
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Krisinger MJ, 2012, BLOOD, V120, P1717, DOI 10.1182/blood-2012-02-412080
   Kudo FA, 2002, INT ANGIOL, V21, P214
   Kuiper KKJ, 1998, SCAND CARDIOVASC J, V32, P261
   Larsson M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006804
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Leyh RG, 2002, EUR J CARDIO-THORAC, V21, P577, DOI 10.1016/S1010-7940(01)01154-X
   Li JM, 2002, J SURG RES, V105, P200, DOI 10.1006/jsre.2002.6381
   Liu T, 2014, ACTA BIOMATER, V10, P1940, DOI 10.1016/j.actbio.2013.12.013
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Lu L, 2012, J BIOMED MATER RES A, V100A, P2421, DOI 10.1002/jbm.a.34143
   MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111
   MCPHERSON DT, 1992, BIOTECHNOL PROGR, V8, P347, DOI 10.1021/bp00016a012
   Mehta SR, 2008, CIRCULATION, V118, P2038, DOI 10.1161/CIRCULATIONAHA.108.789479
   Mehta SR, 2007, J AM COLL CARDIOL, V50, P1742, DOI 10.1016/j.jacc.2007.07.042
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199
   Nakayama Y, 2011, J BIOMED MATER RES B, V99B, P420, DOI 10.1002/jbm.b.31914
   Nelson KD, 1996, ASAIO J, V42, pM884, DOI 10.1097/00002480-199609000-00119
   Ortega-Vinuesa JL, 1998, BIOMATERIALS, V19, P251, DOI 10.1016/S0142-9612(97)00206-8
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Sick PB, 2005, AM HEART J, V149, P681, DOI 10.1016/j.ahj.2004.07.011
   Sick PB, 2004, AM J CARDIOL, V93, P1351, DOI 10.1016/j.amjcard.2004.02.029
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   Vrolix MCM, 2000, AM J CARDIOL, V86, P385, DOI 10.1016/S0002-9149(00)00951-6
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wohrle J, 2001, EUR HEART J, V22, P1808, DOI 10.1053/euhj.2001.2608
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   Yau JW, 2014, THROMB HAEMOSTASIS, V112, P79, DOI 10.1160/TH13-12-1047
   Yau JW, 2014, BLOOD, V123, P2102, DOI 10.1182/blood-2013-12-540872
   Yau JW, 2012, ACTA BIOMATER, V8, P4092, DOI 10.1016/j.actbio.2012.07.019
   Yau JW, 2011, BLOOD, V118, P6667, DOI 10.1182/blood-2011-07-364141
   Yayapour N, 1999, COLLOID SURFACE B, V15, P127, DOI 10.1016/S0927-7765(99)00049-1
   Yeh HY, 2009, J BIOMAT SCI-POLYM E, V20, P807, DOI 10.1163/156856209X426952
NR 79
TC 63
Z9 63
U1 8
U2 54
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD JUN
PY 2015
VL 13
SU 1
SI SI
BP S72
EP S81
DI 10.1111/jth.12961
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CL1BN
UT WOS:000356677500011
PM 26149053
OA Bronze
DA 2018-10-20
ER

PT J
AU Gao, Y
   Wang, YL
   Kong, D
   Qu, B
   Su, XJ
   Li, H
   Pi, HY
AF Gao, Yuan
   Wang, Yu-ling
   Kong, Dan
   Qu, Bo
   Su, Xiao-jing
   Li, Huan
   Pi, Hong-ying
TI Nerve autografts and tissue-engineered materials for the repair of
   peripheral nerve injuries: a 5-year bibliometric analysis
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; peripheral nerve; nerve autograft; nerve
   transplantation; biomaterial; tissue engineering; neural regeneration
ID REGENERATION; CONDUITS; GRAFT; TRANSPLANTATION; BIOMATERIALS; DEFECTS;
   GUIDE; CELLS
AB With advances in biomedical methods, tissue-engineered materials have developed rapidly as an alternative to nerve autografts for the repair of peripheral nerve injuries. However, the materials selected for use in the repair of peripheral nerve injuries, in particular multiple injuries and large-gap defects, must be chosen carefully. Various methods and materials for protecting the healthy tissue and repairing peripheral nerve injuries have been described, and each method or material has advantages and disadvantages. Recently, a large amount of research has been focused on tissue-engineered materials for the repair of peripheral nerve injuries. Using the keywords "peripheral nerve injury", "autotransplant", "nerve graft", and "biomaterial", we retrieved publications using tissue-engineered materials for the repair of peripheral nerve injuries appearing in the Web of Science from 2010 to 2014. The country with the most total publications was the USA. The institutions that were the most productive in this field include Hannover Medical School (Germany), Washington University (USA), and Nantong University (China). The total number of publications using tissue-engineered materials for the repair of peripheral nerve injuries gradually increased over time, as did the number of Chinese publications, suggesting that China has made many scientific contributions to this field of research.
C1 [Gao, Yuan; Kong, Dan; Su, Xiao-jing; Li, Huan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing 100853, Peoples R China.
   [Wang, Yu-ling; Pi, Hong-ying] Chinese Peoples Liberat Army Gen Hosp, Dept Nursing, Beijing 100853, Peoples R China.
   [Qu, Bo] Chinese Peoples Liberat Army Gen Hosp, Dept Surg, Clin Div, Beijing 100853, Peoples R China.
RP Pi, HY (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Nursing, Beijing 100853, Peoples R China.
EM phy301@sina.com
CR Alluin O, 2006, J NEUROTRAUM, V23, P1883, DOI 10.1089/neu.2006.23.1883
   Badoiu S C, 2014, Chirurgia (Bucur), V109, P584
   Beigi MH, 2014, J BIOMED MATER RES A, V102, P4554, DOI 10.1002/jbm.a.35119
   Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018
   Chang CJ, 2009, TISSUE ENG PT A, V15, P547, DOI 10.1089/ten.tea.2007.0342
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Hernandez-Cortes P, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046024
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Koudehi MF, 2014, J MATER SCI-MATER M, V25, P363, DOI 10.1007/s10856-013-5076-1
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Leuzzi S, 2014, G CHIR, V35, P101, DOI 10.11138/gchir/2014.35.3.101
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   Matsumoto K, 2000, ASAIO J, V46, P415, DOI 10.1097/00002480-200007000-00009
   Mukhatyar V, 2014, ANN BIOMED ENG, V42, P1436, DOI 10.1007/s10439-013-0960-x
   Nagao RJ, 2011, NEUROL RES, V33, P600, DOI 10.1179/1743132810Y.0000000023
   Pateman CJ, 2015, BIOMATERIALS, V49, P77, DOI 10.1016/j.biomaterials.2015.01.055
   Peters KM, 2010, J UROLOGY, V183, P1438, DOI 10.1016/j.juro.2009.12.036
   Radtke C, 2014, CELLS TISSUES ORGANS, V200, P48, DOI 10.1159/000369006
   Ramburrun P, 2014, BIOMED RES INT, DOI 10.1155/2014/132350
   Rinker B, 2014, CLIN PLAST SURG, V41, P533, DOI 10.1016/j.cps.2014.03.006
   Rochkind S, 2014, BIOMED RES INT, V2014
   Sivak WN, 2014, METHODS MOL BIOL, V1162, P139, DOI 10.1007/978-1-4939-0777-9_11
   Tom VJ, 2011, EXP NEUROL, V211, P315
   Yue HJ, 2008, KEYAN GUANLI, V5, P43
NR 28
TC 9
Z9 11
U1 2
U2 31
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD JUN
PY 2015
VL 10
IS 6
BP 1003
EP 1008
DI 10.4103/1673-5374.158369
PG 6
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CL9KW
UT WOS:000357298200035
PM 26199621
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Campitiello, F
   Della Corte, A
   Guerniero, R
   Pellino, G
   Canonico, S
AF Campitiello, Ferdinand
   Della Corte, Angela
   Guerniero, Raffaella
   Pellino, Gianluca
   Canonico, Silvestro
TI Efficacy of a New Flowable Wound Matrix in Tunneled and Cavity Ulcers: A
   Preliminary Report
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
DE tunneling lesions; biomaterials; flowable matrix
ID VENOUS ULCERS; SENESCENCE
AB Introduction. In chronic wounds the healing is stagnant, and regenerative surgery is often needed. Many engineered tissues with a conventional bidimensional sheet are ineffective for tunneling wounds, because adherence to the: wound bed is not Complete: An advanced wound Matrix for treating wounds with irregular geometries has been developed (Integra Flowable Wound Matrix, Integra LifeScienee Corp, Plainsboro, NJ). Methods and Materials. Between March 2013 and December 2013 the authors treated 18 patients (11 female) with tunneled or cavity ulcers with the advanced wound matrix at the Unit of General and Geriatric Surgery of the Second University of Naples, Naples, Italy. Two patients (11.1%) had postsurgical Wounds, two (11.1%) had post-traumatic wounds, and 14 (77.8%) had neuropathic ulcers. After debridement and antibiotic therapy, the lesions were filled; with the wound matrix product. Surgical wound edges were either approximated with stitches or left to heal by secondary intention and covered with wet gauze. During the first week, follow-up visits were carried out every 3 days, then once a week until complete healing was achieved. All patients underwent preoperative and postoperative ultrasonography scans and plain radiograph controls. Results. Twenty-one applications were performed. Engraftment was complete in all but 1 patient who bad diabetes and graft failure.. Three patients needed repeated applications to complete the filling of the lesions. Median (range) pain Visual Analog Scores on a scale of 0 to 10, where 0 = no pain, and 10 = intolerable pain were 6.3 (range 3-8) preoperatively and 0.5 (range 0-2) at first follow-up (P <= 0.001). All but 2 patients showed a progressive remodeling of the tissue gap at scheduled radiographic controls. Conclusions. To the author's knowledge, the advanced wound matrix used in this study is the only available biomaterial for the treatment of tunneled lesions. It stimulates tissue regeneration by filling surfaces which cannot be repaired spontaneously or by using conventional biomaterials in the form of sheets. Its application is atraumatic, painless, and safe.
C1 [Campitiello, Ferdinand; Della Corte, Angela; Guerniero, Raffaella; Pellino, Gianluca; Canonico, Silvestro] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, I-80138 Naples, Italy.
RP Canonico, S (reprint author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Unit Gen & Geriatr Surg, Piazza Miraglia 2, I-80138 Naples, Italy.
EM silvestro.canonico@unina2.it
OI Pellino, Gianluca/0000-0002-8322-6421
CR Campitiello E, 2005, Acta Biomed, V76 Suppl 1, P69
   Canonico S, 2013, SKIN GRAFTS, DOI [10.5772/51852, DOI 10.5772/51852]
   Canonico S, 2009, DERMATOL SURG, V35, P195, DOI 10.1111/j.1524-4725.2008.34409.x
   Edwards JS, 2010, KNOWL MAN RES PRACT, V8, P1, DOI 10.1057/kmrp.2009.39
   Gottlieb M, 2004, J BURNS SURG WOUND C, V3, P4
   Iorio ML, 2012, PLAST RECONSTR SURG, V130, p232S, DOI 10.1097/PRS.0b013e3182615703
   Le X., 2013, INT J BIOMATER, V2013
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   Moiemen N, 2011, PLAST RECONSTR SURG, V127, P1149, DOI 10.1097/PRS.0b013e31820436e3
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Stanley A, 2001, J VASC SURG, V33, P1206, DOI 10.1067/mva.2001.115379
   Yang Fan, 2008, P3
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
NR 14
TC 7
Z9 7
U1 0
U2 1
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
EI 1943-2704
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD JUN
PY 2015
VL 27
IS 6
BP 152
EP 157
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA CL8NL
UT WOS:000357231300004
PM 26061490
DA 2018-10-20
ER

PT J
AU Ohta, S
   Nishiyama, T
   Sakoda, M
   Machioka, K
   Fuke, M
   Ichimura, S
   Inagaki, F
   Shimizu, A
   Hasegawa, K
   Kokudo, N
   Kaneko, M
   Yatomi, Y
   Ito, T
AF Ohta, Seiichi
   Nishiyama, Toru
   Sakoda, Megumu
   Machioka, Kyoko
   Fuke, Masaya
   Ichimura, Shigetoshi
   Inagaki, Fuyuki
   Shimizu, Atsushi
   Hasegawa, Kiyoshi
   Kokudo, Norihiro
   Kaneko, Makoto
   Yatomi, Yutaka
   Ito, Taichi
TI Development of carboxymethyl cellulose nonwoven sheet as a novel
   hemostatic agent
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Carboxymethyl cellulose; Nonwoven sheet; Hemostasis; Blood clotting;
   Bandage; Biomaterial
ID BLEEDING-TIME; COLLAGEN; MECHANISM
AB Carboxymethyl cellulose (CMC) is a plant-derived material that has high biocompatibility and water solubility. We developed a CMC nonwoven sheet as a hemostatic agent by carboxymethylating a continuous filament cellulose nonwoven sheet. The CMC nonwoven sheet was able to absorb water and dissolve in it. The rates of absorption and dissolution depended on the degree of carboxymethylation. After dissolving in blood, CMC accelerated clot development (possibly owing to the incorporation of CMC into fibrin fibers) and increased the viscosity of the blood, both of which would contribute to the improved blood clotting of an injured surface. In vivo experiments using a rat tail cutting method showed that a CMC nonwoven sheet shortened the bleeding time of the tail when applied to the cut surface. The hemostatic effect of the CMC nonwoven sheet was almost at the same level as a commercial hemostatic bandage. These results suggest that a CMC nonwoven sheet could be used as a novel sheet-type hemostatic agent. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.
C1 [Ohta, Seiichi; Nishiyama, Toru; Ito, Taichi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan.
   [Sakoda, Megumu; Ichimura, Shigetoshi] Kanagawa Inst Technol, Dept Appl Biosci, Atsugi, Kanagawa 2430292, Japan.
   [Machioka, Kyoko; Fuke, Masaya] Asahi Kasei Fibers Corp, Nobeoka, Miyazaki 8820847, Japan.
   [Inagaki, Fuyuki; Shimizu, Atsushi; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Bunkyo Ku, Tokyo 1130033, Japan.
   [Kaneko, Makoto; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1130033, Japan.
RP Ito, T (reprint author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
EM taichi@m.u-tokyo.ac.jp
FU (PD) from the Japan Society for the Promotion of Science (JSPS) [5621]
FX We thank M. Aoshima for the useful discussion. We also acknowledge Q.
   Pan for her help in conducting ATR-IR measurements. S. Ohta is grateful
   to the Research Fellowship (PD, no. 5621) from the Japan Society for the
   Promotion of Science (JSPS).
CR ABBOTT WM, 1975, SURGERY, V78, P723
   Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Aoshima M., 2012, JPN J THROMB HEMOSTA, V23, P387
   BJORENSON JE, 1986, J ENDODONT, V12, P289, DOI 10.1016/S0099-2399(86)80110-8
   Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028
   DEJANA E, 1982, THROMB HAEMOSTASIS, V48, P108
   Dowling MB, 2011, BIOMATERIALS, V32, P3351, DOI 10.1016/j.biomaterials.2010.12.033
   EYLER RW, 1947, ANAL CHEM, V19, P24, DOI 10.1021/ac60001a007
   Frantz VK, 1944, ANN SURG, V120, P181
   Funahashi M., 2002, NEPHROL DIAL TRANSPL, V17, P1457
   Gu HB, 2013, FIBER POLYM, V14, P1266, DOI 10.1007/s12221-013-1266-1
   Heinze T, 2005, MACROMOL SYMP, V223, P13, DOI 10.1002/masy.200550502
   HETT DA, 1995, BRIT J ANAESTH, V75, P771, DOI 10.1093/bja/75.6.771
   Hori H, 2002, J ALLERGY CLIN IMMUN, V110, P652, DOI 10.1067/mai.2002.127862
   IBARROLA JL, 1985, J ENDODONT, V11, P75, DOI 10.1016/S0099-2399(85)80123-0
   Kihara H, 2001, EUR J PHARMACOL, V433, P157, DOI 10.1016/S0014-2999(01)01432-7
   Low R K, 1993, J Laparoendosc Surg, V3, P415, DOI 10.1089/lps.1993.3.415
   Ogushi Y, 2007, J BIOSCI BIOENG, V104, P30, DOI 10.1263/jbb.104.30
   Rajasekaran A., 2010, INT J BIOL MED RES, V1, P85
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Shilo S, 2013, TISSUE ENG PT A, V19, P1519, DOI [10.1089/ten.tea.2012.0345, 10.1089/ten.TEA.2012.0345]
   Shulda A., 2012, ADV MATER, V24, P492
   Taniguchi R., 2007, WEB J, V86, P29
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   Varma AJ, 2001, CARBOHYD POLYM, V45, P101, DOI 10.1016/S0144-8617(00)00278-2
   Wang HM, 2007, BLOOD COAGUL FIBRIN, V18, P555, DOI 10.1097/MBC.0b013e3281eec966
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   Yan L, 2014, ADV HEALTHC MATER, V3, P555, DOI 10.1002/adhm.201300312
   You KE, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025002
   ZUCKER WH, 1976, AM J PATHOL, V82, P129
NR 31
TC 10
Z9 10
U1 4
U2 57
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUN
PY 2015
VL 119
IS 6
BP 718
EP 723
DI 10.1016/j.jbiosc.2014.10.026
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA CL1ZR
UT WOS:000356743900018
PM 25488042
DA 2018-10-20
ER

PT J
AU Russmueller, G
   Moser, D
   Spassova, E
   Plasenzotti, R
   Poeschl, PW
   Seemann, R
   Becker, S
   Pirklbauer, K
   Eder-Czembirek, C
   Czembirek, C
   Perisanidis, C
   Ewers, R
   Schopper, C
AF Russmueller, G.
   Moser, D.
   Spassova, E.
   Plasenzotti, R.
   Poeschl, P. W.
   Seemann, R.
   Becker, S.
   Pirklbauer, K.
   Eder-Czembirek, C.
   Czembirek, C.
   Perisanidis, C.
   Ewers, R.
   Schopper, C.
TI Tricalcium phosphate-based biocomposites for mandibular bone
   regeneration-A histological study in sheep
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Bone regeneration; Mandibular defect; Tricalcium phosphate; Autologous
   bone marrow; Coagulation factor XIII; Polylactide scaffold
ID MARROW STROMAL CELLS; STEM-CELLS; RECONSTRUCTION; DEFECTS;
   OSTEOPROMOTION; SCAFFOLD; SURGERY; TISSUES; GROWTH; REPAIR
AB The present study investigated the suitability of three different absorbable biocomposites for the repair of critical sized bone defects created at the mandibular angle of adult sheep.
   Each biocomposite was composed of a three-dimensional individualized polylactide scaffold, containing a tricalcium phosphate biomaterial (chronOS (R)). Either autologous bone marrow (chOS/Bone-Marrow) or coagulation factor XIII (chOS/FactorXIII) was added to the biomaterial for osteopromotion. Venous whole blood (chOS/Blood) added to the biomaterial served as a control. A total of 18 adult sheep were used for implantation studies, subdivided into three groups of six animals each.
   After 12 weeks of observation, the animals were sacrificed and the mandibles were retrieved for qualitative and quantitative histologic assessment within three regions of interest (transitional zone, center, and periphery) throughout the biocomposites. Successful bone regeneration was defined by the absence of scaffold deformation and the presence of new bone formation within the biocomposites.
   In histomorphometry, only chOS/BoneMarrow showed elevated area fractions of newly formed bone in all regions of interest (transitional zone 50.7 +/- 7.5, center 31.9 +/- 9.3, periphery 23.1 +/- 13.5). This led to preservation of the macroscopic scaffold structure in all specimens. Zero hurdle regression confirmed this by validating the factor biocomposite as significant (p < 0.001) for regeneration success. In our experiment, chOS/BoneMarrow was the only biocomposite passing the hurdle of regeneration in all three regions of interest.
   In contrast, bone formation was less pronounced and uniform in chOS/FactorXIII and chOS/blood-containing specimens. In these groups, scaffolds showed obvious to significant deformation.
   Overall, autologous bone marrow showed the most promising results in our experimental setting. As opposed to reports in the literature, we could not confirm the suitability of coagulation factor XIII to promote bone formation, since bone formation rates were comparable only to those of the control venous blood. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Russmueller, G.; Moser, D.; Poeschl, P. W.; Seemann, R.; Pirklbauer, K.; Eder-Czembirek, C.; Czembirek, C.; Perisanidis, C.; Ewers, R.; Schopper, C.] Med Univ Vienna, Dept Cranio Maxillofacial & Oral Surg, A-1090 Vienna, Austria.
   [Plasenzotti, R.] Med Univ Vienna, Inst Biomed Res, A-1090 Vienna, Austria.
   [Spassova, E.] Biotechnologies GmbH, AlgOss, Vienna, Austria.
   [Becker, S.] Austrian Cluster Tissue Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.
RP Russmueller, G (reprint author), Med Univ Vienna, Dept Cranio Maxillofacial & Oral Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM guenter.russmueller@meduniwien.ac.at
OI Plasenzotti, Roberto/0000-0001-7652-1249
CR Al-Jallad HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015893
   Ashammakhi N, 2001, PLAST RECONSTR SURG, V108, P167, DOI 10.1097/00006534-200107000-00027
   Becker S, 2006, SPINE, V31, P11, DOI 10.1097/01.brs.0000192762.40274.57
   Becker S, 2008, J MATER SCI-MATER M, V19, P659, DOI 10.1007/s10856-007-3223-2
   Becker SWJ, 2001, SPINAL CORD, V39, P114, DOI 10.1038/sj.sc.3101092
   Bertele G, 2005, Minerva Stomatol, V54, P179
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Chanchareonsook N, 2014, TISSUE ENG PART B-RE, V20, P147, DOI [10.1089/ten.TEB.2013.0131, 10.1089/ten.teb.2013.0131]
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Eichner A, 2002, EXP CELL RES, V275, P132, DOI 10.1006/excr.2002.5488
   Gronthos S, 2004, LANCET, V364, P735, DOI 10.1016/S0140-6736(04)16948-1
   He Y, 2007, J CRANIOFAC SURG, V18, P800, DOI 10.1097/scs.0b013e31806901f5
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249
   Kilian O, 2005, BIOMATERIALS, V26, P1819, DOI 10.1016/j.biomaterials.2004.06.015
   Kinoshita Y, 1996, Tissue Eng, V2, P327, DOI 10.1089/ten.1996.2.327
   Kinoshita Yukihiko, 2005, Nihon Hotetsu Shika Gakkai Zasshi, V49, P569
   Kuznetsov SA, 2008, BIOMATERIALS, V29, P4211, DOI 10.1016/j.biomaterials.2008.07.013
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Louis P, 2004, J ORAL MAXIL SURG, V62, P719, DOI 10.1016/j.joms.2003.12.012
   Lucarelli E, 2005, CLIN ORTHOP RELAT R, P62, DOI 10.1097/01.blo.0000165736.87628.12
   Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567
   Matsuo A, 2012, J CRANIO MAXILL SURG, V40, pE453, DOI 10.1016/j.jcms.2012.03.004
   Muszbek L, 2001, PHYSIOL REV, V91, P931
   Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007
   Nolff MC, 2009, VET COMP ORTHOPAED, V22, P96, DOI 10.3415/VCOT-08-04-0038
   Pieri F, 2008, J CLIN PERIODONTOL, V35, P539, DOI 10.1111/j.1600-051X.2008.01220.x
   Schliephake H, 2000, J ORAL MAXIL SURG, V58, P1212, DOI 10.1053/joms.2000.16616
   Schliephake H, 2001, INT J ORAL MAX SURG, V30, P531, DOI 10.1054/ijom.2001.0164
   Strong EB, 2003, OTOLARYNG HEAD NECK, V129, P417, DOI 10.1016/S0194-5998(03)01315-9
   Sverzut CE, 2008, J ORAL MAXIL SURG, V66, P647, DOI 10.1016/j.joms.2007.06.664
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Zhou LB, 2008, BRIT J ORAL MAX SURG, V46, P445, DOI 10.1016/j.bjoms.2008.01.006
NR 35
TC 8
Z9 8
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD JUN
PY 2015
VL 43
IS 5
BP 696
EP 704
DI 10.1016/j.jcms.2015.03.022
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA CK9GN
UT WOS:000356548700018
PM 25937475
DA 2018-10-20
ER

PT J
AU Mangano, C
   Barboni, B
   Valbonetti, L
   Berardinelli, P
   Manelli, A
   Muttini, A
   Bedini, R
   Tete, S
   Piattelli, A
   Mattioli, M
AF Mangano, Carlo
   Barboni, Barbara
   Valbonetti, Luca
   Berardinelli, Paolo
   Manelli, Alessandra
   Muttini, Aurelio
   Bedini, Rossella
   Tete, Stefano
   Piattelli, Adriano
   Mattioli, Mauro
TI In Vivo Behavior of a Custom-Made 3D Synthetic Bone Substitute in Sinus
   Augmentation Procedures in Sheep
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE bone grafting; hydroxyapatites; tricalcium phosphate; X-ray
   microtomography; scaffolds; sinus floor augmentation
ID BMP-INDUCED OSTEOGENESIS; RAPID PROTOTYPING TECHNIQUE; PIG
   OVARIAN-FOLLICLES; POROUS HYDROXYAPATITE; PORE-SIZE;
   MECHANICAL-PROPERTIES; PERIOVULATORY PERIOD; SCAFFOLDS; FABRICATION;
   EXPRESSION
AB In this study, the in vivo behavior of a custom-made three-dimensional (3D) synthetic bone substitute was evaluated when used as scaffold for sinus augmentation procedures in an animal model. The scaffold was a calcium phosphate ceramic fabricated by the direct rapid prototyping technique, dispense-plotting. The geometrical and chemical properties of the scaffold were first analyzed through light and electron scanning microscopes, helium picnometer, and semi-quantitative X-ray diffraction measurements. Then, 6 sheep underwent monolateral sinus augmentation with the fabricated scaffolds. The animals were euthanized after healing periods of 45 and 90 days, and block sections including the grafted area were obtained. Bone samples were subjected to micro computerized tomography, morphological and histomorphometric analyses. A complete integration of the scaffold was reported, with abundant deposition of newly formed bone tissue within the biomaterial pores,. Moreover, initial foci of bone remodeling were mainly localized at the periphery of the implanted area after 45 days, while continuous bridges of mature lamellar bone were recorded in 90-day specimens. This evidence supports the hypothesis that bone regeneration proceeds from the periphery to the center of the sinus cavity. These results showed how a technique allowing control of porosity, pore design, and external shape of a ceramic bone substitute may be valuable for producing synthetic bone grafts with good clinical performances.
C1 [Mangano, Carlo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
   [Barboni, Barbara; Valbonetti, Luca] Stem TeCh Grp, Chieti, Italy.
   [Barboni, Barbara; Valbonetti, Luca; Berardinelli, Paolo; Manelli, Alessandra; Muttini, Aurelio; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, TE, Italy.
   [Bedini, Rossella] ISS, Dept Technol & Hlth, Rome, Italy.
   [Tete, Stefano; Piattelli, Adriano] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
RP Mangano, C (reprint author), Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
EM francescoguidomangano@gmail.com
RI Bedini, Rossella/B-2465-2013; Valbonetti, Luca/F-4078-2012
OI Valbonetti, Luca/0000-0001-5914-615X; Bedini,
   Rossella/0000-0002-0830-6632
FU Tercas Foundation; Ministry of Education, University and Research
   (M.I.U.R.), Rome, Italy
FX This work was supported by Tercas Foundation and, partially, by the
   Ministry of Education, University and Research (M.I.U.R.), Rome, Italy.
   The authors gratefully acknowledge the help of Sabine Hamisch,
   UweHamhaber, BioCerEntwicklungs-GmbH, Ludwig-Thoma-Str. 36c, 95447
   Bayreuth, Germany, in providing the materials and of Maura Turriani,
   Delia Nardinocchi, and Oriana Di Giacinto for their precious technical
   support in cell cultures and histological analysis.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Barbara B, 2004, THERIOGENOLOGY, V62, P943, DOI 10.1016/j.theriogenology.2003.12.010
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Crespi R, 2009, J PERIODONTOL, V80, P586, DOI 10.1902/jop.2009.080466
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Diaz-Flores L, 2011, J CUTAN PATHOL, V38, P857, DOI 10.1111/j.1600-0560.2011.01778.x
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Fierz FC, 2008, BIOMATERIALS, V29, P3799, DOI 10.1016/j.biomaterials.2008.06.012
   Froum S J, 1998, Int J Periodontics Restorative Dent, V18, P528
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Killingsworth MC, 2011, PATHOBIOLOGY, V78, P24, DOI 10.1159/000322739
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Martelli A, 2006, J MOL ENDOCRINOL, V36, P107, DOI 10.1677/jme.1.01921
   Martelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-72
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3039, DOI 10.1007/s10856-010-4153-y
   Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Zecha PJ, 2011, INT J ORAL MAX SURG, V40, P533, DOI 10.1016/j.ijom.2011.01.007
NR 43
TC 5
Z9 5
U1 1
U2 8
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD JUN
PY 2015
VL 41
IS 3
BP 241
EP 251
DI 10.1563/AAID-JOI-D-13-00053
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CL0PS
UT WOS:000356645200003
PM 23829685
DA 2018-10-20
ER

PT J
AU He, T
   Wang, JN
   Huang, PL
   Zeng, BZ
   Li, HH
   Cao, QY
   Zhang, SY
   Luo, ZO
   Deng, DYB
   Zhang, HW
   Zhou, WY
AF He, Ting
   Wang, Jingnan
   Huang, Peilin
   Zeng, Baozhen
   Li, Haihong
   Cao, Qingyun
   Zhang, Shiying
   Luo, Zhuo
   Deng, David Y. B.
   Zhang, Hongwu
   Zhou, Wuyi
TI Electrospinning polyvinylidene fluoride fibrous membranes containing
   anti-bacterial drugs used as wound dressing
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Electrospinning; Enro/PVDF fibrous membranes; Drug release; Wound
   dressing
ID POLY(VINYLIDENE FLUORIDE); POLYMER NANOFIBERS; CONTROLLED-RELEASE; PVDF;
   BIOMATERIAL; DELIVERY; GELATIN
AB The aim of this study was to synthesis drug-loaded fibrous membrane scaffolds for potential applications as wound dressing. Polyvinylidene fluoride (PVDF) fibrous membranes were loaded with enrofloxacin (Enro) drugs by using an electrospinning process, and their mechanical strength, drug release profile and anti-bacterial properties were evaluated. Enro drug-loaded PVDF membranes exhibited good elasticity, flexibility and excellent mechanical strength. The electrospinning Enro/PVDF membranes showed a burst drug release in the initial 12 h, followed by sustained release for the next 3 days, which was an essential property for antibiotic drugs applied for wound healing. The drug-loaded PVDF fibrous membranes displayed excellent anti-bacterial activity toward Escherichia coli and Staphylococcus aureus. The results suggest that electrospinning PVDF membrane scaffolds loaded with drugs can be used as wound dressing. (C) 2015 Elsevier B.V. All rights reserved.
C1 [He, Ting; Huang, Peilin; Li, Haihong; Zhou, Wuyi] South China Agr Univ, Coll Sci, Dept Appl Chem, Inst Biomat, Guangzhou 510642, Guangdong, Peoples R China.
   [Wang, Jingnan; Deng, David Y. B.] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Cao, Qingyun] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.
   [Zhang, Shiying; Luo, Zhuo] Changsha Univ, Key Lab Applicat Technol Environm Photocatalysis, Changsha 410022, Hunan, Peoples R China.
   [Zeng, Baozhen; Zhang, Hongwu] Southern Med Univ, Guangdong Prov Key Lab Construct & Detect Tissue, Dept Anat, Guangzhou 510515, Guangdong, Peoples R China.
RP Deng, DYB (reprint author), South China Agr Univ, Dept Appl Chem, Inst Biomat, Wushan Rd 493, Guangzhou 510642, Guangdong, Peoples R China.
EM dengyub@mail.sysu.edu.cn; zhanghwu@mail2.sysu.edu.cn;
   zhouwuyi@scau.edu.cn
FU National Natural Science Foundation of China [31101854]; Key Academic
   Program of 211 Project of South China Agricultural University
   [2009B010100001]; Opening Project of the Key Laboratory of Application
   Technology of Environmental Photocatalysis of Hunan Province
   [ccsu-KF-1402]
FX The work was supported by the National Natural Science Foundation of
   China (no. 31101854), the Key Academic Program of 211 Project of South
   China Agricultural University (2009B010100001) and the Opening Project
   of the Key Laboratory of Application Technology of Environmental
   Photocatalysis of Hunan Province (ccsu-KF-1402).
CR Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Aoyagi S, 2007, INT J PHARM, V330, P138, DOI 10.1016/j.ijpharm.2006.09.016
   Bormashenko Y, 2004, POLYM TEST, V23, P791, DOI 10.1016/j.polymertesting.2004.04.001
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   Charernsriwilaiwat N, 2013, INT J PHARMACEUT, V452, P333, DOI 10.1016/j.ijpharm.2013.05.012
   Chen HM, 2010, J MATER PROCESS TECH, V210, P1551, DOI 10.1016/j.jmatprotec.2010.05.001
   Chen ZG, 2008, CARBOHYD POLYM, V72, P410, DOI 10.1016/j.carbpol.2007.09.018
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Donini C., 2008, INT J PHARMACEUT, V245, P87
   Dorna E., 2013, J CONTROL RELEASE, V169, P313
   Hattori T, 1996, POLYMER, V37, P85, DOI 10.1016/0032-3861(96)81602-8
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kanokpanont S, 2012, INT J PHARMACEUT, V436, P141, DOI 10.1016/j.ijpharm.2012.06.046
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Konstantinos N. K., 2011, INT J PHARMACEUT, V409, P216
   Lai ST, 2013, J NANOSCI NANOTECHNO, V13, P91, DOI 10.1166/jnn.2013.7086
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Natthan C., 2012, INT J PHARMACEUT, V427, P379
   Ong S. Y., 2010, BIOMATERIALS, V322, P4323
   Paola L., 2013, ACTA BIOMATER, V9, P7814
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   Shen XX, 2011, INT J PHARMACEUT, V408, P200, DOI 10.1016/j.ijpharm.2011.01.058
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sun XM, 2014, COLLOID SURFACE B, V115, P61, DOI 10.1016/j.colsurfb.2013.11.030
   Torres V. E. A., 2010, ACTA BIOMATER, V6, P1069
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
NR 33
TC 26
Z9 27
U1 11
U2 94
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2015
VL 130
BP 278
EP 286
DI 10.1016/j.colsurfb.2015.04.026
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CL1WJ
UT WOS:000356735300036
PM 25936562
DA 2018-10-20
ER

PT J
AU Barros, J
   Grenho, L
   Fernandes, MH
   Manuel, CM
   Melo, LF
   Nunes, OC
   Monteiro, FJ
   Ferraz, MP
AF Barros, J.
   Grenho, L.
   Fernandes, M. H.
   Manuel, C. M.
   Melo, L. F.
   Nunes, O. C.
   Monteiro, F. J.
   Ferraz, M. P.
TI Anti-sessile bacterial and cytocompatibility properties of CHX-loaded
   nanohydroxyapatite
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Nanohydroxyapatite; Chlorhexidine digluconate; Anti-sessile;
   Cytocompatibility
ID IMPLANT-ASSOCIATED INFECTIONS; EPIDERMIDIS BIOFILM FORMATION; IN VIVO
   CHARACTERIZATION; DELIVERY-SYSTEM; CIPROFLOXACIN IMPLANTS; ANTIMICROBIAL
   PEPTIDES; COATED TITANIUM; BASIC DYE; CHLORHEXIDINE; ADSORPTION
AB Nanohydroxyapatite possesses exceptional biocompatibility and bioactivity regarding bone cells and tissues, justifying its use as a coating material or as a bone substitute. Unfortunately, this feature may also encourage bacterial adhesion and biofilm formation. Surface functionalization with antimicrobials is a promising strategy to reduce the likelihood of bacterial infestation and colonization on medical devices. Chlorhexidine digluconate is a common and effective antimicrobial agent used for a wide range of medical applications. The purpose of this work was the development of a nanoHA biomaterial loaded with CHX to prevent surface bacterial accumulation and, simultaneously, with good cytocompatibility, for application in the medical field. CHX (5-1500 mg/L) was loaded onto nanoHA discs and the materials were evaluated for CHX adsorption and release profile, physic-chemical features, antibacterial activity against Escherichia coli, Staphylococcus aureus and Staphylococcus epidermidis, and cytocompatibility toward L929 fibroblasts. Results showed that the adsorption of CHX on nanoHA surface occurred by electrostatic interactions between the cationic group of CHX and the phosphate group of nanoHA. The release of CHX from CHX-loaded nanoHA showed a fast initial rate followed by a slower kinetics release, due to constraints caused by dilution and diffusion-limiting processes. NanoHA.50 to nanoHA.1500 showed strong anti-sessile activity, inhibiting bacterial adhesion and the biofilm formation. CHX-nanoHA caused a dose- and time-dependent inhibitory effect on the proliferation of fibroblasts for nanoHA.100 to nanoHA.1500. Cellular behavior on nanoHA.5 and nanoHA.50 was similar to control. Therefore, CHX-loaded nanoHA surfaces appear as a promising alternative to prevention of devices-related infections. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Barros, J.; Grenho, L.; Monteiro, F. J.] Univ Porto, I3S, P-4100 Oporto, Portugal.
   [Barros, J.; Grenho, L.; Monteiro, F. J.] INEB Inst Engn Biomed, Oporto, Portugal.
   [Barros, J.; Grenho, L.; Monteiro, F. J.] Univ Porto, Dept Engn Met & Mat, FEUP Fac Engn, P-4100 Oporto, Portugal.
   [Barros, J.; Manuel, C. M.; Melo, L. F.; Nunes, O. C.] Univ Porto, Dept Chem Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, P-4100 Oporto, Portugal.
   [Fernandes, M. H.] Univ Porto, Fac Med Dent, P-4100 Oporto, Portugal.
   [Manuel, C. M.] Univ Lusofona Porto, Oporto, Portugal.
   [Ferraz, M. P.] Univ Fernando Pessoa, CEBIMED Ctr Estudos Biomed, Oporto, Portugal.
RP Barros, J (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM joanabarros@fe.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Barros, Joana/0000-0002-8205-5675; Monteiro,
   Fernando/0000-0002-1361-4605; Nunes, Olga/0000-0003-4742-2537; Duarte
   Manuel, Candida Maria/0000-0002-7030-1525; Melo,
   Luis/0000-0002-8469-4462
FU FEDER through Programa Operacional Factores de Competitividade-COMPETE;
   national (Portuguese) funds through FCT-Fundacao para a Ciencia e a
   Tecnologia within project NanoBiofilm [PTDC/SAU-BMA/111233/2009]
FX This work was co-financed by FEDER funding through Programa Operacional
   Factores de Competitividade-COMPETE and by national (Portuguese) funds
   through FCT-Fundacao para a Ciencia e a Tecnologia within project
   NanoBiofilm (PTDC/SAU-BMA/111233/2009).
CR Alcaide M, 2009, J BIOMED MATER RES A, V89A, P539, DOI 10.1002/jbm.a.31985
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   Alvarez H, 2008, J BIOMED MATER RES B, V85B, P93, DOI 10.1002/jbm.b.30921
   Barbour ME, 2007, COLLOID SURFACE A, V307, P116, DOI 10.1016/j.colsurfa.2007.05.010
   Baro M, 2002, J CONTROL RELEASE, V83, P353, DOI 10.1016/S0168-3659(02)00179-7
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Castro C, 2003, J CONTROL RELEASE, V93, P341, DOI 10.1016/j.jconrel.2003.09.004
   Cheung H. Y., 2012, PLOS ONE, V7
   Chibowski E, 1998, LANGMUIR, V14, P5237, DOI 10.1021/la971107b
   Cortizo MC, 2012, J DENT, V40, P329, DOI 10.1016/j.jdent.2012.01.008
   Desta M.B., 2013, J THERMODYN
   Dou XC, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025002
   Family R, 2012, CASP J INTERN MED, V3, P460
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fong N, 2010, ACTA BIOMATER, V6, P2554, DOI 10.1016/j.actbio.2010.01.005
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Franco CF, 2003, ARTIF ORGANS, V27, P486, DOI 10.1046/j.1525-1594.2003.07245.x
   Gimenez-Martin E, 2009, CELLULOSE, V16, P467, DOI 10.1007/s10570-009-9281-5
   Grenho L., 2013, J BIOMED MAT RES A
   Hameed BH, 2008, J HAZARD MATER, V158, P499, DOI 10.1016/j.jhazmat.2008.01.098
   Hauman CHJ, 2003, INT ENDOD J, V36, P75, DOI 10.1046/j.1365-2591.2003.00631.x
   Hiraishi N, 2010, J BIOMED MATER RES B, V94B, P134, DOI 10.1002/jbm.b.31633
   Hook ER, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-3
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kim J, 2010, DENT MATER, V26, P771, DOI 10.1016/j.dental.2010.04.001
   Kolska Z., 2013, POLYM SCI, P203
   Mittal A, 2007, J HAZARD MATER, V146, P243, DOI 10.1016/j.jhazmat.2006.12.012
   Morra M, 2004, BIOMED PHARMACOTHER, V58, P418, DOI 10.1016/j.biopha.2004.08.002
   Neut D, 2005, J BIOMED MATER RES A, V73A, P165, DOI 10.1002/jbm.a.30253
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   RUSSEL AD, 1986, PHARM INT, V7, P305
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Shi PJ, 2010, J BIOMED MATER RES A, V93A, P1020, DOI 10.1002/jbm.a.32598
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   de Souza CAS, 2011, COLLOID SURFACE B, V87, P310, DOI 10.1016/j.colsurfb.2011.05.035
   Tank K. P., 2013, J NANOPART RES, V15
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Yue IC, 2004, BIOMATERIALS, V25, P3743, DOI 10.1016/j.biomaterials.2003.09.113
   Zamanian A, 2010, ADV APPL CERAM, V109, P440, DOI 10.1179/174367610X12804792635107
NR 47
TC 7
Z9 7
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2015
VL 130
BP 305
EP 314
DI 10.1016/j.colsurfb.2015.04.034
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CL1WJ
UT WOS:000356735300040
PM 25936560
DA 2018-10-20
ER

PT J
AU Wegrzyn, J
   Kaufman, KR
   Hanssen, AD
   Lewallen, DG
AF Wegrzyn, Julien
   Kaufman, Kenton R.
   Hanssen, Arlen D.
   Lewallen, David G.
TI Performance of Porous Tantalum vs. Titanium Cup in Total Hip
   Arthroplasty: Randomized Trial with Minimum 10-Year Follow-Up
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE total hip arthroplasty; porous tantalum monoblock cup; cementless
   fixation; osseointegration; aseptic loosening
ID MONOBLOCK ACETABULAR COMPONENT; BONE INGROWTH; COMPUTED-TOMOGRAPHY;
   POLYETHYLENE WEAR; OSTEOLYSIS; REPLACEMENTS; MULTICENTER; BIOMATERIAL;
   DISLOCATION; INTERFACE
AB Porous tantalum monoblock cups have been proposed to improve survivorship of cementless primary THA. However, there are few direct comparative trials to established implants such as porous-coated titanium cups. 113 patients were randomized into two groups according to the cup: a porous tantalum monoblock cup (TM) or a porous-coated titanium monoblock cup (control). At a mean of 12 years after THA, no implants migrated in both groups. Two TM patients (4%) and 13 control patients (33%) presented with radiolucency around the cup (P > 0.001). In the control group, 1 cup (2%) was revised for aseptic loosening. At 12 years post-implantation, porous tantalum monoblock cups demonstrated 100% survivorship, and significantly less radiolucency as compared to porous-coated titanium monoblock cups. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wegrzyn, Julien; Kaufman, Kenton R.; Hanssen, Arlen D.; Lewallen, David G.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
RP Lewallen, DG (reprint author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.
OI Kaufman, Kenton/0000-0002-7311-3781
CR Beaule PE, 2004, J BONE JOINT SURG AM, V86A, P929, DOI 10.2106/00004623-200405000-00007
   Beck RT, 2012, J ORTHOP RES, V30, P541, DOI 10.1002/jor.21554
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hanzlik JA, 2013, J ARTHROPLASTY, V28, P922, DOI 10.1016/j.arth.2013.01.035
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P1597, DOI 10.2106/JBJS.J.00195
   HUK OL, 1994, J BONE JOINT SURG BR, V76B, P568
   Kitamura N, 2005, CLIN ORTHOP RELAT R, P291, DOI 10.1097/01.blo.0000192359.12573.15
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kostakos AT, 2010, J ARTHROPLASTY, V25, P35, DOI 10.1016/j.arth.2008.09.027
   Leung S, 2005, J BONE JOINT SURG AM, V87A, P592, DOI 10.2106/JBJS.D.02116
   Levi ADO, 1998, SPINE, V23, P1245, DOI 10.1097/00007632-199806010-00014
   Macheras GA, 2010, J BONE JOINT SURG BR, V92B, P624, DOI 10.1302/0301-620X.92B5.23256
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Macheras G, 2009, J ARTHROPLASTY, V24, P705, DOI 10.1016/j.arth.2008.06.020
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Martell JM, 1997, J BONE JOINT SURG AM, V79A, P1635, DOI 10.2106/00004623-199711000-00004
   Martell JM, 2003, J BONE JOINT SURG AM, V85A, P1111, DOI 10.2106/00004623-200306000-00020
   Massin P, 1989, J Arthroplasty, V4, P245, DOI 10.1016/S0883-5403(89)80020-8
   Mayman DJ, 2007, J ARTHROPLASTY, V22, P130, DOI 10.1016/j.arth.2007.04.016
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Moen TC, 2011, CLIN ORTHOP RELAT R, V469, P382, DOI 10.1007/s11999-010-1500-8
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   Noiseux NO, 2014, J ARTHROPLASTY, V29, P617, DOI 10.1016/j.arth.2013.07.037
   NUNN D, 1989, J BONE JOINT SURG BR, V71, P629
   Poggie RA, 1999, T ORTHOP RES SOC, V24, P747
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130, DOI 10.2106/00004623-199274080-00002
   Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004
   Sculco TP, 2002, J ARTHROPLASTY, V17, P118, DOI 10.1054/arth.2002.32690
   Xenakis TA, 2009, INT ORTHOP, V33, P911, DOI 10.1007/s00264-008-0581-4
NR 36
TC 19
Z9 21
U1 3
U2 15
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JUN
PY 2015
VL 30
IS 6
BP 1008
EP 1013
DI 10.1016/j.arth.2015.01.013
PG 6
WC Orthopedics
SC Orthopedics
GA CK4GY
UT WOS:000356183500021
PM 25765132
DA 2018-10-20
ER

PT J
AU Isa, ILM
   Srivastava, A
   Tiernan, D
   Owens, P
   Rooney, P
   Dockery, P
   Pandit, A
AF Isa, Isma Liza Mohd
   Srivastava, Akshay
   Tiernan, David
   Owens, Peter
   Rooney, Peadar
   Dockery, Peter
   Pandit, Abhay
TI Hyaluronic Acid Based Hydrogels Attenuate Inflammatory Receptors and
   Neurotrophins in Interleukin-1 beta Induced Inflammation Model of
   Nucleus Pulposus Cells
SO BIOMACROMOLECULES
LA English
DT Article
ID INTERVERTEBRAL DISC DEGENERATION; NERVE GROWTH-FACTOR;
   SMOOTH-MUSCLE-CELLS; LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS; ROOT
   GANGLION NEURONS; LUNG INJURY; IN-VITRO; REGENERATION; INHIBITION
AB Inflammation plays an important role in symptomatic intervertebral disc degeneration and is associated with the production of neurotrophins in sensitizing innervation into the disc. The use of high molecular weight (HMw) hyaluronic acid (HA) hydrogels offers a potential therapeutic biomaterial for nucleus pulposus (NP) regeneration as it exerts an anti-inflammatory effect and provides a microenvironment that is more suitable for NP. Therefore, it was hypothesized that cross-linked HMw HA hydrogels modulate the inflammatory receptor of IL-1R1, MyD88 and neurotrophin expression of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in an in vitro inflammation model of NP. HA cross-linking was optimized using various concentrations of 4-arm PEG-amine by determination of free carboxyl groups of HA and unreacted free amine groups of PEG-amine. The optimally cross-linked HA hydrogels were characterized for hydrolytic stability, enzymatic degradation and cytotoxicity on NP cells. The therapeutic effect of HA hydrogels was further investigated in IL-1 beta induced inflammation on NP cell cultures and the mechanism of HA by examining the expression of cell surface receptor of CD44. Hydrogel was optimally cross-linked at 75 mM PEG, stable in phosphate buffered saline, and showed greater than 40% resistance to enzymatic degradation. No cytotoxic effect of NP cells was observed in the presence of hydrogels for 1, 3, and 7 days. IL-1R1 and MyD88 were significantly suppressed. Additionally, NGF and BDNF mRNA were down-regulated after treatment with cross-linked HA hydrogel. Possible protective mechanism of HA is shown by high expression of CD44 receptor of NP cells after HA treatment in which suggest the binding of HA to CD44 receptor and prevent NP cells from further undergoing inflammation. These results indicate that optimally stabilized cross-linked HMw HA hydrogel has a therapeutic effect in response to inflammation-associated pain and becomes an ideal matrices hydrogel for NP regeneration.
C1 [Isa, Isma Liza Mohd; Srivastava, Akshay; Tiernan, David; Rooney, Peadar; Pandit, Abhay] Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Owens, Peter; Dockery, Peter] Natl Univ Ireland, Ctr Microscopy & Imaging, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Rooney, Peadar/0000-0003-3119-3928
FU Majlis Amanah Rakyat (MARA), Malaysia [ROG1112]; DiscMat Collaborative
   Research Center AO Foundation
FX The authors would like to thank Majlis Amanah Rakyat (MARA), Malaysia
   (Grant No.: ROG1112) and the DiscMat Collaborative Research Center AO
   Foundation for providing financial support to this project. The authors
   would like to acknowledge Dr. Oliver Carroll for his technical support,
   Mr. Anthony Sloan for editorial assistance with this manuscript, and Mr.
   Maciej Doczyk for his help with diagrams.
CR Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53
   Aoki Y, 2004, LIFE SCI, V74, P2627, DOI 10.1016/j.lfs.2004.01.008
   Aoki Y, 2007, SPINE, V32, P857, DOI 10.1097/01.brs.0000259810.48681.90
   Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009
   de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X
   Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8
   DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596
   Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X
   Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631
   Fontana G., 2014, BIOCONJUGATE CHEM
   FORRESTER JV, 1980, IMMUNOLOGY, V40, P435
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Gingras M, 2003, FASEB J, V17, P2124, DOI 10.1096/fj.02-1180fje
   Gruber HE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2456
   Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009
   Hellard D, 2004, DEV BIOL, V275, P34, DOI 10.1016/j.ydbio.2004.07.021
   Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056
   Ishida O, 1997, J BONE MINER RES, V12, P1657, DOI 10.1359/jbmr.1997.12.10.1657
   Karna E, 2006, PHARMACOL RES, V54, P275, DOI 10.1016/j.phrs.2006.06.002
   Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003
   KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210
   Krock E, 2014, J CELL MOL MED, V18, P1213, DOI 10.1111/jcmm.12268
   Le Maitre Christine Lyn, 2007, Arthritis Res Ther, V9, pR77
   Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732
   Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Levin DA, 2007, BULL HOSP JT DIS, V65, P29
   Li CQ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-27
   Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982
   Luo XM, 2004, SPINE, V29, pE531, DOI 10.1097/01.brs.0000146453.76528.7c
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Majid K., 2008, SEMIN SPINE SURG, V20, P87
   Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004
   Peng BG, 2006, SPINE, V31, P560, DOI 10.1097/01.brs.0000201324.45537.46
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017
   PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597
   Purmessur D., 2015, SPINE J
   Renn CL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-61
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Shankar H, 2009, TECH REG ANESTH PAIN, V13, P67, DOI [10.1053/j.trap.2009.05.001, DOI 10.1053/J.TRAP.2009.05.001]
   Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970
   Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4
   Tan H., 2011, J BIOMED MATER RES A, V92, P979
   Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77
   Wieland J. A., 2009, J CONTROL RELEASE, V120, P233
   Woolf CJ, 1996, J NEUROSCI, V16, P2716
   Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299
   Wuertz K, 2012, EUR CELLS MATER, V23, P103
   Zavan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055510
NR 60
TC 22
Z9 22
U1 1
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2015
VL 16
IS 6
BP 1714
EP 1725
DI 10.1021/acs.biomac.5b00168
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA V39IY
UT WOS:000209405900005
PM 25871410
DA 2018-10-20
ER

PT J
AU Lang, N
   Merkel, E
   Fuchs, F
   Schumann, D
   Klemm, D
   Kramer, F
   Mayer-Wagner, S
   Schroeder, C
   Freudenthal, F
   Netz, H
   Kozlik-Feldmann, R
   Sigler, M
AF Lang, Nora
   Merkel, Elena
   Fuchs, Franziska
   Schumann, Dieter
   Klemm, Dieter
   Kramer, Friederike
   Mayer-Wagner, Susanne
   Schroeder, Christian
   Freudenthal, Franz
   Netz, Heinrich
   Kozlik-Feldmann, Rainer
   Sigler, Matthias
TI Bacterial nanocellulose as a new patch material for closure of
   ventricular septal defects in a pig model
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE Ventricular septal defects; Patch material; Biomaterial;
   Biocompatibility
ID BOVINE PERICARDIUM; BIOCOMPATIBILITY; CELLULOSE; CELLS; IMPLANTS;
   MATRICES
AB Current materials for closure of cardiac defects such as ventricular septal defects (VSDs) are associated with compliance mismatch and a chronic inflammatory response. Bacterial nanocellulose (BNC) is a non-degradable biomaterial with promising properties such as high mechanical strength, favourable elasticity and a negligible inflammatory reaction. The aim of this study was the evaluation of a BNC patch for VSD closure and the investigation of its in vivo biocompatibility in a chronic pig model.
   Young's modulus and tensile strength of BNC patches were determined before and after blood exposure. Muscular VSDs were created and closed with a BNC patch on the beating heart in an in vivo pig model. Hearts were explanted after 7, 30 or 90 days. Macropathology, histology and immunohistochemistry were performed.
   Young's modulus and tensile strength of the BNC patch decreased after blood contact from 6.3 +/- 1.9 to 3.86 +/- 2.2 MPa (P < 0.01) and 0.33 +/- 0.06 to 0.26 +/- 0.06 MPa (P < 0.01), respectively, indicating the development of higher elasticity. Muscular VSDs were closed with a BNC patch without residual shunting. After 90 days, a mild chronic inflammatory reaction was present. Moreover, there was reduced tissue overgrowth in comparison with polyester. Proceeding cellular organization characterized by fibromuscular cells, production of extracellular matrix, neoangiogenesis and complete neoendothelialization were found. There were no signs of thrombogenicity.
   BNC patches can close VSDs with good mid-term results and its biocompatibility can be considered as satisfactory. Its elasticity increases in the presence of blood, which might be advantageous. Therefore, it has potential to be used as an alternative patch material in congenital heart disease.
C1 [Lang, Nora; Merkel, Elena; Fuchs, Franziska; Netz, Heinrich; Kozlik-Feldmann, Rainer] Univ Munich, Dept Pediat Cardiol & Intens Care Med, Munich, Germany.
   [Lang, Nora] Univ Freiburg, Dept Congenital Heart Defects & Pediat Cardiol, Ctr Heart, D-79106 Freiburg, Germany.
   [Schumann, Dieter; Klemm, Dieter; Kramer, Friederike] Transfer Grp Polymet eV, Jena, Germany.
   [Mayer-Wagner, Susanne; Schroeder, Christian] Univ Munich, Dept Orthoped Surg, Munich, Germany.
   [Freudenthal, Franz] Kardiozentrum, La Paz, Bolivia.
   [Sigler, Matthias] Univ Gottingen, Dept Pediat Cardiol & Intens Care Med, D-37073 Gottingen, Germany.
RP Lang, N (reprint author), Univ Freiburg, Dept Congenital Heart Defects & Pediat Cardiol, Ctr Heart, Mathildenstr 1, D-79106 Freiburg, Germany.
EM nora.lang@universitaets-herzzentrum.de
RI Schroder, Christian/I-2920-2016
OI Schroder, Christian/0000-0003-2003-565X
FU German Society of Pediatric Cardiology; Elterninitiative Grosshadern
   e.V.; Heart for Heart Foundation; FoeFoLe Programme of the LMU of Munich
FX The work was awarded by a poster price of the German Society of
   Pediatric Cardiology. The work was supported by the Elterninitiative
   Grosshadern e.V., the Heart for Heart Foundation and the FoeFoLe
   Programme of the LMU of Munich.
CR Santibanez-Salgado JA, 2010, EUR CELLS MATER, V19, P158, DOI 10.22203/eCM.v019a16
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Barros D'Sa AA, 1980, ANN SURG, V192, P645
   Cho SW, 2005, BIOMATERIALS, V26, P1915, DOI 10.1016/j.biomaterials.2004.06.018
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   Foth R, 2009, CIRC-CARDIOVASC INTE, V2, P90, DOI 10.1161/CIRCINTERVENTIONS.108.810507
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Jux Christian, 2003, J Interv Cardiol, V16, P149, DOI 10.1046/j.1540-8183.2003.08027.x
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kozlik-Feldmann R, 2008, J AM COLL CARDIOL, V51, P1597, DOI 10.1016/j.jacc.2007.10.068
   Kozlik-Feldmann R, 2009, J THORAC CARDIOV SUR, V138, P365, DOI 10.1016/j.jtcvs.2009.02.014
   Lang N, 2010, HEART SURG FORUM, V13, pE299, DOI 10.1532/HSF98.20091181
   Matsuhisa H, 2013, ANN THORAC SURG, V96, P891, DOI 10.1016/j.athoracsur.2013.05.013
   Mirensky TL, 2008, PEDIATR RES, V63, P559, DOI 10.1203/01.pdr.0000305938.92695.b9
   Moons P, 2009, ACTA PAEDIATR, V98, P472, DOI 10.1111/j.1651-2227.2008.01152.x
   Pok S, 2011, J CARDIOVASC TRANSL, V4, P646, DOI 10.1007/s12265-011-9289-8
   Quentin T, 2009, ACTA HISTOCHEM, V111, P538, DOI 10.1016/j.acthis.2008.04.001
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   SHRIVASTAVA S, 1989, INT J CARDIOL, V25, P27, DOI 10.1016/0167-5273(89)90158-7
   Sigler M, 2005, Z KARDIOL, V94, P383, DOI 10.1007/s00392-005-0231-4
   Sigler M, 2007, HEART, V93, P444, DOI 10.1136/hrt.2006.098103
   Vasilyev NV, 2008, J THORAC CARDIOV SUR, V135, P603, DOI 10.1016/j.jtcvs.2007.09.045
   Weber B, 2011, BIOMATERIALS, V32, P9630, DOI 10.1016/j.biomaterials.2011.07.070
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
NR 25
TC 6
Z9 6
U1 0
U2 21
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1010-7940
EI 1873-734X
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD JUN
PY 2015
VL 47
IS 6
BP 1013
EP 1021
DI 10.1093/ejcts/ezu292
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CJ7IJ
UT WOS:000355668000011
PM 25064053
OA Bronze
DA 2018-10-20
ER

PT J
AU Maia, LP
   Reino, DM
   Muglia, VA
   Almeida, ALG
   Nanci, A
   Wazen, RM
   de Oliveira, PT
   Palioto, DB
   Novaes, AB
AF Maia, Luciana P.
   Reino, Danilo M.
   Muglia, Valdir A.
   Almeida, Adriana L. G.
   Nanci, Antonio
   Wazen, Rima M.
   de Oliveira, Paulo T.
   Palioto, Daniela B.
   Novaes, Arthur B., Jr.
TI Influence of periodontal tissue thickness on buccal plate remodelling on
   immediate implants with xenograft
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE biomaterials; bone substitutes; bone-implant interactions; immediate
   implant placement; xenograft
ID FRESH EXTRACTION SOCKETS; GUIDED BONE REGENERATION; RIDGE ALTERATIONS;
   FLAPLESS SURGERY; BIO-OSS(R) COLLAGEN; TOOTH EXTRACTION; BEAGLE DOGS;
   PLACEMENT; PRESERVATION; BIOTYPE
AB AimTo evaluate the influence of gingival thickness and bone grafting on buccal bone plate remodelling after immediate implant placement in sockets with thin buccal bone, using a flapless approach.
   Materials and MethodsThe gingiva of eight dogs was thinned at one side of the mandible, mandibular premolars were extracted without flaps, and four implants were installed on each side at 1.5mm from the buccal bone. The sites were randomly assigned into: TG (test group)=thin gingiva; TG+GM (TG with grafting material); CG (control group)=normal gingiva; and CG+GM (CG with grafting material). After 12weeks the dogs were sacrificed and the samples were processed for histological analysis.
   ResultsAll animals exhibited a thin buccal bone initially. In all the experimental groups the buccal gap was filled with newly formed bone and the buccal bone level was slightly apical to the implant shoulder. There were no statistically significant differences among the groups for the histomorphometric parameters.
   ConclusionsThe thickness of the buccal bone was a fundamental factor in buccal bone plate resorption, even with flapless implantation. The gingival thickness or the addition of a biomaterial in the gap did not influence the results.
C1 [Maia, Luciana P.; Reino, Danilo M.; Almeida, Adriana L. G.; Palioto, Daniela B.; Novaes, Arthur B., Jr.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Buccomaxilofacial Surg & Traumatol & Periodo, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Muglia, Valdir A.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Dent Mat Prosthet, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Nanci, Antonio; Wazen, Rima M.] Univ Montreal, Fac Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ, Canada.
   [de Oliveira, Paulo T.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Stomatol & Basic Pathol, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Novaes, AB (reprint author), Univ Sao Paulo, Fac Odontol Ribeirao Preto, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM novaesjr@forp.usp.br
RI novaes, arthur/O-2945-2013; Tambasco de Oliveira, Paulo/F-9749-2010;
   Palioto, Daniela/H-3054-2016
OI Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Maia,
   Luciana/0000-0001-5697-2587
FU State of Sao Paulo Research Foundation (FAPESP) [11/00674-6]; Geistlich
   Pharma AG
FX This study was financially supported by the State of Sao Paulo Research
   Foundation (FAPESP; process number 11/00674-6) and the graft material
   used was provided by Geistlich Pharma AG.
CR Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Barone A, 2011, CLIN ORAL IMPLAN RES, V22, P1131, DOI 10.1111/j.1600-0501.2010.02084.x
   Bashara H, 2012, CLIN ORAL IMPLAN RES, V23, P911, DOI 10.1111/j.1600-0501.2011.02240.x
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Berglundh T, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01827.x
   Blanco J, 2008, J CLIN PERIODONTOL, V35, P640, DOI 10.1111/j.1600-051X.2008.01237.x
   Blanco J, 2010, CLIN ORAL IMPLAN RES, V21, P624, DOI 10.1111/j.1600-0501.2009.01885.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Bragger U, 1996, CLIN ORAL IMPLAN RES, V7, P268, DOI 10.1034/j.1600-0501.1996.070309.x
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P891, DOI 10.1111/j.1600-0501.2010.01946.x
   De Rouck T, 2009, J CLIN PERIODONTOL, V36, P428, DOI 10.1111/j.1600-051X.2009.01398.x
   Denissen H W, 1993, Int J Oral Maxillofac Implants, V8, P191
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P898, DOI 10.1111/j.1600-051X.2009.01463.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P442, DOI 10.1111/j.1600-051X.2009.01381.x
   Gelb D A, 1993, Int J Oral Maxillofac Implants, V8, P388
   GHER ME, 1994, J PERIODONTOL, V65, P881, DOI 10.1902/jop.1994.65.9.881
   Heberer S, 2008, CLIN ORAL IMPLAN RES, V19, P1219, DOI 10.1111/j.1600-0501.2008.01617.x
   Kim BS, 2009, ORAL SURG ORAL MED O, V107, pE24, DOI 10.1016/j.tripleo.2008.12.010
   Kim JI, 2009, ORAL SURG ORAL MED O, V107, P508, DOI 10.1016/j.tripleo.2008.08.003
   Kohal RJ, 1998, J PERIODONTOL, V69, P927, DOI 10.1902/jop.1998.69.8.927
   Lee A, 2011, IMPLANT DENT, V20, pE38, DOI 10.1097/ID.0b013e3182181d3d
   Linkevicius T, 2015, CLIN IMPLANT DENT R, V17, P497, DOI 10.1111/cid.12155
   Linkevicius T, 2010, J ORAL MAXIL SURG, V68, P2272, DOI 10.1016/j.joms.2009.08.018
   Linkevicius T, 2009, INT J ORAL MAX IMPL, V24, P712
   Maia LP, 2015, CLIN ORAL IMPLAN RES, V26, P35, DOI 10.1111/clr.12298
   Muller HP, 1997, J CLIN PERIODONTOL, V24, P65, DOI 10.1111/j.1600-051X.1997.tb01186.x
   Novaes AB, 2012, J ORAL IMPLANTOL, V38, P687, DOI 10.1563/AAID-JOI-D-10-00176
   Novaes AB, 2011, J PERIODONTOL, V82, P872, DOI 10.1902/jop.2010.100244
   Novaes AB, 2011, J OSSEOINTEGRATION, V3, P45
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Qahash M, 2008, CLIN ORAL IMPLAN RES, V19, P166, DOI 10.1111/j.1600-0501.2007.01428.x
   Rungcharassaeng K, 2012, INT J PERIODONT REST, V32, P657
   Sclar AG, 2007, J ORAL MAXIL SURG, V65, P20, DOI 10.1016/j.joms.2007.03.017
   Spinato S, 2014, CLIN ORAL IMPLAN RES, V25, pE120, DOI 10.1111/clr.12073
   Suaid FA, 2014, CLIN ORAL IMPLAN RES, V25, pE10, DOI 10.1111/clr.12036
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
   Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P688, DOI 10.1111/j.1600-051X.2009.01439.x
   Watzek G, 1995, Int J Oral Maxillofac Implants, V10, P561
NR 46
TC 2
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD JUN
PY 2015
VL 42
IS 6
BP 590
EP 598
DI 10.1111/jcpe.12405
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CK6VS
UT WOS:000356367300012
PM 25875308
DA 2018-10-20
ER

PT J
AU Chen, YC
   Huang, HY
   Lin, HM
   Hsu, FY
   Su, YP
   Hwang, DF
AF Chen, Yu-Chun
   Huang, Hsiao-Ya
   Lin, Hsiu-Mei
   Hsu, Fu-Yin
   Su, Yu-Ping
   Hwang, Deng-Fwu
TI Biomaterial availability of magnesium substituted beta-tricalcium
   phosphate converted from sea urchin Tripneustes gratilla shell
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Tripneustes gratilla; Magnesium substituted beta-tricalcium phosphate;
   Hydrothermal reaction; Biomaterial
ID RIETVELD REFINEMENT; BONE; HYDROXYAPATITE; CERAMICS; SCAFFOLDS;
   TRANSFORMATION; OSTEOBLASTS; POROSITY; DEFECTS; GLASS
AB Sea urchin Tripneustes gratilla is one of the valuable fishery products in Taiwan. The edible part of sea urchin is about 10% and the rest is regarded as waste. In this study, sea urchin shell was used here as an ingredient to synthesize magnesium substituted beta-tricalcium phosphate (beta-TCMP). Shell powder of the echinoid Tripneustes gratilla was converted by hydrothermal reaction at 180 degrees C for 24 h (referred as SU-180-24 product), and calcinated into tablet at 800 degrees C for 4 h to form the target ingredient (SU-800-4 product). Then these products were tested for chemical composition analysis and bioassays. These products are confirmed to be rich in magnesium and constitute as beta-TCMP. Results from bioassays showed that SU-180-24 and SU-800-4 products increased cell viability in human osteosarcoma cell (MG-63). Alkaline phosphatase (ALP) activity of MG-63 cell cultured with SU-800-4 tablet also showed significant increase when compared to commercial beta-TCMP. It indicated that sea urchin's beta-TCMP materials including SU-180-24 and SU-800-4 products exhibited the potential for applying as the bone graft material. (C) 2015 The Ceramic Society of Japan. All rights reserved.
C1 [Chen, Yu-Chun; Huang, Hsiao-Ya; Hwang, Deng-Fwu] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung 202, Taiwan.
   [Chen, Yu-Chun; Huang, Hsiao-Ya; Hwang, Deng-Fwu] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung 202, Taiwan.
   [Lin, Hsiu-Mei; Hsu, Fu-Yin] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung 202, Taiwan.
   [Su, Yu-Ping] Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan.
   [Su, Yu-Ping] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan.
RP Hwang, DF (reprint author), Natl Taiwan Ocean Univ, Dept Food Sci, 2 Beining Rd, Keelung 202, Taiwan.
EM dfhwang@mail.ntou.edu.tw
FU Center of Excellence for Marine Science, National Taiwan Ocean
   University
FX The study was supported by funding from the Center of Excellence for
   Marine Science, National Taiwan Ocean University.
CR Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   Cunningham E, 2010, J MATER SCI-MATER M, V21, P2255, DOI 10.1007/s10856-009-3961-4
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   Diba M, 2014, CURR OPIN SOLID ST M, V18, P147, DOI 10.1016/j.cossms.2014.02.004
   Dickson JAD, 2001, GEOCHIM COSMOCHIM AC, V65, P443, DOI 10.1016/S0016-7037(00)00547-0
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Enderle R, 2005, BIOMATERIALS, V26, P3379, DOI 10.1016/j.biomaterials.2004.09.017
   Guha AK, 2009, COLLOID SURFACE B, V73, P146, DOI 10.1016/j.colsurfb.2009.05.009
   Habibovic P., 2008, J ORTHOP RES, V10, P1363
   Hammel EC, 2014, CERAM INT, V40, P15351, DOI 10.1016/j.ceramint.2014.06.095
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kang YQ, 2015, ACTA BIOMATER, V11, P449, DOI 10.1016/j.actbio.2014.09.035
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Le BT, 2014, J CRANIO MAXILL SURG, V42, P552, DOI 10.1016/j.jcms.2013.07.026
   LIN FH, 1994, BIOMATERIALS, V15, P1087
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Nasiri-Tabrizi B, 2013, CERAM INT, V39, P8657, DOI 10.1016/j.ceramint.2013.04.045
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Sader MS, 2009, KEY ENG MATER, V396-398, P277, DOI 10.4028/www.scientific.net/KEM.396-398.277
   Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Stipniece Liga, 2015, Key Engineering Materials, V631, P61, DOI 10.4028/www.scientific.net/KEM.631.61
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Teixeira S., 2009, MAT SCI ENG C, V5, P1510
   Tejero R., 2014, PROG POLYM SCI, P1406
   Truumees E, 1999, U PENN ORTHOP J, V12, P77
   Vecchio KS, 2007, ACTA BIOMATER, V3, P785, DOI 10.1016/j.actbio.2007.03.009
   Walsh W. R., 2007, BIOMATERIALS, V29, P266
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Zhang X, 2013, FRONT MATER SCI, V7, P103, DOI 10.1007/s11706-013-0204-x
   Zhang X, 2009, MAT SCI ENG C-MATER, V29, P2003, DOI 10.1016/j.msec.2009.03.012
NR 35
TC 0
Z9 0
U1 1
U2 13
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUN
PY 2015
VL 123
IS 1438
BP 469
EP 475
DI 10.2109/jcersj2.123.469
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CJ9UW
UT WOS:000355849700003
OA Bronze
DA 2018-10-20
ER

PT J
AU Valdes-Sanchez, T
   Rodriguez-Jimenez, FJ
   Garcia-Cruz, DM
   Escobar-Ivirico, JL
   Alastrue-Agudo, A
   Erceg, S
   Monleon, M
   Moreno-Manzano, V
AF Valdes-Sanchez, Teresa
   Javier Rodriguez-Jimenez, Francisco
   Garcia-Cruz, Dunia M.
   Escobar-Ivirico, Jorge L.
   Alastrue-Agudo, Ana
   Erceg, Slaven
   Monleon, Manuel
   Moreno-Manzano, Victoria
TI Methacrylate-endcapped caprolactone and FM19G11 provide a proper niche
   for spinal cord-derived neural cells
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterials; ependymal stem cells; pharmacology; spinal cord injury
ID STEM-CELLS; INJURY REGENERATION; SCAFFOLDS; NEURONS
AB Spinal cord injury (SCI) is a cause of paralysis. Although some strategies have been proposed to palliate the severity of this condition, so far no effective therapies have been found to reverse it. Recently, we have shown that acute transplantation of ependymal stem/progenitor cells (epSPCs), which are spinal cord-derived neural precursors, rescue lost neurological function after SCI in rodents. However, in a chronic scenario with axon repulsive reactive scar, cell transplantation alone is not sufficient to bridge a spinal cord lesion, therefore a combinatorial approach is necessary to fill cavities in the damaged tissue with biomaterial that supports stem cells and ensures that better neural integration and survival occur. Caprolactone 2-(methacryloyloxy) ethyl ester (CLMA) is a monomer [obtained as a result of epsilon-caprolactone and 2-hydroxyethyl methacrylate (HEMA) ring opening/esterification reaction], which can be processed to obtain a porous non-toxic 3D scaffold that shows good biocompatibility with epSPC cultures. epSPCs adhere to the scaffolds and maintain the ability to expand the culture through the biomaterial. However, a significant reduction of cell viability of epSPCs after 6days in vitro was detected. FM19G11, which has been shown to enhance self-renewal properties, rescues cell viability at 6days. Moreover, addition of FM19G11 enhances the survival rates of mature neurons from the dorsal root ganglia when cultured with epSPCs on 3D CLMA scaffolds. Overall, CLMA porous scaffolds constitute a good niche to support neural cells for cell transplantation approaches that, in combination with FM19G11, offer a new framework for further trials in spinal cord regeneration. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Valdes-Sanchez, Teresa; Javier Rodriguez-Jimenez, Francisco; Alastrue-Agudo, Ana; Moreno-Manzano, Victoria] Ctr Invest Principe Felipe, Neuronal Regenerat Lab, E-46012 Valencia, Spain.
   [Garcia-Cruz, Dunia M.; Escobar-Ivirico, Jorge L.; Monleon, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
   [Erceg, Slaven] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain.
RP Moreno-Manzano, V (reprint author), Ctr Invest Principe Felipe, Neuronal Regenerat Lab, E-46012 Valencia, Spain.
EM vmorenom@cipf.es
RI Moreno, Victoria/B-4175-2014; Escobar ivirico, Jorge/J-1203-2016
OI Moreno, Victoria/0000-0002-6035-9491; Escobar ivirico,
   Jorge/0000-0002-1077-2333
FU Instituto de Salud Carlos III; FEDER [FISS PI10/01683]; Ministerio de
   Ciencia e Innovacion (MICINN; Spanish Consolider Ion Channel Initiative)
   [CSD 2008-00005]
FX We are especially grateful to Richard Griffeth for his English-language
   editing. We also thank the Confocal Microscopy and the Electron
   Microscopy services of the Centro de Investigacion Principe Felipe
   (Valencia, Spain). This work was supported by the Instituto de Salud
   Carlos III (cofinanciacion FEDER; Grant No. FISS PI10/01683) and
   Ministerio de Ciencia e Innovacion (MICINN; Spanish Consolider Ion
   Channel Initiative No. CSD 2008-00005).
CR Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165
   Rodriguez-Jimenez FJ, 2012, STEM CELLS, V30, P2221, DOI 10.1002/stem.1189
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326
   Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24
   Oliveira AL, 2012, J MATER SCI-MATER M, V23, P2821, DOI 10.1007/s10856-012-4741-0
   Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064
   Rodriguez-Jimenez Francisco Javier, 2012, J Funct Biomater, V3, P556, DOI 10.3390/jfb3030556
   Rodriguez-Jimenezs FJ, 2011, CELL CYCLE, V9, P2803
   Scuteri A, 2011, NEUROSCIENCE, V172, P12, DOI 10.1016/j.neuroscience.2010.10.065
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Thouas GA, 2008, IEEE ENG MED BIO, P1825, DOI 10.1109/IEMBS.2008.4649534
   Valdes-Sanchez T, 2010, DEV BIOL, V339, P465, DOI 10.1016/j.ydbio.2010.01.001
   Wilcox JT, 2012, NEUROSCI LETT, V519, P93, DOI 10.1016/j.neulet.2012.02.028
   Yang JS, 2008, NEUROSCI LETT, V445, P246, DOI 10.1016/j.neulet.2008.09.015
NR 18
TC 2
Z9 2
U1 4
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2015
VL 9
IS 6
BP 734
EP 739
DI 10.1002/term.1735
PG 6
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CK6KB
UT WOS:000356335900008
PM 23533014
DA 2018-10-20
ER

PT J
AU Barua, S
   Gogoi, B
   Aidew, L
   Buragohain, AK
   Chattopadhyay, P
   Karak, N
AF Barua, Shaswat
   Gogoi, Bhaskarjyoti
   Aidew, Lipika
   Buragohain, Alak K.
   Chattopadhyay, Pronobesh
   Karak, Niranjan
TI Sustainable Resource based Hyperbranched Epoxy Nanocomposite as an
   Infection Resistant, Biodegradable, Implantable Muscle Scaffold
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Sustainable; Hyperbranched epoxy; Nanofibrillar cellulose; Scaffold;
   Antimicrobial
ID IN-VITRO; CELLULOSE; COMPOSITES; NANOPARTICLES; DESIGN; CELLS
AB Use of sustainable resources in the realm of materials science has opened newer possibilities for fabricating biodegradable biomaterials. Cellulose is an abundantly available bioresource that proved excellent potential in composite science and the biomaterials domain. Hence, in this report the potentiality of a "green" CuO-nanofibrillar cellulose/glycerol based hyperbranched epoxy nanocomposite was presented as an implantable muscle tissue scaffold. Muscles reconstruction has been a longstanding problem in medical science. However, with the evolution of polymeric scaffolds, repairing of damaged or lost tissues becomes possible with the aid of tissue engineering. The prepared material possessed high mechanical properties (tensile strength 55 MPa) to support cell growth. In vitro studies revealed that the material could support the growth and proliferation of L6 muscle cells, without causing any detriment to their cellular morphology. Further, both in vitro and in vivo toxicity assessments established the profound biocompatibility of the material. Moreover, the nanocomposite exhibited inhibitory effect against Staphylococcus aureus, Escherichia coli and Candida albicans, the microorganisms responsible for various surgical site infections. In vivo investigation revealed the biodegradability of the prepared material which overrules the need of repeated surgery for any implantable biomaterial. Thus, the overall work endorses the sustainable resource based nanocomposite as a high performance, biodegradable, antimicrobial scaffold material for reconstruction of muscles tissues.
C1 [Barua, Shaswat; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Ctr Polymer Sci & Technol, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
   [Gogoi, Bhaskarjyoti; Aidew, Lipika; Buragohain, Alak K.] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India.
   [Chattopadhyay, Pronobesh] Def Res Lab, Tezpur 784001, Assam, India.
RP Karak, N (reprint author), Tezpur Univ, Dept Chem Sci, Ctr Polymer Sci & Technol, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
EM karakniranjan@gmail.com
RI Karak, Niranjan/A-1030-2014
OI Karak, Niranjan/0000-0002-3402-9536; Barua, Shaswat/0000-0003-0050-3698
FU NRB [DNRD/05/4003/NRB/251]
FX The authors express their gratitude to NRB for financial assistance
   through Grant no. DNRD/05/4003/NRB/251, dated 29.02.12. SAIF, NEHU,
   Shillong is acknowledged for the TEM imaging.
CR Anyaogu KC, 2008, LANGMUIR, V24, P4340, DOI 10.1021/la800102f
   Arnaoutoglou E, 2011, INTERACT CARDIOV TH, V12, P609, DOI 10.1510/icvts.2010.256784
   Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347
   Barua S., 2014, BIOMED MATER, V9
   Barua S, 2015, POLYM INT, V64, P303, DOI 10.1002/pi.4790
   Barua S, 2013, RSC ADV, V3, P14997, DOI 10.1039/c3ra42209g
   Barua S, 2013, CHEM ENG SCI, V95, P138, DOI 10.1016/j.ces.2013.03.026
   Barua S, 2013, COLLOID SURFACE B, V105, P37, DOI 10.1016/j.colsurfb.2012.12.015
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   Braunegg G, 2004, POLYM-PLAST TECHNOL, V43, P1779, DOI 10.1081/PPT-200040130
   CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5
   Carlsson DO, 2012, J MATER CHEM, V22, P19014, DOI 10.1039/c2jm33975g
   Chaturvedi V., 2011, AUST BIOCH, V42, P8
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Danielsson C, 2006, BIOMATERIALS, V27, P1410, DOI 10.1016/j.biomaterials.2005.08.026
   Das B, 2013, J MATER CHEM B, V1, P4115, DOI 10.1039/c3tb20693a
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]
   Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Kondo T, 1997, J POLYM SCI POL PHYS, V35, P717, DOI 10.1002/(SICI)1099-0488(199703)35:4<717::AID-POLB18>3.0.CO;2-J
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mattoussi H, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2011.09.011
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Novotna K, 2013, CELLULOSE, V20, P2263, DOI 10.1007/s10570-013-0006-4
   Oliver Cassell CS, 2002, BR J PLAST SURG, V55, P603
   Orts WJ, 2005, J POLYM ENVIRON, V13, P301, DOI 10.1007/s10924-005-5514-3
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x
   Shaswat Barua, 2013, Advanced Science, Engineering and Medicine (ASEM), V5, P291, DOI 10.1166/asem.2013.1286
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
NR 37
TC 5
Z9 5
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD JUN
PY 2015
VL 3
IS 6
BP 1136
EP 1144
DI 10.1021/acssuschemeng.5b00069
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA CJ6ZZ
UT WOS:000355645000013
DA 2018-10-20
ER

PT J
AU Calvo-Guirado, JL
   Aguilar-Salvatierra, A
   Delgado-Ruiz, RA
   Negri, B
   Fernandez, MPR
   de Val, JEMS
   Gomez-Moreno, G
   Romanos, GE
AF Luis Calvo-Guirado, Jose
   Aguilar-Salvatierra, Antonio
   Delgado-Ruiz, Rafael Arcesio
   Negri, Bruno
   Piedad Ramirez Fernandez, Maria
   Mate Sanchez de Val, Jose Eduardo
   Gomez-Moreno, Gerardo
   Romanos, Georgios E.
TI Histological and Histomorphometric Evaluation of Zirconia Dental
   Implants Modified by Femtosecond Laser versus Titanium Implants: An
   Experimental Study in Fox Hound Dogs
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE BIC; crestal bone loss; zirconia implants
ID FOLLOW-UP; SINGLE IMPLANTS; OSSEOINTEGRATION; BONE; BIOMATERIAL;
   SURVIVAL
AB PurposeThis study applied femtosecond laser technology to zirconia dental implants (Bredent GmbH & Co.KG, Senden, Germany) to generate a surface texture of microgrooves over the entire intraosseous surface, analyzing its behavior in an in vivo model in comparison with titanium implants with sandblasted and acid-etched surfaces.
   Materials and MethodsThe study used six American Fox Hound dogs. Each received four implants per hemi-mandible, making a total of eight implants per animal. The 48 immediate loaded implants were divided into two groups of 24 titanium implants (control group) and 24 zirconia implants (study/test group), distributed randomly. Bone-to-implant contact (BIC) values and crestal resorption were determined at 1 and 3 months, also measuring calcium, phosphorous, and carbon concentrations by means of energy dispersive x-ray.
   ResultsBIC percentages after 30 days were 51.36% for titanium implants and 44.68% for zirconia implants. After 90 days, values increased to 61.73% in titanium and 47.94% in zirconia implants. After 30 days, there was more crestal bone lost in the titanium group (0.77mm) compared with the zirconia group (0.01mm). After 90 days, zirconia implants showed greater marginal bone resorption (1.25mm) compared with the titanium group (0.37mm).
   ConclusionsThe present study shows that zirconia implants with modified surfaces can produce good osseointegration values when compared with titanium implants in terms of BIC and crestal bone resorption at 1 and 3 months.
C1 [Luis Calvo-Guirado, Jose; Aguilar-Salvatierra, Antonio; Negri, Bruno; Piedad Ramirez Fernandez, Maria; Mate Sanchez de Val, Jose Eduardo] Univ Murcia, Fac Med & Dent, Dept Gen & Implant Dent, Murcia 30007, Spain.
   [Delgado-Ruiz, Rafael Arcesio] SUNY Stony Brook, Sch Dent Med, Dept Prosthodont & Digital Technol, Stony Brook, NY 11794 USA.
   [Negri, Bruno; Mate Sanchez de Val, Jose Eduardo] Univ Murcia, Fac Med & Dent, Restorat Dent, Murcia 30007, Spain.
   [Gomez-Moreno, Gerardo] Univ Granada, Fac Dentristry, Dept Pharmacol Interact, Granada, Spain.
   [Romanos, Georgios E.] SUNY Stony Brook, Sch Dent Med, Clin Affairs, Stony Brook, NY 11794 USA.
RP Calvo-Guirado, JL (reprint author), Univ Murcia, Fac Med & Dent, Hosp Morales Meseguer, 2 Planta Clin Odontol Calle Marques de los Velez, Murcia 30007, Spain.
EM joseluis.calvo@um.es
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; calvo guirado,
   jose luis/0000-0002-4067-2253; Gomez-Moreno,
   Gerardo/0000-0001-9094-4985; Delgado-Ruiz, Rafael/0000-0003-1721-0509;
   RAMIREZ FERNANDEZ, MARIA PIEDAD/0000-0003-1913-9902
CR Al-Hamdan K, 2011, CLIN ORAL IMPLAN RES, V22, P399, DOI 10.1111/j.1600-0501.2010.02106.x
   Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Calvo-Guirado JL, 2011, J CLIN EXPT DENT, V4, P8
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P826, DOI 10.1111/clr.12145
   Cannizzaro G, 2010, EUR J ORAL IMPLANTOL, V3, P111
   Delgado-Ruiz RA, 2011, J BIOMED MATER RES B, V96B, P91, DOI 10.1002/jbm.b.31743
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Dierens M, 2012, CLIN ORAL IMPLAN RES, V23, P197, DOI 10.1111/j.1600-0501.2011.02212.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jacobs R, 2010, J CLIN PERIODONTOL, V37, P1119, DOI 10.1111/j.1600-051X.2010.01626.x
   Javed F, 2013, CLIN IMPLANT DENT R, V15, P47, DOI 10.1111/j.1708-8208.2010.00330.x
   Kan JYK, 2011, INT J ORAL MAX IMPL, V26, P179
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Malo P, 2011, J AM DENT ASSOC, V142, P310, DOI 10.14219/jada.archive.2011.0170
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Nickenig HJ, 2009, CLIN ORAL IMPLAN RES, V20, P550, DOI 10.1111/j.1600-0501.2008.01684.x
   Nisapakultorn K, 2010, CLIN ORAL IMPLAN RES, V21, P662, DOI 10.1111/j.1600-0501.2009.01887.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Romanos G, 2010, J ORAL IMPLANTOL, V36, P315, DOI 10.1563/AAID-JOI-D-09-00060
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   SCHENK EA, 1983, STAIN TECHNOL, V58, P377, DOI 10.3109/10520298309066818
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P13
   Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x
   Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   tersBrugge PJ, 2002, BIOMATERIALS, V23, P3269
   Verdugo F, 2009, J PERIODONTOL, V80, P816, DOI 10.1902/jop.2009.080572
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
NR 35
TC 8
Z9 8
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JUN
PY 2015
VL 17
IS 3
BP 525
EP 532
DI 10.1111/cid.12162
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CJ7DX
UT WOS:000355655500013
PM 24138572
DA 2018-10-20
ER

PT J
AU Mangano, C
   Sinjari, B
   Shibli, JA
   Mangano, F
   Hamisch, S
   Piattelli, A
   Perrotti, V
   Iezzi, G
AF Mangano, Carlo
   Sinjari, Bruna
   Shibli, Jamil A.
   Mangano, Francesco
   Hamisch, Sabine
   Piattelli, Adriano
   Perrotti, Vittoria
   Iezzi, Giovanna
TI A Human Clinical, Histological, Histomorphometrical, and Radiographical
   Study on Biphasic HA-Beta-TCP 30/70 in Maxillary Sinus Augmentation
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE biphasic calcium phosphate; bone regeneration; histology;
   hydroxyapatite; sinus augmentation
ID CALCIUM-PHOSPHATE CERAMICS; DEPROTEINIZED BOVINE BONE; TRICALCIUM
   PHOSPHATE; HYDROXYAPATITE SCAFFOLDS; GRAFT MATERIALS; SULFATE;
   DEGRADATION; OSTEOINDUCTION; COMBINATION; FABRICATION
AB BackgroundBy mixing hydroxyapatite (HA) and tricalcium phosphate (TCP), biphasic calcium phosphate ceramics can be obtained, and by varying their ratio it is possible to tailor the characteristics of the biomaterial.
   PurposeThe aim of the present human study was to evaluate the histological and radiographical aspects of bone formation in maxillary sinus augmentation using a 30/70 HA-beta-TCP with a reticular structure.
   Materials and MethodsA total of 12 patients, undergoing two-stage sinus augmentation procedure using HA-beta-TCP at a ratio of 30/70, were included in the present study. After a 6-month healing period, during implant insertion, radiographical analysis was performed, and then the bone core biopsies were harvested and processed for histology.
   ResultsAt radiographic evaluation, the bone gain was on average 6.850.60mm. HA-beta-TCP 30/70 appeared to be lined by newly formed bone, with no gaps at the interface. The histomorphometric analysis revealed 26 +/- 2% of residual grafted biomaterial, 29 +/- 3% of newly formed bone, and 45 +/- 2% of marrow spaces.
   ConclusionsThe present results indicate histologically the high biocompatibility and osteoconductivity of HA-beta-TCP 30/70, and clinically its successful use for sinus augmentation procedures.
C1 [Mangano, Carlo; Mangano, Francesco] Univ Insubria, Dept Morphol & Surg Sci, Varese, Italy.
   [Sinjari, Bruna; Piattelli, Adriano; Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy.
   [Shibli, Jamil A.] Univ Guarulhos, Oral Surg Dent Res Div, Guarulhos, SP, Brazil.
   [Hamisch, Sabine] BioCer Entwicklungs GmbH, Bayreuth, Germany.
RP Iezzi, G (reprint author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.
EM gio.iezzi@unich.it
OI Mangano, Francesco/0000-0001-5488-4268; Sinjari,
   Bruna/0000-0002-4444-3343
FU PRIN - Ministry of Education, University and Research (M.I.U.R.), Rome,
   Italy [PRIN 20102ZLNJ5]
FX This work was supported by PRIN 2010-2011 (PRIN 20102ZLNJ5), financed by
   the Ministry of Education, University and Research (M.I.U.R.), Rome,
   Italy. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Becker W, 1995, Int J Oral Maxillofac Implants, V10, P143
   Cheng LJ, 2010, ACTA BIOMATER, V6, P1569, DOI 10.1016/j.actbio.2009.10.050
   Daculsi G, 1989, BIOCERAMICS, V2, P3
   De Leonardis D, 2000, J PERIODONTOL, V71, P940
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Deisinger U, 2006, CYTOTHERAPY, V8, P15
   Detsch R, 2011, J BIOMATER APPL, V26, P359, DOI 10.1177/0885328210373285
   EDBERG E, 1930, ACTA CHIR SCAND, V67, P313
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Hattori Hiroyuki, 2010, J Orthop Surg (Hong Kong), V18, P63
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim CK, 1998, J PERIODONTOL, V69, P1317, DOI 10.1902/jop.1998.69.12.1317
   Lindgren C, 2012, CLIN IMPLANT DENT R, V14, P41, DOI 10.1111/j.1708-8208.2010.00224.x
   Lindgren C, 2010, CLIN ORAL IMPLAN RES, V21, P924, DOI 10.1111/j.1600-0501.2010.01933.x
   Lindgren C, 2009, INT J ORAL MAX IMPL, V24, P1093
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Mangano C, 2013, INT J ORAL MAX IMPL, V28, P51, DOI 10.11607/jomi.2667
   Mayr H, 2008, KEY ENG MATER, V361-363, P1043, DOI 10.4028/www.scientific.net/KEM.361-363.1043
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Nystrom C, 1928, ACTA CHIR SCAND, V63, P296
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 2008, J CELL MOL MED, V12, P2609, DOI 10.1111/j.1582-4934.2008.00312.x
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6
   Simon JL, 2007, J BIOMED MATER RES A, V83A, P747, DOI 10.1002/jbm.a.31329
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Sottosanti J, 1992, Compendium, V13, P226
   Sottosanti J., 1992, COMPENDIUM, V13, P232
   Sottosanti J., 1992, COMPENDIUM, V13, P230
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x
   Vorndran E, 2009, ADV ENG MATER, V10, pB67
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
NR 49
TC 19
Z9 20
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JUN
PY 2015
VL 17
IS 3
BP 610
EP 618
DI 10.1111/cid.12145
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CJ7DX
UT WOS:000355655500022
PM 24004190
DA 2018-10-20
ER

PT J
AU Rnjak-Kovacina, J
   DesRochers, TM
   Burke, KA
   Kaplan, DL
AF Rnjak-Kovacina, Jelena
   DesRochers, Teresa M.
   Burke, Kelly A.
   Kaplan, David L.
TI The Effect of Sterilization on Silk Fibroin Biomaterial Properties
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial; scaffolds; silk fibroin; sterilization; tissue engineering
ID SIZED TISSUE CONSTRUCTS; SPIDER SILK; IN-VITRO; GAMMA-IRRADIATION;
   KIDNEY-DISEASE; BLEND FILMS; STEM-CELLS; SCAFFOLDS; BONE; VIVO
AB The effects of common sterilization techniques on the physical and biological properties of lyophilized silk fibroin sponges are described. Sterile silk fibroin sponges were cast using a pre-sterilized silk fibroin solution under aseptic conditions or post-sterilized via autoclaving, radiation, dry heat, exposure to ethylene oxide, or hydrogen peroxide gas plasma. Low average molecular weight and low concentration silk fibroin solutions could be sterilized via autoclaving or filtration without significant loses of protein. However, autoclaving reduced the molecular weight distribution of the silk fibroin protein solution, and silk fibroin sponges cast from autoclaved silk fibroin were significantly stiffer compared to sponges cast from unsterilized or filtered silk fibroin. When silk fibroin sponges were sterilized post-casting, autoclaving increased scaffold stiffness, while decreasing scaffold degradation rate in vitro. In contrast, irradiation accelerated scaffold degradation rate. Exposure to ethylene oxide significantly decreased cell proliferation rate on silk fibroin sponges, which was rescued by leaching ethylene oxide into PBS prior to cell seeding.
C1 [Rnjak-Kovacina, Jelena; DesRochers, Teresa M.; Burke, Kelly A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Rnjak-Kovacina, Jelena] UNSW Australia, Grad Sch Biomed Engn, Sydney, NSW, Australia.
   [DesRochers, Teresa M.] KIYATEC Inc, Greenville, SC USA.
   [Burke, Kelly A.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [NIH P41 EB002520, EY020856, F32-DK093194]; Air Force Office of
   Scientific Research
FX We thank the NIH (NIH P41 EB002520; EY020856; F32-DK093194 awarded to
   KAB) and the Air Force Office of Scientific Research for support. We
   thank Hannah Baker and Dr. George Christ (WFIRM) for their assistance
   with gamma sterilization, Dr. Michael House and staff at Tufts Medical
   for their assistance with plasma sterilization, Dr. Chiara Ghezzi for
   her advice on mechanical testing, and Carmen Preda for technical
   assistance.
CR Bellas E, 2013, BIOMATERIALS, V34, P2960, DOI 10.1016/j.biomaterials.2013.01.058
   Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Choi JH, 2011, METHODS MOL BIOL, V702, P319, DOI 10.1007/978-1-61737-960-4_23
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   De Moraes M.A., 2013, J BIOMED MATER RES B, V102, P869
   DesRochers TM, 2012, J TISSUE ENG REGEN M, V6, P126
   DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002
   DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219
   Faraj KA, 2011, TISSUE ENG REGEN MED, V8, P460
   George KA, 2013, MAT SCI ENG C-MATER, V33, P668, DOI 10.1016/j.msec.2012.10.016
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hattori S, 2012, BIOINSPIR BIOMIM NAN, V1, P195, DOI 10.1680/bbn.11.00006
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hofmann S, 2014, ACTA BIOMATER, V10, P308, DOI 10.1016/j.actbio.2013.08.035
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Kempner ES, 2001, J PHARM SCI, V90, P1637, DOI 10.1002/jps.1114
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Liu Y, 2004, POLYMER, V45, P7705, DOI 10.1016/j.polymer.2004.09.005
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lucke M, 2015, INT J PHARMACEUT, V481, P125, DOI 10.1016/j.ijpharm.2015.01.024
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Marsano E, 2008, INT J BIOL MACROMOL, V43, P106, DOI 10.1016/j.ijbiomac.2008.03.009
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rnjak-Kovacina J, 2014, ADV FUNCT MATER, V24, P2188, DOI 10.1002/adfm.201302901
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rogers W., 2012, STERILISATION BIOMAT
   Seib FP, 2014, BIOMATERIALS, V35, P83, DOI 10.1016/j.biomaterials.2013.09.053
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   Vollrath F, 2000, J Biotechnol, V74, P67
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhao Y., 2011, J BIOMED SCI ENG, V4, P397, DOI [10.4236/jbise.2011.45050, DOI 10.4236/JBISE.2011.45050]
NR 61
TC 11
Z9 11
U1 6
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN
PY 2015
VL 15
IS 6
BP 861
EP 874
DI 10.1002/mabi.201500013
PG 14
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CJ8MA
UT WOS:000355754300012
PM 25761231
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liaqat, F
   Tahir, MN
   Schechtel, E
   Kappl, M
   Auernhammer, GK
   Char, K
   Zentel, R
   Butt, HJ
   Tremel, W
AF Liaqat, Faroha
   Tahir, Muhammad Nawaz
   Schechtel, Eugen
   Kappl, Michael
   Auernhammer, Guenter K.
   Char, Kookheon
   Zentel, Rudolf
   Butt, Hans-Juergen
   Tremel, Wolfgang
TI High-Performance TiO2 Nanoparticle/DOPA-Polymer Composites
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE catechol polymers; fracture toughness; inorganic-organic nanocomposites;
   metal-coordination bonding; TiO2 nanoparticles
ID NANOTUBE SHEET/BISMALEIMIDE NANOCOMPOSITES; LINKED GRAPHENE OXIDE;
   ARTIFICIAL NACRE; MULTIFUNCTIONAL MATERIALS; MECHANICAL PERFORMANCE;
   LAYERED NANOCOMPOSITES; ABRASION RESISTANCE; ORGANIC MATRIX;
   HIGH-STRENGTH; FILMS
AB Many natural materials are complex composites whose mechanical properties are often outstanding considering the weak constituents from which they are assembled. Nacre, made of inorganic (CaCO3) and organic constituents, is a textbook example because of its strength and toughness, which are related to its hierarchical structure and its well-defined organic-inorganic interface. Emulating the construction principles of nacre using simple inorganic materials and polymers is essential for understanding how chemical composition and structure determine biomaterial functions. A hard multilayered nanocomposite is assembled based on alternating layers of TiO2 nanoparticles and a 3-hydroxy-tyramine (DOPA) substituted polymer (DOPA-polymer), strongly cemented together by chelation through infiltration of the polymer into the TiO2 mesocrystal. With a Young's modulus of 17.5 +/- 2.5 GPa and a hardness of 1.1 +/- 0.3 GPa the resulting material exhibits high resistance against elastic as well as plastic deformation. A key feature leading to the high strength is the strong adhesion of the DOPA-polymer to the TiO2 nanoparticles.
C1 [Liaqat, Faroha; Tahir, Muhammad Nawaz; Schechtel, Eugen; Tremel, Wolfgang] Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany.
   [Kappl, Michael; Auernhammer, Guenter K.; Butt, Hans-Juergen] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Char, Kookheon] Seoul Natl Univ, WCU Program Chem Convergence Energy & Environm, Natl Creat Res Initiat Ctr Intelligent Hybrids, Sch Chem & Biol Engn, Seoul 151744, South Korea.
   [Zentel, Rudolf] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany.
RP Tahir, MN (reprint author), Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany.
EM tahir@uni-mainz.de; tremel@uni-mainz.de
RI Tahir, Muhammad/B-4681-2016; Tahir, Muhammad Nawaz/B-2001-2016; Kappl,
   Michael/A-5697-2009; Mainz, EMZ-M/E-3619-2016; Butt,
   Hans-Jurgen/C-4811-2011; MPIP, AK Butt/B-8805-2009; Zentel,
   Rudolf/D-4542-2011; Auernhammer, Gunter/J-1640-2012; Tremel,
   Wolfgang/D-8125-2011
OI Tahir, Muhammad/0000-0002-9031-5537; Tahir, Muhammad
   Nawaz/0000-0002-9031-5537; Auernhammer, Gunter/0000-0003-1515-0143;
   Tremel, Wolfgang/0000-0002-4536-994X
FU IRTG [1404]
FX F.L. thanks the IRTG 1404 for financial support.
CR Akemi Ooka A, 2000, Biopolymers, V57, P92
   An Z, 2011, ADV MATER, V23, P3842, DOI 10.1002/adma.201101544
   Andersen N. H., 2009, LANGMUIR, V25, P3323
   Barrett DG, 2013, ADV FUNCT MATER, V23, P1111, DOI 10.1002/adfm.201201922
   Barthelat F, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/035001
   Bhushan B., 1999, PRINCIPLES APPL TRIB
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/NMAT3915, 10.1038/nmat3915]
   Brau M., 2014, WO Patent, Patent No. [2014095717 A1, 2014095717]
   Burghard Z, 2007, ADV MATER, V19, P970, DOI 10.1002/adma.200601068
   Burghard Z, 2009, NANO LETT, V9, P4103, DOI 10.1021/nl902324x
   Cheng QF, 2010, CARBON, V48, P260, DOI 10.1016/j.carbon.2009.09.014
   Cheng QF, 2014, ACCOUNTS CHEM RES, V47, P1256, DOI 10.1021/ar400279t
   Cheng QF, 2013, ANGEW CHEM INT EDIT, V52, P3750, DOI 10.1002/anie.201210166
   Cheng QF, 2012, ADV MATER, V24, P1838, DOI 10.1002/adma.201200179
   Cheng QF, 2010, SMALL, V6, P763, DOI 10.1002/smll.200901957
   Cheng QF, 2009, ADV FUNCT MATER, V19, P3219, DOI 10.1002/adfm.200900663
   Colfen H., 2008, MESOCRYSTALS NONCLAS
   Cui W, 2014, ACS NANO, V8, P9511, DOI 10.1021/nn503755c
   Dinh CT, 2009, ACS NANO, V3, P3737, DOI 10.1021/nn900940p
   Eberhardt M, 2005, EUR POLYM J, V41, P1569, DOI 10.1016/j.europolymj.2005.01.025
   Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001
   Finnemore A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1970
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gomopoulos N, 2010, NANO LETT, V10, P980, DOI 10.1021/nl903959r
   Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044
   Hu KS, 2013, ADV MATER, V25, P2301, DOI 10.1002/adma.201300179
   Hwang DS, 2012, J MATER CHEM, V22, P15530, DOI 10.1039/c2jm32439c
   Jander G., 1970, LEHRBUCH PRAPARATIVE, P393
   Jang K., 2002, NATURE, V419, P801
   Kickelbick G., 2007, HYBRID MAT SYNTHESIS
   Launspach M, 2012, MICRON, V43, P1351, DOI 10.1016/j.micron.2012.03.014
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Li YQ, 2012, ADV MATER, V24, P3426, DOI 10.1002/adma.201200452
   Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433
   Malisova B., 2010, THESIS VSCHT PRAGUA
   Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54
   Michaud-Soret I., 1995, BIOCHEMISTRY-US, V34, P5501
   Moses DN, 2006, J BIOL CHEM, V281, P34826, DOI 10.1074/jbc.M603429200
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Natalio F., 2011, J MATER CHEM, V21, P11123
   Natalio F, 2013, SCIENCE, V339, P1298, DOI 10.1126/science.1216260
   Natalio F, 2012, NAT NANOTECHNOL, V7, P530, DOI [10.1038/NNANO.2012.91, 10.1038/nnano.2012.91]
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ou JF, 2011, SURF INTERFACE ANAL, V43, P803, DOI 10.1002/sia.3631
   Pierpont C. G., 1994, PROG INORG CHEM, V41, P381
   Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176
   Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706
   Pomogailo A. D., 2000, RUSS CHEM REV, V69, P53
   Rabatic BM, 2006, ADV MATER, V18, P1033, DOI 10.1002/adma.200500988
   Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]
   Ruiz-Hitzky E., 2008, BIOINORGANIC HYBRID, P1, DOI DOI 10.1002/0471238961.BI0NRUIZ.A01/ABSTRACT
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Schneider D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.164301
   Schneider D, 2012, NANO LETT, V12, P3101, DOI 10.1021/nl300982d
   Schottner G, 2001, CHEM MATER, V13, P3422, DOI 10.1021/cm011060m
   Shukoor MI, 2008, ANGEW CHEM INT EDIT, V47, P4748, DOI 10.1002/anie.200704735
   Shukoor MI, 2007, CHEM COMMUN, P4677, DOI 10.1039/b707978h
   Tahir MN, 2006, ANGEW CHEM INT EDIT, V45, P908, DOI 10.1002/anie.200502517
   Tang W, 2014, J AM CHEM SOC, V136, P16357, DOI 10.1021/ja508946h
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   Tian Y, 2013, ADV MATER, V25, P2980, DOI 10.1002/adma.201300118
   Umland F., 1975, CHARAKTERISTISCHE RE
   Villarreal TL, 2005, J AM CHEM SOC, V127, P12601
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   Walther A, 2010, ANGEW CHEM INT EDIT, V49, P6448, DOI 10.1002/anie.201001577
   Walther A, 2010, NANO LETT, V10, P2742, DOI 10.1021/nl1003224
   Wang JF, 2014, ACS NANO, V8, P2739, DOI 10.1021/nn406428n
   Wang JF, 2013, NANOSCALE, V5, P6356, DOI 10.1039/c3nr00801k
   Wang JF, 2012, ANGEW CHEM INT EDIT, V51, P4676, DOI 10.1002/anie.201200267
   Wang JF, 2012, CHEM SOC REV, V41, P1111, DOI 10.1039/c1cs15106a
   Wang JH, 2008, CHEM MATER, V20, P20, DOI 10.1021/cm702375e
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Wu MX, 2014, ANGEW CHEM INT EDIT, V53, P3358, DOI 10.1002/anie.201310656
   Yao HB, 2010, ANGEW CHEM INT EDIT, V49, P10127, DOI 10.1002/anie.201004748
   Yao HB, 2012, J MATER CHEM, V22, P13005, DOI 10.1039/c2jm31492d
   Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y
   Zhu J, 2013, ACS NANO, V7, P4818, DOI 10.1021/nn400972t
   Zok FW, 2007, ACTA MATER, V55, P6365, DOI 10.1016/j.actamat.2007.07.042
   Zvarec O, 2013, LANGMUIR, V29, P10899, DOI 10.1021/la401858s
NR 83
TC 6
Z9 6
U1 5
U2 104
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD JUN
PY 2015
VL 36
IS 11
SI SI
BP 1129
EP 1137
DI 10.1002/marc.201400706
PG 9
WC Polymer Science
SC Polymer Science
GA CJ8IO
UT WOS:000355743700019
PM 25929974
DA 2018-10-20
ER

PT J
AU Colaco, M
   Mettu, J
   Badlani, G
AF Colaco, Marc
   Mettu, Jayadev
   Badlani, Gopal
TI The scientific basis for the use of biomaterials in stress urinary
   incontinence (SUI) and pelvic organ prolapse (POP)
SO BJU INTERNATIONAL
LA English
DT Review
DE mesh; stress urinary incontinence; pelvic organ prolapse; genetics;
   collagen; elastin
ID STEM-CELL THERAPY; 1-YEAR FOLLOW-UP; QUALITY-OF-LIFE; FLOOR DISORDERS;
   UTEROSACRAL LIGAMENTS; POSTMENOPAUSAL WOMEN; GENITAL PROLAPSE; UTERINE
   PROLAPSE; SYNTHETIC MESH; SURGICAL MESH
AB ObjectivesTo review the scientific and clinical literature to assess the basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Pelvic floor diseases (PFDS), such as SUI and POP, are common and vexing disorders. While synthetic mesh-based repairs have long been considered an option for PFD treatment, and their efficacy established in randomised clinical trials, safety of its use has recently been called into question.
   Materials and MethodsUsing the PubMed, MEDLINE and Medical Subject Headings (MeSH) databases, we performed a critical review of English-language publications that contained the following keywords: pelvic organ prolapse', stress urinary incontinence', mesh', biomaterial', collagen', elastin' and extracellular matrix'. After reviewing for relevance for mesh use in the pelvis by two independent reviewers with a third available in the case of disagreement, a total of 60 articles were included in the present review.
   ResultsWe found that many of the potential causes of PFDs are due to altered metabolism of patient extracellular matrix (specifically collagen, elastin, and their respective enzymes) and as such, repairs using native tissue may suffer from the same abnormalities leading to a subsequent lack of repair integrity. However, mesh use is not without its unique risks. Several publications have suggested that biomaterials may undergo alteration after implantation, but these findings have not been demonstrated in the normal milieu.
   ConclusionWhile the decision for the use of synthetic mesh is scientifically sound, its benefits and risks must be discussed with the patient in an informed decision-making process.
C1 [Colaco, Marc; Mettu, Jayadev; Badlani, Gopal] Wake Forest Sch Med, Dept Urol, Winston Salem, NC 27157 USA.
RP Colaco, M (reprint author), Wake Forest Sch Med, Dept Urol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM mcolaco@wakehealth.edu
CR Aboushwareb T, 2011, NEUROUROL URODYNAM, V30, P775, DOI 10.1002/nau.21101
   Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870
   Alarab M, 2010, INT UROGYNECOL J, V21, P1397, DOI 10.1007/s00192-010-1199-9
   Allen-Brady K, 2009, AM J HUM GENET, V84, P678, DOI 10.1016/j.ajhg.2009.04.002
   Altman D, 2008, EUR UROL, V54, P918, DOI 10.1016/j.eururo.2007.12.004
   Barber MD, 2013, INT UROGYNECOL J, V24, P1783, DOI 10.1007/s00192-013-2169-9
   Blaganje M, 2012, INT J GYNECOL OBSTET, V117, P164, DOI 10.1016/j.ijgo.2011.11.029
   Blanchard KT, 1999, TOXICOL PATHOL, V27, P519, DOI 10.1177/019262339902700505
   Campeau L, 2011, BJU INT, V108, P1240, DOI 10.1111/j.1464-410X.2011.10385.x
   Cannon TW, 2005, BJU INT, V96, P664, DOI 10.1111/j.1464-410X.2005.05702.x
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chen B, 2003, AM J OBSTET GYNECOL, V189, P59, DOI 10.1067/mob.2003.378
   Chen BH, 2002, INT UROGYNECOL J PEL, V13, P80, DOI 10.1007/s001920200020
   Chen Y, 2004, NEUROUROL URODYNAM, V23, P367, DOI 10.1002/nau.20006
   Cho HJ, 2009, YONSEI MED J, V50, P564, DOI [10.3349/ymj.2009.50.4.554, 10.3349/ymj.2009.50.4.564]
   Clave A, 2010, INT UROGYNECOL J, V21, P261, DOI 10.1007/s00192-009-1021-8
   Connell KA, 2008, J CLIN INVEST, V118, P1050, DOI 10.1172/JCI34193
   Cosson M, 2004, EUR J OBSTET GYN R B, V112, P201, DOI 10.1016/S0301-2115(03)00333-6
   Costantini E, 2011, UROL INT, V86, P419, DOI 10.1159/000324243
   Culligan P, 2005, OBSTET GYNECOL, V106, P29, DOI 10.1097/01.AOG.0000165824.62167.c1
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   Fenner DE, 2000, CLIN OBSTET GYNECOL, V43, P650, DOI 10.1097/00003081-200009000-00024
   FROSTLING H, 1984, SCAND J WORK ENV HEA, V10, P163, DOI 10.5271/sjweh.2347
   Gil KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-8
   Goepel C, 2008, ACTA HISTOCHEM, V110, P204, DOI 10.1016/j.acthis.2007.10.014
   Hahnestad YS, 2004, BRIT MED J, V329, P889, DOI 10.1136/bmj.329.7471.889
   Hamer MA, 2013, EUR J OBSTET GYN R B, V170, P559, DOI 10.1016/j.ejogrb.2013.07.025
   Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0
   Karam JA, 2007, BJU INT, V100, P346, DOI 10.1111/j.1464-410X.2007.06998.x
   Kerkhof MH, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.881
   Keys T, 2012, UROLOGY, V80, P237, DOI 10.1016/j.urology.2012.04.008
   Keys Tristan, 2011, Curr Urol Rep, V12, P393, DOI 10.1007/s11934-011-0213-1
   Klutke J, 2008, ACTA OBSTET GYN SCAN, V87, P111, DOI 10.1080/00016340701819247
   Kocak I, 2005, EUR UROL, V48, P634, DOI 10.1016/j.eururo.2005.04.017
   Lee CN, 2010, J KOREAN MED SCI, V25, P813, DOI 10.3346/jkms.2010.25.6.813
   Lin SY, 2007, INT UROGYNECOL J, V18, P43, DOI 10.1007/s00192-006-0090-1
   Maher C, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004014.PUB5
   Maher CM, 2011, INT UROGYNECOL J, V22, P1445, DOI 10.1007/s00192-011-1542-9
   Mangera A, 2013, BJU INT, V112, P674, DOI 10.1111/bju.12186
   Mei SS, 2013, FEMALE PELVIC MED RE, V19, P254, DOI 10.1097/SPV.0b013e31829ff74d
   Mitterberger M, 2008, EUR UROL, V53, P169, DOI 10.1016/j.eururo.2007.07.026
   Mitterberger M, 2008, J UROLOGY, V179, P226, DOI 10.1016/j.juro.2007.08.154
   Myers E, 2013, SOUTH MED J, V106, P684, DOI 10.1097/SMJ.0000000000000031
   Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Pelvic Mesh-Bard Caselist, 2013, PELV MESH LIT BARD G
   Pelvic Mesh-Gynecare Caselist, 2013, PELV MESH LIT BARD G
   Pott PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046978
   Rodrigues AM, 2008, INT UROGYNECOL J, V19, P1471, DOI 10.1007/s00192-008-0662-3
   Roman S, 2014, NEUROUROL URODYNAM, V33, P531, DOI 10.1002/nau.22443
   Salman MC, 2010, INT UROGYNECOL J, V21, P235, DOI 10.1007/s00192-009-1006-7
   Schaffer JI, 2005, CLIN OBSTET GYNECOL, V48, P639, DOI 10.1097/01.grf.0000170428.45819.4e
   Schimpf MO, 2014, AM J OBSTET GYNECOL, V211
   Shah HN, 2012, INDIAN J UROL, V28, P129, DOI 10.4103/0970-1591.98453
   Surcel C, 2012, ROM J MORPHOL EMBRYO, V53, P151
   Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170
   VOLLMAR J, 1961, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V298, P729, DOI 10.1007/BF02435362
   Witherspoon P, 2004, BRIT J SURG, V91, P368, DOI 10.1002/bjs.4462
   Wu JM, 2014, OBSTET GYNECOL, V123, P141, DOI 10.1097/AOG.0000000000000057
   Zhou L, 2012, J UROLOGY, V188, P875, DOI 10.1016/j.juro.2012.05.017
   Zong WJ, 2010, OBSTET GYNECOL, V115, P953, DOI 10.1097/AOG.0b013e3181da7946
   Zou XH, 2010, BIOMATERIALS, V31, P4872
NR 62
TC 6
Z9 8
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD JUN
PY 2015
VL 115
IS 6
BP 859
EP 866
DI 10.1111/bju.12819
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA CJ1WL
UT WOS:000355275600010
PM 24889349
OA Bronze
DA 2018-10-20
ER

PT J
AU Harhaus, L
   Huang, JJ
   Kao, SW
   Wu, YL
   Mackert, GA
   Honer, B
   Cheng, MH
   Kneser, U
   Cheng, CM
AF Harhaus, Leila
   Huang, Jung-Ju
   Kao, Shu-Wei
   Wu, Yen-Lin
   Mackert, Gina Alicia
   Hoener, Bernd
   Cheng, Ming-Huei
   Kneser, Ulrich
   Cheng, Chao-Min
TI The vascularized periosteum flap as novel tissue engineering model for
   repair of cartilage defects
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE cartilage repair; tissue engineering; vascularized periosteum flap;
   translational research; osteoarthritis; cartilage defects
ID CONTINUOUS PASSIVE MOTION; DYNAMIC FLUID PRESSURE; FULL-THICKNESS
   DEFECTS; IN-VITRO; JOINT SURFACES; FIBRIN GLUE; GRAFTS; CHONDROGENESIS;
   CULTURE; RABBITS
AB Periosteum is a promising tissue engineering scaffold in research of cartilage repair; so far however, periosteum transfers have not been realized successfully because of insufficient nourishment of the graft. In a translational approach we, for the first time, designed a vascularized periosteum flap as independent' biomaterial with its own blood supply to address this problem and to reconstruct circumscript cartilage defects. In six 3-month-old New Zealand rabbits, a critical size cartilage defect of the medial femur condyle was created and covered by a vascularized periosteum flap pedicled on the saphenous vessels. After 28days, formation of newly built cartilage was assessed macroscopically, histologically and qualitatively via biomechanical compression testing, as well as on molecular biological level via immunohistochemistry. All wounds healed completely, all joints were stable and had full range of motion. All flaps survived and were perfused through their pulsating pedicles. They showed a stable attachment to the bone, although partially incomplete adherence. Hyaline cartilage with typical columnar cell distribution and positive Collagen II staining was formed in the transferred flaps. Biomechanical testing revealed a significantly higher maximum load than the positive control, but a low elasticity. This study proved that vascularization of the periosteum flap is the essential step for flap survival and enables the flap to transform into cartilage. Reconstruction of circumscript cartilage defects seems to be possible. Although these are the first results out of a pilot project, this technique, we believe, can have a wide range of potential applications and high relevance in the clinical field.
C1 [Harhaus, Leila; Mackert, Gina Alicia; Kneser, Ulrich] Heidelberg Univ, Dept Plast Surg, Dept Hand Plast & Reconstruct Surg, Burn Care Ctr,BG Trauma Ctr Ludwigshafen, D-67071 Ludwigshafen, Germany.
   [Harhaus, Leila; Huang, Jung-Ju; Kao, Shu-Wei; Cheng, Ming-Huei] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Coll Med, Taoyuan, Taiwan.
   [Wu, Yen-Lin; Cheng, Chao-Min] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan.
   [Hoener, Bernd] SRH Univ, Dept Social & Legal Sci, Heidelberg, Germany.
RP Harhaus, L (reprint author), Heidelberg Univ, Dept Plast Surg, Dept Hand Plast & Reconstruct Surg, Burn Care Ctr,BG Trauma Ctr Ludwigshafen, Ludwig Guttmann Str 13, D-67071 Ludwigshafen, Germany.
EM leila.harhaus@bgu-ludwigshafen.de
FU Chang Gung Tsing Hua Foundation [CMRPG3C0211]
FX The work was supported by a grant from Chang Gung Tsing Hua Foundation
   (CMRPG3C0211). Thanks to Shu-Rui Yang, PhD, for his valuable
   contributions to the study design and his help and to Ching-Yu Yang for
   her support in many regards.
CR Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P232, DOI 10.1007/s001670050154
   Aroen A, 2006, J ORTHOP RES, V24, P1069, DOI 10.1002/jor.20104
   Chen ACY, 2009, J TRAUMA, V67, P165, DOI 10.1097/TA.0b013e3181881338
   Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/bjm.a.31186
   DELANEY JP, 1989, CLIN ORTHOP RELAT R, P278
   Deponti D, 2014, TISSUE ENG PT A, V20, P1113, DOI [10.1089/ten.tea.2013.0171, 10.1089/ten.TEA.2013.0171]
   GALLAY SH, 1994, J ORTHOPAED RES, V12, P515, DOI 10.1002/jor.1100120408
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   Ivkovic A, 2010, GENE THER, V17, P779, DOI 10.1038/gt.2010.16
   IWASAKI M, 1995, J BONE JOINT SURG AM, V77A, P543, DOI 10.2106/00004623-199504000-00007
   Miura Y, 1994, ORTHOP T, V18, P686
   Mukherjee N, 2001, J ORTHOPAED RES, V19, P524, DOI 10.1016/S0736-0266(00)00045-0
   NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   ODRISCOLL SW, 2001, CLIN ORTHOP S, V391, P190
   Ortak T, 2005, J CRANIOFAC SURG, V16, P594, DOI 10.1097/01.scs.0000168773.71356.62
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P181, DOI 10.3109/17453678208992198
   Rutgers M, 2010, OSTEOARTHR CARTILAGE, V18, P12, DOI 10.1016/j.joca.2009.08.009
   Saris DBF, 1999, J ORTHOPAED RES, V17, P668, DOI 10.1002/jor.1100170508
   Shah NV, 2013, ORTHOPEDICS, V36, P945, DOI 10.3928/01477447-20131120-09
   Tarng YW, 2012, INT ORTHOP, V36, P863, DOI 10.1007/s00264-011-1291-x
   Tarng YW, 2010, J BIOMED MATER RES A, V95A, P156, DOI 10.1002/jbm.a.32830
   TONNA EA, 1960, P SOC EXP BIOL MED, V107, P720
NR 24
TC 4
Z9 4
U1 1
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JUN
PY 2015
VL 19
IS 6
BP 1273
EP 1283
DI 10.1111/jcmm.12485
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA CJ2RP
UT WOS:000355332500012
PM 25754287
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kulaga, E
   Ploux, L
   Roucoules, V
AF Kulaga, Emilia
   Ploux, Lydie
   Roucoules, Vincent
TI Effect of ageing and sterilization on plasma multilayer system
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Polymer coatings for biomaterial; Plasma polymer; Ageing Sterilization
ID SILVER NANOPARTICLES; SURFACE MODIFICATION; FILMS; POLYMERIZATION;
   POLYPROPYLENE; COATINGS; SPECTROSCOPY; INCREASES; TOXICITY; CULTURE
AB Single and coupled effects of sterilization (autoclaving and electron beam) and ageing of plasma polymer multilayer coating on polypropylene mesh are studied. The multilayer system consists in silver nano-particles entrapped between two maleic anhydride plasma polymer layers and acts as a mechanosensitive antibacterial reservoir. Tensile strength generates cracks within the plasma polymer over-layer which might be used as diffusive channels for Ag+ species. Changes in surface and bulk properties are followed by SEM, TEM, XPS and antibacterial assays. Whilst autoclave treatment influences surface structure unfavorably, electron beam irradiation with dose of 25 kGy does not induce surface physical or topographical changes. However, electron beam sterilization induces changes in chemistry of the surface causing a decrease in O/C elemental concentration ratio. The surface shows better antibacterial efficiency towards planktonic bacteria after electron beam sterilization and more surprisingly, the combination of electron beam sterilization and ageing has beneficial effect on final properties of the material under stretching. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Kulaga, Emilia; Ploux, Lydie; Roucoules, Vincent] Univ Haute Alsace, Univ Strasbourg, UMR CNRS 7361, IS2M, F-68057 Mulhouse, France.
RP Roucoules, V (reprint author), UMR CNRS 7361, Inst Sci Mat Mulhouse, 15 Rue Jean Starcky,BP2488, F-68057 Mulhouse, France.
EM vincent.roucoules@uha.fr
OI Kulaga, Emilia/0000-0003-3770-0177
FU Region Alsace in France
FX The authors gratefully acknowledge the financial support from Region
   Alsace in France. The authors would like to thank Cousin Biotech for
   providing polypropylene mesh substrates. Florent Kuntz and Ludovic
   Frechard from Aerial are kindly acknowledged for their expertise and
   assistance in the electron beam sterilization process.
CR Acar N, 2002, RADIAT PHYS CHEM, V63, P185, DOI 10.1016/S0969-806X(01)00231-6
   Ademovic Z, 2005, PLASMA PROCESS POLYM, V2, P53, DOI 10.1002/ppap.200400038
   Airoudj A, 2011, ADV ENG MATER, V13, pB360, DOI 10.1002/adem.201080075
   Alissawi N, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0928-z
   Assumpcao TAA, 2011, APPL PHYS B, V103, P165, DOI DOI 10.1007/S00340-010-4258-5
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bretagnol F, 2008, ACTA BIOMATER, V4, P1745, DOI 10.1016/j.actbio.2008.06.013
   Brito-Silva AM, 2010, POLYM ENG SCI, V50, P2350, DOI 10.1002/pen.21771
   Calderon JG, 1998, J BIOMED MATER RES, V42, P597, DOI 10.1002/(SICI)1097-4636(19981215)42:4<597::AID-JBM16>3.0.CO;2-R
   CHARLESBY A, 1953, PROC R SOC LON SER-A, V218, P245, DOI 10.1098/rspa.1953.0102
   Chu LQ, 2006, LANGMUIR, V22, P2822, DOI 10.1021/la0530283
   Ding ZL, 2013, J APPL POLYM SCI, V130, P1659, DOI 10.1002/app.39351
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   Friedrich M., 2010, Research Journal of Medical Sciences, V4, P330, DOI 10.3923/rjmsci.2010.330.333
   Gahleitner MW, 2003, P 9 EUR PLAC C ROM 3
   Geissler A, 2010, PLASMA PROCESS POLYM, V7, P64, DOI 10.1002/ppap.200900098
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P271, DOI 10.1002/(SICI)1096-9918(199604)24:4<271::AID-SIA116>3.3.CO;2-A
   Gibson RF, 2011, PRINCIPLES COMPOSITE, V219
   Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356
   Hegemann D, 2007, PLASMA PROCESS POLYM, V4, P229, DOI 10.1002/ppap.200600169
   Jiang XC, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9780-1
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p
   Korbekandi H, 2012, DELIVERY OF NANOPARTICLES, P3
   Kulaga E, 2014, PLASMA PROCESS POLYM, V11, P63, DOI 10.1002/ppap.201300091
   Levine H., 1988, WATER SCI REV, V3
   MARTAKIS N, 1994, J APPL POLYM SCI, V51, P313, DOI 10.1002/app.1994.070510214
   Nitschke M, 2012, COLLOID SURFACE B, V90, P41, DOI 10.1016/j.colsurfb.2011.09.034
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Roucoules V, 2007, LANGMUIR, V23, P13136, DOI 10.1021/la701460f
   Schneider K, 2012, POLYPROPYLENE, P459
   Serbetci K, 2007, AM J SURG, V194, P375, DOI 10.1016/j.amjsurg.2005.11.018
   Siffer F, 2005, ANAL CHIM ACTA, V539, P289, DOI 10.1016/j.aca.2005.02.072
   Tamirisa PA, 2006, MACROMOLECULES, V39, P7092, DOI 10.1021/ma060944u
   Thomas M, 2007, PLASMA PROCESS POLYM, V4, pS475, DOI 10.1002/ppap.200731210
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Yamamoto M, 2006, LANGMUIR, V22, P8581, DOI 10.1021/la0600245
NR 38
TC 3
Z9 3
U1 3
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JUN
PY 2015
VL 116
BP 1
EP 13
DI 10.1016/j.polymdegradstab.2015.02.011
PG 13
WC Polymer Science
SC Polymer Science
GA CJ2XU
UT WOS:000355348800001
DA 2018-10-20
ER

PT J
AU Segev-Zarko, L
   Saar-Dover, R
   Brumfeld, V
   Mangoni, ML
   Shai, Y
AF Segev-Zarko, L.
   Saar-Dover, Ron
   Brumfeld, Vlad
   Mangoni, Maria Luisa
   Shai, Yechiel
TI Mechanisms of biofilm inhibition and degradation by antimicrobial
   peptides
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE antibiotic resistance; anti-biofilm activity; antimicrobial peptides;
   biofilm; biophysics; Pseudomonas aeruginosa
ID GENERATION VIBRATIONAL SPECTROSCOPY; PSEUDOMONAS-AERUGINOSA BIOFILMS;
   QUARTZ-CRYSTAL MICROBALANCE; BACTERIAL BIOFILMS; SEQUENCE ALTERATION;
   CATIONIC PEPTIDE; HOST-DEFENSE; SURFACES; ADHESION; MICROORGANISMS
AB Many bacteria live as biofilms to cope with unfavourable surroundings. Biofilms start from (i) a planktonic stage, (ii) initial adhesion to surfaces and (iii) formation of sessile micro-colonies that secrete extracellular polymeric substance (EPS), leading to bacterial resistance to antibiotics. Antimicrobial peptides (AMPs) are extensively studied with regard to planktonic bacteria but much less so with regard to biofilm formation. In the present study, we investigated how the above three steps are affected by the properties of the AMPs using a series of peptides composed of six lysines and nine leucines, which differ in their sequences and hence their biophysical properties. Treatment with bactericidal peptides at non-inhibitory concentrations resulted in reduced biofilm growth, for some starting from 25 nM which is 0.2 and 0.4% of their minimum inhibitory concentration (MIC 6.3 and 12.5 mu M, respectively), continuing in a dose-dependent manner. We suggest that reduced bacterial adhesion to surfaces and decreased biofilm growth are due to the peptide's ability to coat either the biomaterial surface or the bacterium itself. Degradation of established biofilms by bactericidal and non-bactericidal peptides, within 1 h of incubation, occurs by either killing of embedded bacteria or detachment of live ones. In addition to shedding light on the mechanism of biofilm inhibition and degradation, these data may assist in the design of anti-biofilm AMPs.
C1 [Segev-Zarko, L.; Saar-Dover, Ron; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
   [Brumfeld, Vlad] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel.
   [Mangoni, Maria Luisa] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.
RP Shai, Y (reprint author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
EM Yechiel.Shai@weizmann.ac.il
FU Italian Foundation for Cystic Fibrosis [14/2011]; Delegazione FFC di
   Foggia; Gruppo di Sostegno FFC di Seregno; European Community's Seventh
   Framework Programme [278998]
FX This work was partially supported by grants from the Italian Foundation
   for Cystic Fibrosis [Project FFC#14/2011], Delegazione FFC di Foggia,
   Gruppo di Sostegno FFC di Seregno, and the European Community's Seventh
   Framework Programme (FP7/2007-2013) under grant agreement [278998]. Y.S.
   is the incumbent of the Harold S. and Harriet B. Brady Professorial
   Chair in Cancer Research.
CR Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Chennupati SK, 2009, AMJ RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x
   de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Fernebro J, 2011, DRUG RESIST UPDATE, V14, P125, DOI 10.1016/j.drup.2011.02.001
   Fogaca AC, 2010, FEMS MICROBIOL LETT, V306, P152, DOI 10.1111/j.1574-6968.2010.01950.x
   Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004
   Hara T, 2001, BIOPOLYMERS, V58, P437, DOI 10.1002/1097-0282(20010405)58:4<437::AID-BIP1019>3.0.CO;2-I
   Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6
   Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100
   Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210
   Kapoor R, 2011, ANTIMICROB AGENTS CH, V55, P3054, DOI 10.1128/AAC.01516-10
   Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383
   KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158
   Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3
   Liu LH, 2009, NAT NANOTECHNOL, V4, P457, DOI [10.1038/NNANO.2009.153, 10.1038/nnano.2009.153]
   Luca V, 2013, CELL MOL LIFE SCI, V70, P2773, DOI 10.1007/s00018-013-1291-7
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006
   Mermut O, 2006, J AM CHEM SOC, V128, P3598, DOI 10.1021/ja056031h
   Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Otvos L, 2000, PROTEIN SCI, V9, P742
   Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08
   Papo N, 2004, BIOCHEMISTRY-US, V43, P6393, DOI 10.1021/bi049944h
   Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Phillips DC, 2007, J PHYS CHEM C, V111, P255, DOI 10.1021/jp0645263
   Pimentel ND, 2014, INT J FOOD MICROBIOL, V190, P1, DOI 10.1016/j.ijfoodmicro.2014.08.004
   POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802
   Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776
   Rossi LM, 2008, J PHARM SCI-US, V97, P1060, DOI 10.1002/jps.21053
   Saar-Dover R, 2013, METHODS MOL BIOL, V1033, P173, DOI 10.1007/978-1-62703-487-6_12
   Saar-Dover R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002891
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627
   Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023
   Trafny EA, 2013, WORLD J MICROB BIOT, V29, P1635, DOI 10.1007/s11274-013-1326-0
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461
   Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021
NR 50
TC 34
Z9 35
U1 2
U2 50
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUN 1
PY 2015
VL 468
BP 259
EP 270
DI 10.1042/BJ20141251
PN 2
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CI7KS
UT WOS:000354942800006
PM 25761937
DA 2018-10-20
ER

PT J
AU Mohan, G
   Gallant, ND
AF Mohan, Greeshma
   Gallant, Nathan D.
TI Surface chemistry gradients on silicone elastomers for high-throughput
   modulation of cell-adhesive interfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PDMS; hydrophobicity; fibronectin; combinatorial methods;
   mechanotransduction
ID POLYMER SURFACES; INTEGRIN BINDING; FIBRONECTIN CONFORMATION;
   WETTABILITY GRADIENT; SUBSTRATE MECHANICS; FOCAL ADHESIONS; STEM-CELLS;
   DIFFERENTIATION; PROLIFERATION; ADSORPTION
AB Combinatorial and high-throughput approaches to screening cell responses to material properties accelerate the speed of discovery and facilitate the identification of cell instructive cues or trends that may be missed by discrete sampling. However, these technologies have not yet been widely applied to materials with tissue-like stiffness. The fabrication of monotonically varying surface chemistry gradients on polydimethylsiloxane, an elastic biomaterial, and the influence of these engineered surfaces on protein adsorption and adherent cell morphology were explored in this study. Crosslinked networks of polydimethylsiloxane were functionalized with a hydrophobic self-assembled monolayer and then modified by spatiotemporally regulated ultraviolet ozonolysis to obtain gradients of oxygenated species ranging from approximate to 10 degrees to approximate to 100 degrees in water contact angle. Automated microscopy and image analysis of fibroblast cell morphology revealed a strong correlation between cell spreading and hydrophobicity. However, structural and functional analysis of the fibronectin interface indicated a proportional increase in cell spreading with adsorption, but a biphasic relationship with fibronectin conformation, underscoring the complexity of the adhesive interface. This work demonstrates the development of an elastomer surface modification platform that can be extended to future combinatorial studies of biological responses to chemical and mechanical material properties. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2066-2076, 2015.
C1 [Mohan, Greeshma] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
   [Gallant, Nathan D.] Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
RP Gallant, ND (reprint author), Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
EM ngallant@usf.edu
OI Gallant, Nathan/0000-0001-6454-7660
FU National Science Foundation [CAREER DMR-1056475]
FX Contract grant sponsor: National Science Foundation; contract grant
   number: CAREER DMR-1056475
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Hernandez JCR, 2007, BIOPHYS J, V93, P202, DOI 10.1529/biophysj.106.102491
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104
   Efimenko K, 2005, POLYMER, V46, P9329, DOI 10.1016/j.polymer.2005.07.046
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evaraert EP, 1996, J ADHES SCI TECHNOL, V10, P351
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263
   Llopis-Hernandez V, 2011, PLOS ONE, V6, P1
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2
   Mei Y, 2007, CURR OPIN CHEM BIOL, V11, P388, DOI 10.1016/j.cbpa.2007.07.006
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Moore NM, 2010, BIOMATERIALS, V31, P1604, DOI [10.1016/j.biomatetials.2009.11.011, 10.1016/j.biomaterials.2009.11.011]
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   MOSHER DF, 1981, J INVEST DERMATOL, V77, P175, DOI 10.1111/1523-1747.ep12479791
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044
   Roberson SV, 2002, APPL SURF SCI, V200, P150, DOI 10.1016/S0169-4332(02)00887-5
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Williams C, 2011, BIOMATERIALS, V32, P5625, DOI 10.1016/j.biomaterials.2011.04.050
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
NR 60
TC 5
Z9 5
U1 4
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2015
VL 103
IS 6
BP 2066
EP 2076
DI 10.1002/jbm.a.35349
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH4SV
UT WOS:000354024100018
PM 25294744
DA 2018-10-20
ER

PT J
AU Choudhary, R
   Koppala, S
   Srivastava, A
   Sasikumar, S
AF Choudhary, Rajan
   Koppala, Sivasankar
   Srivastava, Aviral
   Sasikumar, Swamiappan
TI In-vitro bioactivity of nanocrystalline and bulk larnite/chitosan
   composites: comparative study
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Eggshell; Sol-gel chemistry; X-ray diffraction; Composites; Bioactivity;
   Surface properties
ID TISSUE ENGINEERING SCAFFOLDS; SUBSTITUTED HYDROXYAPATITE; COMBUSTION
   SYNTHESIS; POLYLACTIDE FOAMS; GLASS COMPOSITES; DRUG-DELIVERY; HENS
   EGGSHELL; BONE; CHITOSAN; CALCIUM
AB A major problem in the field of hard tissue engineering is to develop a biomaterial which could allow the organ to regenerate itself completely by biological fixation. Silicate bioceramics are new hope in this field. Nanocrystalline larnite (Ca2SiO4) was prepared by sol-gel combustion method by using calcium nitrate/eggshell waste. XRD analysis of the synthesized product shows the formation of single phasic larnite and FT-IR spectrum confirms the presence of characteristic functional groups of larnite. In vitro bioactivity of different compositional ratio of larnite/chitosan has been investigated to study the influence of the ratio of constituents of composite on bioactivity. XRD pattern of the composite surface after bioactivity study reveals that the composite which mimics the ratio of bioceramic to biopolymer in natural bone shows good bioactivity and remarkable hydroxyapatite layer deposition. SEM images shows the hydroxyapatite particles deposited on the surface of eggshell derived larnite composite is highly agglomerated with the average particle size of 3-5 nm.
C1 [Choudhary, Rajan; Koppala, Sivasankar; Srivastava, Aviral; Sasikumar, Swamiappan] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
RP Sasikumar, S (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
EM vitsasi@yahoo.co.in
RI Swamiappan, Sasikumar/M-9921-2016; Choudhary, Rajan/R-7998-2018
OI Swamiappan, Sasikumar/0000-0003-2533-4923; Koppala,
   Sivasankar/0000-0002-4086-030X
FU VIT University
FX Authors are thankful to VIT University for providing necessary
   facilities and financial support.
CR Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Anjaneyulu U, 2014, B MATER SCI, V37, P207, DOI 10.1007/s12034-014-0646-5
   Bhatkar VB, 2011, B MATER SCI, V34, P1281, DOI 10.1007/s12034-011-0166-5
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chen QZ, 2012, PROG BIOMATER, V1, DOI 10.1186/2194-0517-1-2
   Cheng W, 2005, MATER LETT, V59, P2214, DOI 10.1016/j.matlet.2005.02.069
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Goloshchapov DL, 2013, CERAM INT, V39, P4539, DOI 10.1016/j.ceramint.2012.11.050
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gou ZR, 2005, J EUR CERAM SOC, V25, P1507, DOI 10.1016/j.jeurceramsoc.2004.05.029
   Han B, 1999, POLYPEPTIDE GROWTH F
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Holme HK, 2008, CARBOHYD POLYM, V73, P656, DOI 10.1016/j.carbpol.2008.01.007
   Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iler R. K., 1979, CHEM SILICA
   Kalinkin AM, 2003, GLASS PHYS CHEM+, V29, P410, DOI 10.1023/A:1025185229274
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   Klug H. P., 1962, XRAY DIFFRACTION PRO
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Krithiga G, 2011, B MATER SCI, V34, P177, DOI 10.1007/s12034-011-0044-1
   Lakshmi R., 2013, Combustion Science and Technology, V185, P1777, DOI 10.1080/00102202.2013.835308
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Lin KL, 2006, J INORG MATER, V21, P1429
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Nalwa H. S., 2003, HDB ORGANIC INORGANI, V1
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Pighinelli L, 2013, CARBOHYD POLYM, V93, P256, DOI 10.1016/j.carbpol.2012.06.004
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Prabakaran K, 2005, B MATER SCI, V28, P115, DOI 10.1007/BF02704229
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Salernitano E, 2003, J Appl Biomater Biomech, V1, P3
   Salinas AJ, 2001, J SOL-GEL SCI TECHN, V21, P13, DOI 10.1023/A:1011249330581
   Samal S.S., 2008, J MINER MAT CHARACT, V7, P355
   Sasikumar S., 2006, TRENDS BIOMATER ARTI, V19, P70
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Shogren RL, 1999, ACS S SERIES, V723
   Sprio S, 2009, J MECH BEHAV BIOMED, V2, P147, DOI 10.1016/j.jmbbm.2008.05.006
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tilekar Ganesh, 2011, Frontiers of Chemical Science and Engineering, V5, P477, DOI 10.1007/s11705-011-1107-y
   Udduttula A, 2013, T INDIAN CERAM SOC, V72, P257, DOI 10.1080/0371750X.2013.867641
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   van Wyk JPH, 2001, TRENDS BIOTECHNOL, V19, P172, DOI 10.1016/S0167-7799(01)01601-8
   Verma N, 2012, POL J ENVIRON STUD, V21, P491
   Wu C, 2007, J BIOMED MATER RES B, V83B, P153, DOI 10.1002/jbm.b.30779
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
   Yunos DM, 2008, J MATER SCI, V43, P4433, DOI 10.1007/s10853-008-2552-y
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhao YK, 2009, J SOL-GEL SCI TECHN, V52, P69, DOI 10.1007/s10971-009-2006-2
   Zhong HB, 2011, CERAM INT, V37, P2459, DOI 10.1016/j.ceramint.2011.03.037
NR 66
TC 7
Z9 7
U1 2
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JUN
PY 2015
VL 74
IS 3
BP 631
EP 640
DI 10.1007/s10971-015-3642-3
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA CH9UN
UT WOS:000354382000007
DA 2018-10-20
ER

PT J
AU Tzur-Balter, A
   Shtenberg, G
   Segal, E
AF Tzur-Balter, Adi
   Shtenberg, Giorgi
   Segal, Ester
TI Porous silicon for cancer therapy: from fundamental research to the
   clinic
SO REVIEWS IN CHEMICAL ENGINEERING
LA English
DT Review
DE cancer; drug delivery; porous silicon
ID MULTISTAGE DELIVERY-SYSTEM; MESOPOROUS SILICON; DRUG-DELIVERY;
   PHOTODYNAMIC THERAPY; BREAST-CANCER; TUMORITROPIC ACCUMULATION;
   GEOMETRICAL CONFINEMENT; BIOMEDICAL APPLICATIONS; CELLULAR-ASSOCIATION;
   PHOTONIC CRYSTALS
AB Porous silicon (PSi) has emerged over the past decade as a promising biomaterial for nanomedicine in general and cancer nanomedicine in particular. PSi offers a unique combination of properties, including large surface area and porous volume, biocompatibility, degradability in vivo into non-toxic silicic acid species, as well as its wealth of intrinsic optical properties (e.g., luminescence, photonic). This arsenal of properties together with the ability to tailor the PSi nanostructure and surface characteristics have led to an immense research effort directed at the development of PSi-based platforms for biomedical applications. After a brief introduction of the biology of cancer and currently practiced therapies, we provide an updated review of the progress of PSi-based platforms for cancer therapy and imaging.
C1 [Shtenberg, Giorgi; Segal, Ester] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.
   [Segal, Ester] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.
   [Tzur-Balter, Adi] Technion Israel Inst Technol, Interdept Program Biotechnol, IL-32000 Haifa, Israel.
RP Segal, E (reprint author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.
EM esegal@tx.technion.ac.il
OI Segal, Ester/0000-0001-9472-754X
FU Russell Berrie Nanotechnology Institute (RBNI); Lorry I. Lokey
   Interdisciplinary Center for Life Sciences and Engineering (LSE)
FX This work is partially supported by the Russell Berrie Nanotechnology
   Institute (RBNI) and the Lorry I. Lokey Interdisciplinary Center for
   Life Sciences and Engineering (LS&E). ATB gratefully acknowledges the
   RBNI Scholarship for Outstanding Graduate Students.
CR Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Baldo BA, 2013, CANCER METAST REV, V32, P723, DOI 10.1007/s10555-013-9447-3
   Bayliss SC, 1997, J MATER SCI LETT, V16, P737, DOI 10.1023/A:1018581014416
   Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009
   Bimbo LM, 2011, BIOMATERIALS, V32, P2625, DOI 10.1016/j.biomaterials.2010.12.011
   Bimbo LM, 2010, ACS NANO, V4, P3023, DOI 10.1021/nn901657w
   Bonanno LM, 2011, NANOMEDICINE-UK, V6, P1755, DOI [10.2217/NNM.11.153, 10.2217/nnm.11.153]
   BOUCHER Y, 1990, CANCER RES, V50, P4478
   Bracci L, 2014, CELL DEATH DIFFER, V21, P15, DOI 10.1038/cdd.2013.67
   Canham L., 1997, PROPERTIES POROUS SI
   Canham L., 2014, HDB POROUS SILICON
   Canham LT, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/18/185704
   Canham L, 2013, NANOMEDICINE-UK, V8, P1573, DOI [10.2217/NNM.13.134, 10.2217/nnm.13.134]
   Canham LT, 1996, ADV MATER, V8, P850, DOI 10.1002/adma.19960081020
   Canham LT, 1996, ADV MATER, V8, P847, DOI 10.1002/adma.19960081019
   Canham LT, 1997, THIN SOLID FILMS, V297, P304, DOI 10.1016/S0040-6090(96)09534-X
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Chiappini C, 2010, CHEMPHYSCHEM, V11, P1029, DOI 10.1002/cphc.200900914
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001
   Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014
   Doherty GJ, 2009, PALO ALTO ANN REV
   Ferlay JS, 2012, GLOBOCAN 2012 CANC I
   Ferrari M, 2010, NAT REV CLIN ONCOL, V7, P485, DOI 10.1038/nrclinonc.2010.131
   Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6
   Gizzatov A, 2014, CANCER LETT, V352, P97, DOI 10.1016/j.canlet.2014.06.001
   Glatstein E, 2008, J CLIN ONCOL, V26, P2438, DOI 10.1200/JCO.2008.17.1843
   Godin B, 2012, ADV FUNCT MATER, V22, P4225, DOI 10.1002/adfm.201200869
   Godin B, 2011, ACCOUNTS CHEM RES, V44, P979, DOI 10.1021/ar200077p
   Godin B, 2010, J BIOMED MATER RES A, V94A, P1236, DOI 10.1002/jbm.a.32807
   Goh ASW, 2007, INT J RADIAT ONCOL, V67, P786, DOI 10.1016/j.ijrobp.2006.09.011
   Gorustovich AA, 2007, J BIOMATER APPL, V21, P431, DOI 10.1177/0885328206068061
   Gu L, 2012, ADV MATER, V24, P4025
   Gu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3326
   Gu L, 2010, SMALL, V6, P2546, DOI 10.1002/smll.201000841
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177
   Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2
   Hong C, 2011, ANTI-CANCER DRUG, V22, P971, DOI 10.1097/CAD.0b013e32834b859c
   Hong C, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-321
   Hua MY, 2010, BIOMATERIALS, V31, P7355, DOI 10.1016/j.biomaterials.2010.05.061
   Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003
   Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102
   JAIN RK, 1988, CANCER RES, V48, P2641
   Jane A, 2009, TRENDS BIOTECHNOL, V27, P230, DOI 10.1016/j.tibtech.2008.12.004
   Juarranz A, 2008, CLIN TRANSL ONCOL, V10, P148, DOI 10.1007/s12094-008-0172-2
   Kallinen AM, 2014, MOL PHARMACEUT, V11, P2876, DOI 10.1021/mp500225b
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kilian KA, 2009, CHEM COMMUN, P630, DOI 10.1039/b815449j
   Kinnari PJ, 2013, BIOMATERIALS, V34, P9134, DOI 10.1016/j.biomaterials.2013.08.034
   Kinsella JM, 2011, ADV MATER, V23, pH248, DOI 10.1002/adma.201101877
   Koukourakis G, 2009, ADV UROL, V2009
   Kovalainen M, 2013, MOL PHARMACEUT, V10, P353, DOI 10.1021/mp300494p
   Kumar R, 2014, ANTI-CANCER AGENT ME, V14, P713, DOI 10.2174/18715206113136660364
   Lee C, 2008, J MATER CHEM, V18, P4790, DOI 10.1039/b808500e
   Lee C, 2007, J MATER CHEM, V17, P2648, DOI 10.1039/b700892a
   Lee C, 2010, PHOTOCHEM PHOTOBIOL, V86, P981, DOI 10.1111/j.1751-1097.2010.00731.x
   Levin WP, 2005, BRIT J CANCER, V93, P849, DOI 10.1038/sj.bjc.6602754
   Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041
   Li X, 2000, BIOMED MICRODEVICES, V2, P265, DOI 10.1023/A:1009951121205
   Li YY, 2003, SCIENCE, V299, P2045, DOI 10.1126/science.1081298
   Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147
   Liu DF, 2013, ADV FUNCT MATER, V23, P1893, DOI 10.1002/adfm.201202491
   Loo C, 2004, TECHNOL CANCER RES T, V3, P33, DOI 10.1177/153303460400300104
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328
   Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1
   Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010
   Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004
   Mann AP, 2011, ONCOTARGET, V2, P298
   Martinez JO, 2013, BIOMATERIALS, V34, P8469, DOI 10.1016/j.biomaterials.2013.07.049
   Martinez JO, 2013, SMALL, V9, P1722, DOI 10.1002/smll.201201939
   Massad-Ivanir N, 2012, ADV EXP MED BIOL, V733, P37, DOI 10.1007/978-94-007-2555-3_4
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Nieto A, 2013, EXP EYE RES, V116, P161, DOI 10.1016/j.exer.2013.09.001
   Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003
   Park JS, 2011, SMALL, V7, P2061, DOI 10.1002/smll.201100438
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212
   Perelman LA, 2008, NANOMEDICINE-UK, V3, P31, DOI 10.2217/17435889.3.1.31
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897
   Russo L, 2011, MATERIALS, V4, P1023, DOI 10.3390/ma4061023
   Salonen J, 2008, CHEM ENG J, V137, P162, DOI 10.1016/j.cej.2007.09.001
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   Santos HA., 2014, POROUS SILICON BIOME
   Sarparanta M, 2012, MOL PHARMACEUT, V9, P654, DOI 10.1021/mp200611d
   Sarparanta MP, 2012, BIOMATERIALS, V33, P3353, DOI 10.1016/j.biomaterials.2012.01.029
   Schott AF, 2012, J CLIN ONCOL, V30, P1747, DOI 10.1200/JCO.2011.41.3161
   Secret E, 2014, ADV MATER, V26, P7643, DOI 10.1002/adma.201403415
   Secret E, 2013, ADV HEALTHC MATER, V2, P718, DOI 10.1002/adhm.201200335
   Secret E, 2013, CHEM COMMUN, V49, P4202, DOI 10.1039/c3cc38837a
   Segal E, 2007, ADV FUNCT MATER, V17, P1153, DOI 10.1002/adfm.200601077
   Serda RE, 2010, SMALL, V6, P2691, DOI 10.1002/smll.201000727
   Serda RE, 2010, SMALL, V6, P1329, DOI 10.1002/smll.201000126
   Shahbazi MA, 2013, BIOMATERIALS, V34, P7776, DOI 10.1016/j.biomaterials.2013.06.052
   Shen HF, 2013, CLIN CANCER RES, V19, P1806, DOI 10.1158/1078-0432.CCR-12-2764
   Shen HF, 2012, ADV HEALTHC MATER, V1, P84, DOI 10.1002/adhm.201100005
   Shen JL, 2014, THERANOSTICS, V4, P487, DOI 10.7150/thno.8263
   Shen JL, 2013, ACS NANO, V7, P9867, DOI 10.1021/nn4035316
   Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007
   Sun W, 2007, PHYS STATUS SOLIDI A, V204, P1429, DOI 10.1002/pssa.200674377
   Sun W, 2007, ADV MATER, V19, P921, DOI 10.1002/adma.200600319
   Tamarov KP, 2014, SCI REP-UK, V4, DOI 10.1038/srep07034
   Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931
   Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34
   Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324
   Tolli MA, 2014, BIOMATERIALS, V35, P8394, DOI 10.1016/j.biomaterials.2014.05.078
   Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4
   Tzur-Balter A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7208
   Tzur-Balter A, 2013, ACTA BIOMATER, V9, P6208, DOI 10.1016/j.actbio.2012.12.010
   van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021
   VAUPEL P, 1989, CANCER RES, V49, P6449
   Veiseh O, 2011, BIOMATERIALS, V32, P5717, DOI 10.1016/j.biomaterials.2011.04.039
   Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544
   Wu EC, 2011, BIOMATERIALS, V32, P1957, DOI 10.1016/j.biomaterials.2010.11.013
   Xiao L, 2011, ACS NANO, V5, P3651, DOI 10.1021/nn1035262
   Xu R, 2013, SMALL, V9, P1799, DOI 10.1002/smll.201201510
   Yokoi K, 2013, CANCER LETT, V334, P319, DOI 10.1016/j.canlet.2012.09.001
   Zhang MZ, 2014, BIOMATERIALS, V35, P423, DOI 10.1016/j.biomaterials.2013.09.033
NR 129
TC 3
Z9 3
U1 5
U2 47
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0167-8299
EI 2191-0235
J9 REV CHEM ENG
JI Rev. Chem. Eng.
PD JUN
PY 2015
VL 31
IS 3
BP 193
EP 207
DI 10.1515/revce-2015-0001
PG 15
WC Engineering, Chemical
SC Engineering
GA CI6UJ
UT WOS:000354897900001
DA 2018-10-20
ER

PT J
AU Tallawi, M
   Zebrowski, DC
   Rai, R
   Roether, JA
   Schubert, DW
   El Fray, M
   Engel, FB
   Aifantis, KE
   Boccaccini, AR
AF Tallawi, Marwa
   Zebrowski, David C.
   Rai, Ranjana
   Roether, Judith A.
   Schubert, Dirk W.
   El Fray, Miroslawa
   Engel, Felix B.
   Aifantis, Katerina E.
   Boccaccini, Aldo R.
TI Poly(Glycerol Sebacate)/Poly(Butylene Succinate-Butylene Dilinoleate)
   Fibrous Scaffolds for Cardiac Tissue Engineering
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID MYOCARDIAL-INFARCTION; MECHANICAL-PROPERTIES; HEART-DISEASE;
   BIOMATERIALS; CARDIOMYOCYTES; REGENERATION; ELASTOMER; SYSTEM
AB The present article investigates the use of a novel electrospun fibrous blend of poly(glycerol sebacate) (PGS) and poly(butylene succinate-butylene dilinoleate) (PBS-DLA) as a candidate for cardiac tissue engineering. Random electrospun fibers with various PGS/PBS-DLA compositions (70/30, 60/40, 50/50, and 0/100) were fabricated. To examine the suitability of these fiber blends for heart patches, their morphology, as well as their physical, chemical, and mechanical properties were measured before examining their biocompatibility through cell adhesion. The fabricated fibers were bead-free and exhibited a relatively narrow diameter distribution. The addition of PBS-DLA to PGS resulted in an increase of the average fiber diameter, whereas increasing the amount of PBS-DLA decreased the hydrophilicity and the water uptake of the nanofibrous scaffolds to values that approached those of neat PBS-DLA nanofibers. Moreover, the addition of PBS-DLA significantly increased the elastic modulus. Initial toxicity studies with C2C12 myoblast cells up to 72 h confirmed nontoxic behavior of the blends. Immunofluorescence analyses and scanning electron microscopy analyses confirmed that C2C12 cells showed better cell attachment and proliferation on electrospun mats with higher PBS-DLA content. However, immunofluorescence analyses of the 3-day-old rat cardiomyocytes cultured for 2 and 5 days demonstrated better attachment on the 70/30 fibers containing well-aligned sarcomeres and expressing high amounts of connexin 43 in cellular junctions indicating efficient cell-to-cell communication. It can be concluded, therefore, that fibrous PGS/PBS-DLA scaffolds exhibit promising characteristics as a biomaterial for cardiac patch applications.
C1 [Tallawi, Marwa; Rai, Ranjana; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91054 Erlangen, Germany.
   [Zebrowski, David C.; Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Expt Renal & Cardiovasc Res, D-91054 Erlangen, Germany.
   [Roether, Judith A.; Schubert, Dirk W.] Univ Erlangen Nurnberg, Inst Polymer Mat, Dept Mat Sci & Engn, D-91054 Erlangen, Germany.
   [El Fray, Miroslawa] West Pomeranian Univ Technol, Inst Polymer, Div Biomat & Microbiol Technol, Szczecin, Poland.
   [Aifantis, Katerina E.] Aristotle Univ Thessaloniki, Sch Engn, Lab Mech & Mat, GR-54006 Thessaloniki, Greece.
   [Aifantis, Katerina E.] Univ Arizona, Dept Civil Engn Engn Mech, Tucson, AZ USA.
RP Engel, FB (reprint author), Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Expt Renal & Cardiovasc Res, Schwabachanlage 12 TRC, D-91054 Erlangen, Germany.
EM felix.engel@uk-erlangen.de; aldo.boccaccini@ww.uni-erlangen.de
RI El Fray, Miroslawa/J-4128-2016; Engel, Felix/A-1767-2008; Boccaccini,
   Aldo/C-7905-2013
OI Engel, Felix/0000-0003-2605-3429; El Fray, Miroslawa/0000-0002-2474-3517
FU ERC [MINATRAN 211166]; ELAN-Programm Grant by the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg
FX The authors acknowledge partial financial support from the ERC Starting
   Grant MINATRAN 211166. Aga Kozlowska is acknowledged for experimental
   assistance, Alina Grunewald for her technical support and Prof. Ben
   Fabry for providing access to his laboratory. This work was also
   supported by an ELAN-Programm Grant by the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg (to F.B.E.).
CR Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Boccaccini A. R., 2011, MYOCARDIAL TISSUE EN
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49
   Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294
   Gibson C. C., 2009, BIOL INTERACTIONS MA
   Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367
   Jager A, 2012, SOFT MATTER, V8, P4343, DOI 10.1039/c2sm07247e
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Liu GY, 1996, J BIOL CHEM, V271, P25338, DOI 10.1074/jbc.271.41.25338
   MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V664, P349, DOI 10.1016/0005-2760(81)90057-6
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rickne A, 2009, SWEDISH POSSIBILITIE
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Supaphol P, 2008, J APPL POLYM SCI, V108, P969, DOI 10.1002/app.27664
   Tallawi M, 2013, MACROMOL SYMP, V334, P57, DOI 10.1002/masy.201300114
   van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Zdebiak P, 2008, FIBRES TEXT EAST EUR, V16, P77
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 32
TC 14
Z9 14
U1 1
U2 47
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN 1
PY 2015
VL 21
IS 6
BP 585
EP 596
DI 10.1089/ten.tec.2014.0445
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CI6LF
UT WOS:000354870000008
PM 25439964
OA Green Published
DA 2018-10-20
ER

PT J
AU Muhamed, J
   Revi, D
   Rajan, A
   Geetha, S
   Anilkumar, TV
AF Muhamed, Jaseer
   Revi, Deepa
   Rajan, Akhila
   Geetha, Surendran
   Anilkumar, Thapasimuthu V.
TI Biocompatibility and Immunophenotypic Characterization of a Porcine
   Cholecyst-derived Scaffold Implanted in Rats
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE safety assessment; biocompatibility; xenograft; cholecyst-derived
   scaffold; immunohistochemistry; medical devices; animal model
ID EXTRACELLULAR-MATRIX; MACROPHAGE PHENOTYPE; IMMUNE-RESPONSE; REJECTION;
   PATHOLOGY; SYSTEM
AB Comparative histomorphological assessment of local response to implanted reference biomaterial, also called biocompatibility testing/evaluation, in an appropriate animal model is a widely practiced safety evaluation procedure performed on biomaterials before clinical use. Standardized protocols and procedures, originally designed for testing synthetic materials, available for the testing/evaluation do not account for the immunogenic potential of a candidate biomaterial. Therefore, it is appropriate to supplement the routine biocompatibility test reports with adjunct data that may provide insight into the immunogenic potential of candidate biomaterials, especially when testing biomaterials that are derived from mammalian sources. This article presents expanded safety evaluation data of a porcine cholecyst-derived scaffold (CDS) intended as a xenogeneic graft. The biocompatibility was tested in rat subcutaneous model in comparison with a reference material and the CDS was found biocompatible. However, when studied by immunohistochemistry and real-time reverse transcription polymerase chain reaction for the number and/or polarization of M1 macrophage, M2 macrophage, cytotoxic T-cell, helper T cell, TH1 cell, and TH2 cell, the CDS appeared to induce a differential local immunopathological tissue reaction despite the similarity in biocompatibility with the reference material. The adjunct data collected were useful for objectively assessing the safety of CDS as a xenograft.
C1 [Muhamed, Jaseer; Revi, Deepa; Rajan, Akhila; Geetha, Surendran; Anilkumar, Thapasimuthu V.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Expt Pathol, Trivandrum 695012, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Satelmond Palace Campus, Trivandrum 695012, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Rajan, Akhila/0000-0002-9624-4696; Muhamed, Jaseer/0000-0001-5046-9438
FU Department of Biotechnology, Government of India
   [BT/PR15461/MED/32/167/2011]
FX The authors thank the Department of Biotechnology, Government of India
   for financial support (BT/PR15461/MED/32/167/2011).
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   [Anonymous], 2010, F2210 ASTM INT
   [Anonymous], 2006, 1099320 ISOTS
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burugapalli K, 2008, OBES SURG, V18, P1418, DOI 10.1007/s11695-008-9518-7
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P928, DOI 10.1021/bm061088x
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236
   Elmore SA, 2012, TOXICOL PATHOL, V40, P148, DOI 10.1177/0192623311427571
   Ettlin RA, 2013, TOXICOL PATHOL, V41, P689, DOI 10.1177/0192623312466192
   Fishman JA, 2012, XENOTRANSPLANTATION, V19, P72, DOI 10.1111/j.1399-3089.2012.00693.x
   Haley P, 2005, TOXICOL PATHOL, V33, P404, DOI 10.1080/01926230590934304
   Hautz T, 2010, AM J TRANSPLANT, V10, P1200, DOI 10.1111/j.1600-6143.2010.03075.x
   Hautz T, 2012, TRANSPL INT, V25, P56, DOI 10.1111/j.1432-2277.2011.01369.x
   Ho KLV, 2004, J UROLOGY, V171, P268, DOI 10.1097/01.ju.0000098680.60020.32
   International Organization for Standardization(ISO), 2007, 109936 ISO
   John TT, 2008, UROLOGY, V72, P1036, DOI 10.1016/j.urology.2008.07.043
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kalota SJ, 2004, J UROLOGY, V172, P1349, DOI 10.1097/01.ju.0000137867.04413.38
   Li RD, 2013, CLIN TRANSPLANT, V27, P666, DOI 10.1111/ctr.12187
   Maronpot RR, 2012, TOXICOL PATHOL, V40, P1082, DOI 10.1177/0192623312446528
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Muhamed J, 2013, TOXICOL PATHOL, V41, P497, DOI 10.1177/0192623312460922
   Petter-Puchner A, 2007, SURG ENDOSC, V21, P830, DOI 10.1007/s00464-006-9158-8
   Revi D., 2013, J TISSUE ENG, V4
   Schuh JCL, 2008, TOXICOL PATHOL, V36, P63, DOI 10.1177/0192623307309926
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Umashankar P R, 2012, Toxicol Int, V19, P51, DOI 10.4103/0971-6580.94513
   Vivo, 2011, 34NF29 USP, P83
   Wang CL, 2009, INT UROGYNECOL J, V20, P1149, DOI 10.1007/s00192-009-0845-6
NR 37
TC 9
Z9 9
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD JUN
PY 2015
VL 43
IS 4
BP 536
EP 545
DI 10.1177/0192623314550722
PG 10
WC Pathology; Toxicology
SC Pathology; Toxicology
GA CI5YJ
UT WOS:000354835400009
PM 25318959
OA Bronze
DA 2018-10-20
ER

PT J
AU Shinonaga, T
   Tsukamoto, M
   Kawa, T
   Chen, P
   Nagai, A
   Hanawa, T
AF Shinonaga, T.
   Tsukamoto, M.
   Kawa, T.
   Chen, P.
   Nagai, A.
   Hanawa, T.
TI Formation of periodic nanostructures using a femtosecond laser to
   control cell spreading on titanium
SO APPLIED PHYSICS B-LASERS AND OPTICS
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Photo-Excited Processes and Applications
   (ICPEPA)
CY SEP 29-OCT 02, 2014
CL Matsue, JAPAN
ID SURFACES; PROLIFERATION; POLYSTYRENE; MORPHOLOGY; ALIGNMENT; ABLATION;
   ADHESION; BEHAVIOR; PLATE
AB Although titanium (Ti) is a common biomaterial, controlling cell spreading by forming periodic structures using a femtosecond laser should improve its biocompatibility. Herein we investigate the influence of periodic nanostructures formed on the surface of a Ti plate on cell spreading. Nanostructures with a periodicity of 590 nm are formed using a femtosecond laser with a wavelength of 775 nm. Cell spreading on the plate without period structures lacks a definite direction, whereas cell spreading on the Ti plate with periodic structures occurs along the grooves, suggesting that forming periodic structures via a femtosecond laser can control cell spreading.
C1 [Shinonaga, T.; Tsukamoto, M.] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.
   [Kawa, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan.
   [Chen, P.; Nagai, A.; Hanawa, T.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Shinonaga, T (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Osaka 5670047, Japan.
EM togo@jwri.osaka-u.ac.jp
CR Das SK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117509
   Dufft D, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074106
   Dumas V, 2012, J BIOMED MATER RES A, V100A, P3108, DOI 10.1002/jbm.a.34239
   Fujita S, 2008, BIOMATERIALS, V29, P4494, DOI 10.1016/j.biomaterials.2008.08.027
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Hanawa T, 2010, JPN DENT SCI REV, V46, P93, DOI 10.1016/j.jdsr.2009.11.001
   Hashida M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803940
   Huang PJ, 1997, THERMOCHIM ACTA, V297, P85, DOI 10.1016/S0040-6031(97)00168-8
   Jia TQ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125429
   Landis EC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752276
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Miyaji G, 2008, OPT EXPRESS, V16, P16265, DOI 10.1364/OE.16.016265
   Miyaji G, 2012, OPT EXPRESS, V20, P14848, DOI 10.1364/OE.20.014848
   Miyazaki K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4826078
   Okamuro K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165417
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Reif J, 2002, APPL SURF SCI, V197, P891, DOI 10.1016/S0169-4332(02)00450-6
   Sakabe S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033409
   Shimizu Y, 2003, PHYS REV LETT, V91, DOI [10.1103/PhysRevLett.91.107001, 10.1103/PhysRevLett.91.247405]
   Shinonaga T, 2014, OPT EXPRESS, V22, P14696, DOI 10.1364/OE.22.014696
   Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090
   Tsukamoto M, 2007, J PHYS CONF SER, V59, P666, DOI 10.1088/1742-6596/59/1/140
   Tsukamoto M, 2014, PROC SPIE, V8969, DOI 10.1117/12.2040957
   Tsukamoto M, 2006, VACUUM, V80, P1346, DOI 10.1016/j.vacuum.2006.01.016
   Wang XF, 2006, J BIOMED MATER RES A, V78A, P746, DOI 10.1002/jbm.a.30764
NR 28
TC 16
Z9 16
U1 4
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2171
EI 1432-0649
J9 APPL PHYS B-LASERS O
JI Appl. Phys. B-Lasers Opt.
PD JUN
PY 2015
VL 119
IS 3
SI SI
BP 493
EP 496
DI 10.1007/s00340-015-6082-4
PG 4
WC Optics; Physics, Applied
SC Optics; Physics
GA CI2ZV
UT WOS:000354618000014
DA 2018-10-20
ER

PT J
AU Jacob, RS
   Ghosh, D
   Singh, PK
   Basu, SK
   Jha, NN
   Das, S
   Sukul, PK
   Patil, S
   Sathaye, S
   Kumar, A
   Chowdhury, A
   Malik, S
   Sen, S
   Maji, SK
AF Jacob, Reeba S.
   Ghosh, Dhiman
   Singh, Pradeep K.
   Basu, Santanu K.
   Jha, Narendra Nath
   Das, Subhadeep
   Sukul, Pradip K.
   Patil, Sachin
   Sathaye, Sadhana
   Kumar, Ashutosh
   Chowdhury, Arindam
   Malik, Sudip
   Sen, Shamik
   Maji, Samir K.
TI Self healing hydrogels composed of amyloid nano fibrils for cell culture
   and stem cell differentiation
SO BIOMATERIALS
LA English
DT Article
DE Amyloid hydrogel; Nanofibrils; Self-assembly; Stem cell; Tissue
   engineering
ID ASSEMBLED PEPTIDE NANOTUBES; BETA-PROTEIN; ALZHEIMERS-DISEASE;
   FMOC-DIPHENYLALANINE; ALPHA-SYNUCLEIN; BIOSENSOR APPLICATIONS; NANOFIBER
   SCAFFOLD; DESIGN; TISSUE; AGGREGATION
AB Amyloids are highly ordered protein/peptide aggregates associated with human diseases as well as various native biological functions. Given the diverse range of physiochemical properties of amyloids, we hypothesized that higher order amyloid self-assembly could be used for fabricating novel hydrogels for biomaterial applications. For proof of concept, we designed a series of peptides based on the high aggregation prone C-terminus of A beta 42, which is associated with Alzheimer's disease. These Fmoc protected peptides self assemble to beta sheet rich nanofibrils, forming hydrogels that are thermoreversible, non-toxic and thixotropic. Mechanistic studies indicate that while hydrophobic, pi-pi interactions and hydrogen bonding drive amyloid network formation to form supramolecular gel structure, the exposed hydrophobic surface of amyloid fibrils may render thixotropicity to these gels. We have demonstrated the utility of these hydrogels in supporting cell attachment and spreading across a diverse range of cell types. Finally, by tuning the stiffness of these gels through modulation of peptide concentration and salt concentration these hydrogels could be used as scaffolds that can drive differentiation of mesenchymal stem cells. Taken together, our results indicate that small size, ease of custom synthesis, thixotropic nature makes these amyloid-based hydrogels ideally suited for biomaterial/nanotechnology applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Jacob, Reeba S.; Ghosh, Dhiman; Singh, Pradeep K.; Basu, Santanu K.; Jha, Narendra Nath; Das, Subhadeep; Kumar, Ashutosh; Sen, Shamik; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Sukul, Pradip K.; Malik, Sudip] Indian Assoc Cultivat Sci, Polymer Sci Unit, Kolkata 700032, India.
   [Patil, Sachin; Sathaye, Sadhana] Inst Chem Technol, Bombay 400031, Maharashtra, India.
   [Chowdhury, Arindam] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.
   [Das, Subhadeep] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India.
RP Maji, SK (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
EM samirmaji@iitb.ac.in
RI Malik, Sudip/B-3340-2008; Das, Subhadeep/J-4038-2016
OI Malik, Sudip/0000-0001-5358-5653; Sen, Shamik/0000-0002-8639-8659; Das,
   Subhadeep/0000-0003-1870-8456
FU IRCC (IIT Bombay); CSIR [37(1404)/10/EMR-II]; DST, Government of India
   [SR/FT/LS-032/2009]; UGC (Govt. of India)
FX Authors wish to acknowledge IRCC (IIT Bombay), CSIR (37(1404)/10/EMR-II)
   and DST (SR/FT/LS-032/2009), Government of India for financial support
   and cell biology lab (BSBE, IIT Bombay) for fluorescence imaging,
   CRNTS/IRCC central facilities for FEG SEM, FTIR, AFM and TIFR Mumbai for
   NMR facility. R.S.J and D.G acknowledge UGC (Govt. of India) for their
   fellowship, Srivastav Ranganathan and Saikat Ghosh for schematics and
   Dr. Shimul Salot and Roshni Ramachandran for giving critical comments
   during manuscript preparation. Authors also acknowledge Prof. D. Teplow,
   UCLA, Prof. R. Riek, ETH Zurich, Prof Rein Ulijn, University of
   Strathclyde Glasgow for their valuable suggestions.
CR Adams DJ, 2010, SOFT MATTER, V6, P1971, DOI 10.1039/b921863g
   Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bhak G, 2010, BIOMATERIALS, V31, P5986, DOI 10.1016/j.biomaterials.2010.03.080
   Bolisetty S, 2012, BIOMACROMOLECULES, V13, P3241, DOI 10.1021/bm301005w
   Bolisetty S, 2012, ADV FUNCT MATER, V22, P3424, DOI 10.1002/adfm.201103054
   Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203
   Bongiovanni MN, 2011, BIOMATERIALS, V32, P6099, DOI 10.1016/j.biomaterials.2011.05.021
   Carrotta R, 2005, J BIOL CHEM, V280, P30001, DOI 10.1074/jbc.M500052200
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fast JL, 2009, BIOCHEMISTRY-US, V48, P11724, DOI 10.1021/bi900853v
   Fichman G, 2014, ACTA BIOMATER, V10, P1671, DOI 10.1016/j.actbio.2013.08.013
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fukuhara S, 2012, BIOCHEMISTRY-US, V51, P5394, DOI 10.1021/bi3004236
   Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Gras SL, 2009, ADV CHEM ENG, V35, P161, DOI 10.1016/S0065-2377(08)00206-8
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hamedi M, 2008, NANO LETT, V8, P1736, DOI 10.1021/nl0808233
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Herland A, 2005, ADV MATER, V17, P1466, DOI 10.1002/adma.200500183
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001
   Klunk WE, 1999, METHOD ENZYMOL, V309, P285
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   Li CX, 2014, ADV MATER, V26, P3207, DOI 10.1002/adma.201306198
   Li CX, 2013, ADV MATER, V25, P1010, DOI 10.1002/adma.201203382
   Li CX, 2012, NAT NANOTECHNOL, V7, P421, DOI [10.1038/NNANO.2012.62, 10.1038/nnano.2012.62]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Mankar S., 2011, NANO REV, V2
   Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Owczarz M, 2015, J COLLOID INTERF SCI, V437, P244, DOI 10.1016/j.jcis.2014.09.022
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Pek YS, 2008, NAT NANOTECHNOL, V3, P671, DOI 10.1038/nnano.2008.270
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Raeburn J, 2015, SOFT MATTER, V11, P927, DOI 10.1039/c4sm02256d
   Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139
   Reynolds NP, 2014, BIOMACROMOLECULES, V15, P599, DOI 10.1021/bm401646x
   Reynolds NP, 2013, BIOMACROMOLECULES, V14, P2305, DOI 10.1021/bm400430t
   Ryan DM, 2012, POLYM CHEM-UK, V3, P18, DOI 10.1039/c1py00335f
   Sasso L, 2014, NANOSCALE, V6, P1629, DOI 10.1039/c3nr05752f
   Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105
   Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203
   Singh PK, 2012, CELL BIOCHEM BIOPHYS, V64, P29, DOI 10.1007/s12013-012-9364-z
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Stupp SI, 2013, FARADAY DISCUSS, V166, P9, DOI 10.1039/c3fd00120b
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tang C, 2011, LANGMUIR, V27, P14438, DOI 10.1021/la202113j
   Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869
   Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075727
   Westermark GT, 1999, METHOD ENZYMOL, V309, P3
   WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170
   Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108
   Yan H, 2008, FARADAY DISCUSS, V139, P71, DOI 10.1039/b717748h
   Yemini M, 2005, ANAL CHEM, V77, P5155, DOI 10.1021/ac050414g
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 83
TC 46
Z9 47
U1 16
U2 290
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 54
BP 97
EP 105
DI 10.1016/j.biomaterials.2015.03.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI2QD
UT WOS:000354591200010
PM 25907043
DA 2018-10-20
ER

PT J
AU Parmar, PA
   Chow, LW
   St-Pierre, JP
   Horejs, CM
   Peng, YY
   Werkmeister, JA
   Ramshaw, JAM
   Stevens, MM
AF Parmar, Paresh A.
   Chow, Lesley W.
   St-Pierre, Jean-Philippe
   Horejs, Christine-Maria
   Peng, Yong Y.
   Werkmeister, Jerome A.
   Ramshaw, John A. M.
   Stevens, Molly M.
TI Collagen-mimetic peptide-modifiable hydrogels for articular cartilage
   regeneration
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Mesenchymal stem cell; Biodegradation; Bioactivity; Biomimetic
   material; Cartilage tissue engineering
ID MATRIX METALLOPROTEINASE-7 MATRILYSIN; TISSUE ENGINEERING APPLICATIONS;
   STREPTOCOCCUS-PYOGENES; ENCAPSULATING CHONDROCYTES; POLY(ETHYLENE
   GLYCOL); CELL ENCAPSULATION; PEG HYDROGELS; PROTEIN; BIOMATERIALS;
   DEGRADATION
AB Regenerative medicine strategies for restoring articular cartilage face significant challenges to recreate the complex and dynamic biochemical and biomechanical functions of native tissues. As an approach to recapitulate the complexity of the extracellular matrix, collagen-mimetic proteins offer a modular template to incorporate bioactive and biodegradable moieties into a single construct. We modified a Streptococcal collagen-like 2 protein with hyaluronic acid (HA) or chondroitin sulfate (CS)-binding peptides and then cross-linked with a matrix metalloproteinase 7 (MMP7)-sensitive peptide to form biodegradable hydrogels. Human mesenchymal stem cells (hMSCs) encapsulated in these hydrogels exhibited improved viability and significantly enhanced chondrogenic differentiation compared to controls that were not functionalized with glycosaminoglycan-binding peptides. Hydrogels functionalized with CS-binding peptides also led to significantly higher MMP7 gene expression and activity while the HA-binding peptides significantly increased chondrogenic differentiation of the hMSCs. Our results highlight the potential of this novel biomaterial to modulate cell-mediated processes and create functional tissue engineered constructs for regenerative medicine applications. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Parmar, Paresh A.; Chow, Lesley W.; St-Pierre, Jean-Philippe; Horejs, Christine-Maria; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Parmar, Paresh A.; Chow, Lesley W.; St-Pierre, Jean-Philippe; Horejs, Christine-Maria; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England.
   [Parmar, Paresh A.; Chow, Lesley W.; St-Pierre, Jean-Philippe; Horejs, Christine-Maria; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
   [Parmar, Paresh A.; Peng, Yong Y.; Werkmeister, Jerome A.; Ramshaw, John A. M.] CSIRO Mfg Flagship, Clayton, Vic 3169, Australia.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Exhibit Rd, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
OI Horejs, Christine-Maria/0000-0002-8614-7737
FU Australian Commonwealth Scientific and Industrial Research Organisation
   (CSIRO) in the Manufacturing Flagship; Medical Engineering Solutions in
   Osteoarthritis Centre of Excellence - Wellcome Trust [088844]; UK
   Regenerative Medicine Platform Hub "Acellular Approaches for Therapeutic
   Delivery" - Medical Research Council [MR/K026682/1]; Engineering and
   Physical Sciences Research Council; Biotechnology and Biological
   Sciences Research Council; ERC; Wellcome Trust Senior Investigator Award
   [098411/Z/12/Z]; Medical Research Council [MR/K026682/1]
FX Our work was supported and funded by the Australian Commonwealth
   Scientific and Industrial Research Organisation (CSIRO) in the
   Manufacturing Flagship and the Medical Engineering Solutions in
   Osteoarthritis Centre of Excellence funded by the Wellcome Trust
   (088844). Prof. M.M. Stevens and Dr. C.-M. Horejs are supported by the
   UK Regenerative Medicine Platform Hub "Acellular Approaches for
   Therapeutic Delivery" (MR/K026682/1), which is funded by the Medical
   Research Council, the Engineering and Physical Sciences Research Council
   and the Biotechnology and Biological Sciences Research Council. Prof. M.
   M. Stevens thanks the ERC consolidator grant "Naturale-CG" and a
   Wellcome Trust Senior Investigator Award (098411/Z/12/Z) for funding.
   The authors would also like to acknowledge the Chemistry Mass
   Spectrometry, NMR and CD Facilities, Harvey Flower Microstructural
   Characterization Suite, Dr. R. V. Law for help with NMR analysis, J. A.
   M. Steele for help with histology and immunohistochemistry, and Dr. E.
   T. Pashuck for help with the cyclic RGDS peptide synthesis.
CR Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Butterfield Karen Chao, 2011, Biomatter, V1, P174, DOI 10.4161/biom.18791
   Centers for Disease Control and Prevention (CDC), 2005, MMWR-MORBID MORTAL W, V2009, P421
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Cremer KA, 1998, J MOL MED, V76, P275
   Feng Q, 2014, PLOS ONE, V9
   Flannery AV, PROTEOLYTIC ENZYMES
   Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ii M, 2006, EXP BIOL MED, V231, P20
   IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691
   Khire VS, 2007, MACROMOLECULES, V40, P5669, DOI 10.1021/ma070146j
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEFEBVRE V, 1995, J CELL BIOL, V128, P239, DOI 10.1083/jcb.128.1.239
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Liu SQ, 2010, BIOMATERIALS, V31, P631
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   McCullen SD, 2011, CURR OPIN BIOTECH, V22, P715, DOI 10.1016/j.copbio.2011.05.001
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898
   Peng YY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-146
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   Perez CMR, 2011, MACROMOL BIOSCI, V11, P1426, DOI 10.1002/mabi.201100230
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Place ES, 2012, ADV HEALTHC MATER, V1, P480, DOI 10.1002/adhm.201200038
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984
   Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Rice MA, 2004, J BIOMED MATER RES A, V70A, P560, DOI 10.1002/jbm.a.30106
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Roberts JJ, 2014, BIOMACROMOLECULES, V15, P1132, DOI 10.1021/bm401524h
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01
   St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Wang QG, 2010, EUR CELLS MATER, V19, P86, DOI 10.22203/eCM.v019a09
   Werkmeister JA, 2012, BIOMED MATER, V7, P1
   Wilkinson JM, PRACTICAL PROTEIN CH
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Zhen EY, 2008, ARTHRITIS RHEUM, V58, P2420, DOI 10.1002/art.23654
NR 54
TC 47
Z9 49
U1 5
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 54
BP 213
EP 225
DI 10.1016/j.biomaterials.2015.02.079
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI2QD
UT WOS:000354591200021
PM 25907054
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Wang, QN
   Jin, Y
   Deng, XY
   Liu, HP
   Pang, HW
   Shi, PP
   Zhan, ZG
AF Wang, Qiannan
   Jin, Ying
   Deng, Xiaoyuan
   Liu, Hanping
   Pang, Hongwen
   Shi, Panpan
   Zhan, Zhigang
TI Second-harmonic generation microscopy for assessment of mesenchymal
   stern cell-seeded acellular dermal matrix in wound-healing
SO BIOMATERIALS
LA English
DT Article
DE Wound healing; Acellular dermal matrix (ADM); Mesenchymal stem cells
   (MSCs); Two-photon fluorescence (TPF) microscopy; Second-harmonic
   generation (SHG) microscopy
ID IN-VIVO; HUMAN SKIN; IMAGING MICROSCOPY; ANGIOGENESIS; REGENERATION;
   DIFFERENTIATION; EQUIVALENTS; TOMOGRAPHY; RESOLUTION; DELIVERY
AB Direct intra-skin injection of mesenchymal stem cells (MSCs) and the use of biomaterial scaffolds for grafts are both promising approaches of skin wound repair, however they still cannot generate skin that completely resembles the natural skin structures. In this study, we combined these two approaches by using acellular dermal matrix (ADM) recellularized with MSCs to repair cutaneous wounds in a murine model and two-photon fluorescence (TPF) microscopy and second-harmonic generation (SHG) microscopy to assess the effects of this therapy on wound healing. Bone marrow-derived mesenchymal stem cells (BM-MSCs) were tagged with GFP and seeded into ADM (ADM-MSC) via MSC and ADM co-culture. ADM-MSC, ADM or saline was applied to murine excisional skin wounds and wound-healing was evaluated by histological examination on days 7, 14, 21 and TFP microscopy on days 1, 3, 5 and 21 post-treatment. ADM-MSC promoted healing significantly more than treatment with ADM or saline alone, as it led to substantial neovascularization and complete skin appendage regeneration. Furthermore, the SHG microscopic imaging technique proved to be a useful tool for monitoring changes in the collagen network at the wound site during the healing process and assessing the effects of different therapies. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Wang, Qiannan; Jin, Ying; Deng, Xiaoyuan; Liu, Hanping; Shi, Panpan; Zhan, Zhigang] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.
   [Deng, Xiaoyuan] S China Normal Univ, Res Resources Ctr, Guangzhou, Guangdong, Peoples R China.
   [Pang, Hongwen] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
RP Jin, Y (reprint author), S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.
EM jinying@scnu.edu.cn; xydeng12@126.com
FU National Natural Science Foundation of China [81171379]; CAS [yg2012048]
FX This work was supported by the National Natural Science Foundation of
   China (No.81171379) and Instrument functional development and
   technological innovation projects of CAS (No.yg2012048).
CR ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J
   Boyd NL, 2013, TISSUE ENG PT A, V19, P211, DOI 10.1089/ten.tea.2011.0408
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Campagnola PJ, 2001, J BIOMED OPT, V6, P277, DOI 10.1117/1.1383294
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Chun JL, 2013, STEM CELL TRANSL MED, V2, P68, DOI 10.5966/sctm.2012-0107
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Cubison TCS, 2006, BURNS, V32, P992, DOI 10.1016/j.burns.2006.02.007
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Feng YP, 2014, NEURAL REGEN RES, V9, P1968, DOI 10.4103/1673-5374.145378
   FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Huang SP, 2012, ANN PLAS SURG, V69, P656, DOI 10.1097/SAP.0b013e318273f909
   Koehler MJ, 2006, OPT LETT, V31, P2879, DOI 10.1364/OL.31.002879
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349
   Ma AL, 2013, INT IMMUNOPHARMACOL, V16, P399, DOI 10.1016/j.intimp.2013.02.005
   Masters BR, 2001, OPT EXPRESS, V8, P2, DOI 10.1364/OE.8.000002
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Palero JA, 2006, OPT EXPRESS, V14, P4395, DOI 10.1364/OE.14.004395
   Portmann-Lanz CB, 2007, PLACENTA, V28, P6, DOI 10.1016/j.placenta.2006.01.004
   Rennert R. C., 2013, INT J BIOMATER, V2013
   Schneider RK, 2010, DIFFERENTIATION, V79, P182, DOI 10.1016/j.diff.2010.01.005
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schneider RKM, 2008, DIFFERENTIATION, V76, P156, DOI 10.1111/j.1432-0436.2007.00204.x
   Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108
   Vishnubalaji R, 2012, CELL TISSUE RES, V350, P1, DOI 10.1007/s00441-012-1471-z
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Zhang XJ, 2009, BIOMATERIALS, V30, P2666, DOI 10.1016/j.biomaterials.2009.01.018
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
NR 40
TC 14
Z9 14
U1 2
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 659
EP 668
DI 10.1016/j.biomaterials.2015.03.011
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800061
PM 25890761
DA 2018-10-20
ER

PT J
AU Rooney, P
   Srivastava, A
   Watson, L
   Quinlan, LR
   Pandit, A
AF Rooney, Peadar
   Srivastava, Akshay
   Watson, Luke
   Quinlan, Leo R.
   Pandit, Abhay
TI Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an
   inflammatory model of interstitial cystitis
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronan; Interstitial cystitis; Inflammation; Permeability; Cytokine
ID BLADDER SYNDROME; GLYCOSAMINOGLYCAN EXCRETION; SULFATED
   GLYCOSAMINOGLYCANS; ANTIPROLIFERATIVE FACTOR; NONBACTERIAL CYSTITIS;
   CHONDROITIN SULFATE; TIGHT JUNCTIONS; URINE MARKERS; INTERLEUKIN-6;
   DERIVATIVES
AB Hyaluronic acid (HA) has received a lot of attention recently as a biomaterial with applications in wound healing, drug delivery, vascular repair and cell and/or gene delivery. Interstitial cystitis (IC) is characterised by an increase in the permeability of the bladder wall urothelium due to loss of the glycosaminoglycan (GAG) layer. The degradation of the urothelium leads to chronic pain and urinary dysfunction. The aetiology of the degradation of the GAG layer in this instance is currently unknown. At a clinical level, GAG replacement therapy using a HA solution is currently utilised as a treatment for IC. However, there is a significant lack of data on the mechanism of action of HA in IC. The current study investigates the mechanistic effect of clinically relevant HA treatment on an in vitro model of IC using urothelial cells, examining cytokine secretion, GAG secretion and trans-epithelial permeability. This study demonstrates that HA can significantly decrease induced cytokine secretion (4-5 fold increase), increase sulphated GAG production (2-fold increase) and without altering tight junction expression, decrease trans-epithelial permeability, suggesting that the HA pathway is a clinical target and potential treatment vector. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rooney, Peadar; Srivastava, Akshay; Watson, Luke; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Quinlan, Leo R.] Natl Univ Ireland, Physiol Sch Med, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
EM Abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Rooney, Peadar/0000-0003-3119-3928;
   Quinlan, Leo/0000-0002-4011-6732
FU Enterprise Ireland [IP/2011/0096]
FX This work was funded with Enterprise Ireland Grant IP/2011/0096.
CR Akcay T., 1999, International Urology and Nephrology, V31, P431, DOI 10.1023/A:1007198708404
   Bresnihan B, 2007, ANN RHEUM DIS, V66, P1656, DOI 10.1136/ard.2006.061143
   Buffington CAT, 1996, J UROLOGY, V155, P1801, DOI 10.1016/S0022-5347(01)66201-3
   Chancellor Michael B, 2007, Rev Urol, V9, P81
   Cheng C, 2012, INT UROGYNECOL J, V23, P1361, DOI 10.1007/s00192-012-1711-5
   Erickson DR, 2008, J UROLOGY, V179, P1850, DOI 10.1016/j.juro.2008.01.047
   Erickson DR, 1997, J UROLOGY, V157, P61, DOI 10.1016/S0022-5347(01)65280-7
   Erickson DR, 1998, J UROLOGY, V160, P1282, DOI 10.1016/S0022-5347(01)62516-3
   Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7
   Fasano A, 2000, ANN NY ACAD SCI, V915, P214
   Frank J, 2003, EUR J TRAUMA, V29, P208
   Garcia Y, 2007, BIOMATERIALS, V28, P175, DOI 10.1016/j.biomaterials.2006.08.037
   Ghazi K., 2012, PLOS ONE, V7, P48351
   Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092
   Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022
   Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064
   Held P, 1990, INTERSTITIAL CYSTITI, P29
   HURST RE, 1993, J UROLOGY, V149, P31, DOI 10.1016/S0022-5347(17)35990-6
   Hurst RE, 1996, J UROLOGY, V4295, P817
   Janssen DAW, 2013, J UROLOGY, V189, P336, DOI 10.1016/j.juro.2012.09.022
   Kallestrup EB, 2005, SCAND J UROL NEPHROL, V39, P143, DOI 10.1080/00365590410015876
   Keay S, 1999, J UROLOGY, V162, P1487, DOI 10.1016/S0022-5347(05)68345-0
   Keay S, 2011, CHEM BIOL DRUG DES, V77, P421, DOI 10.1111/j.1747-0285.2011.01108.x
   Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390
   Koskela LR, 2008, J UROLOGY, V180, P737, DOI 10.1016/j.juro.2008.03.184
   Kuo H-C, 2012, PLOS ONE, V7
   Lamale LM, 2006, UROLOGY, V68, P702, DOI 10.1016/j.urology.2006.04.033
   Lokeshwar VB, 2005, J UROLOGY, V174, P344, DOI 10.1097/01.ju.0000161599.69942.2e
   LOTZ M, 1994, J UROLOGY, V152, P869, DOI 10.1016/S0022-5347(17)32594-6
   Lv YS, 2013, INT J UROL, V20, P1017, DOI 10.1111/iju.12090
   Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003
   Markham T, 2006, J AM ACAD DERMATOL, V54, P1003, DOI 10.1016/j.jaad.2006.01.038
   MARTINS SM, 1994, J UROLOGY, V151, P1198, DOI 10.1016/S0022-5347(17)35212-6
   Moldwin RM, 2007, UROLOGY, V69, P73, DOI 10.1016/j.urology.2006.08.1105
   Nickel JC, 2010, UROLOGY, V76, P804, DOI 10.1016/j.urology.2010.03.016
   Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10
   PARSONS CL, 1991, J UROLOGY, V145, P732, DOI 10.1016/S0022-5347(17)38437-9
   Peters KM, 1999, UROLOGY, V54, P450, DOI 10.1016/S0090-4295(99)00162-4
   Rosenberg MT, 2005, J UROLOGY, V174, P2231, DOI 10.1097/01.ju.0000181203.82693.95
   Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x
   Slobodov G, 2007, J UROLOGY, V171, P945
   Smaldone MC, 2009, UROLOGY, V73, P2
   Soler R, 2008, INT BRAZ J UROL, V34, P503, DOI 10.1590/S1677-55382008000400013
   Tseng-Rogenski S, 2009, AM J PHYSIOL-RENAL, V297, pF816, DOI 10.1152/ajprenal.90733.2008
   Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034
   Valent P, 1995, Exp Dermatol, V4, P255, DOI 10.1111/j.1600-0625.1995.tb00254.x
   Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Wang WL, 2000, J CELL SCI, V113, P4435
   Wei DC, 2000, J UROLOGY, V163, P1577, DOI 10.1016/S0022-5347(05)67682-3
   Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99
NR 51
TC 18
Z9 18
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2015
VL 19
BP 66
EP 75
DI 10.1016/j.actbio.2015.02.030
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH6NA
UT WOS:000354152100008
PM 25818949
DA 2018-10-20
ER

PT J
AU Kasetty, G
   Kalle, M
   Morgelin, M
   Brune, JC
   Schmidtchen, A
AF Kasetty, Gopinath
   Kalle, Martina
   Morgelin, Matthias
   Brune, Jan C.
   Schmidtchen, Artur
TI Anti-endotoxic and antibacterial effects of a dermal substitute coated
   with host defense peptides
SO BIOMATERIALS
LA English
DT Article
DE Host defense peptides; Epiflex; Human acellular dermis; Antimicrobial;
   Inflammation
ID ACUTE INFLAMMATORY RESPONSES; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY;
   INFECTIOUS COMPLICATIONS; BREAST RECONSTRUCTION; BIOMATERIAL SURFACES;
   EXTRACELLULAR-MATRIX; IN-VITRO; ACTIVATION; POLYPEPTIDES
AB Biomaterials used during surgery and wound treatment are of increasing importance in modern medical care. In the present study we set out to evaluate the addition of thrombin-derived host defense peptides to human acellular dermis (hAD, i.e. epiflex (R)). Antimicrobial activity of the functionalized hAD was demonstrated using radial diffusion and viable count assays against Gram-negative Escherichia coil, Pseudornonas aeruginosa and Gram-positive Staphylococcus aureus bacteria. Electron microscopy analyses showed that peptide-mediated bacterial killing led to reduced hAD degradation. Furthermore, peptide-functionalized hAD displayed endotoxin-binding activity in vitro, as evidenced by inhibition of NF-kappa B activation in human monocytic cells (THP-1 cells) and a reduction of pro-inflammatory cytokine production in whole blood in response to lipopolysaccharide stimulation. The dermal substitute retained its anti-endotoxic activity after washing, compatible with results showing that the MD bound a significant amount of peptide. Furthermore, bacteria-induced contact activation was inhibited by peptide addition to the hAD. E. coli infected MD, alone, or after treatment with the antiseptic substance poly-hexamethylenebiguanide (PHMB), yielded NF-kappa B activation in THP-1 cells. The activation was abrogated by peptide addition. Thus, thrombin-derived HDPs should be of interest in the further development of new biomaterials with combined antimicrobial and anti-endotoxic functions for use in surgery and wound treatment. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Kasetty, Gopinath; Kalle, Martina; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden.
   [Kasetty, Gopinath] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Resp Med & Allergol, SE-22184 Lund, Sweden.
   [Morgelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.
   [Brune, Jan C.] Deutsch Inst Zell & Gewebeersatz gGmbH, Berlin, Germany.
   [Schmidtchen, Artur] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore.
RP Kasetty, G (reprint author), Tornavagen 10, SE-22184 Lund, Sweden.
EM gopinath.kasetty@med.lu.se
RI Schmidtchen, Artur/F-9507-2015
FU Swedish Research Council [2012-1883]; Vinnova; Torsten Soderberg;
   Welander-Finsen; Knut and Alice Wallenberg; Crafoord; Osterlund; Kock
   Foundations; Swedish Government Funds for Clinical Research (ALF)
FX We thank Dr. Mark D. Smith from the German Institute for Cell and Tissue
   Replacement (DIZG) for support, stimulating discussions, and valuable
   input and comments on the final manuscript. This work was supported by
   grants from the Swedish Research Council (project 2012-1883), Vinnova,
   Torsten Soderberg, the Welander-Finsen, Knut and Alice Wallenberg,
   Crafoord, Osterlund, Kock Foundations, and The Swedish Government Funds
   for Clinical Research (ALF).
CR Alessandro Bistolfi GM, 2011, ISRN ORTHOP, V2011, P8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Dobbins BM, 2002, J CLIN PATHOL, V55, P824, DOI 10.1136/jcp.55.11.824
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hill JL, 2012, ANN PLAS SURG, V68, P432, DOI 10.1097/SAP.0b013e31823b6ac6
   Kalle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051313
   Kasetty G, 2011, J INNATE IMMUN, V3, P471, DOI 10.1159/000327016
   Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10
   LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7
   Lindman JP, 2006, ARCH FACIAL PLAST S, V8, P208, DOI 10.1001/archfaci.8.3.208
   Liu DZ, 2014, ANN PLAS SURG, V72, P503, DOI 10.1097/SAP.0b013e318268a87c
   Lundqvist K, 2004, THROMB HAEMOSTASIS, V92, P281, DOI 10.1160/TH03-12-0732
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101
   Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200
   Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y
   Orenstein S, 2010, J SURG RES, V158, P10, DOI 10.1016/j.jss.2009.05.033
   Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3
   Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019
   Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857
   Rossner E, 2011, CELL TISSUE BANK, V12, P209, DOI 10.1007/s10561-010-9187-3
   Roessner ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045991
   Schommer NN, 2013, TRENDS MICROBIOL, V21, P660, DOI 10.1016/j.tim.2013.10.001
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Tang L, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thierry B, 2008, LANGMUIR, V24, P11834, DOI 10.1021/la801359w
   Tossi A, 2000, BIOPOLYMERS, V55, P4
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580
   Weichman KE, 2013, PLAST RECONSTR SURG, V132, P725, DOI 10.1097/PRS.0b013e31829fe35b
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883
   Yu K, 2014, COLLOID SURFACE B, V124, P69, DOI 10.1016/j.colsurfb.2014.08.009
   Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147
NR 49
TC 6
Z9 6
U1 0
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 415
EP 425
DI 10.1016/j.biomaterials.2015.02.111
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800039
PM 25890739
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Zhu, Y
   Jiang, H
   Ye, SH
   Yoshizumi, T
   Wagner, WR
AF Zhu, Yang
   Jiang, Hongbin
   Ye, Sang-Ho
   Yoshizumi, Tomo
   Wagner, William R.
TI Tailoring the degradation rates of thermally responsive hydrogels
   designed for soft tissue injection by varying the autocatalytic
   potential
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Thermally responsive material; Degradation; Heart
ID BLOCK-COPOLYMER HYDROGELS; IN-VITRO DEGRADATION; HYDROLYTIC DEGRADATION;
   N-ISOPROPYLACRYLAMIDE; DRUG-DELIVERY; BIODEGRADABLE POLYMERS;
   POLY(ETHYLENE GLYCOL); PLGA MICROSPHERES; ACID) HYDROGELS; TEMPERATURE
AB The ability to modulate the degradation properties of biomaterials such as thermally responsive hydrogels is desirable when exploring new therapeutic strategies that rely on the temporary presence of a placed scaffold or gel. Here we report a method of manipulating the absorption rate of a poly(N-isopropylacrylamide) ((poly(NIPAAm)) based hydrogel across a wide range (from 1 d to 5 mo) by small alterations in the composition. Relying upon the autocatalytic effect, the degradation of poly(NIPAAm-co-HEMA-co-MAPLA), (HEMA = 2-hydroxyethyl methacrylate; MAPLA = methacrylate-polylactide) was greatly accelerated by adding a fourth monomer methacrylic acid (MAA) at no more than 2 mol% to obtain poly(NIPAAm-co-HEMA-co-MAPLA-co-MAA) (pNHMMj) where j reflects the MM molar % in the reactant mixture. MAA residue introduction decreased the pH inside the hydrogels and in surrounding buffered solutions. Accelerated degradation positively, correlated with MM content in pNHMMj polymers, putatively by the accelerated cleavage of MAPLA residues to raise the transition temperature of the polymer above body temperature. Physical properties including thermal transition behavior and initial mechanical strength did not vary significantly with MM content. A rat hindlimb injection model generally reflected the in vitro observation that higher MAA content resulted in more rapid degradation and cellular infiltration. The strategy of tuning the degradation of thermally responsive hydrogels where degradation or solubilization is determined by their polyester components might be applied to other tissue engineering and regenerative medicine applications where designed biomaterial degradation behavior is needed. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhu, Yang; Jiang, Hongbin; Ye, Sang-Ho; Yoshizumi, Tomo; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Zhu, Yang; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Ye, Sang-Ho; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI Ye, Sang-Ho/H-5294-2011
OI Ye, Sang-Ho/0000-0002-4760-9812; Zhu, Yang/0000-0002-7384-607X
FU US National Institutes of Health [R01 HL105911]
FX The financial support for this work by the US National Institutes of
   Health (grant R01 HL105911) is gratefully acknowledged.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Cui ZW, 2010, J BIOMAT SCI-POLYM E, V21, P913, DOI 10.1163/156856209X451323
   Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kumashiro Y, 2004, MACROMOL RAPID COMM, V25, P867, DOI 10.1002/marc.200300279
   Lee BH, 2005, MACROMOL BIOSCI, V5, P629, DOI 10.1002/mabi.200500029
   Lee BH, 2005, POLYM INT, V54, P418, DOI 10.1002/pi.1709
   Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nikouei NS, 2011, ACTA BIOMATER, V7, P3708, DOI 10.1016/j.actbio.2011.05.035
   Nishio S, 2014, CIRCULATION, V129, P534, DOI 10.1161/CIRCULATIONAHA.113.003769
   Overstreet DJ, 2010, BIOMACROMOLECULES, V11, P1154, DOI 10.1021/bm100035f
   Park M. H., 2011, ACCOUNTS CHEM RES, V45, P424, DOI DOI 10.1021/AR200162J
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Potta T, 2011, POLYM DEGRAD STABIL, V96, P1261, DOI 10.1016/j.polymdegradstab.2011.04.010
   Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k
   Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673
   SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Vakkalanka SK, 1996, POLYM BULL, V36, P221, DOI 10.1007/BF00294910
   Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
   Zhang Y, 1997, J BIOMED MATER RES, V34, P531, DOI 10.1002/(SICI)1097-4636(19970315)34:4<531::AID-JBM13>3.0.CO;2-F
   Zolnik BS, 2007, J CONTROL RELEASE, V122, P338, DOI 10.1016/j.jconrel.2007.05.034
NR 56
TC 11
Z9 12
U1 2
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 484
EP 493
DI 10.1016/j.biomaterials.2015.02.100
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800045
PM 25890745
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Qazi, TH
   Mooney, DJ
   Pumberger, M
   Geissler, S
   Duda, GN
AF Qazi, Taimoor H.
   Mooney, David J.
   Pumberger, Matthias
   Geissler, Sven
   Duda, Georg N.
TI Biomaterials based strategies for skeletal muscle tissue engineering:
   Existing technologies and future trends
SO BIOMATERIALS
LA English
DT Review
DE Progenitor cells; Hydrogels; Patterned scaffolds; In situ regeneration;
   Vascularization; Innervation
ID MESENCHYMAL STEM-CELLS; CHRONIC ELECTRICAL-STIMULATION; MYOBLAST
   TRANSFER THERAPY; HINDLIMB ISCHEMIA MODEL; HYBRID MUSCULAR TISSUES;
   FAST-TWITCH MUSCLE; RAT ANIMAL-MODEL; IN-VITRO MODEL; SATELLITE CELLS;
   EXTRACELLULAR-MATRIX
AB Skeletal muscles have a robust capacity to regenerate, but under compromised conditions, such as severe trauma, the loss of muscle functionality is inevitable. Research carried out in the field of skeletal muscle tissue engineering has elucidated multiple intrinsic mechanisms of skeletal muscle repair, and has thus sought to identify various types of cells and bioactive factors which play an important role during regeneration. In order to maximize the potential therapeutic effects of cells and growth factors, several biomaterial based strategies have been developed and successfully implemented in animal muscle injury models. A suitable biomaterial can be utilized as a template to guide tissue reorganization, as a matrix that provides optimum micro-environmental conditions to cells, as a delivery vehicle to carry bioactive factors which can be released in a controlled manner, and as local niches to orchestrate in situ tissue regeneration. A myriad of biomaterials, varying in geometrical structure, physical form, chemical properties, and biofunctionality have been investigated for skeletal muscle tissue engineering applications. In the current review, we present a detailed summary of studies where the use of biomaterials favorably influenced muscle repair. Biomaterials in the form of porous three-dimensional scaffolds, hydrogels, fibrous meshes, and patterned substrates with defined topographies, have each displayed unique benefits, and are discussed herein. Additionally, several biomaterial based approaches aimed specifically at stimulating vascularization, innervation, and inducing contractility in regenerating muscle tissues are also discussed. Finally, we outline promising future trends in the field of muscle regeneration involving a deeper understanding of the endogenous healing cascades and utilization of this knowledge for the development of multifunctional, hybrid, biomaterials which support and enable muscle regeneration under compromised conditions. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Qazi, Taimoor H.; Geissler, Sven; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Qazi, Taimoor H.; Pumberger, Matthias; Geissler, Sven; Duda, Georg N.] Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany.
   [Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Pumberger, Matthias] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Geissler, Sven; Duda, Georg N.] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
RP Duda, GN (reprint author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
EM taimoor.qazi@charite.de; mooneyd@seas.harvard.edu;
   Matthias.Pumberger@charite.de; sven.geissler@charite.de;
   Georg.Duda@charite.de
RI Duda, Georg/H-2085-2016; Qazi, Taimoor Hasan/I-7675-2015
OI Duda, Georg/0000-0001-7605-3908; Qazi, Taimoor
   Hasan/0000-0002-3132-9170; Geissler, Sven/0000-0002-8750-6324
FU Einstein Foundation Berlin through the Charite-Universitatsmedizin
   Berlin; Berlin-Brandenburg School for Regenerative Therapies [GSC 203];
   Friede Springer Stiftung; Federal Ministry of Education and Research
   through the BCRT; German Research Foundation (DFG) [FOR2165, GE2512/2-1]
FX The authors gratefully acknowledge the award of an Einstein Visiting
   Fellowship to D.J.M by the Einstein Foundation Berlin through the
   Charite-Universitatsmedizin Berlin, and the Berlin-Brandenburg School
   for Regenerative Therapies GSC 203. T.H.Q. wishes to acknowledge the
   Friede Springer Stiftung for financial support. This work was partially
   supported by the Federal Ministry of Education and Research by funding
   through the BCRT, and by the German Research Foundation (DFG) by funding
   through the FOR2165 (grant GE2512/2-1). The funders had no role in the
   review design, data collection, decision to publish, or preparation of
   the manuscript.
CR Ahadian S, 2012, LAB CHIP, V12, P3491, DOI 10.1039/c2lc40479f
   Ashley Z, 2007, J MUSCLE RES CELL M, V28, P203, DOI 10.1007/s10974-007-9119-4
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Auluck A, 2005, EUR J ORAL SCI, V113, P218, DOI 10.1111/j.1600-0722.2005.00215.x
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Bach AD, 2006, J CELL MOL MED, V10, P716, DOI 10.2755/jcmm010.003.14
   Bach AD, 2003, CELL TISSUE RES, V314, P263, DOI 10.1007/s00441-003-0757-6
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.TEB.2012.0183, 10.1089/ten.teb.2012.0183]
   Bandyopadhyay B, 2013, BIOTECHNOL PROGR, V29, P197, DOI 10.1002/btpr.1665
   Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773
   Beier JP, 2006, PLAST RECONSTR SURG, V118, P1113, DOI 10.1097/01.prs.0000221007.97115.1d
   Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34
   Bian WN, 2008, IEEE ENG MED BIOL, V27, P109, DOI 10.1109/MEMB.2008.928460
   Bian WN, 2012, FASEB J, V26, P955, DOI 10.1096/fj.11-187575
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   BOLDRIN L, 2010, HEALTH TECHNOL ASSES, V14, P941, DOI DOI 10.1369/JHC.2010.956201
   Boldrin L, 2008, CELL TRANSPLANT, V17, P577, DOI 10.3727/096368908785095980
   Boldrin L, 2007, TISSUE ENG, V13, P253, DOI 10.1089/ten.2006.0093
   Borschel GH, 2006, PLAST RECONSTR SURG, V117, P2235, DOI 10.1097/01.prs.0000224295.54073.49
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7
   Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001
   Brady MA, 2008, J TISSUE ENG REGEN M, V2, P408, DOI 10.1002/term.112
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Cheema U, 2003, CELL MOTIL CYTOSKEL, V54, P226, DOI 10.1002/cm.10095
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761
   Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cronin EM, 2004, J BIOMED MATER RES A, V69A, P373, DOI 10.1002/jbm.a.30009
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2
   De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364
   Dhawan V, 2007, TISSUE ENG, V13, P2813, DOI 10.1089/ten.2007.0003
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Donnelly K, 2010, TISSUE ENG PART C-ME, V16, P711, DOI [10.1089/ten.tec.2009.0125, 10.1089/ten.TEC.2009.0125]
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050
   DUSTERHOFT S, 1990, DIFFERENTIATION, V44, P178, DOI 10.1111/j.1432-0436.1990.tb00616.x
   Egusa H, 2013, TISSUE ENG PT A, V19, P770, DOI [10.1089/ten.tea.2012.0164, 10.1089/ten.TEA.2012.0164]
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fishman JM, 2013, TISSUE ENG PART B-RE, V19, P503, DOI [10.1089/ten.teb.2013.0120, 10.1089/ten.TEB.2013.0120]
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002
   Fuoco C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-24
   Geissler S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.501
   Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Glaeser JD, 2010, TISSUE ENG PT A, V16, P3139, DOI [10.1089/ten.tea.2009.0508, 10.1089/ten.TEA.2009.0508]
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   GOLDSPINK DF, 1995, AM J PHYSIOL-ENDOC M, V268, pE288
   GOLDSPINK G, 1992, AM J PHYSIOL, V262, pR356
   Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67
   Grefte S, 2010, REGEN MED, V5, P737, DOI 10.2217/RME.10.69
   Guerette B, 1997, CELL TRANSPLANT, V6, P101, DOI 10.1016/S0963-6897(96)00230-8
   GUERETTE B, 1995, MUSCLE NERVE, V18, P39
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hong Y, 2012, TISSUE ENG PART C-ME, V18, P122, DOI [10.1089/ten.tec.2011.0295, 10.1089/ten.TEC.2011.0295]
   Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.tea.2012.0181, 10.1089/ten.TEA.2012.0181]
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Huang NF, 2010, AM J TRANSL RES, V2, P43
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Huri PY, 2013, BIOCHEM BIOPH RES CO, V438, P180, DOI 10.1016/j.bbrc.2013.07.049
   Jana S, 2013, ADV HEALTHC MATER, V2, P557, DOI 10.1002/adhm.201200177
   JARVINEN MJ, 1993, SPORTS MED, V15, P78
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Kaji H, 2010, BIOMATERIALS, V31, P6981, DOI 10.1016/j.biomaterials.2010.05.071
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kharraz Y, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/491497
   Kim Jennifer, 2003, Arch Facial Plast Surg, V5, P403, DOI 10.1001/archfaci.5.5.403
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057
   Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Koponen JK, 2007, MOL THER, V15, P2172, DOI 10.1038/sj.mt.6300302
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018
   Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Ladd MR, 2011, BIOMATERIALS, V32, P1549, DOI 10.1016/j.biomaterials.2010.10.038
   Langelaan MLP, 2011, J TISSUE ENG REGEN M, V5, P529, DOI 10.1002/term.345
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Larkin LM, 2006, IN VITRO CELL DEV-AN, V42, P75
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liao IC, 2008, CELL MOL BIOENG, V1, P133, DOI 10.1007/s12195-008-0021-y
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu GH, 2013, BIOMATERIALS, V34, P8617, DOI 10.1016/j.biomaterials.2013.07.077
   Liu J, 2012, TISSUE ENG PT A, V18, P2303, DOI [10.1089/ten.tea.2011.0658, 10.1089/ten.TEA.2011.0658]
   Liu J, 2013, ACTA BIOMATER, V9, P4688, DOI 10.1016/j.actbio.2012.08.009
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Ma JQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812135
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]
   Malerba A, 2010, NEUROL RES, V32, P55, DOI 10.1179/174313209X380865
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211
   Matziolis G, 2006, TISSUE ENG, V12, P361, DOI 10.1089/ten.2006.12.361
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   McCullen SD, 2011, CURR OPIN BIOTECH, V22, P715, DOI 10.1016/j.copbio.2011.05.001
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Mertens JP, 2014, REGEN MED, V9, P89, DOI [10.2217/rme.13.81, 10.2217/RME.13.81]
   Messina A, 2005, FASEB J, V19, P1570, DOI 10.1096/fj.04-3241fje
   Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104
   Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010
   Musina RA, 2006, B EXP BIOL MED+, V141, P147, DOI 10.1007/s10517-006-0115-2
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754
   NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x
   Neumann T, 2003, TISSUE ENG, V9, P995, DOI 10.1089/107632703322495637
   Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301
   Okano T, 1998, CELL TRANSPLANT, V7, P71, DOI 10.1016/S0963-6897(97)00067-5
   Okano T, 1998, CELL TRANSPLANT, V7, P435, DOI 10.1016/S0963-6897(98)00030-X
   Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.teb.2013.0534, 10.1089/ten.TEB.2013.0534]
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Patz TM, 2005, MAT SCI ENG B-SOLID, V123, P242, DOI 10.1016/j.mseb.2005.08.088
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016
   Pette D, 2002, J MUSCLE RES CELL M, V23, P215, DOI 10.1023/A:1020974710389
   Philippou A, 2012, ADV CLIN CHEM, V58, P49, DOI 10.1016/B978-0-12-394383-5.00010-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001
   Qazi TH, 2014, ACTA BIOMATER, V10, P2434, DOI 10.1016/j.actbio.2014.02.023
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rakus D, 2015, J PROTEOME RES, V14, P1400, DOI 10.1021/pr5010357
   Rangarajan S, 2013, ANN BIOMED ENG, V24, P24
   Reinke S, 2013, SCI TRANSL MED, V5
   Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088
   Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0
   Rhim C, 2007, MUSCLE NERVE, V36, P71, DOI 10.1002/mus.20788
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Salimath AS, 2014, J TISSUE ENG REGEN M
   SANDOW A, 1952, YALE J BIOL MED, V25, P176
   Sassoli Chiara, 2012, Cells, V1, P832, DOI 10.3390/cells1040832
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   Saxena AK, 2001, BIO-MED MATER ENG, V11, P275
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sempf K, 2013, EUR J PHARM BIOPHARM, V85, P53, DOI 10.1016/j.ejpb.2012.11.030
   Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109
   Shadrach JL, 2011, PHILOS T R SOC B, V366, P2297, DOI 10.1098/rstb.2011.0027
   Shah R, 2005, BIOMATERIALS, V26, P1497, DOI 10.1016/j.biomaterials.2004.04.049
   Shah R, 2013, J TISSUE ENG REGEN M
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Shvartsman D, 2014, MOL THER, V22, P1243, DOI 10.1038/mt.2014.76
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Smith AST, 2012, J CELL BIOCHEM, V113, P1044, DOI 10.1002/jcb.23437
   Smythe GM, 2000, MOL THER, V1, P304, DOI 10.1006/mthe.2000.0049
   Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x
   Stern-Straeter J, 2007, IN VIVO, V21, P435
   Takahashi H, 2013, BIOMATERIALS, V34, P7372, DOI 10.1016/j.biomaterials.2013.06.033
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Thorrez L, 2008, BIOMATERIALS, V29, P75, DOI 10.1016/j.biomaterials.2007.09.014
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011
   Toumi H, 2003, BRIT J SPORT MED, V37, P284, DOI 10.1136/bjsm.37.4.284
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7
   Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964
   VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901
   Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931
   VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P166
   VANDENBURGH HH, 1989, IN VITRO CELL DEV B, V25, P607
   vanWachem PB, 1996, J BIOMED MATER RES, V30, P353, DOI 10.1002/(SICI)1097-4636(199603)30:3<353::AID-JBM9>3.0.CO;2-P
   von Roth Philipp, 2012, Open Orthop J, V6, P352, DOI 10.2174/1874325001206010352
   Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78
   Wang L, 2013, MOL NEUROBIOL, V48, P397, DOI 10.1007/s12035-013-8412-z
   Wang W, 2009, BIOMED MATER, V4, P1748, DOI DOI 10.1088/1748-6041/4/2/
   Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265
   WEHRLE U, 1994, DIFFERENTIATION, V58, P37, DOI 10.1046/j.1432-0436.1994.5810037.x
   Weir MR, 1999, AM J KIDNEY DIS, V34, P1, DOI 10.1016/S0272-6386(99)70101-0
   Williams ML, 2013, J TISSUE ENG REGEN M, V7, P434, DOI 10.1002/term.537
   Wilschut KJ, 2010, EXP CELL RES, V316, P341, DOI 10.1016/j.yexcr.2009.10.014
   Winkler T, 2012, J TISSUE ENG REGEN M, V6, ps60, DOI 10.1002/term.1542
   Winkler T, 2009, TISSUE ENG PT A, V15, P487, DOI 10.1089/ten.tea.2007.0426
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067
   Yuan CC, 2013, MICRO NANO LETT, V8, P440, DOI 10.1049/mnl.2013.0153
   Zhao Y, 2009, BIOTECHNOL BIOENG, V102, P624, DOI 10.1002/bit.22080
   Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080
NR 227
TC 101
Z9 101
U1 12
U2 179
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 502
EP 521
DI 10.1016/j.biomaterials.2015.02.110
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800047
PM 25890747
DA 2018-10-20
ER

PT J
AU Vasconcelos, DP
   Costa, M
   Amaral, IF
   Barbosa, MA
   Aguas, AP
   Barbosa, JN
AF Vasconcelos, Daniela P.
   Costa, Madalena
   Amaral, Isabel F.
   Barbosa, Mario A.
   Aguas, Artur P.
   Barbosa, Judite N.
TI Development of an immunomodulatory biomaterial: Using resolvin D1 to
   modulate inflammation
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Immune response; Chitosan; Immunomodulation; Resolvin
ID MACROPHAGE POLARIZATION; AIR POUCH; IN-VIVO; RESOLUTION; PHENOTYPE;
   MEDIATORS; CHITOSAN; LYOPHILIZATION; IMPLANTATION; SCAFFOLDS
AB In our search for immunomodulatory biomaterials capable of modulating the inflammatory response through M2 macrophage polarization, we report here on a new strategy that resulted from the incorporation of resolvin D1 (RvD1), a pro-resolution lipid mediator in porous 3D chitosan (Ch) scaffolds, followed by its lyophilisation. We have investigated the inflammatory response caused by this biomaterial in vivo using a mouse air-pouch model of inflammation. We found that this developed material caused a decrease in inflammatory cells recruited to the implant site, together with higher numbers of F4/80(+)/CD206(+) cells (M2 macrophages) and lower numbers of F4/80(+)/CCR7(+) cells (M1 macrophages). It also induced a general decrease in pro-inflammatory cytokines, and caused a decrease in the inflammatory cells observed around and within the implanted scaffolds, when compared with Ch alone or Ch not submitted to lyophilisation after RvD1 incorporation. Our results demonstrate that we were able to develop an immunomodulating biomaterial that triggers a shift in the macrophage response towards a M2 reparative response that will be advantageous for the host. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Vasconcelos, Daniela P.; Costa, Madalena; Barbosa, Mario A.; Aguas, Artur P.; Barbosa, Judite N.] Univ Porto, ICBAS, P-4050313 Oporto, Portugal.
   [Vasconcelos, Daniela P.; Amaral, Isabel F.; Barbosa, Mario A.; Barbosa, Judite N.] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal.
   [Vasconcelos, Daniela P.; Amaral, Isabel F.; Barbosa, Mario A.; Barbosa, Judite N.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Costa, Madalena; Aguas, Artur P.] Univ Porto, ICBAS, UMIB Unit Multidisciplinary Biomed Res, P-4050313 Oporto, Portugal.
RP Barbosa, JN (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM judite@ineb.up.pt
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Santos,
   Madalena/0000-0002-1101-3515; Vasconcelos, Daniela/0000-0002-9242-2336;
   Novais Barbosa, Judite/0000-0003-1852-2790; Amaral,
   Isabel/0000-0003-2921-3627; Aguas, Artur P/0000-0002-1487-9517
FU FEDER Funds through the Programa Operacional Factores de Competitividade
   - COMPETE; FCT - Fundacao para a Ciencia e Tecnologia
   [PTDC/SAU-BMA/113030/2009]; QREN through program ON.2 - "Project on
   Biomedical Engineering for Regenerative Therapies and Cancer"
   [NORTE-07-0124-FEDER-000005]
FX This work was financed by FEDER Funds through the Programa Operacional
   Factores de Competitividade - COMPETE and Portuguese funds through FCT -
   Fundacao para a Ciencia e Tecnologia in the framework of project
   PTDC/SAU-BMA/113030/2009. I.F. Amaral is funded by QREN through program
   ON.2, in the framework of Project "NORTE-07-0124-FEDER-000005 - Project
   on Biomedical Engineering for Regenerative Therapies and Cancer".
CR Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   CASTRO AG, 1991, INFECT IMMUN, V59, P3009
   Couto DS, 2012, ADV DRUG DELIVER REV, V64, P69, DOI 10.1016/j.addr.2011.10.008
   Di Tommaso C, 2010, EUR J PHARM SCI, V40, P38, DOI 10.1016/j.ejps.2010.02.006
   Domb AJ, 2014, FOCAL CONTROLLED DRU
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Franz S, 2011, BIOMATERIALS, V32, P6692
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034
   Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   Howard MD, 2012, DRUG DEV IND PHARM, V38, P1270, DOI 10.3109/03639045.2011.645835
   Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lewis A, 2009, DRUG DEVICE COMBINATION PRODUCTS, pXVII
   Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011
   Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x
   Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Sedwick AD, 1983, J PATHOL, V141, P483
   Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197
   Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035
   Vasconcelos DP, 2013, BIOMATERIALS, V34, P9952, DOI 10.1016/j.biomaterials.2013.09.012
   Widgerow AD, 2012, WOUND REPAIR REGEN, V20, P2, DOI 10.1111/j.1524-475X.2011.00754.x
   Winyard PG, 2003, METHODS MOL BIOL INF
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zilberman M, 2011, STUD MECHANOBIOL TIS, V8, P1, DOI 10.1007/978-3-642-18065-1
NR 35
TC 24
Z9 24
U1 4
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 53
BP 566
EP 573
DI 10.1016/j.biomaterials.2015.02.120
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH3KO
UT WOS:000353929800052
PM 25890752
DA 2018-10-20
ER

PT J
AU Moore, MA
   Samsell, B
   Wallis, G
   Triplett, S
   Chen, S
   Jones, AL
   Qin, XF
AF Moore, Mark A.
   Samsell, Brian
   Wallis, Glenna
   Triplett, Sherry
   Chen, Silvia
   Jones, Alyce Linthurst
   Qin, Xiaofei
TI Decellularization of human dermis using non-denaturing anionic detergent
   and endonuclease: a review
SO CELL AND TISSUE BANKING
LA English
DT Review
DE Allograft; Homograft; Dermis; Decellularized; Acellular dermal matrix;
   MatrACELL
ID REGENERATIVE TISSUE MATRIX; HEART-VALVES; ARTHROSCOPIC REPLACEMENT;
   GRAFTJACKET ALLOGRAFT; ACELLULAR DERMIS; FAILURE LOADS; RECONSTRUCTION;
   REPAIR; TENDON; SYNERGRAFT(TM)
AB Decellularized human dermis has been used for a number of clinical applications including wound healing, soft tissue reconstruction, and sports medicine procedures. A variety of methods exist to prepare this useful class of biomaterial. Here, we describe a decellularization technology (MatrACELL(A (R))) utilizing a non-denaturing anionic detergent, N-Lauroyl sarcosinate, and endonuclease, which was developed to remove potentially immunogenic material while retaining biomechanical properties. Effective decellularization was demonstrated by a residual DNA content of a parts per thousand currency sign4 ng/mg of wet weight which represented > 97 % DNA removal compared to unprocessed dermis. Two millimeter thick MatrACELL processed human acellular dermal matrix (MH-ADM) exhibited average ultimate tensile load to failure of 635.4 +/- A 199.9 N and average suture retention strength of 134.9 +/- A 55.1 N. Using an in vivo mouse skin excisional model, MH-ADM was shown to be biocompatible and capable of supporting cellular and vascular in-growth. Finally, clinical studies of MH-ADM in variety of applications suggest it can be an appropriate scaffold for wound healing, soft tissue reconstruction, and soft tissue augmentation.
C1 [Moore, Mark A.; Samsell, Brian; Wallis, Glenna; Triplett, Sherry; Chen, Silvia; Jones, Alyce Linthurst; Qin, Xiaofei] LifeNet Hlth, Inst Regenerat Med, Virginia Beach, VA 23453 USA.
RP Moore, MA (reprint author), LifeNet Hlth, Inst Regenerat Med, 1864 Concert Dr, Virginia Beach, VA 23453 USA.
EM mark_moore@lifenethealth.org
CR Al-Hamdan KS, 2011, SAUDI DENT J, V23, P205, DOI 10.1016/j.sdentj.2011.05.002
   Albo Daniel, 2006, Am J Surg, V192, pe12, DOI 10.1016/j.amjsurg.2006.08.029
   [Anonymous], 2001, US Patent, Patent No. [6,293,970, 6293970]
   [Anonymous], 2003, US Patent, Patent No. [6,544,289, 6544289]
   [Anonymous], 2003, US Patent, Patent No. [6,569,200, 6569200]
   [Anonymous], 2006, US Patent, Patent No. [7,063,726, 7063726]
   [Anonymous], 2004, US Patent, Patent No. [6,743,574, 6746574]
   Barber FA, 2008, ARTHROSCOPY, V24, P20, DOI 10.1016/j.arthro.2007.07.013
   Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012
   Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021
   Bechtel JFM, 2005, EUR J CARDIO-THORAC, V27, P410, DOI 10.1016/j.ejcts.2004.12.017
   Bechtel JFM, 2003, J HEART VALVE DIS, V12, P734
   Beitzel K, 2012, AM J SPORT MED, V40, P1148, DOI 10.1177/0363546512437835
   Bond JL, 2008, ARTHROSCOPY, V24, P403, DOI 10.1016/j.arthro.2007.07.033
   Brigido SA, 2004, ORTHOPEDICS, V27, pS145
   Burkhead WZ, 2007, SEMIN ARTHROPLASTY, V18, P11, DOI DOI 10.1053/J.SART.2006.11.017
   Candage R, 2008, SURGERY, V144, P703, DOI 10.1016/j.surg.2008.06.018
   Capito AE, 2012, ANN PLAS SURG, V68, P495, DOI 10.1097/SAP.0b013e31823b6b01
   Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85
   Chen SG, 2012, INT J BURNS TRAUMA, V2, P105
   Choe JM, 2001, J UROLOGY, V166, P122, DOI 10.1016/S0022-5347(05)66090-9
   Daniel Lee, 2007, J FOOT ANKLE SURG, V46, P451
   Daniel Lee, 2008, J FOOT ANKLE SURG, V47, P8
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Dopirak R, 2007, INT J SHOULDER SURG, V1, P7, DOI 10.4103/0973-6042.30673
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P87
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Eshan A, 2012, J HAND SURG-AM, V37, P1538
   Hawkins JA, 2003, J THORAC CARDIOV SUR, V126, P247, DOI 10.1016/S0022-5223(03)00116-8
   Hopkins RA, 2009, J THORAC CARDIOV SUR, V137, P907, DOI 10.1016/j.jtcvs.2008.12.009
   Kapfer SA, 2006, J PEDIATR SURG, V41, P216, DOI 10.1016/j.jpedsurg.2005.10.093
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athorascur.2004.09.033
   Ketchedjian A, 2005, J THORAC SURG, V129, P155
   Levenda A, 2012, ANN M ARTHR ASS N AM
   Lofland GK, 2012, ANN THORAC SURG, V93, P968, DOI 10.1016/j.athoracsur.2011.09.039
   Mitchell CR, 2011, UROLOGY, V77, P746, DOI 10.1016/j.urology.2010.05.003
   Moore MA, 2004, AM ASS TISS BANKS AN
   Moore MA, 2012, CELL TISSUE BANK, V13, P401, DOI 10.1007/s10561-011-9266-0
   Mulder, 2012, WOUNDS, V24, P185
   Nahabedian MY, 2009, PLAST RECONSTR SURG, V124, P1743, DOI 10.1097/PRS.0b013e3181bf8087
   Norton L.W., 2009, FUNDAMENTALS TISSUE, P721, DOI 10.1007/978-3-540-77755-7_50
   Ortiz Juan A, 2014, Mil Med, V179, pe249, DOI 10.7205/MILMED-D-13-00276
   Pellegata AF, 2013, BIOMED RES INT, V13, P1
   Qin X, 2008, SOC AM WOUND CAR 21
   Randall KL, 2008, J FOOT ANKLE SURG, V47, P430, DOI 10.1053/j.jfas.2008.04.012
   Salzberg A, 2006, ANN PLAST SURG, V57, P1
   Sbitany H, 2009, PLAST RECONSTR SURG, V124, P1735, DOI 10.1097/PRS.0b013e3181bf803d
   Sievers HH, 2003, Z KARDIOL, V92, P53, DOI 10.1007/s00392-003-0883-x
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Snyder SJ, 2007, OPER TECHN SPORT MED, V15, P86, DOI 10.1053/j.otsm.2006.07.006
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Steinmetz M, 1986, CLIN IMMUN NEWS, V7, P134
   Vashi C, 2014, PLAST SURG INT, V2014, P1
   Wallace SC, 2013, J ORAL IMPLANTOL, V39, P503, DOI 10.1563/AAID-JOI-D-13-00001
   Wilkins RM, 2010, CURR ORTHOP PRACT, V21, P315, DOI 10.1097/BCO.0b013e3181c7ea2e
   Winters Christopher L, 2008, Adv Skin Wound Care, V21, P375, DOI 10.1097/01.ASW.0000323532.98003.26
   Wolfinbarger LJ, 2008, Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced United States Patent US, Patent No. [7338757 B2, 7338757]
   Wolfinbarger LJ, 2004, Patent No. [United States Patent US, 6734018 B2, 6734018]
   Wong Ivan, 2010, J Shoulder Elbow Surg, V19, P104, DOI 10.1016/j.jse.2009.12.017
   Yonehiro L, 2013, WOUNDS, V25, P340
NR 62
TC 26
Z9 27
U1 1
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD JUN
PY 2015
VL 16
IS 2
BP 249
EP 259
DI 10.1007/s10561-014-9467-4
PG 11
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA CH7CC
UT WOS:000354192200009
PM 25163609
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Shen, LR
   Tian, ZH
   Liu, WT
   Li, GY
AF Shen, Lirui
   Tian, Zhenhua
   Liu, Wentao
   Li, Guoying
TI Influence on the physicochemical properties of fish collagen gels using
   self-assembly and simultaneous cross-linking with the
   N-hydroxysuccinimide adipic acid derivative
SO CONNECTIVE TISSUE RESEARCH
LA English
DT Article
DE Collagen gel; cross-linking; N-hydroxysuccinimide adipic acid derivative
   Southern catfish; properties; self-assembly
ID DYNAMIC VISCOELASTIC PROPERTIES; RHEOLOGICAL PROPERTIES; GELATIN FILMS;
   GLUTARALDEHYDE; STABILITY; ORGANIZATION; BIOMATERIAL; TEMPERATURE;
   SCAFFOLDS; DELIVERY
AB Collagen gels from Southern catfish (Silurus meridionalis Chen) skins were prepared via the self-assembly of collagen molecules and simultaneous cross-linking with the N-hydroxysuccinimide adipic acid derivative (NHS-AA). The doses of NHS-AA were converted to [NHS-AA]/[NH2] ratios (0.025-1.6, calculated by the [active ester group] of NHS-AA and [epsilon-NH2] of lysine and hydroxylysine residues of collagen). When the ratio<0.05, collagen gels were formed by collagen molecule self-assembly, resulting in the opalescent appearance of collagen gels and the characteristic D-periodicity of partial collagen fibrils, the collagen gel ([NHS-AA]/ [NH2] = 0.05) displayed a small increase in denaturation temperature (T-d, 42.8 degrees C), remaining weight (12.59%), specific water content (SWC 233.7) and elastic modulus (G' 128.4 Pa) compared with uncross-linked collagen gel (39.1 degrees C, 9.12%, 222.4 and 85.4 Pa, respectively). As the ratio>0.05, disappearance of D-periodicity and a gradual change in appearance from opalescent to transparent suggested that the inhibition of NHS-AA in the self-assembly of collagen molecules was more obvious. As a result, the collagen gel ([NHS-AA]/[NH2] = 0.2) had the lowest T-d (35.8 degrees C), remaining weight (7.96%), SWC (130.9) and G' (31.9 Pa). When the ratio was 1.6, the collagen molecule self-assembly was markedly suppressed and the formation of collagen gel was predominantly via the covalent cross-linking bonds which led to the transparent appearance, and the maximum values of T-d (47.0 degrees C), remaining weight (45.92%) and G' (420.7 Pa) of collagen gel. These results indicated that collagen gels with different properties can be prepared using different NHS-AA doses.
C1 [Shen, Lirui; Li, Guoying] Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
   [Tian, Zhenhua; Liu, Wentao] Sichuan Univ, Natl Engn Lab Clean Technol Leather Manufacture, Chengdu 610065, Peoples R China.
RP Li, GY (reprint author), Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
EM liguoyings@163.com
FU National Natural Science Foundation of China [21276167, 21476147]
FX This work was funded by the National Natural Science Foundation of China
   (Nos. 21276167 and 21476147).
CR Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Chen YH, 2011, KOREA-AUST RHEOL J, V23, P41, DOI 10.1007/s13367-011-0006-6
   CHEUNG DT, 1990, CONNECT TISSUE RES, V25, P27, DOI 10.3109/03008209009009810
   Duan L, 2014, INT J BIOL MACROMOL, V69, P482, DOI 10.1016/j.ijbiomac.2014.06.005
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Fang M, 2013, LANGMUIR, V29, P2330, DOI 10.1021/la3048104
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gasperlin M, 1998, INT J PHARMACEUT, V168, P243, DOI 10.1016/S0378-5173(98)00099-4
   Kasapis S, 2001, INT J BIOL MACROMOL, V29, P315, DOI 10.1016/S0141-8130(01)00180-5
   Korhonen M, 2001, INT J PHARM, V221, P187, DOI 10.1016/S0378-5173(01)00675-5
   Krishnamoorthy G, 2013, J BIOMED MATER RES A, V101, P1173, DOI 10.1002/jbm.a.34411
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3
   Mori H, 2013, MAT SCI ENG C-MATER, V33, P3230, DOI 10.1016/j.msec.2013.03.047
   Mori H, 2012, MAT SCI ENG C-MATER, V32, P2007, DOI 10.1016/j.msec.2012.05.022
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P2028, DOI 10.1021/jf990773a
   Nomura Y, 1995, J FOOD SCI, V60, P1233, DOI 10.1111/j.1365-2621.1995.tb04563.x
   Pietrucha K, 2005, INT J BIOL MACROMOL, V36, P299, DOI 10.1016/j.ijbiomac.2005.07.004
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Saito H, 2004, MAT SCI ENG C-BIO S, V24, P781, DOI 10.1016/j.msec.2004.08.039
   Saito H, 2007, ACTA BIOMATER, V3, P89, DOI 10.1016/j.actbio.2006.08.003
   Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069
   Tian ZH, 2014, CONNECT TISSUE RES, V55, P239, DOI 10.3109/03008207.2014.898066
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Watanabe K, 1997, POLYMER, V38, P5155, DOI 10.1016/S0032-3861(97)00046-3
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang M, 2011, INT J BIOL MACROMOL, V49, P847, DOI 10.1016/j.ijbiomac.2011.08.007
   Zhang M, 2009, FOOD CHEM, V115, P826, DOI 10.1016/j.foodchem.2009.01.006
NR 33
TC 4
Z9 4
U1 1
U2 33
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0300-8207
EI 1607-8438
J9 CONNECT TISSUE RES
JI Connect. Tissue Res.
PD JUN
PY 2015
VL 56
IS 3
BP 244
EP 252
DI 10.3109/03008207.2015.1020941
PG 9
WC Cell Biology; Orthopedics
SC Cell Biology; Orthopedics
GA CH8VT
UT WOS:000354314900008
PM 25689166
DA 2018-10-20
ER

PT J
AU Cicchetto, A
   Kumar, V
   Chapman, J
AF Cicchetto, A.
   Kumar, V.
   Chapman, J.
TI FIBRIN ADIPOSE TISSUE (FAT) AS SURGICAL BIOMATERIAL
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 [Cicchetto, A.; Kumar, V.; Chapman, J.] Calif State Univ Sacramento, Sacramento, CA 95819 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1465-3249
EI 1477-2566
J9 CYTOTHERAPY
JI Cytotherapy
PD JUN
PY 2015
VL 17
IS 6
SU S
MA 231
BP S68
EP S68
DI 10.1016/j.jcyt.2015.03.540
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA CH6JK
UT WOS:000354142700212
DA 2018-10-20
ER

PT J
AU Khanlou, HM
   Ang, BC
   Talebian, S
   Barzani, MM
   Silakhori, M
   Fauzi, H
AF Khanlou, Hossein Mohammad
   Ang, Bee Chin
   Talebian, Sepehr
   Barzani, Mohsen Marani
   Silakhori, Mahyar
   Fauzi, Hadi
TI A systematic study of maghemite/PMMA nano-fibrous composite via an
   electrospinning process: Synthesis and characterization
SO MEASUREMENT
LA English
DT Article
DE Electrospinning; Maghemite; Polymethyl Methacrylate (PMMA); Nano-fibres;
   Composite; Magnetic particle; Fabrication and characterization
ID MAGNETIC NANOPARTICLES; SILVER NANOPARTICLES; POLY(METHYL METHACRYLATE);
   DRUG-DELIVERY; NANOFIBERS; NANOCOMPOSITES; MICROEMULSION; ENVIRONMENTS;
   NANOCRYSTALS; BIOMATERIAL
AB In this study, maghemite/PMMA nano-fibrous composites have been successfully fabricated by using the electrospinning process. PMMA nano-fibres have been selected to be used as the matrix; the PMMA was dissolved in three diverse solvents (Acetone, THF and DMF) in order to obtain fine PMMA nano-fibres. As a result, the PMMA-DMF proved to be the most appropriate polymer solution among the three solvents, with its impressive defect-free surface morphology results. The production of maghemite using Massart's procedure resulted in nano-particles with an average diameter of 4.98 +/- 0.13 nm (using transmission electron microscopy (TEM)). Maghemite nano-particle were then mixed with a prepared polymer solution in order to fabricate maghemite/PMMA nano-fibrous composite. Furthermore, the investigation of the morphology and structure of the composite was carried out using field emission scanning electron microscopy (FESEM), Energy-dispersion X-ray spectroscopy (EDX), Alternating Gradient Magnetometer (AGM), Fourier transform infrared spectrometer (FTIR), X-ray diffraction (XRD) and tensile strength measurement devices. The results indicated that there was a great amount of maghemite, both in and on the composite's surface, which can be utilized in the purpose of magnetic applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Khanlou, Hossein Mohammad; Ang, Bee Chin; Talebian, Sepehr] Univ Malaya, Dept Mech, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia.
   [Barzani, Mohsen Marani; Silakhori, Mahyar; Fauzi, Hadi] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
RP Khanlou, HM (reprint author), Univ Malaya, Dept Mech, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia.
EM khanlou4@um.edu.my
RI Engineering, Faculty/I-7935-2015; Ang, Bee Chin/B-8227-2010
OI Engineering, Faculty/0000-0002-4848-7052; Fauzi,
   Hadi/0000-0001-6867-8000; Mohammad Khanlou, Hossein/0000-0003-0896-1714;
   Silakhori, Mahyar/0000-0001-6713-1425
FU University of Malaya; University of Malaya [UMRG RP022C-13AET, PPP
   PG007-2013A]
FX The authors would like to acknowledge the University of Malaya for
   financial support. This research was carried under the University of
   Malaya research grant No. UMRG RP022C-13AET and PPP PG007-2013A.
CR Agarwal S, 2013, PROG POLYM SCI, V38, P963, DOI 10.1016/j.progpolymsci.2013.02.001
   Ambashta RD, 2010, J HAZARD MATER, V180, P38, DOI 10.1016/j.jhazmat.2010.04.105
   Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1
   Auffan M, 2008, ENVIRON SCI TECHNOL, V42, P6730, DOI 10.1021/es800086f
   Baji A, 2010, COMPOS SCI TECHNOL, V70, P703, DOI 10.1016/j.compscitech.2010.01.010
   Bao Y, 2013, RSC ADV, V3, P8998, DOI 10.1039/c3ra41322e
   Barrera C, 2005, MATER DIV ASME, V100, P467
   Batlle X, 2002, J PHYS D APPL PHYS, V35, pR15, DOI 10.1088/0022-3727/35/6/201
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Brar SK, 2010, WASTE MANAGE, V30, P504, DOI 10.1016/j.wasman.2009.10.012
   Chigome S, 2011, ANAL CHIM ACTA, V706, P25, DOI 10.1016/j.aca.2011.08.021
   Chin AB, 2007, J MATER PROCESS TECH, V191, P235, DOI 10.1016/j.jmatprotec.2007.03.011
   Clark SM, 2005, NANOTECHNOLOGY, V16, P2813, DOI 10.1088/0957-4484/16/12/013
   Galland S, 2013, J MATER CHEM C, V1, P7963, DOI 10.1039/c3tc31748j
   Gopal R, 2006, J MEMBRANE SCI, V281, P581, DOI 10.1016/j.memsci.2006.04.026
   Gubin SP, 2005, USP KHIM+, V74, P539, DOI 10.1070/RC2005V074N06ABEH000897
   HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533
   Han X, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/20/205302
   Hirt AM, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863543
   Hou YW, 2000, J PHYS CHEM B, V104, P212, DOI 10.1021/jp992312y
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Kaufner L, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/11/115710
   Khanlou H., 2015, NEURAL COMPUT APPL, P1
   Khanlou H.M., 2014, TEXT RES J
   Khanlou H.M., 2015, SCI ENG COMPOS MAT
   Khanlou HM, 2014, NEURAL COMPUT APPL, P1
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P307
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P125
   Khanlou HM, 2015, MEASUREMENT, V65, P193, DOI 10.1016/j.measurement.2015.01.014
   Kodama RH, 1999, J MAGN MAGN MATER, V200, P359, DOI 10.1016/S0304-8853(99)00347-9
   Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e
   Lee KJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465201
   Macossay J, 2007, POLYM ADVAN TECHNOL, V18, P180, DOI 10.1002/pat.844
   McCullagh C, 2011, J CHEM TECHNOL BIOT, V86, P1002, DOI 10.1002/jctb.2650
   Nath J.K., 2014, CRYST GROWTH DES
   Ortega D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/47/475706
   Pablico-Lansigan MH, 2013, NANOSCALE, V5, P4040, DOI 10.1039/c3nr00544e
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   De Berti IOP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175601
   Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h
   Piperno S, 2006, APPL SURF SCI, V252, P5583, DOI 10.1016/j.apsusc.2005.12.142
   Santhosh P, 2011, ANALYST, V136, P1557, DOI 10.1039/c0an00616e
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   Shim Il-Wun, 2001, B KOREAN CHEM SOC, V22, P3
   Shukla N, 2009, IONICS, V15, P357, DOI 10.1007/s11581-008-0275-3
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Singh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091584
   Talebian S., 2014, MATER RES INNOV, V18
   Talebian S., 2014, MATER RES INNOV, V18
   Talebian S, 2014, RSC ADV, V4, P49144, DOI 10.1039/c4ra06761d
   Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039
   Thakur M, 2006, J PHYS-CONDENS MAT, V18, P9093, DOI 10.1088/0953-8984/18/39/035
   Tong XZ, 2013, COMPOS SCI TECHNOL, V88, P33, DOI 10.1016/j.compscitech.2013.08.028
   Tsang S.C., 2004, ANGEW CHEM, V116
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vidal-Vidal J, 2006, COLLOID SURFACE A, V288, P44, DOI 10.1016/j.colsurfa.2006.04.027
   Wang HG, 2010, J MATER SCI, V45, P1032, DOI 10.1007/s10853-009-4035-1
   Yu D.-G., 2014, J NANOMATER
   Yu DG, 2013, RSC ADV, V3, P4652, DOI 10.1039/c3ra40334c
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Yu DG, 2012, CARBOHYD POLYM, V90, P1016, DOI 10.1016/j.carbpol.2012.06.036
   Zhang CC, 2009, APPL PHYS A-MATER, V97, P281, DOI [10.1007/s00339-009-53789, 10.1007/s00339-009-5378-9]
   Zhao X, 2011, CHEM ENG J, V170, P381, DOI 10.1016/j.cej.2011.02.071
NR 64
TC 11
Z9 11
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0263-2241
EI 1873-412X
J9 MEASUREMENT
JI Measurement
PD JUN
PY 2015
VL 70
BP 179
EP 187
DI 10.1016/j.measurement.2015.04.004
PG 9
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA CI0BZ
UT WOS:000354402000019
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Lukes, J
   Sepitka, J
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Lukes, Jaroslav
   Sepitka, Josef
TI Nanoindentation studies and modeling of surface layers on austenitic
   stainless steels by extreme electrochemical treatments
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE AISI 304L and 316L SS; electropolishing EP50 and EP1000; nanoindentation
   results; surface layer modeling
ID AISI 316L SS; XPS MEASUREMENTS; BIOMATERIAL
AB The nanoindentation studies were performed on two austenitic stainless steels, AISI 304L and 316L. The steel samples have undergone two different electrochemical treatments, standard (EP50) and a high-current density electropolishing (EP1000). Firstly, the observations of the steels' surfaces were done with the optic images of the AISI 304L and 316L SS after these two treatments displayed. Presented in the paper results have shown clearly that the high-current density close to 1000A/dm(2) allows for obtaining the passive nanolayers with other mechanical properties than those obtained after a standard electropolishing (EP50). The prediction of these results has been confirmed by the preliminary XPS studies allowing for modeling of the steels' surface layers. The main finding of the study is revealing a new method of electrochemical treatment (EP1000) allowing to obtain the reduced Young's modulus of the stainless steels lower than that obtained after EP50. This feature is of high importance regarding the use of these steels as biomaterials. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, PL-75620 Koszalin, Poland.
   [Lukes, Jaroslav; Sepitka, Josef] Czech Tech Univ, Fac Mech Engn, Dept Mech Biomech & Mechatron, Tech 4, Prague 16007 6, Czech Republic.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
CR Aronniemi M, 2005, SURF SCI, V578, P108, DOI 10.1016/j.susc.2005.01.019
   ASM International Handbook Committee, 1990, PROP SEL IR STEELS H, V1, P944
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T., 2014, SURF COATING TECHN C
   Hryniewicz T., 2014, INT LETT CHEM PHYS A, V4, P98, DOI DOI 10.18052/WWW.SCIPRESS.COM/ILCPA.23.98
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Lai JKL, 2012, STAINLESS STEELS: AN INTRODUCTION AND THEIR RECENT DEVELOPMENTS, P1
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P799
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Sedriks AJ., 1996, CORROSION STAINLESS
   Shuman D., 2005, COMPUTERIZED IMAGE A, P21
NR 19
TC 5
Z9 5
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN
PY 2015
VL 47
IS 6
BP 643
EP 647
DI 10.1002/sia.5758
PG 5
WC Chemistry, Physical
SC Chemistry
GA CH6YX
UT WOS:000354183700001
DA 2018-10-20
ER

PT J
AU Bou-Francis, A
   Soyka, RPW
   Ferguson, SJ
   Hall, RM
   Kapur, N
AF Bou-Francis, Antony
   Soyka, Rene P. Widmer
   Ferguson, Stephen J.
   Hall, Richard M.
   Kapur, Nikil
TI Novel methodology for assessing biomaterial-biofluid interaction in
   cancellous bone
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Bone surrogates; Bone cement; Cement injection behavior; Cement leakage;
   Vertebral augmentation; Experimental computational cross-validation
ID PERCUTANEOUS VERTEBROPLASTY; POLYMETHYLMETHACRYLATE CEMENT; VERTEBRAL
   AUGMENTATION; REGIONAL-VARIATIONS; PULMONARY-EMBOLISM;
   EXPERIMENTAL-MODEL; METASTATIC SPINE; FLOW; EXTRAVASATION; PERMEABILITY
AB Understanding the cement flow behaviour and accurately predicting the cement placement within the vertebral body is extremely challenging. Vertebral cancellous bone displays highly complex geometrical structures and architectural inhomogeneities over a range of length scales, thus making the scientific understanding of the cement injection behaviour difficult in clinical or cadaveric studies. Previous experimental studies on cement flow have used open-porous aluminum foam to represent osteoporotic bone. Although the porosity was well controlled, the geometrical structure of each of the foams was inherently unique. This paper presents novel methodology using customized, reproducible and pathologically representative three-dimensional bone surrogates to help study biomaterial-biofluid interaction. The aim was to provide a robust tool for comprehensive assessment of biomaterial injection behaviour through controlling the bone surrogate morphology and the injection parameters (i.e. needle gauge, needle placement, flow rate and injected volume), measuring the injection pressure, and allowing the visualization and quantitative analysis of the spreading distribution. This methodology provides a clinically relevant representation of cement flow patterns and a tool for validating computational simulations. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Bou-Francis, Antony; Hall, Richard M.] Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
   [Bou-Francis, Antony; Kapur, Nikil] Univ Leeds, Sch Mech Engn, Inst Thermofluids, Leeds LS2 9JT, W Yorkshire, England.
   [Soyka, Rene P. Widmer; Ferguson, Stephen J.] ETH, Inst Biomech, CH-8093 Zurich, Switzerland.
RP Bou-Francis, A (reprint author), Univ Leeds, Sch Mech Engn, Room X101, Leeds LS2 9JT, W Yorkshire, England.
EM a.boufrancis@leeds.ac.uk
RI Ferguson, Stephen/A-4118-2012
OI Ferguson, Stephen/0000-0003-0650-5889; Hall, Richard/0000-0001-5504-6717
FU European Union under the FP7 Marie Curie Action
   [PITN-GA-2009-238690-SPINEFX]; Engineering and Physical Sciences
   Research Council [EP/H013385/1]
FX This work was funded by the European Union under the FP7 Marie Curie
   Action, grant agreement no. PITN-GA-2009-238690-SPINEFX.
CR Ahn H, 2007, EUR SPINE J, V16, P1171, DOI 10.1007/s00586-007-0375-1
   Baroud G, 2005, SPINE, V30, P68, DOI 10.1097/01.brs.0000149188.51154.5b
   Baroud G, 2004, J BIOMECH, V37, P189, DOI 10.1016/S0021-9290(03)00246-X
   Baroud G, 2006, SPINE, V31, P2562, DOI 10.1097/01.brs.0000240695.58651.62
   Bohner M, 2003, BIOMATERIALS, V24, P2721, DOI 10.1016/S0142-9612(03)00086-3
   Bou-Francis A, 2014, J BIOMATER APPL, V29, P582, DOI 10.1177/0885328214537858
   Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x
   Bryant J D, 1989, Proc Inst Mech Eng H, V203, P71
   Chen H, 2008, OSTEOPOROSIS INT, V19, P1473, DOI 10.1007/s00198-008-0593-3
   Currey JD, 2001, CALCIFIED TISSUE INT, V68, P205, DOI 10.1007/s002230020040
   Gong H, 2006, SPINE, V31, P24, DOI 10.1097/01.brs.0000193939.99618.ee
   Gosev I, 2013, CIRCULATION, V127, P1251, DOI 10.1161/CIRCULATIONAHA.112.144535
   Habib M, 2010, INT SOC ADV SPINE SU, V4, P26
   Habib N, 2012, HEART LUNG, V41, P509, DOI 10.1016/j.hrtlng.2012.02.008
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hughes S.W., 2005, PHYS EDUC, V40, P5
   Krebs J., 2005, SPINE, V30, pE118
   Lador R, 2010, SPINE J, V10, P1118, DOI 10.1016/j.spinee.2010.09.020
   Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009
   Lin CL, 2005, POWDER TECHNOL, V154, P61, DOI 10.1016/j.powtec.2005.04.031
   Lochmuller EM, 2008, OSTEOPOROSIS INT, V19, P537, DOI 10.1007/s00198-007-0478-x
   Loeffel M, 2008, SPINE, V33, P1352, DOI 10.1097/BRS.0b013e3181732aa9
   Mathis JM, 2003, J VASC INTERV RADIOL, V14, P953
   Mohamed R, 2010, SPINE, V35, P353, DOI 10.1097/BRS.0b013e3181b63673
   Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005
   Nauman EA, 1999, ANN BIOMED ENG, V27, P517, DOI 10.1114/1.195
   Ortiz O, 2010, NEUROIMAG CLIN N AM, V20, P145, DOI 10.1016/j.nic.2010.02.001
   Pinder G. F., 2008, ESSENTIALS MULTIPHAS
   Reidy D, 2003, SPINE, V28, P1534, DOI 10.1097/00007632-200307150-00011
   RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sidhu GS, 2013, J NEUROSURG-SPINE, V19, P61, DOI 10.3171/2013.4.SPINE12978
   Soyka RPW, 2013, J MECH BEHAV BIOMED, V27, P43, DOI 10.1016/j.jmbbm.2013.06.007
   Tourtier JP, 2012, NEW ENGL J MED, V366, P258, DOI 10.1056/NEJMicm1010341
   Tschirhart CE, 2005, J BIOMECH, V38, P1582, DOI 10.1016/j.jbiomech.2004.07.023
   Widmer RP, 2013, COMPUT METHOD BIOMEC, V16, P908, DOI 10.1080/10255842.2011.643787
   Widmer RP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003735
   Widmer Soyka R.P., 2013, J MECH BEHAV BIOMED, V6161
NR 38
TC 1
Z9 1
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2015
VL 46
BP 158
EP 167
DI 10.1016/j.jmbbm.2015.02.027
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH0ZY
UT WOS:000353752100016
PM 25792413
OA Green Published
DA 2018-10-20
ER

PT J
AU Pangdaeng, S
   Sata, V
   Aguiar, JB
   Pacheco-Torgal, F
   Chindaprasirt, P
AF Pangdaeng, S.
   Sata, V.
   Aguiar, J. B.
   Pacheco-Torgal, F.
   Chindaprasirt, P.
TI Apatite formation on calcined kaolin-white Portland cement geopolymer
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Geopolymer; Apatite; Simulated body fluid; Kaolin; White Portland cement
ID IN-VITRO BIOACTIVITY; SIMULATED BODY-FLUID; FLY-ASH GEOPOLYMER; FORMING
   ABILITY; SURFACE; GEL; BIOMATERIALS; TEMPERATURE; INTERFACE; STRENGTH
AB In this study, calcined kaolin-white Portland cement geopolymer was investigated for use as biomaterial. Sodium hydroxide and sodium silicate were used as activators. In vitro test was performed with simulated body fluid (SBF) for bioactivity characterization. The formation of hydroxyapatite bio-layer on the 28-day soaked samples surface was tested using SEM, EDS and XRD analyses. The results showed that the morphology of hydroxyapatite was affected by the source material composition, alkali concentration and curing temperature. The calcined kaolin-white Portland cement geopolymer with relatively high compressive strength, could be fabricated for use as biomaterial. The mix with 50% white Portland cement and 50% calcined kaolin had 28-day compressive strength of 59.0 MPa and the hydroxyapatite bio-layer on the 28-day soaked sample surface was clearly evident. (C) 2015 Elsevier B.V. All rights reserved,
C1 [Pangdaeng, S.; Sata, V.; Chindaprasirt, P.] Khon Kaen Univ, Fac Engn, Dept Civil Engn, Sustainable Infrastruct Res & Dev Ctr, Khon Kaen 40002, Thailand.
   [Aguiar, J. B.; Pacheco-Torgal, F.] Univ Minho, C TAC Res Ctr, Dept Civil Engn, P-4800058 Guimaraes, Portugal.
RP Chindaprasirt, P (reprint author), Khon Kaen Univ, Fac Engn, Dept Civil Engn, Sustainable Infrastruct Res & Dev Ctr, Khon Kaen 40002, Thailand.
EM prinya@kku.ac.th
RI chindaprasirt, prinya/F-6768-2010; Pacheco-Torgal, F./C-5710-2012;
   Aguiar, Jose/B-6597-2009
OI chindaprasirt, prinya/0000-0003-1062-3626; Pacheco-Torgal,
   F./0000-0001-7767-6787; Aguiar, Jose/0000-0003-3954-5721
FU Thailand Research Fund (TRF); Khon Kaen University [PHD/0143/2554,
   RTA5780004]
FX This work was financially supported by the Thailand Research Fund (TRF)
   and Khon Kaen University under the TRF-Royal Golden Jubilee Ph.D.
   program (Grant No. PHD/0143/2554) and TRF-Senior Research Scholar (Grant
   No. RTA5780004).
CR [Anonymous], 2005, C109 ASTM, P76
   [Anonymous], 2005, C191 ASTM, P179
   Buchwald A, 2011, J NON-CRYST SOLIDS, V357, P1376, DOI 10.1016/j.jnoncrysol.2010.12.036
   Cabanas MV, 2002, CHEM MATER, V14, P3550, DOI 10.1021/cm021121w
   Catauro M., 2011, MECH BIOL CHARACTERI
   Chaipanich A, 2011, APPL SURF SCI, V257, P8385, DOI 10.1016/j.apsusc.2011.04.046
   Chindaprasirt P, 2012, J MATER SCI, V47, P4876, DOI 10.1007/s10853-012-6353-y
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Derrien AC, 2004, J THERM ANAL CALORIM, V75, P937, DOI 10.1023/B:JTAN.0000027187.14921.86
   Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z
   Gallego D, 2008, MAT SCI ENG C-BIO S, V28, P347, DOI 10.1016/j.msec.2007.04.020
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Greenspan D. C., 1994, EFFECT SURFACE AREA
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee WKW, 2002, COLLOID SURFACE A, V211, P115, DOI 10.1016/S0927-7757(02)00239-X
   Leivo J, 2006, ACTA BIOMATER, V2, P659, DOI 10.1016/j.actbio.2006.06.001
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Liew YM, 2012, CONSTR BUILD MATER, V30, P794, DOI 10.1016/j.conbuildmat.2011.12.079
   MacKenzie KJD, 2010, J MATER SCI, V45, P999, DOI 10.1007/s10853-009-4031-5
   Maltais Y, 1997, CEMENT CONCRETE RES, V27, P1009, DOI 10.1016/S0008-8846(97)00098-7
   Mami M, 2008, APPL SURF SCI, V254, P7386, DOI 10.1016/j.apsusc.2008.05.340
   Martin S., 2005, EUR CELLS MATER, V9, P71
   Nilsson M, 2002, J BIOMED MATER RES, V61, P600, DOI 10.1002/jbm.10268
   Oudadesse H, 2008, APPL SURF SCI, V255, P593, DOI 10.1016/j.apsusc.2008.06.086
   Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7
   Pacheco-Torgal F, 2008, CONSTR BUILD MATER, V22, P1939, DOI 10.1016/j.conbuildmat.2007.07.015
   Pangdaeng S, 2014, MATER DESIGN, V53, P269, DOI 10.1016/j.matdes.2013.07.018
   Rovnanik P, 2010, CONSTR BUILD MATER, V24, P1176, DOI 10.1016/j.conbuildmat.2009.12.023
   Sata V, 2012, CEMENT CONCRETE COMP, V34, P94, DOI 10.1016/j.cemconcomp.2011.09.003
   Somna K, 2011, FUEL, V90, P2118, DOI 10.1016/j.fuel.2011.01.018
   Sotya Astutiningsih H. W. A, 2010, J CIV ENG ARCHIT, V4, P11
   Tailby J, 2010, CEMENT CONCRETE RES, V40, P787, DOI 10.1016/j.cemconres.2009.12.003
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Temuujin J, 2009, J HAZARD MATER, V167, P82, DOI 10.1016/j.jhazmat.2008.12.121
   Todea M, 2012, CORROS SCI, V54, P299, DOI 10.1016/j.corsci.2011.09.032
   Torldttikul P., 2009, SCIENCEASIA, V35, P358
   Veiga KK, 2012, CONSTR BUILD MATER, V34, P494, DOI 10.1016/j.conbuildmat.2012.02.090
   Wang XJ, 2008, ACTA BIOMATER, V4, P1530, DOI 10.1016/j.actbio.2008.04.005
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   Yao X, 2009, THERMOCHIM ACTA, V493, P49, DOI 10.1016/j.tca.2009.04.002
   Zhang J, 2013, APPL SURF SCI, V280, P256, DOI 10.1016/j.apsusc.2013.04.144
NR 45
TC 10
Z9 10
U1 2
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 1
EP 6
DI 10.1016/j.msec.2015.02.039
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400001
PM 25842101
DA 2018-10-20
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Carbodiimide cross-linking of amniotic membranes in the presence of
   amino acid bridges
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Carbodiimide; Chemical modification; Amniotic membrane; Cross-linking
   bridge; Amino acid type
ID LINKED HYALURONIC-ACID; COMPRISING 2-HYDROXYETHYL METHACRYLATE; PIGMENT
   EPITHELIAL-CELLS; SHEET DELIVERY; CHEMICAL-COMPOSITION; CHITOSAN
   MATERIALS; ENDOTHELIAL-CELLS; GELATIN MEMBRANES; ANTERIOR-CHAMBER;
   ACRYLIC-ACID
AB The purpose of this study was to investigate the carbodiimide cross-linking of amniotic membrane (AM) in the presence of amino acid bridges. The biological tissues were treated with glycine, lysine, or glutamic acid and chemically cross-linked to examine the role of amino acid types in collagenous biomaterial processing. Results of zeta potential measurements showed that the use of uncharged, positively and negatively charged amino acids dictates the charge state of membrane surface. Tensile strength and water content measurements demonstrated that the addition of lysine molecules to the cross-linking system can increase the cross-linking efficiency and dehydration degree while the introduction of glutamic acid in the AM samples decreases the number of cross-links per unit mass of chemically modified tissue collagen. The differences in the cross-linking density further determined the thermal and biological stability by differential scanning calorimetry and in vitro degradation tests. As demonstrated in matrix permeability studies, the improved formation of covalent cross-linkages imposed by lysine facilitated construction of stronger cross-linking structures. In contrast, the added glycine molecules were insufficient to enhance the resistances of the proteinaceous matrices to thermal denaturation and enzymatic degradation. The cytocompatibility of these biological tissue membranes was evaluated by using human corneal epithelial cell cultures. Results of cell viability, metabolic activity, and pro-inflammatory gene expression level showed that the AM materials cross-linked with carbodiimide in the presence of different types of amino acids are well tolerated without evidence of detrimental effect on cell growth. In addition, the amino acid treated and carbodiimide cross-linked AM implants had good biocompatibility in the anterior chamber of the rabbit eye model. Our findings suggest that amino acid type is a very important engineering parameter to mediate carbodiimide cross-linking of AM collagen. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China. The author is grateful to
   Dr. David Hui-Kang Ma (Department of Ophthalmology, Chang Gung Memorial
   Hospital) and Miss Hsiao-Yun Cheng (Molecular Medicine Research Center,
   Chang Gung University) for technical assistance.
CR Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Burugapalli K, 2009, J BIOMAT SCI-POLYM E, V20, P1049, DOI [10.1163/156856209X444411, 10.1163/156856209X4444111]
   CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Highberger J. H., 1939, J AM CHEM SOC, V61, P2302
   Hu M, 1999, J BIOMED MATER RES, V47, P79, DOI 10.1002/(SICI)1097-4636(199910)47:1<79::AID-JBM11>3.0.CO;2-J
   Kim YH, 2011, J NEUROSCI METH, V202, P38, DOI 10.1016/j.jneumeth.2011.08.036
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2014, COLLOID SURFACE B, V122, P277, DOI 10.1016/j.colsurfb.2014.07.009
   Lai JY, 2014, RSC ADV, V4, P18871, DOI 10.1039/c4ra01930j
   Lai JY, 2014, CARBOHYD POLYM, V101, P203, DOI 10.1016/j.carbpol.2013.09.060
   Lai JY, 2014, MAT SCI ENG C-MATER, V34, P334, DOI 10.1016/j.msec.2013.09.026
   Lai JY, 2013, INT J NANOMED, V8, P4157, DOI 10.2147/IJN.S52731
   Lai JY, 2013, DRUG DES DEV THER, V7, P1273, DOI 10.2147/DDDT.S53759
   Lai JY, 2013, J BIOMED NANOTECHNOL, V9, P2048, DOI 10.1166/jbn.2013.1734
   Lai JY, 2013, J MATER SCI-MATER M, V24, P2201, DOI 10.1007/s10856-013-4961-y
   Lai JY, 2013, MAT SCI ENG C-MATER, V33, P3704, DOI 10.1016/j.msec.2013.04.059
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2013, INT J MOL SCI, V14, P2036, DOI 10.3390/ijms14012036
   Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Ma DHK, 2009, OCUL SURF, V7, P128
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884
   Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002
   Wang GX, 2006, ARTIF CELL BLOOD SUB, V34, P11, DOI 10.1080/10731190500428283
NR 45
TC 3
Z9 3
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 28
EP 36
DI 10.1016/j.msec.2015.02.021
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400004
PM 25842104
DA 2018-10-20
ER

PT J
AU Bartneck, M
   Topuz, F
   Tag, CG
   Sauer-Lehnen, S
   Warzecha, KT
   Trautwein, C
   Weiskirchen, R
   Tacke, F
AF Bartneck, Matthias
   Topuz, Fuat
   Tag, Carmen Gabriele
   Sauer-Lehnen, Sibille
   Warzecha, Klaudia Theresa
   Trautwein, Christian
   Weiskirchen, Ralf
   Tacke, Frank
TI Molecular response of liver sinusoidal endothelial cells on hydrogels
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Liver sinusoidal endothelial cells; Cell sorting; FACS; MACS; ICAM; VCAM
ID HEPATIC STELLATE CELLS; ISOLATED KUPFFER CELLS; PORTAL-HYPERTENSION;
   ADHESION MOLECULES; E-SELECTIN; FIBROSIS; ULTRASTRUCTURE; ANGIOGENESIS;
   PURIFICATION; HEPATOCYTES
AB There is a high demand for the isolation of primary endothelial cells for biomaterial endotheliazation studies, tissue engineering, and artificial organ development. Further, biomarkers for monitoring the response of endothelial cells in biomaterials science are required. We systematically compared two strategies for isolating liver sinusoidal endothelial cells (LSEC) from mouse liver. We demonstrate that fluorescence-activated cell sorting results in a considerably higher purity (similar to 97%) compared to magnetic-assisted cell sorting (similar to 80%), but is associated with a lower yield and recovery rate. Cell repellent polyethylene glycol (PEG) substrates affected the morphology of primary LSEC in culture and significantly downregulated the intracellular adhesion molecule (ICAM) and upregulated the vascular cell adhesion molecule (VCAM). This molecular response could partially be reverted by further modification with arginylglycylaspartic acid (RGD). Thus, usage of PEGylated materials may reduce, while applying RGD may support endotheliazation of materials, and we could relate LSEC attachment to their expression of ICAM and VCAM mRNA, suggesting their usage as biomarkers for endothelialization. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Bartneck, Matthias; Tag, Carmen Gabriele; Sauer-Lehnen, Sibille; Warzecha, Klaudia Theresa; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp Aachen, Dept Med 3, D-52074 Aachen, Germany.
   [Topuz, Fuat] Rhein Westfal TH Aachen, DWI eV, D-52056 Aachen, Germany.
   [Topuz, Fuat] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
   [Tag, Carmen Gabriele; Sauer-Lehnen, Sibille; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, D-52074 Aachen, Germany.
RP Tacke, F (reprint author), RWTH Univ Hosp Aachen, Dept Med 3, Pauwelsstr 30, D-52074 Aachen, Germany.
EM frank.tacke@gmx.net
OI Weiskirchen, Ralf/0000-0003-3888-0931
CR Bartneck M, 2014, MACROMOL BIOSCI, V14, P411, DOI 10.1002/mabi.201300362
   Bartneck M, 2012, ACS NANO, V6, P8767, DOI 10.1021/nn302502u
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Beer MV, 2012, ANAL BIOANAL CHEM, V403, P517, DOI 10.1007/s00216-012-5850-9
   BRAET F, 1994, LAB INVEST, V70, P944
   Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522
   DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006.
   DROCHMANS P, 1975, J CELL BIOL, V66, P1, DOI 10.1083/jcb.66.1.1
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   Ehling J, 2013, HEPATOLOGY, V58, P1517, DOI 10.1002/hep.26326
   Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Gulubova MV, 2002, HISTOCHEM J, V34, P67
   Harrington EO, 2006, LUNG, V184, P259, DOI 10.1007/s00408-005-2589-5
   Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x
   KATANO M, 1981, MICROBIOL IMMUNOL, V25, P1059, DOI 10.1111/j.1348-0421.1981.tb00112.x
   Liberek T, 2004, PERITON DIALYSIS INT, V24, P139
   Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550
   Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233
   POLLIACK A, 1978, BLOOD CELLS, V4, P301
   Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3
   Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x
   Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270
   SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509
   Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]
   Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909
   YAN HC, 1994, J IMMUNOL, V152, P3053
   Yokomori H, 2012, MICRON, V43, P129, DOI 10.1016/j.micron.2011.08.002
   You Q, 2013, BIOCHEM PHARMACOL, V86, P836, DOI 10.1016/j.bcp.2013.07.006
   ZAHLTEN RN, 1981, FED PROC, V40, P2460
   Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670
NR 33
TC 4
Z9 4
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 64
EP 72
DI 10.1016/j.msec.2015.02.045
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400009
PM 25842109
DA 2018-10-20
ER

PT J
AU Bernardes, FR
   Rodrigues, SF
   Silva, ES
   Reis, GS
   Silva, MBR
   Junior, AMJ
   Balancin, O
AF Bernardes, Fabiano R.
   Rodrigues, Samuel F.
   Silva, Eden S.
   Reis, Gedeon S.
   Silva, Mariana B. R.
   Junior, Alberto M. J.
   Balancin, Oscar
TI Analytical modeling of the thermomechanical behavior of ASTM F-1586 high
   nitrogen austenitic stainless steel used as a biomaterial under
   multipass deformation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Recrystallization; Precipitates; Z-phase
ID STRAIN-INDUCED PRECIPITATION; NB-BEARING; STATIC RECRYSTALLIZATION; HOT;
   NIOBIUM
AB Precipitation-recrystallization interactions in ASTM F-1586 austenitic stainless steel were studied by means of hot torsion tests with multipass deformation under continuous cooling, simulating an industrial laminating process. Samples were deformed at 0.2 and 03 at a strain rate of 1.0 s(-1), in a temperature range of 900 to 1200 degrees C and interpass times varying from 5 to 80 s. The tests indicate that the stress level depends on deformation temperature and the slope of the equivalent mean stress (EMS) vs. 1/F presents two distinct behaviors, with a transition at around 1100 degrees C, the non-recrystallization temperature (T-nr). Below the T-nr, strain-induced precipitation of Z-phase (NbCrN) occurs in short interpass times (t(pass) < 30 s), inhibiting recrystallization and promoting stepwise stress build-up with strong recovery, which is responsible for increasing the T-nr. At interpass times longer than 30s, the coalescence and dissolution of precipitates promote a decrease in the T-nr and favor the formation of recrystallized grains. Based on this evidence, the physical simulation of controlled processing allows for a domain refined grain with better mechanical properties. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Bernardes, Fabiano R.; Rodrigues, Samuel F.; Silva, Eden S.; Reis, Gedeon S.] Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mat & Mech, BR-65030005 Sao Luis, MA, Brazil.
   [Silva, Mariana B. R.; Junior, Alberto M. J.; Balancin, Oscar] Fed Univ Sao Carlos UFSCar, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Rodrigues, SF (reprint author), Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mat & Mech, Av Getulio Vargas 4, BR-65030005 Sao Luis, MA, Brazil.
EM samuel.filgueiras@ifma.edu.br
RI Silva, Mariana/G-5147-2015; Rodrigues, Samuel/I-2873-2017
OI Silva, Mariana/0000-0001-5044-5436; Rodrigues,
   Samuel/0000-0003-0002-4566
FU CAPES (Federal Agency for the Support and Improvement of Higher
   Education); CNPq (National Council for Scientific and Technological
   Development); FAPEMA (Maranhao Foundation for Scientific Research and
   Development)
FX The authors thank the Brazilian research funding agencies CAPES (Federal
   Agency for the Support and Improvement of Higher Education), CNPq
   (National Council for Scientific and Technological Development) and
   FAPEMA (Maranhao Foundation for Scientific Research and Development) for
   their financial support of this work.
CR ANDERSEN I, 1995, ACTA METALL MATER, V43, P2673, DOI 10.1016/0956-7151(94)00488-4
   BAI DQ, 1993, METALL TRANS A, V24, P2151, DOI 10.1007/BF02648589
   Boratto F., 1988, ISIJ INT TOKYO, P383
   Cuddy L.J., 1982, THERMOMECHANICAL PRO, P129
   Ernrman J., 2004, ACTA MAT, V52, P4337
   Giordani EJ, 2006, SCRIPTA MATER, V55, P743, DOI 10.1016/j.scriptamat.2006.05.015
   Giordani E.J., 2001, MAT SCI ENG C
   Giordani EJ, 2005, MATER SCI FORUM, V500-501, P179, DOI 10.4028/www.scientific.net/MSF.500-501.179
   Gomez M, 2009, MAT SCI ENG A-STRUCT, V501, P188, DOI 10.1016/j.msea.2008.09.074
   HANSEN SS, 1980, METALL TRANS A, V11, P387, DOI 10.1007/BF02654563
   JACK DH, 1973, MATER SCI ENG, V11, P1, DOI 10.1016/0025-5416(73)90055-4
   MEDINA SF, 1995, SCRIPTA METALL MATER, V32, P43, DOI 10.1016/S0956-716X(99)80009-0
   Mousavi Anijdan SH, 2011, MAT SCI ENG A-STRUCT, V528, P803
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Pollak E.l., 1996, ACTA MAT, V44
   Rodrigues SF, 2014, MATER RES-IBERO-AM J, V17, P436, DOI [10.1590/S1516-14392014005000001, 10.1590/S1516-14392014000200023]
   Sakai T, 2014, PROG MATER SCI, V60, P130, DOI 10.1016/j.pmatsci.2013.09.002
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Sousa R.C., 2012, MAT SCI ENG A-STRUCT, V582, P96
NR 20
TC 1
Z9 1
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 87
EP 98
DI 10.1016/j.msec.2015.02.040
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400012
PM 25842112
DA 2018-10-20
ER

PT J
AU Linan, LZ
   Lima, NMN
   Maciel, R
   Sabino, MA
   Kozlowski, MT
   Manenti, F
AF Linan, Lamia Zuniga
   Nascimento Lima, Nadson M.
   Maciel Filho, Rubens
   Sabino, Marcos A.
   Kozlowski, Mark T.
   Manenti, Flavio
TI Pilot-scale synthesis and rheological assessment of poly(methyl
   methacrylate) polymers: Perspectives for medical application
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; PMMA; Synthesis; Viscoelastic properties; Molecular weight
ID BATCH POLYMERIZATION REACTOR; MOLECULAR-WEIGHT CONTROL; POROUS
   POLYMETHYLMETHACRYLATE; VISCOELASTIC PROPERTIES; PREDICTIVE CONTROL;
   BONE-CEMENT; PMMA; ENTANGLEMENT; SPECTROSCOPY; IMPLANTS
AB This work presents the rheological assessment of poly(methyl methacrylate) (PMMA) polymers synthesized in a dedicated pilot-scale plant. This material is to be used for the construction of scaffolds via Rapid Prototyping (RP). The polymers were prepared to match the physical and biological properties required for medical applications. Differential Scanning Calorimetry (DSC) and Size Exclusion Chromatography (SEC) measurements verified that the synthesized polymers were atactic, amorphous and linear in chains. Rheological properties such as viscosity, storage and loss modulus, beyond the loss factor, and creep and recovery were measured in a plate-plate sensor within the viscoelastic linear region. The results showed the relevant influence of the molecular weight on the viscosity and elasticity of the material, and how, as the molecular weight increases, the viscoelastic properties are getting closer to those of human bone. This article demonstrates that by using the implemented methodology it is possible to synthesize a polymer, with properties comparable to commercially-available PMMA. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Linan, Lamia Zuniga; Nascimento Lima, Nadson M.; Maciel Filho, Rubens] Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
   [Sabino, Marcos A.] Univ Simon Bolivar, Dept Quim, Grp B5IDA, Caracas 1080A, Venezuela.
   [Kozlowski, Mark T.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
   [Manenti, Flavio] Politecn Milan, Dipartamento Chim Mat & Ingn Chim, I-20133 Milan, Italy.
RP Linan, LZ (reprint author), Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
EM lazuli@feq.unicamp.br; nadson@feq.unicamp.br; maciel@feq.unicamp.br;
   msabino@usb.ve; kozthought@gmail.com; flavio.manenti@polimi.it
RI Lima, Nadson/E-8572-2014; FAPESP, BIOEN/H-6149-2012
OI Manenti, Flavio/0000-0002-3305-8044
FU Sao Paulo State Research Support Foundation/Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57860-3, 2009/09092-0,
   2011/09631-8, 2010/16952-2]; National Counsel of Technological and
   Scientific Development (CNPq)/INCT-BIOFABRIS/FEQ/UNICAMP [573661/2008-1]
FX This work was supported by the Sao Paulo State Research Support
   Foundation/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP), Grant numbers 2008/57860-3, 2009/09092-0, 2011/09631-8, and
   2010/16952-2 and by the National Counsel of Technological and Scientific
   Development (CNPq)/INCT-BIOFABRIS/FEQ/UNICAMP, Grant number
   573661/2008-1.
CR Ahn SM, 1998, J APPL POLYM SCI, V69, P59, DOI 10.1002/(SICI)1097-4628(19980705)69:1<59::AID-APP8>3.0.CO;2-L
   Antunes AJB, 2005, COMPUT CHEM ENG, V30, P268, DOI 10.1016/j.compchemeng.2005.09.002
   Bruens ML, 2003, J CRANIOFAC SURG, V14, P63, DOI 10.1097/00001665-200301000-00011
   Buechner PM, 2001, ANN BIOMED ENG, V29, P719, DOI 10.1114/1.1385813
   CHANG JS, 1992, IND ENG CHEM RES, V31, P861, DOI 10.1021/ie00003a031
   Chang JS, 1999, IND ENG CHEM RES, V38, P144, DOI 10.1021/ie980403w
   CONGALIDIS JP, 1989, AICHE J, V35, P891, DOI 10.1002/aic.690350603
   Dalosto V.J., 2005, THESIS U FEDERAL RIO
   De Almeida S.G., BIOMATERIAIS
   Eckstein A, 1998, MACROMOLECULES, V31, P1335, DOI 10.1021/ma971270d
   Espalin D, 2010, RAPID PROTOTYPING J, V16, P164, DOI 10.1108/13552541011034825
   Fetters LJ, 1999, MACROMOLECULES, V32, P6847, DOI 10.1021/ma990620o
   Frazer Robert Q, 2005, J Long Term Eff Med Implants, V15, P629
   Fuchs K, 1996, MACROMOLECULES, V29, P5893, DOI 10.1021/ma951385m
   Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541
   Kretlow JD, 2010, TISSUE ENG PART C-ME, V16, P1427, DOI 10.1089/ten.tec.2010.0046
   Lima NMN, 2013, COMPUT-AIDED CHEM EN, V32, P163
   Lima NMN, 2010, AICHE J, V56, P965, DOI 10.1002/aic.12030
   Liulan L, 2007, J RARE EARTH, V25, P379
   Mano JF, 2005, MAT SCI ENG C-BIO S, V25, P145, DOI 10.1016/j.msec.2005.01.017
   Mendes R., THESIS
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Muenstedt H, 2008, MACROMOLECULES, V41, P9777, DOI 10.1021/ma800237x
   Pahija E, 2013, COMPUT-AIDED CHEM EN, V32, P805
   Rho HJ, 1998, CHEM ENG SCI, V53, P3729, DOI 10.1016/S0009-2509(98)00166-3
   Salmoria GV, 2008, PROC MONOGR ENG WATE, P305
   Santos JGF, 2006, MACROMOL SYMP, V243, P1, DOI 10.1002/masy.200651101
   Simon PFW, 2001, MACROMOLECULES, V34, P1677, DOI 10.1021/ma0014766
   Stanczyk M, 2005, J BIOMECH, V38, P1397, DOI 10.1016/j.jbiomech.2004.06.021
   TUMINELLO WH, 1986, POLYM ENG SCI, V26, P1339, DOI 10.1002/pen.760261909
   Zuniga L., 2012, COMPUTER AIDED CHEM, V30, P1352
NR 31
TC 2
Z9 2
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2015
VL 51
BP 107
EP 116
DI 10.1016/j.msec.2015.02.038
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CH0XT
UT WOS:000353746400014
PM 25842114
DA 2018-10-20
ER

PT J
AU Shao, Y
   Sang, JM
   Fu, JP
AF Shao, Yue
   Sang, Jianming
   Fu, Jianping
TI On human pluripotent stem cell control: The rise of 3D bioengineering
   and mechanobiology
SO BIOMATERIALS
LA English
DT Review
DE Human pluripotent stem cells; Mechanobiology; Bioengineering;
   Regenerative medicine; Development; Human disease modeling
ID SELF-RENEWAL; HIPPO PATHWAY; TUMOR-SUPPRESSOR; IN-VITRO; CARDIOMYOCYTE
   PROLIFERATION; FUNCTIONAL MATURATION; CYTOSKELETAL TENSION;
   ALZHEIMERS-DISEASE; MECHANICAL STRAIN; MEDIATED CONTROL
AB Human pluripotent stem cells (hPSCs) provide promising resources for regenerating tissues and organs and modeling development and diseases in vitro. To fulfill their promise, the fate, function, and organization of hPSCs need to be precisely regulated in a three-dimensional (3D) environment to mimic cellular structures and functions of native tissues and organs. In the past decade, innovations in 3D culture systems with functional biomaterials have enabled efficient and versatile control of hPSC fate at the cellular level. However, we are just at the beginning of bringing hPSC-based regeneration and development and disease modeling to the tissue and organ levels. In this review, we summarize existing bioengineered culture platforms for controlling hPSC fate and function by regulating inductive mechanical and biochemical cues coexisting in the synthetic cell microenvironment. We highlight recent excitements in developing 3D hPSC-based in vitro tissue and organ models with in vivolike cellular structures, interactions, and functions. We further discuss an emerging multifaceted mechanotransductive signaling network with transcriptional coactivators YAP and TAZ at the center stage that regulate fates and behaviors of mammalian cells, including hPSCs. Future development of 3D biomaterial systems should incorporate dynamically modulated mechanical and chemical properties targeting specific intracellular signaling events leading to desirable hPSC fate patterning and functional tissue formation in 3D. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Shao, Yue; Sang, Jianming; Fu, Jianping] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Fu, Jianping] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Fu, JP (reprint author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
EM jpfu@umich.edu
RI Shao, Yue/M-4183-2016; Fu, Jianping/C-9605-2009
OI Shao, Yue/0000-0001-7548-3551; Fu, Jianping/0000-0001-9629-6739
FU National Science Foundation [CMMI 1129611, CBET 1149401, ECCS 1231826,
   CBET 1263889]; National Institutes of Health [R21 HL114011, R21
   EB017078, R01 HL119542]; American Heart Association [12SDG12180025];
   Department of Mechanical Engineering at the University of Michigan, Ann
   Arbor
FX We acknowledge valuable comments and suggestions on the manuscript from
   members of the Integrated Biosystems and Biomechanics Laboratory.
   Research in Dr. Fu's laboratory is supported by the National Science
   Foundation (CMMI 1129611, CBET 1149401, ECCS 1231826, and CBET 1263889),
   the National Institutes of Health (R21 HL114011, R21 EB017078, and R01
   HL119542), the American Heart Association (12SDG12180025), and the
   Department of Mechanical Engineering at the University of Michigan, Ann
   Arbor. Finally, we extend our apologies to all our colleagues in the
   field whose work we are unable to discuss formally because of space
   constraints.
CR Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013
   Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693
   Bauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050491
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027
   Blauwkamp TA, 2012, NAT COMMUN, P3
   Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007
   Bratt-Leal AM, 2013, BIOMATERIALS, V34, P7227, DOI 10.1016/j.biomaterials.2013.05.079
   Bratt-Leal AM, 2011, INTEGR BIOL-UK, V3, P1224, DOI 10.1039/c1ib00064k
   Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113
   Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445
   Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Codelia VA, 2014, CURR BIOL, V24, P2012, DOI 10.1016/j.cub.2014.07.034
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dave PC, 2014, NAT MATER, V13, P532, DOI 10.1038/nmat3997
   Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dixon JE, 2014, P NATL ACAD SCI USA, V111, P5580, DOI 10.1073/pnas.1319685111
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540
   Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Fung WT, 2009, LAB CHIP, V9, P2591, DOI [10.1039/b903753e, 10.1039/b903753c]
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039
   Hazeltine LB, 2013, BIOTECHNOL ADV, V31, P1002, DOI 10.1016/j.biotechadv.2013.03.002
   Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010
   Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Hoist J, 2010, NAT BIOTECHNOL, V28, P1123
   Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Irwin EE, 2011, BIOMATERIALS, V32, P6912, DOI 10.1016/j.biomaterials.2011.05.058
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778
   Keung AJ, 2012, INTEGR BIOL-UK, V4, P1049, DOI 10.1039/c2ib20083j
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim JA, 2013, BIOMATERIALS, V34, P8555, DOI 10.1016/j.biomaterials.2013.07.056
   Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Kinney M, 2013, ANN BIOMED ENG, V42, P352
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832
   Kusuma S, 2013, P NATL ACAD SCI USA, V110, P12601, DOI 10.1073/pnas.1306562110
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee CY, 2013, P NATL ACAD SCI USA, V110, P5022, DOI 10.1073/pnas.1218407110
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811
   Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111
   Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070
   Lim HL, 2011, ADV FUNCT MATER, V21, P55, DOI 10.1002/adfm.201001519
   Ma Z, 2013, BIOMATERIALS, V35, P1367
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Mahlstedt MM, 2010, BIOTECHNOL BIOENG, V105, P130, DOI 10.1002/bit.22520
   Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meregalli M, 2011, STEM CELL CLIN RES, P17
   Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513
   Mitalipov S, 2009, ADV BIOCHEM ENG BIOT, V114, P185, DOI 10.1007/10_2008_45
   Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   Musah S, 2014, P NATL ACAD SCI USA, V111, P13805, DOI 10.1073/pnas.1415330111
   Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nawroth JC, 2013, BIOTECHNOL ADV, V31, P632, DOI 10.1016/j.biotechadv.2012.12.005
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018
   Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014
   Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Reddy BVVG, 2013, DEV CELL, V24, P459, DOI [10.1016/j.devce1.2013.01.020, 10.1016/j.devcel.2013.01.020]
   Remue E, 2010, FEBS LETT, V584, P4175, DOI 10.1016/j.febslet.2010.09.020
   Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891
   Samuel R, 2013, P NATL ACAD SCI USA, V110, P12774, DOI 10.1073/pnas.1310675110
   Sara SN, 2013, NAT METHODS, V10, P781
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873
   Shao Y, 2014, ADV MATER, V26, P1494, DOI 10.1002/adma.201304431
   Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014
   Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Stenberg J, 2011, CYTOTECHNOLOGY, V63, P227, DOI 10.1007/s10616-011-9344-y
   SUDOL M, 1994, ONCOGENE, V9, P2145
   Sun GP, 2013, SCI SIGNAL, V6
   Sun YB, 2014, ACS CHEM NEUROSCI, V5, P621, DOI 10.1021/cn5001155
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Sun YB, 2013, INTEGR BIOL-UK, V5, P450, DOI 10.1039/c2ib20256e
   Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110
   Thaxton C, 2007, MOL CELL NEUROSCI, V34, P231, DOI 10.1016/j.mcn.2006.11.003
   Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748
   Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007
   Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Visser-Grieve S, 2011, CELL RES, V21, P1513, DOI 10.1038/cr.2011.122
   Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987
   Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]
   Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107
   Yang Kisuk, 2012, Int J Stem Cells, V5, P1
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025
   Young HE, 2004, ANAT REC PART A, V276A, P75, DOI 10.1002/ar.a.10134
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113
   Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037
   Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111
   Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810
   Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997
   Zweigerdt R, 2009, ADV BIOCHEM ENG BIOT, V114, P201, DOI 10.1007/10_2008_27
NR 170
TC 39
Z9 40
U1 4
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2015
VL 52
BP 26
EP 43
DI 10.1016/j.biomaterials.2015.01.078
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG2FT
UT WOS:000353091000003
PM 25818411
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Andreasen, CM
   Ding, M
   Overgaard, S
   Bollen, P
   Andersen, TL
AF Andreasen, Christina M.
   Ding, Ming
   Overgaard, Soren
   Bollen, Peter
   Andersen, Thomas L.
TI A reversal phase arrest uncoupling the bone formation and resorption
   contributes to the bone loss in glucocorticoid treated ovariectomised
   aged sheep
SO BONE
LA English
DT Article
DE Glucocorticoid-induced osteoporosis; Bone remodelling; Reversal phase;
   Coupling; Bone markers; Sheep model
ID LARGE ANIMAL-MODEL; REMODELING COMPARTMENT CANOPIES; CANCELLOUS BONE;
   TRABECULAR BONE; POSTMENOPAUSAL OSTEOPOROSIS; MECHANICAL-PROPERTIES;
   MICROARCHITECTURE; CELLS; VALIDATION; INCREASE
AB Large animals as sheep are often used as models for human osteoporosis. Our aim was therefore to determine how glucocorticoid treatment of ovariectomised sheep affects the cancellous bone, determining the cellular events within the bone remodelling process that contributes to their bone loss. Twenty female sheep were assigned for two groups; an untreated control group and an ovariectomised group treated with glucocorticoids (0.6 mg/kg/day, 5 times weekly) for 7 months.
   At 7 months the glucocorticoid-treated ovariectomised sheep showed a significant change in the bone microstructure revealed by a decreased trabecular bone volume and thickness compared to the control sheep. The treatment led to a temporary elevation of the bone resorption marker CTX (c-terminal collagen telopeptide), while the bode formation marker osteocalcin remained suppressed all 7 months. Histomorphometrically, the treated sheep had a complete absence of osteoid surfaces, and a 5-fold increase in the extent of eroded/reversal surfaces after 7 months. Most of these reversal surfaces were actually arrested reversal surfaces, defined as reversal surfaces without the presence of neighbouring osteoid surfaces or osteoclasts, which is classically observed next to active reversal surfaces. As in humans, these arrested reversal surfaces had compared to active reversal surfaces a reduced canopy coverage, a significantly decreased cell density, and a decreased immunoreactivity for the osteoblastic markers osterix, runx2 and smooth muscle actin in the mononutlear reversal cells colonising the surfaces.
   In conclusion, glucocorticoid treatment of ovariectomised sheep induced a significant bone loss, caused by an arrest of the reversal phase, resulting in an uncoupling of the bone formation and resorption during the reversal phase, as recently demonstrated in postmenopausal women with glucocorticoid-induced osteoporosis. This supports the relevance of the sheep model to the pathophysiology of glucocorticoid-induced osteoporosis in postmenopausal women, making it a relevant preclinical model for orthopaedic implant and biomaterial research. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Andreasen, Christina M.; Ding, Ming; Overgaard, Soren] Univ Southern Denmark, Odense Univ Hosp, Dept Orthopaed & Traumatol O, Orthopaed Res Lab,Inst Clin Res, DK-5000 Odense C, Denmark.
   [Bollen, Peter] Univ Southern Denmark, Biomed Lab, DK-5000 Odense C, Denmark.
   [Andersen, Thomas L.] Univ Southern Denmark, Inst Reg Hlth Res, Dept Clin Cell Biol KCB, Vejle Hosp,Lillebaelt Hosp, DK-7100 Vejle, Denmark.
RP Andreasen, CM (reprint author), Odense Univ Hosp, Orthopaed Res Lab, Dept Orthopaed Surg & Traumatol O, JB Winslowsvej 15, DK-5000 Odense C, Denmark.
EM cmandreasen@health.sdu.dk; ming.ding@rsyd.dk; Soeren.overgaard@rsyd.dk;
   PBollen@health.sdu.dk; thomas.levin.andersen@rsyd.dk
OI Andreasen, Christina M./0000-0002-2624-5677; Ding,
   Ming/0000-0002-6610-8079; Levin Andersen, Thomas/0000-0002-6981-7276;
   Overgaard, Soren/0000-0001-6829-4787
FU Region of Southern Denmark Research Fund [10-5110, 10-15629]; University
   of Southern Denmark [2010-11202]
FX We are thankful to: Gitte Hojlund Reinberg, Birgit MacDonald, Kaja Rau
   Laursen for their excellent technical assistance, Karen Bentsen for the
   preparation of drug solutions and blood samples, and the staff of the
   Biomedical Laboratory for taking good care of the animals. This study is
   supported by the Region of Southern Denmark Research Fund (MD, J nr.
   10-5110 and 10-15629), and the University of Southern Denmark for 1 year
   PhD fellowship to CMA (November 2010-11202).
CR Andersen TL, 2014, AM J PATHOL, V184, P1142, DOI 10.1016/j.ajpath.2013.12.005
   Andersen TL, 2013, AM J PATHOL, V183, P235, DOI 10.1016/j.ajpath.2013.03.006
   Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627
   Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415
   Augat P, 2003, J BIOMED MATER RES A, V66A, P457, DOI 10.1002/jbm.a.10601
   Baron R, 1983, CLIN DISORDERS BONE, P191
   Baron R, 1980, REVERSAL PHASE OSTEO, P311
   Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7
   Carbonare LD, 2001, J BONE MINER RES, V16, P97, DOI 10.1359/jbmr.2001.16.1.97
   CHAVASSIEUX P, 1993, OSTEOPOROSIS INT, V3, P97, DOI 10.1007/BF01623380
   Chavassieux P, 1997, BONE, V20, P451, DOI 10.1016/S8756-3282(97)00016-1
   Delaisse Jean-Marie, 2014, Bonekey Rep, V3, P561, DOI 10.1038/bonekey.2014.56
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Ding M, 2002, J ORTHOPAED RES, V20, P615, DOI 10.1016/S0736-0266(01)00132-2
   Ding M, 2012, J TISSUE ENG REGEN M, V6, P443, DOI 10.1002/term.448
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Dovio A, 2006, EUR J ENDOCRINOL, V154, P745, DOI 10.1530/eje.1.02147
   Dovio A, 2004, J CLIN ENDOCR METAB, V89, P4923, DOI 10.1210/jc.2004-0164
   ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402
   ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379
   Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77
   Goldhahn J, 2005, J ORTHOP TRAUMA, V19, P23, DOI 10.1097/00005131-200501000-00005
   Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Jensen PA, 2011, J BONE MINER RES  S1, V26, P57
   Jensen PR, 2014, BIOCHEM BIOPH RES CO, V443, P694, DOI 10.1016/j.bbrc.2013.12.036
   Jensen PR, 2012, J BONE MINER RES, V27, P770, DOI 10.1002/jbmr.1490
   Kristensen HB, 2014, AM J PATHOL, V184, P778, DOI 10.1016/j.ajpath.2013.11.022
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047
   Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2
   Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0
   Oheim R, 2012, EUR CELLS MATER, V24, P372, DOI 10.22203/eCM.v024a27
   Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583
   RIGGS BL, 1991, WESTERN J MED, V154, P63
   Rothberg DL, 2015, CURR OSTEOPOROS REP, V13, P16, DOI 10.1007/s11914-014-0245-9
   Saag KG, 2012, BULL HOSP JT DIS, V70, pS21
   Schorlemmer S, 2003, J BONE MINER RES, V18, P2010, DOI 10.1359/jbmr.2003.18.11.2010
   Soe K, 2013, BONE, V56, P191, DOI 10.1016/j.bone.2013.06.007
   Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113
   Turner AS, 2002, VET J, V163, P232, DOI 10.1053/tvjl.2001.0642
   Veigel E, 2011, OSTEOPOROSIS INT, V22, P1115, DOI 10.1007/s00198-010-1289-z
   Weinstein R S, 2001, Rev Endocr Metab Disord, V2, P65, DOI 10.1023/A:1010007108155
   Wu ZX, 2008, MED ENG PHYS, V30, P1112, DOI 10.1016/j.medengphy.2008.01.007
   Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8
NR 45
TC 12
Z9 13
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD JUN
PY 2015
VL 75
BP 32
EP 39
DI 10.1016/j.bone.2015.02.014
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CG1ZQ
UT WOS:000353075100005
PM 25689083
DA 2018-10-20
ER

PT J
AU Iqbal, N
   Kadir, MRA
   Bin Mahmood, NH
   Iqbal, S
   Almasi, D
   Naghizadeh, F
   Balaji, HR
   Kamarul, T
AF Iqbal, Nida
   Kadir, Mohammed Rafiq Abdul
   Bin Mahmood, Nasrul Humaimi
   Iqbal, Saman
   Almasi, D.
   Naghizadeh, Farnaz
   Balaji, H. R.
   Kamarul, Tunku
TI Characterization and biological evaluation of silver containing
   fluoroapatite nanoparticles prepared through microwave synthesis
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Bioactivity; Antibacterial; Metal ions; Microwave; Cell
   culture
ID FLUORIDATED HYDROXYAPATITE COATINGS; ANTIBACTERIAL PROPERTIES;
   SUBSTITUTED HYDROXYAPATITE; CALCIUM HYDROXYAPATITE; BONE; BIOCERAMICS;
   BIOACTIVITY; PHOSPHATES; DEPOSITION; COMPOSITE
AB Nanosized hydroxyapatite is a material that is commonly used as a matrix for bone tissue engineering. Although its chemical property is similar to that of natural bone, its limited antibacterial property has made it less desirable for use in present-day clinical applications. In the present study, we have investigated the possibility of improving the antibacterial and bioactivity of hydroxyapatite, by producing nanosized silver-containing fluorapatite, using the microwave technique.
   Nanosized silver-fluorapatite particles were synthesized using 0.5 and 1=x fluoride through co-precipitation and the microwave refluxing treatment at 800 W, for 8 min. The crystalline phase, chemical composition, and morphology of the prepared samples were characterized using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), energy dispersive X-ray analysis (EDX), and transmission electron microscopy (TEM). The chemical analysis indicated the presence of a nanosized silver-fluorapatite phase. Transmission electron microscopy analysis showed a spheroid-like morphology, with an approximate diameter of +/- 76-92 nm. The bioactivity of the prepared samples, which was evaluated using simulated body fluid (SBF) immersion for 28 days, demonstrated good apatite layer formation. The antibacterial activity was evaluated using the disk diffusion method and showed good growth inhibition, while the osteoblast culture studies indicated that the presence of silver and fluoride provided superior cell attachment and growth. The antibacterial and cell culture results indicated that this new nanosized silver-fluorapatite bioceramic material had good antibacterial qualities, but remained biocompatible with osteoblasts. These findings suggested that nanosized silver-fluorapatite could potentially be used for bone regeneration applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Iqbal, Nida; Kadir, Mohammed Rafiq Abdul; Bin Mahmood, Nasrul Humaimi; Naghizadeh, Farnaz] Univ Teknol Malaysia UTM, Fac Biosci & Med Engn, Med Devices & Technol Grp MEDITEG, Johor Baharu 81310, Johor, Malaysia.
   [Iqbal, Saman] Univ Engn & Technol, Dept Phys, Lahore, Pakistan.
   [Almasi, D.] Univ Teknol Malaysia, Fac Mech Engn, Dept Mfg & Ind Engn, Skudai 81310, Johor, Malaysia.
   [Balaji, H. R.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg NOCERAL, Kuala Lumpur, Malaysia.
RP Kadir, MRA (reprint author), Univ Teknol Malaysia UTM, Fac Biosci & Med Engn, Med Devices & Technol Grp MEDITEG, Johor Baharu 81310, Johor, Malaysia.
EM rafiq@biomedical.utm.my
RI Abdul Kadir, Mohammed/D-1117-2010; balaji raghavendran, hanumantha
   rao/B-8507-2012; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313
FU UTM [45027]; HIR-Ministry of Education University of Malaya
   [UM.C/625/1/HIR/MOHE/CHAN/o3-A000003-50001]
FX The authors would like to acknowledge the Institute of Medical Molecular
   Biotechnology (IMMB), Faculty of Medicine UiTM for providing cell
   culture facilities. The authors would also like to acknowledge the
   financial support provided by UTM research grant science funding (Vote:
   45027) and HIR-Ministry of Education
   (UM.C/625/1/HIR/MOHE/CHAN/o3-A000003-50001) University of Malaya.
CR Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016
   Ann L.C., 2014, J ENV CHEM ENG
   Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Fathi MH, 2006, SURF ENG, V22, P353, DOI 10.1179/174329406X126708
   Fleet ME, 2000, J SOLID STATE CHEM, V149, P391, DOI 10.1006/jssc.1999.8563
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hristoffersen J., 1984, J CRYST GROWTH, V67, P102
   Hund W, 1998, CFI-CERAM FORUM INT, V75, P13
   Iconaru SL, 2012, DIG J NANOMATER BIOS, V7, P399
   Iqbal N, 2014, CERAM INT, V40, P16091, DOI 10.1016/j.ceramint.2014.07.038
   Iqbal N, 2013, ADV MATER RES-SWITZ, V795, P692, DOI 10.4028/www.scientific.net/AMR.795.692
   Iqbal N, 2014, CERAM INT, V40, P4507, DOI 10.1016/j.ceramint.2013.08.125
   Iqbal N, 2013, MATER RES BULL, V48, P3172, DOI 10.1016/j.materresbull.2013.04.068
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kolmas J, 2014, BIOMED RES INT, DOI 10.1155/2014/178123
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   MARQUIS RE, 1995, CAN J MICROBIOL, V41, P955, DOI 10.1139/m95-133
   Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x
   Nie YL, 2012, J HAZARD MATER, V233, P194, DOI 10.1016/j.jhazmat.2012.07.020
   Pripatnanont P, 2007, J ORAL MAXIL SURG, V65, P2418, DOI 10.1016/j.joms.2007.06.619
   Qu HB, 2006, ACTA BIOMATER, V2, P113, DOI 10.1016/j.actbio.2005.09.003
   Rameshbabu N, 2006, B MATER SCI, V29, P611, DOI 10.1007/s12034-006-0012-3
   Solignac M, 1998, PRESSE MED, V27, P27
   Spivak JM, 2001, EUR SPINE J, V10, pS197, DOI 10.1007/s005860100286
   Sun F, 2013, J BIOMED NANOTECHNOL, V9, P1914, DOI 10.1166/jbn.2013.1687
   Tredwin CJ, 2013, DENT MATER, V29, P166, DOI 10.1016/j.dental.2012.11.008
   Turkoz M, 2013, CERAM INT, V39, P8925, DOI 10.1016/j.ceramint.2013.04.088
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Victoria E. Caroline, 2002, TRENDS BIOMATER ARTI, V16, P12
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Wang YS, 2007, ACTA BIOMATER, V3, P191, DOI 10.1016/j.actbio.2006.10.002
   Zhang HG, 2006, J MATER SCI-MATER M, V17, P691, DOI 10.1007/s10856-006-9679-7
   Zhu HL, 2013, ASIAN J CHEM, V25, P8444, DOI 10.14233/ajchem.2013.14779
NR 41
TC 12
Z9 12
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN
PY 2015
VL 41
IS 5
BP 6470
EP 6477
DI 10.1016/j.ceramint.2015.01.086
PN A
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA CG3JK
UT WOS:000353176300046
DA 2018-10-20
ER

PT J
AU Agyemang, FO
   Sheikh, FA
   Appiah-Ntiamoah, R
   Chandradass, J
   Kim, H
AF Agyemang, Frank Ofori
   Sheikh, Faheem A.
   Appiah-Ntiamoah, Richard
   Chandradass, Jeyaseelan
   Kim, Hern
TI Synthesis and characterization of poly (vinylidene fluoride)-calcium
   phosphate composite for potential tissue engineering applications
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Poly (vinylidene fluoride); Calcium phosphate; Scaffolds; Bio-composite;
   Tensile strength
ID POLY(VINYLIDENE FLUORIDE); POLYVINYLIDENE FLUORIDE; PVDF MEMBRANES;
   BOVINE BONES; HYDROXYAPATITE; BIOMATERIALS; EXTRACTION; MORPHOLOGY;
   BEHAVIOR; MINERALIZATION
AB Tricalcium phosphate is the most commonly used biomaterial because of its good biocompatibility. However, its poor mechanical strength under complex stress and powder-like appearance hinder its application. The use of a composite biomaterial which maintains a fine balance between excellent mechanical properties and biocompatibility can be a solution to this problem. In the present study, we aimed to fabricate porous composite scaffolds via phase-inversion technique without using any additional toxic chemicals which can interfere with their biocompatibility. The composite materials fabricated of poly (vinylidene fluoride) and tricalcium phosphates were prepared, using polyvinyl pyrrolidone as a dispersant. The resulting scaffolds were characterized by using attenuated total reflection infrared spectroscopy (FTIR-ATR), scanning electron microscopy (SEM), therm gravimetric analysis (TGA), differential scanning calorimetry (DSC), X-ray diffraction (XRD) and universal tensile strength (UTM) analysis. The composites showed well blend of materials and internal porous structures. The XRD results indicated a mixture of alpha and beta-phases due to successful incorporation of tricalcium phosphate in polymer blends, thereby, exhibiting a crystalline structure. The fabricated composites showed an efficient thermal stability at around 400 degrees C. The tensile strength of scaffolds increased from 140 +/- 1.6 to 148 +/- 2.2 g/mm(2), which makes the composite scaffold potential candidate for hard tissue applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Agyemang, Frank Ofori; Sheikh, Faheem A.; Appiah-Ntiamoah, Richard; Chandradass, Jeyaseelan; Kim, Hern] Myongji Univ, Environm Fus Technol Ctr, Dept Energy & Biotechnol, Yongin 449728, Gyeonggi Do, South Korea.
RP Kim, H (reprint author), Myongji Univ, Environm Fus Technol Ctr, Dept Energy & Biotechnol, Yongin 449728, Gyeonggi Do, South Korea.
EM faheem99in@yahoo.com; hernkim@mju.ac.kr
RI Sheikh, Faheem/Q-9166-2018
OI Sheikh, Faheem/0000-0003-0942-4398
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT
   and Future Planning [2014R1A2A2A01004352]; Ministry of Education,
   Republic of Korea [2009-0093816]
FX This study was supported by National Research Foundation of Korea (NRF)
   - Grants funded by the Ministry of Science, ICT and Future Planning
   (2014R1A2A2A01004352) and the Ministry of Education, Republic of Korea
   (2009-0093816).
CR AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Aoki N, 1997, BBA-GEN SUBJECTS, V1334, P207, DOI 10.1016/S0304-4165(96)00094-3
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BALLINTYN NJ, 1979, BIOMATER ARTIF CELL, V7, P23, DOI 10.3109/10731197909119369
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Barakat NAM, 2008, MAT SCI ENG C-BIO S, V28, P1381, DOI 10.1016/j.msec.2008.03.003
   Boccaccio T, 2002, J MEMBRANE SCI, V210, P315, DOI 10.1016/S0376-7388(02)00407-6
   Bottino A, 2001, SEP PURIF TECHNOL, V22-3, P269, DOI 10.1016/S1383-5866(00)00127-1
   Coles LG, 2014, P I MECH ENG H, V228, P1217, DOI 10.1177/0954411914560835
   Dey A, 2011, CERAM INT, V37, P1377, DOI 10.1016/j.ceramint.2011.01.005
   Dillon DR, 2006, POLYMER, V47, P1678, DOI 10.1016/j.polymer.2006.01.015
   Fang LM, 2005, BIOMATERIALS, V26, P3471, DOI 10.1016/j.biomaterials.2004.09.022
   GALLANTREE HR, 1983, IEE PROC-I, V130, P219, DOI 10.1049/ip-i-1.1983.0040
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Geringer J, 2011, WEAR, V271, P2793, DOI 10.1016/j.wear.2011.05.034
   GUENARD V, 1991, BIOMATERIALS, V12, P259, DOI 10.1016/0142-9612(91)90210-2
   Huang X., 2014, CHIN MED J, V127, P3171
   Kang GD, 2014, J MEMBRANE SCI, V463, P145, DOI 10.1016/j.memsci.2014.03.055
   Laroche G, 1998, J BIOMED MATER RES, V39, P184, DOI 10.1002/(SICI)1097-4636(199802)39:2<184::AID-JBM3>3.0.CO;2-L
   Lemes HD, 2015, INT J ORAL MAX SURG, V44, P389, DOI 10.1016/j.ijom.2014.11.009
   Lin DJ, 2006, EUR POLYM J, V42, P1581, DOI 10.1016/j.eurpolymj.2006.01.027
   Liu F, 2011, J MEMBRANE SCI, V375, P1, DOI 10.1016/j.memsci.2011.03.014
   Liu ZH, 1998, POLYMER, V39, P1779, DOI 10.1016/S0032-3861(97)00222-X
   Lu HF, 2003, BIOMATERIALS, V24, P4893, DOI 10.1016/S0142-9612(03)00404-6
   Ma R, 2014, INT J MOL SCI, V15, P5426, DOI 10.3390/ijms15045426
   Mano JF, 2003, POLYMER, V44, P4293, DOI 10.1016/S0032-3861(03)00361-6
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Niklason LE, 2001, JAMA-J AM MED ASSOC, V285, P573, DOI 10.1001/jama.285.5.573
   Pant HR, 2013, COLLOID SURFACE B, V102, P152, DOI 10.1016/j.colsurfb.2012.08.032
   Rekik H, 2013, COMPOS PART B-ENG, V45, P1199, DOI 10.1016/j.compositesb.2012.08.002
   Rodriguez K, 2011, ACS APPL MATER INTER, V3, P681, DOI 10.1021/am100972r
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   Sheikh FA, 2011, J BIOMATER TISS ENG, V1, P194, DOI 10.1166/jbt.2011.1017
   Slosarczyk A, 2010, CERAM INT, V36, P577, DOI 10.1016/j.ceramint.2009.09.032
   Takauti Carlos Alberto Yoshihiro, 2014, Braz. Dent. J., V25, P379, DOI 10.1590/0103-6440201302383
   Tazaki M, 1997, J APPL POLYM SCI, V65, P1517
   Thein-Han W, 2011, TISSUE ENG PT A, V17, P2943, DOI 10.1089/ten.tea.2010.0674
   Wang W, 2011, ANN ACAD MED SINGAP, V40, P237
   Xu ZH, 2005, J MEMBRANE SCI, V255, P125, DOI 10.1016/j.memsci.2005.02.001
   Yeow ML, 2004, J APPL POLYM SCI, V92, P1782, DOI 10.1002/app.20141
   ZULFIQAR S, 1994, POLYM DEGRAD STABIL, V43, P423, DOI 10.1016/0141-3910(94)90015-9
NR 41
TC 11
Z9 11
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN
PY 2015
VL 41
IS 5
BP 7066
EP 7072
DI 10.1016/j.ceramint.2015.02.014
PN B
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA CG3JL
UT WOS:000353176400054
DA 2018-10-20
ER

PT J
AU Lee, SJ
   Betensky, RA
   Gianneschi, GE
   Gallucci, GO
AF Lee, Sang J.
   Betensky, Rebecca A.
   Gianneschi, Grace E.
   Gallucci, German O.
TI Accuracy of digital versus conventional implant impressions
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; conventional impression; digital impression; implant
   restoration
ID DENTAL CAD/CAM TECHNOLOGY; COMPUTER-AIDED ANALYSIS; IN-VITRO; MODELS
AB ObjectiveThe accuracy of digital impressions greatly influences their clinical viability in implant restorations. The aim of this study was to compare the accuracy of gypsum models acquired from the conventional implant impression to digitally milled models created from direct digitalization by three-dimensional analysis.
   Materials and MethodsThirty gypsum and 30 digitally milled models, impressed directly from a reference model, were prepared. The models and reference model were scanned by a laboratory scanner, and 30 surface tessellation language datasets from each group were imported to an inspection software program. The datasets were aligned to the reference dataset by a repeated best-fit algorithm, and 10 specified contact locations of interest were measured in mean volumetric deviations. The areas were pooled by cusps, fossae, interproximal contacts, horizontal and vertical axes of implant position and angulation. The pooled areas were statistically analysed by comparing each group to the reference model to investigate the mean volumetric deviations accounting for accuracy and standard deviations for precision.
   ResultsMilled models from digital impressions had comparable accuracy to gypsum models from conventional impressions. However, differences in fossae and vertical displacement of the implant position from the gypsum and digitally milled models compared to the reference model exhibited statistical significance (P<0.001, P=0.020, respectively).
   ConclusionMilled models from digital impression are comparable to gypsum models from conventional impression.
C1 [Lee, Sang J.; Gianneschi, Grace E.; Gallucci, German O.] Harvard Univ, Sch Dent Med, Dept Restorat Dent & Biomat Sci, Boston, MA 02115 USA.
   [Betensky, Rebecca A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
RP Lee, SJ (reprint author), Harvard Univ, Sch Dent Med, Dept Restorat Dent & Biomat Sci, 188 Longwood Ave, Boston, MA 02115 USA.
EM sang_lee@hsdm.harvard.edu
RI Gallucci, German/H-4505-2011
FU ITI Foundation (Basel, Switzerland) [733-2010]
FX This study was funded by the ITI Foundation (Basel, Switzerland)
   Research Grant No. 733-2010. The author(s) would like to gratefully
   acknowledge the statistical assistance and collaboration through Harvard
   Catalyst. The author(s) declare no potential conflict of interests with
   respect to the research, authorship and/or publication of this article.
CR Brosky ME, 2003, J PROSTHET DENT, V90, P434, DOI 10.1016/j.prosdent.2003.08.021
   Chandran DT, 2010, BIO-MED MATER ENG, V20, P243, DOI 10.3233/BME-2010-0638
   Christensen GJ, 2008, J AM DENT ASSOC, V139, P761, DOI 10.14219/jada.archive.2008.0258
   Christensen GJ, 2009, J AM DENT ASSOC, V140, P1301, DOI 10.14219/jada.archive.2009.0054
   DeLong R, 2001, J Prosthodont, V10, P78, DOI 10.1111/j.1532-849X.2001.00078.x
   DeLong R, 2003, J DENT RES, V82, P438, DOI 10.1177/154405910308200607
   Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1
   Guth JF, 2013, CLIN ORAL INVEST, V17, P1389, DOI 10.1007/s00784-012-0812-3
   Guth JF, 2013, CLIN ORAL INVEST, V17, P1201, DOI 10.1007/s00784-012-0795-0
   Karl M, 2004, INT J ORAL MAX IMPL, V19, P30
   Larson TD, 2002, J PROSTHET DENT, V87, P625, DOI 10.1067/mpr.2002.125180
   Lee H, 2008, J PROSTHET DENT, V99, P107, DOI 10.1016/S0022-3913(08)60026-8
   Lee SJ, 2013, CLIN ORAL IMPLAN RES, V24, P111, DOI 10.1111/j.1600-0501.2012.02430.x
   Ma T, 1997, INT J ORAL MAX IMPL, V12, P371
   Persson ASK, 2008, DENT MATER, V24, P1123, DOI 10.1016/j.dental.2008.01.008
   Persson ASK, 2009, DENT MATER, V25, P929, DOI 10.1016/j.dental.2009.01.100
   Quaas S, 2007, J DENT, V35, P903, DOI 10.1016/j.jdent.2007.08.008
   Rudolph H, 2007, COMPUT BIOL MED, V37, P579, DOI 10.1016/j.compbiomed.2006.05.006
   Sorrentino Roberto, 2010, Clin Implant Dent Relat Res, V12 Suppl 1, pe63, DOI 10.1111/j.1708-8208.2009.00167.x
   SPECTOR MR, 1990, J PROSTHET DENT, V63, P444, DOI 10.1016/0022-3913(90)90235-5
   Stimmelmayr M., 2012, CLIN ORAL INVEST, V17, P1929
   Stimmelmayr M, 2012, CLIN ORAL INVEST, V16, P1137, DOI 10.1007/s00784-011-0622-z
   Stimmelmayr M, 2012, CLIN ORAL INVEST, V16, P851, DOI 10.1007/s00784-011-0564-5
NR 23
TC 28
Z9 30
U1 0
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2015
VL 26
IS 6
BP 715
EP 719
DI 10.1111/clr.12375
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CG6JQ
UT WOS:000353407000014
PM 24720423
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Afonso, MLCD
   Jaimes, RFVV
   Nascente, PAP
   Rogero, SO
   Agostinho, SML
AF Chaves de Andrade Afonso, Monica Luisa
   Vera Villamil Jaimes, Ruth Flavia
   Nascente, Pedro A. P.
   Rogero, Sizue Ota
   Leite Agostinho, Silvia Maria
TI Surface characterization, electrochemical behaviour and cytotoxicity of
   UNS S31254 stainless steel for orthopaedic applications
SO MATERIALS LETTERS
LA English
DT Article
DE 254 stainless steel; Sodium chloride; Orthopaedic implants
ID CORROSION; IMPLANTS; PASSIVATION; ALBUMIN
AB The surface characterization and electrochemical behaviour of UNS S31254 (254 SS) have been performed in 0.15 mol L-1 NaCl medium in order to evaluate its application as orthopaedic implants. Polarization curves, chronoamperometry, electrochemical impedance spectroscopy and X-ray photoelectron spectroscopy were used for characterizing the samples. A cytotoxicity test was also performed to study the biocompatibility of the proposed steel as biomaterial. The electrochemical behaviour of 254 SS was compared to that observed for ISO 5832-9 and ASTM F138 stainless steels, used in orthopaedic implants. 254 SS is similar to ISO 5832-9 SS: it is passivated on the potential range between the corrosion and the transpassivation potential. Mo (VI) forms an outer layer which blocks Cr (VI) dissolution. Cytotoxicity test showed no cytotoxic character of 254 SS. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Chaves de Andrade Afonso, Monica Luisa] Inst Super Tecn, Inst Telecomun, P-1049001 Lisbon, Portugal.
   [Vera Villamil Jaimes, Ruth Flavia; Leite Agostinho, Silvia Maria] Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, SP, Brazil.
   [Nascente, Pedro A. P.] Univ Fed Sao Carlos, Dept Engn Mat, BR-13565905 Sao Carlos, SP, Brazil.
   [Rogero, Sizue Ota] Inst Pesquisas Energet & Nucl, BR-05508000 Sao Paulo, SP, Brazil.
RP Agostinho, SML (reprint author), Univ Sao Paulo, Inst Quim, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, SP, Brazil.
EM smlagost@iq.usp.br
RI Afonso, Monica/H-9088-2013
OI Afonso, Monica/0000-0003-3100-1906
FU FAPESP [01\10051-4]; CNPq [200989\2011-1]
FX The authors thank FAPESP (Grant no. 01\10051-4), CNPq (Grant no.
   200989\2011-1) and Adolfo Lutz Instiitute by cytotoxicity analysis, ASTM
   International, West Conshohocken, PA.
CR Afonso MLCA, 2008, COLLOID SURFACE A, V317, P760, DOI 10.1016/j.colsurfa.2007.11.014
   Bisquert J, 1998, J ELECTROANAL CHEM, V452, P229, DOI 10.1016/S0022-0728(98)00115-6
   Boukamp B, 1998, EQUIVCRT COMPUTER SO, V4, P51
   Doh SJ, 2003, NUCL INSTRUM METH B, V199, P211, DOI 10.1016/S0168-583X(02)01548-3
   Eschbach L., 2000, INJURY, V31, pD2
   Frateur I, 2006, ELECTROCHIM ACTA, V51, P1550, DOI 10.1016/j.electacta.2005.02.116
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Ilevbare GO, 2003, CORROS SCI, V45, P1545, DOI 10.1016/S0010-938X(02)00229-9
   International Organization for Standardization, 2009, 10993 ISO
   Li R, 1997, SURF COAT TECH, V88, P90, DOI 10.1016/S0257-8972(96)02865-4
   Macdonald JR, 1996, IMPEDANCE SPECTROSCO
   Micheli L. D., 1999, British Corrosion Journal, V34, P67
   Padilha AF, 2005, J MATER PROCESS TECH, V170, P89, DOI 10.1016/j.jmatprotec.2005.05.002
   QVARFORT R, 1989, CORROS SCI, V29, P987
   Rodrigues SF, 2014, MATER RES-IBERO-AM J, V17, P436, DOI [10.1590/S1516-14392014005000001, 10.1590/S1516-14392014000200023]
   Rogero Sizue Ota, 2003, Mat. Res., V6, P317, DOI 10.1590/S1516-14392003000300003
   Salahinejad E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061633
   Jaimes RFVV, 2010, MATER LETT, V64, P1476, DOI 10.1016/j.matlet.2010.03.066
   Villamil R. F. V., 2002, REV BRAS ORTOP, V37, P471
   Villamil RFV, 2003, ASTM STP, V1438, pP168
   Walczak J, 1998, BIOMATERIALS, V19, P229, DOI 10.1016/S0142-9612(97)00208-1
NR 21
TC 2
Z9 2
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUN 1
PY 2015
VL 148
BP 71
EP 75
DI 10.1016/j.matlet.2015.01.157
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CG2IC
UT WOS:000353097100018
DA 2018-10-20
ER

PT J
AU Filli, L
   Luechinger, R
   Frauenfelder, T
   Beck, S
   Guggenberger, R
   Farshad-Amacker, N
   Andreisek, G
AF Filli, Lukas
   Luechinger, Roger
   Frauenfelder, Thomas
   Beck, Stefan
   Guggenberger, Roman
   Farshad-Amacker, Nadja
   Andreisek, Gustav
TI Metal-induced artifacts in computed tomography and magnetic resonance
   imaging: comparison of a biodegradable magnesium alloy versus titanium
   and stainless steel controls
SO SKELETAL RADIOLOGY
LA English
DT Article
DE Biodegradable implants; Magnesium; Artifacts; Magnetic resonance
   imaging; Multidetector computed tomography
ID IN-VITRO; VIVO EVALUATION; REDUCTION; CT; IMPLANTS; ALGORITHM; STRENGTH
AB To evaluate metal artifacts induced by biodegradable magnesium-a new class of degradable biomaterial that is beginning to enter the orthopedic routine-on CT and MRI compared to standard titanium and steel controls.
   Different pins made of titanium, stainless steel, and biodegradable magnesium alloys were scanned using a second-generation dual-energy multidetector CT and a 1.5-T MR scanner. In CT, quantitative assessment of artifacts was performed by two independent readers by measuring the noise in standardized regions of interest close to the pins. In MRI, the artifact diameter was measured. Interobserver agreement was evaluated using intraclass correlation coefficients. Artifacts were compared using Mann Whitney U tests.
   In comparison to stainless steel, biodegradable magnesium alloys induced significantly fewer artifacts in both 1.5-T MRI (p = 0.019-0.021) and CT (p = 0.003-0.006). Compared to titanium, magnesium induced significantly less artifact-related noise in CT (p = 0.003-0.008). Although artifacts were less on MRI for biodegradable magnesium compared to titanium, this result was not statistically significant.
   Biodegradable magnesium alloys induce substantially fewer artifacts in CT compared to standard titanium and stainless steel, and fewer artifacts in MRI for the comparison with stainless steel.
C1 [Filli, Lukas; Frauenfelder, Thomas; Guggenberger, Roman; Farshad-Amacker, Nadja; Andreisek, Gustav] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland.
   [Luechinger, Roger] Univ Zurich, Inst Biomed Engn, CH-8091 Zurich, Switzerland.
   [Luechinger, Roger] Swiss Fed Inst Technol, CH-8091 Zurich, Switzerland.
   [Beck, Stefan] Synthes GmbH, CH-4528 Zuchwil, Switzerland.
   [Filli, Lukas] Univ Zurich Hosp, Dept Radiol, CH-8091 Zurich, Switzerland.
RP Filli, L (reprint author), Univ Zurich Hosp, Dept Radiol, Ramistr 100, CH-8091 Zurich, Switzerland.
EM lukas.filli@usz.ch; roman.guggenberger@usz.ch;
   thomas.frauenfelder@usz.ch; Beck.Stefan@synthes.com;
   roman.guggenberger@usz.ch; nadja.farshad@usz.ch; gustav@andreisek.de
RI Frauenfelder, Thomas/O-1734-2016
OI Frauenfelder, Thomas/0000-0002-3295-6619; Luechinger,
   Roger/0000-0002-7365-0421
CR [Anonymous], 2007, F211907 ASTM
   Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065
   Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   Ernstberger T, 2009, NEURORADIOLOGY, V51, P525, DOI 10.1007/s00234-009-0537-4
   Guggenberger R, 2012, EUR RADIOL, V22, P2357, DOI 10.1007/s00330-012-2501-7
   Harris CA, 2006, ORTHOP CLIN N AM, V37, P349, DOI 10.1016/j.ocl.2006.04.001
   Koch KM, 2011, MAGN RESON MED, V65, P71, DOI 10.1002/mrm.22523
   Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860
   Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087
   Liu PT, 2009, SKELETAL RADIOL, V38, P797, DOI 10.1007/s00256-008-0630-5
   Mahnken AH, 2003, INVEST RADIOL, V38, P769, DOI 10.1097/01.rli.0000086495.96457.54
   Moon SG, 2008, J COMPUT ASSIST TOMO, V32, P630, DOI 10.1097/RCT.0b013e3181568b27
   Morsbach F, 2013, RADIOLOGY, V268, P237, DOI 10.1148/radiol.13122089
   Ostrowski N, 2013, ACTA BIOMATER, V9, P8704, DOI 10.1016/j.actbio.2013.05.010
   Prell D, 2010, INVEST RADIOL, V45, P747, DOI 10.1097/RLI.0b013e3181e94384
   Prell D, 2009, PHYS MED BIOL, V54, P6575, DOI 10.1088/0031-9155/54/21/009
   Shinohara Y, 2013, ACTA RADIOL
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5
   Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408
   Tello R, 2003, RADIOLOGY, V227, P1, DOI 10.1148/radio1.2271020085
   Ulbrich EJ, 2012, AM J ROENTGENOL, V199, pW735, DOI 10.2214/AJR.11.8233
   Waizy H, 2013, J BIOMATER APPL
   Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041
   White Lawrence M, 2002, Semin Musculoskelet Radiol, V6, P5, DOI 10.1055/s-2002-23160
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Zomorodian A, 2013, ACTA BIOMATER, V9, P8660, DOI 10.1016/j.actbio.2013.02.036
NR 30
TC 10
Z9 10
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2348
EI 1432-2161
J9 SKELETAL RADIOL
JI Skeletal Radiol.
PD JUN
PY 2015
VL 44
IS 6
BP 849
EP 856
DI 10.1007/s00256-014-2057-5
PG 8
WC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
SC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
GA CG4ED
UT WOS:000353235100009
PM 25417003
DA 2018-10-20
ER

PT J
AU Zhai, MM
   Cui, RJ
   Gu, N
   Zhang, GH
   Lin, W
   Yu, LJ
AF Zhai, Mumu
   Cui, Rongjing
   Gu, Ning
   Zhang, Genhua
   Lin, Wang
   Yu, Lingjun
TI Nanocomposite of Au Nanoparticles/Helical Carbon Nanofibers and
   Application in Hydrogen Peroxide Biosensor
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Helical Carbon Nanofibers; Hemoglobin; Biosensor; Hydrogen Peroxide
ID DIRECT ELECTROCHEMISTRY; HEMOGLOBIN; ELECTRODE; NANOTUBES;
   ELECTROCATALYSIS; ARRAY; FILM
AB A combined sol-gel/hydrogen reduction method has been developed for the mass production of helical carbon nanofibers (HCNFs) by the pyrolysis of acetylene at 425 degrees C in the presence of NiO nanoparticles. The synthesized HCNFs were characterized with scanning electron microscopy (SEM), X-ray diffraction (XRD) and high resolution transmission electron microscopy (HRTEM). The helical-structured carbon nanofibers have a large specific surface area and excellent biocompatibility. A novel enzymatic hydrogen peroxide sensor was then successfully fabricated based on the nanocomposites containing HCNFs and gold nanoparticles (AuNPs). The results indicated that the Au/HCNFs nanoconnposites exhibited excellent electrocatalytic activity to the reduction of H2O2, offering a wide linear range from 1.0 mu M to 3157 mu M with a detection limit as low as 0.46 AM. The apparent Michaelis-Menten constant of the biosensor was 0.61 mM. The as-fabricated biosensor showed a rapid and sensitive amperometric response to hydrogen peroxide with acceptable preparation reproducibility and excellent stability. Because of their low cost and high stability, these novel HCNFs represent seem to be a kind of promising biomaterial and may find wide new applications in scopes such as biocatalysis, immunoassay, environmental monitoring and so on.
C1 [Cui, Rongjing; Zhang, Genhua; Yu, Lingjun] Changshu Inst Technol, Changshu 215500, Peoples R China.
   [Zhai, Mumu; Gu, Ning; Lin, Wang] Hebei Normal Univ, Dept Chem & Mat, Shijiazhuang 050024, Peoples R China.
RP Cui, RJ (reprint author), Changshu Inst Technol, Changshu 215500, Peoples R China.
FU National Natural Science Foundation of China [20905010, 21005034];
   Jiangsu Provincial Natural Science Foundation [BK 20131191]; Suzhou
   Science and technology project [SYN201302]; Hebei Provincial Natural
   Science Foundation [B2011205079]; Hebei Province Department of Education
   Fund [20052022]
FX We greatly appreciate the support of the National Natural Science
   Foundation of China (20905010 and 21005034), Jiangsu Provincial Natural
   Science Foundation (No. BK 20131191) and Suzhou Science and technology
   project (SYN201302). The work is also supported by Hebei Provincial
   Natural Science Foundation (B2011205079) and Hebei Province Department
   of Education Fund (20052022).
CR Bahshi L, 2008, ANAL CHEM, V80, P8253, DOI 10.1021/ac801398m
   Banks CE, 2005, ANALYST, V130, P1232, DOI 10.1039/b508702c
   Cai CX, 2004, ANAL BIOCHEM, V325, P285, DOI 10.1016/j.ab.2003.10.040
   Chen X, 2009, NANO RES, V2, P210, DOI [10.1007/s12274-009-9019-6, 10.1007/S12274-009-9019-6]
   Dequaire M, 2000, ANAL CHEM, V72, P5521, DOI 10.1021/ac000781m
   Hernadi K, 2001, J PHYS CHEM B, V105, P12464, DOI 10.1021/jp0111208p
   Hu GZ, 2012, J MATER CHEM, V22, P8541, DOI 10.1039/c2jm16075g
   Jia NQ, 2009, SENSOR ACTUAT B-CHEM, V137, P230, DOI 10.1016/j.snb.2008.10.011
   Jiang HR, 2013, J BIOMED NANOTECHNOL, V9, P674, DOI 10.1166/jbn.2013.1575
   KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010
   Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004
   Khan A. J., 2013, J BIONANOSCI, V7, P530
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Li JZ, 2000, ANAL CHEM, V72, P5338, DOI 10.1021/ac000611+
   Li S, 2012, THERANOSTICS, V2, P967, DOI 10.7150/thno.5032
   Liu MC, 2009, ELECTROCHEM COMMUN, V11, P1397, DOI 10.1016/j.elecom.2009.05.015
   Mao CJ, 2012, BIOSENS BIOELECTRON, V31, P544, DOI 10.1016/j.bios.2011.10.001
   Mathur A., 2013, J BIONANOSCI, V7, P140
   MATSUBARA C, 1992, ANALYST, V117, P1781, DOI 10.1039/an9921701781
   Mewada A., 2013, J BIONANOSCI, V7, P174, DOI DOI 10.1166/JBNS.2013.1107
   Nitze F, 2012, ELECTROCHIM ACTA, V63, P323, DOI 10.1016/j.electacta.2011.12.104
   Ren ML, 2005, BIOSENS BIOELECTRON, V21, P433, DOI 10.1016/j.bios.2004.08.052
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1504, DOI 10.1016/j.bios.2009.11.009
   Shan D, 2009, SENSOR ACTUAT B-CHEM, V137, P259, DOI 10.1016/j.snb.2008.11.029
   Singh V. M., 2013, J BIONANOSCI, V7, P420
   Sotiropoulou S, 2003, ANAL BIOANAL CHEM, V375, P103, DOI 10.1007/s00216-002-1617-z
   Sun JY, 2011, BIOELECTROCHEMISTRY, V82, P125, DOI 10.1016/j.bioelechem.2011.06.007
   Sun W, 2009, BIOELECTROCHEMISTRY, V74, P295, DOI 10.1016/j.bioelechem.2008.11.001
   Tang NJ, 2008, J PHYS CHEM C, V112, P10061, DOI 10.1021/jp8017293
   Varma M. M., 2013, J BIONANOSCI, V7, P360
   Wang Y, 2009, ANAL CHEM, V81, P9710, DOI 10.1021/ac901935a
   Xu HF, 2010, TALANTA, V81, P334, DOI 10.1016/j.talanta.2009.12.006
NR 32
TC 4
Z9 4
U1 1
U2 136
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2015
VL 15
IS 6
BP 4682
EP 4687
DI 10.1166/jnn.2015.9700
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AY2QW
UT WOS:000347435300091
PM 26369097
DA 2018-10-20
ER

PT J
AU Leszczak, V
   Baskett, DA
   Popat, KC
AF Leszczak, Victoria
   Baskett, Dominique A.
   Popat, Ketul C.
TI Endothelial Cell Growth and Differentiation on Collagen-Immobilized
   Polycaprolactone Nanowire Surfaces
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Endothelial Cells; Polycaprolactone Nanowire Surfaces; VE-Cadherin; von
   Willebrand Factor; Collagen
ID IN-VITRO; INTEGRIN ALPHA-2-BETA-1; SHEAR-STRESS; SCAFFOLDS; ADHESION;
   PROLIFERATION; FIBROBLASTS; CULTURE; MATRIX; REGENERATION
AB The success of cardiovascular implants is associated with the development of an endothelium on material surface, critical to the prevention of intimal hyperplasia, calcification and thrombosis. A thorough understanding of the interaction between vascular endothelial cells and the biomaterial involved is essential in order to have a successful application which promotes healing and regeneration through integration with native tissue. In this study, we have developed collagen immobilized nanostructured surfaces with controlled arrays of high aspect ratio nanowires for the growth and maintenance of human microvascular endothelial cells (HMVECs). The nanowire surfaces were fabricated from polycaprolactone using a novel nanotemplating technique, and were immobilized with collagen utilizing an aminolysis method. The collagen immobilized nanowire surfaces were characterized using contact angle measurements, scanning electron microscopy and X-ray photoelectron spectroscopy. Human microvascular endothelial cells were used to evaluate the efficacy of the collagen immobilized nanowire surfaces to promote cell adhesion, proliferation, viability and differentiation. The results presented here indicate significantly higher cellular adhesion, proliferation and viability on nanowire and collagen immobilized surfaces as compared to the control surface. Further, HMVECs have a more elongated body and low shape factor on nanostructured surfaces. The differentiation potential of collagen immobilized nanowire surfaces was also evaluated by immunostaining and western blotting for key endothelial cell markers that are expressed when human microvascular endothelial cells are differentiated. Results indicate that expression of VE-cadherin is increased on collagen immobilized surfaces while the expression of von Willebrand factor is statistically similar on all surfaces.
C1 [Leszczak, Victoria; Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Baskett, Dominique A.] Colorado State Univ, Dept Biomed Engn, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
OI Popat, Ketul C./0000-0002-2417-7789
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [5-R21-AR057341-02]
FX Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Number 5-R21-AR057341-02. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Arnoult O., 2010, NOVEL BENIGN SOLUTIO
   Baek J. -Y., 2012, J NANOMATER, V2012, DOI DOI 10.1155/2012/171804
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Bechara SL, 2010, BIOMATERIALS, V31, P3492, DOI 10.1016/j.biomaterials.2010.01.084
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   Chew SY, 2011, J BIOMED MATER RES A, V97A, P355, DOI 10.1002/jbm.a.33064
   CLYMAN RI, 1990, CIRC RES, V67, P175, DOI 10.1161/01.RES.67.1.175
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Farhadi M, 2012, J BIOMED MATER RES A, V100A, P549, DOI 10.1002/jbm.a.33293
   GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Hong Y, 2008, J BIOMED MATER RES A, V85A, P628, DOI 10.1002/jbm.a.31603
   Joseph C., 2008, NANOTECHNOLOGY, V19
   Kim JH, 2002, J BIOMED MATER RES, V62, P613, DOI 10.1002/jbm.10340
   Krithica N, 2012, ADV ENG MATER, V14, pB149, DOI 10.1002/adem.201180035
   Leszczak V., 2013, J BIOMATER SCI POLYM, V1
   Leszczak V, 2013, J BIOMAT SCI-POLYM E, V24, P1529, DOI 10.1080/09205063.2013.777228
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   MANTOVANI A, 1992, FASEB J, V6, P2591
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   PALMER RMJ, 1992, BRIT J PHARMACOL, V105, P11, DOI 10.1111/j.1476-5381.1992.tb14202.x
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Popat KC, 2003, J VAC SCI TECHNOL B, V21, P645, DOI 10.1116/1.1545733
   Porter JR, 2009, TISSUE ENG PT A, V15, P2547, DOI 10.1089/ten.tea.2008.0476
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Pozzi Ambra, 1998, Journal of Cell Biology, V142, P587, DOI 10.1083/jcb.142.2.587
   RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548
   Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001
   Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Tuckwell D, 1996, SEMIN CELL DEV BIOL, V7, P649, DOI 10.1006/scdb.1996.0079
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhu YB, 2009, MAT SCI ENG C-BIO S, V29, P1046, DOI 10.1016/j.msec.2008.09.004
NR 53
TC 5
Z9 5
U1 0
U2 87
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2015
VL 11
IS 6
BP 1080
EP 1092
DI 10.1166/jbn.2015.2021
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AT5FP
UT WOS:000344969900014
PM 26353596
DA 2018-10-20
ER

PT J
AU Babur, BK
   Kabiri, M
   Klein, TJ
   Lott, WB
   Doran, MR
AF Babur, Betul Kul
   Kabiri, Mahboubeh
   Klein, Travis Jacob
   Lott, William B.
   Doran, Michael Robert
TI The Rapid Manufacture of Uniform Composite Multicellular-Biomaterial
   Micropellets, Their Assembly into Macroscopic Organized Tissues, and
   Potential Applications in Cartilage Tissue Engineering
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   ARTICULAR-CARTILAGE; REPAIR; MATRIX; SCAFFOLD; KNEE
AB We and others have published on the rapid manufacture of micropellet tissues, typically formed from 100-500 cells each. The micropellet geometry enhances cellular biological properties, and in many cases the micropellets can subsequently be utilized as building blocks to assemble complex macrotissues. Generally, micropellets are formed from cells alone, however when replicating matrix-rich tissues such as cartilage it would be ideal if matrix or biomaterials supplements could be incorporated directly into the micropellet during the manufacturing process. Herein we describe a method to efficiently incorporate donor cartilage matrix into tissue engineered cartilage micropellets. We lyophilized bovine cartilage matrix, and then shattered it into microscopic pieces having average dimensions < 10 mu m diameter; we termed this microscopic donor matrix "cartilage dust (CD)". Using a microwell platform, we show that similar to 0.83 mu g CD can be rapidly and efficiently incorporated into single multicellular aggregates formed from 180 bone marrow mesenchymal stem/stromal cells (MSC) each. The microwell platform enabled the rapid manufacture of thousands of replica composite micropellets, with each micropellet having a material/CD core and a cellular surface. This micropellet organization enabled the rapid bulking up of the micropellet core matrix content, and left an adhesive cellular outer surface. This morphological organization enabled the ready assembly of the composite micropellets into macroscopic tissues. Generically, this is a versatile method that enables the rapid and uniform integration of biomaterials into multicellular micropellets that can then be used as tissue building blocks. In this study, the addition of CD resulted in an approximate 8-fold volume increase in the micropellets, with the donor matrix functioning to contribute to an increase in total cartilage matrix content. Composite micropellets were readily assembled into macroscopic cartilage tissues; the incorporation of CD enhanced tissue size and matrix content, but did not enhance chondrogenic gene expression.
C1 [Babur, Betul Kul; Kabiri, Mahboubeh; Lott, William B.; Doran, Michael Robert] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.
   [Kabiri, Mahboubeh] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran.
   [Klein, Travis Jacob] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Cartilage Regenerat Lab, Brisbane, Qld 4001, Australia.
   [Doran, Michael Robert] Univ Queensland, Mater Med Res, Brisbane, Qld, Australia.
RP Doran, MR (reprint author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.
EM michael.doran@qut.edu.au
RI Doran, Michael/F-6059-2014; Lott, William/J-1062-2012
OI Lott, William/0000-0001-7118-7560; Doran, Michael/0000-0001-5876-4757;
   Klein, Travis/0000-0002-6669-7766
FU Australian National Health and Medical Research Council (NHMRC) [631629]
FX This study was funded by the Australian National Health and Medical
   Research Council (NHMRC), grant number 631629
   (https://www.nhmrc.gov.au/), MRD received the funding. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Behrens P, 1999, MMW Fortschr Med, V141, P49
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   Brand CA, 2013, ARTHRITIS CARE RES H
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de
   Chen A, 2012, ARTHRITIS, V2012, DOI [10.1155/2012/698709, DOI 10.1155/2012/698709]
   Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541
   Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002
   Ebert JR, 2008, OSTEOARTHR CARTILAGE, V16, P1131, DOI 10.1016/j.joca.2008.03.010
   Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560
   Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367
   POTTENGER LA, 1982, J BIOL CHEM, V257, P1479
   Robertson WB, 2004, STANDARD PRACTICE EX
   Schuurman W., 2013, J TISSUE ENG REGENER
   Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014
   Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
NR 27
TC 6
Z9 6
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 28
PY 2015
VL 10
IS 5
AR e0122250
DI 10.1371/journal.pone.0122250
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ0SC
UT WOS:000355187300003
PM 26020956
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dai, MZ
   Sun, LG
   Chao, L
   Tan, YM
   Fu, YC
   Chen, C
   Xie, QJ
AF Dai, Mengzhen
   Sun, Lingen
   Chao, Long
   Tan, Yueming
   Fu, Yingchun
   Chen, Chao
   Xie, Qingji
TI Immobilization of Enzymes by Electrochemical and Chemical Oxidative
   Polymerization of L-DOPA to Fabricate Amperometric Biosensors and
   Biofuel Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE electrochemical/chemical oxidative polymerization of L-DOPA; polymeric
   bionanocomposite; enzyme electrode; glucose biosensing; biofuel cell
ID MULTIWALLED CARBON NANOTUBES; QUARTZ-CRYSTAL MICROBALANCE; CAST
   THIN-FILMS; GLUCOSE-OXIDASE; GOLD NANOPARTICLES; GRAPHENE OXIDE; AU
   ELECTRODE; PERFORMANCE; ELECTROPOLYMERIZATION; BIONANOCOMPOSITES
AB Electrochemical/chemical oxidative synthesis and biosensing/biofuel cell applications of poly(L-DOPA) (PD) are studied versus polydopamine (PDA) as a recent hotspot biomaterial. The enzyme electrode developed by coelectrodeposition of PD and glucose oxidase (GOx), uricase, or tyrosinase shows biosensing performance superior to that of the corresponding PDA-based enzyme electrode. The chemical oxidative polymerization of L-DOPA (PDC) by NaAuCl4 in GOx-containing neutral aqueous solution is used to immobilize GOx and gold nanoparticles (AuNPs). The thus-prepared chitosan (CS)/GOx-PDC-AuNPs/Auplate/Au electrode working in the first-generation biosensing mode responds linearly to glucose concentration with a sensitivity of 152 mu A mM(-1) cm(-2), which is larger than those of the CS/GOx-PDA(C)-AuNPs/Au-plate/Au electrode, the CS/GOx-poly(3-anilineboronic acid) (PABA)-AuNPs/Au-plate/Au electrode, and the most reported GOx-based enzyme electrodes. This PDC-based enzyme electrode also works well in the second-generation biosensing mode and as an excellent bioanode in biofuel cell construction, probably because PD as an amino acid polymer has the higher biocompatibility and the more favorable affinity to the enzyme than PDA. The PD material of great convenience in synthesis, outstanding biocompatibility for preparing high-performance bionanocomposites, and strong capability of multifunctional coatings on many surfaces may find wide applications in diversified fields including biotechnology and surface-coating.
C1 [Dai, Mengzhen; Sun, Lingen; Chao, Long; Tan, Yueming; Fu, Yingchun; Chen, Chao; Xie, Qingji] Hunan Normal Univ, Natl & Local Joint Engn Lab New Petrochem Mat & F, Key Lab Chem Biol & Tradit Chinese Med Res, Minist Educ,Coll Chem & Chem Engn, Changsha 410081, Hunan, Peoples R China.
RP Xie, QJ (reprint author), Hunan Normal Univ, Natl & Local Joint Engn Lab New Petrochem Mat & F, Key Lab Chem Biol & Tradit Chinese Med Res, Minist Educ,Coll Chem & Chem Engn, Changsha 410081, Hunan, Peoples R China.
EM xieqj@hunnu.edu.cn
OI Fu, Yingchun/0000-0003-0550-9052; Tan, Yueming/0000-0003-3356-9079
FU National Natural Science Foundation of China [21475041, 21175042,
   21305041, 21105026, 21405042]; Hunan Lotus Scholars Program; Foundations
   of Hunan Provincial Education and Science/Technology Department
   [2014SK3096]; Program for Science and Technology Innovative Research
   Team in Higher Educational Institutions of Hunan Province
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 21475041, 21175042, 21305041, 21105026, and 21405042),
   Hunan Lotus Scholars Program, Foundations of Hunan Provincial Education
   and Science/Technology Department (2014SK3096), and Program for Science
   and Technology Innovative Research Team in Higher Educational
   Institutions of Hunan Province.
CR Arnow LE, 1937, J BIOL CHEM, V118, P531
   Ball V., 2012, J BIONANOSCI, V2, P16
   Baron R, 2005, ANAL CHEM, V77, P1566, DOI 10.1021/ac048691v
   Chen C, 2013, RSC ADV, V3, P4473, DOI 10.1039/c2ra22351a
   Chen C, 2011, BIOSENS BIOELECTRON, V26, P2311, DOI 10.1016/j.bios.2010.09.058
   Chen C, 2009, BIOSENS BIOELECTRON, V24, P2726, DOI 10.1016/j.bios.2008.12.016
   Chen SM, 2003, J ELECTROANAL CHEM, V547, P179, DOI 10.1016/S0022-0728(03)00220-1
   Dey RS, 2013, ACS APPL MATER INTER, V5, P4791, DOI 10.1021/am400280u
   FITZPATRICK TB, 1950, SCIENCE, V112, P223, DOI 10.1126/science.112.2904.223
   Fu YC, 2008, ANAL CHEM, V80, P5829, DOI 10.1021/ac800178p
   Fu YC, 2013, ACS APPL MATER INTER, V5, P934, DOI 10.1021/am302602s
   Fu YC, 2011, ANAL CHEM, V83, P6511, DOI 10.1021/ac200471v
   Fu YC, 2010, J PHYS CHEM C, V114, P1472, DOI 10.1021/jp9092767
   Fu YC, 2009, ADV FUNCT MATER, V19, P1784, DOI 10.1002/adfm.200801576
   Herz W., 2007, PROGR CHEM ORGANIC N, P131
   Huang Y, 2012, BIOSENS BIOELECTRON, V31, P357, DOI 10.1016/j.bios.2011.10.045
   JIMBOW K, 1976, J INVEST DERMATOL, V67, P72, DOI 10.1111/1523-1747.ep12512500
   Kohli N, 2007, MACROMOL BIOSCI, V7, P789, DOI 10.1002/mabi.200700006
   Korani A, 2013, BIOSENS BIOELECTRON, V50, P186, DOI 10.1016/j.bios.2013.05.047
   Lakshmi D, 2009, ANAL CHEM, V81, P3576, DOI 10.1021/ac802536p
   Lang QL, 2014, BIOSENS BIOELECTRON, V51, P158, DOI 10.1016/j.bios.2013.07.021
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Levis Joel T, 2011, J Emerg Med, V40, pe107, DOI 10.1016/j.jemermed.2008.01.008
   Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048
   Li YY, 2012, SENSOR ACTUAT B-CHEM, V168, P46, DOI 10.1016/j.snb.2012.01.013
   Li YY, 2010, SENSOR ACTUAT B-CHEM, V151, P30, DOI 10.1016/j.snb.2010.09.061
   Lu CC, 2011, ELECTROANAL, V23, P2421, DOI 10.1002/elan.201100291
   Luo XL, 2004, ANAL BIOCHEM, V334, P284, DOI 10.1016/j.ab.2004.07.005
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   MASON HS, 1948, J BIOL CHEM, V172, P83
   Matsumoto A, 2009, J AM CHEM SOC, V131, P12022, DOI 10.1021/ja902964m
   MCDOWELL F, 1970, ANN INTERN MED, V72, P29, DOI 10.7326/0003-4819-72-1-29
   Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002
   Palanisamy S, 2014, COLLOID SURFACE B, V114, P164, DOI 10.1016/j.colsurfb.2013.10.006
   Porta G. D., 1966, STRUCTURE CONTROL ED, P155
   Rakhi RB, 2009, J PHYS CHEM B, V113, P3190, DOI 10.1021/jp810235v
   Raper HS, 1928, PHYSIOL REV, V8, P245
   Scherbahn V, 2014, BIOSENS BIOELECTRON, V61, P631, DOI 10.1016/j.bios.2014.05.027
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1070, DOI 10.1016/j.bios.2009.09.024
   Smith K., 1978, PHOTOCH PHOTOBIO SCI, P115
   Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271
   Su YH, 2008, BIOTECHNOL PROGR, V24, P262, DOI 10.1021/bp070256+
   Tan YM, 2008, ELECTROANAL, V20, P1599, DOI 10.1002/elan.200804220
   Tan YM, 2010, J PHYS CHEM B, V114, P5016, DOI 10.1021/jp100922t
   Tan YM, 2009, BIOSENS BIOELECTRON, V24, P2225, DOI 10.1016/j.bios.2008.11.026
   Thibault S, 2008, MICROCHIM ACTA, V163, P211, DOI 10.1007/s00604-008-0028-z
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a
   Wang YX, 2013, J CHROMATOGR A, V1283, P20, DOI 10.1016/j.chroma.2013.01.110
   Xiao Y, 2007, NAT PROTOC, V2, P2875, DOI 10.1038/nprot.2007.413
   Xie QJ, 2003, J COLLOID INTERF SCI, V262, P107, DOI 10.1016/S0021-9797(03)00196-6
   Yang ZP, 2014, BIOSENS BIOELECTRON, V51, P268, DOI 10.1016/j.bios.2013.07.054
   Yehezkeli O, 2011, ACS NANO, V5, P2385, DOI 10.1021/nn200313t
   Zayats M, 2002, J AM CHEM SOC, V124, P2120, DOI 10.1021/ja025503e
   Zhang J, 2007, NAT PROTOC, V2, P2888, DOI 10.1038/nprot.2007.419
   Zhang SX, 2005, BIOELECTROCHEMISTRY, V67, P15, DOI 10.1016/j.bioelechem.2004.12.002
   Zhang ZJ, 2011, J ELECTROANAL CHEM, V650, P241, DOI 10.1016/j.jelechem.2010.10.016
NR 58
TC 13
Z9 13
U1 11
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 27
PY 2015
VL 7
IS 20
BP 10843
EP 10852
DI 10.1021/acsami.5b01865
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CJ3KQ
UT WOS:000355382800026
PM 25938891
DA 2018-10-20
ER

PT J
AU Jeffords, ME
   Wu, JL
   Shah, M
   Hong, Y
   Zhang, G
AF Jeffords, Megan E.
   Wu, Jinglei
   Shah, Mickey
   Hong, Yi
   Zhang, Ge
TI Tailoring Material Properties of Cardiac Matrix Hydrogels To Induce
   Endothelial Differentiation of Human Mesenchymal Stem Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE cardiac extracellular matrix; injectable hydrogel; genipin; human
   mesenchymal stem cells; stem cell differentiation
ID EXTRACELLULAR-MATRIX; POSTMYOCARDIAL INFARCTION; HEART-DISEASE;
   CROSS-LINKING; IN-VITRO; GENIPIN; TISSUE; THERAPY; DELIVERY; REPAIR
AB Cardiac matrix hydrogel has shown great promise as an injectable biomaterial due to the possession of cardiac-specific extracellular matrix composition. A cardiac matrix hydrogel facilitating neovascularization will further improve its therapeutic outcomes in cardiac repair. In this study, we explored the feasibility Of tailoring material properties of cardiac matrix hydrogels using a natural compound, genipin, to promote endothelial differentiation of stem cells. Our results demonstrated that the genipin cross-linking could increase the mechanical properties of the cardiac matrix hydrogel to a stiffness range promoting endothelial differentiation of human mesenchymal stem cells (hMSCs). It also decreased. the swelling ratio and prolonged degradation without altering gelation time. Human mesenchymal stem cells cultured on the genipin cross-linked cardiac matrix hydrogels showed great viability. After 1 day culture, hMSCs demonstrated down-regulation of early endothelial marker expression and up-regulation of mature endothelial marker expression. Especially for 1 mM genipin cross-linked cardiac matrix hydrogels, hMSCs showed particularly significant expression of mature endothelial cell marker vWF. These attractive results indicate the potential of using genipin cross-linked cardiac matrix hydrogels to promote rapid vascularization for cardiac infarction treatment through minimally invasive therapy.
C1 [Jeffords, Megan E.; Shah, Mickey; Zhang, Ge] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Wu, Jinglei; Hong, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Wu, Jinglei; Hong, Yi] Univ Texas SW Med Ctr Dallas, Joint Biomed Engn Program, Dallas, TX 75390 USA.
RP Hong, Y (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM yihong@uta.edu; gezhang@uakron.edu
FU National Institutes of Health [1R15HL122949]; American Heart Association
   [14BGIA20510066]; University of Akron
FX We greatly appreciate the financial support from the National Institutes
   of Health (Grant No. 1R15HL122949 to G.Z.) and the American Heart
   Association (Grant No. 14BGIA20510066 to Y.H.). M.E.J. thanks the
   University of Akron for a graduate fellowship.
CR Cashman TJ, 2013, STEM CELL REV REP, V9, P254, DOI 10.1007/s12015-012-9375-6
   Chou SH, 2014, CELL TRANSPLANT, V23, P513, DOI 10.3727/096368914X678436
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   George JC, 2010, TRANSL RES, V155, P10, DOI 10.1016/j.trsl.2009.06.009
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011
   Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Lalit PA, 2014, CIRC RES, V114, P1328, DOI 10.1161/CIRCRESAHA.114.300556
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Macaya D, 2011, ADV FUNCT MATER, V21, P4788, DOI 10.1002/adfm.201101720
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Ni NC, 2014, SEMIN THORAC CARDIOV, V26, P44, DOI 10.1053/j.semtcvs.2014.03.001
   Ong SR, 2006, BIOMATERIALS, V27, P1930, DOI 10.1016/j.biomaterials.2005.10.018
   Patel DM, 2013, STEM CELLS INT, DOI 10.1155/2013/496218
   Przybyt E, 2013, CURR STEM CELL RES T, V8, P270, DOI 10.2174/1574888X11308040002
   Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   TSENG TH, 1995, CANCER LETT, V97, P61, DOI 10.1016/0304-3835(95)03964-X
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Williams C, 2015, ACTA BIOMATER, V14, P84, DOI 10.1016/j.actbio.2014.11.035
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wu JL, 2015, ACTA BIOMATER, V16, P49, DOI 10.1016/j.actbio.2015.01.027
   Yamazaki M, 2009, BIOL PHARM BULL, V32, P1043, DOI 10.1248/bpb.32.1043
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
NR 43
TC 17
Z9 18
U1 2
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 27
PY 2015
VL 7
IS 20
BP 11053
EP 11061
DI 10.1021/acsami.5b03195
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CJ3KQ
UT WOS:000355382800052
PM 25946697
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mueller, V
   Laakmann, E
   Fehm, TN
   Moebus, V
   Von Minckwitz, G
   Loibl, S
   Witzel, I
AF Mueller, Volkmar
   Laakmann, Elena
   Fehm, Tanja N.
   Moebus, Volker
   Von Minckwitz, Gunter
   Loibl, Sibylle
   Witzel, Isabell
TI Brain Metastases in Breast Cancer Network Germany (BMBC; GBG 79):
   Multicentric, retro- and prospective collection of patient data and
   biomaterial from patients with brain metastases.
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) /
   Clinical Science Symposium on Predicting and Improving Adverse Outcomes
   in Older Adults with Cancer
CY MAY 29-JUN 02, 2015
CL Chicago, IL
SP Amer Soc Clin Oncol
C1 Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   Univ Duesseldorf, Dusseldorf, Germany.
   Klinikum Frankfurt Hoechst, Frankfurt, Germany.
   German Breast Grp, Neu Isenburg, Germany.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD MAY 20
PY 2015
VL 33
IS 15
SU S
MA TPS639
PG 1
WC Oncology
SC Oncology
GA CM9OA
UT WOS:000358036904831
DA 2018-10-20
ER

PT J
AU Lu, J
   Zou, X
   Zhao, Z
   Mu, ZD
   Zhao, YJ
   Gu, ZZ
AF Lu, Jie
   Zou, Xin
   Zhao, Ze
   Mu, Zhongde
   Zhao, Yuanjin
   Gu, Zhongze
TI Cell Orientation Gradients on an Inverse Opal Substrate
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE cell gradient; inverse opal; colloidal crystal; cell orientation;
   biomaterial
ID NANOFIBER SCAFFOLDS; BARCODE PARTICLES; BIOMATERIALS; ALIGNMENT; REPAIR
AB The generation of cell gradients is critical for understanding many biological systems and realizing the unique functionality of many implanted biomaterials. However, most previous work can only control the gradient of cell density and this has no effect on the gradient of cell orientation, which has an important role in regulating the functions of many connecting tissues. Here, we report on a simple stretched inverse opal substrate for establishing desired cell orientation gradients. It was demonstrated that tendon fibroblasts on the stretched inverse opal gradient showed a corresponding alignment along with the elongation gradient of the substrate. This "random-to-aligned" cell gradient reproduces the insertion part of many connecting tissues, and thus, will have important applications in tissue engineering.
C1 [Lu, Jie; Zou, Xin; Zhao, Ze; Mu, Zhongde; Zhao, Yuanjin; Gu, Zhongze] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Zhao, Yuanjin; Gu, Zhongze] Southeast Univ, Lab Environm & Biosafety, Res Inst, Suzhou 215123, Peoples R China.
RP Zhao, YJ (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM yjzhao@seu.edu.cn; gu@seu.edu.cn
RI Zhao, Yuanjin/I-1861-2013
FU National Science Foundation of China [21473029, 91227124, 21327902];
   National Science Foundation of Jiangsu [BK20140028, BK20131293];
   research Fund for the Doctoral Program of Higher Education of China
   [20120092130006]; Science and Technology Development Program of Suzhou
   [ZXG2012021]; Program for Changjiang Scholars and Innovative Research
   Team in University [IRT1222]; Technology Invocation Team of Qinglan
   Project of Jiangsu Province; Program for New Century Excellent Talents
   in University
FX This work was supported by the National Science Foundation of China
   (Grants 21473029, 91227124, and 21327902), the National Science
   Foundation of Jiangsu (Grants BK20140028 and BK20131293), the research
   Fund for the Doctoral Program of Higher Education of China
   (20120092130006), the Science and Technology Development Program of
   Suzhou (Grant ZXG2012021), the Program for Changjiang Scholars and
   Innovative Research Team in University (IRT1222), the Technology
   Invocation Team of Qinglan Project of Jiangsu Province, and the Program
   for New Century Excellent Talents in University.
CR Brendon M. B., 2008, BIOMATERIALS, V29, P2348
   Cheng Y, 2014, ADV MATER, V26, P5184, DOI 10.1002/adma.201400798
   Christopher J. B., 2009, ANGEW CHEM INT EDIT, V48, P5406
   Ding B, 2012, J PHYS CHEM B, V116, P2545, DOI 10.1021/jp209604m
   Feng LH, 2013, CHEM SOC REV, V42, P6620, DOI 10.1039/c3cs60036j
   Fujie T, 2013, NANO LETT, V13, P3185, DOI 10.1021/nl401237s
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Gurkan UA, 2014, MOL PHARMACEUT, V11, P2151, DOI 10.1021/mp400573g
   Katarina W., 2003, BLOOD, V102, P3262
   Li H., 2011, J MATER CHEM, V21, P14113
   Li HL, 2008, ADV FUNCT MATER, V18, P3258, DOI 10.1002/adfm.200800507
   Li Y, 2015, BIOMACROMOLECULES, V16, P780, DOI 10.1021/bm501680s
   Lipner J, 2014, J MECH BEHAV BIOMED, V40, P59, DOI 10.1016/j.jmbbm.2014.08.002
   Liu W, 2014, SMALL, V10, P88, DOI 10.1002/smll.201301253
   Liu WY, 2013, ANGEW CHEM INT EDIT, V52, P429, DOI 10.1002/anie.201206060
   Lu J, 2014, NANOSCALE, V6, P10650, DOI 10.1039/c4nr02626h
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Saha S, 2012, LANGMUIR, V28, P2028, DOI 10.1021/la203846w
   Wang DY, 2003, ADV MATER, V15, P205, DOI 10.1002/adma.200390046
   Wang YM, 2014, ACS APPL MATER INTER, V6, P2958, DOI 10.1021/am405556x
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Yang G., 2014, ANGEW CHEM, V126, P2959
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   Zhao YJ, 2015, SMALL, V11, P151, DOI 10.1002/smll.201401600
   Zheng FY, 2014, ADV MATER, V26, P7333, DOI 10.1002/adma.201403530
   Zheng WF, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4898209
   Zhou XT, 2012, ACS APPL MATER INTER, V4, P3888, DOI 10.1021/am301237j
NR 29
TC 12
Z9 12
U1 6
U2 104
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 20
PY 2015
VL 7
IS 19
BP 10091
EP 10095
DI 10.1021/acsami.5b02835
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CI8XM
UT WOS:000355055000005
PM 25942047
DA 2018-10-20
ER

PT J
AU Chou, YN
   Chang, Y
   Wen, TC
AF Chou, Ying-Nien
   Chang, Yung
   Wen, Ten-Chin
TI Applying Thermosettable Zwitterionic Copolymers as General
   Fouling-Resistant and Thermal-Tolerant Biomaterial Interfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE zwitterionic copolymer; temperature tolerance; fouling-resistant;
   thermosetting; charge neutrality; sulfobetaine methacrylate
ID FOREIGN-BODY REACTION; BLOOD COMPATIBILITY; BIOMEDICAL APPLICATIONS;
   PROTEIN ADSORPTION; WHOLE-BLOOD; HYDROGEL; POLYMERS; SURFACES;
   POLYSULFOBETAINE; MEMBRANES
AB We introduced a thermosettable zwitterionic copolymer to design a high temperature tolerance biomaterial as a general antifouling polymer interface: The original synthetic fouling-resistant copolymer, poly(vinylpyrrolidone)co-poly(sulfobetaine methacrylate) (poly(VP-co-SBMA)), is both thermal-tolerant and fouling-resistant, and the antifouling stability of copolymer coated interfaces can be effectively controlled by regulating the VP/SBMA composition ratio. We studied poly(VP-co-SBIVIA) copolymer gels and networks with a focus on their general resistance to protein, tell, and bacterial bioadhesion, as influenced by the thermosetting process. Interestingly, we found that the shape of the poly(VP-co-SBMA) copolymer material can be set at a high annealing temperature of 200 C while maintaining good antifouling properties. However, while the zwitterionic PSBMA. polymer gels were bioinert as expected, control of the fouling resistance of the PSBMA polymer networks was lost in the high temperature annealing process. A poly(VP-co-SBMA) copolymer network composed of PSBMA segments at 32 mol % showed reduced fibrinogen adsorption, tissue Cell adhesion, and bacterial attachment, but a relatively higher PSBMA content of 61 mol % was required to optimize resistance to platelet adhesion and erythrocyte attachment to confer hemocompatibility to human blood. We suggest that poly(VP-co-SBMA) copolymers capable of retaining stable, fouling resistance after high temperature shaping have a potential application as thermosettable materials in a bioinert interface for medical devices, such as the thermosettable coating on a stainless steel blood-compatible metal stent investigated in this study.
C1 [Chou, Ying-Nien; Wen, Ten-Chin] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
RP Chang, Y (reprint author), Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
EM ychang@cycu.edu.tw; tcwen@mail.ncku.edu.tw
FU project of Outstanding Professor Research Program in the Chung Yuan
   Christian University, Taiwan [CYCU-00RD-RA002-11757]; Ministry of
   Science and Technology [100-2221-E-006-165-MY2, 102-2221-E-033-009-MY3,
   103-2221-E-033-078-MY3]
FX The authors would like to acknowledge the project of Outstanding
   Professor Research Program in the Chung Yuan Christian University,
   Taiwan (CYCU-00RD-RA002-11757), and the Ministry of Science and
   Technology (100-2221-E-006-165-MY2, 102-2221-E-033-009-MY3 and
   103-2221-E-033-078-MY3) for their financial support.
CR Ananthanarayan R, 2006, TXB MICROBIOLOGY
   Bai T, 2014, ANGEW CHEM INT EDIT, V53, P12729, DOI 10.1002/anie.201405930
   Bai T, 2014, BIOMATERIALS, V35, P3926, DOI 10.1016/j.biomaterials.2014.01.077
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Cao Z., 2010, ANGEW CHEM, V122, P3859, DOI DOI 10.1002/ANGE.V122:22
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Ekblad T, 2008, BIOMACROMOLECULES, V9, P2775, DOI 10.1021/bm800547m
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hoffman AS, 1982, ADV CHEM SER, V199, P3
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kostina NY, 2012, BIOMACROMOLECULES, V13, P4164, DOI 10.1021/bm301441x
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Liu LY, 2008, J BIOMAT SCI-POLYM E, V19, P821, DOI 10.1163/156856208784522083
   Liu XL, 2012, LANGMUIR, V28, P9451, DOI 10.1021/la300728j
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Sin MC, 2014, POLYM J, V46, P436, DOI 10.1038/pj.2014.46
   Telford AM, 2010, ACS APPL MATER INTER, V2, P2399, DOI 10.1021/am100406j
   Xu FJ, 2009, PROG POLYM SCI, V34, P719, DOI 10.1016/j.progpolymsci.2009.04.005
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zhang Z, 2009, LANGMUIR, V25, P13516, DOI 10.1021/la901957k
NR 36
TC 17
Z9 18
U1 14
U2 132
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 20
PY 2015
VL 7
IS 19
BP 10096
EP 10107
DI 10.1021/acsami.5b01756
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CI8XM
UT WOS:000355055000006
PM 25912841
DA 2018-10-20
ER

PT J
AU Vitacolonna, M
   Belharazem, D
   Maier, P
   Hohenberger, P
   Roessner, ED
AF Vitacolonna, Mario
   Belharazem, Djeda
   Maier, Patrick
   Hohenberger, Peter
   Roessner, Eric Dominic
TI In vivo Quantification of the Effects of Radiation and Presence of Hair
   Follicle Pores on the Proliferation of Fibroblasts in an Acellular Human
   Dermis in a Dorsal Skinfold Chamber: Relevance for Tissue Reconstruction
   following Neoadjuvant Therapy
SO PLOS ONE
LA English
DT Article
ID LENTIVIRAL VECTOR; EXTRACELLULAR-MATRIX; CLINICAL-EXPERIENCE; LASER
   PERFORATION; STEM-CELLS; SCAFFOLD; SUBSTITUTES; IMPLANTATION;
   BIOMATERIAL; PROSTHESES
AB Introduction
   In neoadjuvant therapy, irradiation has a deleterious effect on neoangiogenesis. The aim of this study was to examine the post-implantation effects of neoadjuvant irradiation on the survival and proliferation of autologous cells seeded onto an acellular human dermis (hAD; Epiflex). Additionally, we examined the influence of dermal hair follicle pores on viability and proliferation. We used dorsal skinfold chambers implanted in rats and in-situ microscopy to quantify cell numbers over 9 days.
   Methods
   24 rats received a skinfold chamber and were divided into 2 main groups; irradiated and un-irradiated. In the irradiated groups 20Gy were applied epicutaneously at the dorsum. Epiflex pieces were cut to size 5x5mm such that each piece had either one or more visible hair follicle pores, or no such visible pores. Fibroblasts were transduced lentiviral with a fluorescent protein for cell tracking. Matrices were seeded statically with 2.5x10(4) fluorescent fibroblasts and implanted into the chambers. In each of the two main groups, half of the rats received Epiflex with hair follicle pores and half received Epiflex without pores. Scaffolds were examined in-situ at 0, 3, 6 and 9 days after transplantation. Visible cells on the surface were quantified using ImageJ.
   Results
   In all groups cell numbers were decreased on day 3. A treatment-dependent increase in cell numbers was observed at subsequent time points. Irradiation had an adverse effect on cell survival and proliferation. The number of cells detected in both irradiated and non-irradiated subjects was increased in those subjects that received transplants with hair follicle pores.
   Discussion
   This in-vivo study confirms that radiation negatively affects the survival and proliferation of fibroblasts seeded onto a human dermis transplant. The presence of hair follicle pores in the dermis transplants is shown to have a positive effect on cell survival and proliferation even in irradiated subjects.
C1 [Vitacolonna, Mario; Hohenberger, Peter; Roessner, Eric Dominic] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, D-69115 Heidelberg, Germany.
   [Belharazem, Djeda] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, D-69115 Heidelberg, Germany.
   [Maier, Patrick] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiat Oncol, D-69115 Heidelberg, Germany.
RP Roessner, ED (reprint author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Bergheimer Str 58, D-69115 Heidelberg, Germany.
EM eric.roessner@medma.uni-heidelberg.de
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Bergmeister H, 2005, J BIOMED MATER RES B, V74B, P495, DOI 10.1002/jbm.b.30228
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Brown JM, 2013, SEMIN RADIAT ONCOL, V23, P281, DOI 10.1016/j.semradonc.2013.05.002
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   Dai WD, 2009, BIOSCI TRENDS, V3, P216
   Dellgren G, 1999, SCAND CARDIOVASC J, V33, P259
   Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984
   Grabenwoger M, 1998, ANN THORAC SURG, V66, pS110, DOI 10.1016/S0003-4975(98)00982-5
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Hasegawa T, 2010, J DENT RES, V89, P854, DOI 10.1177/0022034510370022
   Jhaveri HM, 2010, J PERIODONTOL, V81, P616, DOI 10.1902/jop.2009.090530
   Kasyanov VA, 2009, J MATER SCI-MATER M, V20, P329, DOI 10.1007/s10856-008-3590-3
   Kesler CT, 2014, ANGIOGENESIS, V17, P419, DOI 10.1007/s10456-013-9400-7
   Kolker AR, 2005, ANN PLAS SURG, V55, P36, DOI 10.1097/01.sap.0000168248.83197.d4
   Lamme EN, 1998, J INVEST DERMATOL, V111, P989, DOI 10.1046/j.1523-1747.1998.00459.x
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee MS, 2004, ORTHOPEDICS, V27, pS151
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   Maier P, 2012, CANCER GENE THER, V19, P802, DOI 10.1038/cgt.2012.67
   Maier P, 2010, RADIAT RES, V173, P612, DOI 10.1667/RR1952.1
   Mandoli C, 2010, MACROMOL BIOSCI, V10, P127, DOI 10.1002/mabi.200900323
   Mao XW, 2006, TECHNOL CANCER RES T, V5, P127, DOI 10.1177/153303460600500206
   Morimoto N, 2005, J SURG RES, V125, P56, DOI 10.1016/j.jss.2004.11.012
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805
   Novaes AB, 2007, J PERIODONTOL, V78, P296, DOI 10.1902/jop.2007.060060
   Orbay H, 2011, AESTHET PLAST SURG, V35, P756, DOI 10.1007/s00266-011-9683-2
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K
   Rodrigues Annelissa Zorzeto, 2010, Braz. Dent. J., V21, P179, DOI 10.1590/S0103-64402010000300001
   Rossner E, 2011, CELL TISSUE BANK, V12, P209, DOI 10.1007/s10561-010-9187-3
   Roessner E, 2013, ANN SURG ONCOL, V20, pS709, DOI 10.1245/s10434-013-3209-x
   Roessner ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045991
   Roessner ED, 2011, J BIOMATER APPL, V25, P413, DOI 10.1177/0885328209347961
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   Vitacolonna M, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-7
   Vitacolonna M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-55
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
   Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871
NR 46
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2015
VL 10
IS 5
AR UNSP e0125689
DI 10.1371/journal.pone.0125689
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL2IX
UT WOS:000356768100067
PM 25955842
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yang, ZY
   Chen, W
   Xia, ZD
   Liu, YJ
   Peggrem, S
   Geng, T
   Yang, ZX
   Li, H
   Xu, B
   Zhang, C
   Triffitt, JT
   Zhang, YZ
AF Yang, Zongyou
   Chen, Wei
   Xia, Zhidao
   Liu, Yueju
   Peggrem, Shaun
   Geng, Tao
   Yang, Zhaoxu
   Li, Han
   Xu, Bin
   Zhang, Chi
   Triffitt, James T.
   Zhang, Yingze
TI Local Application of Ibandronate/Gelatin Sponge Improves Osteotomy
   Healing in Rabbits
SO PLOS ONE
LA English
DT Article
ID TIBIAL SHAFT FRACTURES; ZOLEDRONIC ACID; CATABOLIC RESPONSES; SKELETAL
   COMPLICATIONS; MULTIPLE-MYELOMA; BONE-RESORPTION; IN-VITRO;
   BISPHOSPHONATE; ALENDRONATE; PAMIDRONATE
AB Delayed healing or non-union of skeletal fractures are common clinical complications. Ibandronate is a highly potent anti-catabolic reagent used for treatment of osteopenia and fracture prevention. We hypothesized that local application of ibandronate after fracture fixation may improve and sustain callus formation and therefore prevent delayed healing or nonunion. This study tested the effect of local application of an ibandronate/gelatin sponge composite on osteotomy healing. A right-side distal-femoral osteotomy was created surgically, with fixation using a k-wire, in forty adult male rabbits. The animals were divided into four groups of ten animals and treated by: (i) intravenous injection of normal saline (Control); (ii) local implantation of absorbable gelatin sponge (GS); (iii) local implantation of absorbable GS containing ibandronate (IB+ GS), and (iv) intravenous injection of ibandronate (IB i. v.). At two and four weeks the affected femora were harvested for X-ray photography, computed tomography (CT), biomechanical testing and histopathology. At both time-points the results showed that the calluses in both the ibandronate-treated groups, but especially in the IB+ GS group, were significantly larger than in the control and GS groups. At four weeks the cross sectional area (CSA) and mechanical test results of ultimate load and energy in the IB+ GS group were significantly higher than in other groups. Histological procedures showed a significant reduction in osteoclast numbers in the IB+ GS and IB i. v. groups at day 14. The results indicate that local application of an ibandronate/gelatin sponge biomaterial improved early osteotomy healing after surgical fixation and suggest that such treatment may be a valuable local therapy to enhance fracture repair and potentially prevent delayed or non-union.
C1 [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.
   [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang 050051, Peoples R China.
   [Yang, Zongyou; Chen, Wei; Liu, Yueju; Geng, Tao; Li, Han; Xu, Bin; Zhang, Chi; Zhang, Yingze] Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China.
   [Xia, Zhidao; Peggrem, Shaun] Swansea Univ, Ctr Nanohlth, Coll Med, Swansea SA2 8PP, W Glam, Wales.
   [Yang, Zhaoxu] Hebei Gen Hosp, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.
   [Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.
RP Zhang, YZ (reprint author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang 050051, Peoples R China.
EM yzling_liu@163.com
OI Xia, Zhidao/0000-0002-2047-7282
CR Amanat N, 2005, J ORTHOP RES, V23, P1029, DOI 10.1016/j.orthres.2005.03.004
   Amanat N, 2007, J BONE MINER RES, V22, P867, DOI 10.1359/JBMR.070318
   Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74
   AZUMA Y, 1995, BONE, V16, P235, DOI 10.1016/8756-3282(94)00035-X
   Bergner R, 2007, J CLIN PHARMACOL, V47, P942, DOI 10.1177/0091270007301801
   Bobba RS, 2006, DRUG SAFETY, V29, P1133, DOI 10.2165/00002018-200629120-00005
   Chennuru S, 2008, INTERN MED J, V38, P635, DOI 10.1111/j.1445-5994.2007.01580.x
   Copuroglu C, 2013, INJURY, V44, P1379, DOI 10.1016/j.injury.2013.08.003
   Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132
   Diel IJ, 2009, SUPPORT CARE CANCER, V17, P719, DOI 10.1007/s00520-008-0553-7
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, piii
   Goodship A E, 1994, Ann Oncol, V5 Suppl 7, pS53
   Grazio S, 2008, CLIN RHEUMATOL, V27, P651, DOI 10.1007/s10067-007-0827-3
   Guyver P, 2012, INJURY, V43, P1187, DOI 10.1016/j.injury.2012.03.035
   Hardeman F, 2012, INJURY, V43, P153, DOI 10.1016/j.injury.2011.04.003
   Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252
   Lipton A, 2002, CANCER INVEST, V20, P45, DOI 10.1081/CNV-120014886
   Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301
   Little DG, 2005, J BONE MINER RES, V20, P2044, DOI 10.1359/JBMR.050712
   Maalouf Naim M, 2006, Endocr Pract, V12, P48
   Manabe T, 2012, CALCIFIED TISSUE INT, V90, P193, DOI 10.1007/s00223-011-9563-4
   Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1
   Mills LA, 2013, BMJ OPEN, P3
   Miura N, 2009, CLIN EXP NEPHROL, V13, P85, DOI 10.1007/s10157-008-0078-x
   Olson Karin, 2007, J Oncol Pharm Pract, V13, P223, DOI 10.1177/1078155207080806
   Peter CP, 1996, J ORTHOP RES, V14, P74, DOI 10.1002/jor.1100140113
   Ralston SH, 2004, CALCIFIED TISSUE INT, V74, P1, DOI 10.1007/s00223-001-1135-6
   Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281
   Rosen LS, 2003, CANCER, V98, P1735, DOI 10.1002/cncr.11701
   Rozental TD, 2009, J HAND SURG-AM, V34A, P595, DOI 10.1016/j.jhsa.2008.12.011
   Ruggiero SL, 2006, ORAL SURG ORAL MED O, V102, P433, DOI 10.1016/j.tripleo.2006.06.004
   Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004
   Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022
   SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Stakkestad JA, 2008, CLIN RHEUMATOL, V27, P955, DOI 10.1007/s10067-007-0824-6
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   VANBEEK E, 1994, J BONE MINER RES, V9, P1875, DOI 10.1002/jbmr.5650091206
   Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P110, DOI 10.1007/s00223-009-9323-x
   Yu NYC, 2013, EUR CELLS MATER, V25, P190, DOI 10.22203/eCM.v025a14
   Yu Nicole Y C, 2012, Front Biosci (Elite Ed), V4, P2647
NR 44
TC 3
Z9 3
U1 5
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2015
VL 10
IS 5
AR UNSP e0125807
DI 10.1371/journal.pone.0125807
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH7KF
UT WOS:000354214400050
PM 25951178
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Peters, GM
   Skala, LP
   Plank, TN
   Oh, H
   Reddy, GNM
   Marsh, A
   Brown, SP
   Raghavan, SR
   Davis, JT
AF Peters, Gretchen Marie
   Skala, Luke P.
   Plank, Taylor N.
   Oh, Hyuntaek
   Reddy, G. N. Manjunatha
   Marsh, Andrew
   Brown, Steven P.
   Raghavan, Srinivasa R.
   Davis, Jeffery T.
TI G4-Quartet center dot M+ Borate Hydrogels
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID HIGH-RESOLUTION H-1; SOLID-STATE NMR; SUPRAMOLECULAR HYDROGELS; GEL
   FORMATION; GELATION; RECOGNITION; POLYMERS; MOLECULES; GELATORS; ACID
AB The ability to modulate the physical properties of a supramolecular hydrogel may be beneficial for biomaterial and biomedical applications. We find that guanosine (G 1), when combined with 0.5 equiv of potassium borate, forms a strong, self-supporting hydrogel with elastic moduli >10 kPa. The countercation in the borate salt (MB(OH)(4)) significantly alters the physical properties of the hydrogel. The gelator combination of G 1 and KB(OH)(4) formed the strongest hydrogel, while the weakest system was obtained with LiB(OH)(4), as judged by H-1 NMR and rheology. Data from powder XRD, H-1 double-quantum solid-state magic-angle spinning (MAS) NMR and small-angle neutron scattering (SANS) were consistent with a structural model that involves formation of borate dimers and G4 center dot K+ quartets by G 1 and KB(OH)(4). Stacking of these G4 center dot M+ quartets into G4-nanowires gives a hydrogel. We found that the M+ cation helps stabilize the anionic guanosine-borate (GB) diesters, as well as the G4-quartets. Supplementing the standard gelator mixture of G 1 and 0.5 equiv of KB(OH)(4) with additional KCl or KNO3 increased the strength of the hydrogel. We found that thioflavin T fluoresces in the presence of G4 center dot M+ precursor structures. This fluorescence response for thioflavin T was the greatest for the K+ GB system, presumably due to the enhanced interaction of the dye with the more stable G4 center dot K+ quartets. The fluorescence of thioflavin T increased as a function of gelator concentration with an increase that correlated with the system's gel point, as measured by solution viscosity
C1 [Peters, Gretchen Marie; Skala, Luke P.; Plank, Taylor N.; Davis, Jeffery T.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
   [Oh, Hyuntaek; Raghavan, Srinivasa R.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Reddy, G. N. Manjunatha; Brown, Steven P.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.
   [Marsh, Andrew] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
RP Davis, JT (reprint author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
EM jdavis@umd.edu
RI Brown, Steven/F-8765-2014
OI Brown, Steven/0000-0003-2069-8496; Raghavan,
   Srinivasa/0000-0003-0710-9845; G N, Manjunatha
   Reddy/0000-0002-8283-2462; Peters, Gretchen Marie/0000-0002-3634-3182
FU US DOE [DE-FG01-98ER14888]; EPSRC [EP/K003674/1]; US Dept. of Education;
   Engineering and Physical Sciences Research Council [EP/K003674/1,
   EP/L027100/1]
FX This work was supported by the US DOE [DE-FG01-98ER14888] and EPSRC
   (EP/K003674/1). G.P. thanks the US Dept. of Education for a GAANN
   fellowship. We thank Wonseok Hwang and Prof. Lawrence Sita for their
   help with the rheology, and we thank TA Instruments (New Castle, DE) for
   providing the rheometer.
CR Adhikari B, 2014, J MATER CHEM B, V2, P4802, DOI 10.1039/c4tb00702f
   Araki K, 2005, TOP CURR CHEM, V256, P133, DOI 10.1007/b107173
   Arnal-Herault C, 2007, ANGEW CHEM INT EDIT, V46, P8409, DOI 10.1002/anie.200702605
   Arnal-Herault C, 2007, ANGEW CHEM INT EDIT, V46, P4268, DOI 10.1002/anie.200700787
   Babu SS, 2014, CHEM REV, V114, P1973, DOI 10.1021/cr400195e
   Bang I, 1910, BIOCHEM Z, V26, P293
   Benner K, 2000, CARBOHYD RES, V327, P287, DOI 10.1016/S0008-6215(00)00054-9
   Bhasikuttan A. C., 2015, J CHEM SOC CHEM COMM, DOI [10.1039/C4CC10030A, DOI 10.1039/C4CC10030A]
   Brown SP, 2007, PROG NUCL MAG RES SP, V50, P199, DOI 10.1016/j.pnmrs.2006.10.002
   Brown SP, 2012, SOLID STATE NUCL MAG, V41, P1, DOI 10.1016/j.ssnmr.2011.11.006
   Buchs B, 2011, ORG BIOMOL CHEM, V9, P2906, DOI 10.1039/c0ob01139h
   Buerkle L. E., 2012, CHEM SOC REV, V41, P6089, DOI DOI 10.1039/C2CS35106D
   Buerkle LE, 2009, LANGMUIR, V25, P8833, DOI 10.1021/la900746w
   Buerlde L. E., 2012, J CHEM SCI, V3, P564, DOI DOI 10.1039/C1SC00729G
   Cafferty BJ, 2013, J AM CHEM SOC, V135, P2447, DOI 10.1021/ja312155v
   Caran KL, 2013, SOFT FIBRILLAR MATERIALS: FABRICATION AND APPLICATIONS, P3
   Case WS, 2007, ELECTROPHORESIS, V28, P3008, DOI 10.1002/elps.200700287
   CHANTOT JF, 1969, FEBS LETT, V4, P173, DOI 10.1016/0014-5793(69)80227-9
   Ciesielski A, 2010, ANGEW CHEM INT EDIT, V49, P1963, DOI 10.1002/anie.200905827
   Cornwell DJ, 2015, MATER HORIZ, V2, P279, DOI 10.1039/c4mh00245h
   Das RN, 2012, CHEM-EUR J, V18, P6008, DOI 10.1002/chem.201103814
   Dash J, 2011, SOFT MATTER, V7, P8120, DOI 10.1039/c1sm05839h
   Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589
   de la Faverie AR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku111
   Dowling VA, 2004, ANAL CHEM, V76, P4558, DOI 10.1021/ac0400010
   Du XW, 2014, CHEM-ASIAN J, V9, P1446, DOI 10.1002/asia.201301693
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Gabel SA, 2008, J BIOL INORG CHEM, V13, P207, DOI 10.1007/s00775-007-0311-1
   Garcia-Arriaga M, 2008, J AM CHEM SOC, V130, P10492, DOI 10.1021/ja8039019
   GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013
   Ghoussoub A, 2005, CHEM COMMUN, P5763, DOI 10.1039/b512527h
   Guo MY, 2014, J AM CHEM SOC, V136, P6969, DOI 10.1021/ja500205v
   Guo WW, 2014, ANGEW CHEM INT EDIT, V53, P10134, DOI 10.1002/anie.201405692
   Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022
   Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/NCHEM.1937, 10.1038/nchem.1937]
   Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z
   Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f
   Kuang Y, 2014, ANGEW CHEM INT EDIT, V53, P8104, DOI 10.1002/anie.201402216
   Kwan ICM, 2011, CHEM COMMUN, V47, P3882, DOI 10.1039/c0cc05654e
   Lau HK, 2015, BIOMACROMOLECULES, V16, P28, DOI 10.1021/bm501361c
   Li Z, 2010, LANGMUIR, V26, P10093, DOI 10.1021/la100211y
   Liu GF, 2014, ANGEW CHEM INT EDIT, V53, P7789, DOI 10.1002/anie.201403249
   Meng LY, 2013, ORG BIOMOL CHEM, V11, P1525, DOI 10.1039/c3ob27204d
   Mihai S, 2010, J MATER CHEM, V20, P9443, DOI 10.1039/c0jm01248c
   Mihai S, 2009, NEW J CHEM, V33, P2335, DOI 10.1039/b908641m
   Mohanty J, 2013, J AM CHEM SOC, V135, P367, DOI 10.1021/ja309588h
   Okano T, 1970, Yakugaku Zasshi, V90, P1542
   Peters GM, 2014, J AM CHEM SOC, V136, P12596, DOI 10.1021/ja507506c
   Peters GM, 2014, SUPRAMOL CHEM, V26, P286, DOI 10.1080/10610278.2013.872782
   Raeburn J, 2015, CHEM COMMUN, V51, P5170, DOI 10.1039/c4cc08626k
   Raghavan SR, 2012, SOFT MATTER, V8, P8539, DOI 10.1039/c2sm25107h
   Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464
   Sangeetha NM, 2005, CHEM SOC REV, V34, P821, DOI 10.1039/b417081b
   SCHOTT H, 1972, ANGEW CHEM INT EDIT, V11, P824, DOI 10.1002/anie.197208241
   Sessler JL, 2007, CHEM SOC REV, V36, P314, DOI 10.1039/b604119c
   Shapiro YE, 2011, PROG POLYM SCI, V36, P1184, DOI 10.1016/j.progpolymsci.2011.04.002
   Simeone L, 2011, CHEM-EUR J, V17, P13854, DOI 10.1002/chem.201101827
   Skilling KJ, 2014, SOFT MATTER, V10, P237, DOI 10.1039/c3sm52244j
   Sreenivasachary N, 2005, P NATL ACAD SCI USA, V102, P5938, DOI 10.1073/pnas.0501663102
   Sreenivasachary N, 2008, CHEM-ASIAN J, V3, P134, DOI 10.1002/asia.200700041
   Steed JW, 2011, CHEM COMMUN, V47, P1379, DOI 10.1039/c0cc03293j
   Wada T, 2004, BIOPOLYMERS, V76, P15, DOI 10.1002/bip.10563
   Wada T, 2000, J AM CHEM SOC, V122, P6900, DOI 10.1021/ja9935456
   Way AE, 2014, MACROMOLECULES, V47, P1810, DOI 10.1021/ma402618z
   Webber AL, 2011, J AM CHEM SOC, V133, P19777, DOI 10.1021/ja206516u
   Weiss R. G., 2006, MOL GELS MAT SELF AS
   Weiss RG, 2014, J AM CHEM SOC, V136, P7519, DOI 10.1021/ja503363v
   Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914
   Yoshii T, 2015, J AM CHEM SOC, V137, P3360, DOI 10.1021/ja5131534
   Yoshii T, 2014, ANGEW CHEM INT EDIT, V53, P7264, DOI 10.1002/anie.201404158
   Yoshikawa I, 2007, TETRAHEDRON, V63, P7474, DOI 10.1016/j.tet.2007.02.010
   Yu GC, 2013, CHEM SOC REV, V42, P6697, DOI 10.1039/c3cs60080g
   Yu Y, 2008, J PHYS CHEM B, V112, P1130, DOI 10.1021/jp709613p
   Zhang XR, 2013, ELECTROPHORESIS, V34, P1778, DOI 10.1002/elps.201200683
   Zhao D, 2014, NUCLEIC ACIDS RES, V42, P11612, DOI 10.1093/nar/gku833
NR 75
TC 43
Z9 43
U1 11
U2 167
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 6
PY 2015
VL 137
IS 17
BP 5819
EP 5827
DI 10.1021/jacs.5b02753
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CH9EJ
UT WOS:000354338500026
PM 25871426
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Pasquini, L
   Molinari, A
   Fantazzini, P
   Dauphen, Y
   Cuif, JP
   Levy, O
   Dubinsky, Z
   Caroselli, E
   Prada, F
   Goffredo, S
   Di Giosia, M
   Reggi, M
   Falini, G
AF Pasquini, Luca
   Molinari, Alan
   Fantazzini, Paola
   Dauphen, Yannicke
   Cuif, Jean-Pierre
   Levy, Oren
   Dubinsky, Zvy
   Caroselli, Erik
   Prada, Fiorella
   Goffredo, Stefano
   Di Giosia, Matteo
   Reggi, Michela
   Falini, Giuseppe
TI Isotropic microscale mechanical properties of coral skeletons
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE corals; mechanical properties; microstructure; biomaterial
ID SINGLE-CRYSTAL ARAGONITE; BONE; BIOMINERALIZATION; INDENTATION;
   ANISOTROPY; FRACTURE; NACRE
AB Scleractinian corals are a major source of biogenic calcium carbonate, yet the relationship between their skeletal microstructure and mechanical properties has been scarcely studied. In this work, the skeletons of two coral species: solitary Balanophyllia europaea and colonial Stylophora pistillata, were investigated by nanoindentation. The hardness HIT and Young's modulus E-IT were determined from the analysis of several load-depth data on two perpendicular sections of the skeletons: longitudinal (parallel to the main growth axis) and transverse. Within the experimental and statistical uncertainty, the average values of the mechanical parameters are independent on the section's orientation. The hydration state of the skeletons did not affect the mechanical properties. The measured values, E-IT in the 76-77 GPa range, and H-IT in the 4.9-5.1 GPa range, are close to the ones expected for polycrystal-line pure aragonite. Notably, a small difference in HIT is observed between the species. Different from corals, single-crystal aragonite and the nacreous layer of the seashell Atrina rigida exhibit clearly orientation-dependent mechanical properties. The homogeneous and isotropic mechanical behaviour of the coral skeletons at the microscale is correlated with the microstructure, observed by electron microscopy and atomic force microscopy, and with the X-ray diffraction patterns of the longitudinal and transverse sections.
C1 [Pasquini, Luca; Molinari, Alan; Fantazzini, Paola] Alma Mater Studiorum Univ Bologna, Dept Phys & Astron, I-40127 Bologna, Italy.
   [Dauphen, Yannicke; Cuif, Jean-Pierre] Univ Paris 11, UMR IDES, F-91405 Orsay, France.
   [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.
   [Caroselli, Erik; Prada, Fiorella; Goffredo, Stefano] Alma Mater Studiorum Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy.
   [Di Giosia, Matteo; Reggi, Michela; Falini, Giuseppe] Alma Mater Studiorum Univ Bologna, Dept Chem Giacomo Ciamician, I-40126 Bologna, Italy.
RP Pasquini, L (reprint author), Alma Mater Studiorum Univ Bologna, Dept Phys & Astron, Viale Berti Pichat 6-2, I-40127 Bologna, Italy.
EM luca.pasquini@unibo.it; giuseppe.falini@unibo.it
RI Pasquini, Luca/U-1826-2017
OI Pasquini, Luca/0000-0001-8939-2204; Di Giosia,
   Matteo/0000-0003-3494-298X; CAROSELLI, ERIK/0000-0001-6434-5663; Prada,
   Fiorella/0000-0003-2499-8074; FANTAZZINI, PAOLA/0000-0002-4203-540X
FU European Research Council under the European Union [249930]
FX The research leading to these results has received funding from the
   European Research Council under the European Union's Seventh Framework
   Programme (FP7/2007-2013)/ERC grant agreement no. (249930-CoralWarm:
   Corals and global warming: the Mediterranean versus the Red Sea).
CR Bull SJ, 2005, J PHYS D APPL PHYS, V38, pR393, DOI 10.1088/0022-3727/38/24/R01
   CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419
   Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151
   Constantz BR., 1986, PALAIOS, V1, P52, DOI [10.2307/3514508, DOI 10.2307/3514508]
   Cuif JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000783
   Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x
   Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4
   Falini G, 2013, J STRUCT BIOL, V183, P226, DOI 10.1016/j.jsb.2013.05.001
   Fantazzini P, 2013, ENVIRON SCI TECHNOL, V47, P12679, DOI 10.1021/es402521b
   Fleischli FD, 2008, ACTA BIOMATER, V4, P1694, DOI 10.1016/j.actbio.2008.05.029
   Fratzl P, 2008, NAT MATER, V7, P610, DOI 10.1038/nmat2240
   Goldstein SA, 1987, BIOMECHANICS, V20, P1055, DOI DOI 10.1016/0021-9290(87)90023-6
   Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HAN YH, 1991, J AM CERAM SOC, V74, P3129, DOI 10.1111/j.1151-2916.1991.tb04311.x
   Hobatho MC, 1997, ST HEAL T, V40, P157
   Kaandorp JA, 2001, J THEOR BIOL, V209, P257, DOI 10.1006/jtbi.2001.2261
   Kearney C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255505
   Kunitake ME, 2013, ACTA BIOMATER, V9, P5353, DOI 10.1016/j.actbio.2012.09.030
   Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k
   Liu LG, 2005, PHYS CHEM MINER, V32, P97, DOI 10.1007/s00269-005-0454-y
   Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y
   Meroz E, 2002, P ROY SOC B-BIOL SCI, V269, P717, DOI 10.1098/rspb.2001.1924
   Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9
   Nowick A. S., 1995, CRYSTAL PROPERTIES V
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Presser V, 2010, J MATER SCI, V45, P2408, DOI 10.1007/s10853-010-4208-y
   Seto J, 2008, ADV FUNCT MATER, V18, P1905, DOI 10.1002/adfm.200800214
   Spalding M., 2001, WORLD ATLAS CORAL RE
   Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4
   Stempfle P, 2010, MAT SCI ENG C-MATER, V30, P715, DOI 10.1016/j.msec.2010.03.003
   Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026
   Ungureanu CG, 2010, EUR J MINERAL, V22, P693, DOI 10.1127/0935-1221/2010/0022-2054
   Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WILFERT M, 1969, Zeitschrift fuer Morphologie der Tiere, V64, P77, DOI 10.1007/BF00300386
   Wu YC, 2009, J MATER SCI-MATER M, V20, P1273, DOI 10.1007/s10856-009-3695-3
NR 37
TC 2
Z9 2
U1 2
U2 33
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD MAY 6
PY 2015
VL 12
IS 106
AR 20150168
DI 10.1098/rsif.2015.0168
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG5TX
UT WOS:000353359900034
PM 25977958
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Lee, SW
   Lee, HJ
   Hwang, HS
   Ko, K
   Han, DW
   Ko, K
AF Lee, Seung-Won
   Lee, Hye Jeong
   Hwang, Han Sung
   Ko, Kisung
   Han, Dong Wook
   Ko, Kinarm
TI Optimization of Matrigel-based culture for expansion of neural stem
   cells
SO ANIMAL CELLS AND SYSTEMS
LA English
DT Article
DE Matrigel; neural stem cells; expansion; neural differentiation
ID PRECURSOR CELLS; IN-VITRO; DIFFERENTIATION; NEUROSPHERES; GROWTH;
   TISSUE; PROLIFERATION; SPECIFICATION; CNS
AB Neural stem cells (NSCs) are capable of self-renewal and can differentiate into neurons and two types of glial cells. NSCs have great potential for basic studies of neurogenesis and neurodegenerative diseases, and for therapeutic transplantation applications. NSCs can be derived from the fetal or adult brain. In vitro expansion of NSCs may help to elucidate their properties involved in neurogenesis and is crucial to obtain on-demand the large numbers of these cells needed for clinical transplantation trials. Laminin is an extracellular matrix molecule commonly used to culture NSCs as an attached monolayer. However, laminin is costly if NSCs need to be cultured in large quantities. Matrigel is a soluble basement membrane biomaterial, which has been widely used for feeder-free cultures of human embryonic stem cells. In the present study, we evaluated the ability of Matrigel to support the attachment and long-term proliferation of NSCs. We investigated the growth and adherence of NSCs derived from the fetal mouse brain on Matrigel at various concentrations (0.01-1%). We found that 0.02% Matrigel is sufficient for NSCs to be expanded in vitro in long-term culture. The NSCs cultured on Matrigel-coated plates showed typical cellular and molecular characteristics and had multipotency to be differentiated into neurons and glial cells. The Matrigel-based monolayer culture system established in this study provides a cost-effective approach to maintain NSCs in vitro in long-term cultures.
C1 [Lee, Seung-Won; Lee, Hye Jeong; Han, Dong Wook; Ko, Kinarm] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea.
   [Lee, Seung-Won; Lee, Hye Jeong; Ko, Kinarm] Konkuk Univ, Inst Adv Biomed Sci, Ctr Stem Cell Res, Seoul 143701, South Korea.
   [Hwang, Han Sung] Konkuk Univ, Sch Med, Dept Obstet & Gynecol, Seoul 143729, South Korea.
   [Ko, Kisung] Chung Ang Univ, Med Res Inst, Dept Med, Coll Med, Seoul 156756, South Korea.
   [Ko, Kinarm] Konkuk Univ, Open Innovat Ctr, Seoul 143701, South Korea.
RP Ko, K (reprint author), Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea.
EM knko@kku.ac.kr
OI Hwang, Han Sung/0000-0003-0622-0701
FU National Research Foundation of Korea (NRF) - Korean Government (MEST)
   [2014R1A2A01007212]; Korean Health Technology RAMP;D Project, Ministry
   of Health and Welfare, Korea [HI12C0337]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korean Government (MEST) (grant number
   2014R1A2A01007212); the Korean Health Technology R&D Project, Ministry
   of Health and Welfare, Korea (No. HI12C0337).
CR ALBINI A, 1992, INT J CANCER, V52, P234, DOI 10.1002/ijc.2910520214
   Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147
   Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061
   Choi NY, 2014, MOL CELLS, V37, P473, DOI 10.14348/molcells.2014.0080
   Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283
   Eriksson C, 2003, EXP NEUROL, V184, P1058, DOI 10.1016/j.expneurol.2003.08.014
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111
   Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012
   Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117
   Isaji M, 1997, BRIT J PHARMACOL, V122, P1061, DOI 10.1038/sj.bjp.0701493
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Lee HJ, 2013, ANIM CELLS SYST, V17, P429, DOI 10.1080/19768354.2013.865675
   Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Malik N, 2014, NEUROTOXICOLOGY, V45, P192, DOI 10.1016/j.neuro.2014.10.007
   Marshall Gregory P. II, 2008, V438, P135, DOI 10.1007/978-1-59745-133-8_12
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Okano Hideyuki, 2002, Keio Journal of Medicine, V51, P115
   Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427
   Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204
   Ramos-Hryb AB, 2013, INT J DEV BIOL, V57, P885, DOI 10.1387/ijdb.130206gw
   Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
NR 29
TC 5
Z9 5
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1976-8354
EI 2151-2485
J9 ANIM CELLS SYST
JI Anim. Cells Syst.
PD MAY 4
PY 2015
VL 19
IS 3
BP 175
EP 180
DI 10.1080/19768354.2015.1035750
PG 6
WC Cell Biology; Zoology
SC Cell Biology; Zoology
GA CL6NV
UT WOS:000357084700003
OA Bronze
DA 2018-10-20
ER

PT J
AU Iijima, K
   Hashizume, M
AF Iijima, Kazutoshi
   Hashizume, Mineo
TI Application of Polysaccharides as Structural Materials
SO TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY
LA English
DT Review
DE polysaccharide; structural material; biomaterial; porous scaffold; film;
   fiber
ID POLYION COMPLEX FIBER; SOLUTION INTERFACES; CRYSTALLINE CELLULOSE;
   COMPOSITE SCAFFOLDS; CHITOSAN MEMBRANES; ULTRATHIN FILMS; ALGINATE
   FIBERS; ALPHA-CHITIN; DELIVERY; SURFACE
AB The preparation of materials from polysaccharides is important from both a functional and industrial aspect. In this review, after a brief explanation on the chemical structures and properties of the representative polysaccharides used in material chemistry, we described the preparation of structural materials, such as porous scaffolds, films, and fibers, from polysaccharides for biomedical applications, with a focus on polysaccharide species and fabrication methods and also discussed our own findings.
C1 [Iijima, Kazutoshi; Hashizume, Mineo] Tokyo Univ Sci, Dept Ind Chem, Shinjuku Ku, Tokyo 1620826, Japan.
RP Iijima, K (reprint author), Tokyo Univ Sci, Dept Ind Chem, Shinjuku Ku, Tokyo 1620826, Japan.
EM mhashizu@ci.kagu.tus.ac.jp
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Amaike M, 1998, MACROMOL RAPID COMM, V19, P287, DOI 10.1002/(SICI)1521-3927(19980601)19:6<287::AID-MARC287>3.0.CO;2-X
   Ariga K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.30
   Caridade SG, 2013, BIOMACROMOLECULES, V14, P1653, DOI 10.1021/bm400314s
   Chow KS, 2000, BIOMACROMOLECULES, V1, P61, DOI 10.1021/bm005503b
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Desai K, 2008, BIOMACROMOLECULES, V9, P1000, DOI 10.1021/bm701017z
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fujie T, 2007, ADV MATER, V19, P3549, DOI 10.1002/adma.200700661
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hagisawa K, 2013, J VASC SURG-VENOUS L, V1, P289, DOI 10.1016/j.jvsv.2013.04.001
   Hashizume M, 2003, LANGMUIR, V19, P10172, DOI 10.1021/la035079a
   Hashizume M, 2011, COLLOID SURFACE B, V88, P534, DOI 10.1016/j.colsurfb.2011.07.031
   Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994
   Iijima K, 2014, KOBUNSHI RONBUNSHU, V71, P11, DOI 10.1295/koron.71.11
   Iwatake A, 2008, COMPOS SCI TECHNOL, V68, P2103, DOI 10.1016/j.compscitech.2008.03.006
   Karakecili A, 2012, POLYM COMPOSITE, V33, P1215, DOI 10.1002/pc.22253
   Karbowiak T, 2006, J COLLOID INTERF SCI, V294, P400, DOI 10.1016/j.jcis.2005.07.030
   Kittle JD, 2012, BIOMACROMOLECULES, V13, P714, DOI 10.1021/bm201631r
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   Kokubo T, 2004, J CERAM SOC JPN, V112, P363, DOI 10.2109/jcersj.112.363
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Li L, 2012, J MATER CHEM, V22, P8585, DOI 10.1039/c2jm30555k
   Li Y, 2013, J APPL POLYM SCI, V130, P1539, DOI [10.1002/APP.39339, 10.1002/app.39339]
   Liang WH, 2010, J BIOMED MATER RES A, V94A, P1050, DOI 10.1002/jbm.a.32774
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mamedov AA, 2000, LANGMUIR, V16, P5530, DOI 10.1021/1a000560b
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Mikhailov GM, 2001, RUSS J APPL CHEM+, V74, P1573, DOI 10.1023/A:1013734008473
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Morimoto N, 2013, BIOMACROMOLECULES, V14, P56, DOI 10.1021/bm301286h
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   Ohkawa K, 2001, MACROMOL MATER ENG, V286, P168, DOI 10.1002/1439-2054(20010301)286:3<168::AID-MAME168>3.3.CO;2-Z
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Park SY, 2001, MATER RES BULL, V36, P511, DOI 10.1016/S0025-5408(01)00545-1
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Qi XN, 2014, J BIOMED MATER RES A, V102, P366, DOI 10.1002/jbm.a.34710
   REES DA, 1981, PURE APPL CHEM, V53, P1, DOI 10.1351/pac198153010001
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Sasaki Y, 2012, CHEM LETT, V41, P202, DOI 10.1246/cl.2012.202
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Sawada S, 2011, COLLOID POLYM SCI, V289, P685, DOI 10.1007/s00396-010-2361-0
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Serizawa T, 2000, BIOMACROMOLECULES, V1, P306, DOI 10.1021/bm000006g
   Serizawa T, 2013, BIOMACROMOLECULES, V14, P613, DOI 10.1021/bm4000822
   Shin S, 2007, LANGMUIR, V23, P9104, DOI 10.1021/la700818q
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   Silva RM, 2004, J MATER SCI-MATER M, V15, P1105, DOI 10.1023/B:JMSM.0000046392.44911.46
   Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p
   Tamura H, 2004, CARBOHYD POLYM, V56, P205, DOI 10.1016/j.carbpol.2004.02.003
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   Tang CY, 2008, COMPOS PART A-APPL S, V39, P1638, DOI 10.1016/j.compositesa.2008.07.005
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   TOKURA S, 1979, POLYM J, V11, P781, DOI 10.1295/polymj.11.781
   URAGAMI T, 1994, J MEMBRANE SCI, V88, P243, DOI 10.1016/0376-7388(94)87010-1
   Voet D., 2012, FUNDAMENTAL BIOCH LI
   Watanabe H, 2007, B CHEM SOC JPN, V80, P433, DOI 10.1246/bcsj.80.433
   Wong T. W., 2009, RECENT PAT DRUG DELI, V3, P5
   Yamamoto H, 2003, B CHEM SOC JPN, V76, P2053, DOI 10.1246/bcsj.76.2053
   Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y
   Yusof NLBM, 2004, CARBOHYD RES, V339, P2701, DOI 10.1016/j.carres.2004.09.008
   Zhong C, 2012, J MATER CHEM, V22, P6080, DOI 10.1039/c2jm15610e
NR 69
TC 5
Z9 5
U1 6
U2 41
PU GAKUSHIN PUBL CO
PI TOKYO
PA YUSHOKAIN7F, 1-38-12 NIHONBASHIKAKIGARACHO, CHUO-KU, TOKYO, 103-0014,
   JAPAN
SN 0915-7352
J9 TRENDS GLYCOSCI GLYC
JI Trends Glycosci. Glycotechnol.
PD MAY
PY 2015
VL 27
IS 155
BP 67
EP 79
DI 10.4052/tigg.1419.1
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CU1HW
UT WOS:000363272500001
DA 2018-10-20
ER

PT J
AU Prabhu, R
   Whittington, WR
   Patnaik, SS
   Mao, YX
   Begonia, MT
   Williams, LN
   Liao, J
   Horstemeyer, MF
AF Prabhu, Rajkumar
   Whittington, Wilburn R.
   Patnaik, Sourav S.
   Mao, Yuxiong
   Begonia, Mark T.
   Williams, Lakiesha N.
   Liao, Jun
   Horstemeyer, M. F.
TI A Coupled Experiment-finite Element Modeling Methodology for Assessing
   High Strain Rate Mechanical Response of Soft Biomaterials
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 99; Split-Hopkinson Pressure Bar; High Strain
   Rate; Finite Element Modeling; Soft Biomaterials; Dynamic Experiments;
   Internal State Variable Modeling; Brain; Liver; Tendon; Fat
ID TISSUE; MUSCLE; BRAIN; BAR
AB This study offers a combined experimental and finite element (FE) simulation approach for examining the mechanical behavior of soft biomaterials (e.g. brain, liver, tendon, fat, etc.) when exposed to high strain rates. This study utilized a Split-Hopkinson Pressure Bar (SHPB) to generate strain rates of 100-1,500 sec(-1). The SHPB employed a striker bar consisting of a viscoelastic material (polycarbonate). A sample of the biomaterial was obtained shortly postmortem and prepared for SHPB testing. The specimen was interposed between the incident and transmitted bars, and the pneumatic components of the SHPB were activated to drive the striker bar toward the incident bar. The resulting impact generated a compressive stress wave (i.e. incident wave) that traveled through the incident bar. When the compressive stress wave reached the end of the incident bar, a portion continued forward through the sample and transmitted bar (i.e. transmitted wave) while another portion reversed through the incident bar as a tensile wave (i.e. reflected wave). These waves were measured using strain gages mounted on the incident and transmitted bars. The true stress-strain behavior of the sample was determined from equations based on wave propagation and dynamic force equilibrium. The experimental stress-strain response was three dimensional in nature because the specimen bulged. As such, the hydrostatic stress (first invariant) was used to generate the stress-strain response. In order to extract the uniaxial (one-dimensional) mechanical response of the tissue, an iterative coupled optimization was performed using experimental results and Finite Element Analysis (FEA), which contained an Internal State Variable (ISV) material model used for the tissue. The ISV material model used in the FE simulations of the experimental setup was iteratively calibrated (i.e. optimized) to the experimental data such that the experiment and FEA strain gage values and first invariant of stresses were in good agreement.
C1 [Prabhu, Rajkumar; Patnaik, Sourav S.; Begonia, Mark T.; Williams, Lakiesha N.; Liao, Jun] Mississippi State Univ, Dept Agr & Biol Engn, Holly Springs, MS 38635 USA.
   [Whittington, Wilburn R.; Mao, Yuxiong; Horstemeyer, M. F.] Mississippi State Univ, Ctr Adv Vehicular Syst, Holly Springs, MS USA.
RP Prabhu, R (reprint author), Mississippi State Univ, Dept Agr & Biol Engn, Holly Springs, MS 38635 USA.
EM praj@cavs.msstate.edu
RI Patnaik, Sourav/E-4595-2010
OI Patnaik, Sourav/0000-0001-7457-8604; Whittington,
   Wilburn/0000-0002-1635-9830; Horstemeyer, Mark/0000-0003-4230-0063
FU Center for Advanced Vehicular Systems (CAVS); Agricultural and
   Biological Engineering Department at Mississippi State University; U.S.
   Army TACOM Life Cycle Command through Mississippi State University
   [W56HZV-08-C-0236]; National Nuclear Security Administration,
   (Department of Energy) [DE-FC26-06NT42755]
FX The authors would like to recognize the Center for Advanced Vehicular
   Systems (CAVS) and the Agricultural and Biological Engineering
   Department at Mississippi State University for supporting this work.
   This material is based upon work supported by the U.S. Army TACOM Life
   Cycle Command under Contract No. W56HZV-08-C-0236, through a subcontract
   with Mississippi State University, and was performed for the Simulation
   Based Reliability and Safety (SimBRS) research program. Also, this
   material is based upon work supported by the National Nuclear Security
   Administration, (Department of Energy) under award number
   [DE-FC26-06NT42755]. Finally, the authors would like to thank Mr. David
   Adams, Mr. Michael McCollum and Ms. Erin Colebeck for their effort in
   this research.
CR Aubry M, 2002, Br J Sports Med, V36, P6, DOI 10.1136/bjsm.36.1.6
   Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406
   Bouvard J. L, 2010, ACTA MECH, V213, P1
   Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f
   Chen J., 2009, P ASME 2009 SUMM BIO
   Cullis I G, 2001, J R Army Med Corps, V147, P16
   DHARAN CKH, 1970, EXP MECH, V10, P370, DOI 10.1007/BF02320419
   Finkelstein E. A., 2006, INCIDENCE EC BURDEN
   Gray G. T., 2000, ASM HDB, V8, P488
   Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549
   Horstemeyer M. F., 2012, INTEGRATED COMPUTATI
   KENNER VH, 1973, J BIOMECH, V6, P1, DOI 10.1016/0021-9290(73)90032-8
   KHALIL TB, 1979, J SOUND VIB, V63, P351, DOI 10.1016/0022-460X(79)90679-5
   Ngo T, 2007, ELECT J STRUCT ENG, V7, P76
   Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023
   Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015
   Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035
   Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021
   Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001
   Usmani Z, 2010, WEB INTELLIGENCE INT
   Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015
   Zhao H, 1996, INT J SOLIDS STRUCT, V33, P3363, DOI 10.1016/0020-7683(95)00186-7
   Zhao H, 1997, INT J IMPACT ENG, V19, P319, DOI 10.1016/S0734-743X(96)00038-3
NR 23
TC 0
Z9 0
U1 0
U2 9
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2015
IS 99
AR e51545
DI 10.3791/51545
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7MV
UT WOS:000361535300002
PM 26067742
OA Green Published
DA 2018-10-20
ER

PT J
AU Alimperti, S
   Andreadis, ST
AF Alimperti, Stella
   Andreadis, Stelios T.
TI CDH2 and CDH11 act as regulators of stem cell fate decisions
SO STEM CELL RESEARCH
LA English
DT Review
ID N-CADHERIN EXPRESSION; LIMB MESENCHYMAL CHONDROGENESIS; GROWTH-FACTOR
   RECEPTOR; SMOOTH-MUSCLE-CELLS; RHO-FAMILY GTPASES; ADHERENS JUNCTIONS;
   BONE-MARROW; SCAFFOLD-FREE; P120 CATENIN; BETA-CATENIN
AB Accumulating evidence suggests that the mechanical and biochemical signals originating from cell-cell adhesion are critical for stem cell lineage specification. In this review, we focus on the role of cadherin mediated signaling in development and stem cell differentiation, with emphasis on two well-known cadherins, cadherin-2 (CDH2) (N-cadherin) and cadherin-11 (CDH11) (OB-cadherin). We summarize the existing knowledge regarding the role of CDH2 and CDH11 during development and differentiation in vivo and in vitro. We also discuss engineering strategies to control stem cell fate decisions by fine-tuning the extent of cell-cell adhesion through surface chemistry and microtopology. These studies may be greatly facilitated by novel strategies that enable monitoring of stem cell specification in real time. We expect that better understanding of how intercellular adhesion signaling affects lineage specification may impact biomaterial and scaffold design to control stem cell fate decisions in three-dimensional context with potential implications for tissue engineering and regenerative medicine. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Alimperti, Stella; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA.
   [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall, Amherst, NY 14260 USA.
EM sandread@buffalo.edu
FU National Science Foundation [CBET-1403086]
FX This work was supported in part by a grant from the National Science
   Foundation (CBET-1403086) to S.T.A.
CR Agarwal SK, 2006, CURR OPIN RHEUMATOL, V18, P268, DOI 10.1097/01.bor.0000218948.42730.39
   Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208
   Alimperti S, 2014, BIOTECHNOL PROGR, V30, P974, DOI 10.1002/btpr.1904
   Alimperti S, 2014, J CELL SCI, V127, P2627, DOI 10.1242/jcs.134833
   Anastasiadis PZ, 2000, J CELL SCI, V113, P1319
   Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637
   Augello A, 2007, ARTHRITIS RHEUM, V56, P1175, DOI 10.1002/art.22511
   Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717
   BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Borghi N, 2009, CURR TOP DEV BIOL, V89, P1, DOI 10.1016/S0070-2153(09)89001-7
   Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008
   Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955067402003733
   Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004
   Brieva TA, 2004, TISSUE ENG, V10, P553, DOI 10.1089/107632704323061915
   Brieva TA, 2004, BIOTECHNOL BIOENG, V85, P283, DOI 10.1002/bit.10855
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068
   Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108
   Charest JL, 2009, J INVEST DERMATOL, V129, P564, DOI 10.1038/jid.2008.265
   Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254
   Chopra A, 2011, AM J PHYSIOL-HEART C, V300, pH1252, DOI 10.1152/ajpheart.00515.2010
   Dander E, 2012, LEUKEMIA, V26, P1681, DOI 10.1038/leu.2011.384
   Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S
   Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld
   Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777
   Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Evans SF, 2013, BIOMATERIALS, V34, P1878, DOI 10.1016/j.biomaterials.2012.09.024
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047
   Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Gray DS, 2008, EXP CELL RES, V314, P2846, DOI 10.1016/j.yexcr.2008.06.023
   Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496
   Grosheva I, 2001, J CELL SCI, V114, P695
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855
   Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806
   Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927
   Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600
   HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386
   Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006
   Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375
   Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857
   Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013
   Jia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051549
   Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014
   Kawaguchi J, 2001, J BONE MINER RES, V16, P1265, DOI 10.1359/jbmr.2001.16.7.1265
   Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260
   Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005
   Kii I, 2004, J BONE MINER RES, V19, P1840, DOI 10.1359/JBMR.040812
   KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149
   Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9
   Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200
   Kuijpers KAJ, 2007, EUR UROL, V52, P1213, DOI 10.1016/j.eururo.2007.01.052
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Lambert M, 2000, J CELL SCI, V113, P2207
   Lecanda F, 2000, J CELL BIOCHEM, V77, P499, DOI 10.1002/(SICI)1097-4644(20000601)77:3<499::AID-JCB14>3.0.CO;2-0
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583
   Lira CBB, 2008, PROTEIN EXPRES PURIF, V61, P220, DOI 10.1016/j.pep.2008.06.007
   Luegmayr E, 2000, HISTOCHEM CELL BIOL, V113, P467
   Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241
   Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   Marthiens V, 2002, MOL CELL NEUROSCI, V20, P458, DOI 10.1006/mcne.2002.1130
   Marthiens W, 2002, BIOL CELL, V94, P315, DOI 10.1016/S0248-4900(02)00005-9
   Martin TA, 2001, CLIN CANCER RES, V7, P734
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mertsching H, 2005, BIOMATERIALS, V26, P6610, DOI 10.1016/j.biomaterials.2005.04.048
   Moharil J., 2015, LENTIVIRAL MIC UNPUB
   Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016
   Myers TJ, 2010, EXPERT OPIN BIOL TH, V10, P1663, DOI 10.1517/14712598.2010.531257
   Nakazora S, 2010, BIOCHEM BIOPH RES CO, V400, P493, DOI 10.1016/j.bbrc.2010.08.070
   Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591
   Nelson Celeste M, 2007, Methods Mol Biol, V370, P1
   Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148
   Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040
   Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200
   Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216
   Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104
   Ouyang MX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2560
   Padilla F, 1998, MOL CELL NEUROSCI, V11, P217, DOI 10.1006/mcne.1998.0681
   Padmashali RM, 2014, MOL THER, V22, P1971, DOI 10.1038/mt.2014.103
   Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035
   Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200
   Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985
   Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443
   Raut SD, 2010, J CONTROL RELEASE, V144, P213, DOI 10.1016/j.jconrel.2010.02.009
   Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2
   Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88
   Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003
   Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0
   Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178
   Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014
   Schiele NR, 2013, TISSUE ENG PT A, V19, P1223, DOI 10.1089/ten.tea.2012.0321
   Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098
   Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053
   Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299
   Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1
   Shih WT, 2012, CELL ADHES MIGR, V6, P513, DOI 10.4161/cam.21766
   Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861
   Shin CS, 2000, J CELL BIOCHEM, V78, P566, DOI 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K
   SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281
   Smutny M, 2010, J CELL BIOL, V189, P1075, DOI 10.1083/jcb.201005151
   Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   SUVA LJ, 1994, MOL ENDOCRINOL, V8, P1507, DOI 10.1210/me.8.11.1507
   Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626
   TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960
   Thompson SA, 2014, J MOL CELL CARDIOL, V68, P29, DOI 10.1016/j.yjmcc.2013.12.025
   Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46
   Tian J, 2010, LAB CHIP, V10, P1967, DOI 10.1039/c003153d
   Tomita K, 2000, CANCER RES, V60, P3650
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Tuan RS, 2003, J BONE JOINT SURG AM, V85A, P137, DOI 10.2106/00004623-200300002-00019
   Tufan AC, 2002, EXP CELL RES, V273, P197, DOI 10.1006/excr.2001.5448
   Tufan AC, 2002, DEV DYNAM, V223, P241, DOI 10.1002/dvdy.10046
   Tufan AC, 2001, FASEB J, V15, P1436, DOI 10.1096/fj.00-0784fje
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wang Lei, 2002, Hematology, V7, P113
   Wang XL, 2013, J BIOMED MATER RES A, V101, P3388, DOI 10.1002/jbm.a.34645
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377
   WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2
   Williams G, 2002, J BIOL CHEM, V277, P4361, DOI 10.1074/jbc.M109185200
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
   Xu L., 2012, MOL BIOL REP
   Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416
   Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156
   Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126
   Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001
   You H, 2013, J CELL SCI, V126, P2718, DOI 10.1242/jcs.122903
   Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183
   Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187
NR 164
TC 22
Z9 22
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD MAY
PY 2015
VL 14
IS 3
BP 270
EP 282
DI 10.1016/j.scr.2015.02.002
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CP6JR
UT WOS:000359993400003
PM 25771201
OA DOAJ Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Opondo, SO
AF Opondo, Sam Okoth
TI Biocolonial and Racial Entanglements: Immunity, Community, and
   Superfluity in the Name of Humanity
SO ALTERNATIVES
LA English
DT Article
DE superfluity; immunity; humanity; biocolonialism
AB Through a reading of Neill Blomkamp's 2009 science fiction/mock documentary District 9 and John le Carre's novel The Constant Gardener, this article illustrates how the acceptance that we are all human has an identity-constituting function that enables bodies and lives to be valued differently with far-reaching implications for both biomedical experiments and experiments with the ethics of cohabitation. More specifically, this article examines biocolonial regimes, imagined immunities, and limited sympathies that transform racialized, class-mediated, and transnational vulnerable bodies into experimental labor or biomaterial (hearts, kidneys, and corneas) to be consumed or disposed of as part of life-sustaining and life-administering apparatuses.
C1 [Opondo, Sam Okoth] Vassar Coll, Comparat Polit Africana Studies, Poughkeepsie, NY 12601 USA.
RP Opondo, SO (reprint author), Vassar Coll, Poughkeepsie, NY 12601 USA.
EM saopondo@vassar.edu
CR Allain J, 2011, MED LAW REV, V19, P117, DOI 10.1093/medlaw/fwr001
   [Anonymous], 1968, EBONY, P118
   Bauman Zygmunt, 1989, MODERNITY HOLOCAUST, p[18, 144]
   Bertani Mauro, 2003, SOC MUST BE DEFENDED, P247
   Carney Scott, 2011, RED MARKET TRAIL WOR, P2
   Cesaire A., 1972, DISCOURSE COLONIALIS
   Colebrook Claire, 2005, DELEUZE AND SPACE, P204
   Comaroff Jean, 2001, SOCIAL IDENTITIES, V7, P252
   Comaroff Jean, 2002, S ATLANTIC Q, V101, P783
   Cooper M, 2008, EAST ASIAN SCI TECHN, V2, P73, DOI 10.1007/s12280-008-9040-y
   Deleuze Gilles, 1988, SPINOZA PRACTICAL PH
   DERRIDA J, 1980, CRIT INQUIRY, V7, P55, DOI 10.1086/448088
   Deustch Albert, 1942, BALTIMORE AFROAMERIA, P9
   Epstein Steven, 2007, INCLUSION POLITICS D, P43
   Esposito Roberto, 2011, IMMUNITAS PROTECTIN
   Esposito Roberto, 2008, BIOS BIOPOLITICS PHI, P111
   Esposito Roberto, 2012, TERMS POLITICAL COMM, P49
   FANON F, 1967, BLACK SKIN WHITE MAS, P109
   Fanon Franz, 1988, AFRICAN REVOLUTION P, P10
   Feldman Ilana, 2010, NAME HUMANITY GOVT T, P4
   Gilroy Paul, 2001, CAMPS NATIONS CULTUR, P14
   Grove, 2014, BLOOD
   Grove Jairus, 2015, MAKING THINGS INT, P184
   Heller-Nicholas Alexandra, 2011, SCREEN ED, V61, P137
   Johnson KerenAmi, 1997, CONSUMP MARK CULT, V1, P255
   Le Carre John, 2001, CONSTANT GARDENER, P417
   Lederer Susan E., 2008, FLESH BLOOD ORGAN TR, P118
   Loeb Elizabeth, 2008, WOMENS STUDIES Q, V36, P45
   Mbembe A, 2003, PUBLIC CULTURE, V15, P11, DOI 10.1215/08992363-15-1-11
   Mbembe Achille, 2004, PUBLIC CULTURE, V16, P380
   Meerpol Abel, 2000, STRANGE FRUIT BILLIE, P15
   Niewijk Alexandria, 1999, HASTINGS CTR REPORT, V29
   Osamu Nishitani, 2006, TRANSLATION BIOPOLIT, P259
   Peterson Bhekizizwe, 2012, NEW VIOLENT CARTOGRA, P222
   Petryna Adriana, 2010, NAME HUMANITY GOVT T, P278
   Rabinow Paul, 2006, BIOSOCIETIES, V1, P211
   Ramose M. B, 1999, AFRICAN PHILOS UBUNT
   Rendall Steven, 2012, MANHUNT PHILOS HIST
   Rieder J, 2011, SCI FICT FILM TELEV, V4, P41, DOI 10.3828/sfftv.2011.3
   Roberts Dorothy, 2011, FATAL INVENTION SCI, P156
   Rose Nikolas, 2001, THEOR CULT SOC, V18, p[1, 21]
   Scheper-Hughes N., 2002, SAIS REV, V22, P61, DOI DOI 10.1353/SAIS.2002.0022
   ScheperHughes N., 2005, GLOBAL ASSEMBLAGES T, P145
   Sharp LA, 2006, STRANGE HARVEST: ORGAN TRANSPLANTS, DENATURED BODIES, AND THE TRANSFORMED SELF, P1
   Sharp LA, 2000, ANNU REV ANTHROPOL, V29, P287, DOI 10.1146/annurev.anthro.29.1.287
   Silverman Kaja, 1996, THRESHOLD VISIBLE WO, P24
   Stein R, 2010, UNDER SIGN NAT, P101
   Stobie Cheryl, 2012, IMAGE TEXT J DESIGN, V20, P128
   Wald Priscilla, 2000, CULTURAL STUDIES POL, P196
NR 49
TC 0
Z9 0
U1 1
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0304-3754
EI 2163-3150
J9 ALTERNATIVES
JI Alternatives
PD MAY
PY 2015
VL 40
IS 2
SI SI
BP 115
EP 132
DI 10.1177/0304375415589432
PG 18
WC International Relations
SC International Relations
GA CN0AX
UT WOS:000358075200004
DA 2018-10-20
ER

PT J
AU Rotaru, I
   Olaru, D
AF Rotaru, I.
   Olaru, D.
TI Theoretical pressure and friction in total disc prosthesis for lumbar
   spine. Influence of ball radius and biomaterial combination
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Ball-and-Socket; Biomaterial; Friction; Pressure; Disc Prosthesis
ID METAL-ON-METAL; INTERVERTEBRAL DISC; ARTHROPLASTY; REPLACEMENT; FUSION;
   DEVICE
AB Total disc prosthesis for lumbar spine is a medical device used to completely replace the damaged intervertebral lumbar disc. The main advantages of prosthesis implantation are that this conserves the intervertebral mobility and prevents the adjacent discs degeneration. The purpose of this work was to study the theoretical effect of ball radius on the maximum pressure and on the frictional torque which occurs within lumbar total disc prostheses made of different biomaterial combination. The design of total disc prosthesis investigated was ball-and-socket and the biomaterial couple was metal-on-metal, polymer-on-metal and ceramic-on-ceramic. The results of this study indicated that the maximum pressure in disc prosthesis decrease with ball radius, while the frictional torque has a linear increase with ball radius. This study suggested designing of total disc prostheses for lumbar spine with small ball radius and with ceramic-on-ceramic material combination.
C1 [Rotaru, I.; Olaru, D.] Gheorghe Asachi Tech Univ Iasi, Dept Mech Engn Mechatron & Robot, Fac Mech Engn, Iasi 700050, Romania.
   [Rotaru, I.] Gr T Popa Univ Med & Pharm Iasi, Dept Biomed Sci, Fac Med Bioengn, Iasi 700454, Romania.
RP Rotaru, I (reprint author), Gheorghe Asachi Tech Univ Iasi, Dept Mech Engn Mechatron & Robot, Fac Mech Engn, 61-63 Bd Dimitrie Mangeron, Iasi 700050, Romania.
EM rotaruiuliana2000@gmail.com
FU POSDRU CUANTUMDOC "DOCTORAL STUDIES FOR EUROPEAN PERFORMANCES IN
   RESEARCH AND INNOVATION" - European Social Fund [ID79407]; Romanian
   Government
FX This paper was realised with the support of POSDRU CUANTUMDOC "DOCTORAL
   STUDIES FOR EUROPEAN PERFORMANCES IN RESEARCH AND INNOVATION" ID79407
   project funded by the European Social Fund and Romanian Government.
CR Bishop NE, 2008, MED ENG PHYS, V30, P1057, DOI 10.1016/j.medengphy.2008.01.001
   Bushelow M, 2008, 23 ANN M N AM SPIN S
   Chen SH, 2009, MED ENG PHYS, V31, P244, DOI 10.1016/j.medengphy.2008.07.007
   Denoziere G, 2006, J BIOMECH, V39, P766, DOI 10.1016/j.jbiomech.2004.07.039
   Fekete TF, 2010, ACTA NEUROCHIR, V152, P393, DOI 10.1007/s00701-009-0529-5
   Gloria A, 2008, J APPL BIOMATER BIOM, V6, P163
   Gloria A, 2011, J BIOMATER APPL, V25, P795, DOI 10.1177/0885328209360933
   GRAVIUS S, 2007, DTSCH ARZTEBL, V104, pA2592
   Grupp TM, 2009, EUR SPINE J, V18, P98, DOI 10.1007/s00586-008-0840-5
   Houpert L., 1999, C ROUL TOUL MAY 5 7
   Kopeliovich D., MAT JOINT PROSTHESES
   Matei L., 2011, TRIBOL INT, V44, P532
   Moghadas P, 2012, J BIOMECH, V45, P504, DOI 10.1016/j.jbiomech.2011.11.045
   Nechtow W., 2008, 54 ANN M ORTH RES SO, P1928
   Pop G., 2004, BIOMATERIALE SI COMP
   Pylos T., 2004, J BIOMECH, V37, P405
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   Reitmaier S, 2012, J MECH BEHAV BIOMED, V14, P67, DOI 10.1016/j.jmbbm.2012.05.010
   Rotaru D. Olaru, 2012, B POLYTECHNIC I IASI, VLVIII, P2
   Rotaru I., 2012, B POLYTECHNIC I IASI, VLVIII, P2
   Rotaru I., 2011, SROMECA, V1, P9
   Rotaru I., 2011, P 3 IEEE INT C EHB, P211
   Rotaru I., 2013, TEHNOMUS, V112
   Sakalkale Durgadas P, 2003, Pain Physician, V6, P195
   Serhan Hassan, 2011, SAS J, V5, P75, DOI 10.1016/j.esas.2011.05.001
   Shaheen A., 2007, J ENG MED, V221, pH 621
   Streicher R M, 1996, Proc Inst Mech Eng H, V210, P223, DOI 10.1243/PIME_PROC_1996_210_416_02
   Tipper JL, 2001, WEAR, V250, P120, DOI 10.1016/S0043-1648(01)00653-6
   van den Eerenbeemt KD, 2010, EUR SPINE J, V19, P1262, DOI 10.1007/s00586-010-1445-3
   Wang WH, 2013, MED ENG PHYS, V35, P357, DOI 10.1016/j.medengphy.2012.05.013
   Zander T, 2009, CLIN BIOMECH, V24, P135, DOI 10.1016/j.clinbiomech.2008.11.008
NR 31
TC 0
Z9 0
U1 1
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAY-JUN
PY 2015
VL 17
IS 5-6
BP 727
EP 733
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA CM5ZD
UT WOS:000357766600034
DA 2018-10-20
ER

EF